data_2lkc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lkc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 1.002 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 10.5 t . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.613 0.721 . . . . 1.57 109.474 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -70.54 118.42 13.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.096 -0.957 . . . . 1.18 111.282 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.702 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.1 mt -87.18 116.06 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.371 0.605 . . . . 1.57 110.549 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.703 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 35.0 mtt -125.17 172.23 9.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.552 -0.749 . . . . 1.41 110.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.991 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 147.54 -96.64 0.18 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 109.851 -1.299 . . . . 1.55 109.851 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 71.3 t60 -175.0 164.28 3.35 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.659 -0.867 . . . . 1.21 108.659 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.09 -52.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.665 0.269 . . . . 2.2 111.439 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.13 -30.12 70.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.792 -0.64 . . . . 1.78 112.651 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.609 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 39.9 m80 -64.76 -19.43 65.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.408 . . . . 0.89 110.949 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.89 44.15 2.92 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.679 -0.772 . . . . 1.06 112.978 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 85' ' ' VAL . 22.0 ptmt -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.966 -0.753 . . . . 2.58 108.966 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.3 p -74.68 -35.68 62.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.738 -1.119 . . . . 2.32 109.62 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.8 m -63.3 -33.68 76.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.138 -0.937 . . . . 2.23 110.522 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.46 -56.19 20.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.217 -0.447 . . . . 2.33 110.408 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.591 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -62.64 -38.51 90.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.12 -0.491 . . . . 2.46 110.006 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 12.3 t70 -63.88 -49.49 72.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.98 0.363 . . . . 1.38 111.98 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . . . -68.02 -37.31 81.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.227 0.537 . . . . 1.42 110.857 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.591 HG21 ' HA ' ' A' ' 25' ' ' LEU . 6.5 tt -74.11 -20.84 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.451 -0.795 . . . . 2.08 109.812 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 33.0 tpt180 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.115 -0.948 . . . . 4.16 109.831 174.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -88.84 7.44 34.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.584 -0.735 . . . . 3.57 110.145 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.316 0.579 . . . . 2.09 110.33 -177.545 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 120.814 0.34 . . . . 2.96 110.658 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HG2' HG23 ' A' ' 58' ' ' THR . 36.8 mt-30 -122.42 122.98 40.26 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.876 -0.787 . . . . 2.45 108.876 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG21 ' HE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.948 0 CA-C-O 121.364 0.602 . . . . 2.49 111.194 -173.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 11' ' ' VAL . 56.1 mt . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.057 0.456 . . . . 1.4 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -88.58 113.21 23.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.874 -0.603 . . . . 1.85 109.442 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.442 ' HE2' HG21 ' A' ' 50' ' ' VAL . 27.6 m-85 . . . . . 0 C--N 1.328 -0.356 0 C-N-CA 120.932 -0.307 . . . . 1.14 111.417 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 1.002 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 24.5 mm . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 110.469 -0.197 . . . . 1.31 110.469 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.949 HG22 ' HB1' ' A' ' 103' ' ' ALA . 13.1 t -99.23 94.97 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 120.418 -0.513 . . . . 1.78 111.703 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.702 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 30.9 mm -80.36 115.27 22.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.206 -1.035 . . . . 1.97 108.206 170.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.807 ' HG ' HD13 ' A' ' 100' ' ' ILE . 2.9 tm? -105.72 101.13 10.66 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.879 -0.6 . . . . 1.98 110.487 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.991 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.1 p -79.96 142.49 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.478 0.656 . . . . 1.8 111.697 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 87' ' ' ALA . 25.3 t -136.1 173.04 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 107.583 -1.265 . . . . 1.79 107.583 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.554 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -148.59 112.8 5.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.231 0.469 . . . . 1.03 112.017 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 41.35 -97.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.599 1.16 . . . . 1.66 113.756 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.26 1.29 25.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 2.01 112.055 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' HG3' ' A' ' 93' ' ' MET . 14.1 t70 -71.24 -49.2 45.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.09 110.635 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 86.43 -107.6 3.21 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.159 -0.928 . . . . 0.52 111.606 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.833 HG12 ' HB ' ' A' ' 96' ' ' THR . 30.7 t -128.81 111.75 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 122.347 0.259 . . . . 1.67 110.709 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.637 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.9 mtp -82.8 172.09 10.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.695 -0.23 . . . . 1.32 110.445 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 99.4 Cg_exo -44.17 -52.03 6.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.028 2.486 . . . . 0.88 113.658 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -65.46 -28.83 69.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.591 -0.277 . . . . 2.01 111.241 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.833 ' HB ' HG12 ' A' ' 92' ' ' VAL . 8.1 m -62.97 -30.29 71.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.248 0.547 . . . . 1.19 110.624 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 134' ' ' TYR . 70.9 t -84.46 -52.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.286 -0.416 . . . . 1.66 111.676 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.35 -18.83 60.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.849 -0.614 . . . . 1.62 111.473 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.703 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -88.09 -39.9 14.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.877 -0.601 . . . . 1.09 109.543 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.807 HD13 ' HG ' ' A' ' 84' ' ' LEU . 1.7 mt -71.59 -48.96 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 1.13 111.311 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.486 HD21 ' HA ' ' A' ' 101' ' ' ASN . 1.0 OUTLIER -50.45 -38.52 44.01 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.965 0.506 . . . . 1.97 110.982 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -76.64 -33.39 58.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.744 -0.662 . . . . 1.02 110.565 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.949 ' HB1' HG22 ' A' ' 82' ' ' VAL . . . -81.13 -50.38 9.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.033 -0.53 . . . . 1.18 112.342 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 11.8 ptmm? -59.87 -21.02 60.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.704 -0.68 . . . . 2.98 112.677 -167.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.48 10.99 30.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.707 0.632 . . . . 1.3 112.707 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.516 ' HB2' ' CG1' ' A' ' 108' ' ' VAL . . . -100.65 -0.12 38.09 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.035 -0.728 . . . . 1.3 109.035 174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.2 t30 75.98 41.54 0.23 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.685 1.231 . . . . 2.59 108.71 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -124.13 142.67 40.47 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 113.289 -1.778 . . . . 1.71 110.54 -174.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.01 154.86 71.64 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.657 2.238 . . . . 0.62 113.981 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.687 HD13 HG12 ' A' ' 100' ' ' ILE . 84.7 mt -127.33 146.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.976 -1.465 . . . . 1.62 109.209 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.8 103.14 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.138 0.494 . . . . 1.31 111.242 -167.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -67.42 133.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.137 -0.938 . . . . 1.07 110.237 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -121.34 87.69 2.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.826 -1.176 . . . . 1.07 107.826 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.705 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 18.5 mm -67.43 95.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.861 -1.063 . . . . 1.56 110.51 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.03 163.46 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.968 -0.753 . . . . 0.88 108.968 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 63.72 20.09 12.05 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.159 0.504 . . . . 3.11 111.162 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.735 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 13.1 tpp . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 121.833 0.825 . . . . 1.55 109.9 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 1.1 p30 . . . . . 0 N--CA 1.435 -1.178 0 CA-C-O 120.529 0.204 . . . . 2.21 111.33 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.9 Cg_exo -37.57 -67.1 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.095 3.197 . . . . 1.01 113.853 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -48.89 -49.78 38.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.882 0.473 . . . . 2.0 112.089 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 2.4 tmt_? -54.73 -56.93 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.098 0.475 . . . . 3.7 109.997 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 91' ' ' GLY . 93.2 t -55.71 -41.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 1.12 111.016 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.687 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 89.4 mtp -66.02 -33.09 75.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 1.07 110.71 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 70.3 mt-30 -73.35 -24.55 60.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.425 . . . . 2.01 111.098 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.8 mm-40 -64.55 -37.66 88.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.715 -0.846 . . . . 2.02 108.715 172.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.574 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -70.28 -46.16 64.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.466 -0.788 . . . . 1.62 109.703 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.908 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -75.16 -1.1 21.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.82 -0.627 . . . . 1.08 110.001 177.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.1 tt0 -78.57 -28.97 46.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 2.18 107.539 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.659 ' CE2' HG11 ' A' ' 92' ' ' VAL . 61.5 m-85 -91.99 16.08 11.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.644 -0.707 . . . . 1.17 109.589 168.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.4 t30 71.01 22.16 4.65 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.048 -1.433 . . . . 2.43 110.188 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 131' ' ' LEU . 7.0 mp -91.65 72.55 5.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.315 -0.857 . . . . 2.28 109.693 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.517 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -64.87 119.95 62.37 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 114.482 -1.236 . . . . 1.28 110.822 178.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.873 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 80.9 Cg_exo -47.05 160.69 0.25 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.634 2.889 . . . . 0.34 113.57 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.29 -21.25 53.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.768 -1.105 . . . . 2.01 109.682 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.814 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -58.8 -41.11 85.99 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.302 -0.999 . . . . 1.18 108.302 168.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.908 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.6 m0 -95.85 -20.44 18.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.644 -1.162 . . . . 0.45 110.896 -170.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.98 31.6 4.7 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.315 -0.945 . . . . 0.45 112.697 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.517 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.15 -99.15 1.96 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.5 112.64 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.06 27.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.68 0.753 . . . . 1.3 110.845 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m -121.39 112.17 18.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 1.06 111.752 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 146' ' ' ILE . 3.9 mp -81.57 109.45 15.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.137 -0.938 . . . . 1.86 110.343 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.873 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -91.21 111.55 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.101 0.476 . . . . 0.38 111.192 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.3 m -105.9 100.0 9.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.759 -0.655 . . . . 1.82 110.036 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.735 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 19.2 pttp -81.37 91.96 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.726 -0.842 . . . . 2.94 108.726 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.854 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 1.1 pt? -119.31 -171.39 2.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.137 0.97 . . . . 1.89 112.851 -166.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.472 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 33.7 t -157.96 129.56 6.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.877 -1.511 . . . . 2.08 109.638 170.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.424 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . . . -88.73 -25.64 22.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.815 -0.629 . . . . 1.43 110.809 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -76.68 -53.5 7.92 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.403 0.62 . . . . 3.46 110.061 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -72.49 -14.97 61.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.868 -1.06 . . . . 1.78 110.504 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.527 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 69.59 17.0 7.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.182 -0.917 . . . . 2.75 111.107 175.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.29 -62.07 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.994 0.902 . . . . 2.64 109.993 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.854 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -75.01 -16.61 80.49 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.686 -1.143 . . . . 0.73 113.514 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 158' ' ' LEU . 1.8 tm? -56.4 -47.37 79.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.909 -0.774 . . . . 2.12 108.909 174.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.608 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -58.02 -53.4 58.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.362 -0.836 . . . . 2.5 110.304 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -60.99 -22.77 64.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.723 -0.672 . . . . 0.84 111.749 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 161' ' ' LEU . 1.2 tm? -69.77 -53.2 19.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.382 -0.372 . . . . 1.54 110.032 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -65.84 -30.52 71.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.654 0.264 . . . . 1.7 110.321 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.5 mm-40 -58.28 -38.97 78.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.035 -0.529 . . . . 2.49 110.723 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.487 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 0.1 OUTLIER -81.25 -32.56 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.2 -0.454 . . . . 1.29 111.096 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 72.8 mt -59.77 -52.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.511 -0.313 . . . . 1.24 110.929 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.498 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -68.96 -30.83 69.35 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.89 0.376 . . . . 2.36 111.372 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.498 ' N ' HD11 ' A' ' 166' ' ' LEU . 65.3 tp -55.51 -31.09 61.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.44 -0.8 . . . . 1.98 110.148 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 41.0 t . . . . . 0 N--CA 1.443 -0.817 0 CA-C-N 115.563 -0.744 . . . . 1.69 109.949 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.694 HG21 ' HB ' ' A' ' 81' ' ' ILE . 54.7 t . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 120.832 0.349 . . . . 1.57 110.586 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -86.24 130.7 34.43 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.024 -0.535 . . . . 1.18 110.943 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -95.9 122.98 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.92 0.391 . . . . 1.57 110.376 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 50.0 mtt -138.24 175.69 9.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.565 0.697 . . . . 1.41 112.214 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.51 -100.27 0.35 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.838 -1.305 . . . . 1.55 109.838 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 16.0 t60 -160.1 132.68 6.47 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.053 -1.091 . . . . 1.21 108.053 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.753 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 14.0 p -62.17 -29.67 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.501 -0.772 . . . . 2.2 112.704 -167.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.92 -27.18 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.288 0.477 . . . . 1.78 112.288 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -56.54 -52.24 65.53 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.287 0.565 . . . . 0.89 111.098 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 177.14 33.45 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.4 -0.818 . . . . 1.06 111.096 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 12.6 tmtt? -88.43 -56.19 3.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.974 0.416 . . . . 2.58 110.277 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -68.19 -30.76 69.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.489 . . . . 2.32 110.062 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -77.06 -27.62 54.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.001 -0.545 . . . . 2.23 110.571 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 8.5 tt -65.98 -50.49 64.14 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.466 -0.568 . . . . 2.33 109.466 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.696 ' O ' HG21 ' A' ' 28' ' ' ILE . 4.9 tt -57.7 -40.51 79.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.762 -0.654 . . . . 2.46 110.195 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.73 -50.0 40.84 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.813 -0.355 . . . . 1.38 111.553 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.54 75.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.17 0.509 . . . . 1.42 111.142 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 25' ' ' LEU . 7.2 tt -70.25 -33.93 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.355 -0.838 . . . . 2.08 110.856 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 60.9 mtm180 -71.21 -33.97 70.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.474 0.654 . . . . 4.16 109.546 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -82.12 14.94 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.35 -0.841 . . . . 3.57 110.169 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 2.09 109.998 179.655 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.613 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 p90 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.131 0.491 . . . . 2.96 111.358 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -116.14 154.75 29.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.108 -1.071 . . . . 2.45 108.108 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 2.49 111.785 179.428 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.4 mt . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.065 0.46 . . . . 1.4 110.948 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -98.89 112.1 24.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.573 -0.739 . . . . 1.85 109.492 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 41.9 m-85 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 1.14 111.477 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.694 ' HB ' HG21 ' A' ' 11' ' ' VAL . 46.1 mm . . . . . 0 C--O 1.225 -0.208 0 N-CA-C 111.263 0.098 . . . . 1.31 111.263 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 103' ' ' ALA . 86.9 t -97.41 106.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.652 0.263 . . . . 1.78 111.562 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.607 HD12 HG12 ' A' ' 165' ' ' ILE . 12.2 mm -89.72 106.72 17.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.651 -0.5 . . . . 1.97 109.651 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.693 HD22 HD12 ' A' ' 100' ' ' ILE . 8.4 tp -92.9 126.06 37.8 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.075 -0.511 . . . . 1.98 110.619 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.68 140.56 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.009 -0.432 . . . . 1.8 112.043 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.0 m -135.03 -177.34 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.94 -0.763 . . . . 1.79 108.94 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 126.66 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.875 0.694 . . . . 1.03 112.875 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 42.92 -104.41 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.302 1.223 . . . . 1.66 114.302 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -112.15 -8.65 13.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.813 -173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.579 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 2.8 t70 -62.83 -38.66 91.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.208 -0.664 . . . . 1.09 109.208 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . 78.98 -147.14 30.21 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.891 -1.05 . . . . 0.52 112.408 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 97' ' ' VAL . 79.1 t -88.21 100.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 114.995 -0.602 . . . . 1.67 109.938 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.579 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 10.3 mtp -70.95 167.75 26.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 1.32 111.411 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 83.0 Cg_exo -47.37 -41.48 28.59 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.507 2.138 . . . . 0.88 112.435 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 4.6 mm-40 -65.74 -42.11 91.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.024 0.44 . . . . 2.01 110.187 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.609 HG22 HD23 ' A' ' 84' ' ' LEU . 3.5 m -61.06 -30.51 70.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.577 -0.738 . . . . 1.19 110.11 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.586 HG21 HG12 ' A' ' 92' ' ' VAL . 44.3 t -78.07 -52.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.048 -0.978 . . . . 1.66 111.594 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.0 pt-20 -65.04 -32.25 73.88 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 1.62 111.681 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.73 87.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.547 0.689 . . . . 1.09 109.404 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.957 HG12 HD11 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -68.19 -43.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.98 -1.009 . . . . 1.13 110.81 176.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.5 -27.25 62.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.909 -0.587 . . . . 1.97 110.743 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -85.57 -36.13 20.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 1.02 110.413 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.928 ' HB3' HG21 ' A' ' 82' ' ' VAL . . . -83.18 -49.54 9.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.554 0.576 . . . . 1.18 112.554 -172.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 100' ' ' ILE . 41.3 pttt -61.99 -16.88 54.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.669 0.618 . . . . 2.98 112.669 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.87 10.54 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.371 0.508 . . . . 1.3 112.371 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HB2' HG12 ' A' ' 108' ' ' VAL . . . -99.57 4.09 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 1.3 109.768 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 86.13 6.11 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.461 1.124 . . . . 2.59 108.794 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -93.11 142.79 25.8 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.169 -1.832 . . . . 1.71 111.585 -174.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.17 160.15 50.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.945 2.43 . . . . 0.62 113.447 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.957 HD11 HG12 ' A' ' 100' ' ' ILE . 91.9 mt -127.54 150.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.163 -0.926 . . . . 1.62 110.394 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 81' ' ' ILE . 5.0 mp -121.79 154.75 26.15 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.687 -0.857 . . . . 1.31 108.687 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -118.25 140.86 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 120.667 0.27 . . . . 1.07 110.494 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.42 89.04 3.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.207 -1.034 . . . . 1.07 108.207 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.683 ' HA ' HG23 ' A' ' 86' ' ' VAL . 33.0 mt -73.54 94.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.587 -1.188 . . . . 1.56 111.075 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.76 156.55 24.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.537 0.208 . . . . 0.88 110.977 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt 59.2 33.86 22.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.863 0.84 . . . . 3.11 109.989 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.987 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 2.4 tpp . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.015 -0.993 . . . . 1.55 110.98 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 28.4 t-20 . . . . . 0 CA--C 1.511 -0.549 0 CA-C-O 122.289 1.043 . . . . 2.21 109.996 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.603 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -27.85 -75.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 1 C-N-CA 126.124 4.549 . . . . 1.01 115.46 169.407 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -43.7 -53.4 5.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.17 0.588 . . . . 2.0 112.293 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 11.8 tpt180 -53.07 -65.27 0.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.229 0.538 . . . . 3.7 110.185 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.417 HG22 ' HA2' ' A' ' 91' ' ' GLY . 47.1 t -55.27 -42.36 65.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.451 -1.249 . . . . 1.12 111.41 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.811 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 83.1 mtp -73.1 -30.83 63.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.141 -0.936 . . . . 1.07 111.405 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.08 -27.77 32.73 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.475 -0.49 . . . . 2.01 111.123 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 9.6 mt-10 -61.78 -40.09 93.96 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.016 -1.105 . . . . 2.02 108.016 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.859 HD23 HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -71.45 -46.82 58.98 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.459 -0.791 . . . . 1.62 111.267 -172.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.946 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.2 ppp? -67.36 -8.64 34.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.49 -0.777 . . . . 1.08 109.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -78.1 -28.17 48.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.667 -0.864 . . . . 2.18 108.667 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -82.07 -1.95 50.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.816 0.817 . . . . 1.17 108.803 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 135' ' ' ASN . 1.5 t-20 76.78 42.95 0.14 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 113.101 -1.863 . . . . 2.43 111.203 163.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -123.05 86.75 2.63 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.942 -1.873 . . . . 2.28 105.942 167.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.41 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.44 131.91 94.24 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.789 -1.55 . . . . 1.28 111.313 -171.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.72 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 88.2 Cg_exo -46.87 152.64 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.178 2.585 . . . . 0.34 113.296 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.97 -30.57 62.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.078 -1.419 . . . . 2.01 108.469 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.834 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -51.34 -45.28 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.41 -1.268 . . . . 1.18 109.485 170.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.946 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.0 m0 -89.53 -21.98 22.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.366 -1.288 . . . . 0.45 110.598 -170.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.31 18.5 4.95 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.049 -1.072 . . . . 0.45 112.678 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.41 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.09 -115.54 3.08 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.701 -0.762 . . . . 0.5 112.499 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.07 30.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.886 0.374 . . . . 1.3 111.485 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.859 HG21 HD23 ' A' ' 131' ' ' LEU . 24.9 m -129.22 108.99 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.857 -0.737 . . . . 1.06 112.175 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 164' ' ' MET . 2.2 mp -80.15 110.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.77 . . . . 1.86 110.698 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CE2' ' HG2' ' A' ' 128' ' ' MET . 19.4 m-85 -88.09 115.54 25.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.19 0.519 . . . . 0.38 111.311 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 63.9 m -104.03 117.13 33.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.054 -0.721 . . . . 1.82 109.054 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.987 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 14.5 pttp -98.16 85.95 3.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.106 0.955 . . . . 2.94 109.72 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.692 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -110.64 -179.62 3.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.988 -1.005 . . . . 1.89 112.534 -170.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.408 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 10.1 t -143.46 131.7 21.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.418 -1.265 . . . . 2.08 109.196 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.484 0.659 . . . . 1.43 109.93 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -92.51 -58.92 2.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.371 -0.831 . . . . 3.46 110.038 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 151' ' ' SER . 3.9 m -68.71 -29.67 68.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.654 -1.157 . . . . 1.78 110.644 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 58.88 26.8 15.33 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.507 -1.224 . . . . 2.75 111.414 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -83.4 -45.84 13.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.86 0.838 . . . . 2.64 109.81 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.692 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -75.6 -11.65 84.28 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.01 -0.996 . . . . 0.73 112.668 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 158' ' ' LEU . 26.2 mt -64.18 -39.81 94.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 2.12 110.475 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -78.87 -37.5 40.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.38 -0.373 . . . . 2.5 110.089 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 164' ' ' MET . 65.1 t60 -59.45 -37.21 77.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.069 -0.514 . . . . 0.84 109.986 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 165' ' ' ILE . 63.5 tp -60.61 -58.32 8.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 1.54 110.528 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.556 ' HA ' HD11 ' A' ' 165' ' ' ILE . 89.8 mt -54.24 -39.49 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.944 -0.571 . . . . 1.7 111.357 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.45 -41.33 96.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 2.49 111.251 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 146' ' ' ILE . 29.8 mmt -69.89 -38.54 76.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 1.29 110.096 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.607 HG12 HD12 ' A' ' 83' ' ' ILE . 80.7 mt -54.72 -54.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.61 -0.723 . . . . 1.24 110.242 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.45 -38.09 89.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 2.36 111.104 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.64 -42.22 87.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 1.98 110.312 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 116.354 -0.385 . . . . 1.69 110.978 -178.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.592 HG13 HD11 ' A' ' 83' ' ' ILE . 51.5 t . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 120.771 0.32 . . . . 1.57 111.569 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -104.36 136.3 44.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 1.18 110.741 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 ' HE2' ' A' ' 21' ' ' LYS . 56.3 mt -92.96 124.16 45.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 1.57 110.684 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.656 ' HG3' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -108.69 -175.04 2.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.365 -0.834 . . . . 1.41 110.326 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.922 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 109.15 133.9 6.91 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.27 -0.967 . . . . 1.55 111.834 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.488 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 65.8 t60 -44.58 135.88 4.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.564 -0.818 . . . . 1.21 110.887 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.08 -29.33 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.93 -1.032 . . . . 2.2 113.563 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -86.23 -21.78 27.25 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.045 0.387 . . . . 1.78 112.045 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.447 ' HB2' HG12 ' A' ' 85' ' ' VAL . 51.5 m170 -61.8 -35.92 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.89 111.14 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 152.55 71.49 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.175 -1.012 . . . . 1.06 113.041 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 28.9 mmtp -90.38 -71.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.029 0.443 . . . . 2.58 110.98 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 t -64.5 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 2.32 110.604 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -73.41 -26.17 60.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.292 -0.413 . . . . 2.23 110.787 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.3 tm? -79.35 -49.77 11.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.363 -0.977 . . . . 2.33 108.363 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.623 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.776 -1.102 . . . . 2.46 110.588 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.62 -56.53 9.05 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.174 -0.329 . . . . 1.38 111.794 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.56 92.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.316 -0.402 . . . . 1.42 110.849 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.7 tt -63.9 -32.91 58.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.128 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 70.4 mtp180 -70.4 -34.68 72.82 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.306 0.574 . . . . 4.16 110.657 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -77.59 14.48 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 3.57 111.028 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 108.538 -0.912 . . . . 2.09 108.538 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.497 ' OH ' HD12 ' A' ' 28' ' ' ILE . 9.6 p90 . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.953 0.406 . . . . 2.96 111.238 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.41 131.93 34.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.828 -0.805 . . . . 2.45 108.828 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 162' ' ' LEU . 61.0 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.541 0.686 . . . . 2.49 110.975 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.1 mt . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.61 0.243 . . . . 1.4 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -84.83 124.75 31.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.768 -0.456 . . . . 1.85 109.768 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.641 0.258 . . . . 1.14 110.581 -179.238 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 11' ' ' VAL . 36.0 mm . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.161 -0.311 . . . . 1.31 110.161 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 103' ' ' ALA . 73.1 t -113.24 112.71 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.022 -0.535 . . . . 1.78 111.46 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.751 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.9 mt -94.96 99.97 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 C-N-CA 120.264 -0.574 . . . . 1.97 110.049 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.766 HD22 HD12 ' A' ' 100' ' ' ILE . 6.7 tp -87.1 113.14 22.59 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.693 -0.403 . . . . 1.98 110.796 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.922 HG13 ' HA3' ' A' ' 15' ' ' GLY . 8.7 p -81.39 142.41 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 1.8 110.667 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 87' ' ' ALA . 18.2 t -134.68 175.27 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 107.489 -1.3 . . . . 1.79 107.489 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.02 114.7 6.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.623 0.647 . . . . 1.03 112.497 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 40.63 -96.88 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.84 1.052 . . . . 1.66 113.84 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -108.11 -3.1 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.891 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.567 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 3.8 t70 -71.05 -45.24 64.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.185 0.517 . . . . 1.09 110.423 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.727 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 81.41 -109.8 3.06 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.52 111.84 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.53 HG11 ' HB ' ' A' ' 96' ' ' THR . 42.5 t -124.73 109.25 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.053 0.454 . . . . 1.67 111.349 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.567 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 65.4 mmm -80.48 168.84 22.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 1.32 110.246 173.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.54 ' HD2' ' HE2' ' A' ' 93' ' ' MET . 82.7 Cg_exo -47.0 -50.07 11.55 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.633 2.222 . . . . 0.88 112.877 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.95 -37.02 73.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 2.01 111.041 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.533 HG23 HD13 ' A' ' 84' ' ' LEU . 33.7 m -63.39 -25.95 68.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.235 -0.438 . . . . 1.19 111.038 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' CG1' ' A' ' 92' ' ' VAL . 22.5 t -85.88 -55.54 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 112.177 0.436 . . . . 1.66 112.177 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.2 -21.56 61.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.9 0.381 . . . . 1.62 110.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.656 ' HB1' ' HG3' ' A' ' 14' ' ' MET . . . -82.18 -34.56 28.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 1.09 109.997 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.766 HD12 HD22 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -77.83 -44.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 1.13 110.41 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -55.1 -37.39 66.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.464 -0.789 . . . . 1.97 111.206 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -79.5 -25.72 41.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 1.02 110.521 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.956 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -86.0 -59.49 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.284 0.476 . . . . 1.18 112.284 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -17.25 63.95 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.286 0.476 . . . . 2.98 112.286 -167.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.22 5.3 17.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.849 0.357 . . . . 1.3 111.891 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.85 8.38 30.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.667 -0.864 . . . . 1.3 108.667 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.8 t30 75.44 30.38 0.83 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.361 -1.29 . . . . 2.59 110.242 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -107.97 146.48 33.56 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.245 -0.889 . . . . 1.71 110.734 178.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 108' ' ' VAL . 5.7 Cg_exo -76.15 158.16 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.369 2.713 . . . . 0.62 113.311 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' A' ' 136' ' ' LEU . 4.4 mp -124.27 154.57 31.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.084 -0.962 . . . . 1.62 109.583 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.751 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 6.1 mt -118.94 155.83 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 108.353 -0.98 . . . . 1.31 108.353 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -119.77 134.13 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.002 0.429 . . . . 1.07 110.249 174.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -120.99 88.01 2.86 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.111 -1.07 . . . . 1.07 108.111 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 13.8 mm -66.85 95.1 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.042 -0.981 . . . . 1.56 110.148 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 55.0 t30 -92.85 169.02 10.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.164 -0.68 . . . . 0.88 109.164 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 87' ' ' ALA . 55.7 mtpt 58.51 26.37 14.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.688 0.756 . . . . 3.11 110.056 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.536 ' SD ' ' HE2' ' A' ' 149' ' ' LYS . 5.2 tpp . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 114.973 -1.012 . . . . 1.55 110.269 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.66 -0.496 . . . . 2.21 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.632 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.3 Cg_exo -38.95 -61.98 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.077 3.185 . . . . 1.01 113.694 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -47.21 -49.68 22.47 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.572 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 2.0 tmt_? -53.77 -56.44 17.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.325 0.583 . . . . 3.7 109.58 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.727 HG11 ' HA2' ' A' ' 91' ' ' GLY . 88.3 t -56.78 -41.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.787 -1.097 . . . . 1.12 110.847 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.661 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -67.07 -32.86 74.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.954 -0.567 . . . . 1.07 110.943 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.411 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 75.1 mt-30 -75.75 -24.32 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.665 -0.243 . . . . 2.01 110.883 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.6 mm-40 -63.48 -39.92 95.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.598 -0.89 . . . . 2.02 108.598 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.608 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.4 mm? -68.42 -46.6 69.45 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.62 110.016 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.833 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -73.44 -5.49 40.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.618 -0.719 . . . . 1.08 110.276 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 43.8 tt0 -76.56 -28.56 56.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.457 -0.942 . . . . 2.18 108.457 171.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.442 ' CE2' HG13 ' A' ' 92' ' ' VAL . 42.7 m-85 -90.49 13.01 16.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.507 0.67 . . . . 1.17 109.309 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.94 37.93 2.15 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.212 -1.358 . . . . 2.43 109.216 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.442 ' N ' ' HA ' ' A' ' 132' ' ' MET . 5.1 mp -105.7 70.97 0.89 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.575 -1.193 . . . . 2.28 109.471 170.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.974 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -67.45 121.02 77.14 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.016 -0.993 . . . . 1.28 109.677 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.846 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.5 Cg_exo -48.64 157.94 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.833 2.355 . . . . 0.34 112.969 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.8 -22.64 42.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.918 -1.037 . . . . 2.01 108.204 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.59 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 7.6 mp0 -46.46 -48.56 18.97 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.148 -1.387 . . . . 1.18 109.714 161.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.833 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.9 m0 -96.0 -30.07 13.79 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.533 -1.667 . . . . 0.45 110.896 -166.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.81 22.12 3.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.303 -0.951 . . . . 0.45 112.985 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.974 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.3 -113.91 2.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.445 -0.883 . . . . 0.5 112.725 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.44 32.9 0.51 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.193 0.521 . . . . 1.3 111.356 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 23.3 m -134.91 123.49 23.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.29 -0.564 . . . . 1.06 111.825 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.743 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.2 mp -92.68 109.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 1.86 110.55 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.846 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -86.35 134.77 33.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.173 0.511 . . . . 0.38 111.098 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.4 m -131.44 107.8 9.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.454 -0.794 . . . . 1.82 110.03 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.778 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.9 ptmm? -85.51 86.17 7.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.691 0.758 . . . . 2.94 109.89 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.493 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -103.92 -167.23 1.34 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.256 1.027 . . . . 1.89 112.129 -169.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p -161.36 116.08 2.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.802 -1.545 . . . . 2.08 109.318 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.29 -0.84 18.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.178 0.513 . . . . 1.43 111.029 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -83.46 -55.41 4.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.807 0.813 . . . . 3.46 109.681 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.5 p -98.85 -20.64 16.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.548 -1.206 . . . . 1.78 111.395 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HZ1' ' HB3' ' A' ' 155' ' ' LYS . 9.7 mtpm? 72.75 18.1 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 2.75 112.132 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -54.49 -70.51 0.1 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.826 0.822 . . . . 2.64 110.729 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -75.64 -7.48 83.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.128 -0.942 . . . . 0.73 112.945 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -72.28 -51.18 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.634 -0.506 . . . . 2.12 109.634 -178.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.98 -30.61 70.78 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.447 -0.575 . . . . 2.5 109.447 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.556 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 84.9 t60 -66.49 -25.76 66.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.42 -0.809 . . . . 0.84 110.888 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 158' ' ' LEU . 56.0 tp -67.17 -47.57 70.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.461 . . . . 1.54 110.014 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.704 HD13 HG11 ' A' ' 50' ' ' VAL . 32.8 mt -58.64 -38.78 78.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.461 -0.79 . . . . 1.7 111.277 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 13.5 pt-20 -71.8 -32.35 67.51 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.127 -0.323 . . . . 2.49 110.127 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.743 ' HB3' HG21 ' A' ' 146' ' ' ILE . 25.9 mmt -69.85 -38.24 76.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.311 0.577 . . . . 1.29 109.897 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 162' ' ' LEU . 63.3 mt -56.3 -53.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.073 -0.967 . . . . 1.24 111.136 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.5 pp -71.85 -34.29 69.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 121.041 -0.264 . . . . 2.36 111.491 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.444 ' N ' HD11 ' A' ' 166' ' ' LEU . 14.0 tp -53.06 -31.62 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.97 -0.559 . . . . 1.98 110.73 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.444 -0.754 0 CA-C-N 116.033 -0.53 . . . . 1.69 110.281 -178.488 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 1.087 HG11 ' HB ' ' A' ' 81' ' ' ILE . 13.7 m . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 120.843 0.354 . . . . 1.57 110.755 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.0 m -129.64 134.57 47.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.239 -0.437 . . . . 1.18 111.102 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.727 HD11 HG13 ' A' ' 83' ' ' ILE . 35.7 mm -81.07 129.7 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 1.57 111.062 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 14.4 mmt -138.29 157.12 46.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.684 0.394 . . . . 1.41 111.435 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.66 -110.55 0.46 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.116 -0.793 . . . . 1.55 111.116 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -156.85 137.61 13.31 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.75 -0.725 . . . . 1.21 109.594 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.64 -47.47 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.335 0.865 . . . . 2.2 113.335 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.55 -27.54 68.51 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.504 0.557 . . . . 1.78 112.504 -170.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -63.35 -21.27 66.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.281 0.562 . . . . 0.89 110.649 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.53 42.46 1.86 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.661 -0.699 . . . . 1.06 112.465 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -82.02 -22.12 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 2.58 110.215 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -39.88 23.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.174 -1.047 . . . . 2.32 108.174 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 m -62.57 -33.6 75.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.622 -1.172 . . . . 2.23 110.512 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.588 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 59.7 tp -57.39 -56.07 26.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 2.33 110.524 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.685 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.6 tt -63.78 -36.81 85.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.072 0.463 . . . . 2.46 109.994 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.18 -53.76 44.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.955 0.407 . . . . 1.38 111.596 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -32.17 72.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.42 111.196 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.635 HD11 ' OH ' ' A' ' 48' ' ' TYR . 3.9 tt -67.78 -33.47 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.84 -0.618 . . . . 2.08 110.43 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 15.5 mtm180 -73.62 -28.03 61.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.454 0.645 . . . . 4.16 110.031 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -84.9 5.18 30.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.626 -0.715 . . . . 3.57 110.148 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.319 -0.727 0 N-CA-C 106.703 -1.591 . . . . 2.09 106.703 168.633 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.635 ' OH ' HD11 ' A' ' 28' ' ' ILE . 23.2 p90 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.778 -0.453 . . . . 2.96 109.778 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.934 ' HG2' HG23 ' A' ' 58' ' ' THR . 37.0 mt-30 -126.17 118.06 24.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.257 -0.646 . . . . 2.45 109.257 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.571 HG23 ' HE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 115.632 -0.713 . . . . 2.49 112.372 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.425 ' HB ' HG21 ' A' ' 50' ' ' VAL . 19.0 mt . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.023 0.44 . . . . 1.4 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.934 HG23 ' HG2' ' A' ' 49' ' ' GLN . 36.2 m -119.97 130.85 54.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.162 -0.681 . . . . 1.85 109.162 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HE1' HG23 ' A' ' 50' ' ' VAL . 16.1 m-85 . . . . . 0 C--O 1.222 -0.372 0 N-CA-C 109.048 -0.723 . . . . 1.14 109.048 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 1.087 ' HB ' HG11 ' A' ' 11' ' ' VAL . 28.4 mm . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 121.077 0.465 . . . . 1.31 109.782 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 1.002 HG23 ' HB2' ' A' ' 103' ' ' ALA . 76.4 t -81.45 108.14 14.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.063 -0.517 . . . . 1.78 111.182 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.727 HG13 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -85.47 102.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.971 -0.751 . . . . 1.97 108.971 177.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.787 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.1 tm? -94.64 111.77 23.53 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.919 -0.582 . . . . 1.98 109.946 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 39.5 t -87.56 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.1 -0.5 . . . . 1.8 111.488 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 114' ' ' ILE . 17.9 m -135.29 -167.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.161 -0.927 . . . . 1.79 108.501 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . . . -140.07 143.27 36.25 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.31 -0.556 . . . . 1.03 111.691 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -34.26 -55.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.678 1.236 . . . . 1.66 112.992 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -109.1 13.83 24.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.883 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -110.68 -43.02 3.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.511 -0.476 . . . . 1.09 111.284 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 78.0 -139.8 23.18 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.667 -0.778 . . . . 0.52 111.949 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.72 HG12 ' HB ' ' A' ' 96' ' ' THR . 44.0 t -96.97 114.8 34.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 122.783 0.433 . . . . 1.67 111.311 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.571 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 53.7 mtp -84.12 169.77 15.97 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.434 -0.348 . . . . 1.32 110.199 171.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 93.8 Cg_exo -45.25 -50.79 8.58 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.696 2.264 . . . . 0.88 113.341 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -72.72 -21.9 60.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.387 -0.369 . . . . 2.01 111.356 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.72 ' HB ' HG12 ' A' ' 92' ' ' VAL . 25.5 m -60.38 -28.74 68.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.397 0.617 . . . . 1.19 110.274 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.04 -45.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.958 -0.565 . . . . 1.66 111.726 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.79 -23.19 59.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 1.62 110.961 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -87.96 -30.96 19.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.811 -0.631 . . . . 1.09 110.018 -177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.845 HG12 HD13 ' A' ' 110' ' ' ILE . 1.7 mt -80.93 -51.21 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.261 -0.881 . . . . 1.13 111.293 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -49.13 -39.28 27.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 1.97 110.78 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -77.35 -30.2 53.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 1.02 110.968 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 1.002 ' HB2' HG23 ' A' ' 82' ' ' VAL . . . -81.27 -56.29 4.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.436 . . . . 1.18 111.967 -173.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -73.2 -15.72 61.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.304 -0.407 . . . . 2.98 111.899 -168.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.12 -0.48 44.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 1.3 111.206 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -101.39 14.07 33.1 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.814 -0.81 . . . . 1.3 108.814 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 4.8 m-20 72.19 27.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.705 -1.134 . . . . 2.59 111.759 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.623 HG21 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.13 152.85 42.75 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-O 121.061 0.458 . . . . 1.71 111.254 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.623 ' O ' HG21 ' A' ' 108' ' ' VAL . 15.4 Cg_exo -72.54 162.82 40.31 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.678 2.919 . . . . 0.62 113.437 171.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.845 HD13 HG12 ' A' ' 100' ' ' ILE . 73.7 mt -132.61 148.17 31.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.672 -0.695 . . . . 1.62 110.586 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.787 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 37.3 mt -113.61 164.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 109.072 -0.714 . . . . 1.31 109.072 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.555 HG22 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -123.63 129.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 N-CA-C 109.044 -0.724 . . . . 1.07 109.044 169.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.28 87.25 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.592 -1.262 . . . . 1.07 107.592 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.698 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 54.1 mt -69.61 97.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.315 -1.311 . . . . 1.56 109.904 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -96.91 170.82 8.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.88 109.023 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 77.5 tttt 64.14 18.35 11.2 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.365 1.078 . . . . 3.11 109.227 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.1 tpp . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 123.063 1.411 . . . . 1.55 109.511 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.266 -0.272 . . . . 2.21 110.266 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.605 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.1 Cg_endo -44.53 -61.3 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.581 2.854 . . . . 1.01 113.325 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.73 -49.63 19.29 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.441 0.697 . . . . 2.0 112.352 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -49.21 -62.13 1.7 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.351 0.596 . . . . 3.7 109.69 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.595 HG13 ' HA2' ' A' ' 91' ' ' GLY . 66.8 t -54.2 -47.84 67.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.341 -1.299 . . . . 1.12 110.848 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.647 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 90.4 mtp -59.42 -34.51 72.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 1.07 111.122 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -76.77 -20.14 56.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.618 -0.264 . . . . 2.01 111.23 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.649 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 4.2 mt-10 -75.98 -30.39 58.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.962 -0.755 . . . . 2.02 108.962 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.903 HD12 HD13 ' A' ' 136' ' ' LEU . 3.5 mm? -72.77 -44.27 61.79 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.831 -0.747 . . . . 1.62 109.311 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.822 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -73.01 -4.54 32.97 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.163 -0.615 . . . . 1.08 109.977 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.649 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 40.9 tt0 -74.41 -32.75 62.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 170.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CE2' HG11 ' A' ' 92' ' ' VAL . 44.9 m-85 -89.9 9.39 27.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.911 0.862 . . . . 1.17 109.446 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 72.32 26.59 2.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 113.536 -1.665 . . . . 2.43 110.234 168.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.903 HD13 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.04 76.69 1.37 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.433 -1.321 . . . . 2.28 107.433 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.93 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -63.24 134.04 95.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 113.436 -1.711 . . . . 1.28 110.279 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.77 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -52.29 154.34 11.35 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 122.359 2.039 . . . . 0.34 112.135 173.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 mm-40 -80.28 -19.77 45.96 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.05 -0.977 . . . . 2.01 109.141 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.596 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.1 mp0 -47.2 -52.98 14.28 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.709 1.243 . . . . 1.18 108.958 160.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.822 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -89.73 -23.78 21.71 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.897 -1.956 . . . . 0.45 110.68 -167.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.87 23.02 4.79 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.553 -0.832 . . . . 0.45 112.446 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.93 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.93 -108.15 1.99 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.924 -0.655 . . . . 0.5 113.17 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.25 27.37 0.35 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 1.3 111.314 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.662 HG23 HD12 ' A' ' 136' ' ' LEU . 63.5 m -132.67 133.34 43.43 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.83 1.048 . . . . 1.06 113.83 -174.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.794 HG13 HG12 ' A' ' 168' ' ' VAL . 4.1 mp -87.48 108.15 17.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.123 -0.944 . . . . 1.86 110.382 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.77 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 11.8 m-85 -94.54 115.77 27.99 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.839 -0.538 . . . . 0.38 111.224 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.9 t -118.63 128.7 54.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.439 -0.578 . . . . 1.82 109.439 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.698 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.6 pttm -103.65 87.06 2.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.609 0.718 . . . . 2.94 109.393 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.854 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -105.64 -177.03 3.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.43 -0.804 . . . . 1.89 112.486 -172.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.1 p -155.87 124.05 5.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.929 -1.032 . . . . 2.08 109.636 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 158' ' ' LEU . . . -76.24 -13.19 60.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.141 0.496 . . . . 1.43 110.926 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -75.89 -57.64 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.47 -0.786 . . . . 3.46 109.855 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -97.29 -15.71 20.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.148 -0.933 . . . . 1.78 111.376 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.808 ' HG2' HD12 ' A' ' 158' ' ' LEU . 59.4 mttp 64.58 24.82 13.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.23 -0.896 . . . . 2.75 111.888 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.21 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.843 0.83 . . . . 2.64 109.822 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.717 ' HA3' ' HA ' ' A' ' 150' ' ' LEU . . . -71.83 -10.46 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.811 -1.086 . . . . 0.73 113.543 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.808 HD12 ' HG2' ' A' ' 155' ' ' LYS . 25.5 mt -71.89 -43.1 65.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.699 0.75 . . . . 2.12 110.295 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 12.8 t70 -61.66 -42.82 99.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.753 -0.832 . . . . 2.5 108.753 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -66.7 -24.25 66.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.039 -0.982 . . . . 0.84 111.507 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.3 tp -63.31 -56.43 16.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.661 -0.245 . . . . 1.54 110.401 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.8 mt -54.62 -39.84 68.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 1.7 110.585 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.0 mm-40 -63.56 -47.28 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 2.49 110.339 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.73 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -67.07 -38.77 86.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 1.29 110.593 -176.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.14 -49.42 40.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 1.24 111.845 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 167' ' ' LEU . 1.6 pp -84.67 -35.15 22.8 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.406 0.521 . . . . 2.36 112.406 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.6 tp -63.41 -21.98 66.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.99 0.424 . . . . 1.98 110.937 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.794 HG12 HG13 ' A' ' 146' ' ' ILE . 48.5 t . . . . . 0 N--CA 1.442 -0.845 0 CA-C-N 116.515 -0.311 . . . . 1.69 110.447 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.714 HG23 ' HB ' ' A' ' 81' ' ' ILE . 89.2 t . . . . . 0 N--CA 1.433 -1.309 0 CA-C-O 121.165 0.507 . . . . 1.57 110.051 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.996 -0.547 . . . . 1.18 110.728 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.663 ' HA ' HG13 ' A' ' 83' ' ' ILE . 26.4 mt -83.69 121.45 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.056 0.455 . . . . 1.57 111.148 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 20.8 mmt -115.7 178.99 4.1 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.077 -0.712 . . . . 1.41 109.077 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.912 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 114.67 131.05 5.04 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.852 -1.166 . . . . 1.55 111.411 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -44.88 132.37 6.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.332 0.586 . . . . 1.21 110.198 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -56.35 -30.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.55 0.944 . . . . 2.2 113.55 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.63 -15.8 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.78 111.296 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.455 ' HE1' ' H ' ' A' ' 93' ' ' MET . 32.8 m170 -67.25 -43.0 82.99 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.845 -0.428 . . . . 0.89 109.845 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 85' ' ' VAL . . . 147.12 69.79 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.034 -1.079 . . . . 1.06 113.766 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -87.55 -50.11 6.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.453 0.644 . . . . 2.58 109.513 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -64.12 -30.56 71.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.032 -0.986 . . . . 2.32 110.561 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.487 HG23 ' ND2' ' A' ' 115' ' ' ASN . 5.4 t -67.73 -26.64 66.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 2.23 110.64 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.02 -55.82 6.73 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.775 -0.824 . . . . 2.33 108.775 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.643 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 1.9 tt -55.49 -41.69 73.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.945 -0.571 . . . . 2.46 109.78 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.54 -62.5 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.507 0.558 . . . . 1.38 112.507 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.423 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -68.27 -38.48 81.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 1.42 111.843 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.78 -31.04 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.453 . . . . 2.08 110.536 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -64.04 -41.25 97.46 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.223 0.535 . . . . 4.16 110.372 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -76.5 9.3 2.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.38 -0.827 . . . . 3.57 109.818 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.876 -0.602 . . . . 2.09 110.342 174.468 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.643 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.943 0.402 . . . . 2.96 110.761 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.618 ' HG2' HG21 ' A' ' 58' ' ' THR . 47.8 mt-30 -98.98 152.0 20.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.169 -0.469 . . . . 2.45 109.879 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 95.1 t . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.891 0.853 . . . . 2.49 111.945 -172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.774 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 42.2 mt . . . . . 0 CA--C 1.523 -0.095 0 N-CA-C 110.019 -0.363 . . . . 1.4 110.019 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 49' ' ' GLN . 11.0 m -121.67 113.8 20.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.128 -0.323 . . . . 1.85 110.128 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HD2' HD12 ' A' ' 13' ' ' ILE . 3.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 1.14 110.876 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.714 ' HB ' HG23 ' A' ' 11' ' ' VAL . 45.8 mm . . . . . 0 C--O 1.231 0.128 0 N-CA-C 111.794 0.294 . . . . 1.31 111.794 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.903 HG21 ' HB1' ' A' ' 103' ' ' ALA . 89.7 t -100.92 98.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.79 -0.364 . . . . 1.78 111.274 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.663 HG13 ' HA ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -87.11 104.38 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.093 -0.643 . . . . 1.97 110.472 174.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.615 HD22 ' CD1' ' A' ' 100' ' ' ILE . 9.7 tp -91.46 114.08 26.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.884 -0.598 . . . . 1.98 110.33 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.912 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.6 p -85.7 142.72 12.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.882 -0.727 . . . . 1.8 110.844 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -137.3 -170.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.36 -0.978 . . . . 1.79 108.36 175.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.24 139.68 30.33 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.238 -0.585 . . . . 1.03 111.681 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB2' HG23 ' A' ' 114' ' ' ILE . . . -78.91 58.23 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.035 -0.984 . . . . 1.66 111.207 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -164.97 -33.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.452 -1.249 . . . . 2.01 109.301 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.51 -63.26 1.18 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.522 0.677 . . . . 1.09 110.954 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.742 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 117.07 -106.36 1.42 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.996 -1.002 . . . . 0.52 110.887 -172.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.94 HG13 ' HB ' ' A' ' 96' ' ' THR . 38.5 t -129.67 114.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 120.952 0.406 . . . . 1.67 110.572 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 60.3 mtp -91.96 172.81 5.92 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 1.32 109.741 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.696 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 58.0 Cg_exo -39.32 -59.76 0.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.269 2.646 . . . . 0.88 113.857 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -54.27 -35.01 62.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 2.01 111.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.94 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.3 m -64.26 -34.04 77.19 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.762 0.282 . . . . 1.19 111.762 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.62 HG11 ' CG1' ' A' ' 92' ' ' VAL . 1.4 m -85.7 -38.86 13.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 121.967 -0.458 . . . . 1.66 111.328 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.65 -30.06 70.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.165 0.507 . . . . 1.62 110.916 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -76.31 -17.6 59.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.647 -0.706 . . . . 1.09 110.491 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -93.41 -45.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 1.13 110.966 -176.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -53.41 -38.54 63.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.566 0.698 . . . . 1.97 110.086 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -75.2 -28.66 60.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.191 -0.913 . . . . 1.02 110.943 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.903 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.74 -53.88 3.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.889 0.7 . . . . 1.18 112.889 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -67.7 -16.21 64.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.225 0.454 . . . . 2.98 112.225 -166.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.65 10.7 4.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.309 0.485 . . . . 1.3 112.309 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.598 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -107.96 4.21 24.99 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.08 -0.711 . . . . 1.3 109.08 173.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 21.0 t-20 80.46 19.31 0.55 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 123.204 1.478 . . . . 2.59 108.858 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.598 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -96.06 142.47 24.61 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 113.741 -1.572 . . . . 1.71 110.462 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 8.3 Cg_exo -73.19 152.02 49.96 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.904 2.403 . . . . 0.62 114.264 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 100' ' ' ILE . 1.7 mp -114.48 143.11 24.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 113.239 -1.8 . . . . 1.62 109.637 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mp -113.46 147.52 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.079 -1.082 . . . . 1.31 108.079 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -110.37 138.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 109.32 -0.622 . . . . 1.07 109.32 174.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.1 87.8 2.82 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.232 -1.025 . . . . 1.07 108.232 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.663 ' HA ' HG21 ' A' ' 86' ' ' VAL . 37.5 mt -73.3 95.92 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.581 -1.191 . . . . 1.56 110.153 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.487 ' ND2' HG23 ' A' ' 23' ' ' THR . 53.3 t30 -90.8 156.53 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.671 -0.412 . . . . 0.88 111.174 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.2 mttp 71.51 37.32 1.15 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.732 0.813 . . . . 3.11 112.178 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 C-N-CA 119.873 -0.731 . . . . 1.55 111.661 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 34.1 t30 . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 119.841 -0.124 . . . . 2.21 110.826 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HG3' ' HE3' ' A' ' 117' ' ' MET . 58.1 Cg_exo -28.79 -69.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.548 3.499 . . . . 1.01 114.545 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.94 -45.72 15.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.725 0.81 . . . . 2.0 112.206 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -55.17 -56.13 23.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.493 0.663 . . . . 3.7 110.177 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.742 HG11 ' HA2' ' A' ' 91' ' ' GLY . 56.7 t -59.44 -39.73 79.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.565 -1.198 . . . . 1.12 110.346 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.648 ' HE2' ' HG3' ' A' ' 140' ' ' GLU . 87.3 mtp -66.29 -30.01 70.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.558 -0.746 . . . . 1.07 111.225 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.34 -21.06 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.627 0.251 . . . . 2.01 110.778 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.1 -38.58 85.93 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.646 -0.872 . . . . 2.02 108.646 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.904 HD12 HD12 ' A' ' 136' ' ' LEU . 3.9 mm? -69.47 -45.35 69.21 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.802 -0.636 . . . . 1.62 110.031 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.9 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -73.26 -5.04 36.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.84 -0.618 . . . . 1.08 110.363 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.62 -37.19 68.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.726 -1.213 . . . . 2.18 107.726 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.91 ' CE2' HG12 ' A' ' 92' ' ' VAL . 28.6 m-85 -84.38 7.6 19.0 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.944 0.878 . . . . 1.17 109.283 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.71 44.08 1.21 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.829 -1.532 . . . . 2.43 109.505 170.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.904 HD12 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -122.43 81.77 1.89 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 113.517 -1.674 . . . . 2.28 106.96 169.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.807 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -65.37 130.53 94.72 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.006 -1.452 . . . . 1.28 110.242 -173.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.764 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 58.2 Cg_exo -44.69 154.79 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.888 2.392 . . . . 0.34 112.54 170.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -74.43 -29.17 61.38 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.346 -1.297 . . . . 2.01 108.012 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.669 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -51.11 -42.17 60.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.584 -1.189 . . . . 1.18 109.572 168.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.9 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.2 m0 -96.16 -20.35 18.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.419 -0.81 . . . . 0.45 111.167 -172.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.99 29.85 4.44 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.139 -1.029 . . . . 0.45 112.707 170.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.807 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.78 -106.67 2.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.366 -0.921 . . . . 0.5 112.923 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.34 27.99 0.45 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.714 -0.243 . . . . 1.3 111.42 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.506 HG21 HG21 ' A' ' 110' ' ' ILE . 26.6 m -134.55 129.04 34.45 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 119.171 -1.011 . . . . 1.06 113.548 -171.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.713 HG22 ' HB3' ' A' ' 164' ' ' MET . 49.9 mm -94.35 110.33 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.332 -0.849 . . . . 1.86 110.566 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.764 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 14.2 m-85 -90.89 119.4 31.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.034 0.445 . . . . 0.38 111.429 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 75.8 m -110.37 111.99 23.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.625 -0.509 . . . . 1.82 109.625 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.676 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 25.9 pttt -93.29 100.06 12.48 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.811 -0.631 . . . . 2.94 109.392 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -123.07 179.13 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.615 1.198 . . . . 1.89 113.681 -169.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.58 116.83 5.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.285 -1.78 . . . . 2.08 108.15 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 158' ' ' LEU . . . -63.02 -16.32 59.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.013 0.375 . . . . 1.43 112.013 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.71 -57.34 3.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.802 0.81 . . . . 3.46 109.503 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -72.69 -17.96 61.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.129 -1.396 . . . . 1.78 112.01 -175.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.685 ' HD3' HD12 ' A' ' 158' ' ' LEU . 30.2 mmtp 71.63 -0.11 3.28 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.791 -0.641 . . . . 2.75 112.007 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -45.99 -74.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.037 0.754 . . . . 2.64 113.037 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.51 -6.7 66.77 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.496 -0.774 . . . . 0.73 113.536 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.685 HD12 ' HD3' ' A' ' 155' ' ' LYS . 57.7 mt -73.55 -43.16 60.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.288 0.544 . . . . 2.12 110.561 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 26.9 m-20 -66.94 -40.43 87.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 174.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -65.29 -30.64 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.84 110.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 60.7 tp -63.39 -53.89 45.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 1.54 110.639 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.63 -39.29 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 1.7 110.731 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 8.1 mm-40 -61.41 -48.34 81.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.573 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.736 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 21.7 mmt -69.29 -40.12 77.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 1.29 110.854 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.41 -47.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.041 -0.527 . . . . 1.24 110.43 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.2 -46.72 87.68 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.29 -0.414 . . . . 2.36 111.137 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.43 -46.28 76.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.555 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 77.4 t . . . . . 0 N--CA 1.442 -0.871 0 CA-C-N 116.094 -0.503 . . . . 1.69 111.427 -178.371 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.727 HG21 ' HB ' ' A' ' 81' ' ' ILE . 4.0 t . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.751 -0.462 . . . . 1.57 109.751 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 14' ' ' MET . 10.8 m -95.34 121.66 37.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.244 -0.435 . . . . 1.18 111.466 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 83' ' ' ILE . 32.6 mt -95.67 120.06 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.316 0.579 . . . . 1.57 110.01 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.498 ' HE3' HG23 ' A' ' 12' ' ' THR . 50.0 mtt -128.59 152.28 48.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.75 -0.659 . . . . 1.41 110.798 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.899 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 168.82 -113.8 0.54 Allowed Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.281 -1.128 . . . . 1.55 110.281 173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 85.3 t60 -161.99 147.12 12.97 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.083 -0.71 . . . . 1.21 109.083 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -56.95 -51.38 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.592 0.59 . . . . 2.2 112.592 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -61.33 -28.23 69.06 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.796 0.665 . . . . 1.78 112.796 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.445 ' HE1' ' H ' ' A' ' 93' ' ' MET . 27.7 m170 -66.63 -19.02 65.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.89 110.799 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.09 1.38 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.654 -0.784 . . . . 1.06 112.163 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -73.13 -48.8 32.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.235 0.541 . . . . 2.58 110.566 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 2.32 110.067 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 m -70.83 -29.08 65.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.779 -0.646 . . . . 2.23 110.428 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 41.3 tp -63.33 -49.0 75.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.459 -0.571 . . . . 2.33 109.459 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.73 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 8.3 tt -60.09 -45.42 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.406 -0.816 . . . . 2.46 110.519 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.8 t70 -66.17 -48.33 71.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.144 -0.48 . . . . 1.38 111.908 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.06 99.66 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.115 0.483 . . . . 1.42 110.735 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 25' ' ' LEU . 9.6 tt -66.67 -34.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.383 -0.826 . . . . 2.08 110.753 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 29.5 ptt180 -78.33 -36.31 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.675 0.75 . . . . 4.16 109.092 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -76.16 14.39 0.73 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.799 -1.091 . . . . 3.57 111.578 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.369 -0.604 . . . . 2.09 109.369 177.313 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.73 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.609 0.242 . . . . 2.96 110.368 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 45.5 mt-30 -125.32 136.97 54.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.493 -0.321 . . . . 2.45 110.15 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 57' ' ' ILE . 5.0 m . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.135 0.493 . . . . 2.49 111.43 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 ' HB ' HG22 ' A' ' 50' ' ' VAL . 39.3 mt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.4 110.309 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 5.0 m -80.88 100.79 9.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.551 -0.537 . . . . 1.85 109.551 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HE2' ' CG1' ' A' ' 50' ' ' VAL . 59.5 m-85 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.001 0.429 . . . . 1.14 111.985 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.727 ' HB ' HG21 ' A' ' 11' ' ' VAL . 41.9 mm . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.32 -0.622 . . . . 1.31 109.32 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 103' ' ' ALA . 90.5 t -106.85 105.85 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 116.193 -0.458 . . . . 1.78 111.402 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.788 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -87.48 107.75 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.057 -0.72 . . . . 1.97 109.057 174.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -96.76 114.65 26.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.236 -0.893 . . . . 1.98 109.928 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.899 HG13 ' HA3' ' A' ' 15' ' ' GLY . 9.9 p -88.04 141.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.295 0.569 . . . . 1.8 111.341 -176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.647 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.8 m -138.4 -171.09 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.243 -0.89 . . . . 1.79 108.631 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.87 136.91 25.88 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.752 -0.379 . . . . 1.03 110.535 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 59.37 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 1.66 111.235 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.72 -30.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.242 -1.344 . . . . 2.01 109.655 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -108.98 -52.53 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.102 0.477 . . . . 1.09 110.991 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 102.5 -113.42 4.59 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.581 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.709 HG11 ' HB ' ' A' ' 96' ' ' THR . 41.4 t -125.85 112.26 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.973 0.415 . . . . 1.67 110.919 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.573 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.7 mtp -88.26 171.8 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.327 -0.397 . . . . 1.32 110.452 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 84.7 Cg_exo -46.98 -48.5 14.36 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.818 2.345 . . . . 0.88 114.112 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 6.1 mt-30 -62.03 -38.41 88.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.006 -0.278 . . . . 2.01 110.91 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.709 ' HB ' HG11 ' A' ' 92' ' ' VAL . 6.4 m -58.57 -33.54 70.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.786 0.803 . . . . 1.19 110.102 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 134' ' ' TYR . 21.4 t -76.99 -57.93 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.691 -1.14 . . . . 1.66 111.536 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.56 -8.55 56.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.857 -0.611 . . . . 1.62 112.543 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.42 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -84.32 -44.67 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.053 -1.091 . . . . 1.09 108.053 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.616 HD13 ' HG ' ' A' ' 84' ' ' LEU . 7.8 mt -62.9 -45.9 97.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.185 -1.371 . . . . 1.13 111.055 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 5.2 m-20 -54.61 -29.0 50.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 1.97 111.134 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -85.04 -28.89 25.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 1.02 110.284 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -84.02 -46.25 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.491 . . . . 1.18 111.691 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 101' ' ' ASN . 21.4 ptmt -54.89 -37.01 65.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 2.98 112.639 -171.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.98 11.41 34.07 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.627 0.973 . . . . 1.3 113.627 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.678 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -86.92 -51.59 5.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.023 -1.473 . . . . 1.3 107.023 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.678 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 2.5 p-10 149.59 14.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 125.858 1.974 . . . . 2.59 108.839 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -102.02 143.69 27.09 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.771 . . . . 1.71 112.204 -166.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 10.7 Cg_exo -72.72 156.96 52.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.215 2.61 . . . . 0.62 112.908 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.55 HD13 HG12 ' A' ' 100' ' ' ILE . 82.3 mt -126.33 149.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.151 -0.931 . . . . 1.62 110.056 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.788 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mt -120.28 161.1 20.22 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 N-CA-C 108.697 -0.853 . . . . 1.31 108.697 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -123.71 140.93 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 121.049 0.452 . . . . 1.07 110.67 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -122.39 88.63 2.97 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.039 -1.097 . . . . 1.07 108.039 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.672 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 44.1 mt -69.66 96.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.043 -0.981 . . . . 1.56 109.543 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -94.14 165.39 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.258 -0.428 . . . . 0.88 110.686 -172.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 64.62 14.18 8.82 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.652 -0.704 . . . . 3.11 112.641 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.715 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 119.622 -0.831 . . . . 1.55 111.433 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 109.226 -0.657 . . . . 2.21 109.226 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.672 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.6 Cg_exo -38.77 -55.74 1.29 Allowed 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 123.338 2.692 . . . . 1.01 113.73 171.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -47.39 -49.28 25.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.403 0.52 . . . . 2.0 112.403 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 20.5 tpt180 -49.08 -59.53 3.56 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.51 0.671 . . . . 3.7 109.798 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.482 HG13 ' HA2' ' A' ' 91' ' ' GLY . 51.4 t -55.99 -45.9 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.966 -1.47 . . . . 1.12 110.399 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.689 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 91.0 mtp -60.45 -34.37 73.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 1.07 111.449 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' A' ' 132' ' ' MET . 92.9 mt-30 -73.9 -22.39 59.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 2.01 110.359 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.8 mt-10 -75.49 -32.64 60.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.875 -0.787 . . . . 2.02 108.875 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.924 HD11 HD11 ' A' ' 136' ' ' LEU . 3.4 mm? -68.73 -45.56 71.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.609 0.719 . . . . 1.62 109.465 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.878 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -73.43 -5.82 42.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.563 -0.744 . . . . 1.08 110.181 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 19.8 tp10 -76.6 -29.57 56.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.865 -1.161 . . . . 2.18 107.865 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 97' ' ' VAL . 22.6 m-85 -92.29 6.67 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.424 0.63 . . . . 1.17 109.654 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.2 m120 78.43 24.47 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.277 -1.328 . . . . 2.43 111.585 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.924 HD11 HD11 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -105.63 78.94 1.39 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.626 -1.25 . . . . 2.28 107.626 172.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.436 HG22 ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -65.63 130.95 94.68 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 113.565 -1.652 . . . . 1.28 111.697 -176.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.803 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 71.1 Cg_exo -49.44 157.09 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.503 2.802 . . . . 0.34 113.376 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HG3' HG13 ' A' ' 146' ' ' ILE . 43.2 mm-40 -72.45 -26.32 61.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.302 -1.317 . . . . 2.01 109.488 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.853 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 3.3 mm-40 -58.55 -43.42 89.29 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.288 -0.869 . . . . 1.18 108.696 171.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.878 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -88.51 -24.78 22.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.064 -1.425 . . . . 0.45 110.283 -169.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.93 26.7 3.74 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.988 -1.101 . . . . 0.45 112.186 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 137' ' ' VAL . . . -101.73 -115.47 3.96 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.405 -0.902 . . . . 0.5 111.896 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.91 33.39 0.48 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.596 0.236 . . . . 1.3 111.234 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.654 HG23 HD13 ' A' ' 136' ' ' LEU . 36.2 m -128.0 120.24 27.14 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.779 -0.769 . . . . 1.06 112.588 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.46 HG13 ' HG3' ' A' ' 139' ' ' GLU . 3.5 mp -88.16 109.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.645 -0.707 . . . . 1.86 110.385 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.803 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 21.1 m-85 -88.55 108.03 19.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.896 0.379 . . . . 0.38 111.116 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 20.2 t -98.33 118.65 35.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.243 -0.651 . . . . 1.82 109.243 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.715 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 14.2 ptpt -92.3 102.97 15.46 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.162 -0.681 . . . . 2.94 109.162 173.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.622 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -130.17 -169.32 2.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.978 0.894 . . . . 1.89 112.789 -172.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 m -165.8 121.02 1.25 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 113.916 -1.493 . . . . 2.08 109.516 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.54 -12.51 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.623 -0.262 . . . . 1.43 111.668 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 154' ' ' THR . 18.9 pttp -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.879 0.847 . . . . 3.46 109.463 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.449 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.93 -22.57 45.59 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.246 -1.343 . . . . 1.78 109.84 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.711 ' HG2' HD13 ' A' ' 158' ' ' LEU . 9.3 mtpm? 63.93 3.86 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.593 -1.185 . . . . 2.75 113.71 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.84 -56.11 25.88 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.058 0.932 . . . . 2.64 110.38 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.577 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -69.29 -11.98 65.28 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.519 -1.219 . . . . 0.73 113.535 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.711 HD13 ' HG2' ' A' ' 155' ' ' LYS . 31.5 mt -68.54 -43.0 77.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.314 0.557 . . . . 2.12 110.397 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.0 -45.65 91.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.764 -0.653 . . . . 2.5 109.611 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 164' ' ' MET . 75.4 t60 -64.56 -29.82 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.84 110.783 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.1 tp -67.12 -59.38 3.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.383 -0.371 . . . . 1.54 111.149 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.33 -40.04 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.319 0.387 . . . . 1.7 110.704 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.76 -37.82 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 2.49 111.215 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.727 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 25.1 mmt -72.41 -39.84 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 1.29 110.077 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 161' ' ' LEU . 84.5 mt -58.49 -49.46 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.897 -0.592 . . . . 1.24 111.257 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -70.32 -35.19 73.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.77 0.319 . . . . 2.36 111.268 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.48 ' N ' HD11 ' A' ' 166' ' ' LEU . 59.1 tp -56.93 -32.99 66.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.055 -0.521 . . . . 1.98 109.837 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 164' ' ' MET . 43.7 t . . . . . 0 N--CA 1.445 -0.688 0 CA-C-N 115.898 -0.592 . . . . 1.69 109.918 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.667 HG21 ' HB ' ' A' ' 81' ' ' ILE . 74.4 t . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.698 0.761 . . . . 1.57 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -87.19 112.5 22.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 1.18 110.308 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 53.3 mt -74.34 117.08 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 121.613 0.72 . . . . 1.57 110.205 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.557 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 43.9 mtt -118.37 179.18 4.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.687 -1.142 . . . . 1.41 109.984 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.831 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.38 -96.8 0.2 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.158 -1.177 . . . . 1.55 110.158 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -172.33 143.56 1.45 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.969 -1.122 . . . . 1.21 107.969 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -24.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.387 0.884 . . . . 2.2 113.387 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.32 -33.74 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.855 0.317 . . . . 1.78 111.855 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -62.86 -23.95 67.56 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.503 0.557 . . . . 0.89 112.503 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 65.41 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.337 -0.935 . . . . 1.06 112.434 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -87.09 -15.58 38.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.332 0.587 . . . . 2.58 109.721 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -78.06 -30.05 49.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 2.32 110.451 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -27.49 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.089 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.02 -50.19 30.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.592 -0.521 . . . . 2.33 109.592 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -60.44 -22.18 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 2.46 110.789 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -92.64 -56.73 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.172 0.434 . . . . 1.38 112.172 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -28.16 69.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 1.42 111.397 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.12 -32.62 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.954 0.407 . . . . 2.08 110.109 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 29' ' ' ARG . 33.6 mtp-105 -68.52 -32.28 72.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.522 0.677 . . . . 4.16 109.347 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 10.1 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.066 -0.97 . . . . 3.57 110.601 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 m . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 2.09 109.456 175.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.281 0.563 . . . . 2.96 110.935 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.447 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 28.4 mt-30 -116.31 137.33 52.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.677 -0.692 . . . . 2.45 109.458 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.626 HG22 ' HE2' ' A' ' 59' ' ' PHE . 3.9 m . . . . . 0 N--CA 1.441 -0.907 0 CA-C-O 121.606 0.717 . . . . 2.49 111.291 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.62 ' HB ' HG23 ' A' ' 50' ' ' VAL . 73.3 mt . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.656 0.265 . . . . 1.4 110.932 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 23.1 m -99.11 117.11 32.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.398 -0.365 . . . . 1.85 110.221 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.626 ' HE2' HG22 ' A' ' 50' ' ' VAL . 28.9 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.689 0.28 . . . . 1.14 110.775 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.667 ' HB ' HG21 ' A' ' 11' ' ' VAL . 40.8 mm . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.622 0.249 . . . . 1.31 110.85 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.939 HG22 ' HB1' ' A' ' 103' ' ' ALA . 98.7 t -95.16 103.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 120.75 0.31 . . . . 1.78 111.01 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.65 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 9.2 mm -87.22 99.75 8.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.316 -0.624 . . . . 1.97 109.316 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.591 HD23 ' CD1' ' A' ' 100' ' ' ILE . 11.4 tp -85.97 106.56 17.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.557 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.831 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.4 p -80.19 141.19 15.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.263 0.554 . . . . 1.8 110.978 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.3 m -141.2 -171.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 107.868 -1.16 . . . . 1.79 107.868 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.14 146.95 43.4 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.426 -0.51 . . . . 1.03 110.839 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 117' ' ' MET . . . -35.51 -53.89 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.778 1.299 . . . . 1.66 112.677 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.11 -9.93 20.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.593 0.59 . . . . 2.01 112.593 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.67 -40.46 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.126 -0.63 . . . . 1.09 111.559 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.529 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.49 -138.42 23.2 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.296 -0.954 . . . . 0.52 111.115 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.999 HG12 ' HB ' ' A' ' 96' ' ' THR . 23.9 t -101.04 113.44 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 122.766 0.426 . . . . 1.67 110.553 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.556 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -85.0 166.79 29.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.502 -0.925 . . . . 1.32 108.502 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.556 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 31.8 Cg_exo -34.56 -52.05 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.848 3.032 . . . . 0.88 115.09 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -78.06 -17.99 56.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 122.124 -0.36 . . . . 2.01 111.415 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.999 ' HB ' HG12 ' A' ' 92' ' ' VAL . 3.9 m -67.72 -19.06 65.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.35 0.595 . . . . 1.19 109.947 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.15 -44.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.266 -0.425 . . . . 1.66 110.78 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -27.25 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 1.62 110.967 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -75.9 -37.39 58.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.974 -0.557 . . . . 1.09 110.08 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -75.09 -43.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.13 111.209 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -51.43 -36.22 42.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.171 0.51 . . . . 1.97 110.669 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -83.85 -26.48 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.649 -0.705 . . . . 1.02 110.493 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB1' HG22 ' A' ' 82' ' ' VAL . . . -88.08 -50.22 6.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.49 0.552 . . . . 1.18 112.49 -173.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -69.57 -21.68 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.031 0.443 . . . . 2.98 111.174 -171.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.37 7.2 20.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.954 -0.567 . . . . 1.3 111.936 -172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.11 -2.68 27.02 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.001 -0.741 . . . . 1.3 109.001 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 t30 80.09 52.48 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.129 -1.396 . . . . 2.59 107.734 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.523 HG12 HG23 ' A' ' 82' ' ' VAL . 25.3 t -124.34 143.4 42.82 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.427 -1.715 . . . . 1.71 111.051 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.462 ' N ' HG11 ' A' ' 108' ' ' VAL . 3.0 Cg_exo -75.27 152.72 39.87 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.799 2.333 . . . . 0.62 113.152 172.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.575 HG23 HG22 ' A' ' 145' ' ' THR . 1.4 mp -123.48 143.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.471 -1.24 . . . . 1.62 110.773 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 mp -114.54 147.81 17.75 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.044 -1.095 . . . . 1.31 108.044 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.27 130.86 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 109.308 -0.627 . . . . 1.07 109.308 172.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 85' ' ' VAL . . . -115.22 87.59 2.69 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.991 -1.114 . . . . 1.07 107.991 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.814 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 23.3 mt -71.26 95.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.57 -1.195 . . . . 1.56 110.26 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.06 164.49 12.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.299 -0.259 . . . . 0.88 110.299 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 62.47 22.7 13.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.815 0.817 . . . . 3.11 109.964 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.504 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 4.8 tpp . . . . . 0 N--CA 1.45 -0.454 0 CA-C-N 114.348 -1.296 . . . . 1.55 109.687 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 . . . . . 0 C--O 1.233 0.186 0 N-CA-C 110.489 -0.189 . . . . 2.21 110.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.637 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.3 Cg_exo -43.07 -55.5 2.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 123.289 2.66 . . . . 1.01 113.611 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -46.64 -48.98 19.79 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.884 0.698 . . . . 2.0 112.884 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -53.81 -56.68 15.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 3.7 110.245 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.529 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.7 t -53.64 -46.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.338 -1.301 . . . . 1.12 110.094 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.651 ' HE1' ' HG3' ' A' ' 140' ' ' GLU . 88.1 mtp -63.23 -38.65 92.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.33 -0.85 . . . . 1.07 111.475 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.56 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.9 mt-30 -74.32 -25.06 59.32 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 110.073 -0.343 . . . . 2.01 110.073 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -74.22 -30.24 62.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.151 -0.477 . . . . 2.02 109.889 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.537 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.2 mm? -69.43 -45.14 69.87 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.635 0.731 . . . . 1.62 109.645 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.879 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -73.93 -6.07 45.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.957 -1.02 . . . . 1.08 109.793 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 35.5 tt0 -77.39 -28.62 52.85 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.251 -1.018 . . . . 2.18 108.251 173.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HB2' HD11 ' A' ' 136' ' ' LEU . 30.5 m-85 -90.05 12.35 17.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.67 0.748 . . . . 1.17 108.987 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.54 42.75 1.48 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.102 -1.408 . . . . 2.43 109.93 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.767 HD13 HD12 ' A' ' 100' ' ' ILE . 2.1 mp -117.7 78.24 1.22 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.617 -1.174 . . . . 2.28 108.803 171.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.474 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.54 125.76 91.64 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.608 -1.178 . . . . 1.28 110.913 -178.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.748 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -49.36 158.78 1.47 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.213 2.608 . . . . 0.34 112.822 172.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' OE1' HG12 ' A' ' 146' ' ' ILE . 30.4 mt-10 -81.14 -20.55 41.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.247 -0.888 . . . . 2.01 109.695 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.841 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -55.87 -39.89 72.15 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.252 -1.018 . . . . 1.18 108.252 168.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.879 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.1 m0 -94.08 -30.3 14.74 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.748 -1.569 . . . . 0.45 109.492 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.25 21.57 3.37 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.754 -1.212 . . . . 0.45 112.921 168.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.29 -114.97 2.14 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.243 -0.979 . . . . 0.5 112.545 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -151.23 28.88 0.65 Allowed 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.313 0.577 . . . . 1.3 111.237 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.575 HG22 HG23 ' A' ' 110' ' ' ILE . 18.9 m -127.62 122.35 32.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.459 0.647 . . . . 1.06 112.05 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.829 HD12 HG21 ' A' ' 168' ' ' VAL . 15.8 mt -91.69 106.88 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 1.86 111.241 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.748 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -88.59 108.31 19.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.38 111.583 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 79.1 m -104.28 100.31 10.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.82 110.188 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.814 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 16.4 ptmt -82.03 94.68 7.23 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.306 -0.627 . . . . 2.94 109.306 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 117' ' ' MET . 0.7 OUTLIER -112.77 -176.84 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.955 0.884 . . . . 1.89 112.684 -168.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.448 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 24.6 t -165.97 121.64 1.27 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.263 -1.335 . . . . 2.08 109.737 177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -9.2 44.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.894 0.378 . . . . 1.43 111.197 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -83.89 -56.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.736 0.779 . . . . 3.46 109.675 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 46.5 p -81.04 -20.54 41.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.421 -1.263 . . . . 1.78 111.562 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 73.14 -2.65 2.67 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.659 -0.7 . . . . 2.75 111.201 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -48.35 -71.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.772 0.796 . . . . 2.64 112.061 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.63 -9.58 69.74 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.875 -1.057 . . . . 0.73 113.822 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 158' ' ' LEU . 4.3 mm? -69.09 -50.25 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.677 0.738 . . . . 2.12 110.367 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.91 -38.48 82.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.068 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.435 ' O ' ' HG2' ' A' ' 164' ' ' MET . 80.2 t60 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.657 -0.701 . . . . 0.84 110.921 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 165' ' ' ILE . 62.0 tp -63.25 -58.19 7.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.038 -0.356 . . . . 1.54 110.038 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.75 -37.05 65.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.381 0.61 . . . . 1.7 110.054 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.29 -48.26 73.77 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.027 -0.988 . . . . 2.49 110.829 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.796 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 17.3 mmt -63.12 -42.79 99.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.309 . . . . 1.29 110.466 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 161' ' ' LEU . 87.8 mt -53.72 -53.56 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.667 -0.697 . . . . 1.24 110.15 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.402 ' CD2' HD13 ' A' ' 57' ' ' ILE . 76.8 mt -59.58 -48.97 79.58 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.659 -0.7 . . . . 2.36 111.872 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.39 -47.18 73.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.746 -0.661 . . . . 1.98 111.098 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.829 HG21 HD12 ' A' ' 146' ' ' ILE . 2.1 t . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.509 -0.314 . . . . 1.69 111.371 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 81' ' ' ILE . 59.9 t . . . . . 0 N--CA 1.435 -1.192 0 CA-C-O 121.157 0.503 . . . . 1.57 110.944 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -86.07 128.09 34.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.572 -0.74 . . . . 1.18 110.764 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.682 ' HA ' HG13 ' A' ' 83' ' ' ILE . 29.0 mt -90.94 122.94 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 1.57 111.549 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.512 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.7 mtt -137.82 171.86 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.099 -0.501 . . . . 1.41 110.596 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.8 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 150.2 -104.52 0.27 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.051 -1.219 . . . . 1.55 110.051 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.493 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 66.1 t60 -167.07 158.68 12.45 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.46 -0.57 . . . . 1.21 109.46 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.45 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.728 0.27 . . . . 2.2 111.728 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.32 -22.07 65.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.114 -0.494 . . . . 1.78 112.233 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -71.07 -18.25 62.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.078 0.466 . . . . 0.89 110.565 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.29 40.47 3.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.926 -0.654 . . . . 1.06 113.566 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.597 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -76.92 -27.38 54.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.468 0.634 . . . . 2.58 110.974 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 -30.97 31.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 2.32 110.126 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -81.08 -17.06 51.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.111 -0.495 . . . . 2.23 110.283 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.37 -51.55 59.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.825 -0.806 . . . . 2.33 108.825 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.669 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 2.7 tt -62.18 -38.63 89.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 2.46 110.248 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.0 t70 -68.82 -46.84 67.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.489 -0.323 . . . . 1.38 111.373 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -64.69 -42.03 95.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.926 0.393 . . . . 1.42 110.784 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.1 tt -66.51 -28.98 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.54 -0.755 . . . . 2.08 109.62 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 14.3 tpt180 -69.37 -33.32 72.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 4.16 109.934 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -83.45 14.58 3.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.876 -0.602 . . . . 3.57 111.361 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 t . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.452 -0.34 . . . . 2.09 110.798 -178.324 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.8 p90 . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.056 0.455 . . . . 2.96 110.585 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -115.26 148.15 39.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.237 -0.653 . . . . 2.45 109.237 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.726 0.774 . . . . 2.49 110.813 -179.131 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mt . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.042 -0.355 . . . . 1.4 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 m -112.68 137.59 50.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.363 . . . . 1.85 110.101 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 110.191 -0.3 . . . . 1.14 110.191 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.703 HG23 HD11 ' A' ' 111' ' ' ILE . 31.7 mm . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.628 0.251 . . . . 1.31 111.457 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG23 ' HB1' ' A' ' 103' ' ' ALA . 85.7 t -108.36 108.88 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.709 -0.223 . . . . 1.78 110.565 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.805 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -87.39 113.32 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 119.768 -0.773 . . . . 1.97 109.89 172.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 96' ' ' THR . 12.4 tp -98.12 111.91 24.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.506 -0.77 . . . . 1.98 110.26 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.8 HG13 ' HA3' ' A' ' 15' ' ' GLY . 7.5 p -84.25 143.04 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.245 0.545 . . . . 1.8 111.036 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 114' ' ' ILE . 30.0 m -135.31 -179.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.158 -1.053 . . . . 1.79 108.158 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.31 133.11 14.97 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.431 -0.908 . . . . 1.03 113.195 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 49.81 -115.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.404 -1.271 . . . . 1.66 113.1 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -115.47 8.95 15.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 2.01 110.289 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.58 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 16.4 t70 -64.04 -37.34 87.06 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.75 0.786 . . . . 1.09 109.422 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.61 -109.59 2.98 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.52 111.385 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.951 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.0 t -128.25 110.86 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.66 0.266 . . . . 1.67 110.698 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.641 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 72.6 mmm -74.52 170.96 12.7 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.307 -0.406 . . . . 1.32 110.181 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.641 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 88.2 Cg_exo -45.3 -52.11 6.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.611 2.208 . . . . 0.88 112.709 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.67 -34.31 75.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.431 -0.349 . . . . 2.01 111.19 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.951 ' HB ' HG13 ' A' ' 92' ' ' VAL . 2.6 m -64.58 -25.91 68.18 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.058 0.456 . . . . 1.19 110.759 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.443 HG23 HG11 ' A' ' 92' ' ' VAL . 69.1 t -86.31 -48.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.547 -0.297 . . . . 1.66 110.478 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 46.4 mt-10 -59.83 -23.94 63.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 1.62 111.335 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.23 -40.11 31.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.16 -0.681 . . . . 1.09 109.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 110' ' ' ILE . 1.4 mt -72.31 -56.28 10.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 115.258 -0.883 . . . . 1.13 110.212 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.447 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.7 t-20 -44.47 -34.34 2.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.438 0.695 . . . . 1.97 111.48 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 7.1 t60 -84.17 -35.25 23.69 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.983 -0.553 . . . . 1.02 111.354 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.659 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -92.32 -28.84 16.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.497 0.554 . . . . 1.18 112.497 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.491 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -76.95 -11.15 59.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.917 0.389 . . . . 2.98 110.978 -169.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.4 -1.55 56.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 1.3 111.895 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.91 8.64 43.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.915 -1.143 . . . . 1.3 107.915 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.15 33.11 14.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 113.866 -1.515 . . . . 2.59 110.457 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER -91.94 158.27 39.98 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.715 -0.675 . . . . 1.71 110.343 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.516 ' O ' HG21 ' A' ' 108' ' ' VAL . 6.9 Cg_exo -72.49 146.98 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.614 2.21 . . . . 0.62 113.047 170.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -120.24 142.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.089 -1.414 . . . . 1.62 109.331 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.805 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 mt -116.88 155.67 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 108.937 -0.764 . . . . 1.31 108.937 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -120.81 138.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 109.527 -0.546 . . . . 1.07 109.527 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.19 88.33 2.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.894 -1.15 . . . . 1.07 107.894 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.842 ' HA ' HG21 ' A' ' 86' ' ' VAL . 30.6 mt -68.57 90.2 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.837 -1.074 . . . . 1.56 110.264 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -80.31 154.8 27.57 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.112 0.258 . . . . 0.88 110.528 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 64.62 32.49 11.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.646 0.591 . . . . 3.11 110.946 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.51 ' HE3' ' HD3' ' A' ' 124' ' ' PRO . 4.2 tpp . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 1.55 110.469 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 51.5 t-20 . . . . . 0 CA--C 1.51 -0.563 0 CA-C-O 121.457 0.646 . . . . 2.21 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.578 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -20.4 -81.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 1 C-N-CA 126.28 4.654 . . . . 1.01 115.904 175.793 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.84 -46.63 74.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.992 0.517 . . . . 2.0 112.255 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 30.3 tpt180 -50.78 -60.28 3.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.659 0.742 . . . . 3.7 109.658 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.4 t -59.69 -45.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 113.906 -1.497 . . . . 1.12 110.583 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.787 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 91.5 mtp -67.19 -26.13 66.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.906 -0.588 . . . . 1.07 111.25 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.31 -18.63 33.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.719 -0.392 . . . . 2.01 111.29 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.624 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.1 mm-40 -60.07 -42.52 94.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.557 -0.905 . . . . 2.02 108.557 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.726 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -73.63 -40.01 64.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.79 -1.095 . . . . 1.62 110.766 -173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.973 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -79.52 -3.68 47.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.811 -0.631 . . . . 1.08 109.76 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 11.2 tp10 -73.83 -33.47 64.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 2.18 107.463 171.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 92' ' ' VAL . 27.1 m-85 -87.83 7.94 28.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.613 -0.721 . . . . 1.17 109.862 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.56 34.22 1.28 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.755 -1.111 . . . . 2.43 110.638 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.6 mp -111.61 80.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.246 -1.02 . . . . 2.28 108.246 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.525 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.07 129.15 93.99 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.93 -1.486 . . . . 1.28 111.077 -176.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.816 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 76.0 Cg_exo -49.48 157.37 2.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.236 2.624 . . . . 0.34 113.649 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.543 ' HG3' HG13 ' A' ' 146' ' ' ILE . 8.2 mm-40 -70.6 -31.29 68.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.304 -1.317 . . . . 2.01 109.006 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.648 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.3 mp0 -46.16 -54.02 9.41 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.576 -1.193 . . . . 1.18 110.698 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.973 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.2 m0 -89.45 -18.69 26.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.836 -1.529 . . . . 0.45 110.91 -166.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.59 28.08 4.14 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 120.014 -1.088 . . . . 0.45 112.287 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.525 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -99.65 -110.81 3.17 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.373 -0.918 . . . . 0.5 111.814 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 p30 -159.32 33.5 0.2 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.522 0.677 . . . . 1.3 110.81 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 27.7 m -125.56 112.45 16.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.412 0.625 . . . . 1.06 111.8 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 168' ' ' VAL . 4.0 mp -79.08 104.66 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.657 -0.701 . . . . 1.86 111.079 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.816 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -87.91 113.96 24.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.201 0.524 . . . . 0.38 111.811 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.401 ' O ' HD11 ' A' ' 150' ' ' LEU . 64.1 m -105.32 100.81 10.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.551 -0.75 . . . . 1.82 109.568 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.596 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 15.3 pttm -81.27 85.36 6.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.577 -0.897 . . . . 2.94 108.577 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.863 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -123.25 -175.64 3.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.176 -0.92 . . . . 1.89 112.671 -166.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 m -157.24 124.62 5.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.645 -1.161 . . . . 2.08 109.628 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -85.52 -12.93 50.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 1.43 110.297 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -73.49 -56.31 5.21 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.364 -0.834 . . . . 3.46 109.304 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.6 p -78.71 -21.57 47.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.884 -1.053 . . . . 1.78 108.997 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.983 ' HG3' HD12 ' A' ' 158' ' ' LEU . 2.1 ttmp? 70.79 7.03 6.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.715 -1.584 . . . . 2.75 112.038 172.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.26 -49.46 64.24 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.12 0.962 . . . . 2.64 110.652 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.863 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -62.14 -23.81 64.47 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 114.778 -1.101 . . . . 0.73 113.012 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.983 HD12 ' HG3' ' A' ' 155' ' ' LYS . 29.9 mt -64.65 -32.22 73.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.715 0.258 . . . . 2.12 110.558 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 13.7 m-20 -60.65 -53.26 59.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.036 -0.727 . . . . 2.5 109.036 172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.441 -0.8 . . . . 0.84 111.049 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.2 tp -61.05 -60.55 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.342 -0.39 . . . . 1.54 111.062 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.46 -40.36 68.32 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.221 0.325 . . . . 1.7 110.533 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 78.5 mm-40 -61.64 -49.7 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.539 . . . . 2.49 110.715 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -69.56 -34.66 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 1.29 110.444 -175.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.98 -52.32 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.928 -0.578 . . . . 1.24 110.714 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.563 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -76.8 -37.15 56.29 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.303 0.483 . . . . 2.36 112.303 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.563 ' N ' HD11 ' A' ' 166' ' ' LEU . 40.7 tp -61.53 -25.13 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.061 0.458 . . . . 1.98 110.166 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 146' ' ' ILE . 2.7 t . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 1.69 110.12 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 81' ' ' ILE . 51.4 t . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 121.146 0.498 . . . . 1.57 110.231 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -96.56 130.05 43.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.078 -0.51 . . . . 1.18 110.497 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 55.3 mt -97.76 126.75 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.712 0.292 . . . . 1.57 110.691 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.403 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 70.3 mtm -144.25 -177.73 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.075 -0.511 . . . . 1.41 110.888 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 84' ' ' LEU . . . 107.18 59.27 0.58 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.634 -0.793 . . . . 1.55 112.464 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 18.0 t60 62.07 163.62 0.09 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.068 0.937 . . . . 1.21 112.065 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.92 -32.28 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.861 -0.609 . . . . 2.2 111.633 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.421 ' HB3' ' NE2' ' A' ' 16' ' ' HIS . 28.0 t70 -72.83 -25.42 61.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.612 0.227 . . . . 1.78 111.612 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' HE1' ' HB2' ' A' ' 93' ' ' MET . 32.5 m80 -61.71 -20.25 63.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 0.89 110.63 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.63 51.2 1.13 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.638 -0.71 . . . . 1.06 113.086 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.832 0.825 . . . . 2.58 109.021 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -36.79 80.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.451 -1.25 . . . . 2.32 110.76 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.5 p -73.24 -20.82 60.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 2.23 111.257 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.8 mm? -71.91 -48.13 47.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.947 -0.39 . . . . 2.33 109.947 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.22 -35.89 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.827 -0.624 . . . . 2.46 109.932 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.12 -58.31 8.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.794 0.331 . . . . 1.38 111.528 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -62.14 -29.15 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 1.42 111.133 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 25' ' ' LEU . 5.2 tt -75.43 -25.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 2.08 111.029 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.0 mtp180 -78.97 -21.33 47.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.373 0.606 . . . . 4.16 110.049 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -88.6 -0.31 57.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 3.57 109.695 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.576 -0.738 . . . . 2.09 110.156 -179.511 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.162 0.506 . . . . 2.96 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.547 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 21.3 mt-30 -142.31 117.5 10.1 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.956 -1.127 . . . . 2.45 107.956 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--N 1.309 -1.168 0 N-CA-C 108.41 -0.959 . . . . 2.49 108.41 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 58' ' ' THR . 10.5 mt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.335 0.588 . . . . 1.4 110.966 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 4.0 t -151.61 144.16 24.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.6 -0.889 . . . . 1.85 108.6 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.431 ' HD2' HD12 ' A' ' 13' ' ' ILE . 42.7 m-85 . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 120.715 -0.394 . . . . 1.14 110.481 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HD13 ' A' ' 111' ' ' ILE . 28.3 mm . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.22 0.452 . . . . 1.31 112.22 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.712 ' HB ' HD13 ' A' ' 110' ' ' ILE . 75.8 t -107.09 120.62 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 116.44 -0.345 . . . . 1.78 110.899 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 8.3 mm -86.31 123.08 39.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.531 -0.914 . . . . 1.97 108.531 171.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.0 tm? -107.66 113.94 27.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.704 . . . . 1.98 109.302 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.83 139.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.141 0.496 . . . . 1.8 111.855 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.777 HG22 ' HA ' ' A' ' 114' ' ' ILE . 25.8 m -139.42 -171.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 108.822 -0.807 . . . . 1.79 108.822 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.9 109.92 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.968 0.729 . . . . 1.03 112.968 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.68 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.809 1.041 . . . . 1.66 113.809 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -107.67 -3.96 18.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.347 0.499 . . . . 2.01 112.347 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.562 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 31.0 t70 -64.34 -43.79 93.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.419 0.628 . . . . 1.09 111.054 -175.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 88.93 -113.17 4.06 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.518 -0.848 . . . . 0.52 111.249 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.918 HG11 ' HB ' ' A' ' 96' ' ' THR . 35.5 t -129.36 119.2 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 120.656 0.265 . . . . 1.67 110.625 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.562 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 42.0 mtp -85.83 169.35 15.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.675 -0.491 . . . . 1.32 109.675 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.4 Cg_exo -42.64 -60.01 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.753 2.302 . . . . 0.88 112.801 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.697 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 42.0 mt-30 -59.27 -25.39 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.703 0.631 . . . . 2.01 112.703 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.918 ' HB ' HG11 ' A' ' 92' ' ' VAL . 29.9 m -60.21 -46.01 91.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.277 -0.169 . . . . 1.19 111.001 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.522 ' HA ' ' HB ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -88.52 -30.25 5.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 O-C-N 121.847 -0.533 . . . . 1.66 111.444 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.36 -26.94 68.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.411 . . . . 1.62 111.099 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -88.13 -22.31 24.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 1.09 109.959 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.63 HD11 HD23 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -80.79 -47.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.169 -0.923 . . . . 1.13 110.796 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -57.63 -32.78 67.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.398 0.618 . . . . 1.97 110.056 170.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.09 -29.46 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.35 -0.841 . . . . 1.02 109.936 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.764 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -96.18 -54.68 3.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.471 0.545 . . . . 1.18 112.471 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 24.5 mmmt -55.18 -44.8 75.6 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.601 0.715 . . . . 2.98 111.021 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.59 10.24 2.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.318 -1.31 . . . . 1.3 112.133 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.53 8.43 21.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.374 -0.973 . . . . 1.3 108.374 167.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 70.1 48.6 0.52 Allowed 'General case' 0 C--N 1.339 0.149 0 CA-C-N 114.226 -1.352 . . . . 2.59 111.084 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -126.48 157.61 70.08 Favored Pre-proline 0 C--O 1.238 0.485 0 N-CA-C 112.954 0.724 . . . . 1.71 112.954 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.561 ' O ' HG21 ' A' ' 108' ' ' VAL . 10.5 Cg_exo -76.2 159.56 36.89 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 124.611 3.541 . . . . 0.62 114.498 168.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.764 HD12 ' HB2' ' A' ' 103' ' ' ALA . 22.1 mm -129.66 148.26 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.78 -1.1 . . . . 1.62 111.166 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.652 HD13 HG23 ' A' ' 81' ' ' ILE . 3.9 mt -122.06 150.95 25.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 N-CA-C 109.283 -0.636 . . . . 1.31 109.283 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.2 136.34 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.282 0.563 . . . . 1.07 110.442 174.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.9 88.41 2.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.022 -1.103 . . . . 1.07 108.022 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.777 ' HA ' HG22 ' A' ' 86' ' ' VAL . 45.2 mt -69.36 91.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.686 -1.143 . . . . 1.56 109.697 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.637 ' HA ' HD21 ' A' ' 150' ' ' LEU . 53.9 t30 -88.67 151.71 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.88 111.204 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt 54.89 36.47 26.74 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.951 0.782 . . . . 3.11 111.018 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.497 -0.774 . . . . 1.55 109.365 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 109.859 -0.422 . . . . 2.21 109.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.647 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.5 Cg_endo -42.89 -59.25 1.04 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.496 2.797 . . . . 1.01 113.063 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.9 -47.51 32.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.582 0.586 . . . . 2.0 112.582 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.624 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 24.0 tpt180 -58.43 -55.86 29.6 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.329 0.585 . . . . 3.7 109.709 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.567 HG12 ' HA2' ' A' ' 91' ' ' GLY . 82.3 t -52.46 -43.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.4 -1.273 . . . . 1.12 110.677 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.664 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 81.5 mtp -64.24 -34.05 77.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.032 -0.531 . . . . 1.07 110.527 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -73.63 -24.28 60.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 2.01 111.025 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 3.0 mm-40 -68.7 -36.78 78.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.685 -0.857 . . . . 2.02 108.685 172.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.6 mm? -71.73 -43.59 65.6 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.55 -0.75 . . . . 1.62 109.844 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.83 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -77.55 0.26 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.521 -0.763 . . . . 1.08 109.819 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 16.4 tp10 -81.18 -27.58 35.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.911 -1.144 . . . . 2.18 107.911 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.757 ' CE2' HG13 ' A' ' 92' ' ' VAL . 48.5 m-85 -91.99 10.35 29.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.533 0.683 . . . . 1.17 109.19 168.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.2 m120 72.46 32.57 1.58 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.23 -1.35 . . . . 2.43 110.889 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 100' ' ' ILE . 7.5 mp -107.84 79.51 1.29 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.402 1.096 . . . . 2.28 109.475 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.017 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.3 t -66.94 126.18 92.04 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.245 -1.798 . . . . 1.28 112.014 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.852 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 74.5 Cg_exo -47.45 160.11 0.4 Allowed 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 123.848 3.032 . . . . 0.34 113.878 170.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.56 -19.07 42.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.677 -1.147 . . . . 2.01 109.835 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.888 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 1.9 mm-40 -59.23 -40.8 87.03 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.878 -1.156 . . . . 1.18 107.878 168.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.888 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.7 m0 -91.67 -31.64 15.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.952 -1.476 . . . . 0.45 110.979 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.37 28.61 2.98 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.018 -1.087 . . . . 0.45 112.045 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 1.017 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.96 -104.77 1.79 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.717 -0.754 . . . . 0.5 111.913 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -165.49 33.47 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.174 0.511 . . . . 1.3 111.248 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 16.0 m -130.8 113.43 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.244 -0.582 . . . . 1.06 112.016 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.801 HD12 HG21 ' A' ' 168' ' ' VAL . 37.6 mt -81.44 110.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 116.02 -0.537 . . . . 1.86 111.347 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.852 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 23.4 m-85 -89.55 115.0 26.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.933 0.397 . . . . 0.38 111.805 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.481 ' HG ' ' HB2' ' A' ' 161' ' ' LEU . 13.8 t -113.27 135.94 53.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.866 -0.606 . . . . 1.82 109.386 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.2 pttp -110.74 85.13 2.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.689 0.757 . . . . 2.94 109.949 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.879 HD11 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -103.55 168.97 8.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.223 1.011 . . . . 1.89 112.906 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.56 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 27.7 t -145.14 117.37 8.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.392 -1.276 . . . . 2.08 108.131 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.53 -26.44 61.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.27 0.841 . . . . 1.43 113.27 -170.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.651 ' HG3' ' H ' ' A' ' 154' ' ' THR . 46.4 pttt -84.27 -55.24 4.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.33 0.586 . . . . 3.46 110.945 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.651 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 40.8 p -64.21 -25.08 67.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.096 -0.956 . . . . 1.78 110.628 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.796 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 2.5 tppp? 66.8 16.27 10.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.88 -1.055 . . . . 2.75 111.805 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.85 -72.42 0.16 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.712 0.768 . . . . 2.64 111.021 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -61.97 -16.67 53.15 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.739 -1.119 . . . . 0.73 113.24 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 150' ' ' LEU . 4.5 mm? -61.4 -46.21 91.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.912 0.387 . . . . 2.12 110.692 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.58 -42.16 68.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.074 -0.512 . . . . 2.5 110.205 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.468 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.9 t60 -66.61 -21.23 66.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.802 -0.635 . . . . 0.84 110.827 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HB2' ' HG ' ' A' ' 148' ' ' CYS . 54.5 tp -72.55 -51.13 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.056 -0.35 . . . . 1.54 110.056 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 28' ' ' ILE . 93.8 mt -56.17 -39.95 73.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.635 . . . . 1.7 111.107 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.476 ' HG3' ' HE1' ' A' ' 164' ' ' MET . 13.6 pt-20 -69.54 -32.59 71.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 2.49 110.648 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.691 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 25.6 mmt -73.13 -41.34 64.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.073 0.463 . . . . 1.29 109.898 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.43 -51.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.323 -0.853 . . . . 1.24 111.123 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -75.99 -36.85 59.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.246 0.461 . . . . 2.36 112.246 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 166' ' ' LEU . 62.4 tp -52.23 -33.64 42.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.036 0.446 . . . . 1.98 110.575 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.801 HG21 HD12 ' A' ' 146' ' ' ILE . 19.0 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.856 -0.611 . . . . 1.69 110.71 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 1.009 HG23 ' HB ' ' A' ' 81' ' ' ILE . 58.9 t . . . . . 0 N--CA 1.437 -1.123 0 CA-C-O 121.041 0.448 . . . . 1.57 110.671 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 127.2 43.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 1.18 110.77 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.407 HD12 ' HD2' ' A' ' 59' ' ' PHE . 39.9 mt -83.99 115.77 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.319 0.58 . . . . 1.57 110.512 177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 15.3 mmt -107.49 -175.44 2.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.208 -0.905 . . . . 1.41 110.139 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.34 134.56 7.54 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.238 -0.982 . . . . 1.55 110.805 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 84.3 t60 -36.58 128.61 0.8 Allowed 'General case' 0 C--N 1.315 -0.894 0 O-C-N 124.634 0.843 . . . . 1.21 111.124 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 11.3 p -55.61 -21.28 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.352 -0.84 . . . . 2.2 113.107 -170.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 31.5 t70 -93.16 -8.22 43.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.8 0.333 . . . . 1.78 111.78 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' ND1' ' HA ' ' A' ' 86' ' ' VAL . 21.9 m170 -77.26 -7.24 55.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.484 0.55 . . . . 0.89 112.484 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.64 46.36 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.224 -0.989 . . . . 1.06 112.773 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 ptmm? -87.22 -24.26 24.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 2.58 110.174 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 t -72.8 -29.75 63.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 2.32 110.254 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 p -75.42 -25.74 57.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.128 -0.487 . . . . 2.23 110.871 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 152' ' ' ALA . 43.0 mt -67.9 -54.04 21.87 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.986 -0.746 . . . . 2.33 108.986 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -41.21 62.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.851 -0.613 . . . . 2.46 110.258 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.9 t70 -77.96 -51.38 10.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.54 -33.38 64.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.897 0.332 . . . . 1.42 111.897 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.946 ' HB ' ' HH ' ' A' ' 48' ' ' TYR . 76.2 mt -70.0 -39.05 76.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 2.08 110.046 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 7.2 ptt180 -66.67 -33.47 75.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.325 0.584 . . . . 4.16 109.967 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -83.06 -3.85 57.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.485 -0.78 . . . . 3.57 111.604 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.713 0.292 . . . . 2.09 110.714 -177.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.946 ' HH ' ' HB ' ' A' ' 28' ' ' ILE . 5.7 p90 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.019 0.438 . . . . 2.96 111.468 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -140.14 133.56 30.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.359 -0.837 . . . . 2.45 110.191 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.688 0.756 . . . . 2.49 109.832 176.413 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.603 HG23 HG21 ' A' ' 11' ' ' VAL . 4.0 mt . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.803 0.335 . . . . 1.4 111.663 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.9 m -99.23 112.29 24.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.167 -0.47 . . . . 1.85 109.793 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.407 ' HD2' HD12 ' A' ' 13' ' ' ILE . 39.8 m-85 . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 110.217 -0.29 . . . . 1.14 110.217 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 1.009 ' HB ' HG23 ' A' ' 11' ' ' VAL . 47.8 mm . . . . . 0 C--O 1.235 0.303 0 N-CA-C 113.162 0.801 . . . . 1.31 113.162 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.873 HG23 ' HB1' ' A' ' 103' ' ' ALA . 70.0 t -106.29 107.55 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 1.78 110.758 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.706 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -94.14 110.13 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 109.36 -0.607 . . . . 1.97 109.36 174.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.723 HD23 HD13 ' A' ' 100' ' ' ILE . 10.5 tp -90.28 108.33 19.69 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.923 -0.581 . . . . 1.98 110.749 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HA ' ' HB1' ' A' ' 113' ' ' ALA . 46.3 t -82.0 133.68 28.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.559 . . . . 1.8 111.483 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 114' ' ' ILE . 16.3 m -134.08 -177.88 2.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.888 -1.153 . . . . 1.79 107.888 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.08 11.84 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.792 -0.763 . . . . 1.03 112.215 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.75 -109.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.625 -1.17 . . . . 1.66 112.903 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -116.51 19.05 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 2.01 110.472 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.14 -33.35 73.29 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.817 0.818 . . . . 1.09 109.0 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.802 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 75.68 -142.15 28.46 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.251 -1.341 . . . . 0.52 111.912 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.792 HG12 ' HB ' ' A' ' 96' ' ' THR . 71.2 t -98.01 110.2 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 120.809 0.337 . . . . 1.67 111.391 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.644 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 80.5 mmm -80.49 171.61 11.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.15 -0.477 . . . . 1.32 109.804 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.644 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.67 -54.49 4.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.138 2.559 . . . . 0.88 113.257 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.674 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 35.6 mt-30 -60.74 -30.33 69.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 2.01 111.574 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.792 ' HB ' HG12 ' A' ' 92' ' ' VAL . 9.8 m -64.58 -22.96 67.11 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.851 0.358 . . . . 1.19 111.102 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.65 -46.5 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.885 0.374 . . . . 1.66 111.111 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.0 -12.74 40.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 1.62 111.315 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -96.68 -18.82 19.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.286 0.565 . . . . 1.09 110.085 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.723 HD13 HD23 ' A' ' 84' ' ' LEU . 3.4 mt -93.3 -53.07 8.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 1.13 110.507 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -50.4 -37.79 39.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.53 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -75.9 -32.04 59.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.233 -0.894 . . . . 1.02 110.728 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.873 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -84.21 -55.79 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.18 112.084 -173.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -71.41 -12.16 61.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 116.165 -0.47 . . . . 2.98 112.075 -168.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.37 -0.32 19.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.241 -0.436 . . . . 1.3 111.869 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.1 1.99 26.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 t30 82.14 38.04 0.06 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 114.566 -1.197 . . . . 2.59 108.113 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 23.5 t -101.93 142.01 23.72 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 113.151 -1.841 . . . . 1.71 111.122 -173.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 6.4 Cg_exo -73.86 149.98 43.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.754 2.303 . . . . 0.62 113.165 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.669 HD13 HG12 ' A' ' 100' ' ' ILE . 97.8 mt -124.78 149.79 29.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.325 -1.307 . . . . 1.62 109.989 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.706 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mt -125.11 157.35 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 109.065 -0.717 . . . . 1.31 109.065 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.533 HG23 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -115.25 134.6 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 109.651 -0.499 . . . . 1.07 109.651 171.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 85' ' ' VAL . . . -121.69 87.71 2.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.748 -1.204 . . . . 1.07 107.748 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.753 ' HA ' HG22 ' A' ' 86' ' ' VAL . 7.0 mt -73.66 93.08 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.661 -1.154 . . . . 1.56 109.749 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.55 166.44 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.88 110.095 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 57.3 tptt 63.0 47.9 4.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.27 1.033 . . . . 3.11 110.585 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 149' ' ' LYS . 69.3 mmm . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.13 -0.941 . . . . 1.55 108.501 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.458 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.5 t30 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.179 -0.674 . . . . 2.21 109.179 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.545 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.3 Cg_exo -19.29 -66.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 1 C-N-CA 126.389 4.726 . . . . 1.01 116.456 175.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -39.68 -52.03 2.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.096 0.776 . . . . 2.0 113.096 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.0 tmt_? -55.55 -56.7 17.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.985 0.422 . . . . 3.7 109.926 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.802 HG11 ' HA2' ' A' ' 91' ' ' GLY . 31.0 t -58.45 -45.17 89.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.98 -1.009 . . . . 1.12 110.008 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.69 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 88.8 mtp -63.41 -30.11 71.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.395 -0.82 . . . . 1.07 111.181 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 132' ' ' MET . 58.8 mt-30 -78.61 -25.21 45.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.118 -0.233 . . . . 2.01 110.669 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.741 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.6 mt-10 -63.45 -38.61 91.79 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.847 -0.798 . . . . 2.02 108.847 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -70.85 -42.36 70.23 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.62 110.094 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.81 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -72.92 -7.76 52.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.728 -0.669 . . . . 1.08 110.227 178.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.85 -24.36 35.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.649 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 19.1 m-85 -89.05 5.95 42.01 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 122.216 1.008 . . . . 1.17 108.306 167.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.2 m120 72.37 26.35 2.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 113.158 -1.837 . . . . 2.43 110.541 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.947 HD11 HD13 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -103.56 73.02 1.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.205 -1.406 . . . . 2.28 107.205 169.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.898 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -58.31 132.56 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 113.403 -1.726 . . . . 1.28 110.291 -173.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.858 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 94.4 Cg_exo -47.35 151.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.631 2.221 . . . . 0.34 112.971 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -76.0 -25.68 56.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.149 -1.387 . . . . 2.01 108.028 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.824 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -55.99 -38.9 71.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.288 -1.323 . . . . 1.18 109.149 169.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.824 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.6 m0 -96.03 -25.31 15.97 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.581 -1.191 . . . . 0.45 110.453 -172.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.48 24.15 3.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.908 -1.139 . . . . 0.45 112.192 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.898 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -115.85 2.93 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.396 -0.907 . . . . 0.5 112.978 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.28 25.03 1.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.965 0.358 . . . . 1.3 111.965 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.607 HG22 HD13 ' A' ' 136' ' ' LEU . 31.7 m -142.91 123.12 13.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 119.541 -0.864 . . . . 1.06 113.267 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.4 mp -85.19 118.42 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 1.86 110.36 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.858 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.3 m-85 -92.88 116.61 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.911 0.386 . . . . 0.38 111.352 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.6 m -114.46 110.24 19.54 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.948 -0.569 . . . . 1.82 110.72 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.563 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 14.9 ptmt -84.91 85.75 7.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.354 0.597 . . . . 2.94 109.707 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.487 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.3 -175.22 2.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.446 0.641 . . . . 1.89 111.816 -171.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.658 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 35.9 m -160.02 119.59 2.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.51 -0.768 . . . . 2.08 110.011 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 24' ' ' LEU . . . -73.94 -53.25 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.897 -0.592 . . . . 1.43 112.553 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -75.34 -43.26 51.58 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.583 0.706 . . . . 3.46 109.785 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.641 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.3 OUTLIER -57.88 -22.14 46.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.15 -1.387 . . . . 1.78 110.196 171.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.731 ' HD3' HD11 ' A' ' 158' ' ' LEU . 0.0 OUTLIER 74.22 -39.28 0.42 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.601 -1.181 . . . . 2.75 113.903 170.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.99 -46.48 43.91 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.649 0.738 . . . . 2.64 112.024 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.658 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -63.99 -33.1 86.34 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.05 -0.977 . . . . 0.73 113.58 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.731 HD11 ' HD3' ' A' ' 155' ' ' LYS . 74.7 mt -59.68 -47.02 87.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.809 0.338 . . . . 2.12 111.182 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -59.96 -44.52 94.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.64 -0.709 . . . . 2.5 110.251 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -65.46 -38.75 90.74 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.309 -0.405 . . . . 0.84 110.898 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 165' ' ' ILE . 64.1 tp -59.9 -51.61 68.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 1.54 111.011 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.417 HD21 HD12 ' A' ' 165' ' ' ILE . 81.7 mt -60.16 -33.88 72.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 1.7 110.911 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.83 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 2.49 110.642 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.56 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 1.29 110.638 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.417 HD12 HD21 ' A' ' 162' ' ' LEU . 81.7 mt -61.4 -48.77 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.048 -0.524 . . . . 1.24 110.596 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.6 -37.97 89.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 2.36 110.821 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.7 -45.45 73.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.733 -0.667 . . . . 1.98 109.656 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 116.078 -0.51 . . . . 1.69 111.035 -178.147 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.78 HG23 ' HB ' ' A' ' 81' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 112.082 0.401 . . . . 1.57 112.082 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -97.75 109.63 22.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 1.18 110.717 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG13 ' HB ' ' A' ' 83' ' ' ILE . 14.7 tt -82.69 143.99 11.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.092 0.472 . . . . 1.57 110.772 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 59.4 mtt -139.94 -172.6 3.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.069 -0.514 . . . . 1.41 110.934 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.886 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 107.76 129.64 6.13 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.944 -0.862 . . . . 1.55 110.944 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 83.4 t60 -49.01 136.58 14.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.499 0.666 . . . . 1.21 110.971 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG12 ' HE2' ' A' ' 21' ' ' LYS . 29.2 m -64.74 -33.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.294 0.85 . . . . 2.2 113.294 -169.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 9.7 m-20 -67.15 -19.8 65.65 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.745 0.276 . . . . 1.78 111.745 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.427 ' HE2' ' HG3' ' A' ' 93' ' ' MET . 28.5 m170 -68.93 -16.25 63.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.89 110.916 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 114.63 47.27 0.58 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.87 -0.681 . . . . 1.06 112.472 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.613 ' HE2' HG12 ' A' ' 17' ' ' VAL . 36.3 ttpt -87.09 -34.99 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.547 -0.538 . . . . 2.58 109.547 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -67.35 -47.73 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 2.32 109.954 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -69.49 -20.37 63.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.663 -0.699 . . . . 2.23 110.432 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 3.0 tm? -73.57 -51.01 18.4 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.519 -0.919 . . . . 2.33 108.519 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -58.09 -37.1 73.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.455 -0.793 . . . . 2.46 110.668 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.26 -55.55 11.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 1.38 110.81 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 152' ' ' ALA . . . -61.04 -42.2 98.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 1.42 111.203 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.88 HD13 ' HH ' ' A' ' 48' ' ' TYR . 13.0 tt -65.03 -31.51 54.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.588 -0.733 . . . . 2.08 111.02 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -79.9 -28.07 39.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.475 0.655 . . . . 4.16 109.29 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.92 -9.29 59.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 3.57 111.489 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 CA--C 1.534 0.345 0 CA-C-N 116.442 -0.345 . . . . 2.09 111.709 -178.073 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.88 ' HH ' HD13 ' A' ' 28' ' ' ILE . 7.5 p90 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.19 0.519 . . . . 2.96 110.025 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.941 ' HG2' HG23 ' A' ' 58' ' ' THR . 77.9 mt-30 -100.07 114.78 28.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.925 -0.769 . . . . 2.45 108.925 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG21 ' HE1' ' A' ' 59' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.596 0.713 . . . . 2.49 111.909 -174.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.702 HD11 ' HB3' ' A' ' 166' ' ' LEU . 63.5 mt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.45 0.643 . . . . 1.4 111.781 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.941 HG23 ' HG2' ' A' ' 49' ' ' GLN . 28.9 m -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.556 -0.905 . . . . 1.85 108.556 170.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.519 ' HE1' HG21 ' A' ' 50' ' ' VAL . 83.0 m-85 . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 108.872 -0.788 . . . . 1.14 108.872 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.78 ' HB ' HG23 ' A' ' 11' ' ' VAL . 37.5 mm . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.439 -0.578 . . . . 1.31 109.439 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.723 HG23 ' HB3' ' A' ' 103' ' ' ALA . 87.5 t -91.84 95.7 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.409 -0.36 . . . . 1.78 111.257 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.789 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -81.94 97.66 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 120.291 -0.564 . . . . 1.97 109.632 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 96' ' ' THR . 20.4 tp -86.94 109.0 19.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.757 -0.656 . . . . 1.98 110.643 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.886 HG12 ' HA3' ' A' ' 15' ' ' GLY . 5.0 p -85.23 142.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 1.8 111.298 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.741 HG21 ' HA ' ' A' ' 114' ' ' ILE . 18.1 m -138.9 -177.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.553 -0.906 . . . . 1.79 108.553 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.81 98.26 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.953 -0.699 . . . . 1.03 112.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.97 -95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.106 1.15 . . . . 1.66 114.106 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.17 -8.21 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 2.01 112.002 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.06 -32.58 39.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 1.09 110.458 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 72.31 -139.11 27.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.259 -0.882 . . . . 0.52 112.443 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' A' ' 96' ' ' THR . 78.4 t -97.1 106.54 18.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 123.012 0.525 . . . . 1.67 111.512 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.546 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 51.0 mtp -75.9 170.85 13.9 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 1.32 110.634 173.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 79.0 Cg_exo -43.85 -58.07 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.79 2.327 . . . . 0.88 112.898 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.592 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.2 mt-30 -56.13 -32.86 64.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.387 0.514 . . . . 2.01 112.387 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.577 HG22 HD23 ' A' ' 84' ' ' LEU . 11.4 m -66.68 -23.16 66.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.134 0.492 . . . . 1.19 110.579 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.447 HG21 HG12 ' A' ' 92' ' ' VAL . 91.1 t -91.79 -45.25 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.404 -0.362 . . . . 1.66 110.69 175.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 46.1 mt-10 -61.36 -18.13 57.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 1.62 111.147 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.664 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -86.32 -41.47 14.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.814 -0.63 . . . . 1.09 109.358 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.624 HG12 HG12 ' A' ' 110' ' ' ILE . 1.3 mt -68.35 -55.46 16.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 CA-C-N 115.452 -0.795 . . . . 1.13 110.631 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.412 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 t-20 -45.33 -36.8 4.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.791 0.436 . . . . 1.97 111.432 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -79.01 -29.16 43.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.897 -0.592 . . . . 1.02 111.012 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.723 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -99.51 -42.62 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.96 0.726 . . . . 1.18 112.96 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -17.4 64.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.074 0.464 . . . . 2.98 111.092 -166.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.441 ' N ' ' HD3' ' A' ' 104' ' ' LYS . . . -87.47 5.22 40.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.52 . . . . 1.3 111.741 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -96.59 1.63 51.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.401 -0.592 . . . . 1.3 109.401 174.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 74.71 39.01 0.45 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.38 1.086 . . . . 2.59 108.966 176.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -118.52 143.59 33.62 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 113.5 -1.682 . . . . 1.71 110.248 -176.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.1 Cg_exo -69.14 154.35 70.33 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.628 2.219 . . . . 0.62 114.157 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.624 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -122.3 146.87 26.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 113.913 -1.494 . . . . 1.62 109.806 -177.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.789 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.54 148.36 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.89 -1.152 . . . . 1.31 107.89 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -115.41 130.03 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 109.851 -0.426 . . . . 1.07 109.851 174.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -116.66 87.28 2.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.911 -1.144 . . . . 1.07 107.911 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.741 ' HA ' HG21 ' A' ' 86' ' ' VAL . 7.5 mt -73.87 97.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.432 -1.258 . . . . 1.56 109.976 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 23.1 t-20 -88.19 147.5 24.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.448 -0.342 . . . . 0.88 111.066 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 31.0 mtmm 76.98 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.024 0.828 . . . . 3.11 111.753 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.51 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 23.8 mmm . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 108.343 -0.984 . . . . 1.55 108.343 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 26.2 t-20 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.505 -0.554 . . . . 2.21 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.9 Cg_endo -42.15 -53.46 3.55 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 124.003 3.135 . . . . 1.01 113.627 175.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.53 -48.23 19.41 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.549 0.574 . . . . 2.0 112.549 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -52.2 -60.83 2.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.459 0.647 . . . . 3.7 110.115 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.4 HG13 ' HA2' ' A' ' 91' ' ' GLY . 48.4 t -54.1 -45.1 65.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.248 -1.342 . . . . 1.12 110.537 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.72 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.6 mtp -62.79 -33.11 74.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.85 -0.614 . . . . 1.07 111.029 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -72.15 -23.04 61.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.434 -0.348 . . . . 2.01 111.196 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 7.0 mt-10 -72.5 -32.52 66.24 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.976 -0.75 . . . . 2.02 108.976 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.518 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -72.35 -44.32 62.77 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.575 0.702 . . . . 1.62 109.295 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.969 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -76.0 -2.07 28.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.926 -1.034 . . . . 1.08 109.778 177.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.7 tp10 -78.63 -31.32 46.88 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.303 -1.369 . . . . 2.18 107.303 173.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 136' ' ' LEU . 40.1 m-85 -90.11 9.66 27.38 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.812 . . . . 1.17 109.107 171.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 74.99 16.96 2.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.814 -1.539 . . . . 2.43 110.37 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.56 HD21 HD12 ' A' ' 100' ' ' ILE . 6.1 mp -91.13 72.19 6.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.212 1.006 . . . . 2.28 108.488 173.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.471 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.49 129.89 92.96 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.917 -1.492 . . . . 1.28 110.711 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.791 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -50.72 158.32 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.953 2.436 . . . . 0.34 112.831 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.7 -29.8 62.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.056 -0.974 . . . . 2.01 108.504 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.679 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.4 mp0 -42.14 -55.08 3.38 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.431 -1.259 . . . . 1.18 110.597 163.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.969 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 13.5 m0 -90.7 -23.21 20.79 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.861 -1.518 . . . . 0.45 111.286 -166.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.28 25.98 2.81 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.709 -1.234 . . . . 0.45 112.44 171.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.471 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -102.84 -113.81 3.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.45 -0.881 . . . . 0.5 112.689 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -154.45 30.15 0.43 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.087 0.47 . . . . 1.3 111.503 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 136' ' ' LEU . 30.6 m -125.22 124.0 40.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.157 -0.617 . . . . 1.06 112.254 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 164' ' ' MET . 4.3 mp -91.94 103.33 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.498 . . . . 1.86 111.419 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.791 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 30.7 m-85 -85.54 126.33 33.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.906 0.384 . . . . 0.38 111.842 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.4 m -126.91 124.63 39.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.501 -0.772 . . . . 1.82 109.959 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.51 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 18.6 ptpt -98.75 86.94 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.655 0.74 . . . . 2.94 109.369 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.583 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.75 174.01 6.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.89 0.852 . . . . 1.89 112.52 -173.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.64 127.68 5.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.599 -1.182 . . . . 2.08 110.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . . . -80.27 -3.25 48.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 1.43 110.768 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -74.71 -46.62 36.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.281 -0.872 . . . . 3.46 109.897 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -106.61 -11.1 15.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.612 -1.176 . . . . 1.78 111.182 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.556 ' HA ' HD22 ' A' ' 158' ' ' LEU . 54.6 mttp 62.78 15.82 8.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.339 -0.846 . . . . 2.75 112.706 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.16 -65.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.892 0.854 . . . . 2.64 110.912 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.583 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -67.04 -11.43 58.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.764 -1.107 . . . . 0.73 113.267 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 155' ' ' LYS . 4.2 mm? -64.44 -44.56 90.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.314 0.557 . . . . 2.12 109.844 178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.9 -48.36 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.053 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.93 -35.06 77.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.84 111.22 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 165' ' ' ILE . 65.5 tp -61.85 -57.84 10.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.558 -0.292 . . . . 1.54 111.398 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 165' ' ' ILE . 4.0 pp -63.08 -29.93 71.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.755 -0.202 . . . . 1.7 110.877 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.404 ' N ' HD11 ' A' ' 162' ' ' LEU . 52.1 mm-40 -63.58 -41.3 98.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 2.49 110.71 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.536 ' HB3' HG22 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -73.02 -38.68 66.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.669 0.271 . . . . 1.29 110.964 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 81' ' ' ILE . 85.6 mt -55.36 -52.73 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.931 -0.577 . . . . 1.24 110.991 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.702 ' HB3' HD11 ' A' ' 57' ' ' ILE . 3.7 pp -71.19 -35.42 71.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.668 0.27 . . . . 2.36 111.526 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 166' ' ' LEU . 61.8 tp -52.12 -32.25 34.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.747 -0.661 . . . . 1.98 110.212 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.44 -0.963 0 CA-C-N 115.912 -0.585 . . . . 1.69 110.26 -179.43 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 1.019 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 4.2 t . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 109.024 -0.732 . . . . 1.57 109.024 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 83' ' ' ILE . 20.0 m -77.7 123.03 26.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.332 -0.849 . . . . 1.18 110.793 -173.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 HD12 HD11 ' A' ' 24' ' ' LEU . 15.0 tt -86.61 135.57 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.486 0.66 . . . . 1.57 109.276 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 37.6 mtt -140.67 -175.58 4.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.455 -0.793 . . . . 1.41 110.954 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.832 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 142.86 -99.04 0.22 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.09 -1.204 . . . . 1.55 110.09 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.402 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 29.5 t60 -156.19 156.13 33.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.019 -0.734 . . . . 1.21 109.019 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.72 -56.35 18.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.653 0.263 . . . . 2.2 111.614 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.91 -18.37 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.314 0.487 . . . . 1.78 112.314 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 7.3 m170 -57.62 -37.03 72.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.012 0.435 . . . . 0.89 111.042 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 127.56 59.17 0.13 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.188 -1.006 . . . . 1.06 113.527 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -87.22 -37.18 17.49 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.512 -0.551 . . . . 2.58 109.512 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -68.99 -44.67 72.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.518 -0.765 . . . . 2.32 110.022 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -71.37 -16.91 62.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.178 -0.465 . . . . 2.23 110.398 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 13' ' ' ILE . 5.8 tt -81.17 -53.77 6.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.083 -0.71 . . . . 2.33 109.083 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 ' O ' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -64.09 -36.07 82.83 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.211 -0.449 . . . . 2.46 110.022 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.25 -54.53 39.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 1.38 111.46 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.02 79.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 1.42 110.973 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 25' ' ' LEU . 4.1 tt -72.59 -30.33 33.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.717 -0.674 . . . . 2.08 109.961 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 2.0 tpt180 -74.09 -33.34 63.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.603 -0.726 . . . . 4.16 110.084 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -73.01 -12.11 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 3.57 110.507 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 108.823 -0.806 . . . . 2.09 108.823 173.75 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 p90 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 108.207 -1.035 . . . . 2.96 108.207 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 50.2 mt-30 -118.76 137.92 53.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.939 0.4 . . . . 2.45 110.642 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.787 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 72.7 t . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.875 0.845 . . . . 2.49 110.991 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.956 HG22 HG22 ' A' ' 11' ' ' VAL . 55.5 mt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 111.927 0.343 . . . . 1.4 111.927 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.402 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 13.4 m -94.44 107.91 19.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.493 -0.321 . . . . 1.85 110.262 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 1.14 111.282 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 1.019 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 40.2 mm . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 111.485 0.179 . . . . 1.31 111.485 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 103' ' ' ALA . 92.3 t -113.78 106.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.541 -0.299 . . . . 1.78 111.077 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.764 HD11 HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -94.39 99.65 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.36 -0.607 . . . . 1.97 109.36 175.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 15.1 tp -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.146 -0.479 . . . . 1.98 111.254 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.832 HG13 ' HA3' ' A' ' 15' ' ' GLY . 4.5 p -79.39 141.54 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.372 0.606 . . . . 1.8 110.809 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 114' ' ' ILE . 26.7 m -140.94 -160.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.569 -1.271 . . . . 1.79 107.569 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.14 147.99 34.45 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.139 -0.624 . . . . 1.03 111.684 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.25 -59.33 0.52 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.606 1.191 . . . . 1.66 112.893 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.79 -9.87 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.507 . . . . 2.01 112.1 -172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.49 -51.3 5.99 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.293 0.568 . . . . 1.09 111.402 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.454 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 85.65 -136.93 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.248 -0.887 . . . . 0.52 111.62 -172.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.953 HG12 ' HB ' ' A' ' 96' ' ' THR . 37.7 t -101.18 114.08 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 122.898 0.479 . . . . 1.67 111.248 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.614 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 39.5 mtp -81.19 169.79 17.85 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 1.32 110.025 172.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.1 Cg_endo -44.9 -48.01 11.25 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.121 2.547 . . . . 0.88 113.324 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 95' ' ' GLN . 2.9 mt-30 -71.35 -25.95 62.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.579 0.228 . . . . 2.01 110.83 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.953 ' HB ' HG12 ' A' ' 92' ' ' VAL . 4.5 m -64.54 -22.58 67.01 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.115 0.483 . . . . 1.19 110.389 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.69 -38.84 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.516 -0.311 . . . . 1.66 110.821 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.0 -29.49 65.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.877 0.37 . . . . 1.62 111.49 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.565 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -79.31 -37.54 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.511 . . . . 1.09 109.661 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -72.63 -49.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 1.13 110.384 178.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -45.1 -35.62 3.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.385 0.674 . . . . 1.97 111.122 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -83.19 -34.68 25.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 1.02 111.2 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 82' ' ' VAL . . . -91.95 -33.12 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.916 0.709 . . . . 1.18 112.916 -170.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.548 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.73 -16.92 60.72 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.114 0.483 . . . . 2.98 110.326 -167.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.8 7.66 44.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.3 112.307 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HB3' HG22 ' A' ' 108' ' ' VAL . . . -108.99 3.2 21.9 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.212 -0.662 . . . . 1.3 109.212 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t30 73.65 34.1 0.98 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.316 -1.364 . . . . 2.59 107.316 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 103' ' ' ALA . 9.6 t -91.96 143.99 28.55 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 112.425 -2.171 . . . . 1.71 110.597 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.17 142.88 31.3 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.344 2.029 . . . . 0.62 113.061 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.628 HG21 HG22 ' A' ' 145' ' ' THR . 1.6 mp -121.6 143.4 34.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 113.19 -1.823 . . . . 1.62 109.442 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 11.3 mt -118.6 155.84 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 108.69 -0.855 . . . . 1.31 108.69 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -118.0 136.07 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 109.936 -0.394 . . . . 1.07 109.936 174.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.33 87.92 2.84 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.24 -1.022 . . . . 1.07 108.24 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.831 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 4.5 mm -66.09 88.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.546 -1.206 . . . . 1.56 109.658 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.12 161.29 18.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.525 -0.176 . . . . 0.88 110.525 -171.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.5 tttm 62.42 29.93 17.24 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.171 0.986 . . . . 3.11 109.402 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.652 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 3.0 tpp . . . . . 0 CA--C 1.542 0.665 0 CA-C-N 114.689 -1.141 . . . . 1.55 111.041 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 126' ' ' ARG . 50.5 t30 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 2.21 110.618 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.4 Cg_endo -47.73 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.178 3.252 . . . . 1.01 113.744 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -46.28 -43.23 15.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.774 0.657 . . . . 2.0 112.774 -175.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.469 ' HB2' ' ND2' ' A' ' 123' ' ' ASN . 4.1 tmt_? -56.94 -53.99 51.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.428 0.632 . . . . 3.7 109.775 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.744 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 47.3 t -60.64 -45.18 97.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.614 -1.176 . . . . 1.12 109.559 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.663 ' HA ' ' CZ ' ' A' ' 147' ' ' PHE . 86.3 mtp -64.2 -32.14 73.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.425 -0.807 . . . . 1.07 111.609 -176.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.507 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.6 mt-30 -83.41 -20.83 33.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.019 0.438 . . . . 2.01 110.283 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.744 ' OE1' ' HA ' ' A' ' 127' ' ' VAL . 3.0 pt-20 -79.05 -27.68 43.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.111 -0.7 . . . . 2.02 109.111 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.61 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.1 mm? -71.72 -42.69 67.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.542 0.687 . . . . 1.62 109.597 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.901 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.6 ppp? -77.11 -2.36 33.85 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.086 -0.961 . . . . 1.08 109.719 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.22 -27.09 35.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.674 -1.232 . . . . 2.18 107.674 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.4 ' CE2' HG11 ' A' ' 92' ' ' VAL . 25.6 m-85 -85.99 4.85 35.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.73 -0.841 . . . . 1.17 108.73 169.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.7 m120 75.11 19.35 2.32 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.203 -1.362 . . . . 2.43 111.126 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.3 mp -97.52 77.72 2.62 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.665 -1.235 . . . . 2.28 107.665 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.531 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.05 129.87 92.3 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 113.559 -1.655 . . . . 1.28 110.799 -176.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.875 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 99.7 Cg_exo -47.16 152.92 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.897 2.398 . . . . 0.34 112.78 172.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -73.65 -29.84 62.57 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.17 -1.377 . . . . 2.01 107.844 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.779 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -49.08 -47.56 44.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.549 -1.205 . . . . 1.18 109.462 168.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.901 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.1 m0 -92.66 -17.65 24.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.967 -1.015 . . . . 0.45 111.2 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.18 19.85 5.77 Favored Glycine 0 CA--C 1.507 -0.41 0 C-N-CA 119.612 -1.28 . . . . 0.45 112.892 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.531 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.12 -113.65 2.23 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.205 -0.998 . . . . 0.5 112.017 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -150.07 19.9 0.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.649 0.24 . . . . 1.3 111.649 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.628 HG22 HG21 ' A' ' 110' ' ' ILE . 23.4 m -125.87 115.09 19.43 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.81 -0.756 . . . . 1.06 112.572 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.704 HG22 ' HB3' ' A' ' 164' ' ' MET . 3.1 mp -84.56 110.73 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.86 110.526 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.875 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.4 m-85 -87.32 121.26 29.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.215 0.531 . . . . 0.38 111.673 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 61.5 m -115.87 103.52 10.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.764 -0.653 . . . . 1.82 110.012 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.831 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 12.1 ptmm? -81.64 84.61 6.74 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.687 -0.857 . . . . 2.94 108.687 172.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.88 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.08 -175.02 2.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.045 -0.98 . . . . 1.89 112.574 -168.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.411 ' N ' HD23 ' A' ' 150' ' ' LEU . 34.0 t -150.41 117.96 6.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.88 -1.055 . . . . 2.08 109.687 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 24' ' ' LEU . . . -74.4 -28.78 61.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 1.43 110.777 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 154' ' ' THR . 11.2 ptmm? -77.42 -50.4 12.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.807 0.813 . . . . 3.46 110.58 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.456 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 6.0 m -77.65 -11.69 59.89 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.425 -1.261 . . . . 1.78 111.655 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 71.25 -20.35 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.012 0.745 . . . . 2.75 113.012 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 154' ' ' THR . 10.8 tp10 -43.3 -63.18 0.87 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.617 0.722 . . . . 2.64 111.809 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.88 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.15 -17.69 74.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.329 -0.851 . . . . 0.73 113.663 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 28' ' ' ILE . 40.5 mt -66.45 -46.08 77.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.469 0.635 . . . . 2.12 110.685 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.88 -37.65 88.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.826 -0.625 . . . . 2.5 110.212 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.6 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 78.4 t60 -73.38 -26.02 60.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.84 111.067 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.76 -47.26 75.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.421 -0.585 . . . . 1.54 109.421 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.494 ' O ' HD22 ' A' ' 166' ' ' LEU . 91.5 mt -53.61 -44.0 69.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.802 -0.635 . . . . 1.7 110.642 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.6 ' OE1' ' HA ' ' A' ' 160' ' ' HIS . 45.3 mt-10 -54.99 -43.14 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.068 0.461 . . . . 2.49 110.866 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.84 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 8.4 mmt -71.2 -31.48 67.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 1.29 110.651 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 162' ' ' LEU . 79.7 mt -63.95 -53.02 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 1.24 110.524 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.58 -33.91 70.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.173 0.435 . . . . 2.36 112.173 174.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.67 -41.48 77.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.15 -0.685 . . . . 1.98 109.15 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.445 -0.695 0 CA-C-N 115.867 -0.606 . . . . 1.69 110.86 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.236 0.378 0 CA-C-O 120.993 0.425 . . . . 1.57 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -92.95 122.47 35.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.681 -0.69 . . . . 1.18 111.272 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.707 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 33.3 mt -104.47 122.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.866 -0.42 . . . . 1.57 109.866 172.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.56 165.57 19.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.187 -0.461 . . . . 1.41 110.075 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.809 ' HA3' HG11 ' A' ' 85' ' ' VAL . . . 166.27 -107.75 0.3 Allowed Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.486 -1.046 . . . . 1.55 110.486 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.437 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 60.1 t60 -159.21 137.58 10.65 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.431 -0.952 . . . . 1.21 108.431 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -59.93 -31.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.257 -0.883 . . . . 2.2 113.201 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.92 -20.57 52.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.271 . . . . 1.78 111.309 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.437 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 47.8 m170 -70.34 -2.61 14.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.152 0.501 . . . . 0.89 111.282 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.65 43.55 3.89 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.772 -0.728 . . . . 1.06 112.848 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -66.45 -39.42 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.276 0.56 . . . . 2.58 109.823 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -67.01 -36.04 81.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.414 -0.812 . . . . 2.32 109.82 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -67.78 -35.91 79.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.676 -0.693 . . . . 2.23 110.273 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 47.4 tp -65.36 -49.11 70.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.706 . . . . 2.33 110.209 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.642 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -66.96 -32.21 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 2.46 110.051 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 28.6 t70 -66.14 -56.8 9.63 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.171 -0.331 . . . . 1.38 111.481 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.62 70.63 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.07 0.462 . . . . 1.42 110.89 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 158' ' ' LEU . 3.1 tt -74.32 -27.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.839 -0.619 . . . . 2.08 110.644 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.9 mtm180 -80.23 -32.47 38.41 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 4.16 109.807 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -65.62 -8.51 20.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.136 -0.938 . . . . 3.57 109.918 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.626 -0.715 . . . . 2.09 109.47 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.75 ' HE2' ' HB ' ' A' ' 50' ' ' VAL . 4.2 p90 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.8 -0.445 . . . . 2.96 109.8 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.602 ' HG2' HG21 ' A' ' 58' ' ' THR . 71.8 mt-30 -139.07 113.36 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.136 -1.061 . . . . 2.45 108.136 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HE2' ' A' ' 48' ' ' TYR . 4.6 p . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.976 0.893 . . . . 2.49 111.914 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 HD11 ' A' ' 166' ' ' LEU . 4.8 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.882 0.372 . . . . 1.4 111.415 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.602 HG21 ' HG2' ' A' ' 49' ' ' GLN . 16.9 m -92.64 125.65 37.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.154 -0.684 . . . . 1.85 109.154 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 112.461 0.541 . . . . 1.14 112.461 -173.578 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.6 mm . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.649 -0.5 . . . . 1.31 109.649 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 103' ' ' ALA . 99.0 t -118.86 101.58 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 O-C-N 122.173 -0.329 . . . . 1.78 111.101 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.707 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 7.0 mm -79.03 121.28 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.776 -1.194 . . . . 1.97 107.776 170.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -118.75 103.59 9.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.16 -0.473 . . . . 1.98 110.855 -176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.809 HG11 ' HA3' ' A' ' 15' ' ' GLY . 6.6 p -89.24 146.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.294 0.568 . . . . 1.8 112.09 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 114' ' ' ILE . 21.5 m -141.59 -175.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.926 -1.033 . . . . 1.79 108.223 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.47 134.37 13.0 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.341 -0.544 . . . . 1.03 112.078 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.47 -125.21 2.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.295 -0.866 . . . . 1.66 112.146 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -105.3 5.17 31.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.92 0.39 . . . . 2.01 110.022 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.78 -32.64 71.96 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.57 0.7 . . . . 1.09 109.75 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.757 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 68.42 -134.74 28.77 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 114.706 -1.133 . . . . 0.52 111.677 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.701 HG11 ' HB ' ' A' ' 96' ' ' THR . 64.2 t -102.32 103.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.145 0.498 . . . . 1.67 111.033 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.603 ' HE2' ' HD2' ' A' ' 94' ' ' PRO . 83.4 mmm -72.77 170.74 12.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 1.32 110.631 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.603 ' HD2' ' HE2' ' A' ' 93' ' ' MET . 72.4 Cg_exo -42.69 -51.21 5.4 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.789 2.326 . . . . 0.88 113.09 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.02 -37.87 89.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.841 0.353 . . . . 2.01 110.717 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.701 ' HB ' HG11 ' A' ' 92' ' ' VAL . 3.1 m -62.18 -35.27 78.32 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.965 -0.562 . . . . 1.19 110.376 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.697 HG21 HG12 ' A' ' 92' ' ' VAL . 41.1 t -74.15 -50.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.152 -0.476 . . . . 1.66 110.688 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.52 -31.22 34.44 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.547 0.53 . . . . 1.62 111.528 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.03 -37.86 28.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 1.09 109.895 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.753 HG12 HD12 ' A' ' 110' ' ' ILE . 1.5 mt -75.45 -37.66 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.646 -0.706 . . . . 1.13 110.47 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -34.93 68.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.731 0.776 . . . . 1.97 109.737 174.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -85.15 -30.65 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.831 -1.077 . . . . 1.02 110.551 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.943 ' HB3' HG21 ' A' ' 82' ' ' VAL . . . -82.41 -49.2 10.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.168 -0.469 . . . . 1.18 111.9 -173.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -53.08 -27.24 19.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.39 0.885 . . . . 2.98 113.39 -166.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.1 10.87 36.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.079 0.77 . . . . 1.3 113.079 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB1' ' CG1' ' A' ' 108' ' ' VAL . . . -97.57 2.37 49.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.213 -0.662 . . . . 1.3 109.213 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t30 71.3 46.64 0.42 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 123.11 1.433 . . . . 2.59 107.831 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.824 HG23 HG22 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -129.5 143.06 47.43 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 112.809 -1.996 . . . . 1.71 111.194 -168.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.516 ' O ' HG22 ' A' ' 108' ' ' VAL . 21.9 Cg_exo -67.26 156.41 66.38 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.486 2.124 . . . . 0.62 112.982 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.753 HD12 HG12 ' A' ' 100' ' ' ILE . 85.1 mt -124.48 141.85 43.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.702 -1.135 . . . . 1.62 109.201 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 3.7 mt -125.93 96.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 C-N-CA 120.35 -0.54 . . . . 1.31 111.238 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -65.82 139.82 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.005 -0.998 . . . . 1.07 110.265 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.474 ' HB3' HG21 ' A' ' 85' ' ' VAL . . . -124.02 89.37 3.07 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.868 -1.16 . . . . 1.07 107.868 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 9.7 mm -65.92 86.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.565 -1.198 . . . . 1.56 110.197 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.05 148.45 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.88 110.721 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 60.63 33.31 20.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.404 -0.817 . . . . 3.11 110.758 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 117' ' ' MET . 1.4 ppp? . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.812 -0.631 . . . . 1.55 110.007 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 16.4 t-20 . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 121.228 0.537 . . . . 2.21 111.016 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.503 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -16.12 -82.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.119 1 C-N-CA 126.301 4.667 . . . . 1.01 116.579 172.73 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -43.81 -55.31 4.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.345 0.658 . . . . 2.0 112.344 -169.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 tpt85 -56.17 -62.16 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.401 0.62 . . . . 3.7 110.786 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.757 HG12 ' HA2' ' A' ' 91' ' ' GLY . 28.1 t -51.82 -49.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.441 -1.254 . . . . 1.12 110.489 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.742 ' HE1' ' HG3' ' A' ' 140' ' ' GLU . 86.5 mtp -66.45 -33.04 74.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 1.07 111.96 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 132' ' ' MET . 87.0 mt-30 -76.38 -26.2 55.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.813 -0.44 . . . . 2.01 109.813 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.447 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -71.12 -31.11 67.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.239 -0.652 . . . . 2.02 109.239 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.885 HD12 HD11 ' A' ' 136' ' ' LEU . 2.8 mm? -68.54 -46.31 69.86 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.506 0.669 . . . . 1.62 109.716 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.867 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.3 ppp? -73.31 -4.57 34.12 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.392 -0.822 . . . . 1.08 110.0 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -81.77 -24.63 35.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.039 -0.726 . . . . 2.18 109.039 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.568 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 39.5 m-85 -84.75 0.61 50.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.896 . . . . 1.17 108.582 167.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 74.14 45.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 113.967 -1.47 . . . . 2.43 109.464 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.885 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -126.19 83.36 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.028 -1.442 . . . . 2.28 107.439 170.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.851 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.23 131.42 94.35 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.592 -1.64 . . . . 1.28 111.28 -173.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.742 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 87.5 Cg_exo -49.87 155.47 4.1 Favored 'Trans proline' 0 CA--C 1.516 -0.377 0 C-N-CA 123.315 2.677 . . . . 0.34 113.705 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HG3' HG13 ' A' ' 146' ' ' ILE . 6.8 mm-40 -80.17 -19.18 47.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.53 -1.214 . . . . 2.01 109.268 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.816 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -58.24 -40.17 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.501 -0.926 . . . . 1.18 108.501 167.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.867 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.3 m0 -96.71 -21.43 17.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.384 -1.28 . . . . 0.45 110.841 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.49 25.22 5.84 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.372 -0.918 . . . . 0.45 112.43 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.851 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.47 -101.11 1.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.721 -0.752 . . . . 0.5 112.612 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -165.11 27.01 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.244 0.545 . . . . 1.3 111.114 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.715 HG22 HD13 ' A' ' 136' ' ' LEU . 62.2 m -130.17 116.85 19.03 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.241 -0.584 . . . . 1.06 112.389 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.742 HG12 HG22 ' A' ' 168' ' ' VAL . 4.0 mp -82.14 109.04 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 1.86 110.546 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.742 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.9 m-85 -89.54 96.24 10.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.984 0.421 . . . . 0.38 111.186 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.437 ' O ' HD12 ' A' ' 150' ' ' LEU . 75.1 m -84.32 99.55 10.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.313 -0.625 . . . . 1.82 109.313 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.609 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 2.4 pttm -82.83 84.16 7.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.552 -0.907 . . . . 2.94 108.552 176.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.567 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.44 -179.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.298 -0.865 . . . . 1.89 112.97 -168.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p -152.94 111.28 3.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 2.08 110.156 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.95 64.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.362 -0.381 . . . . 1.43 111.237 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -75.14 -46.91 31.27 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.896 0.855 . . . . 3.46 110.15 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m -72.62 -14.78 61.68 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.251 -1.34 . . . . 1.78 110.397 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tptp 58.61 27.33 15.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.499 -1.228 . . . . 2.75 111.576 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -92.35 -67.43 0.86 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.534 0.683 . . . . 2.64 110.266 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.567 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.02 -13.04 69.26 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.248 -0.887 . . . . 0.73 113.55 -176.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 28' ' ' ILE . 3.3 tm? -60.54 -54.44 45.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 2.12 109.38 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.29 -33.75 76.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.293 -0.867 . . . . 2.5 109.89 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.7 t60 -65.38 -25.98 67.8 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.666 -0.697 . . . . 0.84 111.075 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 165' ' ' ILE . 59.7 tp -66.59 -55.4 15.54 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.002 -0.369 . . . . 1.54 110.002 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 165' ' ' ILE . 92.1 mt -55.9 -41.6 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 1.7 110.723 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.676 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 6.4 pt-20 -69.48 -27.73 65.46 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.598 -0.441 . . . . 2.49 110.61 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG2' HG22 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -81.3 -32.2 33.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 1.29 109.821 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 162' ' ' LEU . 32.6 mt -55.41 -54.63 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.361 -0.836 . . . . 1.24 111.896 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -81.2 -30.06 34.39 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.748 -0.595 . . . . 2.36 111.969 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.3 tt -59.53 -31.56 69.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.849 -0.426 . . . . 1.98 109.849 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.742 HG22 HG12 ' A' ' 146' ' ' ILE . 25.2 t . . . . . 0 N--CA 1.444 -0.737 0 CA-C-N 115.941 -0.572 . . . . 1.69 111.283 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.915 HG12 HG21 ' A' ' 81' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.408 0.623 . . . . 1.57 109.715 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 83' ' ' ILE . 19.3 m -80.42 128.09 33.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 1.18 111.452 -171.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.626 HG12 HD11 ' A' ' 83' ' ' ILE . 52.1 mt -94.95 128.52 46.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.041 -0.527 . . . . 1.57 110.271 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.59 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 55.6 mtt -125.29 -177.94 4.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 1.41 110.459 177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.92 130.44 4.45 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.504 -0.855 . . . . 1.55 110.984 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -50.69 138.38 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.512 . . . . 1.21 110.4 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.427 ' HA ' ' CG ' ' A' ' 21' ' ' LYS . 30.3 m -61.63 -27.5 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.871 1.063 . . . . 2.2 113.871 -167.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.31 -19.16 60.57 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.025 0.38 . . . . 1.78 112.025 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -72.01 -34.26 68.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.761 0.282 . . . . 0.89 111.761 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.58 67.63 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.392 -0.909 . . . . 1.06 112.75 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' A' ' 13' ' ' ILE . 14.0 mmmm -89.03 -56.33 3.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.067 0.461 . . . . 2.58 111.128 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -65.91 -18.08 65.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 2.32 110.799 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 p -74.75 -19.94 60.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.127 -0.488 . . . . 2.23 111.011 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 68.0 mt -69.01 -52.19 31.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.715 -0.394 . . . . 2.33 110.307 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 8.7 mp -60.32 -34.09 73.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.973 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.74 -51.38 41.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.882 0.327 . . . . 1.38 111.882 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -69.6 -33.33 72.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.007 0.432 . . . . 1.42 111.008 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -66.06 -24.21 33.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.996 -0.547 . . . . 2.08 110.54 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 51.5 mtp180 -79.09 -21.65 46.39 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.215 0.531 . . . . 4.16 110.636 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -71.78 -7.74 50.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.718 0.77 . . . . 3.57 109.647 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.966 -1.016 . . . . 2.09 110.172 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.454 ' CE2' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.407 0.622 . . . . 2.96 111.045 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.13 153.97 21.86 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.39 -0.823 . . . . 2.45 108.857 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.468 HG22 ' HE2' ' A' ' 59' ' ' PHE . 71.7 t . . . . . 0 C--N 1.309 -1.173 0 CA-C-N 115.468 -0.787 . . . . 2.49 109.259 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.656 HG21 HG21 ' A' ' 11' ' ' VAL . 48.3 mt . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 110.18 -0.304 . . . . 1.4 110.18 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -105.75 131.71 52.77 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.172 -0.677 . . . . 1.85 109.172 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' HE2' HG22 ' A' ' 50' ' ' VAL . 43.7 m-85 . . . . . 0 CA--C 1.513 -0.469 0 C-N-CA 119.979 -0.688 . . . . 1.14 111.104 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.915 HG21 HG12 ' A' ' 11' ' ' VAL . 23.8 mm . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.673 0.273 . . . . 1.31 110.308 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' CB ' ' A' ' 103' ' ' ALA . 53.5 t -117.28 106.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 116.331 -0.395 . . . . 1.78 110.818 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.831 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -90.5 105.15 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.222 -0.659 . . . . 1.97 109.222 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.608 HD23 HD12 ' A' ' 100' ' ' ILE . 11.3 tp -90.34 109.65 20.75 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.289 -0.414 . . . . 1.98 111.361 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.2 t -80.89 130.91 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 1.8 110.953 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -131.36 -174.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.585 -0.894 . . . . 1.79 108.585 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.543 ' HB2' ' HD2' ' A' ' 116' ' ' LYS . . . -147.74 129.73 15.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.981 -0.687 . . . . 1.03 112.564 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 20.89 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.16 1.538 . . . . 1.66 114.97 169.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.95 -2.57 22.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.693 -0.685 . . . . 2.01 112.11 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -32.91 24.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.08 0.467 . . . . 1.09 110.725 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.687 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 69.77 -120.6 9.99 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.453 -0.794 . . . . 0.52 111.805 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.69 HG13 HG23 ' A' ' 97' ' ' VAL . 58.7 t -124.21 109.77 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 120.847 0.356 . . . . 1.67 110.693 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.546 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 67.5 mtp -77.29 169.01 23.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 1.32 110.569 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.5 Cg_exo -44.79 -51.23 7.59 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.037 2.491 . . . . 0.88 113.417 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -66.78 -29.72 69.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.629 0.252 . . . . 2.01 111.366 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.584 ' HB ' HG12 ' A' ' 92' ' ' VAL . 4.4 m -69.47 -28.05 65.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.564 0.697 . . . . 1.19 109.467 174.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG23 HG13 ' A' ' 92' ' ' VAL . 12.4 t -76.69 -52.24 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.66 111.078 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -65.02 -19.24 65.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.04 0.385 . . . . 1.62 112.04 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -73.62 -37.36 65.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.203 -1.036 . . . . 1.09 108.203 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.805 HG12 HD12 ' A' ' 110' ' ' ILE . 2.8 mt -76.63 -41.16 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 113.969 -1.469 . . . . 1.13 110.727 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 98' ' ' GLU . 7.2 m-20 -54.04 -37.96 64.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.374 0.607 . . . . 1.97 110.367 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -74.85 -31.9 61.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 1.02 110.501 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -82.79 -48.62 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.447 . . . . 1.18 111.949 -175.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -56.86 -34.37 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.398 -0.819 . . . . 2.98 111.985 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.23 10.16 37.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.365 0.506 . . . . 1.3 112.365 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 108' ' ' VAL . . . -104.39 5.87 34.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.151 -1.055 . . . . 1.3 108.151 169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.0 38.25 6.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.448 -1.251 . . . . 2.59 110.317 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 109' ' ' PRO . 2.0 m -105.68 148.48 36.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.57 -0.741 . . . . 1.71 110.95 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.93 155.27 62.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.098 2.532 . . . . 0.62 113.09 171.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.805 HD12 HG12 ' A' ' 100' ' ' ILE . 68.8 mt -125.91 145.92 32.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.107 -0.951 . . . . 1.62 110.259 -174.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.831 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 mt -120.47 155.93 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 109.24 -0.652 . . . . 1.31 109.24 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -120.32 137.3 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 120.997 0.427 . . . . 1.07 110.403 174.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.03 88.42 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.91 -1.145 . . . . 1.07 107.91 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 86' ' ' VAL . 30.3 mt -72.51 97.02 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.956 -1.02 . . . . 1.56 110.487 178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.56 165.45 15.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.69 -0.485 . . . . 0.88 109.69 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 87' ' ' ALA . 63.0 mttm 64.35 19.24 11.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.324 0.583 . . . . 3.11 110.896 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.864 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.3 tpp . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.646 -0.706 . . . . 1.55 110.949 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 109.838 -0.43 . . . . 2.21 109.838 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.566 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.8 Cg_exo -39.54 -60.01 0.59 Allowed 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.876 3.051 . . . . 1.01 112.77 172.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.8 -52.92 7.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.776 0.43 . . . . 2.0 111.53 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.566 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -54.97 -59.71 4.37 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.875 0.369 . . . . 3.7 110.061 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.687 HG11 ' HA2' ' A' ' 91' ' ' GLY . 60.3 t -53.99 -44.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.266 -0.879 . . . . 1.12 110.831 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.664 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.6 mtp -68.17 -31.83 71.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.641 -0.709 . . . . 1.07 111.184 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.6 mt-30 -73.68 -26.87 60.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.458 -0.337 . . . . 2.01 110.621 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.1 mm-40 -62.52 -39.85 94.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.551 -0.907 . . . . 2.02 108.551 172.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.852 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -68.25 -42.95 78.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.55 0.69 . . . . 1.62 110.062 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.836 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -76.03 -5.87 48.43 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.346 -0.843 . . . . 1.08 110.107 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -82.32 -26.28 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.886 -0.783 . . . . 2.18 108.886 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.617 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 13.5 m-85 -84.6 -0.41 53.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.282 -1.007 . . . . 1.17 108.282 168.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 72.18 42.67 0.56 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 113.931 -1.486 . . . . 2.43 110.44 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -121.8 82.73 1.99 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 106.479 -1.674 . . . . 2.28 106.479 168.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.583 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -63.33 131.59 94.84 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.002 -1.454 . . . . 1.28 110.773 -172.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.748 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 86.7 Cg_exo -46.52 151.74 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.879 2.386 . . . . 0.34 112.894 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -25.74 53.71 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.25 -1.341 . . . . 2.01 108.335 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.746 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.35 -43.0 64.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.258 -1.337 . . . . 1.18 109.435 167.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.836 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.1 m0 -94.56 -26.0 16.58 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.879 -1.055 . . . . 0.45 111.218 -170.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.46 25.3 2.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.943 -1.123 . . . . 0.45 112.583 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.88 -111.79 2.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.5 -0.857 . . . . 0.5 112.573 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -151.01 21.99 0.77 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.679 0.276 . . . . 1.3 111.606 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 36.4 m -125.78 118.79 26.3 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.932 -0.707 . . . . 1.06 112.743 -172.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 164' ' ' MET . 4.0 mp -85.44 108.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.86 110.554 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.748 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.3 m-85 -88.83 119.38 29.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.199 0.523 . . . . 0.38 111.486 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 56.8 m -114.93 121.75 44.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.68 -0.691 . . . . 1.82 109.557 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.864 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 58.2 pttt -97.15 104.37 16.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.302 -0.629 . . . . 2.94 109.302 174.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.488 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -125.47 -170.88 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.36 1.076 . . . . 1.89 113.07 -171.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.418 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 30.2 t -169.87 126.92 0.87 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.4 -1.727 . . . . 2.08 108.252 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.12 -12.37 59.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.072 0.463 . . . . 1.43 111.083 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -84.93 -57.13 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 3.46 110.174 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 28.4 p -81.53 -17.6 47.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.13 -0.941 . . . . 1.78 110.51 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HE3' ' O ' ' A' ' 27' ' ' ALA . 6.5 tptm 74.22 -11.98 0.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.905 0.753 . . . . 2.75 112.311 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -44.17 -70.11 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.499 0.72 . . . . 2.64 112.86 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -73.6 -5.62 68.87 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.73 113.872 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.494 HD13 ' HE2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -73.36 -45.46 54.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.0 -0.741 . . . . 2.12 109.0 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.69 -36.53 76.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 2.5 109.889 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.422 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 82.4 t60 -70.72 -20.21 62.68 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.862 -0.608 . . . . 0.84 110.812 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.04 -49.62 42.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.843 0.354 . . . . 1.54 110.123 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.475 HD22 HD11 ' A' ' 28' ' ' ILE . 98.4 mt -58.2 -37.48 74.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.708 -0.678 . . . . 1.7 111.384 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -70.02 -36.37 75.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.798 -0.361 . . . . 2.49 110.67 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.751 ' HB3' HG22 ' A' ' 146' ' ' ILE . 22.0 mmt -69.06 -38.56 79.15 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.24 0.543 . . . . 1.29 109.72 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.51 -52.27 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.239 -0.891 . . . . 1.24 110.514 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.35 -42.5 98.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.986 -0.552 . . . . 2.36 111.491 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.2 -45.99 65.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.807 -0.633 . . . . 1.98 110.0 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 116.101 -0.5 . . . . 1.69 111.315 -177.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.898 HG23 ' HB ' ' A' ' 81' ' ' ILE . 56.2 t . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 109.281 -0.637 . . . . 1.57 109.281 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -82.59 120.6 25.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 1.18 111.557 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.544 HD11 ' HG ' ' A' ' 25' ' ' LEU . 42.7 mt -78.97 121.03 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 1.57 109.711 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 19.5 mmt -110.97 176.75 4.9 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.158 -0.928 . . . . 1.41 109.938 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 1.091 ' HA3' HG11 ' A' ' 85' ' ' VAL . . . 123.26 136.05 4.7 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.341 -0.933 . . . . 1.55 111.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 67.6 t60 -45.62 136.27 6.01 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.646 0.736 . . . . 1.21 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.79 -35.27 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.331 -1.304 . . . . 2.2 113.45 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.28 -18.48 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 1.78 111.095 -175.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -71.33 -12.22 61.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.182 0.515 . . . . 0.89 110.766 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.47 45.77 6.75 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.506 -0.77 . . . . 1.06 113.34 172.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HA ' HD22 ' A' ' 24' ' ' LEU . 58.7 pttt -67.46 -26.33 66.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 2.58 110.835 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -67.7 -28.56 67.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 2.32 110.324 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 90.5 m -68.16 -28.17 67.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.89 -0.596 . . . . 2.23 111.039 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.655 HD22 ' HA ' ' A' ' 21' ' ' LYS . 3.9 mm? -62.51 -51.12 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 2.33 110.4 176.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HA ' HG22 ' A' ' 28' ' ' ILE . 6.6 mt -72.3 -25.65 61.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 2.46 111.474 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 20.9 t70 -68.39 -49.07 62.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.502 -0.317 . . . . 1.38 111.356 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.06 73.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.932 0.396 . . . . 1.42 110.683 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 162' ' ' LEU . 4.7 tt -76.71 -33.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.867 -0.606 . . . . 2.08 110.945 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 15.3 ptt180 -75.19 -32.23 61.17 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.742 0.782 . . . . 4.16 109.729 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -82.11 15.58 2.3 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.469 -1.242 . . . . 3.57 111.641 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 120.862 0.363 . . . . 2.09 111.278 -173.645 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.198 0.523 . . . . 2.96 111.898 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.489 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 13.9 mt-30 -107.55 109.71 21.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.869 -1.16 . . . . 2.45 107.869 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 121.362 0.601 . . . . 2.49 111.736 -171.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 HG21 ' A' ' 11' ' ' VAL . 61.7 mt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.012 0.434 . . . . 1.4 112.044 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.489 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -101.2 97.83 8.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 1.85 109.896 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 110.394 -0.224 . . . . 1.14 110.394 -178.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.898 ' HB ' HG23 ' A' ' 11' ' ' VAL . 44.9 mm . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.815 -0.439 . . . . 1.31 109.815 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.949 HG22 ' HB3' ' A' ' 103' ' ' ALA . 61.2 t -85.68 96.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 116.328 -0.396 . . . . 1.78 111.616 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.692 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 6.5 mm -84.11 93.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.97 109.283 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.7 tm? -86.97 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.737 -0.665 . . . . 1.98 109.749 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 1.091 HG11 ' HA3' ' A' ' 15' ' ' GLY . 3.1 p -77.41 144.32 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.622 0.725 . . . . 1.8 110.728 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 127' ' ' VAL . 8.4 t -136.72 175.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.58 -1.267 . . . . 1.79 107.58 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -138.06 131.16 30.18 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 122.101 -0.375 . . . . 1.03 110.251 175.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB1' HG21 ' A' ' 114' ' ' ILE . . . -77.44 27.55 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.882 -0.599 . . . . 1.66 112.325 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 87' ' ' ALA . 16.4 p-10 -135.35 10.06 3.47 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.98 0.419 . . . . 2.01 110.056 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.81 -58.78 0.4 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.349 0.595 . . . . 1.09 110.605 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.547 ' O ' HG13 ' A' ' 86' ' ' VAL . . . 118.24 -115.09 3.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.232 -0.895 . . . . 0.52 111.457 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 97' ' ' VAL . 46.6 t -122.81 109.38 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.078 0.465 . . . . 1.67 110.233 -175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.89 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 62.5 mtp -88.49 174.45 5.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.121 -0.49 . . . . 1.32 109.775 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.89 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 7.0 Cg_endo -49.46 -53.13 7.53 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.769 2.313 . . . . 0.88 113.04 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 38.7 mt-30 -61.15 -32.39 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.624 0.231 . . . . 2.01 111.624 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.526 ' CG2' HD12 ' A' ' 84' ' ' LEU . 21.1 m -63.5 -31.24 72.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.806 0.812 . . . . 1.19 109.926 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 1.043 ' CG2' ' HH ' ' A' ' 134' ' ' TYR . 41.2 t -82.18 -52.54 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.713 -1.13 . . . . 1.66 111.305 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 48.4 mt-10 -55.71 -34.1 64.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.746 -0.661 . . . . 1.62 111.972 -176.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -70.6 -39.46 73.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.541 0.686 . . . . 1.09 109.504 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.507 HD13 HD22 ' A' ' 136' ' ' LEU . 1.7 mt -70.74 -42.18 77.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.395 -1.275 . . . . 1.13 110.188 174.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.48 ' ND2' HG11 ' A' ' 97' ' ' VAL . 94.8 m-20 -54.25 -37.79 65.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.522 . . . . 1.97 110.408 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -79.29 -27.02 42.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.294 -0.867 . . . . 1.02 110.874 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.949 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -97.72 -35.26 10.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.331 0.863 . . . . 1.18 113.331 -169.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -60.95 -27.11 68.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.863 0.69 . . . . 2.98 112.863 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.3 11.89 19.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.095 0.776 . . . . 1.3 113.095 -166.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.32 19.15 18.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.654 -1.239 . . . . 1.3 107.654 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 50.56 37.83 17.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.547 -1.661 . . . . 2.59 111.721 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -94.27 155.53 39.77 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.021 -0.99 . . . . 1.71 110.014 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.523 ' O ' HG22 ' A' ' 108' ' ' VAL . 7.1 Cg_exo -73.97 150.12 43.05 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.686 2.257 . . . . 0.62 113.443 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.652 HG22 HG21 ' A' ' 145' ' ' THR . 1.4 mp -120.72 142.57 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.067 -1.424 . . . . 1.62 109.836 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.692 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.04 146.28 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 108.022 -1.103 . . . . 1.31 108.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -114.06 132.19 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.025 0 N-CA-C 109.634 -0.506 . . . . 1.07 109.634 174.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.48 ' HB3' HG22 ' A' ' 85' ' ' VAL . . . -118.82 87.09 2.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.636 -1.246 . . . . 1.07 107.636 175.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 28.2 mt -69.65 91.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.499 -1.228 . . . . 1.56 110.024 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -92.89 167.58 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.515 . . . . 0.88 109.748 -170.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 66.76 8.45 5.97 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.5 0.5 . . . . 3.11 110.411 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.542 ' HE1' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 1.55 110.649 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 50.4 t-20 . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.042 -0.355 . . . . 2.21 110.042 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.678 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.0 OUTLIER -46.16 -65.62 0.18 Allowed 'Trans proline' 0 C--O 1.219 -0.436 0 C-N-CA 123.538 2.825 . . . . 1.01 112.834 173.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.34 -48.57 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.395 0.678 . . . . 2.0 112.601 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 126' ' ' ARG . 9.0 tpt180 -53.48 -55.85 21.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.621 0.724 . . . . 3.7 109.951 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 86' ' ' VAL . 81.9 t -57.97 -42.43 82.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.357 -1.292 . . . . 1.12 110.412 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.687 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.3 mtp -63.46 -31.43 72.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.61 -0.723 . . . . 1.07 111.265 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.45 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 73.8 mt-30 -77.8 -18.01 56.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.897 -0.321 . . . . 2.01 110.949 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.3 mm-40 -70.39 -35.28 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.934 -0.765 . . . . 2.02 108.934 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.51 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.0 mm? -71.21 -44.61 65.05 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.516 0.674 . . . . 1.62 109.741 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.916 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.5 ppp? -76.08 -2.57 31.48 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.099 -0.955 . . . . 1.08 109.61 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 36.4 tt0 -78.13 -28.91 48.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.411 -1.329 . . . . 2.18 107.411 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 1.043 ' HH ' ' CG2' ' A' ' 97' ' ' VAL . 60.8 m-85 -91.07 10.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.646 -0.706 . . . . 1.17 109.819 170.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 72.36 22.5 3.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.362 -1.29 . . . . 2.43 111.057 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.507 HD22 HD13 ' A' ' 100' ' ' ILE . 6.5 mp -96.94 76.41 2.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.951 -1.129 . . . . 2.28 107.951 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.487 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -66.8 127.99 93.68 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 113.506 -1.679 . . . . 1.28 110.899 -176.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.799 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 91.7 Cg_exo -47.76 155.16 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.221 2.614 . . . . 0.34 112.726 172.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -27.08 54.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.559 -1.2 . . . . 2.01 108.175 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.702 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.29 -42.73 64.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.548 -1.206 . . . . 1.18 109.336 169.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.916 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.0 m0 -95.19 -18.73 20.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.901 -1.045 . . . . 0.45 111.351 -171.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.67 26.52 4.16 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 119.989 -1.101 . . . . 0.45 112.447 170.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.487 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.95 -107.84 2.64 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.393 -0.908 . . . . 0.5 112.452 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -162.87 28.86 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.307 0.575 . . . . 1.3 111.127 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.652 HG21 HG22 ' A' ' 110' ' ' ILE . 23.3 m -121.85 123.73 42.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.064 -0.654 . . . . 1.06 111.983 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.567 HD12 HG13 ' A' ' 111' ' ' ILE . 26.5 mt -91.49 108.7 20.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.616 -0.72 . . . . 1.86 111.137 -175.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.799 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 24.3 m-85 -93.38 118.78 31.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.38 112.204 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 77.3 m -117.16 111.6 19.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.596 -0.729 . . . . 1.82 110.06 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.3 pttp -89.39 89.22 7.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.964 0.887 . . . . 2.94 108.83 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.914 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -116.66 179.93 3.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.696 -1.138 . . . . 1.89 112.745 -165.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 p -145.95 110.39 5.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.491 -1.231 . . . . 2.08 109.886 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -19.5 36.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.474 . . . . 1.43 111.298 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 154' ' ' THR . 19.2 ptpt -80.16 -52.76 7.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.382 0.61 . . . . 3.46 110.296 -176.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 28.1 p -78.39 -2.12 36.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.107 -0.951 . . . . 1.78 111.145 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.0 tptp 61.66 45.72 7.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.872 -1.058 . . . . 2.75 111.989 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -107.23 -73.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.855 0.835 . . . . 2.64 110.167 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.914 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -65.95 -18.67 66.88 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.724 -1.126 . . . . 0.73 113.899 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.04 -47.07 71.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.213 0.53 . . . . 2.12 109.79 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.69 -35.37 67.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.625 -0.716 . . . . 2.5 110.678 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -66.25 -34.81 78.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.184 -0.462 . . . . 0.84 110.668 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 165' ' ' ILE . 61.8 tp -59.68 -53.07 62.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.819 -0.628 . . . . 1.54 110.806 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 28' ' ' ILE . 94.9 mt -56.28 -37.6 70.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.886 -0.597 . . . . 1.7 111.351 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -61.92 -38.59 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 2.49 110.913 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.727 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 17.9 mmt -74.02 -44.29 54.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 1.29 110.368 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 162' ' ' LEU . 94.7 mt -51.94 -56.08 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.525 -0.762 . . . . 1.24 110.544 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.52 -42.85 91.56 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.685 -0.689 . . . . 2.36 111.654 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.4 tp -51.42 -44.75 62.36 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.513 0.508 . . . . 1.98 110.62 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 146' ' ' ILE . 24.6 t . . . . . 0 N--CA 1.445 -0.717 0 CA-C-N 116.09 -0.505 . . . . 1.69 111.416 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.927 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 13.9 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.946 0.403 . . . . 1.57 111.159 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -98.08 141.42 31.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.18 110.812 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.8 mt -96.29 127.36 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.966 0.413 . . . . 1.57 110.517 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.552 ' SD ' HG12 ' A' ' 82' ' ' VAL . 51.2 mtt -133.84 177.81 7.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.31 0.576 . . . . 1.41 111.529 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.31 -92.32 0.21 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.508 -1.037 . . . . 1.55 110.508 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.454 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 t60 -164.24 149.29 10.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.765 -0.828 . . . . 1.21 108.765 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.37 -17.35 22.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.419 0.896 . . . . 2.2 113.419 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.76 -13.12 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.454 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 16.4 m170 -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.703 0.287 . . . . 0.89 111.544 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.29 61.08 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.84 -1.172 . . . . 1.06 113.904 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.39 -22.8 24.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.347 0.594 . . . . 2.58 109.49 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -71.03 -38.32 72.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.503 -0.771 . . . . 2.32 110.762 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -78.66 -23.93 45.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 2.23 109.823 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.5 tm? -63.54 -48.13 78.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.771 -0.826 . . . . 2.33 108.771 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.729 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 18.8 mt -66.41 -36.46 82.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.038 -0.528 . . . . 2.46 110.738 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -55.27 -58.05 9.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.873 0.323 . . . . 1.38 111.873 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 158' ' ' LEU . . . -68.55 -24.82 64.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 1.42 111.313 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 25' ' ' LEU . 1.4 tt -78.79 -23.62 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.418 . . . . 2.08 110.097 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 53.4 mtt180 -76.27 -26.76 56.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.646 0.736 . . . . 4.16 109.264 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -75.32 6.22 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.059 -0.973 . . . . 3.57 109.411 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 29' ' ' ARG . 48.1 m . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.529 -0.76 . . . . 2.09 109.453 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.559 ' HE1' ' HG2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.006 0.431 . . . . 2.96 110.71 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 95.0 mt-30 -135.13 98.31 3.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 2.45 108.433 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.8 -173.505 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.784 HD13 HD22 ' A' ' 166' ' ' LEU . 44.0 mt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.65 0.262 . . . . 1.4 110.767 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.8 m -83.92 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.704 -0.48 . . . . 1.85 109.704 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 14.9 m-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.98 0.419 . . . . 1.14 111.426 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.927 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 23.5 mm . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 111.745 0.276 . . . . 1.31 111.745 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.552 HG12 ' SD ' ' A' ' 14' ' ' MET . 46.8 t -89.89 87.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 116.413 -0.358 . . . . 1.78 110.768 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 165' ' ' ILE . 32.0 mm -75.76 104.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.866 -0.791 . . . . 1.97 108.866 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.725 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.6 tm? -91.26 92.9 8.84 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.254 -0.885 . . . . 1.98 110.235 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 ' HA ' ' HB1' ' A' ' 113' ' ' ALA . 61.7 t -80.86 129.44 37.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.19 0.519 . . . . 1.8 111.122 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.66 HG21 ' HA ' ' A' ' 114' ' ' ILE . 16.8 m -131.3 -165.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.208 -1.034 . . . . 1.79 108.208 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 90' ' ' ASP . . . -139.61 143.86 37.45 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.24 -0.584 . . . . 1.03 111.861 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.08 -58.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.495 1.122 . . . . 1.66 112.709 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -103.92 19.19 20.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.571 . . . . 2.01 111.602 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 2.5 t70 -113.61 -51.59 2.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.237 0.541 . . . . 1.09 110.773 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.706 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.18 -138.6 17.43 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.294 -0.866 . . . . 0.52 111.198 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.896 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.2 t -97.02 115.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 122.818 0.447 . . . . 1.67 111.423 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.589 ' HE3' ' HD2' ' A' ' 94' ' ' PRO . 80.0 mmm -80.06 167.09 36.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.676 -0.49 . . . . 1.32 109.676 171.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HE3' ' A' ' 93' ' ' MET . 90.1 Cg_exo -46.35 -45.5 18.69 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.578 2.186 . . . . 0.88 113.054 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.84 -22.71 60.75 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.644 -0.253 . . . . 2.01 110.855 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.896 ' HB ' HG13 ' A' ' 92' ' ' VAL . 26.2 m -62.23 -30.71 71.29 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.177 0.513 . . . . 1.19 110.649 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.95 -46.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.272 -0.422 . . . . 1.66 111.345 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 1.07 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.717 -0.674 . . . . 1.62 111.196 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.49 -41.09 8.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.528 -0.916 . . . . 1.09 108.528 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.754 HG22 HD22 ' A' ' 136' ' ' LEU . 7.2 mt -73.13 -55.62 12.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.276 -0.874 . . . . 1.13 111.545 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.432 HD21 ' HA ' ' A' ' 101' ' ' ASN . 1.3 t-20 -51.7 -30.08 20.73 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.218 0.607 . . . . 1.97 111.101 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -82.91 -28.9 29.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.769 -0.651 . . . . 1.02 110.584 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 82' ' ' VAL . . . -91.56 -57.83 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.668 0.618 . . . . 1.18 112.668 -172.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.678 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -64.18 -21.32 66.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.615 0.598 . . . . 2.98 112.615 -163.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.02 4.56 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.831 0.348 . . . . 1.3 111.629 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.64 2.56 44.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 1.3 109.37 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t30 81.16 49.27 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.618 -1.174 . . . . 2.59 108.998 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -134.98 143.33 45.64 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 114.037 -1.438 . . . . 1.71 110.873 -175.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 13.8 Cg_exo -71.94 159.28 50.76 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.371 2.714 . . . . 0.62 114.675 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.731 HD11 HG12 ' A' ' 100' ' ' ILE . 46.8 mt -125.24 146.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.235 -1.348 . . . . 1.62 109.89 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 81' ' ' ILE . 5.0 mp -131.52 107.59 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 120.872 0.368 . . . . 1.31 111.726 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -70.9 133.68 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.492 0.663 . . . . 1.07 110.717 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 150' ' ' LEU . . . -124.08 89.41 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.328 -1.36 . . . . 1.07 107.328 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.719 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 56.1 mt -72.18 92.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.069 -0.969 . . . . 1.56 109.615 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.28 169.16 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.88 109.696 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 62.94 20.47 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.522 0.677 . . . . 3.11 109.826 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.657 ' O ' ' HG3' ' A' ' 117' ' ' MET . 17.4 tpp . . . . . 0 N--CA 1.426 -1.645 0 CA-C-O 123.274 1.511 . . . . 1.55 108.856 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 110.194 -0.299 . . . . 2.21 110.194 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.595 ' O ' ' HG3' ' A' ' 128' ' ' MET . 8.1 Cg_exo -33.53 -62.26 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.634 3.556 . . . . 1.01 113.998 171.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.18 -53.8 4.84 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.007 0.523 . . . . 2.0 112.247 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -50.75 -59.15 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 3.7 110.824 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.706 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.8 t -55.31 -48.17 77.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.364 -1.289 . . . . 1.12 110.738 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.649 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 89.2 mtp -62.78 -31.31 72.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.85 -0.614 . . . . 1.07 111.261 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -76.42 -17.5 59.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.364 -0.38 . . . . 2.01 111.064 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.5 mt-10 -73.81 -36.35 64.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.55 -0.907 . . . . 2.02 108.55 171.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.005 HD11 HD13 ' A' ' 136' ' ' LEU . 3.8 mm? -69.12 -43.48 74.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.628 0.728 . . . . 1.62 109.369 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.863 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.698 -0.683 . . . . 1.08 109.884 177.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.597 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 39.4 tt0 -74.29 -32.06 62.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.728 -0.841 . . . . 2.18 108.728 171.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.593 ' CE2' HG12 ' A' ' 92' ' ' VAL . 6.0 m-85 -89.63 2.73 54.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.762 0.791 . . . . 1.17 108.879 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.5 m120 75.15 29.99 0.91 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.544 -1.662 . . . . 2.43 110.913 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.53 74.25 1.15 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.984 -1.487 . . . . 2.28 106.984 168.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.751 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -60.84 131.39 91.44 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 113.796 -1.547 . . . . 1.28 110.459 -172.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 79.7 Cg_exo -47.52 154.82 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.705 2.27 . . . . 0.34 112.509 173.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.98 -23.99 48.18 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.614 -1.176 . . . . 2.01 107.833 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.799 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -55.05 -40.97 70.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.114 -1.403 . . . . 1.18 109.163 167.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.863 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.4 m0 -96.55 -20.53 18.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.789 -1.096 . . . . 0.45 110.66 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.66 28.74 4.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.147 -1.025 . . . . 0.45 112.179 170.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.751 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -98.32 -113.4 3.26 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.593 -0.813 . . . . 0.5 112.797 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -147.4 26.34 1.06 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.936 0.398 . . . . 1.3 111.717 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.584 HG22 HD12 ' A' ' 136' ' ' LEU . 57.3 m -137.01 126.62 25.29 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 119.09 -1.044 . . . . 1.06 113.685 -174.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 164' ' ' MET . 38.8 mm -86.13 115.25 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.001 -1.0 . . . . 1.86 110.406 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.5 m-85 -95.95 123.51 39.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.726 0.298 . . . . 0.38 111.269 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 62.9 m -126.01 133.62 51.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.936 -0.575 . . . . 1.82 109.947 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.719 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pttp -101.47 123.53 45.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.494 -0.928 . . . . 2.94 108.494 170.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.753 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -145.96 175.5 10.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.493 1.14 . . . . 1.89 113.852 -173.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.31 6.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.382 -1.735 . . . . 2.08 109.154 170.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -66.57 -18.08 65.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.31 0.576 . . . . 1.43 110.881 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 154' ' ' THR . 18.1 ptmt -71.57 -52.11 19.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.774 0.797 . . . . 3.46 110.016 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 156' ' ' GLU . 33.7 p -81.74 -5.32 58.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.486 -1.234 . . . . 1.78 111.855 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 76.97 -29.22 0.17 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.787 0.835 . . . . 2.75 112.178 175.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 154' ' ' THR . 23.2 mt-10 -41.1 -69.33 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.08 0.952 . . . . 2.64 112.95 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.753 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.3 -22.29 70.93 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.988 -1.005 . . . . 0.73 114.28 -172.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.691 HD11 ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -67.29 -39.47 85.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.326 0.563 . . . . 2.12 110.023 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.2 m-20 -65.19 -39.53 92.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.268 -0.424 . . . . 2.5 110.085 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -68.79 -29.81 68.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.352 -0.386 . . . . 0.84 110.701 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 165' ' ' ILE . 54.4 tp -63.31 -51.82 64.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.383 -0.372 . . . . 1.54 110.644 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.4 mt -53.36 -41.03 65.43 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.255 -0.43 . . . . 1.7 110.637 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 22.1 mm-40 -56.35 -45.02 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.552 . . . . 2.49 110.644 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.593 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 21.8 mmt -76.07 -31.32 58.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 1.29 110.674 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.469 HG12 HD13 ' A' ' 83' ' ' ILE . 70.9 mt -59.04 -56.81 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.066 -0.516 . . . . 1.24 110.796 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.784 HD22 HD13 ' A' ' 57' ' ' ILE . 3.8 mm? -58.52 -42.25 87.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.524 -0.307 . . . . 2.36 111.032 176.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.58 -41.91 67.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.775 -0.648 . . . . 1.98 110.559 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 1.69 111.446 -179.366 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 96.3 t . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 121.839 0.828 . . . . 1.57 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.634 HG22 ' HG3' ' A' ' 14' ' ' MET . 21.1 m -82.31 121.78 27.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.525 -1.216 . . . . 1.18 111.143 -171.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.577 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 34.3 mt -88.93 114.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.672 -0.492 . . . . 1.57 109.672 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.634 ' HG3' HG22 ' A' ' 12' ' ' THR . 73.7 mtm -139.59 168.0 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.592 -0.731 . . . . 1.41 111.94 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.33 -95.96 0.17 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.438 -1.065 . . . . 1.55 110.438 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.87 149.9 14.89 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.816 -0.809 . . . . 1.21 108.816 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.85 -27.1 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 113.499 0.926 . . . . 2.2 113.499 -168.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.48 -22.78 40.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 1.78 111.683 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -70.78 -60.16 2.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.029 0.442 . . . . 0.89 110.847 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 166.92 58.31 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.546 -0.835 . . . . 1.06 112.484 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -87.93 -73.56 0.48 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.641 0.734 . . . . 2.58 109.876 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.833 -1.076 . . . . 2.32 111.107 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.452 HG22 ' HA2' ' A' ' 20' ' ' GLY . 8.9 t -76.74 -18.24 58.59 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.981 -0.288 . . . . 2.23 110.234 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.59 -44.62 66.93 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.02 -1.104 . . . . 2.33 108.02 174.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.623 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.9 tt -63.28 -40.64 97.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.996 -1.002 . . . . 2.46 110.083 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 t70 -63.64 -52.29 61.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.521 -0.308 . . . . 1.38 111.725 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 158' ' ' LEU . . . -62.15 -41.46 98.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 1.42 111.012 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 25' ' ' LEU . 3.2 tt -66.6 -30.04 48.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.577 -0.738 . . . . 2.08 109.54 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 29.4 tpt180 -69.99 -33.19 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.285 -0.87 . . . . 4.16 109.956 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -63.78 -28.33 69.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 3.57 109.521 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 114.923 -1.035 . . . . 2.09 110.774 178.233 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.617 ' CZ ' ' HG ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 121.273 0.558 . . . . 2.96 111.604 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -104.66 133.69 49.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.48 -0.782 . . . . 2.45 109.729 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.669 HG22 ' HE2' ' A' ' 59' ' ' PHE . 15.1 m . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.268 0.556 . . . . 2.49 111.965 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 HG22 HG21 ' A' ' 11' ' ' VAL . 70.2 mt . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.09 0.471 . . . . 1.4 111.38 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -87.66 105.65 17.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 1.85 109.993 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.669 ' HE2' HG22 ' A' ' 50' ' ' VAL . 35.9 m-85 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.33 . . . . 1.14 110.422 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mm . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 112.008 0.373 . . . . 1.31 112.008 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 1.052 HG22 ' HB3' ' A' ' 103' ' ' ALA . 98.1 t -105.2 111.09 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 120.622 -0.431 . . . . 1.78 111.687 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 16.1 mm -87.42 107.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.82 -0.808 . . . . 1.97 108.82 173.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 100' ' ' ILE . 2.9 tm? -97.45 99.7 11.12 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.989 -1.005 . . . . 1.98 109.509 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.58 133.59 29.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.932 -0.576 . . . . 1.8 110.771 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.694 HG22 ' HA ' ' A' ' 114' ' ' ILE . 23.0 m -131.48 -174.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.4 -0.818 . . . . 1.79 108.809 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.49 143.86 44.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.59 -0.444 . . . . 1.03 110.671 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -36.83 -61.84 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.734 1.271 . . . . 1.66 113.312 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.84 8.47 39.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.729 0.64 . . . . 2.01 112.729 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.36 -44.76 2.96 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.179 -0.608 . . . . 1.09 111.077 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.0 -144.49 23.89 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.827 -0.701 . . . . 0.52 111.409 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.741 HG23 ' HB ' ' A' ' 96' ' ' THR . 3.5 p -94.06 106.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.305 0.574 . . . . 1.67 110.12 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.592 ' HE3' ' HD2' ' A' ' 94' ' ' PRO . 2.7 ppp? -83.95 169.29 17.53 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 1.32 109.263 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.592 ' HD2' ' HE3' ' A' ' 93' ' ' MET . 40.9 Cg_exo -35.76 -51.98 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.614 2.876 . . . . 0.88 115.029 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.81 -24.11 55.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.827 0.346 . . . . 2.01 111.109 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.741 ' HB ' HG23 ' A' ' 92' ' ' VAL . 2.4 m -65.24 -23.78 67.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.416 0.627 . . . . 1.19 110.035 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.444 HG22 HG21 ' A' ' 92' ' ' VAL . 64.0 t -87.73 -42.72 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.778 -0.646 . . . . 1.66 111.052 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -56.58 -33.92 66.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.013 0.435 . . . . 1.62 111.095 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.72 -33.27 46.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 1.09 110.187 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.656 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -75.25 -45.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.635 . . . . 1.13 110.761 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -51.4 -38.13 51.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.264 0.554 . . . . 1.97 110.504 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -78.55 -28.52 46.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.246 -0.888 . . . . 1.02 110.898 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 1.052 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -91.74 -44.78 8.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.588 . . . . 1.18 112.48 -172.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -65.69 -24.19 66.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.577 -0.738 . . . . 2.98 111.383 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.6 8.58 33.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 1.3 111.707 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.36 9.38 39.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.692 -0.855 . . . . 1.3 108.692 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t30 69.44 38.78 1.73 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 114.589 -1.187 . . . . 2.59 110.651 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.668 HG22 HG23 ' A' ' 82' ' ' VAL . 1.5 m -119.23 150.05 48.46 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.372 -0.831 . . . . 1.71 110.779 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.1 Cg_exo -73.19 155.22 52.0 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.175 2.584 . . . . 0.62 113.639 171.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.612 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -115.86 142.44 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.261 -1.336 . . . . 1.62 109.922 -176.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 82' ' ' VAL . 4.8 mp -112.7 140.55 31.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 108.521 -0.918 . . . . 1.31 108.521 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -107.58 136.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 C-N-CA 120.259 -0.576 . . . . 1.07 110.673 176.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.76 87.68 2.76 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.701 -1.222 . . . . 1.07 107.701 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.694 ' HA ' HG22 ' A' ' 86' ' ' VAL . 14.3 mt -75.58 92.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.941 -1.027 . . . . 1.56 109.469 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 1.02 ' HA ' ' HB2' ' A' ' 150' ' ' LEU . 55.4 t30 -84.6 163.6 19.2 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.094 -0.243 . . . . 0.88 110.43 -171.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 73.38 41.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.229 0.612 . . . . 3.11 112.223 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.613 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 5.3 mmm . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 108.371 -0.974 . . . . 1.55 108.371 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.692 0.282 . . . . 2.21 110.591 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.702 ' O ' ' HG3' ' A' ' 128' ' ' MET . 68.4 Cg_exo -39.9 -58.35 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.625 2.883 . . . . 1.01 113.386 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.23 -48.22 9.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.419 0.688 . . . . 2.0 112.375 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.4 tmt_? -52.91 -55.13 25.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.112 0.482 . . . . 3.7 109.794 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.402 HG13 HG21 ' A' ' 86' ' ' VAL . 54.7 t -60.22 -43.57 93.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.839 -1.073 . . . . 1.12 110.144 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.702 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 81.0 mtp -62.14 -31.8 72.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.34 -0.845 . . . . 1.07 111.059 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.433 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 18.7 mt-30 -75.79 -25.15 56.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.392 -0.367 . . . . 2.01 110.439 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.7 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.3 mt-10 -74.24 -32.23 62.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.176 -0.676 . . . . 2.02 109.176 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.564 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.5 mm? -69.75 -43.41 72.31 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.0 -0.68 . . . . 1.62 109.712 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.846 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -74.85 -5.52 44.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.529 -0.759 . . . . 1.08 109.986 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.7 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 9.2 tp10 -71.03 -34.43 71.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.573 -1.269 . . . . 2.18 107.573 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB2' HD13 ' A' ' 136' ' ' LEU . 41.3 m-85 -91.26 21.8 4.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.77 0.795 . . . . 1.17 109.535 172.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.36 29.55 17.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.189 -1.368 . . . . 2.43 109.636 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.619 ' CD1' HD12 ' A' ' 100' ' ' ILE . 13.8 mt -101.51 70.75 1.3 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.408 -1.269 . . . . 2.28 108.848 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -64.54 123.27 82.51 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.438 -1.255 . . . . 1.28 110.531 -178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.701 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.3 Cg_exo -47.25 158.24 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.306 2.67 . . . . 0.34 113.171 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -26.29 57.93 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.567 -1.197 . . . . 2.01 108.718 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.711 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.5 mp0 -44.73 -51.17 9.58 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.597 -1.183 . . . . 1.18 110.703 160.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.846 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 17.2 m0 -94.95 -24.17 17.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.996 -1.456 . . . . 0.45 111.123 -165.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.2 27.6 2.86 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 119.989 -1.1 . . . . 0.45 112.291 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.4 -115.9 4.13 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.265 -0.969 . . . . 0.5 112.514 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -151.89 34.61 0.54 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.645 0.736 . . . . 1.3 111.112 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 22.4 m -130.78 114.32 15.19 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.278 -0.569 . . . . 1.06 111.767 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.6 mp -84.87 110.76 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.826 -0.624 . . . . 1.86 110.379 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.701 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.6 m-85 -92.12 135.16 34.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.366 0.603 . . . . 0.38 111.427 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.1 m -133.53 126.41 30.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 1.82 109.505 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.613 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 25.2 pttt -91.72 110.83 22.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.582 0.706 . . . . 2.94 109.618 172.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 1.02 ' HB2' ' HA ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -83.07 173.89 11.34 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.217 1.932 . . . . 1.89 116.217 -166.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.773 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 24.8 p -175.27 99.3 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 110.562 -3.017 . . . . 2.08 109.245 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.18 -17.73 56.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.7 -0.682 . . . . 1.43 111.913 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.47 -50.42 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.651 0.739 . . . . 3.46 110.086 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 p -82.2 -2.41 52.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.626 -1.17 . . . . 1.78 111.434 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 75.72 -6.9 1.9 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.351 -0.84 . . . . 2.75 113.156 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB2' ' OG ' ' A' ' 151' ' ' SER . 15.8 mm-40 -64.67 -37.16 86.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.151 0.5 . . . . 2.64 110.597 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.773 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -59.97 -44.35 97.27 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.446 -0.797 . . . . 0.73 112.5 176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 27' ' ' ALA . 91.7 mt -67.31 -51.19 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.864 0.32 . . . . 2.12 111.864 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 30.2 t70 -57.97 -53.38 58.89 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.321 0.388 . . . . 2.5 111.077 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.515 ' O ' ' HG2' ' A' ' 164' ' ' MET . 76.1 t60 -61.14 -34.75 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.84 110.854 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 165' ' ' ILE . 52.5 tp -65.15 -56.18 14.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 1.54 111.078 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.82 -39.34 68.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 1.7 110.844 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 57.9 mm-40 -63.56 -40.68 97.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.853 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.75 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.8 mmt -71.82 -38.48 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.424 . . . . 1.29 110.282 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 161' ' ' LEU . 85.6 mt -56.23 -53.43 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.516 -0.766 . . . . 1.24 111.345 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 1.8 pp -72.25 -30.49 64.92 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.84 -0.344 . . . . 2.36 111.904 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.416 ' N ' HD11 ' A' ' 166' ' ' LEU . 55.3 tp -54.45 -33.95 60.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 1.98 110.511 175.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 164' ' ' MET . 76.6 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-N 115.837 -0.619 . . . . 1.69 110.523 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.781 HG13 ' HB ' ' A' ' 81' ' ' ILE . 5.7 m . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.147 0.499 . . . . 1.57 111.244 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -109.32 125.92 52.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.617 -0.72 . . . . 1.18 110.142 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.488 HG23 ' HD2' ' A' ' 21' ' ' LYS . 23.5 mt -89.12 116.85 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 1.57 110.705 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.5 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 21.6 mmt -119.78 -179.21 3.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.015 -0.993 . . . . 1.41 110.11 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.904 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 105.44 131.49 7.02 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.941 -1.264 . . . . 1.55 109.941 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -44.48 135.67 4.6 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.854 0.835 . . . . 1.21 111.102 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.22 -39.08 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.104 -1.407 . . . . 2.2 112.84 -167.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.53 -18.16 55.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.879 0.326 . . . . 1.78 111.879 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.523 ' HE1' ' H ' ' A' ' 93' ' ' MET . 25.1 m170 -64.62 -31.24 72.38 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.037 0.446 . . . . 0.89 110.298 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.18 55.14 0.3 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.198 -1.001 . . . . 1.06 113.624 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.488 ' HD2' HG23 ' A' ' 13' ' ' ILE . 35.8 pttt -87.83 -22.36 24.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.478 -0.934 . . . . 2.58 108.478 172.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -34.8 77.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.627 -1.169 . . . . 2.32 110.002 176.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 p -71.23 -24.67 62.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 2.23 111.068 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.65 -54.93 28.05 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.006 -0.739 . . . . 2.33 109.006 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.651 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 6.0 tt -51.61 -45.31 63.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.094 0.473 . . . . 2.46 110.487 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.51 -52.2 16.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 1.38 112.538 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.63 85.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.367 -0.208 . . . . 1.42 111.116 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.509 HG22 ' HE2' ' A' ' 48' ' ' TYR . 74.3 mt -67.22 -36.87 77.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.541 -0.54 . . . . 2.08 109.541 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.475 ' NH2' ' HB3' ' A' ' 48' ' ' TYR . 15.9 tpp180 -59.49 -38.77 81.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.425 0.631 . . . . 4.16 109.765 171.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -85.14 16.28 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 3.57 111.386 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.449 -0.341 . . . . 2.09 110.804 179.168 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.651 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.561 0.696 . . . . 2.96 111.628 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.788 ' HG2' HG22 ' A' ' 58' ' ' THR . 34.9 mt-30 -125.74 146.92 49.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.551 -1.204 . . . . 2.45 107.762 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 C--N 1.318 -0.794 0 N-CA-C 109.135 -0.691 . . . . 2.49 109.135 178.522 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.571 HD13 HG23 ' A' ' 165' ' ' ILE . 14.8 mt . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.731 0.3 . . . . 1.4 110.509 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.788 HG22 ' HG2' ' A' ' 49' ' ' GLN . 6.9 m -95.04 119.99 34.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.12 -0.326 . . . . 1.85 110.12 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HD2' HD11 ' A' ' 13' ' ' ILE . 54.2 m-85 . . . . . 0 CA--C 1.515 -0.396 0 C-N-CA 120.71 -0.396 . . . . 1.14 110.311 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.781 ' HB ' HG13 ' A' ' 11' ' ' VAL . 41.4 mm . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.005 -0.368 . . . . 1.31 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 103' ' ' ALA . 42.0 t -92.65 101.6 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 120.764 0.316 . . . . 1.78 111.136 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.1 mm -84.94 105.42 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.73 -0.841 . . . . 1.97 108.73 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -100.22 104.81 16.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.92 -0.582 . . . . 1.98 110.81 -174.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.904 HG12 ' HA3' ' A' ' 15' ' ' GLY . 2.8 p -83.59 143.82 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.337 0.589 . . . . 1.8 111.6 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.741 HG23 ' HA ' ' A' ' 114' ' ' ILE . 31.2 m -140.79 -166.77 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.357 -0.979 . . . . 1.79 108.357 174.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.52 144.04 34.1 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.378 -0.529 . . . . 1.03 111.885 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.73 -54.71 1.2 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.504 1.127 . . . . 1.66 113.092 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.34 -37.65 9.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.644 0.609 . . . . 2.01 112.644 -172.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 13.7 t70 -68.66 -45.0 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.613 -0.435 . . . . 1.09 111.354 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.584 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 84.92 -119.76 5.1 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.476 -0.868 . . . . 0.52 111.503 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.892 HG13 ' HB ' ' A' ' 96' ' ' THR . 25.0 t -114.13 116.15 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 122.611 0.364 . . . . 1.67 111.505 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.523 ' H ' ' HE1' ' A' ' 19' ' ' HIS . 39.6 mtp -82.38 166.54 35.98 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.327 -0.62 . . . . 1.32 109.327 169.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 89.2 Cg_exo -44.32 -50.42 7.89 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.88 113.107 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 2.1 mt-30 -66.73 -23.79 66.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.411 0.523 . . . . 2.01 112.411 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.892 ' HB ' HG13 ' A' ' 92' ' ' VAL . 24.4 m -63.3 -38.24 90.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.647 0.26 . . . . 1.19 110.61 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -29.33 5.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 C-N-CA 120.615 -0.434 . . . . 1.66 111.053 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 20.9 mm-40 -51.42 -45.51 62.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.177 0.513 . . . . 1.62 110.524 174.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.457 -0.792 . . . . 1.09 110.973 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.689 HD12 HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -78.55 -45.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.908 -0.587 . . . . 1.13 111.256 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.36 -35.89 68.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.516 0.674 . . . . 1.97 110.048 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -76.03 -29.8 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 1.02 110.324 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.667 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -90.04 -45.95 8.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.265 0.469 . . . . 1.18 112.265 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -55.84 -26.55 47.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.681 0.622 . . . . 2.98 112.681 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.53 7.08 15.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.555 0.576 . . . . 1.3 112.555 -171.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -95.58 -4.25 44.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.823 -0.806 . . . . 1.3 108.823 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 t30 78.15 47.56 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.381 -1.281 . . . . 2.59 108.091 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -130.35 142.5 45.68 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.393 -1.73 . . . . 1.71 111.164 -171.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.66 160.22 50.56 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.308 2.672 . . . . 0.62 114.449 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 145' ' ' THR . 1.4 mp -124.57 145.92 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.43 -1.259 . . . . 1.62 110.566 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 84' ' ' LEU . 5.2 mp -123.88 108.78 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 120.873 0.368 . . . . 1.31 110.97 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -74.26 136.04 26.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.935 -0.575 . . . . 1.07 110.424 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.417 ' HB2' HG21 ' A' ' 85' ' ' VAL . . . -121.59 88.38 2.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.007 -1.108 . . . . 1.07 108.007 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.915 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 38.2 mt -68.21 93.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.306 -1.315 . . . . 1.56 110.722 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -91.5 169.51 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.967 -0.383 . . . . 0.88 109.967 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 60.7 22.47 12.38 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.855 0.836 . . . . 3.11 110.081 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.503 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.2 tpp . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 122.564 1.173 . . . . 1.55 109.018 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 4.5 t-20 . . . . . 0 N--CA 1.462 0.129 0 N-CA-C 109.87 -0.419 . . . . 2.21 109.87 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.0 Cg_exo -39.15 -61.31 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.253 3.302 . . . . 1.01 113.727 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -49.45 -43.85 45.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.991 0.517 . . . . 2.0 112.19 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -53.5 -55.56 24.38 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.31 0.576 . . . . 3.7 109.696 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.584 HG11 ' HA2' ' A' ' 91' ' ' GLY . 55.2 t -61.37 -43.82 97.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.605 -1.179 . . . . 1.12 110.052 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.782 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.5 mtp -63.5 -28.14 69.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.249 -0.887 . . . . 1.07 111.303 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.9 mt-30 -79.06 -23.59 44.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.628 -0.26 . . . . 2.01 110.477 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -71.93 -34.42 69.04 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.249 -0.649 . . . . 2.02 109.249 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.814 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -72.26 -41.0 67.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.571 0.7 . . . . 1.62 109.827 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.832 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -75.63 -5.38 45.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.091 -0.959 . . . . 1.08 109.462 176.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.2 tt0 -84.01 -21.51 31.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.664 -0.865 . . . . 2.18 108.664 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.684 ' CE2' HG12 ' A' ' 92' ' ' VAL . 31.9 m-85 -94.27 10.57 33.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.281 -1.007 . . . . 1.17 108.281 166.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.4 m120 70.97 35.29 1.7 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 113.683 -1.599 . . . . 2.43 111.449 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.553 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.0 mp -112.0 78.16 1.1 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.402 -0.962 . . . . 2.28 108.402 170.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.957 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.63 130.13 93.35 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 113.936 -1.484 . . . . 1.28 110.682 -176.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.806 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 75.8 Cg_exo -51.13 153.33 9.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.849 2.366 . . . . 0.34 113.295 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.7 mm-40 -79.52 -23.52 42.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.488 -1.233 . . . . 2.01 109.083 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.673 ' HB3' ' CD1' ' A' ' 141' ' ' TRP . 8.1 mp0 -42.96 -53.06 4.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.676 -1.147 . . . . 1.18 110.547 159.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.832 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -93.82 -22.06 18.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.739 -1.573 . . . . 0.45 111.237 -167.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.32 25.61 3.73 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.086 -1.054 . . . . 0.45 112.364 172.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.957 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -106.71 2.12 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.623 -0.799 . . . . 0.5 113.114 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.83 23.02 0.27 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.999 0.428 . . . . 1.3 110.944 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.721 HG23 HG21 ' A' ' 110' ' ' ILE . 17.5 m -136.44 112.21 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.912 -0.715 . . . . 1.06 112.834 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.711 HG23 ' HB3' ' A' ' 164' ' ' MET . 52.9 mt -76.89 117.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 1.86 110.808 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.814 ' HZ ' ' HB2' ' A' ' 131' ' ' LEU . 16.3 m-85 -94.69 101.86 13.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.38 111.839 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.2 m -96.42 99.37 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.726 -0.67 . . . . 1.82 109.99 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.915 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 18.6 pttm -79.26 85.17 5.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.776 -0.824 . . . . 2.94 108.776 172.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.665 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -109.82 179.25 4.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.301 -0.863 . . . . 1.89 112.542 -169.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 p -146.17 104.71 3.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.062 -0.972 . . . . 2.08 110.772 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.767 ' HA ' HD22 ' A' ' 158' ' ' LEU . . . -66.86 -17.93 65.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.981 0.42 . . . . 1.43 111.44 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -78.62 -60.76 2.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.42 0.628 . . . . 3.46 110.299 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -85.45 -5.46 59.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.033 -0.985 . . . . 1.78 112.067 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.59 ' HA ' HD23 ' A' ' 158' ' ' LEU . 5.1 tppp? 73.05 -7.08 1.56 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.618 0.574 . . . . 2.75 112.423 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -56.35 -55.39 33.99 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.984 0.897 . . . . 2.64 111.141 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -67.36 -19.57 70.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.995 -1.002 . . . . 0.73 113.695 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.767 HD22 ' HA ' ' A' ' 152' ' ' ALA . 4.0 mm? -67.58 -41.43 84.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.486 0.643 . . . . 2.12 110.367 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.88 -44.47 97.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.728 -0.669 . . . . 2.5 109.926 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.47 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.4 t60 -65.55 -38.14 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.84 111.041 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.51 -58.34 8.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 1.54 112.051 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 166' ' ' LEU . 93.7 mt -56.05 -40.97 74.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.595 -0.275 . . . . 1.7 110.716 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.5 -30.98 71.43 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.954 -0.299 . . . . 2.49 111.144 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.748 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 24.5 mmt -70.4 -39.76 74.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.134 0.492 . . . . 1.29 109.888 175.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.571 HG23 HD13 ' A' ' 57' ' ' ILE . 78.9 mt -57.08 -56.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.093 -0.958 . . . . 1.24 110.559 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.577 0.584 . . . . 2.36 112.577 176.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.43 -37.15 77.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 1.98 110.462 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.589 ' CG2' HD13 ' A' ' 146' ' ' ILE . 1.4 t . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.146 -0.479 . . . . 1.69 110.612 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 81' ' ' ILE . 21.3 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.237 0.542 . . . . 1.57 109.898 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 m -64.93 116.66 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.112 -0.949 . . . . 1.18 111.585 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.847 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.6 mt -104.73 128.19 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.45 . . . . 1.57 110.831 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.6 mtm -139.78 166.56 24.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.021 0.439 . . . . 1.41 111.096 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.59 -107.56 0.29 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.919 -0.872 . . . . 1.55 110.919 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -156.44 160.16 39.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.929 -0.397 . . . . 1.21 109.929 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.82 -56.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.68 0.252 . . . . 2.2 111.68 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.87 -15.14 63.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.435 0.532 . . . . 1.78 112.435 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HE1' ' H ' ' A' ' 93' ' ' MET . 64.3 m170 -77.43 -2.52 35.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.653 0.739 . . . . 0.89 110.421 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.53 47.79 47.93 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.966 -1.015 . . . . 1.06 113.4 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.8 pttp -70.89 -10.84 60.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.798 0.808 . . . . 2.58 109.481 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -81.31 -5.22 57.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.957 -1.019 . . . . 2.32 110.563 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 p -84.67 -32.56 23.55 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 120.801 -0.36 . . . . 2.23 110.821 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.603 HD11 ' N ' ' A' ' 25' ' ' LEU . 4.5 pp -69.66 -34.96 74.73 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.593 -0.891 . . . . 2.33 108.593 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -56.98 -38.84 73.58 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.484 -0.932 . . . . 2.46 108.484 175.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.41 -52.89 7.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 1.38 112.216 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . . . -67.73 -33.59 75.18 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.348 -0.387 . . . . 1.42 111.274 -171.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CG2' ' HE2' ' A' ' 48' ' ' TYR . 96.2 mt -71.65 -29.7 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 2.08 110.314 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 75.2 mtm180 -66.42 -40.96 89.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.218 -0.66 . . . . 4.16 109.218 172.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.34 -12.6 57.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 3.57 110.606 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 115.84 -0.618 . . . . 2.09 110.199 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.5 ' HE1' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.481 0.658 . . . . 2.96 111.893 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 58' ' ' THR . 43.1 mt-30 -101.82 123.4 45.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.175 -0.921 . . . . 2.45 108.921 175.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.513 HG22 ' HE2' ' A' ' 59' ' ' PHE . 12.3 m . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 121.151 0.5 . . . . 2.49 111.954 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.744 HG21 HG23 ' A' ' 11' ' ' VAL . 58.4 mt . . . . . 0 C--O 1.236 0.36 0 CA-C-O 121.033 0.444 . . . . 1.4 110.191 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 49' ' ' GLN . 14.2 m -86.69 111.1 20.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.913 -0.585 . . . . 1.85 110.103 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' HE2' HG22 ' A' ' 50' ' ' VAL . 34.9 m-85 . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.715 0.293 . . . . 1.14 110.352 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.754 HG22 HG11 ' A' ' 11' ' ' VAL . 8.5 mm . . . . . 0 N--CA 1.458 -0.043 0 N-CA-C 110.321 -0.251 . . . . 1.31 110.321 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 103' ' ' ALA . 40.5 t -99.51 96.24 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.107 -0.637 . . . . 1.78 111.283 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.847 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 17.3 mm -74.29 117.41 18.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.198 -1.038 . . . . 1.97 108.198 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.6 tm? -110.65 96.03 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.784 -0.643 . . . . 1.98 110.245 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 49.4 t -84.9 130.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.213 0.53 . . . . 1.8 111.388 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.784 HG13 HG21 ' A' ' 96' ' ' THR . 28.0 m -128.4 -164.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.511 -0.922 . . . . 1.79 108.511 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.56 40.53 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.116 -0.634 . . . . 1.03 111.965 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.712 ' HB2' ' HB3' ' A' ' 117' ' ' MET . . . -31.94 -64.68 0.16 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.93 1.394 . . . . 1.66 113.922 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.71 -20.13 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.864 -0.607 . . . . 2.01 112.356 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.36 -37.0 15.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.362 -0.535 . . . . 1.09 111.598 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 82.87 -144.35 22.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.528 -0.844 . . . . 0.52 111.783 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 96' ' ' THR . 2.8 p -100.85 102.57 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 109.279 -0.637 . . . . 1.67 109.279 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.594 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -83.49 169.54 17.08 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.57 -0.53 . . . . 1.32 109.57 -175.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 29.0 Cg_exo -30.42 -56.17 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.092 3.195 . . . . 0.88 115.1 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -69.98 -34.68 73.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.533 0.206 . . . . 2.01 111.016 -175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.784 HG21 HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.65 -31.48 72.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.649 0.738 . . . . 1.19 109.931 176.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.51 HG21 HG23 ' A' ' 92' ' ' VAL . 72.5 t -78.79 -45.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.354 -0.839 . . . . 1.66 111.055 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.6 mt-10 -63.94 -19.06 64.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.62 111.086 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.79 -41.04 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.863 -0.608 . . . . 1.09 109.646 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.577 HD12 ' HG ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.21 -47.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 1.13 110.79 176.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 101' ' ' ASN . 1.1 t-20 -49.24 -34.78 15.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.926 0.491 . . . . 1.97 110.735 173.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -85.69 -31.93 22.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 1.02 111.02 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.622 ' HB2' HG23 ' A' ' 82' ' ' VAL . . . -82.83 -44.78 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.925 0.343 . . . . 1.18 111.925 -173.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -54.59 -30.75 55.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.654 . . . . 2.98 112.759 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.32 3.37 15.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.973 0.731 . . . . 1.3 112.973 -167.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.443 ' HB1' ' CG1' ' A' ' 108' ' ' VAL . . . -91.39 -2.3 57.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.721 -0.844 . . . . 1.3 108.721 173.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.457 HD21 ' HA ' ' A' ' 107' ' ' ASN . 1.2 t-20 72.22 46.14 0.34 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.986 -1.461 . . . . 2.59 107.534 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.562 HG23 HG21 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -121.24 144.58 40.07 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 112.663 -2.062 . . . . 1.71 110.942 -170.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.45 154.47 73.67 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.681 2.254 . . . . 0.62 114.264 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.662 HG22 HG22 ' A' ' 145' ' ' THR . 1.2 mp -122.57 142.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.746 -1.57 . . . . 1.62 109.645 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.431 ' CD1' HG23 ' A' ' 81' ' ' ILE . 2.7 mp -121.23 99.96 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 CA-C-O 121.272 0.558 . . . . 1.31 111.292 -176.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -68.56 137.12 25.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.361 -0.836 . . . . 1.07 110.613 179.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -122.52 89.48 3.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.966 -1.124 . . . . 1.07 107.966 173.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.782 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 6.6 mm -65.22 85.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.595 -1.184 . . . . 1.56 109.745 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -95.75 168.36 10.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.88 110.128 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 69.46 12.92 8.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.333 0.587 . . . . 3.11 110.206 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.712 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.424 0.63 . . . . 1.55 110.642 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.439 0.162 . . . . 2.21 110.781 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.652 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.2 Cg_exo -38.98 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.051 3.168 . . . . 1.01 114.094 171.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -45.48 -49.02 13.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.859 0.688 . . . . 2.0 112.859 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.563 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -50.68 -57.06 9.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.496 0.665 . . . . 3.7 109.872 175.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.563 ' N ' ' HD3' ' A' ' 126' ' ' ARG . 74.3 t -58.5 -45.51 90.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.389 -1.278 . . . . 1.12 110.514 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.756 ' HE3' ' HG3' ' A' ' 140' ' ' GLU . 84.0 mtp -62.74 -29.05 70.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.3 -0.864 . . . . 1.07 111.376 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -78.32 -24.31 46.67 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.513 -0.312 . . . . 2.01 110.773 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -72.61 -32.82 66.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.793 -0.817 . . . . 2.02 108.793 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.589 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -70.15 -44.67 68.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 120.048 -0.661 . . . . 1.62 109.569 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.886 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -76.95 -0.49 24.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.436 -0.802 . . . . 1.08 110.006 177.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.568 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.0 tp10 -77.5 -31.84 53.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.288 -1.375 . . . . 2.18 107.288 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -95.35 17.51 14.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.146 -0.933 . . . . 1.17 109.696 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.9 34.27 4.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.054 -1.43 . . . . 2.43 110.333 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -106.96 87.09 2.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.09 1.424 . . . . 2.28 109.0 173.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.817 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 93.3 t -83.91 119.74 73.93 Favored Pre-proline 0 C--N 1.285 -2.21 0 CA-C-N 111.559 -2.564 . . . . 1.28 111.334 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.846 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -47.74 157.97 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.791 2.994 . . . . 0.34 113.963 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.524 ' OE1' ' HA ' ' A' ' 144' ' ' ASP . 6.8 mm-40 -74.33 -24.69 59.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.13 -1.395 . . . . 2.01 109.183 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.833 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -56.86 -40.65 76.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.286 -0.87 . . . . 1.18 109.045 169.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.886 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.6 m0 -96.04 -21.24 18.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.858 -1.065 . . . . 0.45 111.089 -169.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.36 30.16 4.51 Favored Glycine 0 CA--C 1.501 -0.786 0 C-N-CA 119.762 -1.209 . . . . 0.45 112.011 170.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.817 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.93 -109.48 2.64 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.377 -0.916 . . . . 0.5 111.48 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.524 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 9.0 p-10 -166.42 46.36 0.07 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.623 1.201 . . . . 1.3 109.591 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.662 HG22 HG22 ' A' ' 110' ' ' ILE . 21.4 m -132.02 110.37 10.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.286 -1.325 . . . . 1.06 111.377 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 146' ' ' ILE . 3.9 mp -81.73 107.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.092 -0.958 . . . . 1.86 110.422 -175.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.846 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 22.6 m-85 -89.76 96.59 10.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.5 . . . . 0.38 111.33 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.428 ' O ' HD13 ' A' ' 150' ' ' LEU . 68.8 m -88.02 99.22 12.0 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.759 -0.655 . . . . 1.82 110.161 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.782 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.8 ptmt -76.35 83.97 3.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.872 -0.788 . . . . 2.94 108.872 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.486 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.5 -178.95 3.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.585 0.707 . . . . 1.89 112.23 -170.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -165.77 130.1 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.036 -0.983 . . . . 2.08 110.792 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . -84.47 -9.65 58.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 1.43 110.32 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -78.34 -58.69 3.12 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.295 -0.866 . . . . 3.46 109.342 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.697 ' HB ' ' HG2' ' A' ' 156' ' ' GLU . 22.1 p -73.99 -22.53 59.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.619 -1.173 . . . . 1.78 110.783 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 tptp 72.61 -2.64 2.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.092 -0.958 . . . . 2.75 110.981 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.697 ' HG2' ' HB ' ' A' ' 154' ' ' THR . 22.1 mm-40 -59.15 -73.33 0.08 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.459 0.647 . . . . 2.64 112.022 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -67.69 -9.1 55.06 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.73 113.454 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.413 HD11 HG12 ' A' ' 28' ' ' ILE . 2.6 tm? -64.27 -51.22 64.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.513 -0.551 . . . . 2.12 109.513 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.71 -36.51 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 2.5 109.938 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.544 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 80.1 t60 -58.75 -37.71 76.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.258 -0.883 . . . . 0.84 110.478 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.79 -49.49 77.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.921 -0.581 . . . . 1.54 110.634 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.26 -38.53 77.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 1.7 110.769 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.5 -42.99 91.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 2.49 110.499 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -39.0 92.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 1.29 110.621 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.23 -48.8 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.985 -0.552 . . . . 1.24 110.213 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.84 -46.98 85.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.854 -0.612 . . . . 2.36 111.034 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.0 tp -48.8 -49.29 39.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.393 -0.821 . . . . 1.98 110.86 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.445 -0.693 0 CA-C-N 116.014 -0.539 . . . . 1.69 111.032 -179.131 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.731 HG23 ' HB ' ' A' ' 81' ' ' ILE . 47.5 t . . . . . 0 N--CA 1.439 -1.004 0 CA-C-O 120.968 0.413 . . . . 1.57 111.028 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -98.12 132.53 43.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.157 0.503 . . . . 1.18 110.413 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.419 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 66.1 mt -94.87 127.51 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 1.57 110.708 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.69 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 54.8 mtt -127.48 173.12 10.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.726 -0.67 . . . . 1.41 110.922 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.11 -104.92 0.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.908 -0.877 . . . . 1.55 110.908 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 18' ' ' ASP . 81.6 t60 -166.55 143.34 4.88 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.261 -0.644 . . . . 1.21 109.261 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.42 -24.47 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.2 1.185 . . . . 2.2 114.2 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 21.1 m-20 -88.3 -11.83 45.3 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.561 0.578 . . . . 1.78 112.561 -173.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -77.6 -3.6 41.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.162 0.43 . . . . 0.89 112.162 -174.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.58 64.63 0.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.656 -0.783 . . . . 1.06 112.763 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -87.08 -34.69 19.06 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 2.58 110.871 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.628 -0.26 . . . . 2.32 110.472 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 p -78.54 -32.07 47.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.954 0.407 . . . . 2.23 110.635 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -54.45 13.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.851 -0.796 . . . . 2.33 108.851 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.62 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -59.1 -33.9 71.38 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.099 -0.955 . . . . 2.46 110.724 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.88 -55.83 6.81 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.035 -0.416 . . . . 1.38 111.398 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -59.71 -39.61 85.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.005 0.431 . . . . 1.42 110.898 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.552 HD12 ' OH ' ' A' ' 48' ' ' TYR . 10.8 tt -65.96 -28.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.504 -0.771 . . . . 2.08 111.252 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 85.4 mtm180 -77.25 -26.59 52.71 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.595 0.712 . . . . 4.16 109.463 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -85.58 15.21 4.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.829 -1.078 . . . . 3.57 110.091 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.65 -0.704 . . . . 2.09 111.736 179.13 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' OH ' HD12 ' A' ' 28' ' ' ILE . 7.2 p90 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.133 0.492 . . . . 2.96 111.156 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.78 ' HG2' HG22 ' A' ' 58' ' ' THR . 18.0 mt-30 -109.44 134.09 52.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.581 -0.736 . . . . 2.45 109.284 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 CA--C 1.509 -0.608 0 CA-C-O 121.649 0.738 . . . . 2.49 110.609 -178.005 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.984 0.421 . . . . 1.4 111.179 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.78 HG22 ' HG2' ' A' ' 49' ' ' GLN . 18.9 m -104.3 127.99 52.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 1.85 108.977 171.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.7 m-85 . . . . . 0 C--N 1.325 -0.463 0 C-N-CA 120.976 -0.29 . . . . 1.14 110.92 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.77 HG21 HD12 ' A' ' 111' ' ' ILE . 38.6 mm . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 109.716 -0.476 . . . . 1.31 109.716 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 108' ' ' VAL . 86.7 t -82.18 94.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 120.376 -0.53 . . . . 1.78 110.714 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 10.0 mm -80.66 97.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.369 -0.604 . . . . 1.97 109.369 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -87.71 96.26 10.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.005 -0.739 . . . . 1.98 109.005 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 t -81.71 137.98 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.428 0.632 . . . . 1.8 111.266 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 114' ' ' ILE . 27.2 m -132.84 -168.19 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 1.79 108.547 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.26 20.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.371 -0.603 . . . . 1.03 109.371 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -58.64 -19.94 43.42 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.421 -0.809 . . . . 1.66 112.437 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.75 -12.48 33.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.515 0.191 . . . . 2.01 111.515 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 28.5 t70 -119.43 -49.65 2.36 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.375 0.607 . . . . 1.09 110.94 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 100.49 -124.67 8.32 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.18 -0.918 . . . . 0.52 111.239 -174.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.882 HG12 ' HE2' ' A' ' 134' ' ' TYR . 38.1 t -111.82 113.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.957 0.408 . . . . 1.67 111.029 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.558 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 77.2 mmm -80.33 168.12 28.06 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.557 -0.535 . . . . 1.32 109.557 172.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 6.3 Cg_endo -49.64 -42.83 41.87 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.393 2.062 . . . . 0.88 112.885 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.76 -26.86 62.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.659 0.266 . . . . 2.01 110.609 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.788 ' HB ' HG13 ' A' ' 92' ' ' VAL . 18.6 m -60.79 -35.77 77.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.128 -0.487 . . . . 1.19 110.483 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.57 ' CG1' ' HH ' ' A' ' 134' ' ' TYR . 2.0 m -84.15 -35.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.518 -0.31 . . . . 1.66 110.81 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.945 0.402 . . . . 1.62 111.474 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.69 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -66.82 -45.09 79.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.984 -0.553 . . . . 1.09 110.137 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.634 HG21 ' HD3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -64.27 -42.65 96.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.522 -0.763 . . . . 1.13 111.216 177.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -62.81 -30.73 71.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.509 0.723 . . . . 1.97 109.814 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -83.96 -32.54 24.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 1.02 110.333 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 82' ' ' VAL . . . -87.11 -48.78 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.334 0.494 . . . . 1.18 112.334 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.634 ' HD3' HG21 ' A' ' 100' ' ' ILE . 14.0 pttp -63.74 -16.4 61.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.526 0.565 . . . . 2.98 112.526 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.31 6.74 21.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.855 0.317 . . . . 1.3 111.855 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.585 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -98.21 2.14 48.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.803 -0.444 . . . . 1.3 109.803 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 77.92 31.87 0.4 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.742 1.258 . . . . 2.59 108.569 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -109.48 147.63 36.45 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 113.206 -1.815 . . . . 1.71 110.523 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.38 151.42 48.17 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.569 2.179 . . . . 0.62 113.547 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.618 HG22 HG21 ' A' ' 145' ' ' THR . 1.1 mp -118.82 142.59 33.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.225 -1.352 . . . . 1.62 110.212 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.77 HD12 HG21 ' A' ' 81' ' ' ILE . 4.3 mp -112.17 148.24 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 107.933 -1.136 . . . . 1.31 107.933 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -112.84 138.01 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 109.364 -0.606 . . . . 1.07 109.364 172.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -118.95 88.17 2.88 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.758 -1.201 . . . . 1.07 107.758 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.777 HD12 ' HD2' ' A' ' 147' ' ' PHE . 21.1 mt -73.79 83.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.754 -1.112 . . . . 1.56 109.507 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -89.09 164.63 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.934 -0.575 . . . . 0.88 110.105 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 66.97 34.1 5.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.04 -0.527 . . . . 3.11 112.131 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.583 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 4.3 ptp . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 1.55 109.792 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.092 0.404 . . . . 2.21 112.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.4 Cg_exo -36.72 -60.78 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.572 3.515 . . . . 1.01 115.198 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -42.72 -41.85 3.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.6 0.76 . . . . 2.0 113.014 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.87 -54.07 51.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.701 0.762 . . . . 3.7 109.387 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.712 ' HA ' ' OE2' ' A' ' 130' ' ' GLU . 58.4 t -60.06 -39.38 80.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.338 -1.301 . . . . 1.12 110.083 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.77 ' HE3' ' HG3' ' A' ' 140' ' ' GLU . 86.3 mtp -65.64 -30.62 71.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.253 -0.885 . . . . 1.07 111.114 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.33 -15.45 57.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.543 -0.463 . . . . 2.01 110.898 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.712 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 12.9 mt-10 -72.3 -37.12 69.05 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.656 -0.868 . . . . 2.02 108.656 170.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.579 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -69.95 -45.17 68.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.45 0.643 . . . . 1.62 110.087 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.889 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -75.79 -5.52 46.24 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.309 -0.859 . . . . 1.08 109.645 177.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 14.4 tp10 -74.02 -32.37 63.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.785 -1.191 . . . . 2.18 107.785 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.882 ' HE2' HG12 ' A' ' 92' ' ' VAL . 30.2 m-85 -90.0 10.13 25.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.68 0.753 . . . . 1.17 109.1 173.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 71.95 38.73 0.89 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 113.898 -1.501 . . . . 2.43 110.565 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.2 mp -117.28 84.11 2.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.444 1.116 . . . . 2.28 108.679 172.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.963 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.2 t -69.67 127.31 92.7 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.022 -1.899 . . . . 1.28 112.139 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.843 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 81.3 Cg_exo -47.14 160.24 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.296 0 C-N-CA 124.109 3.206 . . . . 0.34 114.441 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -85.26 -5.87 59.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.336 -1.302 . . . . 2.01 110.11 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.861 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -74.13 -32.79 63.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.452 -1.314 . . . . 1.18 107.452 167.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.889 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -101.3 -26.27 13.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.191 -1.368 . . . . 0.45 111.286 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.5 30.8 3.19 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.845 -1.169 . . . . 0.45 112.315 172.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.963 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.87 -102.53 1.95 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 120.486 -0.864 . . . . 0.5 111.609 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -169.6 37.29 0.02 OUTLIER 'General case' 0 C--O 1.247 0.922 0 CA-C-O 122.168 0.985 . . . . 1.3 110.594 172.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.618 HG21 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.47 113.84 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.909 -1.041 . . . . 1.06 111.49 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.728 HG22 ' HB3' ' A' ' 164' ' ' MET . 3.7 mp -82.72 108.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.555 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.843 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.7 m-85 -91.33 111.75 23.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.701 0.286 . . . . 0.38 111.752 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 16.0 t -102.11 117.24 34.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.804 -0.813 . . . . 1.82 108.804 174.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.672 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.4 pttm -93.34 101.49 13.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.129 -0.693 . . . . 2.94 109.129 175.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.719 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -130.12 176.91 7.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.244 1.021 . . . . 1.89 113.567 -168.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.9 m -147.45 117.27 7.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.6 -1.636 . . . . 2.08 109.101 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.63 66.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.445 0.535 . . . . 1.43 112.445 -174.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.735 ' HG3' ' H ' ' A' ' 154' ' ' THR . 15.0 ptpt -73.95 -56.08 5.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.77 0.795 . . . . 3.46 110.12 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.735 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 10.3 p -72.77 -12.45 61.01 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.16 -1.382 . . . . 1.78 112.098 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.683 ' HD2' HD11 ' A' ' 158' ' ' LEU . 3.0 tptm 71.72 2.75 4.41 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.061 0.544 . . . . 2.75 111.779 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.94 -72.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.714 0.768 . . . . 2.64 111.423 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.719 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.36 -9.3 60.85 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.155 -0.93 . . . . 0.73 113.623 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 155' ' ' LYS . 31.2 mt -70.12 -42.69 72.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.365 0.582 . . . . 2.12 110.256 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.57 -44.86 92.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 2.5 109.569 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -67.39 -24.63 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.84 111.361 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.28 -50.02 65.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.551 -0.295 . . . . 1.54 110.289 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -55.7 -36.75 67.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.007 -0.542 . . . . 1.7 110.459 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.16 -51.6 69.31 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.032 0.444 . . . . 2.49 110.526 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.766 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 16.2 mmt -65.5 -40.84 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 1.29 110.799 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.92 -53.18 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.709 -0.678 . . . . 1.24 110.314 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.21 -43.94 95.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.792 -0.64 . . . . 2.36 111.44 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.4 tp -54.01 -47.8 71.1 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.043 -0.526 . . . . 1.98 110.196 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.446 -0.628 0 CA-C-N 116.07 -0.513 . . . . 1.69 111.317 -177.81 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 112.481 -0.248 . . . . 16.58 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -88.77 -9.21 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.699 0.285 . . . . 14.94 111.379 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 15.21 110.017 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.409 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 24.5 mmt -101.91 32.6 3.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 12.92 109.732 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 4' ' ' MET . 98.4 t 72.68 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.491 -0.777 . . . . 10.47 111.039 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -72.73 88.87 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.591 . . . . 9.14 110.135 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -67.86 128.66 93.4 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 9.01 109.946 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.25 115.68 2.54 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.063 2.509 . . . . 5.24 112.278 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.38 85.92 0.85 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.709 2.273 . . . . 4.88 111.955 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -72.32 107.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.631 0.729 . . . . 3.08 109.936 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 1.002 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 10.5 t -85.36 84.72 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.613 0.721 . . . . 1.57 109.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -70.54 118.42 13.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.096 -0.957 . . . . 1.18 111.282 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.702 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.1 mt -87.18 116.06 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.371 0.605 . . . . 1.57 110.549 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.703 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 35.0 mtt -125.17 172.23 9.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.552 -0.749 . . . . 1.41 110.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.991 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 147.54 -96.64 0.18 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 109.851 -1.299 . . . . 1.55 109.851 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 71.3 t60 -175.0 164.28 3.35 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.659 -0.867 . . . . 1.21 108.659 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.09 -52.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.665 0.269 . . . . 2.2 111.439 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.13 -30.12 70.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.792 -0.64 . . . . 1.78 112.651 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.609 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 39.9 m80 -64.76 -19.43 65.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.408 . . . . 0.89 110.949 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.89 44.15 2.92 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.679 -0.772 . . . . 1.06 112.978 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 85' ' ' VAL . 22.0 ptmt -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.966 -0.753 . . . . 2.58 108.966 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.3 p -74.68 -35.68 62.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.738 -1.119 . . . . 2.32 109.62 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.8 m -63.3 -33.68 76.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.138 -0.937 . . . . 2.23 110.522 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.46 -56.19 20.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.217 -0.447 . . . . 2.33 110.408 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.591 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -62.64 -38.51 90.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.12 -0.491 . . . . 2.46 110.006 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 12.3 t70 -63.88 -49.49 72.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.98 0.363 . . . . 1.38 111.98 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . . . -68.02 -37.31 81.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.227 0.537 . . . . 1.42 110.857 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.591 HG21 ' HA ' ' A' ' 25' ' ' LEU . 6.5 tt -74.11 -20.84 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.451 -0.795 . . . . 2.08 109.812 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 33.0 tpt180 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.115 -0.948 . . . . 4.16 109.831 174.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -88.84 7.44 34.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.584 -0.735 . . . . 3.57 110.145 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -149.81 49.63 0.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.316 0.579 . . . . 2.09 110.33 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -93.18 160.61 14.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.71 . . . . 5.98 111.077 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.63 -2.4 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 113.072 0.768 . . . . 3.41 113.072 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 93.9 m -161.81 -63.26 0.05 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.091 -0.381 . . . . 4.35 111.478 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 34' ' ' THR . 8.4 pt-20 46.22 -169.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.973 1.309 . . . . 4.2 114.194 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -102.13 -80.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.712 -0.676 . . . . 6.16 110.435 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -139.39 -48.01 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.459 -0.791 . . . . 5.79 110.202 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.38 118.18 9.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.471 -0.786 . . . . 4.64 110.649 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.58 38.11 3.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 4.95 111.426 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -101.8 149.93 18.21 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.697 -0.561 . . . . 6.66 111.697 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 41' ' ' ILE . 4.0 mp -75.71 88.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 9.5 110.867 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 m -145.03 139.2 27.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.933 -1.136 . . . . 7.68 107.933 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -70.8 24.78 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.278 1.214 . . . . 9.39 114.278 -167.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -111.82 -10.08 14.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 7.29 109.067 171.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.924 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.7 tp -168.59 -157.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.141 -1.059 . . . . 5.6 108.141 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.924 ' H ' HG13 ' A' ' 45' ' ' ILE . . . 146.3 -62.27 0.46 Allowed Glycine 0 C--N 1.311 -0.82 0 C-N-CA 120.437 -0.887 . . . . 3.5 112.556 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.77 179.25 7.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.757 0.313 . . . . 2.15 110.167 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.415 ' HB2' ' HA ' ' A' ' 35' ' ' GLU . 3.0 p90 -157.47 -172.83 4.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.814 0.34 . . . . 2.96 110.658 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HG2' HG23 ' A' ' 58' ' ' THR . 36.8 mt-30 -122.42 122.98 40.26 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.876 -0.787 . . . . 2.45 108.876 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG21 ' HE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -107.37 133.61 51.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.364 0.602 . . . . 2.49 111.194 -173.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 54' ' ' ASP . 87.0 m -110.08 82.46 1.6 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.962 -1.017 . . . . 2.26 110.088 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 54' ' ' ASP . 5.9 p -112.02 124.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.704 -1.221 . . . . 4.49 107.704 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.606 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER 73.87 -5.69 1.97 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.325 1.059 . . . . 4.58 108.705 -172.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.645 ' HA ' HG22 ' A' ' 51' ' ' THR . 1.7 m-20 77.21 23.85 0.88 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 112.263 -2.244 . . . . 3.62 110.933 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HD3' ' HB3' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -88.69 129.15 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.572 -0.899 . . . . 7.78 108.572 172.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -72.06 92.08 1.29 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.388 0.43 . . . . 5.81 111.558 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 11' ' ' VAL . 56.1 mt -94.61 95.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 1.4 110.085 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -88.58 113.21 23.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.874 -0.603 . . . . 1.85 109.442 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' HE2' HG21 ' A' ' 50' ' ' VAL . 27.6 m-85 -90.63 142.28 27.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.932 -0.307 . . . . 1.14 111.417 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.8 tp 73.79 137.47 0.05 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.306 1.004 . . . . 3.46 111.889 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.41 174.35 6.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.279 -0.873 . . . . 6.48 110.878 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -109.74 101.08 45.35 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.981 -0.554 . . . . 5.89 110.067 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.52 84.8 0.47 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.975 2.45 . . . . 5.92 112.391 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.66 -48.52 5.22 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.343 -0.703 . . . . 5.92 111.343 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -123.45 -59.5 1.54 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.043 -0.725 . . . . 8.81 109.043 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.857 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 5.4 mp0 -116.96 140.76 49.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.883 -0.599 . . . . 6.36 110.169 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -75.31 128.17 34.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.687 -0.857 . . . . 3.89 108.687 170.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.727 ' HZ ' HG12 ' A' ' 108' ' ' VAL . 84.1 t80 68.87 87.19 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.693 0.621 . . . . 2.61 110.143 -170.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.1 m 54.96 107.77 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.143 0.794 . . . . 5.11 113.143 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.857 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 10.9 t -52.64 131.2 34.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.338 -0.615 . . . . 6.34 109.338 174.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -82.33 64.21 6.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.308 0.575 . . . . 5.64 111.826 -167.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -158.63 74.32 0.67 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.554 -0.748 . . . . 10.31 109.687 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -174.45 116.58 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 7.85 110.526 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -129.07 3.35 5.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.254 0.55 . . . . 11.11 110.374 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 19.52 23.3 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.941 -0.864 . . . . 6.78 110.941 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.14 79.14 0.83 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.543 . . . . 7.11 110.088 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -79.04 101.95 8.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.149 0.5 . . . . 8.32 109.779 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -76.45 153.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.889 -0.596 . . . . 4.75 111.49 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.35 57.78 4.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.517 -0.765 . . . . 4.44 111.444 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.9 145.54 31.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.726 -0.67 . . . . 3.12 109.344 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 1.002 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 24.5 mm -120.31 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.685 -0.234 . . . . 1.31 110.469 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.949 HG22 ' HB1' ' A' ' 103' ' ' ALA . 13.1 t -99.23 94.97 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 120.418 -0.513 . . . . 1.78 111.703 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.702 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 30.9 mm -80.36 115.27 22.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.206 -1.035 . . . . 1.97 108.206 170.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.807 ' HG ' HD13 ' A' ' 100' ' ' ILE . 2.9 tm? -105.72 101.13 10.66 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.879 -0.6 . . . . 1.98 110.487 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.991 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.1 p -79.96 142.49 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.478 0.656 . . . . 1.8 111.697 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.554 HG13 ' N ' ' A' ' 87' ' ' ALA . 25.3 t -136.1 173.04 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 107.583 -1.265 . . . . 1.79 107.583 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.554 ' N ' HG13 ' A' ' 86' ' ' VAL . . . -148.59 112.8 5.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.231 0.469 . . . . 1.03 112.017 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 41.35 -97.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.599 1.16 . . . . 1.66 113.756 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.26 1.29 25.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 2.01 112.055 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' HG3' ' A' ' 93' ' ' MET . 14.1 t70 -71.24 -49.2 45.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.09 110.635 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 86.43 -107.6 3.21 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.159 -0.928 . . . . 0.52 111.606 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.833 HG12 ' HB ' ' A' ' 96' ' ' THR . 30.7 t -128.81 111.75 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 122.347 0.259 . . . . 1.67 110.709 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.637 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.9 mtp -82.8 172.09 10.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.695 -0.23 . . . . 1.32 110.445 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 99.4 Cg_exo -44.17 -52.03 6.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.028 2.486 . . . . 0.88 113.658 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -65.46 -28.83 69.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.591 -0.277 . . . . 2.01 111.241 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.833 ' HB ' HG12 ' A' ' 92' ' ' VAL . 8.1 m -62.97 -30.29 71.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.248 0.547 . . . . 1.19 110.624 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 134' ' ' TYR . 70.9 t -84.46 -52.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.286 -0.416 . . . . 1.66 111.676 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.35 -18.83 60.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.849 -0.614 . . . . 1.62 111.473 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.703 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -88.09 -39.9 14.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.877 -0.601 . . . . 1.09 109.543 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.807 HD13 ' HG ' ' A' ' 84' ' ' LEU . 1.7 mt -71.59 -48.96 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 1.13 111.311 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.486 HD21 ' HA ' ' A' ' 101' ' ' ASN . 1.0 OUTLIER -50.45 -38.52 44.01 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.965 0.506 . . . . 1.97 110.982 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.454 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 53.2 t60 -76.64 -33.39 58.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.744 -0.662 . . . . 1.02 110.565 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.949 ' HB1' HG22 ' A' ' 82' ' ' VAL . . . -81.13 -50.38 9.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.033 -0.53 . . . . 1.18 112.342 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 11.8 ptmm? -59.87 -21.02 60.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.704 -0.68 . . . . 2.98 112.677 -167.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.48 10.99 30.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.707 0.632 . . . . 1.3 112.707 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.516 ' HB2' ' CG1' ' A' ' 108' ' ' VAL . . . -100.65 -0.12 38.09 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.035 -0.728 . . . . 1.3 109.035 174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.2 t30 75.98 41.54 0.23 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.685 1.231 . . . . 2.59 108.71 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.727 HG12 ' HZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -124.13 142.67 40.47 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 113.289 -1.778 . . . . 1.71 110.54 -174.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.01 154.86 71.64 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.657 2.238 . . . . 0.62 113.981 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.687 HD13 HG12 ' A' ' 100' ' ' ILE . 84.7 mt -127.33 146.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.976 -1.465 . . . . 1.62 109.209 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.8 103.14 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.138 0.494 . . . . 1.31 111.242 -167.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -67.42 133.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.137 -0.938 . . . . 1.07 110.237 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -121.34 87.69 2.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.826 -1.176 . . . . 1.07 107.826 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.705 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 18.5 mm -67.43 95.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.861 -1.063 . . . . 1.56 110.51 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.03 163.46 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.968 -0.753 . . . . 0.88 108.968 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 63.72 20.09 12.05 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.159 0.504 . . . . 3.11 111.162 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.735 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 13.1 tpp -88.57 -6.09 57.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.833 0.825 . . . . 1.55 109.9 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.538 ' HB3' ' CB ' ' A' ' 151' ' ' SER . 2.5 p-10 -61.79 -4.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.001 -0.999 . . . . 2.45 112.581 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.724 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 21.0 ptmt -83.3 -172.18 0.34 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.415 -1.328 . . . . 4.11 107.415 167.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.724 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 36.8 Cg_exo -52.17 -56.42 2.93 Favored 'Trans proline' 0 C--N 1.348 0.514 0 CA-C-N 120.793 1.319 . . . . 3.16 111.366 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 11.1 pt-20 159.99 128.93 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.532 1.133 . . . . 4.03 108.205 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.64 -88.27 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.006 -0.543 . . . . 1.9 109.813 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 1.1 p30 -156.49 75.46 4.61 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.554 -0.294 . . . . 2.21 111.33 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.9 Cg_exo -37.57 -67.1 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.095 3.197 . . . . 1.01 113.853 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -48.89 -49.78 38.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.882 0.473 . . . . 2.0 112.089 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 2.4 tmt_? -54.73 -56.93 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.098 0.475 . . . . 3.7 109.997 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 91' ' ' GLY . 93.2 t -55.71 -41.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 1.12 111.016 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.687 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 89.4 mtp -66.02 -33.09 75.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 1.07 110.71 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 70.3 mt-30 -73.35 -24.55 60.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.425 . . . . 2.01 111.098 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.8 mm-40 -64.55 -37.66 88.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.715 -0.846 . . . . 2.02 108.715 172.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.574 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -70.28 -46.16 64.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.466 -0.788 . . . . 1.62 109.703 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.908 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -75.16 -1.1 21.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.82 -0.627 . . . . 1.08 110.001 177.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.1 tt0 -78.57 -28.97 46.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 2.18 107.539 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.659 ' CE2' HG11 ' A' ' 92' ' ' VAL . 61.5 m-85 -91.99 16.08 11.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.644 -0.707 . . . . 1.17 109.589 168.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.4 t30 71.01 22.16 4.65 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.048 -1.433 . . . . 2.43 110.188 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 131' ' ' LEU . 7.0 mp -91.65 72.55 5.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.315 -0.857 . . . . 2.28 109.693 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.517 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -64.87 119.95 62.37 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 114.482 -1.236 . . . . 1.28 110.822 178.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.873 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 80.9 Cg_exo -47.05 160.69 0.25 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.634 2.889 . . . . 0.34 113.57 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.29 -21.25 53.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.768 -1.105 . . . . 2.01 109.682 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.814 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -58.8 -41.11 85.99 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.302 -0.999 . . . . 1.18 108.302 168.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.908 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.6 m0 -95.85 -20.44 18.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.644 -1.162 . . . . 0.45 110.896 -170.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.98 31.6 4.7 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.315 -0.945 . . . . 0.45 112.697 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.517 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.15 -99.15 1.96 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.5 112.64 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.06 27.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.68 0.753 . . . . 1.3 110.845 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m -121.39 112.17 18.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 1.06 111.752 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 146' ' ' ILE . 3.9 mp -81.57 109.45 15.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.137 -0.938 . . . . 1.86 110.343 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.873 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -91.21 111.55 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.101 0.476 . . . . 0.38 111.192 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.3 m -105.9 100.0 9.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.759 -0.655 . . . . 1.82 110.036 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.735 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 19.2 pttp -81.37 91.96 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.726 -0.842 . . . . 2.94 108.726 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.854 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 1.1 pt? -119.31 -171.39 2.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.137 0.97 . . . . 1.89 112.851 -166.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.538 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 33.7 t -157.96 129.56 6.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.877 -1.511 . . . . 2.08 109.638 170.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.424 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . . . -88.73 -25.64 22.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.815 -0.629 . . . . 1.43 110.809 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -76.68 -53.5 7.92 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.403 0.62 . . . . 3.46 110.061 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.2 p -72.49 -14.97 61.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.868 -1.06 . . . . 1.78 110.504 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.527 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 69.59 17.0 7.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.182 -0.917 . . . . 2.75 111.107 175.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.29 -62.07 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.994 0.902 . . . . 2.64 109.993 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.854 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -75.01 -16.61 80.49 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.686 -1.143 . . . . 0.73 113.514 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 158' ' ' LEU . 1.8 tm? -56.4 -47.37 79.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.909 -0.774 . . . . 2.12 108.909 174.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.608 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -58.02 -53.4 58.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.362 -0.836 . . . . 2.5 110.304 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -60.99 -22.77 64.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.723 -0.672 . . . . 0.84 111.749 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 161' ' ' LEU . 1.2 tm? -69.77 -53.2 19.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.382 -0.372 . . . . 1.54 110.032 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -65.84 -30.52 71.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.654 0.264 . . . . 1.7 110.321 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.5 mm-40 -58.28 -38.97 78.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.035 -0.529 . . . . 2.49 110.723 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.487 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 0.1 OUTLIER -81.25 -32.56 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.2 -0.454 . . . . 1.29 111.096 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 72.8 mt -59.77 -52.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.511 -0.313 . . . . 1.24 110.929 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.498 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -68.96 -30.83 69.35 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.89 0.376 . . . . 2.36 111.372 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.498 ' N ' HD11 ' A' ' 166' ' ' LEU . 65.3 tp -55.51 -31.09 61.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.44 -0.8 . . . . 1.98 110.148 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 41.0 t -73.03 -44.48 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 115.563 -0.744 . . . . 1.69 109.949 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.2 m -63.2 -15.39 56.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.366 0.603 . . . . 2.07 110.786 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -86.8 -62.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.806 -0.634 . . . . 2.79 109.827 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -71.41 -30.82 66.54 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.784 0.661 . . . . 2.22 112.784 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 29.5 mm-40 -65.1 -22.05 66.89 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.844 -0.342 . . . . 3.45 111.29 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -73.49 -18.98 61.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.364 . . . . 3.36 110.607 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.63 -78.01 0.56 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 4.51 111.204 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.9 5.2 0.19 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.207 0.447 . . . . 6.66 112.207 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 69.14 -112.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.605 0.566 . . . . 4.98 111.405 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.657 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 21.4 t-20 -88.87 -56.79 0.28 Allowed Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.961 0.356 . . . . 6.96 111.961 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 5.2 Cg_exo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.658 2.239 . . . . 7.47 112.559 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 111.752 -0.539 . . . . 16.58 111.752 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -106.98 136.62 46.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 14.94 110.494 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -101.35 14.6 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.37 0.605 . . . . 15.21 109.864 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.1 ttm -74.7 95.08 2.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.453 -0.573 . . . . 12.92 109.453 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.16 110.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 10.47 111.041 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -95.74 166.15 11.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 9.14 110.317 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 58.45 75.7 0.51 Allowed Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 123.752 0.658 . . . . 9.01 111.948 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.32 149.28 39.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.376 2.051 . . . . 5.24 111.371 175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.89 91.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.086 2.524 . . . . 4.88 112.732 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.444 ' HB ' HD23 ' A' ' 60' ' ' LEU . 13.1 m -86.02 119.3 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 3.08 110.695 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.694 HG21 ' HB ' ' A' ' 81' ' ' ILE . 54.7 t -117.11 118.62 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 115.85 -0.614 . . . . 1.57 110.586 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 11.8 m -86.24 130.7 34.43 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.024 -0.535 . . . . 1.18 110.943 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -95.9 122.98 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.92 0.391 . . . . 1.57 110.376 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 50.0 mtt -138.24 175.69 9.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.565 0.697 . . . . 1.41 112.214 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.51 -100.27 0.35 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.838 -1.305 . . . . 1.55 109.838 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 16.0 t60 -160.1 132.68 6.47 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.053 -1.091 . . . . 1.21 108.053 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.753 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 14.0 p -62.17 -29.67 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.501 -0.772 . . . . 2.2 112.704 -167.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.92 -27.18 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.288 0.477 . . . . 1.78 112.288 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -56.54 -52.24 65.53 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.287 0.565 . . . . 0.89 111.098 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 177.14 33.45 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.4 -0.818 . . . . 1.06 111.096 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.753 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 12.6 tmtt? -88.43 -56.19 3.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.974 0.416 . . . . 2.58 110.277 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -68.19 -30.76 69.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.489 . . . . 2.32 110.062 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -77.06 -27.62 54.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.001 -0.545 . . . . 2.23 110.571 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.639 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 8.5 tt -65.98 -50.49 64.14 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.466 -0.568 . . . . 2.33 109.466 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.696 ' O ' HG21 ' A' ' 28' ' ' ILE . 4.9 tt -57.7 -40.51 79.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.762 -0.654 . . . . 2.46 110.195 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.73 -50.0 40.84 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.813 -0.355 . . . . 1.38 111.553 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.54 75.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.17 0.509 . . . . 1.42 111.142 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 25' ' ' LEU . 7.2 tt -70.25 -33.93 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.355 -0.838 . . . . 2.08 110.856 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.816 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 60.9 mtm180 -71.21 -33.97 70.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.474 0.654 . . . . 4.16 109.546 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -82.12 14.94 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.35 -0.841 . . . . 3.57 110.169 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 34.5 t -123.76 -59.69 1.5 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 2.09 109.998 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -110.58 -177.13 3.15 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.546 0.689 . . . . 5.98 111.284 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.26 137.97 52.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.731 -1.122 . . . . 3.41 111.169 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m 153.57 -26.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 125.605 1.816 . . . . 4.35 110.073 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.816 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -61.64 146.87 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 4.2 112.311 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -129.16 -74.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.576 -0.738 . . . . 6.16 110.319 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.693 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 2.9 pt-20 -56.65 -68.13 0.25 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.943 -0.572 . . . . 5.79 110.02 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.575 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . 42.54 81.12 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.988 0.805 . . . . 4.64 113.092 168.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 79.66 0.14 Allowed Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.297 -0.721 . . . . 4.95 111.297 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' H ' HD12 ' A' ' 25' ' ' LEU . . . -77.21 40.19 1.7 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.337 -0.459 . . . . 6.66 113.457 -174.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.44 -30.53 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.478 -0.564 . . . . 9.5 109.478 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 m -77.44 118.67 20.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 7.68 110.661 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -79.9 57.36 2.57 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.888 0.852 . . . . 9.39 110.841 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -145.38 -49.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.933 -1.03 . . . . 7.29 108.269 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.839 HG13 ' H ' ' A' ' 46' ' ' GLY . 9.9 tp -177.05 -176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.543 -1.28 . . . . 5.6 107.543 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.839 ' H ' HG13 ' A' ' 45' ' ' ILE . . . 142.85 44.87 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.759 -0.734 . . . . 3.5 111.661 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.693 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -99.64 -169.56 1.77 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.282 -0.636 . . . . 2.15 109.282 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.772 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 10.6 p90 -170.24 166.24 8.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.131 0.491 . . . . 2.96 111.358 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -116.14 154.75 29.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.108 -1.071 . . . . 2.45 108.108 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.26 131.23 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 2.49 111.785 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 54' ' ' ASP . 8.3 m -81.61 94.92 7.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.674 0.75 . . . . 2.26 109.2 171.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 54' ' ' ASP . 5.8 p -127.92 113.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.461 -0.94 . . . . 4.49 108.461 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t30 70.97 -39.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.049 -0.978 . . . . 4.58 110.198 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.645 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 36.5 t70 -147.13 -86.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.53 -0.759 . . . . 3.62 112.874 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 36.4 ttpt 158.51 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 7.78 110.009 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -105.76 -24.13 12.57 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.042 0.756 . . . . 5.81 113.042 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.4 mt -74.33 109.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.266 -0.574 . . . . 1.4 110.948 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -98.89 112.1 24.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.573 -0.739 . . . . 1.85 109.492 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.584 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 41.9 m-85 -85.77 120.45 27.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 1.14 111.477 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 3.5 mm? -89.75 102.48 15.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.105 -0.702 . . . . 3.46 109.105 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 14.9 t70 -80.9 149.1 29.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.775 -0.648 . . . . 6.48 111.201 -175.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.87 HG23 ' HB3' ' A' ' 67' ' ' ALA . 2.0 p -103.48 93.33 4.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 5.89 110.603 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 61' ' ' ASP . 83.3 Cg_endo -88.32 55.57 2.4 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.787 2.325 . . . . 5.92 112.774 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.56 -127.06 1.47 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.606 -0.807 . . . . 5.92 112.49 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -117.66 -47.51 2.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.685 0.279 . . . . 8.81 110.861 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -117.19 130.81 56.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.005 0.431 . . . . 6.36 110.451 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.87 ' HB3' HG23 ' A' ' 62' ' ' THR . . . -170.68 179.07 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 3.89 109.748 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HB2' ' HE2' ' A' ' 71' ' ' MET . 24.2 t80 -166.83 179.56 5.25 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.665 -0.865 . . . . 2.61 108.665 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 m -49.32 -46.48 46.78 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.855 0.462 . . . . 5.11 111.936 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 m -151.01 97.62 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 6.34 111.106 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.649 ' HE2' ' HB2' ' A' ' 68' ' ' PHE . 20.8 mmt -86.15 88.42 7.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 5.64 109.946 175.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -155.34 -59.9 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.426 -0.352 . . . . 10.31 111.19 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.63 -168.52 1.82 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 7.85 111.547 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 74' ' ' ARG . 1.7 tpm_? -51.31 -49.28 61.63 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.937 0.773 . . . . 11.11 111.45 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.26 108.18 0.67 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.914 -0.585 . . . . 6.78 111.905 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.14 -14.94 19.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.25 0.548 . . . . 7.11 110.482 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -82.23 110.28 17.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.507 -0.77 . . . . 8.32 110.315 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.5 m -87.08 -32.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.99 -0.55 . . . . 4.75 110.721 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.464 ' HB ' ' OE2' ' A' ' 172' ' ' GLU . 23.5 p -146.38 123.81 11.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.991 -0.549 . . . . 4.44 110.242 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.46 -172.08 3.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.45 -0.574 . . . . 3.12 109.45 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.694 ' HB ' HG21 ' A' ' 11' ' ' VAL . 46.1 mm -123.26 116.65 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 111.263 0.098 . . . . 1.31 111.263 -172.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 103' ' ' ALA . 86.9 t -97.41 106.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.652 0.263 . . . . 1.78 111.562 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.607 HD12 HG12 ' A' ' 165' ' ' ILE . 12.2 mm -89.72 106.72 17.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.651 -0.5 . . . . 1.97 109.651 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.693 HD22 HD12 ' A' ' 100' ' ' ILE . 8.4 tp -92.9 126.06 37.8 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.075 -0.511 . . . . 1.98 110.619 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.68 140.56 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.009 -0.432 . . . . 1.8 112.043 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.0 m -135.03 -177.34 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.94 -0.763 . . . . 1.79 108.94 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 126.66 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.875 0.694 . . . . 1.03 112.875 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . . . 42.92 -104.41 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.302 1.223 . . . . 1.66 114.302 168.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -112.15 -8.65 13.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.813 -173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.579 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 2.8 t70 -62.83 -38.66 91.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.208 -0.664 . . . . 1.09 109.208 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . 78.98 -147.14 30.21 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.891 -1.05 . . . . 0.52 112.408 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.586 HG12 HG21 ' A' ' 97' ' ' VAL . 79.1 t -88.21 100.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 114.995 -0.602 . . . . 1.67 109.938 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.579 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 10.3 mtp -70.95 167.75 26.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 1.32 111.411 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 83.0 Cg_exo -47.37 -41.48 28.59 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.507 2.138 . . . . 0.88 112.435 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 4.6 mm-40 -65.74 -42.11 91.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.024 0.44 . . . . 2.01 110.187 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.609 HG22 HD23 ' A' ' 84' ' ' LEU . 3.5 m -61.06 -30.51 70.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.577 -0.738 . . . . 1.19 110.11 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.586 HG21 HG12 ' A' ' 92' ' ' VAL . 44.3 t -78.07 -52.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.048 -0.978 . . . . 1.66 111.594 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.0 pt-20 -65.04 -32.25 73.88 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 1.62 111.681 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.29 -42.73 87.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.547 0.689 . . . . 1.09 109.404 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.957 HG12 HD11 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -68.19 -43.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.98 -1.009 . . . . 1.13 110.81 176.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.5 -27.25 62.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.909 -0.587 . . . . 1.97 110.743 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -85.57 -36.13 20.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 1.02 110.413 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.928 ' HB3' HG21 ' A' ' 82' ' ' VAL . . . -83.18 -49.54 9.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.554 0.576 . . . . 1.18 112.554 -172.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 100' ' ' ILE . 41.3 pttt -61.99 -16.88 54.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.669 0.618 . . . . 2.98 112.669 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.87 10.54 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.371 0.508 . . . . 1.3 112.371 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HB2' HG12 ' A' ' 108' ' ' VAL . . . -99.57 4.09 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 1.3 109.768 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 86.13 6.11 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.461 1.124 . . . . 2.59 108.794 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.679 HG12 ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -93.11 142.79 25.8 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.169 -1.832 . . . . 1.71 111.585 -174.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.17 160.15 50.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.945 2.43 . . . . 0.62 113.447 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.957 HD11 HG12 ' A' ' 100' ' ' ILE . 91.9 mt -127.54 150.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.163 -0.926 . . . . 1.62 110.394 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 81' ' ' ILE . 5.0 mp -121.79 154.75 26.15 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.687 -0.857 . . . . 1.31 108.687 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -118.25 140.86 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 120.667 0.27 . . . . 1.07 110.494 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.42 89.04 3.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.207 -1.034 . . . . 1.07 108.207 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.683 ' HA ' HG23 ' A' ' 86' ' ' VAL . 33.0 mt -73.54 94.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.587 -1.188 . . . . 1.56 111.075 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.76 156.55 24.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.537 0.208 . . . . 0.88 110.977 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt 59.2 33.86 22.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.863 0.84 . . . . 3.11 109.989 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.987 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 2.4 tpp -88.49 -22.46 23.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.015 -0.993 . . . . 1.55 110.98 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -53.71 -30.87 45.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.561 0.696 . . . . 2.45 109.825 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 121' ' ' GLU . 25.6 mtpp -97.0 149.74 36.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 114.916 -1.038 . . . . 4.11 109.85 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.2 -3.04 0.44 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.463 3.442 . . . . 3.16 114.545 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 119' ' ' LYS . 64.3 mm-40 -61.18 -32.91 72.65 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.179 0.592 . . . . 4.03 110.471 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -81.65 133.74 35.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.902 -0.59 . . . . 1.9 112.132 -174.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 28.4 t-20 -131.02 93.49 30.6 Favored Pre-proline 0 CA--C 1.511 -0.549 0 CA-C-O 122.289 1.043 . . . . 2.21 109.996 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.603 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -27.85 -75.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 1 C-N-CA 126.124 4.549 . . . . 1.01 115.46 169.407 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -43.7 -53.4 5.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.17 0.588 . . . . 2.0 112.293 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 11.8 tpt180 -53.07 -65.27 0.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.229 0.538 . . . . 3.7 110.185 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.417 HG22 ' HA2' ' A' ' 91' ' ' GLY . 47.1 t -55.27 -42.36 65.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.451 -1.249 . . . . 1.12 111.41 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.811 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 83.1 mtp -73.1 -30.83 63.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.141 -0.936 . . . . 1.07 111.405 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.08 -27.77 32.73 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.475 -0.49 . . . . 2.01 111.123 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 9.6 mt-10 -61.78 -40.09 93.96 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.016 -1.105 . . . . 2.02 108.016 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.859 HD23 HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -71.45 -46.82 58.98 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.459 -0.791 . . . . 1.62 111.267 -172.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.946 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.2 ppp? -67.36 -8.64 34.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.49 -0.777 . . . . 1.08 109.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -78.1 -28.17 48.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.667 -0.864 . . . . 2.18 108.667 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -82.07 -1.95 50.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.816 0.817 . . . . 1.17 108.803 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 135' ' ' ASN . 1.5 t-20 76.78 42.95 0.14 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 113.101 -1.863 . . . . 2.43 111.203 163.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -123.05 86.75 2.63 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.942 -1.873 . . . . 2.28 105.942 167.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.41 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.44 131.91 94.24 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.789 -1.55 . . . . 1.28 111.313 -171.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.72 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 88.2 Cg_exo -46.87 152.64 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.178 2.585 . . . . 0.34 113.296 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.97 -30.57 62.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.078 -1.419 . . . . 2.01 108.469 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.834 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -51.34 -45.28 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.41 -1.268 . . . . 1.18 109.485 170.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.946 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.0 m0 -89.53 -21.98 22.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.366 -1.288 . . . . 0.45 110.598 -170.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.31 18.5 4.95 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.049 -1.072 . . . . 0.45 112.678 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.41 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.09 -115.54 3.08 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.701 -0.762 . . . . 0.5 112.499 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.07 30.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.886 0.374 . . . . 1.3 111.485 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.859 HG21 HD23 ' A' ' 131' ' ' LEU . 24.9 m -129.22 108.99 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.857 -0.737 . . . . 1.06 112.175 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 164' ' ' MET . 2.2 mp -80.15 110.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.77 . . . . 1.86 110.698 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CE2' ' HG2' ' A' ' 128' ' ' MET . 19.4 m-85 -88.09 115.54 25.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.19 0.519 . . . . 0.38 111.311 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 63.9 m -104.03 117.13 33.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.054 -0.721 . . . . 1.82 109.054 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.987 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 14.5 pttp -98.16 85.95 3.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.106 0.955 . . . . 2.94 109.72 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.692 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -110.64 -179.62 3.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.988 -1.005 . . . . 1.89 112.534 -170.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.408 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 10.1 t -143.46 131.7 21.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.418 -1.265 . . . . 2.08 109.196 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.484 0.659 . . . . 1.43 109.93 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -92.51 -58.92 2.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.371 -0.831 . . . . 3.46 110.038 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 151' ' ' SER . 3.9 m -68.71 -29.67 68.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.654 -1.157 . . . . 1.78 110.644 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 58.88 26.8 15.33 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.507 -1.224 . . . . 2.75 111.414 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -83.4 -45.84 13.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.86 0.838 . . . . 2.64 109.81 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.692 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -75.6 -11.65 84.28 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.01 -0.996 . . . . 0.73 112.668 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 158' ' ' LEU . 26.2 mt -64.18 -39.81 94.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 2.12 110.475 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -78.87 -37.5 40.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.38 -0.373 . . . . 2.5 110.089 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 164' ' ' MET . 65.1 t60 -59.45 -37.21 77.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.069 -0.514 . . . . 0.84 109.986 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 165' ' ' ILE . 63.5 tp -60.61 -58.32 8.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 1.54 110.528 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.556 ' HA ' HD11 ' A' ' 165' ' ' ILE . 89.8 mt -54.24 -39.49 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.944 -0.571 . . . . 1.7 111.357 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.45 -41.33 96.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 2.49 111.251 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 146' ' ' ILE . 29.8 mmt -69.89 -38.54 76.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 1.29 110.096 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.607 HG12 HD12 ' A' ' 83' ' ' ILE . 80.7 mt -54.72 -54.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.61 -0.723 . . . . 1.24 110.242 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.45 -38.09 89.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 2.36 111.104 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.64 -42.22 87.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 1.98 110.312 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 45.3 t -76.39 -35.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.354 -0.385 . . . . 1.69 110.978 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -57.74 -22.41 46.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 2.07 110.063 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -97.23 -38.96 9.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.482 -0.781 . . . . 2.79 110.426 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.632 ' HE3' ' HB2' ' A' ' 174' ' ' LEU . 23.5 ttp -87.3 5.86 36.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 2.22 112.095 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 8.4 mm-40 -34.73 -26.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.07 1.137 . . . . 3.45 114.07 173.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.62 -15.62 20.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.349 0.26 . . . . 3.36 111.281 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.632 ' HB2' ' HE3' ' A' ' 171' ' ' MET . 63.7 tp -46.98 -50.68 18.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.117 0.567 . . . . 4.51 111.577 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -118.33 104.71 11.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.783 -0.644 . . . . 6.66 109.284 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.78 32.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.166 0.508 . . . . 4.98 111.834 -172.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.496 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.8 p30 -116.57 133.98 22.95 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 6.96 109.293 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 123.138 2.558 . . . . 7.47 112.339 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 111.609 -0.597 . . . . 16.58 111.609 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -81.53 -14.51 56.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.771 0.32 . . . . 14.94 111.743 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.28 37.98 13.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.521 -0.763 . . . . 15.21 111.22 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.4 mtt -68.31 -25.12 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.172 0.51 . . . . 12.92 109.937 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.5 -10.67 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.476 -0.784 . . . . 10.47 110.729 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.94 85.25 3.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.013 -0.736 . . . . 9.14 109.013 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.477 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -138.56 58.84 15.1 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.369 -0.378 . . . . 9.01 110.515 -177.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.09 -59.44 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.596 2.197 . . . . 5.24 115.058 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 8' ' ' PRO . 86.1 Cg_endo -92.68 35.86 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.051 1.834 . . . . 4.88 113.758 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG2' ' HG3' ' A' ' 7' ' ' ARG . 89.6 t -108.77 104.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.305 0.574 . . . . 3.08 109.837 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.592 HG13 HD11 ' A' ' 83' ' ' ILE . 51.5 t -113.11 137.63 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.625 -0.716 . . . . 1.57 111.569 -172.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 79' ' ' THR . 82.9 m -104.36 136.3 44.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 1.18 110.741 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 ' HE2' ' A' ' 21' ' ' LYS . 56.3 mt -92.96 124.16 45.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 1.57 110.684 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.656 ' HG3' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -108.69 -175.04 2.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.365 -0.834 . . . . 1.41 110.326 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.922 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 109.15 133.9 6.91 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.27 -0.967 . . . . 1.55 111.834 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 65.8 t60 -44.58 135.88 4.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.564 -0.818 . . . . 1.21 110.887 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.08 -29.33 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.93 -1.032 . . . . 2.2 113.563 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -86.23 -21.78 27.25 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.045 0.387 . . . . 1.78 112.045 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.447 ' HB2' HG12 ' A' ' 85' ' ' VAL . 51.5 m170 -61.8 -35.92 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.89 111.14 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 152.55 71.49 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.175 -1.012 . . . . 1.06 113.041 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 28.9 mmtp -90.38 -71.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.029 0.443 . . . . 2.58 110.98 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 t -64.5 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 2.32 110.604 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -73.41 -26.17 60.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.292 -0.413 . . . . 2.23 110.787 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.3 tm? -79.35 -49.77 11.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.363 -0.977 . . . . 2.33 108.363 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.623 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.776 -1.102 . . . . 2.46 110.588 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.62 -56.53 9.05 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.174 -0.329 . . . . 1.38 111.794 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.56 92.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.316 -0.402 . . . . 1.42 110.849 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.7 tt -63.9 -32.91 58.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.128 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.628 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 70.4 mtp180 -70.4 -34.68 72.82 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.306 0.574 . . . . 4.16 110.657 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -77.59 14.48 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 3.57 111.028 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.742 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -88.91 -13.05 39.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.538 -0.912 . . . . 2.09 108.538 175.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.742 ' HG2' ' O ' ' A' ' 31' ' ' SER . 16.9 ptmt 64.26 -14.84 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.862 1.801 . . . . 5.98 115.862 160.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.98 -27.95 19.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.203 0.446 . . . . 3.41 112.203 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.9 m -167.67 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.891 0.376 . . . . 4.35 111.795 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.628 ' HG3' ' HA ' ' A' ' 29' ' ' ARG . 1.4 pm0 -59.71 145.85 43.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.566 0.95 . . . . 4.2 113.566 -166.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.14 -161.04 1.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.998 -1.456 . . . . 6.16 110.594 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.45 -29.45 28.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.8 0.333 . . . . 5.79 111.861 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.757 ' HB3' ' HA ' ' A' ' 45' ' ' ILE . . . -140.89 162.0 36.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.635 -0.257 . . . . 4.64 110.79 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.62 -34.42 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.436 -0.888 . . . . 4.95 112.995 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' ' H ' ' A' ' 48' ' ' TYR . . . -70.68 62.58 0.89 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.281 0.472 . . . . 6.66 114.281 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.46 HG12 ' HA3' ' A' ' 46' ' ' GLY . 24.2 mm -148.7 -54.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.941 -1.133 . . . . 9.5 107.941 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 43' ' ' GLN . 1.3 t -145.53 -82.57 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.723 -1.126 . . . . 7.68 109.681 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.796 ' H ' HG23 ' A' ' 42' ' ' THR . 12.8 pt20 -157.75 31.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 9.39 109.821 172.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -120.58 -94.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.371 -0.831 . . . . 7.29 110.917 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.757 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 2.6 pp -126.58 172.07 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 5.6 110.223 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' HG12 ' A' ' 41' ' ' ILE . . . 141.5 -85.95 0.2 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.311 -0.947 . . . . 3.5 112.672 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.92 -100.08 0.25 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.844 0.313 . . . . 2.15 111.844 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' H ' ' HA3' ' A' ' 40' ' ' GLY . 9.6 p90 -169.37 178.97 4.06 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.953 0.406 . . . . 2.96 111.238 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.41 131.93 34.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.828 -0.805 . . . . 2.45 108.828 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.704 HG11 HD13 ' A' ' 162' ' ' LEU . 61.0 t -97.56 153.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.541 0.686 . . . . 2.49 110.975 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.706 HG22 ' HA ' ' A' ' 54' ' ' ASP . 71.2 m -131.32 82.8 2.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.473 -1.24 . . . . 2.26 110.653 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.6 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.9 p -116.55 122.01 68.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.473 -1.306 . . . . 4.49 107.473 170.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 74.13 -11.55 0.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.029 0.919 . . . . 4.58 109.694 -172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.706 ' HA ' HG22 ' A' ' 51' ' ' THR . 5.6 t70 79.28 42.22 0.08 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.039 -1.891 . . . . 3.62 110.14 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -81.61 -22.12 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.093 -0.958 . . . . 7.78 109.949 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 55.86 73.37 0.44 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.884 -0.598 . . . . 5.81 111.196 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.1 mt -89.35 123.97 41.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.405 -0.816 . . . . 1.4 110.784 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -84.83 124.75 31.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.768 -0.456 . . . . 1.85 109.768 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -107.69 119.08 38.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.641 0.258 . . . . 1.14 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.0 mt -86.61 119.53 26.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.08 -0.509 . . . . 3.46 110.471 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.26 135.76 35.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.818 -0.628 . . . . 6.48 110.677 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -125.74 77.85 69.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 5.89 111.477 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.19 -22.94 21.71 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.455 2.103 . . . . 5.92 112.132 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.64 62.26 0.28 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.925 -0.655 . . . . 5.92 112.352 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -148.99 137.66 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.543 0.211 . . . . 8.81 110.438 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.05 -31.92 6.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 6.36 110.104 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.43 60.91 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.85 -0.614 . . . . 3.89 110.474 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.774 ' HD1' ' HD2' ' A' ' 102' ' ' HIS . 5.1 m-85 62.7 -99.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.28 -0.873 . . . . 2.61 110.651 -175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.417 HG22 HG21 ' A' ' 12' ' ' THR . 3.9 p -133.99 -82.21 0.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.956 0.407 . . . . 5.11 111.065 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -112.24 21.73 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.673 0.749 . . . . 6.34 109.513 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.467 ' HG3' ' HA2' ' A' ' 75' ' ' GLY . 55.9 ttm -79.42 68.42 5.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.208 -0.905 . . . . 5.64 110.283 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -90.46 -48.31 7.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 10.31 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.24 -77.08 0.59 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.837 -0.345 . . . . 7.85 111.586 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -96.46 27.67 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.321 0.582 . . . . 11.11 110.86 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA2' ' HG3' ' A' ' 71' ' ' MET . . . 83.78 -55.82 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.895 -0.669 . . . . 6.78 112.801 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 70.01 -60.95 0.47 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.599 0.76 . . . . 7.11 111.973 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -111.41 100.64 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.977 -0.379 . . . . 8.32 109.977 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 50.2 t -66.54 128.18 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 4.75 110.6 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' OG1' ' A' ' 12' ' ' THR . 7.0 t -164.42 132.09 3.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.069 -0.514 . . . . 4.44 110.059 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -126.06 25.18 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 3.12 110.882 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 11' ' ' VAL . 36.0 mm -128.22 118.08 47.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.22 -0.446 . . . . 1.31 110.161 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 103' ' ' ALA . 73.1 t -113.24 112.71 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.022 -0.535 . . . . 1.78 111.46 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.751 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.9 mt -94.96 99.97 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 C-N-CA 120.264 -0.574 . . . . 1.97 110.049 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.766 HD22 HD12 ' A' ' 100' ' ' ILE . 6.7 tp -87.1 113.14 22.59 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.693 -0.403 . . . . 1.98 110.796 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.922 HG13 ' HA3' ' A' ' 15' ' ' GLY . 8.7 p -81.39 142.41 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 1.8 110.667 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 87' ' ' ALA . 18.2 t -134.68 175.27 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 107.489 -1.3 . . . . 1.79 107.489 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.02 114.7 6.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.623 0.647 . . . . 1.03 112.497 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 40.63 -96.88 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.84 1.052 . . . . 1.66 113.84 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 122' ' ' ALA . 10.9 p-10 -108.11 -3.1 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.891 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.567 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 3.8 t70 -71.05 -45.24 64.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.185 0.517 . . . . 1.09 110.423 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.727 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 81.41 -109.8 3.06 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.52 111.84 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.53 HG11 ' HB ' ' A' ' 96' ' ' THR . 42.5 t -124.73 109.25 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.053 0.454 . . . . 1.67 111.349 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.567 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 65.4 mmm -80.48 168.84 22.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 1.32 110.246 173.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.54 ' HD2' ' HE2' ' A' ' 93' ' ' MET . 82.7 Cg_exo -47.0 -50.07 11.55 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.633 2.222 . . . . 0.88 112.877 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.95 -37.02 73.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 2.01 111.041 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.533 HG23 HD13 ' A' ' 84' ' ' LEU . 33.7 m -63.39 -25.95 68.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.235 -0.438 . . . . 1.19 111.038 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' CG1' ' A' ' 92' ' ' VAL . 22.5 t -85.88 -55.54 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 112.177 0.436 . . . . 1.66 112.177 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.2 -21.56 61.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.9 0.381 . . . . 1.62 110.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.656 ' HB1' ' HG3' ' A' ' 14' ' ' MET . . . -82.18 -34.56 28.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 1.09 109.997 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.766 HD12 HD22 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -77.83 -44.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 1.13 110.41 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -55.1 -37.39 66.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.464 -0.789 . . . . 1.97 111.206 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.774 ' HD2' ' HD1' ' A' ' 68' ' ' PHE . 20.3 t60 -79.5 -25.72 41.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 1.02 110.521 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.956 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -86.0 -59.49 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.284 0.476 . . . . 1.18 112.284 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -17.25 63.95 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.286 0.476 . . . . 2.98 112.286 -167.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.22 5.3 17.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.849 0.357 . . . . 1.3 111.891 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.85 8.38 30.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.667 -0.864 . . . . 1.3 108.667 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.8 t30 75.44 30.38 0.83 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.361 -1.29 . . . . 2.59 110.242 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -107.97 146.48 33.56 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.245 -0.889 . . . . 1.71 110.734 178.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 108' ' ' VAL . 5.7 Cg_exo -76.15 158.16 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.369 2.713 . . . . 0.62 113.311 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.433 ' HB ' ' CD2' ' A' ' 136' ' ' LEU . 4.4 mp -124.27 154.57 31.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.084 -0.962 . . . . 1.62 109.583 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.751 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 6.1 mt -118.94 155.83 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 108.353 -0.98 . . . . 1.31 108.353 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -119.77 134.13 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.002 0.429 . . . . 1.07 110.249 174.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -120.99 88.01 2.86 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.111 -1.07 . . . . 1.07 108.111 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 13.8 mm -66.85 95.1 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.042 -0.981 . . . . 1.56 110.148 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 55.0 t30 -92.85 169.02 10.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.164 -0.68 . . . . 0.88 109.164 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 87' ' ' ALA . 55.7 mtpt 58.51 26.37 14.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.688 0.756 . . . . 3.11 110.056 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.549 ' C ' ' H ' ' A' ' 119' ' ' LYS . 5.2 tpp -95.97 2.62 53.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.973 -1.012 . . . . 1.55 110.269 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.96 43.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.17 -0.923 . . . . 2.45 111.09 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 58.4 mttm -125.07 -175.33 0.39 Allowed Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.368 -1.715 . . . . 4.11 106.368 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 31.3 Cg_exo -56.16 -51.87 8.5 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 CA-C-N 120.277 1.135 . . . . 3.16 110.353 169.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 6.4 pt-20 157.73 132.98 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 125.373 1.469 . . . . 4.03 107.364 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 89' ' ' ASP . . . -68.61 -72.96 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.67 -0.863 . . . . 1.9 108.67 168.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 11.2 t-20 177.11 81.4 0.12 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.459 -0.791 . . . . 2.21 109.66 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.632 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.3 Cg_exo -38.95 -61.98 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.077 3.185 . . . . 1.01 113.694 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -47.21 -49.68 22.47 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.572 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 2.0 tmt_? -53.77 -56.44 17.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.325 0.583 . . . . 3.7 109.58 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.727 HG11 ' HA2' ' A' ' 91' ' ' GLY . 88.3 t -56.78 -41.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.787 -1.097 . . . . 1.12 110.847 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.661 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -67.07 -32.86 74.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.954 -0.567 . . . . 1.07 110.943 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.411 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 75.1 mt-30 -75.75 -24.32 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.665 -0.243 . . . . 2.01 110.883 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.6 mm-40 -63.48 -39.92 95.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.598 -0.89 . . . . 2.02 108.598 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.608 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.4 mm? -68.42 -46.6 69.45 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.62 110.016 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.833 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -73.44 -5.49 40.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.618 -0.719 . . . . 1.08 110.276 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 43.8 tt0 -76.56 -28.56 56.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.457 -0.942 . . . . 2.18 108.457 171.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.442 ' CE2' HG13 ' A' ' 92' ' ' VAL . 42.7 m-85 -90.49 13.01 16.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.507 0.67 . . . . 1.17 109.309 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.94 37.93 2.15 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.212 -1.358 . . . . 2.43 109.216 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.442 ' N ' ' HA ' ' A' ' 132' ' ' MET . 5.1 mp -105.7 70.97 0.89 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.575 -1.193 . . . . 2.28 109.471 170.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.974 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -67.45 121.02 77.14 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.016 -0.993 . . . . 1.28 109.677 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.846 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.5 Cg_exo -48.64 157.94 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.833 2.355 . . . . 0.34 112.969 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.8 -22.64 42.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.918 -1.037 . . . . 2.01 108.204 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.59 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 7.6 mp0 -46.46 -48.56 18.97 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.148 -1.387 . . . . 1.18 109.714 161.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.833 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.9 m0 -96.0 -30.07 13.79 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.533 -1.667 . . . . 0.45 110.896 -166.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.81 22.12 3.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.303 -0.951 . . . . 0.45 112.985 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.974 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.3 -113.91 2.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.445 -0.883 . . . . 0.5 112.725 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.44 32.9 0.51 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.193 0.521 . . . . 1.3 111.356 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 23.3 m -134.91 123.49 23.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.29 -0.564 . . . . 1.06 111.825 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.743 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.2 mp -92.68 109.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 1.86 110.55 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.846 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -86.35 134.77 33.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.173 0.511 . . . . 0.38 111.098 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.4 m -131.44 107.8 9.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.454 -0.794 . . . . 1.82 110.03 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.778 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.9 ptmm? -85.51 86.17 7.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.691 0.758 . . . . 2.94 109.89 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.493 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -103.92 -167.23 1.34 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.256 1.027 . . . . 1.89 112.129 -169.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p -161.36 116.08 2.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.802 -1.545 . . . . 2.08 109.318 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.29 -0.84 18.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.178 0.513 . . . . 1.43 111.029 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -83.46 -55.41 4.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.807 0.813 . . . . 3.46 109.681 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.5 p -98.85 -20.64 16.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.548 -1.206 . . . . 1.78 111.395 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HZ1' ' HB3' ' A' ' 155' ' ' LYS . 9.7 mtpm? 72.75 18.1 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 2.75 112.132 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -54.49 -70.51 0.1 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.826 0.822 . . . . 2.64 110.729 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.556 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -75.64 -7.48 83.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.128 -0.942 . . . . 0.73 112.945 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -72.28 -51.18 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.634 -0.506 . . . . 2.12 109.634 -178.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.98 -30.61 70.78 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.447 -0.575 . . . . 2.5 109.447 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.556 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 84.9 t60 -66.49 -25.76 66.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.42 -0.809 . . . . 0.84 110.888 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 158' ' ' LEU . 56.0 tp -67.17 -47.57 70.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.461 . . . . 1.54 110.014 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.704 HD13 HG11 ' A' ' 50' ' ' VAL . 32.8 mt -58.64 -38.78 78.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.461 -0.79 . . . . 1.7 111.277 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 13.5 pt-20 -71.8 -32.35 67.51 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.127 -0.323 . . . . 2.49 110.127 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.743 ' HB3' HG21 ' A' ' 146' ' ' ILE . 25.9 mmt -69.85 -38.24 76.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.311 0.577 . . . . 1.29 109.897 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 162' ' ' LEU . 63.3 mt -56.3 -53.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.073 -0.967 . . . . 1.24 111.136 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.5 pp -71.85 -34.29 69.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 121.041 -0.264 . . . . 2.36 111.491 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.444 ' N ' HD11 ' A' ' 166' ' ' LEU . 14.0 tp -53.06 -31.62 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.97 -0.559 . . . . 1.98 110.73 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.52 -37.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.033 -0.53 . . . . 1.69 110.281 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.4 m -65.29 -32.38 74.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.843 -0.617 . . . . 2.07 110.288 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -86.02 -9.16 57.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 2.79 110.605 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.772 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 35.0 ttm -88.79 -63.23 1.33 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 2.22 111.433 -177.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -38.45 -62.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.242 1.201 . . . . 3.45 114.242 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.48 2.14 54.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.613 0.597 . . . . 3.36 112.613 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 4.3 mm? -103.39 -62.8 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.936 -0.394 . . . . 4.51 109.936 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 20.4 ttpp 166.15 -64.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.05 -1.093 . . . . 6.66 108.05 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.772 ' HA ' ' HG3' ' A' ' 171' ' ' MET . . . -160.53 -168.64 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.054 -1.43 . . . . 4.98 107.988 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.3 91.47 2.37 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 120.686 -0.406 . . . . 6.96 110.22 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.564 2.843 . . . . 7.47 111.725 177.526 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.92 -0.472 . . . . 16.58 111.92 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 t -89.9 -3.33 58.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.596 0.198 . . . . 14.94 111.519 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -93.91 16.43 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.347 -0.541 . . . . 15.21 111.888 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.6 ptp -87.05 109.73 19.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.451 -0.574 . . . . 12.92 109.451 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 27.6 m -87.35 134.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.998 -0.547 . . . . 10.47 111.992 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 9.2 tp10 -148.44 147.09 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.003 -1.11 . . . . 9.14 108.003 174.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -100.01 131.07 24.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.725 0.298 . . . . 9.01 111.3 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.42 ' HG2' HG12 ' A' ' 78' ' ' VAL . 61.3 Cg_endo -76.46 111.05 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.779 2.319 . . . . 5.24 111.836 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -95.1 -56.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.371 2.714 . . . . 4.88 113.372 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' H ' ' A' ' 58' ' ' THR . 93.9 t -134.1 -59.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.473 . . . . 3.08 109.724 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 1.087 HG11 ' HB ' ' A' ' 81' ' ' ILE . 13.7 m -125.29 150.96 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 120.843 0.354 . . . . 1.57 110.755 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.658 HG21 HD21 ' A' ' 60' ' ' LEU . 51.0 m -129.64 134.57 47.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.239 -0.437 . . . . 1.18 111.102 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.727 HD11 HG13 ' A' ' 83' ' ' ILE . 35.7 mm -81.07 129.7 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 1.57 111.062 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.608 ' HE2' ' HB3' ' A' ' 68' ' ' PHE . 14.4 mmt -138.29 157.12 46.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.684 0.394 . . . . 1.41 111.435 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.66 -110.55 0.46 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.116 -0.793 . . . . 1.55 111.116 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -156.85 137.61 13.31 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.75 -0.725 . . . . 1.21 109.594 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.64 -47.47 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.335 0.865 . . . . 2.2 113.335 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.55 -27.54 68.51 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.504 0.557 . . . . 1.78 112.504 -170.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -63.35 -21.27 66.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.281 0.562 . . . . 0.89 110.649 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.53 42.46 1.86 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.661 -0.699 . . . . 1.06 112.465 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -82.02 -22.12 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 2.58 110.215 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -39.88 23.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.174 -1.047 . . . . 2.32 108.174 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 m -62.57 -33.6 75.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.622 -1.172 . . . . 2.23 110.512 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.588 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 59.7 tp -57.39 -56.07 26.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 2.33 110.524 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.685 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.6 tt -63.78 -36.81 85.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.072 0.463 . . . . 2.46 109.994 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.18 -53.76 44.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.955 0.407 . . . . 1.38 111.596 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -32.17 72.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.42 111.196 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.635 HD11 ' OH ' ' A' ' 48' ' ' TYR . 3.9 tt -67.78 -33.47 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.84 -0.618 . . . . 2.08 110.43 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.685 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 15.5 mtm180 -73.62 -28.03 61.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.454 0.645 . . . . 4.16 110.031 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -84.9 5.18 30.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.626 -0.715 . . . . 3.57 110.148 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 m -115.81 38.49 3.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.703 -1.591 . . . . 2.09 106.703 168.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 20.0 pttm -54.85 150.23 10.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 113.349 -1.75 . . . . 5.98 113.567 -166.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.0 -27.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.285 -1.325 . . . . 3.41 110.296 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.8 m -159.93 -21.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.205 0.817 . . . . 4.35 113.205 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.5 pm0 -50.12 151.82 1.89 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.509 0.929 . . . . 4.2 113.509 -174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.688 ' HG3' ' HG3' ' A' ' 37' ' ' GLU . 10.9 pt20 -124.92 -28.87 3.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.648 -1.16 . . . . 6.16 111.003 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.688 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 47.9 mt-10 -117.93 -166.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 5.79 110.869 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.67 89.12 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.896 -0.593 . . . . 4.64 110.732 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -68.6 144.83 42.84 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.812 -0.708 . . . . 4.95 112.196 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.34 -115.12 0.62 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.758 -0.734 . . . . 6.66 112.438 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 pt -82.11 -26.81 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 9.5 111.601 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 45' ' ' ILE . 1.9 p -89.53 91.64 8.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.338 -0.392 . . . . 7.68 110.968 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -77.4 63.03 2.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.907 0.86 . . . . 9.39 111.169 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -132.98 19.45 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.138 -0.937 . . . . 7.29 108.99 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.621 HD12 ' H ' ' A' ' 47' ' ' ALA . 1.8 pp -126.47 178.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.97 -1.014 . . . . 5.6 111.583 -171.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.58 31.08 7.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.07 -1.212 . . . . 3.5 110.07 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.621 ' H ' HD12 ' A' ' 45' ' ' ILE . . . 50.63 -93.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.76 0.824 . . . . 2.15 111.369 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.85 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 23.2 p90 -170.32 156.24 5.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.778 -0.453 . . . . 2.96 109.778 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.934 ' HG2' HG23 ' A' ' 58' ' ' THR . 37.0 mt-30 -126.17 118.06 24.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.257 -0.646 . . . . 2.45 109.257 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -92.37 126.45 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.632 -0.713 . . . . 2.49 112.372 -171.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.7 ' HA ' ' CA ' ' A' ' 55' ' ' LYS . 89.7 m -84.09 81.9 8.59 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.12 0.962 . . . . 2.26 109.008 171.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -96.74 108.71 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.557 -1.275 . . . . 4.49 107.557 170.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.55 -53.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.482 1.114 . . . . 4.58 111.851 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -131.12 -24.86 2.3 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.063 1.135 . . . . 3.62 114.063 -172.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.7 ' CA ' ' HA ' ' A' ' 51' ' ' THR . 20.5 ttpp 79.01 52.11 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.715 0.769 . . . . 7.78 109.442 -167.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -101.92 4.24 39.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.405 -0.816 . . . . 5.81 110.347 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HA ' HG12 ' A' ' 10' ' ' VAL . 19.0 mt -119.19 127.06 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 1.4 110.712 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.934 HG23 ' HG2' ' A' ' 49' ' ' GLN . 36.2 m -119.97 130.85 54.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.162 -0.681 . . . . 1.85 109.162 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HE1' HG23 ' A' ' 50' ' ' VAL . 16.1 m-85 -103.9 89.84 3.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.048 -0.723 . . . . 1.14 109.048 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.658 HD21 HG21 ' A' ' 12' ' ' THR . 95.1 mt 62.57 145.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.78 0.675 . . . . 3.46 111.067 -171.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -171.38 113.85 0.38 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.889 0.7 . . . . 6.48 112.889 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 m 70.03 89.94 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.095 -0.957 . . . . 5.89 112.09 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 5' ' ' VAL . 51.1 Cg_exo -55.41 143.74 75.77 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.302 2.668 . . . . 5.92 112.781 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.95 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.787 -0.72 . . . . 5.92 112.23 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -67.28 120.52 13.95 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.743 -0.466 . . . . 8.81 109.743 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 10.4 pt-20 -84.16 175.25 9.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.151 0.5 . . . . 6.36 111.653 -174.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.6 -42.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.426 -0.806 . . . . 3.89 110.651 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' HD1' ' HD2' ' A' ' 102' ' ' HIS . 51.6 m-85 -109.82 23.0 14.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 2.61 111.805 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 71' ' ' MET . 13.9 p -114.76 67.24 0.69 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.26 -0.427 . . . . 5.11 111.028 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 71' ' ' MET . 88.5 m 72.95 -20.24 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.239 0.459 . . . . 6.34 112.239 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.462 ' H ' ' C ' ' A' ' 69' ' ' THR . 49.4 mtt 70.98 59.89 0.18 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.387 0.613 . . . . 5.64 110.792 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -76.19 -27.92 57.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 10.31 108.689 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.56 90.66 3.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.665 -1.152 . . . . 7.85 109.022 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.9 93.19 0.18 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.757 -0.656 . . . . 11.11 111.342 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.43 51.6 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.763 -0.653 . . . . 6.78 111.51 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 62.16 7.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.196 0.522 . . . . 7.11 111.245 -176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -81.34 64.98 6.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.996 -0.547 . . . . 8.32 110.532 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.42 HG12 ' HG2' ' A' ' 8' ' ' PRO . 29.9 m -132.02 -178.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.752 -0.658 . . . . 4.75 110.624 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.0 t -143.27 39.4 1.43 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.866 0.841 . . . . 4.44 108.739 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -63.64 148.68 48.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.505 -1.225 . . . . 3.12 112.97 -173.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 1.087 ' HB ' HG11 ' A' ' 11' ' ' VAL . 28.4 mm -90.18 108.72 19.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 1.31 109.782 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 1.002 HG23 ' HB2' ' A' ' 103' ' ' ALA . 76.4 t -81.45 108.14 14.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.063 -0.517 . . . . 1.78 111.182 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.727 HG13 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -85.47 102.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.971 -0.751 . . . . 1.97 108.971 177.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.787 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.1 tm? -94.64 111.77 23.53 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.919 -0.582 . . . . 1.98 109.946 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 39.5 t -87.56 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.1 -0.5 . . . . 1.8 111.488 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 114' ' ' ILE . 17.9 m -135.29 -167.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.161 -0.927 . . . . 1.79 108.501 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . . . -140.07 143.27 36.25 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.31 -0.556 . . . . 1.03 111.691 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -34.26 -55.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.678 1.236 . . . . 1.66 112.992 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -109.1 13.83 24.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.883 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -110.68 -43.02 3.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.511 -0.476 . . . . 1.09 111.284 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 78.0 -139.8 23.18 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.667 -0.778 . . . . 0.52 111.949 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.72 HG12 ' HB ' ' A' ' 96' ' ' THR . 44.0 t -96.97 114.8 34.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 122.783 0.433 . . . . 1.67 111.311 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.571 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 53.7 mtp -84.12 169.77 15.97 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.434 -0.348 . . . . 1.32 110.199 171.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 93.8 Cg_exo -45.25 -50.79 8.58 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.696 2.264 . . . . 0.88 113.341 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -72.72 -21.9 60.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.387 -0.369 . . . . 2.01 111.356 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.72 ' HB ' HG12 ' A' ' 92' ' ' VAL . 25.5 m -60.38 -28.74 68.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.397 0.617 . . . . 1.19 110.274 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.04 -45.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.958 -0.565 . . . . 1.66 111.726 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.79 -23.19 59.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 1.62 110.961 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -87.96 -30.96 19.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.811 -0.631 . . . . 1.09 110.018 -177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.845 HG12 HD13 ' A' ' 110' ' ' ILE . 1.7 mt -80.93 -51.21 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.261 -0.881 . . . . 1.13 111.293 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -49.13 -39.28 27.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 1.97 110.78 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.612 ' HD2' ' HD1' ' A' ' 68' ' ' PHE . 12.3 t60 -77.35 -30.2 53.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 1.02 110.968 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 1.002 ' HB2' HG23 ' A' ' 82' ' ' VAL . . . -81.27 -56.29 4.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.436 . . . . 1.18 111.967 -173.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -73.2 -15.72 61.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.304 -0.407 . . . . 2.98 111.899 -168.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.12 -0.48 44.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 1.3 111.206 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -101.39 14.07 33.1 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.814 -0.81 . . . . 1.3 108.814 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 4.8 m-20 72.19 27.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.705 -1.134 . . . . 2.59 111.759 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.623 HG21 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.13 152.85 42.75 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-O 121.061 0.458 . . . . 1.71 111.254 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.623 ' O ' HG21 ' A' ' 108' ' ' VAL . 15.4 Cg_exo -72.54 162.82 40.31 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.678 2.919 . . . . 0.62 113.437 171.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.845 HD13 HG12 ' A' ' 100' ' ' ILE . 73.7 mt -132.61 148.17 31.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.672 -0.695 . . . . 1.62 110.586 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.787 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 37.3 mt -113.61 164.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 109.072 -0.714 . . . . 1.31 109.072 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.555 HG22 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -123.63 129.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 N-CA-C 109.044 -0.724 . . . . 1.07 109.044 169.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.28 87.25 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.592 -1.262 . . . . 1.07 107.592 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.698 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 54.1 mt -69.61 97.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.315 -1.311 . . . . 1.56 109.904 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -96.91 170.82 8.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.88 109.023 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 77.5 tttt 64.14 18.35 11.2 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.365 1.078 . . . . 3.11 109.227 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.1 tpp -95.09 13.97 23.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 123.063 1.411 . . . . 1.55 109.511 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 151' ' ' SER . 4.3 p-10 -64.14 48.71 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.585 -1.189 . . . . 2.45 112.234 171.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.83 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 94.2 mttt -144.84 -172.82 0.33 Allowed Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 105.669 -1.975 . . . . 4.11 105.669 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.83 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.2 Cg_endo -56.95 -56.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 120.536 1.227 . . . . 3.16 110.98 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 12.7 pt-20 164.04 121.98 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.28 1.032 . . . . 4.03 108.238 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -60.41 3.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.641 -0.708 . . . . 1.9 109.934 173.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -179.57 76.82 0.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.656 -0.702 . . . . 2.21 110.266 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.605 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.1 Cg_endo -44.53 -61.3 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.581 2.854 . . . . 1.01 113.325 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.73 -49.63 19.29 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.441 0.697 . . . . 2.0 112.352 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -49.21 -62.13 1.7 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.351 0.596 . . . . 3.7 109.69 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.595 HG13 ' HA2' ' A' ' 91' ' ' GLY . 66.8 t -54.2 -47.84 67.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.341 -1.299 . . . . 1.12 110.848 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.647 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 90.4 mtp -59.42 -34.51 72.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 1.07 111.122 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -76.77 -20.14 56.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.618 -0.264 . . . . 2.01 111.23 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.649 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 4.2 mt-10 -75.98 -30.39 58.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.962 -0.755 . . . . 2.02 108.962 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.903 HD12 HD13 ' A' ' 136' ' ' LEU . 3.5 mm? -72.77 -44.27 61.79 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.831 -0.747 . . . . 1.62 109.311 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.822 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -73.01 -4.54 32.97 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.163 -0.615 . . . . 1.08 109.977 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.649 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 40.9 tt0 -74.41 -32.75 62.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 170.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.601 ' CE2' HG11 ' A' ' 92' ' ' VAL . 44.9 m-85 -89.9 9.39 27.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.911 0.862 . . . . 1.17 109.446 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 72.32 26.59 2.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 113.536 -1.665 . . . . 2.43 110.234 168.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.903 HD13 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.04 76.69 1.37 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.433 -1.321 . . . . 2.28 107.433 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.93 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -63.24 134.04 95.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 113.436 -1.711 . . . . 1.28 110.279 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.77 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -52.29 154.34 11.35 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 122.359 2.039 . . . . 0.34 112.135 173.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.55 ' HB3' ' HE3' ' A' ' 171' ' ' MET . 3.3 mm-40 -80.28 -19.77 45.96 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.05 -0.977 . . . . 2.01 109.141 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.596 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.1 mp0 -47.2 -52.98 14.28 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.709 1.243 . . . . 1.18 108.958 160.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.822 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -89.73 -23.78 21.71 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.897 -1.956 . . . . 0.45 110.68 -167.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.87 23.02 4.79 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.553 -0.832 . . . . 0.45 112.446 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.93 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.93 -108.15 1.99 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.924 -0.655 . . . . 0.5 113.17 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.25 27.37 0.35 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 1.3 111.314 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.662 HG23 HD12 ' A' ' 136' ' ' LEU . 63.5 m -132.67 133.34 43.43 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.83 1.048 . . . . 1.06 113.83 -174.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.794 HG13 HG12 ' A' ' 168' ' ' VAL . 4.1 mp -87.48 108.15 17.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.123 -0.944 . . . . 1.86 110.382 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.77 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 11.8 m-85 -94.54 115.77 27.99 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.839 -0.538 . . . . 0.38 111.224 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.9 t -118.63 128.7 54.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.439 -0.578 . . . . 1.82 109.439 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.698 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.6 pttm -103.65 87.06 2.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.609 0.718 . . . . 2.94 109.393 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.854 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -105.64 -177.03 3.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.43 -0.804 . . . . 1.89 112.486 -172.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 118' ' ' ASP . 12.1 p -155.87 124.05 5.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.929 -1.032 . . . . 2.08 109.636 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 158' ' ' LEU . . . -76.24 -13.19 60.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.141 0.496 . . . . 1.43 110.926 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.465 ' HG3' ' CG ' ' A' ' 118' ' ' ASP . 23.3 mmtp -75.89 -57.64 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.47 -0.786 . . . . 3.46 109.855 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -97.29 -15.71 20.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.148 -0.933 . . . . 1.78 111.376 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.808 ' HG2' HD12 ' A' ' 158' ' ' LEU . 59.4 mttp 64.58 24.82 13.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.23 -0.896 . . . . 2.75 111.888 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.21 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.843 0.83 . . . . 2.64 109.822 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.717 ' HA3' ' HA ' ' A' ' 150' ' ' LEU . . . -71.83 -10.46 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.811 -1.086 . . . . 0.73 113.543 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.808 HD12 ' HG2' ' A' ' 155' ' ' LYS . 25.5 mt -71.89 -43.1 65.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.699 0.75 . . . . 2.12 110.295 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 12.8 t70 -61.66 -42.82 99.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.753 -0.832 . . . . 2.5 108.753 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -66.7 -24.25 66.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.039 -0.982 . . . . 0.84 111.507 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.3 tp -63.31 -56.43 16.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.661 -0.245 . . . . 1.54 110.401 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.8 mt -54.62 -39.84 68.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 1.7 110.585 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.0 mm-40 -63.56 -47.28 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 2.49 110.339 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.73 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -67.07 -38.77 86.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 1.29 110.593 -176.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.14 -49.42 40.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 1.24 111.845 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 167' ' ' LEU . 1.6 pp -84.67 -35.15 22.8 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.406 0.521 . . . . 2.36 112.406 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.6 tp -63.41 -21.98 66.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.99 0.424 . . . . 1.98 110.937 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.794 HG12 HG13 ' A' ' 146' ' ' ILE . 48.5 t -85.34 -28.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.515 -0.311 . . . . 1.69 110.447 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.2 m -61.56 -28.16 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.012 -0.736 . . . . 2.07 109.012 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -73.21 -48.82 31.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.15 -0.932 . . . . 2.79 109.39 169.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.55 ' HE3' ' HB3' ' A' ' 139' ' ' GLU . 11.1 tpp -50.33 -48.56 55.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.756 -0.657 . . . . 2.22 111.506 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 42.6 mt-10 -50.58 -62.98 1.27 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.549 0.69 . . . . 3.45 110.941 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.18 -31.76 71.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.741 -1.118 . . . . 3.36 111.642 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.34 -28.05 38.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.802 0.334 . . . . 4.51 111.291 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HE3' ' HG3' ' A' ' 171' ' ' MET . 20.8 ttpp -94.51 -73.24 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.485 -0.325 . . . . 6.66 111.62 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 176.58 -174.25 0.11 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.113 -0.328 . . . . 4.98 110.113 -173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 86.4 m-20 64.41 67.03 0.93 Allowed Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 123.869 0.73 . . . . 6.96 111.421 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 177' ' ' ASN . 2.3 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.996 2.464 . . . . 7.47 111.552 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.072 -0.411 . . . . 16.58 112.072 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 t -87.73 102.85 15.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.972 0.415 . . . . 14.94 110.349 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -133.1 13.24 4.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.176 0.512 . . . . 15.21 109.813 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.04 132.43 54.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.588 -0.733 . . . . 12.92 110.259 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 -48.27 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 10.47 110.467 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -72.98 111.71 8.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 9.14 110.579 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.452 ' HD2' ' HD2' ' A' ' 8' ' ' PRO . 6.2 tpt180 -110.25 118.52 49.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.11 -0.329 . . . . 9.01 110.11 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.452 ' HD2' ' HD2' ' A' ' 7' ' ' ARG . 10.4 Cg_endo -53.83 127.21 24.62 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.996 2.464 . . . . 5.24 112.101 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.711 ' HG2' ' HB3' ' A' ' 169' ' ' SER . 31.3 Cg_exo -60.55 118.57 5.45 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.086 2.524 . . . . 4.88 112.709 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG21 HD12 ' A' ' 60' ' ' LEU . 6.2 p -79.0 125.52 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.486 0.66 . . . . 3.08 109.928 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.714 HG23 ' HB ' ' A' ' 81' ' ' ILE . 89.2 t -107.37 114.91 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.555 -0.748 . . . . 1.57 110.051 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.996 -0.547 . . . . 1.18 110.728 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.663 ' HA ' HG13 ' A' ' 83' ' ' ILE . 26.4 mt -83.69 121.45 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.056 0.455 . . . . 1.57 111.148 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 20.8 mmt -115.7 178.99 4.1 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.077 -0.712 . . . . 1.41 109.077 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.912 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 114.67 131.05 5.04 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.852 -1.166 . . . . 1.55 111.411 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -44.88 132.37 6.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.332 0.586 . . . . 1.21 110.198 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -56.35 -30.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.55 0.944 . . . . 2.2 113.55 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.63 -15.8 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.78 111.296 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.455 ' HE1' ' H ' ' A' ' 93' ' ' MET . 32.8 m170 -67.25 -43.0 82.99 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.845 -0.428 . . . . 0.89 109.845 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 85' ' ' VAL . . . 147.12 69.79 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.034 -1.079 . . . . 1.06 113.766 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -87.55 -50.11 6.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.453 0.644 . . . . 2.58 109.513 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -64.12 -30.56 71.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.032 -0.986 . . . . 2.32 110.561 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.487 HG23 ' ND2' ' A' ' 115' ' ' ASN . 5.4 t -67.73 -26.64 66.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 2.23 110.64 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.02 -55.82 6.73 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.775 -0.824 . . . . 2.33 108.775 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.643 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 1.9 tt -55.49 -41.69 73.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.945 -0.571 . . . . 2.46 109.78 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.54 -62.5 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.507 0.558 . . . . 1.38 112.507 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.423 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -68.27 -38.48 81.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 1.42 111.843 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.78 -31.04 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.453 . . . . 2.08 110.536 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 37' ' ' GLU . 15.2 mmm180 -64.04 -41.25 97.46 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.223 0.535 . . . . 4.16 110.372 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -76.5 9.3 2.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.38 -0.827 . . . . 3.57 109.818 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.8 m -105.76 12.07 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.876 -0.602 . . . . 2.09 110.342 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 34' ' ' THR . 33.9 mmtp 73.73 -37.86 0.39 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.927 1.084 . . . . 5.98 113.927 169.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.862 HG23 ' HB ' ' A' ' 51' ' ' THR . 9.9 p -71.47 27.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 123.696 0.798 . . . . 3.41 113.14 -172.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' HD2' ' A' ' 48' ' ' TYR . 2.8 p -111.6 120.74 43.1 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 121.56 -0.712 . . . . 4.35 111.817 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.708 ' OE1' ' HG3' ' A' ' 55' ' ' LYS . 7.7 mt-10 -66.51 -58.82 4.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.981 -1.008 . . . . 4.2 112.348 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.561 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 77.1 mt-30 -87.1 136.81 32.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.343 0.592 . . . . 6.16 111.063 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 35.9 mm-40 -85.44 -52.44 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.86 -1.064 . . . . 5.79 113.489 -167.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -100.53 58.76 0.95 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.775 0.321 . . . . 4.64 111.591 -167.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -68.73 101.85 0.83 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.575 -0.821 . . . . 4.95 111.903 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.495 ' H ' ' HA2' ' A' ' 46' ' ' GLY . . . -179.79 -144.31 5.88 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.41 -0.9 . . . . 6.66 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.9 pt -91.25 21.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 112.426 0.528 . . . . 9.5 112.426 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.1 p -91.43 155.9 18.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.62 0.247 . . . . 7.68 111.038 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.75 20.21 5.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 9.39 110.386 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -103.13 -62.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.005 -0.739 . . . . 7.29 109.005 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 36' ' ' GLN . 43.6 mm -127.14 166.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.526 -0.916 . . . . 5.6 108.526 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' HG21 ' A' ' 45' ' ' ILE . . . -160.63 -52.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.492 -0.643 . . . . 3.5 111.492 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -96.81 -169.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.352 -0.61 . . . . 2.15 109.352 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.643 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 1.1 p90 -163.71 137.91 5.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 2.96 110.761 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.618 ' HG2' HG21 ' A' ' 58' ' ' THR . 47.8 mt-30 -98.98 152.0 20.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.169 -0.469 . . . . 2.45 109.879 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 95.1 t -107.08 150.31 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.891 0.853 . . . . 2.49 111.945 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.862 ' HB ' HG23 ' A' ' 33' ' ' VAL . 85.6 m -96.08 93.15 6.8 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.677 -1.601 . . . . 2.26 112.067 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.2 p -122.99 116.19 47.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.269 -1.012 . . . . 4.49 108.269 169.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 71.34 -44.62 0.6 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.032 0.92 . . . . 4.58 109.254 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 52' ' ' VAL . 14.4 t70 -167.35 -57.85 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.931 -1.486 . . . . 3.62 109.029 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.708 ' HG3' ' OE1' ' A' ' 35' ' ' GLU . 5.3 tmmm? -177.75 110.47 0.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.664 -1.153 . . . . 7.78 109.085 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 35.1 mmtp -132.97 -3.08 3.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 5.81 110.519 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.774 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 42.2 mt -117.84 139.47 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.019 -0.363 . . . . 1.4 110.019 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 49' ' ' GLN . 11.0 m -121.67 113.8 20.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.128 -0.323 . . . . 1.85 110.128 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.473 ' HD2' HD12 ' A' ' 13' ' ' ILE . 3.7 m-85 -93.76 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 1.14 110.876 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD12 HG21 ' A' ' 10' ' ' VAL . 9.7 mp -111.06 92.54 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 3.46 110.81 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.66 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 36.7 t70 -75.08 -36.67 61.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.299 0.571 . . . . 6.48 109.464 174.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.1 p -121.12 100.38 45.61 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.205 -0.907 . . . . 5.89 109.817 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.52 -18.2 20.22 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.715 2.277 . . . . 5.92 112.581 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.12 -90.2 0.35 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.12 -0.792 . . . . 5.92 111.12 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -147.69 -28.4 0.35 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.028 0.442 . . . . 8.81 109.96 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.88 125.44 26.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.723 -0.671 . . . . 6.36 109.482 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.09 110.3 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.374 -0.376 . . . . 3.89 110.946 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.591 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 15.0 t80 64.93 58.75 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.637 -0.71 . . . . 2.61 111.202 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.4 p 55.24 -165.33 0.11 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.714 0.806 . . . . 5.11 112.518 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.3 m -120.32 38.03 4.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.442 -0.799 . . . . 6.34 109.164 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 mmt 60.52 46.78 9.21 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.636 -0.711 . . . . 5.64 110.485 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 72' ' ' ARG . 6.3 mmt180 65.69 -76.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.961 -1.018 . . . . 10.31 111.885 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -9.74 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.572 0.225 . . . . 7.85 111.603 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -168.79 -58.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.436 . . . . 11.11 110.232 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.83 71.45 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.704 -0.68 . . . . 6.78 111.766 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.29 -84.68 0.51 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 7.11 110.561 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.957 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -91.93 133.79 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.812 -0.44 . . . . 8.32 109.812 175.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.07 146.23 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.638 -0.505 . . . . 4.75 109.638 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -152.31 31.43 0.53 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.079 -1.082 . . . . 4.44 108.079 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.7 96.04 6.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.095 -1.411 . . . . 3.12 109.513 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.714 ' HB ' HG23 ' A' ' 11' ' ' VAL . 45.8 mm -68.01 126.57 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.798 -1.092 . . . . 1.31 111.794 -170.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.903 HG21 ' HB1' ' A' ' 103' ' ' ALA . 89.7 t -100.92 98.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.79 -0.364 . . . . 1.78 111.274 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.663 HG13 ' HA ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -87.11 104.38 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.093 -0.643 . . . . 1.97 110.472 174.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.615 HD22 ' CD1' ' A' ' 100' ' ' ILE . 9.7 tp -91.46 114.08 26.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.884 -0.598 . . . . 1.98 110.33 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.912 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.6 p -85.7 142.72 12.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.882 -0.727 . . . . 1.8 110.844 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -137.3 -170.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.36 -0.978 . . . . 1.79 108.36 175.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.24 139.68 30.33 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.238 -0.585 . . . . 1.03 111.681 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB2' HG23 ' A' ' 114' ' ' ILE . . . -78.91 58.23 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.035 -0.984 . . . . 1.66 111.207 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -164.97 -33.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.452 -1.249 . . . . 2.01 109.301 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.51 -63.26 1.18 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.522 0.677 . . . . 1.09 110.954 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.742 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 117.07 -106.36 1.42 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.996 -1.002 . . . . 0.52 110.887 -172.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.94 HG13 ' HB ' ' A' ' 96' ' ' THR . 38.5 t -129.67 114.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 120.952 0.406 . . . . 1.67 110.572 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.696 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 60.3 mtp -91.96 172.81 5.92 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 1.32 109.741 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.696 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 58.0 Cg_exo -39.32 -59.76 0.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.269 2.646 . . . . 0.88 113.857 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -54.27 -35.01 62.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 2.01 111.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.94 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.3 m -64.26 -34.04 77.19 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.762 0.282 . . . . 1.19 111.762 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.62 HG11 ' CG1' ' A' ' 92' ' ' VAL . 1.4 m -85.7 -38.86 13.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 121.967 -0.458 . . . . 1.66 111.328 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.65 -30.06 70.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.165 0.507 . . . . 1.62 110.916 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -76.31 -17.6 59.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.647 -0.706 . . . . 1.09 110.491 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -93.41 -45.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 1.13 110.966 -176.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -53.41 -38.54 63.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.566 0.698 . . . . 1.97 110.086 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -75.2 -28.66 60.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.191 -0.913 . . . . 1.02 110.943 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.903 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.74 -53.88 3.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.889 0.7 . . . . 1.18 112.889 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -67.7 -16.21 64.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.225 0.454 . . . . 2.98 112.225 -166.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.65 10.7 4.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.309 0.485 . . . . 1.3 112.309 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.598 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -107.96 4.21 24.99 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.08 -0.711 . . . . 1.3 109.08 173.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 21.0 t-20 80.46 19.31 0.55 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 123.204 1.478 . . . . 2.59 108.858 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.598 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -96.06 142.47 24.61 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 113.741 -1.572 . . . . 1.71 110.462 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 8.3 Cg_exo -73.19 152.02 49.96 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.904 2.403 . . . . 0.62 114.264 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 100' ' ' ILE . 1.7 mp -114.48 143.11 24.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 113.239 -1.8 . . . . 1.62 109.637 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mp -113.46 147.52 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.079 -1.082 . . . . 1.31 108.079 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -110.37 138.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 109.32 -0.622 . . . . 1.07 109.32 174.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.1 87.8 2.82 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.232 -1.025 . . . . 1.07 108.232 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.663 ' HA ' HG21 ' A' ' 86' ' ' VAL . 37.5 mt -73.3 95.92 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.581 -1.191 . . . . 1.56 110.153 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.487 ' ND2' HG23 ' A' ' 23' ' ' THR . 53.3 t30 -90.8 156.53 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.671 -0.412 . . . . 0.88 111.174 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.2 mttp 71.51 37.32 1.15 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.732 0.813 . . . . 3.11 112.178 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -110.86 18.41 19.57 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.873 -0.731 . . . . 1.55 111.661 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.98 -28.35 69.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.088 -0.506 . . . . 2.45 111.44 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.695 ' H ' ' HD2' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -133.57 -56.17 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.503 0.927 . . . . 4.11 113.503 178.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.695 ' HD2' ' H ' ' A' ' 119' ' ' LYS . 29.1 Cg_endo -73.38 -53.38 0.13 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.251 2.634 . . . . 3.16 112.706 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' CB ' ' HB2' ' A' ' 117' ' ' MET . 10.1 pt-20 59.69 0.19 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.87 1.668 . . . . 4.03 113.793 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 42.99 -98.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.293 0.637 . . . . 1.9 111.381 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -163.65 93.87 1.08 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.114 -0.494 . . . . 2.21 110.826 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HG3' ' HE3' ' A' ' 117' ' ' MET . 58.1 Cg_exo -28.79 -69.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.548 3.499 . . . . 1.01 114.545 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.94 -45.72 15.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.725 0.81 . . . . 2.0 112.206 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -55.17 -56.13 23.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.493 0.663 . . . . 3.7 110.177 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.742 HG11 ' HA2' ' A' ' 91' ' ' GLY . 56.7 t -59.44 -39.73 79.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.565 -1.198 . . . . 1.12 110.346 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.648 ' HE2' ' HG3' ' A' ' 140' ' ' GLU . 87.3 mtp -66.29 -30.01 70.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.558 -0.746 . . . . 1.07 111.225 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.34 -21.06 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.627 0.251 . . . . 2.01 110.778 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.1 -38.58 85.93 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.646 -0.872 . . . . 2.02 108.646 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.904 HD12 HD12 ' A' ' 136' ' ' LEU . 3.9 mm? -69.47 -45.35 69.21 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.802 -0.636 . . . . 1.62 110.031 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.9 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -73.26 -5.04 36.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.84 -0.618 . . . . 1.08 110.363 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.62 -37.19 68.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.726 -1.213 . . . . 2.18 107.726 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.91 ' CE2' HG12 ' A' ' 92' ' ' VAL . 28.6 m-85 -84.38 7.6 19.0 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.944 0.878 . . . . 1.17 109.283 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.71 44.08 1.21 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.829 -1.532 . . . . 2.43 109.505 170.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.904 HD12 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -122.43 81.77 1.89 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 113.517 -1.674 . . . . 2.28 106.96 169.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.807 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -65.37 130.53 94.72 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.006 -1.452 . . . . 1.28 110.242 -173.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.764 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 58.2 Cg_exo -44.69 154.79 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.888 2.392 . . . . 0.34 112.54 170.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -74.43 -29.17 61.38 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.346 -1.297 . . . . 2.01 108.012 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.669 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -51.11 -42.17 60.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.584 -1.189 . . . . 1.18 109.572 168.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.9 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.2 m0 -96.16 -20.35 18.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.419 -0.81 . . . . 0.45 111.167 -172.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.99 29.85 4.44 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.139 -1.029 . . . . 0.45 112.707 170.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.807 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.78 -106.67 2.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.366 -0.921 . . . . 0.5 112.923 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.34 27.99 0.45 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.714 -0.243 . . . . 1.3 111.42 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.506 HG21 HG21 ' A' ' 110' ' ' ILE . 26.6 m -134.55 129.04 34.45 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 119.171 -1.011 . . . . 1.06 113.548 -171.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.713 HG22 ' HB3' ' A' ' 164' ' ' MET . 49.9 mm -94.35 110.33 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.332 -0.849 . . . . 1.86 110.566 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.764 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 14.2 m-85 -90.89 119.4 31.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.034 0.445 . . . . 0.38 111.429 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 75.8 m -110.37 111.99 23.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.625 -0.509 . . . . 1.82 109.625 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.676 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 25.9 pttt -93.29 100.06 12.48 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.811 -0.631 . . . . 2.94 109.392 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.682 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -123.07 179.13 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.615 1.198 . . . . 1.89 113.681 -169.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.58 116.83 5.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.285 -1.78 . . . . 2.08 108.15 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 158' ' ' LEU . . . -63.02 -16.32 59.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.013 0.375 . . . . 1.43 112.013 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.71 -57.34 3.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.802 0.81 . . . . 3.46 109.503 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -72.69 -17.96 61.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.129 -1.396 . . . . 1.78 112.01 -175.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.685 ' HD3' HD12 ' A' ' 158' ' ' LEU . 30.2 mmtp 71.63 -0.11 3.28 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.791 -0.641 . . . . 2.75 112.007 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -45.99 -74.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.037 0.754 . . . . 2.64 113.037 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.51 -6.7 66.77 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.496 -0.774 . . . . 0.73 113.536 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.685 HD12 ' HD3' ' A' ' 155' ' ' LYS . 57.7 mt -73.55 -43.16 60.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.288 0.544 . . . . 2.12 110.561 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 26.9 m-20 -66.94 -40.43 87.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 174.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -65.29 -30.64 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.84 110.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 60.7 tp -63.39 -53.89 45.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 1.54 110.639 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.63 -39.29 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 1.7 110.731 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 8.1 mm-40 -61.41 -48.34 81.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.573 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.736 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 21.7 mmt -69.29 -40.12 77.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 1.29 110.854 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.41 -47.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.041 -0.527 . . . . 1.24 110.43 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.2 -46.72 87.68 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.29 -0.414 . . . . 2.36 111.137 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.43 -46.28 76.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.555 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.593 HG21 ' HE3' ' A' ' 171' ' ' MET . 77.4 t -74.05 -41.61 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.094 -0.503 . . . . 1.69 111.427 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.711 ' HB3' ' HG2' ' A' ' 9' ' ' PRO . 50.3 m -60.65 -26.88 67.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.471 . . . . 2.07 110.811 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -83.62 -45.75 13.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 2.79 111.061 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.593 ' HE3' HG21 ' A' ' 168' ' ' VAL . 19.6 ptt? -88.04 -11.96 45.71 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.391 0.515 . . . . 2.22 112.391 -172.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.1 -31.99 14.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.33 0.493 . . . . 3.45 112.33 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.2 -23.28 61.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.167 -0.47 . . . . 3.36 111.366 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.24 -65.54 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.888 -0.597 . . . . 4.51 109.413 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt 60.75 99.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.963 -1.017 . . . . 6.66 112.584 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -110.17 81.75 1.49 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.235 -0.893 . . . . 4.98 110.169 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -113.09 155.41 44.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.509 . . . . 6.96 110.303 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.849 2.366 . . . . 7.47 111.839 177.304 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.257 -0.337 . . . . 16.58 112.257 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -79.73 -11.23 59.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.758 0.313 . . . . 14.94 111.793 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -107.54 100.79 10.17 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 15.21 109.723 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -79.29 72.51 5.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 12.92 111.433 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.51 6.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.509 0.671 . . . . 10.47 109.946 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -85.43 38.58 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 9.14 111.177 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 ttt180 -144.89 66.34 12.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.485 . . . . 9.01 110.289 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 53.8 Cg_endo -95.33 138.44 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.918 2.412 . . . . 5.24 112.294 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 13.4 Cg_exo -71.0 65.38 2.53 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.944 2.429 . . . . 4.88 111.619 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.647 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 3.8 p -73.57 124.15 30.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 3.08 111.06 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.727 HG21 ' HB ' ' A' ' 81' ' ' ILE . 4.0 t -118.32 141.2 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.654 -0.703 . . . . 1.57 109.751 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 14' ' ' MET . 10.8 m -95.34 121.66 37.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.244 -0.435 . . . . 1.18 111.466 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 83' ' ' ILE . 32.6 mt -95.67 120.06 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.316 0.579 . . . . 1.57 110.01 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.498 ' HE3' HG23 ' A' ' 12' ' ' THR . 50.0 mtt -128.59 152.28 48.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.75 -0.659 . . . . 1.41 110.798 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.899 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 168.82 -113.8 0.54 Allowed Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.281 -1.128 . . . . 1.55 110.281 173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 85.3 t60 -161.99 147.12 12.97 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.083 -0.71 . . . . 1.21 109.083 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -56.95 -51.38 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.592 0.59 . . . . 2.2 112.592 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -61.33 -28.23 69.06 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.796 0.665 . . . . 1.78 112.796 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.445 ' HE1' ' H ' ' A' ' 93' ' ' MET . 27.7 m170 -66.63 -19.02 65.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.89 110.799 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.09 1.38 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.654 -0.784 . . . . 1.06 112.163 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -73.13 -48.8 32.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.235 0.541 . . . . 2.58 110.566 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 2.32 110.067 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 m -70.83 -29.08 65.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.779 -0.646 . . . . 2.23 110.428 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 41.3 tp -63.33 -49.0 75.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.459 -0.571 . . . . 2.33 109.459 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.73 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 8.3 tt -60.09 -45.42 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.406 -0.816 . . . . 2.46 110.519 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.8 t70 -66.17 -48.33 71.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.144 -0.48 . . . . 1.38 111.908 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.06 99.66 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.115 0.483 . . . . 1.42 110.735 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 25' ' ' LEU . 9.6 tt -66.67 -34.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.383 -0.826 . . . . 2.08 110.753 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 29.5 ptt180 -78.33 -36.31 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.675 0.75 . . . . 4.16 109.092 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -76.16 14.39 0.73 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.799 -1.091 . . . . 3.57 111.578 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.729 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 71.2 m -98.42 11.86 36.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.369 -0.604 . . . . 2.09 109.369 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' A' ' 31' ' ' SER . 0.3 OUTLIER 57.53 1.36 0.12 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.525 1.53 . . . . 5.98 115.005 166.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.26 0.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.539 0.685 . . . . 3.41 109.227 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.506 ' HB ' ' HA ' ' A' ' 29' ' ' ARG . 2.4 m -119.99 150.95 39.7 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.163 -0.926 . . . . 4.35 112.039 -166.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.71 -162.76 0.67 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.279 -1.328 . . . . 4.2 108.659 170.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.708 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 2.1 pt20 -178.17 177.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.413 0.625 . . . . 6.16 111.422 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 11.6 tp10 -161.32 -179.09 7.13 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.653 -1.61 . . . . 5.79 106.653 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.479 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.87 90.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.145 0.429 . . . . 4.64 110.667 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.81 132.72 8.79 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 116.125 -0.488 . . . . 4.95 112.24 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.08 -102.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.918 -0.873 . . . . 6.66 110.918 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.97 -37.62 80.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.824 -0.806 . . . . 9.5 108.824 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.3 m -79.44 105.32 10.67 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.995 -1.002 . . . . 7.68 109.538 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 43' ' ' GLN . 1.4 pt20 -116.31 38.36 3.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.797 0.808 . . . . 9.39 110.649 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -103.2 -29.29 11.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.992 -1.114 . . . . 7.29 107.992 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 pt -142.58 -164.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.114 -1.403 . . . . 5.6 108.679 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . 117.32 7.13 12.68 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.04 -1.076 . . . . 3.5 112.879 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.65 170.32 14.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.222 0.534 . . . . 2.15 111.242 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.73 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 -162.48 159.11 24.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.559 -0.746 . . . . 2.96 110.368 -169.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 45.5 mt-30 -125.32 136.97 54.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.493 -0.321 . . . . 2.45 110.15 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 57' ' ' ILE . 5.0 m -93.22 145.0 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.135 0.493 . . . . 2.49 111.43 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -106.24 82.68 1.78 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.691 -0.686 . . . . 2.26 109.711 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.62 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.1 p -132.68 120.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.004 -0.998 . . . . 4.49 108.456 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 72.24 -10.47 0.9 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.14 0.972 . . . . 4.58 109.49 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.4 t70 75.24 28.06 1.04 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.697 -2.047 . . . . 3.62 109.774 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 57' ' ' ILE . 18.3 tptm -93.82 101.54 13.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.055 -1.461 . . . . 7.78 107.055 170.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -74.3 76.94 1.85 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.291 0.567 . . . . 5.81 111.34 -168.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 ' HB ' HG22 ' A' ' 50' ' ' VAL . 39.3 mt -66.9 106.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.247 -0.888 . . . . 1.4 110.309 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.647 ' HB ' ' HA ' ' A' ' 10' ' ' VAL . 5.0 m -80.88 100.79 9.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.551 -0.537 . . . . 1.85 109.551 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HE2' ' CG1' ' A' ' 50' ' ' VAL . 59.5 m-85 -80.0 118.7 21.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.001 0.429 . . . . 1.14 111.985 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -104.6 137.26 42.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.476 -0.784 . . . . 3.46 109.496 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.82 134.94 44.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.747 0.308 . . . . 6.48 110.565 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.465 HG21 ' HB1' ' A' ' 67' ' ' ALA . 35.4 m -122.07 94.57 48.0 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 5.89 111.308 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -94.53 13.13 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.079 2.519 . . . . 5.92 112.475 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.11 -163.64 12.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.869 -0.681 . . . . 5.92 112.446 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -99.36 -78.65 0.5 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 8.81 111.709 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.94 58.83 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.238 0.542 . . . . 6.36 111.652 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.465 ' HB1' HG21 ' A' ' 62' ' ' THR . . . -121.86 115.73 23.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.832 -0.622 . . . . 3.89 110.244 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' HD2' ' HD2' ' A' ' 102' ' ' HIS . 1.1 t80 -157.19 -53.29 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.791 -0.448 . . . . 2.61 109.791 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -71.37 90.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 5.11 111.245 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -113.63 0.46 14.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.907 -0.588 . . . . 6.34 110.662 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -80.48 143.09 33.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.643 -0.708 . . . . 5.64 110.422 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -88.67 45.42 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.587 0.708 . . . . 10.31 110.048 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -178.17 169.46 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.031 -0.986 . . . . 7.85 109.196 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -112.44 48.96 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.825 0.821 . . . . 11.11 109.068 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.07 -177.26 46.69 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.994 -1.242 . . . . 6.78 109.994 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.63 36.89 28.31 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.662 0.744 . . . . 7.11 109.942 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -88.01 119.38 28.31 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.94 -1.027 . . . . 8.32 111.216 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.57 7.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.259 -1.015 . . . . 4.75 108.259 173.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 1.1 m -84.74 5.46 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.495 -1.229 . . . . 4.44 111.507 -173.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' ' 108' ' ' VAL . 19.6 m-20 -80.12 38.3 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 3.12 111.315 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.727 ' HB ' HG21 ' A' ' 11' ' ' VAL . 41.9 mm -125.02 104.98 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.32 -0.622 . . . . 1.31 109.32 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 103' ' ' ALA . 90.5 t -106.85 105.85 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 116.193 -0.458 . . . . 1.78 111.402 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.788 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -87.48 107.75 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.057 -0.72 . . . . 1.97 109.057 174.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -96.76 114.65 26.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.236 -0.893 . . . . 1.98 109.928 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.899 HG13 ' HA3' ' A' ' 15' ' ' GLY . 9.9 p -88.04 141.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.295 0.569 . . . . 1.8 111.341 -176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.647 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.8 m -138.4 -171.09 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.243 -0.89 . . . . 1.79 108.631 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.87 136.91 25.88 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.752 -0.379 . . . . 1.03 110.535 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 59.37 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 1.66 111.235 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.72 -30.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.242 -1.344 . . . . 2.01 109.655 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -108.98 -52.53 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.102 0.477 . . . . 1.09 110.991 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 102.5 -113.42 4.59 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.581 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.709 HG11 ' HB ' ' A' ' 96' ' ' THR . 41.4 t -125.85 112.26 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.973 0.415 . . . . 1.67 110.919 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.573 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.7 mtp -88.26 171.8 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.327 -0.397 . . . . 1.32 110.452 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 84.7 Cg_exo -46.98 -48.5 14.36 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.818 2.345 . . . . 0.88 114.112 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 6.1 mt-30 -62.03 -38.41 88.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.006 -0.278 . . . . 2.01 110.91 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.709 ' HB ' HG11 ' A' ' 92' ' ' VAL . 6.4 m -58.57 -33.54 70.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.786 0.803 . . . . 1.19 110.102 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 134' ' ' TYR . 21.4 t -76.99 -57.93 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.691 -1.14 . . . . 1.66 111.536 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.56 -8.55 56.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.857 -0.611 . . . . 1.62 112.543 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.42 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -84.32 -44.67 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.053 -1.091 . . . . 1.09 108.053 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.616 HD13 ' HG ' ' A' ' 84' ' ' LEU . 7.8 mt -62.9 -45.9 97.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.185 -1.371 . . . . 1.13 111.055 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 5.2 m-20 -54.61 -29.0 50.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 1.97 111.134 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.453 ' HD2' ' HD2' ' A' ' 68' ' ' PHE . 13.3 t60 -85.04 -28.89 25.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 1.02 110.284 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -84.02 -46.25 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.491 . . . . 1.18 111.691 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 101' ' ' ASN . 21.4 ptmt -54.89 -37.01 65.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 2.98 112.639 -171.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.98 11.41 34.07 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.627 0.973 . . . . 1.3 113.627 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.678 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -86.92 -51.59 5.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.023 -1.473 . . . . 1.3 107.023 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.678 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 2.5 p-10 149.59 14.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 125.858 1.974 . . . . 2.59 108.839 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 80' ' ' ASP . 0.4 OUTLIER -102.02 143.69 27.09 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.771 . . . . 1.71 112.204 -166.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 10.7 Cg_exo -72.72 156.96 52.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.215 2.61 . . . . 0.62 112.908 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.55 HD13 HG12 ' A' ' 100' ' ' ILE . 82.3 mt -126.33 149.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.151 -0.931 . . . . 1.62 110.056 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.788 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mt -120.28 161.1 20.22 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 N-CA-C 108.697 -0.853 . . . . 1.31 108.697 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -123.71 140.93 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 121.049 0.452 . . . . 1.07 110.67 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -122.39 88.63 2.97 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.039 -1.097 . . . . 1.07 108.039 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.672 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 44.1 mt -69.66 96.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.043 -0.981 . . . . 1.56 109.543 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -94.14 165.39 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.258 -0.428 . . . . 0.88 110.686 -172.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 48.8 mttp 64.62 14.18 8.82 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.652 -0.704 . . . . 3.11 112.641 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.715 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -85.29 9.13 16.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.622 -0.831 . . . . 1.55 111.433 -175.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.535 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 33.8 t70 -77.38 57.77 1.56 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.065 0.936 . . . . 2.45 109.038 171.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.994 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 16.6 pttm -164.84 -171.35 0.26 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.403 -1.332 . . . . 4.11 107.403 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.994 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.3 Cg_endo -46.03 -21.26 1.01 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.925 2.417 . . . . 3.16 114.08 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 121' ' ' GLU . 12.4 pt-20 53.47 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.545 1.138 . . . . 4.03 111.789 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -41.44 -67.14 0.27 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.933 -1.485 . . . . 1.9 111.483 -172.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 42.4 t-20 170.31 104.4 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 O-C-N 124.316 1.01 . . . . 2.21 109.226 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.672 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.6 Cg_exo -38.77 -55.74 1.29 Allowed 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 123.338 2.692 . . . . 1.01 113.73 171.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -47.39 -49.28 25.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.403 0.52 . . . . 2.0 112.403 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 20.5 tpt180 -49.08 -59.53 3.56 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.51 0.671 . . . . 3.7 109.798 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.482 HG13 ' HA2' ' A' ' 91' ' ' GLY . 51.4 t -55.99 -45.9 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.966 -1.47 . . . . 1.12 110.399 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.689 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 91.0 mtp -60.45 -34.37 73.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 1.07 111.449 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' A' ' 132' ' ' MET . 92.9 mt-30 -73.9 -22.39 59.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 2.01 110.359 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.8 mt-10 -75.49 -32.64 60.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.875 -0.787 . . . . 2.02 108.875 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.924 HD11 HD11 ' A' ' 136' ' ' LEU . 3.4 mm? -68.73 -45.56 71.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.609 0.719 . . . . 1.62 109.465 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.878 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -73.43 -5.82 42.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.563 -0.744 . . . . 1.08 110.181 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 19.8 tp10 -76.6 -29.57 56.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.865 -1.161 . . . . 2.18 107.865 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 97' ' ' VAL . 22.6 m-85 -92.29 6.67 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.424 0.63 . . . . 1.17 109.654 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.2 m120 78.43 24.47 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.277 -1.328 . . . . 2.43 111.585 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.924 HD11 HD11 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -105.63 78.94 1.39 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.626 -1.25 . . . . 2.28 107.626 172.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.436 HG22 ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -65.63 130.95 94.68 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 113.565 -1.652 . . . . 1.28 111.697 -176.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.803 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 71.1 Cg_exo -49.44 157.09 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.503 2.802 . . . . 0.34 113.376 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HG3' HG13 ' A' ' 146' ' ' ILE . 43.2 mm-40 -72.45 -26.32 61.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.302 -1.317 . . . . 2.01 109.488 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.853 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 3.3 mm-40 -58.55 -43.42 89.29 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.288 -0.869 . . . . 1.18 108.696 171.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.878 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -88.51 -24.78 22.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.064 -1.425 . . . . 0.45 110.283 -169.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.93 26.7 3.74 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.988 -1.101 . . . . 0.45 112.186 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 137' ' ' VAL . . . -101.73 -115.47 3.96 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.405 -0.902 . . . . 0.5 111.896 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.447 ' CG ' ' HZ2' ' A' ' 175' ' ' LYS . 0.4 OUTLIER -152.91 33.39 0.48 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.596 0.236 . . . . 1.3 111.234 -177.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.654 HG23 HD13 ' A' ' 136' ' ' LEU . 36.2 m -128.0 120.24 27.14 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.779 -0.769 . . . . 1.06 112.588 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.46 HG13 ' HG3' ' A' ' 139' ' ' GLU . 3.5 mp -88.16 109.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.645 -0.707 . . . . 1.86 110.385 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.803 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 21.1 m-85 -88.55 108.03 19.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.896 0.379 . . . . 0.38 111.116 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 20.2 t -98.33 118.65 35.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.243 -0.651 . . . . 1.82 109.243 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.715 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 14.2 ptpt -92.3 102.97 15.46 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.162 -0.681 . . . . 2.94 109.162 173.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.622 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -130.17 -169.32 2.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.978 0.894 . . . . 1.89 112.789 -172.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 m -165.8 121.02 1.25 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 113.916 -1.493 . . . . 2.08 109.516 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.54 -12.51 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.623 -0.262 . . . . 1.43 111.668 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.535 ' HE3' ' HB3' ' A' ' 118' ' ' ASP . 18.9 pttp -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.879 0.847 . . . . 3.46 109.463 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.449 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.93 -22.57 45.59 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.246 -1.343 . . . . 1.78 109.84 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.711 ' HG2' HD13 ' A' ' 158' ' ' LEU . 9.3 mtpm? 63.93 3.86 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.593 -1.185 . . . . 2.75 113.71 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.84 -56.11 25.88 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.058 0.932 . . . . 2.64 110.38 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.577 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -69.29 -11.98 65.28 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.519 -1.219 . . . . 0.73 113.535 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.711 HD13 ' HG2' ' A' ' 155' ' ' LYS . 31.5 mt -68.54 -43.0 77.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.314 0.557 . . . . 2.12 110.397 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.0 -45.65 91.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.764 -0.653 . . . . 2.5 109.611 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 164' ' ' MET . 75.4 t60 -64.56 -29.82 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.84 110.783 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.1 tp -67.12 -59.38 3.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.383 -0.371 . . . . 1.54 111.149 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.444 ' HB3' HG11 ' A' ' 52' ' ' VAL . 91.1 mt -54.33 -40.04 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.319 0.387 . . . . 1.7 110.704 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.76 -37.82 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 2.49 111.215 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.727 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 25.1 mmt -72.41 -39.84 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 1.29 110.077 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 161' ' ' LEU . 84.5 mt -58.49 -49.46 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.897 -0.592 . . . . 1.24 111.257 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -70.32 -35.19 73.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.77 0.319 . . . . 2.36 111.268 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.48 ' N ' HD11 ' A' ' 166' ' ' LEU . 59.1 tp -56.93 -32.99 66.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.055 -0.521 . . . . 1.98 109.837 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 164' ' ' MET . 43.7 t -78.03 -37.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.898 -0.592 . . . . 1.69 109.918 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 t -55.16 -35.46 64.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.642 -0.708 . . . . 2.07 110.483 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.45 -45.04 8.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 2.79 111.13 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.8 ttp -65.22 -19.75 66.11 Favored 'General case' 0 C--O 1.223 -0.289 0 N-CA-C 111.459 0.17 . . . . 2.22 111.459 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.95 -30.83 15.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.088 0.471 . . . . 3.45 111.188 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.94 -20.04 19.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 3.36 111.086 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.5 mp -107.36 -6.58 17.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.228 0.825 . . . . 4.51 113.228 -172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' A' ' 144' ' ' ASP . 81.7 tttt -56.15 117.33 3.65 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.138 0.494 . . . . 6.66 111.393 -176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -112.29 17.42 19.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.637 -0.71 . . . . 4.98 110.891 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.3 t30 -108.3 126.76 28.89 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.836 -0.62 . . . . 6.96 110.055 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 12.2 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.008 2.472 . . . . 7.47 111.334 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 111.916 -0.474 . . . . 16.58 111.916 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t -89.6 45.35 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 14.94 110.545 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.11 123.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 15.21 110.102 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 tpt -113.13 98.18 6.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.186 0.517 . . . . 12.92 110.14 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -107.7 139.49 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.776 -0.647 . . . . 10.47 109.574 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.92 58.99 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.161 0.505 . . . . 9.14 110.839 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -118.68 84.01 23.65 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.668 -0.696 . . . . 9.01 109.192 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -76.7 113.92 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.938 2.426 . . . . 5.24 112.298 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -91.47 92.85 0.22 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.068 2.512 . . . . 4.88 110.712 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.15 109.89 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 3.08 110.194 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.667 HG21 ' HB ' ' A' ' 81' ' ' ILE . 74.4 t -84.75 89.22 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 121.698 0.761 . . . . 1.57 110.131 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -87.19 112.5 22.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 1.18 110.308 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 53.3 mt -74.34 117.08 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 121.613 0.72 . . . . 1.57 110.205 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.557 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 43.9 mtt -118.37 179.18 4.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.687 -1.142 . . . . 1.41 109.984 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.831 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.38 -96.8 0.2 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.158 -1.177 . . . . 1.55 110.158 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -172.33 143.56 1.45 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.969 -1.122 . . . . 1.21 107.969 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -24.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.387 0.884 . . . . 2.2 113.387 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.32 -33.74 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.855 0.317 . . . . 1.78 111.855 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -62.86 -23.95 67.56 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.503 0.557 . . . . 0.89 112.503 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 65.41 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.337 -0.935 . . . . 1.06 112.434 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -87.09 -15.58 38.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.332 0.587 . . . . 2.58 109.721 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -78.06 -30.05 49.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 2.32 110.451 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -27.49 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.089 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.02 -50.19 30.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.592 -0.521 . . . . 2.33 109.592 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -60.44 -22.18 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 2.46 110.789 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -92.64 -56.73 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.172 0.434 . . . . 1.38 112.172 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -28.16 69.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 1.42 111.397 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.12 -32.62 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.954 0.407 . . . . 2.08 110.109 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HA ' HG21 ' A' ' 34' ' ' THR . 33.6 mtp-105 -68.52 -32.28 72.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.522 0.677 . . . . 4.16 109.347 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 10.1 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.066 -0.97 . . . . 3.57 110.601 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 m -119.38 27.89 8.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 2.09 109.456 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.737 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER 48.08 -161.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.569 1.168 . . . . 5.98 112.459 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 32' ' ' LYS . 2.9 m 58.75 2.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.35 1.46 . . . . 3.41 113.768 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.3 t -86.35 156.65 20.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.181 0.515 . . . . 4.35 111.589 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 11.9 mm-40 -77.62 -92.72 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.279 -0.873 . . . . 4.2 111.522 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.599 HE21 ' HG3' ' A' ' 37' ' ' GLU . 13.5 pt20 -164.0 -179.65 6.38 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.372 0.878 . . . . 6.16 113.372 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.599 ' HG3' HE21 ' A' ' 36' ' ' GLN . 43.7 mt-10 62.79 -99.64 0.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.221 -1.354 . . . . 5.79 114.2 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.575 ' HB2' ' H ' ' A' ' 47' ' ' ALA . . . -47.07 121.23 3.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.118 0.785 . . . . 4.64 113.118 -171.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.64 35.73 0.24 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.358 -0.837 . . . . 4.95 112.305 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.54 -164.71 13.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.839 -0.696 . . . . 6.66 112.133 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.5 mm -92.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.093 0.473 . . . . 9.5 110.388 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -78.69 -19.12 53.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.008 -0.542 . . . . 7.68 110.36 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -77.57 86.05 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.439 -0.578 . . . . 9.39 109.439 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -92.38 118.66 31.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 7.29 111.194 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.8 pt 51.0 -175.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.039 1.336 . . . . 5.6 113.207 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.09 -32.16 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.006 -0.997 . . . . 3.5 110.952 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.575 ' H ' ' HB2' ' A' ' 38' ' ' ALA . . . 62.99 -179.4 0.14 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.441 0.697 . . . . 2.15 110.826 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 -159.37 154.17 24.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 2.96 110.935 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.543 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 28.4 mt-30 -116.31 137.33 52.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.677 -0.692 . . . . 2.45 109.458 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.626 HG22 ' HE2' ' A' ' 59' ' ' PHE . 3.9 m -105.34 129.75 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 121.606 0.717 . . . . 2.49 111.291 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.2 m -99.23 82.26 2.68 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.122 -0.945 . . . . 2.26 110.392 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.665 ' C ' ' H ' ' A' ' 54' ' ' ASP . 4.5 p -124.48 123.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.83 -1.174 . . . . 4.49 107.83 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 72.52 -16.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.105 0.955 . . . . 4.58 109.973 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.665 ' H ' ' C ' ' A' ' 52' ' ' VAL . 46.7 t0 75.83 40.43 0.28 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.129 -1.85 . . . . 3.62 109.968 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 14.7 tptm -95.84 -2.79 46.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.213 -0.903 . . . . 7.78 109.683 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.6 mttp 60.21 51.33 5.64 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.358 -1.292 . . . . 5.81 112.3 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.62 ' HB ' HG23 ' A' ' 50' ' ' VAL . 73.3 mt -61.35 127.01 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 1.4 110.932 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 23.1 m -99.11 117.11 32.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.398 -0.365 . . . . 1.85 110.221 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.626 ' HE2' HG22 ' A' ' 50' ' ' VAL . 28.9 m-85 -96.31 109.67 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.689 0.28 . . . . 1.14 110.775 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.497 HD23 ' HB ' ' A' ' 13' ' ' ILE . 3.9 mm? 67.85 172.88 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.333 -0.849 . . . . 3.46 112.187 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 5.2 t70 -168.93 -160.18 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.704 -1.221 . . . . 6.48 107.704 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.52 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 21.7 m -67.89 -53.68 19.7 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.518 0.192 . . . . 5.89 111.518 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 71.9 Cg_endo -74.51 55.64 3.73 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.585 2.19 . . . . 5.92 113.221 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.05 -177.35 49.04 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.749 -0.739 . . . . 5.92 112.343 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 69.12 -72.94 0.1 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.219 0.607 . . . . 8.81 112.247 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -122.42 -24.26 5.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.439 0.533 . . . . 6.36 112.439 -170.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.53 4.74 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.45 0.537 . . . . 3.89 112.45 -171.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.777 ' HE1' ' HA ' ' A' ' 103' ' ' ALA . 26.6 t80 66.62 -95.32 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.211 -0.449 . . . . 2.61 111.118 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.3 p -147.21 -102.29 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.086 0.469 . . . . 5.11 111.288 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.3 m -79.73 105.78 11.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.418 -0.355 . . . . 6.34 110.819 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.6 mmt -116.26 14.62 15.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.38 0.61 . . . . 5.64 110.848 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -137.13 120.45 16.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.383 -0.826 . . . . 10.31 108.777 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.64 59.82 2.77 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.513 0.673 . . . . 7.85 109.233 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -96.03 126.71 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.396 -0.82 . . . . 11.11 111.332 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.81 154.21 52.56 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.702 -0.761 . . . . 6.78 111.824 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.93 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.865 0.364 . . . . 7.11 111.137 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.38 83.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.06 0.457 . . . . 8.32 110.173 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.29 153.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.978 -0.555 . . . . 4.75 109.958 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 ' HA ' HG21 ' A' ' 108' ' ' VAL . 5.9 t -153.71 58.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.839 0.828 . . . . 4.44 110.211 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.55 -173.53 2.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.116 -0.947 . . . . 3.12 110.884 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.667 ' HB ' HG21 ' A' ' 11' ' ' VAL . 40.8 mm -111.84 109.89 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.977 -0.556 . . . . 1.31 110.85 -174.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.939 HG22 ' HB1' ' A' ' 103' ' ' ALA . 98.7 t -95.16 103.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 120.75 0.31 . . . . 1.78 111.01 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.65 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 9.2 mm -87.22 99.75 8.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.316 -0.624 . . . . 1.97 109.316 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.591 HD23 ' CD1' ' A' ' 100' ' ' ILE . 11.4 tp -85.97 106.56 17.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.557 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.831 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.4 p -80.19 141.19 15.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.263 0.554 . . . . 1.8 110.978 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.3 m -141.2 -171.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 107.868 -1.16 . . . . 1.79 107.868 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.14 146.95 43.4 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.426 -0.51 . . . . 1.03 110.839 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 117' ' ' MET . . . -35.51 -53.89 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.778 1.299 . . . . 1.66 112.677 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.11 -9.93 20.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.593 0.59 . . . . 2.01 112.593 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.67 -40.46 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.126 -0.63 . . . . 1.09 111.559 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.529 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.49 -138.42 23.2 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.296 -0.954 . . . . 0.52 111.115 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.999 HG12 ' HB ' ' A' ' 96' ' ' THR . 23.9 t -101.04 113.44 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 122.766 0.426 . . . . 1.67 110.553 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.556 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -85.0 166.79 29.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.502 -0.925 . . . . 1.32 108.502 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.556 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 31.8 Cg_exo -34.56 -52.05 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.848 3.032 . . . . 0.88 115.09 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -78.06 -17.99 56.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 122.124 -0.36 . . . . 2.01 111.415 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.999 ' HB ' HG12 ' A' ' 92' ' ' VAL . 3.9 m -67.72 -19.06 65.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.35 0.595 . . . . 1.19 109.947 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.15 -44.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.266 -0.425 . . . . 1.66 110.78 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -27.25 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 1.62 110.967 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -75.9 -37.39 58.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.974 -0.557 . . . . 1.09 110.08 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -75.09 -43.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 1.13 111.209 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -51.43 -36.22 42.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.171 0.51 . . . . 1.97 110.669 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -83.85 -26.48 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.649 -0.705 . . . . 1.02 110.493 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.939 ' HB1' HG22 ' A' ' 82' ' ' VAL . . . -88.08 -50.22 6.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.49 0.552 . . . . 1.18 112.49 -173.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -69.57 -21.68 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.031 0.443 . . . . 2.98 111.174 -171.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.37 7.2 20.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.954 -0.567 . . . . 1.3 111.936 -172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.11 -2.68 27.02 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.001 -0.741 . . . . 1.3 109.001 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 t30 80.09 52.48 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.129 -1.396 . . . . 2.59 107.734 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.706 HG22 ' HZ ' ' A' ' 68' ' ' PHE . 25.3 t -124.34 143.4 42.82 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.427 -1.715 . . . . 1.71 111.051 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.462 ' N ' HG11 ' A' ' 108' ' ' VAL . 3.0 Cg_exo -75.27 152.72 39.87 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.799 2.333 . . . . 0.62 113.152 172.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.575 HG23 HG22 ' A' ' 145' ' ' THR . 1.4 mp -123.48 143.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.471 -1.24 . . . . 1.62 110.773 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 mp -114.54 147.81 17.75 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.044 -1.095 . . . . 1.31 108.044 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.27 130.86 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 109.308 -0.627 . . . . 1.07 109.308 172.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.586 ' HB1' ' HA ' ' A' ' 85' ' ' VAL . . . -115.22 87.59 2.69 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.991 -1.114 . . . . 1.07 107.991 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.814 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 23.3 mt -71.26 95.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.57 -1.195 . . . . 1.56 110.26 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.06 164.49 12.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.299 -0.259 . . . . 0.88 110.299 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 62.47 22.7 13.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.815 0.817 . . . . 3.11 109.964 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.504 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 4.8 tpp -82.51 1.34 38.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.348 -1.296 . . . . 1.55 109.687 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.932 ' HB3' ' HG ' ' A' ' 151' ' ' SER . 1.6 p30 -52.59 -6.68 0.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.666 -1.152 . . . . 2.45 113.111 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 38.1 mmtm -72.71 -172.83 0.24 Allowed Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.639 -1.245 . . . . 4.11 107.639 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 121' ' ' GLU . 31.8 Cg_exo -56.38 -53.06 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.243 1.122 . . . . 3.16 109.852 166.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 20.1 pt-20 154.68 118.54 0.0 OUTLIER 'General case' 0 C--N 1.341 0.21 0 C-N-CA 125.969 1.707 . . . . 4.03 107.328 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -60.43 -67.08 0.43 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 1.9 110.557 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 16.3 t-20 -179.39 80.85 0.2 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 123.513 0.508 . . . . 2.21 110.489 171.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.637 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.3 Cg_exo -43.07 -55.5 2.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 123.289 2.66 . . . . 1.01 113.611 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -46.64 -48.98 19.79 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.884 0.698 . . . . 2.0 112.884 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -53.81 -56.68 15.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 3.7 110.245 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.529 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.7 t -53.64 -46.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.338 -1.301 . . . . 1.12 110.094 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.651 ' HE1' ' HG3' ' A' ' 140' ' ' GLU . 88.1 mtp -63.23 -38.65 92.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.33 -0.85 . . . . 1.07 111.475 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.56 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.9 mt-30 -74.32 -25.06 59.32 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 110.073 -0.343 . . . . 2.01 110.073 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -74.22 -30.24 62.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.151 -0.477 . . . . 2.02 109.889 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.537 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.2 mm? -69.43 -45.14 69.87 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.635 0.731 . . . . 1.62 109.645 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.879 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -73.93 -6.07 45.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.957 -1.02 . . . . 1.08 109.793 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 35.5 tt0 -77.39 -28.62 52.85 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.251 -1.018 . . . . 2.18 108.251 173.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HB2' HD11 ' A' ' 136' ' ' LEU . 30.5 m-85 -90.05 12.35 17.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.67 0.748 . . . . 1.17 108.987 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.54 42.75 1.48 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.102 -1.408 . . . . 2.43 109.93 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.767 HD13 HD12 ' A' ' 100' ' ' ILE . 2.1 mp -117.7 78.24 1.22 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.617 -1.174 . . . . 2.28 108.803 171.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.474 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.54 125.76 91.64 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.608 -1.178 . . . . 1.28 110.913 -178.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.748 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -49.36 158.78 1.47 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.213 2.608 . . . . 0.34 112.822 172.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' OE1' HG12 ' A' ' 146' ' ' ILE . 30.4 mt-10 -81.14 -20.55 41.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.247 -0.888 . . . . 2.01 109.695 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.841 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -55.87 -39.89 72.15 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.252 -1.018 . . . . 1.18 108.252 168.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.879 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.1 m0 -94.08 -30.3 14.74 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.748 -1.569 . . . . 0.45 109.492 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.25 21.57 3.37 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.754 -1.212 . . . . 0.45 112.921 168.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.29 -114.97 2.14 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.243 -0.979 . . . . 0.5 112.545 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -151.23 28.88 0.65 Allowed 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.313 0.577 . . . . 1.3 111.237 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.575 HG22 HG23 ' A' ' 110' ' ' ILE . 18.9 m -127.62 122.35 32.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.459 0.647 . . . . 1.06 112.05 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.829 HD12 HG21 ' A' ' 168' ' ' VAL . 15.8 mt -91.69 106.88 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 1.86 111.241 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.748 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -88.59 108.31 19.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.38 111.583 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 79.1 m -104.28 100.31 10.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.82 110.188 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.814 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 16.4 ptmt -82.03 94.68 7.23 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.306 -0.627 . . . . 2.94 109.306 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 117' ' ' MET . 0.7 OUTLIER -112.77 -176.84 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.955 0.884 . . . . 1.89 112.684 -168.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.932 ' HG ' ' HB3' ' A' ' 118' ' ' ASP . 24.6 t -165.97 121.64 1.27 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.263 -1.335 . . . . 2.08 109.737 177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -9.2 44.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.894 0.378 . . . . 1.43 111.197 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -83.89 -56.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.736 0.779 . . . . 3.46 109.675 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 46.5 p -81.04 -20.54 41.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.421 -1.263 . . . . 1.78 111.562 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 73.14 -2.65 2.67 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.659 -0.7 . . . . 2.75 111.201 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -48.35 -71.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.772 0.796 . . . . 2.64 112.061 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.63 -9.58 69.74 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.875 -1.057 . . . . 0.73 113.822 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 158' ' ' LEU . 4.3 mm? -69.09 -50.25 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.677 0.738 . . . . 2.12 110.367 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.91 -38.48 82.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.068 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.435 ' O ' ' HG2' ' A' ' 164' ' ' MET . 80.2 t60 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.657 -0.701 . . . . 0.84 110.921 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 165' ' ' ILE . 62.0 tp -63.25 -58.19 7.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.038 -0.356 . . . . 1.54 110.038 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.75 -37.05 65.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.381 0.61 . . . . 1.7 110.054 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.29 -48.26 73.77 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.027 -0.988 . . . . 2.49 110.829 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.796 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 17.3 mmt -63.12 -42.79 99.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.309 . . . . 1.29 110.466 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 161' ' ' LEU . 87.8 mt -53.72 -53.56 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.667 -0.697 . . . . 1.24 110.15 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.44 HD12 HG13 ' A' ' 52' ' ' VAL . 76.8 mt -59.58 -48.97 79.58 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.659 -0.7 . . . . 2.36 111.872 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.39 -47.18 73.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.746 -0.661 . . . . 1.98 111.098 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.829 HG21 HD12 ' A' ' 146' ' ' ILE . 2.1 t -67.58 -38.39 80.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.509 -0.314 . . . . 1.69 111.371 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.2 m -60.86 -25.18 66.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.514 . . . . 2.07 110.561 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.63 -22.84 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 2.79 110.856 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.511 ' HE3' HG23 ' A' ' 168' ' ' VAL . 56.4 ttp -77.9 -15.21 59.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 2.22 110.779 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.444 ' CD ' ' HZ2' ' A' ' 175' ' ' LYS . 25.6 mm-40 -56.85 -19.68 18.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 3.45 111.793 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -63.37 -26.94 68.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.166 0.507 . . . . 3.36 109.691 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 mt -106.29 -71.97 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 4.51 109.481 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.578 ' HG2' ' H ' ' A' ' 176' ' ' ALA . 45.0 tttp 69.54 175.14 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.303 -0.862 . . . . 6.66 112.207 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.578 ' H ' ' HG2' ' A' ' 175' ' ' LYS . . . 74.12 -82.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.006 0.923 . . . . 4.98 112.315 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.726 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 53.2 t-20 -163.07 -58.33 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 119.696 -0.193 . . . . 6.96 111.155 -175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 1.4 Cg_endo . . . . . 0 C--O 1.251 1.127 0 C-N-CA 122.734 2.289 . . . . 7.47 112.685 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.359 -0.296 . . . . 16.58 112.359 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -64.04 131.28 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.577 0.227 . . . . 14.94 110.418 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -104.93 10.03 34.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.936 0.398 . . . . 15.21 111.165 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt -81.97 96.15 7.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.1 -0.5 . . . . 12.92 110.216 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 m -83.94 92.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 10.47 110.876 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.79 79.08 5.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 9.14 110.031 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -106.64 137.25 19.41 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.715 -0.675 . . . . 9.01 110.18 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.25 130.92 25.19 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.449 2.099 . . . . 5.24 111.366 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HB3' ' OD2' ' A' ' 80' ' ' ASP . 63.9 Cg_exo -52.99 140.68 58.71 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.476 2.784 . . . . 4.88 112.853 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.826 HG22 ' HB3' ' A' ' 77' ' ' GLN . 20.5 t -112.13 111.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.257 0.551 . . . . 3.08 110.354 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.641 HG23 HG22 ' A' ' 81' ' ' ILE . 59.9 t -82.72 104.06 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.415 -0.811 . . . . 1.57 110.944 -177.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.787 HG23 ' HA ' ' A' ' 61' ' ' ASP . 53.1 m -86.07 128.09 34.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.572 -0.74 . . . . 1.18 110.764 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.682 ' HA ' HG13 ' A' ' 83' ' ' ILE . 29.0 mt -90.94 122.94 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 1.57 111.549 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.512 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.7 mtt -137.82 171.86 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.099 -0.501 . . . . 1.41 110.596 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.8 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 150.2 -104.52 0.27 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.051 -1.219 . . . . 1.55 110.051 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.493 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 66.1 t60 -167.07 158.68 12.45 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.46 -0.57 . . . . 1.21 109.46 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.45 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.728 0.27 . . . . 2.2 111.728 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.32 -22.07 65.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.114 -0.494 . . . . 1.78 112.233 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -71.07 -18.25 62.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.078 0.466 . . . . 0.89 110.565 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.29 40.47 3.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.926 -0.654 . . . . 1.06 113.566 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.597 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -76.92 -27.38 54.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.468 0.634 . . . . 2.58 110.974 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 -30.97 31.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 2.32 110.126 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -81.08 -17.06 51.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.111 -0.495 . . . . 2.23 110.283 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.37 -51.55 59.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.825 -0.806 . . . . 2.33 108.825 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.792 HD12 ' HA3' ' A' ' 39' ' ' GLY . 2.7 tt -62.18 -38.63 89.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 2.46 110.248 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.0 t70 -68.82 -46.84 67.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.489 -0.323 . . . . 1.38 111.373 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -64.69 -42.03 95.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.926 0.393 . . . . 1.42 110.784 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.1 tt -66.51 -28.98 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.54 -0.755 . . . . 2.08 109.62 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HA ' HG21 ' A' ' 34' ' ' THR . 14.3 tpt180 -69.37 -33.32 72.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 4.16 109.934 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -83.45 14.58 3.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.876 -0.602 . . . . 3.57 111.361 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 t -100.58 13.89 33.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.452 -0.34 . . . . 2.09 110.798 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 71.49 -41.23 0.5 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 5.98 113.388 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG2' HG11 ' A' ' 50' ' ' VAL . 32.7 m -75.75 16.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.088 0.773 . . . . 3.41 113.088 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.608 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -96.96 121.46 38.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.386 0.613 . . . . 4.35 110.699 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -54.07 -63.22 1.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.643 -1.162 . . . . 4.2 112.466 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -162.59 167.1 23.81 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.177 -0.209 . . . . 6.16 111.409 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.38 174.71 0.24 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.248 0.967 . . . . 5.79 112.611 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.22 161.92 33.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.279 -0.873 . . . . 4.64 109.855 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.792 ' HA3' HD12 ' A' ' 25' ' ' LEU . . . -138.63 53.33 0.71 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.174 -0.536 . . . . 4.95 112.204 -176.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.47 -96.1 0.58 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.746 -0.74 . . . . 6.66 112.469 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.59 -2.97 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.974 0.416 . . . . 9.5 111.687 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 p -88.03 128.84 35.4 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.102 -0.499 . . . . 7.68 111.192 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -84.39 74.04 10.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.782 0.801 . . . . 9.39 110.047 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -143.15 -67.57 0.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.803 -1.09 . . . . 7.29 108.576 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.4 mm 68.9 148.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 114.953 -1.021 . . . . 5.6 111.788 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.4 -100.32 0.17 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.367 -1.288 . . . . 3.5 110.9 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.832 ' HB3' HD12 ' A' ' 60' ' ' LEU . . . -171.6 174.35 4.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.816 0.341 . . . . 2.15 110.653 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.8 p90 -150.83 153.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.016 -0.538 . . . . 2.96 110.585 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -115.26 148.15 39.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.237 -0.653 . . . . 2.45 109.237 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 96.7 t -109.11 149.1 12.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.726 0.774 . . . . 2.49 110.813 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -84.53 85.49 7.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.176 -1.374 . . . . 2.26 111.365 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 54' ' ' ASP . 98.1 t -106.78 110.39 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.983 -1.117 . . . . 4.49 107.983 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.1 -50.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.414 1.071 . . . . 4.58 110.069 -167.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 52' ' ' VAL . 32.9 t70 -151.23 -56.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.682 -1.145 . . . . 3.62 109.336 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 20.2 pttt 175.94 67.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.99 -1.005 . . . . 7.78 109.588 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -94.1 6.26 49.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 5.81 111.065 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mt -130.69 129.22 63.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 110.042 -0.355 . . . . 1.4 110.042 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 m -112.68 137.59 50.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.363 . . . . 1.85 110.101 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -112.7 117.79 33.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.191 -0.3 . . . . 1.14 110.191 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.832 HD12 ' HB3' ' A' ' 47' ' ' ALA . 42.7 tp -175.53 147.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.35 0.407 . . . . 3.46 111.081 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.787 ' HA ' HG23 ' A' ' 12' ' ' THR . 29.7 m-20 -74.54 85.56 2.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.743 -0.836 . . . . 6.48 108.743 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.552 ' HB ' HG12 ' A' ' 10' ' ' VAL . 14.9 t -90.29 139.39 26.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 5.89 112.051 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.629 ' HB3' ' HG2' ' A' ' 71' ' ' MET . 72.3 Cg_endo -99.14 77.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 124.206 3.271 . . . . 5.92 112.017 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 78' ' ' VAL . . . -73.44 -8.0 74.61 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.674 -0.774 . . . . 5.92 113.207 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -178.03 -49.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.552 -0.536 . . . . 8.81 109.552 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.35 153.31 33.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 6.36 110.08 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.0 34.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.031 -0.359 . . . . 3.89 110.031 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' HA ' ' CD2' ' A' ' 102' ' ' HIS . 56.8 m-85 -102.63 -17.3 15.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.597 0.591 . . . . 2.61 112.597 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 70' ' ' THR . 3.4 t -151.8 -70.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.807 -0.357 . . . . 5.11 111.084 174.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.695 ' H ' HG22 ' A' ' 69' ' ' THR . 24.6 m -144.86 84.58 1.73 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 6.34 110.053 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.629 ' HG2' ' HB3' ' A' ' 63' ' ' PRO . 2.5 mpt? -119.83 138.12 53.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.916 -0.584 . . . . 5.64 110.106 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -114.08 -29.12 7.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.11 -0.495 . . . . 10.31 110.215 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.63 173.1 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.917 -0.583 . . . . 7.85 110.294 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -132.62 140.94 48.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.413 -0.358 . . . . 11.11 110.065 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.73 -179.23 16.1 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.75 -0.738 . . . . 6.78 112.423 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.59 -8.39 41.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.217 0.532 . . . . 7.11 110.331 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.826 ' HB3' HG22 ' A' ' 10' ' ' VAL . 15.9 mm100 -75.67 100.96 4.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.504 -0.771 . . . . 8.32 110.441 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 27.3 m -66.85 152.87 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.634 . . . . 4.75 111.711 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m -91.51 74.7 5.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.58 -0.737 . . . . 4.44 109.694 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 9' ' ' PRO . 12.5 p-10 -90.99 -25.86 19.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.072 -0.513 . . . . 3.12 111.639 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.703 HG23 HD11 ' A' ' 111' ' ' ILE . 31.7 mm -116.73 112.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.628 0.251 . . . . 1.31 111.457 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG23 ' HB1' ' A' ' 103' ' ' ALA . 85.7 t -108.36 108.88 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.709 -0.223 . . . . 1.78 110.565 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.805 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -87.39 113.32 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 119.768 -0.773 . . . . 1.97 109.89 172.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 96' ' ' THR . 12.4 tp -98.12 111.91 24.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.506 -0.77 . . . . 1.98 110.26 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.8 HG13 ' HA3' ' A' ' 15' ' ' GLY . 7.5 p -84.25 143.04 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.245 0.545 . . . . 1.8 111.036 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 114' ' ' ILE . 30.0 m -135.31 -179.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.158 -1.053 . . . . 1.79 108.158 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.31 133.11 14.97 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.431 -0.908 . . . . 1.03 113.195 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.816 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . . . 49.81 -115.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.404 -1.271 . . . . 1.66 113.1 169.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 13.8 p-10 -115.47 8.95 15.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 2.01 110.289 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.58 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 16.4 t70 -64.04 -37.34 87.06 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.75 0.786 . . . . 1.09 109.422 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.61 -109.59 2.98 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.52 111.385 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.951 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.0 t -128.25 110.86 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.66 0.266 . . . . 1.67 110.698 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.641 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 72.6 mmm -74.52 170.96 12.7 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.307 -0.406 . . . . 1.32 110.181 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.641 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 88.2 Cg_exo -45.3 -52.11 6.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.611 2.208 . . . . 0.88 112.709 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.67 -34.31 75.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.431 -0.349 . . . . 2.01 111.19 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.951 ' HB ' HG13 ' A' ' 92' ' ' VAL . 2.6 m -64.58 -25.91 68.18 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.058 0.456 . . . . 1.19 110.759 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.443 HG23 HG11 ' A' ' 92' ' ' VAL . 69.1 t -86.31 -48.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.547 -0.297 . . . . 1.66 110.478 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 46.4 mt-10 -59.83 -23.94 63.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 1.62 111.335 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.23 -40.11 31.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.16 -0.681 . . . . 1.09 109.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 110' ' ' ILE . 1.4 mt -72.31 -56.28 10.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 115.258 -0.883 . . . . 1.13 110.212 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.447 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.7 t-20 -44.47 -34.34 2.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.438 0.695 . . . . 1.97 111.48 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.569 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 7.1 t60 -84.17 -35.25 23.69 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.983 -0.553 . . . . 1.02 111.354 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.659 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -92.32 -28.84 16.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.497 0.554 . . . . 1.18 112.497 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.491 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -76.95 -11.15 59.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.917 0.389 . . . . 2.98 110.978 -169.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.4 -1.55 56.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 1.3 111.895 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.91 8.64 43.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.915 -1.143 . . . . 1.3 107.915 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.15 33.11 14.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 113.866 -1.515 . . . . 2.59 110.457 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER -91.94 158.27 39.98 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.715 -0.675 . . . . 1.71 110.343 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.516 ' O ' HG21 ' A' ' 108' ' ' VAL . 6.9 Cg_exo -72.49 146.98 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.614 2.21 . . . . 0.62 113.047 170.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.587 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -120.24 142.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.089 -1.414 . . . . 1.62 109.331 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.805 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 mt -116.88 155.67 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 108.937 -0.764 . . . . 1.31 108.937 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -120.81 138.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 109.527 -0.546 . . . . 1.07 109.527 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.19 88.33 2.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.894 -1.15 . . . . 1.07 107.894 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.842 ' HA ' HG21 ' A' ' 86' ' ' VAL . 30.6 mt -68.57 90.2 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.837 -1.074 . . . . 1.56 110.264 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -80.31 154.8 27.57 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.112 0.258 . . . . 0.88 110.528 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 64.62 32.49 11.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.646 0.591 . . . . 3.11 110.946 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.51 ' HE3' ' HD3' ' A' ' 124' ' ' PRO . 4.2 tpp -85.54 -11.39 54.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 1.55 110.469 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.56 -10.44 59.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.337 0.589 . . . . 2.45 109.489 172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 119' ' ' LYS . 7.2 mtpm? -113.76 155.23 45.37 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.537 -0.756 . . . . 4.11 110.053 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 13.1 Cg_endo -60.03 -8.97 8.94 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 124.144 3.229 . . . . 3.16 114.756 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -62.8 -38.27 90.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 4.03 110.39 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.56 133.14 47.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.146 -0.479 . . . . 1.9 111.775 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 51.5 t-20 -126.05 88.09 54.91 Favored Pre-proline 0 CA--C 1.51 -0.563 0 CA-C-O 121.457 0.646 . . . . 2.21 109.963 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.578 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -20.4 -81.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 1 C-N-CA 126.28 4.654 . . . . 1.01 115.904 175.793 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.84 -46.63 74.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.992 0.517 . . . . 2.0 112.255 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 30.3 tpt180 -50.78 -60.28 3.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.659 0.742 . . . . 3.7 109.658 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.4 t -59.69 -45.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 113.906 -1.497 . . . . 1.12 110.583 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.787 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 91.5 mtp -67.19 -26.13 66.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.906 -0.588 . . . . 1.07 111.25 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.31 -18.63 33.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.719 -0.392 . . . . 2.01 111.29 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.624 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.1 mm-40 -60.07 -42.52 94.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.557 -0.905 . . . . 2.02 108.557 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.726 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -73.63 -40.01 64.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.79 -1.095 . . . . 1.62 110.766 -173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.973 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -79.52 -3.68 47.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.811 -0.631 . . . . 1.08 109.76 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 11.2 tp10 -73.83 -33.47 64.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 2.18 107.463 171.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 92' ' ' VAL . 27.1 m-85 -87.83 7.94 28.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.613 -0.721 . . . . 1.17 109.862 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.56 34.22 1.28 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.755 -1.111 . . . . 2.43 110.638 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.6 mp -111.61 80.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.246 -1.02 . . . . 2.28 108.246 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.525 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.07 129.15 93.99 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.93 -1.486 . . . . 1.28 111.077 -176.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.816 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 76.0 Cg_exo -49.48 157.37 2.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.236 2.624 . . . . 0.34 113.649 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.543 ' HG3' HG13 ' A' ' 146' ' ' ILE . 8.2 mm-40 -70.6 -31.29 68.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.304 -1.317 . . . . 2.01 109.006 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.648 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.3 mp0 -46.16 -54.02 9.41 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.576 -1.193 . . . . 1.18 110.698 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.973 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.2 m0 -89.45 -18.69 26.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.836 -1.529 . . . . 0.45 110.91 -166.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.59 28.08 4.14 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 120.014 -1.088 . . . . 0.45 112.287 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.525 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -99.65 -110.81 3.17 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.373 -0.918 . . . . 0.5 111.814 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 p30 -159.32 33.5 0.2 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.522 0.677 . . . . 1.3 110.81 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 27.7 m -125.56 112.45 16.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.412 0.625 . . . . 1.06 111.8 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 168' ' ' VAL . 4.0 mp -79.08 104.66 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.657 -0.701 . . . . 1.86 111.079 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.816 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -87.91 113.96 24.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.201 0.524 . . . . 0.38 111.811 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.401 ' O ' HD11 ' A' ' 150' ' ' LEU . 64.1 m -105.32 100.81 10.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.551 -0.75 . . . . 1.82 109.568 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.596 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 15.3 pttm -81.27 85.36 6.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.577 -0.897 . . . . 2.94 108.577 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.863 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -123.25 -175.64 3.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.176 -0.92 . . . . 1.89 112.671 -166.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 m -157.24 124.62 5.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.645 -1.161 . . . . 2.08 109.628 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -85.52 -12.93 50.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 1.43 110.297 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -73.49 -56.31 5.21 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.364 -0.834 . . . . 3.46 109.304 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.6 p -78.71 -21.57 47.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.884 -1.053 . . . . 1.78 108.997 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.983 ' HG3' HD12 ' A' ' 158' ' ' LEU . 2.1 ttmp? 70.79 7.03 6.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.715 -1.584 . . . . 2.75 112.038 172.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.26 -49.46 64.24 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.12 0.962 . . . . 2.64 110.652 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.863 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -62.14 -23.81 64.47 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 114.778 -1.101 . . . . 0.73 113.012 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.983 HD12 ' HG3' ' A' ' 155' ' ' LYS . 29.9 mt -64.65 -32.22 73.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.715 0.258 . . . . 2.12 110.558 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 13.7 m-20 -60.65 -53.26 59.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.036 -0.727 . . . . 2.5 109.036 172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.441 -0.8 . . . . 0.84 111.049 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.2 tp -61.05 -60.55 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.342 -0.39 . . . . 1.54 111.062 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.46 -40.36 68.32 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.221 0.325 . . . . 1.7 110.533 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 78.5 mm-40 -61.64 -49.7 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.539 . . . . 2.49 110.715 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -69.56 -34.66 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 1.29 110.444 -175.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.98 -52.32 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.928 -0.578 . . . . 1.24 110.714 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.563 HD11 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -76.8 -37.15 56.29 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.303 0.483 . . . . 2.36 112.303 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.563 ' N ' HD11 ' A' ' 166' ' ' LEU . 40.7 tp -61.53 -25.13 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.061 0.458 . . . . 1.98 110.166 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 146' ' ' ILE . 2.7 t -85.19 -37.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 1.69 110.12 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -42.19 81.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.98 -0.554 . . . . 2.07 110.294 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.18 -28.15 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 2.79 110.629 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.444 ' HE3' HG22 ' A' ' 168' ' ' VAL . 56.0 ttp -66.25 -34.58 78.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.302 . . . . 2.22 110.354 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -53.13 -35.24 59.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.221 -0.445 . . . . 3.45 111.593 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -24.22 65.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 3.36 110.836 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.97 -77.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 4.51 110.127 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -172.35 143.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.954 -0.566 . . . . 6.66 109.63 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -135.79 98.45 3.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.643 -0.253 . . . . 4.98 110.968 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.532 ' N ' ' HD2' ' A' ' 178' ' ' PRO . 28.7 t-20 178.74 -52.73 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.76 -0.654 . . . . 6.96 111.076 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 177' ' ' ASN . 18.0 Cg_endo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.587 2.191 . . . . 7.47 112.441 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.493 -0.643 . . . . 16.58 111.493 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.467 ' OG ' ' HA2' ' A' ' 75' ' ' GLY . 8.6 t -80.6 64.65 5.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.607 0.718 . . . . 14.94 110.402 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -134.86 88.57 2.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.084 -0.71 . . . . 15.21 109.084 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 ttt -176.5 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.246 -0.888 . . . . 12.92 109.944 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 7' ' ' ARG . 22.3 t -81.7 -35.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 10.47 110.315 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 53.92 70.35 0.61 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.673 0.608 . . . . 9.14 111.754 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.612 ' HB2' ' H ' ' A' ' 77' ' ' GLN . 11.4 mmt85 -126.0 97.36 35.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 9.01 110.297 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -75.04 142.64 27.97 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.434 2.756 . . . . 5.24 112.595 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.468 ' HB3' ' OE1' ' A' ' 77' ' ' GLN . 91.3 Cg_endo -80.18 53.09 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.86 2.373 . . . . 4.88 112.513 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.529 HG12 HG21 ' A' ' 58' ' ' THR . 27.9 m -115.42 127.87 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.299 -0.409 . . . . 3.08 110.867 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 81' ' ' ILE . 51.4 t -73.48 111.84 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.146 0.498 . . . . 1.57 110.231 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -96.56 130.05 43.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.078 -0.51 . . . . 1.18 110.497 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 55.3 mt -97.76 126.75 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.712 0.292 . . . . 1.57 110.691 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.403 ' HB3' ' HB2' ' A' ' 99' ' ' ALA . 70.3 mtm -144.25 -177.73 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.075 -0.511 . . . . 1.41 110.888 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 84' ' ' LEU . . . 107.18 59.27 0.58 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.634 -0.793 . . . . 1.55 112.464 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 18.0 t60 62.07 163.62 0.09 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.068 0.937 . . . . 1.21 112.065 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.92 -32.28 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.861 -0.609 . . . . 2.2 111.633 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' HB3' ' NE2' ' A' ' 16' ' ' HIS . 28.0 t70 -72.83 -25.42 61.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.612 0.227 . . . . 1.78 111.612 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' HE1' ' HB2' ' A' ' 93' ' ' MET . 32.5 m80 -61.71 -20.25 63.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 0.89 110.63 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.63 51.2 1.13 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.638 -0.71 . . . . 1.06 113.086 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.832 0.825 . . . . 2.58 109.021 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -36.79 80.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.451 -1.25 . . . . 2.32 110.76 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.5 p -73.24 -20.82 60.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 2.23 111.257 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.8 mm? -71.91 -48.13 47.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.947 -0.39 . . . . 2.33 109.947 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.22 -35.89 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.827 -0.624 . . . . 2.46 109.932 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.12 -58.31 8.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.794 0.331 . . . . 1.38 111.528 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -62.14 -29.15 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 1.42 111.133 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 25' ' ' LEU . 5.2 tt -75.43 -25.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 2.08 111.029 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.622 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.0 mtp180 -78.97 -21.33 47.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.373 0.606 . . . . 4.16 110.049 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -88.6 -0.31 57.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 3.57 109.695 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -140.43 44.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.576 -0.738 . . . . 2.09 110.156 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.682 ' HD3' ' HG3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -112.37 160.91 17.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.761 . . . . 5.98 111.169 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' OG1' ' A' ' 34' ' ' THR . 13.8 t -93.43 -57.1 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 108.84 -0.8 . . . . 3.41 108.84 167.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -123.74 148.93 46.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.927 -1.033 . . . . 4.35 110.293 -176.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.682 ' HG3' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.5 150.12 37.06 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.284 -0.871 . . . . 4.2 110.705 170.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.474 ' CG ' ' HB2' ' A' ' 49' ' ' GLN . 83.3 mm-40 -118.89 175.76 5.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.371 -0.831 . . . . 6.16 109.045 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.85 32.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.461 -0.336 . . . . 5.79 110.695 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 36' ' ' GLN . . . 176.13 157.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.228 -0.896 . . . . 4.64 109.157 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 48' ' ' TYR . . . -105.54 31.34 8.57 Favored Glycine 0 CA--C 1.512 -0.131 0 N-CA-C 111.046 -0.822 . . . . 4.95 111.046 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.57 -170.98 43.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.976 -0.85 . . . . 6.66 110.976 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.461 HD11 ' O ' ' A' ' 72' ' ' ARG . 19.5 pt -86.19 27.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 9.5 111.653 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -109.5 127.16 54.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.64 -0.709 . . . . 7.68 109.246 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.6 63.83 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.479 . . . . 9.39 112.01 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.08 126.93 13.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.255 -0.646 . . . . 7.29 109.255 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.616 HG12 ' H ' ' A' ' 46' ' ' GLY . 15.4 tt -84.45 170.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.386 0.612 . . . . 5.6 110.725 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 45' ' ' ILE . . . 129.41 -34.83 2.71 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 110.037 -1.225 . . . . 3.5 110.037 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -107.93 -173.86 2.38 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.362 -0.977 . . . . 2.15 108.362 172.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 1.8 p90 -152.77 178.97 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.048 -0.661 . . . . 2.96 111.121 -175.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.547 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 21.3 mt-30 -142.31 117.5 10.1 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.956 -1.127 . . . . 2.45 107.956 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.594 HG21 ' H ' ' A' ' 51' ' ' THR . 3.4 p -80.97 176.7 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.41 -0.959 . . . . 2.49 108.41 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.988 HG23 ' HB3' ' A' ' 54' ' ' ASP . 5.5 t -53.59 145.02 15.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.73 0.776 . . . . 2.26 111.08 -170.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 54' ' ' ASP . 62.2 t -111.6 138.06 41.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.336 -0.847 . . . . 4.49 109.59 -166.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -44.09 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.729 -0.841 . . . . 4.58 108.729 -172.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.988 ' HB3' HG23 ' A' ' 51' ' ' THR . 9.2 t70 -65.65 -46.13 80.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.958 -1.019 . . . . 3.62 109.806 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' HB2' HG21 ' A' ' 51' ' ' THR . 2.8 mptp? -123.72 -37.88 2.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.15 -0.62 . . . . 7.78 111.431 169.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 76.83 -1.91 2.77 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.442 0.464 . . . . 5.81 111.691 170.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 58' ' ' THR . 10.5 mt -86.94 156.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.335 0.588 . . . . 1.4 110.966 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 4.0 t -151.61 144.16 24.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.6 -0.889 . . . . 1.85 108.6 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.576 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 42.7 m-85 -118.92 121.09 39.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.715 -0.394 . . . . 1.14 110.481 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.08 121.39 44.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 3.46 111.724 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -141.29 114.4 8.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.361 -0.836 . . . . 6.48 109.109 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.2 m -154.17 126.69 3.98 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 5.89 110.16 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 122.38 11.23 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.846 2.364 . . . . 5.92 111.939 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.01 38.66 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.447 -0.661 . . . . 5.92 111.447 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.6 9.13 43.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.829 0.314 . . . . 8.81 111.571 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.41 75.21 1.5 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.58 0.705 . . . . 6.36 110.61 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.72 79.74 7.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.548 -0.751 . . . . 3.89 110.697 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.592 ' HZ ' HG12 ' A' ' 108' ' ' VAL . 26.5 t80 -173.2 96.26 0.12 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.914 -0.773 . . . . 2.61 108.914 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p 53.54 -162.58 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.719 0.637 . . . . 5.11 111.001 -174.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.4 p -89.06 -23.5 22.53 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.601 -0.44 . . . . 6.34 110.369 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.3 tpp 67.09 -46.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.087 -0.961 . . . . 5.64 110.898 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' O ' HD11 ' A' ' 41' ' ' ILE . 74.7 mtp180 -64.77 98.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 10.31 109.065 170.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -177.46 -163.81 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 7.85 110.805 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -138.64 169.96 16.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.531 -0.759 . . . . 11.11 109.064 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 84.2 160.96 31.99 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.747 -0.739 . . . . 6.78 113.714 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.74 87.8 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.667 -0.494 . . . . 7.11 109.667 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.612 ' H ' ' HB2' ' A' ' 7' ' ' ARG . 26.9 tp60 -65.85 -54.41 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.219 -0.446 . . . . 8.32 111.109 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t 73.96 -25.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.516 0.726 . . . . 4.75 111.197 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 77' ' ' GLN . 19.7 m -61.37 -40.8 95.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.505 -0.554 . . . . 4.44 109.505 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.623 ' HB2' ' HB ' ' A' ' 108' ' ' VAL . 24.5 m-20 28.51 69.9 0.07 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.012 1.445 . . . . 3.12 112.412 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.652 HG23 HD13 ' A' ' 111' ' ' ILE . 28.3 mm -69.2 112.15 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.317 -0.856 . . . . 1.31 112.22 -172.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.712 ' HB ' HD13 ' A' ' 110' ' ' ILE . 75.8 t -107.09 120.62 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 116.44 -0.345 . . . . 1.78 110.899 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 8.3 mm -86.31 123.08 39.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.531 -0.914 . . . . 1.97 108.531 171.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.0 tm? -107.66 113.94 27.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.704 . . . . 1.98 109.302 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.83 139.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.141 0.496 . . . . 1.8 111.855 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.777 HG22 ' HA ' ' A' ' 114' ' ' ILE . 25.8 m -139.42 -171.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 108.822 -0.807 . . . . 1.79 108.822 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.9 109.92 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.968 0.729 . . . . 1.03 112.968 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.68 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.809 1.041 . . . . 1.66 113.809 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.827 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 10.2 p-10 -107.67 -3.96 18.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.347 0.499 . . . . 2.01 112.347 -170.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.562 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 31.0 t70 -64.34 -43.79 93.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.419 0.628 . . . . 1.09 111.054 -175.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 88.93 -113.17 4.06 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.518 -0.848 . . . . 0.52 111.249 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.918 HG11 ' HB ' ' A' ' 96' ' ' THR . 35.5 t -129.36 119.2 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 120.656 0.265 . . . . 1.67 110.625 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.562 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 42.0 mtp -85.83 169.35 15.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.675 -0.491 . . . . 1.32 109.675 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.4 Cg_exo -42.64 -60.01 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.753 2.302 . . . . 0.88 112.801 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.697 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 42.0 mt-30 -59.27 -25.39 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.703 0.631 . . . . 2.01 112.703 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.918 ' HB ' HG11 ' A' ' 92' ' ' VAL . 29.9 m -60.21 -46.01 91.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.277 -0.169 . . . . 1.19 111.001 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.522 ' HA ' ' HB ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -88.52 -30.25 5.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 O-C-N 121.847 -0.533 . . . . 1.66 111.444 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.36 -26.94 68.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.411 . . . . 1.62 111.099 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 14' ' ' MET . . . -88.13 -22.31 24.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 1.09 109.959 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.63 HD11 HD23 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -80.79 -47.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.169 -0.923 . . . . 1.13 110.796 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -57.63 -32.78 67.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.398 0.618 . . . . 1.97 110.056 170.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.09 -29.46 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.35 -0.841 . . . . 1.02 109.936 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.764 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -96.18 -54.68 3.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.471 0.545 . . . . 1.18 112.471 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 100' ' ' ILE . 24.5 mmmt -55.18 -44.8 75.6 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.601 0.715 . . . . 2.98 111.021 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.59 10.24 2.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.318 -1.31 . . . . 1.3 112.133 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.53 8.43 21.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.374 -0.973 . . . . 1.3 108.374 167.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 70.1 48.6 0.52 Allowed 'General case' 0 C--N 1.339 0.149 0 CA-C-N 114.226 -1.352 . . . . 2.59 111.084 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -126.48 157.61 70.08 Favored Pre-proline 0 C--O 1.238 0.485 0 N-CA-C 112.954 0.724 . . . . 1.71 112.954 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.561 ' O ' HG21 ' A' ' 108' ' ' VAL . 10.5 Cg_exo -76.2 159.56 36.89 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 124.611 3.541 . . . . 0.62 114.498 168.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.764 HD12 ' HB2' ' A' ' 103' ' ' ALA . 22.1 mm -129.66 148.26 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.78 -1.1 . . . . 1.62 111.166 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.652 HD13 HG23 ' A' ' 81' ' ' ILE . 3.9 mt -122.06 150.95 25.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 N-CA-C 109.283 -0.636 . . . . 1.31 109.283 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.2 136.34 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.282 0.563 . . . . 1.07 110.442 174.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.9 88.41 2.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.022 -1.103 . . . . 1.07 108.022 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.777 ' HA ' HG22 ' A' ' 86' ' ' VAL . 45.2 mt -69.36 91.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.686 -1.143 . . . . 1.56 109.697 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.637 ' HA ' HD21 ' A' ' 150' ' ' LEU . 53.9 t30 -88.67 151.71 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.88 111.204 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt 54.89 36.47 26.74 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.951 0.782 . . . . 3.11 111.018 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -97.19 29.37 3.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.497 -0.774 . . . . 1.55 109.365 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.452 ' HB2' ' HG ' ' A' ' 151' ' ' SER . 32.8 t70 -62.6 66.44 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.615 -1.175 . . . . 2.45 112.293 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.707 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 54.2 mtmt -150.56 -179.89 1.09 Allowed Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 105.721 -1.955 . . . . 4.11 105.721 171.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.707 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 4.2 Cg_endo -49.54 -46.22 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.285 1.323 . . . . 3.16 110.848 171.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.513 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 13.2 pt-20 166.68 122.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.901 -1.148 . . . . 4.03 107.901 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.827 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . . . -58.64 -68.13 0.29 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 1.9 109.577 171.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -176.38 70.97 0.25 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.515 -0.766 . . . . 2.21 109.859 170.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.647 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.5 Cg_endo -42.89 -59.25 1.04 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.496 2.797 . . . . 1.01 113.063 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.9 -47.51 32.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.582 0.586 . . . . 2.0 112.582 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.624 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 24.0 tpt180 -58.43 -55.86 29.6 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.329 0.585 . . . . 3.7 109.709 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.567 HG12 ' HA2' ' A' ' 91' ' ' GLY . 82.3 t -52.46 -43.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.4 -1.273 . . . . 1.12 110.677 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.664 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 81.5 mtp -64.24 -34.05 77.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.032 -0.531 . . . . 1.07 110.527 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -73.63 -24.28 60.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 2.01 111.025 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 3.0 mm-40 -68.7 -36.78 78.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.685 -0.857 . . . . 2.02 108.685 172.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.6 mm? -71.73 -43.59 65.6 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.55 -0.75 . . . . 1.62 109.844 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.83 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -77.55 0.26 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.521 -0.763 . . . . 1.08 109.819 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 16.4 tp10 -81.18 -27.58 35.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.911 -1.144 . . . . 2.18 107.911 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.757 ' CE2' HG13 ' A' ' 92' ' ' VAL . 48.5 m-85 -91.99 10.35 29.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.533 0.683 . . . . 1.17 109.19 168.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.2 m120 72.46 32.57 1.58 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.23 -1.35 . . . . 2.43 110.889 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 100' ' ' ILE . 7.5 mp -107.84 79.51 1.29 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.402 1.096 . . . . 2.28 109.475 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.017 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.3 t -66.94 126.18 92.04 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.245 -1.798 . . . . 1.28 112.014 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.852 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 74.5 Cg_exo -47.45 160.11 0.4 Allowed 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 123.848 3.032 . . . . 0.34 113.878 170.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.56 -19.07 42.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.677 -1.147 . . . . 2.01 109.835 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.888 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 1.9 mm-40 -59.23 -40.8 87.03 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.878 -1.156 . . . . 1.18 107.878 168.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.888 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.7 m0 -91.67 -31.64 15.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.952 -1.476 . . . . 0.45 110.979 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.37 28.61 2.98 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.018 -1.087 . . . . 0.45 112.045 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 1.017 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.96 -104.77 1.79 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.717 -0.754 . . . . 0.5 111.913 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -165.49 33.47 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.174 0.511 . . . . 1.3 111.248 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 16.0 m -130.8 113.43 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.244 -0.582 . . . . 1.06 112.016 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.801 HD12 HG21 ' A' ' 168' ' ' VAL . 37.6 mt -81.44 110.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 116.02 -0.537 . . . . 1.86 111.347 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.852 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 23.4 m-85 -89.55 115.0 26.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.933 0.397 . . . . 0.38 111.805 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.481 ' HG ' ' HB2' ' A' ' 161' ' ' LEU . 13.8 t -113.27 135.94 53.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.866 -0.606 . . . . 1.82 109.386 173.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.2 pttp -110.74 85.13 2.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.689 0.757 . . . . 2.94 109.949 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.879 HD11 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -103.55 168.97 8.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.223 1.011 . . . . 1.89 112.906 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.56 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 27.7 t -145.14 117.37 8.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.392 -1.276 . . . . 2.08 108.131 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.53 -26.44 61.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.27 0.841 . . . . 1.43 113.27 -170.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.651 ' HG3' ' H ' ' A' ' 154' ' ' THR . 46.4 pttt -84.27 -55.24 4.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.33 0.586 . . . . 3.46 110.945 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.651 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 40.8 p -64.21 -25.08 67.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.096 -0.956 . . . . 1.78 110.628 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.796 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 2.5 tppp? 66.8 16.27 10.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.88 -1.055 . . . . 2.75 111.805 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.85 -72.42 0.16 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.712 0.768 . . . . 2.64 111.021 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -61.97 -16.67 53.15 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.739 -1.119 . . . . 0.73 113.24 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 150' ' ' LEU . 4.5 mm? -61.4 -46.21 91.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.912 0.387 . . . . 2.12 110.692 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.58 -42.16 68.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.074 -0.512 . . . . 2.5 110.205 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.468 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.9 t60 -66.61 -21.23 66.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.802 -0.635 . . . . 0.84 110.827 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HB2' ' HG ' ' A' ' 148' ' ' CYS . 54.5 tp -72.55 -51.13 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.056 -0.35 . . . . 1.54 110.056 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.604 HD23 HD12 ' A' ' 28' ' ' ILE . 93.8 mt -56.17 -39.95 73.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.635 . . . . 1.7 111.107 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.476 ' HG3' ' HE1' ' A' ' 164' ' ' MET . 13.6 pt-20 -69.54 -32.59 71.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 2.49 110.648 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.691 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 25.6 mmt -73.13 -41.34 64.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.073 0.463 . . . . 1.29 109.898 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.43 -51.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.323 -0.853 . . . . 1.24 111.123 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -75.99 -36.85 59.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.246 0.461 . . . . 2.36 112.246 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 166' ' ' LEU . 62.4 tp -52.23 -33.64 42.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.036 0.446 . . . . 1.98 110.575 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.801 HG21 HD12 ' A' ' 146' ' ' ILE . 19.0 t -78.88 -38.37 20.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.856 -0.611 . . . . 1.69 110.71 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.9 t -61.27 -29.09 69.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 2.07 110.57 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.68 -29.86 13.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 2.79 111.753 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 10.7 ptt? -67.61 -30.29 69.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.973 -0.291 . . . . 2.22 110.718 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 36.4 mt-10 -61.03 -33.96 74.11 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.874 0.369 . . . . 3.45 110.529 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -81.27 -36.08 30.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 3.36 110.005 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 171' ' ' MET . 96.8 mt -57.97 -60.36 3.84 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.365 -0.606 . . . . 4.51 109.365 173.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 176' ' ' ALA . 46.2 tptt -167.87 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.334 -0.848 . . . . 6.66 109.939 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.406 ' H ' ' HB3' ' A' ' 175' ' ' LYS . . . -165.8 -58.47 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.721 -0.672 . . . . 4.98 109.864 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.675 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 62.3 t30 -111.24 -50.37 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.576 -0.738 . . . . 6.96 110.511 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 10.6 Cg_endo . . . . . 0 C--O 1.253 1.254 0 C-N-CA 122.843 2.362 . . . . 7.47 112.004 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.324 -0.31 . . . . 16.58 112.324 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -59.95 130.63 47.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 14.94 111.536 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -113.4 50.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 15.21 109.483 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.5 mtp -74.48 120.41 20.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.936 -0.575 . . . . 12.92 110.424 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 t -87.14 85.39 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.112 -0.699 . . . . 10.47 109.112 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.61 85.72 7.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.563 -0.744 . . . . 9.14 110.375 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.657 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 16.8 ttm180 -150.82 -52.0 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.448 -0.796 . . . . 9.01 111.157 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 53.0 Cg_exo -56.74 128.89 31.82 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.07 1.847 . . . . 5.24 112.025 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 38.3 Cg_exo -60.44 118.3 5.16 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.841 2.361 . . . . 4.88 112.091 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.08 85.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.408 0.623 . . . . 3.08 109.334 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 1.009 HG23 ' HB ' ' A' ' 81' ' ' ILE . 58.9 t -72.4 123.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 115.492 -0.776 . . . . 1.57 110.671 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 127.2 43.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 1.18 110.77 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' H ' HD23 ' A' ' 60' ' ' LEU . 39.9 mt -83.99 115.77 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.319 0.58 . . . . 1.57 110.512 177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 15.3 mmt -107.49 -175.44 2.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.208 -0.905 . . . . 1.41 110.139 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.34 134.56 7.54 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.238 -0.982 . . . . 1.55 110.805 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 84.3 t60 -36.58 128.61 0.8 Allowed 'General case' 0 C--N 1.315 -0.894 0 O-C-N 124.634 0.843 . . . . 1.21 111.124 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 11.3 p -55.61 -21.28 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.352 -0.84 . . . . 2.2 113.107 -170.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 31.5 t70 -93.16 -8.22 43.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.8 0.333 . . . . 1.78 111.78 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' ND1' ' HA ' ' A' ' 86' ' ' VAL . 21.9 m170 -77.26 -7.24 55.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.484 0.55 . . . . 0.89 112.484 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.64 46.36 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.224 -0.989 . . . . 1.06 112.773 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 ptmm? -87.22 -24.26 24.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 2.58 110.174 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HA ' ' CD1' ' A' ' 41' ' ' ILE . 9.4 t -72.8 -29.75 63.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 2.32 110.254 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 p -75.42 -25.74 57.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.128 -0.487 . . . . 2.23 110.871 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 152' ' ' ALA . 43.0 mt -67.9 -54.04 21.87 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.986 -0.746 . . . . 2.33 108.986 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.04 -41.21 62.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.851 -0.613 . . . . 2.46 110.258 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.9 t70 -77.96 -51.38 10.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.54 -33.38 64.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.897 0.332 . . . . 1.42 111.897 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.946 ' HB ' ' HH ' ' A' ' 48' ' ' TYR . 76.2 mt -70.0 -39.05 76.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 2.08 110.046 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 7.2 ptt180 -66.67 -33.47 75.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.325 0.584 . . . . 4.16 109.967 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -83.06 -3.85 57.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.485 -0.78 . . . . 3.57 111.604 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t -97.83 -40.11 8.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.713 0.292 . . . . 2.09 110.714 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -100.43 -165.83 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.464 -0.334 . . . . 5.98 111.342 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.4 t -96.7 -67.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 112.979 0.733 . . . . 3.41 112.979 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 3.4 m -80.84 153.58 27.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.69 0.996 . . . . 4.35 113.69 -165.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.04 170.35 22.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.618 -1.174 . . . . 4.2 109.93 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -147.62 178.79 8.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.566 0.222 . . . . 6.16 110.94 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' HA ' HD13 ' A' ' 45' ' ' ILE . 42.5 mt-10 -76.67 79.2 3.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.052 0.453 . . . . 5.79 111.336 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.784 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . . . -140.95 154.03 45.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.011 -0.54 . . . . 4.64 110.058 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.93 -62.83 2.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.436 -0.888 . . . . 4.95 112.936 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.49 -67.77 3.28 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.682 -0.771 . . . . 6.66 111.579 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 22' ' ' THR . 84.1 mt -141.29 -44.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.358 . . . . 9.5 110.302 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.89 148.73 47.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 7.68 111.607 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -83.64 23.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 9.39 111.641 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.406 ' HB2' ' H ' ' A' ' 45' ' ' ILE . 79.3 m-70 -133.78 -95.81 0.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.701 -0.852 . . . . 7.29 108.701 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 37' ' ' GLU . 45.6 mm -130.46 158.91 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.09 -1.078 . . . . 5.6 108.09 173.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 177.26 -39.94 0.09 OUTLIER Glycine 0 C--N 1.311 -0.837 0 C-N-CA 120.685 -0.769 . . . . 3.5 112.225 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.784 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . . . -67.96 168.12 12.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.977 0.418 . . . . 2.15 110.864 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.946 ' HH ' ' HB ' ' A' ' 28' ' ' ILE . 5.7 p90 -162.71 -177.56 5.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.019 0.438 . . . . 2.96 111.468 -166.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.645 ' O ' ' HB ' ' A' ' 34' ' ' THR . 81.5 mt-30 -140.14 133.56 30.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.359 -0.837 . . . . 2.45 110.191 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -84.95 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.688 0.756 . . . . 2.49 109.832 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.897 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 21.7 m -137.54 98.47 3.7 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.043 -1.435 . . . . 2.26 110.658 -171.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 46.7 t -114.31 118.79 59.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.458 -1.312 . . . . 4.49 107.458 170.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 45.2 t30 71.93 -57.56 0.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.107 0.88 . . . . 4.58 110.88 -173.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.57 ' O ' HG21 ' A' ' 51' ' ' THR . 8.2 t70 -132.43 -63.98 0.78 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.158 -0.928 . . . . 3.62 111.395 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.897 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ptpp? 168.29 151.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.82 -1.082 . . . . 7.78 108.394 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -149.9 -80.49 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.989 0.423 . . . . 5.81 112.04 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.603 HG23 HG21 ' A' ' 11' ' ' VAL . 4.0 mt -76.42 113.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 1.4 111.663 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' A' ' 61' ' ' ASP . 60.9 m -99.23 112.29 24.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.167 -0.47 . . . . 1.85 109.793 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.407 ' HD2' HD12 ' A' ' 13' ' ' ILE . 39.8 m-85 -89.46 92.85 9.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.217 -0.29 . . . . 1.14 110.217 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 13' ' ' ILE . 3.3 mm? 55.2 85.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.984 0.802 . . . . 3.46 111.834 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 10.5 p-10 -82.02 26.83 0.5 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.549 0.69 . . . . 6.48 110.566 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 5.0 t -122.89 143.77 41.29 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.209 -0.905 . . . . 5.89 110.443 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 6.3 Cg_exo -80.17 -3.25 12.55 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.089 2.526 . . . . 5.92 111.768 175.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.81 153.6 19.86 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.942 -0.647 . . . . 5.92 112.556 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -86.01 64.59 8.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.089 0.471 . . . . 8.81 110.057 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.36 169.43 14.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.611 -0.722 . . . . 6.36 111.598 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.28 86.92 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 3.89 110.229 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 108' ' ' VAL . 53.8 t80 56.48 73.49 0.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.658 -0.701 . . . . 2.61 110.886 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -85.23 -24.5 27.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.324 0.583 . . . . 5.11 109.827 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.7 m -76.97 81.58 3.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.496 -0.774 . . . . 6.34 111.402 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.523 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 53.7 ttm -106.26 60.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.67 0.748 . . . . 5.64 109.186 173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -82.79 93.7 7.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.189 -0.914 . . . . 10.31 109.848 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.6 57.18 3.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 7.85 111.921 -173.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.14 110.83 15.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.884 -0.598 . . . . 11.11 109.565 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.77 93.85 0.07 OUTLIER Glycine 0 C--N 1.33 0.212 0 O-C-N 123.52 0.512 . . . . 6.78 112.943 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.13 53.83 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 7.11 110.336 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 66.23 44.67 2.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.582 -0.735 . . . . 8.32 110.97 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.12 96.8 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 4.75 109.907 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -121.61 54.08 1.15 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.05 0.928 . . . . 4.44 110.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.35 91.42 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.672 0.748 . . . . 3.12 109.402 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 1.009 ' HB ' HG23 ' A' ' 11' ' ' VAL . 47.8 mm -52.37 121.91 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.209 -1.36 . . . . 1.31 113.162 -172.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.873 HG23 ' HB1' ' A' ' 103' ' ' ALA . 70.0 t -106.29 107.55 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 1.78 110.758 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.706 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -94.14 110.13 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 109.36 -0.607 . . . . 1.97 109.36 174.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.723 HD23 HD13 ' A' ' 100' ' ' ILE . 10.5 tp -90.28 108.33 19.69 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.923 -0.581 . . . . 1.98 110.749 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HA ' ' HB1' ' A' ' 113' ' ' ALA . 46.3 t -82.0 133.68 28.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.559 . . . . 1.8 111.483 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 114' ' ' ILE . 16.3 m -134.08 -177.88 2.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.888 -1.153 . . . . 1.79 107.888 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.08 11.84 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.792 -0.763 . . . . 1.03 112.215 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.75 -109.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.625 -1.17 . . . . 1.66 112.903 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.734 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 8.8 p-10 -116.51 19.05 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 2.01 110.472 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.14 -33.35 73.29 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.817 0.818 . . . . 1.09 109.0 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.802 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 75.68 -142.15 28.46 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.251 -1.341 . . . . 0.52 111.912 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.792 HG12 ' HB ' ' A' ' 96' ' ' THR . 71.2 t -98.01 110.2 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 120.809 0.337 . . . . 1.67 111.391 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.644 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 80.5 mmm -80.49 171.61 11.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.15 -0.477 . . . . 1.32 109.804 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.644 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.67 -54.49 4.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.138 2.559 . . . . 0.88 113.257 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.674 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 35.6 mt-30 -60.74 -30.33 69.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 2.01 111.574 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.792 ' HB ' HG12 ' A' ' 92' ' ' VAL . 9.8 m -64.58 -22.96 67.11 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.851 0.358 . . . . 1.19 111.102 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.65 -46.5 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.885 0.374 . . . . 1.66 111.111 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.0 -12.74 40.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 1.62 111.315 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -96.68 -18.82 19.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.286 0.565 . . . . 1.09 110.085 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.723 HD13 HD23 ' A' ' 84' ' ' LEU . 3.4 mt -93.3 -53.07 8.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 1.13 110.507 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -50.4 -37.79 39.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.53 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.442 ' HD2' ' HB3' ' A' ' 68' ' ' PHE . 29.4 t60 -75.9 -32.04 59.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.233 -0.894 . . . . 1.02 110.728 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.873 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -84.21 -55.79 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.18 112.084 -173.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -71.41 -12.16 61.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 116.165 -0.47 . . . . 2.98 112.075 -168.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.37 -0.32 19.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.241 -0.436 . . . . 1.3 111.869 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.523 ' HB2' ' HG3' ' A' ' 71' ' ' MET . . . -106.1 1.99 26.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 t30 82.14 38.04 0.06 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 114.566 -1.197 . . . . 2.59 108.113 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 23.5 t -101.93 142.01 23.72 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 113.151 -1.841 . . . . 1.71 111.122 -173.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 6.4 Cg_exo -73.86 149.98 43.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.754 2.303 . . . . 0.62 113.165 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.669 HD13 HG12 ' A' ' 100' ' ' ILE . 97.8 mt -124.78 149.79 29.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.325 -1.307 . . . . 1.62 109.989 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.706 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mt -125.11 157.35 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 109.065 -0.717 . . . . 1.31 109.065 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.533 HG23 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -115.25 134.6 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 109.651 -0.499 . . . . 1.07 109.651 171.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 85' ' ' VAL . . . -121.69 87.71 2.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.748 -1.204 . . . . 1.07 107.748 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.753 ' HA ' HG22 ' A' ' 86' ' ' VAL . 7.0 mt -73.66 93.08 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.661 -1.154 . . . . 1.56 109.749 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.55 166.44 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.88 110.095 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 57.3 tptt 63.0 47.9 4.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.27 1.033 . . . . 3.11 110.585 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.946 ' HE3' ' HB2' ' A' ' 121' ' ' GLU . 69.3 mmm -85.14 -45.9 11.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.13 -0.941 . . . . 1.55 108.501 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.12 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 O-C-N 125.203 1.565 . . . . 2.45 113.028 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 1.066 ' HG3' ' HD3' ' A' ' 120' ' ' PRO . 3.4 ptpt -145.32 -53.97 0.02 OUTLIER Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.137 -0.938 . . . . 4.11 113.528 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 1.066 ' HD3' ' HG3' ' A' ' 119' ' ' LYS . 35.8 Cg_endo -73.82 -27.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.169 2.579 . . . . 3.16 111.378 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.946 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 13.0 pt-20 50.34 32.95 6.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.201 -1.363 . . . . 4.03 113.106 170.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 89' ' ' ASP . . . 49.25 -129.17 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 1.9 111.748 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.458 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.5 t30 -160.67 84.93 1.92 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 2.21 109.179 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.545 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.3 Cg_exo -19.29 -66.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 1 C-N-CA 126.389 4.726 . . . . 1.01 116.456 175.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -39.68 -52.03 2.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.096 0.776 . . . . 2.0 113.096 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.0 tmt_? -55.55 -56.7 17.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.985 0.422 . . . . 3.7 109.926 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.802 HG11 ' HA2' ' A' ' 91' ' ' GLY . 31.0 t -58.45 -45.17 89.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.98 -1.009 . . . . 1.12 110.008 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.69 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 88.8 mtp -63.41 -30.11 71.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.395 -0.82 . . . . 1.07 111.181 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 132' ' ' MET . 58.8 mt-30 -78.61 -25.21 45.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.118 -0.233 . . . . 2.01 110.669 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.741 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.6 mt-10 -63.45 -38.61 91.79 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.847 -0.798 . . . . 2.02 108.847 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -70.85 -42.36 70.23 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.62 110.094 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.81 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -72.92 -7.76 52.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.728 -0.669 . . . . 1.08 110.227 178.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.85 -24.36 35.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.649 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 19.1 m-85 -89.05 5.95 42.01 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 122.216 1.008 . . . . 1.17 108.306 167.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.2 m120 72.37 26.35 2.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 113.158 -1.837 . . . . 2.43 110.541 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.947 HD11 HD13 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -103.56 73.02 1.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.205 -1.406 . . . . 2.28 107.205 169.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.898 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -58.31 132.56 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 113.403 -1.726 . . . . 1.28 110.291 -173.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.858 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 94.4 Cg_exo -47.35 151.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.631 2.221 . . . . 0.34 112.971 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -76.0 -25.68 56.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.149 -1.387 . . . . 2.01 108.028 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.824 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -55.99 -38.9 71.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.288 -1.323 . . . . 1.18 109.149 169.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.824 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.6 m0 -96.03 -25.31 15.97 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.581 -1.191 . . . . 0.45 110.453 -172.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.48 24.15 3.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.908 -1.139 . . . . 0.45 112.192 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.898 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -115.85 2.93 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.396 -0.907 . . . . 0.5 112.978 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.28 25.03 1.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.965 0.358 . . . . 1.3 111.965 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.607 HG22 HD13 ' A' ' 136' ' ' LEU . 31.7 m -142.91 123.12 13.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 119.541 -0.864 . . . . 1.06 113.267 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.4 mp -85.19 118.42 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 1.86 110.36 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.858 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.3 m-85 -92.88 116.61 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.911 0.386 . . . . 0.38 111.352 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.6 m -114.46 110.24 19.54 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.948 -0.569 . . . . 1.82 110.72 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.563 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 14.9 ptmt -84.91 85.75 7.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.354 0.597 . . . . 2.94 109.707 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.487 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.3 -175.22 2.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.446 0.641 . . . . 1.89 111.816 -171.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.658 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 35.9 m -160.02 119.59 2.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.51 -0.768 . . . . 2.08 110.011 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 24' ' ' LEU . . . -73.94 -53.25 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.897 -0.592 . . . . 1.43 112.553 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -75.34 -43.26 51.58 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.583 0.706 . . . . 3.46 109.785 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.641 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.3 OUTLIER -57.88 -22.14 46.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.15 -1.387 . . . . 1.78 110.196 171.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.731 ' HD3' HD11 ' A' ' 158' ' ' LEU . 0.0 OUTLIER 74.22 -39.28 0.42 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.601 -1.181 . . . . 2.75 113.903 170.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.99 -46.48 43.91 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.649 0.738 . . . . 2.64 112.024 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.658 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -63.99 -33.1 86.34 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.05 -0.977 . . . . 0.73 113.58 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.731 HD11 ' HD3' ' A' ' 155' ' ' LYS . 74.7 mt -59.68 -47.02 87.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.809 0.338 . . . . 2.12 111.182 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -59.96 -44.52 94.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.64 -0.709 . . . . 2.5 110.251 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -65.46 -38.75 90.74 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.309 -0.405 . . . . 0.84 110.898 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 165' ' ' ILE . 64.1 tp -59.9 -51.61 68.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 1.54 111.011 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.417 HD21 HD12 ' A' ' 165' ' ' ILE . 81.7 mt -60.16 -33.88 72.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 1.7 110.911 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.83 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 2.49 110.642 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.56 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 1.29 110.638 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.417 HD12 HD21 ' A' ' 162' ' ' LEU . 81.7 mt -61.4 -48.77 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.048 -0.524 . . . . 1.24 110.596 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.6 -37.97 89.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 2.36 110.821 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.7 -45.45 73.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.733 -0.667 . . . . 1.98 109.656 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.85 -43.55 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.078 -0.51 . . . . 1.69 111.035 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -56.17 -43.96 78.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 2.07 110.911 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.11 -28.26 35.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.702 -0.226 . . . . 2.79 111.336 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.7 ttp -67.28 -58.97 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.523 -0.308 . . . . 2.22 111.063 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.916 ' HA ' ' HB3' ' A' ' 176' ' ' ALA . 18.0 mt-10 -60.69 -35.39 76.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.537 0.569 . . . . 3.45 112.537 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -13.7 60.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.928 0.394 . . . . 3.36 110.778 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.8 tp -106.83 -61.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.058 0.456 . . . . 4.51 110.739 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -149.97 106.84 3.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.539 . . . . 6.66 110.405 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -138.36 49.4 1.92 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.278 0.561 . . . . 4.98 110.055 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -144.47 119.73 6.02 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 6.96 109.624 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 C--O 1.25 1.12 0 C-N-CA 122.791 2.327 . . . . 7.47 112.428 179.156 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 112.167 -0.373 . . . . 16.58 112.167 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 p -116.98 26.52 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.871 0.367 . . . . 14.94 111.192 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.3 73.65 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 15.21 110.107 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.8 ptp -142.33 136.59 29.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 12.92 110.539 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.41 119.81 34.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.043 -0.526 . . . . 10.47 110.295 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.314 -0.403 . . . . 9.14 110.605 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -158.54 78.01 3.25 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.042 0.449 . . . . 9.01 110.793 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.04 136.35 10.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.337 2.024 . . . . 5.24 111.126 172.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -43.99 -52.44 5.53 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.421 2.747 . . . . 4.88 113.831 -173.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t 63.59 91.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.547 0.689 . . . . 3.08 109.653 -172.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.78 HG23 ' HB ' ' A' ' 81' ' ' ILE . 44.5 t -87.81 132.12 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.222 -0.899 . . . . 1.57 112.082 -171.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -97.75 109.63 22.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 1.18 110.717 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG13 ' HB ' ' A' ' 83' ' ' ILE . 14.7 tt -82.69 143.99 11.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.092 0.472 . . . . 1.57 110.772 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 59.4 mtt -139.94 -172.6 3.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.069 -0.514 . . . . 1.41 110.934 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.886 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 107.76 129.64 6.13 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.944 -0.862 . . . . 1.55 110.944 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 83.4 t60 -49.01 136.58 14.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.499 0.666 . . . . 1.21 110.971 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG12 ' HE2' ' A' ' 21' ' ' LYS . 29.2 m -64.74 -33.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.294 0.85 . . . . 2.2 113.294 -169.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 9.7 m-20 -67.15 -19.8 65.65 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.745 0.276 . . . . 1.78 111.745 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.427 ' HE2' ' HG3' ' A' ' 93' ' ' MET . 28.5 m170 -68.93 -16.25 63.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.89 110.916 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 114.63 47.27 0.58 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.87 -0.681 . . . . 1.06 112.472 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.613 ' HE2' HG12 ' A' ' 17' ' ' VAL . 36.3 ttpt -87.09 -34.99 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.547 -0.538 . . . . 2.58 109.547 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -67.35 -47.73 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 2.32 109.954 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -69.49 -20.37 63.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.663 -0.699 . . . . 2.23 110.432 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 3.0 tm? -73.57 -51.01 18.4 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.519 -0.919 . . . . 2.33 108.519 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD13 ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -58.09 -37.1 73.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.455 -0.793 . . . . 2.46 110.668 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.26 -55.55 11.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 1.38 110.81 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 152' ' ' ALA . . . -61.04 -42.2 98.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 1.42 111.203 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.88 HD13 ' HH ' ' A' ' 48' ' ' TYR . 13.0 tt -65.03 -31.51 54.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.588 -0.733 . . . . 2.08 111.02 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -79.9 -28.07 39.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.475 0.655 . . . . 4.16 109.29 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.92 -9.29 59.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 3.57 111.489 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -77.35 16.32 0.63 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.442 -0.345 . . . . 2.09 111.709 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.584 ' O ' HG11 ' A' ' 33' ' ' VAL . 47.2 mmtm 68.19 177.59 0.25 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.323 0.649 . . . . 5.98 112.611 171.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.12 HG23 ' HB ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 59.78 6.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.813 1.245 . . . . 3.41 111.779 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.429 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -82.49 120.17 25.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.984 -0.553 . . . . 4.35 111.16 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.5 -46.22 64.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.301 -0.863 . . . . 4.2 109.827 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -116.57 142.97 46.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.868 -1.16 . . . . 6.16 107.868 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.07 37.72 2.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.55 0.691 . . . . 5.79 110.283 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.575 ' HA ' HD11 ' A' ' 41' ' ' ILE . . . -85.32 56.4 3.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.373 -0.83 . . . . 4.64 110.387 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.543 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . -124.92 99.13 0.57 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.879 -0.677 . . . . 4.95 111.853 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' H ' HG22 ' A' ' 45' ' ' ILE . . . 90.52 54.04 2.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 6.66 111.993 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.575 HD11 ' HA ' ' A' ' 38' ' ' ALA . 56.1 mt -104.76 -73.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 9.5 109.994 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.5 m -131.26 55.31 1.86 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.709 -0.678 . . . . 7.68 109.271 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.492 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.8 mm-40 69.92 -54.49 0.61 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.034 -0.985 . . . . 9.39 111.684 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -65.21 132.8 50.03 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.189 -0.671 . . . . 7.29 109.189 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 40' ' ' GLY . 28.6 pt -124.59 176.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.554 0.692 . . . . 5.6 111.545 -177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.69 20.65 1.3 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.964 -1.017 . . . . 3.5 111.304 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 65.1 -168.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.046 0.497 . . . . 2.15 111.666 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.88 ' HH ' HD13 ' A' ' 28' ' ' ILE . 7.5 p90 -154.26 121.87 5.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.19 0.519 . . . . 2.96 110.025 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.941 ' HG2' HG23 ' A' ' 58' ' ' THR . 77.9 mt-30 -100.07 114.78 28.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.925 -0.769 . . . . 2.45 108.925 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG21 ' HE1' ' A' ' 59' ' ' PHE . 16.5 m -92.25 147.02 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.596 0.713 . . . . 2.49 111.909 -174.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 1.12 ' HB ' HG23 ' A' ' 33' ' ' VAL . 25.4 m -88.17 80.47 7.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.188 -0.915 . . . . 2.26 109.135 172.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 54' ' ' ASP . 12.7 p -112.1 117.08 54.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.03 -1.1 . . . . 4.49 108.03 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 68.75 -51.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.847 0.717 . . . . 4.58 109.498 -164.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' VAL . 19.6 t70 147.97 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.602 1.561 . . . . 3.62 110.298 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 tptt 67.21 -2.1 1.31 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.568 0.951 . . . . 7.78 113.568 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -60.22 -64.54 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 5.81 112.62 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.702 HD11 ' HB3' ' A' ' 166' ' ' LEU . 63.5 mt -90.15 109.25 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.45 0.643 . . . . 1.4 111.781 -174.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.941 HG23 ' HG2' ' A' ' 49' ' ' GLN . 28.9 m -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.556 -0.905 . . . . 1.85 108.556 170.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 83.0 m-85 -96.34 93.2 6.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.872 -0.788 . . . . 1.14 108.872 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.0 mt 65.8 160.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.154 0 O-C-N 124.018 0.824 . . . . 3.46 110.524 -170.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -139.17 -59.71 0.58 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.195 0.521 . . . . 6.48 109.699 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 m -105.41 102.32 36.6 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.665 -0.698 . . . . 5.89 109.574 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.31 177.48 8.58 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.792 2.328 . . . . 5.92 112.399 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.58 -125.43 5.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.501 -0.857 . . . . 5.92 112.617 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -119.99 37.82 4.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.128 0.489 . . . . 8.81 110.674 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.8 -38.26 86.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.716 -0.675 . . . . 6.36 110.496 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.85 63.87 1.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 O-C-N 123.674 0.609 . . . . 3.89 111.842 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB2' ' CE ' ' A' ' 14' ' ' MET . 44.5 t80 57.33 71.16 0.59 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.395 0.617 . . . . 2.61 109.816 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 5.5 t -97.66 14.71 25.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.585 -0.734 . . . . 5.11 110.338 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 m -64.74 -12.43 46.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.488 -0.778 . . . . 6.34 111.138 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.3 mtt -71.65 7.11 1.58 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.978 -0.555 . . . . 5.64 111.817 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 69' ' ' THR . 60.1 mtt180 -84.95 -23.78 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 10.31 109.545 172.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.96 71.97 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.407 0.623 . . . . 7.85 110.455 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.68 154.56 19.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.539 -0.755 . . . . 11.11 110.369 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.6 -81.81 0.3 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.819 . . . . 6.78 112.815 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.58 59.41 5.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.82 0.304 . . . . 7.11 111.82 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 66.75 110.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.588 0.709 . . . . 8.32 112.251 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.67 71.21 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.664 -0.698 . . . . 4.75 109.278 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -93.11 111.32 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.546 0.689 . . . . 4.44 111.647 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.73 176.97 5.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.925 -1.139 . . . . 3.12 107.925 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.78 ' HB ' HG23 ' A' ' 11' ' ' VAL . 37.5 mm -124.08 102.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.439 -0.578 . . . . 1.31 109.439 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.723 HG23 ' HB3' ' A' ' 103' ' ' ALA . 87.5 t -91.84 95.7 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.409 -0.36 . . . . 1.78 111.257 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.789 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -81.94 97.66 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 120.291 -0.564 . . . . 1.97 109.632 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 96' ' ' THR . 20.4 tp -86.94 109.0 19.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.757 -0.656 . . . . 1.98 110.643 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.886 HG12 ' HA3' ' A' ' 15' ' ' GLY . 5.0 p -85.23 142.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 1.8 111.298 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.741 HG21 ' HA ' ' A' ' 114' ' ' ILE . 18.1 m -138.9 -177.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.553 -0.906 . . . . 1.79 108.553 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.81 98.26 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.953 -0.699 . . . . 1.03 112.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.97 -95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.106 1.15 . . . . 1.66 114.106 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.17 -8.21 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 2.01 112.002 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.06 -32.58 39.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 1.09 110.458 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 72.31 -139.11 27.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.259 -0.882 . . . . 0.52 112.443 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' A' ' 96' ' ' THR . 78.4 t -97.1 106.54 18.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 123.012 0.525 . . . . 1.67 111.512 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.546 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 51.0 mtp -75.9 170.85 13.9 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 1.32 110.634 173.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 79.0 Cg_exo -43.85 -58.07 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.79 2.327 . . . . 0.88 112.898 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.592 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.2 mt-30 -56.13 -32.86 64.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.387 0.514 . . . . 2.01 112.387 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.577 HG22 HD23 ' A' ' 84' ' ' LEU . 11.4 m -66.68 -23.16 66.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.134 0.492 . . . . 1.19 110.579 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.447 HG21 HG12 ' A' ' 92' ' ' VAL . 91.1 t -91.79 -45.25 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.404 -0.362 . . . . 1.66 110.69 175.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 46.1 mt-10 -61.36 -18.13 57.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 1.62 111.147 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.664 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -86.32 -41.47 14.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.814 -0.63 . . . . 1.09 109.358 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.624 HG12 HG12 ' A' ' 110' ' ' ILE . 1.3 mt -68.35 -55.46 16.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 CA-C-N 115.452 -0.795 . . . . 1.13 110.631 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.412 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 t-20 -45.33 -36.8 4.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.791 0.436 . . . . 1.97 111.432 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 18.2 t60 -79.01 -29.16 43.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.897 -0.592 . . . . 1.02 111.012 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.723 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -99.51 -42.62 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.96 0.726 . . . . 1.18 112.96 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -17.4 64.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.074 0.464 . . . . 2.98 111.092 -166.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.441 ' N ' ' HD3' ' A' ' 104' ' ' LYS . . . -87.47 5.22 40.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.52 . . . . 1.3 111.741 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -96.59 1.63 51.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.401 -0.592 . . . . 1.3 109.401 174.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 74.71 39.01 0.45 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.38 1.086 . . . . 2.59 108.966 176.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -118.52 143.59 33.62 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 113.5 -1.682 . . . . 1.71 110.248 -176.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.1 Cg_exo -69.14 154.35 70.33 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.628 2.219 . . . . 0.62 114.157 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.624 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -122.3 146.87 26.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 113.913 -1.494 . . . . 1.62 109.806 -177.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.789 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.54 148.36 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.89 -1.152 . . . . 1.31 107.89 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -115.41 130.03 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 109.851 -0.426 . . . . 1.07 109.851 174.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -116.66 87.28 2.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.911 -1.144 . . . . 1.07 107.911 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.741 ' HA ' HG21 ' A' ' 86' ' ' VAL . 7.5 mt -73.87 97.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.432 -1.258 . . . . 1.56 109.976 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 23.1 t-20 -88.19 147.5 24.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.448 -0.342 . . . . 0.88 111.066 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.579 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 31.0 mtmm 76.98 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.024 0.828 . . . . 3.11 111.753 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.656 ' HE3' ' HB2' ' A' ' 121' ' ' GLU . 23.8 mmm -117.99 4.22 12.11 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.343 -0.984 . . . . 1.55 108.343 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -67.99 -17.17 64.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.828 -1.533 . . . . 2.45 110.751 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.986 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 50.6 pttt -78.01 -160.31 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.189 -1.412 . . . . 4.11 107.189 165.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.986 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -47.9 -63.24 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 121.989 1.746 . . . . 3.16 109.575 167.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.931 ' HG3' ' H ' ' A' ' 122' ' ' ALA . 13.6 pt-20 152.8 -92.19 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.797 2.039 . . . . 4.03 108.574 167.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.931 ' H ' ' HG3' ' A' ' 121' ' ' GLU . . . 174.43 -89.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.728 0.811 . . . . 1.9 109.642 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 26.2 t-20 -175.8 86.41 0.29 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.377 -0.828 . . . . 2.21 109.505 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.645 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.9 Cg_endo -42.15 -53.46 3.55 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 124.003 3.135 . . . . 1.01 113.627 175.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.53 -48.23 19.41 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.549 0.574 . . . . 2.0 112.549 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -52.2 -60.83 2.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.459 0.647 . . . . 3.7 110.115 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.4 HG13 ' HA2' ' A' ' 91' ' ' GLY . 48.4 t -54.1 -45.1 65.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.248 -1.342 . . . . 1.12 110.537 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.72 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.6 mtp -62.79 -33.11 74.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.85 -0.614 . . . . 1.07 111.029 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -72.15 -23.04 61.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.434 -0.348 . . . . 2.01 111.196 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 7.0 mt-10 -72.5 -32.52 66.24 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.976 -0.75 . . . . 2.02 108.976 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.518 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -72.35 -44.32 62.77 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.575 0.702 . . . . 1.62 109.295 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.969 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -76.0 -2.07 28.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.926 -1.034 . . . . 1.08 109.778 177.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.7 tp10 -78.63 -31.32 46.88 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.303 -1.369 . . . . 2.18 107.303 173.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 136' ' ' LEU . 40.1 m-85 -90.11 9.66 27.38 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.812 . . . . 1.17 109.107 171.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 74.99 16.96 2.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.814 -1.539 . . . . 2.43 110.37 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.56 HD21 HD12 ' A' ' 100' ' ' ILE . 6.1 mp -91.13 72.19 6.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.212 1.006 . . . . 2.28 108.488 173.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.471 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.49 129.89 92.96 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.917 -1.492 . . . . 1.28 110.711 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.791 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -50.72 158.32 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.953 2.436 . . . . 0.34 112.831 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -73.7 -29.8 62.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.056 -0.974 . . . . 2.01 108.504 175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.679 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.4 mp0 -42.14 -55.08 3.38 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.431 -1.259 . . . . 1.18 110.597 163.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.969 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 13.5 m0 -90.7 -23.21 20.79 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.861 -1.518 . . . . 0.45 111.286 -166.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.28 25.98 2.81 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.709 -1.234 . . . . 0.45 112.44 171.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.471 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -102.84 -113.81 3.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.45 -0.881 . . . . 0.5 112.689 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -154.45 30.15 0.43 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.087 0.47 . . . . 1.3 111.503 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 136' ' ' LEU . 30.6 m -125.22 124.0 40.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.157 -0.617 . . . . 1.06 112.254 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 164' ' ' MET . 4.3 mp -91.94 103.33 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.498 . . . . 1.86 111.419 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.791 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 30.7 m-85 -85.54 126.33 33.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.906 0.384 . . . . 0.38 111.842 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.4 m -126.91 124.63 39.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.501 -0.772 . . . . 1.82 109.959 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.51 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 18.6 ptpt -98.75 86.94 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.655 0.74 . . . . 2.94 109.369 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.583 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.75 174.01 6.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.89 0.852 . . . . 1.89 112.52 -173.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.64 127.68 5.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.599 -1.182 . . . . 2.08 110.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . . . -80.27 -3.25 48.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 1.43 110.768 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -74.71 -46.62 36.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.281 -0.872 . . . . 3.46 109.897 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -106.61 -11.1 15.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.612 -1.176 . . . . 1.78 111.182 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.556 ' HA ' HD22 ' A' ' 158' ' ' LEU . 54.6 mttp 62.78 15.82 8.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.339 -0.846 . . . . 2.75 112.706 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.16 -65.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.892 0.854 . . . . 2.64 110.912 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.583 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -67.04 -11.43 58.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.764 -1.107 . . . . 0.73 113.267 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 155' ' ' LYS . 4.2 mm? -64.44 -44.56 90.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.314 0.557 . . . . 2.12 109.844 178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.9 -48.36 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.053 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.93 -35.06 77.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.84 111.22 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 165' ' ' ILE . 65.5 tp -61.85 -57.84 10.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.558 -0.292 . . . . 1.54 111.398 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 165' ' ' ILE . 4.0 pp -63.08 -29.93 71.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.755 -0.202 . . . . 1.7 110.877 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.404 ' N ' HD11 ' A' ' 162' ' ' LEU . 52.1 mm-40 -63.58 -41.3 98.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 2.49 110.71 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.536 ' HB3' HG22 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -73.02 -38.68 66.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.669 0.271 . . . . 1.29 110.964 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.74 HG21 HG21 ' A' ' 81' ' ' ILE . 85.6 mt -55.36 -52.73 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.931 -0.577 . . . . 1.24 110.991 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.702 ' HB3' HD11 ' A' ' 57' ' ' ILE . 3.7 pp -71.19 -35.42 71.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.668 0.27 . . . . 2.36 111.526 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 166' ' ' LEU . 61.8 tp -52.12 -32.25 34.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.747 -0.661 . . . . 1.98 110.212 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.693 HG23 ' HE2' ' A' ' 171' ' ' MET . 19.6 t -74.06 -51.47 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.912 -0.585 . . . . 1.69 110.26 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.5 m -59.76 -33.47 71.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 2.07 110.201 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -48.78 21.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 2.79 111.207 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.693 ' HE2' HG23 ' A' ' 168' ' ' VAL . 24.6 ptt? -71.66 -24.36 61.84 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.554 -0.458 . . . . 2.22 111.443 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 42.6 mt-10 -47.38 -53.3 14.22 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 3.45 111.383 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.93 -8.23 54.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 3.36 111.423 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 171' ' ' MET . 3.0 tm? -90.52 -49.06 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.002 0.43 . . . . 4.51 110.345 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -155.78 -76.27 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.1 -0.5 . . . . 6.66 110.314 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . 60.36 77.13 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 O-C-N 123.837 0.71 . . . . 4.98 111.742 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.78 96.64 41.74 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 6.96 110.121 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.684 2.256 . . . . 7.47 111.644 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 N-CA-C 111.8 -0.52 . . . . 16.58 111.8 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -74.04 122.53 22.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.698 0.249 . . . . 14.94 110.8 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 54.12 57.61 5.77 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 15.21 111.325 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -85.38 76.39 10.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.497 -0.774 . . . . 12.92 110.161 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -64.75 136.52 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.625 -0.716 . . . . 10.47 110.895 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 31.4 mm-40 -80.55 64.43 5.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.784 -0.644 . . . . 9.14 110.558 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.0 93.72 11.4 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 9.01 109.755 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 71.5 Cg_endo -86.58 115.14 1.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.836 2.357 . . . . 5.24 112.161 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 56' ' ' LYS . 22.9 Cg_exo -64.78 104.29 0.54 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.935 2.424 . . . . 4.88 111.608 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.9 t -78.1 92.33 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.054 0.454 . . . . 3.08 110.29 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 1.019 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 4.2 t -76.2 82.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.024 -0.732 . . . . 1.57 109.024 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 83' ' ' ILE . 20.0 m -77.7 123.03 26.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.332 -0.849 . . . . 1.18 110.793 -173.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 HD12 HD11 ' A' ' 24' ' ' LEU . 15.0 tt -86.61 135.57 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.486 0.66 . . . . 1.57 109.276 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 99' ' ' ALA . 37.6 mtt -140.67 -175.58 4.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.455 -0.793 . . . . 1.41 110.954 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.832 ' HA3' HG13 ' A' ' 85' ' ' VAL . . . 142.86 -99.04 0.22 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.09 -1.204 . . . . 1.55 110.09 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.402 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 29.5 t60 -156.19 156.13 33.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.019 -0.734 . . . . 1.21 109.019 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.72 -56.35 18.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.653 0.263 . . . . 2.2 111.614 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.91 -18.37 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.314 0.487 . . . . 1.78 112.314 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 7.3 m170 -57.62 -37.03 72.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.012 0.435 . . . . 0.89 111.042 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 127.56 59.17 0.13 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.188 -1.006 . . . . 1.06 113.527 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -87.22 -37.18 17.49 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.512 -0.551 . . . . 2.58 109.512 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -68.99 -44.67 72.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.518 -0.765 . . . . 2.32 110.022 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -71.37 -16.91 62.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.178 -0.465 . . . . 2.23 110.398 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 13' ' ' ILE . 5.8 tt -81.17 -53.77 6.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.083 -0.71 . . . . 2.33 109.083 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.69 HD12 ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -64.09 -36.07 82.83 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.211 -0.449 . . . . 2.46 110.022 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.25 -54.53 39.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 1.38 111.46 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.02 79.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 1.42 110.973 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 25' ' ' LEU . 4.1 tt -72.59 -30.33 33.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.717 -0.674 . . . . 2.08 109.961 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 2.0 tpt180 -74.09 -33.34 63.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.603 -0.726 . . . . 4.16 110.084 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -73.01 -12.11 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 3.57 110.507 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.1 t -93.05 -61.25 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.823 -0.806 . . . . 2.09 108.823 173.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 51.47 151.99 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.4 1.48 . . . . 5.98 114.542 176.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG21 HG13 ' A' ' 50' ' ' VAL . 15.4 m -126.57 -33.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.267 -0.879 . . . . 3.41 111.652 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.475 ' CB ' ' HG1' ' A' ' 51' ' ' THR . 98.4 m -153.86 -74.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 4.35 111.298 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 1.0 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 10.3 mm-40 -81.64 164.53 21.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.108 -0.33 . . . . 4.2 110.108 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -177.19 65.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.367 0.603 . . . . 6.16 110.639 -175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.6 -73.17 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.729 -0.669 . . . . 5.79 110.526 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' ALA . . . -159.97 130.08 5.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.288 -0.869 . . . . 4.64 109.554 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.51 67.58 2.83 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.084 -0.579 . . . . 4.95 114.192 -170.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.42 -36.25 2.22 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.368 0.507 . . . . 6.66 114.368 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.41 -32.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.529 0.566 . . . . 9.5 112.529 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.445 ' HB ' ' CG1' ' A' ' 45' ' ' ILE . 2.5 m -78.25 -5.02 50.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.828 0.346 . . . . 7.68 111.299 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.769 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 90.2 mt-30 69.32 -67.12 0.23 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.788 0.835 . . . . 9.39 112.578 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -82.1 30.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.926 0.393 . . . . 7.29 111.875 -173.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 ' CG1' ' HB ' ' A' ' 42' ' ' THR . 44.1 mm -122.2 155.19 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 5.6 109.644 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 45' ' ' ILE . . . -95.48 21.03 46.76 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.69 -0.687 . . . . 3.5 111.831 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' A' ' 38' ' ' ALA . . . 61.35 -77.49 0.03 OUTLIER 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.984 0.913 . . . . 2.15 112.052 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 27.3 p90 -167.79 157.23 9.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.207 -1.035 . . . . 2.96 108.207 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.0 ' H ' ' HB2' ' A' ' 35' ' ' GLU . 50.2 mt-30 -118.76 137.92 53.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.939 0.4 . . . . 2.45 110.642 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.787 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 72.7 t -91.54 150.64 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.875 0.845 . . . . 2.49 110.991 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 54' ' ' ASP . 21.0 m -115.26 103.65 11.04 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.836 -1.529 . . . . 2.26 110.724 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 93.3 t -126.81 119.67 53.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.337 -1.357 . . . . 4.49 107.337 169.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 59.4 t30 73.87 -50.06 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 124.096 0.873 . . . . 4.58 110.324 -173.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.625 ' O ' HG23 ' A' ' 51' ' ' THR . 15.6 t70 -145.15 -68.78 0.29 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.265 -0.88 . . . . 3.62 111.839 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 26.0 ttpp 161.76 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 124.31 1.006 . . . . 7.78 108.604 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.544 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 27.3 mtpp -133.58 -26.71 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.267 0.469 . . . . 5.81 112.267 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.956 HG22 HG22 ' A' ' 11' ' ' VAL . 55.5 mt -86.89 103.51 13.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.642 -0.423 . . . . 1.4 111.927 -171.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.402 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 13.4 m -94.44 107.91 19.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.493 -0.321 . . . . 1.85 110.262 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -81.48 93.47 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 1.14 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.9 tp -98.79 132.86 43.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.647 -0.252 . . . . 3.46 110.874 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -114.77 144.04 44.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.798 -0.815 . . . . 6.48 108.798 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.689 HG21 ' HA ' ' A' ' 67' ' ' ALA . 16.0 m -115.53 94.66 40.82 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 5.89 111.428 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.769 ' HG2' ' HG2' ' A' ' 43' ' ' GLN . 61.1 Cg_endo -95.62 42.23 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.322 2.681 . . . . 5.92 112.169 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.55 -133.77 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 5.92 112.748 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -88.0 174.48 8.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 8.81 111.724 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 62.27 37.0 14.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.165 -0.925 . . . . 6.36 111.25 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' HG21 ' A' ' 62' ' ' THR . . . -64.97 103.63 0.75 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.761 -0.654 . . . . 3.89 110.714 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 20.6 t80 61.05 64.35 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.499 -0.773 . . . . 2.61 110.944 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.705 HG23 HG13 ' A' ' 78' ' ' VAL . 44.7 p 62.99 144.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.522 1.129 . . . . 5.11 113.572 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.9 m -79.89 78.25 6.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.233 -0.894 . . . . 6.34 110.304 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 63.7 mtt -62.2 -17.42 58.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.632 -0.713 . . . . 5.64 112.165 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.19 -7.66 54.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.383 . . . . 10.31 110.589 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.33 -57.67 1.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.144 -0.48 . . . . 7.85 109.943 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.24 127.83 21.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.086 0.469 . . . . 11.11 110.481 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.07 65.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.508 -0.637 . . . . 6.78 111.508 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.61 -53.43 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 7.11 110.575 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -141.41 40.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.319 0.58 . . . . 8.32 110.365 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.705 HG13 HG23 ' A' ' 69' ' ' THR . 9.3 t -78.39 72.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.063 -0.717 . . . . 4.75 109.063 175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 108' ' ' VAL . 17.0 m -87.14 89.79 8.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.453 -0.794 . . . . 4.44 111.722 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 8.3 m-20 -97.3 -169.83 1.92 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.364 -0.606 . . . . 3.12 109.364 169.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 1.019 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 40.2 mm -98.89 133.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 121.136 -0.226 . . . . 1.31 111.485 -173.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 103' ' ' ALA . 92.3 t -113.78 106.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.541 -0.299 . . . . 1.78 111.077 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.764 HD11 HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -94.39 99.65 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.36 -0.607 . . . . 1.97 109.36 175.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 15.1 tp -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.146 -0.479 . . . . 1.98 111.254 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.832 HG13 ' HA3' ' A' ' 15' ' ' GLY . 4.5 p -79.39 141.54 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.372 0.606 . . . . 1.8 110.809 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 114' ' ' ILE . 26.7 m -140.94 -160.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.569 -1.271 . . . . 1.79 107.569 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.14 147.99 34.45 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.139 -0.624 . . . . 1.03 111.684 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -35.25 -59.33 0.52 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.606 1.191 . . . . 1.66 112.893 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.79 -9.87 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.507 . . . . 2.01 112.1 -172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.49 -51.3 5.99 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.293 0.568 . . . . 1.09 111.402 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.454 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 85.65 -136.93 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.248 -0.887 . . . . 0.52 111.62 -172.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.953 HG12 ' HB ' ' A' ' 96' ' ' THR . 37.7 t -101.18 114.08 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 122.898 0.479 . . . . 1.67 111.248 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.614 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 39.5 mtp -81.19 169.79 17.85 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 1.32 110.025 172.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.1 Cg_endo -44.9 -48.01 11.25 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.121 2.547 . . . . 0.88 113.324 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 95' ' ' GLN . 2.9 mt-30 -71.35 -25.95 62.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.579 0.228 . . . . 2.01 110.83 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.953 ' HB ' HG12 ' A' ' 92' ' ' VAL . 4.5 m -64.54 -22.58 67.01 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.115 0.483 . . . . 1.19 110.389 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.69 -38.84 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.516 -0.311 . . . . 1.66 110.821 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.0 -29.49 65.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.877 0.37 . . . . 1.62 111.49 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.565 ' HB2' ' SD ' ' A' ' 14' ' ' MET . . . -79.31 -37.54 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.511 . . . . 1.09 109.661 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -72.63 -49.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 1.13 110.384 178.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -45.1 -35.62 3.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.385 0.674 . . . . 1.97 111.122 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.404 ' HD2' ' HD2' ' A' ' 68' ' ' PHE . 38.8 t60 -83.19 -34.68 25.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 1.02 111.2 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 82' ' ' VAL . . . -91.95 -33.12 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.916 0.709 . . . . 1.18 112.916 -170.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.548 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.73 -16.92 60.72 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.114 0.483 . . . . 2.98 110.326 -167.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.8 7.66 44.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 1.3 112.307 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HB3' HG22 ' A' ' 108' ' ' VAL . . . -108.99 3.2 21.9 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.212 -0.662 . . . . 1.3 109.212 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 177' ' ' ASN . 2.7 t30 73.65 34.1 0.98 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.316 -1.364 . . . . 2.59 107.316 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 79' ' ' THR . 9.6 t -91.96 143.99 28.55 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 112.425 -2.171 . . . . 1.71 110.597 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.17 142.88 31.3 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.344 2.029 . . . . 0.62 113.061 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.628 HG21 HG22 ' A' ' 145' ' ' THR . 1.6 mp -121.6 143.4 34.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 113.19 -1.823 . . . . 1.62 109.442 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 11.3 mt -118.6 155.84 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 108.69 -0.855 . . . . 1.31 108.69 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -118.0 136.07 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 109.936 -0.394 . . . . 1.07 109.936 174.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.33 87.92 2.84 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.24 -1.022 . . . . 1.07 108.24 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.831 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 4.5 mm -66.09 88.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.546 -1.206 . . . . 1.56 109.658 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.12 161.29 18.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.525 -0.176 . . . . 0.88 110.525 -171.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.5 tttm 62.42 29.93 17.24 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.171 0.986 . . . . 3.11 109.402 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.652 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 3.0 tpp -109.97 10.04 24.3 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.689 -1.141 . . . . 1.55 111.041 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.47 ' HB3' ' CB ' ' A' ' 151' ' ' SER . 4.9 p-10 -64.84 43.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.963 0.887 . . . . 2.45 112.873 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.939 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 99.1 mttt -120.77 -163.97 0.05 OUTLIER Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 105.669 -1.974 . . . . 4.11 105.669 166.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.939 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 11.6 Cg_endo -59.58 -53.79 3.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 CA-C-N 120.401 1.179 . . . . 3.16 111.306 164.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.642 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 12.9 pt-20 168.4 127.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.532 0.733 . . . . 4.03 109.261 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.1 -62.36 1.53 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.437 -0.802 . . . . 1.9 109.336 166.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 126' ' ' ARG . 50.5 t30 -177.79 80.53 0.24 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.623 -0.717 . . . . 2.21 110.618 169.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.642 ' CD ' ' HB2' ' A' ' 121' ' ' GLU . 6.4 Cg_endo -47.73 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.178 3.252 . . . . 1.01 113.744 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -46.28 -43.23 15.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.774 0.657 . . . . 2.0 112.774 -175.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.469 ' HB2' ' ND2' ' A' ' 123' ' ' ASN . 4.1 tmt_? -56.94 -53.99 51.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.428 0.632 . . . . 3.7 109.775 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.744 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 47.3 t -60.64 -45.18 97.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.614 -1.176 . . . . 1.12 109.559 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.663 ' HA ' ' CZ ' ' A' ' 147' ' ' PHE . 86.3 mtp -64.2 -32.14 73.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.425 -0.807 . . . . 1.07 111.609 -176.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.507 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.6 mt-30 -83.41 -20.83 33.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.019 0.438 . . . . 2.01 110.283 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.744 ' OE1' ' HA ' ' A' ' 127' ' ' VAL . 3.0 pt-20 -79.05 -27.68 43.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.111 -0.7 . . . . 2.02 109.111 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.61 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.1 mm? -71.72 -42.69 67.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.542 0.687 . . . . 1.62 109.597 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.901 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.6 ppp? -77.11 -2.36 33.85 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.086 -0.961 . . . . 1.08 109.719 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.22 -27.09 35.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.674 -1.232 . . . . 2.18 107.674 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.4 ' CE2' HG11 ' A' ' 92' ' ' VAL . 25.6 m-85 -85.99 4.85 35.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.73 -0.841 . . . . 1.17 108.73 169.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.7 m120 75.11 19.35 2.32 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.203 -1.362 . . . . 2.43 111.126 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.3 mp -97.52 77.72 2.62 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.665 -1.235 . . . . 2.28 107.665 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.531 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.05 129.87 92.3 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 113.559 -1.655 . . . . 1.28 110.799 -176.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.875 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 99.7 Cg_exo -47.16 152.92 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.897 2.398 . . . . 0.34 112.78 172.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -73.65 -29.84 62.57 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.17 -1.377 . . . . 2.01 107.844 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.779 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -49.08 -47.56 44.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.549 -1.205 . . . . 1.18 109.462 168.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.901 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.1 m0 -92.66 -17.65 24.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.967 -1.015 . . . . 0.45 111.2 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.18 19.85 5.77 Favored Glycine 0 CA--C 1.507 -0.41 0 C-N-CA 119.612 -1.28 . . . . 0.45 112.892 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.531 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.12 -113.65 2.23 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.205 -0.998 . . . . 0.5 112.017 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -150.07 19.9 0.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.649 0.24 . . . . 1.3 111.649 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.628 HG22 HG21 ' A' ' 110' ' ' ILE . 23.4 m -125.87 115.09 19.43 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.81 -0.756 . . . . 1.06 112.572 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.704 HG22 ' HB3' ' A' ' 164' ' ' MET . 3.1 mp -84.56 110.73 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.86 110.526 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.875 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.4 m-85 -87.32 121.26 29.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.215 0.531 . . . . 0.38 111.673 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 61.5 m -115.87 103.52 10.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.764 -0.653 . . . . 1.82 110.012 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.831 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 12.1 ptmm? -81.64 84.61 6.74 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.687 -0.857 . . . . 2.94 108.687 172.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.88 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.08 -175.02 2.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.045 -0.98 . . . . 1.89 112.574 -168.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.47 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 34.0 t -150.41 117.96 6.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.88 -1.055 . . . . 2.08 109.687 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 24' ' ' LEU . . . -74.4 -28.78 61.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 1.43 110.777 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 154' ' ' THR . 11.2 ptmm? -77.42 -50.4 12.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.807 0.813 . . . . 3.46 110.58 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.456 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 6.0 m -77.65 -11.69 59.89 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.425 -1.261 . . . . 1.78 111.655 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 71.25 -20.35 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.012 0.745 . . . . 2.75 113.012 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 154' ' ' THR . 10.8 tp10 -43.3 -63.18 0.87 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.617 0.722 . . . . 2.64 111.809 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.88 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.15 -17.69 74.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.329 -0.851 . . . . 0.73 113.663 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 28' ' ' ILE . 40.5 mt -66.45 -46.08 77.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.469 0.635 . . . . 2.12 110.685 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.88 -37.65 88.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.826 -0.625 . . . . 2.5 110.212 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.6 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 78.4 t60 -73.38 -26.02 60.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.84 111.067 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.76 -47.26 75.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.421 -0.585 . . . . 1.54 109.421 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.494 ' O ' HD22 ' A' ' 166' ' ' LEU . 91.5 mt -53.61 -44.0 69.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.802 -0.635 . . . . 1.7 110.642 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.6 ' OE1' ' HA ' ' A' ' 160' ' ' HIS . 45.3 mt-10 -54.99 -43.14 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.068 0.461 . . . . 2.49 110.866 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.84 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 8.4 mmt -71.2 -31.48 67.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 1.29 110.651 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 162' ' ' LEU . 79.7 mt -63.95 -53.02 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 1.24 110.524 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.58 -33.91 70.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.173 0.435 . . . . 2.36 112.173 174.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.67 -41.48 77.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.15 -0.685 . . . . 1.98 109.15 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 38.1 t -79.07 -29.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.867 -0.606 . . . . 1.69 110.86 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 m -57.83 -32.18 67.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.869 0.366 . . . . 2.07 110.626 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.61 -27.78 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 2.79 110.832 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.467 ' HB3' ' HA ' ' A' ' 168' ' ' VAL . 39.2 ttp -70.28 -13.79 62.32 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.327 -0.397 . . . . 2.22 110.233 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 5.2 mm-40 -46.78 -38.16 9.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 3.45 112.045 171.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -76.12 -23.18 54.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.033 0.444 . . . . 3.36 110.908 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 174' ' ' LEU . 52.5 tp -95.25 -0.9 52.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.354 0.597 . . . . 4.51 109.872 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.574 ' HD2' HG21 ' A' ' 79' ' ' THR . 7.9 ttpm? -61.2 105.69 0.52 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.679 -0.692 . . . . 6.66 109.912 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.2 122.09 36.37 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.69 -0.686 . . . . 4.98 111.341 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.725 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 51.4 m-80 -86.0 -51.7 0.47 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.68 -0.691 . . . . 6.96 109.856 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 177' ' ' ASN . 4.4 Cg_exo . . . . . 0 C--O 1.252 1.211 0 C-N-CA 122.67 2.247 . . . . 7.47 111.57 174.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.938 -0.465 . . . . 16.58 111.938 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 5.1 t -82.78 99.06 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.146 -0.687 . . . . 14.94 109.146 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 2' ' ' SER . 83.9 m-70 72.47 127.78 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.868 0.73 . . . . 15.21 110.26 -173.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -78.77 83.75 4.89 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.881 -0.599 . . . . 12.92 111.042 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 m -104.13 -27.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.907 -0.588 . . . . 10.47 110.472 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 35.0 tt0 -107.49 66.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.388 -0.597 . . . . 9.14 109.388 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.818 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 50.1 mtm180 -88.63 -63.36 0.21 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.826 -0.625 . . . . 9.01 111.888 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.818 ' HD3' ' HB2' ' A' ' 7' ' ' ARG . 19.9 Cg_exo -66.05 116.28 3.91 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.41 2.073 . . . . 5.24 111.941 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.764 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 71.8 Cg_endo -70.53 -174.22 1.01 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 123.685 2.923 . . . . 4.88 113.711 -168.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.693 HG13 ' HB ' ' A' ' 58' ' ' THR . 10.6 m -57.42 179.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 122.908 0.483 . . . . 3.08 111.259 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -109.22 133.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 121.476 -0.765 . . . . 1.57 111.175 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.567 HG21 ' HA ' ' A' ' 68' ' ' PHE . 6.7 m -92.95 122.47 35.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.681 -0.69 . . . . 1.18 111.272 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.707 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 33.3 mt -104.47 122.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.866 -0.42 . . . . 1.57 109.866 172.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.56 165.57 19.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.187 -0.461 . . . . 1.41 110.075 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.809 ' HA3' HG11 ' A' ' 85' ' ' VAL . . . 166.27 -107.75 0.3 Allowed Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.486 -1.046 . . . . 1.55 110.486 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.437 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 60.1 t60 -159.21 137.58 10.65 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.431 -0.952 . . . . 1.21 108.431 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -59.93 -31.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.257 -0.883 . . . . 2.2 113.201 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.92 -20.57 52.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.271 . . . . 1.78 111.309 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.437 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 47.8 m170 -70.34 -2.61 14.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.152 0.501 . . . . 0.89 111.282 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.65 43.55 3.89 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.772 -0.728 . . . . 1.06 112.848 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -66.45 -39.42 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.276 0.56 . . . . 2.58 109.823 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -67.01 -36.04 81.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.414 -0.812 . . . . 2.32 109.82 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -67.78 -35.91 79.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.676 -0.693 . . . . 2.23 110.273 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 47.4 tp -65.36 -49.11 70.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.706 . . . . 2.33 110.209 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.642 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -66.96 -32.21 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 2.46 110.051 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 28.6 t70 -66.14 -56.8 9.63 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.171 -0.331 . . . . 1.38 111.481 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.62 70.63 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.07 0.462 . . . . 1.42 110.89 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 158' ' ' LEU . 3.1 tt -74.32 -27.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.839 -0.619 . . . . 2.08 110.644 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.9 mtm180 -80.23 -32.47 38.41 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 4.16 109.807 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -65.62 -8.51 20.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.136 -0.938 . . . . 3.57 109.918 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.44 -41.94 19.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.626 -0.715 . . . . 2.09 109.47 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 40.5 mmtm 61.55 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.595 0.758 . . . . 5.98 112.631 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.723 HG21 HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -146.98 -55.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.736 -0.665 . . . . 3.41 112.742 -174.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.897 HG23 ' HG3' ' A' ' 35' ' ' GLU . 71.6 m -152.25 -78.78 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.602 0.593 . . . . 4.35 112.602 -168.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.897 ' HG3' HG23 ' A' ' 34' ' ' THR . 41.9 mt-10 -118.67 -178.99 3.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.003 0.43 . . . . 4.2 111.921 -173.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 1.035 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 24.0 pt20 -151.02 162.69 40.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.362 -0.977 . . . . 6.16 108.362 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 11.8 tp10 -156.87 173.77 16.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.847 0.356 . . . . 5.79 111.221 -169.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . . . -95.64 115.41 27.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 4.64 110.33 175.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.09 -146.3 15.76 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.666 -0.574 . . . . 4.95 111.666 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.49 -66.83 1.6 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.18 -0.533 . . . . 6.66 112.655 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.13 -46.65 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.237 0.542 . . . . 9.5 110.257 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 43' ' ' GLN . 23.4 m -156.01 168.25 27.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.985 -1.117 . . . . 7.68 107.985 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.473 ' H ' HG23 ' A' ' 42' ' ' THR . 14.0 pt20 -75.76 26.08 0.11 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.758 0.651 . . . . 9.39 112.758 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.66 -172.73 2.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.918 -1.512 . . . . 7.29 106.918 164.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 13.8 tt -72.58 153.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 118.786 -1.165 . . . . 5.6 109.127 172.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.633 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . 152.18 -12.51 0.7 Allowed Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.319 -0.943 . . . . 3.5 112.894 -174.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . . . -92.0 -172.33 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.507 -0.553 . . . . 2.15 109.507 175.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.035 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.2 p90 -168.61 177.47 5.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.8 -0.445 . . . . 2.96 109.8 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.797 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 71.8 mt-30 -139.07 113.36 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.136 -1.061 . . . . 2.45 108.136 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HE2' ' A' ' 48' ' ' TYR . 4.6 p -97.07 155.06 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.976 0.893 . . . . 2.49 111.914 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.6 m -130.0 83.94 2.17 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.18 -1.373 . . . . 2.26 110.243 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.649 ' C ' ' H ' ' A' ' 54' ' ' ASP . 70.0 t -123.68 122.87 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.189 -1.412 . . . . 4.49 107.189 171.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 23.6 t-20 75.96 -26.74 0.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 122.473 1.13 . . . . 4.58 109.724 -172.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.649 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.8 t70 85.62 66.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.377 -2.192 . . . . 3.62 111.596 173.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.731 ' HD2' ' HB3' ' A' ' 166' ' ' LEU . 42.5 mttp -115.75 3.65 13.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.149 -0.932 . . . . 7.78 109.486 170.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.1 mttp 52.2 45.71 27.92 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.211 -1.359 . . . . 5.81 111.455 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 HD11 ' A' ' 166' ' ' LEU . 4.8 mt -59.08 115.52 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.859 . . . . 1.4 111.415 -171.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.693 ' HB ' HG13 ' A' ' 10' ' ' VAL . 16.9 m -92.64 125.65 37.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.154 -0.684 . . . . 1.85 109.154 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -100.94 116.46 32.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.461 0.541 . . . . 1.14 112.461 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 13' ' ' ILE . 86.1 mt 58.73 56.28 4.25 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.722 -1.126 . . . . 3.46 113.309 170.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' C ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 t70 -71.37 93.96 1.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.553 -0.906 . . . . 6.48 108.553 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.444 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 2.9 p -126.0 65.33 55.35 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.093 0.775 . . . . 5.89 113.093 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD3' ' C ' ' A' ' 61' ' ' ASP . 55.5 Cg_endo -102.19 37.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.446 2.764 . . . . 5.92 111.138 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.81 35.4 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.705 -0.759 . . . . 5.92 112.02 -174.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.48 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 30.5 m170 -127.09 -77.26 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.729 -0.841 . . . . 8.81 108.729 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 62' ' ' THR . 1.3 mp0 62.24 178.36 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.975 -1.012 . . . . 6.36 112.449 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 54.05 -105.87 0.28 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.005 -0.998 . . . . 3.89 111.705 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.691 ' CE1' ' HG2' ' A' ' 71' ' ' MET . 24.1 t80 -138.46 84.48 2.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 2.61 110.037 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 65' ' ' HIS . 7.1 p -140.96 145.01 35.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.843 -0.617 . . . . 5.11 110.115 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.764 ' HB ' ' HB2' ' A' ' 9' ' ' PRO . 38.1 p 54.35 97.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.886 0.741 . . . . 6.34 112.335 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.691 ' HG2' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -147.39 107.57 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.248 0.833 . . . . 5.64 113.248 -175.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' HA ' HG13 ' A' ' 81' ' ' ILE . 17.4 tpt180 -173.43 -55.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.457 -0.338 . . . . 10.31 111.818 169.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.47 -76.89 0.05 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 111.916 0.339 . . . . 7.85 111.916 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -162.8 113.34 1.46 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.925 0.49 . . . . 11.11 110.531 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 9' ' ' PRO . . . 156.45 -135.9 4.72 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.77 -0.729 . . . . 6.78 112.614 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.608 ' HA ' ' HB3' ' A' ' 9' ' ' PRO . . . -162.89 106.8 1.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.484 0.313 . . . . 7.11 110.599 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.598 ' O ' ' HG3' ' A' ' 9' ' ' PRO . 25.8 tt0 -174.46 154.57 2.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.723 0.297 . . . . 8.32 110.315 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -79.63 103.75 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.638 -0.505 . . . . 4.75 109.638 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -127.41 -147.19 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.046 -0.524 . . . . 4.44 109.77 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.579 ' HB2' ' HB ' ' A' ' 108' ' ' VAL . 5.5 p-10 -153.21 103.51 2.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.613 0.598 . . . . 3.12 112.613 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 72' ' ' ARG . 15.6 mm -151.76 113.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.933 -0.576 . . . . 1.31 109.649 170.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 103' ' ' ALA . 99.0 t -118.86 101.58 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 O-C-N 122.173 -0.329 . . . . 1.78 111.101 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.707 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 7.0 mm -79.03 121.28 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.776 -1.194 . . . . 1.97 107.776 170.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -118.75 103.59 9.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.16 -0.473 . . . . 1.98 110.855 -176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.809 HG11 ' HA3' ' A' ' 15' ' ' GLY . 6.6 p -89.24 146.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.294 0.568 . . . . 1.8 112.09 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 114' ' ' ILE . 21.5 m -141.59 -175.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.926 -1.033 . . . . 1.79 108.223 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.47 134.37 13.0 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.341 -0.544 . . . . 1.03 112.078 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 122' ' ' ALA . . . 51.47 -125.21 2.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.295 -0.866 . . . . 1.66 112.146 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -105.3 5.17 31.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.92 0.39 . . . . 2.01 110.022 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.78 -32.64 71.96 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.57 0.7 . . . . 1.09 109.75 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.757 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 68.42 -134.74 28.77 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 114.706 -1.133 . . . . 0.52 111.677 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.701 HG11 ' HB ' ' A' ' 96' ' ' THR . 64.2 t -102.32 103.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.145 0.498 . . . . 1.67 111.033 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.603 ' HE2' ' HD2' ' A' ' 94' ' ' PRO . 83.4 mmm -72.77 170.74 12.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 1.32 110.631 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.603 ' HD2' ' HE2' ' A' ' 93' ' ' MET . 72.4 Cg_exo -42.69 -51.21 5.4 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.789 2.326 . . . . 0.88 113.09 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.02 -37.87 89.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.841 0.353 . . . . 2.01 110.717 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.701 ' HB ' HG11 ' A' ' 92' ' ' VAL . 3.1 m -62.18 -35.27 78.32 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.965 -0.562 . . . . 1.19 110.376 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.697 HG21 HG12 ' A' ' 92' ' ' VAL . 41.1 t -74.15 -50.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.152 -0.476 . . . . 1.66 110.688 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.52 -31.22 34.44 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.547 0.53 . . . . 1.62 111.528 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.03 -37.86 28.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 1.09 109.895 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.753 HG12 HD12 ' A' ' 110' ' ' ILE . 1.5 mt -75.45 -37.66 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.646 -0.706 . . . . 1.13 110.47 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -34.93 68.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.731 0.776 . . . . 1.97 109.737 174.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 28.3 t60 -85.15 -30.65 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.831 -1.077 . . . . 1.02 110.551 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.943 ' HB3' HG21 ' A' ' 82' ' ' VAL . . . -82.41 -49.2 10.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.168 -0.469 . . . . 1.18 111.9 -173.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -53.08 -27.24 19.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.39 0.885 . . . . 2.98 113.39 -166.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.1 10.87 36.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.079 0.77 . . . . 1.3 113.079 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB1' ' CG1' ' A' ' 108' ' ' VAL . . . -97.57 2.37 49.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.213 -0.662 . . . . 1.3 109.213 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t30 71.3 46.64 0.42 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 123.11 1.433 . . . . 2.59 107.831 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.824 HG23 HG22 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -129.5 143.06 47.43 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 112.809 -1.996 . . . . 1.71 111.194 -168.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.516 ' O ' HG22 ' A' ' 108' ' ' VAL . 21.9 Cg_exo -67.26 156.41 66.38 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.486 2.124 . . . . 0.62 112.982 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.753 HD12 HG12 ' A' ' 100' ' ' ILE . 85.1 mt -124.48 141.85 43.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.702 -1.135 . . . . 1.62 109.201 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 3.7 mt -125.93 96.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 C-N-CA 120.35 -0.54 . . . . 1.31 111.238 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -65.82 139.82 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.005 -0.998 . . . . 1.07 110.265 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.474 ' HB3' HG21 ' A' ' 85' ' ' VAL . . . -124.02 89.37 3.07 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.868 -1.16 . . . . 1.07 107.868 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 9.7 mm -65.92 86.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.565 -1.198 . . . . 1.56 110.197 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.05 148.45 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.88 110.721 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 60.63 33.31 20.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.404 -0.817 . . . . 3.11 110.758 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 117' ' ' MET . 1.4 ppp? -87.73 -0.74 57.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.812 -0.631 . . . . 1.55 110.007 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.17 -33.78 20.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.973 -1.012 . . . . 2.45 111.639 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.553 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 18.0 pttp -120.61 158.23 52.16 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.264 . . . . 4.11 110.718 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 5.2 Cg_endo -48.58 -4.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 1 C-N-CA 125.749 4.299 . . . . 3.16 117.044 -171.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -21.54 65.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 4.03 110.125 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 88' ' ' ALA . . . -98.53 127.87 44.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.598 -0.728 . . . . 1.9 110.4 173.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 16.4 t-20 -124.45 89.38 52.19 Favored Pre-proline 0 CA--C 1.51 -0.583 0 CA-C-O 121.228 0.537 . . . . 2.21 111.016 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.503 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -16.12 -82.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.119 1 C-N-CA 126.301 4.667 . . . . 1.01 116.579 172.73 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -43.81 -55.31 4.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.345 0.658 . . . . 2.0 112.344 -169.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 tpt85 -56.17 -62.16 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.401 0.62 . . . . 3.7 110.786 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.757 HG12 ' HA2' ' A' ' 91' ' ' GLY . 28.1 t -51.82 -49.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.441 -1.254 . . . . 1.12 110.489 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.742 ' HE1' ' HG3' ' A' ' 140' ' ' GLU . 86.5 mtp -66.45 -33.04 74.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 1.07 111.96 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 132' ' ' MET . 87.0 mt-30 -76.38 -26.2 55.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.813 -0.44 . . . . 2.01 109.813 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.447 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -71.12 -31.11 67.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.239 -0.652 . . . . 2.02 109.239 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.885 HD12 HD11 ' A' ' 136' ' ' LEU . 2.8 mm? -68.54 -46.31 69.86 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.506 0.669 . . . . 1.62 109.716 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.867 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.3 ppp? -73.31 -4.57 34.12 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.392 -0.822 . . . . 1.08 110.0 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -81.77 -24.63 35.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.039 -0.726 . . . . 2.18 109.039 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.568 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 39.5 m-85 -84.75 0.61 50.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.896 . . . . 1.17 108.582 167.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 74.14 45.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 113.967 -1.47 . . . . 2.43 109.464 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.885 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -126.19 83.36 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.028 -1.442 . . . . 2.28 107.439 170.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.851 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.23 131.42 94.35 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.592 -1.64 . . . . 1.28 111.28 -173.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.742 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 87.5 Cg_exo -49.87 155.47 4.1 Favored 'Trans proline' 0 CA--C 1.516 -0.377 0 C-N-CA 123.315 2.677 . . . . 0.34 113.705 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HG3' HG13 ' A' ' 146' ' ' ILE . 6.8 mm-40 -80.17 -19.18 47.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.53 -1.214 . . . . 2.01 109.268 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.816 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -58.24 -40.17 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.501 -0.926 . . . . 1.18 108.501 167.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.867 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.3 m0 -96.71 -21.43 17.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.384 -1.28 . . . . 0.45 110.841 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.49 25.22 5.84 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.372 -0.918 . . . . 0.45 112.43 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.851 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.47 -101.11 1.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.721 -0.752 . . . . 0.5 112.612 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -165.11 27.01 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.244 0.545 . . . . 1.3 111.114 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.715 HG22 HD13 ' A' ' 136' ' ' LEU . 62.2 m -130.17 116.85 19.03 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.241 -0.584 . . . . 1.06 112.389 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.742 HG12 HG22 ' A' ' 168' ' ' VAL . 4.0 mp -82.14 109.04 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 1.86 110.546 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.742 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.9 m-85 -89.54 96.24 10.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.984 0.421 . . . . 0.38 111.186 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.437 ' O ' HD12 ' A' ' 150' ' ' LEU . 75.1 m -84.32 99.55 10.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.313 -0.625 . . . . 1.82 109.313 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.609 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 2.4 pttm -82.83 84.16 7.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.552 -0.907 . . . . 2.94 108.552 176.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.567 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.44 -179.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.298 -0.865 . . . . 1.89 112.97 -168.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p -152.94 111.28 3.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 2.08 110.156 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.95 64.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.362 -0.381 . . . . 1.43 111.237 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -75.14 -46.91 31.27 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.896 0.855 . . . . 3.46 110.15 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m -72.62 -14.78 61.68 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.251 -1.34 . . . . 1.78 110.397 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tptp 58.61 27.33 15.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.499 -1.228 . . . . 2.75 111.576 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -92.35 -67.43 0.86 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.534 0.683 . . . . 2.64 110.266 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.567 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.02 -13.04 69.26 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.248 -0.887 . . . . 0.73 113.55 -176.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 28' ' ' ILE . 3.3 tm? -60.54 -54.44 45.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 2.12 109.38 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.29 -33.75 76.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.293 -0.867 . . . . 2.5 109.89 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.7 t60 -65.38 -25.98 67.8 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.666 -0.697 . . . . 0.84 111.075 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 165' ' ' ILE . 59.7 tp -66.59 -55.4 15.54 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.002 -0.369 . . . . 1.54 110.002 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 165' ' ' ILE . 92.1 mt -55.9 -41.6 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 1.7 110.723 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.676 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 6.4 pt-20 -69.48 -27.73 65.46 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.598 -0.441 . . . . 2.49 110.61 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG2' HG22 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -81.3 -32.2 33.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 1.29 109.821 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 162' ' ' LEU . 32.6 mt -55.41 -54.63 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.361 -0.836 . . . . 1.24 111.896 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.731 ' HB3' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.2 -30.06 34.39 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.748 -0.595 . . . . 2.36 111.969 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 171' ' ' MET . 10.3 tt -59.53 -31.56 69.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.849 -0.426 . . . . 1.98 109.849 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.742 HG22 HG12 ' A' ' 146' ' ' ILE . 25.2 t -87.37 -41.28 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.941 -0.572 . . . . 1.69 111.283 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.54 ' HG ' ' HA ' ' A' ' 166' ' ' LEU . 4.7 p -64.04 -24.17 67.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.317 . . . . 2.07 111.477 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.74 -21.69 18.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.644 0.259 . . . . 2.79 110.952 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 167' ' ' LEU . 55.9 ttp -68.82 -42.44 77.24 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.941 -0.392 . . . . 2.22 109.941 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 25.7 mm-40 -50.3 -31.36 14.16 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.946 0.779 . . . . 3.45 112.62 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.63 -34.86 65.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.142 0.496 . . . . 3.36 110.623 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -103.9 -49.56 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.956 -0.757 . . . . 4.51 108.956 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.414 ' HB3' ' H ' ' A' ' 176' ' ' ALA . 50.8 tptt 61.54 -86.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.634 -1.166 . . . . 6.66 111.123 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 175' ' ' LYS . . . -157.46 146.75 20.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.586 -0.734 . . . . 4.98 109.26 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -110.69 132.52 21.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.357 . . . . 6.96 110.035 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--O 1.25 1.103 0 C-N-CA 122.982 2.455 . . . . 7.47 111.932 178.822 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.867 -0.493 . . . . 16.58 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -77.62 67.12 3.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.343 0.592 . . . . 14.94 111.808 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -121.79 71.33 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.552 -0.907 . . . . 15.21 108.552 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.0 mmm -85.7 69.86 10.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.048 -0.524 . . . . 12.92 110.628 -171.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.98 35.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 10.47 111.151 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.35 -45.22 80.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 9.14 110.607 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -67.99 118.67 60.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.678 -0.692 . . . . 9.01 111.534 -174.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 18.0 Cg_endo -96.62 145.45 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.651 2.901 . . . . 5.24 111.316 172.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.13 128.75 21.27 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.243 1.962 . . . . 4.88 111.969 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.451 ' CG2' HG23 ' A' ' 79' ' ' THR . 5.3 m -77.67 81.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.945 0.879 . . . . 3.08 110.626 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.915 HG12 HG21 ' A' ' 81' ' ' ILE . 45.2 t -72.53 98.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.816 -1.084 . . . . 1.57 109.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 83' ' ' ILE . 19.3 m -80.42 128.09 33.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 1.18 111.452 -171.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.626 HG12 HD11 ' A' ' 83' ' ' ILE . 52.1 mt -94.95 128.52 46.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.041 -0.527 . . . . 1.57 110.271 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.59 ' SD ' ' HB3' ' A' ' 99' ' ' ALA . 55.6 mtt -125.29 -177.94 4.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 1.41 110.459 177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.92 130.44 4.45 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.504 -0.855 . . . . 1.55 110.984 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -50.69 138.38 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.512 . . . . 1.21 110.4 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.427 ' HA ' ' CG ' ' A' ' 21' ' ' LYS . 30.3 m -61.63 -27.5 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.871 1.063 . . . . 2.2 113.871 -167.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.31 -19.16 60.57 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.025 0.38 . . . . 1.78 112.025 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -72.01 -34.26 68.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.761 0.282 . . . . 0.89 111.761 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.58 67.63 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.392 -0.909 . . . . 1.06 112.75 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' A' ' 13' ' ' ILE . 14.0 mmmm -89.03 -56.33 3.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.067 0.461 . . . . 2.58 111.128 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -65.91 -18.08 65.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 2.32 110.799 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 p -74.75 -19.94 60.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.127 -0.488 . . . . 2.23 111.011 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 68.0 mt -69.01 -52.19 31.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.715 -0.394 . . . . 2.33 110.307 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 8.7 mp -60.32 -34.09 73.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 2.46 110.973 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.74 -51.38 41.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.882 0.327 . . . . 1.38 111.882 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -69.6 -33.33 72.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.007 0.432 . . . . 1.42 111.008 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -66.06 -24.21 33.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.996 -0.547 . . . . 2.08 110.54 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 51.5 mtp180 -79.09 -21.65 46.39 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.215 0.531 . . . . 4.16 110.636 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -71.78 -7.74 50.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.718 0.77 . . . . 3.57 109.647 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.74 18.37 21.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.966 -1.016 . . . . 2.09 110.172 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' HG13 ' A' ' 33' ' ' VAL . 59.8 mttp 53.31 -133.42 1.81 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.795 -0.817 . . . . 5.98 108.795 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.857 HG21 ' HB ' ' A' ' 51' ' ' THR . 2.9 p 53.3 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.135 0.897 . . . . 3.41 112.981 167.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.516 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -109.99 115.89 30.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.382 0.611 . . . . 4.35 111.453 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.63 -42.28 12.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.045 -0.98 . . . . 4.2 110.049 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.699 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 41.9 mt-30 71.14 10.9 6.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.972 -1.013 . . . . 6.16 112.961 170.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.14 103.24 15.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.029 -0.268 . . . . 5.79 110.747 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.17 77.67 0.21 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.904 0.752 . . . . 4.64 112.374 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' A' ' 48' ' ' TYR . . . -82.98 56.08 5.06 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.612 -0.804 . . . . 4.95 112.475 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.95 47.12 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.513 -0.851 . . . . 6.66 112.421 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.6 -43.54 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 9.5 110.431 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.596 HG21 ' HD2' ' A' ' 44' ' ' HIS . 6.2 m -80.42 114.39 19.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.403 -0.592 . . . . 7.68 109.403 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.31 93.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.416 0.627 . . . . 9.39 111.596 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.596 ' HD2' HG21 ' A' ' 42' ' ' THR . 29.1 m-70 -141.96 151.88 42.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.317 -0.856 . . . . 7.29 108.887 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.27 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 5.6 110.704 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.78 -46.67 1.2 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.864 -0.894 . . . . 3.5 110.864 -174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.78 169.25 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.708 -0.849 . . . . 2.15 108.708 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.699 ' HB2' ' HA ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -153.18 151.15 29.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.989 -0.684 . . . . 2.96 111.045 -169.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.13 153.97 21.86 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.39 -0.823 . . . . 2.45 108.857 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 33' ' ' VAL . 71.7 t -92.9 172.05 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.468 -0.787 . . . . 2.49 109.259 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.857 ' HB ' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -51.94 161.05 0.62 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.365 1.078 . . . . 2.26 113.605 -167.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.1 p -101.32 127.73 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-N 115.231 -0.895 . . . . 4.49 110.85 -163.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.54 -31.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.204 0.94 . . . . 4.58 110.845 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.776 ' HB3' ' CG2' ' A' ' 51' ' ' THR . 31.4 t70 -85.85 -45.95 11.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.584 -0.28 . . . . 3.62 111.004 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HG3' HG23 ' A' ' 33' ' ' VAL . 49.9 mmtm -133.74 73.09 1.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.17 -0.612 . . . . 7.78 111.659 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.29 84.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 5.81 111.954 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.656 HG21 HG21 ' A' ' 11' ' ' VAL . 48.3 mt -139.59 127.86 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 1.4 110.18 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -105.75 131.71 52.77 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.172 -0.677 . . . . 1.85 109.172 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' HE2' HG22 ' A' ' 50' ' ' VAL . 43.7 m-85 -116.46 110.53 18.74 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.979 -0.688 . . . . 1.14 111.104 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD23 ' SD ' ' A' ' 71' ' ' MET . 44.3 tp -117.16 114.48 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.763 -0.653 . . . . 3.46 110.106 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.41 131.36 54.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.538 -0.912 . . . . 6.48 108.538 171.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.97 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 19.9 m -119.3 97.32 50.33 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.396 -0.365 . . . . 5.89 110.934 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.52 44.65 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.262 2.641 . . . . 5.92 111.393 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.7 69.77 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.507 -0.77 . . . . 5.92 111.241 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.2 m170 70.18 -71.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.55 0.74 . . . . 8.81 111.001 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.39 130.92 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 6.36 110.093 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.97 ' HA ' ' HB ' ' A' ' 62' ' ' THR . . . -69.72 -26.89 64.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 3.89 111.977 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -84.35 68.0 10.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.806 0.336 . . . . 2.61 110.629 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.8 m -126.53 123.29 37.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.351 -0.386 . . . . 5.11 110.828 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 p 50.29 37.09 14.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.497 0.719 . . . . 6.34 112.776 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.578 ' SD ' HD23 ' A' ' 60' ' ' LEU . 47.4 ttp -136.55 110.6 8.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.457 . . . . 5.64 111.503 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -139.56 19.65 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.72 . . . . 10.31 109.685 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 74' ' ' ARG . . . 58.98 -164.52 0.2 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.216 -0.902 . . . . 7.85 110.385 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 73' ' ' ALA . 36.9 mmt180 -126.85 29.05 5.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.442 -0.577 . . . . 11.11 109.442 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.85 -173.84 22.04 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.525 -0.761 . . . . 6.78 112.146 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 75.08 -59.8 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.763 0.825 . . . . 7.11 112.692 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -111.38 152.88 26.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.853 0.359 . . . . 8.32 111.159 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -75.69 147.61 7.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.78 -0.645 . . . . 4.75 111.278 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.451 HG23 ' CG2' ' A' ' 10' ' ' VAL . 39.8 p -111.2 0.28 16.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 4.44 110.679 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.633 ' HB3' ' HB ' ' A' ' 108' ' ' VAL . 47.4 m-20 -86.89 61.85 7.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 3.12 111.188 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.915 HG21 HG12 ' A' ' 11' ' ' VAL . 23.8 mm -133.15 111.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.924 -0.58 . . . . 1.31 110.308 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' CB ' ' A' ' 103' ' ' ALA . 53.5 t -117.28 106.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 116.331 -0.395 . . . . 1.78 110.818 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.831 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -90.5 105.15 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.222 -0.659 . . . . 1.97 109.222 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.608 HD23 HD12 ' A' ' 100' ' ' ILE . 11.3 tp -90.34 109.65 20.75 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.289 -0.414 . . . . 1.98 111.361 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.2 t -80.89 130.91 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 1.8 110.953 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -131.36 -174.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.585 -0.894 . . . . 1.79 108.585 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.543 ' HB2' ' HD2' ' A' ' 116' ' ' LYS . . . -147.74 129.73 15.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.981 -0.687 . . . . 1.03 112.564 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 20.89 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.16 1.538 . . . . 1.66 114.97 169.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.95 -2.57 22.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.693 -0.685 . . . . 2.01 112.11 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -32.91 24.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.08 0.467 . . . . 1.09 110.725 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.687 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 69.77 -120.6 9.99 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.453 -0.794 . . . . 0.52 111.805 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.69 HG13 HG23 ' A' ' 97' ' ' VAL . 58.7 t -124.21 109.77 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 120.847 0.356 . . . . 1.67 110.693 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.546 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 67.5 mtp -77.29 169.01 23.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 1.32 110.569 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.5 Cg_exo -44.79 -51.23 7.59 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.037 2.491 . . . . 0.88 113.417 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -66.78 -29.72 69.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.629 0.252 . . . . 2.01 111.366 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.584 ' HB ' HG12 ' A' ' 92' ' ' VAL . 4.4 m -69.47 -28.05 65.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.564 0.697 . . . . 1.19 109.467 174.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG23 HG13 ' A' ' 92' ' ' VAL . 12.4 t -76.69 -52.24 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.66 111.078 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -65.02 -19.24 65.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.04 0.385 . . . . 1.62 112.04 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HB3' ' SD ' ' A' ' 14' ' ' MET . . . -73.62 -37.36 65.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.203 -1.036 . . . . 1.09 108.203 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.805 HG12 HD12 ' A' ' 110' ' ' ILE . 2.8 mt -76.63 -41.16 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 113.969 -1.469 . . . . 1.13 110.727 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 98' ' ' GLU . 7.2 m-20 -54.04 -37.96 64.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.374 0.607 . . . . 1.97 110.367 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -74.85 -31.9 61.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 1.02 110.501 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.608 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -82.79 -48.62 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.447 . . . . 1.18 111.949 -175.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -56.86 -34.37 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.398 -0.819 . . . . 2.98 111.985 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.23 10.16 37.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.365 0.506 . . . . 1.3 112.365 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 108' ' ' VAL . . . -104.39 5.87 34.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.151 -1.055 . . . . 1.3 108.151 169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.0 38.25 6.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.448 -1.251 . . . . 2.59 110.317 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 80' ' ' ASP . 2.0 m -105.68 148.48 36.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.57 -0.741 . . . . 1.71 110.95 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.93 155.27 62.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.098 2.532 . . . . 0.62 113.09 171.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.805 HD12 HG12 ' A' ' 100' ' ' ILE . 68.8 mt -125.91 145.92 32.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.107 -0.951 . . . . 1.62 110.259 -174.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.831 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 mt -120.47 155.93 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 109.24 -0.652 . . . . 1.31 109.24 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -120.32 137.3 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 120.997 0.427 . . . . 1.07 110.403 174.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.03 88.42 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.91 -1.145 . . . . 1.07 107.91 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 86' ' ' VAL . 30.3 mt -72.51 97.02 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.956 -1.02 . . . . 1.56 110.487 178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.56 165.45 15.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.69 -0.485 . . . . 0.88 109.69 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 87' ' ' ALA . 63.0 mttm 64.35 19.24 11.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.324 0.583 . . . . 3.11 110.896 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.864 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.3 tpp -87.55 -4.45 58.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.646 -0.706 . . . . 1.55 110.949 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.78 0.74 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.87 -0.605 . . . . 2.45 112.469 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.615 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 22.1 mtpp -73.78 -176.4 0.49 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.313 -0.995 . . . . 4.11 108.313 167.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 37.1 Cg_exo -57.29 -49.77 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 CA-C-N 119.922 1.008 . . . . 3.16 110.163 169.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 6.4 pt-20 160.22 130.34 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.204 -1.406 . . . . 4.03 107.204 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -66.52 -61.15 2.14 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.012 -1.107 . . . . 1.9 108.012 166.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 3.3 t-20 168.75 91.4 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 114.641 -1.163 . . . . 2.21 109.838 166.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.566 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.8 Cg_exo -39.54 -60.01 0.59 Allowed 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.876 3.051 . . . . 1.01 112.77 172.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.8 -52.92 7.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.776 0.43 . . . . 2.0 111.53 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.566 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -54.97 -59.71 4.37 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.875 0.369 . . . . 3.7 110.061 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.687 HG11 ' HA2' ' A' ' 91' ' ' GLY . 60.3 t -53.99 -44.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.266 -0.879 . . . . 1.12 110.831 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.664 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.6 mtp -68.17 -31.83 71.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.641 -0.709 . . . . 1.07 111.184 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.6 mt-30 -73.68 -26.87 60.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.458 -0.337 . . . . 2.01 110.621 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.1 mm-40 -62.52 -39.85 94.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.551 -0.907 . . . . 2.02 108.551 172.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.852 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -68.25 -42.95 78.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.55 0.69 . . . . 1.62 110.062 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.836 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -76.03 -5.87 48.43 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.346 -0.843 . . . . 1.08 110.107 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -82.32 -26.28 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.886 -0.783 . . . . 2.18 108.886 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.617 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 13.5 m-85 -84.6 -0.41 53.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.282 -1.007 . . . . 1.17 108.282 168.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 72.18 42.67 0.56 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 113.931 -1.486 . . . . 2.43 110.44 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -121.8 82.73 1.99 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 106.479 -1.674 . . . . 2.28 106.479 168.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.583 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -63.33 131.59 94.84 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.002 -1.454 . . . . 1.28 110.773 -172.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.748 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 86.7 Cg_exo -46.52 151.74 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.879 2.386 . . . . 0.34 112.894 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -25.74 53.71 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.25 -1.341 . . . . 2.01 108.335 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.746 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.35 -43.0 64.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.258 -1.337 . . . . 1.18 109.435 167.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.836 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.1 m0 -94.56 -26.0 16.58 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.879 -1.055 . . . . 0.45 111.218 -170.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.46 25.3 2.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.943 -1.123 . . . . 0.45 112.583 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.88 -111.79 2.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.5 -0.857 . . . . 0.5 112.573 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -151.01 21.99 0.77 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.679 0.276 . . . . 1.3 111.606 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 36.4 m -125.78 118.79 26.3 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.932 -0.707 . . . . 1.06 112.743 -172.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 164' ' ' MET . 4.0 mp -85.44 108.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.86 110.554 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.748 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.3 m-85 -88.83 119.38 29.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.199 0.523 . . . . 0.38 111.486 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 56.8 m -114.93 121.75 44.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.68 -0.691 . . . . 1.82 109.557 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.864 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 58.2 pttt -97.15 104.37 16.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.302 -0.629 . . . . 2.94 109.302 174.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.488 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -125.47 -170.88 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.36 1.076 . . . . 1.89 113.07 -171.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.418 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 30.2 t -169.87 126.92 0.87 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.4 -1.727 . . . . 2.08 108.252 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.12 -12.37 59.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.072 0.463 . . . . 1.43 111.083 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -84.93 -57.13 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 3.46 110.174 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 28.4 p -81.53 -17.6 47.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.13 -0.941 . . . . 1.78 110.51 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HE3' ' O ' ' A' ' 27' ' ' ALA . 6.5 tptm 74.22 -11.98 0.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.905 0.753 . . . . 2.75 112.311 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -44.17 -70.11 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.499 0.72 . . . . 2.64 112.86 -174.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -73.6 -5.62 68.87 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.73 113.872 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.494 HD13 ' HE2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -73.36 -45.46 54.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.0 -0.741 . . . . 2.12 109.0 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.69 -36.53 76.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 2.5 109.889 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.422 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 82.4 t60 -70.72 -20.21 62.68 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.862 -0.608 . . . . 0.84 110.812 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.04 -49.62 42.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.843 0.354 . . . . 1.54 110.123 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.475 HD22 HD11 ' A' ' 28' ' ' ILE . 98.4 mt -58.2 -37.48 74.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.708 -0.678 . . . . 1.7 111.384 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -70.02 -36.37 75.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.798 -0.361 . . . . 2.49 110.67 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.751 ' HB3' HG22 ' A' ' 146' ' ' ILE . 22.0 mmt -69.06 -38.56 79.15 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.24 0.543 . . . . 1.29 109.72 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.51 -52.27 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.239 -0.891 . . . . 1.24 110.514 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.35 -42.5 98.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.986 -0.552 . . . . 2.36 111.491 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.2 -45.99 65.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.807 -0.633 . . . . 1.98 110.0 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.45 -26.44 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.101 -0.5 . . . . 1.69 111.315 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.9 m -61.24 -27.38 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.968 0.413 . . . . 2.07 110.443 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.23 -35.9 10.21 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.274 -0.421 . . . . 2.79 111.028 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.587 ' HE1' ' HG ' ' A' ' 174' ' ' LEU . 24.0 ttp -85.66 5.53 31.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 2.22 111.675 -175.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -32.83 -40.56 0.05 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.319 1.229 . . . . 3.45 114.319 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -76.01 4.77 7.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 3.36 112.38 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.587 ' HG ' ' HE1' ' A' ' 171' ' ' MET . 2.0 tm? -36.26 -80.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.653 0.781 . . . . 4.51 112.303 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.481 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.9 mptm? 53.17 -173.94 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.717 0.636 . . . . 6.66 112.717 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 59.95 74.26 0.45 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.484 -0.78 . . . . 4.98 112.871 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 178' ' ' PRO . 43.0 t30 -117.92 112.39 38.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.864 -0.421 . . . . 6.96 109.864 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 177' ' ' ASN . 11.8 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 123.339 2.693 . . . . 7.47 112.502 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.883 -0.487 . . . . 16.58 111.883 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 m -89.97 132.35 35.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.752 0.31 . . . . 14.94 110.453 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -76.61 78.77 3.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.834 0.35 . . . . 15.21 110.674 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 ttt -61.9 -37.89 86.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.657 -0.701 . . . . 12.92 110.205 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.0 m -99.62 137.51 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.524 -0.762 . . . . 10.47 109.95 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -86.13 59.15 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.534 0.683 . . . . 9.14 109.954 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -118.12 95.88 48.93 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.273 -0.876 . . . . 9.01 110.001 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.25 130.16 27.8 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.302 2.002 . . . . 5.24 110.967 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.33 118.22 5.06 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.038 2.492 . . . . 4.88 112.156 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 17.9 m -84.63 140.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.023 -0.535 . . . . 3.08 110.683 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.898 HG23 ' HB ' ' A' ' 81' ' ' ILE . 56.2 t -116.3 100.41 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.69 -0.686 . . . . 1.57 109.281 176.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -82.59 120.6 25.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 1.18 111.557 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.544 HD11 ' HG ' ' A' ' 25' ' ' LEU . 42.7 mt -78.97 121.03 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 1.57 109.711 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 19.5 mmt -110.97 176.75 4.9 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.158 -0.928 . . . . 1.41 109.938 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 1.091 ' HA3' HG11 ' A' ' 85' ' ' VAL . . . 123.26 136.05 4.7 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.341 -0.933 . . . . 1.55 111.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 67.6 t60 -45.62 136.27 6.01 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.646 0.736 . . . . 1.21 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.79 -35.27 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.331 -1.304 . . . . 2.2 113.45 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.28 -18.48 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 1.78 111.095 -175.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -71.33 -12.22 61.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.182 0.515 . . . . 0.89 110.766 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.47 45.77 6.75 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.506 -0.77 . . . . 1.06 113.34 172.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HA ' HD22 ' A' ' 24' ' ' LEU . 58.7 pttt -67.46 -26.33 66.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 2.58 110.835 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -67.7 -28.56 67.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 2.32 110.324 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 90.5 m -68.16 -28.17 67.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.89 -0.596 . . . . 2.23 111.039 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.655 HD22 ' HA ' ' A' ' 21' ' ' LYS . 3.9 mm? -62.51 -51.12 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 2.33 110.4 176.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HA ' HG22 ' A' ' 28' ' ' ILE . 6.6 mt -72.3 -25.65 61.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 2.46 111.474 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.624 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 20.9 t70 -68.39 -49.07 62.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.502 -0.317 . . . . 1.38 111.356 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.06 73.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.932 0.396 . . . . 1.42 110.683 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 162' ' ' LEU . 4.7 tt -76.71 -33.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.867 -0.606 . . . . 2.08 110.945 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 15.3 ptt180 -75.19 -32.23 61.17 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.742 0.782 . . . . 4.16 109.729 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -82.11 15.58 2.3 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.469 -1.242 . . . . 3.57 111.641 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 t -135.28 -65.1 0.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.862 0.363 . . . . 2.09 111.278 -173.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' HB2' HG13 ' A' ' 50' ' ' VAL . 28.3 mmmt -93.1 170.02 9.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.131 -0.486 . . . . 5.98 110.702 -172.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.903 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 91.7 t -75.43 102.94 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 120.957 0.408 . . . . 3.41 110.729 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.735 ' HB ' HG12 ' A' ' 50' ' ' VAL . 2.6 t -104.93 153.08 21.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.438 0.533 . . . . 4.35 112.438 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 11.8 mm-40 -63.51 -59.53 4.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 4.2 109.687 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -126.18 158.79 34.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.957 -1.02 . . . . 6.16 109.893 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.19 153.78 46.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.125 -0.695 . . . . 5.79 109.125 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 69.17 -167.07 0.18 Allowed 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.9 0.75 . . . . 4.64 110.117 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -108.67 -36.55 2.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.621 -0.799 . . . . 4.95 112.337 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.75 -90.69 0.87 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.951 -0.642 . . . . 6.66 112.261 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.9 pt -79.1 -15.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.988 0.423 . . . . 9.5 111.214 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 63' ' ' PRO . 12.2 t -128.24 126.45 40.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.313 0.577 . . . . 7.68 109.993 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -82.6 50.49 1.67 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.481 0.657 . . . . 9.39 110.476 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.409 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 92.3 m-70 -133.61 -10.01 2.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 7.29 110.812 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 pt 47.31 -164.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 124.287 0.992 . . . . 5.6 111.791 -173.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.24 66.35 1.98 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.839 -0.696 . . . . 3.5 113.442 173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . . . -163.53 87.12 0.52 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.758 0.314 . . . . 2.15 110.982 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -165.26 160.79 18.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.198 0.523 . . . . 2.96 111.898 -176.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.489 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 13.9 mt-30 -107.55 109.71 21.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.869 -1.16 . . . . 2.45 107.869 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.735 HG12 ' HB ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -94.96 131.83 40.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.362 0.601 . . . . 2.49 111.736 -171.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.903 ' HB ' ' HB ' ' A' ' 33' ' ' VAL . 22.6 m -69.83 94.44 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.964 -1.016 . . . . 2.26 111.201 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.0 p -123.52 119.01 56.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.847 -0.797 . . . . 4.49 108.847 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 58.9 t30 71.51 -41.46 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.795 0.807 . . . . 4.58 109.866 -170.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 52' ' ' VAL . 18.2 t70 -158.37 -63.05 0.08 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 3.62 110.197 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 23.1 ttmm 167.59 -92.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.471 -1.307 . . . . 7.78 107.471 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.441 ' H ' ' HB3' ' A' ' 55' ' ' LYS . 22.1 mtpp 65.75 -63.17 0.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.839 0.856 . . . . 5.81 113.283 170.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 HG21 ' A' ' 11' ' ' VAL . 61.7 mt -65.21 120.59 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 1.4 112.044 -172.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.489 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -101.2 97.83 8.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 1.85 109.896 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -81.27 100.01 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.394 -0.224 . . . . 1.14 110.394 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 60' ' ' LEU . 3.9 mm? 67.92 112.17 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.113 0.883 . . . . 3.46 111.771 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' HB2' HG11 ' A' ' 10' ' ' VAL . 15.4 t70 -79.31 -42.22 26.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.815 -0.629 . . . . 6.48 109.843 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.0 p -124.36 108.79 29.22 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.836 -0.62 . . . . 5.89 110.422 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.59 ' HB2' HG23 ' A' ' 42' ' ' THR . 66.6 Cg_endo -74.42 60.82 5.04 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.922 2.415 . . . . 5.92 112.412 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.76 -86.08 0.48 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.928 -0.578 . . . . 5.92 112.194 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.73 -5.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.531 0.205 . . . . 8.81 111.454 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.81 98.52 4.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.126 0.488 . . . . 6.36 110.874 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -115.75 109.87 18.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.678 -0.692 . . . . 3.89 109.767 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.477 ' HB3' ' HD2' ' A' ' 102' ' ' HIS . 82.3 t80 68.74 121.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.884 0.74 . . . . 2.61 110.075 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 t -48.6 121.45 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 5.11 111.218 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.5 m -59.96 121.19 11.19 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.738 -0.664 . . . . 6.34 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.3 ptp -71.34 113.56 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 5.64 111.691 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -118.9 -35.77 3.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.457 -0.792 . . . . 10.31 109.064 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.45 145.1 44.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.239 -0.891 . . . . 7.85 110.039 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -80.31 -30.62 38.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.783 -0.644 . . . . 11.11 110.709 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.35 60.66 4.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.95 -0.643 . . . . 6.78 112.212 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.29 -33.05 17.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.451 0.167 . . . . 7.11 111.391 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 70.18 -54.04 0.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.442 0.697 . . . . 8.32 111.73 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -79.56 80.59 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.605 0.717 . . . . 4.75 110.523 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -70.15 143.55 52.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.503 -0.772 . . . . 4.44 111.024 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.452 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 17.9 t0 -82.51 130.33 35.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.715 -0.846 . . . . 3.12 108.715 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.898 ' HB ' HG23 ' A' ' 11' ' ' VAL . 44.9 mm -88.53 107.66 17.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.815 -0.439 . . . . 1.31 109.815 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.949 HG22 ' HB3' ' A' ' 103' ' ' ALA . 61.2 t -85.68 96.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 116.328 -0.396 . . . . 1.78 111.616 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.692 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 6.5 mm -84.11 93.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.97 109.283 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.7 tm? -86.97 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.737 -0.665 . . . . 1.98 109.749 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 1.091 HG11 ' HA3' ' A' ' 15' ' ' GLY . 3.1 p -77.41 144.32 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.622 0.725 . . . . 1.8 110.728 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 127' ' ' VAL . 8.4 t -136.72 175.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.58 -1.267 . . . . 1.79 107.58 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -138.06 131.16 30.18 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 122.101 -0.375 . . . . 1.03 110.251 175.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.629 ' HB1' HG21 ' A' ' 114' ' ' ILE . . . -77.44 27.55 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.882 -0.599 . . . . 1.66 112.325 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.593 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 16.4 p-10 -135.35 10.06 3.47 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.98 0.419 . . . . 2.01 110.056 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.81 -58.78 0.4 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.349 0.595 . . . . 1.09 110.605 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.547 ' O ' HG13 ' A' ' 86' ' ' VAL . . . 118.24 -115.09 3.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.232 -0.895 . . . . 0.52 111.457 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 97' ' ' VAL . 46.6 t -122.81 109.38 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.078 0.465 . . . . 1.67 110.233 -175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.89 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 62.5 mtp -88.49 174.45 5.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.121 -0.49 . . . . 1.32 109.775 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.89 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 7.0 Cg_endo -49.46 -53.13 7.53 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.769 2.313 . . . . 0.88 113.04 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 38.7 mt-30 -61.15 -32.39 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.624 0.231 . . . . 2.01 111.624 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.526 ' CG2' HD12 ' A' ' 84' ' ' LEU . 21.1 m -63.5 -31.24 72.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.806 0.812 . . . . 1.19 109.926 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 1.043 ' CG2' ' HH ' ' A' ' 134' ' ' TYR . 41.2 t -82.18 -52.54 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.713 -1.13 . . . . 1.66 111.305 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 48.4 mt-10 -55.71 -34.1 64.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.746 -0.661 . . . . 1.62 111.972 -176.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -70.6 -39.46 73.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.541 0.686 . . . . 1.09 109.504 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.507 HD13 HD22 ' A' ' 136' ' ' LEU . 1.7 mt -70.74 -42.18 77.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.395 -1.275 . . . . 1.13 110.188 174.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.48 ' ND2' HG11 ' A' ' 97' ' ' VAL . 94.8 m-20 -54.25 -37.79 65.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.522 . . . . 1.97 110.408 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.477 ' HD2' ' HB3' ' A' ' 68' ' ' PHE . 58.3 t60 -79.29 -27.02 42.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.294 -0.867 . . . . 1.02 110.874 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.949 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -97.72 -35.26 10.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.331 0.863 . . . . 1.18 113.331 -169.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -60.95 -27.11 68.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.863 0.69 . . . . 2.98 112.863 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.3 11.89 19.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.095 0.776 . . . . 1.3 113.095 -166.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . . . -111.32 19.15 18.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.654 -1.239 . . . . 1.3 107.654 172.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 50.56 37.83 17.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.547 -1.661 . . . . 2.59 111.721 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -94.27 155.53 39.77 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.021 -0.99 . . . . 1.71 110.014 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.523 ' O ' HG22 ' A' ' 108' ' ' VAL . 7.1 Cg_exo -73.97 150.12 43.05 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.686 2.257 . . . . 0.62 113.443 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.652 HG22 HG21 ' A' ' 145' ' ' THR . 1.4 mp -120.72 142.57 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.067 -1.424 . . . . 1.62 109.836 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.692 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.04 146.28 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 108.022 -1.103 . . . . 1.31 108.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -114.06 132.19 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.025 0 N-CA-C 109.634 -0.506 . . . . 1.07 109.634 174.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.48 ' HB3' HG22 ' A' ' 85' ' ' VAL . . . -118.82 87.09 2.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.636 -1.246 . . . . 1.07 107.636 175.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 28.2 mt -69.65 91.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.499 -1.228 . . . . 1.56 110.024 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -92.89 167.58 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.515 . . . . 0.88 109.748 -170.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 91.2 mttt 66.76 8.45 5.97 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.5 0.5 . . . . 3.11 110.411 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.542 ' HE1' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -76.96 -2.66 34.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 1.55 110.649 -176.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' OD2' ' HD2' ' A' ' 153' ' ' LYS . 5.1 p-10 -69.82 -13.85 62.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.187 -0.915 . . . . 2.45 110.222 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.88 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 18.6 ptmt -80.47 -175.66 0.64 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.182 -0.673 . . . . 4.11 109.182 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.88 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -45.07 -22.43 0.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.0 2.467 . . . . 3.16 114.496 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.722 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 6.6 pt-20 68.66 122.13 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.489 1.516 . . . . 4.03 110.46 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -75.81 0.08 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.18 -1.373 . . . . 1.9 110.821 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 50.4 t-20 -179.1 105.92 0.2 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 2.21 110.042 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.678 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.0 OUTLIER -46.16 -65.62 0.18 Allowed 'Trans proline' 0 C--O 1.219 -0.436 0 C-N-CA 123.538 2.825 . . . . 1.01 112.834 173.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.34 -48.57 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.395 0.678 . . . . 2.0 112.601 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 126' ' ' ARG . 9.0 tpt180 -53.48 -55.85 21.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.621 0.724 . . . . 3.7 109.951 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.653 HG12 HG12 ' A' ' 86' ' ' VAL . 81.9 t -57.97 -42.43 82.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.357 -1.292 . . . . 1.12 110.412 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.687 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.3 mtp -63.46 -31.43 72.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.61 -0.723 . . . . 1.07 111.265 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.45 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 73.8 mt-30 -77.8 -18.01 56.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.897 -0.321 . . . . 2.01 110.949 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.3 mm-40 -70.39 -35.28 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.934 -0.765 . . . . 2.02 108.934 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.51 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.0 mm? -71.21 -44.61 65.05 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.516 0.674 . . . . 1.62 109.741 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.916 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.5 ppp? -76.08 -2.57 31.48 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.099 -0.955 . . . . 1.08 109.61 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 36.4 tt0 -78.13 -28.91 48.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.411 -1.329 . . . . 2.18 107.411 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 1.043 ' HH ' ' CG2' ' A' ' 97' ' ' VAL . 60.8 m-85 -91.07 10.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.646 -0.706 . . . . 1.17 109.819 170.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 72.36 22.5 3.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.362 -1.29 . . . . 2.43 111.057 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.507 HD22 HD13 ' A' ' 100' ' ' ILE . 6.5 mp -96.94 76.41 2.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.951 -1.129 . . . . 2.28 107.951 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.487 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -66.8 127.99 93.68 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 113.506 -1.679 . . . . 1.28 110.899 -176.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.799 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 91.7 Cg_exo -47.76 155.16 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.221 2.614 . . . . 0.34 112.726 172.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -27.08 54.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.559 -1.2 . . . . 2.01 108.175 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.702 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.29 -42.73 64.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.548 -1.206 . . . . 1.18 109.336 169.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.916 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.0 m0 -95.19 -18.73 20.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.901 -1.045 . . . . 0.45 111.351 -171.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.67 26.52 4.16 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 119.989 -1.101 . . . . 0.45 112.447 170.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.487 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.95 -107.84 2.64 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.393 -0.908 . . . . 0.5 112.452 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -162.87 28.86 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.307 0.575 . . . . 1.3 111.127 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.652 HG21 HG22 ' A' ' 110' ' ' ILE . 23.3 m -121.85 123.73 42.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.064 -0.654 . . . . 1.06 111.983 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.567 HD12 HG13 ' A' ' 111' ' ' ILE . 26.5 mt -91.49 108.7 20.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.616 -0.72 . . . . 1.86 111.137 -175.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.799 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 24.3 m-85 -93.38 118.78 31.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.38 112.204 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 77.3 m -117.16 111.6 19.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.596 -0.729 . . . . 1.82 110.06 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.3 pttp -89.39 89.22 7.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.964 0.887 . . . . 2.94 108.83 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.914 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -116.66 179.93 3.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.696 -1.138 . . . . 1.89 112.745 -165.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 p -145.95 110.39 5.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.491 -1.231 . . . . 2.08 109.886 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -19.5 36.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.474 . . . . 1.43 111.298 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 154' ' ' THR . 19.2 ptpt -80.16 -52.76 7.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.382 0.61 . . . . 3.46 110.296 -176.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 28.1 p -78.39 -2.12 36.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.107 -0.951 . . . . 1.78 111.145 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.0 tptp 61.66 45.72 7.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.872 -1.058 . . . . 2.75 111.989 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -107.23 -73.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.855 0.835 . . . . 2.64 110.167 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.914 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -65.95 -18.67 66.88 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.724 -1.126 . . . . 0.73 113.899 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.04 -47.07 71.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.213 0.53 . . . . 2.12 109.79 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.69 -35.37 67.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.625 -0.716 . . . . 2.5 110.678 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -66.25 -34.81 78.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.184 -0.462 . . . . 0.84 110.668 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 165' ' ' ILE . 61.8 tp -59.68 -53.07 62.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.819 -0.628 . . . . 1.54 110.806 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 28' ' ' ILE . 94.9 mt -56.28 -37.6 70.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.886 -0.597 . . . . 1.7 111.351 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -61.92 -38.59 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 2.49 110.913 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.727 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 17.9 mmt -74.02 -44.29 54.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 1.29 110.368 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 162' ' ' LEU . 94.7 mt -51.94 -56.08 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.525 -0.762 . . . . 1.24 110.544 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 52' ' ' VAL . 97.2 mt -65.52 -42.85 91.56 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.685 -0.689 . . . . 2.36 111.654 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.4 tp -51.42 -44.75 62.36 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.513 0.508 . . . . 1.98 110.62 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 146' ' ' ILE . 24.6 t -80.24 -40.67 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.09 -0.505 . . . . 1.69 111.416 -176.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.3 p -59.58 -29.64 68.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.909 0.385 . . . . 2.07 110.813 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -91.1 -35.12 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 2.79 110.412 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.1 ttp -60.3 -42.82 96.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.375 -0.375 . . . . 2.22 111.494 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.228 0.825 . . . . 3.45 113.228 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.17 -35.7 69.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.749 . . . . 3.36 109.174 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 mp -107.96 -34.97 6.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.011 . . . . 4.51 109.65 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttp 63.12 95.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.0 -1.0 . . . . 6.66 110.63 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -89.5 51.56 2.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.36 -0.837 . . . . 4.98 112.135 -170.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.435 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 11.8 m120 -77.0 -50.08 2.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.292 -0.413 . . . . 6.96 110.724 173.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 177' ' ' ASN . 66.0 Cg_endo . . . . . 0 C--O 1.247 0.928 0 C-N-CA 121.921 1.747 . . . . 7.47 111.181 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.587 -0.605 . . . . 16.58 111.587 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 m -61.7 110.65 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.123 0.487 . . . . 14.94 112.144 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -99.7 114.88 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.842 -0.799 . . . . 15.21 108.842 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -85.79 77.31 9.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 12.92 111.695 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 m -90.38 60.42 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.609 -0.723 . . . . 10.47 109.615 173.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -67.31 123.53 20.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.48 -0.782 . . . . 9.14 112.02 -173.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 17.8 mtp180 -83.22 -42.62 0.84 Allowed Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.143 -0.935 . . . . 9.01 112.575 177.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 81.9 Cg_exo -45.26 127.43 9.02 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.582 2.188 . . . . 5.24 113.774 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.882 ' HB3' HD13 ' A' ' 60' ' ' LEU . 4.3 Cg_exo -75.54 155.48 40.47 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.418 2.745 . . . . 4.88 112.101 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HB ' ' H ' ' A' ' 58' ' ' THR . 47.0 t -133.53 -65.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.326 -0.397 . . . . 3.08 110.6 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.927 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 13.9 t -118.85 111.42 33.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.946 0.403 . . . . 1.57 111.159 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -98.08 141.42 31.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.18 110.812 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.8 mt -96.29 127.36 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.966 0.413 . . . . 1.57 110.517 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.552 ' SD ' HG12 ' A' ' 82' ' ' VAL . 51.2 mtt -133.84 177.81 7.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.31 0.576 . . . . 1.41 111.529 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.31 -92.32 0.21 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.508 -1.037 . . . . 1.55 110.508 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.454 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 t60 -164.24 149.29 10.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.765 -0.828 . . . . 1.21 108.765 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.37 -17.35 22.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.419 0.896 . . . . 2.2 113.419 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.76 -13.12 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.454 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 16.4 m170 -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.703 0.287 . . . . 0.89 111.544 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.29 61.08 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.84 -1.172 . . . . 1.06 113.904 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.39 -22.8 24.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.347 0.594 . . . . 2.58 109.49 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -71.03 -38.32 72.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.503 -0.771 . . . . 2.32 110.762 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -78.66 -23.93 45.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 2.23 109.823 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.5 tm? -63.54 -48.13 78.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.771 -0.826 . . . . 2.33 108.771 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.729 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 18.8 mt -66.41 -36.46 82.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.038 -0.528 . . . . 2.46 110.738 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -55.27 -58.05 9.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.873 0.323 . . . . 1.38 111.873 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 158' ' ' LEU . . . -68.55 -24.82 64.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 1.42 111.313 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 25' ' ' LEU . 1.4 tt -78.79 -23.62 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.418 . . . . 2.08 110.097 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 53.4 mtt180 -76.27 -26.76 56.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.646 0.736 . . . . 4.16 109.264 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -75.32 6.22 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.059 -0.973 . . . . 3.57 109.411 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 29' ' ' ARG . 48.1 m -145.37 39.83 1.19 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.529 -0.76 . . . . 2.09 109.453 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' HE3' ' OE2' ' A' ' 35' ' ' GLU . 20.2 ptmt -68.04 159.17 31.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.216 -0.902 . . . . 5.98 111.699 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 m -163.27 -47.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.562 -0.745 . . . . 3.41 112.85 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.499 ' O ' HG21 ' A' ' 34' ' ' THR . 39.9 m -134.55 -1.88 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.634 0.605 . . . . 4.35 112.634 -166.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.685 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.9 pm0 -47.89 153.41 0.63 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.893 0.854 . . . . 4.2 113.027 -177.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -134.61 -146.32 0.25 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.27 -1.332 . . . . 6.16 109.576 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.752 ' HA ' HD13 ' A' ' 41' ' ' ILE . 39.9 mt-10 -55.77 -31.33 62.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 5.79 108.912 171.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . -68.28 77.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.228 -0.896 . . . . 4.64 109.403 164.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.96 23.94 0.47 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.186 -0.915 . . . . 4.95 110.906 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.89 70.23 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.0 -0.6 . . . . 6.66 112.451 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.752 HD13 ' HA ' ' A' ' 37' ' ' GLU . 62.5 mt -78.47 -64.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.5 . . . . 9.5 110.418 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 m -135.93 145.54 46.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.596 . . . . 7.68 109.71 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.08 71.15 4.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.289 0.566 . . . . 9.39 111.507 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -141.69 28.93 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.505 -0.77 . . . . 7.29 109.129 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.957 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.8 tp -171.29 -165.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.768 . . . . 5.6 108.928 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.957 ' H ' HG13 ' A' ' 45' ' ' ILE . . . -89.27 -116.61 1.53 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.774 -0.727 . . . . 3.5 112.43 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.432 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -134.32 -34.21 0.97 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.134 0.42 . . . . 2.15 112.134 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.685 ' CE2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -165.45 162.2 19.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.006 0.431 . . . . 2.96 110.71 -174.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 95.0 mt-30 -135.13 98.31 3.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 2.45 108.433 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 51' ' ' THR . 59.2 t -96.82 158.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.8 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.726 HG21 ' HA ' ' A' ' 54' ' ' ASP . 52.6 m -128.27 97.78 4.86 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.729 -1.123 . . . . 2.26 110.759 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 54' ' ' ASP . 72.4 t -118.97 127.81 75.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 4.49 108.154 173.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 66.98 8.04 5.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.636 1.208 . . . . 4.58 109.087 -176.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.726 ' HA ' HG21 ' A' ' 51' ' ' THR . 5.5 p-10 48.96 45.31 22.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 111.751 -2.477 . . . . 3.62 111.275 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 53' ' ' ASN . 68.8 mmtt -87.46 -90.22 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.09 -0.959 . . . . 7.78 108.808 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt 175.97 131.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 5.81 109.879 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.784 HD13 HD22 ' A' ' 166' ' ' LEU . 44.0 mt -133.35 91.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.65 0.262 . . . . 1.4 110.767 175.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.445 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 16.8 m -83.92 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.704 -0.48 . . . . 1.85 109.704 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 14.9 m-85 -78.4 129.53 35.06 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.98 0.419 . . . . 1.14 111.426 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.882 HD13 ' HB3' ' A' ' 9' ' ' PRO . 91.3 mt -114.74 104.58 12.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.757 -0.656 . . . . 3.46 110.219 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -73.04 -55.34 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.045 -0.724 . . . . 6.48 109.045 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.9 p -97.78 106.72 35.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.365 -0.834 . . . . 5.89 109.986 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.51 49.28 2.84 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.958 2.438 . . . . 5.92 112.939 -175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.54 -81.19 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.298 -0.477 . . . . 5.92 112.803 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -160.63 150.02 17.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.228 0.211 . . . . 8.81 110.44 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 62.5 30.62 17.19 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.747 0.654 . . . . 6.36 112.158 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 54.67 45.49 26.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 3.89 112.764 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' ' HA ' ' A' ' 103' ' ' ALA . 4.2 t80 179.78 145.34 0.19 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.791 -0.448 . . . . 2.61 109.791 174.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.527 HG22 ' HG2' ' A' ' 9' ' ' PRO . 3.1 m -73.07 76.59 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.077 -0.712 . . . . 5.11 109.077 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 p -58.45 99.66 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.193 0.52 . . . . 6.34 111.028 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.2 ptp -112.73 27.87 9.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 5.64 110.216 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 65.69 -176.35 0.18 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.37 -0.832 . . . . 10.31 110.57 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 68.93 169.03 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.812 0.695 . . . . 7.85 111.663 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -136.98 74.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.926 -0.579 . . . . 11.11 109.926 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 125.98 3.43 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.659 -0.781 . . . . 6.78 112.723 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.56 -82.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 7.11 110.165 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.28 52.51 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.728 0.775 . . . . 8.32 109.53 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.99 90.69 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.325 -0.852 . . . . 4.75 110.803 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 58.7 m -82.62 66.26 8.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.928 0.871 . . . . 4.44 109.85 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.42 82.78 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.452 -1.314 . . . . 3.12 107.452 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.927 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 23.5 mm -50.05 117.1 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.152 -0.931 . . . . 1.31 111.745 -172.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.552 HG12 ' SD ' ' A' ' 14' ' ' MET . 46.8 t -89.89 87.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 116.413 -0.358 . . . . 1.78 110.768 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 165' ' ' ILE . 32.0 mm -75.76 104.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.866 -0.791 . . . . 1.97 108.866 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.725 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.6 tm? -91.26 92.9 8.84 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.254 -0.885 . . . . 1.98 110.235 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 ' HA ' ' HB1' ' A' ' 113' ' ' ALA . 61.7 t -80.86 129.44 37.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.19 0.519 . . . . 1.8 111.122 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.66 HG21 ' HA ' ' A' ' 114' ' ' ILE . 16.8 m -131.3 -165.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.208 -1.034 . . . . 1.79 108.208 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 90' ' ' ASP . . . -139.61 143.86 37.45 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.24 -0.584 . . . . 1.03 111.861 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.08 -58.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.495 1.122 . . . . 1.66 112.709 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -103.92 19.19 20.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.571 . . . . 2.01 111.602 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 2.5 t70 -113.61 -51.59 2.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.237 0.541 . . . . 1.09 110.773 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.706 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.18 -138.6 17.43 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.294 -0.866 . . . . 0.52 111.198 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.896 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.2 t -97.02 115.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 122.818 0.447 . . . . 1.67 111.423 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.589 ' HE3' ' HD2' ' A' ' 94' ' ' PRO . 80.0 mmm -80.06 167.09 36.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.676 -0.49 . . . . 1.32 109.676 171.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HE3' ' A' ' 93' ' ' MET . 90.1 Cg_exo -46.35 -45.5 18.69 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.578 2.186 . . . . 0.88 113.054 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.84 -22.71 60.75 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.644 -0.253 . . . . 2.01 110.855 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.896 ' HB ' HG13 ' A' ' 92' ' ' VAL . 26.2 m -62.23 -30.71 71.29 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.177 0.513 . . . . 1.19 110.649 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.95 -46.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.272 -0.422 . . . . 1.66 111.345 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 1.07 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.717 -0.674 . . . . 1.62 111.196 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.49 -41.09 8.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.528 -0.916 . . . . 1.09 108.528 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.754 HG22 HD22 ' A' ' 136' ' ' LEU . 7.2 mt -73.13 -55.62 12.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.276 -0.874 . . . . 1.13 111.545 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.432 HD21 ' HA ' ' A' ' 101' ' ' ASN . 1.3 t-20 -51.7 -30.08 20.73 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.218 0.607 . . . . 1.97 111.101 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.55 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 18.8 t60 -82.91 -28.9 29.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.769 -0.651 . . . . 1.02 110.584 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HA ' ' HE2' ' A' ' 68' ' ' PHE . . . -91.56 -57.83 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.668 0.618 . . . . 1.18 112.668 -172.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.678 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -64.18 -21.32 66.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.615 0.598 . . . . 2.98 112.615 -163.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.02 4.56 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.831 0.348 . . . . 1.3 111.629 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.64 2.56 44.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 1.3 109.37 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t30 81.16 49.27 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.618 -1.174 . . . . 2.59 108.998 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -134.98 143.33 45.64 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 114.037 -1.438 . . . . 1.71 110.873 -175.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 13.8 Cg_exo -71.94 159.28 50.76 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.371 2.714 . . . . 0.62 114.675 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.731 HD11 HG12 ' A' ' 100' ' ' ILE . 46.8 mt -125.24 146.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.235 -1.348 . . . . 1.62 109.89 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 81' ' ' ILE . 5.0 mp -131.52 107.59 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 120.872 0.368 . . . . 1.31 111.726 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -70.9 133.68 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.492 0.663 . . . . 1.07 110.717 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 150' ' ' LEU . . . -124.08 89.41 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.328 -1.36 . . . . 1.07 107.328 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.719 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 56.1 mt -72.18 92.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.069 -0.969 . . . . 1.56 109.615 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.28 169.16 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.88 109.696 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 62.94 20.47 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.522 0.677 . . . . 3.11 109.826 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.742 ' SD ' ' HA ' ' A' ' 121' ' ' GLU . 17.4 tpp -94.64 64.39 2.99 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 123.274 1.511 . . . . 1.55 108.856 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.545 ' N ' ' HG ' ' A' ' 151' ' ' SER . 3.4 p30 -92.91 -9.52 39.8 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.755 -1.566 . . . . 2.45 108.935 171.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 73.5 mmtt -85.32 171.53 10.59 Favored Pre-proline 0 N--CA 1.445 -0.72 0 N-CA-C 107.665 -1.235 . . . . 4.11 107.665 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 7.1 Cg_endo -51.98 -51.19 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.701 1.601 . . . . 3.16 111.547 175.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.742 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 13.5 pt-20 163.17 116.76 0.0 OUTLIER 'General case' 0 C--O 1.232 0.139 0 O-C-N 124.309 1.005 . . . . 4.03 109.376 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -58.63 -58.81 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.516 -0.765 . . . . 1.9 109.989 174.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 15.6 t-20 174.05 78.65 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.302 -0.863 . . . . 2.21 110.194 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.595 ' O ' ' HG3' ' A' ' 128' ' ' MET . 8.1 Cg_exo -33.53 -62.26 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.634 3.556 . . . . 1.01 113.998 171.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.18 -53.8 4.84 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.007 0.523 . . . . 2.0 112.247 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -50.75 -59.15 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 3.7 110.824 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.706 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.8 t -55.31 -48.17 77.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.364 -1.289 . . . . 1.12 110.738 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.649 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 89.2 mtp -62.78 -31.31 72.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.85 -0.614 . . . . 1.07 111.261 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -76.42 -17.5 59.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.364 -0.38 . . . . 2.01 111.064 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.597 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.5 mt-10 -73.81 -36.35 64.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.55 -0.907 . . . . 2.02 108.55 171.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.005 HD11 HD13 ' A' ' 136' ' ' LEU . 3.8 mm? -69.12 -43.48 74.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.628 0.728 . . . . 1.62 109.369 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.863 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.698 -0.683 . . . . 1.08 109.884 177.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.597 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 39.4 tt0 -74.29 -32.06 62.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.728 -0.841 . . . . 2.18 108.728 171.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.593 ' CE2' HG12 ' A' ' 92' ' ' VAL . 6.0 m-85 -89.63 2.73 54.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.762 0.791 . . . . 1.17 108.879 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.5 m120 75.15 29.99 0.91 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.544 -1.662 . . . . 2.43 110.913 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.53 74.25 1.15 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.984 -1.487 . . . . 2.28 106.984 168.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.751 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -60.84 131.39 91.44 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 113.796 -1.547 . . . . 1.28 110.459 -172.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 79.7 Cg_exo -47.52 154.82 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.705 2.27 . . . . 0.34 112.509 173.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.98 -23.99 48.18 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.614 -1.176 . . . . 2.01 107.833 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.799 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -55.05 -40.97 70.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.114 -1.403 . . . . 1.18 109.163 167.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.863 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.4 m0 -96.55 -20.53 18.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.789 -1.096 . . . . 0.45 110.66 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.66 28.74 4.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.147 -1.025 . . . . 0.45 112.179 170.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.751 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -98.32 -113.4 3.26 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.593 -0.813 . . . . 0.5 112.797 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -147.4 26.34 1.06 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.936 0.398 . . . . 1.3 111.717 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.584 HG22 HD12 ' A' ' 136' ' ' LEU . 57.3 m -137.01 126.62 25.29 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 119.09 -1.044 . . . . 1.06 113.685 -174.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 164' ' ' MET . 38.8 mm -86.13 115.25 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.001 -1.0 . . . . 1.86 110.406 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.5 m-85 -95.95 123.51 39.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.726 0.298 . . . . 0.38 111.269 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 62.9 m -126.01 133.62 51.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.936 -0.575 . . . . 1.82 109.947 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.719 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pttp -101.47 123.53 45.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.494 -0.928 . . . . 2.94 108.494 170.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.753 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -145.96 175.5 10.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.493 1.14 . . . . 1.89 113.852 -173.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.545 ' HG ' ' N ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -146.38 114.31 6.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.382 -1.735 . . . . 2.08 109.154 170.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -66.57 -18.08 65.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.31 0.576 . . . . 1.43 110.881 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 154' ' ' THR . 18.1 ptmt -71.57 -52.11 19.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.774 0.797 . . . . 3.46 110.016 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 156' ' ' GLU . 33.7 p -81.74 -5.32 58.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.486 -1.234 . . . . 1.78 111.855 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 76.97 -29.22 0.17 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.787 0.835 . . . . 2.75 112.178 175.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 154' ' ' THR . 23.2 mt-10 -41.1 -69.33 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.08 0.952 . . . . 2.64 112.95 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.753 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.3 -22.29 70.93 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.988 -1.005 . . . . 0.73 114.28 -172.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.691 HD11 ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -67.29 -39.47 85.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.326 0.563 . . . . 2.12 110.023 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.2 m-20 -65.19 -39.53 92.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.268 -0.424 . . . . 2.5 110.085 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -68.79 -29.81 68.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.352 -0.386 . . . . 0.84 110.701 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 165' ' ' ILE . 54.4 tp -63.31 -51.82 64.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.383 -0.372 . . . . 1.54 110.644 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.4 mt -53.36 -41.03 65.43 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.255 -0.43 . . . . 1.7 110.637 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 22.1 mm-40 -56.35 -45.02 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.552 . . . . 2.49 110.644 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.593 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 21.8 mmt -76.07 -31.32 58.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 1.29 110.674 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.469 HG12 HD13 ' A' ' 83' ' ' ILE . 70.9 mt -59.04 -56.81 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.066 -0.516 . . . . 1.24 110.796 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.784 HD22 HD13 ' A' ' 57' ' ' ILE . 3.8 mm? -58.52 -42.25 87.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.524 -0.307 . . . . 2.36 111.032 176.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.58 -41.91 67.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.775 -0.648 . . . . 1.98 110.559 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 18.3 t -72.65 -42.67 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 1.69 111.446 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.568 ' HA ' ' OE2' ' A' ' 172' ' ' GLU . 14.1 t -60.62 -33.45 72.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.86 0.362 . . . . 2.07 110.596 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -88.23 -25.35 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.895 -0.322 . . . . 2.79 110.562 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -62.5 -42.38 99.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.178 -0.465 . . . . 2.22 110.038 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 169' ' ' SER . 41.5 mt-10 -44.45 -45.98 9.39 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.864 0.728 . . . . 3.45 111.344 175.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.77 -41.61 18.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 3.36 110.538 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.09 -70.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 4.51 111.761 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -155.83 96.89 1.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.332 -0.394 . . . . 6.66 110.629 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -106.36 133.52 50.93 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.898 -0.592 . . . . 4.98 109.462 176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 10.2 p30 -83.73 116.6 65.46 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.444 0.64 . . . . 6.96 111.819 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.0 Cg_exo . . . . . 0 C--O 1.251 1.134 0 C-N-CA 123.367 2.711 . . . . 7.47 112.085 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 112.261 -0.336 . . . . 16.58 112.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 m -74.09 131.93 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.81 0.338 . . . . 14.94 110.762 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -96.16 -0.18 50.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 15.21 111.098 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.1 tpt -82.66 85.22 7.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.88 -0.415 . . . . 12.92 109.88 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t 62.12 84.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.395 -0.821 . . . . 10.47 110.384 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -94.47 25.89 3.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.831 -0.622 . . . . 9.14 110.986 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 80' ' ' ASP . 16.7 tpt180 -129.28 99.17 21.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.498 -0.774 . . . . 9.01 109.344 172.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.67 119.68 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.289 1.993 . . . . 5.24 111.554 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.93 93.69 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.539 2.159 . . . . 4.88 110.672 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 m -62.46 107.25 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 3.08 111.192 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 96.3 t -72.35 90.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.839 0.828 . . . . 1.57 108.816 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.634 HG22 ' HG3' ' A' ' 14' ' ' MET . 21.1 m -82.31 121.78 27.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.525 -1.216 . . . . 1.18 111.143 -171.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.577 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 34.3 mt -88.93 114.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.672 -0.492 . . . . 1.57 109.672 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.634 ' HG3' HG22 ' A' ' 12' ' ' THR . 73.7 mtm -139.59 168.0 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.592 -0.731 . . . . 1.41 111.94 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.33 -95.96 0.17 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.438 -1.065 . . . . 1.55 110.438 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.87 149.9 14.89 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.816 -0.809 . . . . 1.21 108.816 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.85 -27.1 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 113.499 0.926 . . . . 2.2 113.499 -168.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.48 -22.78 40.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 1.78 111.683 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -70.78 -60.16 2.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.029 0.442 . . . . 0.89 110.847 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 166.92 58.31 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.546 -0.835 . . . . 1.06 112.484 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 17.2 ttpp -87.93 -73.56 0.48 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.641 0.734 . . . . 2.58 109.876 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.833 -1.076 . . . . 2.32 111.107 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 HG22 ' HA2' ' A' ' 20' ' ' GLY . 8.9 t -76.74 -18.24 58.59 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.981 -0.288 . . . . 2.23 110.234 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.59 -44.62 66.93 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.02 -1.104 . . . . 2.33 108.02 174.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.623 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.9 tt -63.28 -40.64 97.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.996 -1.002 . . . . 2.46 110.083 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 t70 -63.64 -52.29 61.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.521 -0.308 . . . . 1.38 111.725 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.608 ' HB3' HD12 ' A' ' 158' ' ' LEU . . . -62.15 -41.46 98.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 1.42 111.012 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 25' ' ' LEU . 3.2 tt -66.6 -30.04 48.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.577 -0.738 . . . . 2.08 109.54 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 29.4 tpt180 -69.99 -33.19 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.285 -0.87 . . . . 4.16 109.956 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -63.78 -28.33 69.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 3.57 109.521 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m -87.88 11.66 15.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.923 -1.035 . . . . 2.09 110.774 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm 57.2 -131.88 1.46 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.441 -0.8 . . . . 5.98 111.282 175.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m 49.67 20.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.985 1.314 . . . . 3.41 113.525 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.476 HG23 ' HD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -101.29 123.45 45.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.359 0.599 . . . . 4.35 112.052 -174.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -74.08 -48.37 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.27 -0.877 . . . . 4.2 109.785 174.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 73.5 mm-40 -96.91 126.45 42.06 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.625 -0.879 . . . . 6.16 108.625 176.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.32 -65.56 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 5.79 112.712 -170.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.17 173.53 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 4.64 110.86 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.49 126.74 6.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.705 -0.558 . . . . 4.95 111.705 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.54 -156.11 6.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.677 -0.773 . . . . 6.66 112.514 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -90.53 -26.82 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.134 0.492 . . . . 9.5 110.451 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -66.5 151.9 46.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 7.68 110.526 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -70.44 179.29 2.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.146 -0.479 . . . . 9.39 111.377 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 77.97 -37.54 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.873 0.869 . . . . 7.29 110.916 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.63 -176.85 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.431 -0.35 . . . . 5.6 110.818 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.54 -51.51 0.46 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.187 -0.765 . . . . 3.5 111.187 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 59' ' ' PHE . . . -117.3 171.18 8.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.415 -0.587 . . . . 2.15 109.415 173.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.661 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -148.64 143.51 26.57 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.273 0.558 . . . . 2.96 111.604 -173.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -104.66 133.69 49.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.48 -0.782 . . . . 2.45 109.729 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.669 HG22 ' HE2' ' A' ' 59' ' ' PHE . 15.1 m -110.93 151.87 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.268 0.556 . . . . 2.49 111.965 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -108.62 80.57 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.694 0.759 . . . . 2.26 109.97 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.3 p -120.69 123.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.057 -1.09 . . . . 4.49 108.057 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 69.6 -8.16 0.79 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.035 0.922 . . . . 4.58 110.067 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.583 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.1 t0 67.62 35.29 4.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.08 -1.873 . . . . 3.62 109.65 -174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HZ1' ' CD ' ' A' ' 170' ' ' GLU . 11.8 tptm -83.89 -9.37 58.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.065 -0.97 . . . . 7.78 109.526 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 57.76 44.94 19.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.333 -1.303 . . . . 5.81 111.1 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 HG22 HG21 ' A' ' 11' ' ' VAL . 70.2 mt -62.58 119.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.275 -0.875 . . . . 1.4 111.38 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -87.66 105.65 17.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 1.85 109.993 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.669 ' HE2' HG22 ' A' ' 50' ' ' VAL . 35.9 m-85 -88.8 109.07 19.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.33 . . . . 1.14 110.422 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 12' ' ' THR . 36.0 tp -90.0 82.11 6.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.97 -0.559 . . . . 3.46 109.576 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' OD1' ' HG2' ' A' ' 21' ' ' LYS . 16.6 t0 -76.89 142.08 40.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.765 -0.652 . . . . 6.48 109.616 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.469 ' HB ' ' HD2' ' A' ' 21' ' ' LYS . 21.5 m -64.29 108.99 2.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.464 0.477 . . . . 5.89 111.189 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -95.99 2.33 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.345 2.697 . . . . 5.92 113.224 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.09 -101.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.569 -0.824 . . . . 5.92 112.592 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -112.29 -35.87 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.882 0.373 . . . . 8.81 110.858 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.93 107.6 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.279 -0.638 . . . . 6.36 109.279 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -106.23 -63.19 1.29 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 3.89 110.787 -176.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' HB3' ' CD2' ' A' ' 102' ' ' HIS . 47.9 t80 -98.81 162.16 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.992 -0.549 . . . . 2.61 109.849 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 m -51.13 145.95 7.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.026 0.441 . . . . 5.11 111.027 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -90.33 24.24 2.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.388 0.613 . . . . 6.34 110.201 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 61.03 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.131 -0.941 . . . . 5.64 111.77 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -91.55 -33.89 14.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.488 -0.778 . . . . 10.31 110.041 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.42 119.91 23.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.089 -0.505 . . . . 7.85 110.75 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -47.28 -58.04 4.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.823 0.702 . . . . 11.11 112.6 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.08 29.55 12.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.76 . . . . 6.78 112.578 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 106' ' ' ALA . . . 56.59 66.37 1.2 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.28 0.562 . . . . 7.11 111.008 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.24 -6.7 23.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.702 . . . . 8.32 110.839 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.78 115.51 49.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.287 -0.415 . . . . 4.75 111.281 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.2 m -77.36 90.42 3.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 4.44 110.655 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.497 ' O ' HG22 ' A' ' 108' ' ' VAL . 67.4 m-20 -85.57 105.52 16.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.267 -0.642 . . . . 3.12 109.267 173.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mm -51.04 120.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.567 -0.742 . . . . 1.31 112.008 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 1.052 HG22 ' HB3' ' A' ' 103' ' ' ALA . 98.1 t -105.2 111.09 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 120.622 -0.431 . . . . 1.78 111.687 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.577 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 16.1 mm -87.42 107.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.82 -0.808 . . . . 1.97 108.82 173.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 100' ' ' ILE . 2.9 tm? -97.45 99.7 11.12 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.989 -1.005 . . . . 1.98 109.509 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.58 133.59 29.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.932 -0.576 . . . . 1.8 110.771 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.694 HG22 ' HA ' ' A' ' 114' ' ' ILE . 23.0 m -131.48 -174.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.4 -0.818 . . . . 1.79 108.809 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.49 143.86 44.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.59 -0.444 . . . . 1.03 110.671 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -36.83 -61.84 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.734 1.271 . . . . 1.66 113.312 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.84 8.47 39.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.729 0.64 . . . . 2.01 112.729 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.36 -44.76 2.96 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.179 -0.608 . . . . 1.09 111.077 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.0 -144.49 23.89 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.827 -0.701 . . . . 0.52 111.409 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.741 HG23 ' HB ' ' A' ' 96' ' ' THR . 3.5 p -94.06 106.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.305 0.574 . . . . 1.67 110.12 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.592 ' HE3' ' HD2' ' A' ' 94' ' ' PRO . 2.7 ppp? -83.95 169.29 17.53 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 1.32 109.263 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.592 ' HD2' ' HE3' ' A' ' 93' ' ' MET . 40.9 Cg_exo -35.76 -51.98 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.614 2.876 . . . . 0.88 115.029 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.81 -24.11 55.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.827 0.346 . . . . 2.01 111.109 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.741 ' HB ' HG23 ' A' ' 92' ' ' VAL . 2.4 m -65.24 -23.78 67.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.416 0.627 . . . . 1.19 110.035 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.444 HG22 HG21 ' A' ' 92' ' ' VAL . 64.0 t -87.73 -42.72 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.778 -0.646 . . . . 1.66 111.052 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -56.58 -33.92 66.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.013 0.435 . . . . 1.62 111.095 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.72 -33.27 46.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 1.09 110.187 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.656 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -75.25 -45.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.635 . . . . 1.13 110.761 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -51.4 -38.13 51.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.264 0.554 . . . . 1.97 110.504 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.516 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 55.0 t60 -78.55 -28.52 46.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.246 -0.888 . . . . 1.02 110.898 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 1.052 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -91.74 -44.78 8.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.588 . . . . 1.18 112.48 -172.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -65.69 -24.19 66.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.577 -0.738 . . . . 2.98 111.383 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.6 8.58 33.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 1.3 111.707 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -102.36 9.38 39.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.692 -0.855 . . . . 1.3 108.692 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t30 69.44 38.78 1.73 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 114.589 -1.187 . . . . 2.59 110.651 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.668 HG22 HG23 ' A' ' 82' ' ' VAL . 1.5 m -119.23 150.05 48.46 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.372 -0.831 . . . . 1.71 110.779 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.1 Cg_exo -73.19 155.22 52.0 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.175 2.584 . . . . 0.62 113.639 171.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.612 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -115.86 142.44 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.261 -1.336 . . . . 1.62 109.922 -176.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 82' ' ' VAL . 4.8 mp -112.7 140.55 31.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 108.521 -0.918 . . . . 1.31 108.521 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -107.58 136.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 C-N-CA 120.259 -0.576 . . . . 1.07 110.673 176.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.76 87.68 2.76 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.701 -1.222 . . . . 1.07 107.701 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.694 ' HA ' HG22 ' A' ' 86' ' ' VAL . 14.3 mt -75.58 92.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.941 -1.027 . . . . 1.56 109.469 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 1.02 ' HA ' ' HB2' ' A' ' 150' ' ' LEU . 55.4 t30 -84.6 163.6 19.2 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.094 -0.243 . . . . 0.88 110.43 -171.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 73.38 41.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.229 0.612 . . . . 3.11 112.223 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.613 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 5.3 mmm -95.93 6.61 48.47 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.371 -0.974 . . . . 1.55 108.371 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.08 -13.24 62.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.363 -1.289 . . . . 2.45 108.316 166.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 11.2 mmmm -70.47 -156.79 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 106.544 -1.65 . . . . 4.11 106.544 160.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.57 ' O ' ' HB3' ' A' ' 121' ' ' GLU . 44.0 Cg_exo -56.77 -60.84 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 CA-C-N 121.827 1.688 . . . . 3.16 110.988 165.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.57 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 15.4 pt-20 155.74 -8.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.069 1.348 . . . . 4.03 108.098 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.21 -88.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.676 -1.602 . . . . 1.9 110.699 -172.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -177.36 89.71 0.24 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.544 -0.298 . . . . 2.21 110.591 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.702 ' O ' ' HG3' ' A' ' 128' ' ' MET . 68.4 Cg_exo -39.9 -58.35 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.625 2.883 . . . . 1.01 113.386 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.23 -48.22 9.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.419 0.688 . . . . 2.0 112.375 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.4 tmt_? -52.91 -55.13 25.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.112 0.482 . . . . 3.7 109.794 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.402 HG13 HG21 ' A' ' 86' ' ' VAL . 54.7 t -60.22 -43.57 93.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.839 -1.073 . . . . 1.12 110.144 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.702 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 81.0 mtp -62.14 -31.8 72.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.34 -0.845 . . . . 1.07 111.059 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.433 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 18.7 mt-30 -75.79 -25.15 56.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.392 -0.367 . . . . 2.01 110.439 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.7 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.3 mt-10 -74.24 -32.23 62.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.176 -0.676 . . . . 2.02 109.176 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.564 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.5 mm? -69.75 -43.41 72.31 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.0 -0.68 . . . . 1.62 109.712 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.846 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -74.85 -5.52 44.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.529 -0.759 . . . . 1.08 109.986 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.7 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 9.2 tp10 -71.03 -34.43 71.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.573 -1.269 . . . . 2.18 107.573 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.417 ' HB2' HD13 ' A' ' 136' ' ' LEU . 41.3 m-85 -91.26 21.8 4.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.77 0.795 . . . . 1.17 109.535 172.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.36 29.55 17.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.189 -1.368 . . . . 2.43 109.636 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.619 ' CD1' HD12 ' A' ' 100' ' ' ILE . 13.8 mt -101.51 70.75 1.3 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.408 -1.269 . . . . 2.28 108.848 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -64.54 123.27 82.51 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.438 -1.255 . . . . 1.28 110.531 -178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.701 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.3 Cg_exo -47.25 158.24 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.306 2.67 . . . . 0.34 113.171 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -26.29 57.93 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.567 -1.197 . . . . 2.01 108.718 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.711 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.5 mp0 -44.73 -51.17 9.58 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.597 -1.183 . . . . 1.18 110.703 160.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.846 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 17.2 m0 -94.95 -24.17 17.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.996 -1.456 . . . . 0.45 111.123 -165.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.2 27.6 2.86 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 119.989 -1.1 . . . . 0.45 112.291 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.4 -115.9 4.13 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.265 -0.969 . . . . 0.5 112.514 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -151.89 34.61 0.54 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.645 0.736 . . . . 1.3 111.112 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 22.4 m -130.78 114.32 15.19 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.278 -0.569 . . . . 1.06 111.767 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.6 mp -84.87 110.76 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.826 -0.624 . . . . 1.86 110.379 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.701 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.6 m-85 -92.12 135.16 34.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.366 0.603 . . . . 0.38 111.427 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.1 m -133.53 126.41 30.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 1.82 109.505 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.613 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 25.2 pttt -91.72 110.83 22.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.582 0.706 . . . . 2.94 109.618 172.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 1.02 ' HB2' ' HA ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -83.07 173.89 11.34 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.217 1.932 . . . . 1.89 116.217 -166.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.773 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 24.8 p -175.27 99.3 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 110.562 -3.017 . . . . 2.08 109.245 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.18 -17.73 56.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.7 -0.682 . . . . 1.43 111.913 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.47 -50.42 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.651 0.739 . . . . 3.46 110.086 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.3 p -82.2 -2.41 52.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.626 -1.17 . . . . 1.78 111.434 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 75.72 -6.9 1.9 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.351 -0.84 . . . . 2.75 113.156 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB2' ' OG ' ' A' ' 151' ' ' SER . 15.8 mm-40 -64.67 -37.16 86.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.151 0.5 . . . . 2.64 110.597 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.773 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -59.97 -44.35 97.27 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.446 -0.797 . . . . 0.73 112.5 176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 27' ' ' ALA . 91.7 mt -67.31 -51.19 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.864 0.32 . . . . 2.12 111.864 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 30.2 t70 -57.97 -53.38 58.89 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.321 0.388 . . . . 2.5 111.077 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.515 ' O ' ' HG2' ' A' ' 164' ' ' MET . 76.1 t60 -61.14 -34.75 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.84 110.854 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 165' ' ' ILE . 52.5 tp -65.15 -56.18 14.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 1.54 111.078 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.82 -39.34 68.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 1.7 110.844 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 57.9 mm-40 -63.56 -40.68 97.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.853 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.75 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.8 mmt -71.82 -38.48 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.424 . . . . 1.29 110.282 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 161' ' ' LEU . 85.6 mt -56.23 -53.43 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.516 -0.766 . . . . 1.24 111.345 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 1.8 pp -72.25 -30.49 64.92 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.84 -0.344 . . . . 2.36 111.904 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.416 ' N ' HD11 ' A' ' 166' ' ' LEU . 55.3 tp -54.45 -33.95 60.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 1.98 110.511 175.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 164' ' ' MET . 76.6 t -77.18 -30.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.837 -0.619 . . . . 1.69 110.523 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.6 t -54.44 -32.06 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 2.07 110.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.548 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.3 mp0 -94.77 -36.54 11.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.473 -0.331 . . . . 2.79 110.833 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.423 ' HE1' HG13 ' A' ' 168' ' ' VAL . 60.4 ttp -52.66 -45.37 66.71 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.269 -0.423 . . . . 2.22 111.873 -174.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -53.46 -45.02 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.499 0.5 . . . . 3.45 111.504 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -83.01 -7.74 59.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.99 -0.55 . . . . 3.36 111.689 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 170' ' ' GLU . 87.8 mt -91.97 -59.29 2.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.437 -0.579 . . . . 4.51 109.437 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -170.01 104.03 0.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.246 -0.888 . . . . 6.66 110.217 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.57 56.35 1.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.213 0.53 . . . . 4.98 110.183 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.6 t30 -170.64 131.85 0.91 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.734 -0.666 . . . . 6.96 110.183 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 25.9 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.938 2.426 . . . . 7.47 112.485 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 111.903 -0.479 . . . . 16.58 111.903 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 t -92.87 99.08 11.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.999 0.4 . . . . 14.94 110.718 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -171.99 57.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.716 0.77 . . . . 15.21 109.24 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 mmt -69.93 -69.65 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.942 -1.026 . . . . 12.92 111.696 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 61' ' ' ASP . 33.0 m -140.37 161.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.597 -0.274 . . . . 10.47 110.841 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 65' ' ' HIS . 9.0 pt-20 -131.03 122.68 27.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 9.14 110.831 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 60.03 72.34 0.77 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.333 -0.849 . . . . 9.01 112.03 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.44 113.04 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.107 2.538 . . . . 5.24 111.247 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HB3' HG12 ' A' ' 41' ' ' ILE . 48.8 Cg_endo -72.81 -37.72 3.58 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.709 2.273 . . . . 4.88 113.686 -177.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG11 HG12 ' A' ' 11' ' ' VAL . 61.2 t -126.23 -85.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 121.106 -0.238 . . . . 3.08 110.844 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.781 HG13 ' HB ' ' A' ' 81' ' ' ILE . 5.7 m -98.03 147.36 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 119.717 -0.793 . . . . 1.57 111.244 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.51 HG22 HG23 ' A' ' 5' ' ' VAL . 21.8 m -109.32 125.92 52.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.617 -0.72 . . . . 1.18 110.142 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 61' ' ' ASP . 23.5 mt -89.12 116.85 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 1.57 110.705 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.5 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 21.6 mmt -119.78 -179.21 3.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.015 -0.993 . . . . 1.41 110.11 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.904 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 105.44 131.49 7.02 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.941 -1.264 . . . . 1.55 109.941 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -44.48 135.67 4.6 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.854 0.835 . . . . 1.21 111.102 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.22 -39.08 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.104 -1.407 . . . . 2.2 112.84 -167.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.53 -18.16 55.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.879 0.326 . . . . 1.78 111.879 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.523 ' HE1' ' H ' ' A' ' 93' ' ' MET . 25.1 m170 -64.62 -31.24 72.38 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.037 0.446 . . . . 0.89 110.298 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.18 55.14 0.3 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.198 -1.001 . . . . 1.06 113.624 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.488 ' HD2' HG23 ' A' ' 13' ' ' ILE . 35.8 pttt -87.83 -22.36 24.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.478 -0.934 . . . . 2.58 108.478 172.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -34.8 77.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.627 -1.169 . . . . 2.32 110.002 176.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 p -71.23 -24.67 62.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 2.23 111.068 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.65 -54.93 28.05 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.006 -0.739 . . . . 2.33 109.006 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 61' ' ' ASP . 6.0 tt -51.61 -45.31 63.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.094 0.473 . . . . 2.46 110.487 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.51 -52.2 16.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 1.38 112.538 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.63 85.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.367 -0.208 . . . . 1.42 111.116 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.509 HG22 ' HE2' ' A' ' 48' ' ' TYR . 74.3 mt -67.22 -36.87 77.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.541 -0.54 . . . . 2.08 109.541 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.963 ' HA ' HG23 ' A' ' 34' ' ' THR . 15.9 tpp180 -59.49 -38.77 81.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.425 0.631 . . . . 4.16 109.765 171.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -85.14 16.28 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 3.57 111.386 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -103.24 25.13 9.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.449 -0.341 . . . . 2.09 110.804 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.3 mttm 74.72 -53.33 0.68 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.481 0.919 . . . . 5.98 113.481 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -73.99 28.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.242 1.201 . . . . 3.41 114.242 -168.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.963 HG23 ' HA ' ' A' ' 29' ' ' ARG . 36.1 p -91.22 126.09 36.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.348 0.594 . . . . 4.35 111.712 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -74.48 -57.2 4.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.806 -1.088 . . . . 4.2 113.019 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -146.8 -178.98 6.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.281 -0.568 . . . . 6.16 111.783 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -99.35 155.13 17.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.98 -1.118 . . . . 5.79 107.98 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.84 131.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.786 0.678 . . . . 4.64 110.282 -172.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -86.49 57.59 4.71 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.026 -0.607 . . . . 4.95 113.004 -170.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 -124.39 8.17 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.669 -0.776 . . . . 6.66 113.884 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' A' ' 9' ' ' PRO . 35.1 pt -86.76 26.59 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 112.526 0.565 . . . . 9.5 112.526 -171.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.53 HG23 HD22 ' A' ' 60' ' ' LEU . 10.5 t -131.6 134.61 46.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.757 -0.46 . . . . 7.68 109.757 174.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.66 71.01 7.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.415 0.626 . . . . 9.39 111.307 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -132.93 127.38 34.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 7.29 108.881 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.3 154.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.465 -0.494 . . . . 5.6 110.212 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.57 39.27 3.71 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.873 -0.891 . . . . 3.5 110.873 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB2' ' N ' ' A' ' 39' ' ' GLY . . . -163.23 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.997 -0.742 . . . . 2.15 108.997 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.651 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -170.09 168.75 8.29 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.561 0.696 . . . . 2.96 111.628 -163.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.788 ' HG2' HG22 ' A' ' 58' ' ' THR . 34.9 mt-30 -125.74 146.92 49.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.551 -1.204 . . . . 2.45 107.762 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.673 HG11 ' H ' ' A' ' 51' ' ' THR . 56.6 t -82.74 175.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.135 -0.691 . . . . 2.49 109.135 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.994 HG23 ' HB2' ' A' ' 54' ' ' ASP . 10.8 t -53.11 166.13 0.26 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.541 0.686 . . . . 2.26 111.518 -175.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 54' ' ' ASP . 12.9 p -121.6 144.25 31.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.27 -0.641 . . . . 4.49 109.27 -166.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t30 70.96 -40.45 0.48 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.944 0.778 . . . . 4.58 109.196 -167.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.994 ' HB2' HG23 ' A' ' 51' ' ' THR . 27.2 m-20 -75.22 -66.57 0.75 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 3.62 110.962 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 57.3 mttm -150.5 70.95 1.03 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.633 -0.427 . . . . 7.78 110.669 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.544 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -76.77 59.04 1.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.871 0.693 . . . . 5.81 112.871 -169.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.571 HD13 HG23 ' A' ' 165' ' ' ILE . 14.8 mt -88.62 125.41 41.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.152 -0.476 . . . . 1.4 110.509 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.788 HG22 ' HG2' ' A' ' 49' ' ' GLN . 6.9 m -95.04 119.99 34.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.12 -0.326 . . . . 1.85 110.12 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HD2' HD11 ' A' ' 13' ' ' ILE . 54.2 m-85 -104.9 111.16 23.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.71 -0.396 . . . . 1.14 110.311 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.606 HD13 ' HB ' ' A' ' 5' ' ' VAL . 1.8 tm? -108.38 111.16 22.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.941 -0.572 . . . . 3.46 110.002 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.724 ' HB3' HD12 ' A' ' 25' ' ' LEU . 25.3 t0 -140.02 70.54 1.36 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.842 0.829 . . . . 6.48 109.556 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.5 m -109.79 105.57 57.34 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.03 -0.986 . . . . 5.89 109.971 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.59 75.95 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.198 2.599 . . . . 5.92 112.626 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.37 -93.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.148 -0.781 . . . . 5.92 111.148 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 83.1 m-70 -81.76 178.97 8.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.707 0.289 . . . . 8.81 110.478 176.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.58 97.56 5.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.377 0.608 . . . . 6.36 110.314 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.61 112.24 6.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 3.89 111.168 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.681 ' CE2' ' HA ' ' A' ' 103' ' ' ALA . 8.5 t80 -86.12 -81.61 0.21 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.147 -0.479 . . . . 2.61 110.889 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 t -145.64 15.3 1.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.338 0.589 . . . . 5.11 111.104 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m 57.45 68.12 0.89 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.619 -0.719 . . . . 6.34 109.69 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 71' ' ' MET . 1.5 mpp? -72.09 95.47 1.63 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.49 -0.777 . . . . 5.64 111.022 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -118.62 -14.11 9.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.927 0.394 . . . . 10.31 110.075 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.03 169.23 18.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.768 -0.651 . . . . 7.85 110.164 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -96.59 123.38 40.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.762 -0.458 . . . . 11.11 109.762 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.31 110.37 3.2 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.699 -0.762 . . . . 6.78 113.004 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.96 -33.77 57.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.404 0.621 . . . . 7.11 109.385 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -110.47 90.22 3.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.375 -0.83 . . . . 8.32 109.102 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 m -92.3 137.9 21.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.094 0.473 . . . . 4.75 111.8 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 m -114.39 0.46 14.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.022 -1.103 . . . . 4.44 108.022 171.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.94 130.19 35.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.914 -1.493 . . . . 3.12 109.933 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.781 ' HB ' HG13 ' A' ' 11' ' ' VAL . 41.4 mm -120.74 117.64 53.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 1.31 110.005 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 103' ' ' ALA . 42.0 t -92.65 101.6 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 120.764 0.316 . . . . 1.78 111.136 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.1 mm -84.94 105.42 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.73 -0.841 . . . . 1.97 108.73 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -100.22 104.81 16.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.92 -0.582 . . . . 1.98 110.81 -174.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.904 HG12 ' HA3' ' A' ' 15' ' ' GLY . 2.8 p -83.59 143.82 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.337 0.589 . . . . 1.8 111.6 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.741 HG23 ' HA ' ' A' ' 114' ' ' ILE . 31.2 m -140.79 -166.77 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.357 -0.979 . . . . 1.79 108.357 174.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.52 144.04 34.1 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.378 -0.529 . . . . 1.03 111.885 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.73 -54.71 1.2 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.504 1.127 . . . . 1.66 113.092 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.34 -37.65 9.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.644 0.609 . . . . 2.01 112.644 -172.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.409 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 13.7 t70 -68.66 -45.0 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.613 -0.435 . . . . 1.09 111.354 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.584 ' HA2' HG11 ' A' ' 127' ' ' VAL . . . 84.92 -119.76 5.1 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.476 -0.868 . . . . 0.52 111.503 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.892 HG13 ' HB ' ' A' ' 96' ' ' THR . 25.0 t -114.13 116.15 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 122.611 0.364 . . . . 1.67 111.505 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.523 ' H ' ' HE1' ' A' ' 19' ' ' HIS . 39.6 mtp -82.38 166.54 35.98 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.327 -0.62 . . . . 1.32 109.327 169.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 89.2 Cg_exo -44.32 -50.42 7.89 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.88 113.107 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 2.1 mt-30 -66.73 -23.79 66.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.411 0.523 . . . . 2.01 112.411 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.892 ' HB ' HG13 ' A' ' 92' ' ' VAL . 24.4 m -63.3 -38.24 90.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.647 0.26 . . . . 1.19 110.61 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -29.33 5.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 C-N-CA 120.615 -0.434 . . . . 1.66 111.053 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 20.9 mm-40 -51.42 -45.51 62.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.177 0.513 . . . . 1.62 110.524 174.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 14' ' ' MET . . . -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.457 -0.792 . . . . 1.09 110.973 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.689 HD12 HG22 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -78.55 -45.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.908 -0.587 . . . . 1.13 111.256 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.36 -35.89 68.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.516 0.674 . . . . 1.97 110.048 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -76.03 -29.8 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 1.02 110.324 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.681 ' HA ' ' CE2' ' A' ' 68' ' ' PHE . . . -90.04 -45.95 8.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.265 0.469 . . . . 1.18 112.265 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -55.84 -26.55 47.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.681 0.622 . . . . 2.98 112.681 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.53 7.08 15.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.555 0.576 . . . . 1.3 112.555 -171.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -95.58 -4.25 44.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.823 -0.806 . . . . 1.3 108.823 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 t30 78.15 47.56 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.381 -1.281 . . . . 2.59 108.091 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -130.35 142.5 45.68 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.393 -1.73 . . . . 1.71 111.164 -171.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.66 160.22 50.56 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.308 2.672 . . . . 0.62 114.449 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.721 HG21 HG23 ' A' ' 145' ' ' THR . 1.4 mp -124.57 145.92 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.43 -1.259 . . . . 1.62 110.566 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 84' ' ' LEU . 5.2 mp -123.88 108.78 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 120.873 0.368 . . . . 1.31 110.97 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -74.26 136.04 26.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.935 -0.575 . . . . 1.07 110.424 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.417 ' HB2' HG21 ' A' ' 85' ' ' VAL . . . -121.59 88.38 2.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.007 -1.108 . . . . 1.07 108.007 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.915 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 38.2 mt -68.21 93.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.306 -1.315 . . . . 1.56 110.722 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -91.5 169.51 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.967 -0.383 . . . . 0.88 109.967 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 60.7 22.47 12.38 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.855 0.836 . . . . 3.11 110.081 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.503 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.2 tpp -93.04 2.03 56.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.564 1.173 . . . . 1.55 109.018 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.7 -18.52 4.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.498 -1.228 . . . . 2.45 112.332 173.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.904 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 19.2 pttm -83.84 -176.99 0.87 Allowed Pre-proline 0 C--O 1.221 -0.399 0 N-CA-C 108.475 -0.935 . . . . 4.11 108.475 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.904 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 4.7 Cg_exo -42.41 -61.86 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.993 1.795 . . . . 3.16 113.19 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.611 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 12.8 pt-20 149.42 127.66 0.0 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.922 1.289 . . . . 4.03 108.019 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.85 -71.56 0.23 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.022 -0.535 . . . . 1.9 109.731 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 4.5 t-20 -176.89 88.68 0.26 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 2.21 109.87 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.0 Cg_exo -39.15 -61.31 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.253 3.302 . . . . 1.01 113.727 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -49.45 -43.85 45.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.991 0.517 . . . . 2.0 112.19 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -53.5 -55.56 24.38 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.31 0.576 . . . . 3.7 109.696 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.584 HG11 ' HA2' ' A' ' 91' ' ' GLY . 55.2 t -61.37 -43.82 97.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.605 -1.179 . . . . 1.12 110.052 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.782 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.5 mtp -63.5 -28.14 69.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.249 -0.887 . . . . 1.07 111.303 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.9 mt-30 -79.06 -23.59 44.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.628 -0.26 . . . . 2.01 110.477 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -71.93 -34.42 69.04 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.249 -0.649 . . . . 2.02 109.249 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.814 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -72.26 -41.0 67.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.571 0.7 . . . . 1.62 109.827 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.832 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -75.63 -5.38 45.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.091 -0.959 . . . . 1.08 109.462 176.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.2 tt0 -84.01 -21.51 31.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.664 -0.865 . . . . 2.18 108.664 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.684 ' CE2' HG12 ' A' ' 92' ' ' VAL . 31.9 m-85 -94.27 10.57 33.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.281 -1.007 . . . . 1.17 108.281 166.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.4 m120 70.97 35.29 1.7 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 113.683 -1.599 . . . . 2.43 111.449 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.553 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.0 mp -112.0 78.16 1.1 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.402 -0.962 . . . . 2.28 108.402 170.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.957 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.63 130.13 93.35 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 113.936 -1.484 . . . . 1.28 110.682 -176.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.806 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 75.8 Cg_exo -51.13 153.33 9.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.849 2.366 . . . . 0.34 113.295 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.7 mm-40 -79.52 -23.52 42.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.488 -1.233 . . . . 2.01 109.083 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.673 ' HB3' ' CD1' ' A' ' 141' ' ' TRP . 8.1 mp0 -42.96 -53.06 4.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.676 -1.147 . . . . 1.18 110.547 159.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.832 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -93.82 -22.06 18.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.739 -1.573 . . . . 0.45 111.237 -167.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.32 25.61 3.73 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.086 -1.054 . . . . 0.45 112.364 172.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.957 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -106.71 2.12 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.623 -0.799 . . . . 0.5 113.114 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' CG ' ' HZ3' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -157.83 23.02 0.27 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.999 0.428 . . . . 1.3 110.944 -176.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.721 HG23 HG21 ' A' ' 110' ' ' ILE . 17.5 m -136.44 112.21 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.912 -0.715 . . . . 1.06 112.834 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.711 HG23 ' HB3' ' A' ' 164' ' ' MET . 52.9 mt -76.89 117.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 1.86 110.808 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.814 ' HZ ' ' HB2' ' A' ' 131' ' ' LEU . 16.3 m-85 -94.69 101.86 13.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.38 111.839 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.2 m -96.42 99.37 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.726 -0.67 . . . . 1.82 109.99 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.915 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 18.6 pttm -79.26 85.17 5.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.776 -0.824 . . . . 2.94 108.776 172.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.665 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -109.82 179.25 4.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.301 -0.863 . . . . 1.89 112.542 -169.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 p -146.17 104.71 3.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.062 -0.972 . . . . 2.08 110.772 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.767 ' HA ' HD22 ' A' ' 158' ' ' LEU . . . -66.86 -17.93 65.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.981 0.42 . . . . 1.43 111.44 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -78.62 -60.76 2.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.42 0.628 . . . . 3.46 110.299 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -85.45 -5.46 59.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.033 -0.985 . . . . 1.78 112.067 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.59 ' HA ' HD23 ' A' ' 158' ' ' LEU . 5.1 tppp? 73.05 -7.08 1.56 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.618 0.574 . . . . 2.75 112.423 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -56.35 -55.39 33.99 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.984 0.897 . . . . 2.64 111.141 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -67.36 -19.57 70.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.995 -1.002 . . . . 0.73 113.695 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.767 HD22 ' HA ' ' A' ' 152' ' ' ALA . 4.0 mm? -67.58 -41.43 84.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.486 0.643 . . . . 2.12 110.367 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.88 -44.47 97.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.728 -0.669 . . . . 2.5 109.926 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.47 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.4 t60 -65.55 -38.14 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.84 111.041 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.51 -58.34 8.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 1.54 112.051 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 166' ' ' LEU . 93.7 mt -56.05 -40.97 74.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.595 -0.275 . . . . 1.7 110.716 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.5 -30.98 71.43 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.954 -0.299 . . . . 2.49 111.144 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.748 ' HE1' ' HA ' ' A' ' 164' ' ' MET . 24.5 mmt -70.4 -39.76 74.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.134 0.492 . . . . 1.29 109.888 175.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.571 HG23 HD13 ' A' ' 57' ' ' ILE . 78.9 mt -57.08 -56.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.093 -0.958 . . . . 1.24 110.559 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.577 0.584 . . . . 2.36 112.577 176.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.43 -37.15 77.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 1.98 110.462 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.589 ' CG2' HD13 ' A' ' 146' ' ' ILE . 1.4 t -78.74 -35.14 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.146 -0.479 . . . . 1.69 110.612 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.532 ' HA ' ' HG3' ' A' ' 172' ' ' GLU . 20.3 t -65.32 -24.95 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.543 0.687 . . . . 2.07 110.071 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.05 -25.49 34.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 2.79 109.88 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.5 ttp -93.64 -13.43 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 2.22 111.163 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' A' ' 169' ' ' SER . 45.4 mt-10 -40.22 -45.42 2.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.198 0.599 . . . . 3.45 112.523 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -60.33 -30.82 69.77 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.485 0.55 . . . . 3.36 112.485 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -106.95 -40.91 5.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.731 0.301 . . . . 4.51 111.127 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.512 ' HZ3' ' CG ' ' A' ' 144' ' ' ASP . 24.8 tptp 66.05 -57.2 0.35 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.442 1.097 . . . . 6.66 112.27 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -125.77 -177.63 3.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.768 -0.456 . . . . 4.98 109.768 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 42.5 m-80 61.25 62.0 2.77 Favored Pre-proline 0 N--CA 1.467 0.386 0 O-C-N 123.618 0.574 . . . . 6.96 110.842 -177.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 177' ' ' ASN . 5.8 Cg_endo . . . . . 0 C--O 1.247 0.925 0 C-N-CA 122.918 2.412 . . . . 7.47 111.662 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.027 -0.429 . . . . 16.58 112.027 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -68.38 117.39 10.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.821 0.344 . . . . 14.94 110.837 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -122.99 65.75 0.97 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.377 0.608 . . . . 15.21 110.075 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.0 ptm -133.07 29.24 4.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.435 -0.802 . . . . 12.92 109.736 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.72 61.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 10.47 111.197 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -61.58 119.11 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.38 . . . . 9.14 110.831 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 60.67 78.85 0.3 Allowed Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.08 0.863 . . . . 9.01 112.154 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.23 128.52 15.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.977 1.785 . . . . 5.24 109.566 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.744 ' HD2' ' HG2' ' A' ' 56' ' ' LYS . 74.2 Cg_exo -48.71 101.33 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.008 2.472 . . . . 4.88 112.886 -178.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.525 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 35.6 m -71.85 116.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.225 -0.657 . . . . 3.08 109.225 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 81' ' ' ILE . 21.3 t -86.29 94.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.832 -0.622 . . . . 1.57 109.898 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 m -64.93 116.66 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.112 -0.949 . . . . 1.18 111.585 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.847 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.6 mt -104.73 128.19 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.45 . . . . 1.57 110.831 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.6 mtm -139.78 166.56 24.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.021 0.439 . . . . 1.41 111.096 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.59 -107.56 0.29 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.919 -0.872 . . . . 1.55 110.919 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -156.44 160.16 39.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.929 -0.397 . . . . 1.21 109.929 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.82 -56.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.68 0.252 . . . . 2.2 111.68 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.87 -15.14 63.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.435 0.532 . . . . 1.78 112.435 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HE1' ' H ' ' A' ' 93' ' ' MET . 64.3 m170 -77.43 -2.52 35.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.653 0.739 . . . . 0.89 110.421 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.53 47.79 47.93 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.966 -1.015 . . . . 1.06 113.4 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.8 pttp -70.89 -10.84 60.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.798 0.808 . . . . 2.58 109.481 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -81.31 -5.22 57.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.957 -1.019 . . . . 2.32 110.563 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 p -84.67 -32.56 23.55 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 120.801 -0.36 . . . . 2.23 110.821 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD11 ' N ' ' A' ' 25' ' ' LEU . 4.5 pp -69.66 -34.96 74.73 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.593 -0.891 . . . . 2.33 108.593 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -56.98 -38.84 73.58 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.484 -0.932 . . . . 2.46 108.484 175.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.41 -52.89 7.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 1.38 112.216 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . . . -67.73 -33.59 75.18 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.348 -0.387 . . . . 1.42 111.274 -171.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.482 ' CG2' ' HE2' ' A' ' 48' ' ' TYR . 96.2 mt -71.65 -29.7 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 2.08 110.314 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 75.2 mtm180 -66.42 -40.96 89.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.218 -0.66 . . . . 4.16 109.218 172.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.34 -12.6 57.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 3.57 110.606 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -2.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.84 -0.618 . . . . 2.09 110.199 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.579 ' O ' HG12 ' A' ' 33' ' ' VAL . 43.1 mttp 65.01 -161.17 0.28 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 115.518 -0.764 . . . . 5.98 111.386 172.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.081 HG21 ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 57.33 17.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.952 0.901 . . . . 3.41 112.438 174.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.574 HG21 HG12 ' A' ' 50' ' ' VAL . 3.5 p -84.68 135.3 34.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.243 0.544 . . . . 4.35 112.197 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.04 -41.68 61.42 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.435 -0.802 . . . . 4.2 110.345 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 26.9 mt-30 -108.17 78.3 1.17 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.392 -0.822 . . . . 6.16 109.183 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 49.72 1.39 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.303 -0.862 . . . . 5.79 112.464 -172.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -151.27 37.24 0.61 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.285 0.564 . . . . 4.64 110.516 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.09 96.65 0.23 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.18 -0.918 . . . . 4.95 112.888 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.628 ' H ' ' HA2' ' A' ' 46' ' ' GLY . . . 87.01 15.34 62.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.265 -0.493 . . . . 6.66 113.003 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 38' ' ' ALA . 59.2 mt -90.89 -69.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 9.5 110.36 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.424 ' O ' HD11 ' A' ' 45' ' ' ILE . 48.2 m -94.49 143.52 26.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.817 -0.629 . . . . 7.68 109.482 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -80.39 65.54 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.417 0.627 . . . . 9.39 111.193 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -148.93 -43.54 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.998 -1.001 . . . . 7.29 108.351 175.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.56 ' H ' HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -103.42 -168.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.659 -1.155 . . . . 5.6 109.464 173.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.628 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . 162.12 -42.94 0.37 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.121 -1.037 . . . . 3.5 112.025 -173.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.91 172.29 11.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.761 -0.829 . . . . 2.15 108.761 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.737 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -164.19 138.72 5.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.481 0.658 . . . . 2.96 111.893 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.594 ' HG2' HG23 ' A' ' 58' ' ' THR . 43.1 mt-30 -101.82 123.4 45.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.175 -0.921 . . . . 2.45 108.921 175.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG12 HG21 ' A' ' 34' ' ' THR . 12.3 m -97.6 144.64 10.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.151 0.5 . . . . 2.49 111.954 -175.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 1.081 ' HB ' HG21 ' A' ' 33' ' ' VAL . 59.8 m -88.1 82.6 7.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.614 0.721 . . . . 2.26 110.363 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.674 HG11 HD13 ' A' ' 166' ' ' LEU . 45.5 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.072 -1.085 . . . . 4.49 108.072 173.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 t30 70.39 -52.45 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.279 0.987 . . . . 4.58 111.177 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.688 ' O ' HG22 ' A' ' 51' ' ' THR . 19.8 t70 -126.72 -70.84 0.71 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.523 -0.762 . . . . 3.62 111.695 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 12.7 pttp 147.65 30.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.733 1.613 . . . . 7.78 108.121 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HG2' ' HD2' ' A' ' 9' ' ' PRO . 12.1 ttmm -99.29 10.29 41.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.645 -1.161 . . . . 5.81 111.585 -167.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.744 HG21 HG23 ' A' ' 11' ' ' VAL . 58.4 mt -102.51 98.61 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 1.4 110.191 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.594 HG23 ' HG2' ' A' ' 49' ' ' GLN . 14.2 m -86.69 111.1 20.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.913 -0.585 . . . . 1.85 110.103 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' HE2' HG22 ' A' ' 50' ' ' VAL . 34.9 m-85 -93.39 130.13 39.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.715 0.293 . . . . 1.14 110.352 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.34 164.05 36.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 3.46 110.622 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -136.64 -94.61 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.845 -0.798 . . . . 6.48 108.845 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.5 m 51.85 80.33 0.3 Allowed Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.788 0.662 . . . . 5.89 112.788 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.82 64.33 3.98 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.056 2.504 . . . . 5.92 111.99 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.36 -114.07 2.98 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.121 -0.561 . . . . 5.92 112.384 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -80.11 100.44 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.608 -0.145 . . . . 8.81 110.608 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.76 98.49 0.05 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.944 0.778 . . . . 6.36 110.106 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.2 58.98 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.611 . . . . 3.89 111.194 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 103' ' ' ALA . 22.1 t80 172.76 155.57 0.09 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.184 -1.043 . . . . 2.61 108.184 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -60.3 110.59 1.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.848 0.356 . . . . 5.11 110.395 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -58.96 130.86 49.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 6.34 111.43 -176.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.461 ' HE2' ' HB2' ' A' ' 106' ' ' ALA . 57.0 mtt -81.86 24.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 5.64 112.422 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -163.02 59.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.611 0.719 . . . . 10.31 110.429 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.09 24.32 9.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.53 -0.759 . . . . 7.85 109.967 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 69.13 -58.76 0.49 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.59 0.756 . . . . 11.11 111.385 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.18 -113.52 2.12 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.147 -0.781 . . . . 6.78 111.147 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.08 38.62 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.816 0.446 . . . . 7.11 111.002 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 71.79 92.78 0.08 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.963 0.79 . . . . 8.32 111.474 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.85 -18.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.876 0.846 . . . . 4.75 109.076 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -109.2 96.85 6.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.834 -1.075 . . . . 4.44 109.212 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.56 -175.47 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.863 -0.608 . . . . 3.12 110.353 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.754 HG22 HG11 ' A' ' 11' ' ' VAL . 8.5 mm -140.36 119.15 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.026 -0.534 . . . . 1.31 110.321 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 103' ' ' ALA . 40.5 t -99.51 96.24 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.107 -0.637 . . . . 1.78 111.283 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.847 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 17.3 mm -74.29 117.41 18.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.198 -1.038 . . . . 1.97 108.198 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.6 tm? -110.65 96.03 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.784 -0.643 . . . . 1.98 110.245 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 49.4 t -84.9 130.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.213 0.53 . . . . 1.8 111.388 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.784 HG13 HG21 ' A' ' 96' ' ' THR . 28.0 m -128.4 -164.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.511 -0.922 . . . . 1.79 108.511 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.56 40.53 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.116 -0.634 . . . . 1.03 111.965 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.712 ' HB2' ' HB3' ' A' ' 117' ' ' MET . . . -31.94 -64.68 0.16 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.93 1.394 . . . . 1.66 113.922 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.71 -20.13 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.864 -0.607 . . . . 2.01 112.356 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.36 -37.0 15.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.362 -0.535 . . . . 1.09 111.598 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 82.87 -144.35 22.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.528 -0.844 . . . . 0.52 111.783 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 96' ' ' THR . 2.8 p -100.85 102.57 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 109.279 -0.637 . . . . 1.67 109.279 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.594 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -83.49 169.54 17.08 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.57 -0.53 . . . . 1.32 109.57 -175.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 29.0 Cg_exo -30.42 -56.17 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.092 3.195 . . . . 0.88 115.1 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -69.98 -34.68 73.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.533 0.206 . . . . 2.01 111.016 -175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.784 HG21 HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.65 -31.48 72.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.649 0.738 . . . . 1.19 109.931 176.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.51 HG21 HG23 ' A' ' 92' ' ' VAL . 72.5 t -78.79 -45.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.354 -0.839 . . . . 1.66 111.055 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.6 mt-10 -63.94 -19.06 64.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.62 111.086 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.79 -41.04 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.863 -0.608 . . . . 1.09 109.646 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.577 HD12 ' HG ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.21 -47.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 1.13 110.79 176.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 101' ' ' ASN . 1.1 t-20 -49.24 -34.78 15.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.926 0.491 . . . . 1.97 110.735 173.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -85.69 -31.93 22.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 1.02 111.02 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.622 ' HB2' HG23 ' A' ' 82' ' ' VAL . . . -82.83 -44.78 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.925 0.343 . . . . 1.18 111.925 -173.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -54.59 -30.75 55.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.654 . . . . 2.98 112.759 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.32 3.37 15.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.973 0.731 . . . . 1.3 112.973 -167.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HB2' ' HE2' ' A' ' 71' ' ' MET . . . -91.39 -2.3 57.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.721 -0.844 . . . . 1.3 108.721 173.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.457 HD21 ' HA ' ' A' ' 107' ' ' ASN . 1.2 t-20 72.22 46.14 0.34 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.986 -1.461 . . . . 2.59 107.534 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.562 HG23 HG21 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -121.24 144.58 40.07 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 112.663 -2.062 . . . . 1.71 110.942 -170.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.45 154.47 73.67 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.681 2.254 . . . . 0.62 114.264 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.662 HG22 HG22 ' A' ' 145' ' ' THR . 1.2 mp -122.57 142.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.746 -1.57 . . . . 1.62 109.645 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.431 ' CD1' HG23 ' A' ' 81' ' ' ILE . 2.7 mp -121.23 99.96 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 CA-C-O 121.272 0.558 . . . . 1.31 111.292 -176.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -68.56 137.12 25.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.361 -0.836 . . . . 1.07 110.613 179.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -122.52 89.48 3.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.966 -1.124 . . . . 1.07 107.966 173.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.782 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 6.6 mm -65.22 85.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.595 -1.184 . . . . 1.56 109.745 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -95.75 168.36 10.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.88 110.128 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 69.46 12.92 8.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.333 0.587 . . . . 3.11 110.206 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.712 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -95.54 41.09 1.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.424 0.63 . . . . 1.55 110.642 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.48 57.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.633 -1.167 . . . . 2.45 110.798 170.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.843 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 63.8 mttp -154.44 -172.91 0.34 Allowed Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 105.48 -2.045 . . . . 4.11 105.48 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.843 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.8 Cg_endo -55.59 -54.41 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.524 1.223 . . . . 3.16 110.705 168.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 6.2 pt-20 164.71 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.456 1.102 . . . . 4.03 108.346 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -53.4 -69.58 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 1.9 110.325 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -173.52 75.44 0.39 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 2.21 110.781 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.652 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.2 Cg_exo -38.98 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.051 3.168 . . . . 1.01 114.094 171.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -45.48 -49.02 13.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.859 0.688 . . . . 2.0 112.859 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.563 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -50.68 -57.06 9.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.496 0.665 . . . . 3.7 109.872 175.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.563 ' N ' ' HD3' ' A' ' 126' ' ' ARG . 74.3 t -58.5 -45.51 90.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.389 -1.278 . . . . 1.12 110.514 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.756 ' HE3' ' HG3' ' A' ' 140' ' ' GLU . 84.0 mtp -62.74 -29.05 70.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.3 -0.864 . . . . 1.07 111.376 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -78.32 -24.31 46.67 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.513 -0.312 . . . . 2.01 110.773 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -72.61 -32.82 66.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.793 -0.817 . . . . 2.02 108.793 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.589 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -70.15 -44.67 68.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 120.048 -0.661 . . . . 1.62 109.569 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.886 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -76.95 -0.49 24.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.436 -0.802 . . . . 1.08 110.006 177.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.568 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.0 tp10 -77.5 -31.84 53.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.288 -1.375 . . . . 2.18 107.288 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -95.35 17.51 14.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.146 -0.933 . . . . 1.17 109.696 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.9 34.27 4.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.054 -1.43 . . . . 2.43 110.333 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 100' ' ' ILE . 1.0 OUTLIER -106.96 87.09 2.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.09 1.424 . . . . 2.28 109.0 173.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.817 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 93.3 t -83.91 119.74 73.93 Favored Pre-proline 0 C--N 1.285 -2.21 0 CA-C-N 111.559 -2.564 . . . . 1.28 111.334 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.846 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -47.74 157.97 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.791 2.994 . . . . 0.34 113.963 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.524 ' OE1' ' HA ' ' A' ' 144' ' ' ASP . 6.8 mm-40 -74.33 -24.69 59.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.13 -1.395 . . . . 2.01 109.183 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.833 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -56.86 -40.65 76.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.286 -0.87 . . . . 1.18 109.045 169.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.886 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.6 m0 -96.04 -21.24 18.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.858 -1.065 . . . . 0.45 111.089 -169.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.36 30.16 4.51 Favored Glycine 0 CA--C 1.501 -0.786 0 C-N-CA 119.762 -1.209 . . . . 0.45 112.011 170.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.817 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.93 -109.48 2.64 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.377 -0.916 . . . . 0.5 111.48 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.524 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 9.0 p-10 -166.42 46.36 0.07 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.623 1.201 . . . . 1.3 109.591 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.662 HG22 HG22 ' A' ' 110' ' ' ILE . 21.4 m -132.02 110.37 10.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.286 -1.325 . . . . 1.06 111.377 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 146' ' ' ILE . 3.9 mp -81.73 107.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.092 -0.958 . . . . 1.86 110.422 -175.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.846 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 22.6 m-85 -89.76 96.59 10.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.5 . . . . 0.38 111.33 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.428 ' O ' HD13 ' A' ' 150' ' ' LEU . 68.8 m -88.02 99.22 12.0 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.759 -0.655 . . . . 1.82 110.161 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.782 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.8 ptmt -76.35 83.97 3.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.872 -0.788 . . . . 2.94 108.872 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.486 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.5 -178.95 3.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.585 0.707 . . . . 1.89 112.23 -170.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -165.77 130.1 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.036 -0.983 . . . . 2.08 110.792 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . -84.47 -9.65 58.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 1.43 110.32 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -78.34 -58.69 3.12 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.295 -0.866 . . . . 3.46 109.342 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.697 ' HB ' ' HG2' ' A' ' 156' ' ' GLU . 22.1 p -73.99 -22.53 59.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.619 -1.173 . . . . 1.78 110.783 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 tptp 72.61 -2.64 2.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.092 -0.958 . . . . 2.75 110.981 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.697 ' HG2' ' HB ' ' A' ' 154' ' ' THR . 22.1 mm-40 -59.15 -73.33 0.08 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.459 0.647 . . . . 2.64 112.022 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -67.69 -9.1 55.06 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.73 113.454 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.413 HD11 HG12 ' A' ' 28' ' ' ILE . 2.6 tm? -64.27 -51.22 64.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.513 -0.551 . . . . 2.12 109.513 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.71 -36.51 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 2.5 109.938 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.544 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 80.1 t60 -58.75 -37.71 76.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.258 -0.883 . . . . 0.84 110.478 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.79 -49.49 77.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.921 -0.581 . . . . 1.54 110.634 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.26 -38.53 77.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 1.7 110.769 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.5 -42.99 91.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 2.49 110.499 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -39.0 92.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 1.29 110.621 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.23 -48.8 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.985 -0.552 . . . . 1.24 110.213 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.674 HD13 HG11 ' A' ' 52' ' ' VAL . 94.4 mt -62.84 -46.98 85.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.854 -0.612 . . . . 2.36 111.034 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.0 tp -48.8 -49.29 39.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.393 -0.821 . . . . 1.98 110.86 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.85 -44.96 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.014 -0.539 . . . . 1.69 111.032 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 m -58.38 -35.04 71.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.45 . . . . 2.07 111.117 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.94 -31.62 25.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 2.79 110.463 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 50.0 ttp -71.57 -43.4 66.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 2.22 111.307 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -54.39 -24.89 21.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.113 0.782 . . . . 3.45 113.113 -176.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.71 -30.39 70.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.301 0.572 . . . . 3.36 109.746 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.2 mt -106.57 -70.21 0.8 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.548 -0.751 . . . . 4.51 109.317 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttp 63.1 104.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.937 -1.029 . . . . 6.66 111.995 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -134.06 -58.17 0.85 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.614 -0.721 . . . . 4.98 109.989 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.89 137.5 5.69 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.467 -0.568 . . . . 6.96 109.467 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.208 2.606 . . . . 7.47 112.376 175.508 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.912 -0.475 . . . . 16.58 111.912 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -92.71 -4.91 52.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.004 0.431 . . . . 14.94 110.697 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -77.11 77.1 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.98 -0.555 . . . . 15.21 110.879 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.0 mtm -106.82 122.67 46.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.67 . . . . 12.92 110.015 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -86.03 32.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 10.47 111.428 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 13.8 mm-40 -69.83 -42.78 73.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.779 -0.646 . . . . 9.14 111.243 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 6' ' ' GLU . 15.0 mmm180 67.73 104.71 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 121.271 0.558 . . . . 9.01 111.286 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -87.13 116.77 1.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.837 2.358 . . . . 5.24 111.712 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 61' ' ' ASP . 76.3 Cg_exo -50.69 123.34 11.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.93 2.42 . . . . 4.88 111.993 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.791 HG13 ' HA ' ' A' ' 57' ' ' ILE . 43.0 t -93.57 -72.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.125 -0.488 . . . . 3.08 110.802 -177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.731 HG23 ' HB ' ' A' ' 81' ' ' ILE . 47.5 t -125.04 107.06 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 120.968 0.413 . . . . 1.57 111.028 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -98.12 132.53 43.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.157 0.503 . . . . 1.18 110.413 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 ' HB ' HD21 ' A' ' 60' ' ' LEU . 66.1 mt -94.87 127.51 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 1.57 110.708 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.69 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 54.8 mtt -127.48 173.12 10.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.726 -0.67 . . . . 1.41 110.922 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.11 -104.92 0.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.908 -0.877 . . . . 1.55 110.908 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 18' ' ' ASP . 81.6 t60 -166.55 143.34 4.88 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.261 -0.644 . . . . 1.21 109.261 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.42 -24.47 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.2 1.185 . . . . 2.2 114.2 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 21.1 m-20 -88.3 -11.83 45.3 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.561 0.578 . . . . 1.78 112.561 -173.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -77.6 -3.6 41.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.162 0.43 . . . . 0.89 112.162 -174.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.58 64.63 0.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.656 -0.783 . . . . 1.06 112.763 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -87.08 -34.69 19.06 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 2.58 110.871 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.628 -0.26 . . . . 2.32 110.472 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 p -78.54 -32.07 47.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.954 0.407 . . . . 2.23 110.635 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -54.45 13.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.851 -0.796 . . . . 2.33 108.851 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.62 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -59.1 -33.9 71.38 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.099 -0.955 . . . . 2.46 110.724 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.88 -55.83 6.81 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.035 -0.416 . . . . 1.38 111.398 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -59.71 -39.61 85.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.005 0.431 . . . . 1.42 110.898 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.552 HD12 ' OH ' ' A' ' 48' ' ' TYR . 10.8 tt -65.96 -28.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.504 -0.771 . . . . 2.08 111.252 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.761 ' HA ' HG23 ' A' ' 34' ' ' THR . 85.4 mtm180 -77.25 -26.59 52.71 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.595 0.712 . . . . 4.16 109.463 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -85.58 15.21 4.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.829 -1.078 . . . . 3.57 110.091 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 m -100.14 22.97 10.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.65 -0.704 . . . . 2.09 111.736 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 71.78 -48.13 0.67 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.181 1.178 . . . . 5.98 114.181 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 50' ' ' VAL . 29.2 m -71.95 6.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.473 0.916 . . . . 3.41 113.473 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.761 HG23 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -81.71 124.26 29.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.195 0.521 . . . . 4.35 111.623 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' OE1' ' HD3' ' A' ' 55' ' ' LYS . 37.3 mt-10 -72.38 -73.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 4.2 111.701 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -144.38 176.78 9.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.429 -0.805 . . . . 6.16 109.767 -173.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.817 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.6 mt-10 -124.95 100.67 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.427 0.454 . . . . 5.79 111.736 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.36 129.94 11.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.021 -0.536 . . . . 4.64 110.878 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . 105.51 -129.78 9.94 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.108 -0.567 . . . . 4.95 112.037 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . 72.5 165.2 8.15 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.516 0.566 . . . . 6.66 114.516 170.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.55 HG23 ' HA ' ' A' ' 63' ' ' PRO . 40.1 pt -97.87 -25.8 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.007 0.432 . . . . 9.5 110.823 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 44' ' ' HIS . 1.4 p -77.69 114.72 16.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 7.68 110.712 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -78.11 24.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 9.39 111.787 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 42' ' ' THR . 57.5 m-70 -90.31 -20.39 22.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.481 -0.562 . . . . 7.29 109.481 172.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.929 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.2 tp -174.76 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.262 -1.014 . . . . 5.6 108.262 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.929 ' H ' HG13 ' A' ' 45' ' ' ILE . . . -90.94 -119.74 2.24 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.224 -0.989 . . . . 3.5 112.629 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.817 ' O ' ' HA ' ' A' ' 37' ' ' GLU . . . -135.4 -169.3 2.36 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.456 -0.942 . . . . 2.15 108.456 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.584 ' HB2' HG22 ' A' ' 34' ' ' THR . 7.2 p90 -153.0 137.56 16.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.133 0.492 . . . . 2.96 111.156 -174.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.78 ' HG2' HG22 ' A' ' 58' ' ' THR . 18.0 mt-30 -109.44 134.09 52.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.581 -0.736 . . . . 2.45 109.284 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 90.3 t -88.62 150.26 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 CA-C-O 121.649 0.738 . . . . 2.49 110.609 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -92.63 83.8 4.94 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.606 -1.179 . . . . 2.26 110.588 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.732 HG12 ' HB2' ' A' ' 56' ' ' LYS . 3.3 p -125.31 120.3 57.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.38 -1.341 . . . . 4.49 107.38 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 73.73 -43.28 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.213 0.945 . . . . 4.58 108.889 -166.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 52' ' ' VAL . 16.5 t70 178.18 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.681 -1.599 . . . . 3.62 108.712 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 3.1 pttm -176.98 57.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.049 -0.978 . . . . 7.78 110.501 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.732 ' HB2' HG12 ' A' ' 52' ' ' VAL . 12.9 mmmm -73.95 -43.69 57.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 5.81 111.483 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HA ' HG13 ' A' ' 10' ' ' VAL . 59.5 mt -87.02 112.38 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.524 -0.47 . . . . 1.4 111.179 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.78 HG22 ' HG2' ' A' ' 49' ' ' GLN . 18.9 m -104.3 127.99 52.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 1.85 108.977 171.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.7 m-85 -97.28 127.01 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.976 -0.29 . . . . 1.14 110.92 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 13' ' ' ILE . 95.0 mt 67.68 59.73 0.47 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.969 0.793 . . . . 3.46 111.285 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' CG ' ' HA ' ' A' ' 9' ' ' PRO . 4.2 m-20 -66.58 -24.78 66.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 6.48 110.806 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -121.04 136.89 26.0 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.921 -0.581 . . . . 5.89 110.563 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 41' ' ' ILE . 66.0 Cg_endo -75.94 55.41 4.43 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.735 2.29 . . . . 5.92 111.537 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.86 88.23 1.16 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.504 -0.771 . . . . 5.92 113.331 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -80.12 -33.32 38.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.106 -1.072 . . . . 8.81 108.106 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -94.89 46.3 1.13 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.614 -1.176 . . . . 6.36 108.907 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 73.87 -75.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.972 -1.013 . . . . 3.89 111.604 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.677 ' HB2' ' CD2' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -130.68 127.32 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.702 0.287 . . . . 2.61 110.915 -177.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.71 -31.8 61.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 5.11 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 71' ' ' MET . 1.5 m -114.16 -178.04 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.526 -0.761 . . . . 6.34 109.626 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.7 ' H ' HG23 ' A' ' 70' ' ' THR . 72.4 mtm 59.29 54.07 4.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.632 0.73 . . . . 5.64 111.251 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.45 -42.17 5.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.108 -0.951 . . . . 10.31 109.087 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.25 34.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.736 -1.12 . . . . 7.85 109.058 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -165.79 133.59 2.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.237 -0.892 . . . . 11.11 109.654 -172.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.76 140.95 7.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.937 -0.649 . . . . 6.78 111.505 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.4 -65.72 0.29 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 7.11 110.968 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -87.87 76.02 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.504 0.668 . . . . 8.32 110.116 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.04 101.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.431 -0.804 . . . . 4.75 109.959 176.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 p -87.06 71.83 10.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.797 -0.638 . . . . 4.44 111.042 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.51 134.58 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 3.12 109.774 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.77 HG21 HD12 ' A' ' 111' ' ' ILE . 38.6 mm -83.78 103.21 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.911 -0.586 . . . . 1.31 109.716 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 108' ' ' VAL . 86.7 t -82.18 94.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 120.376 -0.53 . . . . 1.78 110.714 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 10.0 mm -80.66 97.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.369 -0.604 . . . . 1.97 109.369 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -87.71 96.26 10.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.005 -0.739 . . . . 1.98 109.005 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 t -81.71 137.98 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.428 0.632 . . . . 1.8 111.266 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' A' ' 114' ' ' ILE . 27.2 m -132.84 -168.19 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 1.79 108.547 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.26 20.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.371 -0.603 . . . . 1.03 109.371 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -58.64 -19.94 43.42 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.421 -0.809 . . . . 1.66 112.437 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.75 -12.48 33.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.515 0.191 . . . . 2.01 111.515 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 28.5 t70 -119.43 -49.65 2.36 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.375 0.607 . . . . 1.09 110.94 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.546 ' HA2' HG12 ' A' ' 127' ' ' VAL . . . 100.49 -124.67 8.32 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.18 -0.918 . . . . 0.52 111.239 -174.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.882 HG12 ' HE2' ' A' ' 134' ' ' TYR . 38.1 t -111.82 113.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.957 0.408 . . . . 1.67 111.029 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.558 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 77.2 mmm -80.33 168.12 28.06 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.557 -0.535 . . . . 1.32 109.557 172.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 6.3 Cg_endo -49.64 -42.83 41.87 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.393 2.062 . . . . 0.88 112.885 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.76 -26.86 62.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.659 0.266 . . . . 2.01 110.609 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.788 ' HB ' HG13 ' A' ' 92' ' ' VAL . 18.6 m -60.79 -35.77 77.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.128 -0.487 . . . . 1.19 110.483 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.57 ' CG1' ' HH ' ' A' ' 134' ' ' TYR . 2.0 m -84.15 -35.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.518 -0.31 . . . . 1.66 110.81 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.945 0.402 . . . . 1.62 111.474 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.69 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -66.82 -45.09 79.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.984 -0.553 . . . . 1.09 110.137 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.634 HG21 ' HD3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -64.27 -42.65 96.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.522 -0.763 . . . . 1.13 111.216 177.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -62.81 -30.73 71.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.509 0.723 . . . . 1.97 109.814 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.677 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 8.8 t60 -83.96 -32.54 24.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 1.02 110.333 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 82' ' ' VAL . . . -87.11 -48.78 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.334 0.494 . . . . 1.18 112.334 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.634 ' HD3' HG21 ' A' ' 100' ' ' ILE . 14.0 pttp -63.74 -16.4 61.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.526 0.565 . . . . 2.98 112.526 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.31 6.74 21.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.855 0.317 . . . . 1.3 111.855 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.585 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -98.21 2.14 48.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.803 -0.444 . . . . 1.3 109.803 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 77.92 31.87 0.4 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.742 1.258 . . . . 2.59 108.569 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -109.48 147.63 36.45 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 113.206 -1.815 . . . . 1.71 110.523 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.38 151.42 48.17 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.569 2.179 . . . . 0.62 113.547 172.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.618 HG22 HG21 ' A' ' 145' ' ' THR . 1.1 mp -118.82 142.59 33.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.225 -1.352 . . . . 1.62 110.212 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.77 HD12 HG21 ' A' ' 81' ' ' ILE . 4.3 mp -112.17 148.24 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 107.933 -1.136 . . . . 1.31 107.933 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -112.84 138.01 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 109.364 -0.606 . . . . 1.07 109.364 172.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 85' ' ' VAL . . . -118.95 88.17 2.88 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.758 -1.201 . . . . 1.07 107.758 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.777 HD12 ' HD2' ' A' ' 147' ' ' PHE . 21.1 mt -73.79 83.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.754 -1.112 . . . . 1.56 109.507 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -89.09 164.63 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.934 -0.575 . . . . 0.88 110.105 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 66.97 34.1 5.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.04 -0.527 . . . . 3.11 112.131 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.583 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 4.3 ptp -88.22 13.19 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 1.55 109.792 169.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -24.37 67.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.676 -1.147 . . . . 2.45 108.904 165.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.898 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 14.7 mmmm -77.92 -178.76 1.09 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 114.902 -1.044 . . . . 4.11 109.343 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.898 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.8 Cg_endo -52.85 -21.35 15.1 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.315 2.01 . . . . 3.16 113.629 177.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 7.3 pt-20 64.11 123.34 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.765 1.626 . . . . 4.03 110.955 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -79.28 11.78 2.72 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.123 -1.399 . . . . 1.9 110.958 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 122' ' ' ALA . 43.5 t30 77.6 108.87 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 114.74 -1.118 . . . . 2.21 112.092 171.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.4 Cg_exo -36.72 -60.78 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.572 3.515 . . . . 1.01 115.198 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -42.72 -41.85 3.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.6 0.76 . . . . 2.0 113.014 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.87 -54.07 51.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.701 0.762 . . . . 3.7 109.387 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.712 ' HA ' ' OE2' ' A' ' 130' ' ' GLU . 58.4 t -60.06 -39.38 80.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.338 -1.301 . . . . 1.12 110.083 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.77 ' HE3' ' HG3' ' A' ' 140' ' ' GLU . 86.3 mtp -65.64 -30.62 71.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.253 -0.885 . . . . 1.07 111.114 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.33 -15.45 57.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.543 -0.463 . . . . 2.01 110.898 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.712 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 12.9 mt-10 -72.3 -37.12 69.05 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.656 -0.868 . . . . 2.02 108.656 170.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.579 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -69.95 -45.17 68.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.45 0.643 . . . . 1.62 110.087 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.889 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -75.79 -5.52 46.24 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.309 -0.859 . . . . 1.08 109.645 177.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 14.4 tp10 -74.02 -32.37 63.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.785 -1.191 . . . . 2.18 107.785 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.882 ' HE2' HG12 ' A' ' 92' ' ' VAL . 30.2 m-85 -90.0 10.13 25.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.68 0.753 . . . . 1.17 109.1 173.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 71.95 38.73 0.89 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 113.898 -1.501 . . . . 2.43 110.565 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.2 mp -117.28 84.11 2.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.444 1.116 . . . . 2.28 108.679 172.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.963 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.2 t -69.67 127.31 92.7 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.022 -1.899 . . . . 1.28 112.139 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.843 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 81.3 Cg_exo -47.14 160.24 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.296 0 C-N-CA 124.109 3.206 . . . . 0.34 114.441 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -85.26 -5.87 59.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.336 -1.302 . . . . 2.01 110.11 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.861 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -74.13 -32.79 63.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.452 -1.314 . . . . 1.18 107.452 167.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.889 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -101.3 -26.27 13.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.191 -1.368 . . . . 0.45 111.286 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.5 30.8 3.19 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.845 -1.169 . . . . 0.45 112.315 172.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.963 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.87 -102.53 1.95 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 120.486 -0.864 . . . . 0.5 111.609 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -169.6 37.29 0.02 OUTLIER 'General case' 0 C--O 1.247 0.922 0 CA-C-O 122.168 0.985 . . . . 1.3 110.594 172.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.618 HG21 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.47 113.84 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.909 -1.041 . . . . 1.06 111.49 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.728 HG22 ' HB3' ' A' ' 164' ' ' MET . 3.7 mp -82.72 108.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.555 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.843 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.7 m-85 -91.33 111.75 23.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.701 0.286 . . . . 0.38 111.752 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 16.0 t -102.11 117.24 34.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.804 -0.813 . . . . 1.82 108.804 174.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.672 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.4 pttm -93.34 101.49 13.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.129 -0.693 . . . . 2.94 109.129 175.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.719 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -130.12 176.91 7.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.244 1.021 . . . . 1.89 113.567 -168.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.9 m -147.45 117.27 7.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.6 -1.636 . . . . 2.08 109.101 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.63 66.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.445 0.535 . . . . 1.43 112.445 -174.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.735 ' HG3' ' H ' ' A' ' 154' ' ' THR . 15.0 ptpt -73.95 -56.08 5.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.77 0.795 . . . . 3.46 110.12 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.735 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 10.3 p -72.77 -12.45 61.01 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.16 -1.382 . . . . 1.78 112.098 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.683 ' HD2' HD11 ' A' ' 158' ' ' LEU . 3.0 tptm 71.72 2.75 4.41 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.061 0.544 . . . . 2.75 111.779 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.94 -72.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.714 0.768 . . . . 2.64 111.423 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.719 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.36 -9.3 60.85 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.155 -0.93 . . . . 0.73 113.623 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 155' ' ' LYS . 31.2 mt -70.12 -42.69 72.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.365 0.582 . . . . 2.12 110.256 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.57 -44.86 92.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 2.5 109.569 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -67.39 -24.63 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.84 111.361 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.28 -50.02 65.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.551 -0.295 . . . . 1.54 110.289 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -55.7 -36.75 67.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.007 -0.542 . . . . 1.7 110.459 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.16 -51.6 69.31 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.032 0.444 . . . . 2.49 110.526 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.766 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 16.2 mmt -65.5 -40.84 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 1.29 110.799 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.92 -53.18 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.709 -0.678 . . . . 1.24 110.314 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.21 -43.94 95.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.792 -0.64 . . . . 2.36 111.44 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.4 tp -54.01 -47.8 71.1 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.043 -0.526 . . . . 1.98 110.196 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 171' ' ' MET . 48.0 t -73.0 -23.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.07 -0.513 . . . . 1.69 111.317 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.7 t -60.14 -32.11 70.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 2.07 110.13 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -99.25 -27.8 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.017 0.437 . . . . 2.79 110.593 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.575 ' HE3' ' HB2' ' A' ' 174' ' ' LEU . 13.5 ttp -82.45 5.67 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 2.22 111.432 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -40.97 -31.61 0.18 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.031 0.443 . . . . 3.45 111.235 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -57.84 -8.9 1.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.637 -0.71 . . . . 3.36 112.367 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.575 ' HB2' ' HE3' ' A' ' 171' ' ' MET . 58.7 tp -46.89 -49.97 19.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.177 0.513 . . . . 4.51 110.797 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -145.99 0.5 0.84 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.815 -0.629 . . . . 6.66 111.555 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.77 11.45 35.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.215 0.531 . . . . 4.98 110.217 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 27.2 t-20 -88.64 131.97 40.16 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.72 -0.673 . . . . 6.96 109.373 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 16.6 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.793 2.328 . . . . 7.47 112.108 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.023 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 10.5 t . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.613 0.721 . . . . 1.0 109.474 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -70.54 118.42 13.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.096 -0.957 . . . . 0.66 111.282 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.724 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.1 mt -87.18 116.06 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.371 0.605 . . . . 1.03 110.549 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 35.0 mtt -125.17 172.23 9.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.552 -0.749 . . . . 1.04 110.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 1.019 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 147.54 -96.64 0.18 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 109.851 -1.299 . . . . 1.55 109.851 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.622 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 27.2 t-80 -175.0 164.28 3.35 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.659 -0.867 . . . . 0.66 108.659 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.09 -52.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.665 0.269 . . . . 1.62 111.439 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.13 -30.12 70.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.792 -0.64 . . . . 1.78 112.651 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.622 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 39.9 m80 -64.76 -19.43 65.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.408 . . . . 0.65 110.949 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.89 44.15 2.92 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.679 -0.772 . . . . 0.93 112.978 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG11 ' A' ' 85' ' ' VAL . 22.0 ptmt -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.3 p -74.68 -35.68 62.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.738 -1.119 . . . . 1.8 109.62 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.8 m -63.3 -33.68 76.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.138 -0.937 . . . . 1.77 110.522 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.46 -56.19 20.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.408 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' HG22 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -62.64 -38.51 90.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.12 -0.491 . . . . 1.96 110.006 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 12.3 t70 -63.88 -49.49 72.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.98 0.363 . . . . 1.38 111.98 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -68.02 -37.31 81.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.227 0.537 . . . . 0.91 110.857 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.597 HG22 ' HA ' ' A' ' 25' ' ' LEU . 6.5 tt -74.11 -20.84 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.451 -0.795 . . . . 1.56 109.812 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 33.0 tpt180 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.115 -0.948 . . . . 3.56 109.831 174.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -88.84 7.44 34.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.584 -0.735 . . . . 2.88 110.145 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.316 0.579 . . . . 1.76 110.33 -177.545 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' A' ' 28' ' ' ILE . 3.0 p90 . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 120.814 0.34 . . . . 2.54 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HG2' HG23 ' A' ' 58' ' ' THR . 36.8 mt-30 -122.42 122.98 40.26 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.876 -0.787 . . . . 1.96 108.876 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' HE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.948 0 CA-C-O 121.364 0.602 . . . . 1.93 111.194 -173.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 11' ' ' VAL . 56.1 mt . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.057 0.456 . . . . 1.14 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -88.58 113.21 23.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.874 -0.603 . . . . 1.28 109.442 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HE2' HG21 ' A' ' 50' ' ' VAL . 27.6 m-85 . . . . . 0 C--N 1.328 -0.356 0 C-N-CA 120.932 -0.307 . . . . 0.84 111.417 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 24.5 mm . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 110.469 -0.197 . . . . 0.74 110.469 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.954 HG21 ' HB1' ' A' ' 103' ' ' ALA . 13.1 t -99.23 94.97 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 120.418 -0.513 . . . . 1.19 111.703 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 30.9 mm -80.36 115.27 22.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.206 -1.035 . . . . 1.32 108.206 170.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.9 tm? -105.72 101.13 10.66 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.487 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.019 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.1 p -79.96 142.49 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.478 0.656 . . . . 1.2 111.697 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 87' ' ' ALA . 25.3 t -136.1 173.04 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 107.583 -1.265 . . . . 1.12 107.583 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.59 112.8 5.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.231 0.469 . . . . 0.75 112.017 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 41.35 -97.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.599 1.16 . . . . 1.18 113.756 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.26 1.29 25.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 2.01 112.055 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.543 ' OD1' ' HG3' ' A' ' 93' ' ' MET . 14.1 t70 -71.24 -49.2 45.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.09 110.635 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.765 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 86.43 -107.6 3.21 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.159 -0.928 . . . . 0.52 111.606 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.874 HG13 ' HB ' ' A' ' 96' ' ' THR . 30.7 t -128.81 111.75 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 122.347 0.259 . . . . 1.08 110.709 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.633 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.9 mtp -82.8 172.09 10.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.695 -0.23 . . . . 1.32 110.445 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.633 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 99.4 Cg_exo -44.17 -52.03 6.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.028 2.486 . . . . 0.61 113.658 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -65.46 -28.83 69.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.591 -0.277 . . . . 1.47 111.241 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.874 ' HB ' HG13 ' A' ' 92' ' ' VAL . 8.1 m -62.97 -30.29 71.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.248 0.547 . . . . 0.46 110.624 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 70.9 t -84.46 -52.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.286 -0.416 . . . . 1.05 111.676 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.35 -18.83 60.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.849 -0.614 . . . . 1.62 111.473 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -88.09 -39.9 14.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.877 -0.601 . . . . 0.34 109.543 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.865 HD11 ' HG ' ' A' ' 84' ' ' LEU . 1.7 mt -71.59 -48.96 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.38 111.311 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -50.45 -38.52 44.01 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.965 0.506 . . . . 1.85 110.982 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -76.64 -33.39 58.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.744 -0.662 . . . . 0.85 110.565 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.954 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.13 -50.38 9.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.033 -0.53 . . . . 0.48 112.342 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 11.8 ptmm? -59.87 -21.02 60.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.704 -0.68 . . . . 2.56 112.677 -167.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.48 10.99 30.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.707 0.632 . . . . 0.76 112.707 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -100.65 -0.12 38.09 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.035 -0.728 . . . . 0.9 109.035 174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.2 t30 75.98 41.54 0.23 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.685 1.231 . . . . 2.06 108.71 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -124.13 142.67 40.47 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 113.289 -1.778 . . . . 1.08 110.54 -174.001 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 19.4 Cg_exo -68.01 154.86 71.64 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.657 2.238 . . . . 0.51 113.981 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.709 HD13 HG12 ' A' ' 100' ' ' ILE . 84.7 mt -127.33 146.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.976 -1.465 . . . . 0.96 109.209 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 83' ' ' ILE . 3.4 mp -129.8 103.14 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.71 111.242 -167.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -67.42 133.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.137 -0.938 . . . . 0.23 110.237 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.34 87.69 2.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.826 -1.176 . . . . 0.25 107.826 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.746 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 18.5 mm -67.43 95.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.861 -1.063 . . . . 0.85 110.51 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.03 163.46 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.968 -0.753 . . . . 0.69 108.968 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 63.72 20.09 12.05 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.159 0.504 . . . . 2.61 111.162 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.761 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 13.1 tpp . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 121.833 0.825 . . . . 1.37 109.9 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.516 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 1.1 p30 . . . . . 0 N--CA 1.435 -1.178 0 CA-C-O 120.529 0.204 . . . . 1.84 111.33 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.9 Cg_exo -37.57 -67.1 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.095 3.197 . . . . 0.7 113.853 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -48.89 -49.78 38.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.882 0.473 . . . . 2.0 112.089 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 2.4 tmt_? -54.73 -56.93 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.098 0.475 . . . . 2.99 109.997 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.765 HG13 ' HA2' ' A' ' 91' ' ' GLY . 93.2 t -55.71 -41.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 0.4 111.016 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 89.4 mtp -66.02 -33.09 75.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 0.3 110.71 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 70.3 mt-30 -73.35 -24.55 60.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.425 . . . . 1.28 111.098 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.8 mm-40 -64.55 -37.66 88.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.715 -0.846 . . . . 2.02 108.715 172.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -70.28 -46.16 64.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.466 -0.788 . . . . 1.06 109.703 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.926 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -75.16 -1.1 21.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.001 177.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.1 tt0 -78.57 -28.97 46.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 2.18 107.539 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.665 ' CE2' HG11 ' A' ' 92' ' ' VAL . 61.5 m-85 -91.99 16.08 11.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.644 -0.707 . . . . 0.74 109.589 168.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.4 t30 71.01 22.16 4.65 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.048 -1.433 . . . . 1.94 110.188 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 100' ' ' ILE . 7.0 mp -91.65 72.55 5.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.315 -0.857 . . . . 1.68 109.693 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -64.87 119.95 62.37 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 114.482 -1.236 . . . . 0.61 110.822 178.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.869 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 80.9 Cg_exo -47.05 160.69 0.25 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.634 2.889 . . . . 0.3 113.57 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.29 -21.25 53.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.768 -1.105 . . . . 2.01 109.682 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.809 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -58.8 -41.11 85.99 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.302 -0.999 . . . . 1.14 108.302 168.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.926 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.6 m0 -95.85 -20.44 18.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.644 -1.162 . . . . 0.45 110.896 -170.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.98 31.6 4.7 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.315 -0.945 . . . . 0.45 112.697 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.15 -99.15 1.96 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.5 112.64 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.06 27.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.68 0.753 . . . . 1.3 110.845 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m -121.39 112.17 18.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 0.32 111.752 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.57 109.45 15.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.137 -0.938 . . . . 1.23 110.343 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.869 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -91.21 111.55 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.101 0.476 . . . . 0.38 111.192 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.3 m -105.9 100.0 9.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.036 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.761 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 19.2 pttp -81.37 91.96 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.726 -0.842 . . . . 2.44 108.726 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.859 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 1.1 pt? -119.31 -171.39 2.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.137 0.97 . . . . 1.27 112.851 -166.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.445 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 33.7 t -157.96 129.56 6.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.877 -1.511 . . . . 1.79 109.638 170.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -88.73 -25.64 22.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.815 -0.629 . . . . 0.87 110.809 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.3 ptmm? -76.68 -53.5 7.92 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.403 0.62 . . . . 3.03 110.061 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 153' ' ' LYS . 81.2 p -72.49 -14.97 61.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.868 -1.06 . . . . 1.2 110.504 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 69.59 17.0 7.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.182 -0.917 . . . . 2.27 111.107 175.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.29 -62.07 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.994 0.902 . . . . 2.64 109.993 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -75.01 -16.61 80.49 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.686 -1.143 . . . . 0.62 113.514 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 158' ' ' LEU . 1.8 tm? -56.4 -47.37 79.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.909 -0.774 . . . . 1.55 108.909 174.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.614 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -58.02 -53.4 58.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.362 -0.836 . . . . 2.5 110.304 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -60.99 -22.77 64.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.723 -0.672 . . . . 0.73 111.749 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 1.2 tm? -69.77 -53.2 19.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.382 -0.372 . . . . 0.91 110.032 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -65.84 -30.52 71.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.654 0.264 . . . . 1.06 110.321 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.5 mm-40 -58.28 -38.97 78.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.035 -0.529 . . . . 2.49 110.723 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -32.56 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.2 -0.454 . . . . 0.87 111.096 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 72.8 mt -59.77 -52.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.511 -0.313 . . . . 0.64 110.929 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -68.96 -30.83 69.35 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.89 0.376 . . . . 1.81 111.372 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 166' ' ' LEU . 65.3 tp -55.51 -31.09 61.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.44 -0.8 . . . . 1.42 110.148 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 41.0 t . . . . . 0 N--CA 1.443 -0.817 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.949 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 81' ' ' ILE . 54.7 t . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 120.832 0.349 . . . . 1.0 110.586 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -86.24 130.7 34.43 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.024 -0.535 . . . . 0.66 110.943 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -95.9 122.98 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.92 0.391 . . . . 1.03 110.376 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.404 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 50.0 mtt -138.24 175.69 9.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.565 0.697 . . . . 1.04 112.214 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.51 -100.27 0.35 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.838 -1.305 . . . . 1.55 109.838 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 16.0 t60 -160.1 132.68 6.47 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.053 -1.091 . . . . 0.66 108.053 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.793 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 14.0 p -62.17 -29.67 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.501 -0.772 . . . . 1.62 112.704 -167.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.92 -27.18 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.288 0.477 . . . . 1.78 112.288 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -56.54 -52.24 65.53 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.287 0.565 . . . . 0.65 111.098 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 177.14 33.45 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.4 -0.818 . . . . 0.93 111.096 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.793 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 12.6 tmtt? -88.43 -56.19 3.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.974 0.416 . . . . 2.11 110.277 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -68.19 -30.76 69.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.489 . . . . 1.8 110.062 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -77.06 -27.62 54.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.001 -0.545 . . . . 1.77 110.571 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 8.5 tt -65.98 -50.49 64.14 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.466 -0.568 . . . . 1.78 109.466 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 28' ' ' ILE . 4.9 tt -57.7 -40.51 79.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.762 -0.654 . . . . 1.96 110.195 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 24.7 t70 -70.73 -50.0 40.84 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.813 -0.355 . . . . 1.38 111.553 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.54 75.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.17 0.509 . . . . 0.91 111.142 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 25' ' ' LEU . 7.2 tt -70.25 -33.93 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.355 -0.838 . . . . 1.56 110.856 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 60.9 mtm180 -71.21 -33.97 70.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.474 0.654 . . . . 3.56 109.546 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -82.12 14.94 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.35 -0.841 . . . . 2.88 110.169 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 1.76 109.998 179.655 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.608 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 p90 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.131 0.491 . . . . 2.54 111.358 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -116.14 154.75 29.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.108 -1.071 . . . . 1.96 108.108 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.93 111.785 179.428 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.4 mt . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.065 0.46 . . . . 1.14 110.948 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -98.89 112.1 24.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.573 -0.739 . . . . 1.28 109.492 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 41.9 m-85 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.84 111.477 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 11' ' ' VAL . 46.1 mm . . . . . 0 C--O 1.225 -0.208 0 N-CA-C 111.263 0.098 . . . . 0.74 111.263 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.9 t -97.41 106.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.652 0.263 . . . . 1.19 111.562 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.608 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 12.2 mm -89.72 106.72 17.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.651 -0.5 . . . . 1.32 109.651 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.627 HD22 HD11 ' A' ' 100' ' ' ILE . 8.4 tp -92.9 126.06 37.8 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.075 -0.511 . . . . 1.33 110.619 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.68 140.56 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.009 -0.432 . . . . 1.2 112.043 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.0 m -135.03 -177.34 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.94 -0.763 . . . . 1.12 108.94 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 126.66 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.875 0.694 . . . . 0.75 112.875 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 42.92 -104.41 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.302 1.223 . . . . 1.18 114.302 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -112.15 -8.65 13.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.813 -173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 2.8 t70 -62.83 -38.66 91.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.208 -0.664 . . . . 1.09 109.208 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . 78.98 -147.14 30.21 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.891 -1.05 . . . . 0.52 112.408 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.595 HG12 HG23 ' A' ' 97' ' ' VAL . 79.1 t -88.21 100.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 114.995 -0.602 . . . . 1.08 109.938 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 10.3 mtp -70.95 167.75 26.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 1.32 111.411 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 83.0 Cg_exo -47.37 -41.48 28.59 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.507 2.138 . . . . 0.61 112.435 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.668 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 4.6 mm-40 -65.74 -42.11 91.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.024 0.44 . . . . 1.47 110.187 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.624 HG22 HD21 ' A' ' 84' ' ' LEU . 3.5 m -61.06 -30.51 70.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.46 110.11 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 92' ' ' VAL . 44.3 t -78.07 -52.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.048 -0.978 . . . . 1.05 111.594 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.0 pt-20 -65.04 -32.25 73.88 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 1.62 111.681 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -66.29 -42.73 87.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.547 0.689 . . . . 0.34 109.404 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.977 HG12 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -68.19 -43.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.98 -1.009 . . . . 0.38 110.81 176.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.5 -27.25 62.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.909 -0.587 . . . . 1.85 110.743 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -85.57 -36.13 20.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.85 110.413 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -83.18 -49.54 9.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.554 0.576 . . . . 0.48 112.554 -172.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HD3' HG23 ' A' ' 100' ' ' ILE . 41.3 pttt -61.99 -16.88 54.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.669 0.618 . . . . 2.56 112.669 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.87 10.54 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.371 0.508 . . . . 0.76 112.371 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.666 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -99.57 4.09 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 0.9 109.768 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 86.13 6.11 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.461 1.124 . . . . 2.06 108.794 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -93.11 142.79 25.8 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.169 -1.832 . . . . 1.08 111.585 -174.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.17 160.15 50.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.945 2.43 . . . . 0.51 113.447 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.977 HD13 HG12 ' A' ' 100' ' ' ILE . 91.9 mt -127.54 150.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.163 -0.926 . . . . 0.96 110.394 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 mp -121.79 154.75 26.15 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.687 -0.857 . . . . 0.71 108.687 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -118.25 140.86 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 120.667 0.27 . . . . 0.23 110.494 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.42 89.04 3.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.207 -1.034 . . . . 0.25 108.207 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 86' ' ' VAL . 33.0 mt -73.54 94.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.587 -1.188 . . . . 0.85 111.075 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.76 156.55 24.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.537 0.208 . . . . 0.69 110.977 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt 59.2 33.86 22.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.863 0.84 . . . . 2.61 109.989 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.974 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 2.4 tpp . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.015 -0.993 . . . . 1.37 110.98 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.475 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 28.4 t-20 . . . . . 0 CA--C 1.511 -0.549 0 CA-C-O 122.289 1.043 . . . . 1.84 109.996 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.599 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -27.85 -75.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 1 C-N-CA 126.124 4.549 . . . . 0.7 115.46 169.407 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -43.7 -53.4 5.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.17 0.588 . . . . 2.0 112.293 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 11.8 tpt180 -53.07 -65.27 0.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.229 0.538 . . . . 2.99 110.185 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.475 HG22 ' HA2' ' A' ' 91' ' ' GLY . 47.1 t -55.27 -42.36 65.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.451 -1.249 . . . . 0.4 111.41 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.822 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 83.1 mtp -73.1 -30.83 63.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.141 -0.936 . . . . 0.3 111.405 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.08 -27.77 32.73 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.475 -0.49 . . . . 1.28 111.123 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 9.6 mt-10 -61.78 -40.09 93.96 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.016 -1.105 . . . . 2.02 108.016 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -71.45 -46.82 58.98 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.459 -0.791 . . . . 1.06 111.267 -172.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.939 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.2 ppp? -67.36 -8.64 34.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.49 -0.777 . . . . 0.35 109.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -78.1 -28.17 48.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.667 -0.864 . . . . 2.18 108.667 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -82.07 -1.95 50.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.816 0.817 . . . . 0.74 108.803 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.1 t30 76.78 42.95 0.14 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 113.101 -1.863 . . . . 1.94 111.203 163.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -123.05 86.75 2.63 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.942 -1.873 . . . . 1.68 105.942 167.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.43 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.44 131.91 94.24 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.789 -1.55 . . . . 0.61 111.313 -171.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.715 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 88.2 Cg_exo -46.87 152.64 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.178 2.585 . . . . 0.3 113.296 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.97 -30.57 62.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.078 -1.419 . . . . 2.01 108.469 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.837 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -51.34 -45.28 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.41 -1.268 . . . . 1.14 109.485 170.066 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.939 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.0 m0 -89.53 -21.98 22.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.366 -1.288 . . . . 0.45 110.598 -170.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.31 18.5 4.95 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.049 -1.072 . . . . 0.45 112.678 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.43 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.09 -115.54 3.08 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.701 -0.762 . . . . 0.5 112.499 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.07 30.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.886 0.374 . . . . 1.3 111.485 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 131' ' ' LEU . 24.9 m -129.22 108.99 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.857 -0.737 . . . . 0.32 112.175 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 164' ' ' MET . 2.2 mp -80.15 110.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.77 . . . . 1.23 110.698 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.822 ' CE2' ' HG2' ' A' ' 128' ' ' MET . 19.4 m-85 -88.09 115.54 25.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.19 0.519 . . . . 0.38 111.311 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 63.9 m -104.03 117.13 33.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.054 -0.721 . . . . 1.1 109.054 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.974 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 14.5 pttp -98.16 85.95 3.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.106 0.955 . . . . 2.44 109.72 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.691 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -110.64 -179.62 3.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.988 -1.005 . . . . 1.27 112.534 -170.278 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 10.1 t -143.46 131.7 21.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.418 -1.265 . . . . 1.79 109.196 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.484 0.659 . . . . 0.87 109.93 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -92.51 -58.92 2.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.371 -0.831 . . . . 3.03 110.038 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 151' ' ' SER . 3.9 m -68.71 -29.67 68.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.654 -1.157 . . . . 1.2 110.644 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 58.88 26.8 15.33 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.507 -1.224 . . . . 2.27 111.414 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -83.4 -45.84 13.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.86 0.838 . . . . 2.64 109.81 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -75.6 -11.65 84.28 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.01 -0.996 . . . . 0.62 112.668 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 158' ' ' LEU . 26.2 mt -64.18 -39.81 94.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 1.55 110.475 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -78.87 -37.5 40.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.38 -0.373 . . . . 2.5 110.089 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 164' ' ' MET . 65.1 t60 -59.45 -37.21 77.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.069 -0.514 . . . . 0.73 109.986 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 165' ' ' ILE . 63.5 tp -60.61 -58.32 8.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.91 110.528 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 165' ' ' ILE . 89.8 mt -54.24 -39.49 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.944 -0.571 . . . . 1.06 111.357 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.45 -41.33 96.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 2.49 111.251 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.75 ' HB3' HG21 ' A' ' 146' ' ' ILE . 29.8 mmt -69.89 -38.54 76.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.87 110.096 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 83' ' ' ILE . 80.7 mt -54.72 -54.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.64 110.242 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.45 -38.09 89.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 1.81 111.104 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.64 -42.22 87.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 1.42 110.312 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 116.354 -0.385 . . . . 1.17 110.978 -178.419 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.599 HG11 HD11 ' A' ' 83' ' ' ILE . 51.5 t . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 120.771 0.32 . . . . 1.0 111.569 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -104.36 136.3 44.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.66 110.741 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG22 ' HE2' ' A' ' 21' ' ' LYS . 56.3 mt -92.96 124.16 45.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 1.03 110.684 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.684 ' HG3' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -108.69 -175.04 2.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.365 -0.834 . . . . 1.04 110.326 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.949 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 109.15 133.9 6.91 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.27 -0.967 . . . . 1.55 111.834 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 65.8 t60 -44.58 135.88 4.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.564 -0.818 . . . . 0.66 110.887 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.08 -29.33 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.93 -1.032 . . . . 1.62 113.563 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 26.8 t70 -86.23 -21.78 27.25 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.045 0.387 . . . . 1.78 112.045 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.483 ' HB2' HG13 ' A' ' 85' ' ' VAL . 51.5 m170 -61.8 -35.92 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.65 111.14 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 152.55 71.49 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.175 -1.012 . . . . 0.93 113.041 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 28.9 mmtp -90.38 -71.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.029 0.443 . . . . 2.11 110.98 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 t -64.5 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 1.8 110.604 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -73.41 -26.17 60.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.292 -0.413 . . . . 1.77 110.787 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.3 tm? -79.35 -49.77 11.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.363 -0.977 . . . . 1.78 108.363 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.776 -1.102 . . . . 1.96 110.588 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.62 -56.53 9.05 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.174 -0.329 . . . . 1.38 111.794 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.56 92.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.316 -0.402 . . . . 0.91 110.849 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.651 HD13 ' OH ' ' A' ' 48' ' ' TYR . 6.7 tt -63.9 -32.91 58.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.029 -0.532 . . . . 1.56 110.128 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 70.4 mtp180 -70.4 -34.68 72.82 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.306 0.574 . . . . 3.56 110.657 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -77.59 14.48 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 2.88 111.028 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 108.538 -0.912 . . . . 1.76 108.538 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.651 ' OH ' HD13 ' A' ' 28' ' ' ILE . 9.6 p90 . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.953 0.406 . . . . 2.54 111.238 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.41 131.93 34.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.828 -0.805 . . . . 1.96 108.828 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 162' ' ' LEU . 61.0 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.541 0.686 . . . . 1.93 110.975 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.1 mt . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.61 0.243 . . . . 1.14 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -84.83 124.75 31.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.768 -0.456 . . . . 1.28 109.768 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.641 0.258 . . . . 0.84 110.581 -179.238 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' HB ' HG22 ' A' ' 11' ' ' VAL . 36.0 mm . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.161 -0.311 . . . . 0.74 110.161 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 73.1 t -113.24 112.71 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.022 -0.535 . . . . 1.19 111.46 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.77 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.9 mt -94.96 99.97 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 C-N-CA 120.264 -0.574 . . . . 1.32 110.049 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 100' ' ' ILE . 6.7 tp -87.1 113.14 22.59 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.693 -0.403 . . . . 1.33 110.796 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.949 HG12 ' HA3' ' A' ' 15' ' ' GLY . 8.7 p -81.39 142.41 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 1.2 110.667 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 87' ' ' ALA . 18.2 t -134.68 175.27 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 107.489 -1.3 . . . . 1.12 107.489 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.02 114.7 6.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.623 0.647 . . . . 0.75 112.497 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 40.63 -96.88 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.84 1.052 . . . . 1.18 113.84 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -108.11 -3.1 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.891 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 3.8 t70 -71.05 -45.24 64.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.185 0.517 . . . . 1.09 110.423 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.74 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 81.41 -109.8 3.06 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.52 111.84 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 96' ' ' THR . 42.5 t -124.73 109.25 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.053 0.454 . . . . 1.08 111.349 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 65.4 mmm -80.48 168.84 22.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 1.32 110.246 173.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.7 Cg_exo -47.0 -50.07 11.55 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.633 2.222 . . . . 0.61 112.877 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.95 -37.02 73.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.47 111.041 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.59 HG23 HD11 ' A' ' 84' ' ' LEU . 33.7 m -63.39 -25.95 68.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.235 -0.438 . . . . 0.46 111.038 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG23 ' CG1' ' A' ' 92' ' ' VAL . 22.5 t -85.88 -55.54 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 112.177 0.436 . . . . 1.05 112.177 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.2 -21.56 61.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.9 0.381 . . . . 1.62 110.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.684 ' HB1' ' HG3' ' A' ' 14' ' ' MET . . . -82.18 -34.56 28.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 0.34 109.997 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.767 HD11 HD22 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -77.83 -44.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.38 110.41 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -55.1 -37.39 66.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.464 -0.789 . . . . 1.85 111.206 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -79.5 -25.72 41.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 0.85 110.521 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -86.0 -59.49 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.284 0.476 . . . . 0.48 112.284 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -17.25 63.95 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.286 0.476 . . . . 2.56 112.286 -167.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.22 5.3 17.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.849 0.357 . . . . 0.76 111.891 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.85 8.38 30.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.667 -0.864 . . . . 0.9 108.667 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.8 t30 75.44 30.38 0.83 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.361 -1.29 . . . . 2.06 110.242 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -107.97 146.48 33.56 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.245 -0.889 . . . . 1.08 110.734 178.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 5.7 Cg_exo -76.15 158.16 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.369 2.713 . . . . 0.51 113.311 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 145' ' ' THR . 4.4 mp -124.27 154.57 31.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.084 -0.962 . . . . 0.96 109.583 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.77 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 6.1 mt -118.94 155.83 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 108.353 -0.98 . . . . 0.71 108.353 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -119.77 134.13 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.002 0.429 . . . . 0.23 110.249 174.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.99 88.01 2.86 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.111 -1.07 . . . . 0.25 108.111 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.823 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 13.8 mm -66.85 95.1 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.042 -0.981 . . . . 0.85 110.148 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 55.0 t30 -92.85 169.02 10.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.164 -0.68 . . . . 0.69 109.164 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HD3' ' HB1' ' A' ' 87' ' ' ALA . 55.7 mtpt 58.51 26.37 14.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.688 0.756 . . . . 2.61 110.056 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.551 ' SD ' ' HE2' ' A' ' 149' ' ' LYS . 5.2 tpp . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 114.973 -1.012 . . . . 1.37 110.269 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.66 -0.496 . . . . 1.84 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.63 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.3 Cg_exo -38.95 -61.98 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.077 3.185 . . . . 0.7 113.694 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -47.21 -49.68 22.47 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 2.0 tmt_? -53.77 -56.44 17.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.325 0.583 . . . . 2.99 109.58 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.74 HG13 ' HA2' ' A' ' 91' ' ' GLY . 88.3 t -56.78 -41.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.787 -1.097 . . . . 0.4 110.847 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.673 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -67.07 -32.86 74.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.954 -0.567 . . . . 0.3 110.943 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 75.1 mt-30 -75.75 -24.32 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.665 -0.243 . . . . 1.28 110.883 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.6 mm-40 -63.48 -39.92 95.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.598 -0.89 . . . . 2.02 108.598 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.4 mm? -68.42 -46.6 69.45 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.06 110.016 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.827 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -73.44 -5.49 40.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.618 -0.719 . . . . 0.35 110.276 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 43.8 tt0 -76.56 -28.56 56.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.457 -0.942 . . . . 2.18 108.457 171.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.451 ' CE2' HG11 ' A' ' 92' ' ' VAL . 42.7 m-85 -90.49 13.01 16.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.507 0.67 . . . . 0.74 109.309 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.94 37.93 2.15 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.212 -1.358 . . . . 1.94 109.216 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.441 ' N ' ' HA ' ' A' ' 132' ' ' MET . 5.1 mp -105.7 70.97 0.89 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.575 -1.193 . . . . 1.68 109.471 170.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.991 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -67.45 121.02 77.14 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.016 -0.993 . . . . 0.61 109.677 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.844 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.5 Cg_exo -48.64 157.94 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.833 2.355 . . . . 0.3 112.969 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.8 -22.64 42.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.918 -1.037 . . . . 2.01 108.204 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 7.6 mp0 -46.46 -48.56 18.97 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.148 -1.387 . . . . 1.14 109.714 161.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.827 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.9 m0 -96.0 -30.07 13.79 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.533 -1.667 . . . . 0.45 110.896 -166.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.81 22.12 3.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.303 -0.951 . . . . 0.45 112.985 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.991 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.3 -113.91 2.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.445 -0.883 . . . . 0.5 112.725 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.44 32.9 0.51 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.193 0.521 . . . . 1.3 111.356 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 23.3 m -134.91 123.49 23.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.29 -0.564 . . . . 0.32 111.825 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.761 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.2 mp -92.68 109.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 1.23 110.55 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.844 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -86.35 134.77 33.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.173 0.511 . . . . 0.38 111.098 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.4 m -131.44 107.8 9.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.454 -0.794 . . . . 1.1 110.03 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.823 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.9 ptmm? -85.51 86.17 7.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.691 0.758 . . . . 2.44 109.89 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -103.92 -167.23 1.34 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.256 1.027 . . . . 1.27 112.129 -169.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p -161.36 116.08 2.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.802 -1.545 . . . . 1.79 109.318 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.29 -0.84 18.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.178 0.513 . . . . 0.87 111.029 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -83.46 -55.41 4.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.807 0.813 . . . . 3.03 109.681 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.5 p -98.85 -20.64 16.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.548 -1.206 . . . . 1.2 111.395 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 158' ' ' LEU . 9.7 mtpm? 72.75 18.1 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 2.27 112.132 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -54.49 -70.51 0.1 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.826 0.822 . . . . 2.64 110.729 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -75.64 -7.48 83.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.128 -0.942 . . . . 0.62 112.945 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -72.28 -51.18 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.634 -0.506 . . . . 1.55 109.634 -178.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.98 -30.61 70.78 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.447 -0.575 . . . . 2.5 109.447 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.594 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 84.9 t60 -66.49 -25.76 66.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.42 -0.809 . . . . 0.73 110.888 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 158' ' ' LEU . 56.0 tp -67.17 -47.57 70.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.461 . . . . 0.91 110.014 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.698 HD13 HG11 ' A' ' 50' ' ' VAL . 32.8 mt -58.64 -38.78 78.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.461 -0.79 . . . . 1.06 111.277 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 13.5 pt-20 -71.8 -32.35 67.51 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.127 -0.323 . . . . 2.49 110.127 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.761 ' HB3' HG21 ' A' ' 146' ' ' ILE . 25.9 mmt -69.85 -38.24 76.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.311 0.577 . . . . 0.87 109.897 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 162' ' ' LEU . 63.3 mt -56.3 -53.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.073 -0.967 . . . . 0.64 111.136 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.5 pp -71.85 -34.29 69.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 121.041 -0.264 . . . . 1.81 111.491 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 166' ' ' LEU . 14.0 tp -53.06 -31.62 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.97 -0.559 . . . . 1.42 110.73 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.444 -0.754 0 CA-C-N 116.033 -0.53 . . . . 1.17 110.281 -178.488 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.081 HG12 ' HB ' ' A' ' 81' ' ' ILE . 13.7 m . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 120.843 0.354 . . . . 1.0 110.755 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' HG12 ' A' ' 83' ' ' ILE . 51.0 m -129.64 134.57 47.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.239 -0.437 . . . . 0.66 111.102 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.719 HD13 HG13 ' A' ' 83' ' ' ILE . 35.7 mm -81.07 129.7 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 1.03 111.062 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.46 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 14.4 mmt -138.29 157.12 46.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.684 0.394 . . . . 1.04 111.435 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.66 -110.55 0.46 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.116 -0.793 . . . . 1.55 111.116 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -156.85 137.61 13.31 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.75 -0.725 . . . . 0.66 109.594 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.64 -47.47 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.335 0.865 . . . . 1.62 113.335 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.55 -27.54 68.51 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.504 0.557 . . . . 1.78 112.504 -170.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -63.35 -21.27 66.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.281 0.562 . . . . 0.65 110.649 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.53 42.46 1.86 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.661 -0.699 . . . . 0.93 112.465 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -82.02 -22.12 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 2.11 110.215 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -39.88 23.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.174 -1.047 . . . . 1.8 108.174 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 m -62.57 -33.6 75.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.622 -1.172 . . . . 1.77 110.512 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.596 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 59.7 tp -57.39 -56.07 26.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 1.78 110.524 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.683 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.6 tt -63.78 -36.81 85.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.072 0.463 . . . . 1.96 109.994 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.18 -53.76 44.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.955 0.407 . . . . 1.38 111.596 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -32.17 72.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.91 111.196 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.654 HD13 ' OH ' ' A' ' 48' ' ' TYR . 3.9 tt -67.78 -33.47 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.84 -0.618 . . . . 1.56 110.43 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 15.5 mtm180 -73.62 -28.03 61.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.454 0.645 . . . . 3.56 110.031 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -84.9 5.18 30.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.626 -0.715 . . . . 2.88 110.148 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.319 -0.727 0 N-CA-C 106.703 -1.591 . . . . 1.76 106.703 168.633 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.654 ' OH ' HD13 ' A' ' 28' ' ' ILE . 23.2 p90 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.778 -0.453 . . . . 2.54 109.778 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 58' ' ' THR . 37.0 mt-30 -126.17 118.06 24.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.257 -0.646 . . . . 1.96 109.257 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.554 HG21 ' HE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 115.632 -0.713 . . . . 1.93 112.372 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.447 ' HB ' HG23 ' A' ' 50' ' ' VAL . 19.0 mt . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.023 0.44 . . . . 1.14 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.949 HG23 ' HG2' ' A' ' 49' ' ' GLN . 36.2 m -119.97 130.85 54.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.162 -0.681 . . . . 1.28 109.162 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HE1' HG21 ' A' ' 50' ' ' VAL . 16.1 m-85 . . . . . 0 C--O 1.222 -0.372 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.081 ' HB ' HG12 ' A' ' 11' ' ' VAL . 28.4 mm . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.74 109.782 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 76.4 t -81.45 108.14 14.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.063 -0.517 . . . . 1.19 111.182 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.747 HD11 ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -85.47 102.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.971 -0.751 . . . . 1.32 108.971 177.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.801 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.1 tm? -94.64 111.77 23.53 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.919 -0.582 . . . . 1.33 109.946 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.524 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 39.5 t -87.56 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.1 -0.5 . . . . 1.2 111.488 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 114' ' ' ILE . 17.9 m -135.29 -167.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.161 -0.927 . . . . 1.12 108.501 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -140.07 143.27 36.25 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.31 -0.556 . . . . 0.75 111.691 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -34.26 -55.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.678 1.236 . . . . 1.18 112.992 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -109.1 13.83 24.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.883 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -110.68 -43.02 3.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.511 -0.476 . . . . 1.09 111.284 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 78.0 -139.8 23.18 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.667 -0.778 . . . . 0.52 111.949 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.733 HG13 ' HB ' ' A' ' 96' ' ' THR . 44.0 t -96.97 114.8 34.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 122.783 0.433 . . . . 1.08 111.311 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.585 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 53.7 mtp -84.12 169.77 15.97 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.434 -0.348 . . . . 1.32 110.199 171.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 93.8 Cg_exo -45.25 -50.79 8.58 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.696 2.264 . . . . 0.61 113.341 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -72.72 -21.9 60.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.387 -0.369 . . . . 1.47 111.356 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.733 ' HB ' HG13 ' A' ' 92' ' ' VAL . 25.5 m -60.38 -28.74 68.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.397 0.617 . . . . 0.46 110.274 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.04 -45.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.958 -0.565 . . . . 1.05 111.726 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.79 -23.19 59.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 1.62 110.961 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -87.96 -30.96 19.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.34 110.018 -177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.863 HG12 HD13 ' A' ' 110' ' ' ILE . 1.7 mt -80.93 -51.21 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.261 -0.881 . . . . 0.38 111.293 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -49.13 -39.28 27.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 1.85 110.78 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -77.35 -30.2 53.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.85 110.968 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.27 -56.29 4.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.436 . . . . 0.48 111.967 -173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -73.2 -15.72 61.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.304 -0.407 . . . . 2.56 111.899 -168.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.12 -0.48 44.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.76 111.206 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -101.39 14.07 33.1 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.814 -0.81 . . . . 0.9 108.814 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 4.8 m-20 72.19 27.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.705 -1.134 . . . . 2.06 111.759 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.13 152.85 42.75 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-O 121.061 0.458 . . . . 1.08 111.254 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.63 ' O ' HG23 ' A' ' 108' ' ' VAL . 15.4 Cg_exo -72.54 162.82 40.31 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.678 2.919 . . . . 0.51 113.437 171.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.863 HD13 HG12 ' A' ' 100' ' ' ILE . 73.7 mt -132.61 148.17 31.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.672 -0.695 . . . . 0.96 110.586 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.801 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 37.3 mt -113.61 164.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 109.072 -0.714 . . . . 0.71 109.072 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.544 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -123.63 129.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 N-CA-C 109.044 -0.724 . . . . 0.23 109.044 169.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.28 87.25 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.592 -1.262 . . . . 0.25 107.592 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 54.1 mt -69.61 97.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.315 -1.311 . . . . 0.85 109.904 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -96.91 170.82 8.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.69 109.023 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 77.5 tttt 64.14 18.35 11.2 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.365 1.078 . . . . 2.61 109.227 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.622 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.1 tpp . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 123.063 1.411 . . . . 1.37 109.511 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.266 -0.272 . . . . 1.84 110.266 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.1 Cg_endo -44.53 -61.3 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.581 2.854 . . . . 0.7 113.325 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.73 -49.63 19.29 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.441 0.697 . . . . 2.0 112.352 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -49.21 -62.13 1.7 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.351 0.596 . . . . 2.99 109.69 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 91' ' ' GLY . 66.8 t -54.2 -47.84 67.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.341 -1.299 . . . . 0.4 110.848 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.654 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 90.4 mtp -59.42 -34.51 72.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.3 111.122 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -76.77 -20.14 56.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.618 -0.264 . . . . 1.28 111.23 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.662 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 4.2 mt-10 -75.98 -30.39 58.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.962 -0.755 . . . . 2.02 108.962 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -72.77 -44.27 61.79 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.831 -0.747 . . . . 1.06 109.311 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.834 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -73.01 -4.54 32.97 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.163 -0.615 . . . . 0.35 109.977 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.662 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 40.9 tt0 -74.41 -32.75 62.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 170.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.672 ' HE2' HG11 ' A' ' 92' ' ' VAL . 44.9 m-85 -89.9 9.39 27.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.911 0.862 . . . . 0.74 109.446 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 72.32 26.59 2.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 113.536 -1.665 . . . . 1.94 110.234 168.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.04 76.69 1.37 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.433 -1.321 . . . . 1.68 107.433 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.942 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -63.24 134.04 95.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 113.436 -1.711 . . . . 0.61 110.279 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -52.29 154.34 11.35 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 122.359 2.039 . . . . 0.3 112.135 173.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 mm-40 -80.28 -19.77 45.96 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.05 -0.977 . . . . 2.01 109.141 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.579 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.1 mp0 -47.2 -52.98 14.28 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.709 1.243 . . . . 1.14 108.958 160.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.834 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -89.73 -23.78 21.71 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.897 -1.956 . . . . 0.45 110.68 -167.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.87 23.02 4.79 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.553 -0.832 . . . . 0.45 112.446 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.942 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.93 -108.15 1.99 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.924 -0.655 . . . . 0.5 113.17 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.25 27.37 0.35 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 1.3 111.314 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 HD12 ' A' ' 136' ' ' LEU . 63.5 m -132.67 133.34 43.43 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.83 1.048 . . . . 0.32 113.83 -174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.797 HG13 HG11 ' A' ' 168' ' ' VAL . 4.1 mp -87.48 108.15 17.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.123 -0.944 . . . . 1.23 110.382 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 11.8 m-85 -94.54 115.77 27.99 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.839 -0.538 . . . . 0.38 111.224 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.9 t -118.63 128.7 54.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.439 -0.578 . . . . 1.1 109.439 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.718 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.6 pttm -103.65 87.06 2.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.609 0.718 . . . . 2.44 109.393 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -105.64 -177.03 3.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.43 -0.804 . . . . 1.27 112.486 -172.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.1 p -155.87 124.05 5.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.929 -1.032 . . . . 1.79 109.636 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -76.24 -13.19 60.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.141 0.496 . . . . 0.87 110.926 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -75.89 -57.64 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.47 -0.786 . . . . 3.03 109.855 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -97.29 -15.71 20.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.148 -0.933 . . . . 1.2 111.376 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HD12 ' A' ' 158' ' ' LEU . 59.4 mttp 64.58 24.82 13.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.23 -0.896 . . . . 2.27 111.888 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.21 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.843 0.83 . . . . 2.64 109.822 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.718 ' HA3' ' HA ' ' A' ' 150' ' ' LEU . . . -71.83 -10.46 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.811 -1.086 . . . . 0.62 113.543 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.816 HD12 ' HG2' ' A' ' 155' ' ' LYS . 25.5 mt -71.89 -43.1 65.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.699 0.75 . . . . 1.55 110.295 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 12.8 t70 -61.66 -42.82 99.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.753 -0.832 . . . . 2.5 108.753 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -66.7 -24.25 66.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.039 -0.982 . . . . 0.73 111.507 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.3 tp -63.31 -56.43 16.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.661 -0.245 . . . . 0.91 110.401 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.8 mt -54.62 -39.84 68.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 1.06 110.585 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.0 mm-40 -63.56 -47.28 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 2.49 110.339 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -67.07 -38.77 86.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.87 110.593 -176.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.14 -49.42 40.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.64 111.845 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 167' ' ' LEU . 1.6 pp -84.67 -35.15 22.8 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.406 0.521 . . . . 1.81 112.406 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.6 tp -63.41 -21.98 66.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.99 0.424 . . . . 1.42 110.937 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 146' ' ' ILE . 48.5 t . . . . . 0 N--CA 1.442 -0.845 0 CA-C-N 116.515 -0.311 . . . . 1.17 110.447 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 89.2 t . . . . . 0 N--CA 1.433 -1.309 0 CA-C-O 121.165 0.507 . . . . 1.0 110.051 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.996 -0.547 . . . . 0.66 110.728 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.681 ' HA ' HG13 ' A' ' 83' ' ' ILE . 26.4 mt -83.69 121.45 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.056 0.455 . . . . 1.03 111.148 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.448 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 20.8 mmt -115.7 178.99 4.1 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.077 -0.712 . . . . 1.04 109.077 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.931 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 114.67 131.05 5.04 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.852 -1.166 . . . . 1.55 111.411 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -44.88 132.37 6.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.332 0.586 . . . . 0.66 110.198 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -56.35 -30.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.55 0.944 . . . . 1.62 113.55 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.63 -15.8 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.78 111.296 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.439 ' HE1' ' H ' ' A' ' 93' ' ' MET . 32.8 m170 -67.25 -43.0 82.99 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.845 -0.428 . . . . 0.65 109.845 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 85' ' ' VAL . . . 147.12 69.79 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.034 -1.079 . . . . 0.93 113.766 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -87.55 -50.11 6.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.453 0.644 . . . . 2.11 109.513 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -64.12 -30.56 71.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.032 -0.986 . . . . 1.8 110.561 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.497 HG21 ' ND2' ' A' ' 115' ' ' ASN . 5.4 t -67.73 -26.64 66.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 1.77 110.64 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.02 -55.82 6.73 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.775 -0.824 . . . . 1.78 108.775 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.653 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 1.9 tt -55.49 -41.69 73.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.945 -0.571 . . . . 1.96 109.78 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.54 -62.5 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.507 0.558 . . . . 1.38 112.507 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -68.27 -38.48 81.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.91 111.843 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.78 -31.04 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.453 . . . . 1.56 110.536 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -64.04 -41.25 97.46 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.223 0.535 . . . . 3.56 110.372 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -76.5 9.3 2.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.38 -0.827 . . . . 2.88 109.818 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.876 -0.602 . . . . 1.76 110.342 174.468 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.653 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.943 0.402 . . . . 2.54 110.761 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.651 ' HG2' HG23 ' A' ' 58' ' ' THR . 47.8 mt-30 -98.98 152.0 20.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.169 -0.469 . . . . 1.96 109.879 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.796 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 95.1 t . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.891 0.853 . . . . 1.93 111.945 -172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.796 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 42.2 mt . . . . . 0 CA--C 1.523 -0.095 0 N-CA-C 110.019 -0.363 . . . . 1.14 110.019 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 49' ' ' GLN . 11.0 m -121.67 113.8 20.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.128 -0.323 . . . . 1.28 110.128 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HD2' HD11 ' A' ' 13' ' ' ILE . 3.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.84 110.876 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 45.8 mm . . . . . 0 C--O 1.231 0.128 0 N-CA-C 111.794 0.294 . . . . 0.74 111.794 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG21 ' HB1' ' A' ' 103' ' ' ALA . 89.7 t -100.92 98.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.79 -0.364 . . . . 1.19 111.274 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.681 HG13 ' HA ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -87.11 104.38 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.093 -0.643 . . . . 1.32 110.472 174.015 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.599 HD22 ' CD1' ' A' ' 100' ' ' ILE . 9.7 tp -91.46 114.08 26.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.884 -0.598 . . . . 1.33 110.33 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.931 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.6 p -85.7 142.72 12.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.882 -0.727 . . . . 1.2 110.844 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -137.3 -170.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.36 -0.978 . . . . 1.12 108.36 175.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.24 139.68 30.33 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.238 -0.585 . . . . 0.75 111.681 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -78.91 58.23 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.035 -0.984 . . . . 1.18 111.207 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -164.97 -33.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.452 -1.249 . . . . 2.01 109.301 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.51 -63.26 1.18 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.522 0.677 . . . . 1.09 110.954 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.77 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 117.07 -106.36 1.42 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.996 -1.002 . . . . 0.52 110.887 -172.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.98 HG13 ' HB ' ' A' ' 96' ' ' THR . 38.5 t -129.67 114.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 120.952 0.406 . . . . 1.08 110.572 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.711 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 60.3 mtp -91.96 172.81 5.92 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 1.32 109.741 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.711 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 58.0 Cg_exo -39.32 -59.76 0.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.269 2.646 . . . . 0.61 113.857 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -54.27 -35.01 62.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.47 111.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.98 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.3 m -64.26 -34.04 77.19 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.762 0.282 . . . . 0.46 111.762 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.621 HG12 ' CG1' ' A' ' 92' ' ' VAL . 1.4 m -85.7 -38.86 13.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 121.967 -0.458 . . . . 1.05 111.328 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.65 -30.06 70.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.165 0.507 . . . . 1.62 110.916 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.31 -17.6 59.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.647 -0.706 . . . . 0.34 110.491 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -93.41 -45.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.38 110.966 -176.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -53.41 -38.54 63.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.566 0.698 . . . . 1.85 110.086 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -75.2 -28.66 60.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.191 -0.913 . . . . 0.85 110.943 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.907 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.74 -53.88 3.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.889 0.7 . . . . 0.48 112.889 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -67.7 -16.21 64.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.225 0.454 . . . . 2.56 112.225 -166.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.65 10.7 4.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.309 0.485 . . . . 0.76 112.309 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -107.96 4.21 24.99 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.08 -0.711 . . . . 0.9 109.08 173.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 21.0 t-20 80.46 19.31 0.55 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 123.204 1.478 . . . . 2.06 108.858 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -96.06 142.47 24.61 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 113.741 -1.572 . . . . 1.08 110.462 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 8.3 Cg_exo -73.19 152.02 49.96 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.904 2.403 . . . . 0.51 114.264 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 100' ' ' ILE . 1.7 mp -114.48 143.11 24.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 113.239 -1.8 . . . . 0.96 109.637 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mp -113.46 147.52 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -110.37 138.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 109.32 -0.622 . . . . 0.23 109.32 174.317 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.1 87.8 2.82 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.232 -1.025 . . . . 0.25 108.232 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.687 ' HA ' HG23 ' A' ' 86' ' ' VAL . 37.5 mt -73.3 95.92 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.581 -1.191 . . . . 0.85 110.153 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.497 ' ND2' HG21 ' A' ' 23' ' ' THR . 53.3 t30 -90.8 156.53 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.671 -0.412 . . . . 0.69 111.174 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.2 mttp 71.51 37.32 1.15 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.732 0.813 . . . . 2.61 112.178 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.688 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 C-N-CA 119.873 -0.731 . . . . 1.37 111.661 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 34.1 t30 . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 119.841 -0.124 . . . . 1.84 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 58.1 Cg_exo -28.79 -69.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.548 3.499 . . . . 0.7 114.545 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.94 -45.72 15.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.725 0.81 . . . . 2.0 112.206 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -55.17 -56.13 23.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.493 0.663 . . . . 2.99 110.177 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.77 HG13 ' HA2' ' A' ' 91' ' ' GLY . 56.7 t -59.44 -39.73 79.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.565 -1.198 . . . . 0.4 110.346 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 87.3 mtp -66.29 -30.01 70.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.558 -0.746 . . . . 0.3 111.225 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.34 -21.06 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.627 0.251 . . . . 1.28 110.778 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.1 -38.58 85.93 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.646 -0.872 . . . . 2.02 108.646 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.929 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -69.47 -45.35 69.21 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.031 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.89 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -73.26 -5.04 36.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.363 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.62 -37.19 68.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.726 -1.213 . . . . 2.18 107.726 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.949 ' HE2' HG11 ' A' ' 92' ' ' VAL . 28.6 m-85 -84.38 7.6 19.0 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.944 0.878 . . . . 0.74 109.283 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.71 44.08 1.21 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.829 -1.532 . . . . 1.94 109.505 170.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.929 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -122.43 81.77 1.89 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 113.517 -1.674 . . . . 1.68 106.96 169.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -65.37 130.53 94.72 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.006 -1.452 . . . . 0.61 110.242 -173.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 58.2 Cg_exo -44.69 154.79 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.888 2.392 . . . . 0.3 112.54 170.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -74.43 -29.17 61.38 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.346 -1.297 . . . . 2.01 108.012 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.654 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -51.11 -42.17 60.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.584 -1.189 . . . . 1.14 109.572 168.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.89 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.2 m0 -96.16 -20.35 18.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.419 -0.81 . . . . 0.45 111.167 -172.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.99 29.85 4.44 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.139 -1.029 . . . . 0.45 112.707 170.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.824 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.78 -106.67 2.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.366 -0.921 . . . . 0.5 112.923 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.34 27.99 0.45 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.714 -0.243 . . . . 1.3 111.42 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 136' ' ' LEU . 26.6 m -134.55 129.04 34.45 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 119.171 -1.011 . . . . 0.32 113.548 -171.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 164' ' ' MET . 49.9 mm -94.35 110.33 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.332 -0.849 . . . . 1.23 110.566 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.757 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 14.2 m-85 -90.89 119.4 31.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.034 0.445 . . . . 0.38 111.429 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 75.8 m -110.37 111.99 23.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.625 -0.509 . . . . 1.1 109.625 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.688 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 25.9 pttt -93.29 100.06 12.48 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.811 -0.631 . . . . 2.44 109.392 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.69 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -123.07 179.13 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.615 1.198 . . . . 1.27 113.681 -169.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.58 116.83 5.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.285 -1.78 . . . . 1.79 108.15 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -63.02 -16.32 59.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.013 0.375 . . . . 0.87 112.013 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.71 -57.34 3.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.802 0.81 . . . . 3.03 109.503 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -72.69 -17.96 61.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.129 -1.396 . . . . 1.2 112.01 -175.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.713 ' HD3' HD12 ' A' ' 158' ' ' LEU . 30.2 mmtp 71.63 -0.11 3.28 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.791 -0.641 . . . . 2.27 112.007 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -45.99 -74.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.037 0.754 . . . . 2.64 113.037 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.69 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.51 -6.7 66.77 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.496 -0.774 . . . . 0.62 113.536 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.713 HD12 ' HD3' ' A' ' 155' ' ' LYS . 57.7 mt -73.55 -43.16 60.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.288 0.544 . . . . 1.55 110.561 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 26.9 m-20 -66.94 -40.43 87.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 174.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -65.29 -30.64 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.73 110.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 60.7 tp -63.39 -53.89 45.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.91 110.639 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.63 -39.29 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 1.06 110.731 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 8.1 mm-40 -61.41 -48.34 81.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.573 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.729 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.7 mmt -69.29 -40.12 77.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.87 110.854 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.41 -47.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.041 -0.527 . . . . 0.64 110.43 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.2 -46.72 87.68 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.29 -0.414 . . . . 1.81 111.137 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.43 -46.28 76.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 1.42 110.555 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 77.4 t . . . . . 0 N--CA 1.442 -0.871 0 CA-C-N 116.094 -0.503 . . . . 1.17 111.427 -178.371 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 4.0 t . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -95.34 121.66 37.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.244 -0.435 . . . . 0.66 111.466 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 83' ' ' ILE . 32.6 mt -95.67 120.06 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.316 0.579 . . . . 1.03 110.01 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' LEU . 50.0 mtt -128.59 152.28 48.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.798 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.913 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 168.82 -113.8 0.54 Allowed Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.281 -1.128 . . . . 1.55 110.281 173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 85.3 t60 -161.99 147.12 12.97 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.083 -0.71 . . . . 0.66 109.083 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -56.95 -51.38 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.592 0.59 . . . . 1.62 112.592 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -61.33 -28.23 69.06 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.796 0.665 . . . . 1.78 112.796 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HE1' ' H ' ' A' ' 93' ' ' MET . 27.7 m170 -66.63 -19.02 65.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.65 110.799 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.09 1.38 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.654 -0.784 . . . . 0.93 112.163 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -73.13 -48.8 32.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.235 0.541 . . . . 2.11 110.566 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 1.8 110.067 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 m -70.83 -29.08 65.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.779 -0.646 . . . . 1.77 110.428 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.33 -49.0 75.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.459 -0.571 . . . . 1.78 109.459 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 8.3 tt -60.09 -45.42 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.406 -0.816 . . . . 1.96 110.519 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.8 t70 -66.17 -48.33 71.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.144 -0.48 . . . . 1.38 111.908 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.06 99.66 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.115 0.483 . . . . 0.91 110.735 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 25' ' ' LEU . 9.6 tt -66.67 -34.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.753 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 29.5 ptt180 -78.33 -36.31 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.675 0.75 . . . . 3.56 109.092 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -76.16 14.39 0.73 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.799 -1.091 . . . . 2.88 111.578 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.369 -0.604 . . . . 1.76 109.369 177.313 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.721 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.609 0.242 . . . . 2.54 110.368 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 45.5 mt-30 -125.32 136.97 54.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.493 -0.321 . . . . 1.96 110.15 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 57' ' ' ILE . 5.0 m . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.135 0.493 . . . . 1.93 111.43 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 50' ' ' VAL . 39.3 mt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.14 110.309 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.54 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 5.0 m -80.88 100.79 9.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.551 -0.537 . . . . 1.28 109.551 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HE2' ' CG1' ' A' ' 50' ' ' VAL . 59.5 m-85 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.001 0.429 . . . . 0.84 111.985 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 41.9 mm . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.32 -0.622 . . . . 0.74 109.32 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 103' ' ' ALA . 90.5 t -106.85 105.85 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.402 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -87.48 107.75 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.057 -0.72 . . . . 1.32 109.057 174.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 100' ' ' ILE . 3.1 tm? -96.76 114.65 26.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.236 -0.893 . . . . 1.33 109.928 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.913 HG12 ' HA3' ' A' ' 15' ' ' GLY . 9.9 p -88.04 141.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.295 0.569 . . . . 1.2 111.341 -176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.8 m -138.4 -171.09 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.243 -0.89 . . . . 1.12 108.631 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.87 136.91 25.88 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.752 -0.379 . . . . 0.75 110.535 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 59.37 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 1.18 111.235 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.72 -30.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.242 -1.344 . . . . 2.01 109.655 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -108.98 -52.53 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.102 0.477 . . . . 1.09 110.991 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 102.5 -113.42 4.59 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.581 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 96' ' ' THR . 41.4 t -125.85 112.26 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.973 0.415 . . . . 1.08 110.919 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.7 mtp -88.26 171.8 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.327 -0.397 . . . . 1.32 110.452 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 84.7 Cg_exo -46.98 -48.5 14.36 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.818 2.345 . . . . 0.61 114.112 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 13.6 mt-30 -62.03 -38.41 88.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.006 -0.278 . . . . 1.47 110.91 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 92' ' ' VAL . 6.4 m -58.57 -33.54 70.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.786 0.803 . . . . 0.46 110.102 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 21.4 t -76.99 -57.93 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.691 -1.14 . . . . 1.05 111.536 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -73.56 -8.55 56.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.857 -0.611 . . . . 1.62 112.543 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -84.32 -44.67 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.053 -1.091 . . . . 0.34 108.053 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.683 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.8 mt -62.9 -45.9 97.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.185 -1.371 . . . . 0.38 111.055 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 5.2 m-20 -54.61 -29.0 50.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 1.85 111.134 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -85.04 -28.89 25.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.85 110.284 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.02 -46.25 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.491 . . . . 0.48 111.691 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 101' ' ' ASN . 21.4 ptmt -54.89 -37.01 65.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 2.56 112.639 -171.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.98 11.41 34.07 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.627 0.973 . . . . 0.76 113.627 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -86.92 -51.59 5.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.023 -1.473 . . . . 0.9 107.023 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 2.5 p-10 149.59 14.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 125.858 1.974 . . . . 2.06 108.839 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.518 HG21 HG23 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -102.02 143.69 27.09 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.771 . . . . 1.08 112.204 -166.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 10.7 Cg_exo -72.72 156.96 52.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.215 2.61 . . . . 0.51 112.908 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.562 HD13 HG12 ' A' ' 100' ' ' ILE . 82.3 mt -126.33 149.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.151 -0.931 . . . . 0.96 110.056 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mt -120.28 161.1 20.22 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 N-CA-C 108.697 -0.853 . . . . 0.71 108.697 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -123.71 140.93 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 121.049 0.452 . . . . 0.23 110.67 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -122.39 88.63 2.97 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.039 -1.097 . . . . 0.25 108.039 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.695 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 44.1 mt -69.66 96.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.043 -0.981 . . . . 0.85 109.543 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -94.14 165.39 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.258 -0.428 . . . . 0.69 110.686 -172.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 64.62 14.18 8.82 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.652 -0.704 . . . . 2.61 112.641 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 119.622 -0.831 . . . . 1.37 111.433 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 109.226 -0.657 . . . . 1.84 109.226 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.673 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.6 Cg_exo -38.77 -55.74 1.29 Allowed 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 123.338 2.692 . . . . 0.7 113.73 171.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -47.39 -49.28 25.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.403 0.52 . . . . 2.0 112.403 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 20.5 tpt180 -49.08 -59.53 3.56 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.51 0.671 . . . . 2.99 109.798 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.475 HG13 ' HA2' ' A' ' 91' ' ' GLY . 51.4 t -55.99 -45.9 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.966 -1.47 . . . . 0.4 110.399 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.703 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 91.0 mtp -60.45 -34.37 73.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.3 111.449 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 132' ' ' MET . 92.9 mt-30 -73.9 -22.39 59.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 1.28 110.359 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 5.8 mt-10 -75.49 -32.64 60.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.875 -0.787 . . . . 2.02 108.875 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 136' ' ' LEU . 3.4 mm? -68.73 -45.56 71.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.609 0.719 . . . . 1.06 109.465 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.892 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -73.43 -5.82 42.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.563 -0.744 . . . . 0.35 110.181 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 19.8 tp10 -76.6 -29.57 56.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.865 -1.161 . . . . 2.18 107.865 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.538 ' CZ ' HG22 ' A' ' 97' ' ' VAL . 22.6 m-85 -92.29 6.67 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.424 0.63 . . . . 0.74 109.654 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.2 m120 78.43 24.47 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.277 -1.328 . . . . 1.94 111.585 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.93 HD11 HD12 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -105.63 78.94 1.39 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.626 -1.25 . . . . 1.68 107.626 172.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.416 HG23 ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -65.63 130.95 94.68 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 113.565 -1.652 . . . . 0.61 111.697 -176.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 71.1 Cg_exo -49.44 157.09 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.503 2.802 . . . . 0.3 113.376 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 146' ' ' ILE . 43.2 mm-40 -72.45 -26.32 61.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.302 -1.317 . . . . 2.01 109.488 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.868 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 3.3 mm-40 -58.55 -43.42 89.29 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.288 -0.869 . . . . 1.14 108.696 171.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.892 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -88.51 -24.78 22.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.064 -1.425 . . . . 0.45 110.283 -169.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.93 26.7 3.74 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.988 -1.101 . . . . 0.45 112.186 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA3' HG23 ' A' ' 137' ' ' VAL . . . -101.73 -115.47 3.96 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.405 -0.902 . . . . 0.5 111.896 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.91 33.39 0.48 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.596 0.236 . . . . 1.3 111.234 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HD12 ' A' ' 136' ' ' LEU . 36.2 m -128.0 120.24 27.14 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.779 -0.769 . . . . 0.32 112.588 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.479 HG13 ' HG3' ' A' ' 139' ' ' GLU . 3.5 mp -88.16 109.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.645 -0.707 . . . . 1.23 110.385 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.796 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 21.1 m-85 -88.55 108.03 19.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.896 0.379 . . . . 0.38 111.116 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 20.2 t -98.33 118.65 35.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.243 -0.651 . . . . 1.1 109.243 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 14.2 ptpt -92.3 102.97 15.46 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.162 -0.681 . . . . 2.44 109.162 173.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -130.17 -169.32 2.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.978 0.894 . . . . 1.27 112.789 -172.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 m -165.8 121.02 1.25 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 113.916 -1.493 . . . . 1.79 109.516 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.54 -12.51 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.623 -0.262 . . . . 0.87 111.668 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 154' ' ' THR . 18.9 pttp -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.879 0.847 . . . . 3.03 109.463 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.93 -22.57 45.59 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.246 -1.343 . . . . 1.2 109.84 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 158' ' ' LEU . 9.3 mtpm? 63.93 3.86 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.593 -1.185 . . . . 2.27 113.71 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.84 -56.11 25.88 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.058 0.932 . . . . 2.64 110.38 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -69.29 -11.98 65.28 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.519 -1.219 . . . . 0.62 113.535 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.7 HD12 ' HG2' ' A' ' 155' ' ' LYS . 31.5 mt -68.54 -43.0 77.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.314 0.557 . . . . 1.55 110.397 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.0 -45.65 91.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.764 -0.653 . . . . 2.5 109.611 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' A' ' 164' ' ' MET . 51.4 t-80 -64.56 -29.82 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.73 110.783 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.1 tp -67.12 -59.38 3.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.383 -0.371 . . . . 0.91 111.149 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.33 -40.04 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.319 0.387 . . . . 1.06 110.704 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.76 -37.82 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 2.49 111.215 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 25.1 mmt -72.41 -39.84 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 0.87 110.077 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 161' ' ' LEU . 84.5 mt -58.49 -49.46 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.64 111.257 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -70.32 -35.19 73.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.81 111.268 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 166' ' ' LEU . 59.1 tp -56.93 -32.99 66.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.055 -0.521 . . . . 1.42 109.837 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 164' ' ' MET . 43.7 t . . . . . 0 N--CA 1.445 -0.688 0 CA-C-N 115.898 -0.592 . . . . 1.17 109.918 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 81' ' ' ILE . 74.4 t . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.698 0.761 . . . . 1.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -87.19 112.5 22.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 0.66 110.308 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 53.3 mt -74.34 117.08 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 121.613 0.72 . . . . 1.03 110.205 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 43.9 mtt -118.37 179.18 4.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.687 -1.142 . . . . 1.04 109.984 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.862 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.38 -96.8 0.2 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.158 -1.177 . . . . 1.55 110.158 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -172.33 143.56 1.45 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.969 -1.122 . . . . 0.66 107.969 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -24.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.387 0.884 . . . . 1.62 113.387 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.32 -33.74 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.855 0.317 . . . . 1.78 111.855 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -62.86 -23.95 67.56 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.503 0.557 . . . . 0.65 112.503 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 65.41 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.337 -0.935 . . . . 0.93 112.434 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -87.09 -15.58 38.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.332 0.587 . . . . 2.11 109.721 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -78.06 -30.05 49.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 1.8 110.451 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -27.49 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 1.77 111.089 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.02 -50.19 30.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.592 -0.521 . . . . 1.78 109.592 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -60.44 -22.18 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 1.96 110.789 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -92.64 -56.73 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.172 0.434 . . . . 1.38 112.172 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -28.16 69.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.91 111.397 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.12 -32.62 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.954 0.407 . . . . 1.56 110.109 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 29' ' ' ARG . 33.6 mtp-105 -68.52 -32.28 72.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.522 0.677 . . . . 3.56 109.347 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 10.1 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.066 -0.97 . . . . 2.88 110.601 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 m . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 1.76 109.456 175.87 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.281 0.563 . . . . 2.54 110.935 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 79.1 mt-30 -116.31 137.33 52.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.677 -0.692 . . . . 1.96 109.458 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 57' ' ' ILE . 3.9 m . . . . . 0 N--CA 1.441 -0.907 0 CA-C-O 121.606 0.717 . . . . 1.93 111.291 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.637 ' HB ' HG23 ' A' ' 50' ' ' VAL . 73.3 mt . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.656 0.265 . . . . 1.14 110.932 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 23.1 m -99.11 117.11 32.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.398 -0.365 . . . . 1.28 110.221 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.625 ' HE2' HG21 ' A' ' 50' ' ' VAL . 28.9 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.689 0.28 . . . . 0.84 110.775 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 11' ' ' VAL . 40.8 mm . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.622 0.249 . . . . 0.74 110.85 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.928 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.7 t -95.16 103.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 120.75 0.31 . . . . 1.19 111.01 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.673 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 9.2 mm -87.22 99.75 8.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.316 -0.624 . . . . 1.32 109.316 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 100' ' ' ILE . 11.4 tp -85.97 106.56 17.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.269 -0.423 . . . . 1.33 110.557 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.4 p -80.19 141.19 15.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.263 0.554 . . . . 1.2 110.978 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.3 m -141.2 -171.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 107.868 -1.16 . . . . 1.12 107.868 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.14 146.95 43.4 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.426 -0.51 . . . . 0.75 110.839 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -35.51 -53.89 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.778 1.299 . . . . 1.18 112.677 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.11 -9.93 20.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.593 0.59 . . . . 2.01 112.593 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.67 -40.46 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.126 -0.63 . . . . 1.09 111.559 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.49 -138.42 23.2 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.296 -0.954 . . . . 0.52 111.115 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.03 HG13 ' HB ' ' A' ' 96' ' ' THR . 23.9 t -101.04 113.44 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 122.766 0.426 . . . . 1.08 110.553 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.511 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -85.0 166.79 29.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.502 -0.925 . . . . 1.32 108.502 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 31.8 Cg_exo -34.56 -52.05 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.848 3.032 . . . . 0.61 115.09 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -78.06 -17.99 56.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 122.124 -0.36 . . . . 1.47 111.415 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.03 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.9 m -67.72 -19.06 65.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.35 0.595 . . . . 0.46 109.947 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.15 -44.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.266 -0.425 . . . . 1.05 110.78 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -27.25 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 1.62 110.967 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -75.9 -37.39 58.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.974 -0.557 . . . . 0.34 110.08 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.745 HD13 HD13 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -75.09 -43.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.38 111.209 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -51.43 -36.22 42.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.171 0.51 . . . . 1.85 110.669 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -83.85 -26.48 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.649 -0.705 . . . . 0.85 110.493 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.928 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -88.08 -50.22 6.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.49 0.552 . . . . 0.48 112.49 -173.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -69.57 -21.68 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.031 0.443 . . . . 2.56 111.174 -171.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.37 7.2 20.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.954 -0.567 . . . . 0.76 111.936 -172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.11 -2.68 27.02 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.001 -0.741 . . . . 0.9 109.001 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 t30 80.09 52.48 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.129 -1.396 . . . . 2.06 107.734 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.491 HG11 HG23 ' A' ' 82' ' ' VAL . 25.3 t -124.34 143.4 42.82 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.427 -1.715 . . . . 1.08 111.051 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 Cg_exo -75.27 152.72 39.87 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.799 2.333 . . . . 0.51 113.152 172.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.591 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -123.48 143.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.471 -1.24 . . . . 0.96 110.773 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 mp -114.54 147.81 17.75 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.044 -1.095 . . . . 0.71 108.044 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.27 130.86 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 109.308 -0.627 . . . . 0.23 109.308 172.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -115.22 87.59 2.69 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.25 107.991 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.842 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 23.3 mt -71.26 95.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.57 -1.195 . . . . 0.85 110.26 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.06 164.49 12.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.299 -0.259 . . . . 0.69 110.299 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 62.47 22.7 13.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.815 0.817 . . . . 2.61 109.964 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 4.8 tpp . . . . . 0 N--CA 1.45 -0.454 0 CA-C-N 114.348 -1.296 . . . . 1.37 109.687 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 . . . . . 0 C--O 1.233 0.186 0 N-CA-C 110.489 -0.189 . . . . 1.84 110.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.3 Cg_exo -43.07 -55.5 2.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 123.289 2.66 . . . . 0.7 113.611 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -46.64 -48.98 19.79 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.884 0.698 . . . . 2.0 112.884 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -53.81 -56.68 15.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 2.99 110.245 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.7 t -53.64 -46.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.094 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.648 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -63.23 -38.65 92.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.33 -0.85 . . . . 0.3 111.475 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.9 mt-30 -74.32 -25.06 59.32 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 110.073 -0.343 . . . . 1.28 110.073 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -74.22 -30.24 62.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.151 -0.477 . . . . 2.02 109.889 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.2 mm? -69.43 -45.14 69.87 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.635 0.731 . . . . 1.06 109.645 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.883 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -73.93 -6.07 45.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.957 -1.02 . . . . 0.35 109.793 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 35.5 tt0 -77.39 -28.62 52.85 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.251 -1.018 . . . . 2.18 108.251 173.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.596 ' HB2' HD12 ' A' ' 136' ' ' LEU . 30.5 m-85 -90.05 12.35 17.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.67 0.748 . . . . 0.74 108.987 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 68.54 42.75 1.48 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.102 -1.408 . . . . 1.94 109.93 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 100' ' ' ILE . 2.1 mp -117.7 78.24 1.22 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.617 -1.174 . . . . 1.68 108.803 171.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.54 125.76 91.64 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.608 -1.178 . . . . 0.61 110.913 -178.016 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.745 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -49.36 158.78 1.47 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.213 2.608 . . . . 0.3 112.822 172.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' HG12 ' A' ' 146' ' ' ILE . 30.4 mt-10 -81.14 -20.55 41.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.247 -0.888 . . . . 2.01 109.695 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.841 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -55.87 -39.89 72.15 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.252 -1.018 . . . . 1.14 108.252 168.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.883 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.1 m0 -94.08 -30.3 14.74 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.748 -1.569 . . . . 0.45 109.492 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.25 21.57 3.37 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.754 -1.212 . . . . 0.45 112.921 168.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.492 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.29 -114.97 2.14 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.243 -0.979 . . . . 0.5 112.545 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -151.23 28.88 0.65 Allowed 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.313 0.577 . . . . 1.3 111.237 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.62 122.35 32.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.459 0.647 . . . . 0.32 112.05 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 168' ' ' VAL . 15.8 mt -91.69 106.88 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 1.23 111.241 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.745 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -88.59 108.31 19.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.38 111.583 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 79.1 m -104.28 100.31 10.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.1 110.188 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.842 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 16.4 ptmt -82.03 94.68 7.23 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.306 -0.627 . . . . 2.44 109.306 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' MET . 0.7 OUTLIER -112.77 -176.84 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.955 0.884 . . . . 1.27 112.684 -168.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 24.6 t -165.97 121.64 1.27 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.263 -1.335 . . . . 1.79 109.737 177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -9.2 44.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.894 0.378 . . . . 0.87 111.197 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -83.89 -56.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.736 0.779 . . . . 3.03 109.675 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 46.5 p -81.04 -20.54 41.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.421 -1.263 . . . . 1.2 111.562 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 73.14 -2.65 2.67 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.659 -0.7 . . . . 2.27 111.201 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -48.35 -71.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.772 0.796 . . . . 2.64 112.061 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.63 -9.58 69.74 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.875 -1.057 . . . . 0.62 113.822 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 158' ' ' LEU . 4.3 mm? -69.09 -50.25 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.677 0.738 . . . . 1.55 110.367 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.91 -38.48 82.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.068 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' A' ' 164' ' ' MET . 80.2 t60 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.657 -0.701 . . . . 0.73 110.921 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 62.0 tp -63.25 -58.19 7.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.038 -0.356 . . . . 0.91 110.038 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.75 -37.05 65.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.381 0.61 . . . . 1.06 110.054 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' HE2' ' A' ' 164' ' ' MET . 16.1 tt0 -65.29 -48.26 73.77 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.027 -0.988 . . . . 2.49 110.829 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.632 ' HB3' HG21 ' A' ' 146' ' ' ILE . 17.3 mmt -63.12 -42.79 99.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.309 . . . . 0.87 110.466 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 161' ' ' LEU . 87.8 mt -53.72 -53.56 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.667 -0.697 . . . . 0.64 110.15 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.408 ' CD2' HD11 ' A' ' 57' ' ' ILE . 76.8 mt -59.58 -48.97 79.58 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.659 -0.7 . . . . 1.81 111.872 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.39 -47.18 73.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.746 -0.661 . . . . 1.42 111.098 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 146' ' ' ILE . 2.1 t . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.509 -0.314 . . . . 1.17 111.371 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 81' ' ' ILE . 59.9 t . . . . . 0 N--CA 1.435 -1.192 0 CA-C-O 121.157 0.503 . . . . 1.0 110.944 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -86.07 128.09 34.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.572 -0.74 . . . . 0.66 110.764 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 83' ' ' ILE . 29.0 mt -90.94 122.94 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 1.03 111.549 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.522 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.7 mtt -137.82 171.86 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.099 -0.501 . . . . 1.04 110.596 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.826 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 150.2 -104.52 0.27 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.051 -1.219 . . . . 1.55 110.051 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 66.1 t60 -167.07 158.68 12.45 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.46 -0.57 . . . . 0.66 109.46 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.45 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.728 0.27 . . . . 1.62 111.728 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.32 -22.07 65.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.114 -0.494 . . . . 1.78 112.233 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.412 ' HE1' ' H ' ' A' ' 93' ' ' MET . 62.0 m170 -71.07 -18.25 62.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.078 0.466 . . . . 0.65 110.565 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.29 40.47 3.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.926 -0.654 . . . . 0.93 113.566 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -76.92 -27.38 54.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.468 0.634 . . . . 2.11 110.974 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 -30.97 31.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 1.8 110.126 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -81.08 -17.06 51.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.283 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.37 -51.55 59.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.825 -0.806 . . . . 1.78 108.825 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.658 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 2.7 tt -62.18 -38.63 89.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 1.96 110.248 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.0 t70 -68.82 -46.84 67.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.489 -0.323 . . . . 1.38 111.373 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -64.69 -42.03 95.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.926 0.393 . . . . 0.91 110.784 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.1 tt -66.51 -28.98 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.54 -0.755 . . . . 1.56 109.62 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 14.3 tpt180 -69.37 -33.32 72.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 3.56 109.934 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -83.45 14.58 3.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.876 -0.602 . . . . 2.88 111.361 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 t . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.452 -0.34 . . . . 1.76 110.798 -178.324 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.8 p90 . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.056 0.455 . . . . 2.54 110.585 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -115.26 148.15 39.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.237 -0.653 . . . . 1.96 109.237 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.726 0.774 . . . . 1.93 110.813 -179.131 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mt . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.042 -0.355 . . . . 1.14 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 m -112.68 137.59 50.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.363 . . . . 1.28 110.101 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 110.191 -0.3 . . . . 0.84 110.191 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.638 HG21 HG22 ' A' ' 11' ' ' VAL . 31.7 mm . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.628 0.251 . . . . 0.74 111.457 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 103' ' ' ALA . 85.7 t -108.36 108.88 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.709 -0.223 . . . . 1.19 110.565 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.787 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -87.39 113.32 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 119.768 -0.773 . . . . 1.32 109.89 172.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG22 ' A' ' 96' ' ' THR . 12.4 tp -98.12 111.91 24.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.506 -0.77 . . . . 1.33 110.26 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.826 HG12 ' HA3' ' A' ' 15' ' ' GLY . 7.5 p -84.25 143.04 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.245 0.545 . . . . 1.2 111.036 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.849 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.0 m -135.31 -179.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.158 -1.053 . . . . 1.12 108.158 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.31 133.11 14.97 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.431 -0.908 . . . . 0.75 113.195 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 49.81 -115.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.404 -1.271 . . . . 1.18 113.1 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -115.47 8.95 15.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 2.01 110.289 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 16.4 t70 -64.04 -37.34 87.06 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.75 0.786 . . . . 1.09 109.422 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.61 -109.59 2.98 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.52 111.385 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.0 t -128.25 110.86 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.66 0.266 . . . . 1.08 110.698 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 72.6 mmm -74.52 170.96 12.7 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.307 -0.406 . . . . 1.32 110.181 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.2 Cg_exo -45.3 -52.11 6.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.611 2.208 . . . . 0.61 112.709 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.67 -34.31 75.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.431 -0.349 . . . . 1.47 111.19 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.989 ' HB ' HG13 ' A' ' 92' ' ' VAL . 2.6 m -64.58 -25.91 68.18 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.46 110.759 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 92' ' ' VAL . 69.1 t -86.31 -48.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.547 -0.297 . . . . 1.05 110.478 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 46.4 mt-10 -59.83 -23.94 63.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 1.62 111.335 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.522 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.23 -40.11 31.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.16 -0.681 . . . . 0.34 109.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 110' ' ' ILE . 1.4 mt -72.31 -56.28 10.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.38 110.212 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.444 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.7 t-20 -44.47 -34.34 2.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.438 0.695 . . . . 1.85 111.48 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 7.1 t60 -84.17 -35.25 23.69 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.983 -0.553 . . . . 0.85 111.354 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.32 -28.84 16.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.497 0.554 . . . . 0.48 112.497 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -76.95 -11.15 59.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.917 0.389 . . . . 2.56 110.978 -169.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.4 -1.55 56.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 0.76 111.895 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -95.91 8.64 43.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.915 -1.143 . . . . 0.9 107.915 170.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 63.15 33.11 14.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 113.866 -1.515 . . . . 2.06 110.457 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER -91.94 158.27 39.98 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.715 -0.675 . . . . 1.08 110.343 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.533 ' O ' HG23 ' A' ' 108' ' ' VAL . 6.9 Cg_exo -72.49 146.98 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.614 2.21 . . . . 0.51 113.047 170.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -120.24 142.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.089 -1.414 . . . . 0.96 109.331 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 mt -116.88 155.67 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 108.937 -0.764 . . . . 0.71 108.937 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -120.81 138.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 109.527 -0.546 . . . . 0.23 109.527 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.19 88.33 2.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.849 ' HA ' HG23 ' A' ' 86' ' ' VAL . 30.6 mt -68.57 90.2 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.837 -1.074 . . . . 0.85 110.264 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -80.31 154.8 27.57 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.112 0.258 . . . . 0.69 110.528 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 64.62 32.49 11.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.646 0.591 . . . . 2.61 110.946 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.2 tpp . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 1.37 110.469 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 51.5 t-20 . . . . . 0 CA--C 1.51 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.84 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -20.4 -81.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 1 C-N-CA 126.28 4.654 . . . . 0.7 115.904 175.793 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.84 -46.63 74.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.992 0.517 . . . . 2.0 112.255 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 30.3 tpt180 -50.78 -60.28 3.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.659 0.742 . . . . 2.99 109.658 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.4 t -59.69 -45.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 113.906 -1.497 . . . . 0.4 110.583 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.795 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 91.5 mtp -67.19 -26.13 66.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.906 -0.588 . . . . 0.3 111.25 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.31 -18.63 33.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.719 -0.392 . . . . 1.28 111.29 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.637 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.1 mm-40 -60.07 -42.52 94.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.557 -0.905 . . . . 2.02 108.557 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -73.63 -40.01 64.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.79 -1.095 . . . . 1.06 110.766 -173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.976 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -79.52 -3.68 47.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.811 -0.631 . . . . 0.35 109.76 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 11.2 tp10 -73.83 -33.47 64.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 2.18 107.463 171.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CE2' HG11 ' A' ' 92' ' ' VAL . 27.1 m-85 -87.83 7.94 28.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.613 -0.721 . . . . 0.74 109.862 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 72.56 34.22 1.28 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.755 -1.111 . . . . 1.94 110.638 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.6 mp -111.61 80.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.246 -1.02 . . . . 1.68 108.246 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.07 129.15 93.99 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.93 -1.486 . . . . 0.61 111.077 -176.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.811 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 76.0 Cg_exo -49.48 157.37 2.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.236 2.624 . . . . 0.3 113.649 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 146' ' ' ILE . 8.2 mm-40 -70.6 -31.29 68.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.304 -1.317 . . . . 2.01 109.006 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.639 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.3 mp0 -46.16 -54.02 9.41 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.576 -1.193 . . . . 1.14 110.698 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.976 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.2 m0 -89.45 -18.69 26.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.836 -1.529 . . . . 0.45 110.91 -166.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.59 28.08 4.14 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 120.014 -1.088 . . . . 0.45 112.287 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -99.65 -110.81 3.17 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.373 -0.918 . . . . 0.5 111.814 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.434 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 p30 -159.32 33.5 0.2 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.522 0.677 . . . . 1.3 110.81 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 27.7 m -125.56 112.45 16.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.412 0.625 . . . . 0.32 111.8 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -79.08 104.66 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.657 -0.701 . . . . 1.23 111.079 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -87.91 113.96 24.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.201 0.524 . . . . 0.38 111.811 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.41 ' O ' HD12 ' A' ' 150' ' ' LEU . 64.1 m -105.32 100.81 10.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.551 -0.75 . . . . 1.1 109.568 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 15.3 pttm -81.27 85.36 6.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.577 -0.897 . . . . 2.44 108.577 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.876 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -123.25 -175.64 3.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.176 -0.92 . . . . 1.27 112.671 -166.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 m -157.24 124.62 5.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.645 -1.161 . . . . 1.79 109.628 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -85.52 -12.93 50.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 0.87 110.297 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -73.49 -56.31 5.21 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.364 -0.834 . . . . 3.03 109.304 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.6 p -78.71 -21.57 47.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.884 -1.053 . . . . 1.2 108.997 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 1.023 ' HG3' HD12 ' A' ' 158' ' ' LEU . 2.1 ttmp? 70.79 7.03 6.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.715 -1.584 . . . . 2.27 112.038 172.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.26 -49.46 64.24 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.12 0.962 . . . . 2.64 110.652 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.876 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -62.14 -23.81 64.47 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 114.778 -1.101 . . . . 0.62 113.012 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.023 HD12 ' HG3' ' A' ' 155' ' ' LYS . 29.9 mt -64.65 -32.22 73.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.715 0.258 . . . . 1.55 110.558 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 13.7 m-20 -60.65 -53.26 59.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.036 -0.727 . . . . 2.5 109.036 172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.441 -0.8 . . . . 0.73 111.049 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.2 tp -61.05 -60.55 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.342 -0.39 . . . . 0.91 111.062 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.46 -40.36 68.32 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.221 0.325 . . . . 1.06 110.533 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 78.5 mm-40 -61.64 -49.7 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.539 . . . . 2.49 110.715 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.503 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -69.56 -34.66 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.87 110.444 -175.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.98 -52.32 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.928 -0.578 . . . . 0.64 110.714 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -76.8 -37.15 56.29 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.303 0.483 . . . . 1.81 112.303 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 166' ' ' LEU . 40.7 tp -61.53 -25.13 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.061 0.458 . . . . 1.42 110.166 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.615 HG21 HG12 ' A' ' 146' ' ' ILE . 2.7 t . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 1.17 110.12 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 58' ' ' THR . 51.4 t . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 121.146 0.498 . . . . 1.0 110.231 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -96.56 130.05 43.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.497 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 55.3 mt -97.76 126.75 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.712 0.292 . . . . 1.03 110.691 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.424 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 70.3 mtm -144.25 -177.73 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.075 -0.511 . . . . 1.04 110.888 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 84' ' ' LEU . . . 107.18 59.27 0.58 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.634 -0.793 . . . . 1.55 112.464 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 18.0 t60 62.07 163.62 0.09 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.068 0.937 . . . . 0.66 112.065 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.92 -32.28 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.861 -0.609 . . . . 1.62 111.633 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.444 ' HB3' ' NE2' ' A' ' 16' ' ' HIS . 28.0 t70 -72.83 -25.42 61.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.612 0.227 . . . . 1.78 111.612 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' MET . 32.5 m80 -61.71 -20.25 63.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 0.65 110.63 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.63 51.2 1.13 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.638 -0.71 . . . . 0.93 113.086 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.832 0.825 . . . . 2.11 109.021 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -36.79 80.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.451 -1.25 . . . . 1.8 110.76 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.5 p -73.24 -20.82 60.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 1.77 111.257 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.8 mm? -71.91 -48.13 47.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.947 -0.39 . . . . 1.78 109.947 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.22 -35.89 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.827 -0.624 . . . . 1.96 109.932 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.12 -58.31 8.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.794 0.331 . . . . 1.38 111.528 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -62.14 -29.15 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.91 111.133 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 HD21 ' A' ' 162' ' ' LEU . 5.2 tt -75.43 -25.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 1.56 111.029 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.0 mtp180 -78.97 -21.33 47.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.373 0.606 . . . . 3.56 110.049 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -88.6 -0.31 57.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 2.88 109.695 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.576 -0.738 . . . . 1.76 110.156 -179.511 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.162 0.506 . . . . 2.54 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.559 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 72.4 mt-30 -142.31 117.5 10.1 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.956 -1.127 . . . . 1.96 107.956 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--N 1.309 -1.168 0 N-CA-C 108.41 -0.959 . . . . 1.93 108.41 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 58' ' ' THR . 10.5 mt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.335 0.588 . . . . 1.14 110.966 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 4.0 t -151.61 144.16 24.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.6 -0.889 . . . . 1.28 108.6 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 13' ' ' ILE . 42.7 m-85 . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 120.715 -0.394 . . . . 0.84 110.481 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.673 HG23 HD11 ' A' ' 111' ' ' ILE . 28.3 mm . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.22 0.452 . . . . 0.74 112.22 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.731 ' HB ' HD13 ' A' ' 110' ' ' ILE . 75.8 t -107.09 120.62 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 116.44 -0.345 . . . . 1.19 110.899 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 111' ' ' ILE . 8.3 mm -86.31 123.08 39.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.531 -0.914 . . . . 1.32 108.531 171.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.0 tm? -107.66 113.94 27.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.704 . . . . 1.33 109.302 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.83 139.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.141 0.496 . . . . 1.2 111.855 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 114' ' ' ILE . 25.8 m -139.42 -171.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 108.822 -0.807 . . . . 1.12 108.822 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.9 109.92 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.968 0.729 . . . . 0.75 112.968 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . 44.68 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.809 1.041 . . . . 1.18 113.809 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -107.67 -3.96 18.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.347 0.499 . . . . 2.01 112.347 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 31.0 t70 -64.34 -43.79 93.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.419 0.628 . . . . 1.09 111.054 -175.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 88.93 -113.17 4.06 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.518 -0.848 . . . . 0.52 111.249 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.966 HG13 ' HB ' ' A' ' 96' ' ' THR . 35.5 t -129.36 119.2 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 120.656 0.265 . . . . 1.08 110.625 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 42.0 mtp -85.83 169.35 15.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.675 -0.491 . . . . 1.32 109.675 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.4 Cg_exo -42.64 -60.01 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.753 2.302 . . . . 0.61 112.801 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.684 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 42.0 mt-30 -59.27 -25.39 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.703 0.631 . . . . 1.47 112.703 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.966 ' HB ' HG13 ' A' ' 92' ' ' VAL . 29.9 m -60.21 -46.01 91.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.277 -0.169 . . . . 0.46 111.001 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.572 ' HA ' ' HB ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -88.52 -30.25 5.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 O-C-N 121.847 -0.533 . . . . 1.05 111.444 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 44.5 mt-10 -61.36 -26.94 68.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.411 . . . . 1.62 111.099 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -88.13 -22.31 24.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.34 109.959 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.805 HD13 HD22 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -80.79 -47.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.169 -0.923 . . . . 0.38 110.796 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -57.63 -32.78 67.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.398 0.618 . . . . 1.85 110.056 170.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.09 -29.46 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.35 -0.841 . . . . 0.85 109.936 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -96.18 -54.68 3.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.471 0.545 . . . . 0.48 112.471 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HG3' HD11 ' A' ' 136' ' ' LEU . 24.5 mmmt -55.18 -44.8 75.6 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.601 0.715 . . . . 2.56 111.021 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.59 10.24 2.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.318 -1.31 . . . . 0.76 112.133 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.53 8.43 21.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.374 -0.973 . . . . 0.9 108.374 167.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 70.1 48.6 0.52 Allowed 'General case' 0 C--N 1.339 0.149 0 CA-C-N 114.226 -1.352 . . . . 2.06 111.084 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -126.48 157.61 70.08 Favored Pre-proline 0 C--O 1.238 0.485 0 N-CA-C 112.954 0.724 . . . . 1.08 112.954 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.575 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.5 Cg_exo -76.2 159.56 36.89 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 124.611 3.541 . . . . 0.51 114.498 168.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.756 HD11 ' HB3' ' A' ' 103' ' ' ALA . 22.1 mm -129.66 148.26 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.78 -1.1 . . . . 0.96 111.166 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 83' ' ' ILE . 3.9 mt -122.06 150.95 25.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 N-CA-C 109.283 -0.636 . . . . 0.71 109.283 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.2 136.34 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.282 0.563 . . . . 0.23 110.442 174.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.9 88.41 2.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.022 -1.103 . . . . 0.25 108.022 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.779 ' HA ' HG23 ' A' ' 86' ' ' VAL . 45.2 mt -69.36 91.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.686 -1.143 . . . . 0.85 109.697 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.643 ' HA ' HD22 ' A' ' 150' ' ' LEU . 53.9 t30 -88.67 151.71 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.69 111.204 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt 54.89 36.47 26.74 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.951 0.782 . . . . 2.61 111.018 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.497 -0.774 . . . . 1.37 109.365 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 109.859 -0.422 . . . . 1.84 109.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.5 Cg_endo -42.89 -59.25 1.04 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.496 2.797 . . . . 0.7 113.063 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.9 -47.51 32.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.582 0.586 . . . . 2.0 112.582 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.634 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 24.0 tpt180 -58.43 -55.86 29.6 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.329 0.585 . . . . 2.99 109.709 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.583 HG13 ' HA2' ' A' ' 91' ' ' GLY . 82.3 t -52.46 -43.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.4 -1.273 . . . . 0.4 110.677 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.683 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 81.5 mtp -64.24 -34.05 77.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.032 -0.531 . . . . 0.3 110.527 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 58.1 mt-30 -73.63 -24.28 60.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 1.28 111.025 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 3.0 mm-40 -68.7 -36.78 78.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.685 -0.857 . . . . 2.02 108.685 172.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.6 mm? -71.73 -43.59 65.6 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.55 -0.75 . . . . 1.06 109.844 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.838 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -77.55 0.26 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.521 -0.763 . . . . 0.35 109.819 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.546 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 16.4 tp10 -81.18 -27.58 35.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.911 -1.144 . . . . 2.18 107.911 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.763 ' CE2' HG11 ' A' ' 92' ' ' VAL . 48.5 m-85 -91.99 10.35 29.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.533 0.683 . . . . 0.74 109.19 168.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.2 m120 72.46 32.57 1.58 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.23 -1.35 . . . . 1.94 110.889 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.805 HD22 HD13 ' A' ' 100' ' ' ILE . 7.5 mp -107.84 79.51 1.29 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.402 1.096 . . . . 1.68 109.475 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.027 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.3 t -66.94 126.18 92.04 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.245 -1.798 . . . . 0.61 112.014 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.85 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 74.5 Cg_exo -47.45 160.11 0.4 Allowed 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 123.848 3.032 . . . . 0.3 113.878 170.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.56 -19.07 42.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.677 -1.147 . . . . 2.01 109.835 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 1.9 mm-40 -59.23 -40.8 87.03 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.878 -1.156 . . . . 1.14 107.878 168.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.893 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.7 m0 -91.67 -31.64 15.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.952 -1.476 . . . . 0.45 110.979 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.37 28.61 2.98 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.018 -1.087 . . . . 0.45 112.045 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 1.027 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.96 -104.77 1.79 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.717 -0.754 . . . . 0.5 111.913 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -165.49 33.47 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.174 0.511 . . . . 1.3 111.248 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 16.0 m -130.8 113.43 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.244 -0.582 . . . . 0.32 112.016 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.823 HD11 HG21 ' A' ' 168' ' ' VAL . 37.6 mt -81.44 110.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 116.02 -0.537 . . . . 1.23 111.347 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.85 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 23.4 m-85 -89.55 115.0 26.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.933 0.397 . . . . 0.38 111.805 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 13.8 t -113.27 135.94 53.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.866 -0.606 . . . . 1.1 109.386 173.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.758 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.2 pttp -110.74 85.13 2.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.689 0.757 . . . . 2.44 109.949 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -103.55 168.97 8.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.223 1.011 . . . . 1.27 112.906 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.578 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 27.7 t -145.14 117.37 8.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.392 -1.276 . . . . 1.79 108.131 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.53 -26.44 61.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.27 0.841 . . . . 0.87 113.27 -170.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.639 ' HG3' ' H ' ' A' ' 154' ' ' THR . 46.4 pttt -84.27 -55.24 4.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.33 0.586 . . . . 3.03 110.945 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.639 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 40.8 p -64.21 -25.08 67.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.096 -0.956 . . . . 1.2 110.628 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.849 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 2.5 tppp? 66.8 16.27 10.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.88 -1.055 . . . . 2.27 111.805 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.85 -72.42 0.16 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.712 0.768 . . . . 2.64 111.021 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -61.97 -16.67 53.15 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.739 -1.119 . . . . 0.62 113.24 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 150' ' ' LEU . 4.5 mm? -61.4 -46.21 91.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.912 0.387 . . . . 1.55 110.692 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.58 -42.16 68.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.074 -0.512 . . . . 2.5 110.205 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.9 t60 -66.61 -21.23 66.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.802 -0.635 . . . . 0.73 110.827 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.55 -51.13 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.056 -0.35 . . . . 0.91 110.056 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.668 HD21 HD11 ' A' ' 28' ' ' ILE . 93.8 mt -56.17 -39.95 73.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.635 . . . . 1.06 111.107 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 13.6 pt-20 -69.54 -32.59 71.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 2.49 110.648 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.706 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 25.6 mmt -73.13 -41.34 64.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.073 0.463 . . . . 0.87 109.898 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.43 -51.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.323 -0.853 . . . . 0.64 111.123 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -75.99 -36.85 59.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.246 0.461 . . . . 1.81 112.246 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 166' ' ' LEU . 62.4 tp -52.23 -33.64 42.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.036 0.446 . . . . 1.42 110.575 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 146' ' ' ILE . 19.0 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.856 -0.611 . . . . 1.17 110.71 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 81' ' ' ILE . 58.9 t . . . . . 0 N--CA 1.437 -1.123 0 CA-C-O 121.041 0.448 . . . . 1.0 110.671 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 127.2 43.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.66 110.77 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.423 HD11 ' HD2' ' A' ' 59' ' ' PHE . 39.9 mt -83.99 115.77 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.319 0.58 . . . . 1.03 110.512 177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.419 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 mmt -107.49 -175.44 2.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.208 -0.905 . . . . 1.04 110.139 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.34 134.56 7.54 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.238 -0.982 . . . . 1.55 110.805 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 84.3 t60 -36.58 128.61 0.8 Allowed 'General case' 0 C--N 1.315 -0.894 0 O-C-N 124.634 0.843 . . . . 0.66 111.124 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 11.3 p -55.61 -21.28 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.352 -0.84 . . . . 1.62 113.107 -170.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 31.5 t70 -93.16 -8.22 43.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.8 0.333 . . . . 1.78 111.78 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.446 ' ND1' ' HA ' ' A' ' 86' ' ' VAL . 21.9 m170 -77.26 -7.24 55.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.484 0.55 . . . . 0.65 112.484 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.64 46.36 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.224 -0.989 . . . . 0.93 112.773 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 ptmm? -87.22 -24.26 24.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 2.11 110.174 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 t -72.8 -29.75 63.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.8 110.254 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 p -75.42 -25.74 57.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.128 -0.487 . . . . 1.77 110.871 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 152' ' ' ALA . 43.0 mt -67.9 -54.04 21.87 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.986 -0.746 . . . . 1.78 108.986 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.04 -41.21 62.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.851 -0.613 . . . . 1.96 110.258 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.9 t70 -77.96 -51.38 10.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.54 -33.38 64.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.897 0.332 . . . . 0.91 111.897 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.576 ' HB ' ' OH ' ' A' ' 48' ' ' TYR . 76.2 mt -70.0 -39.05 76.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 1.56 110.046 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.682 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 7.2 ptt180 -66.67 -33.47 75.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.325 0.584 . . . . 3.56 109.967 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -83.06 -3.85 57.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.485 -0.78 . . . . 2.88 111.604 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.713 0.292 . . . . 1.76 110.714 -177.923 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.576 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 5.7 p90 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.019 0.438 . . . . 2.54 111.468 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -140.14 133.56 30.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.359 -0.837 . . . . 1.96 110.191 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.688 0.756 . . . . 1.93 109.832 176.413 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 11' ' ' VAL . 4.0 mt . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.803 0.335 . . . . 1.14 111.663 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.9 m -99.23 112.29 24.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.167 -0.47 . . . . 1.28 109.793 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HD2' HD11 ' A' ' 13' ' ' ILE . 39.8 m-85 . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 110.217 -0.29 . . . . 0.84 110.217 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.988 ' HB ' HG22 ' A' ' 11' ' ' VAL . 47.8 mm . . . . . 0 C--O 1.235 0.303 0 N-CA-C 113.162 0.801 . . . . 0.74 113.162 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 103' ' ' ALA . 70.0 t -106.29 107.55 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 1.19 110.758 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.722 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -94.14 110.13 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 174.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 100' ' ' ILE . 10.5 tp -90.28 108.33 19.69 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.923 -0.581 . . . . 1.33 110.749 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.3 t -82.0 133.68 28.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.559 . . . . 1.2 111.483 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.3 m -134.08 -177.88 2.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.888 -1.153 . . . . 1.12 107.888 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.08 11.84 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.792 -0.763 . . . . 0.75 112.215 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.75 -109.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.625 -1.17 . . . . 1.18 112.903 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -116.51 19.05 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 2.01 110.472 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.14 -33.35 73.29 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.817 0.818 . . . . 1.09 109.0 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.822 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.68 -142.15 28.46 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.251 -1.341 . . . . 0.52 111.912 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 96' ' ' THR . 71.2 t -98.01 110.2 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 120.809 0.337 . . . . 1.08 111.391 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 80.5 mmm -80.49 171.61 11.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.15 -0.477 . . . . 1.32 109.804 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.67 -54.49 4.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.138 2.559 . . . . 0.61 113.257 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 35.6 mt-30 -60.74 -30.33 69.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 1.47 111.574 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 92' ' ' VAL . 9.8 m -64.58 -22.96 67.11 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.851 0.358 . . . . 0.46 111.102 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.65 -46.5 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.885 0.374 . . . . 1.05 111.111 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.0 -12.74 40.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 1.62 111.315 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -96.68 -18.82 19.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.34 110.085 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 84' ' ' LEU . 3.4 mt -93.3 -53.07 8.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.38 110.507 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -50.4 -37.79 39.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.708 -0.678 . . . . 1.85 110.53 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -75.9 -32.04 59.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.233 -0.894 . . . . 0.85 110.728 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.21 -55.79 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 0.48 112.084 -173.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HB3' HD11 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -71.41 -12.16 61.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 116.165 -0.47 . . . . 2.56 112.075 -168.367 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.37 -0.32 19.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.241 -0.436 . . . . 0.76 111.869 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.1 1.99 26.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 t30 82.14 38.04 0.06 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 114.566 -1.197 . . . . 2.06 108.113 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 23.5 t -101.93 142.01 23.72 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 113.151 -1.841 . . . . 1.08 111.122 -173.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 6.4 Cg_exo -73.86 149.98 43.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.754 2.303 . . . . 0.51 113.165 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.683 HD13 HG12 ' A' ' 100' ' ' ILE . 97.8 mt -124.78 149.79 29.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.325 -1.307 . . . . 0.96 109.989 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mt -125.11 157.35 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 109.065 -0.717 . . . . 0.71 109.065 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -115.25 134.6 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 109.651 -0.499 . . . . 0.23 109.651 171.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.69 87.71 2.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.748 -1.204 . . . . 0.25 107.748 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.0 mt -73.66 93.08 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.661 -1.154 . . . . 0.85 109.749 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.55 166.44 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.095 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 57.3 tptt 63.0 47.9 4.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.27 1.033 . . . . 2.61 110.585 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.427 ' SD ' HG22 ' A' ' 114' ' ' ILE . 69.3 mmm . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.13 -0.941 . . . . 1.37 108.501 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.5 t30 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.179 -0.674 . . . . 1.84 109.179 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.3 Cg_exo -19.29 -66.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 1 C-N-CA 126.389 4.726 . . . . 0.7 116.456 175.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -39.68 -52.03 2.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.096 0.776 . . . . 2.0 113.096 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.0 tmt_? -55.55 -56.7 17.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.985 0.422 . . . . 2.99 109.926 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.822 HG13 ' HA2' ' A' ' 91' ' ' GLY . 31.0 t -58.45 -45.17 89.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.4 110.008 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.695 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 88.8 mtp -63.41 -30.11 71.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.395 -0.82 . . . . 0.3 111.181 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 58.8 mt-30 -78.61 -25.21 45.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.118 -0.233 . . . . 1.28 110.669 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.75 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.6 mt-10 -63.45 -38.61 91.79 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.847 -0.798 . . . . 2.02 108.847 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.984 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -70.85 -42.36 70.23 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.094 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.824 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -72.92 -7.76 52.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.728 -0.669 . . . . 0.35 110.227 178.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.85 -24.36 35.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 19.1 m-85 -89.05 5.95 42.01 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 122.216 1.008 . . . . 0.74 108.306 167.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 72.37 26.35 2.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 113.158 -1.837 . . . . 1.94 110.541 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.984 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -103.56 73.02 1.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.205 -1.406 . . . . 1.68 107.205 169.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.909 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -58.31 132.56 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 113.403 -1.726 . . . . 0.61 110.291 -173.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.856 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 94.4 Cg_exo -47.35 151.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.631 2.221 . . . . 0.3 112.971 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -76.0 -25.68 56.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.149 -1.387 . . . . 2.01 108.028 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.828 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -55.99 -38.9 71.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.288 -1.323 . . . . 1.14 109.149 169.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.828 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.6 m0 -96.03 -25.31 15.97 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.581 -1.191 . . . . 0.45 110.453 -172.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.48 24.15 3.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.908 -1.139 . . . . 0.45 112.192 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.909 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -115.85 2.93 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.396 -0.907 . . . . 0.5 112.978 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.28 25.03 1.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.965 0.358 . . . . 1.3 111.965 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.588 HG21 HD12 ' A' ' 136' ' ' LEU . 31.7 m -142.91 123.12 13.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 119.541 -0.864 . . . . 0.32 113.267 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.4 mp -85.19 118.42 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 1.23 110.36 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.3 m-85 -92.88 116.61 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.911 0.386 . . . . 0.38 111.352 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.6 m -114.46 110.24 19.54 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.72 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 14.9 ptmt -84.91 85.75 7.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.354 0.597 . . . . 2.44 109.707 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -114.3 -175.22 2.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.446 0.641 . . . . 1.27 111.816 -171.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.65 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 35.9 m -160.02 119.59 2.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.51 -0.768 . . . . 1.79 110.011 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' A' ' 24' ' ' LEU . . . -73.94 -53.25 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.897 -0.592 . . . . 0.87 112.553 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -75.34 -43.26 51.58 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.583 0.706 . . . . 3.03 109.785 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.3 OUTLIER -57.88 -22.14 46.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.15 -1.387 . . . . 1.2 110.196 171.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.743 ' HD3' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER 74.22 -39.28 0.42 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.601 -1.181 . . . . 2.27 113.903 170.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.99 -46.48 43.91 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.649 0.738 . . . . 2.64 112.024 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.65 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -63.99 -33.1 86.34 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.05 -0.977 . . . . 0.62 113.58 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.743 HD12 ' HD3' ' A' ' 155' ' ' LYS . 74.7 mt -59.68 -47.02 87.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.809 0.338 . . . . 1.55 111.182 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -59.96 -44.52 94.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.64 -0.709 . . . . 2.5 110.251 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -65.46 -38.75 90.74 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.309 -0.405 . . . . 0.73 110.898 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.9 -51.61 68.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 0.91 111.011 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 165' ' ' ILE . 81.7 mt -60.16 -33.88 72.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 1.06 110.911 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.83 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 2.49 110.642 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.56 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.87 110.638 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.43 HD12 HD23 ' A' ' 162' ' ' LEU . 81.7 mt -61.4 -48.77 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.64 110.596 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.6 -37.97 89.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.81 110.821 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.7 -45.45 73.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.733 -0.667 . . . . 1.42 109.656 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 116.078 -0.51 . . . . 1.17 111.035 -178.147 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 ' HB ' ' A' ' 81' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -97.75 109.63 22.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 0.66 110.717 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 83' ' ' ILE . 14.7 tt -82.69 143.99 11.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.092 0.472 . . . . 1.03 110.772 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.68 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 59.4 mtt -139.94 -172.6 3.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.069 -0.514 . . . . 1.04 110.934 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.905 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 107.76 129.64 6.13 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.944 -0.862 . . . . 1.55 110.944 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 83.4 t60 -49.01 136.58 14.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.499 0.666 . . . . 0.66 110.971 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.624 HG12 ' HE2' ' A' ' 21' ' ' LYS . 29.2 m -64.74 -33.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.294 0.85 . . . . 1.62 113.294 -169.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.483 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 9.7 m-20 -67.15 -19.8 65.65 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.745 0.276 . . . . 1.78 111.745 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -68.93 -16.25 63.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.65 110.916 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 114.63 47.27 0.58 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.87 -0.681 . . . . 0.93 112.472 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.624 ' HE2' HG12 ' A' ' 17' ' ' VAL . 36.3 ttpt -87.09 -34.99 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.547 -0.538 . . . . 2.11 109.547 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -67.35 -47.73 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 1.8 109.954 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -69.49 -20.37 63.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.663 -0.699 . . . . 1.77 110.432 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 3.0 tm? -73.57 -51.01 18.4 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.519 -0.919 . . . . 1.78 108.519 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -58.09 -37.1 73.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.455 -0.793 . . . . 1.96 110.668 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.26 -55.55 11.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 1.38 110.81 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.2 98.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.91 111.203 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 25' ' ' LEU . 13.0 tt -65.03 -31.51 54.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.588 -0.733 . . . . 1.56 111.02 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -79.9 -28.07 39.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.475 0.655 . . . . 3.56 109.29 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.92 -9.29 59.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 2.88 111.489 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 CA--C 1.534 0.345 0 CA-C-N 116.442 -0.345 . . . . 1.76 111.709 -178.073 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.439 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.5 p90 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.19 0.519 . . . . 2.54 110.025 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.941 ' HG2' HG23 ' A' ' 58' ' ' THR . 77.9 mt-30 -100.07 114.78 28.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.925 -0.769 . . . . 1.96 108.925 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG21 ' HE1' ' A' ' 59' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.596 0.713 . . . . 1.93 111.909 -174.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 166' ' ' LEU . 63.5 mt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.45 0.643 . . . . 1.14 111.781 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.941 HG23 ' HG2' ' A' ' 49' ' ' GLN . 28.9 m -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 170.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HE1' HG21 ' A' ' 50' ' ' VAL . 83.0 m-85 . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 108.872 -0.788 . . . . 0.84 108.872 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 11' ' ' VAL . 37.5 mm . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.439 -0.578 . . . . 0.74 109.439 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 103' ' ' ALA . 87.5 t -91.84 95.7 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.257 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.806 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -81.94 97.66 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 120.291 -0.564 . . . . 1.32 109.632 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 96' ' ' THR . 20.4 tp -86.94 109.0 19.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.643 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HA3' ' A' ' 15' ' ' GLY . 5.0 p -85.23 142.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 1.2 111.298 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.1 m -138.9 -177.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.553 -0.906 . . . . 1.12 108.553 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.81 98.26 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.953 -0.699 . . . . 0.75 112.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.97 -95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.106 1.15 . . . . 1.18 114.106 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.17 -8.21 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 2.01 112.002 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.06 -32.58 39.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 1.09 110.458 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 72.31 -139.11 27.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.259 -0.882 . . . . 0.52 112.443 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.572 HG13 ' HB ' ' A' ' 96' ' ' THR . 78.4 t -97.1 106.54 18.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 123.012 0.525 . . . . 1.08 111.512 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.553 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 51.0 mtp -75.9 170.85 13.9 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 1.32 110.634 173.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 79.0 Cg_exo -43.85 -58.07 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.79 2.327 . . . . 0.61 112.898 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.2 mt-30 -56.13 -32.86 64.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.387 0.514 . . . . 1.47 112.387 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 84' ' ' LEU . 11.4 m -66.68 -23.16 66.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.134 0.492 . . . . 0.46 110.579 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 92' ' ' VAL . 91.1 t -91.79 -45.25 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.404 -0.362 . . . . 1.05 110.69 175.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 46.1 mt-10 -61.36 -18.13 57.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 1.62 111.147 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.68 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -86.32 -41.47 14.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.814 -0.63 . . . . 0.34 109.358 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 110' ' ' ILE . 1.3 mt -68.35 -55.46 16.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 CA-C-N 115.452 -0.795 . . . . 0.38 110.631 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 t-20 -45.33 -36.8 4.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.791 0.436 . . . . 1.85 111.432 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -79.01 -29.16 43.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.897 -0.592 . . . . 0.85 111.012 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -99.51 -42.62 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.96 0.726 . . . . 0.48 112.96 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -17.4 64.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.074 0.464 . . . . 2.56 111.092 -166.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' N ' ' HD3' ' A' ' 104' ' ' LYS . . . -87.47 5.22 40.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.52 . . . . 0.76 111.741 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -96.59 1.63 51.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.401 -0.592 . . . . 0.9 109.401 174.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 74.71 39.01 0.45 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.38 1.086 . . . . 2.06 108.966 176.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -118.52 143.59 33.62 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 113.5 -1.682 . . . . 1.08 110.248 -176.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.1 Cg_exo -69.14 154.35 70.33 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.628 2.219 . . . . 0.51 114.157 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -122.3 146.87 26.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 113.913 -1.494 . . . . 0.96 109.806 -177.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.806 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.54 148.36 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.89 -1.152 . . . . 0.71 107.89 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -115.41 130.03 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 109.851 -0.426 . . . . 0.23 109.851 174.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.66 87.28 2.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.911 -1.144 . . . . 0.25 107.911 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.748 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.5 mt -73.87 97.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.432 -1.258 . . . . 0.85 109.976 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 23.1 t-20 -88.19 147.5 24.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.448 -0.342 . . . . 0.69 111.066 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 31.0 mtmm 76.98 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.024 0.828 . . . . 2.61 111.753 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 23.8 mmm . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 108.343 -0.984 . . . . 1.37 108.343 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.505 -0.554 . . . . 1.84 109.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.9 Cg_endo -42.15 -53.46 3.55 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 124.003 3.135 . . . . 0.7 113.627 175.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.53 -48.23 19.41 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.549 0.574 . . . . 2.0 112.549 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -52.2 -60.83 2.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.459 0.647 . . . . 2.99 110.115 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' HA2' ' A' ' 91' ' ' GLY . 48.4 t -54.1 -45.1 65.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.248 -1.342 . . . . 0.4 110.537 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.733 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.6 mtp -62.79 -33.11 74.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.029 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -72.15 -23.04 61.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.434 -0.348 . . . . 1.28 111.196 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 7.0 mt-10 -72.5 -32.52 66.24 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.976 -0.75 . . . . 2.02 108.976 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.487 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -72.35 -44.32 62.77 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.575 0.702 . . . . 1.06 109.295 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.964 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -76.0 -2.07 28.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.35 109.778 177.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.7 tp10 -78.63 -31.32 46.88 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.303 -1.369 . . . . 2.18 107.303 173.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 136' ' ' LEU . 40.1 m-85 -90.11 9.66 27.38 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.812 . . . . 0.74 109.107 171.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 74.99 16.96 2.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.814 -1.539 . . . . 1.94 110.37 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 100' ' ' ILE . 6.1 mp -91.13 72.19 6.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.212 1.006 . . . . 1.68 108.488 173.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.486 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.49 129.89 92.96 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.917 -1.492 . . . . 0.61 110.711 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.789 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -50.72 158.32 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.953 2.436 . . . . 0.3 112.831 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' OE1' HG13 ' A' ' 146' ' ' ILE . 9.6 mt-10 -73.7 -29.8 62.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.056 -0.974 . . . . 2.01 108.504 175.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.665 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.4 mp0 -42.14 -55.08 3.38 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.431 -1.259 . . . . 1.14 110.597 163.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.964 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 13.5 m0 -90.7 -23.21 20.79 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.861 -1.518 . . . . 0.45 111.286 -166.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.28 25.98 2.81 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.709 -1.234 . . . . 0.45 112.44 171.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -102.84 -113.81 3.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.45 -0.881 . . . . 0.5 112.689 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -154.45 30.15 0.43 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.087 0.47 . . . . 1.3 111.503 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 136' ' ' LEU . 30.6 m -125.22 124.0 40.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.157 -0.617 . . . . 0.32 112.254 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.3 mp -91.94 103.33 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.498 . . . . 1.23 111.419 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.789 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 30.7 m-85 -85.54 126.33 33.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.906 0.384 . . . . 0.38 111.842 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.4 m -126.91 124.63 39.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.501 -0.772 . . . . 1.1 109.959 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 18.6 ptpt -98.75 86.94 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.655 0.74 . . . . 2.44 109.369 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -106.75 174.01 6.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.89 0.852 . . . . 1.27 112.52 -173.152 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.64 127.68 5.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.599 -1.182 . . . . 1.79 110.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.27 -3.25 48.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.87 110.768 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -74.71 -46.62 36.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.281 -0.872 . . . . 3.03 109.897 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -106.61 -11.1 15.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.612 -1.176 . . . . 1.2 111.182 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HA ' HD23 ' A' ' 158' ' ' LEU . 54.6 mttp 62.78 15.82 8.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.339 -0.846 . . . . 2.27 112.706 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.16 -65.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.892 0.854 . . . . 2.64 110.912 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -67.04 -11.43 58.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.764 -1.107 . . . . 0.62 113.267 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 155' ' ' LYS . 4.2 mm? -64.44 -44.56 90.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.314 0.557 . . . . 1.55 109.844 178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.9 -48.36 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.053 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.93 -35.06 77.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.73 111.22 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' ILE . 65.5 tp -61.85 -57.84 10.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.558 -0.292 . . . . 0.91 111.398 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 165' ' ' ILE . 4.0 pp -63.08 -29.93 71.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.755 -0.202 . . . . 1.06 110.877 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 162' ' ' LEU . 52.1 mm-40 -63.58 -41.3 98.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 2.49 110.71 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.549 ' HB3' HG21 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -73.02 -38.68 66.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.669 0.271 . . . . 0.87 110.964 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 81' ' ' ILE . 85.6 mt -55.36 -52.73 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.931 -0.577 . . . . 0.64 110.991 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 57' ' ' ILE . 3.7 pp -71.19 -35.42 71.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.668 0.27 . . . . 1.81 111.526 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 166' ' ' LEU . 61.8 tp -52.12 -32.25 34.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.747 -0.661 . . . . 1.42 110.212 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.44 -0.963 0 CA-C-N 115.912 -0.585 . . . . 1.17 110.26 -179.43 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.029 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 4.2 t . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 83' ' ' ILE . 20.0 m -77.7 123.03 26.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.332 -0.849 . . . . 0.66 110.793 -173.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 24' ' ' LEU . 15.0 tt -86.61 135.57 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.486 0.66 . . . . 1.03 109.276 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.567 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 37.6 mtt -140.67 -175.58 4.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.455 -0.793 . . . . 1.04 110.954 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.835 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.86 -99.04 0.22 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.09 -1.204 . . . . 1.55 110.09 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.415 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 29.5 t60 -156.19 156.13 33.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.72 -56.35 18.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.653 0.263 . . . . 1.62 111.614 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.91 -18.37 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.314 0.487 . . . . 1.78 112.314 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 7.3 m170 -57.62 -37.03 72.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.012 0.435 . . . . 0.65 111.042 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 127.56 59.17 0.13 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.527 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -87.22 -37.18 17.49 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.512 -0.551 . . . . 2.11 109.512 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -68.99 -44.67 72.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.518 -0.765 . . . . 1.8 110.022 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -71.37 -16.91 62.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.178 -0.465 . . . . 1.77 110.398 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 13' ' ' ILE . 5.8 tt -81.17 -53.77 6.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.083 -0.71 . . . . 1.78 109.083 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.535 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -64.09 -36.07 82.83 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.211 -0.449 . . . . 1.96 110.022 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.25 -54.53 39.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 1.38 111.46 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.02 79.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.973 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.1 tt -72.59 -30.33 33.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.717 -0.674 . . . . 1.56 109.961 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 2.0 tpt180 -74.09 -33.34 63.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.603 -0.726 . . . . 3.56 110.084 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -73.01 -12.11 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 2.88 110.507 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 108.823 -0.806 . . . . 1.76 108.823 173.75 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 p90 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 108.207 -1.035 . . . . 2.54 108.207 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 50.2 mt-30 -118.76 137.92 53.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.939 0.4 . . . . 1.96 110.642 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.815 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 72.7 t . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.875 0.845 . . . . 1.93 110.991 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 11' ' ' VAL . 55.5 mt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 111.927 0.343 . . . . 1.14 111.927 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 13.4 m -94.44 107.91 19.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.493 -0.321 . . . . 1.28 110.262 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.84 111.282 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.029 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 40.2 mm . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 111.485 0.179 . . . . 0.74 111.485 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.679 HG21 ' HB1' ' A' ' 103' ' ' ALA . 92.3 t -113.78 106.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.541 -0.299 . . . . 1.19 111.077 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -94.39 99.65 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 175.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 15.1 tp -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.146 -0.479 . . . . 1.33 111.254 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.835 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.5 p -79.39 141.54 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.372 0.606 . . . . 1.2 110.809 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 114' ' ' ILE . 26.7 m -140.94 -160.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.569 -1.271 . . . . 1.12 107.569 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.14 147.99 34.45 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.139 -0.624 . . . . 0.75 111.684 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -35.25 -59.33 0.52 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.606 1.191 . . . . 1.18 112.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.79 -9.87 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.507 . . . . 2.01 112.1 -172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.49 -51.3 5.99 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.293 0.568 . . . . 1.09 111.402 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 85.65 -136.93 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.248 -0.887 . . . . 0.52 111.62 -172.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.971 HG13 ' HB ' ' A' ' 96' ' ' THR . 37.7 t -101.18 114.08 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 122.898 0.479 . . . . 1.08 111.248 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 39.5 mtp -81.19 169.79 17.85 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 1.32 110.025 172.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.1 Cg_endo -44.9 -48.01 11.25 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.121 2.547 . . . . 0.61 113.324 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.35 -25.95 62.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.579 0.228 . . . . 1.47 110.83 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.971 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.5 m -64.54 -22.58 67.01 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.46 110.389 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.69 -38.84 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.516 -0.311 . . . . 1.05 110.821 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.0 -29.49 65.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.877 0.37 . . . . 1.62 111.49 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.567 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.31 -37.54 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.511 . . . . 0.34 109.661 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.598 HG12 HG12 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -72.63 -49.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.38 110.384 178.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -45.1 -35.62 3.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.385 0.674 . . . . 1.85 111.122 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -83.19 -34.68 25.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.85 111.2 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.95 -33.12 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.916 0.709 . . . . 0.48 112.916 -170.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.73 -16.92 60.72 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.114 0.483 . . . . 2.56 110.326 -167.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.8 7.66 44.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.76 112.307 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 108' ' ' VAL . . . -108.99 3.2 21.9 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.212 -0.662 . . . . 0.9 109.212 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t30 73.65 34.1 0.98 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.316 -1.364 . . . . 2.06 107.316 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' A' ' 103' ' ' ALA . 9.6 t -91.96 143.99 28.55 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 112.425 -2.171 . . . . 1.08 110.597 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 4.7 Cg_exo -74.17 142.88 31.3 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.344 2.029 . . . . 0.51 113.061 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 145' ' ' THR . 1.6 mp -121.6 143.4 34.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 113.19 -1.823 . . . . 0.96 109.442 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.766 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 11.3 mt -118.6 155.84 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 108.69 -0.855 . . . . 0.71 108.69 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -118.0 136.07 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 109.936 -0.394 . . . . 0.23 109.936 174.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.33 87.92 2.84 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.24 -1.022 . . . . 0.25 108.24 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.864 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 4.5 mm -66.09 88.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.546 -1.206 . . . . 0.85 109.658 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.12 161.29 18.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.525 -0.176 . . . . 0.69 110.525 -171.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.5 tttm 62.42 29.93 17.24 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.171 0.986 . . . . 2.61 109.402 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.668 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 3.0 tpp . . . . . 0 CA--C 1.542 0.665 0 CA-C-N 114.689 -1.141 . . . . 1.37 111.041 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 126' ' ' ARG . 50.5 t30 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 1.84 110.618 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.573 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.4 Cg_endo -47.73 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.178 3.252 . . . . 0.7 113.744 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -46.28 -43.23 15.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.774 0.657 . . . . 2.0 112.774 -175.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.488 ' HB2' ' ND2' ' A' ' 123' ' ' ASN . 4.1 tmt_? -56.94 -53.99 51.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.428 0.632 . . . . 2.99 109.775 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.751 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 47.3 t -60.64 -45.18 97.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.614 -1.176 . . . . 0.4 109.559 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.672 ' HA ' ' CZ ' ' A' ' 147' ' ' PHE . 86.3 mtp -64.2 -32.14 73.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.425 -0.807 . . . . 0.3 111.609 -176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.6 mt-30 -83.41 -20.83 33.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.019 0.438 . . . . 1.28 110.283 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.751 ' OE1' ' HA ' ' A' ' 127' ' ' VAL . 3.0 pt-20 -79.05 -27.68 43.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.111 -0.7 . . . . 2.02 109.111 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.1 mm? -71.72 -42.69 67.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.542 0.687 . . . . 1.06 109.597 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.909 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.6 ppp? -77.11 -2.36 33.85 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.086 -0.961 . . . . 0.35 109.719 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.22 -27.09 35.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.674 -1.232 . . . . 2.18 107.674 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.456 ' HE2' HG11 ' A' ' 92' ' ' VAL . 25.6 m-85 -85.99 4.85 35.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.73 -0.841 . . . . 0.74 108.73 169.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.7 m120 75.11 19.35 2.32 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.203 -1.362 . . . . 1.94 111.126 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.3 mp -97.52 77.72 2.62 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.665 -1.235 . . . . 1.68 107.665 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.546 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.05 129.87 92.3 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 113.559 -1.655 . . . . 0.61 110.799 -176.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.873 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 99.7 Cg_exo -47.16 152.92 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.897 2.398 . . . . 0.3 112.78 172.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -73.65 -29.84 62.57 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.17 -1.377 . . . . 2.01 107.844 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.773 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -49.08 -47.56 44.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.549 -1.205 . . . . 1.14 109.462 168.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.909 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.1 m0 -92.66 -17.65 24.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.967 -1.015 . . . . 0.45 111.2 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.18 19.85 5.77 Favored Glycine 0 CA--C 1.507 -0.41 0 C-N-CA 119.612 -1.28 . . . . 0.45 112.892 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.12 -113.65 2.23 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.205 -0.998 . . . . 0.5 112.017 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -150.07 19.9 0.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.649 0.24 . . . . 1.3 111.649 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 110' ' ' ILE . 23.4 m -125.87 115.09 19.43 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.81 -0.756 . . . . 0.32 112.572 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.1 mp -84.56 110.73 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.526 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.873 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.4 m-85 -87.32 121.26 29.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.215 0.531 . . . . 0.38 111.673 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 61.5 m -115.87 103.52 10.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.764 -0.653 . . . . 1.1 110.012 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.864 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 12.1 ptmm? -81.64 84.61 6.74 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.687 -0.857 . . . . 2.44 108.687 172.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.886 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.08 -175.02 2.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.045 -0.98 . . . . 1.27 112.574 -168.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 150' ' ' LEU . 34.0 t -150.41 117.96 6.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.88 -1.055 . . . . 1.79 109.687 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 24' ' ' LEU . . . -74.4 -28.78 61.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.87 110.777 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 11.2 ptmm? -77.42 -50.4 12.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.807 0.813 . . . . 3.03 110.58 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.406 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 6.0 m -77.65 -11.69 59.89 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.425 -1.261 . . . . 1.2 111.655 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 71.25 -20.35 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.012 0.745 . . . . 2.27 113.012 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 154' ' ' THR . 10.8 tp10 -43.3 -63.18 0.87 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.617 0.722 . . . . 2.64 111.809 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.886 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.15 -17.69 74.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.329 -0.851 . . . . 0.62 113.663 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.5 mt -66.45 -46.08 77.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.469 0.635 . . . . 1.55 110.685 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.88 -37.65 88.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.826 -0.625 . . . . 2.5 110.212 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.609 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 78.4 t60 -73.38 -26.02 60.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.73 111.067 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.76 -47.26 75.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.421 -0.585 . . . . 0.91 109.421 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.5 mt -53.61 -44.0 69.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.802 -0.635 . . . . 1.06 110.642 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.609 ' OE1' ' HA ' ' A' ' 160' ' ' HIS . 45.3 mt-10 -54.99 -43.14 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.068 0.461 . . . . 2.49 110.866 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.713 ' HB3' HG21 ' A' ' 146' ' ' ILE . 8.4 mmt -71.2 -31.48 67.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.87 110.651 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 162' ' ' LEU . 79.7 mt -63.95 -53.02 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 0.64 110.524 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.58 -33.91 70.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.173 0.435 . . . . 1.81 112.173 174.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.67 -41.48 77.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.15 -0.685 . . . . 1.42 109.15 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.445 -0.695 0 CA-C-N 115.867 -0.606 . . . . 1.17 110.86 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.236 0.378 0 CA-C-O 120.993 0.425 . . . . 1.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -92.95 122.47 35.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.681 -0.69 . . . . 0.66 111.272 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.728 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 33.3 mt -104.47 122.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.866 -0.42 . . . . 1.03 109.866 172.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.56 165.57 19.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.187 -0.461 . . . . 1.04 110.075 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.828 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 166.27 -107.75 0.3 Allowed Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.486 -1.046 . . . . 1.55 110.486 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.451 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 60.1 t60 -159.21 137.58 10.65 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.431 -0.952 . . . . 0.66 108.431 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -59.93 -31.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.257 -0.883 . . . . 1.62 113.201 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.92 -20.57 52.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.271 . . . . 1.78 111.309 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.451 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 47.8 m170 -70.34 -2.61 14.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.152 0.501 . . . . 0.65 111.282 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.65 43.55 3.89 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.772 -0.728 . . . . 0.93 112.848 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -66.45 -39.42 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.276 0.56 . . . . 2.11 109.823 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -67.01 -36.04 81.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.414 -0.812 . . . . 1.8 109.82 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -67.78 -35.91 79.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.676 -0.693 . . . . 1.77 110.273 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 47.4 tp -65.36 -49.11 70.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.706 . . . . 1.78 110.209 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.649 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.96 -32.21 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 1.96 110.051 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 28.6 t70 -66.14 -56.8 9.63 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.171 -0.331 . . . . 1.38 111.481 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -61.35 -30.62 70.63 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.07 0.462 . . . . 0.91 110.89 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' A' ' 158' ' ' LEU . 3.1 tt -74.32 -27.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.644 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.9 mtm180 -80.23 -32.47 38.41 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 3.56 109.807 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -65.62 -8.51 20.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.136 -0.938 . . . . 2.88 109.918 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.626 -0.715 . . . . 1.76 109.47 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.769 ' HE2' ' HB ' ' A' ' 50' ' ' VAL . 4.2 p90 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.8 -0.445 . . . . 2.54 109.8 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.62 ' HG2' HG23 ' A' ' 58' ' ' THR . 71.8 mt-30 -139.07 113.36 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.136 -1.061 . . . . 1.96 108.136 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.769 ' HB ' ' HE2' ' A' ' 48' ' ' TYR . 4.6 p . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.976 0.893 . . . . 1.93 111.914 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 166' ' ' LEU . 4.8 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.882 0.372 . . . . 1.14 111.415 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.62 HG23 ' HG2' ' A' ' 49' ' ' GLN . 16.9 m -92.64 125.65 37.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.154 -0.684 . . . . 1.28 109.154 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 112.461 0.541 . . . . 0.84 112.461 -173.578 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.6 mm . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.649 -0.5 . . . . 0.74 109.649 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.981 HG21 ' HB1' ' A' ' 103' ' ' ALA . 99.0 t -118.86 101.58 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 O-C-N 122.173 -0.329 . . . . 1.19 111.101 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 7.0 mm -79.03 121.28 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.776 -1.194 . . . . 1.32 107.776 170.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -118.75 103.59 9.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.855 -176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.6 p -89.24 146.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.294 0.568 . . . . 1.2 112.09 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 114' ' ' ILE . 21.5 m -141.59 -175.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.926 -1.033 . . . . 1.12 108.223 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.47 134.37 13.0 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.341 -0.544 . . . . 0.75 112.078 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.47 -125.21 2.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.295 -0.866 . . . . 1.18 112.146 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -105.3 5.17 31.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.92 0.39 . . . . 2.01 110.022 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.78 -32.64 71.96 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.57 0.7 . . . . 1.09 109.75 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.773 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 68.42 -134.74 28.77 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 114.706 -1.133 . . . . 0.52 111.677 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 96' ' ' THR . 64.2 t -102.32 103.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.145 0.498 . . . . 1.08 111.033 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.573 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.4 mmm -72.77 170.74 12.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 1.32 110.631 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 72.4 Cg_exo -42.69 -51.21 5.4 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.789 2.326 . . . . 0.61 113.09 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.02 -37.87 89.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.47 110.717 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.726 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.1 m -62.18 -35.27 78.32 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.965 -0.562 . . . . 0.46 110.376 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.715 HG23 HG12 ' A' ' 92' ' ' VAL . 41.1 t -74.15 -50.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.152 -0.476 . . . . 1.05 110.688 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.52 -31.22 34.44 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.547 0.53 . . . . 1.62 111.528 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.03 -37.86 28.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.34 109.895 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.774 HG12 HD13 ' A' ' 110' ' ' ILE . 1.5 mt -75.45 -37.66 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.646 -0.706 . . . . 0.38 110.47 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -34.93 68.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.731 0.776 . . . . 1.85 109.737 174.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -85.15 -30.65 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.831 -1.077 . . . . 0.85 110.551 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.981 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.41 -49.2 10.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.48 111.9 -173.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -53.08 -27.24 19.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.39 0.885 . . . . 2.56 113.39 -166.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.1 10.87 36.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.079 0.77 . . . . 0.76 113.079 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.481 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -97.57 2.37 49.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.213 -0.662 . . . . 0.9 109.213 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t30 71.3 46.64 0.42 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 123.11 1.433 . . . . 2.06 107.831 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.657 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -129.5 143.06 47.43 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 112.809 -1.996 . . . . 1.08 111.194 -168.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 108' ' ' VAL . 21.9 Cg_exo -67.26 156.41 66.38 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.486 2.124 . . . . 0.51 112.982 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.774 HD13 HG12 ' A' ' 100' ' ' ILE . 85.1 mt -124.48 141.85 43.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.702 -1.135 . . . . 0.96 109.201 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.706 HD13 HD13 ' A' ' 83' ' ' ILE . 3.7 mt -125.93 96.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 C-N-CA 120.35 -0.54 . . . . 0.71 111.238 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -65.82 139.82 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.005 -0.998 . . . . 0.23 110.265 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -124.02 89.37 3.07 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.868 -1.16 . . . . 0.25 107.868 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.637 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 9.7 mm -65.92 86.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.565 -1.198 . . . . 0.85 110.197 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.05 148.45 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.69 110.721 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 60.63 33.31 20.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.404 -0.817 . . . . 2.61 110.758 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.418 ' HB3' HG22 ' A' ' 114' ' ' ILE . 1.4 ppp? . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.812 -0.631 . . . . 1.37 110.007 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 16.4 t-20 . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 121.228 0.537 . . . . 1.84 111.016 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -16.12 -82.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.119 1 C-N-CA 126.301 4.667 . . . . 0.7 116.579 172.73 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -43.81 -55.31 4.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.345 0.658 . . . . 2.0 112.344 -169.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 tpt85 -56.17 -62.16 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.401 0.62 . . . . 2.99 110.786 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.773 HG13 ' HA2' ' A' ' 91' ' ' GLY . 28.1 t -51.82 -49.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.441 -1.254 . . . . 0.4 110.489 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.625 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 86.5 mtp -66.45 -33.04 74.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 0.3 111.96 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.534 ' O ' ' HG3' ' A' ' 132' ' ' MET . 87.0 mt-30 -76.38 -26.2 55.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.813 -0.44 . . . . 1.28 109.813 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.458 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -71.12 -31.11 67.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.239 -0.652 . . . . 2.02 109.239 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 136' ' ' LEU . 2.8 mm? -68.54 -46.31 69.86 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.506 0.669 . . . . 1.06 109.716 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.863 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.3 ppp? -73.31 -4.57 34.12 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.392 -0.822 . . . . 0.35 110.0 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -81.77 -24.63 35.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.039 -0.726 . . . . 2.18 109.039 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.607 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 39.5 m-85 -84.75 0.61 50.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.896 . . . . 0.74 108.582 167.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 74.14 45.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 113.967 -1.47 . . . . 1.94 109.464 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -126.19 83.36 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.028 -1.442 . . . . 1.68 107.439 170.02 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.876 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.23 131.42 94.35 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.592 -1.64 . . . . 0.61 111.28 -173.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.741 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 87.5 Cg_exo -49.87 155.47 4.1 Favored 'Trans proline' 0 CA--C 1.516 -0.377 0 C-N-CA 123.315 2.677 . . . . 0.3 113.705 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 146' ' ' ILE . 6.8 mm-40 -80.17 -19.18 47.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.53 -1.214 . . . . 2.01 109.268 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.808 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -58.24 -40.17 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.501 -0.926 . . . . 1.14 108.501 167.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.863 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.3 m0 -96.71 -21.43 17.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.384 -1.28 . . . . 0.45 110.841 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.49 25.22 5.84 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.372 -0.918 . . . . 0.45 112.43 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.876 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.47 -101.11 1.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.721 -0.752 . . . . 0.5 112.612 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -165.11 27.01 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.244 0.545 . . . . 1.3 111.114 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.772 HG21 HD12 ' A' ' 136' ' ' LEU . 62.2 m -130.17 116.85 19.03 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.241 -0.584 . . . . 0.32 112.389 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -82.14 109.04 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.546 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.741 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.9 m-85 -89.54 96.24 10.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.984 0.421 . . . . 0.38 111.186 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.444 ' O ' HD12 ' A' ' 150' ' ' LEU . 75.1 m -84.32 99.55 10.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.313 -0.625 . . . . 1.1 109.313 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.637 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 2.4 pttm -82.83 84.16 7.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.552 -0.907 . . . . 2.44 108.552 176.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.568 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.44 -179.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.298 -0.865 . . . . 1.27 112.97 -168.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p -152.94 111.28 3.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 1.79 110.156 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.95 64.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.362 -0.381 . . . . 0.87 111.237 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -75.14 -46.91 31.27 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.896 0.855 . . . . 3.03 110.15 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m -72.62 -14.78 61.68 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.251 -1.34 . . . . 1.2 110.397 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 27' ' ' ALA . 21.2 tptp 58.61 27.33 15.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.499 -1.228 . . . . 2.27 111.576 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -92.35 -67.43 0.86 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.534 0.683 . . . . 2.64 110.266 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.02 -13.04 69.26 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.248 -0.887 . . . . 0.62 113.55 -176.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 28' ' ' ILE . 3.3 tm? -60.54 -54.44 45.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 1.55 109.38 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.29 -33.75 76.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.293 -0.867 . . . . 2.5 109.89 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.682 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.7 t60 -65.38 -25.98 67.8 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.666 -0.697 . . . . 0.73 111.075 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 59.7 tp -66.59 -55.4 15.54 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.002 -0.369 . . . . 0.91 110.002 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 165' ' ' ILE . 92.1 mt -55.9 -41.6 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 1.06 110.723 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 6.4 pt-20 -69.48 -27.73 65.46 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.598 -0.441 . . . . 2.49 110.61 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.467 ' HG2' HG21 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -81.3 -32.2 33.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 0.87 109.821 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 162' ' ' LEU . 32.6 mt -55.41 -54.63 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.361 -0.836 . . . . 0.64 111.896 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.607 HD12 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -81.2 -30.06 34.39 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.748 -0.595 . . . . 1.81 111.969 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.3 tt -59.53 -31.56 69.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.849 -0.426 . . . . 1.42 109.849 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.779 HG21 HG12 ' A' ' 146' ' ' ILE . 25.2 t . . . . . 0 N--CA 1.444 -0.737 0 CA-C-N 115.941 -0.572 . . . . 1.17 111.283 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.947 HG13 HG21 ' A' ' 81' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.408 0.623 . . . . 1.0 109.715 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.477 ' O ' HG13 ' A' ' 83' ' ' ILE . 19.3 m -80.42 128.09 33.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 0.66 111.452 -171.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 HD12 ' A' ' 83' ' ' ILE . 52.1 mt -94.95 128.52 46.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.041 -0.527 . . . . 1.03 110.271 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.599 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 55.6 mtt -125.29 -177.94 4.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.459 177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.92 130.44 4.45 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.504 -0.855 . . . . 1.55 110.984 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -50.69 138.38 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.512 . . . . 0.66 110.4 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 21' ' ' LYS . 30.3 m -61.63 -27.5 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.871 1.063 . . . . 1.62 113.871 -167.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.31 -19.16 60.57 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.025 0.38 . . . . 1.78 112.025 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -72.01 -34.26 68.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.761 0.282 . . . . 0.65 111.761 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.58 67.63 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.392 -0.909 . . . . 0.93 112.75 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HE3' HG22 ' A' ' 13' ' ' ILE . 14.0 mmmm -89.03 -56.33 3.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.067 0.461 . . . . 2.11 111.128 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -65.91 -18.08 65.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 1.8 110.799 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 p -74.75 -19.94 60.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.011 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 68.0 mt -69.01 -52.19 31.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.715 -0.394 . . . . 1.78 110.307 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 8.7 mp -60.32 -34.09 73.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 1.96 110.973 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.74 -51.38 41.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.882 0.327 . . . . 1.38 111.882 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -69.6 -33.33 72.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.91 111.008 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.63 HD11 HD21 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -66.06 -24.21 33.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.996 -0.547 . . . . 1.56 110.54 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 51.5 mtp180 -79.09 -21.65 46.39 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.215 0.531 . . . . 3.56 110.636 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -71.78 -7.74 50.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.718 0.77 . . . . 2.88 109.647 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.966 -1.016 . . . . 1.76 110.172 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' CE2' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.407 0.622 . . . . 2.54 111.045 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -107.13 153.97 21.86 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.39 -0.823 . . . . 1.96 108.857 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG21 ' HE2' ' A' ' 59' ' ' PHE . 71.7 t . . . . . 0 C--N 1.309 -1.173 0 CA-C-N 115.468 -0.787 . . . . 1.93 109.259 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 11' ' ' VAL . 48.3 mt . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 110.18 -0.304 . . . . 1.14 110.18 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -105.75 131.71 52.77 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.172 -0.677 . . . . 1.28 109.172 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.461 ' HE2' HG21 ' A' ' 50' ' ' VAL . 43.7 m-85 . . . . . 0 CA--C 1.513 -0.469 0 C-N-CA 119.979 -0.688 . . . . 0.84 111.104 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.947 HG21 HG13 ' A' ' 11' ' ' VAL . 23.8 mm . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.673 0.273 . . . . 0.74 110.308 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 103' ' ' ALA . 53.5 t -117.28 106.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 116.331 -0.395 . . . . 1.19 110.818 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.83 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -90.5 105.15 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.222 -0.659 . . . . 1.32 109.222 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 100' ' ' ILE . 11.3 tp -90.34 109.65 20.75 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.289 -0.414 . . . . 1.33 111.361 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.2 t -80.89 130.91 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 1.2 110.953 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.648 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -131.36 -174.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.585 -0.894 . . . . 1.12 108.585 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -147.74 129.73 15.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.981 -0.687 . . . . 0.75 112.564 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 20.89 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.16 1.538 . . . . 1.18 114.97 169.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.95 -2.57 22.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.693 -0.685 . . . . 2.01 112.11 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -32.91 24.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.08 0.467 . . . . 1.09 110.725 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 69.77 -120.6 9.99 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.453 -0.794 . . . . 0.52 111.805 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 97' ' ' VAL . 58.7 t -124.21 109.77 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 120.847 0.356 . . . . 1.08 110.693 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.551 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 67.5 mtp -77.29 169.01 23.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 1.32 110.569 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.5 Cg_exo -44.79 -51.23 7.59 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.037 2.491 . . . . 0.61 113.417 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -66.78 -29.72 69.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.629 0.252 . . . . 1.47 111.366 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.596 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.4 m -69.47 -28.05 65.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.564 0.697 . . . . 0.46 109.467 174.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.682 HG23 HG12 ' A' ' 92' ' ' VAL . 12.4 t -76.69 -52.24 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.05 111.078 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -65.02 -19.24 65.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.04 0.385 . . . . 1.62 112.04 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -73.62 -37.36 65.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.203 -1.036 . . . . 0.34 108.203 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.815 HG12 HD13 ' A' ' 110' ' ' ILE . 2.8 mt -76.63 -41.16 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 113.969 -1.469 . . . . 0.38 110.727 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 98' ' ' GLU . 7.2 m-20 -54.04 -37.96 64.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.374 0.607 . . . . 1.85 110.367 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -74.85 -31.9 61.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.85 110.501 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.618 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -82.79 -48.62 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.447 . . . . 0.48 111.949 -175.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -56.86 -34.37 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.398 -0.819 . . . . 2.56 111.985 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.23 10.16 37.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.365 0.506 . . . . 0.76 112.365 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -104.39 5.87 34.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.151 -1.055 . . . . 0.9 108.151 169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.0 38.25 6.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.448 -1.251 . . . . 2.06 110.317 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 109' ' ' PRO . 2.0 m -105.68 148.48 36.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.57 -0.741 . . . . 1.08 110.95 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.93 155.27 62.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.098 2.532 . . . . 0.51 113.09 171.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 100' ' ' ILE . 68.8 mt -125.91 145.92 32.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.107 -0.951 . . . . 0.96 110.259 -174.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.83 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 mt -120.47 155.93 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 109.24 -0.652 . . . . 0.71 109.24 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.486 HG21 ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -120.32 137.3 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 120.997 0.427 . . . . 0.23 110.403 174.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.03 88.42 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.91 -1.145 . . . . 0.25 107.91 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 30.3 mt -72.51 97.02 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.956 -1.02 . . . . 0.85 110.487 178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.56 165.45 15.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.69 -0.485 . . . . 0.69 109.69 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.537 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 63.0 mttm 64.35 19.24 11.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.324 0.583 . . . . 2.61 110.896 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.884 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.3 tpp . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.646 -0.706 . . . . 1.37 110.949 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 109.838 -0.43 . . . . 1.84 109.838 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.8 Cg_exo -39.54 -60.01 0.59 Allowed 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.876 3.051 . . . . 0.7 112.77 172.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.8 -52.92 7.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.776 0.43 . . . . 2.0 111.53 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.568 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -54.97 -59.71 4.37 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.875 0.369 . . . . 2.99 110.061 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 91' ' ' GLY . 60.3 t -53.99 -44.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.266 -0.879 . . . . 0.4 110.831 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.675 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.6 mtp -68.17 -31.83 71.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.641 -0.709 . . . . 0.3 111.184 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.6 mt-30 -73.68 -26.87 60.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.458 -0.337 . . . . 1.28 110.621 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.1 mm-40 -62.52 -39.85 94.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.551 -0.907 . . . . 2.02 108.551 172.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.858 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -68.25 -42.95 78.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.55 0.69 . . . . 1.06 110.062 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.83 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -76.03 -5.87 48.43 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.346 -0.843 . . . . 0.35 110.107 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 45.5 tt0 -82.32 -26.28 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.886 -0.783 . . . . 2.18 108.886 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.651 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 13.5 m-85 -84.6 -0.41 53.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.282 -1.007 . . . . 0.74 108.282 168.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 72.18 42.67 0.56 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 113.931 -1.486 . . . . 1.94 110.44 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -121.8 82.73 1.99 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 106.479 -1.674 . . . . 1.68 106.479 168.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.6 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -63.33 131.59 94.84 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.002 -1.454 . . . . 0.61 110.773 -172.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.74 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 86.7 Cg_exo -46.52 151.74 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.879 2.386 . . . . 0.3 112.894 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -25.74 53.71 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.25 -1.341 . . . . 2.01 108.335 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.737 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.35 -43.0 64.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.258 -1.337 . . . . 1.14 109.435 167.446 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.83 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.1 m0 -94.56 -26.0 16.58 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.879 -1.055 . . . . 0.45 111.218 -170.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.46 25.3 2.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.943 -1.123 . . . . 0.45 112.583 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.88 -111.79 2.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.5 -0.857 . . . . 0.5 112.573 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -151.01 21.99 0.77 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.679 0.276 . . . . 1.3 111.606 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 36.4 m -125.78 118.79 26.3 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.932 -0.707 . . . . 0.32 112.743 -172.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.0 mp -85.44 108.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.23 110.554 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.74 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.3 m-85 -88.83 119.38 29.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.199 0.523 . . . . 0.38 111.486 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 56.8 m -114.93 121.75 44.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.68 -0.691 . . . . 1.1 109.557 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.884 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 58.2 pttt -97.15 104.37 16.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.302 -0.629 . . . . 2.44 109.302 174.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -125.47 -170.88 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.36 1.076 . . . . 1.27 113.07 -171.099 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 30.2 t -169.87 126.92 0.87 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.4 -1.727 . . . . 1.79 108.252 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.12 -12.37 59.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.072 0.463 . . . . 0.87 111.083 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -84.93 -57.13 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 3.03 110.174 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 28.4 p -81.53 -17.6 47.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.13 -0.941 . . . . 1.2 110.51 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 27' ' ' ALA . 6.5 tptm 74.22 -11.98 0.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.905 0.753 . . . . 2.27 112.311 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 156' ' ' GLU . 9.9 mm-40 -44.17 -70.11 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.499 0.72 . . . . 2.64 112.86 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -73.6 -5.62 68.87 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.62 113.872 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.513 HD12 ' HE2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -73.36 -45.46 54.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.0 -0.741 . . . . 1.55 109.0 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.69 -36.53 76.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 2.5 109.889 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 82.4 t60 -70.72 -20.21 62.68 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.862 -0.608 . . . . 0.73 110.812 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.04 -49.62 42.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.843 0.354 . . . . 0.91 110.123 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 28' ' ' ILE . 98.4 mt -58.2 -37.48 74.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.708 -0.678 . . . . 1.06 111.384 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -70.02 -36.37 75.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.798 -0.361 . . . . 2.49 110.67 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.751 ' HB3' HG21 ' A' ' 146' ' ' ILE . 22.0 mmt -69.06 -38.56 79.15 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.24 0.543 . . . . 0.87 109.72 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.51 -52.27 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.64 110.514 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.35 -42.5 98.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.986 -0.552 . . . . 1.81 111.491 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.2 -45.99 65.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.807 -0.633 . . . . 1.42 110.0 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 116.101 -0.5 . . . . 1.17 111.315 -177.967 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB ' ' A' ' 81' ' ' ILE . 56.2 t . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -82.59 120.6 25.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.66 111.557 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.552 HD12 ' HG ' ' A' ' 25' ' ' LEU . 42.7 mt -78.97 121.03 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 1.03 109.711 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 19.5 mmt -110.97 176.75 4.9 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.158 -0.928 . . . . 1.04 109.938 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 1.106 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 123.26 136.05 4.7 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.341 -0.933 . . . . 1.55 111.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.725 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 67.6 t60 -45.62 136.27 6.01 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.646 0.736 . . . . 0.66 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.79 -35.27 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.331 -1.304 . . . . 1.62 113.45 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 11.8 t70 -74.28 -18.48 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 1.78 111.095 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -71.33 -12.22 61.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.182 0.515 . . . . 0.65 110.766 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.47 45.77 6.75 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.506 -0.77 . . . . 0.93 113.34 172.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.672 ' HA ' HD23 ' A' ' 24' ' ' LEU . 58.7 pttt -67.46 -26.33 66.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 2.11 110.835 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -67.7 -28.56 67.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 1.8 110.324 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 90.5 m -68.16 -28.17 67.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.89 -0.596 . . . . 1.77 111.039 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 21' ' ' LYS . 3.9 mm? -62.51 -51.12 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 1.78 110.4 176.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HG ' HD12 ' A' ' 13' ' ' ILE . 6.6 mt -72.3 -25.65 61.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 1.96 111.474 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 20.9 t70 -68.39 -49.07 62.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.502 -0.317 . . . . 1.38 111.356 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.06 73.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.932 0.396 . . . . 0.91 110.683 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 162' ' ' LEU . 4.7 tt -76.71 -33.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.867 -0.606 . . . . 1.56 110.945 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 15.3 ptt180 -75.19 -32.23 61.17 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.742 0.782 . . . . 3.56 109.729 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -82.11 15.58 2.3 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.469 -1.242 . . . . 2.88 111.641 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 120.862 0.363 . . . . 1.76 111.278 -173.645 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.198 0.523 . . . . 2.54 111.898 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 77.1 mt-30 -107.55 109.71 21.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.869 -1.16 . . . . 1.96 107.869 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 121.362 0.601 . . . . 1.93 111.736 -171.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 11' ' ' VAL . 61.7 mt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.012 0.434 . . . . 1.14 112.044 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -101.2 97.83 8.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 1.28 109.896 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 110.394 -0.224 . . . . 0.84 110.394 -178.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 11' ' ' VAL . 44.9 mm . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.815 -0.439 . . . . 0.74 109.815 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.952 HG21 ' HB1' ' A' ' 103' ' ' ALA . 61.2 t -85.68 96.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 116.328 -0.396 . . . . 1.19 111.616 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 111' ' ' ILE . 6.5 mm -84.11 93.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.32 109.283 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.7 tm? -86.97 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.737 -0.665 . . . . 1.33 109.749 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.106 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.1 p -77.41 144.32 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.622 0.725 . . . . 1.2 110.728 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 127' ' ' VAL . 8.4 t -136.72 175.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.58 -1.267 . . . . 1.12 107.58 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -138.06 131.16 30.18 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 122.101 -0.375 . . . . 0.75 110.251 175.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -77.44 27.55 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.882 -0.599 . . . . 1.18 112.325 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -135.35 10.06 3.47 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.98 0.419 . . . . 2.01 110.056 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.81 -58.78 0.4 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.349 0.595 . . . . 1.09 110.605 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 86' ' ' VAL . . . 118.24 -115.09 3.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.232 -0.895 . . . . 0.52 111.457 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 97' ' ' VAL . 46.6 t -122.81 109.38 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.078 0.465 . . . . 1.08 110.233 -175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.899 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 62.5 mtp -88.49 174.45 5.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.121 -0.49 . . . . 1.32 109.775 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 7.0 Cg_endo -49.46 -53.13 7.53 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.769 2.313 . . . . 0.61 113.04 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 38.7 mt-30 -61.15 -32.39 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.624 0.231 . . . . 1.47 111.624 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.538 ' CG2' HD11 ' A' ' 84' ' ' LEU . 21.1 m -63.5 -31.24 72.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.806 0.812 . . . . 0.46 109.926 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.619 HG22 ' CE2' ' A' ' 134' ' ' TYR . 41.2 t -82.18 -52.54 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.713 -1.13 . . . . 1.05 111.305 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 48.4 mt-10 -55.71 -34.1 64.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.746 -0.661 . . . . 1.62 111.972 -176.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -70.6 -39.46 73.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.541 0.686 . . . . 0.34 109.504 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.535 HG12 HG12 ' A' ' 110' ' ' ILE . 1.7 mt -70.74 -42.18 77.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.395 -1.275 . . . . 0.38 110.188 174.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.467 ' ND2' HG12 ' A' ' 97' ' ' VAL . 94.8 m-20 -54.25 -37.79 65.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.522 . . . . 1.85 110.408 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -79.29 -27.02 42.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.294 -0.867 . . . . 0.85 110.874 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.952 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -97.72 -35.26 10.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.331 0.863 . . . . 0.48 113.331 -169.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -60.95 -27.11 68.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.863 0.69 . . . . 2.56 112.863 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.3 11.89 19.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.095 0.776 . . . . 0.76 113.095 -166.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.32 19.15 18.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.654 -1.239 . . . . 0.9 107.654 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 50.56 37.83 17.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.547 -1.661 . . . . 2.06 111.721 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.528 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -94.27 155.53 39.77 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.021 -0.99 . . . . 1.08 110.014 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.1 Cg_exo -73.97 150.12 43.05 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.686 2.257 . . . . 0.51 113.443 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.645 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -120.72 142.57 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.067 -1.424 . . . . 0.96 109.836 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 83' ' ' ILE . 4.3 mp -114.04 146.28 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 108.022 -1.103 . . . . 0.71 108.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -114.06 132.19 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.025 0 N-CA-C 109.634 -0.506 . . . . 0.23 109.634 174.003 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -118.82 87.09 2.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.636 -1.246 . . . . 0.25 107.636 175.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 28.2 mt -69.65 91.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.499 -1.228 . . . . 0.85 110.024 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 62.5 t30 -92.89 167.58 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.515 . . . . 0.69 109.748 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 66.76 8.45 5.97 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.5 0.5 . . . . 2.61 110.411 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.428 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 1.37 110.649 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.473 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 50.4 t-20 . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.042 -0.355 . . . . 1.84 110.042 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.678 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.0 OUTLIER -46.16 -65.62 0.18 Allowed 'Trans proline' 0 C--O 1.219 -0.436 0 C-N-CA 123.538 2.825 . . . . 0.7 112.834 173.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.34 -48.57 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.395 0.678 . . . . 2.0 112.601 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 126' ' ' ARG . 9.0 tpt180 -53.48 -55.85 21.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.621 0.724 . . . . 2.99 109.951 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 86' ' ' VAL . 81.9 t -57.97 -42.43 82.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.357 -1.292 . . . . 0.4 110.412 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.3 mtp -63.46 -31.43 72.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.61 -0.723 . . . . 0.3 111.265 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.473 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 73.8 mt-30 -77.8 -18.01 56.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.897 -0.321 . . . . 1.28 110.949 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.3 mm-40 -70.39 -35.28 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.934 -0.765 . . . . 2.02 108.934 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.515 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.0 mm? -71.21 -44.61 65.05 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.516 0.674 . . . . 1.06 109.741 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.934 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.5 ppp? -76.08 -2.57 31.48 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.099 -0.955 . . . . 0.35 109.61 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 36.4 tt0 -78.13 -28.91 48.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.411 -1.329 . . . . 2.18 107.411 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 97' ' ' VAL . 60.8 m-85 -91.07 10.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.646 -0.706 . . . . 0.74 109.819 170.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 72.36 22.5 3.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.362 -1.29 . . . . 1.94 111.057 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 100' ' ' ILE . 6.5 mp -96.94 76.41 2.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.951 -1.129 . . . . 1.68 107.951 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -66.8 127.99 93.68 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 113.506 -1.679 . . . . 0.61 110.899 -176.446 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.799 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 91.7 Cg_exo -47.76 155.16 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.221 2.614 . . . . 0.3 112.726 172.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -27.08 54.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.559 -1.2 . . . . 2.01 108.175 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.29 -42.73 64.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.548 -1.206 . . . . 1.14 109.336 169.265 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.934 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.0 m0 -95.19 -18.73 20.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.901 -1.045 . . . . 0.45 111.351 -171.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.67 26.52 4.16 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 119.989 -1.101 . . . . 0.45 112.447 170.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.95 -107.84 2.64 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.393 -0.908 . . . . 0.5 112.452 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -162.87 28.86 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.307 0.575 . . . . 1.3 111.127 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.645 HG23 HG22 ' A' ' 110' ' ' ILE . 23.3 m -121.85 123.73 42.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.064 -0.654 . . . . 0.32 111.983 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.59 HD12 HG13 ' A' ' 111' ' ' ILE . 26.5 mt -91.49 108.7 20.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.616 -0.72 . . . . 1.23 111.137 -175.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.799 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 24.3 m-85 -93.38 118.78 31.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.38 112.204 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 77.3 m -117.16 111.6 19.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.596 -0.729 . . . . 1.1 110.06 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.744 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.3 pttp -89.39 89.22 7.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.964 0.887 . . . . 2.44 108.83 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -116.66 179.93 3.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.696 -1.138 . . . . 1.27 112.745 -165.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 p -145.95 110.39 5.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.491 -1.231 . . . . 1.79 109.886 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -19.5 36.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.474 . . . . 0.87 111.298 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 154' ' ' THR . 19.2 ptpt -80.16 -52.76 7.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.382 0.61 . . . . 3.03 110.296 -176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.499 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 28.1 p -78.39 -2.12 36.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.107 -0.951 . . . . 1.2 111.145 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.0 tptp 61.66 45.72 7.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.872 -1.058 . . . . 2.27 111.989 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -107.23 -73.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.855 0.835 . . . . 2.64 110.167 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -65.95 -18.67 66.88 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.724 -1.126 . . . . 0.62 113.899 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.04 -47.07 71.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.213 0.53 . . . . 1.55 109.79 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.69 -35.37 67.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.625 -0.716 . . . . 2.5 110.678 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -66.25 -34.81 78.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.184 -0.462 . . . . 0.73 110.668 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 165' ' ' ILE . 61.8 tp -59.68 -53.07 62.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.819 -0.628 . . . . 0.91 110.806 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.796 HD21 HD11 ' A' ' 28' ' ' ILE . 94.9 mt -56.28 -37.6 70.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.886 -0.597 . . . . 1.06 111.351 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -61.92 -38.59 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 2.49 110.913 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.9 mmt -74.02 -44.29 54.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.87 110.368 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.447 HD12 HD23 ' A' ' 162' ' ' LEU . 94.7 mt -51.94 -56.08 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.525 -0.762 . . . . 0.64 110.544 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.52 -42.85 91.56 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.685 -0.689 . . . . 1.81 111.654 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.4 tp -51.42 -44.75 62.36 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.513 0.508 . . . . 1.42 110.62 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 146' ' ' ILE . 24.6 t . . . . . 0 N--CA 1.445 -0.717 0 CA-C-N 116.09 -0.505 . . . . 1.17 111.416 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.938 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 13.9 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.946 0.403 . . . . 1.0 111.159 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -98.08 141.42 31.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.66 110.812 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.8 mt -96.29 127.36 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.966 0.413 . . . . 1.03 110.517 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' HG13 ' A' ' 82' ' ' VAL . 51.2 mtt -133.84 177.81 7.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.31 0.576 . . . . 1.04 111.529 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.31 -92.32 0.21 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.508 -1.037 . . . . 1.55 110.508 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.469 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 t60 -164.24 149.29 10.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.765 -0.828 . . . . 0.66 108.765 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.37 -17.35 22.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.419 0.896 . . . . 1.62 113.419 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.76 -13.12 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.469 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 16.4 m170 -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.703 0.287 . . . . 0.65 111.544 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.29 61.08 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.84 -1.172 . . . . 0.93 113.904 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.39 -22.8 24.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.347 0.594 . . . . 2.11 109.49 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -71.03 -38.32 72.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.762 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -78.66 -23.93 45.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 1.77 109.823 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.5 tm? -63.54 -48.13 78.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.771 -0.826 . . . . 1.78 108.771 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.731 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 18.8 mt -66.41 -36.46 82.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.038 -0.528 . . . . 1.96 110.738 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -55.27 -58.05 9.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.873 0.323 . . . . 1.38 111.873 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.694 ' HB3' HD12 ' A' ' 158' ' ' LEU . . . -68.55 -24.82 64.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.91 111.313 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 25' ' ' LEU . 1.4 tt -78.79 -23.62 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.418 . . . . 1.56 110.097 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 53.4 mtt180 -76.27 -26.76 56.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.646 0.736 . . . . 3.56 109.264 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -75.32 6.22 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.059 -0.973 . . . . 2.88 109.411 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.529 -0.76 . . . . 1.76 109.453 176.888 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' HE1' ' HG2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.006 0.431 . . . . 2.54 110.71 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 95.0 mt-30 -135.13 98.31 3.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 1.96 108.433 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.591 -0.731 . . . . 1.93 110.8 -173.505 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.818 HD11 HD21 ' A' ' 166' ' ' LEU . 44.0 mt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.65 0.262 . . . . 1.14 110.767 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.8 m -83.92 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.704 -0.48 . . . . 1.28 109.704 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 14.9 m-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.98 0.419 . . . . 0.84 111.426 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 23.5 mm . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 111.745 0.276 . . . . 0.74 111.745 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.657 HG21 ' HB1' ' A' ' 103' ' ' ALA . 46.8 t -89.89 87.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 116.413 -0.358 . . . . 1.19 110.768 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.47 HD11 HG12 ' A' ' 165' ' ' ILE . 32.0 mm -75.76 104.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.866 -0.791 . . . . 1.32 108.866 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.926 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.6 tm? -91.26 92.9 8.84 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.254 -0.885 . . . . 1.33 110.235 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 61.7 t -80.86 129.44 37.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.19 0.519 . . . . 1.2 111.122 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.8 m -131.3 -165.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.208 -1.034 . . . . 1.12 108.208 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -139.61 143.86 37.45 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.24 -0.584 . . . . 0.75 111.861 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -37.08 -58.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.495 1.122 . . . . 1.18 112.709 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -103.92 19.19 20.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.571 . . . . 2.01 111.602 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 2.5 t70 -113.61 -51.59 2.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.237 0.541 . . . . 1.09 110.773 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.731 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.18 -138.6 17.43 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.294 -0.866 . . . . 0.52 111.198 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.2 t -97.02 115.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 122.818 0.447 . . . . 1.08 111.423 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.453 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 80.0 mmm -80.06 167.09 36.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.676 -0.49 . . . . 1.32 109.676 171.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 90.1 Cg_exo -46.35 -45.5 18.69 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.578 2.186 . . . . 0.61 113.054 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -72.84 -22.71 60.75 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.644 -0.253 . . . . 1.47 110.855 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.915 ' HB ' HG13 ' A' ' 92' ' ' VAL . 26.2 m -62.23 -30.71 71.29 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.177 0.513 . . . . 0.46 110.649 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.95 -46.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.272 -0.422 . . . . 1.05 111.345 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 1.07 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.717 -0.674 . . . . 1.62 111.196 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.49 -41.09 8.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.528 -0.916 . . . . 0.34 108.528 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.926 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.2 mt -73.13 -55.62 12.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.276 -0.874 . . . . 0.38 111.545 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -51.7 -30.08 20.73 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.218 0.607 . . . . 1.85 111.101 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -82.91 -28.9 29.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.769 -0.651 . . . . 0.85 110.584 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.657 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.56 -57.83 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.668 0.618 . . . . 0.48 112.668 -172.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.706 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -64.18 -21.32 66.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.615 0.598 . . . . 2.56 112.615 -163.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.02 4.56 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.831 0.348 . . . . 0.76 111.629 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.64 2.56 44.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 0.9 109.37 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t30 81.16 49.27 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.618 -1.174 . . . . 2.06 108.998 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -134.98 143.33 45.64 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 114.037 -1.438 . . . . 1.08 110.873 -175.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 13.8 Cg_exo -71.94 159.28 50.76 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.371 2.714 . . . . 0.51 114.675 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 HG12 ' A' ' 100' ' ' ILE . 46.8 mt -125.24 146.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.235 -1.348 . . . . 0.96 109.89 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 84' ' ' LEU . 5.0 mp -131.52 107.59 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 120.872 0.368 . . . . 0.71 111.726 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -70.9 133.68 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.492 0.663 . . . . 0.23 110.717 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -124.08 89.41 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.328 -1.36 . . . . 0.25 107.328 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 56.1 mt -72.18 92.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.069 -0.969 . . . . 0.85 109.615 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.28 169.16 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.69 109.696 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 62.94 20.47 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.522 0.677 . . . . 2.61 109.826 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.635 ' O ' ' HG3' ' A' ' 117' ' ' MET . 17.4 tpp . . . . . 0 N--CA 1.426 -1.645 0 CA-C-O 123.274 1.511 . . . . 1.37 108.856 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 110.194 -0.299 . . . . 1.84 110.194 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.595 ' O ' ' HG3' ' A' ' 128' ' ' MET . 8.1 Cg_exo -33.53 -62.26 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.634 3.556 . . . . 0.7 113.998 171.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.18 -53.8 4.84 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.007 0.523 . . . . 2.0 112.247 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -50.75 -59.15 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 2.99 110.824 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.731 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.8 t -55.31 -48.17 77.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.364 -1.289 . . . . 0.4 110.738 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.66 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 89.2 mtp -62.78 -31.31 72.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.261 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -76.42 -17.5 59.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.364 -0.38 . . . . 1.28 111.064 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.5 mt-10 -73.81 -36.35 64.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.55 -0.907 . . . . 2.02 108.55 171.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 136' ' ' LEU . 3.8 mm? -69.12 -43.48 74.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.628 0.728 . . . . 1.06 109.369 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.864 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.698 -0.683 . . . . 0.35 109.884 177.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.606 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 39.4 tt0 -74.29 -32.06 62.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.728 -0.841 . . . . 2.18 108.728 171.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CE2' HG11 ' A' ' 92' ' ' VAL . 6.0 m-85 -89.63 2.73 54.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.762 0.791 . . . . 0.74 108.879 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.5 m120 75.15 29.99 0.91 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.544 -1.662 . . . . 1.94 110.913 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 1.024 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.53 74.25 1.15 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.984 -1.487 . . . . 1.68 106.984 168.189 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.763 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -60.84 131.39 91.44 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 113.796 -1.547 . . . . 0.61 110.459 -172.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 79.7 Cg_exo -47.52 154.82 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.705 2.27 . . . . 0.3 112.509 173.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.98 -23.99 48.18 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.614 -1.176 . . . . 2.01 107.833 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.788 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -55.05 -40.97 70.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.114 -1.403 . . . . 1.14 109.163 167.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.864 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.4 m0 -96.55 -20.53 18.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.789 -1.096 . . . . 0.45 110.66 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.66 28.74 4.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.147 -1.025 . . . . 0.45 112.179 170.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -98.32 -113.4 3.26 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.593 -0.813 . . . . 0.5 112.797 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -147.4 26.34 1.06 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.936 0.398 . . . . 1.3 111.717 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.605 HG21 HD12 ' A' ' 136' ' ' LEU . 57.3 m -137.01 126.62 25.29 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 119.09 -1.044 . . . . 0.32 113.685 -174.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.602 HG21 ' HB3' ' A' ' 164' ' ' MET . 38.8 mm -86.13 115.25 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.406 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.5 m-85 -95.95 123.51 39.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.726 0.298 . . . . 0.38 111.269 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 62.9 m -126.01 133.62 51.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.936 -0.575 . . . . 1.1 109.947 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.765 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pttp -101.47 123.53 45.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.494 -0.928 . . . . 2.44 108.494 170.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -145.96 175.5 10.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.493 1.14 . . . . 1.27 113.852 -173.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.31 6.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.382 -1.735 . . . . 1.79 109.154 170.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -66.57 -18.08 65.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.31 0.576 . . . . 0.87 110.881 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 18.1 ptmt -71.57 -52.11 19.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.774 0.797 . . . . 3.03 110.016 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.7 p -81.74 -5.32 58.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.486 -1.234 . . . . 1.2 111.855 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 76.97 -29.22 0.17 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.787 0.835 . . . . 2.27 112.178 175.12 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 156' ' ' GLU . 23.2 mt-10 -41.1 -69.33 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.08 0.952 . . . . 2.64 112.95 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.76 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.3 -22.29 70.93 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.988 -1.005 . . . . 0.62 114.28 -172.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -67.29 -39.47 85.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.326 0.563 . . . . 1.55 110.023 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.2 m-20 -65.19 -39.53 92.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.268 -0.424 . . . . 2.5 110.085 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -68.79 -29.81 68.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.352 -0.386 . . . . 0.73 110.701 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 165' ' ' ILE . 54.4 tp -63.31 -51.82 64.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.383 -0.372 . . . . 0.91 110.644 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.563 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.4 mt -53.36 -41.03 65.43 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.255 -0.43 . . . . 1.06 110.637 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 22.1 mm-40 -56.35 -45.02 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.552 . . . . 2.49 110.644 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.8 mmt -76.07 -31.32 58.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.87 110.674 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 83' ' ' ILE . 70.9 mt -59.04 -56.81 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.066 -0.516 . . . . 0.64 110.796 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 57' ' ' ILE . 3.8 mm? -58.52 -42.25 87.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.524 -0.307 . . . . 1.81 111.032 176.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.58 -41.91 67.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.775 -0.648 . . . . 1.42 110.559 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 1.17 111.446 -179.366 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.545 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 96.3 t . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 121.839 0.828 . . . . 1.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.652 HG22 ' HG3' ' A' ' 14' ' ' MET . 21.1 m -82.31 121.78 27.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.525 -1.216 . . . . 0.66 111.143 -171.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.6 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 34.3 mt -88.93 114.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.672 -0.492 . . . . 1.03 109.672 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.652 ' HG3' HG22 ' A' ' 12' ' ' THR . 73.7 mtm -139.59 168.0 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.592 -0.731 . . . . 1.04 111.94 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.33 -95.96 0.17 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.438 -1.065 . . . . 1.55 110.438 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.87 149.9 14.89 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.816 -0.809 . . . . 0.66 108.816 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.85 -27.1 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 113.499 0.926 . . . . 1.62 113.499 -168.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.48 -22.78 40.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 1.78 111.683 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -70.78 -60.16 2.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.029 0.442 . . . . 0.65 110.847 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 166.92 58.31 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.546 -0.835 . . . . 0.93 112.484 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -87.93 -73.56 0.48 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.641 0.734 . . . . 2.11 109.876 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.833 -1.076 . . . . 1.8 111.107 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.461 HG22 ' HA2' ' A' ' 20' ' ' GLY . 8.9 t -76.74 -18.24 58.59 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.981 -0.288 . . . . 1.77 110.234 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -70.59 -44.62 66.93 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.02 -1.104 . . . . 1.78 108.02 174.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.9 tt -63.28 -40.64 97.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.996 -1.002 . . . . 1.96 110.083 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 t70 -63.64 -52.29 61.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.521 -0.308 . . . . 1.38 111.725 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' HD11 ' A' ' 158' ' ' LEU . . . -62.15 -41.46 98.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.91 111.012 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 25' ' ' LEU . 3.2 tt -66.6 -30.04 48.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.577 -0.738 . . . . 1.56 109.54 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 29.4 tpt180 -69.99 -33.19 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.285 -0.87 . . . . 3.56 109.956 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -63.78 -28.33 69.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 2.88 109.521 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 114.923 -1.035 . . . . 1.76 110.774 178.233 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.63 ' CZ ' ' HG ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 121.273 0.558 . . . . 2.54 111.604 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -104.66 133.69 49.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.48 -0.782 . . . . 1.96 109.729 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 59' ' ' PHE . 15.1 m . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.268 0.556 . . . . 1.93 111.965 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 11' ' ' VAL . 70.2 mt . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.09 0.471 . . . . 1.14 111.38 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -87.66 105.65 17.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 1.28 109.993 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 50' ' ' VAL . 35.9 m-85 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.33 . . . . 0.84 110.422 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mm . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 112.008 0.373 . . . . 0.74 112.008 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.078 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.1 t -105.2 111.09 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 120.622 -0.431 . . . . 1.19 111.687 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 16.1 mm -87.42 107.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.82 -0.808 . . . . 1.32 108.82 173.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 100' ' ' ILE . 2.9 tm? -97.45 99.7 11.12 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.989 -1.005 . . . . 1.33 109.509 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.58 133.59 29.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.932 -0.576 . . . . 1.2 110.771 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG23 ' HA ' ' A' ' 114' ' ' ILE . 23.0 m -131.48 -174.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.4 -0.818 . . . . 1.12 108.809 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.49 143.86 44.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.59 -0.444 . . . . 0.75 110.671 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -36.83 -61.84 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.734 1.271 . . . . 1.18 113.312 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.84 8.47 39.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.729 0.64 . . . . 2.01 112.729 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.36 -44.76 2.96 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.179 -0.608 . . . . 1.09 111.077 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.0 -144.49 23.89 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.827 -0.701 . . . . 0.52 111.409 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.782 HG23 ' HB ' ' A' ' 96' ' ' THR . 3.5 p -94.06 106.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.305 0.574 . . . . 1.08 110.12 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.567 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.7 ppp? -83.95 169.29 17.53 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 1.32 109.263 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 40.9 Cg_exo -35.76 -51.98 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.614 2.876 . . . . 0.61 115.029 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.81 -24.11 55.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.827 0.346 . . . . 1.47 111.109 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.782 ' HB ' HG23 ' A' ' 92' ' ' VAL . 2.4 m -65.24 -23.78 67.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.416 0.627 . . . . 0.46 110.035 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 92' ' ' VAL . 64.0 t -87.73 -42.72 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.778 -0.646 . . . . 1.05 111.052 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -56.58 -33.92 66.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.013 0.435 . . . . 1.62 111.095 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.72 -33.27 46.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.34 110.187 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.667 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -75.25 -45.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.635 . . . . 0.38 110.761 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -51.4 -38.13 51.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.264 0.554 . . . . 1.85 110.504 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -78.55 -28.52 46.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.246 -0.888 . . . . 0.85 110.898 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.078 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.74 -44.78 8.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.588 . . . . 0.48 112.48 -172.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -65.69 -24.19 66.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.577 -0.738 . . . . 2.56 111.383 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.6 8.58 33.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.76 111.707 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.36 9.38 39.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.692 -0.855 . . . . 0.9 108.692 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t30 69.44 38.78 1.73 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 114.589 -1.187 . . . . 2.06 110.651 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 82' ' ' VAL . 1.5 m -119.23 150.05 48.46 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.372 -0.831 . . . . 1.08 110.779 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.1 Cg_exo -73.19 155.22 52.0 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.175 2.584 . . . . 0.51 113.639 171.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -115.86 142.44 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.261 -1.336 . . . . 0.96 109.922 -176.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 mp -112.7 140.55 31.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 108.521 -0.918 . . . . 0.71 108.521 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -107.58 136.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 C-N-CA 120.259 -0.576 . . . . 0.23 110.673 176.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.76 87.68 2.76 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.701 -1.222 . . . . 0.25 107.701 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.712 ' HA ' HG23 ' A' ' 86' ' ' VAL . 14.3 mt -75.58 92.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.941 -1.027 . . . . 0.85 109.469 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.988 ' HA ' ' HB2' ' A' ' 150' ' ' LEU . 55.4 t30 -84.6 163.6 19.2 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.094 -0.243 . . . . 0.69 110.43 -171.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 73.38 41.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.229 0.612 . . . . 2.61 112.223 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.632 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 5.3 mmm . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 108.371 -0.974 . . . . 1.37 108.371 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.692 0.282 . . . . 1.84 110.591 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.704 ' O ' ' HG3' ' A' ' 128' ' ' MET . 68.4 Cg_exo -39.9 -58.35 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.625 2.883 . . . . 0.7 113.386 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.23 -48.22 9.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.419 0.688 . . . . 2.0 112.375 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.4 tmt_? -52.91 -55.13 25.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.112 0.482 . . . . 2.99 109.794 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 86' ' ' VAL . 54.7 t -60.22 -43.57 93.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.839 -1.073 . . . . 0.4 110.144 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.704 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 81.0 mtp -62.14 -31.8 72.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.34 -0.845 . . . . 0.3 111.059 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.454 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 18.7 mt-30 -75.79 -25.15 56.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.392 -0.367 . . . . 1.28 110.439 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.3 mt-10 -74.24 -32.23 62.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.176 -0.676 . . . . 2.02 109.176 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.572 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.5 mm? -69.75 -43.41 72.31 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.0 -0.68 . . . . 1.06 109.712 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.846 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -74.85 -5.52 44.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.529 -0.759 . . . . 0.35 109.986 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 9.2 tp10 -71.03 -34.43 71.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.573 -1.269 . . . . 2.18 107.573 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HB2' HD12 ' A' ' 136' ' ' LEU . 41.3 m-85 -91.26 21.8 4.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.77 0.795 . . . . 0.74 109.535 172.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.36 29.55 17.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.189 -1.368 . . . . 1.94 109.636 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.637 ' CD1' HD13 ' A' ' 100' ' ' ILE . 13.8 mt -101.51 70.75 1.3 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.408 -1.269 . . . . 1.68 108.848 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.489 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -64.54 123.27 82.51 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.438 -1.255 . . . . 0.61 110.531 -178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.699 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.3 Cg_exo -47.25 158.24 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.306 2.67 . . . . 0.3 113.171 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -26.29 57.93 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.567 -1.197 . . . . 2.01 108.718 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.5 mp0 -44.73 -51.17 9.58 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.597 -1.183 . . . . 1.14 110.703 160.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.846 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 17.2 m0 -94.95 -24.17 17.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.996 -1.456 . . . . 0.45 111.123 -165.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.2 27.6 2.86 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 119.989 -1.1 . . . . 0.45 112.291 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.4 -115.9 4.13 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.265 -0.969 . . . . 0.5 112.514 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -151.89 34.61 0.54 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.645 0.736 . . . . 1.3 111.112 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 22.4 m -130.78 114.32 15.19 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.278 -0.569 . . . . 0.32 111.767 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.771 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.6 mp -84.87 110.76 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.826 -0.624 . . . . 1.23 110.379 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.699 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.6 m-85 -92.12 135.16 34.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.366 0.603 . . . . 0.38 111.427 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.1 m -133.53 126.41 30.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 1.1 109.505 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.632 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 25.2 pttt -91.72 110.83 22.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.582 0.706 . . . . 2.44 109.618 172.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.988 ' HB2' ' HA ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -83.07 173.89 11.34 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.217 1.932 . . . . 1.27 116.217 -166.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.839 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 24.8 p -175.27 99.3 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 110.562 -3.017 . . . . 1.79 109.245 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.18 -17.73 56.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.7 -0.682 . . . . 0.87 111.913 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 154' ' ' THR . 18.2 ptpt -80.47 -50.42 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.651 0.739 . . . . 3.03 110.086 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.401 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 3.3 p -82.2 -2.41 52.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.626 -1.17 . . . . 1.2 111.434 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 75.72 -6.9 1.9 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.351 -0.84 . . . . 2.27 113.156 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB2' ' OG ' ' A' ' 151' ' ' SER . 15.8 mm-40 -64.67 -37.16 86.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.151 0.5 . . . . 2.64 110.597 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.839 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -59.97 -44.35 97.27 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.446 -0.797 . . . . 0.62 112.5 176.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 27' ' ' ALA . 91.7 mt -67.31 -51.19 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.864 0.32 . . . . 1.55 111.864 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 30.2 t70 -57.97 -53.38 58.89 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.321 0.388 . . . . 2.5 111.077 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 164' ' ' MET . 54.5 t-80 -61.14 -34.75 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.73 110.854 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 165' ' ' ILE . 52.5 tp -65.15 -56.18 14.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.91 111.078 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.82 -39.34 68.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 1.06 110.844 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 57.9 mm-40 -63.56 -40.68 97.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.853 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.771 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.8 mmt -71.82 -38.48 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.424 . . . . 0.87 110.282 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 162' ' ' LEU . 85.6 mt -56.23 -53.43 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.516 -0.766 . . . . 0.64 111.345 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 1.8 pp -72.25 -30.49 64.92 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.84 -0.344 . . . . 1.81 111.904 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 166' ' ' LEU . 55.3 tp -54.45 -33.95 60.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 1.42 110.511 175.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 164' ' ' MET . 76.6 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-N 115.837 -0.619 . . . . 1.17 110.523 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.776 HG12 ' HB ' ' A' ' 81' ' ' ILE . 5.7 m . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.147 0.499 . . . . 1.0 111.244 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -109.32 125.92 52.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.617 -0.72 . . . . 0.66 110.142 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' A' ' 21' ' ' LYS . 23.5 mt -89.12 116.85 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 1.03 110.705 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.526 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 21.6 mmt -119.78 -179.21 3.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.015 -0.993 . . . . 1.04 110.11 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.92 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 105.44 131.49 7.02 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.941 -1.264 . . . . 1.55 109.941 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -44.48 135.67 4.6 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.854 0.835 . . . . 0.66 111.102 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.7 t -56.22 -39.08 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.104 -1.407 . . . . 1.62 112.84 -167.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.53 -18.16 55.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.879 0.326 . . . . 1.78 111.879 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HE1' ' H ' ' A' ' 93' ' ' MET . 25.1 m170 -64.62 -31.24 72.38 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.037 0.446 . . . . 0.65 110.298 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.18 55.14 0.3 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.198 -1.001 . . . . 0.93 113.624 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 13' ' ' ILE . 35.8 pttt -87.83 -22.36 24.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.478 -0.934 . . . . 2.11 108.478 172.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -34.8 77.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.627 -1.169 . . . . 1.8 110.002 176.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 p -71.23 -24.67 62.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 1.77 111.068 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.65 -54.93 28.05 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.662 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 6.0 tt -51.61 -45.31 63.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.094 0.473 . . . . 1.96 110.487 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.51 -52.2 16.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 1.38 112.538 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.63 85.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.367 -0.208 . . . . 0.91 111.116 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' HE2' ' A' ' 48' ' ' TYR . 74.3 mt -67.22 -36.87 77.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.541 -0.54 . . . . 1.56 109.541 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' NH2' ' HB3' ' A' ' 48' ' ' TYR . 15.9 tpp180 -59.49 -38.77 81.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.425 0.631 . . . . 3.56 109.765 171.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -85.14 16.28 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 2.88 111.386 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.449 -0.341 . . . . 1.76 110.804 179.168 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.561 0.696 . . . . 2.54 111.628 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.804 ' HG2' HG23 ' A' ' 58' ' ' THR . 34.9 mt-30 -125.74 146.92 49.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.551 -1.204 . . . . 1.96 107.762 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 C--N 1.318 -0.794 0 N-CA-C 109.135 -0.691 . . . . 1.93 109.135 178.522 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 165' ' ' ILE . 14.8 mt . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.731 0.3 . . . . 1.14 110.509 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.804 HG23 ' HG2' ' A' ' 49' ' ' GLN . 6.9 m -95.04 119.99 34.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.12 -0.326 . . . . 1.28 110.12 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.454 ' HD2' HD11 ' A' ' 13' ' ' ILE . 54.2 m-85 . . . . . 0 CA--C 1.515 -0.396 0 C-N-CA 120.71 -0.396 . . . . 0.84 110.311 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.776 ' HB ' HG12 ' A' ' 11' ' ' VAL . 41.4 mm . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.74 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.709 HG21 ' HB1' ' A' ' 103' ' ' ALA . 42.0 t -92.65 101.6 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 120.764 0.316 . . . . 1.19 111.136 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 111' ' ' ILE . 11.1 mm -84.94 105.42 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.73 -0.841 . . . . 1.32 108.73 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -100.22 104.81 16.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.92 -0.582 . . . . 1.33 110.81 -174.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.92 HG12 ' HA3' ' A' ' 15' ' ' GLY . 2.8 p -83.59 143.82 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.337 0.589 . . . . 1.2 111.6 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 114' ' ' ILE . 31.2 m -140.79 -166.77 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.357 -0.979 . . . . 1.12 108.357 174.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.52 144.04 34.1 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.378 -0.529 . . . . 0.75 111.885 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.73 -54.71 1.2 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.504 1.127 . . . . 1.18 113.092 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.34 -37.65 9.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.644 0.609 . . . . 2.01 112.644 -172.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 13.7 t70 -68.66 -45.0 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.613 -0.435 . . . . 1.09 111.354 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.92 -119.76 5.1 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.476 -0.868 . . . . 0.52 111.503 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.919 HG13 ' HB ' ' A' ' 96' ' ' THR . 25.0 t -114.13 116.15 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 122.611 0.364 . . . . 1.08 111.505 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.576 ' H ' ' HE1' ' A' ' 19' ' ' HIS . 39.6 mtp -82.38 166.54 35.98 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.327 -0.62 . . . . 1.32 109.327 169.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 89.2 Cg_exo -44.32 -50.42 7.89 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.61 113.107 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 2.1 mt-30 -66.73 -23.79 66.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.411 0.523 . . . . 1.47 112.411 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.919 ' HB ' HG13 ' A' ' 92' ' ' VAL . 24.4 m -63.3 -38.24 90.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.647 0.26 . . . . 0.46 110.61 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -29.33 5.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 C-N-CA 120.615 -0.434 . . . . 1.05 111.053 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 20.9 mm-40 -51.42 -45.51 62.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.177 0.513 . . . . 1.62 110.524 174.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.457 -0.792 . . . . 0.34 110.973 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -78.55 -45.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.908 -0.587 . . . . 0.38 111.256 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.36 -35.89 68.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.516 0.674 . . . . 1.85 110.048 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -76.03 -29.8 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 0.85 110.324 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.709 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -90.04 -45.95 8.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.265 0.469 . . . . 0.48 112.265 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -55.84 -26.55 47.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.681 0.622 . . . . 2.56 112.681 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.53 7.08 15.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.555 0.576 . . . . 0.76 112.555 -171.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -95.58 -4.25 44.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.823 -0.806 . . . . 0.9 108.823 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 t30 78.15 47.56 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.381 -1.281 . . . . 2.06 108.091 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -130.35 142.5 45.68 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.393 -1.73 . . . . 1.08 111.164 -171.488 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.5 Cg_exo -69.66 160.22 50.56 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.308 2.672 . . . . 0.51 114.449 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.748 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -124.57 145.92 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.43 -1.259 . . . . 0.96 110.566 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 83' ' ' ILE . 5.2 mp -123.88 108.78 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 120.873 0.368 . . . . 0.71 110.97 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -74.26 136.04 26.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.424 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -121.59 88.38 2.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.908 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 38.2 mt -68.21 93.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.306 -1.315 . . . . 0.85 110.722 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -91.5 169.51 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.967 -0.383 . . . . 0.69 109.967 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 60.7 22.47 12.38 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.855 0.836 . . . . 2.61 110.081 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.2 tpp . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 122.564 1.173 . . . . 1.37 109.018 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 4.5 t-20 . . . . . 0 N--CA 1.462 0.129 0 N-CA-C 109.87 -0.419 . . . . 1.84 109.87 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.0 Cg_exo -39.15 -61.31 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.253 3.302 . . . . 0.7 113.727 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -49.45 -43.85 45.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.991 0.517 . . . . 2.0 112.19 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -53.5 -55.56 24.38 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.31 0.576 . . . . 2.99 109.696 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.569 HG13 ' HA2' ' A' ' 91' ' ' GLY . 55.2 t -61.37 -43.82 97.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.605 -1.179 . . . . 0.4 110.052 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.799 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.5 mtp -63.5 -28.14 69.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.249 -0.887 . . . . 0.3 111.303 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.9 mt-30 -79.06 -23.59 44.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.628 -0.26 . . . . 1.28 110.477 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -71.93 -34.42 69.04 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.249 -0.649 . . . . 2.02 109.249 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -72.26 -41.0 67.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.571 0.7 . . . . 1.06 109.827 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.839 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -75.63 -5.38 45.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.091 -0.959 . . . . 0.35 109.462 176.094 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.2 tt0 -84.01 -21.51 31.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.664 -0.865 . . . . 2.18 108.664 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.745 ' HE2' HG11 ' A' ' 92' ' ' VAL . 31.9 m-85 -94.27 10.57 33.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.281 -1.007 . . . . 0.74 108.281 166.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.4 m120 70.97 35.29 1.7 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 113.683 -1.599 . . . . 1.94 111.449 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.564 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.0 mp -112.0 78.16 1.1 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.402 -0.962 . . . . 1.68 108.402 170.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.984 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.63 130.13 93.35 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 113.936 -1.484 . . . . 0.61 110.682 -176.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.802 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 75.8 Cg_exo -51.13 153.33 9.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.849 2.366 . . . . 0.3 113.295 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.7 mm-40 -79.52 -23.52 42.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.488 -1.233 . . . . 2.01 109.083 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.69 ' HB3' ' CD1' ' A' ' 141' ' ' TRP . 8.1 mp0 -42.96 -53.06 4.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.676 -1.147 . . . . 1.14 110.547 159.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.839 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -93.82 -22.06 18.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.739 -1.573 . . . . 0.45 111.237 -167.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.32 25.61 3.73 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.086 -1.054 . . . . 0.45 112.364 172.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.984 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -106.71 2.12 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.623 -0.799 . . . . 0.5 113.114 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.83 23.02 0.27 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.999 0.428 . . . . 1.3 110.944 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.748 HG23 HG22 ' A' ' 110' ' ' ILE . 17.5 m -136.44 112.21 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.912 -0.715 . . . . 0.32 112.834 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.737 HG21 ' HB3' ' A' ' 164' ' ' MET . 52.9 mt -76.89 117.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 1.23 110.808 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.802 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.3 m-85 -94.69 101.86 13.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.38 111.839 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.2 m -96.42 99.37 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.726 -0.67 . . . . 1.1 109.99 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.908 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 18.6 pttm -79.26 85.17 5.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.776 -0.824 . . . . 2.44 108.776 172.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.672 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -109.82 179.25 4.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.301 -0.863 . . . . 1.27 112.542 -169.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 p -146.17 104.71 3.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.062 -0.972 . . . . 1.79 110.772 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 158' ' ' LEU . . . -66.86 -17.93 65.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.981 0.42 . . . . 0.87 111.44 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -78.62 -60.76 2.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.42 0.628 . . . . 3.03 110.299 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -85.45 -5.46 59.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.033 -0.985 . . . . 1.2 112.067 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HD23 ' A' ' 158' ' ' LEU . 5.1 tppp? 73.05 -7.08 1.56 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.618 0.574 . . . . 2.27 112.423 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -56.35 -55.39 33.99 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.984 0.897 . . . . 2.64 111.141 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.672 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -67.36 -19.57 70.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.995 -1.002 . . . . 0.62 113.695 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 152' ' ' ALA . 4.0 mm? -67.58 -41.43 84.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.486 0.643 . . . . 1.55 110.367 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.88 -44.47 97.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.728 -0.669 . . . . 2.5 109.926 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.483 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.4 t60 -65.55 -38.14 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.73 111.041 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.51 -58.34 8.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.91 112.051 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.604 ' O ' HD23 ' A' ' 166' ' ' LEU . 93.7 mt -56.05 -40.97 74.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.595 -0.275 . . . . 1.06 110.716 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.5 -30.98 71.43 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.954 -0.299 . . . . 2.49 111.144 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.737 ' HB3' HG21 ' A' ' 146' ' ' ILE . 24.5 mmt -70.4 -39.76 74.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.87 109.888 175.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 57' ' ' ILE . 78.9 mt -57.08 -56.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.093 -0.958 . . . . 0.64 110.559 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.577 0.584 . . . . 1.81 112.577 176.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.43 -37.15 77.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 1.42 110.462 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 146' ' ' ILE . 1.4 t . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.146 -0.479 . . . . 1.17 110.612 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.792 HG21 HG23 ' A' ' 57' ' ' ILE . 21.3 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.237 0.542 . . . . 1.0 109.898 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 m -64.93 116.66 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.112 -0.949 . . . . 0.66 111.585 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.869 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.6 mt -104.73 128.19 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.45 . . . . 1.03 110.831 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.6 mtm -139.78 166.56 24.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.021 0.439 . . . . 1.04 111.096 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.59 -107.56 0.29 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.919 -0.872 . . . . 1.55 110.919 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -156.44 160.16 39.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.929 -0.397 . . . . 0.66 109.929 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.82 -56.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.68 0.252 . . . . 1.62 111.68 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.87 -15.14 63.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.435 0.532 . . . . 1.78 112.435 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' H ' ' A' ' 93' ' ' MET . 64.3 m170 -77.43 -2.52 35.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.653 0.739 . . . . 0.65 110.421 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.53 47.79 47.93 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.966 -1.015 . . . . 0.93 113.4 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.8 pttp -70.89 -10.84 60.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.798 0.808 . . . . 2.11 109.481 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -81.31 -5.22 57.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.957 -1.019 . . . . 1.8 110.563 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 p -84.67 -32.56 23.55 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 120.801 -0.36 . . . . 1.77 110.821 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 25' ' ' LEU . 4.5 pp -69.66 -34.96 74.73 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.593 -0.891 . . . . 1.78 108.593 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -56.98 -38.84 73.58 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.484 -0.932 . . . . 1.96 108.484 175.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.41 -52.89 7.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 1.38 112.216 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . . . -67.73 -33.59 75.18 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.348 -0.387 . . . . 0.91 111.274 -171.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' A' ' 48' ' ' TYR . 96.2 mt -71.65 -29.7 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 1.56 110.314 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 75.2 mtm180 -66.42 -40.96 89.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.218 -0.66 . . . . 3.56 109.218 172.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.34 -12.6 57.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 2.88 110.606 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 115.84 -0.618 . . . . 1.76 110.199 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.521 ' HE1' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.481 0.658 . . . . 2.54 111.893 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 58' ' ' THR . 43.1 mt-30 -101.82 123.4 45.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.175 -0.921 . . . . 1.96 108.921 175.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG21 ' HE2' ' A' ' 59' ' ' PHE . 12.3 m . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 121.151 0.5 . . . . 1.93 111.954 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.792 HG23 HG21 ' A' ' 11' ' ' VAL . 58.4 mt . . . . . 0 C--O 1.236 0.36 0 CA-C-O 121.033 0.444 . . . . 1.14 110.191 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 49' ' ' GLN . 14.2 m -86.69 111.1 20.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.913 -0.585 . . . . 1.28 110.103 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HE2' HG21 ' A' ' 50' ' ' VAL . 34.9 m-85 . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.715 0.293 . . . . 0.84 110.352 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 11' ' ' VAL . 8.5 mm . . . . . 0 N--CA 1.458 -0.043 0 N-CA-C 110.321 -0.251 . . . . 0.74 110.321 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 ' HB1' ' A' ' 103' ' ' ALA . 40.5 t -99.51 96.24 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.107 -0.637 . . . . 1.19 111.283 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.869 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 17.3 mm -74.29 117.41 18.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.198 -1.038 . . . . 1.32 108.198 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.6 tm? -110.65 96.03 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.784 -0.643 . . . . 1.33 110.245 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 49.4 t -84.9 130.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.213 0.53 . . . . 1.2 111.388 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.799 HG12 HG21 ' A' ' 96' ' ' THR . 28.0 m -128.4 -164.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.511 -0.922 . . . . 1.12 108.511 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.56 40.53 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.116 -0.634 . . . . 0.75 111.965 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 117' ' ' MET . . . -31.94 -64.68 0.16 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.93 1.394 . . . . 1.18 113.922 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.71 -20.13 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.864 -0.607 . . . . 2.01 112.356 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.36 -37.0 15.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.362 -0.535 . . . . 1.09 111.598 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.59 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 82.87 -144.35 22.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.528 -0.844 . . . . 0.52 111.783 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' HB ' ' A' ' 96' ' ' THR . 2.8 p -100.85 102.57 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 109.279 -0.637 . . . . 1.08 109.279 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.603 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -83.49 169.54 17.08 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.57 -0.53 . . . . 1.32 109.57 -175.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 29.0 Cg_exo -30.42 -56.17 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.092 3.195 . . . . 0.61 115.1 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -69.98 -34.68 73.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.533 0.206 . . . . 1.47 111.016 -175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.65 -31.48 72.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.649 0.738 . . . . 0.46 109.931 176.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.548 HG23 HG22 ' A' ' 92' ' ' VAL . 72.5 t -78.79 -45.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.354 -0.839 . . . . 1.05 111.055 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.6 mt-10 -63.94 -19.06 64.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.62 111.086 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.79 -41.04 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.646 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.581 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.21 -47.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.79 176.502 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -49.24 -34.78 15.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.926 0.491 . . . . 1.85 110.735 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -85.69 -31.93 22.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 0.85 111.02 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.83 -44.78 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.925 0.343 . . . . 0.48 111.925 -173.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -54.59 -30.75 55.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.654 . . . . 2.56 112.759 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.32 3.37 15.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.973 0.731 . . . . 0.76 112.973 -167.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.45 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -91.39 -2.3 57.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.721 -0.844 . . . . 0.9 108.721 173.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.1 t30 72.22 46.14 0.34 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.986 -1.461 . . . . 2.06 107.534 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -121.24 144.58 40.07 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 112.663 -2.062 . . . . 1.08 110.942 -170.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 108' ' ' VAL . 18.0 Cg_exo -67.45 154.47 73.67 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.681 2.254 . . . . 0.51 114.264 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.661 HG22 HG23 ' A' ' 145' ' ' THR . 1.2 mp -122.57 142.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.746 -1.57 . . . . 0.96 109.645 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.682 HD13 HD13 ' A' ' 83' ' ' ILE . 2.7 mp -121.23 99.96 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 CA-C-O 121.272 0.558 . . . . 0.71 111.292 -176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -68.56 137.12 25.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.361 -0.836 . . . . 0.23 110.613 179.108 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -122.52 89.48 3.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.966 -1.124 . . . . 0.25 107.966 173.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.812 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 6.6 mm -65.22 85.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.595 -1.184 . . . . 0.85 109.745 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -95.75 168.36 10.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.69 110.128 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 69.46 12.92 8.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.333 0.587 . . . . 2.61 110.206 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.424 0.63 . . . . 1.37 110.642 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.439 0.162 . . . . 1.84 110.781 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.65 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.2 Cg_exo -38.98 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.051 3.168 . . . . 0.7 114.094 171.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -45.48 -49.02 13.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.859 0.688 . . . . 2.0 112.859 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -50.68 -57.06 9.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.496 0.665 . . . . 2.99 109.872 175.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.59 HG13 ' HA2' ' A' ' 91' ' ' GLY . 74.3 t -58.5 -45.51 90.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.389 -1.278 . . . . 0.4 110.514 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.676 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.0 mtp -62.74 -29.05 70.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.3 111.376 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -78.32 -24.31 46.67 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.513 -0.312 . . . . 1.28 110.773 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -72.61 -32.82 66.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.793 -0.817 . . . . 2.02 108.793 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -70.15 -44.67 68.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 120.048 -0.661 . . . . 1.06 109.569 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.875 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -76.95 -0.49 24.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.35 110.006 177.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.0 tp10 -77.5 -31.84 53.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.288 -1.375 . . . . 2.18 107.288 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -95.35 17.51 14.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.146 -0.933 . . . . 0.74 109.696 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.9 34.27 4.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.054 -1.43 . . . . 1.94 110.333 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -106.96 87.09 2.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.09 1.424 . . . . 1.68 109.0 173.225 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.842 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 93.3 t -83.91 119.74 73.93 Favored Pre-proline 0 C--N 1.285 -2.21 0 CA-C-N 111.559 -2.564 . . . . 0.61 111.334 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.84 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -47.74 157.97 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.791 2.994 . . . . 0.3 113.963 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 144' ' ' ASP . 6.8 mm-40 -74.33 -24.69 59.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.13 -1.395 . . . . 2.01 109.183 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.836 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -56.86 -40.65 76.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.286 -0.87 . . . . 1.14 109.045 169.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.875 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.6 m0 -96.04 -21.24 18.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.858 -1.065 . . . . 0.45 111.089 -169.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.36 30.16 4.51 Favored Glycine 0 CA--C 1.501 -0.786 0 C-N-CA 119.762 -1.209 . . . . 0.45 112.011 170.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.842 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.93 -109.48 2.64 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.377 -0.916 . . . . 0.5 111.48 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.485 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 9.0 p-10 -166.42 46.36 0.07 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.623 1.201 . . . . 1.3 109.591 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 110' ' ' ILE . 21.4 m -132.02 110.37 10.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.286 -1.325 . . . . 0.32 111.377 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.73 107.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.092 -0.958 . . . . 1.23 110.422 -175.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.84 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 22.6 m-85 -89.76 96.59 10.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.5 . . . . 0.38 111.33 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 150' ' ' LEU . 68.8 m -88.02 99.22 12.0 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.161 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.812 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.8 ptmt -76.35 83.97 3.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.872 -0.788 . . . . 2.44 108.872 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.488 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.5 -178.95 3.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.585 0.707 . . . . 1.27 112.23 -170.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -165.77 130.1 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.036 -0.983 . . . . 1.79 110.792 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 27' ' ' ALA . . . -84.47 -9.65 58.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.32 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 153' ' ' LYS . 5.3 tppp? -78.34 -58.69 3.12 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.295 -0.866 . . . . 3.03 109.342 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.711 ' HB ' ' HG2' ' A' ' 156' ' ' GLU . 22.1 p -73.99 -22.53 59.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.619 -1.173 . . . . 1.2 110.783 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 tptp 72.61 -2.64 2.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.092 -0.958 . . . . 2.27 110.981 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.711 ' HG2' ' HB ' ' A' ' 154' ' ' THR . 22.1 mm-40 -59.15 -73.33 0.08 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.459 0.647 . . . . 2.64 112.022 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -67.69 -9.1 55.06 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.62 113.454 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 28' ' ' ILE . 2.6 tm? -64.27 -51.22 64.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.513 -0.551 . . . . 1.55 109.513 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.71 -36.51 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 2.5 109.938 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.576 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 80.1 t60 -58.75 -37.71 76.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.258 -0.883 . . . . 0.73 110.478 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.79 -49.49 77.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.921 -0.581 . . . . 0.91 110.634 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.26 -38.53 77.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 1.06 110.769 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.5 -42.99 91.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 2.49 110.499 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -39.0 92.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.87 110.621 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.23 -48.8 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.985 -0.552 . . . . 0.64 110.213 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.84 -46.98 85.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.854 -0.612 . . . . 1.81 111.034 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.0 tp -48.8 -49.29 39.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.393 -0.821 . . . . 1.42 110.86 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.445 -0.693 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.032 -179.131 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG22 ' HB ' ' A' ' 81' ' ' ILE . 47.5 t . . . . . 0 N--CA 1.439 -1.004 0 CA-C-O 120.968 0.413 . . . . 1.0 111.028 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -98.12 132.53 43.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.157 0.503 . . . . 0.66 110.413 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.439 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 66.1 mt -94.87 127.51 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.708 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 54.8 mtt -127.48 173.12 10.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.726 -0.67 . . . . 1.04 110.922 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.11 -104.92 0.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.908 -0.877 . . . . 1.55 110.908 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.488 ' CD2' ' H ' ' A' ' 18' ' ' ASP . 81.6 t60 -166.55 143.34 4.88 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.261 -0.644 . . . . 0.66 109.261 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.42 -24.47 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.2 1.185 . . . . 1.62 114.2 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 21.1 m-20 -88.3 -11.83 45.3 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.561 0.578 . . . . 1.78 112.561 -173.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -77.6 -3.6 41.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.162 0.43 . . . . 0.65 112.162 -174.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.58 64.63 0.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.656 -0.783 . . . . 0.93 112.763 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -87.08 -34.69 19.06 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 2.11 110.871 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.628 -0.26 . . . . 1.8 110.472 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 p -78.54 -32.07 47.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.954 0.407 . . . . 1.77 110.635 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -54.45 13.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.851 -0.796 . . . . 1.78 108.851 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -59.1 -33.9 71.38 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.099 -0.955 . . . . 1.96 110.724 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.88 -55.83 6.81 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.035 -0.416 . . . . 1.38 111.398 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -59.71 -39.61 85.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.91 110.898 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 48' ' ' TYR . 10.8 tt -65.96 -28.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.504 -0.771 . . . . 1.56 111.252 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 85.4 mtm180 -77.25 -26.59 52.71 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.595 0.712 . . . . 3.56 109.463 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -85.58 15.21 4.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.829 -1.078 . . . . 2.88 110.091 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 3.8 m . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.65 -0.704 . . . . 1.76 111.736 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.62 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.2 p90 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.133 0.492 . . . . 2.54 111.156 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.813 ' HG2' HG23 ' A' ' 58' ' ' THR . 79.2 mt-30 -109.44 134.09 52.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.581 -0.736 . . . . 1.96 109.284 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 CA--C 1.509 -0.608 0 CA-C-O 121.649 0.738 . . . . 1.93 110.609 -178.005 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.984 0.421 . . . . 1.14 111.179 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.813 HG23 ' HG2' ' A' ' 49' ' ' GLN . 18.9 m -104.3 127.99 52.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 1.28 108.977 171.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.7 m-85 . . . . . 0 C--N 1.325 -0.463 0 C-N-CA 120.976 -0.29 . . . . 0.84 110.92 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.697 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.6 mm . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 109.716 -0.476 . . . . 0.74 109.716 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.7 t -82.18 94.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 120.376 -0.53 . . . . 1.19 110.714 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.609 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 10.0 mm -80.66 97.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.369 -0.604 . . . . 1.32 109.369 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -87.71 96.26 10.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.005 -0.739 . . . . 1.33 109.005 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 55.2 t -81.71 137.98 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.428 0.632 . . . . 1.2 111.266 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.2 m -132.84 -168.19 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 1.12 108.547 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.26 20.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -58.64 -19.94 43.42 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.421 -0.809 . . . . 1.18 112.437 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.75 -12.48 33.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.515 0.191 . . . . 2.01 111.515 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.563 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 28.5 t70 -119.43 -49.65 2.36 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.375 0.607 . . . . 1.09 110.94 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 100.49 -124.67 8.32 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.18 -0.918 . . . . 0.52 111.239 -174.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.017 HG11 ' HE2' ' A' ' 134' ' ' TYR . 38.1 t -111.82 113.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.957 0.408 . . . . 1.08 111.029 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.563 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 77.2 mmm -80.33 168.12 28.06 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.557 -0.535 . . . . 1.32 109.557 172.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 6.3 Cg_endo -49.64 -42.83 41.87 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.393 2.062 . . . . 0.61 112.885 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.76 -26.86 62.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.659 0.266 . . . . 1.47 110.609 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.823 ' HB ' HG13 ' A' ' 92' ' ' VAL . 18.6 m -60.79 -35.77 77.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.128 -0.487 . . . . 0.46 110.483 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.584 HG12 ' CG1' ' A' ' 92' ' ' VAL . 2.0 m -84.15 -35.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.518 -0.31 . . . . 1.05 110.81 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.945 0.402 . . . . 1.62 111.474 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.695 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -66.82 -45.09 79.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.34 110.137 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.643 HG23 ' HD3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -64.27 -42.65 96.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.522 -0.763 . . . . 0.38 111.216 177.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -62.81 -30.73 71.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.509 0.723 . . . . 1.85 109.814 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -83.96 -32.54 24.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.85 110.333 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -87.11 -48.78 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.334 0.494 . . . . 0.48 112.334 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.643 ' HD3' HG23 ' A' ' 100' ' ' ILE . 14.0 pttp -63.74 -16.4 61.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.526 0.565 . . . . 2.56 112.526 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.31 6.74 21.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.855 0.317 . . . . 0.76 111.855 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.542 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -98.21 2.14 48.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.803 -0.444 . . . . 0.9 109.803 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 77.92 31.87 0.4 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.742 1.258 . . . . 2.06 108.569 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -109.48 147.63 36.45 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 113.206 -1.815 . . . . 1.08 110.523 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_exo -73.38 151.42 48.17 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.569 2.179 . . . . 0.51 113.547 172.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.628 HG22 HG23 ' A' ' 145' ' ' THR . 1.1 mp -118.82 142.59 33.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.225 -1.352 . . . . 0.96 110.212 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -112.17 148.24 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 107.933 -1.136 . . . . 0.71 107.933 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -112.84 138.01 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 109.364 -0.606 . . . . 0.23 109.364 172.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -118.95 88.17 2.88 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.758 -1.201 . . . . 0.25 107.758 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.786 HD11 ' HD2' ' A' ' 147' ' ' PHE . 21.1 mt -73.79 83.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.754 -1.112 . . . . 0.85 109.507 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -89.09 164.63 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.934 -0.575 . . . . 0.69 110.105 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 66.97 34.1 5.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.04 -0.527 . . . . 2.61 112.131 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 4.3 ptp . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 1.37 109.792 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.092 0.404 . . . . 1.84 112.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.4 Cg_exo -36.72 -60.78 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.572 3.515 . . . . 0.7 115.198 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -42.72 -41.85 3.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.6 0.76 . . . . 2.0 113.014 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.87 -54.07 51.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.701 0.762 . . . . 2.99 109.387 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.721 ' HA ' ' OE2' ' A' ' 130' ' ' GLU . 58.4 t -60.06 -39.38 80.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.083 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.679 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 86.3 mtp -65.64 -30.62 71.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.253 -0.885 . . . . 0.3 111.114 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.33 -15.45 57.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.543 -0.463 . . . . 1.28 110.898 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.721 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 12.9 mt-10 -72.3 -37.12 69.05 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.656 -0.868 . . . . 2.02 108.656 170.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.576 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -69.95 -45.17 68.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.45 0.643 . . . . 1.06 110.087 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.905 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -75.79 -5.52 46.24 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.309 -0.859 . . . . 0.35 109.645 177.544 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 14.4 tp10 -74.02 -32.37 63.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.785 -1.191 . . . . 2.18 107.785 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 1.017 ' HE2' HG11 ' A' ' 92' ' ' VAL . 30.2 m-85 -90.0 10.13 25.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.68 0.753 . . . . 0.74 109.1 173.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 71.95 38.73 0.89 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 113.898 -1.501 . . . . 1.94 110.565 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.2 mp -117.28 84.11 2.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.444 1.116 . . . . 1.68 108.679 172.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.977 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.2 t -69.67 127.31 92.7 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.022 -1.899 . . . . 0.61 112.139 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.839 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 81.3 Cg_exo -47.14 160.24 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.296 0 C-N-CA 124.109 3.206 . . . . 0.3 114.441 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -85.26 -5.87 59.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.336 -1.302 . . . . 2.01 110.11 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -74.13 -32.79 63.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.452 -1.314 . . . . 1.14 107.452 167.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.905 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -101.3 -26.27 13.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.191 -1.368 . . . . 0.45 111.286 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.5 30.8 3.19 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.845 -1.169 . . . . 0.45 112.315 172.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.977 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.87 -102.53 1.95 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 120.486 -0.864 . . . . 0.5 111.609 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -169.6 37.29 0.02 OUTLIER 'General case' 0 C--O 1.247 0.922 0 CA-C-O 122.168 0.985 . . . . 1.3 110.594 172.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.47 113.84 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.909 -1.041 . . . . 0.32 111.49 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.7 mp -82.72 108.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.587 -0.733 . . . . 1.23 110.555 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.839 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.7 m-85 -91.33 111.75 23.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.701 0.286 . . . . 0.38 111.752 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.403 ' O ' HD23 ' A' ' 150' ' ' LEU . 16.0 t -102.11 117.24 34.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.804 -0.813 . . . . 1.1 108.804 174.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.4 pttm -93.34 101.49 13.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.129 -0.693 . . . . 2.44 109.129 175.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.719 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -130.12 176.91 7.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.244 1.021 . . . . 1.27 113.567 -168.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.9 m -147.45 117.27 7.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.6 -1.636 . . . . 1.79 109.101 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.63 66.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.445 0.535 . . . . 0.87 112.445 -174.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.71 ' HG3' ' H ' ' A' ' 154' ' ' THR . 15.0 ptpt -73.95 -56.08 5.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.77 0.795 . . . . 3.03 110.12 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.71 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 10.3 p -72.77 -12.45 61.01 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.16 -1.382 . . . . 1.2 112.098 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HD2' HD12 ' A' ' 158' ' ' LEU . 3.0 tptm 71.72 2.75 4.41 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.061 0.544 . . . . 2.27 111.779 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.94 -72.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.714 0.768 . . . . 2.64 111.423 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.719 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.36 -9.3 60.85 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.155 -0.93 . . . . 0.62 113.623 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.684 HD12 ' HD2' ' A' ' 155' ' ' LYS . 31.2 mt -70.12 -42.69 72.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.365 0.582 . . . . 1.55 110.256 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.57 -44.86 92.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 2.5 109.569 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -67.39 -24.63 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.73 111.361 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.28 -50.02 65.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.551 -0.295 . . . . 0.91 110.289 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -55.7 -36.75 67.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.007 -0.542 . . . . 1.06 110.459 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.16 -51.6 69.31 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.032 0.444 . . . . 2.49 110.526 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.733 ' HB3' HG21 ' A' ' 146' ' ' ILE . 16.2 mmt -65.5 -40.84 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.87 110.799 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.92 -53.18 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.709 -0.678 . . . . 0.64 110.314 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.21 -43.94 95.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.792 -0.64 . . . . 1.81 111.44 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.4 tp -54.01 -47.8 71.1 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.043 -0.526 . . . . 1.42 110.196 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.446 -0.628 0 CA-C-N 116.07 -0.513 . . . . 1.17 111.317 -177.81 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 112.481 -0.248 . . . . 16.35 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -88.77 -9.21 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.699 0.285 . . . . 14.69 111.379 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 14.68 110.017 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.418 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 24.5 mmt -101.91 32.6 3.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 12.73 109.732 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 4' ' ' MET . 98.4 t 72.68 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.491 -0.777 . . . . 10.18 111.039 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -72.73 88.87 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.591 . . . . 9.14 110.135 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -67.86 128.66 93.4 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 8.35 109.946 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.25 115.68 2.54 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.063 2.509 . . . . 4.6 112.278 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.38 85.92 0.85 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.709 2.273 . . . . 4.29 111.955 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -72.32 107.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.631 0.729 . . . . 2.58 109.936 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.023 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 10.5 t -85.36 84.72 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.613 0.721 . . . . 1.0 109.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -70.54 118.42 13.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.096 -0.957 . . . . 0.66 111.282 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.724 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.1 mt -87.18 116.06 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.371 0.605 . . . . 1.03 110.549 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 35.0 mtt -125.17 172.23 9.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.552 -0.749 . . . . 1.04 110.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 1.019 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 147.54 -96.64 0.18 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 109.851 -1.299 . . . . 1.55 109.851 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.622 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 27.2 t-80 -175.0 164.28 3.35 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.659 -0.867 . . . . 0.66 108.659 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.09 -52.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.665 0.269 . . . . 1.62 111.439 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.13 -30.12 70.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.792 -0.64 . . . . 1.78 112.651 -172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.622 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 39.9 m80 -64.76 -19.43 65.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.408 . . . . 0.65 110.949 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.89 44.15 2.92 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.679 -0.772 . . . . 0.93 112.978 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG11 ' A' ' 85' ' ' VAL . 22.0 ptmt -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.3 p -74.68 -35.68 62.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.738 -1.119 . . . . 1.8 109.62 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.8 m -63.3 -33.68 76.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.138 -0.937 . . . . 1.77 110.522 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.46 -56.19 20.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.408 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' HG22 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -62.64 -38.51 90.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.12 -0.491 . . . . 1.96 110.006 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 12.3 t70 -63.88 -49.49 72.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.98 0.363 . . . . 1.38 111.98 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -68.02 -37.31 81.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.227 0.537 . . . . 0.91 110.857 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.597 HG22 ' HA ' ' A' ' 25' ' ' LEU . 6.5 tt -74.11 -20.84 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.451 -0.795 . . . . 1.56 109.812 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 33.0 tpt180 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.115 -0.948 . . . . 3.56 109.831 174.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -88.84 7.44 34.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.584 -0.735 . . . . 2.88 110.145 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -149.81 49.63 0.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.316 0.579 . . . . 1.76 110.33 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -93.18 160.61 14.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.71 . . . . 5.71 111.077 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 51' ' ' THR . 3.4 m -138.63 -2.4 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 113.072 0.768 . . . . 2.99 113.072 -174.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 93.9 m -161.81 -63.26 0.05 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.091 -0.381 . . . . 3.93 111.478 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 34' ' ' THR . 8.4 pt-20 46.22 -169.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.973 1.309 . . . . 4.2 114.194 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -102.13 -80.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.712 -0.676 . . . . 5.38 110.435 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -139.39 -48.01 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.459 -0.791 . . . . 5.79 110.202 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.38 118.18 9.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.471 -0.786 . . . . 4.24 110.649 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.58 38.11 3.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 4.95 111.426 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -101.8 149.93 18.21 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.697 -0.561 . . . . 6.66 111.697 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.0 mp -75.71 88.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 9.17 110.867 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 m -145.03 139.2 27.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.933 -1.136 . . . . 7.36 107.933 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -70.8 24.78 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.278 1.214 . . . . 8.83 114.278 -167.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -111.82 -10.08 14.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 6.76 109.067 171.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.913 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.7 tp -168.59 -157.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.141 -1.059 . . . . 5.19 108.141 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.913 ' H ' HG13 ' A' ' 45' ' ' ILE . . . 146.3 -62.27 0.46 Allowed Glycine 0 C--N 1.311 -0.82 0 C-N-CA 120.437 -0.887 . . . . 2.97 112.556 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.77 179.25 7.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.757 0.313 . . . . 1.71 110.167 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' A' ' 28' ' ' ILE . 3.0 p90 -157.47 -172.83 4.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.814 0.34 . . . . 2.54 110.658 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HG2' HG23 ' A' ' 58' ' ' THR . 36.8 mt-30 -122.42 122.98 40.26 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.876 -0.787 . . . . 1.96 108.876 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' HE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -107.37 133.61 51.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.364 0.602 . . . . 1.93 111.194 -173.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 54' ' ' ASP . 87.0 m -110.08 82.46 1.6 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.962 -1.017 . . . . 2.06 110.088 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 54' ' ' ASP . 5.9 p -112.02 124.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.704 -1.221 . . . . 4.12 107.704 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.619 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER 73.87 -5.69 1.97 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.325 1.059 . . . . 4.43 108.705 -172.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.674 ' HA ' HG23 ' A' ' 51' ' ' THR . 1.7 m-20 77.21 23.85 0.88 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 112.263 -2.244 . . . . 3.62 110.933 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.619 ' HD3' ' HB3' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -88.69 129.15 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.572 -0.899 . . . . 7.44 108.572 172.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -72.06 92.08 1.29 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.388 0.43 . . . . 5.43 111.558 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 11' ' ' VAL . 56.1 mt -94.61 95.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 1.14 110.085 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -88.58 113.21 23.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.874 -0.603 . . . . 1.28 109.442 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HE2' HG21 ' A' ' 50' ' ' VAL . 27.6 m-85 -90.63 142.28 27.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.932 -0.307 . . . . 0.84 111.417 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.8 tp 73.79 137.47 0.05 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.306 1.004 . . . . 3.0 111.889 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.41 174.35 6.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.279 -0.873 . . . . 6.48 110.878 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -109.74 101.08 45.35 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.981 -0.554 . . . . 5.57 110.067 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.52 84.8 0.47 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.975 2.45 . . . . 5.77 112.391 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.66 -48.52 5.22 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.343 -0.703 . . . . 5.54 111.343 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -123.45 -59.5 1.54 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.043 -0.725 . . . . 8.09 109.043 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.87 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 5.4 mp0 -116.96 140.76 49.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.883 -0.599 . . . . 6.36 110.169 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -75.31 128.17 34.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.687 -0.857 . . . . 3.51 108.687 170.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' HZ ' HG11 ' A' ' 108' ' ' VAL . 84.1 t80 68.87 87.19 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.693 0.621 . . . . 2.61 110.143 -170.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.1 m 54.96 107.77 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.143 0.794 . . . . 4.74 113.143 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.87 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 10.9 t -52.64 131.2 34.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.338 -0.615 . . . . 5.89 109.338 174.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -82.33 64.21 6.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.308 0.575 . . . . 5.64 111.826 -167.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -158.63 74.32 0.67 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.554 -0.748 . . . . 9.71 109.687 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -174.45 116.58 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 7.52 110.526 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -129.07 3.35 5.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.254 0.55 . . . . 10.42 110.374 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 19.52 23.3 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.941 -0.864 . . . . 6.75 110.941 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.14 79.14 0.83 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.543 . . . . 6.69 110.088 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -79.04 101.95 8.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.149 0.5 . . . . 7.72 109.779 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -76.45 153.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.889 -0.596 . . . . 4.38 111.49 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.35 57.78 4.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.517 -0.765 . . . . 4.18 111.444 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.9 145.54 31.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.726 -0.67 . . . . 3.12 109.344 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 24.5 mm -120.31 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.685 -0.234 . . . . 0.74 110.469 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.954 HG21 ' HB1' ' A' ' 103' ' ' ALA . 13.1 t -99.23 94.97 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 120.418 -0.513 . . . . 1.19 111.703 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 30.9 mm -80.36 115.27 22.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.206 -1.035 . . . . 1.32 108.206 170.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.9 tm? -105.72 101.13 10.66 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.487 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.019 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.1 p -79.96 142.49 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.478 0.656 . . . . 1.2 111.697 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 87' ' ' ALA . 25.3 t -136.1 173.04 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 107.583 -1.265 . . . . 1.12 107.583 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.59 112.8 5.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.231 0.469 . . . . 0.75 112.017 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 41.35 -97.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.599 1.16 . . . . 1.18 113.756 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.26 1.29 25.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 2.01 112.055 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.543 ' OD1' ' HG3' ' A' ' 93' ' ' MET . 14.1 t70 -71.24 -49.2 45.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.09 110.635 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.765 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 86.43 -107.6 3.21 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.159 -0.928 . . . . 0.52 111.606 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.874 HG13 ' HB ' ' A' ' 96' ' ' THR . 30.7 t -128.81 111.75 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 122.347 0.259 . . . . 1.08 110.709 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.633 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.9 mtp -82.8 172.09 10.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.695 -0.23 . . . . 1.32 110.445 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.633 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 99.4 Cg_exo -44.17 -52.03 6.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.028 2.486 . . . . 0.61 113.658 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -65.46 -28.83 69.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.591 -0.277 . . . . 1.47 111.241 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.874 ' HB ' HG13 ' A' ' 92' ' ' VAL . 8.1 m -62.97 -30.29 71.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.248 0.547 . . . . 0.46 110.624 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 70.9 t -84.46 -52.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.286 -0.416 . . . . 1.05 111.676 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.35 -18.83 60.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.849 -0.614 . . . . 1.62 111.473 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -88.09 -39.9 14.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.877 -0.601 . . . . 0.34 109.543 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.865 HD11 ' HG ' ' A' ' 84' ' ' LEU . 1.7 mt -71.59 -48.96 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.38 111.311 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -50.45 -38.52 44.01 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.965 0.506 . . . . 1.85 110.982 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 53.2 t60 -76.64 -33.39 58.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.744 -0.662 . . . . 0.85 110.565 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.954 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.13 -50.38 9.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.033 -0.53 . . . . 0.48 112.342 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 11.8 ptmm? -59.87 -21.02 60.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.704 -0.68 . . . . 2.56 112.677 -167.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.48 10.99 30.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.707 0.632 . . . . 0.76 112.707 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -100.65 -0.12 38.09 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.035 -0.728 . . . . 0.9 109.035 174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.2 t30 75.98 41.54 0.23 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.685 1.231 . . . . 2.06 108.71 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.736 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -124.13 142.67 40.47 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 113.289 -1.778 . . . . 1.08 110.54 -174.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 19.4 Cg_exo -68.01 154.86 71.64 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.657 2.238 . . . . 0.51 113.981 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.709 HD13 HG12 ' A' ' 100' ' ' ILE . 84.7 mt -127.33 146.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.976 -1.465 . . . . 0.96 109.209 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 83' ' ' ILE . 3.4 mp -129.8 103.14 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.71 111.242 -167.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -67.42 133.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.137 -0.938 . . . . 0.23 110.237 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.34 87.69 2.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.826 -1.176 . . . . 0.25 107.826 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.746 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 18.5 mm -67.43 95.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.861 -1.063 . . . . 0.85 110.51 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.03 163.46 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.968 -0.753 . . . . 0.69 108.968 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 63.72 20.09 12.05 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.159 0.504 . . . . 2.61 111.162 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.761 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 13.1 tpp -88.57 -6.09 57.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.833 0.825 . . . . 1.37 109.9 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' HB3' ' CB ' ' A' ' 151' ' ' SER . 2.5 p-10 -61.79 -4.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.001 -0.999 . . . . 2.45 112.581 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.745 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 21.0 ptmt -83.3 -172.18 0.34 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.415 -1.328 . . . . 3.7 107.415 167.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 36.8 Cg_exo -52.17 -56.42 2.93 Favored 'Trans proline' 0 C--N 1.348 0.514 0 CA-C-N 120.793 1.319 . . . . 2.67 111.366 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 11.1 pt-20 159.99 128.93 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.532 1.133 . . . . 4.03 108.205 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.64 -88.27 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.006 -0.543 . . . . 1.47 109.813 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.516 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 1.1 p30 -156.49 75.46 4.61 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.554 -0.294 . . . . 1.84 111.33 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.9 Cg_exo -37.57 -67.1 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.095 3.197 . . . . 0.7 113.853 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -48.89 -49.78 38.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.882 0.473 . . . . 2.0 112.089 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 2.4 tmt_? -54.73 -56.93 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.098 0.475 . . . . 2.99 109.997 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.765 HG13 ' HA2' ' A' ' 91' ' ' GLY . 93.2 t -55.71 -41.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 0.4 111.016 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 89.4 mtp -66.02 -33.09 75.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 0.3 110.71 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 70.3 mt-30 -73.35 -24.55 60.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.425 . . . . 1.28 111.098 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.8 mm-40 -64.55 -37.66 88.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.715 -0.846 . . . . 2.02 108.715 172.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -70.28 -46.16 64.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.466 -0.788 . . . . 1.06 109.703 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.926 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -75.16 -1.1 21.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.001 177.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.1 tt0 -78.57 -28.97 46.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 2.18 107.539 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.665 ' CE2' HG11 ' A' ' 92' ' ' VAL . 61.5 m-85 -91.99 16.08 11.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.644 -0.707 . . . . 0.74 109.589 168.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.4 t30 71.01 22.16 4.65 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.048 -1.433 . . . . 1.94 110.188 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 100' ' ' ILE . 7.0 mp -91.65 72.55 5.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.315 -0.857 . . . . 1.68 109.693 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -64.87 119.95 62.37 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 114.482 -1.236 . . . . 0.61 110.822 178.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.869 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 80.9 Cg_exo -47.05 160.69 0.25 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.634 2.889 . . . . 0.3 113.57 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.29 -21.25 53.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.768 -1.105 . . . . 2.01 109.682 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.809 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -58.8 -41.11 85.99 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.302 -0.999 . . . . 1.14 108.302 168.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.926 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.6 m0 -95.85 -20.44 18.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.644 -1.162 . . . . 0.45 110.896 -170.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.98 31.6 4.7 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.315 -0.945 . . . . 0.45 112.697 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.15 -99.15 1.96 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.5 112.64 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.06 27.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.68 0.753 . . . . 1.3 110.845 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m -121.39 112.17 18.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 0.32 111.752 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.57 109.45 15.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.137 -0.938 . . . . 1.23 110.343 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.869 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -91.21 111.55 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.101 0.476 . . . . 0.38 111.192 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.3 m -105.9 100.0 9.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.036 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.761 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 19.2 pttp -81.37 91.96 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.726 -0.842 . . . . 2.44 108.726 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.859 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 1.1 pt? -119.31 -171.39 2.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.137 0.97 . . . . 1.27 112.851 -166.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 33.7 t -157.96 129.56 6.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.877 -1.511 . . . . 1.79 109.638 170.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -88.73 -25.64 22.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.815 -0.629 . . . . 0.87 110.809 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.3 ptmm? -76.68 -53.5 7.92 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.403 0.62 . . . . 3.03 110.061 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 153' ' ' LYS . 81.2 p -72.49 -14.97 61.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.868 -1.06 . . . . 1.2 110.504 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 69.59 17.0 7.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.182 -0.917 . . . . 2.27 111.107 175.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.29 -62.07 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.994 0.902 . . . . 2.64 109.993 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -75.01 -16.61 80.49 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.686 -1.143 . . . . 0.62 113.514 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 158' ' ' LEU . 1.8 tm? -56.4 -47.37 79.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.909 -0.774 . . . . 1.55 108.909 174.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.614 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -58.02 -53.4 58.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.362 -0.836 . . . . 2.5 110.304 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -60.99 -22.77 64.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.723 -0.672 . . . . 0.73 111.749 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 1.2 tm? -69.77 -53.2 19.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.382 -0.372 . . . . 0.91 110.032 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -65.84 -30.52 71.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.654 0.264 . . . . 1.06 110.321 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.5 mm-40 -58.28 -38.97 78.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.035 -0.529 . . . . 2.49 110.723 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -32.56 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.2 -0.454 . . . . 0.87 111.096 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 72.8 mt -59.77 -52.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.511 -0.313 . . . . 0.64 110.929 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -68.96 -30.83 69.35 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.89 0.376 . . . . 1.81 111.372 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 166' ' ' LEU . 65.3 tp -55.51 -31.09 61.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.44 -0.8 . . . . 1.42 110.148 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 41.0 t -73.03 -44.48 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.949 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.2 m -63.2 -15.39 56.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.366 0.603 . . . . 1.54 110.786 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -86.8 -62.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.806 -0.634 . . . . 2.79 109.827 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -71.41 -30.82 66.54 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.784 0.661 . . . . 1.82 112.784 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 29.5 mm-40 -65.1 -22.05 66.89 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.844 -0.342 . . . . 3.45 111.29 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -73.49 -18.98 61.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.364 . . . . 3.36 110.607 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 174' ' ' LEU . 3.9 mm? -103.63 -78.01 0.56 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 4.14 111.204 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.9 5.2 0.19 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.207 0.447 . . . . 6.31 112.207 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 69.14 -112.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.605 0.566 . . . . 4.57 111.405 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.648 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 21.4 t-20 -88.87 -56.79 0.28 Allowed Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.961 0.356 . . . . 6.38 111.961 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 5.2 Cg_exo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.658 2.239 . . . . 7.47 112.559 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 111.752 -0.539 . . . . 16.35 111.752 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -106.98 136.62 46.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 14.69 110.494 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -101.35 14.6 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.37 0.605 . . . . 14.68 109.864 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.1 ttm -74.7 95.08 2.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.453 -0.573 . . . . 12.73 109.453 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.16 110.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 10.18 111.041 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -95.74 166.15 11.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 9.14 110.317 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 58.45 75.7 0.51 Allowed Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 123.752 0.658 . . . . 8.35 111.948 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 63.0 Cg_endo -74.32 149.28 39.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.376 2.051 . . . . 4.6 111.371 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 41.7 Cg_exo -57.89 91.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.086 2.524 . . . . 4.29 112.732 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 60' ' ' LEU . 13.1 m -86.02 119.3 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 2.58 110.695 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 81' ' ' ILE . 54.7 t -117.11 118.62 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.586 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.504 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 11.8 m -86.24 130.7 34.43 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.024 -0.535 . . . . 0.66 110.943 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -95.9 122.98 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.92 0.391 . . . . 1.03 110.376 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.404 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 50.0 mtt -138.24 175.69 9.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.565 0.697 . . . . 1.04 112.214 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.51 -100.27 0.35 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.838 -1.305 . . . . 1.55 109.838 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 16.0 t60 -160.1 132.68 6.47 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.053 -1.091 . . . . 0.66 108.053 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.793 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 14.0 p -62.17 -29.67 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.501 -0.772 . . . . 1.62 112.704 -167.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.92 -27.18 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.288 0.477 . . . . 1.78 112.288 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -56.54 -52.24 65.53 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.287 0.565 . . . . 0.65 111.098 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 177.14 33.45 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.4 -0.818 . . . . 0.93 111.096 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.793 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 12.6 tmtt? -88.43 -56.19 3.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.974 0.416 . . . . 2.11 110.277 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -68.19 -30.76 69.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.489 . . . . 1.8 110.062 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -77.06 -27.62 54.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.001 -0.545 . . . . 1.77 110.571 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 8.5 tt -65.98 -50.49 64.14 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.466 -0.568 . . . . 1.78 109.466 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 28' ' ' ILE . 4.9 tt -57.7 -40.51 79.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.762 -0.654 . . . . 1.96 110.195 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 24.7 t70 -70.73 -50.0 40.84 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.813 -0.355 . . . . 1.38 111.553 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.54 75.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.17 0.509 . . . . 0.91 111.142 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 25' ' ' LEU . 7.2 tt -70.25 -33.93 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.355 -0.838 . . . . 1.56 110.856 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.819 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 60.9 mtm180 -71.21 -33.97 70.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.474 0.654 . . . . 3.56 109.546 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -82.12 14.94 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.35 -0.841 . . . . 2.88 110.169 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 34.5 t -123.76 -59.69 1.5 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 1.76 109.998 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -110.58 -177.13 3.15 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.546 0.689 . . . . 5.71 111.284 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.26 137.97 52.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.731 -1.122 . . . . 2.99 111.169 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m 153.57 -26.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 125.605 1.816 . . . . 3.93 110.073 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.819 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -61.64 146.87 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 4.2 112.311 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -129.16 -74.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.576 -0.738 . . . . 5.38 110.319 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.703 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 2.9 pt-20 -56.65 -68.13 0.25 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.943 -0.572 . . . . 5.79 110.02 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . 42.54 81.12 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.988 0.805 . . . . 4.24 113.092 168.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 79.66 0.14 Allowed Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.297 -0.721 . . . . 4.95 111.297 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' H ' HD13 ' A' ' 25' ' ' LEU . . . -77.21 40.19 1.7 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.337 -0.459 . . . . 6.66 113.457 -174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.44 -30.53 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.478 -0.564 . . . . 9.17 109.478 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 m -77.44 118.67 20.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 7.36 110.661 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -79.9 57.36 2.57 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.888 0.852 . . . . 8.83 110.841 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -145.38 -49.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.933 -1.03 . . . . 6.76 108.269 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.836 HG13 ' H ' ' A' ' 46' ' ' GLY . 9.9 tp -177.05 -176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.543 -1.28 . . . . 5.19 107.543 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.836 ' H ' HG13 ' A' ' 45' ' ' ILE . . . 142.85 44.87 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.759 -0.734 . . . . 2.97 111.661 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.703 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -99.64 -169.56 1.77 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.282 -0.636 . . . . 1.71 109.282 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.78 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 10.6 p90 -170.24 166.24 8.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.131 0.491 . . . . 2.54 111.358 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -116.14 154.75 29.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.108 -1.071 . . . . 1.96 108.108 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.26 131.23 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.93 111.785 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 54' ' ' ASP . 8.3 m -81.61 94.92 7.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.674 0.75 . . . . 2.06 109.2 171.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 54' ' ' ASP . 5.8 p -127.92 113.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.461 -0.94 . . . . 4.12 108.461 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t30 70.97 -39.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.049 -0.978 . . . . 4.43 110.198 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 51' ' ' THR . 36.5 t70 -147.13 -86.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.53 -0.759 . . . . 3.62 112.874 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 36.4 ttpt 158.51 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 7.44 110.009 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 62.4 mttp -105.76 -24.13 12.57 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.042 0.756 . . . . 5.43 113.042 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.4 mt -74.33 109.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.266 -0.574 . . . . 1.14 110.948 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -98.89 112.1 24.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.573 -0.739 . . . . 1.28 109.492 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.572 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 41.9 m-85 -85.77 120.45 27.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.84 111.477 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 3.5 mm? -89.75 102.48 15.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.105 -0.702 . . . . 3.0 109.105 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 14.9 t70 -80.9 149.1 29.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.775 -0.648 . . . . 6.48 111.201 -175.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.867 HG22 ' HB3' ' A' ' 67' ' ' ALA . 2.0 p -103.48 93.33 4.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 5.57 110.603 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 61' ' ' ASP . 83.3 Cg_endo -88.32 55.57 2.4 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.787 2.325 . . . . 5.77 112.774 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.56 -127.06 1.47 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.606 -0.807 . . . . 5.54 112.49 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -117.66 -47.51 2.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.685 0.279 . . . . 8.09 110.861 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -117.19 130.81 56.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.005 0.431 . . . . 6.36 110.451 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.867 ' HB3' HG22 ' A' ' 62' ' ' THR . . . -170.68 179.07 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 3.51 109.748 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' HE1' ' HA ' ' A' ' 103' ' ' ALA . 24.2 t80 -166.83 179.56 5.25 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.665 -0.865 . . . . 2.61 108.665 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 m -49.32 -46.48 46.78 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.855 0.462 . . . . 4.74 111.936 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 m -151.01 97.62 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 5.89 111.106 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.8 mmt -86.15 88.42 7.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 5.64 109.946 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -155.34 -59.9 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.426 -0.352 . . . . 9.71 111.19 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.63 -168.52 1.82 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 7.52 111.547 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 74' ' ' ARG . 1.7 tpm_? -51.31 -49.28 61.63 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.937 0.773 . . . . 10.42 111.45 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.26 108.18 0.67 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.914 -0.585 . . . . 6.75 111.905 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.14 -14.94 19.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.25 0.548 . . . . 6.69 110.482 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -82.23 110.28 17.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.507 -0.77 . . . . 7.72 110.315 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.5 m -87.08 -32.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.99 -0.55 . . . . 4.38 110.721 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.472 ' HB ' ' OE2' ' A' ' 172' ' ' GLU . 23.5 p -146.38 123.81 11.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.991 -0.549 . . . . 4.18 110.242 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.46 -172.08 3.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.45 -0.574 . . . . 3.12 109.45 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 11' ' ' VAL . 46.1 mm -123.26 116.65 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 111.263 0.098 . . . . 0.74 111.263 -172.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.9 t -97.41 106.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.652 0.263 . . . . 1.19 111.562 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.608 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 12.2 mm -89.72 106.72 17.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.651 -0.5 . . . . 1.32 109.651 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.627 HD22 HD11 ' A' ' 100' ' ' ILE . 8.4 tp -92.9 126.06 37.8 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.075 -0.511 . . . . 1.33 110.619 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.68 140.56 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.009 -0.432 . . . . 1.2 112.043 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.0 m -135.03 -177.34 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.94 -0.763 . . . . 1.12 108.94 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 126.66 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.875 0.694 . . . . 0.75 112.875 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 121' ' ' GLU . . . 42.92 -104.41 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.302 1.223 . . . . 1.18 114.302 168.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -112.15 -8.65 13.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.813 -173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 2.8 t70 -62.83 -38.66 91.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.208 -0.664 . . . . 1.09 109.208 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . 78.98 -147.14 30.21 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.891 -1.05 . . . . 0.52 112.408 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.595 HG12 HG23 ' A' ' 97' ' ' VAL . 79.1 t -88.21 100.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 114.995 -0.602 . . . . 1.08 109.938 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 10.3 mtp -70.95 167.75 26.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 1.32 111.411 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 83.0 Cg_exo -47.37 -41.48 28.59 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.507 2.138 . . . . 0.61 112.435 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.668 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 4.6 mm-40 -65.74 -42.11 91.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.024 0.44 . . . . 1.47 110.187 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.624 HG22 HD21 ' A' ' 84' ' ' LEU . 3.5 m -61.06 -30.51 70.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.46 110.11 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 92' ' ' VAL . 44.3 t -78.07 -52.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.048 -0.978 . . . . 1.05 111.594 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.0 pt-20 -65.04 -32.25 73.88 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 1.62 111.681 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -66.29 -42.73 87.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.547 0.689 . . . . 0.34 109.404 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.977 HG12 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -68.19 -43.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.98 -1.009 . . . . 0.38 110.81 176.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.5 -27.25 62.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.909 -0.587 . . . . 1.85 110.743 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -85.57 -36.13 20.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.85 110.413 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -83.18 -49.54 9.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.554 0.576 . . . . 0.48 112.554 -172.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HD3' HG23 ' A' ' 100' ' ' ILE . 41.3 pttt -61.99 -16.88 54.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.669 0.618 . . . . 2.56 112.669 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.87 10.54 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.371 0.508 . . . . 0.76 112.371 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.666 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -99.57 4.09 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 0.9 109.768 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 86.13 6.11 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.461 1.124 . . . . 2.06 108.794 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -93.11 142.79 25.8 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.169 -1.832 . . . . 1.08 111.585 -174.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.17 160.15 50.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.945 2.43 . . . . 0.51 113.447 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.977 HD13 HG12 ' A' ' 100' ' ' ILE . 91.9 mt -127.54 150.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.163 -0.926 . . . . 0.96 110.394 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 mp -121.79 154.75 26.15 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.687 -0.857 . . . . 0.71 108.687 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -118.25 140.86 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 120.667 0.27 . . . . 0.23 110.494 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.42 89.04 3.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.207 -1.034 . . . . 0.25 108.207 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 86' ' ' VAL . 33.0 mt -73.54 94.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.587 -1.188 . . . . 0.85 111.075 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.76 156.55 24.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.537 0.208 . . . . 0.69 110.977 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt 59.2 33.86 22.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.863 0.84 . . . . 2.61 109.989 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.974 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 2.4 tpp -88.49 -22.46 23.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.015 -0.993 . . . . 1.37 110.98 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -53.71 -30.87 45.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.561 0.696 . . . . 2.45 109.825 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -97.0 149.74 36.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 114.916 -1.038 . . . . 3.7 109.85 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.2 -3.04 0.44 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.463 3.442 . . . . 2.67 114.545 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . 64.3 mm-40 -61.18 -32.91 72.65 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.179 0.592 . . . . 4.03 110.471 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.417 ' HA ' ' C ' ' A' ' 88' ' ' ALA . . . -81.65 133.74 35.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.902 -0.59 . . . . 1.47 112.132 -174.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.475 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 28.4 t-20 -131.02 93.49 30.6 Favored Pre-proline 0 CA--C 1.511 -0.549 0 CA-C-O 122.289 1.043 . . . . 1.84 109.996 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.599 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -27.85 -75.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 1 C-N-CA 126.124 4.549 . . . . 0.7 115.46 169.407 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -43.7 -53.4 5.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.17 0.588 . . . . 2.0 112.293 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 11.8 tpt180 -53.07 -65.27 0.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.229 0.538 . . . . 2.99 110.185 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.475 HG22 ' HA2' ' A' ' 91' ' ' GLY . 47.1 t -55.27 -42.36 65.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.451 -1.249 . . . . 0.4 111.41 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.822 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 83.1 mtp -73.1 -30.83 63.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.141 -0.936 . . . . 0.3 111.405 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.08 -27.77 32.73 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.475 -0.49 . . . . 1.28 111.123 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 9.6 mt-10 -61.78 -40.09 93.96 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.016 -1.105 . . . . 2.02 108.016 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -71.45 -46.82 58.98 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.459 -0.791 . . . . 1.06 111.267 -172.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.939 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.2 ppp? -67.36 -8.64 34.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.49 -0.777 . . . . 0.35 109.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -78.1 -28.17 48.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.667 -0.864 . . . . 2.18 108.667 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -82.07 -1.95 50.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.816 0.817 . . . . 0.74 108.803 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.1 t30 76.78 42.95 0.14 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 113.101 -1.863 . . . . 1.94 111.203 163.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -123.05 86.75 2.63 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.942 -1.873 . . . . 1.68 105.942 167.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.43 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.44 131.91 94.24 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.789 -1.55 . . . . 0.61 111.313 -171.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.715 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 88.2 Cg_exo -46.87 152.64 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.178 2.585 . . . . 0.3 113.296 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.97 -30.57 62.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.078 -1.419 . . . . 2.01 108.469 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.837 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -51.34 -45.28 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.41 -1.268 . . . . 1.14 109.485 170.066 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.939 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.0 m0 -89.53 -21.98 22.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.366 -1.288 . . . . 0.45 110.598 -170.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.31 18.5 4.95 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.049 -1.072 . . . . 0.45 112.678 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.43 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.09 -115.54 3.08 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.701 -0.762 . . . . 0.5 112.499 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.07 30.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.886 0.374 . . . . 1.3 111.485 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 131' ' ' LEU . 24.9 m -129.22 108.99 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.857 -0.737 . . . . 0.32 112.175 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 164' ' ' MET . 2.2 mp -80.15 110.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.77 . . . . 1.23 110.698 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.822 ' CE2' ' HG2' ' A' ' 128' ' ' MET . 19.4 m-85 -88.09 115.54 25.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.19 0.519 . . . . 0.38 111.311 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 63.9 m -104.03 117.13 33.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.054 -0.721 . . . . 1.1 109.054 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.974 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 14.5 pttp -98.16 85.95 3.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.106 0.955 . . . . 2.44 109.72 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.691 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -110.64 -179.62 3.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.988 -1.005 . . . . 1.27 112.534 -170.278 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 10.1 t -143.46 131.7 21.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.418 -1.265 . . . . 1.79 109.196 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.484 0.659 . . . . 0.87 109.93 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -92.51 -58.92 2.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.371 -0.831 . . . . 3.03 110.038 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 151' ' ' SER . 3.9 m -68.71 -29.67 68.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.654 -1.157 . . . . 1.2 110.644 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 58.88 26.8 15.33 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.507 -1.224 . . . . 2.27 111.414 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -83.4 -45.84 13.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.86 0.838 . . . . 2.64 109.81 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -75.6 -11.65 84.28 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.01 -0.996 . . . . 0.62 112.668 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 158' ' ' LEU . 26.2 mt -64.18 -39.81 94.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 1.55 110.475 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -78.87 -37.5 40.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.38 -0.373 . . . . 2.5 110.089 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 164' ' ' MET . 65.1 t60 -59.45 -37.21 77.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.069 -0.514 . . . . 0.73 109.986 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 165' ' ' ILE . 63.5 tp -60.61 -58.32 8.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.91 110.528 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 165' ' ' ILE . 89.8 mt -54.24 -39.49 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.944 -0.571 . . . . 1.06 111.357 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.45 -41.33 96.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 2.49 111.251 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.75 ' HB3' HG21 ' A' ' 146' ' ' ILE . 29.8 mmt -69.89 -38.54 76.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.87 110.096 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 83' ' ' ILE . 80.7 mt -54.72 -54.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.64 110.242 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.45 -38.09 89.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 1.81 111.104 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.64 -42.22 87.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 1.42 110.312 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 45.3 t -76.39 -35.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.354 -0.385 . . . . 1.17 110.978 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -57.74 -22.41 46.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 1.54 110.063 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -97.23 -38.96 9.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.482 -0.781 . . . . 2.79 110.426 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 23.5 ttp -87.3 5.86 36.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 1.82 112.095 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.472 ' OE2' ' HB ' ' A' ' 79' ' ' THR . 8.4 mm-40 -34.73 -26.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.07 1.137 . . . . 3.45 114.07 173.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.62 -15.62 20.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.349 0.26 . . . . 3.36 111.281 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.7 tp -46.98 -50.68 18.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.117 0.567 . . . . 4.14 111.577 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -118.33 104.71 11.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.783 -0.644 . . . . 6.31 109.284 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.78 32.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.166 0.508 . . . . 4.57 111.834 -172.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.8 p30 -116.57 133.98 22.95 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 6.38 109.293 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 123.138 2.558 . . . . 7.47 112.339 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 111.609 -0.597 . . . . 16.35 111.609 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -81.53 -14.51 56.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.771 0.32 . . . . 14.69 111.743 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.28 37.98 13.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.521 -0.763 . . . . 14.68 111.22 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.4 mtt -68.31 -25.12 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.172 0.51 . . . . 12.73 109.937 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.5 -10.67 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.476 -0.784 . . . . 10.18 110.729 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.94 85.25 3.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.013 -0.736 . . . . 9.14 109.013 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -138.56 58.84 15.1 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.369 -0.378 . . . . 8.35 110.515 -177.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.09 -59.44 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.596 2.197 . . . . 4.6 115.058 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 8' ' ' PRO . 86.1 Cg_endo -92.68 35.86 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.051 1.834 . . . . 4.29 113.758 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' CG2' ' HG3' ' A' ' 7' ' ' ARG . 89.6 t -108.77 104.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.305 0.574 . . . . 2.58 109.837 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.599 HG11 HD11 ' A' ' 83' ' ' ILE . 51.5 t -113.11 137.63 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.569 -172.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.451 ' OG1' HG21 ' A' ' 79' ' ' THR . 82.9 m -104.36 136.3 44.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.66 110.741 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG22 ' HE2' ' A' ' 21' ' ' LYS . 56.3 mt -92.96 124.16 45.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 1.03 110.684 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.684 ' HG3' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -108.69 -175.04 2.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.365 -0.834 . . . . 1.04 110.326 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.949 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 109.15 133.9 6.91 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.27 -0.967 . . . . 1.55 111.834 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 65.8 t60 -44.58 135.88 4.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.564 -0.818 . . . . 0.66 110.887 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.08 -29.33 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.93 -1.032 . . . . 1.62 113.563 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 26.8 t70 -86.23 -21.78 27.25 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.045 0.387 . . . . 1.78 112.045 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.483 ' HB2' HG13 ' A' ' 85' ' ' VAL . 51.5 m170 -61.8 -35.92 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.65 111.14 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 152.55 71.49 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.175 -1.012 . . . . 0.93 113.041 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 28.9 mmtp -90.38 -71.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.029 0.443 . . . . 2.11 110.98 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 t -64.5 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 1.8 110.604 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -73.41 -26.17 60.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.292 -0.413 . . . . 1.77 110.787 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.3 tm? -79.35 -49.77 11.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.363 -0.977 . . . . 1.78 108.363 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.776 -1.102 . . . . 1.96 110.588 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.62 -56.53 9.05 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.174 -0.329 . . . . 1.38 111.794 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.56 92.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.316 -0.402 . . . . 0.91 110.849 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.651 HD13 ' OH ' ' A' ' 48' ' ' TYR . 6.7 tt -63.9 -32.91 58.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.029 -0.532 . . . . 1.56 110.128 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.655 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 70.4 mtp180 -70.4 -34.68 72.82 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.306 0.574 . . . . 3.56 110.657 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -77.59 14.48 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 2.88 111.028 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.747 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -88.91 -13.05 39.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.538 -0.912 . . . . 1.76 108.538 175.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 31' ' ' SER . 16.9 ptmt 64.26 -14.84 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.862 1.801 . . . . 5.71 115.862 160.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.98 -27.95 19.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.203 0.446 . . . . 2.99 112.203 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.9 m -167.67 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.891 0.376 . . . . 3.93 111.795 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.655 ' HG3' ' HA ' ' A' ' 29' ' ' ARG . 1.4 pm0 -59.71 145.85 43.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.566 0.95 . . . . 4.2 113.566 -166.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -138.14 -161.04 1.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.998 -1.456 . . . . 5.38 110.594 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.45 -29.45 28.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.8 0.333 . . . . 5.79 111.861 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.784 ' HB1' ' HA ' ' A' ' 45' ' ' ILE . . . -140.89 162.0 36.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.635 -0.257 . . . . 4.24 110.79 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.62 -34.42 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.436 -0.888 . . . . 4.95 112.995 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.519 ' HA3' ' H ' ' A' ' 48' ' ' TYR . . . -70.68 62.58 0.89 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.281 0.472 . . . . 6.66 114.281 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.501 HG12 ' HA3' ' A' ' 46' ' ' GLY . 24.2 mm -148.7 -54.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.941 -1.133 . . . . 9.17 107.941 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.816 HG23 ' H ' ' A' ' 43' ' ' GLN . 1.3 t -145.53 -82.57 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.723 -1.126 . . . . 7.36 109.681 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.816 ' H ' HG23 ' A' ' 42' ' ' THR . 12.8 pt20 -157.75 31.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 8.83 109.821 172.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -120.58 -94.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.371 -0.831 . . . . 6.76 110.917 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.784 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 2.6 pp -126.58 172.07 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 5.19 110.223 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA3' HG12 ' A' ' 41' ' ' ILE . . . 141.5 -85.95 0.2 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.311 -0.947 . . . . 2.97 112.672 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.92 -100.08 0.25 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.844 0.313 . . . . 1.71 111.844 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.651 ' OH ' HD13 ' A' ' 28' ' ' ILE . 9.6 p90 -169.37 178.97 4.06 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.953 0.406 . . . . 2.54 111.238 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.41 131.93 34.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.828 -0.805 . . . . 1.96 108.828 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 162' ' ' LEU . 61.0 t -97.56 153.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.541 0.686 . . . . 1.93 110.975 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 54' ' ' ASP . 71.2 m -131.32 82.8 2.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.473 -1.24 . . . . 2.06 110.653 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.9 p -116.55 122.01 68.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.473 -1.306 . . . . 4.12 107.473 170.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 74.13 -11.55 0.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.029 0.919 . . . . 4.43 109.694 -172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.75 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.6 t70 79.28 42.22 0.08 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.039 -1.891 . . . . 3.62 110.14 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -81.61 -22.12 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.093 -0.958 . . . . 7.44 109.949 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 55.86 73.37 0.44 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.884 -0.598 . . . . 5.43 111.196 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.1 mt -89.35 123.97 41.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.405 -0.816 . . . . 1.14 110.784 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -84.83 124.75 31.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.768 -0.456 . . . . 1.28 109.768 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -107.69 119.08 38.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.641 0.258 . . . . 0.84 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 69' ' ' THR . 87.0 mt -86.61 119.53 26.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.08 -0.509 . . . . 3.0 110.471 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.26 135.76 35.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.818 -0.628 . . . . 6.48 110.677 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -125.74 77.85 69.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 5.57 111.477 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.19 -22.94 21.71 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.455 2.103 . . . . 5.77 112.132 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.64 62.26 0.28 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.925 -0.655 . . . . 5.54 112.352 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -148.99 137.66 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.543 0.211 . . . . 8.09 110.438 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -114.05 -31.92 6.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 6.36 110.104 178.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.43 60.91 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.85 -0.614 . . . . 3.51 110.474 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.773 ' HD1' ' HD2' ' A' ' 102' ' ' HIS . 5.1 m-85 62.7 -99.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.28 -0.873 . . . . 2.61 110.651 -175.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.42 HG23 HG23 ' A' ' 12' ' ' THR . 3.9 p -133.99 -82.21 0.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.956 0.407 . . . . 4.74 111.065 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -112.24 21.73 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.673 0.749 . . . . 5.89 109.513 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.48 ' HG3' ' HA2' ' A' ' 75' ' ' GLY . 55.9 ttm -79.42 68.42 5.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.208 -0.905 . . . . 5.64 110.283 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -90.46 -48.31 7.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 9.71 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.24 -77.08 0.59 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.837 -0.345 . . . . 7.52 111.586 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -96.46 27.67 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.321 0.582 . . . . 10.42 110.86 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.48 ' HA2' ' HG3' ' A' ' 71' ' ' MET . . . 83.78 -55.82 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.895 -0.669 . . . . 6.75 112.801 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 70.01 -60.95 0.47 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.599 0.76 . . . . 6.69 111.973 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -111.41 100.64 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.977 -0.379 . . . . 7.72 109.977 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 50.2 t -66.54 128.18 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 4.38 110.6 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.451 HG21 ' OG1' ' A' ' 12' ' ' THR . 7.0 t -164.42 132.09 3.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.069 -0.514 . . . . 4.18 110.059 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -126.06 25.18 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 3.12 110.882 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' HB ' HG22 ' A' ' 11' ' ' VAL . 36.0 mm -128.22 118.08 47.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.22 -0.446 . . . . 0.74 110.161 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 73.1 t -113.24 112.71 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.022 -0.535 . . . . 1.19 111.46 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.77 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.9 mt -94.96 99.97 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 C-N-CA 120.264 -0.574 . . . . 1.32 110.049 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 100' ' ' ILE . 6.7 tp -87.1 113.14 22.59 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.693 -0.403 . . . . 1.33 110.796 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.949 HG12 ' HA3' ' A' ' 15' ' ' GLY . 8.7 p -81.39 142.41 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 1.2 110.667 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 87' ' ' ALA . 18.2 t -134.68 175.27 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 107.489 -1.3 . . . . 1.12 107.489 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.02 114.7 6.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.623 0.647 . . . . 0.75 112.497 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 40.63 -96.88 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.84 1.052 . . . . 1.18 113.84 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 122' ' ' ALA . 10.9 p-10 -108.11 -3.1 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.891 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 3.8 t70 -71.05 -45.24 64.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.185 0.517 . . . . 1.09 110.423 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.74 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 81.41 -109.8 3.06 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.52 111.84 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 96' ' ' THR . 42.5 t -124.73 109.25 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.053 0.454 . . . . 1.08 111.349 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 65.4 mmm -80.48 168.84 22.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 1.32 110.246 173.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.7 Cg_exo -47.0 -50.07 11.55 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.633 2.222 . . . . 0.61 112.877 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.95 -37.02 73.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.47 111.041 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.59 HG23 HD11 ' A' ' 84' ' ' LEU . 33.7 m -63.39 -25.95 68.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.235 -0.438 . . . . 0.46 111.038 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG23 ' CG1' ' A' ' 92' ' ' VAL . 22.5 t -85.88 -55.54 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 112.177 0.436 . . . . 1.05 112.177 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.2 -21.56 61.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.9 0.381 . . . . 1.62 110.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.684 ' HB1' ' HG3' ' A' ' 14' ' ' MET . . . -82.18 -34.56 28.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 0.34 109.997 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.767 HD11 HD22 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -77.83 -44.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.38 110.41 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -55.1 -37.39 66.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.464 -0.789 . . . . 1.85 111.206 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.773 ' HD2' ' HD1' ' A' ' 68' ' ' PHE . 20.3 t60 -79.5 -25.72 41.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 0.85 110.521 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -86.0 -59.49 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.284 0.476 . . . . 0.48 112.284 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -17.25 63.95 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.286 0.476 . . . . 2.56 112.286 -167.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.22 5.3 17.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.849 0.357 . . . . 0.76 111.891 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.85 8.38 30.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.667 -0.864 . . . . 0.9 108.667 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.8 t30 75.44 30.38 0.83 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.361 -1.29 . . . . 2.06 110.242 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -107.97 146.48 33.56 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.245 -0.889 . . . . 1.08 110.734 178.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 5.7 Cg_exo -76.15 158.16 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.369 2.713 . . . . 0.51 113.311 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 145' ' ' THR . 4.4 mp -124.27 154.57 31.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.084 -0.962 . . . . 0.96 109.583 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.77 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 6.1 mt -118.94 155.83 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 108.353 -0.98 . . . . 0.71 108.353 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -119.77 134.13 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.002 0.429 . . . . 0.23 110.249 174.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.99 88.01 2.86 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.111 -1.07 . . . . 0.25 108.111 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.823 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 13.8 mm -66.85 95.1 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.042 -0.981 . . . . 0.85 110.148 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 55.0 t30 -92.85 169.02 10.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.164 -0.68 . . . . 0.69 109.164 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HD3' ' HB1' ' A' ' 87' ' ' ALA . 55.7 mtpt 58.51 26.37 14.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.688 0.756 . . . . 2.61 110.056 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.551 ' SD ' ' HE2' ' A' ' 149' ' ' LYS . 5.2 tpp -95.97 2.62 53.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.973 -1.012 . . . . 1.37 110.269 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.96 43.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.17 -0.923 . . . . 2.45 111.09 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 58.4 mttm -125.07 -175.33 0.39 Allowed Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.368 -1.715 . . . . 3.7 106.368 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 31.3 Cg_exo -56.16 -51.87 8.5 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 CA-C-N 120.277 1.135 . . . . 2.67 110.353 169.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 6.4 pt-20 157.73 132.98 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 125.373 1.469 . . . . 4.03 107.364 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 89' ' ' ASP . . . -68.61 -72.96 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.67 -0.863 . . . . 1.47 108.67 168.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 11.2 t-20 177.11 81.4 0.12 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.459 -0.791 . . . . 1.84 109.66 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.63 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.3 Cg_exo -38.95 -61.98 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.077 3.185 . . . . 0.7 113.694 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -47.21 -49.68 22.47 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 2.0 tmt_? -53.77 -56.44 17.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.325 0.583 . . . . 2.99 109.58 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.74 HG13 ' HA2' ' A' ' 91' ' ' GLY . 88.3 t -56.78 -41.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.787 -1.097 . . . . 0.4 110.847 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.673 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -67.07 -32.86 74.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.954 -0.567 . . . . 0.3 110.943 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 75.1 mt-30 -75.75 -24.32 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.665 -0.243 . . . . 1.28 110.883 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.6 mm-40 -63.48 -39.92 95.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.598 -0.89 . . . . 2.02 108.598 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.4 mm? -68.42 -46.6 69.45 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.06 110.016 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.827 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -73.44 -5.49 40.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.618 -0.719 . . . . 0.35 110.276 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 43.8 tt0 -76.56 -28.56 56.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.457 -0.942 . . . . 2.18 108.457 171.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.451 ' CE2' HG11 ' A' ' 92' ' ' VAL . 42.7 m-85 -90.49 13.01 16.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.507 0.67 . . . . 0.74 109.309 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.94 37.93 2.15 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.212 -1.358 . . . . 1.94 109.216 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.441 ' N ' ' HA ' ' A' ' 132' ' ' MET . 5.1 mp -105.7 70.97 0.89 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.575 -1.193 . . . . 1.68 109.471 170.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.991 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -67.45 121.02 77.14 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.016 -0.993 . . . . 0.61 109.677 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.844 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.5 Cg_exo -48.64 157.94 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.833 2.355 . . . . 0.3 112.969 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.8 -22.64 42.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.918 -1.037 . . . . 2.01 108.204 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 7.6 mp0 -46.46 -48.56 18.97 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.148 -1.387 . . . . 1.14 109.714 161.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.827 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.9 m0 -96.0 -30.07 13.79 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.533 -1.667 . . . . 0.45 110.896 -166.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.81 22.12 3.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.303 -0.951 . . . . 0.45 112.985 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.991 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.3 -113.91 2.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.445 -0.883 . . . . 0.5 112.725 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.44 32.9 0.51 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.193 0.521 . . . . 1.3 111.356 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 23.3 m -134.91 123.49 23.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.29 -0.564 . . . . 0.32 111.825 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.761 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.2 mp -92.68 109.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 1.23 110.55 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.844 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -86.35 134.77 33.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.173 0.511 . . . . 0.38 111.098 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.4 m -131.44 107.8 9.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.454 -0.794 . . . . 1.1 110.03 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.823 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.9 ptmm? -85.51 86.17 7.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.691 0.758 . . . . 2.44 109.89 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -103.92 -167.23 1.34 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.256 1.027 . . . . 1.27 112.129 -169.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p -161.36 116.08 2.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.802 -1.545 . . . . 1.79 109.318 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.29 -0.84 18.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.178 0.513 . . . . 0.87 111.029 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -83.46 -55.41 4.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.807 0.813 . . . . 3.03 109.681 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.5 p -98.85 -20.64 16.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.548 -1.206 . . . . 1.2 111.395 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 158' ' ' LEU . 9.7 mtpm? 72.75 18.1 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 2.27 112.132 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -54.49 -70.51 0.1 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.826 0.822 . . . . 2.64 110.729 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -75.64 -7.48 83.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.128 -0.942 . . . . 0.62 112.945 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -72.28 -51.18 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.634 -0.506 . . . . 1.55 109.634 -178.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.98 -30.61 70.78 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.447 -0.575 . . . . 2.5 109.447 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.594 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 84.9 t60 -66.49 -25.76 66.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.42 -0.809 . . . . 0.73 110.888 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 158' ' ' LEU . 56.0 tp -67.17 -47.57 70.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.461 . . . . 0.91 110.014 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.698 HD13 HG11 ' A' ' 50' ' ' VAL . 32.8 mt -58.64 -38.78 78.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.461 -0.79 . . . . 1.06 111.277 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 13.5 pt-20 -71.8 -32.35 67.51 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.127 -0.323 . . . . 2.49 110.127 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.761 ' HB3' HG21 ' A' ' 146' ' ' ILE . 25.9 mmt -69.85 -38.24 76.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.311 0.577 . . . . 0.87 109.897 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 162' ' ' LEU . 63.3 mt -56.3 -53.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.073 -0.967 . . . . 0.64 111.136 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.5 pp -71.85 -34.29 69.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 121.041 -0.264 . . . . 1.81 111.491 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 166' ' ' LEU . 14.0 tp -53.06 -31.62 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.97 -0.559 . . . . 1.42 110.73 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.52 -37.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.033 -0.53 . . . . 1.17 110.281 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.4 m -65.29 -32.38 74.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.843 -0.617 . . . . 1.54 110.288 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -86.02 -9.16 57.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 2.79 110.605 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.806 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 35.0 ttm -88.79 -63.23 1.33 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 1.82 111.433 -177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -38.45 -62.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.242 1.201 . . . . 3.45 114.242 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.48 2.14 54.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.613 0.597 . . . . 3.36 112.613 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 4.3 mm? -103.39 -62.8 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.936 -0.394 . . . . 4.14 109.936 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 20.4 ttpp 166.15 -64.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.05 -1.093 . . . . 6.31 108.05 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.806 ' HA ' ' HG3' ' A' ' 171' ' ' MET . . . -160.53 -168.64 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.054 -1.43 . . . . 4.57 107.988 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -157.3 91.47 2.37 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 120.686 -0.406 . . . . 6.38 110.22 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.564 2.843 . . . . 7.47 111.725 177.526 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.92 -0.472 . . . . 16.35 111.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 t -89.9 -3.33 58.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.596 0.198 . . . . 14.69 111.519 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -93.91 16.43 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.347 -0.541 . . . . 14.68 111.888 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.6 ptp -87.05 109.73 19.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.451 -0.574 . . . . 12.73 109.451 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 27.6 m -87.35 134.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.998 -0.547 . . . . 10.18 111.992 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.44 147.09 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.003 -1.11 . . . . 9.14 108.003 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -100.01 131.07 24.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.725 0.298 . . . . 8.35 111.3 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HG2' HG11 ' A' ' 78' ' ' VAL . 61.3 Cg_endo -76.46 111.05 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.779 2.319 . . . . 4.6 111.836 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -95.1 -56.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.371 2.714 . . . . 4.29 113.372 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.586 ' HB ' ' H ' ' A' ' 58' ' ' THR . 93.9 t -134.1 -59.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.473 . . . . 2.58 109.724 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.081 HG12 ' HB ' ' A' ' 81' ' ' ILE . 13.7 m -125.29 150.96 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 120.843 0.354 . . . . 1.0 110.755 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.678 HG23 HD21 ' A' ' 60' ' ' LEU . 51.0 m -129.64 134.57 47.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.239 -0.437 . . . . 0.66 111.102 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.719 HD13 HG13 ' A' ' 83' ' ' ILE . 35.7 mm -81.07 129.7 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 1.03 111.062 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.54 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 14.4 mmt -138.29 157.12 46.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.684 0.394 . . . . 1.04 111.435 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.66 -110.55 0.46 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.116 -0.793 . . . . 1.55 111.116 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -156.85 137.61 13.31 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.75 -0.725 . . . . 0.66 109.594 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.64 -47.47 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.335 0.865 . . . . 1.62 113.335 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.55 -27.54 68.51 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.504 0.557 . . . . 1.78 112.504 -170.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -63.35 -21.27 66.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.281 0.562 . . . . 0.65 110.649 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.53 42.46 1.86 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.661 -0.699 . . . . 0.93 112.465 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -82.02 -22.12 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 2.11 110.215 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -39.88 23.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.174 -1.047 . . . . 1.8 108.174 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 m -62.57 -33.6 75.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.622 -1.172 . . . . 1.77 110.512 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.596 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 59.7 tp -57.39 -56.07 26.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 1.78 110.524 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.683 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.6 tt -63.78 -36.81 85.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.072 0.463 . . . . 1.96 109.994 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.18 -53.76 44.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.955 0.407 . . . . 1.38 111.596 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -32.17 72.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.91 111.196 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.654 HD13 ' OH ' ' A' ' 48' ' ' TYR . 3.9 tt -67.78 -33.47 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.84 -0.618 . . . . 1.56 110.43 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 15.5 mtm180 -73.62 -28.03 61.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.454 0.645 . . . . 3.56 110.031 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -84.9 5.18 30.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.626 -0.715 . . . . 2.88 110.148 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 m -115.81 38.49 3.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.703 -1.591 . . . . 1.76 106.703 168.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 20.0 pttm -54.85 150.23 10.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 113.349 -1.75 . . . . 5.71 113.567 -166.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.0 -27.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.285 -1.325 . . . . 2.99 110.296 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.8 m -159.93 -21.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.205 0.817 . . . . 3.93 113.205 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.5 pm0 -50.12 151.82 1.89 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.509 0.929 . . . . 4.2 113.509 -174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.717 ' HG3' ' HG3' ' A' ' 37' ' ' GLU . 10.9 pt20 -124.92 -28.87 3.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.648 -1.16 . . . . 5.38 111.003 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.717 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 47.9 mt-10 -117.93 -166.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 5.79 110.869 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.67 89.12 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.896 -0.593 . . . . 4.24 110.732 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -68.6 144.83 42.84 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.812 -0.708 . . . . 4.95 112.196 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.34 -115.12 0.62 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.758 -0.734 . . . . 6.66 112.438 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 pt -82.11 -26.81 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 9.17 111.601 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 45' ' ' ILE . 1.9 p -89.53 91.64 8.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.338 -0.392 . . . . 7.36 110.968 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -77.4 63.03 2.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.907 0.86 . . . . 8.83 111.169 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -132.98 19.45 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.138 -0.937 . . . . 6.76 108.99 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 47' ' ' ALA . 1.8 pp -126.47 178.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.97 -1.014 . . . . 5.19 111.583 -171.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.58 31.08 7.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.07 -1.212 . . . . 2.97 110.07 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.694 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 50.63 -93.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.76 0.824 . . . . 1.71 111.369 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.87 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 23.2 p90 -170.32 156.24 5.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.778 -0.453 . . . . 2.54 109.778 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 58' ' ' THR . 37.0 mt-30 -126.17 118.06 24.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.257 -0.646 . . . . 1.96 109.257 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -92.37 126.45 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.632 -0.713 . . . . 1.93 112.372 -171.357 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 89.7 m -84.09 81.9 8.59 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.12 0.962 . . . . 2.06 109.008 171.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -96.74 108.71 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.557 -1.275 . . . . 4.12 107.557 170.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.55 -53.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.482 1.114 . . . . 4.43 111.851 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -131.12 -24.86 2.3 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.063 1.135 . . . . 3.62 114.063 -172.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 20.5 ttpp 79.01 52.11 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.715 0.769 . . . . 7.44 109.442 -167.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -101.92 4.24 39.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.405 -0.816 . . . . 5.43 110.347 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.519 ' HA ' HG11 ' A' ' 10' ' ' VAL . 19.0 mt -119.19 127.06 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 1.14 110.712 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.949 HG23 ' HG2' ' A' ' 49' ' ' GLN . 36.2 m -119.97 130.85 54.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.162 -0.681 . . . . 1.28 109.162 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HE1' HG21 ' A' ' 50' ' ' VAL . 16.1 m-85 -103.9 89.84 3.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.678 HD21 HG23 ' A' ' 12' ' ' THR . 95.1 mt 62.57 145.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.78 0.675 . . . . 3.0 111.067 -171.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -171.38 113.85 0.38 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.889 0.7 . . . . 6.48 112.889 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 m 70.03 89.94 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.095 -0.957 . . . . 5.57 112.09 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 5' ' ' VAL . 51.1 Cg_exo -55.41 143.74 75.77 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.302 2.668 . . . . 5.77 112.781 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.95 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.787 -0.72 . . . . 5.54 112.23 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -67.28 120.52 13.95 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.743 -0.466 . . . . 8.09 109.743 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 10.4 pt-20 -84.16 175.25 9.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.151 0.5 . . . . 6.36 111.653 -174.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.6 -42.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.426 -0.806 . . . . 3.51 110.651 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.607 ' HD1' ' HD2' ' A' ' 102' ' ' HIS . 51.6 m-85 -109.82 23.0 14.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 2.61 111.805 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 13.9 p -114.76 67.24 0.69 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.26 -0.427 . . . . 4.74 111.028 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 71' ' ' MET . 88.5 m 72.95 -20.24 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.239 0.459 . . . . 5.89 112.239 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 70' ' ' THR . 49.4 mtt 70.98 59.89 0.18 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.387 0.613 . . . . 5.64 110.792 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -76.19 -27.92 57.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 9.71 108.689 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.56 90.66 3.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.665 -1.152 . . . . 7.52 109.022 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.9 93.19 0.18 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.757 -0.656 . . . . 10.42 111.342 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.43 51.6 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.763 -0.653 . . . . 6.75 111.51 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 62.16 7.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.196 0.522 . . . . 6.69 111.245 -176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -81.34 64.98 6.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.996 -0.547 . . . . 7.72 110.532 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.433 HG11 ' HG2' ' A' ' 8' ' ' PRO . 29.9 m -132.02 -178.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.752 -0.658 . . . . 4.38 110.624 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.0 t -143.27 39.4 1.43 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.866 0.841 . . . . 4.18 108.739 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -63.64 148.68 48.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.505 -1.225 . . . . 3.12 112.97 -173.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.081 ' HB ' HG12 ' A' ' 11' ' ' VAL . 28.4 mm -90.18 108.72 19.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 0.74 109.782 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 76.4 t -81.45 108.14 14.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.063 -0.517 . . . . 1.19 111.182 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.747 HD11 ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -85.47 102.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.971 -0.751 . . . . 1.32 108.971 177.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.801 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.1 tm? -94.64 111.77 23.53 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.919 -0.582 . . . . 1.33 109.946 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.524 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 39.5 t -87.56 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.1 -0.5 . . . . 1.2 111.488 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 114' ' ' ILE . 17.9 m -135.29 -167.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.161 -0.927 . . . . 1.12 108.501 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -140.07 143.27 36.25 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.31 -0.556 . . . . 0.75 111.691 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -34.26 -55.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.678 1.236 . . . . 1.18 112.992 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -109.1 13.83 24.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.883 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -110.68 -43.02 3.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.511 -0.476 . . . . 1.09 111.284 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 78.0 -139.8 23.18 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.667 -0.778 . . . . 0.52 111.949 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.733 HG13 ' HB ' ' A' ' 96' ' ' THR . 44.0 t -96.97 114.8 34.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 122.783 0.433 . . . . 1.08 111.311 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.585 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 53.7 mtp -84.12 169.77 15.97 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.434 -0.348 . . . . 1.32 110.199 171.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 93.8 Cg_exo -45.25 -50.79 8.58 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.696 2.264 . . . . 0.61 113.341 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -72.72 -21.9 60.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.387 -0.369 . . . . 1.47 111.356 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.733 ' HB ' HG13 ' A' ' 92' ' ' VAL . 25.5 m -60.38 -28.74 68.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.397 0.617 . . . . 0.46 110.274 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.04 -45.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.958 -0.565 . . . . 1.05 111.726 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.79 -23.19 59.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 1.62 110.961 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -87.96 -30.96 19.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.34 110.018 -177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.863 HG12 HD13 ' A' ' 110' ' ' ILE . 1.7 mt -80.93 -51.21 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.261 -0.881 . . . . 0.38 111.293 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -49.13 -39.28 27.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 1.85 110.78 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.607 ' HD2' ' HD1' ' A' ' 68' ' ' PHE . 12.3 t60 -77.35 -30.2 53.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.85 110.968 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.27 -56.29 4.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.436 . . . . 0.48 111.967 -173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -73.2 -15.72 61.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.304 -0.407 . . . . 2.56 111.899 -168.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.12 -0.48 44.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.76 111.206 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -101.39 14.07 33.1 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.814 -0.81 . . . . 0.9 108.814 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 4.8 m-20 72.19 27.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.705 -1.134 . . . . 2.06 111.759 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.13 152.85 42.75 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-O 121.061 0.458 . . . . 1.08 111.254 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.63 ' O ' HG23 ' A' ' 108' ' ' VAL . 15.4 Cg_exo -72.54 162.82 40.31 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.678 2.919 . . . . 0.51 113.437 171.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.863 HD13 HG12 ' A' ' 100' ' ' ILE . 73.7 mt -132.61 148.17 31.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.672 -0.695 . . . . 0.96 110.586 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.801 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 37.3 mt -113.61 164.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 109.072 -0.714 . . . . 0.71 109.072 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.544 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -123.63 129.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 N-CA-C 109.044 -0.724 . . . . 0.23 109.044 169.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.28 87.25 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.592 -1.262 . . . . 0.25 107.592 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 54.1 mt -69.61 97.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.315 -1.311 . . . . 0.85 109.904 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -96.91 170.82 8.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.69 109.023 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 77.5 tttt 64.14 18.35 11.2 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.365 1.078 . . . . 2.61 109.227 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.622 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.1 tpp -95.09 13.97 23.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 123.063 1.411 . . . . 1.37 109.511 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 151' ' ' SER . 4.3 p-10 -64.14 48.71 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.585 -1.189 . . . . 2.45 112.234 171.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.836 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 94.2 mttt -144.84 -172.82 0.33 Allowed Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 105.669 -1.975 . . . . 3.7 105.669 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.836 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.2 Cg_endo -56.95 -56.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 120.536 1.227 . . . . 2.67 110.98 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 12.7 pt-20 164.04 121.98 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.28 1.032 . . . . 4.03 108.238 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -60.41 3.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.641 -0.708 . . . . 1.47 109.934 173.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -179.57 76.82 0.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.656 -0.702 . . . . 1.84 110.266 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.1 Cg_endo -44.53 -61.3 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.581 2.854 . . . . 0.7 113.325 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.73 -49.63 19.29 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.441 0.697 . . . . 2.0 112.352 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -49.21 -62.13 1.7 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.351 0.596 . . . . 2.99 109.69 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 91' ' ' GLY . 66.8 t -54.2 -47.84 67.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.341 -1.299 . . . . 0.4 110.848 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.654 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 90.4 mtp -59.42 -34.51 72.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.3 111.122 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -76.77 -20.14 56.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.618 -0.264 . . . . 1.28 111.23 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.662 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 4.2 mt-10 -75.98 -30.39 58.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.962 -0.755 . . . . 2.02 108.962 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -72.77 -44.27 61.79 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.831 -0.747 . . . . 1.06 109.311 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.834 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -73.01 -4.54 32.97 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.163 -0.615 . . . . 0.35 109.977 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.662 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 40.9 tt0 -74.41 -32.75 62.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 170.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.672 ' HE2' HG11 ' A' ' 92' ' ' VAL . 44.9 m-85 -89.9 9.39 27.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.911 0.862 . . . . 0.74 109.446 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 72.32 26.59 2.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 113.536 -1.665 . . . . 1.94 110.234 168.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.04 76.69 1.37 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.433 -1.321 . . . . 1.68 107.433 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.942 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -63.24 134.04 95.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 113.436 -1.711 . . . . 0.61 110.279 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -52.29 154.34 11.35 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 122.359 2.039 . . . . 0.3 112.135 173.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 mm-40 -80.28 -19.77 45.96 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.05 -0.977 . . . . 2.01 109.141 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.579 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.1 mp0 -47.2 -52.98 14.28 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.709 1.243 . . . . 1.14 108.958 160.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.834 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -89.73 -23.78 21.71 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.897 -1.956 . . . . 0.45 110.68 -167.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.87 23.02 4.79 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.553 -0.832 . . . . 0.45 112.446 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.942 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.93 -108.15 1.99 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.924 -0.655 . . . . 0.5 113.17 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.25 27.37 0.35 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 1.3 111.314 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 HD12 ' A' ' 136' ' ' LEU . 63.5 m -132.67 133.34 43.43 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.83 1.048 . . . . 0.32 113.83 -174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.797 HG13 HG11 ' A' ' 168' ' ' VAL . 4.1 mp -87.48 108.15 17.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.123 -0.944 . . . . 1.23 110.382 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 11.8 m-85 -94.54 115.77 27.99 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.839 -0.538 . . . . 0.38 111.224 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.9 t -118.63 128.7 54.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.439 -0.578 . . . . 1.1 109.439 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.718 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.6 pttm -103.65 87.06 2.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.609 0.718 . . . . 2.44 109.393 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -105.64 -177.03 3.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.43 -0.804 . . . . 1.27 112.486 -172.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 118' ' ' ASP . 12.1 p -155.87 124.05 5.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.929 -1.032 . . . . 1.79 109.636 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -76.24 -13.19 60.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.141 0.496 . . . . 0.87 110.926 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.483 ' HG3' ' CG ' ' A' ' 118' ' ' ASP . 23.3 mmtp -75.89 -57.64 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.47 -0.786 . . . . 3.03 109.855 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -97.29 -15.71 20.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.148 -0.933 . . . . 1.2 111.376 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HD12 ' A' ' 158' ' ' LEU . 59.4 mttp 64.58 24.82 13.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.23 -0.896 . . . . 2.27 111.888 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.21 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.843 0.83 . . . . 2.64 109.822 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.718 ' HA3' ' HA ' ' A' ' 150' ' ' LEU . . . -71.83 -10.46 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.811 -1.086 . . . . 0.62 113.543 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.816 HD12 ' HG2' ' A' ' 155' ' ' LYS . 25.5 mt -71.89 -43.1 65.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.699 0.75 . . . . 1.55 110.295 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 12.8 t70 -61.66 -42.82 99.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.753 -0.832 . . . . 2.5 108.753 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -66.7 -24.25 66.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.039 -0.982 . . . . 0.73 111.507 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.3 tp -63.31 -56.43 16.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.661 -0.245 . . . . 0.91 110.401 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.8 mt -54.62 -39.84 68.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 1.06 110.585 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.0 mm-40 -63.56 -47.28 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 2.49 110.339 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -67.07 -38.77 86.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.87 110.593 -176.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.14 -49.42 40.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.64 111.845 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 167' ' ' LEU . 1.6 pp -84.67 -35.15 22.8 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.406 0.521 . . . . 1.81 112.406 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.6 tp -63.41 -21.98 66.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.99 0.424 . . . . 1.42 110.937 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 146' ' ' ILE . 48.5 t -85.34 -28.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.515 -0.311 . . . . 1.17 110.447 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.2 m -61.56 -28.16 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.012 -0.736 . . . . 1.54 109.012 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -73.21 -48.82 31.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.15 -0.932 . . . . 2.79 109.39 169.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.463 ' HG3' ' HE3' ' A' ' 175' ' ' LYS . 11.1 tpp -50.33 -48.56 55.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.756 -0.657 . . . . 1.82 111.506 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 42.6 mt-10 -50.58 -62.98 1.27 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.549 0.69 . . . . 3.45 110.941 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.18 -31.76 71.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.741 -1.118 . . . . 3.36 111.642 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.34 -28.05 38.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.802 0.334 . . . . 4.14 111.291 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.463 ' HE3' ' HG3' ' A' ' 171' ' ' MET . 20.8 ttpp -94.51 -73.24 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.485 -0.325 . . . . 6.31 111.62 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 176.58 -174.25 0.11 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.113 -0.328 . . . . 4.57 110.113 -173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 64.41 67.03 0.93 Allowed Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 123.869 0.73 . . . . 6.38 111.421 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.996 2.464 . . . . 7.47 111.552 178.082 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.072 -0.411 . . . . 16.35 112.072 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 t -87.73 102.85 15.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.972 0.415 . . . . 14.69 110.349 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -133.1 13.24 4.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.176 0.512 . . . . 14.68 109.813 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.04 132.43 54.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.588 -0.733 . . . . 12.73 110.259 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 -48.27 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 10.18 110.467 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -72.98 111.71 8.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 9.14 110.579 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' HD2' ' HD2' ' A' ' 8' ' ' PRO . 6.2 tpt180 -110.25 118.52 49.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.11 -0.329 . . . . 8.35 110.11 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 10.4 Cg_endo -53.83 127.21 24.62 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.996 2.464 . . . . 4.6 112.101 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.726 ' HG2' ' HB3' ' A' ' 169' ' ' SER . 31.3 Cg_exo -60.55 118.57 5.45 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.086 2.524 . . . . 4.29 112.709 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HD13 ' A' ' 60' ' ' LEU . 6.2 p -79.0 125.52 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.486 0.66 . . . . 2.58 109.928 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 89.2 t -107.37 114.91 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.051 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.996 -0.547 . . . . 0.66 110.728 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.682 ' HB ' ' HA ' ' A' ' 61' ' ' ASP . 26.4 mt -83.69 121.45 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.056 0.455 . . . . 1.03 111.148 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.448 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 20.8 mmt -115.7 178.99 4.1 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.077 -0.712 . . . . 1.04 109.077 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.931 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 114.67 131.05 5.04 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.852 -1.166 . . . . 1.55 111.411 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -44.88 132.37 6.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.332 0.586 . . . . 0.66 110.198 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -56.35 -30.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.55 0.944 . . . . 1.62 113.55 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.63 -15.8 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.78 111.296 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' HE1' ' H ' ' A' ' 93' ' ' MET . 32.8 m170 -67.25 -43.0 82.99 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.845 -0.428 . . . . 0.65 109.845 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 85' ' ' VAL . . . 147.12 69.79 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.034 -1.079 . . . . 0.93 113.766 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -87.55 -50.11 6.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.453 0.644 . . . . 2.11 109.513 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -64.12 -30.56 71.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.032 -0.986 . . . . 1.8 110.561 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.497 HG21 ' ND2' ' A' ' 115' ' ' ASN . 5.4 t -67.73 -26.64 66.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 1.77 110.64 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.02 -55.82 6.73 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.775 -0.824 . . . . 1.78 108.775 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.653 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 1.9 tt -55.49 -41.69 73.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.945 -0.571 . . . . 1.96 109.78 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.54 -62.5 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.507 0.558 . . . . 1.38 112.507 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -68.27 -38.48 81.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.91 111.843 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.78 -31.04 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.453 . . . . 1.56 110.536 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 37' ' ' GLU . 15.2 mmm180 -64.04 -41.25 97.46 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.223 0.535 . . . . 3.56 110.372 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -76.5 9.3 2.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.38 -0.827 . . . . 2.88 109.818 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.8 m -105.76 12.07 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.876 -0.602 . . . . 1.76 110.342 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 73.73 -37.86 0.39 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.927 1.084 . . . . 5.71 113.927 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.894 HG22 ' H ' ' A' ' 51' ' ' THR . 9.9 p -71.47 27.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 123.696 0.798 . . . . 2.99 113.14 -172.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 48' ' ' TYR . 2.8 p -111.6 120.74 43.1 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 121.56 -0.712 . . . . 3.93 111.817 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.712 ' OE1' ' HG3' ' A' ' 55' ' ' LYS . 7.7 mt-10 -66.51 -58.82 4.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.981 -1.008 . . . . 4.2 112.348 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.575 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 77.1 mt-30 -87.1 136.81 32.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.343 0.592 . . . . 5.38 111.063 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 35.9 mm-40 -85.44 -52.44 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.86 -1.064 . . . . 5.79 113.489 -167.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -100.53 58.76 0.95 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.775 0.321 . . . . 4.24 111.591 -167.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -68.73 101.85 0.83 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.575 -0.821 . . . . 4.95 111.903 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' H ' ' HA2' ' A' ' 46' ' ' GLY . . . -179.79 -144.31 5.88 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.41 -0.9 . . . . 6.66 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.414 ' H ' HG12 ' A' ' 41' ' ' ILE . 20.9 pt -91.25 21.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 112.426 0.528 . . . . 9.17 112.426 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.1 p -91.43 155.9 18.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.62 0.247 . . . . 7.36 111.038 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -91.75 20.21 5.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 8.83 110.386 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -103.13 -62.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.005 -0.739 . . . . 6.76 109.005 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.575 ' CG2' ' HB3' ' A' ' 36' ' ' GLN . 43.6 mm -127.14 166.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.526 -0.916 . . . . 5.19 108.526 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . -160.63 -52.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.492 -0.643 . . . . 2.97 111.492 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -96.81 -169.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.352 -0.61 . . . . 1.71 109.352 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.685 ' HD2' HG22 ' A' ' 34' ' ' THR . 1.1 p90 -163.71 137.91 5.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 2.54 110.761 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.651 ' HG2' HG23 ' A' ' 58' ' ' THR . 47.8 mt-30 -98.98 152.0 20.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.169 -0.469 . . . . 1.96 109.879 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.796 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 95.1 t -107.08 150.31 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.891 0.853 . . . . 1.93 111.945 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.894 ' H ' HG22 ' A' ' 33' ' ' VAL . 85.6 m -96.08 93.15 6.8 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.677 -1.601 . . . . 2.06 112.067 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.2 p -122.99 116.19 47.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.269 -1.012 . . . . 4.12 108.269 169.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.4 t30 71.34 -44.62 0.6 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.032 0.92 . . . . 4.43 109.254 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 52' ' ' VAL . 14.4 t70 -167.35 -57.85 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.931 -1.486 . . . . 3.62 109.029 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.712 ' HG3' ' OE1' ' A' ' 35' ' ' GLU . 5.3 tmmm? -177.75 110.47 0.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.664 -1.153 . . . . 7.44 109.085 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.455 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 35.1 mmtp -132.97 -3.08 3.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 5.43 110.519 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.796 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 42.2 mt -117.84 139.47 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.019 -0.363 . . . . 1.14 110.019 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 49' ' ' GLN . 11.0 m -121.67 113.8 20.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.128 -0.323 . . . . 1.28 110.128 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HD2' HD11 ' A' ' 13' ' ' ILE . 3.7 m-85 -93.76 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.84 110.876 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD13 HG23 ' A' ' 10' ' ' VAL . 9.7 mp -111.06 92.54 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 3.0 110.81 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.682 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 36.7 t70 -75.08 -36.67 61.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.299 0.571 . . . . 6.48 109.464 174.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.1 p -121.12 100.38 45.61 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.205 -0.907 . . . . 5.57 109.817 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.52 -18.2 20.22 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.715 2.277 . . . . 5.77 112.581 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.12 -90.2 0.35 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.12 -0.792 . . . . 5.54 111.12 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -147.69 -28.4 0.35 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.028 0.442 . . . . 8.09 109.96 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.88 125.44 26.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.723 -0.671 . . . . 6.36 109.482 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.09 110.3 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.374 -0.376 . . . . 3.51 110.946 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' HZ ' HG11 ' A' ' 108' ' ' VAL . 15.0 t80 64.93 58.75 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.637 -0.71 . . . . 2.61 111.202 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.4 p 55.24 -165.33 0.11 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.714 0.806 . . . . 4.74 112.518 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.3 m -120.32 38.03 4.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.442 -0.799 . . . . 5.89 109.164 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 mmt 60.52 46.78 9.21 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.636 -0.711 . . . . 5.64 110.485 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 72' ' ' ARG . 6.3 mmt180 65.69 -76.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.961 -1.018 . . . . 9.71 111.885 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -9.74 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.572 0.225 . . . . 7.52 111.603 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -168.79 -58.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.436 . . . . 10.42 110.232 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.83 71.45 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.704 -0.68 . . . . 6.75 111.766 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.29 -84.68 0.51 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.69 110.561 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 77' ' ' GLN . 14.5 mm-40 -91.93 133.79 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.812 -0.44 . . . . 7.72 109.812 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.463 HG22 ' H ' ' A' ' 80' ' ' ASP . 12.5 p -113.07 146.23 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.638 -0.505 . . . . 4.38 109.638 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -152.31 31.43 0.53 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.079 -1.082 . . . . 4.18 108.079 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 78' ' ' VAL . 4.8 m-20 -102.7 96.04 6.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.095 -1.411 . . . . 3.12 109.513 -174.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 45.8 mm -68.01 126.57 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.798 -1.092 . . . . 0.74 111.794 -170.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG21 ' HB1' ' A' ' 103' ' ' ALA . 89.7 t -100.92 98.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.79 -0.364 . . . . 1.19 111.274 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.681 HG13 ' HA ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -87.11 104.38 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.093 -0.643 . . . . 1.32 110.472 174.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.599 HD22 ' CD1' ' A' ' 100' ' ' ILE . 9.7 tp -91.46 114.08 26.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.884 -0.598 . . . . 1.33 110.33 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.931 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.6 p -85.7 142.72 12.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.882 -0.727 . . . . 1.2 110.844 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -137.3 -170.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.36 -0.978 . . . . 1.12 108.36 175.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.24 139.68 30.33 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.238 -0.585 . . . . 0.75 111.681 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -78.91 58.23 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.035 -0.984 . . . . 1.18 111.207 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -164.97 -33.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.452 -1.249 . . . . 2.01 109.301 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.51 -63.26 1.18 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.522 0.677 . . . . 1.09 110.954 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.77 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 117.07 -106.36 1.42 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.996 -1.002 . . . . 0.52 110.887 -172.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.98 HG13 ' HB ' ' A' ' 96' ' ' THR . 38.5 t -129.67 114.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 120.952 0.406 . . . . 1.08 110.572 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.711 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 60.3 mtp -91.96 172.81 5.92 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 1.32 109.741 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.711 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 58.0 Cg_exo -39.32 -59.76 0.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.269 2.646 . . . . 0.61 113.857 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -54.27 -35.01 62.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.47 111.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.98 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.3 m -64.26 -34.04 77.19 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.762 0.282 . . . . 0.46 111.762 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.621 HG12 ' CG1' ' A' ' 92' ' ' VAL . 1.4 m -85.7 -38.86 13.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 121.967 -0.458 . . . . 1.05 111.328 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.65 -30.06 70.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.165 0.507 . . . . 1.62 110.916 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.31 -17.6 59.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.647 -0.706 . . . . 0.34 110.491 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -93.41 -45.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.38 110.966 -176.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -53.41 -38.54 63.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.566 0.698 . . . . 1.85 110.086 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -75.2 -28.66 60.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.191 -0.913 . . . . 0.85 110.943 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.907 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.74 -53.88 3.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.889 0.7 . . . . 0.48 112.889 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -67.7 -16.21 64.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.225 0.454 . . . . 2.56 112.225 -166.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.65 10.7 4.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.309 0.485 . . . . 0.76 112.309 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -107.96 4.21 24.99 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.08 -0.711 . . . . 0.9 109.08 173.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 21.0 t-20 80.46 19.31 0.55 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 123.204 1.478 . . . . 2.06 108.858 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.6 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -96.06 142.47 24.61 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 113.741 -1.572 . . . . 1.08 110.462 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 8.3 Cg_exo -73.19 152.02 49.96 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.904 2.403 . . . . 0.51 114.264 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 100' ' ' ILE . 1.7 mp -114.48 143.11 24.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 113.239 -1.8 . . . . 0.96 109.637 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mp -113.46 147.52 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -110.37 138.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 109.32 -0.622 . . . . 0.23 109.32 174.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.1 87.8 2.82 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.232 -1.025 . . . . 0.25 108.232 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.687 ' HA ' HG23 ' A' ' 86' ' ' VAL . 37.5 mt -73.3 95.92 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.581 -1.191 . . . . 0.85 110.153 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.497 ' ND2' HG21 ' A' ' 23' ' ' THR . 53.3 t30 -90.8 156.53 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.671 -0.412 . . . . 0.69 111.174 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.2 mttp 71.51 37.32 1.15 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.732 0.813 . . . . 2.61 112.178 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.688 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -110.86 18.41 19.57 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.873 -0.731 . . . . 1.37 111.661 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 5.8 t70 -64.98 -28.35 69.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.088 -0.506 . . . . 2.45 111.44 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.761 ' H ' ' HD2' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -133.57 -56.17 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.503 0.927 . . . . 3.7 113.503 178.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.761 ' HD2' ' H ' ' A' ' 119' ' ' LYS . 29.1 Cg_endo -73.38 -53.38 0.13 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.251 2.634 . . . . 2.67 112.706 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' CB ' ' HB2' ' A' ' 117' ' ' MET . 10.1 pt-20 59.69 0.19 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.87 1.668 . . . . 4.03 113.793 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 42.99 -98.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.293 0.637 . . . . 1.47 111.381 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 34.1 t30 -163.65 93.87 1.08 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.114 -0.494 . . . . 1.84 110.826 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 58.1 Cg_exo -28.79 -69.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.548 3.499 . . . . 0.7 114.545 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.94 -45.72 15.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.725 0.81 . . . . 2.0 112.206 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -55.17 -56.13 23.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.493 0.663 . . . . 2.99 110.177 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.77 HG13 ' HA2' ' A' ' 91' ' ' GLY . 56.7 t -59.44 -39.73 79.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.565 -1.198 . . . . 0.4 110.346 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 87.3 mtp -66.29 -30.01 70.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.558 -0.746 . . . . 0.3 111.225 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.34 -21.06 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.627 0.251 . . . . 1.28 110.778 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.1 -38.58 85.93 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.646 -0.872 . . . . 2.02 108.646 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.929 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -69.47 -45.35 69.21 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.031 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.89 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -73.26 -5.04 36.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.363 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.62 -37.19 68.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.726 -1.213 . . . . 2.18 107.726 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.949 ' HE2' HG11 ' A' ' 92' ' ' VAL . 28.6 m-85 -84.38 7.6 19.0 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.944 0.878 . . . . 0.74 109.283 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.71 44.08 1.21 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.829 -1.532 . . . . 1.94 109.505 170.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.929 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -122.43 81.77 1.89 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 113.517 -1.674 . . . . 1.68 106.96 169.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -65.37 130.53 94.72 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.006 -1.452 . . . . 0.61 110.242 -173.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 58.2 Cg_exo -44.69 154.79 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.888 2.392 . . . . 0.3 112.54 170.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -74.43 -29.17 61.38 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.346 -1.297 . . . . 2.01 108.012 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.654 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -51.11 -42.17 60.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.584 -1.189 . . . . 1.14 109.572 168.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.89 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.2 m0 -96.16 -20.35 18.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.419 -0.81 . . . . 0.45 111.167 -172.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.99 29.85 4.44 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.139 -1.029 . . . . 0.45 112.707 170.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.824 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.78 -106.67 2.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.366 -0.921 . . . . 0.5 112.923 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.34 27.99 0.45 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.714 -0.243 . . . . 1.3 111.42 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 136' ' ' LEU . 26.6 m -134.55 129.04 34.45 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 119.171 -1.011 . . . . 0.32 113.548 -171.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 164' ' ' MET . 49.9 mm -94.35 110.33 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.332 -0.849 . . . . 1.23 110.566 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.757 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 14.2 m-85 -90.89 119.4 31.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.034 0.445 . . . . 0.38 111.429 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 75.8 m -110.37 111.99 23.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.625 -0.509 . . . . 1.1 109.625 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.688 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 25.9 pttt -93.29 100.06 12.48 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.811 -0.631 . . . . 2.44 109.392 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.69 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -123.07 179.13 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.615 1.198 . . . . 1.27 113.681 -169.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.42 ' CB ' ' HB2' ' A' ' 118' ' ' ASP . 2.7 p -150.58 116.83 5.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.285 -1.78 . . . . 1.79 108.15 171.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -63.02 -16.32 59.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.013 0.375 . . . . 0.87 112.013 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.71 -57.34 3.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.802 0.81 . . . . 3.03 109.503 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -72.69 -17.96 61.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.129 -1.396 . . . . 1.2 112.01 -175.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.713 ' HD3' HD12 ' A' ' 158' ' ' LEU . 30.2 mmtp 71.63 -0.11 3.28 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.791 -0.641 . . . . 2.27 112.007 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -45.99 -74.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.037 0.754 . . . . 2.64 113.037 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.69 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.51 -6.7 66.77 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.496 -0.774 . . . . 0.62 113.536 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.713 HD12 ' HD3' ' A' ' 155' ' ' LYS . 57.7 mt -73.55 -43.16 60.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.288 0.544 . . . . 1.55 110.561 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 26.9 m-20 -66.94 -40.43 87.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 174.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -65.29 -30.64 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.73 110.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 60.7 tp -63.39 -53.89 45.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.91 110.639 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.63 -39.29 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 1.06 110.731 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 8.1 mm-40 -61.41 -48.34 81.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.573 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.729 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.7 mmt -69.29 -40.12 77.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.87 110.854 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.41 -47.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.041 -0.527 . . . . 0.64 110.43 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.2 -46.72 87.68 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.29 -0.414 . . . . 1.81 111.137 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.43 -46.28 76.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 1.42 110.555 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.594 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 77.4 t -74.05 -41.61 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.094 -0.503 . . . . 1.17 111.427 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.726 ' HB3' ' HG2' ' A' ' 9' ' ' PRO . 50.3 m -60.65 -26.88 67.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.471 . . . . 1.54 110.811 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -83.62 -45.75 13.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 2.79 111.061 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 19.6 ptt? -88.04 -11.96 45.71 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.391 0.515 . . . . 1.82 112.391 -172.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.1 -31.99 14.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.33 0.493 . . . . 3.45 112.33 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.2 -23.28 61.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.167 -0.47 . . . . 3.36 111.366 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.24 -65.54 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.888 -0.597 . . . . 4.14 109.413 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt 60.75 99.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.963 -1.017 . . . . 6.31 112.584 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -110.17 81.75 1.49 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.235 -0.893 . . . . 4.57 110.169 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -113.09 155.41 44.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.509 . . . . 6.38 110.303 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.849 2.366 . . . . 7.47 111.839 177.304 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.257 -0.337 . . . . 16.35 112.257 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -79.73 -11.23 59.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.758 0.313 . . . . 14.69 111.793 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -107.54 100.79 10.17 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 14.68 109.723 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -79.29 72.51 5.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 12.73 111.433 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.51 6.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.509 0.671 . . . . 10.18 109.946 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -85.43 38.58 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 9.14 111.177 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 ttt180 -144.89 66.34 12.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.485 . . . . 8.35 110.289 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 53.8 Cg_endo -95.33 138.44 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.918 2.412 . . . . 4.6 112.294 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 13.4 Cg_exo -71.0 65.38 2.53 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.944 2.429 . . . . 4.29 111.619 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.664 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 3.8 p -73.57 124.15 30.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 2.58 111.06 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 4.0 t -118.32 141.2 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.751 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -95.34 121.66 37.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.244 -0.435 . . . . 0.66 111.466 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 83' ' ' ILE . 32.6 mt -95.67 120.06 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.316 0.579 . . . . 1.03 110.01 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' LEU . 50.0 mtt -128.59 152.28 48.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.798 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.913 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 168.82 -113.8 0.54 Allowed Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.281 -1.128 . . . . 1.55 110.281 173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 85.3 t60 -161.99 147.12 12.97 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.083 -0.71 . . . . 0.66 109.083 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -56.95 -51.38 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.592 0.59 . . . . 1.62 112.592 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -61.33 -28.23 69.06 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.796 0.665 . . . . 1.78 112.796 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HE1' ' H ' ' A' ' 93' ' ' MET . 27.7 m170 -66.63 -19.02 65.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.65 110.799 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.09 1.38 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.654 -0.784 . . . . 0.93 112.163 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -73.13 -48.8 32.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.235 0.541 . . . . 2.11 110.566 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 1.8 110.067 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 m -70.83 -29.08 65.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.779 -0.646 . . . . 1.77 110.428 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.33 -49.0 75.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.459 -0.571 . . . . 1.78 109.459 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 8.3 tt -60.09 -45.42 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.406 -0.816 . . . . 1.96 110.519 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.8 t70 -66.17 -48.33 71.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.144 -0.48 . . . . 1.38 111.908 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.06 99.66 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.115 0.483 . . . . 0.91 110.735 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 25' ' ' LEU . 9.6 tt -66.67 -34.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.753 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 29.5 ptt180 -78.33 -36.31 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.675 0.75 . . . . 3.56 109.092 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -76.16 14.39 0.73 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.799 -1.091 . . . . 2.88 111.578 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.716 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 71.2 m -98.42 11.86 36.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.369 -0.604 . . . . 1.76 109.369 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 31' ' ' SER . 0.3 OUTLIER 57.53 1.36 0.12 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.525 1.53 . . . . 5.71 115.005 166.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.26 0.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.539 0.685 . . . . 2.99 109.227 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.525 ' HB ' ' HA ' ' A' ' 29' ' ' ARG . 2.4 m -119.99 150.95 39.7 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.163 -0.926 . . . . 3.93 112.039 -166.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 41.5 mt-10 -83.71 -162.76 0.67 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.279 -1.328 . . . . 4.2 108.659 170.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 21.2 pt20 -178.17 177.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.413 0.625 . . . . 5.38 111.422 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.527 ' HB3' ' CA ' ' A' ' 46' ' ' GLY . 11.6 tp10 -161.32 -179.09 7.13 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.653 -1.61 . . . . 5.79 106.653 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.452 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.87 90.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.145 0.429 . . . . 4.24 110.667 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.81 132.72 8.79 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 116.125 -0.488 . . . . 4.95 112.24 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.08 -102.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.918 -0.873 . . . . 6.66 110.918 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.97 -37.62 80.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.824 -0.806 . . . . 9.17 108.824 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.3 m -79.44 105.32 10.67 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.995 -1.002 . . . . 7.36 109.538 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -116.31 38.36 3.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.797 0.808 . . . . 8.83 110.649 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -103.2 -29.29 11.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.992 -1.114 . . . . 6.76 107.992 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 pt -142.58 -164.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.114 -1.403 . . . . 5.19 108.679 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' CA ' ' HB3' ' A' ' 37' ' ' GLU . . . 117.32 7.13 12.68 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.04 -1.076 . . . . 2.97 112.879 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.65 170.32 14.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.222 0.534 . . . . 1.71 111.242 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.746 ' HB3' ' HA ' ' A' ' 36' ' ' GLN . 3.4 p90 -162.48 159.11 24.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.559 -0.746 . . . . 2.54 110.368 -169.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 45.5 mt-30 -125.32 136.97 54.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.493 -0.321 . . . . 1.96 110.15 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 57' ' ' ILE . 5.0 m -93.22 145.0 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.135 0.493 . . . . 1.93 111.43 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -106.24 82.68 1.78 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.691 -0.686 . . . . 2.06 109.711 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.1 p -132.68 120.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.004 -0.998 . . . . 4.12 108.456 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 72.24 -10.47 0.9 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.14 0.972 . . . . 4.43 109.49 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.4 t70 75.24 28.06 1.04 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.697 -2.047 . . . . 3.62 109.774 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 57' ' ' ILE . 18.3 tptm -93.82 101.54 13.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.055 -1.461 . . . . 7.44 107.055 170.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -74.3 76.94 1.85 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.291 0.567 . . . . 5.43 111.34 -168.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 50' ' ' VAL . 39.3 mt -66.9 106.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.247 -0.888 . . . . 1.14 110.309 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.664 ' HB ' ' HA ' ' A' ' 10' ' ' VAL . 5.0 m -80.88 100.79 9.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.551 -0.537 . . . . 1.28 109.551 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HE2' ' CG1' ' A' ' 50' ' ' VAL . 59.5 m-85 -80.0 118.7 21.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.001 0.429 . . . . 0.84 111.985 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -104.6 137.26 42.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.476 -0.784 . . . . 3.0 109.496 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.82 134.94 44.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.747 0.308 . . . . 6.48 110.565 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 67' ' ' ALA . 35.4 m -122.07 94.57 48.0 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 5.57 111.308 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -94.53 13.13 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.079 2.519 . . . . 5.77 112.475 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.11 -163.64 12.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.869 -0.681 . . . . 5.54 112.446 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -99.36 -78.65 0.5 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 8.09 111.709 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.94 58.83 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.238 0.542 . . . . 6.36 111.652 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' HG23 ' A' ' 62' ' ' THR . . . -121.86 115.73 23.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.832 -0.622 . . . . 3.51 110.244 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB2' ' CD2' ' A' ' 102' ' ' HIS . 1.1 t80 -157.19 -53.29 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.791 -0.448 . . . . 2.61 109.791 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -71.37 90.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 4.74 111.245 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -113.63 0.46 14.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.907 -0.588 . . . . 5.89 110.662 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -80.48 143.09 33.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.643 -0.708 . . . . 5.64 110.422 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -88.67 45.42 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.587 0.708 . . . . 9.71 110.048 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -178.17 169.46 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.031 -0.986 . . . . 7.52 109.196 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -112.44 48.96 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.825 0.821 . . . . 10.42 109.068 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.07 -177.26 46.69 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.994 -1.242 . . . . 6.75 109.994 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.63 36.89 28.31 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.662 0.744 . . . . 6.69 109.942 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -88.01 119.38 28.31 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.94 -1.027 . . . . 7.72 111.216 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.57 7.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.259 -1.015 . . . . 4.38 108.259 173.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 1.1 m -84.74 5.46 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.495 -1.229 . . . . 4.18 111.507 -173.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 108' ' ' VAL . 19.6 m-20 -80.12 38.3 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 3.12 111.315 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 41.9 mm -125.02 104.98 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.32 -0.622 . . . . 0.74 109.32 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 103' ' ' ALA . 90.5 t -106.85 105.85 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.402 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -87.48 107.75 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.057 -0.72 . . . . 1.32 109.057 174.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 100' ' ' ILE . 3.1 tm? -96.76 114.65 26.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.236 -0.893 . . . . 1.33 109.928 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.913 HG12 ' HA3' ' A' ' 15' ' ' GLY . 9.9 p -88.04 141.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.295 0.569 . . . . 1.2 111.341 -176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.8 m -138.4 -171.09 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.243 -0.89 . . . . 1.12 108.631 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.87 136.91 25.88 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.752 -0.379 . . . . 0.75 110.535 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 59.37 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 1.18 111.235 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.72 -30.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.242 -1.344 . . . . 2.01 109.655 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -108.98 -52.53 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.102 0.477 . . . . 1.09 110.991 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 102.5 -113.42 4.59 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.581 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 96' ' ' THR . 41.4 t -125.85 112.26 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.973 0.415 . . . . 1.08 110.919 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.7 mtp -88.26 171.8 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.327 -0.397 . . . . 1.32 110.452 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 84.7 Cg_exo -46.98 -48.5 14.36 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.818 2.345 . . . . 0.61 114.112 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 6.1 mt-30 -62.03 -38.41 88.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.006 -0.278 . . . . 1.47 110.91 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 92' ' ' VAL . 6.4 m -58.57 -33.54 70.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.786 0.803 . . . . 0.46 110.102 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 21.4 t -76.99 -57.93 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.691 -1.14 . . . . 1.05 111.536 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -73.56 -8.55 56.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.857 -0.611 . . . . 1.62 112.543 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -84.32 -44.67 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.053 -1.091 . . . . 0.34 108.053 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.683 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.8 mt -62.9 -45.9 97.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.185 -1.371 . . . . 0.38 111.055 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 5.2 m-20 -54.61 -29.0 50.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 1.85 111.134 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 13.3 t60 -85.04 -28.89 25.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.85 110.284 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.02 -46.25 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.491 . . . . 0.48 111.691 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 101' ' ' ASN . 21.4 ptmt -54.89 -37.01 65.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 2.56 112.639 -171.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.98 11.41 34.07 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.627 0.973 . . . . 0.76 113.627 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -86.92 -51.59 5.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.023 -1.473 . . . . 0.9 107.023 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 2.5 p-10 149.59 14.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 125.858 1.974 . . . . 2.06 108.839 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 80' ' ' ASP . 0.4 OUTLIER -102.02 143.69 27.09 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.771 . . . . 1.08 112.204 -166.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 10.7 Cg_exo -72.72 156.96 52.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.215 2.61 . . . . 0.51 112.908 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.562 HD13 HG12 ' A' ' 100' ' ' ILE . 82.3 mt -126.33 149.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.151 -0.931 . . . . 0.96 110.056 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mt -120.28 161.1 20.22 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 N-CA-C 108.697 -0.853 . . . . 0.71 108.697 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -123.71 140.93 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 121.049 0.452 . . . . 0.23 110.67 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -122.39 88.63 2.97 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.039 -1.097 . . . . 0.25 108.039 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.695 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 44.1 mt -69.66 96.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.043 -0.981 . . . . 0.85 109.543 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -94.14 165.39 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.258 -0.428 . . . . 0.69 110.686 -172.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 48.8 mttp 64.62 14.18 8.82 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.652 -0.704 . . . . 2.61 112.641 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -85.29 9.13 16.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.622 -0.831 . . . . 1.37 111.433 -175.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.555 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 33.8 t70 -77.38 57.77 1.56 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.065 0.936 . . . . 2.45 109.038 171.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.995 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 16.6 pttm -164.84 -171.35 0.26 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.403 -1.332 . . . . 3.7 107.403 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.995 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.3 Cg_endo -46.03 -21.26 1.01 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.925 2.417 . . . . 2.67 114.08 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 12.4 pt-20 53.47 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.545 1.138 . . . . 4.03 111.789 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -41.44 -67.14 0.27 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.933 -1.485 . . . . 1.47 111.483 -172.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 42.4 t-20 170.31 104.4 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 O-C-N 124.316 1.01 . . . . 1.84 109.226 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.673 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.6 Cg_exo -38.77 -55.74 1.29 Allowed 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 123.338 2.692 . . . . 0.7 113.73 171.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -47.39 -49.28 25.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.403 0.52 . . . . 2.0 112.403 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 20.5 tpt180 -49.08 -59.53 3.56 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.51 0.671 . . . . 2.99 109.798 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.475 HG13 ' HA2' ' A' ' 91' ' ' GLY . 51.4 t -55.99 -45.9 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.966 -1.47 . . . . 0.4 110.399 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.703 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 91.0 mtp -60.45 -34.37 73.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.3 111.449 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 132' ' ' MET . 92.9 mt-30 -73.9 -22.39 59.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 1.28 110.359 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 5.8 mt-10 -75.49 -32.64 60.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.875 -0.787 . . . . 2.02 108.875 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 136' ' ' LEU . 3.4 mm? -68.73 -45.56 71.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.609 0.719 . . . . 1.06 109.465 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.892 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -73.43 -5.82 42.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.563 -0.744 . . . . 0.35 110.181 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 19.8 tp10 -76.6 -29.57 56.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.865 -1.161 . . . . 2.18 107.865 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.538 ' CZ ' HG22 ' A' ' 97' ' ' VAL . 22.6 m-85 -92.29 6.67 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.424 0.63 . . . . 0.74 109.654 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.2 m120 78.43 24.47 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.277 -1.328 . . . . 1.94 111.585 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.93 HD11 HD12 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -105.63 78.94 1.39 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.626 -1.25 . . . . 1.68 107.626 172.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.416 HG23 ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -65.63 130.95 94.68 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 113.565 -1.652 . . . . 0.61 111.697 -176.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 71.1 Cg_exo -49.44 157.09 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.503 2.802 . . . . 0.3 113.376 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 146' ' ' ILE . 43.2 mm-40 -72.45 -26.32 61.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.302 -1.317 . . . . 2.01 109.488 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.868 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 3.3 mm-40 -58.55 -43.42 89.29 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.288 -0.869 . . . . 1.14 108.696 171.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.892 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -88.51 -24.78 22.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.064 -1.425 . . . . 0.45 110.283 -169.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.93 26.7 3.74 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.988 -1.101 . . . . 0.45 112.186 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA3' HG23 ' A' ' 137' ' ' VAL . . . -101.73 -115.47 3.96 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.405 -0.902 . . . . 0.5 111.896 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.91 33.39 0.48 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.596 0.236 . . . . 1.3 111.234 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HD12 ' A' ' 136' ' ' LEU . 36.2 m -128.0 120.24 27.14 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.779 -0.769 . . . . 0.32 112.588 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.479 HG13 ' HG3' ' A' ' 139' ' ' GLU . 3.5 mp -88.16 109.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.645 -0.707 . . . . 1.23 110.385 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.796 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 21.1 m-85 -88.55 108.03 19.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.896 0.379 . . . . 0.38 111.116 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 20.2 t -98.33 118.65 35.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.243 -0.651 . . . . 1.1 109.243 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 14.2 ptpt -92.3 102.97 15.46 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.162 -0.681 . . . . 2.44 109.162 173.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -130.17 -169.32 2.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.978 0.894 . . . . 1.27 112.789 -172.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 m -165.8 121.02 1.25 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 113.916 -1.493 . . . . 1.79 109.516 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.54 -12.51 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.623 -0.262 . . . . 0.87 111.668 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.555 ' HE3' ' HB3' ' A' ' 118' ' ' ASP . 18.9 pttp -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.879 0.847 . . . . 3.03 109.463 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.93 -22.57 45.59 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.246 -1.343 . . . . 1.2 109.84 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 158' ' ' LEU . 9.3 mtpm? 63.93 3.86 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.593 -1.185 . . . . 2.27 113.71 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.84 -56.11 25.88 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.058 0.932 . . . . 2.64 110.38 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -69.29 -11.98 65.28 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.519 -1.219 . . . . 0.62 113.535 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.7 HD12 ' HG2' ' A' ' 155' ' ' LYS . 31.5 mt -68.54 -43.0 77.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.314 0.557 . . . . 1.55 110.397 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.0 -45.65 91.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.764 -0.653 . . . . 2.5 109.611 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' A' ' 164' ' ' MET . 51.4 t-80 -64.56 -29.82 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.73 110.783 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.1 tp -67.12 -59.38 3.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.383 -0.371 . . . . 0.91 111.149 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.472 ' HB3' HG11 ' A' ' 52' ' ' VAL . 91.1 mt -54.33 -40.04 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.319 0.387 . . . . 1.06 110.704 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.76 -37.82 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 2.49 111.215 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 25.1 mmt -72.41 -39.84 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 0.87 110.077 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 161' ' ' LEU . 84.5 mt -58.49 -49.46 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.64 111.257 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -70.32 -35.19 73.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.81 111.268 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 166' ' ' LEU . 59.1 tp -56.93 -32.99 66.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.055 -0.521 . . . . 1.42 109.837 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 164' ' ' MET . 43.7 t -78.03 -37.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.898 -0.592 . . . . 1.17 109.918 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 t -55.16 -35.46 64.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.483 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.45 -45.04 8.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 2.79 111.13 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.8 ttp -65.22 -19.75 66.11 Favored 'General case' 0 C--O 1.223 -0.289 0 N-CA-C 111.459 0.17 . . . . 1.82 111.459 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.95 -30.83 15.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.088 0.471 . . . . 3.45 111.188 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.94 -20.04 19.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 3.36 111.086 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.5 mp -107.36 -6.58 17.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.228 0.825 . . . . 4.14 113.228 -172.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -56.15 117.33 3.65 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.138 0.494 . . . . 6.31 111.393 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -112.29 17.42 19.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.637 -0.71 . . . . 4.57 110.891 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.3 t30 -108.3 126.76 28.89 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.836 -0.62 . . . . 6.38 110.055 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 12.2 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.008 2.472 . . . . 7.47 111.334 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 111.916 -0.474 . . . . 16.35 111.916 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t -89.6 45.35 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 14.69 110.545 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.11 123.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 14.68 110.102 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 tpt -113.13 98.18 6.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.186 0.517 . . . . 12.73 110.14 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -107.7 139.49 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.776 -0.647 . . . . 10.18 109.574 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.92 58.99 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.161 0.505 . . . . 9.14 110.839 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -118.68 84.01 23.65 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.668 -0.696 . . . . 8.35 109.192 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -76.7 113.92 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.938 2.426 . . . . 4.6 112.298 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -91.47 92.85 0.22 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.068 2.512 . . . . 4.29 110.712 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.15 109.89 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 2.58 110.194 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 81' ' ' ILE . 74.4 t -84.75 89.22 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 121.698 0.761 . . . . 1.0 110.131 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -87.19 112.5 22.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 0.66 110.308 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 53.3 mt -74.34 117.08 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 121.613 0.72 . . . . 1.03 110.205 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 43.9 mtt -118.37 179.18 4.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.687 -1.142 . . . . 1.04 109.984 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.862 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.38 -96.8 0.2 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.158 -1.177 . . . . 1.55 110.158 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -172.33 143.56 1.45 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.969 -1.122 . . . . 0.66 107.969 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -24.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.387 0.884 . . . . 1.62 113.387 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.32 -33.74 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.855 0.317 . . . . 1.78 111.855 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -62.86 -23.95 67.56 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.503 0.557 . . . . 0.65 112.503 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 65.41 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.337 -0.935 . . . . 0.93 112.434 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -87.09 -15.58 38.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.332 0.587 . . . . 2.11 109.721 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -78.06 -30.05 49.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 1.8 110.451 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -27.49 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 1.77 111.089 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.02 -50.19 30.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.592 -0.521 . . . . 1.78 109.592 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -60.44 -22.18 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 1.96 110.789 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -92.64 -56.73 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.172 0.434 . . . . 1.38 112.172 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -28.16 69.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.91 111.397 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.12 -32.62 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.954 0.407 . . . . 1.56 110.109 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HA ' HG21 ' A' ' 34' ' ' THR . 33.6 mtp-105 -68.52 -32.28 72.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.522 0.677 . . . . 3.56 109.347 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 10.1 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.066 -0.97 . . . . 2.88 110.601 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 m -119.38 27.89 8.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 1.76 109.456 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.751 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER 48.08 -161.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.569 1.168 . . . . 5.71 112.459 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.751 HG13 ' HG3' ' A' ' 32' ' ' LYS . 2.9 m 58.75 2.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.35 1.46 . . . . 2.99 113.768 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.3 t -86.35 156.65 20.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.181 0.515 . . . . 3.93 111.589 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 11.9 mm-40 -77.62 -92.72 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.279 -0.873 . . . . 4.2 111.522 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -164.0 -179.65 6.38 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.372 0.878 . . . . 5.38 113.372 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 62.79 -99.64 0.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.221 -1.354 . . . . 5.79 114.2 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.591 ' HB2' ' H ' ' A' ' 47' ' ' ALA . . . -47.07 121.23 3.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.118 0.785 . . . . 4.24 113.118 -171.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.64 35.73 0.24 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.358 -0.837 . . . . 4.95 112.305 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.54 -164.71 13.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.839 -0.696 . . . . 6.66 112.133 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.5 mm -92.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.093 0.473 . . . . 9.17 110.388 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -78.69 -19.12 53.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.008 -0.542 . . . . 7.36 110.36 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -77.57 86.05 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.439 -0.578 . . . . 8.83 109.439 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -92.38 118.66 31.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 6.76 111.194 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.8 pt 51.0 -175.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.039 1.336 . . . . 5.19 113.207 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.09 -32.16 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.006 -0.997 . . . . 2.97 110.952 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.591 ' H ' ' HB2' ' A' ' 38' ' ' ALA . . . 62.99 -179.4 0.14 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.441 0.697 . . . . 1.71 110.826 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 -159.37 154.17 24.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 2.54 110.935 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 79.1 mt-30 -116.31 137.33 52.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.677 -0.692 . . . . 1.96 109.458 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 57' ' ' ILE . 3.9 m -105.34 129.75 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 121.606 0.717 . . . . 1.93 111.291 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.2 m -99.23 82.26 2.68 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.122 -0.945 . . . . 2.06 110.392 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.605 ' C ' ' H ' ' A' ' 54' ' ' ASP . 4.5 p -124.48 123.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.83 -1.174 . . . . 4.12 107.83 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 72.52 -16.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.105 0.955 . . . . 4.43 109.973 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.605 ' H ' ' C ' ' A' ' 52' ' ' VAL . 46.7 t0 75.83 40.43 0.28 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.129 -1.85 . . . . 3.62 109.968 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 14.7 tptm -95.84 -2.79 46.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.213 -0.903 . . . . 7.44 109.683 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.6 mttp 60.21 51.33 5.64 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.358 -1.292 . . . . 5.43 112.3 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.637 ' HB ' HG23 ' A' ' 50' ' ' VAL . 73.3 mt -61.35 127.01 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 1.14 110.932 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 23.1 m -99.11 117.11 32.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.398 -0.365 . . . . 1.28 110.221 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.625 ' HE2' HG21 ' A' ' 50' ' ' VAL . 28.9 m-85 -96.31 109.67 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.689 0.28 . . . . 0.84 110.775 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.509 HD21 ' HB ' ' A' ' 13' ' ' ILE . 3.9 mm? 67.85 172.88 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.333 -0.849 . . . . 3.0 112.187 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 5.2 t70 -168.93 -160.18 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.704 -1.221 . . . . 6.48 107.704 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.536 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 21.7 m -67.89 -53.68 19.7 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.518 0.192 . . . . 5.57 111.518 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 71.9 Cg_endo -74.51 55.64 3.73 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.585 2.19 . . . . 5.77 113.221 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.05 -177.35 49.04 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.749 -0.739 . . . . 5.54 112.343 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 69.12 -72.94 0.1 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.219 0.607 . . . . 8.09 112.247 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -122.42 -24.26 5.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.439 0.533 . . . . 6.36 112.439 -170.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.53 4.74 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.45 0.537 . . . . 3.51 112.45 -171.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.784 ' HE1' ' HA ' ' A' ' 103' ' ' ALA . 26.6 t80 66.62 -95.32 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.211 -0.449 . . . . 2.61 111.118 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.3 p -147.21 -102.29 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.086 0.469 . . . . 4.74 111.288 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.3 m -79.73 105.78 11.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.418 -0.355 . . . . 5.89 110.819 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.6 mmt -116.26 14.62 15.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.38 0.61 . . . . 5.64 110.848 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -137.13 120.45 16.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.383 -0.826 . . . . 9.71 108.777 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.64 59.82 2.77 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.513 0.673 . . . . 7.52 109.233 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -96.03 126.71 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.396 -0.82 . . . . 10.42 111.332 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.81 154.21 52.56 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.702 -0.761 . . . . 6.75 111.824 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.93 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.865 0.364 . . . . 6.69 111.137 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.38 83.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.06 0.457 . . . . 7.72 110.173 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.29 153.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.978 -0.555 . . . . 4.38 109.958 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 108' ' ' VAL . 5.9 t -153.71 58.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.839 0.828 . . . . 4.18 110.211 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.55 -173.53 2.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.116 -0.947 . . . . 3.12 110.884 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 11' ' ' VAL . 40.8 mm -111.84 109.89 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.977 -0.556 . . . . 0.74 110.85 -174.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.928 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.7 t -95.16 103.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 120.75 0.31 . . . . 1.19 111.01 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.673 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 9.2 mm -87.22 99.75 8.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.316 -0.624 . . . . 1.32 109.316 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 100' ' ' ILE . 11.4 tp -85.97 106.56 17.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.269 -0.423 . . . . 1.33 110.557 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.4 p -80.19 141.19 15.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.263 0.554 . . . . 1.2 110.978 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.3 m -141.2 -171.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 107.868 -1.16 . . . . 1.12 107.868 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.14 146.95 43.4 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.426 -0.51 . . . . 0.75 110.839 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -35.51 -53.89 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.778 1.299 . . . . 1.18 112.677 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.11 -9.93 20.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.593 0.59 . . . . 2.01 112.593 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.67 -40.46 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.126 -0.63 . . . . 1.09 111.559 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.49 -138.42 23.2 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.296 -0.954 . . . . 0.52 111.115 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.03 HG13 ' HB ' ' A' ' 96' ' ' THR . 23.9 t -101.04 113.44 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 122.766 0.426 . . . . 1.08 110.553 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.511 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -85.0 166.79 29.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.502 -0.925 . . . . 1.32 108.502 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 31.8 Cg_exo -34.56 -52.05 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.848 3.032 . . . . 0.61 115.09 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -78.06 -17.99 56.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 122.124 -0.36 . . . . 1.47 111.415 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.03 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.9 m -67.72 -19.06 65.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.35 0.595 . . . . 0.46 109.947 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.15 -44.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.266 -0.425 . . . . 1.05 110.78 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -27.25 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 1.62 110.967 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -75.9 -37.39 58.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.974 -0.557 . . . . 0.34 110.08 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.745 HD13 HD13 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -75.09 -43.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.38 111.209 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -51.43 -36.22 42.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.171 0.51 . . . . 1.85 110.669 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -83.85 -26.48 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.649 -0.705 . . . . 0.85 110.493 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.928 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -88.08 -50.22 6.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.49 0.552 . . . . 0.48 112.49 -173.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -69.57 -21.68 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.031 0.443 . . . . 2.56 111.174 -171.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.37 7.2 20.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.954 -0.567 . . . . 0.76 111.936 -172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.11 -2.68 27.02 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.001 -0.741 . . . . 0.9 109.001 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 t30 80.09 52.48 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.129 -1.396 . . . . 2.06 107.734 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.711 HG21 ' HZ ' ' A' ' 68' ' ' PHE . 25.3 t -124.34 143.4 42.82 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.427 -1.715 . . . . 1.08 111.051 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 Cg_exo -75.27 152.72 39.87 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.799 2.333 . . . . 0.51 113.152 172.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.591 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -123.48 143.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.471 -1.24 . . . . 0.96 110.773 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 mp -114.54 147.81 17.75 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.044 -1.095 . . . . 0.71 108.044 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.27 130.86 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 109.308 -0.627 . . . . 0.23 109.308 172.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -115.22 87.59 2.69 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.25 107.991 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.842 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 23.3 mt -71.26 95.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.57 -1.195 . . . . 0.85 110.26 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.06 164.49 12.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.299 -0.259 . . . . 0.69 110.299 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 62.47 22.7 13.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.815 0.817 . . . . 2.61 109.964 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 4.8 tpp -82.51 1.34 38.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.348 -1.296 . . . . 1.37 109.687 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.593 ' HB3' ' OG ' ' A' ' 151' ' ' SER . 1.6 p30 -52.59 -6.68 0.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.666 -1.152 . . . . 2.45 113.111 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 38.1 mmtm -72.71 -172.83 0.24 Allowed Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.639 -1.245 . . . . 3.7 107.639 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 31.8 Cg_exo -56.38 -53.06 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.243 1.122 . . . . 2.67 109.852 166.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 20.1 pt-20 154.68 118.54 0.0 OUTLIER 'General case' 0 C--N 1.341 0.21 0 C-N-CA 125.969 1.707 . . . . 4.03 107.328 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -60.43 -67.08 0.43 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 1.47 110.557 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 16.3 t-20 -179.39 80.85 0.2 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 123.513 0.508 . . . . 1.84 110.489 171.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.3 Cg_exo -43.07 -55.5 2.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 123.289 2.66 . . . . 0.7 113.611 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -46.64 -48.98 19.79 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.884 0.698 . . . . 2.0 112.884 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -53.81 -56.68 15.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 2.99 110.245 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.7 t -53.64 -46.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.094 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.648 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -63.23 -38.65 92.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.33 -0.85 . . . . 0.3 111.475 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.9 mt-30 -74.32 -25.06 59.32 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 110.073 -0.343 . . . . 1.28 110.073 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -74.22 -30.24 62.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.151 -0.477 . . . . 2.02 109.889 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.2 mm? -69.43 -45.14 69.87 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.635 0.731 . . . . 1.06 109.645 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.883 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -73.93 -6.07 45.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.957 -1.02 . . . . 0.35 109.793 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 35.5 tt0 -77.39 -28.62 52.85 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.251 -1.018 . . . . 2.18 108.251 173.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.596 ' HB2' HD12 ' A' ' 136' ' ' LEU . 30.5 m-85 -90.05 12.35 17.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.67 0.748 . . . . 0.74 108.987 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 68.54 42.75 1.48 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.102 -1.408 . . . . 1.94 109.93 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 100' ' ' ILE . 2.1 mp -117.7 78.24 1.22 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.617 -1.174 . . . . 1.68 108.803 171.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.54 125.76 91.64 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.608 -1.178 . . . . 0.61 110.913 -178.016 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.745 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -49.36 158.78 1.47 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.213 2.608 . . . . 0.3 112.822 172.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' HG12 ' A' ' 146' ' ' ILE . 30.4 mt-10 -81.14 -20.55 41.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.247 -0.888 . . . . 2.01 109.695 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.841 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -55.87 -39.89 72.15 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.252 -1.018 . . . . 1.14 108.252 168.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.883 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.1 m0 -94.08 -30.3 14.74 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.748 -1.569 . . . . 0.45 109.492 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.25 21.57 3.37 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.754 -1.212 . . . . 0.45 112.921 168.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.492 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.29 -114.97 2.14 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.243 -0.979 . . . . 0.5 112.545 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -151.23 28.88 0.65 Allowed 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.313 0.577 . . . . 1.3 111.237 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.62 122.35 32.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.459 0.647 . . . . 0.32 112.05 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 168' ' ' VAL . 15.8 mt -91.69 106.88 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 1.23 111.241 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.745 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -88.59 108.31 19.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.38 111.583 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 79.1 m -104.28 100.31 10.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.1 110.188 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.842 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 16.4 ptmt -82.03 94.68 7.23 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.306 -0.627 . . . . 2.44 109.306 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' MET . 0.7 OUTLIER -112.77 -176.84 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.955 0.884 . . . . 1.27 112.684 -168.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 118' ' ' ASP . 24.6 t -165.97 121.64 1.27 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.263 -1.335 . . . . 1.79 109.737 177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -9.2 44.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.894 0.378 . . . . 0.87 111.197 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -83.89 -56.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.736 0.779 . . . . 3.03 109.675 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 46.5 p -81.04 -20.54 41.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.421 -1.263 . . . . 1.2 111.562 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 73.14 -2.65 2.67 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.659 -0.7 . . . . 2.27 111.201 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -48.35 -71.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.772 0.796 . . . . 2.64 112.061 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.63 -9.58 69.74 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.875 -1.057 . . . . 0.62 113.822 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 158' ' ' LEU . 4.3 mm? -69.09 -50.25 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.677 0.738 . . . . 1.55 110.367 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.91 -38.48 82.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.068 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' A' ' 164' ' ' MET . 80.2 t60 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.657 -0.701 . . . . 0.73 110.921 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 62.0 tp -63.25 -58.19 7.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.038 -0.356 . . . . 0.91 110.038 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.75 -37.05 65.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.381 0.61 . . . . 1.06 110.054 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' HE2' ' A' ' 164' ' ' MET . 16.1 tt0 -65.29 -48.26 73.77 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.027 -0.988 . . . . 2.49 110.829 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.632 ' HB3' HG21 ' A' ' 146' ' ' ILE . 17.3 mmt -63.12 -42.79 99.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.309 . . . . 0.87 110.466 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 161' ' ' LEU . 87.8 mt -53.72 -53.56 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.667 -0.697 . . . . 0.64 110.15 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.461 HD11 HG13 ' A' ' 52' ' ' VAL . 76.8 mt -59.58 -48.97 79.58 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.659 -0.7 . . . . 1.81 111.872 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.39 -47.18 73.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.746 -0.661 . . . . 1.42 111.098 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 146' ' ' ILE . 2.1 t -67.58 -38.39 80.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.509 -0.314 . . . . 1.17 111.371 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.2 m -60.86 -25.18 66.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.514 . . . . 1.54 110.561 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.63 -22.84 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 2.79 110.856 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 56.4 ttp -77.9 -15.21 59.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.82 110.779 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -56.85 -19.68 18.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 3.45 111.793 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -63.37 -26.94 68.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.166 0.507 . . . . 3.36 109.691 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 mt -106.29 -71.97 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 4.14 109.481 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.584 ' HG2' ' H ' ' A' ' 176' ' ' ALA . 45.0 tttp 69.54 175.14 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.303 -0.862 . . . . 6.31 112.207 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.584 ' H ' ' HG2' ' A' ' 175' ' ' LYS . . . 74.12 -82.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.006 0.923 . . . . 4.57 112.315 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.72 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 53.2 t-20 -163.07 -58.33 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 119.696 -0.193 . . . . 6.38 111.155 -175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 1.4 Cg_endo . . . . . 0 C--O 1.251 1.127 0 C-N-CA 122.734 2.289 . . . . 7.47 112.685 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.359 -0.296 . . . . 16.35 112.359 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -64.04 131.28 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.577 0.227 . . . . 14.69 110.418 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -104.93 10.03 34.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.936 0.398 . . . . 14.68 111.165 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt -81.97 96.15 7.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.1 -0.5 . . . . 12.73 110.216 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 m -83.94 92.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 10.18 110.876 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.79 79.08 5.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 9.14 110.031 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -106.64 137.25 19.41 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.715 -0.675 . . . . 8.35 110.18 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 34.2 Cg_endo -66.25 130.92 25.19 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.449 2.099 . . . . 4.6 111.366 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 63.9 Cg_exo -52.99 140.68 58.71 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.476 2.784 . . . . 4.29 112.853 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.851 HG21 ' HB3' ' A' ' 77' ' ' GLN . 20.5 t -112.13 111.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.257 0.551 . . . . 2.58 110.354 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 81' ' ' ILE . 59.9 t -82.72 104.06 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.944 -177.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.799 HG23 ' HA ' ' A' ' 61' ' ' ASP . 53.1 m -86.07 128.09 34.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.572 -0.74 . . . . 0.66 110.764 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 83' ' ' ILE . 29.0 mt -90.94 122.94 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 1.03 111.549 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.522 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.7 mtt -137.82 171.86 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.099 -0.501 . . . . 1.04 110.596 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.826 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 150.2 -104.52 0.27 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.051 -1.219 . . . . 1.55 110.051 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 66.1 t60 -167.07 158.68 12.45 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.46 -0.57 . . . . 0.66 109.46 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.45 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.728 0.27 . . . . 1.62 111.728 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.32 -22.07 65.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.114 -0.494 . . . . 1.78 112.233 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.412 ' HE1' ' H ' ' A' ' 93' ' ' MET . 62.0 m170 -71.07 -18.25 62.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.078 0.466 . . . . 0.65 110.565 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.29 40.47 3.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.926 -0.654 . . . . 0.93 113.566 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -76.92 -27.38 54.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.468 0.634 . . . . 2.11 110.974 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 -30.97 31.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 1.8 110.126 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -81.08 -17.06 51.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.283 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.37 -51.55 59.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.825 -0.806 . . . . 1.78 108.825 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.781 HD13 ' HA3' ' A' ' 39' ' ' GLY . 2.7 tt -62.18 -38.63 89.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 1.96 110.248 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.0 t70 -68.82 -46.84 67.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.489 -0.323 . . . . 1.38 111.373 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -64.69 -42.03 95.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.926 0.393 . . . . 0.91 110.784 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.1 tt -66.51 -28.98 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.54 -0.755 . . . . 1.56 109.62 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HA ' HG21 ' A' ' 34' ' ' THR . 14.3 tpt180 -69.37 -33.32 72.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 3.56 109.934 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -83.45 14.58 3.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.876 -0.602 . . . . 2.88 111.361 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 t -100.58 13.89 33.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.452 -0.34 . . . . 1.76 110.798 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 71.49 -41.23 0.5 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 5.71 113.388 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' CG2' HG13 ' A' ' 50' ' ' VAL . 32.7 m -75.75 16.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.088 0.773 . . . . 2.99 113.088 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -96.96 121.46 38.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.386 0.613 . . . . 3.93 110.699 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -54.07 -63.22 1.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.643 -1.162 . . . . 4.2 112.466 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -162.59 167.1 23.81 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.177 -0.209 . . . . 5.38 111.409 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.38 174.71 0.24 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.248 0.967 . . . . 5.79 112.611 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.22 161.92 33.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.279 -0.873 . . . . 4.24 109.855 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.781 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . -138.63 53.33 0.71 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.174 -0.536 . . . . 4.95 112.204 -176.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.47 -96.1 0.58 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.746 -0.74 . . . . 6.66 112.469 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 41' ' ' ILE . 2.6 pp -96.59 -2.97 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.974 0.416 . . . . 9.17 111.687 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 p -88.03 128.84 35.4 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.102 -0.499 . . . . 7.36 111.192 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -84.39 74.04 10.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.782 0.801 . . . . 8.83 110.047 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -143.15 -67.57 0.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.803 -1.09 . . . . 6.76 108.576 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.4 mm 68.9 148.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 114.953 -1.021 . . . . 5.19 111.788 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.4 -100.32 0.17 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.367 -1.288 . . . . 2.97 110.9 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.863 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -171.6 174.35 4.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.816 0.341 . . . . 1.71 110.653 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.8 p90 -150.83 153.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.016 -0.538 . . . . 2.54 110.585 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -115.26 148.15 39.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.237 -0.653 . . . . 1.96 109.237 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 96.7 t -109.11 149.1 12.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.726 0.774 . . . . 1.93 110.813 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 54' ' ' ASP . 25.4 m -84.53 85.49 7.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.176 -1.374 . . . . 2.06 111.365 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -106.78 110.39 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.983 -1.117 . . . . 4.12 107.983 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 68.1 -50.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.414 1.071 . . . . 4.43 110.069 -167.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' OD2' ' HG2' ' A' ' 55' ' ' LYS . 32.9 t70 -151.23 -56.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.682 -1.145 . . . . 3.62 109.336 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 20.2 pttt 175.94 67.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.99 -1.005 . . . . 7.44 109.588 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -94.1 6.26 49.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 5.43 111.065 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mt -130.69 129.22 63.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 110.042 -0.355 . . . . 1.14 110.042 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 m -112.68 137.59 50.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.363 . . . . 1.28 110.101 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -112.7 117.79 33.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.191 -0.3 . . . . 0.84 110.191 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.863 HD13 ' HB2' ' A' ' 47' ' ' ALA . 42.7 tp -175.53 147.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.35 0.407 . . . . 3.0 111.081 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.799 ' HA ' HG23 ' A' ' 12' ' ' THR . 29.7 m-20 -74.54 85.56 2.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.743 -0.836 . . . . 6.48 108.743 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.571 ' HB ' HG11 ' A' ' 10' ' ' VAL . 14.9 t -90.29 139.39 26.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 5.57 112.051 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HB3' ' HG2' ' A' ' 71' ' ' MET . 72.3 Cg_endo -99.14 77.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 124.206 3.271 . . . . 5.77 112.017 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 78' ' ' VAL . . . -73.44 -8.0 74.61 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.674 -0.774 . . . . 5.54 113.207 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -178.03 -49.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.552 -0.536 . . . . 8.09 109.552 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.35 153.31 33.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 6.36 110.08 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.0 34.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.031 -0.359 . . . . 3.51 110.031 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 102' ' ' HIS . 56.8 m-85 -102.63 -17.3 15.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.597 0.591 . . . . 2.61 112.597 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 70' ' ' THR . 3.4 t -151.8 -70.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.807 -0.357 . . . . 4.74 111.084 174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.707 ' H ' HG23 ' A' ' 69' ' ' THR . 24.6 m -144.86 84.58 1.73 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 5.89 110.053 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.61 ' HG2' ' HB3' ' A' ' 63' ' ' PRO . 2.5 mpt? -119.83 138.12 53.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.916 -0.584 . . . . 5.64 110.106 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -114.08 -29.12 7.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.11 -0.495 . . . . 9.71 110.215 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.63 173.1 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.917 -0.583 . . . . 7.52 110.294 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -132.62 140.94 48.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.413 -0.358 . . . . 10.42 110.065 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.73 -179.23 16.1 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.75 -0.738 . . . . 6.75 112.423 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.59 -8.39 41.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.217 0.532 . . . . 6.69 110.331 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.851 ' HB3' HG21 ' A' ' 10' ' ' VAL . 15.9 mm100 -75.67 100.96 4.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.504 -0.771 . . . . 7.72 110.441 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 27.3 m -66.85 152.87 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.634 . . . . 4.38 111.711 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m -91.51 74.7 5.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.58 -0.737 . . . . 4.18 109.694 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD2' ' HB3' ' A' ' 9' ' ' PRO . 12.5 p-10 -90.99 -25.86 19.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.072 -0.513 . . . . 3.12 111.639 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.638 HG21 HG22 ' A' ' 11' ' ' VAL . 31.7 mm -116.73 112.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.628 0.251 . . . . 0.74 111.457 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 103' ' ' ALA . 85.7 t -108.36 108.88 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.709 -0.223 . . . . 1.19 110.565 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.787 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -87.39 113.32 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 119.768 -0.773 . . . . 1.32 109.89 172.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG22 ' A' ' 96' ' ' THR . 12.4 tp -98.12 111.91 24.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.506 -0.77 . . . . 1.33 110.26 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.826 HG12 ' HA3' ' A' ' 15' ' ' GLY . 7.5 p -84.25 143.04 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.245 0.545 . . . . 1.2 111.036 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.849 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.0 m -135.31 -179.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.158 -1.053 . . . . 1.12 108.158 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.31 133.11 14.97 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.431 -0.908 . . . . 0.75 113.195 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB1' ' HB2' ' A' ' 121' ' ' GLU . . . 49.81 -115.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.404 -1.271 . . . . 1.18 113.1 169.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 13.8 p-10 -115.47 8.95 15.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 2.01 110.289 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 16.4 t70 -64.04 -37.34 87.06 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.75 0.786 . . . . 1.09 109.422 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.61 -109.59 2.98 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.52 111.385 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.0 t -128.25 110.86 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.66 0.266 . . . . 1.08 110.698 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 72.6 mmm -74.52 170.96 12.7 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.307 -0.406 . . . . 1.32 110.181 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.2 Cg_exo -45.3 -52.11 6.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.611 2.208 . . . . 0.61 112.709 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.67 -34.31 75.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.431 -0.349 . . . . 1.47 111.19 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.989 ' HB ' HG13 ' A' ' 92' ' ' VAL . 2.6 m -64.58 -25.91 68.18 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.46 110.759 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 92' ' ' VAL . 69.1 t -86.31 -48.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.547 -0.297 . . . . 1.05 110.478 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 46.4 mt-10 -59.83 -23.94 63.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 1.62 111.335 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.522 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.23 -40.11 31.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.16 -0.681 . . . . 0.34 109.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 110' ' ' ILE . 1.4 mt -72.31 -56.28 10.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.38 110.212 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.444 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.7 t-20 -44.47 -34.34 2.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.438 0.695 . . . . 1.85 111.48 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.581 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 7.1 t60 -84.17 -35.25 23.69 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.983 -0.553 . . . . 0.85 111.354 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.32 -28.84 16.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.497 0.554 . . . . 0.48 112.497 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -76.95 -11.15 59.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.917 0.389 . . . . 2.56 110.978 -169.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.4 -1.55 56.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 0.76 111.895 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -95.91 8.64 43.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.915 -1.143 . . . . 0.9 107.915 170.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 63.15 33.11 14.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 113.866 -1.515 . . . . 2.06 110.457 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER -91.94 158.27 39.98 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.715 -0.675 . . . . 1.08 110.343 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.533 ' O ' HG23 ' A' ' 108' ' ' VAL . 6.9 Cg_exo -72.49 146.98 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.614 2.21 . . . . 0.51 113.047 170.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -120.24 142.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.089 -1.414 . . . . 0.96 109.331 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 mt -116.88 155.67 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 108.937 -0.764 . . . . 0.71 108.937 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -120.81 138.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 109.527 -0.546 . . . . 0.23 109.527 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.19 88.33 2.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.849 ' HA ' HG23 ' A' ' 86' ' ' VAL . 30.6 mt -68.57 90.2 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.837 -1.074 . . . . 0.85 110.264 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -80.31 154.8 27.57 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.112 0.258 . . . . 0.69 110.528 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 64.62 32.49 11.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.646 0.591 . . . . 2.61 110.946 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.2 tpp -85.54 -11.39 54.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 1.37 110.469 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.56 -10.44 59.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.337 0.589 . . . . 2.45 109.489 172.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.46 ' NZ ' ' HB3' ' A' ' 119' ' ' LYS . 7.2 mtpm? -113.76 155.23 45.37 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.537 -0.756 . . . . 3.7 110.053 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 13.1 Cg_endo -60.03 -8.97 8.94 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 124.144 3.229 . . . . 2.67 114.756 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.801 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -62.8 -38.27 90.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 4.03 110.39 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 88' ' ' ALA . . . -69.56 133.14 47.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.775 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 51.5 t-20 -126.05 88.09 54.91 Favored Pre-proline 0 CA--C 1.51 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.84 109.963 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -20.4 -81.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 1 C-N-CA 126.28 4.654 . . . . 0.7 115.904 175.793 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.84 -46.63 74.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.992 0.517 . . . . 2.0 112.255 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 30.3 tpt180 -50.78 -60.28 3.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.659 0.742 . . . . 2.99 109.658 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.4 t -59.69 -45.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 113.906 -1.497 . . . . 0.4 110.583 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.795 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 91.5 mtp -67.19 -26.13 66.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.906 -0.588 . . . . 0.3 111.25 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.31 -18.63 33.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.719 -0.392 . . . . 1.28 111.29 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.637 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.1 mm-40 -60.07 -42.52 94.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.557 -0.905 . . . . 2.02 108.557 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -73.63 -40.01 64.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.79 -1.095 . . . . 1.06 110.766 -173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.976 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -79.52 -3.68 47.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.811 -0.631 . . . . 0.35 109.76 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 11.2 tp10 -73.83 -33.47 64.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 2.18 107.463 171.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CE2' HG11 ' A' ' 92' ' ' VAL . 27.1 m-85 -87.83 7.94 28.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.613 -0.721 . . . . 0.74 109.862 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 72.56 34.22 1.28 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.755 -1.111 . . . . 1.94 110.638 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.6 mp -111.61 80.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.246 -1.02 . . . . 1.68 108.246 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.07 129.15 93.99 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.93 -1.486 . . . . 0.61 111.077 -176.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.811 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 76.0 Cg_exo -49.48 157.37 2.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.236 2.624 . . . . 0.3 113.649 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 146' ' ' ILE . 8.2 mm-40 -70.6 -31.29 68.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.304 -1.317 . . . . 2.01 109.006 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.639 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.3 mp0 -46.16 -54.02 9.41 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.576 -1.193 . . . . 1.14 110.698 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.976 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.2 m0 -89.45 -18.69 26.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.836 -1.529 . . . . 0.45 110.91 -166.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.59 28.08 4.14 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 120.014 -1.088 . . . . 0.45 112.287 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -99.65 -110.81 3.17 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.373 -0.918 . . . . 0.5 111.814 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.434 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 p30 -159.32 33.5 0.2 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.522 0.677 . . . . 1.3 110.81 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 27.7 m -125.56 112.45 16.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.412 0.625 . . . . 0.32 111.8 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -79.08 104.66 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.657 -0.701 . . . . 1.23 111.079 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -87.91 113.96 24.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.201 0.524 . . . . 0.38 111.811 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.41 ' O ' HD12 ' A' ' 150' ' ' LEU . 64.1 m -105.32 100.81 10.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.551 -0.75 . . . . 1.1 109.568 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 15.3 pttm -81.27 85.36 6.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.577 -0.897 . . . . 2.44 108.577 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.876 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -123.25 -175.64 3.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.176 -0.92 . . . . 1.27 112.671 -166.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 m -157.24 124.62 5.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.645 -1.161 . . . . 1.79 109.628 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -85.52 -12.93 50.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 0.87 110.297 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -73.49 -56.31 5.21 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.364 -0.834 . . . . 3.03 109.304 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.6 p -78.71 -21.57 47.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.884 -1.053 . . . . 1.2 108.997 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 1.023 ' HG3' HD12 ' A' ' 158' ' ' LEU . 2.1 ttmp? 70.79 7.03 6.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.715 -1.584 . . . . 2.27 112.038 172.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.26 -49.46 64.24 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.12 0.962 . . . . 2.64 110.652 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.876 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -62.14 -23.81 64.47 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 114.778 -1.101 . . . . 0.62 113.012 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.023 HD12 ' HG3' ' A' ' 155' ' ' LYS . 29.9 mt -64.65 -32.22 73.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.715 0.258 . . . . 1.55 110.558 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 13.7 m-20 -60.65 -53.26 59.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.036 -0.727 . . . . 2.5 109.036 172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.441 -0.8 . . . . 0.73 111.049 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.2 tp -61.05 -60.55 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.342 -0.39 . . . . 0.91 111.062 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.46 -40.36 68.32 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.221 0.325 . . . . 1.06 110.533 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 78.5 mm-40 -61.64 -49.7 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.539 . . . . 2.49 110.715 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.503 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -69.56 -34.66 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.87 110.444 -175.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.98 -52.32 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.928 -0.578 . . . . 0.64 110.714 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -76.8 -37.15 56.29 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.303 0.483 . . . . 1.81 112.303 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 166' ' ' LEU . 40.7 tp -61.53 -25.13 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.061 0.458 . . . . 1.42 110.166 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.615 HG21 HG12 ' A' ' 146' ' ' ILE . 2.7 t -85.19 -37.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 1.17 110.12 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -42.19 81.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.98 -0.554 . . . . 1.54 110.294 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.18 -28.15 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 2.79 110.629 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 56.0 ttp -66.25 -34.58 78.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.302 . . . . 1.82 110.354 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -53.13 -35.24 59.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.221 -0.445 . . . . 3.45 111.593 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -24.22 65.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 3.36 110.836 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.97 -77.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 4.14 110.127 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -172.35 143.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.954 -0.566 . . . . 6.31 109.63 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -135.79 98.45 3.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.643 -0.253 . . . . 4.57 110.968 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.536 ' N ' ' HD2' ' A' ' 178' ' ' PRO . 28.7 t-20 178.74 -52.73 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.76 -0.654 . . . . 6.38 111.076 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 177' ' ' ASN . 18.0 Cg_endo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.587 2.191 . . . . 7.47 112.441 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.493 -0.643 . . . . 16.35 111.493 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.467 ' OG ' ' HA2' ' A' ' 75' ' ' GLY . 8.6 t -80.6 64.65 5.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.607 0.718 . . . . 14.69 110.402 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -134.86 88.57 2.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.084 -0.71 . . . . 14.68 109.084 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 ttt -176.5 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.246 -0.888 . . . . 12.73 109.944 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 7' ' ' ARG . 22.3 t -81.7 -35.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 10.18 110.315 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 53.92 70.35 0.61 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.673 0.608 . . . . 9.14 111.754 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HB2' ' H ' ' A' ' 77' ' ' GLN . 11.4 mmt85 -126.0 97.36 35.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 8.35 110.297 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HG3' ' HB3' ' A' ' 73' ' ' ALA . 4.4 Cg_exo -75.04 142.64 27.97 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.434 2.756 . . . . 4.6 112.595 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB3' ' OE1' ' A' ' 77' ' ' GLN . 91.3 Cg_endo -80.18 53.09 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.86 2.373 . . . . 4.29 112.513 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.552 HG12 HG21 ' A' ' 58' ' ' THR . 27.9 m -115.42 127.87 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.299 -0.409 . . . . 2.58 110.867 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 58' ' ' THR . 51.4 t -73.48 111.84 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.146 0.498 . . . . 1.0 110.231 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -96.56 130.05 43.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.497 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 55.3 mt -97.76 126.75 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.712 0.292 . . . . 1.03 110.691 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.424 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 70.3 mtm -144.25 -177.73 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.075 -0.511 . . . . 1.04 110.888 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 84' ' ' LEU . . . 107.18 59.27 0.58 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.634 -0.793 . . . . 1.55 112.464 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 18.0 t60 62.07 163.62 0.09 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.068 0.937 . . . . 0.66 112.065 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.92 -32.28 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.861 -0.609 . . . . 1.62 111.633 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.444 ' HB3' ' NE2' ' A' ' 16' ' ' HIS . 28.0 t70 -72.83 -25.42 61.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.612 0.227 . . . . 1.78 111.612 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' MET . 32.5 m80 -61.71 -20.25 63.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 0.65 110.63 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.63 51.2 1.13 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.638 -0.71 . . . . 0.93 113.086 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.832 0.825 . . . . 2.11 109.021 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -36.79 80.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.451 -1.25 . . . . 1.8 110.76 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.5 p -73.24 -20.82 60.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 1.77 111.257 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.8 mm? -71.91 -48.13 47.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.947 -0.39 . . . . 1.78 109.947 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.22 -35.89 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.827 -0.624 . . . . 1.96 109.932 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.12 -58.31 8.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.794 0.331 . . . . 1.38 111.528 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -62.14 -29.15 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.91 111.133 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 HD21 ' A' ' 162' ' ' LEU . 5.2 tt -75.43 -25.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 1.56 111.029 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.0 mtp180 -78.97 -21.33 47.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.373 0.606 . . . . 3.56 110.049 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -88.6 -0.31 57.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 2.88 109.695 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -140.43 44.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.576 -0.738 . . . . 1.76 110.156 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.693 ' HD3' ' HG3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -112.37 160.91 17.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.761 . . . . 5.71 111.169 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG12 ' OG1' ' A' ' 34' ' ' THR . 13.8 t -93.43 -57.1 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 108.84 -0.8 . . . . 2.99 108.84 167.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.457 ' OG1' HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -123.74 148.93 46.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.927 -1.033 . . . . 3.93 110.293 -176.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.693 ' HG3' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.5 150.12 37.06 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.284 -0.871 . . . . 4.2 110.705 170.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.486 ' CG ' ' HB2' ' A' ' 49' ' ' GLN . 83.3 mm-40 -118.89 175.76 5.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.371 -0.831 . . . . 5.38 109.045 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.85 32.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.461 -0.336 . . . . 5.79 110.695 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 176.13 157.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.228 -0.896 . . . . 4.24 109.157 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 48' ' ' TYR . . . -105.54 31.34 8.57 Favored Glycine 0 CA--C 1.512 -0.131 0 N-CA-C 111.046 -0.822 . . . . 4.95 111.046 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.57 -170.98 43.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.976 -0.85 . . . . 6.66 110.976 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.448 HD11 ' O ' ' A' ' 72' ' ' ARG . 19.5 pt -86.19 27.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 9.17 111.653 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -109.5 127.16 54.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.64 -0.709 . . . . 7.36 109.246 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.6 63.83 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.479 . . . . 8.83 112.01 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.08 126.93 13.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.255 -0.646 . . . . 6.76 109.255 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.632 HG12 ' H ' ' A' ' 46' ' ' GLY . 15.4 tt -84.45 170.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.386 0.612 . . . . 5.19 110.725 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 45' ' ' ILE . . . 129.41 -34.83 2.71 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 110.037 -1.225 . . . . 2.97 110.037 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.585 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -107.93 -173.86 2.38 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.362 -0.977 . . . . 1.71 108.362 172.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.527 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 1.8 p90 -152.77 178.97 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.048 -0.661 . . . . 2.54 111.121 -175.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.559 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 72.4 mt-30 -142.31 117.5 10.1 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.956 -1.127 . . . . 1.96 107.956 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 HG22 ' H ' ' A' ' 51' ' ' THR . 3.4 p -80.97 176.7 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.41 -0.959 . . . . 1.93 108.41 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.738 HG23 ' HB3' ' A' ' 54' ' ' ASP . 5.5 t -53.59 145.02 15.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.73 0.776 . . . . 2.06 111.08 -170.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 54' ' ' ASP . 62.2 t -111.6 138.06 41.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.336 -0.847 . . . . 4.12 109.59 -166.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 71.95 -44.09 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.729 -0.841 . . . . 4.43 108.729 -172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.738 ' HB3' HG23 ' A' ' 51' ' ' THR . 9.2 t70 -65.65 -46.13 80.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.958 -1.019 . . . . 3.62 109.806 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 51' ' ' THR . 2.8 mptp? -123.72 -37.88 2.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.15 -0.62 . . . . 7.44 111.431 169.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 76.83 -1.91 2.77 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.442 0.464 . . . . 5.43 111.691 170.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 58' ' ' THR . 10.5 mt -86.94 156.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.335 0.588 . . . . 1.14 110.966 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 4.0 t -151.61 144.16 24.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.6 -0.889 . . . . 1.28 108.6 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 42.7 m-85 -118.92 121.09 39.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.715 -0.394 . . . . 0.84 110.481 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.08 121.39 44.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 3.0 111.724 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -141.29 114.4 8.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.361 -0.836 . . . . 6.48 109.109 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.2 m -154.17 126.69 3.98 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 5.57 110.16 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 122.38 11.23 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.846 2.364 . . . . 5.77 111.939 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.01 38.66 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.447 -0.661 . . . . 5.54 111.447 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.6 9.13 43.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.829 0.314 . . . . 8.09 111.571 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.41 75.21 1.5 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.58 0.705 . . . . 6.36 110.61 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.72 79.74 7.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.548 -0.751 . . . . 3.51 110.697 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.606 ' HZ ' HG11 ' A' ' 108' ' ' VAL . 26.5 t80 -173.2 96.26 0.12 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.914 -0.773 . . . . 2.61 108.914 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p 53.54 -162.58 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.719 0.637 . . . . 4.74 111.001 -174.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.4 p -89.06 -23.5 22.53 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.601 -0.44 . . . . 5.89 110.369 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.3 tpp 67.09 -46.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.087 -0.961 . . . . 5.64 110.898 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' O ' HD11 ' A' ' 41' ' ' ILE . 74.7 mtp180 -64.77 98.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 9.71 109.065 170.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . . . -177.46 -163.81 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 7.52 110.805 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -138.64 169.96 16.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.531 -0.759 . . . . 10.42 109.064 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 84.2 160.96 31.99 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.747 -0.739 . . . . 6.75 113.714 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.74 87.8 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.667 -0.494 . . . . 6.69 109.667 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.643 ' H ' ' HB2' ' A' ' 7' ' ' ARG . 26.9 tp60 -65.85 -54.41 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.219 -0.446 . . . . 7.72 111.109 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t 73.96 -25.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.516 0.726 . . . . 4.38 111.197 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 77' ' ' GLN . 19.7 m -61.37 -40.8 95.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.505 -0.554 . . . . 4.18 109.505 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.669 ' HB2' ' HB ' ' A' ' 108' ' ' VAL . 24.5 m-20 28.51 69.9 0.07 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.012 1.445 . . . . 3.12 112.412 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.673 HG23 HD11 ' A' ' 111' ' ' ILE . 28.3 mm -69.2 112.15 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.317 -0.856 . . . . 0.74 112.22 -172.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.731 ' HB ' HD13 ' A' ' 110' ' ' ILE . 75.8 t -107.09 120.62 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 116.44 -0.345 . . . . 1.19 110.899 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 111' ' ' ILE . 8.3 mm -86.31 123.08 39.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.531 -0.914 . . . . 1.32 108.531 171.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.0 tm? -107.66 113.94 27.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.704 . . . . 1.33 109.302 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.83 139.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.141 0.496 . . . . 1.2 111.855 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 114' ' ' ILE . 25.8 m -139.42 -171.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 108.822 -0.807 . . . . 1.12 108.822 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.9 109.92 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.968 0.729 . . . . 0.75 112.968 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . 44.68 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.809 1.041 . . . . 1.18 113.809 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.843 ' HB3' ' HB1' ' A' ' 122' ' ' ALA . 10.2 p-10 -107.67 -3.96 18.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.347 0.499 . . . . 2.01 112.347 -170.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 31.0 t70 -64.34 -43.79 93.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.419 0.628 . . . . 1.09 111.054 -175.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 88.93 -113.17 4.06 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.518 -0.848 . . . . 0.52 111.249 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.966 HG13 ' HB ' ' A' ' 96' ' ' THR . 35.5 t -129.36 119.2 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 120.656 0.265 . . . . 1.08 110.625 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 42.0 mtp -85.83 169.35 15.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.675 -0.491 . . . . 1.32 109.675 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.4 Cg_exo -42.64 -60.01 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.753 2.302 . . . . 0.61 112.801 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.684 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 42.0 mt-30 -59.27 -25.39 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.703 0.631 . . . . 1.47 112.703 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.966 ' HB ' HG13 ' A' ' 92' ' ' VAL . 29.9 m -60.21 -46.01 91.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.277 -0.169 . . . . 0.46 111.001 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.572 ' HA ' ' HB ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -88.52 -30.25 5.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 O-C-N 121.847 -0.533 . . . . 1.05 111.444 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 44.5 mt-10 -61.36 -26.94 68.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.411 . . . . 1.62 111.099 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -88.13 -22.31 24.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.34 109.959 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.805 HD13 HD22 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -80.79 -47.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.169 -0.923 . . . . 0.38 110.796 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -57.63 -32.78 67.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.398 0.618 . . . . 1.85 110.056 170.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.09 -29.46 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.35 -0.841 . . . . 0.85 109.936 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -96.18 -54.68 3.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.471 0.545 . . . . 0.48 112.471 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HG3' HD11 ' A' ' 136' ' ' LEU . 24.5 mmmt -55.18 -44.8 75.6 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.601 0.715 . . . . 2.56 111.021 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.59 10.24 2.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.318 -1.31 . . . . 0.76 112.133 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.53 8.43 21.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.374 -0.973 . . . . 0.9 108.374 167.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 70.1 48.6 0.52 Allowed 'General case' 0 C--N 1.339 0.149 0 CA-C-N 114.226 -1.352 . . . . 2.06 111.084 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -126.48 157.61 70.08 Favored Pre-proline 0 C--O 1.238 0.485 0 N-CA-C 112.954 0.724 . . . . 1.08 112.954 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.575 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.5 Cg_exo -76.2 159.56 36.89 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 124.611 3.541 . . . . 0.51 114.498 168.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.756 HD11 ' HB3' ' A' ' 103' ' ' ALA . 22.1 mm -129.66 148.26 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.78 -1.1 . . . . 0.96 111.166 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 83' ' ' ILE . 3.9 mt -122.06 150.95 25.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 N-CA-C 109.283 -0.636 . . . . 0.71 109.283 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.2 136.34 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.282 0.563 . . . . 0.23 110.442 174.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.9 88.41 2.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.022 -1.103 . . . . 0.25 108.022 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.779 ' HA ' HG23 ' A' ' 86' ' ' VAL . 45.2 mt -69.36 91.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.686 -1.143 . . . . 0.85 109.697 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.643 ' HA ' HD22 ' A' ' 150' ' ' LEU . 53.9 t30 -88.67 151.71 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.69 111.204 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt 54.89 36.47 26.74 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.951 0.782 . . . . 2.61 111.018 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -97.19 29.37 3.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.497 -0.774 . . . . 1.37 109.365 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.6 66.44 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.615 -1.175 . . . . 2.45 112.293 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.701 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 54.2 mtmt -150.56 -179.89 1.09 Allowed Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 105.721 -1.955 . . . . 3.7 105.721 171.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.701 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 4.2 Cg_endo -49.54 -46.22 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.285 1.323 . . . . 2.67 110.848 171.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.519 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 13.2 pt-20 166.68 122.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.901 -1.148 . . . . 4.03 107.901 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.843 ' HB1' ' HB3' ' A' ' 89' ' ' ASP . . . -58.64 -68.13 0.29 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 1.47 109.577 171.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -176.38 70.97 0.25 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.515 -0.766 . . . . 1.84 109.859 170.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.5 Cg_endo -42.89 -59.25 1.04 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.496 2.797 . . . . 0.7 113.063 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.9 -47.51 32.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.582 0.586 . . . . 2.0 112.582 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.634 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 24.0 tpt180 -58.43 -55.86 29.6 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.329 0.585 . . . . 2.99 109.709 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.583 HG13 ' HA2' ' A' ' 91' ' ' GLY . 82.3 t -52.46 -43.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.4 -1.273 . . . . 0.4 110.677 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.683 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 81.5 mtp -64.24 -34.05 77.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.032 -0.531 . . . . 0.3 110.527 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 58.1 mt-30 -73.63 -24.28 60.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 1.28 111.025 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 3.0 mm-40 -68.7 -36.78 78.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.685 -0.857 . . . . 2.02 108.685 172.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.6 mm? -71.73 -43.59 65.6 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.55 -0.75 . . . . 1.06 109.844 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.838 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -77.55 0.26 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.521 -0.763 . . . . 0.35 109.819 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.546 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 16.4 tp10 -81.18 -27.58 35.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.911 -1.144 . . . . 2.18 107.911 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.763 ' CE2' HG11 ' A' ' 92' ' ' VAL . 48.5 m-85 -91.99 10.35 29.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.533 0.683 . . . . 0.74 109.19 168.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.2 m120 72.46 32.57 1.58 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.23 -1.35 . . . . 1.94 110.889 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.805 HD22 HD13 ' A' ' 100' ' ' ILE . 7.5 mp -107.84 79.51 1.29 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.402 1.096 . . . . 1.68 109.475 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.027 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.3 t -66.94 126.18 92.04 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.245 -1.798 . . . . 0.61 112.014 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.85 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 74.5 Cg_exo -47.45 160.11 0.4 Allowed 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 123.848 3.032 . . . . 0.3 113.878 170.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.56 -19.07 42.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.677 -1.147 . . . . 2.01 109.835 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 1.9 mm-40 -59.23 -40.8 87.03 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.878 -1.156 . . . . 1.14 107.878 168.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.893 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.7 m0 -91.67 -31.64 15.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.952 -1.476 . . . . 0.45 110.979 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.37 28.61 2.98 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.018 -1.087 . . . . 0.45 112.045 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 1.027 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.96 -104.77 1.79 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.717 -0.754 . . . . 0.5 111.913 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -165.49 33.47 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.174 0.511 . . . . 1.3 111.248 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 16.0 m -130.8 113.43 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.244 -0.582 . . . . 0.32 112.016 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.823 HD11 HG21 ' A' ' 168' ' ' VAL . 37.6 mt -81.44 110.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 116.02 -0.537 . . . . 1.23 111.347 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.85 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 23.4 m-85 -89.55 115.0 26.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.933 0.397 . . . . 0.38 111.805 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 13.8 t -113.27 135.94 53.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.866 -0.606 . . . . 1.1 109.386 173.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.758 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.2 pttp -110.74 85.13 2.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.689 0.757 . . . . 2.44 109.949 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -103.55 168.97 8.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.223 1.011 . . . . 1.27 112.906 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.578 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 27.7 t -145.14 117.37 8.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.392 -1.276 . . . . 1.79 108.131 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.53 -26.44 61.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.27 0.841 . . . . 0.87 113.27 -170.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.639 ' HG3' ' H ' ' A' ' 154' ' ' THR . 46.4 pttt -84.27 -55.24 4.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.33 0.586 . . . . 3.03 110.945 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.639 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 40.8 p -64.21 -25.08 67.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.096 -0.956 . . . . 1.2 110.628 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.849 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 2.5 tppp? 66.8 16.27 10.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.88 -1.055 . . . . 2.27 111.805 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.85 -72.42 0.16 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.712 0.768 . . . . 2.64 111.021 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -61.97 -16.67 53.15 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.739 -1.119 . . . . 0.62 113.24 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 150' ' ' LEU . 4.5 mm? -61.4 -46.21 91.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.912 0.387 . . . . 1.55 110.692 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.58 -42.16 68.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.074 -0.512 . . . . 2.5 110.205 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.9 t60 -66.61 -21.23 66.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.802 -0.635 . . . . 0.73 110.827 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.55 -51.13 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.056 -0.35 . . . . 0.91 110.056 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.668 HD21 HD11 ' A' ' 28' ' ' ILE . 93.8 mt -56.17 -39.95 73.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.635 . . . . 1.06 111.107 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 13.6 pt-20 -69.54 -32.59 71.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 2.49 110.648 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.706 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 25.6 mmt -73.13 -41.34 64.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.073 0.463 . . . . 0.87 109.898 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.43 -51.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.323 -0.853 . . . . 0.64 111.123 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -75.99 -36.85 59.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.246 0.461 . . . . 1.81 112.246 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 166' ' ' LEU . 62.4 tp -52.23 -33.64 42.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.036 0.446 . . . . 1.42 110.575 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 146' ' ' ILE . 19.0 t -78.88 -38.37 20.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.856 -0.611 . . . . 1.17 110.71 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.9 t -61.27 -29.09 69.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 1.54 110.57 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.68 -29.86 13.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 2.79 111.753 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.623 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 10.7 ptt? -67.61 -30.29 69.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.973 -0.291 . . . . 1.82 110.718 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 36.4 mt-10 -61.03 -33.96 74.11 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.874 0.369 . . . . 3.45 110.529 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -81.27 -36.08 30.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 3.36 110.005 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 171' ' ' MET . 96.8 mt -57.97 -60.36 3.84 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.365 -0.606 . . . . 4.14 109.365 173.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 176' ' ' ALA . 46.2 tptt -167.87 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.334 -0.848 . . . . 6.31 109.939 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' A' ' 175' ' ' LYS . . . -165.8 -58.47 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.721 -0.672 . . . . 4.57 109.864 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 62.3 t30 -111.24 -50.37 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.576 -0.738 . . . . 6.38 110.511 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 10.6 Cg_endo . . . . . 0 C--O 1.253 1.254 0 C-N-CA 122.843 2.362 . . . . 7.47 112.004 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.324 -0.31 . . . . 16.35 112.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -59.95 130.63 47.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 14.69 111.536 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -113.4 50.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 14.68 109.483 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.5 mtp -74.48 120.41 20.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.936 -0.575 . . . . 12.73 110.424 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 t -87.14 85.39 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.112 -0.699 . . . . 10.18 109.112 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.61 85.72 7.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.563 -0.744 . . . . 9.14 110.375 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 16.8 ttm180 -150.82 -52.0 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.448 -0.796 . . . . 8.35 111.157 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 53.0 Cg_exo -56.74 128.89 31.82 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.07 1.847 . . . . 4.6 112.025 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 38.3 Cg_exo -60.44 118.3 5.16 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.841 2.361 . . . . 4.29 112.091 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.08 85.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.408 0.623 . . . . 2.58 109.334 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 81' ' ' ILE . 58.9 t -72.4 123.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.671 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 127.2 43.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.66 110.77 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.505 ' H ' HD21 ' A' ' 60' ' ' LEU . 39.9 mt -83.99 115.77 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.319 0.58 . . . . 1.03 110.512 177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.419 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 mmt -107.49 -175.44 2.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.208 -0.905 . . . . 1.04 110.139 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.34 134.56 7.54 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.238 -0.982 . . . . 1.55 110.805 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 84.3 t60 -36.58 128.61 0.8 Allowed 'General case' 0 C--N 1.315 -0.894 0 O-C-N 124.634 0.843 . . . . 0.66 111.124 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 11.3 p -55.61 -21.28 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.352 -0.84 . . . . 1.62 113.107 -170.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 31.5 t70 -93.16 -8.22 43.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.8 0.333 . . . . 1.78 111.78 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.446 ' ND1' ' HA ' ' A' ' 86' ' ' VAL . 21.9 m170 -77.26 -7.24 55.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.484 0.55 . . . . 0.65 112.484 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.64 46.36 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.224 -0.989 . . . . 0.93 112.773 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 ptmm? -87.22 -24.26 24.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 2.11 110.174 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 41' ' ' ILE . 9.4 t -72.8 -29.75 63.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.8 110.254 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 p -75.42 -25.74 57.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.128 -0.487 . . . . 1.77 110.871 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 152' ' ' ALA . 43.0 mt -67.9 -54.04 21.87 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.986 -0.746 . . . . 1.78 108.986 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.04 -41.21 62.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.851 -0.613 . . . . 1.96 110.258 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.9 t70 -77.96 -51.38 10.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.54 -33.38 64.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.897 0.332 . . . . 0.91 111.897 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.576 ' HB ' ' OH ' ' A' ' 48' ' ' TYR . 76.2 mt -70.0 -39.05 76.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 1.56 110.046 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.682 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 7.2 ptt180 -66.67 -33.47 75.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.325 0.584 . . . . 3.56 109.967 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -83.06 -3.85 57.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.485 -0.78 . . . . 2.88 111.604 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t -97.83 -40.11 8.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.713 0.292 . . . . 1.76 110.714 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -100.43 -165.83 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.464 -0.334 . . . . 5.71 111.342 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.4 t -96.7 -67.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 112.979 0.733 . . . . 2.99 112.979 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 3.4 m -80.84 153.58 27.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.69 0.996 . . . . 3.93 113.69 -165.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.04 170.35 22.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.618 -1.174 . . . . 4.2 109.93 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -147.62 178.79 8.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.566 0.222 . . . . 5.38 110.94 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' HD12 ' A' ' 45' ' ' ILE . 42.5 mt-10 -76.67 79.2 3.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.052 0.453 . . . . 5.79 111.336 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -140.95 154.03 45.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.011 -0.54 . . . . 4.24 110.058 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.93 -62.83 2.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.436 -0.888 . . . . 4.95 112.936 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.49 -67.77 3.28 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.682 -0.771 . . . . 6.66 111.579 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 22' ' ' THR . 84.1 mt -141.29 -44.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.358 . . . . 9.17 110.302 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.89 148.73 47.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 7.36 111.607 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -83.64 23.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 8.83 111.641 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.435 ' HB2' ' H ' ' A' ' 45' ' ' ILE . 79.3 m-70 -133.78 -95.81 0.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.701 -0.852 . . . . 6.76 108.701 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 37' ' ' GLU . 45.6 mm -130.46 158.91 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.09 -1.078 . . . . 5.19 108.09 173.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 45' ' ' ILE . . . 177.26 -39.94 0.09 OUTLIER Glycine 0 C--N 1.311 -0.837 0 C-N-CA 120.685 -0.769 . . . . 2.97 112.225 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . . . -67.96 168.12 12.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.977 0.418 . . . . 1.71 110.864 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.576 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 5.7 p90 -162.71 -177.56 5.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.019 0.438 . . . . 2.54 111.468 -166.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.656 ' O ' ' HB ' ' A' ' 34' ' ' THR . 81.5 mt-30 -140.14 133.56 30.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.359 -0.837 . . . . 1.96 110.191 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -84.95 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.688 0.756 . . . . 1.93 109.832 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 21.7 m -137.54 98.47 3.7 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.043 -1.435 . . . . 2.06 110.658 -171.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 46.7 t -114.31 118.79 59.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.458 -1.312 . . . . 4.12 107.458 170.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 45.2 t30 71.93 -57.56 0.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.107 0.88 . . . . 4.43 110.88 -173.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 51' ' ' THR . 8.2 t70 -132.43 -63.98 0.78 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.158 -0.928 . . . . 3.62 111.395 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.893 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ptpp? 168.29 151.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.82 -1.082 . . . . 7.44 108.394 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -149.9 -80.49 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.989 0.423 . . . . 5.43 112.04 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 11' ' ' VAL . 4.0 mt -76.42 113.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 1.14 111.663 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 61' ' ' ASP . 60.9 m -99.23 112.29 24.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.167 -0.47 . . . . 1.28 109.793 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HD2' HD11 ' A' ' 13' ' ' ILE . 39.8 m-85 -89.46 92.85 9.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.217 -0.29 . . . . 0.84 110.217 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.505 HD21 ' H ' ' A' ' 13' ' ' ILE . 3.3 mm? 55.2 85.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.984 0.802 . . . . 3.0 111.834 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 10.5 p-10 -82.02 26.83 0.5 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.549 0.69 . . . . 6.48 110.566 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 5.0 t -122.89 143.77 41.29 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.209 -0.905 . . . . 5.57 110.443 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 6.3 Cg_exo -80.17 -3.25 12.55 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.089 2.526 . . . . 5.77 111.768 175.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.81 153.6 19.86 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.942 -0.647 . . . . 5.54 112.556 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -86.01 64.59 8.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.089 0.471 . . . . 8.09 110.057 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.36 169.43 14.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.611 -0.722 . . . . 6.36 111.598 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.28 86.92 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 3.51 110.229 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CZ ' HG21 ' A' ' 108' ' ' VAL . 53.8 t80 56.48 73.49 0.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.658 -0.701 . . . . 2.61 110.886 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -85.23 -24.5 27.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.324 0.583 . . . . 4.74 109.827 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.7 m -76.97 81.58 3.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.496 -0.774 . . . . 5.89 111.402 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.545 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 53.7 ttm -106.26 60.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.67 0.748 . . . . 5.64 109.186 173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -82.79 93.7 7.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.189 -0.914 . . . . 9.71 109.848 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.6 57.18 3.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 7.52 111.921 -173.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.14 110.83 15.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.884 -0.598 . . . . 10.42 109.565 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.77 93.85 0.07 OUTLIER Glycine 0 C--N 1.33 0.212 0 O-C-N 123.52 0.512 . . . . 6.75 112.943 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.13 53.83 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 6.69 110.336 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 66.23 44.67 2.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.582 -0.735 . . . . 7.72 110.97 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.12 96.8 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 4.38 109.907 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -121.61 54.08 1.15 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.05 0.928 . . . . 4.18 110.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.35 91.42 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.672 0.748 . . . . 3.12 109.402 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.988 ' HB ' HG22 ' A' ' 11' ' ' VAL . 47.8 mm -52.37 121.91 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.209 -1.36 . . . . 0.74 113.162 -172.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 103' ' ' ALA . 70.0 t -106.29 107.55 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 1.19 110.758 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.722 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -94.14 110.13 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 174.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 100' ' ' ILE . 10.5 tp -90.28 108.33 19.69 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.923 -0.581 . . . . 1.33 110.749 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.3 t -82.0 133.68 28.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.559 . . . . 1.2 111.483 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.3 m -134.08 -177.88 2.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.888 -1.153 . . . . 1.12 107.888 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.08 11.84 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.792 -0.763 . . . . 0.75 112.215 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.75 -109.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.625 -1.17 . . . . 1.18 112.903 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.718 ' HB3' ' HB1' ' A' ' 122' ' ' ALA . 8.8 p-10 -116.51 19.05 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 2.01 110.472 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.14 -33.35 73.29 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.817 0.818 . . . . 1.09 109.0 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.822 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.68 -142.15 28.46 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.251 -1.341 . . . . 0.52 111.912 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 96' ' ' THR . 71.2 t -98.01 110.2 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 120.809 0.337 . . . . 1.08 111.391 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 80.5 mmm -80.49 171.61 11.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.15 -0.477 . . . . 1.32 109.804 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.67 -54.49 4.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.138 2.559 . . . . 0.61 113.257 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 35.6 mt-30 -60.74 -30.33 69.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 1.47 111.574 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 92' ' ' VAL . 9.8 m -64.58 -22.96 67.11 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.851 0.358 . . . . 0.46 111.102 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.65 -46.5 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.885 0.374 . . . . 1.05 111.111 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.0 -12.74 40.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 1.62 111.315 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -96.68 -18.82 19.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.34 110.085 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 84' ' ' LEU . 3.4 mt -93.3 -53.07 8.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.38 110.507 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -50.4 -37.79 39.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.708 -0.678 . . . . 1.85 110.53 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 68' ' ' PHE . 29.4 t60 -75.9 -32.04 59.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.233 -0.894 . . . . 0.85 110.728 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.21 -55.79 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 0.48 112.084 -173.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HB3' HD11 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -71.41 -12.16 61.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 116.165 -0.47 . . . . 2.56 112.075 -168.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.37 -0.32 19.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.241 -0.436 . . . . 0.76 111.869 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.545 ' HB2' ' HG3' ' A' ' 71' ' ' MET . . . -106.1 1.99 26.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 t30 82.14 38.04 0.06 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 114.566 -1.197 . . . . 2.06 108.113 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 23.5 t -101.93 142.01 23.72 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 113.151 -1.841 . . . . 1.08 111.122 -173.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 6.4 Cg_exo -73.86 149.98 43.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.754 2.303 . . . . 0.51 113.165 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.683 HD13 HG12 ' A' ' 100' ' ' ILE . 97.8 mt -124.78 149.79 29.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.325 -1.307 . . . . 0.96 109.989 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mt -125.11 157.35 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 109.065 -0.717 . . . . 0.71 109.065 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -115.25 134.6 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 109.651 -0.499 . . . . 0.23 109.651 171.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.69 87.71 2.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.748 -1.204 . . . . 0.25 107.748 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.0 mt -73.66 93.08 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.661 -1.154 . . . . 0.85 109.749 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.55 166.44 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.095 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 57.3 tptt 63.0 47.9 4.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.27 1.033 . . . . 2.61 110.585 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.57 ' HE2' ' HB2' ' A' ' 121' ' ' GLU . 69.3 mmm -85.14 -45.9 11.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.13 -0.941 . . . . 1.37 108.501 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.12 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 O-C-N 125.203 1.565 . . . . 2.45 113.028 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 1.076 ' HG3' ' HD3' ' A' ' 120' ' ' PRO . 3.4 ptpt -145.32 -53.97 0.02 OUTLIER Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.137 -0.938 . . . . 3.7 113.528 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 1.076 ' HD3' ' HG3' ' A' ' 119' ' ' LYS . 35.8 Cg_endo -73.82 -27.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.169 2.579 . . . . 2.67 111.378 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.57 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 13.0 pt-20 50.34 32.95 6.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.201 -1.363 . . . . 4.03 113.106 170.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 89' ' ' ASP . . . 49.25 -129.17 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 1.47 111.748 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.5 t30 -160.67 84.93 1.92 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 1.84 109.179 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.3 Cg_exo -19.29 -66.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 1 C-N-CA 126.389 4.726 . . . . 0.7 116.456 175.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -39.68 -52.03 2.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.096 0.776 . . . . 2.0 113.096 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.0 tmt_? -55.55 -56.7 17.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.985 0.422 . . . . 2.99 109.926 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.822 HG13 ' HA2' ' A' ' 91' ' ' GLY . 31.0 t -58.45 -45.17 89.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.4 110.008 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.695 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 88.8 mtp -63.41 -30.11 71.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.395 -0.82 . . . . 0.3 111.181 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 58.8 mt-30 -78.61 -25.21 45.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.118 -0.233 . . . . 1.28 110.669 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.75 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.6 mt-10 -63.45 -38.61 91.79 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.847 -0.798 . . . . 2.02 108.847 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.984 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -70.85 -42.36 70.23 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.094 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.824 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -72.92 -7.76 52.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.728 -0.669 . . . . 0.35 110.227 178.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.85 -24.36 35.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 19.1 m-85 -89.05 5.95 42.01 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 122.216 1.008 . . . . 0.74 108.306 167.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 72.37 26.35 2.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 113.158 -1.837 . . . . 1.94 110.541 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.984 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -103.56 73.02 1.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.205 -1.406 . . . . 1.68 107.205 169.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.909 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -58.31 132.56 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 113.403 -1.726 . . . . 0.61 110.291 -173.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.856 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 94.4 Cg_exo -47.35 151.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.631 2.221 . . . . 0.3 112.971 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -76.0 -25.68 56.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.149 -1.387 . . . . 2.01 108.028 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.828 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -55.99 -38.9 71.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.288 -1.323 . . . . 1.14 109.149 169.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.828 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.6 m0 -96.03 -25.31 15.97 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.581 -1.191 . . . . 0.45 110.453 -172.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.48 24.15 3.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.908 -1.139 . . . . 0.45 112.192 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.909 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -115.85 2.93 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.396 -0.907 . . . . 0.5 112.978 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.28 25.03 1.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.965 0.358 . . . . 1.3 111.965 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.588 HG21 HD12 ' A' ' 136' ' ' LEU . 31.7 m -142.91 123.12 13.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 119.541 -0.864 . . . . 0.32 113.267 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.4 mp -85.19 118.42 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 1.23 110.36 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.3 m-85 -92.88 116.61 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.911 0.386 . . . . 0.38 111.352 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.6 m -114.46 110.24 19.54 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.72 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 14.9 ptmt -84.91 85.75 7.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.354 0.597 . . . . 2.44 109.707 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -114.3 -175.22 2.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.446 0.641 . . . . 1.27 111.816 -171.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.65 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 35.9 m -160.02 119.59 2.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.51 -0.768 . . . . 1.79 110.011 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' A' ' 24' ' ' LEU . . . -73.94 -53.25 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.897 -0.592 . . . . 0.87 112.553 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -75.34 -43.26 51.58 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.583 0.706 . . . . 3.03 109.785 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.3 OUTLIER -57.88 -22.14 46.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.15 -1.387 . . . . 1.2 110.196 171.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.743 ' HD3' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER 74.22 -39.28 0.42 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.601 -1.181 . . . . 2.27 113.903 170.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.99 -46.48 43.91 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.649 0.738 . . . . 2.64 112.024 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.65 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -63.99 -33.1 86.34 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.05 -0.977 . . . . 0.62 113.58 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.743 HD12 ' HD3' ' A' ' 155' ' ' LYS . 74.7 mt -59.68 -47.02 87.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.809 0.338 . . . . 1.55 111.182 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -59.96 -44.52 94.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.64 -0.709 . . . . 2.5 110.251 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -65.46 -38.75 90.74 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.309 -0.405 . . . . 0.73 110.898 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.9 -51.61 68.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 0.91 111.011 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 165' ' ' ILE . 81.7 mt -60.16 -33.88 72.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 1.06 110.911 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.83 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 2.49 110.642 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.56 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.87 110.638 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.43 HD12 HD23 ' A' ' 162' ' ' LEU . 81.7 mt -61.4 -48.77 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.64 110.596 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.6 -37.97 89.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.81 110.821 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.7 -45.45 73.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.733 -0.667 . . . . 1.42 109.656 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.85 -43.55 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.078 -0.51 . . . . 1.17 111.035 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -56.17 -43.96 78.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 1.54 110.911 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.11 -28.26 35.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.702 -0.226 . . . . 2.79 111.336 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.7 ttp -67.28 -58.97 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.523 -0.308 . . . . 1.82 111.063 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 18.0 mt-10 -60.69 -35.39 76.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.537 0.569 . . . . 3.45 112.537 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -13.7 60.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.928 0.394 . . . . 3.36 110.778 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.8 tp -106.83 -61.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.058 0.456 . . . . 4.14 110.739 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -149.97 106.84 3.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.539 . . . . 6.31 110.405 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.919 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -138.36 49.4 1.92 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.278 0.561 . . . . 4.57 110.055 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -144.47 119.73 6.02 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 6.38 109.624 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 C--O 1.25 1.12 0 C-N-CA 122.791 2.327 . . . . 7.47 112.428 179.156 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 112.167 -0.373 . . . . 16.35 112.167 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 p -116.98 26.52 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.871 0.367 . . . . 14.69 111.192 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.3 73.65 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 14.68 110.107 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.8 ptp -142.33 136.59 29.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 12.73 110.539 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.41 119.81 34.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.043 -0.526 . . . . 10.18 110.295 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.314 -0.403 . . . . 9.14 110.605 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -158.54 78.01 3.25 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.042 0.449 . . . . 8.35 110.793 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.04 136.35 10.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.337 2.024 . . . . 4.6 111.126 172.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 56' ' ' LYS . 98.5 Cg_exo -43.99 -52.44 5.53 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.421 2.747 . . . . 4.29 113.831 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t 63.59 91.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.547 0.689 . . . . 2.58 109.653 -172.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 ' HB ' ' A' ' 81' ' ' ILE . 44.5 t -87.81 132.12 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.222 -0.899 . . . . 1.0 112.082 -171.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -97.75 109.63 22.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 0.66 110.717 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 83' ' ' ILE . 14.7 tt -82.69 143.99 11.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.092 0.472 . . . . 1.03 110.772 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.68 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 59.4 mtt -139.94 -172.6 3.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.069 -0.514 . . . . 1.04 110.934 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.905 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 107.76 129.64 6.13 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.944 -0.862 . . . . 1.55 110.944 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 83.4 t60 -49.01 136.58 14.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.499 0.666 . . . . 0.66 110.971 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.624 HG12 ' HE2' ' A' ' 21' ' ' LYS . 29.2 m -64.74 -33.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.294 0.85 . . . . 1.62 113.294 -169.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 9.7 m-20 -67.15 -19.8 65.65 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.745 0.276 . . . . 1.78 111.745 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -68.93 -16.25 63.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.65 110.916 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 114.63 47.27 0.58 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.87 -0.681 . . . . 0.93 112.472 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.624 ' HE2' HG12 ' A' ' 17' ' ' VAL . 36.3 ttpt -87.09 -34.99 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.547 -0.538 . . . . 2.11 109.547 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -67.35 -47.73 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 1.8 109.954 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -69.49 -20.37 63.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.663 -0.699 . . . . 1.77 110.432 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 3.0 tm? -73.57 -51.01 18.4 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.519 -0.919 . . . . 1.78 108.519 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.561 HD12 ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -58.09 -37.1 73.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.455 -0.793 . . . . 1.96 110.668 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.26 -55.55 11.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 1.38 110.81 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.2 98.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.91 111.203 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 25' ' ' LEU . 13.0 tt -65.03 -31.51 54.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.588 -0.733 . . . . 1.56 111.02 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' HG21 ' A' ' 34' ' ' THR . 9.0 ptt180 -79.9 -28.07 39.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.475 0.655 . . . . 3.56 109.29 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.92 -9.29 59.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 2.88 111.489 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -77.35 16.32 0.63 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.442 -0.345 . . . . 1.76 111.709 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' HG12 ' A' ' 33' ' ' VAL . 47.2 mmtm 68.19 177.59 0.25 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.323 0.649 . . . . 5.71 112.611 171.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.068 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 59.78 6.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.813 1.245 . . . . 2.99 111.779 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -82.49 120.17 25.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.984 -0.553 . . . . 3.93 111.16 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.5 -46.22 64.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.301 -0.863 . . . . 4.2 109.827 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -116.57 142.97 46.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.868 -1.16 . . . . 5.38 107.868 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.07 37.72 2.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.55 0.691 . . . . 5.79 110.283 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.574 ' HA ' HD11 ' A' ' 41' ' ' ILE . . . -85.32 56.4 3.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.373 -0.83 . . . . 4.24 110.387 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.561 ' HA3' HD12 ' A' ' 25' ' ' LEU . . . -124.92 99.13 0.57 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.879 -0.677 . . . . 4.95 111.853 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.568 ' H ' HG22 ' A' ' 45' ' ' ILE . . . 90.52 54.04 2.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 6.66 111.993 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 38' ' ' ALA . 56.1 mt -104.76 -73.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 9.17 109.994 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.5 m -131.26 55.31 1.86 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.709 -0.678 . . . . 7.36 109.271 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.501 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.8 mm-40 69.92 -54.49 0.61 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.034 -0.985 . . . . 8.83 111.684 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -65.21 132.8 50.03 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.189 -0.671 . . . . 6.76 109.189 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 40' ' ' GLY . 28.6 pt -124.59 176.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.554 0.692 . . . . 5.19 111.545 -177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.69 20.65 1.3 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.964 -1.017 . . . . 2.97 111.304 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 65.1 -168.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.046 0.497 . . . . 1.71 111.666 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.439 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.5 p90 -154.26 121.87 5.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.19 0.519 . . . . 2.54 110.025 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.941 ' HG2' HG23 ' A' ' 58' ' ' THR . 77.9 mt-30 -100.07 114.78 28.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.925 -0.769 . . . . 1.96 108.925 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG21 ' HE1' ' A' ' 59' ' ' PHE . 16.5 m -92.25 147.02 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.596 0.713 . . . . 1.93 111.909 -174.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.068 ' HB ' HG22 ' A' ' 33' ' ' VAL . 25.4 m -88.17 80.47 7.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.188 -0.915 . . . . 2.06 109.135 172.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG11 HD12 ' A' ' 57' ' ' ILE . 12.7 p -112.1 117.08 54.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.03 -1.1 . . . . 4.12 108.03 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 68.75 -51.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.847 0.717 . . . . 4.43 109.498 -164.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 52' ' ' VAL . 19.6 t70 147.97 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.602 1.561 . . . . 3.62 110.298 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 tptt 67.21 -2.1 1.31 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.568 0.951 . . . . 7.44 113.568 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 44.5 mttm -60.22 -64.54 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 5.43 112.62 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 166' ' ' LEU . 63.5 mt -90.15 109.25 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.45 0.643 . . . . 1.14 111.781 -174.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.941 HG23 ' HG2' ' A' ' 49' ' ' GLN . 28.9 m -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 170.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HE1' HG21 ' A' ' 50' ' ' VAL . 83.0 m-85 -96.34 93.2 6.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.872 -0.788 . . . . 0.84 108.872 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.0 mt 65.8 160.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.154 0 O-C-N 124.018 0.824 . . . . 3.0 110.524 -170.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -139.17 -59.71 0.58 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.195 0.521 . . . . 6.48 109.699 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 m -105.41 102.32 36.6 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.665 -0.698 . . . . 5.57 109.574 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.31 177.48 8.58 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.792 2.328 . . . . 5.77 112.399 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.58 -125.43 5.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.501 -0.857 . . . . 5.54 112.617 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -119.99 37.82 4.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.128 0.489 . . . . 8.09 110.674 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.8 -38.26 86.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.716 -0.675 . . . . 6.36 110.496 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.85 63.87 1.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 O-C-N 123.674 0.609 . . . . 3.51 111.842 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' HB2' ' CE ' ' A' ' 14' ' ' MET . 44.5 t80 57.33 71.16 0.59 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.395 0.617 . . . . 2.61 109.816 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.508 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 5.5 t -97.66 14.71 25.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.585 -0.734 . . . . 4.74 110.338 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 m -64.74 -12.43 46.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.488 -0.778 . . . . 5.89 111.138 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.3 mtt -71.65 7.11 1.58 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.978 -0.555 . . . . 5.64 111.817 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 69' ' ' THR . 60.1 mtt180 -84.95 -23.78 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 9.71 109.545 172.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.96 71.97 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.407 0.623 . . . . 7.52 110.455 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.68 154.56 19.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.539 -0.755 . . . . 10.42 110.369 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.6 -81.81 0.3 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.819 . . . . 6.75 112.815 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.58 59.41 5.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.82 0.304 . . . . 6.69 111.82 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 66.75 110.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.588 0.709 . . . . 7.72 112.251 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.67 71.21 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.664 -0.698 . . . . 4.38 109.278 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -93.11 111.32 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.546 0.689 . . . . 4.18 111.647 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.73 176.97 5.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.925 -1.139 . . . . 3.12 107.925 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 11' ' ' VAL . 37.5 mm -124.08 102.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.439 -0.578 . . . . 0.74 109.439 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 103' ' ' ALA . 87.5 t -91.84 95.7 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.257 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.806 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -81.94 97.66 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 120.291 -0.564 . . . . 1.32 109.632 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 96' ' ' THR . 20.4 tp -86.94 109.0 19.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.643 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HA3' ' A' ' 15' ' ' GLY . 5.0 p -85.23 142.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 1.2 111.298 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.1 m -138.9 -177.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.553 -0.906 . . . . 1.12 108.553 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.81 98.26 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.953 -0.699 . . . . 0.75 112.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.97 -95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.106 1.15 . . . . 1.18 114.106 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.17 -8.21 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 2.01 112.002 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.06 -32.58 39.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 1.09 110.458 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 72.31 -139.11 27.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.259 -0.882 . . . . 0.52 112.443 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.572 HG13 ' HB ' ' A' ' 96' ' ' THR . 78.4 t -97.1 106.54 18.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 123.012 0.525 . . . . 1.08 111.512 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.553 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 51.0 mtp -75.9 170.85 13.9 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 1.32 110.634 173.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 79.0 Cg_exo -43.85 -58.07 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.79 2.327 . . . . 0.61 112.898 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.2 mt-30 -56.13 -32.86 64.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.387 0.514 . . . . 1.47 112.387 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 84' ' ' LEU . 11.4 m -66.68 -23.16 66.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.134 0.492 . . . . 0.46 110.579 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 92' ' ' VAL . 91.1 t -91.79 -45.25 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.404 -0.362 . . . . 1.05 110.69 175.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 46.1 mt-10 -61.36 -18.13 57.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 1.62 111.147 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.68 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -86.32 -41.47 14.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.814 -0.63 . . . . 0.34 109.358 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 110' ' ' ILE . 1.3 mt -68.35 -55.46 16.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 CA-C-N 115.452 -0.795 . . . . 0.38 110.631 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 t-20 -45.33 -36.8 4.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.791 0.436 . . . . 1.85 111.432 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 18.2 t60 -79.01 -29.16 43.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.897 -0.592 . . . . 0.85 111.012 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -99.51 -42.62 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.96 0.726 . . . . 0.48 112.96 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -17.4 64.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.074 0.464 . . . . 2.56 111.092 -166.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' N ' ' HD3' ' A' ' 104' ' ' LYS . . . -87.47 5.22 40.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.52 . . . . 0.76 111.741 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -96.59 1.63 51.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.401 -0.592 . . . . 0.9 109.401 174.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 74.71 39.01 0.45 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.38 1.086 . . . . 2.06 108.966 176.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -118.52 143.59 33.62 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 113.5 -1.682 . . . . 1.08 110.248 -176.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.1 Cg_exo -69.14 154.35 70.33 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.628 2.219 . . . . 0.51 114.157 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -122.3 146.87 26.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 113.913 -1.494 . . . . 0.96 109.806 -177.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.806 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.54 148.36 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.89 -1.152 . . . . 0.71 107.89 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -115.41 130.03 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 109.851 -0.426 . . . . 0.23 109.851 174.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.66 87.28 2.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.911 -1.144 . . . . 0.25 107.911 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.748 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.5 mt -73.87 97.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.432 -1.258 . . . . 0.85 109.976 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 23.1 t-20 -88.19 147.5 24.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.448 -0.342 . . . . 0.69 111.066 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.599 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 31.0 mtmm 76.98 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.024 0.828 . . . . 2.61 111.753 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 23.8 mmm -117.99 4.22 12.11 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.343 -0.984 . . . . 1.37 108.343 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -67.99 -17.17 64.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.828 -1.533 . . . . 2.45 110.751 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 1.002 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 50.6 pttt -78.01 -160.31 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.189 -1.412 . . . . 3.7 107.189 165.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 1.002 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -47.9 -63.24 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 121.989 1.746 . . . . 2.67 109.575 167.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.973 ' HG3' ' H ' ' A' ' 122' ' ' ALA . 13.6 pt-20 152.8 -92.19 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.797 2.039 . . . . 4.03 108.574 167.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.973 ' H ' ' HG3' ' A' ' 121' ' ' GLU . . . 174.43 -89.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.728 0.811 . . . . 1.47 109.642 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.8 86.41 0.29 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.377 -0.828 . . . . 1.84 109.505 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.9 Cg_endo -42.15 -53.46 3.55 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 124.003 3.135 . . . . 0.7 113.627 175.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.53 -48.23 19.41 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.549 0.574 . . . . 2.0 112.549 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -52.2 -60.83 2.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.459 0.647 . . . . 2.99 110.115 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' HA2' ' A' ' 91' ' ' GLY . 48.4 t -54.1 -45.1 65.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.248 -1.342 . . . . 0.4 110.537 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.733 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.6 mtp -62.79 -33.11 74.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.029 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -72.15 -23.04 61.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.434 -0.348 . . . . 1.28 111.196 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 7.0 mt-10 -72.5 -32.52 66.24 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.976 -0.75 . . . . 2.02 108.976 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.487 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -72.35 -44.32 62.77 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.575 0.702 . . . . 1.06 109.295 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.964 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -76.0 -2.07 28.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.35 109.778 177.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.7 tp10 -78.63 -31.32 46.88 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.303 -1.369 . . . . 2.18 107.303 173.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 136' ' ' LEU . 40.1 m-85 -90.11 9.66 27.38 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.812 . . . . 0.74 109.107 171.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 74.99 16.96 2.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.814 -1.539 . . . . 1.94 110.37 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 100' ' ' ILE . 6.1 mp -91.13 72.19 6.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.212 1.006 . . . . 1.68 108.488 173.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.486 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.49 129.89 92.96 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.917 -1.492 . . . . 0.61 110.711 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.789 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -50.72 158.32 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.953 2.436 . . . . 0.3 112.831 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' OE1' HG13 ' A' ' 146' ' ' ILE . 9.6 mt-10 -73.7 -29.8 62.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.056 -0.974 . . . . 2.01 108.504 175.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.665 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.4 mp0 -42.14 -55.08 3.38 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.431 -1.259 . . . . 1.14 110.597 163.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.964 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 13.5 m0 -90.7 -23.21 20.79 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.861 -1.518 . . . . 0.45 111.286 -166.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.28 25.98 2.81 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.709 -1.234 . . . . 0.45 112.44 171.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -102.84 -113.81 3.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.45 -0.881 . . . . 0.5 112.689 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -154.45 30.15 0.43 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.087 0.47 . . . . 1.3 111.503 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 136' ' ' LEU . 30.6 m -125.22 124.0 40.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.157 -0.617 . . . . 0.32 112.254 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.3 mp -91.94 103.33 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.498 . . . . 1.23 111.419 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.789 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 30.7 m-85 -85.54 126.33 33.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.906 0.384 . . . . 0.38 111.842 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.4 m -126.91 124.63 39.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.501 -0.772 . . . . 1.1 109.959 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 18.6 ptpt -98.75 86.94 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.655 0.74 . . . . 2.44 109.369 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -106.75 174.01 6.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.89 0.852 . . . . 1.27 112.52 -173.152 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.64 127.68 5.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.599 -1.182 . . . . 1.79 110.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.27 -3.25 48.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.87 110.768 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -74.71 -46.62 36.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.281 -0.872 . . . . 3.03 109.897 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -106.61 -11.1 15.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.612 -1.176 . . . . 1.2 111.182 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HA ' HD23 ' A' ' 158' ' ' LEU . 54.6 mttp 62.78 15.82 8.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.339 -0.846 . . . . 2.27 112.706 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.16 -65.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.892 0.854 . . . . 2.64 110.912 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -67.04 -11.43 58.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.764 -1.107 . . . . 0.62 113.267 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 155' ' ' LYS . 4.2 mm? -64.44 -44.56 90.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.314 0.557 . . . . 1.55 109.844 178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.9 -48.36 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.053 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.93 -35.06 77.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.73 111.22 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' ILE . 65.5 tp -61.85 -57.84 10.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.558 -0.292 . . . . 0.91 111.398 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 165' ' ' ILE . 4.0 pp -63.08 -29.93 71.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.755 -0.202 . . . . 1.06 110.877 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 162' ' ' LEU . 52.1 mm-40 -63.58 -41.3 98.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 2.49 110.71 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.549 ' HB3' HG21 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -73.02 -38.68 66.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.669 0.271 . . . . 0.87 110.964 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 81' ' ' ILE . 85.6 mt -55.36 -52.73 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.931 -0.577 . . . . 0.64 110.991 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 57' ' ' ILE . 3.7 pp -71.19 -35.42 71.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.668 0.27 . . . . 1.81 111.526 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 166' ' ' LEU . 61.8 tp -52.12 -32.25 34.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.747 -0.661 . . . . 1.42 110.212 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 19.6 t -74.06 -51.47 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.912 -0.585 . . . . 1.17 110.26 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.5 m -59.76 -33.47 71.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 1.54 110.201 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -48.78 21.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 2.79 111.207 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 24.6 ptt? -71.66 -24.36 61.84 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.554 -0.458 . . . . 1.82 111.443 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 42.6 mt-10 -47.38 -53.3 14.22 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 3.45 111.383 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.93 -8.23 54.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 3.36 111.423 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 171' ' ' MET . 3.0 tm? -90.52 -49.06 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.002 0.43 . . . . 4.14 110.345 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -155.78 -76.27 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.1 -0.5 . . . . 6.31 110.314 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . 60.36 77.13 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 O-C-N 123.837 0.71 . . . . 4.57 111.742 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.78 96.64 41.74 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 6.38 110.121 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.684 2.256 . . . . 7.47 111.644 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 N-CA-C 111.8 -0.52 . . . . 16.35 111.8 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -74.04 122.53 22.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.698 0.249 . . . . 14.69 110.8 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 54.12 57.61 5.77 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 14.68 111.325 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -85.38 76.39 10.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.497 -0.774 . . . . 12.73 110.161 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -64.75 136.52 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.625 -0.716 . . . . 10.18 110.895 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 31.4 mm-40 -80.55 64.43 5.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.784 -0.644 . . . . 9.14 110.558 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.0 93.72 11.4 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 8.35 109.755 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 71.5 Cg_endo -86.58 115.14 1.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.836 2.357 . . . . 4.6 112.161 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 56' ' ' LYS . 22.9 Cg_exo -64.78 104.29 0.54 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.935 2.424 . . . . 4.29 111.608 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.9 t -78.1 92.33 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.054 0.454 . . . . 2.58 110.29 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.029 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 4.2 t -76.2 82.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 83' ' ' ILE . 20.0 m -77.7 123.03 26.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.332 -0.849 . . . . 0.66 110.793 -173.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 24' ' ' LEU . 15.0 tt -86.61 135.57 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.486 0.66 . . . . 1.03 109.276 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.567 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 37.6 mtt -140.67 -175.58 4.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.455 -0.793 . . . . 1.04 110.954 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.835 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.86 -99.04 0.22 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.09 -1.204 . . . . 1.55 110.09 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.415 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 29.5 t60 -156.19 156.13 33.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.72 -56.35 18.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.653 0.263 . . . . 1.62 111.614 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.91 -18.37 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.314 0.487 . . . . 1.78 112.314 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 7.3 m170 -57.62 -37.03 72.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.012 0.435 . . . . 0.65 111.042 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 127.56 59.17 0.13 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.527 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -87.22 -37.18 17.49 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.512 -0.551 . . . . 2.11 109.512 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -68.99 -44.67 72.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.518 -0.765 . . . . 1.8 110.022 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -71.37 -16.91 62.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.178 -0.465 . . . . 1.77 110.398 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 13' ' ' ILE . 5.8 tt -81.17 -53.77 6.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.083 -0.71 . . . . 1.78 109.083 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -64.09 -36.07 82.83 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.211 -0.449 . . . . 1.96 110.022 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.25 -54.53 39.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 1.38 111.46 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.02 79.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.973 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.1 tt -72.59 -30.33 33.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.717 -0.674 . . . . 1.56 109.961 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 2.0 tpt180 -74.09 -33.34 63.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.603 -0.726 . . . . 3.56 110.084 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -73.01 -12.11 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 2.88 110.507 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.1 t -93.05 -61.25 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.823 -0.806 . . . . 1.76 108.823 173.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 51.47 151.99 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.4 1.48 . . . . 5.71 114.542 176.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.672 HG21 HG13 ' A' ' 50' ' ' VAL . 15.4 m -126.57 -33.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.267 -0.879 . . . . 2.99 111.652 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -153.86 -74.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 3.93 111.298 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 1.026 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 10.3 mm-40 -81.64 164.53 21.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.108 -0.33 . . . . 4.2 110.108 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -177.19 65.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.367 0.603 . . . . 5.38 110.639 -175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.6 -73.17 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.729 -0.669 . . . . 5.79 110.526 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.757 ' O ' ' HA ' ' A' ' 47' ' ' ALA . . . -159.97 130.08 5.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.288 -0.869 . . . . 4.24 109.554 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.51 67.58 2.83 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.084 -0.579 . . . . 4.95 114.192 -170.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.42 -36.25 2.22 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.368 0.507 . . . . 6.66 114.368 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.41 -32.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.529 0.566 . . . . 9.17 112.529 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.451 ' HB ' ' CG1' ' A' ' 45' ' ' ILE . 2.5 m -78.25 -5.02 50.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.828 0.346 . . . . 7.36 111.299 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.787 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 90.2 mt-30 69.32 -67.12 0.23 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.788 0.835 . . . . 8.83 112.578 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -82.1 30.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.926 0.393 . . . . 6.76 111.875 -173.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 47' ' ' ALA . 44.1 mm -122.2 155.19 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 5.19 109.644 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -95.48 21.03 46.76 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.69 -0.687 . . . . 2.97 111.831 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.757 ' HA ' ' O ' ' A' ' 38' ' ' ALA . . . 61.35 -77.49 0.03 OUTLIER 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.984 0.913 . . . . 1.71 112.052 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 27.3 p90 -167.79 157.23 9.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.207 -1.035 . . . . 2.54 108.207 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.026 ' H ' ' HB2' ' A' ' 35' ' ' GLU . 50.2 mt-30 -118.76 137.92 53.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.939 0.4 . . . . 1.96 110.642 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.815 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 72.7 t -91.54 150.64 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.875 0.845 . . . . 1.93 110.991 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 54' ' ' ASP . 21.0 m -115.26 103.65 11.04 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.836 -1.529 . . . . 2.06 110.724 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 93.3 t -126.81 119.67 53.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.337 -1.357 . . . . 4.12 107.337 169.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 59.4 t30 73.87 -50.06 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 124.096 0.873 . . . . 4.43 110.324 -173.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 51' ' ' THR . 15.6 t70 -145.15 -68.78 0.29 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.265 -0.88 . . . . 3.62 111.839 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 26.0 ttpp 161.76 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 124.31 1.006 . . . . 7.44 108.604 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 27.3 mtpp -133.58 -26.71 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.267 0.469 . . . . 5.43 112.267 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 11' ' ' VAL . 55.5 mt -86.89 103.51 13.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.642 -0.423 . . . . 1.14 111.927 -171.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 13.4 m -94.44 107.91 19.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.493 -0.321 . . . . 1.28 110.262 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -81.48 93.47 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.84 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.9 tp -98.79 132.86 43.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.647 -0.252 . . . . 3.0 110.874 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 31.9 t0 -114.77 144.04 44.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.798 -0.815 . . . . 6.48 108.798 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.716 HG21 ' HA ' ' A' ' 67' ' ' ALA . 16.0 m -115.53 94.66 40.82 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 5.57 111.428 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HG2' ' HG2' ' A' ' 43' ' ' GLN . 61.1 Cg_endo -95.62 42.23 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.322 2.681 . . . . 5.77 112.169 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.55 -133.77 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 5.54 112.748 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -88.0 174.48 8.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 8.09 111.724 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 62.27 37.0 14.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.165 -0.925 . . . . 6.36 111.25 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' A' ' 62' ' ' THR . . . -64.97 103.63 0.75 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.761 -0.654 . . . . 3.51 110.714 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 20.6 t80 61.05 64.35 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.499 -0.773 . . . . 2.61 110.944 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.745 HG21 HG11 ' A' ' 78' ' ' VAL . 44.7 p 62.99 144.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.522 1.129 . . . . 4.74 113.572 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.9 m -79.89 78.25 6.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.233 -0.894 . . . . 5.89 110.304 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 63.7 mtt -62.2 -17.42 58.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.632 -0.713 . . . . 5.64 112.165 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.19 -7.66 54.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.383 . . . . 9.71 110.589 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.33 -57.67 1.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.144 -0.48 . . . . 7.52 109.943 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.24 127.83 21.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.086 0.469 . . . . 10.42 110.481 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.07 65.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.508 -0.637 . . . . 6.75 111.508 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.61 -53.43 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 6.69 110.575 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -141.41 40.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.319 0.58 . . . . 7.72 110.365 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.745 HG11 HG21 ' A' ' 69' ' ' THR . 9.3 t -78.39 72.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.063 -0.717 . . . . 4.38 109.063 175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 108' ' ' VAL . 17.0 m -87.14 89.79 8.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.453 -0.794 . . . . 4.18 111.722 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 8.3 m-20 -97.3 -169.83 1.92 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.364 -0.606 . . . . 3.12 109.364 169.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.029 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 40.2 mm -98.89 133.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 121.136 -0.226 . . . . 0.74 111.485 -173.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.679 HG21 ' HB1' ' A' ' 103' ' ' ALA . 92.3 t -113.78 106.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.541 -0.299 . . . . 1.19 111.077 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -94.39 99.65 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 175.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 15.1 tp -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.146 -0.479 . . . . 1.33 111.254 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.835 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.5 p -79.39 141.54 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.372 0.606 . . . . 1.2 110.809 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 114' ' ' ILE . 26.7 m -140.94 -160.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.569 -1.271 . . . . 1.12 107.569 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.14 147.99 34.45 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.139 -0.624 . . . . 0.75 111.684 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -35.25 -59.33 0.52 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.606 1.191 . . . . 1.18 112.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.79 -9.87 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.507 . . . . 2.01 112.1 -172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.49 -51.3 5.99 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.293 0.568 . . . . 1.09 111.402 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 85.65 -136.93 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.248 -0.887 . . . . 0.52 111.62 -172.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.971 HG13 ' HB ' ' A' ' 96' ' ' THR . 37.7 t -101.18 114.08 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 122.898 0.479 . . . . 1.08 111.248 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 39.5 mtp -81.19 169.79 17.85 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 1.32 110.025 172.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.1 Cg_endo -44.9 -48.01 11.25 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.121 2.547 . . . . 0.61 113.324 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.35 -25.95 62.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.579 0.228 . . . . 1.47 110.83 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.971 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.5 m -64.54 -22.58 67.01 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.46 110.389 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.69 -38.84 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.516 -0.311 . . . . 1.05 110.821 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.0 -29.49 65.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.877 0.37 . . . . 1.62 111.49 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.567 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.31 -37.54 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.511 . . . . 0.34 109.661 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.598 HG12 HG12 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -72.63 -49.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.38 110.384 178.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -45.1 -35.62 3.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.385 0.674 . . . . 1.85 111.122 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -83.19 -34.68 25.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.85 111.2 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.95 -33.12 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.916 0.709 . . . . 0.48 112.916 -170.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.73 -16.92 60.72 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.114 0.483 . . . . 2.56 110.326 -167.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.8 7.66 44.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.76 112.307 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 108' ' ' VAL . . . -108.99 3.2 21.9 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.212 -0.662 . . . . 0.9 109.212 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 73.65 34.1 0.98 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.316 -1.364 . . . . 2.06 107.316 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 79' ' ' THR . 9.6 t -91.96 143.99 28.55 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 112.425 -2.171 . . . . 1.08 110.597 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 4.7 Cg_exo -74.17 142.88 31.3 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.344 2.029 . . . . 0.51 113.061 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 145' ' ' THR . 1.6 mp -121.6 143.4 34.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 113.19 -1.823 . . . . 0.96 109.442 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.766 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 11.3 mt -118.6 155.84 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 108.69 -0.855 . . . . 0.71 108.69 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -118.0 136.07 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 109.936 -0.394 . . . . 0.23 109.936 174.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.33 87.92 2.84 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.24 -1.022 . . . . 0.25 108.24 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.864 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 4.5 mm -66.09 88.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.546 -1.206 . . . . 0.85 109.658 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.12 161.29 18.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.525 -0.176 . . . . 0.69 110.525 -171.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.5 tttm 62.42 29.93 17.24 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.171 0.986 . . . . 2.61 109.402 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.668 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 3.0 tpp -109.97 10.04 24.3 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.689 -1.141 . . . . 1.37 111.041 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' HB3' ' CB ' ' A' ' 151' ' ' SER . 4.9 p-10 -64.84 43.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.963 0.887 . . . . 2.45 112.873 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.957 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 99.1 mttt -120.77 -163.97 0.05 OUTLIER Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 105.669 -1.974 . . . . 3.7 105.669 166.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.957 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 11.6 Cg_endo -59.58 -53.79 3.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 CA-C-N 120.401 1.179 . . . . 2.67 111.306 164.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.653 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 12.9 pt-20 168.4 127.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.532 0.733 . . . . 4.03 109.261 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.1 -62.36 1.53 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.437 -0.802 . . . . 1.47 109.336 166.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 126' ' ' ARG . 50.5 t30 -177.79 80.53 0.24 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.623 -0.717 . . . . 1.84 110.618 169.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.653 ' CD ' ' HB2' ' A' ' 121' ' ' GLU . 6.4 Cg_endo -47.73 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.178 3.252 . . . . 0.7 113.744 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -46.28 -43.23 15.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.774 0.657 . . . . 2.0 112.774 -175.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.488 ' HB2' ' ND2' ' A' ' 123' ' ' ASN . 4.1 tmt_? -56.94 -53.99 51.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.428 0.632 . . . . 2.99 109.775 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.751 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 47.3 t -60.64 -45.18 97.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.614 -1.176 . . . . 0.4 109.559 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.672 ' HA ' ' CZ ' ' A' ' 147' ' ' PHE . 86.3 mtp -64.2 -32.14 73.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.425 -0.807 . . . . 0.3 111.609 -176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.6 mt-30 -83.41 -20.83 33.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.019 0.438 . . . . 1.28 110.283 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.751 ' OE1' ' HA ' ' A' ' 127' ' ' VAL . 3.0 pt-20 -79.05 -27.68 43.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.111 -0.7 . . . . 2.02 109.111 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.1 mm? -71.72 -42.69 67.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.542 0.687 . . . . 1.06 109.597 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.909 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.6 ppp? -77.11 -2.36 33.85 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.086 -0.961 . . . . 0.35 109.719 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.22 -27.09 35.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.674 -1.232 . . . . 2.18 107.674 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.456 ' HE2' HG11 ' A' ' 92' ' ' VAL . 25.6 m-85 -85.99 4.85 35.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.73 -0.841 . . . . 0.74 108.73 169.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.7 m120 75.11 19.35 2.32 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.203 -1.362 . . . . 1.94 111.126 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.3 mp -97.52 77.72 2.62 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.665 -1.235 . . . . 1.68 107.665 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.546 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.05 129.87 92.3 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 113.559 -1.655 . . . . 0.61 110.799 -176.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.873 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 99.7 Cg_exo -47.16 152.92 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.897 2.398 . . . . 0.3 112.78 172.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -73.65 -29.84 62.57 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.17 -1.377 . . . . 2.01 107.844 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.773 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -49.08 -47.56 44.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.549 -1.205 . . . . 1.14 109.462 168.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.909 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.1 m0 -92.66 -17.65 24.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.967 -1.015 . . . . 0.45 111.2 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.18 19.85 5.77 Favored Glycine 0 CA--C 1.507 -0.41 0 C-N-CA 119.612 -1.28 . . . . 0.45 112.892 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.12 -113.65 2.23 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.205 -0.998 . . . . 0.5 112.017 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -150.07 19.9 0.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.649 0.24 . . . . 1.3 111.649 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 110' ' ' ILE . 23.4 m -125.87 115.09 19.43 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.81 -0.756 . . . . 0.32 112.572 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.1 mp -84.56 110.73 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.526 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.873 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.4 m-85 -87.32 121.26 29.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.215 0.531 . . . . 0.38 111.673 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 61.5 m -115.87 103.52 10.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.764 -0.653 . . . . 1.1 110.012 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.864 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 12.1 ptmm? -81.64 84.61 6.74 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.687 -0.857 . . . . 2.44 108.687 172.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.886 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.08 -175.02 2.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.045 -0.98 . . . . 1.27 112.574 -168.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.471 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 34.0 t -150.41 117.96 6.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.88 -1.055 . . . . 1.79 109.687 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 24' ' ' LEU . . . -74.4 -28.78 61.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.87 110.777 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 11.2 ptmm? -77.42 -50.4 12.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.807 0.813 . . . . 3.03 110.58 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.406 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 6.0 m -77.65 -11.69 59.89 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.425 -1.261 . . . . 1.2 111.655 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 71.25 -20.35 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.012 0.745 . . . . 2.27 113.012 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 154' ' ' THR . 10.8 tp10 -43.3 -63.18 0.87 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.617 0.722 . . . . 2.64 111.809 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.886 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.15 -17.69 74.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.329 -0.851 . . . . 0.62 113.663 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.5 mt -66.45 -46.08 77.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.469 0.635 . . . . 1.55 110.685 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.88 -37.65 88.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.826 -0.625 . . . . 2.5 110.212 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.609 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 78.4 t60 -73.38 -26.02 60.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.73 111.067 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.76 -47.26 75.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.421 -0.585 . . . . 0.91 109.421 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.5 mt -53.61 -44.0 69.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.802 -0.635 . . . . 1.06 110.642 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.609 ' OE1' ' HA ' ' A' ' 160' ' ' HIS . 45.3 mt-10 -54.99 -43.14 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.068 0.461 . . . . 2.49 110.866 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.713 ' HB3' HG21 ' A' ' 146' ' ' ILE . 8.4 mmt -71.2 -31.48 67.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.87 110.651 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 162' ' ' LEU . 79.7 mt -63.95 -53.02 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 0.64 110.524 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.58 -33.91 70.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.173 0.435 . . . . 1.81 112.173 174.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.67 -41.48 77.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.15 -0.685 . . . . 1.42 109.15 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 171' ' ' MET . 38.1 t -79.07 -29.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.867 -0.606 . . . . 1.17 110.86 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 m -57.83 -32.18 67.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.869 0.366 . . . . 1.54 110.626 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.61 -27.78 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 2.79 110.832 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.503 ' HB3' ' HA ' ' A' ' 168' ' ' VAL . 39.2 ttp -70.28 -13.79 62.32 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.327 -0.397 . . . . 1.82 110.233 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 5.2 mm-40 -46.78 -38.16 9.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 3.45 112.045 171.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -76.12 -23.18 54.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.033 0.444 . . . . 3.36 110.908 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 52.5 tp -95.25 -0.9 52.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.354 0.597 . . . . 4.14 109.872 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.602 ' HD2' HG21 ' A' ' 79' ' ' THR . 7.9 ttpm? -61.2 105.69 0.52 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.679 -0.692 . . . . 6.31 109.912 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.2 122.09 36.37 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.69 -0.686 . . . . 4.57 111.341 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.713 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 51.4 m-80 -86.0 -51.7 0.47 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.68 -0.691 . . . . 6.38 109.856 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.713 ' HD3' ' HB2' ' A' ' 177' ' ' ASN . 4.4 Cg_exo . . . . . 0 C--O 1.252 1.211 0 C-N-CA 122.67 2.247 . . . . 7.47 111.57 174.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.938 -0.465 . . . . 16.35 111.938 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 5.1 t -82.78 99.06 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.146 -0.687 . . . . 14.69 109.146 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 2' ' ' SER . 83.9 m-70 72.47 127.78 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.868 0.73 . . . . 14.68 110.26 -173.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -78.77 83.75 4.89 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.881 -0.599 . . . . 12.73 111.042 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 m -104.13 -27.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.907 -0.588 . . . . 10.18 110.472 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 35.0 tt0 -107.49 66.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.388 -0.597 . . . . 9.14 109.388 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.817 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 50.1 mtm180 -88.63 -63.36 0.21 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.826 -0.625 . . . . 8.35 111.888 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.817 ' HD3' ' HB2' ' A' ' 7' ' ' ARG . 19.9 Cg_exo -66.05 116.28 3.91 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.41 2.073 . . . . 4.6 111.941 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.779 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 71.8 Cg_endo -70.53 -174.22 1.01 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 123.685 2.923 . . . . 4.29 113.711 -168.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -57.42 179.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 122.908 0.483 . . . . 2.58 111.259 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -109.22 133.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 121.476 -0.765 . . . . 1.0 111.175 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 68' ' ' PHE . 6.7 m -92.95 122.47 35.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.681 -0.69 . . . . 0.66 111.272 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.728 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 33.3 mt -104.47 122.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.866 -0.42 . . . . 1.03 109.866 172.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.56 165.57 19.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.187 -0.461 . . . . 1.04 110.075 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.828 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 166.27 -107.75 0.3 Allowed Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.486 -1.046 . . . . 1.55 110.486 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.451 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 60.1 t60 -159.21 137.58 10.65 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.431 -0.952 . . . . 0.66 108.431 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -59.93 -31.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.257 -0.883 . . . . 1.62 113.201 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.92 -20.57 52.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.271 . . . . 1.78 111.309 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.451 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 47.8 m170 -70.34 -2.61 14.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.152 0.501 . . . . 0.65 111.282 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.65 43.55 3.89 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.772 -0.728 . . . . 0.93 112.848 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -66.45 -39.42 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.276 0.56 . . . . 2.11 109.823 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -67.01 -36.04 81.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.414 -0.812 . . . . 1.8 109.82 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -67.78 -35.91 79.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.676 -0.693 . . . . 1.77 110.273 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 47.4 tp -65.36 -49.11 70.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.706 . . . . 1.78 110.209 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.649 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.96 -32.21 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 1.96 110.051 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 28.6 t70 -66.14 -56.8 9.63 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.171 -0.331 . . . . 1.38 111.481 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -61.35 -30.62 70.63 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.07 0.462 . . . . 0.91 110.89 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' A' ' 158' ' ' LEU . 3.1 tt -74.32 -27.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.644 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 74.9 mtm180 -80.23 -32.47 38.41 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 3.56 109.807 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -65.62 -8.51 20.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.136 -0.938 . . . . 2.88 109.918 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.44 -41.94 19.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.626 -0.715 . . . . 1.76 109.47 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 40.5 mmtm 61.55 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.595 0.758 . . . . 5.71 112.631 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.748 HG21 HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -146.98 -55.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.736 -0.665 . . . . 2.99 112.742 -174.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.897 HG22 ' HG3' ' A' ' 35' ' ' GLU . 71.6 m -152.25 -78.78 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.602 0.593 . . . . 3.93 112.602 -168.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.897 ' HG3' HG22 ' A' ' 34' ' ' THR . 41.9 mt-10 -118.67 -178.99 3.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.003 0.43 . . . . 4.2 111.921 -173.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 1.026 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 24.0 pt20 -151.02 162.69 40.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.362 -0.977 . . . . 5.38 108.362 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -156.87 173.77 16.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.847 0.356 . . . . 5.79 111.221 -169.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . . . -95.64 115.41 27.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 4.24 110.33 175.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' HB2' ' A' ' 47' ' ' ALA . . . 148.09 -146.3 15.76 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.666 -0.574 . . . . 4.95 111.666 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.49 -66.83 1.6 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.18 -0.533 . . . . 6.66 112.655 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.13 -46.65 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.237 0.542 . . . . 9.17 110.257 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 43' ' ' GLN . 23.4 m -156.01 168.25 27.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.985 -1.117 . . . . 7.36 107.985 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 42' ' ' THR . 14.0 pt20 -75.76 26.08 0.11 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.758 0.651 . . . . 8.83 112.758 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.66 -172.73 2.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.918 -1.512 . . . . 6.76 106.918 164.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 13.8 tt -72.58 153.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 118.786 -1.165 . . . . 5.19 109.127 172.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.652 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . 152.18 -12.51 0.7 Allowed Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.319 -0.943 . . . . 2.97 112.894 -174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB2' ' C ' ' A' ' 39' ' ' GLY . . . -92.0 -172.33 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.507 -0.553 . . . . 1.71 109.507 175.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 1.026 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.2 p90 -168.61 177.47 5.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.8 -0.445 . . . . 2.54 109.8 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.814 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 71.8 mt-30 -139.07 113.36 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.136 -1.061 . . . . 1.96 108.136 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.769 ' HB ' ' HE2' ' A' ' 48' ' ' TYR . 4.6 p -97.07 155.06 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.976 0.893 . . . . 1.93 111.914 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.6 m -130.0 83.94 2.17 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.18 -1.373 . . . . 2.06 110.243 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 54' ' ' ASP . 70.0 t -123.68 122.87 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.189 -1.412 . . . . 4.12 107.189 171.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' HG ' ' A' ' 166' ' ' LEU . 23.6 t-20 75.96 -26.74 0.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 122.473 1.13 . . . . 4.43 109.724 -172.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.8 t70 85.62 66.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.377 -2.192 . . . . 3.62 111.596 173.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.748 ' HD2' ' HB3' ' A' ' 166' ' ' LEU . 42.5 mttp -115.75 3.65 13.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.149 -0.932 . . . . 7.44 109.486 170.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 51.1 mttp 52.2 45.71 27.92 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.211 -1.359 . . . . 5.43 111.455 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 166' ' ' LEU . 4.8 mt -59.08 115.52 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.859 . . . . 1.14 111.415 -171.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' HG12 ' A' ' 10' ' ' VAL . 16.9 m -92.64 125.65 37.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.154 -0.684 . . . . 1.28 109.154 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -100.94 116.46 32.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.461 0.541 . . . . 0.84 112.461 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 13' ' ' ILE . 86.1 mt 58.73 56.28 4.25 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.722 -1.126 . . . . 3.0 113.309 170.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' C ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 t70 -71.37 93.96 1.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.553 -0.906 . . . . 6.48 108.553 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 66' ' ' GLU . 2.9 p -126.0 65.33 55.35 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.093 0.775 . . . . 5.57 113.093 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' C ' ' A' ' 61' ' ' ASP . 55.5 Cg_endo -102.19 37.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.446 2.764 . . . . 5.77 111.138 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.81 35.4 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.705 -0.759 . . . . 5.54 112.02 -174.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 30.5 m170 -127.09 -77.26 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.729 -0.841 . . . . 8.09 108.729 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 62' ' ' THR . 1.3 mp0 62.24 178.36 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.975 -1.012 . . . . 6.36 112.449 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 54.05 -105.87 0.28 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.005 -0.998 . . . . 3.51 111.705 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' CE1' ' HG2' ' A' ' 71' ' ' MET . 24.1 t80 -138.46 84.48 2.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 2.61 110.037 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 65' ' ' HIS . 7.1 p -140.96 145.01 35.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.843 -0.617 . . . . 4.74 110.115 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.779 ' HB ' ' HB2' ' A' ' 9' ' ' PRO . 38.1 p 54.35 97.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.886 0.741 . . . . 5.89 112.335 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.714 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -147.39 107.57 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.248 0.833 . . . . 5.64 113.248 -175.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HA ' HG13 ' A' ' 81' ' ' ILE . 17.4 tpt180 -173.43 -55.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.457 -0.338 . . . . 9.71 111.818 169.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.47 -76.89 0.05 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 111.916 0.339 . . . . 7.52 111.916 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 47.2 ttt180 -162.8 113.34 1.46 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.925 0.49 . . . . 10.42 110.531 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.514 ' C ' ' HA ' ' A' ' 9' ' ' PRO . . . 156.45 -135.9 4.72 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.77 -0.729 . . . . 6.75 112.614 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 9' ' ' PRO . . . -162.89 106.8 1.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.484 0.313 . . . . 6.69 110.599 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 9' ' ' PRO . 25.8 tt0 -174.46 154.57 2.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.723 0.297 . . . . 7.72 110.315 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -79.63 103.75 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.638 -0.505 . . . . 4.38 109.638 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -127.41 -147.19 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.046 -0.524 . . . . 4.18 109.77 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 108' ' ' VAL . 5.5 p-10 -153.21 103.51 2.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.613 0.598 . . . . 3.12 112.613 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.607 HG13 ' HA ' ' A' ' 72' ' ' ARG . 15.6 mm -151.76 113.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.933 -0.576 . . . . 0.74 109.649 170.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.981 HG21 ' HB1' ' A' ' 103' ' ' ALA . 99.0 t -118.86 101.58 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 O-C-N 122.173 -0.329 . . . . 1.19 111.101 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 7.0 mm -79.03 121.28 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.776 -1.194 . . . . 1.32 107.776 170.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -118.75 103.59 9.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.855 -176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.6 p -89.24 146.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.294 0.568 . . . . 1.2 112.09 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 114' ' ' ILE . 21.5 m -141.59 -175.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.926 -1.033 . . . . 1.12 108.223 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.47 134.37 13.0 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.341 -0.544 . . . . 0.75 112.078 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . 51.47 -125.21 2.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.295 -0.866 . . . . 1.18 112.146 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -105.3 5.17 31.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.92 0.39 . . . . 2.01 110.022 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.78 -32.64 71.96 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.57 0.7 . . . . 1.09 109.75 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.773 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 68.42 -134.74 28.77 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 114.706 -1.133 . . . . 0.52 111.677 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 96' ' ' THR . 64.2 t -102.32 103.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.145 0.498 . . . . 1.08 111.033 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.573 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.4 mmm -72.77 170.74 12.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 1.32 110.631 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 72.4 Cg_exo -42.69 -51.21 5.4 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.789 2.326 . . . . 0.61 113.09 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.02 -37.87 89.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.47 110.717 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.726 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.1 m -62.18 -35.27 78.32 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.965 -0.562 . . . . 0.46 110.376 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.715 HG23 HG12 ' A' ' 92' ' ' VAL . 41.1 t -74.15 -50.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.152 -0.476 . . . . 1.05 110.688 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.52 -31.22 34.44 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.547 0.53 . . . . 1.62 111.528 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.03 -37.86 28.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.34 109.895 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.774 HG12 HD13 ' A' ' 110' ' ' ILE . 1.5 mt -75.45 -37.66 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.646 -0.706 . . . . 0.38 110.47 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -34.93 68.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.731 0.776 . . . . 1.85 109.737 174.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -85.15 -30.65 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.831 -1.077 . . . . 0.85 110.551 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.981 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.41 -49.2 10.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.48 111.9 -173.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -53.08 -27.24 19.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.39 0.885 . . . . 2.56 113.39 -166.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.1 10.87 36.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.079 0.77 . . . . 0.76 113.079 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.481 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -97.57 2.37 49.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.213 -0.662 . . . . 0.9 109.213 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t30 71.3 46.64 0.42 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 123.11 1.433 . . . . 2.06 107.831 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.657 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -129.5 143.06 47.43 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 112.809 -1.996 . . . . 1.08 111.194 -168.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 108' ' ' VAL . 21.9 Cg_exo -67.26 156.41 66.38 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.486 2.124 . . . . 0.51 112.982 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.774 HD13 HG12 ' A' ' 100' ' ' ILE . 85.1 mt -124.48 141.85 43.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.702 -1.135 . . . . 0.96 109.201 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.706 HD13 HD13 ' A' ' 83' ' ' ILE . 3.7 mt -125.93 96.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 C-N-CA 120.35 -0.54 . . . . 0.71 111.238 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -65.82 139.82 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.005 -0.998 . . . . 0.23 110.265 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -124.02 89.37 3.07 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.868 -1.16 . . . . 0.25 107.868 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.637 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 9.7 mm -65.92 86.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.565 -1.198 . . . . 0.85 110.197 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.05 148.45 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.69 110.721 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 60.63 33.31 20.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.404 -0.817 . . . . 2.61 110.758 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.418 ' HB3' HG22 ' A' ' 114' ' ' ILE . 1.4 ppp? -87.73 -0.74 57.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.812 -0.631 . . . . 1.37 110.007 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.17 -33.78 20.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.973 -1.012 . . . . 2.45 111.639 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.561 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 18.0 pttp -120.61 158.23 52.16 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.264 . . . . 3.7 110.718 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 5.2 Cg_endo -48.58 -4.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 1 C-N-CA 125.749 4.299 . . . . 2.67 117.044 -171.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -21.54 65.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 4.03 110.125 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 88' ' ' ALA . . . -98.53 127.87 44.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.598 -0.728 . . . . 1.47 110.4 173.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 16.4 t-20 -124.45 89.38 52.19 Favored Pre-proline 0 CA--C 1.51 -0.583 0 CA-C-O 121.228 0.537 . . . . 1.84 111.016 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -16.12 -82.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.119 1 C-N-CA 126.301 4.667 . . . . 0.7 116.579 172.73 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -43.81 -55.31 4.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.345 0.658 . . . . 2.0 112.344 -169.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 tpt85 -56.17 -62.16 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.401 0.62 . . . . 2.99 110.786 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.773 HG13 ' HA2' ' A' ' 91' ' ' GLY . 28.1 t -51.82 -49.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.441 -1.254 . . . . 0.4 110.489 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.625 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 86.5 mtp -66.45 -33.04 74.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 0.3 111.96 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.534 ' O ' ' HG3' ' A' ' 132' ' ' MET . 87.0 mt-30 -76.38 -26.2 55.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.813 -0.44 . . . . 1.28 109.813 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.458 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -71.12 -31.11 67.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.239 -0.652 . . . . 2.02 109.239 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 136' ' ' LEU . 2.8 mm? -68.54 -46.31 69.86 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.506 0.669 . . . . 1.06 109.716 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.863 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.3 ppp? -73.31 -4.57 34.12 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.392 -0.822 . . . . 0.35 110.0 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -81.77 -24.63 35.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.039 -0.726 . . . . 2.18 109.039 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.607 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 39.5 m-85 -84.75 0.61 50.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.896 . . . . 0.74 108.582 167.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 74.14 45.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 113.967 -1.47 . . . . 1.94 109.464 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -126.19 83.36 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.028 -1.442 . . . . 1.68 107.439 170.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.876 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.23 131.42 94.35 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.592 -1.64 . . . . 0.61 111.28 -173.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.741 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 87.5 Cg_exo -49.87 155.47 4.1 Favored 'Trans proline' 0 CA--C 1.516 -0.377 0 C-N-CA 123.315 2.677 . . . . 0.3 113.705 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 146' ' ' ILE . 6.8 mm-40 -80.17 -19.18 47.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.53 -1.214 . . . . 2.01 109.268 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.808 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -58.24 -40.17 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.501 -0.926 . . . . 1.14 108.501 167.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.863 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.3 m0 -96.71 -21.43 17.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.384 -1.28 . . . . 0.45 110.841 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.49 25.22 5.84 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.372 -0.918 . . . . 0.45 112.43 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.876 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.47 -101.11 1.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.721 -0.752 . . . . 0.5 112.612 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -165.11 27.01 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.244 0.545 . . . . 1.3 111.114 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.772 HG21 HD12 ' A' ' 136' ' ' LEU . 62.2 m -130.17 116.85 19.03 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.241 -0.584 . . . . 0.32 112.389 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -82.14 109.04 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.546 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.741 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.9 m-85 -89.54 96.24 10.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.984 0.421 . . . . 0.38 111.186 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.444 ' O ' HD12 ' A' ' 150' ' ' LEU . 75.1 m -84.32 99.55 10.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.313 -0.625 . . . . 1.1 109.313 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.637 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 2.4 pttm -82.83 84.16 7.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.552 -0.907 . . . . 2.44 108.552 176.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.568 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.44 -179.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.298 -0.865 . . . . 1.27 112.97 -168.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p -152.94 111.28 3.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 1.79 110.156 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.95 64.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.362 -0.381 . . . . 0.87 111.237 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -75.14 -46.91 31.27 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.896 0.855 . . . . 3.03 110.15 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m -72.62 -14.78 61.68 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.251 -1.34 . . . . 1.2 110.397 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 27' ' ' ALA . 21.2 tptp 58.61 27.33 15.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.499 -1.228 . . . . 2.27 111.576 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -92.35 -67.43 0.86 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.534 0.683 . . . . 2.64 110.266 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.02 -13.04 69.26 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.248 -0.887 . . . . 0.62 113.55 -176.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 28' ' ' ILE . 3.3 tm? -60.54 -54.44 45.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 1.55 109.38 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.29 -33.75 76.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.293 -0.867 . . . . 2.5 109.89 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.682 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.7 t60 -65.38 -25.98 67.8 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.666 -0.697 . . . . 0.73 111.075 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 59.7 tp -66.59 -55.4 15.54 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.002 -0.369 . . . . 0.91 110.002 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 165' ' ' ILE . 92.1 mt -55.9 -41.6 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 1.06 110.723 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 6.4 pt-20 -69.48 -27.73 65.46 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.598 -0.441 . . . . 2.49 110.61 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.467 ' HG2' HG21 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -81.3 -32.2 33.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 0.87 109.821 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 162' ' ' LEU . 32.6 mt -55.41 -54.63 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.361 -0.836 . . . . 0.64 111.896 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.2 -30.06 34.39 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.748 -0.595 . . . . 1.81 111.969 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 171' ' ' MET . 10.3 tt -59.53 -31.56 69.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.849 -0.426 . . . . 1.42 109.849 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.779 HG21 HG12 ' A' ' 146' ' ' ILE . 25.2 t -87.37 -41.28 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.941 -0.572 . . . . 1.17 111.283 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 4.7 p -64.04 -24.17 67.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.317 . . . . 1.54 111.477 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.74 -21.69 18.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.644 0.259 . . . . 2.79 110.952 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 167' ' ' LEU . 55.9 ttp -68.82 -42.44 77.24 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.941 -0.392 . . . . 1.82 109.941 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 25.7 mm-40 -50.3 -31.36 14.16 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.946 0.779 . . . . 3.45 112.62 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.63 -34.86 65.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.142 0.496 . . . . 3.36 110.623 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -103.9 -49.56 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.956 -0.757 . . . . 4.14 108.956 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 61.54 -86.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.634 -1.166 . . . . 6.31 111.123 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.46 146.75 20.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.586 -0.734 . . . . 4.57 109.26 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -110.69 132.52 21.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.357 . . . . 6.38 110.035 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--O 1.25 1.103 0 C-N-CA 122.982 2.455 . . . . 7.47 111.932 178.822 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.867 -0.493 . . . . 16.35 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -77.62 67.12 3.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.343 0.592 . . . . 14.69 111.808 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -121.79 71.33 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.552 -0.907 . . . . 14.68 108.552 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.0 mmm -85.7 69.86 10.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.048 -0.524 . . . . 12.73 110.628 -171.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.98 35.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 10.18 111.151 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.35 -45.22 80.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 9.14 110.607 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -67.99 118.67 60.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.678 -0.692 . . . . 8.35 111.534 -174.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 18.0 Cg_endo -96.62 145.45 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.651 2.901 . . . . 4.6 111.316 172.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.13 128.75 21.27 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.243 1.962 . . . . 4.29 111.969 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.46 ' CG2' HG22 ' A' ' 79' ' ' THR . 5.3 m -77.67 81.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.945 0.879 . . . . 2.58 110.626 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.947 HG13 HG21 ' A' ' 81' ' ' ILE . 45.2 t -72.53 98.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.477 ' O ' HG13 ' A' ' 83' ' ' ILE . 19.3 m -80.42 128.09 33.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 0.66 111.452 -171.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 HD12 ' A' ' 83' ' ' ILE . 52.1 mt -94.95 128.52 46.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.041 -0.527 . . . . 1.03 110.271 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.599 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 55.6 mtt -125.29 -177.94 4.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.459 177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.92 130.44 4.45 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.504 -0.855 . . . . 1.55 110.984 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -50.69 138.38 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.512 . . . . 0.66 110.4 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 21' ' ' LYS . 30.3 m -61.63 -27.5 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.871 1.063 . . . . 1.62 113.871 -167.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.31 -19.16 60.57 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.025 0.38 . . . . 1.78 112.025 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -72.01 -34.26 68.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.761 0.282 . . . . 0.65 111.761 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.58 67.63 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.392 -0.909 . . . . 0.93 112.75 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HE3' HG22 ' A' ' 13' ' ' ILE . 14.0 mmmm -89.03 -56.33 3.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.067 0.461 . . . . 2.11 111.128 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -65.91 -18.08 65.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 1.8 110.799 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 p -74.75 -19.94 60.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.011 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 68.0 mt -69.01 -52.19 31.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.715 -0.394 . . . . 1.78 110.307 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.607 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 8.7 mp -60.32 -34.09 73.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 1.96 110.973 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.74 -51.38 41.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.882 0.327 . . . . 1.38 111.882 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -69.6 -33.33 72.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.91 111.008 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.63 HD11 HD21 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -66.06 -24.21 33.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.996 -0.547 . . . . 1.56 110.54 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 51.5 mtp180 -79.09 -21.65 46.39 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.215 0.531 . . . . 3.56 110.636 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -71.78 -7.74 50.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.718 0.77 . . . . 2.88 109.647 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.74 18.37 21.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.966 -1.016 . . . . 1.76 110.172 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' HG12 ' A' ' 33' ' ' VAL . 59.8 mttp 53.31 -133.42 1.81 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.795 -0.817 . . . . 5.71 108.795 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.84 HG23 ' HB ' ' A' ' 51' ' ' THR . 2.9 p 53.3 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.135 0.897 . . . . 2.99 112.981 167.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -109.99 115.89 30.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.382 0.611 . . . . 3.93 111.453 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.63 -42.28 12.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.045 -0.98 . . . . 4.2 110.049 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 41.9 mt-30 71.14 10.9 6.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.972 -1.013 . . . . 5.38 112.961 170.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.14 103.24 15.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.029 -0.268 . . . . 5.79 110.747 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.17 77.67 0.21 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.904 0.752 . . . . 4.24 112.374 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 48' ' ' TYR . . . -82.98 56.08 5.06 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.612 -0.804 . . . . 4.95 112.475 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.95 47.12 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.513 -0.851 . . . . 6.66 112.421 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.6 -43.54 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 9.17 110.431 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.2 m -80.42 114.39 19.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.403 -0.592 . . . . 7.36 109.403 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.31 93.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.416 0.627 . . . . 8.83 111.596 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -141.96 151.88 42.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.317 -0.856 . . . . 6.76 108.887 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.27 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 5.19 110.704 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.78 -46.67 1.2 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.864 -0.894 . . . . 2.97 110.864 -174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.78 169.25 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.708 -0.849 . . . . 1.71 108.708 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.731 ' HB2' ' HA ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -153.18 151.15 29.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.989 -0.684 . . . . 2.54 111.045 -169.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -107.13 153.97 21.86 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.39 -0.823 . . . . 1.96 108.857 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' A' ' 55' ' ' LYS . 71.7 t -92.9 172.05 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.468 -0.787 . . . . 1.93 109.259 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -51.94 161.05 0.62 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.365 1.078 . . . . 2.06 113.605 -167.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.1 p -101.32 127.73 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-N 115.231 -0.895 . . . . 4.12 110.85 -163.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.54 -31.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.204 0.94 . . . . 4.43 110.845 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.79 ' HB3' ' CG2' ' A' ' 51' ' ' THR . 31.4 t70 -85.85 -45.95 11.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.584 -0.28 . . . . 3.62 111.004 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HG3' HG21 ' A' ' 33' ' ' VAL . 49.9 mmtm -133.74 73.09 1.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.17 -0.612 . . . . 7.44 111.659 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.29 84.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 5.43 111.954 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 11' ' ' VAL . 48.3 mt -139.59 127.86 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 1.14 110.18 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -105.75 131.71 52.77 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.172 -0.677 . . . . 1.28 109.172 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.461 ' HE2' HG21 ' A' ' 50' ' ' VAL . 43.7 m-85 -116.46 110.53 18.74 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.979 -0.688 . . . . 0.84 111.104 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.596 HD23 ' SD ' ' A' ' 71' ' ' MET . 44.3 tp -117.16 114.48 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.763 -0.653 . . . . 3.0 110.106 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.41 131.36 54.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.538 -0.912 . . . . 6.48 108.538 171.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.95 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 19.9 m -119.3 97.32 50.33 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.396 -0.365 . . . . 5.57 110.934 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.52 44.65 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.262 2.641 . . . . 5.77 111.393 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.7 69.77 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.507 -0.77 . . . . 5.54 111.241 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.2 m170 70.18 -71.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.55 0.74 . . . . 8.09 111.001 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.39 130.92 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 6.36 110.093 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.95 ' HA ' ' HB ' ' A' ' 62' ' ' THR . . . -69.72 -26.89 64.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 3.51 111.977 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -84.35 68.0 10.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.806 0.336 . . . . 2.61 110.629 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.8 m -126.53 123.29 37.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.351 -0.386 . . . . 4.74 110.828 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 p 50.29 37.09 14.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.497 0.719 . . . . 5.89 112.776 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.596 ' SD ' HD23 ' A' ' 60' ' ' LEU . 47.4 ttp -136.55 110.6 8.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.457 . . . . 5.64 111.503 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -139.56 19.65 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.72 . . . . 9.71 109.685 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 74' ' ' ARG . . . 58.98 -164.52 0.2 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.216 -0.902 . . . . 7.52 110.385 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 73' ' ' ALA . 36.9 mmt180 -126.85 29.05 5.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.442 -0.577 . . . . 10.42 109.442 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.85 -173.84 22.04 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.525 -0.761 . . . . 6.75 112.146 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 75.08 -59.8 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.763 0.825 . . . . 6.69 112.692 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 7' ' ' ARG . 26.1 mm-40 -111.38 152.88 26.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.853 0.359 . . . . 7.72 111.159 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -75.69 147.61 7.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.78 -0.645 . . . . 4.38 111.278 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.46 HG22 ' CG2' ' A' ' 10' ' ' VAL . 39.8 p -111.2 0.28 16.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 4.18 110.679 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 108' ' ' VAL . 47.4 m-20 -86.89 61.85 7.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 3.12 111.188 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.947 HG21 HG13 ' A' ' 11' ' ' VAL . 23.8 mm -133.15 111.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.924 -0.58 . . . . 0.74 110.308 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 103' ' ' ALA . 53.5 t -117.28 106.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 116.331 -0.395 . . . . 1.19 110.818 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.83 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -90.5 105.15 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.222 -0.659 . . . . 1.32 109.222 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 100' ' ' ILE . 11.3 tp -90.34 109.65 20.75 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.289 -0.414 . . . . 1.33 111.361 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.2 t -80.89 130.91 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 1.2 110.953 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.648 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -131.36 -174.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.585 -0.894 . . . . 1.12 108.585 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -147.74 129.73 15.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.981 -0.687 . . . . 0.75 112.564 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 20.89 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.16 1.538 . . . . 1.18 114.97 169.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.95 -2.57 22.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.693 -0.685 . . . . 2.01 112.11 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -32.91 24.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.08 0.467 . . . . 1.09 110.725 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 69.77 -120.6 9.99 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.453 -0.794 . . . . 0.52 111.805 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 97' ' ' VAL . 58.7 t -124.21 109.77 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 120.847 0.356 . . . . 1.08 110.693 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.551 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 67.5 mtp -77.29 169.01 23.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 1.32 110.569 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.5 Cg_exo -44.79 -51.23 7.59 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.037 2.491 . . . . 0.61 113.417 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -66.78 -29.72 69.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.629 0.252 . . . . 1.47 111.366 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.596 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.4 m -69.47 -28.05 65.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.564 0.697 . . . . 0.46 109.467 174.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.682 HG23 HG12 ' A' ' 92' ' ' VAL . 12.4 t -76.69 -52.24 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.05 111.078 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -65.02 -19.24 65.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.04 0.385 . . . . 1.62 112.04 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -73.62 -37.36 65.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.203 -1.036 . . . . 0.34 108.203 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.815 HG12 HD13 ' A' ' 110' ' ' ILE . 2.8 mt -76.63 -41.16 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 113.969 -1.469 . . . . 0.38 110.727 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 98' ' ' GLU . 7.2 m-20 -54.04 -37.96 64.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.374 0.607 . . . . 1.85 110.367 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -74.85 -31.9 61.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.85 110.501 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.618 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -82.79 -48.62 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.447 . . . . 0.48 111.949 -175.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -56.86 -34.37 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.398 -0.819 . . . . 2.56 111.985 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.23 10.16 37.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.365 0.506 . . . . 0.76 112.365 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -104.39 5.87 34.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.151 -1.055 . . . . 0.9 108.151 169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.0 38.25 6.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.448 -1.251 . . . . 2.06 110.317 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 80' ' ' ASP . 2.0 m -105.68 148.48 36.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.57 -0.741 . . . . 1.08 110.95 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.93 155.27 62.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.098 2.532 . . . . 0.51 113.09 171.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 100' ' ' ILE . 68.8 mt -125.91 145.92 32.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.107 -0.951 . . . . 0.96 110.259 -174.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.83 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 mt -120.47 155.93 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 109.24 -0.652 . . . . 0.71 109.24 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.486 HG21 ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -120.32 137.3 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 120.997 0.427 . . . . 0.23 110.403 174.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.03 88.42 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.91 -1.145 . . . . 0.25 107.91 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 30.3 mt -72.51 97.02 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.956 -1.02 . . . . 0.85 110.487 178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.56 165.45 15.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.69 -0.485 . . . . 0.69 109.69 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.537 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 63.0 mttm 64.35 19.24 11.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.324 0.583 . . . . 2.61 110.896 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.884 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.3 tpp -87.55 -4.45 58.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.646 -0.706 . . . . 1.37 110.949 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.78 0.74 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.87 -0.605 . . . . 2.45 112.469 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.65 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 22.1 mtpp -73.78 -176.4 0.49 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.313 -0.995 . . . . 3.7 108.313 167.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.65 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 37.1 Cg_exo -57.29 -49.77 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 CA-C-N 119.922 1.008 . . . . 2.67 110.163 169.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 6.4 pt-20 160.22 130.34 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.204 -1.406 . . . . 4.03 107.204 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -66.52 -61.15 2.14 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.012 -1.107 . . . . 1.47 108.012 166.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 3.3 t-20 168.75 91.4 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 114.641 -1.163 . . . . 1.84 109.838 166.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.8 Cg_exo -39.54 -60.01 0.59 Allowed 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.876 3.051 . . . . 0.7 112.77 172.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.8 -52.92 7.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.776 0.43 . . . . 2.0 111.53 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.568 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -54.97 -59.71 4.37 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.875 0.369 . . . . 2.99 110.061 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 91' ' ' GLY . 60.3 t -53.99 -44.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.266 -0.879 . . . . 0.4 110.831 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.675 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.6 mtp -68.17 -31.83 71.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.641 -0.709 . . . . 0.3 111.184 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.6 mt-30 -73.68 -26.87 60.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.458 -0.337 . . . . 1.28 110.621 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.1 mm-40 -62.52 -39.85 94.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.551 -0.907 . . . . 2.02 108.551 172.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.858 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -68.25 -42.95 78.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.55 0.69 . . . . 1.06 110.062 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.83 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -76.03 -5.87 48.43 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.346 -0.843 . . . . 0.35 110.107 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 45.5 tt0 -82.32 -26.28 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.886 -0.783 . . . . 2.18 108.886 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.651 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 13.5 m-85 -84.6 -0.41 53.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.282 -1.007 . . . . 0.74 108.282 168.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 72.18 42.67 0.56 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 113.931 -1.486 . . . . 1.94 110.44 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -121.8 82.73 1.99 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 106.479 -1.674 . . . . 1.68 106.479 168.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.6 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -63.33 131.59 94.84 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.002 -1.454 . . . . 0.61 110.773 -172.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.74 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 86.7 Cg_exo -46.52 151.74 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.879 2.386 . . . . 0.3 112.894 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -25.74 53.71 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.25 -1.341 . . . . 2.01 108.335 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.737 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.35 -43.0 64.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.258 -1.337 . . . . 1.14 109.435 167.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.83 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.1 m0 -94.56 -26.0 16.58 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.879 -1.055 . . . . 0.45 111.218 -170.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.46 25.3 2.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.943 -1.123 . . . . 0.45 112.583 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.88 -111.79 2.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.5 -0.857 . . . . 0.5 112.573 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -151.01 21.99 0.77 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.679 0.276 . . . . 1.3 111.606 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 36.4 m -125.78 118.79 26.3 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.932 -0.707 . . . . 0.32 112.743 -172.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.0 mp -85.44 108.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.23 110.554 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.74 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.3 m-85 -88.83 119.38 29.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.199 0.523 . . . . 0.38 111.486 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 56.8 m -114.93 121.75 44.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.68 -0.691 . . . . 1.1 109.557 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.884 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 58.2 pttt -97.15 104.37 16.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.302 -0.629 . . . . 2.44 109.302 174.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -125.47 -170.88 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.36 1.076 . . . . 1.27 113.07 -171.099 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 30.2 t -169.87 126.92 0.87 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.4 -1.727 . . . . 1.79 108.252 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.12 -12.37 59.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.072 0.463 . . . . 0.87 111.083 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -84.93 -57.13 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 3.03 110.174 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 28.4 p -81.53 -17.6 47.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.13 -0.941 . . . . 1.2 110.51 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 27' ' ' ALA . 6.5 tptm 74.22 -11.98 0.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.905 0.753 . . . . 2.27 112.311 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 156' ' ' GLU . 9.9 mm-40 -44.17 -70.11 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.499 0.72 . . . . 2.64 112.86 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -73.6 -5.62 68.87 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.62 113.872 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.513 HD12 ' HE2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -73.36 -45.46 54.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.0 -0.741 . . . . 1.55 109.0 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.69 -36.53 76.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 2.5 109.889 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 82.4 t60 -70.72 -20.21 62.68 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.862 -0.608 . . . . 0.73 110.812 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.04 -49.62 42.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.843 0.354 . . . . 0.91 110.123 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 28' ' ' ILE . 98.4 mt -58.2 -37.48 74.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.708 -0.678 . . . . 1.06 111.384 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -70.02 -36.37 75.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.798 -0.361 . . . . 2.49 110.67 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.751 ' HB3' HG21 ' A' ' 146' ' ' ILE . 22.0 mmt -69.06 -38.56 79.15 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.24 0.543 . . . . 0.87 109.72 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.51 -52.27 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.64 110.514 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.35 -42.5 98.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.986 -0.552 . . . . 1.81 111.491 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.2 -45.99 65.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.807 -0.633 . . . . 1.42 110.0 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.45 -26.44 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.101 -0.5 . . . . 1.17 111.315 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.9 m -61.24 -27.38 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.968 0.413 . . . . 1.54 110.443 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.23 -35.9 10.21 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.274 -0.421 . . . . 2.79 111.028 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.456 ' HE3' ' HB2' ' A' ' 174' ' ' LEU . 24.0 ttp -85.66 5.53 31.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 1.82 111.675 -175.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -32.83 -40.56 0.05 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.319 1.229 . . . . 3.45 114.319 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -76.01 4.77 7.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 3.36 112.38 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 175' ' ' LYS . 2.0 tm? -36.26 -80.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.653 0.781 . . . . 4.14 112.303 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.49 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mptm? 53.17 -173.94 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.717 0.636 . . . . 6.31 112.717 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 59.95 74.26 0.45 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.484 -0.78 . . . . 4.57 112.871 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 178' ' ' PRO . 43.0 t30 -117.92 112.39 38.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.864 -0.421 . . . . 6.38 109.864 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 177' ' ' ASN . 11.8 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 123.339 2.693 . . . . 7.47 112.502 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.883 -0.487 . . . . 16.35 111.883 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 m -89.97 132.35 35.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.752 0.31 . . . . 14.69 110.453 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -76.61 78.77 3.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.834 0.35 . . . . 14.68 110.674 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 ttt -61.9 -37.89 86.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.657 -0.701 . . . . 12.73 110.205 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.0 m -99.62 137.51 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.524 -0.762 . . . . 10.18 109.95 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -86.13 59.15 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.534 0.683 . . . . 9.14 109.954 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -118.12 95.88 48.93 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.273 -0.876 . . . . 8.35 110.001 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.25 130.16 27.8 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.302 2.002 . . . . 4.6 110.967 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.33 118.22 5.06 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.038 2.492 . . . . 4.29 112.156 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 17.9 m -84.63 140.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.023 -0.535 . . . . 2.58 110.683 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB ' ' A' ' 81' ' ' ILE . 56.2 t -116.3 100.41 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.281 176.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -82.59 120.6 25.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.66 111.557 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.552 HD12 ' HG ' ' A' ' 25' ' ' LEU . 42.7 mt -78.97 121.03 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 1.03 109.711 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 19.5 mmt -110.97 176.75 4.9 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.158 -0.928 . . . . 1.04 109.938 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 1.106 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 123.26 136.05 4.7 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.341 -0.933 . . . . 1.55 111.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.725 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 67.6 t60 -45.62 136.27 6.01 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.646 0.736 . . . . 0.66 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.79 -35.27 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.331 -1.304 . . . . 1.62 113.45 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 11.8 t70 -74.28 -18.48 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 1.78 111.095 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -71.33 -12.22 61.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.182 0.515 . . . . 0.65 110.766 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.47 45.77 6.75 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.506 -0.77 . . . . 0.93 113.34 172.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.672 ' HA ' HD23 ' A' ' 24' ' ' LEU . 58.7 pttt -67.46 -26.33 66.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 2.11 110.835 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -67.7 -28.56 67.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 1.8 110.324 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 90.5 m -68.16 -28.17 67.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.89 -0.596 . . . . 1.77 111.039 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 21' ' ' LYS . 3.9 mm? -62.51 -51.12 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 1.78 110.4 176.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HG ' HD12 ' A' ' 13' ' ' ILE . 6.6 mt -72.3 -25.65 61.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 1.96 111.474 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 20.9 t70 -68.39 -49.07 62.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.502 -0.317 . . . . 1.38 111.356 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.06 73.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.932 0.396 . . . . 0.91 110.683 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 162' ' ' LEU . 4.7 tt -76.71 -33.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.867 -0.606 . . . . 1.56 110.945 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 15.3 ptt180 -75.19 -32.23 61.17 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.742 0.782 . . . . 3.56 109.729 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -82.11 15.58 2.3 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.469 -1.242 . . . . 2.88 111.641 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 t -135.28 -65.1 0.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.862 0.363 . . . . 1.76 111.278 -173.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 51' ' ' THR . 28.3 mmmt -93.1 170.02 9.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.131 -0.486 . . . . 5.71 110.702 -172.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.895 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 91.7 t -75.43 102.94 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 120.957 0.408 . . . . 2.99 110.729 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.74 ' HB ' HG13 ' A' ' 50' ' ' VAL . 2.6 t -104.93 153.08 21.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.438 0.533 . . . . 3.93 112.438 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 11.8 mm-40 -63.51 -59.53 4.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 4.2 109.687 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -126.18 158.79 34.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.957 -1.02 . . . . 5.38 109.893 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.19 153.78 46.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.125 -0.695 . . . . 5.79 109.125 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 69.17 -167.07 0.18 Allowed 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.9 0.75 . . . . 4.24 110.117 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -108.67 -36.55 2.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.621 -0.799 . . . . 4.95 112.337 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.75 -90.69 0.87 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.951 -0.642 . . . . 6.66 112.261 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.9 pt -79.1 -15.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.988 0.423 . . . . 9.17 111.214 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.616 HG21 ' HB2' ' A' ' 63' ' ' PRO . 12.2 t -128.24 126.45 40.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.313 0.577 . . . . 7.36 109.993 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -82.6 50.49 1.67 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.481 0.657 . . . . 8.83 110.476 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -133.61 -10.01 2.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 6.76 110.812 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 pt 47.31 -164.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 124.287 0.992 . . . . 5.19 111.791 -173.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.24 66.35 1.98 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.839 -0.696 . . . . 2.97 113.442 173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . . . -163.53 87.12 0.52 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.758 0.314 . . . . 1.71 110.982 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -165.26 160.79 18.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.198 0.523 . . . . 2.54 111.898 -176.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 13.9 mt-30 -107.55 109.71 21.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.869 -1.16 . . . . 1.96 107.869 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 ' HB ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -94.96 131.83 40.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.362 0.601 . . . . 1.93 111.736 -171.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.895 ' HB ' ' HB ' ' A' ' 33' ' ' VAL . 22.6 m -69.83 94.44 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.964 -1.016 . . . . 2.06 111.201 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.0 p -123.52 119.01 56.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.847 -0.797 . . . . 4.12 108.847 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 58.9 t30 71.51 -41.46 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.795 0.807 . . . . 4.43 109.866 -170.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 52' ' ' VAL . 18.2 t70 -158.37 -63.05 0.08 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 3.62 110.197 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 23.1 ttmm 167.59 -92.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.471 -1.307 . . . . 7.44 107.471 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 55' ' ' LYS . 22.1 mtpp 65.75 -63.17 0.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.839 0.856 . . . . 5.43 113.283 170.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 11' ' ' VAL . 61.7 mt -65.21 120.59 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 1.14 112.044 -172.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -101.2 97.83 8.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 1.28 109.896 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -81.27 100.01 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.394 -0.224 . . . . 0.84 110.394 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 60' ' ' LEU . 3.9 mm? 67.92 112.17 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.113 0.883 . . . . 3.0 111.771 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' HB2' HG11 ' A' ' 10' ' ' VAL . 15.4 t70 -79.31 -42.22 26.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.815 -0.629 . . . . 6.48 109.843 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.0 p -124.36 108.79 29.22 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.836 -0.62 . . . . 5.57 110.422 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.616 ' HB2' HG21 ' A' ' 42' ' ' THR . 66.6 Cg_endo -74.42 60.82 5.04 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.922 2.415 . . . . 5.77 112.412 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.76 -86.08 0.48 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.928 -0.578 . . . . 5.54 112.194 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.73 -5.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.531 0.205 . . . . 8.09 111.454 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.81 98.52 4.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.126 0.488 . . . . 6.36 110.874 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -115.75 109.87 18.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.678 -0.692 . . . . 3.51 109.767 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 80' ' ' ASP . 82.3 t80 68.74 121.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.884 0.74 . . . . 2.61 110.075 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 t -48.6 121.45 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 4.74 111.218 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.5 m -59.96 121.19 11.19 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.738 -0.664 . . . . 5.89 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.3 ptp -71.34 113.56 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 5.64 111.691 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -118.9 -35.77 3.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.457 -0.792 . . . . 9.71 109.064 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.45 145.1 44.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.239 -0.891 . . . . 7.52 110.039 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -80.31 -30.62 38.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.783 -0.644 . . . . 10.42 110.709 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.35 60.66 4.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.95 -0.643 . . . . 6.75 112.212 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.29 -33.05 17.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.451 0.167 . . . . 6.69 111.391 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 70.18 -54.04 0.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.442 0.697 . . . . 7.72 111.73 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -79.56 80.59 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.605 0.717 . . . . 4.38 110.523 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -70.15 143.55 52.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.503 -0.772 . . . . 4.18 111.024 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 17.9 t0 -82.51 130.33 35.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.715 -0.846 . . . . 3.12 108.715 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 11' ' ' VAL . 44.9 mm -88.53 107.66 17.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.815 -0.439 . . . . 0.74 109.815 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.952 HG21 ' HB1' ' A' ' 103' ' ' ALA . 61.2 t -85.68 96.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 116.328 -0.396 . . . . 1.19 111.616 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 111' ' ' ILE . 6.5 mm -84.11 93.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.32 109.283 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.7 tm? -86.97 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.737 -0.665 . . . . 1.33 109.749 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.106 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.1 p -77.41 144.32 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.622 0.725 . . . . 1.2 110.728 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 127' ' ' VAL . 8.4 t -136.72 175.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.58 -1.267 . . . . 1.12 107.58 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -138.06 131.16 30.18 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 122.101 -0.375 . . . . 0.75 110.251 175.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -77.44 27.55 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.882 -0.599 . . . . 1.18 112.325 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.618 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 16.4 p-10 -135.35 10.06 3.47 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.98 0.419 . . . . 2.01 110.056 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.81 -58.78 0.4 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.349 0.595 . . . . 1.09 110.605 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 86' ' ' VAL . . . 118.24 -115.09 3.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.232 -0.895 . . . . 0.52 111.457 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 97' ' ' VAL . 46.6 t -122.81 109.38 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.078 0.465 . . . . 1.08 110.233 -175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.899 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 62.5 mtp -88.49 174.45 5.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.121 -0.49 . . . . 1.32 109.775 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 7.0 Cg_endo -49.46 -53.13 7.53 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.769 2.313 . . . . 0.61 113.04 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 38.7 mt-30 -61.15 -32.39 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.624 0.231 . . . . 1.47 111.624 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.538 ' CG2' HD11 ' A' ' 84' ' ' LEU . 21.1 m -63.5 -31.24 72.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.806 0.812 . . . . 0.46 109.926 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.619 HG22 ' CE2' ' A' ' 134' ' ' TYR . 41.2 t -82.18 -52.54 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.713 -1.13 . . . . 1.05 111.305 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 48.4 mt-10 -55.71 -34.1 64.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.746 -0.661 . . . . 1.62 111.972 -176.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -70.6 -39.46 73.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.541 0.686 . . . . 0.34 109.504 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.535 HG12 HG12 ' A' ' 110' ' ' ILE . 1.7 mt -70.74 -42.18 77.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.395 -1.275 . . . . 0.38 110.188 174.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.467 ' ND2' HG12 ' A' ' 97' ' ' VAL . 94.8 m-20 -54.25 -37.79 65.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.522 . . . . 1.85 110.408 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -79.29 -27.02 42.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.294 -0.867 . . . . 0.85 110.874 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.952 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -97.72 -35.26 10.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.331 0.863 . . . . 0.48 113.331 -169.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -60.95 -27.11 68.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.863 0.69 . . . . 2.56 112.863 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.3 11.89 19.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.095 0.776 . . . . 0.76 113.095 -166.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . . . -111.32 19.15 18.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.654 -1.239 . . . . 0.9 107.654 172.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 50.56 37.83 17.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.547 -1.661 . . . . 2.06 111.721 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.528 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -94.27 155.53 39.77 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.021 -0.99 . . . . 1.08 110.014 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.1 Cg_exo -73.97 150.12 43.05 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.686 2.257 . . . . 0.51 113.443 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.645 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -120.72 142.57 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.067 -1.424 . . . . 0.96 109.836 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 83' ' ' ILE . 4.3 mp -114.04 146.28 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 108.022 -1.103 . . . . 0.71 108.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -114.06 132.19 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.025 0 N-CA-C 109.634 -0.506 . . . . 0.23 109.634 174.003 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -118.82 87.09 2.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.636 -1.246 . . . . 0.25 107.636 175.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 28.2 mt -69.65 91.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.499 -1.228 . . . . 0.85 110.024 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 62.5 t30 -92.89 167.58 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.515 . . . . 0.69 109.748 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 91.2 mttt 66.76 8.45 5.97 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.5 0.5 . . . . 2.61 110.411 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.428 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -76.96 -2.66 34.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 1.37 110.649 -176.19 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' ' 153' ' ' LYS . 5.1 p-10 -69.82 -13.85 62.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.187 -0.915 . . . . 2.45 110.222 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.879 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 18.6 ptmt -80.47 -175.66 0.64 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.182 -0.673 . . . . 3.7 109.182 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.879 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -45.07 -22.43 0.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.0 2.467 . . . . 2.67 114.496 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.725 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 6.6 pt-20 68.66 122.13 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.489 1.516 . . . . 4.03 110.46 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -75.81 0.08 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.18 -1.373 . . . . 1.47 110.821 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.473 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 50.4 t-20 -179.1 105.92 0.2 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 1.84 110.042 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.678 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.0 OUTLIER -46.16 -65.62 0.18 Allowed 'Trans proline' 0 C--O 1.219 -0.436 0 C-N-CA 123.538 2.825 . . . . 0.7 112.834 173.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.34 -48.57 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.395 0.678 . . . . 2.0 112.601 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 126' ' ' ARG . 9.0 tpt180 -53.48 -55.85 21.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.621 0.724 . . . . 2.99 109.951 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 86' ' ' VAL . 81.9 t -57.97 -42.43 82.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.357 -1.292 . . . . 0.4 110.412 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.3 mtp -63.46 -31.43 72.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.61 -0.723 . . . . 0.3 111.265 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.473 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 73.8 mt-30 -77.8 -18.01 56.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.897 -0.321 . . . . 1.28 110.949 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.3 mm-40 -70.39 -35.28 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.934 -0.765 . . . . 2.02 108.934 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.515 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.0 mm? -71.21 -44.61 65.05 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.516 0.674 . . . . 1.06 109.741 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.934 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.5 ppp? -76.08 -2.57 31.48 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.099 -0.955 . . . . 0.35 109.61 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 36.4 tt0 -78.13 -28.91 48.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.411 -1.329 . . . . 2.18 107.411 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 97' ' ' VAL . 60.8 m-85 -91.07 10.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.646 -0.706 . . . . 0.74 109.819 170.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 72.36 22.5 3.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.362 -1.29 . . . . 1.94 111.057 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 100' ' ' ILE . 6.5 mp -96.94 76.41 2.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.951 -1.129 . . . . 1.68 107.951 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -66.8 127.99 93.68 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 113.506 -1.679 . . . . 0.61 110.899 -176.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.799 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 91.7 Cg_exo -47.76 155.16 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.221 2.614 . . . . 0.3 112.726 172.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -27.08 54.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.559 -1.2 . . . . 2.01 108.175 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.29 -42.73 64.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.548 -1.206 . . . . 1.14 109.336 169.265 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.934 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.0 m0 -95.19 -18.73 20.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.901 -1.045 . . . . 0.45 111.351 -171.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.67 26.52 4.16 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 119.989 -1.101 . . . . 0.45 112.447 170.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.95 -107.84 2.64 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.393 -0.908 . . . . 0.5 112.452 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -162.87 28.86 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.307 0.575 . . . . 1.3 111.127 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.645 HG23 HG22 ' A' ' 110' ' ' ILE . 23.3 m -121.85 123.73 42.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.064 -0.654 . . . . 0.32 111.983 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.59 HD12 HG13 ' A' ' 111' ' ' ILE . 26.5 mt -91.49 108.7 20.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.616 -0.72 . . . . 1.23 111.137 -175.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.799 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 24.3 m-85 -93.38 118.78 31.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.38 112.204 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 77.3 m -117.16 111.6 19.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.596 -0.729 . . . . 1.1 110.06 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.744 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.3 pttp -89.39 89.22 7.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.964 0.887 . . . . 2.44 108.83 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -116.66 179.93 3.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.696 -1.138 . . . . 1.27 112.745 -165.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 p -145.95 110.39 5.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.491 -1.231 . . . . 1.79 109.886 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -19.5 36.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.474 . . . . 0.87 111.298 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 154' ' ' THR . 19.2 ptpt -80.16 -52.76 7.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.382 0.61 . . . . 3.03 110.296 -176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.499 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 28.1 p -78.39 -2.12 36.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.107 -0.951 . . . . 1.2 111.145 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.0 tptp 61.66 45.72 7.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.872 -1.058 . . . . 2.27 111.989 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -107.23 -73.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.855 0.835 . . . . 2.64 110.167 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -65.95 -18.67 66.88 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.724 -1.126 . . . . 0.62 113.899 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.04 -47.07 71.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.213 0.53 . . . . 1.55 109.79 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.69 -35.37 67.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.625 -0.716 . . . . 2.5 110.678 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -66.25 -34.81 78.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.184 -0.462 . . . . 0.73 110.668 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 165' ' ' ILE . 61.8 tp -59.68 -53.07 62.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.819 -0.628 . . . . 0.91 110.806 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.796 HD21 HD11 ' A' ' 28' ' ' ILE . 94.9 mt -56.28 -37.6 70.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.886 -0.597 . . . . 1.06 111.351 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -61.92 -38.59 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 2.49 110.913 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.9 mmt -74.02 -44.29 54.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.87 110.368 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.447 HD12 HD23 ' A' ' 162' ' ' LEU . 94.7 mt -51.94 -56.08 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.525 -0.762 . . . . 0.64 110.544 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 52' ' ' VAL . 97.2 mt -65.52 -42.85 91.56 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.685 -0.689 . . . . 1.81 111.654 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.4 tp -51.42 -44.75 62.36 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.513 0.508 . . . . 1.42 110.62 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 146' ' ' ILE . 24.6 t -80.24 -40.67 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.09 -0.505 . . . . 1.17 111.416 -176.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 72.3 p -59.58 -29.64 68.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.909 0.385 . . . . 1.54 110.813 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -91.1 -35.12 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 2.79 110.412 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.1 ttp -60.3 -42.82 96.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.375 -0.375 . . . . 1.82 111.494 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.228 0.825 . . . . 3.45 113.228 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.17 -35.7 69.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.749 . . . . 3.36 109.174 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 mp -107.96 -34.97 6.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.011 . . . . 4.14 109.65 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttp 63.12 95.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.0 -1.0 . . . . 6.31 110.63 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -89.5 51.56 2.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.36 -0.837 . . . . 4.57 112.135 -170.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.47 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 11.8 m120 -77.0 -50.08 2.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.292 -0.413 . . . . 6.38 110.724 173.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 177' ' ' ASN . 66.0 Cg_endo . . . . . 0 C--O 1.247 0.928 0 C-N-CA 121.921 1.747 . . . . 7.47 111.181 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.587 -0.605 . . . . 16.35 111.587 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 m -61.7 110.65 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.123 0.487 . . . . 14.69 112.144 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -99.7 114.88 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.842 -0.799 . . . . 14.68 108.842 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -85.79 77.31 9.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 12.73 111.695 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 m -90.38 60.42 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.609 -0.723 . . . . 10.18 109.615 173.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -67.31 123.53 20.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.48 -0.782 . . . . 9.14 112.02 -173.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 7' ' ' ARG . 17.8 mtp180 -83.22 -42.62 0.84 Allowed Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.143 -0.935 . . . . 8.35 112.575 177.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 81.9 Cg_exo -45.26 127.43 9.02 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.582 2.188 . . . . 4.6 113.774 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.882 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.3 Cg_exo -75.54 155.48 40.47 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.418 2.745 . . . . 4.29 112.101 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.503 ' HB ' ' H ' ' A' ' 58' ' ' THR . 47.0 t -133.53 -65.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.326 -0.397 . . . . 2.58 110.6 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.938 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 13.9 t -118.85 111.42 33.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.946 0.403 . . . . 1.0 111.159 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -98.08 141.42 31.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.66 110.812 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.8 mt -96.29 127.36 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.966 0.413 . . . . 1.03 110.517 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' HG13 ' A' ' 82' ' ' VAL . 51.2 mtt -133.84 177.81 7.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.31 0.576 . . . . 1.04 111.529 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.31 -92.32 0.21 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.508 -1.037 . . . . 1.55 110.508 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.469 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 t60 -164.24 149.29 10.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.765 -0.828 . . . . 0.66 108.765 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.37 -17.35 22.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.419 0.896 . . . . 1.62 113.419 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.76 -13.12 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.469 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 16.4 m170 -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.703 0.287 . . . . 0.65 111.544 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.29 61.08 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.84 -1.172 . . . . 0.93 113.904 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.39 -22.8 24.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.347 0.594 . . . . 2.11 109.49 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -71.03 -38.32 72.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.762 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -78.66 -23.93 45.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 1.77 109.823 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.5 tm? -63.54 -48.13 78.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.771 -0.826 . . . . 1.78 108.771 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.731 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 18.8 mt -66.41 -36.46 82.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.038 -0.528 . . . . 1.96 110.738 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -55.27 -58.05 9.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.873 0.323 . . . . 1.38 111.873 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.694 ' HB3' HD12 ' A' ' 158' ' ' LEU . . . -68.55 -24.82 64.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.91 111.313 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 25' ' ' LEU . 1.4 tt -78.79 -23.62 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.418 . . . . 1.56 110.097 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 53.4 mtt180 -76.27 -26.76 56.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.646 0.736 . . . . 3.56 109.264 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -75.32 6.22 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.059 -0.973 . . . . 2.88 109.411 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.1 m -145.37 39.83 1.19 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.529 -0.76 . . . . 1.76 109.453 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HE3' ' OE2' ' A' ' 35' ' ' GLU . 20.2 ptmt -68.04 159.17 31.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.216 -0.902 . . . . 5.71 111.699 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 m -163.27 -47.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.562 -0.745 . . . . 2.99 112.85 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 34' ' ' THR . 39.9 m -134.55 -1.88 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.634 0.605 . . . . 3.93 112.634 -166.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.9 pm0 -47.89 153.41 0.63 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.893 0.854 . . . . 4.2 113.027 -177.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -134.61 -146.32 0.25 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.27 -1.332 . . . . 5.38 109.576 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' HA ' HD12 ' A' ' 41' ' ' ILE . 39.9 mt-10 -55.77 -31.33 62.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 5.79 108.912 171.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . -68.28 77.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.228 -0.896 . . . . 4.24 109.403 164.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.96 23.94 0.47 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.186 -0.915 . . . . 4.95 110.906 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.89 70.23 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.0 -0.6 . . . . 6.66 112.451 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 37' ' ' GLU . 62.5 mt -78.47 -64.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.5 . . . . 9.17 110.418 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 m -135.93 145.54 46.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.596 . . . . 7.36 109.71 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.08 71.15 4.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.289 0.566 . . . . 8.83 111.507 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -141.69 28.93 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.505 -0.77 . . . . 6.76 109.129 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.956 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.8 tp -171.29 -165.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.768 . . . . 5.19 108.928 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.956 ' H ' HG13 ' A' ' 45' ' ' ILE . . . -89.27 -116.61 1.53 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.774 -0.727 . . . . 2.97 112.43 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -134.32 -34.21 0.97 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.134 0.42 . . . . 1.71 112.134 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -165.45 162.2 19.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.006 0.431 . . . . 2.54 110.71 -174.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 95.0 mt-30 -135.13 98.31 3.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 1.96 108.433 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 51' ' ' THR . 59.2 t -96.82 158.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.591 -0.731 . . . . 1.93 110.8 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.745 HG23 ' HA ' ' A' ' 54' ' ' ASP . 52.6 m -128.27 97.78 4.86 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.729 -1.123 . . . . 2.06 110.759 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 54' ' ' ASP . 72.4 t -118.97 127.81 75.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 4.12 108.154 173.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' HB3' ' HG2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 66.98 8.04 5.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.636 1.208 . . . . 4.43 109.087 -176.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.745 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.5 p-10 48.96 45.31 22.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 111.751 -2.477 . . . . 3.62 111.275 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 53' ' ' ASN . 68.8 mmtt -87.46 -90.22 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.09 -0.959 . . . . 7.44 108.808 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' A' ' 55' ' ' LYS . 17.5 ptpt 175.97 131.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 5.43 109.879 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.818 HD11 HD21 ' A' ' 166' ' ' LEU . 44.0 mt -133.35 91.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.65 0.262 . . . . 1.14 110.767 175.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.503 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 16.8 m -83.92 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.704 -0.48 . . . . 1.28 109.704 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 14.9 m-85 -78.4 129.53 35.06 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.98 0.419 . . . . 0.84 111.426 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 9' ' ' PRO . 91.3 mt -114.74 104.58 12.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.757 -0.656 . . . . 3.0 110.219 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -73.04 -55.34 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.045 -0.724 . . . . 6.48 109.045 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.9 p -97.78 106.72 35.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.365 -0.834 . . . . 5.57 109.986 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.51 49.28 2.84 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.958 2.438 . . . . 5.77 112.939 -175.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.54 -81.19 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.298 -0.477 . . . . 5.54 112.803 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -160.63 150.02 17.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.228 0.211 . . . . 8.09 110.44 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 62.5 30.62 17.19 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.747 0.654 . . . . 6.36 112.158 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 54.67 45.49 26.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 3.51 112.764 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.638 ' HE2' ' HA ' ' A' ' 103' ' ' ALA . 4.2 t80 179.78 145.34 0.19 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.791 -0.448 . . . . 2.61 109.791 174.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 9' ' ' PRO . 3.1 m -73.07 76.59 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.077 -0.712 . . . . 4.74 109.077 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 p -58.45 99.66 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.193 0.52 . . . . 5.89 111.028 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.2 ptp -112.73 27.87 9.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 5.64 110.216 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 65.69 -176.35 0.18 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.37 -0.832 . . . . 9.71 110.57 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 68.93 169.03 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.812 0.695 . . . . 7.52 111.663 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -136.98 74.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.926 -0.579 . . . . 10.42 109.926 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 125.98 3.43 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.659 -0.781 . . . . 6.75 112.723 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.56 -82.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 6.69 110.165 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.28 52.51 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.728 0.775 . . . . 7.72 109.53 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.99 90.69 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.325 -0.852 . . . . 4.38 110.803 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 58.7 m -82.62 66.26 8.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.928 0.871 . . . . 4.18 109.85 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.42 82.78 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.452 -1.314 . . . . 3.12 107.452 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 23.5 mm -50.05 117.1 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.152 -0.931 . . . . 0.74 111.745 -172.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.657 HG21 ' HB1' ' A' ' 103' ' ' ALA . 46.8 t -89.89 87.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 116.413 -0.358 . . . . 1.19 110.768 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.47 HD11 HG12 ' A' ' 165' ' ' ILE . 32.0 mm -75.76 104.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.866 -0.791 . . . . 1.32 108.866 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.926 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.6 tm? -91.26 92.9 8.84 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.254 -0.885 . . . . 1.33 110.235 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 61.7 t -80.86 129.44 37.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.19 0.519 . . . . 1.2 111.122 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.8 m -131.3 -165.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.208 -1.034 . . . . 1.12 108.208 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -139.61 143.86 37.45 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.24 -0.584 . . . . 0.75 111.861 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -37.08 -58.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.495 1.122 . . . . 1.18 112.709 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -103.92 19.19 20.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.571 . . . . 2.01 111.602 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 2.5 t70 -113.61 -51.59 2.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.237 0.541 . . . . 1.09 110.773 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.731 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.18 -138.6 17.43 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.294 -0.866 . . . . 0.52 111.198 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.2 t -97.02 115.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 122.818 0.447 . . . . 1.08 111.423 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.453 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 80.0 mmm -80.06 167.09 36.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.676 -0.49 . . . . 1.32 109.676 171.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 90.1 Cg_exo -46.35 -45.5 18.69 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.578 2.186 . . . . 0.61 113.054 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -72.84 -22.71 60.75 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.644 -0.253 . . . . 1.47 110.855 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.915 ' HB ' HG13 ' A' ' 92' ' ' VAL . 26.2 m -62.23 -30.71 71.29 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.177 0.513 . . . . 0.46 110.649 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.95 -46.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.272 -0.422 . . . . 1.05 111.345 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 1.07 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.717 -0.674 . . . . 1.62 111.196 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.49 -41.09 8.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.528 -0.916 . . . . 0.34 108.528 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.926 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.2 mt -73.13 -55.62 12.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.276 -0.874 . . . . 0.38 111.545 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -51.7 -30.08 20.73 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.218 0.607 . . . . 1.85 111.101 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -82.91 -28.9 29.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.769 -0.651 . . . . 0.85 110.584 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.657 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.56 -57.83 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.668 0.618 . . . . 0.48 112.668 -172.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.706 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -64.18 -21.32 66.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.615 0.598 . . . . 2.56 112.615 -163.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.02 4.56 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.831 0.348 . . . . 0.76 111.629 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.64 2.56 44.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 0.9 109.37 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t30 81.16 49.27 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.618 -1.174 . . . . 2.06 108.998 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -134.98 143.33 45.64 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 114.037 -1.438 . . . . 1.08 110.873 -175.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 13.8 Cg_exo -71.94 159.28 50.76 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.371 2.714 . . . . 0.51 114.675 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 HG12 ' A' ' 100' ' ' ILE . 46.8 mt -125.24 146.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.235 -1.348 . . . . 0.96 109.89 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 84' ' ' LEU . 5.0 mp -131.52 107.59 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 120.872 0.368 . . . . 0.71 111.726 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -70.9 133.68 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.492 0.663 . . . . 0.23 110.717 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -124.08 89.41 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.328 -1.36 . . . . 0.25 107.328 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 56.1 mt -72.18 92.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.069 -0.969 . . . . 0.85 109.615 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.28 169.16 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.69 109.696 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 62.94 20.47 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.522 0.677 . . . . 2.61 109.826 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.749 ' SD ' ' HA ' ' A' ' 121' ' ' GLU . 17.4 tpp -94.64 64.39 2.99 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 123.274 1.511 . . . . 1.37 108.856 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.91 -9.52 39.8 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.755 -1.566 . . . . 2.45 108.935 171.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 73.5 mmtt -85.32 171.53 10.59 Favored Pre-proline 0 N--CA 1.445 -0.72 0 N-CA-C 107.665 -1.235 . . . . 3.7 107.665 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 7.1 Cg_endo -51.98 -51.19 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.701 1.601 . . . . 2.67 111.547 175.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.749 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 13.5 pt-20 163.17 116.76 0.0 OUTLIER 'General case' 0 C--O 1.232 0.139 0 O-C-N 124.309 1.005 . . . . 4.03 109.376 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -58.63 -58.81 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.516 -0.765 . . . . 1.47 109.989 174.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 15.6 t-20 174.05 78.65 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.302 -0.863 . . . . 1.84 110.194 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.595 ' O ' ' HG3' ' A' ' 128' ' ' MET . 8.1 Cg_exo -33.53 -62.26 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.634 3.556 . . . . 0.7 113.998 171.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.18 -53.8 4.84 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.007 0.523 . . . . 2.0 112.247 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -50.75 -59.15 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 2.99 110.824 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.731 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.8 t -55.31 -48.17 77.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.364 -1.289 . . . . 0.4 110.738 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.66 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 89.2 mtp -62.78 -31.31 72.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.261 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -76.42 -17.5 59.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.364 -0.38 . . . . 1.28 111.064 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.5 mt-10 -73.81 -36.35 64.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.55 -0.907 . . . . 2.02 108.55 171.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 136' ' ' LEU . 3.8 mm? -69.12 -43.48 74.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.628 0.728 . . . . 1.06 109.369 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.864 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.698 -0.683 . . . . 0.35 109.884 177.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.606 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 39.4 tt0 -74.29 -32.06 62.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.728 -0.841 . . . . 2.18 108.728 171.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CE2' HG11 ' A' ' 92' ' ' VAL . 6.0 m-85 -89.63 2.73 54.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.762 0.791 . . . . 0.74 108.879 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.5 m120 75.15 29.99 0.91 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.544 -1.662 . . . . 1.94 110.913 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 1.024 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.53 74.25 1.15 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.984 -1.487 . . . . 1.68 106.984 168.189 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.763 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -60.84 131.39 91.44 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 113.796 -1.547 . . . . 0.61 110.459 -172.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 79.7 Cg_exo -47.52 154.82 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.705 2.27 . . . . 0.3 112.509 173.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.98 -23.99 48.18 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.614 -1.176 . . . . 2.01 107.833 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.788 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -55.05 -40.97 70.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.114 -1.403 . . . . 1.14 109.163 167.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.864 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.4 m0 -96.55 -20.53 18.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.789 -1.096 . . . . 0.45 110.66 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.66 28.74 4.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.147 -1.025 . . . . 0.45 112.179 170.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -98.32 -113.4 3.26 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.593 -0.813 . . . . 0.5 112.797 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -147.4 26.34 1.06 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.936 0.398 . . . . 1.3 111.717 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.605 HG21 HD12 ' A' ' 136' ' ' LEU . 57.3 m -137.01 126.62 25.29 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 119.09 -1.044 . . . . 0.32 113.685 -174.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.602 HG21 ' HB3' ' A' ' 164' ' ' MET . 38.8 mm -86.13 115.25 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.406 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.5 m-85 -95.95 123.51 39.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.726 0.298 . . . . 0.38 111.269 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 62.9 m -126.01 133.62 51.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.936 -0.575 . . . . 1.1 109.947 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.765 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pttp -101.47 123.53 45.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.494 -0.928 . . . . 2.44 108.494 170.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -145.96 175.5 10.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.493 1.14 . . . . 1.27 113.852 -173.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.31 6.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.382 -1.735 . . . . 1.79 109.154 170.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -66.57 -18.08 65.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.31 0.576 . . . . 0.87 110.881 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 18.1 ptmt -71.57 -52.11 19.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.774 0.797 . . . . 3.03 110.016 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.7 p -81.74 -5.32 58.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.486 -1.234 . . . . 1.2 111.855 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 76.97 -29.22 0.17 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.787 0.835 . . . . 2.27 112.178 175.12 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 156' ' ' GLU . 23.2 mt-10 -41.1 -69.33 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.08 0.952 . . . . 2.64 112.95 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.76 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.3 -22.29 70.93 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.988 -1.005 . . . . 0.62 114.28 -172.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -67.29 -39.47 85.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.326 0.563 . . . . 1.55 110.023 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.2 m-20 -65.19 -39.53 92.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.268 -0.424 . . . . 2.5 110.085 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -68.79 -29.81 68.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.352 -0.386 . . . . 0.73 110.701 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 165' ' ' ILE . 54.4 tp -63.31 -51.82 64.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.383 -0.372 . . . . 0.91 110.644 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.563 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.4 mt -53.36 -41.03 65.43 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.255 -0.43 . . . . 1.06 110.637 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 22.1 mm-40 -56.35 -45.02 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.552 . . . . 2.49 110.644 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.8 mmt -76.07 -31.32 58.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.87 110.674 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 83' ' ' ILE . 70.9 mt -59.04 -56.81 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.066 -0.516 . . . . 0.64 110.796 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 57' ' ' ILE . 3.8 mm? -58.52 -42.25 87.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.524 -0.307 . . . . 1.81 111.032 176.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 171' ' ' MET . 60.0 tp -53.58 -41.91 67.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.775 -0.648 . . . . 1.42 110.559 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.491 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 18.3 t -72.65 -42.67 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 1.17 111.446 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.58 ' HA ' ' OE2' ' A' ' 172' ' ' GLU . 14.1 t -60.62 -33.45 72.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.86 0.362 . . . . 1.54 110.596 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -88.23 -25.35 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.895 -0.322 . . . . 2.79 110.562 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 167' ' ' LEU . 15.8 tmm? -62.5 -42.38 99.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.178 -0.465 . . . . 1.82 110.038 176.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 169' ' ' SER . 41.5 mt-10 -44.45 -45.98 9.39 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.864 0.728 . . . . 3.45 111.344 175.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.77 -41.61 18.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 3.36 110.538 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.09 -70.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 4.14 111.761 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -155.83 96.89 1.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.332 -0.394 . . . . 6.31 110.629 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -106.36 133.52 50.93 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.898 -0.592 . . . . 4.57 109.462 176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 10.2 p30 -83.73 116.6 65.46 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.444 0.64 . . . . 6.38 111.819 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.0 Cg_exo . . . . . 0 C--O 1.251 1.134 0 C-N-CA 123.367 2.711 . . . . 7.47 112.085 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 112.261 -0.336 . . . . 16.35 112.261 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 m -74.09 131.93 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.81 0.338 . . . . 14.69 110.762 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -96.16 -0.18 50.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 14.68 111.098 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.1 tpt -82.66 85.22 7.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.88 -0.415 . . . . 12.73 109.88 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t 62.12 84.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.395 -0.821 . . . . 10.18 110.384 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -94.47 25.89 3.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.831 -0.622 . . . . 9.14 110.986 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 80' ' ' ASP . 16.7 tpt180 -129.28 99.17 21.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.498 -0.774 . . . . 8.35 109.344 172.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.67 119.68 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.289 1.993 . . . . 4.6 111.554 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.93 93.69 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.539 2.159 . . . . 4.29 110.672 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 m -62.46 107.25 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 2.58 111.192 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.545 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 96.3 t -72.35 90.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.839 0.828 . . . . 1.0 108.816 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.652 HG22 ' HG3' ' A' ' 14' ' ' MET . 21.1 m -82.31 121.78 27.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.525 -1.216 . . . . 0.66 111.143 -171.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.6 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 34.3 mt -88.93 114.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.672 -0.492 . . . . 1.03 109.672 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.652 ' HG3' HG22 ' A' ' 12' ' ' THR . 73.7 mtm -139.59 168.0 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.592 -0.731 . . . . 1.04 111.94 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.33 -95.96 0.17 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.438 -1.065 . . . . 1.55 110.438 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.87 149.9 14.89 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.816 -0.809 . . . . 0.66 108.816 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.85 -27.1 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 113.499 0.926 . . . . 1.62 113.499 -168.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.48 -22.78 40.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 1.78 111.683 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -70.78 -60.16 2.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.029 0.442 . . . . 0.65 110.847 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 166.92 58.31 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.546 -0.835 . . . . 0.93 112.484 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 17.2 ttpp -87.93 -73.56 0.48 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.641 0.734 . . . . 2.11 109.876 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.833 -1.076 . . . . 1.8 111.107 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.461 HG22 ' HA2' ' A' ' 20' ' ' GLY . 8.9 t -76.74 -18.24 58.59 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.981 -0.288 . . . . 1.77 110.234 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -70.59 -44.62 66.93 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.02 -1.104 . . . . 1.78 108.02 174.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.9 tt -63.28 -40.64 97.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.996 -1.002 . . . . 1.96 110.083 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 t70 -63.64 -52.29 61.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.521 -0.308 . . . . 1.38 111.725 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' HD11 ' A' ' 158' ' ' LEU . . . -62.15 -41.46 98.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.91 111.012 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 25' ' ' LEU . 3.2 tt -66.6 -30.04 48.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.577 -0.738 . . . . 1.56 109.54 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 29.4 tpt180 -69.99 -33.19 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.285 -0.87 . . . . 3.56 109.956 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -63.78 -28.33 69.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 2.88 109.521 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m -87.88 11.66 15.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.923 -1.035 . . . . 1.76 110.774 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm 57.2 -131.88 1.46 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.441 -0.8 . . . . 5.71 111.282 175.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m 49.67 20.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.985 1.314 . . . . 2.99 113.525 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.488 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -101.29 123.45 45.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.359 0.599 . . . . 3.93 112.052 -174.214 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -74.08 -48.37 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.27 -0.877 . . . . 4.2 109.785 174.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 73.5 mm-40 -96.91 126.45 42.06 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.625 -0.879 . . . . 5.38 108.625 176.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.32 -65.56 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 5.79 112.712 -170.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.17 173.53 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 4.24 110.86 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.49 126.74 6.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.705 -0.558 . . . . 4.95 111.705 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.54 -156.11 6.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.677 -0.773 . . . . 6.66 112.514 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -90.53 -26.82 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.134 0.492 . . . . 9.17 110.451 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -66.5 151.9 46.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 7.36 110.526 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -70.44 179.29 2.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.146 -0.479 . . . . 8.83 111.377 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 77.97 -37.54 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.873 0.869 . . . . 6.76 110.916 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.63 -176.85 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.431 -0.35 . . . . 5.19 110.818 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.54 -51.51 0.46 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.187 -0.765 . . . . 2.97 111.187 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -117.3 171.18 8.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.415 -0.587 . . . . 1.71 109.415 173.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -148.64 143.51 26.57 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.273 0.558 . . . . 2.54 111.604 -173.313 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -104.66 133.69 49.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.48 -0.782 . . . . 1.96 109.729 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 59' ' ' PHE . 15.1 m -110.93 151.87 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.268 0.556 . . . . 1.93 111.965 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -108.62 80.57 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.694 0.759 . . . . 2.06 109.97 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.3 p -120.69 123.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.057 -1.09 . . . . 4.12 108.057 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 69.6 -8.16 0.79 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.035 0.922 . . . . 4.43 110.067 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.1 t0 67.62 35.29 4.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.08 -1.873 . . . . 3.62 109.65 -174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 170' ' ' GLU . 11.8 tptm -83.89 -9.37 58.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.065 -0.97 . . . . 7.44 109.526 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 57.76 44.94 19.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.333 -1.303 . . . . 5.43 111.1 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 11' ' ' VAL . 70.2 mt -62.58 119.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.275 -0.875 . . . . 1.14 111.38 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -87.66 105.65 17.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 1.28 109.993 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 50' ' ' VAL . 35.9 m-85 -88.8 109.07 19.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.33 . . . . 0.84 110.422 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 12' ' ' THR . 36.0 tp -90.0 82.11 6.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.97 -0.559 . . . . 3.0 109.576 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 21' ' ' LYS . 16.6 t0 -76.89 142.08 40.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.765 -0.652 . . . . 6.48 109.616 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 21' ' ' LYS . 21.5 m -64.29 108.99 2.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.464 0.477 . . . . 5.57 111.189 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -95.99 2.33 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.345 2.697 . . . . 5.77 113.224 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.09 -101.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.569 -0.824 . . . . 5.54 112.592 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -112.29 -35.87 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.882 0.373 . . . . 8.09 110.858 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.93 107.6 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.279 -0.638 . . . . 6.36 109.279 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -106.23 -63.19 1.29 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 3.51 110.787 -176.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.404 ' HB2' ' CE ' ' A' ' 14' ' ' MET . 47.9 t80 -98.81 162.16 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.992 -0.549 . . . . 2.61 109.849 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.442 ' O ' ' HE1' ' A' ' 102' ' ' HIS . 11.0 m -51.13 145.95 7.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.026 0.441 . . . . 4.74 111.027 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -90.33 24.24 2.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.388 0.613 . . . . 5.89 110.201 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 61.03 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.131 -0.941 . . . . 5.64 111.77 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -91.55 -33.89 14.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.488 -0.778 . . . . 9.71 110.041 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.42 119.91 23.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.089 -0.505 . . . . 7.52 110.75 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -47.28 -58.04 4.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.823 0.702 . . . . 10.42 112.6 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.08 29.55 12.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.76 . . . . 6.75 112.578 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 106' ' ' ALA . . . 56.59 66.37 1.2 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.28 0.562 . . . . 6.69 111.008 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.24 -6.7 23.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.702 . . . . 7.72 110.839 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.78 115.51 49.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.287 -0.415 . . . . 4.38 111.281 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.2 m -77.36 90.42 3.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 4.18 110.655 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.44 ' O ' HG21 ' A' ' 108' ' ' VAL . 67.4 m-20 -85.57 105.52 16.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.267 -0.642 . . . . 3.12 109.267 173.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mm -51.04 120.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.567 -0.742 . . . . 0.74 112.008 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.078 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.1 t -105.2 111.09 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 120.622 -0.431 . . . . 1.19 111.687 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 16.1 mm -87.42 107.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.82 -0.808 . . . . 1.32 108.82 173.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 100' ' ' ILE . 2.9 tm? -97.45 99.7 11.12 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.989 -1.005 . . . . 1.33 109.509 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.58 133.59 29.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.932 -0.576 . . . . 1.2 110.771 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG23 ' HA ' ' A' ' 114' ' ' ILE . 23.0 m -131.48 -174.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.4 -0.818 . . . . 1.12 108.809 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.49 143.86 44.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.59 -0.444 . . . . 0.75 110.671 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -36.83 -61.84 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.734 1.271 . . . . 1.18 113.312 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.84 8.47 39.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.729 0.64 . . . . 2.01 112.729 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.36 -44.76 2.96 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.179 -0.608 . . . . 1.09 111.077 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.0 -144.49 23.89 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.827 -0.701 . . . . 0.52 111.409 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.782 HG23 ' HB ' ' A' ' 96' ' ' THR . 3.5 p -94.06 106.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.305 0.574 . . . . 1.08 110.12 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.567 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.7 ppp? -83.95 169.29 17.53 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 1.32 109.263 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 40.9 Cg_exo -35.76 -51.98 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.614 2.876 . . . . 0.61 115.029 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.81 -24.11 55.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.827 0.346 . . . . 1.47 111.109 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.782 ' HB ' HG23 ' A' ' 92' ' ' VAL . 2.4 m -65.24 -23.78 67.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.416 0.627 . . . . 0.46 110.035 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 92' ' ' VAL . 64.0 t -87.73 -42.72 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.778 -0.646 . . . . 1.05 111.052 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -56.58 -33.92 66.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.013 0.435 . . . . 1.62 111.095 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.72 -33.27 46.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.34 110.187 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.667 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -75.25 -45.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.635 . . . . 0.38 110.761 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -51.4 -38.13 51.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.264 0.554 . . . . 1.85 110.504 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.442 ' HE1' ' O ' ' A' ' 69' ' ' THR . 58.6 t-80 -78.55 -28.52 46.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.246 -0.888 . . . . 0.85 110.898 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.078 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.74 -44.78 8.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.588 . . . . 0.48 112.48 -172.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -65.69 -24.19 66.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.577 -0.738 . . . . 2.56 111.383 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.6 8.58 33.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.76 111.707 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' A' ' 76' ' ' ALA . . . -102.36 9.38 39.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.692 -0.855 . . . . 0.9 108.692 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t30 69.44 38.78 1.73 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 114.589 -1.187 . . . . 2.06 110.651 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 82' ' ' VAL . 1.5 m -119.23 150.05 48.46 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.372 -0.831 . . . . 1.08 110.779 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.1 Cg_exo -73.19 155.22 52.0 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.175 2.584 . . . . 0.51 113.639 171.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -115.86 142.44 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.261 -1.336 . . . . 0.96 109.922 -176.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 mp -112.7 140.55 31.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 108.521 -0.918 . . . . 0.71 108.521 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -107.58 136.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 C-N-CA 120.259 -0.576 . . . . 0.23 110.673 176.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.76 87.68 2.76 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.701 -1.222 . . . . 0.25 107.701 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.712 ' HA ' HG23 ' A' ' 86' ' ' VAL . 14.3 mt -75.58 92.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.941 -1.027 . . . . 0.85 109.469 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.988 ' HA ' ' HB2' ' A' ' 150' ' ' LEU . 55.4 t30 -84.6 163.6 19.2 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.094 -0.243 . . . . 0.69 110.43 -171.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 73.38 41.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.229 0.612 . . . . 2.61 112.223 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.632 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 5.3 mmm -95.93 6.61 48.47 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.371 -0.974 . . . . 1.37 108.371 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.08 -13.24 62.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.363 -1.289 . . . . 2.45 108.316 166.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 11.2 mmmm -70.47 -156.79 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 106.544 -1.65 . . . . 3.7 106.544 160.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 44.0 Cg_exo -56.77 -60.84 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 CA-C-N 121.827 1.688 . . . . 2.67 110.988 165.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 15.4 pt-20 155.74 -8.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.069 1.348 . . . . 4.03 108.098 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.21 -88.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.676 -1.602 . . . . 1.47 110.699 -172.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -177.36 89.71 0.24 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.544 -0.298 . . . . 1.84 110.591 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.704 ' O ' ' HG3' ' A' ' 128' ' ' MET . 68.4 Cg_exo -39.9 -58.35 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.625 2.883 . . . . 0.7 113.386 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.23 -48.22 9.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.419 0.688 . . . . 2.0 112.375 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.4 tmt_? -52.91 -55.13 25.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.112 0.482 . . . . 2.99 109.794 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 86' ' ' VAL . 54.7 t -60.22 -43.57 93.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.839 -1.073 . . . . 0.4 110.144 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.704 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 81.0 mtp -62.14 -31.8 72.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.34 -0.845 . . . . 0.3 111.059 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.454 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 18.7 mt-30 -75.79 -25.15 56.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.392 -0.367 . . . . 1.28 110.439 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.3 mt-10 -74.24 -32.23 62.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.176 -0.676 . . . . 2.02 109.176 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.572 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.5 mm? -69.75 -43.41 72.31 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.0 -0.68 . . . . 1.06 109.712 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.846 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -74.85 -5.52 44.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.529 -0.759 . . . . 0.35 109.986 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 9.2 tp10 -71.03 -34.43 71.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.573 -1.269 . . . . 2.18 107.573 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HB2' HD12 ' A' ' 136' ' ' LEU . 41.3 m-85 -91.26 21.8 4.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.77 0.795 . . . . 0.74 109.535 172.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.4 t30 62.36 29.55 17.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.189 -1.368 . . . . 1.94 109.636 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.637 ' CD1' HD13 ' A' ' 100' ' ' ILE . 13.8 mt -101.51 70.75 1.3 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.408 -1.269 . . . . 1.68 108.848 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.489 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -64.54 123.27 82.51 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.438 -1.255 . . . . 0.61 110.531 -178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.699 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.3 Cg_exo -47.25 158.24 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.306 2.67 . . . . 0.3 113.171 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -26.29 57.93 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.567 -1.197 . . . . 2.01 108.718 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.5 mp0 -44.73 -51.17 9.58 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.597 -1.183 . . . . 1.14 110.703 160.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.846 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 17.2 m0 -94.95 -24.17 17.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.996 -1.456 . . . . 0.45 111.123 -165.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.2 27.6 2.86 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 119.989 -1.1 . . . . 0.45 112.291 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.4 -115.9 4.13 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.265 -0.969 . . . . 0.5 112.514 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -151.89 34.61 0.54 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.645 0.736 . . . . 1.3 111.112 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 22.4 m -130.78 114.32 15.19 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.278 -0.569 . . . . 0.32 111.767 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.771 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.6 mp -84.87 110.76 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.826 -0.624 . . . . 1.23 110.379 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.699 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.6 m-85 -92.12 135.16 34.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.366 0.603 . . . . 0.38 111.427 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.1 m -133.53 126.41 30.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 1.1 109.505 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.632 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 25.2 pttt -91.72 110.83 22.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.582 0.706 . . . . 2.44 109.618 172.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.988 ' HB2' ' HA ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -83.07 173.89 11.34 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.217 1.932 . . . . 1.27 116.217 -166.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.839 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 24.8 p -175.27 99.3 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 110.562 -3.017 . . . . 1.79 109.245 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.18 -17.73 56.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.7 -0.682 . . . . 0.87 111.913 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 154' ' ' THR . 18.2 ptpt -80.47 -50.42 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.651 0.739 . . . . 3.03 110.086 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.401 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 3.3 p -82.2 -2.41 52.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.626 -1.17 . . . . 1.2 111.434 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 75.72 -6.9 1.9 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.351 -0.84 . . . . 2.27 113.156 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB2' ' OG ' ' A' ' 151' ' ' SER . 15.8 mm-40 -64.67 -37.16 86.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.151 0.5 . . . . 2.64 110.597 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.839 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -59.97 -44.35 97.27 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.446 -0.797 . . . . 0.62 112.5 176.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 27' ' ' ALA . 91.7 mt -67.31 -51.19 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.864 0.32 . . . . 1.55 111.864 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 30.2 t70 -57.97 -53.38 58.89 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.321 0.388 . . . . 2.5 111.077 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 164' ' ' MET . 54.5 t-80 -61.14 -34.75 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.73 110.854 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 165' ' ' ILE . 52.5 tp -65.15 -56.18 14.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.91 111.078 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.82 -39.34 68.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 1.06 110.844 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 57.9 mm-40 -63.56 -40.68 97.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.853 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.771 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.8 mmt -71.82 -38.48 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.424 . . . . 0.87 110.282 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 162' ' ' LEU . 85.6 mt -56.23 -53.43 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.516 -0.766 . . . . 0.64 111.345 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 1.8 pp -72.25 -30.49 64.92 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.84 -0.344 . . . . 1.81 111.904 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 166' ' ' LEU . 55.3 tp -54.45 -33.95 60.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 1.42 110.511 175.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 164' ' ' MET . 76.6 t -77.18 -30.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.837 -0.619 . . . . 1.17 110.523 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.6 t -54.44 -32.06 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 1.54 110.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.561 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.3 mp0 -94.77 -36.54 11.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.473 -0.331 . . . . 2.79 110.833 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 60.4 ttp -52.66 -45.37 66.71 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.269 -0.423 . . . . 1.82 111.873 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -53.46 -45.02 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.499 0.5 . . . . 3.45 111.504 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -83.01 -7.74 59.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.99 -0.55 . . . . 3.36 111.689 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 170' ' ' GLU . 87.8 mt -91.97 -59.29 2.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.437 -0.579 . . . . 4.14 109.437 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -170.01 104.03 0.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.246 -0.888 . . . . 6.31 110.217 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.57 56.35 1.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.213 0.53 . . . . 4.57 110.183 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.6 t30 -170.64 131.85 0.91 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.734 -0.666 . . . . 6.38 110.183 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 25.9 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.938 2.426 . . . . 7.47 112.485 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 111.903 -0.479 . . . . 16.35 111.903 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 t -92.87 99.08 11.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.999 0.4 . . . . 14.69 110.718 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -171.99 57.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.716 0.77 . . . . 14.68 109.24 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 mmt -69.93 -69.65 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.942 -1.026 . . . . 12.73 111.696 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 61' ' ' ASP . 33.0 m -140.37 161.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.597 -0.274 . . . . 10.18 110.841 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 65' ' ' HIS . 9.0 pt-20 -131.03 122.68 27.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 9.14 110.831 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 60.03 72.34 0.77 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.333 -0.849 . . . . 8.35 112.03 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.44 113.04 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.107 2.538 . . . . 4.6 111.247 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HB3' HG12 ' A' ' 41' ' ' ILE . 48.8 Cg_endo -72.81 -37.72 3.58 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.709 2.273 . . . . 4.29 113.686 -177.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 11' ' ' VAL . 61.2 t -126.23 -85.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 121.106 -0.238 . . . . 2.58 110.844 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.776 HG12 ' HB ' ' A' ' 81' ' ' ILE . 5.7 m -98.03 147.36 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.244 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.543 HG23 HG21 ' A' ' 5' ' ' VAL . 21.8 m -109.32 125.92 52.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.617 -0.72 . . . . 0.66 110.142 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 61' ' ' ASP . 23.5 mt -89.12 116.85 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 1.03 110.705 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.526 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 21.6 mmt -119.78 -179.21 3.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.015 -0.993 . . . . 1.04 110.11 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.92 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 105.44 131.49 7.02 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.941 -1.264 . . . . 1.55 109.941 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -44.48 135.67 4.6 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.854 0.835 . . . . 0.66 111.102 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.7 t -56.22 -39.08 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.104 -1.407 . . . . 1.62 112.84 -167.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.53 -18.16 55.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.879 0.326 . . . . 1.78 111.879 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HE1' ' H ' ' A' ' 93' ' ' MET . 25.1 m170 -64.62 -31.24 72.38 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.037 0.446 . . . . 0.65 110.298 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.18 55.14 0.3 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.198 -1.001 . . . . 0.93 113.624 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 13' ' ' ILE . 35.8 pttt -87.83 -22.36 24.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.478 -0.934 . . . . 2.11 108.478 172.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -34.8 77.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.627 -1.169 . . . . 1.8 110.002 176.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 p -71.23 -24.67 62.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 1.77 111.068 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.65 -54.93 28.05 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 61' ' ' ASP . 6.0 tt -51.61 -45.31 63.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.094 0.473 . . . . 1.96 110.487 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.51 -52.2 16.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 1.38 112.538 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.63 85.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.367 -0.208 . . . . 0.91 111.116 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' HE2' ' A' ' 48' ' ' TYR . 74.3 mt -67.22 -36.87 77.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.541 -0.54 . . . . 1.56 109.541 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 1.009 ' HA ' HG21 ' A' ' 34' ' ' THR . 15.9 tpp180 -59.49 -38.77 81.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.425 0.631 . . . . 3.56 109.765 171.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -85.14 16.28 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 2.88 111.386 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -103.24 25.13 9.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.449 -0.341 . . . . 1.76 110.804 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.3 mttm 74.72 -53.33 0.68 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.481 0.919 . . . . 5.71 113.481 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG23 HG13 ' A' ' 50' ' ' VAL . 32.8 m -73.99 28.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.242 1.201 . . . . 2.99 114.242 -168.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.009 HG21 ' HA ' ' A' ' 29' ' ' ARG . 36.1 p -91.22 126.09 36.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.348 0.594 . . . . 3.93 111.712 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -74.48 -57.2 4.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.806 -1.088 . . . . 4.2 113.019 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -146.8 -178.98 6.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.281 -0.568 . . . . 5.38 111.783 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 12.7 tp10 -99.35 155.13 17.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.98 -1.118 . . . . 5.79 107.98 172.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . 73.84 131.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.786 0.678 . . . . 4.24 110.282 -172.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.481 ' N ' ' HB3' ' A' ' 47' ' ' ALA . . . -86.49 57.59 4.71 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.026 -0.607 . . . . 4.95 113.004 -170.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 -124.39 8.17 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.669 -0.776 . . . . 6.66 113.884 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' A' ' 9' ' ' PRO . 35.1 pt -86.76 26.59 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 112.526 0.565 . . . . 9.17 112.526 -171.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.548 HG21 HD21 ' A' ' 60' ' ' LEU . 10.5 t -131.6 134.61 46.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.757 -0.46 . . . . 7.36 109.757 174.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -89.66 71.01 7.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.415 0.626 . . . . 8.83 111.307 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -132.93 127.38 34.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 6.76 108.881 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 45' ' ' ILE . 2.8 pp -76.3 154.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.465 -0.494 . . . . 5.19 110.212 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.57 39.27 3.71 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.873 -0.891 . . . . 2.97 110.873 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' N ' ' A' ' 39' ' ' GLY . . . -163.23 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.997 -0.742 . . . . 1.71 108.997 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -170.09 168.75 8.29 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.561 0.696 . . . . 2.54 111.628 -163.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.804 ' HG2' HG23 ' A' ' 58' ' ' THR . 34.9 mt-30 -125.74 146.92 49.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.551 -1.204 . . . . 1.96 107.762 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 51' ' ' THR . 56.6 t -82.74 175.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.135 -0.691 . . . . 1.93 109.135 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.846 HG23 ' HB2' ' A' ' 54' ' ' ASP . 10.8 t -53.11 166.13 0.26 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.541 0.686 . . . . 2.06 111.518 -175.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 54' ' ' ASP . 12.9 p -121.6 144.25 31.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.27 -0.641 . . . . 4.12 109.27 -166.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t30 70.96 -40.45 0.48 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.944 0.778 . . . . 4.43 109.196 -167.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.846 ' HB2' HG23 ' A' ' 51' ' ' THR . 27.2 m-20 -75.22 -66.57 0.75 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 3.62 110.962 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' H ' HG23 ' A' ' 51' ' ' THR . 57.3 mttm -150.5 70.95 1.03 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.633 -0.427 . . . . 7.44 110.669 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -76.77 59.04 1.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.871 0.693 . . . . 5.43 112.871 -169.484 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 165' ' ' ILE . 14.8 mt -88.62 125.41 41.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.152 -0.476 . . . . 1.14 110.509 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.804 HG23 ' HG2' ' A' ' 49' ' ' GLN . 6.9 m -95.04 119.99 34.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.12 -0.326 . . . . 1.28 110.12 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.454 ' HD2' HD11 ' A' ' 13' ' ' ILE . 54.2 m-85 -104.9 111.16 23.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.71 -0.396 . . . . 0.84 110.311 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.61 HD12 ' HB ' ' A' ' 5' ' ' VAL . 1.8 tm? -108.38 111.16 22.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.941 -0.572 . . . . 3.0 110.002 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.74 ' HB3' HD12 ' A' ' 25' ' ' LEU . 25.3 t0 -140.02 70.54 1.36 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.842 0.829 . . . . 6.48 109.556 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.5 m -109.79 105.57 57.34 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.03 -0.986 . . . . 5.57 109.971 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.59 75.95 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.198 2.599 . . . . 5.77 112.626 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.37 -93.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.148 -0.781 . . . . 5.54 111.148 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 83.1 m-70 -81.76 178.97 8.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.707 0.289 . . . . 8.09 110.478 176.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.58 97.56 5.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.377 0.608 . . . . 6.36 110.314 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.61 112.24 6.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 3.51 111.168 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.687 ' CE2' ' HA ' ' A' ' 103' ' ' ALA . 8.5 t80 -86.12 -81.61 0.21 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.147 -0.479 . . . . 2.61 110.889 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 t -145.64 15.3 1.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.338 0.589 . . . . 4.74 111.104 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m 57.45 68.12 0.89 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.619 -0.719 . . . . 5.89 109.69 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 71' ' ' MET . 1.5 mpp? -72.09 95.47 1.63 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.49 -0.777 . . . . 5.64 111.022 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -118.62 -14.11 9.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.927 0.394 . . . . 9.71 110.075 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.03 169.23 18.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.768 -0.651 . . . . 7.52 110.164 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -96.59 123.38 40.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.762 -0.458 . . . . 10.42 109.762 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.31 110.37 3.2 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.699 -0.762 . . . . 6.75 113.004 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.96 -33.77 57.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.404 0.621 . . . . 6.69 109.385 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -110.47 90.22 3.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.375 -0.83 . . . . 7.72 109.102 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 m -92.3 137.9 21.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.094 0.473 . . . . 4.38 111.8 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 m -114.39 0.46 14.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.022 -1.103 . . . . 4.18 108.022 171.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.94 130.19 35.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.914 -1.493 . . . . 3.12 109.933 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.776 ' HB ' HG12 ' A' ' 11' ' ' VAL . 41.4 mm -120.74 117.64 53.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 0.74 110.005 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.709 HG21 ' HB1' ' A' ' 103' ' ' ALA . 42.0 t -92.65 101.6 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 120.764 0.316 . . . . 1.19 111.136 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 111' ' ' ILE . 11.1 mm -84.94 105.42 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.73 -0.841 . . . . 1.32 108.73 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -100.22 104.81 16.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.92 -0.582 . . . . 1.33 110.81 -174.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.92 HG12 ' HA3' ' A' ' 15' ' ' GLY . 2.8 p -83.59 143.82 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.337 0.589 . . . . 1.2 111.6 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 114' ' ' ILE . 31.2 m -140.79 -166.77 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.357 -0.979 . . . . 1.12 108.357 174.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.52 144.04 34.1 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.378 -0.529 . . . . 0.75 111.885 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.73 -54.71 1.2 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.504 1.127 . . . . 1.18 113.092 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.34 -37.65 9.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.644 0.609 . . . . 2.01 112.644 -172.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 13.7 t70 -68.66 -45.0 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.613 -0.435 . . . . 1.09 111.354 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.92 -119.76 5.1 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.476 -0.868 . . . . 0.52 111.503 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.919 HG13 ' HB ' ' A' ' 96' ' ' THR . 25.0 t -114.13 116.15 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 122.611 0.364 . . . . 1.08 111.505 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.576 ' H ' ' HE1' ' A' ' 19' ' ' HIS . 39.6 mtp -82.38 166.54 35.98 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.327 -0.62 . . . . 1.32 109.327 169.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 89.2 Cg_exo -44.32 -50.42 7.89 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.61 113.107 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 2.1 mt-30 -66.73 -23.79 66.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.411 0.523 . . . . 1.47 112.411 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.919 ' HB ' HG13 ' A' ' 92' ' ' VAL . 24.4 m -63.3 -38.24 90.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.647 0.26 . . . . 0.46 110.61 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -29.33 5.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 C-N-CA 120.615 -0.434 . . . . 1.05 111.053 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 20.9 mm-40 -51.42 -45.51 62.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.177 0.513 . . . . 1.62 110.524 174.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.457 -0.792 . . . . 0.34 110.973 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -78.55 -45.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.908 -0.587 . . . . 0.38 111.256 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.36 -35.89 68.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.516 0.674 . . . . 1.85 110.048 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -76.03 -29.8 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 0.85 110.324 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.709 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -90.04 -45.95 8.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.265 0.469 . . . . 0.48 112.265 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -55.84 -26.55 47.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.681 0.622 . . . . 2.56 112.681 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.53 7.08 15.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.555 0.576 . . . . 0.76 112.555 -171.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -95.58 -4.25 44.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.823 -0.806 . . . . 0.9 108.823 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 t30 78.15 47.56 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.381 -1.281 . . . . 2.06 108.091 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -130.35 142.5 45.68 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.393 -1.73 . . . . 1.08 111.164 -171.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.5 Cg_exo -69.66 160.22 50.56 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.308 2.672 . . . . 0.51 114.449 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.748 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -124.57 145.92 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.43 -1.259 . . . . 0.96 110.566 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 83' ' ' ILE . 5.2 mp -123.88 108.78 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 120.873 0.368 . . . . 0.71 110.97 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -74.26 136.04 26.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.424 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -121.59 88.38 2.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.908 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 38.2 mt -68.21 93.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.306 -1.315 . . . . 0.85 110.722 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -91.5 169.51 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.967 -0.383 . . . . 0.69 109.967 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 60.7 22.47 12.38 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.855 0.836 . . . . 2.61 110.081 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.2 tpp -93.04 2.03 56.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.564 1.173 . . . . 1.37 109.018 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 151' ' ' SER . 2.6 p30 -54.7 -18.52 4.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.498 -1.228 . . . . 2.45 112.332 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.917 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 19.2 pttm -83.84 -176.99 0.87 Allowed Pre-proline 0 C--O 1.221 -0.399 0 N-CA-C 108.475 -0.935 . . . . 3.7 108.475 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.917 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 4.7 Cg_exo -42.41 -61.86 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.993 1.795 . . . . 2.67 113.19 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 12.8 pt-20 149.42 127.66 0.0 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.922 1.289 . . . . 4.03 108.019 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.85 -71.56 0.23 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.022 -0.535 . . . . 1.47 109.731 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 4.5 t-20 -176.89 88.68 0.26 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 1.84 109.87 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.0 Cg_exo -39.15 -61.31 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.253 3.302 . . . . 0.7 113.727 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -49.45 -43.85 45.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.991 0.517 . . . . 2.0 112.19 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -53.5 -55.56 24.38 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.31 0.576 . . . . 2.99 109.696 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.569 HG13 ' HA2' ' A' ' 91' ' ' GLY . 55.2 t -61.37 -43.82 97.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.605 -1.179 . . . . 0.4 110.052 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.799 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.5 mtp -63.5 -28.14 69.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.249 -0.887 . . . . 0.3 111.303 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.9 mt-30 -79.06 -23.59 44.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.628 -0.26 . . . . 1.28 110.477 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -71.93 -34.42 69.04 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.249 -0.649 . . . . 2.02 109.249 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -72.26 -41.0 67.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.571 0.7 . . . . 1.06 109.827 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.839 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -75.63 -5.38 45.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.091 -0.959 . . . . 0.35 109.462 176.094 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.2 tt0 -84.01 -21.51 31.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.664 -0.865 . . . . 2.18 108.664 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.745 ' HE2' HG11 ' A' ' 92' ' ' VAL . 31.9 m-85 -94.27 10.57 33.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.281 -1.007 . . . . 0.74 108.281 166.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.4 m120 70.97 35.29 1.7 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 113.683 -1.599 . . . . 1.94 111.449 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.564 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.0 mp -112.0 78.16 1.1 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.402 -0.962 . . . . 1.68 108.402 170.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.984 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.63 130.13 93.35 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 113.936 -1.484 . . . . 0.61 110.682 -176.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.802 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 75.8 Cg_exo -51.13 153.33 9.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.849 2.366 . . . . 0.3 113.295 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.7 mm-40 -79.52 -23.52 42.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.488 -1.233 . . . . 2.01 109.083 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.69 ' HB3' ' CD1' ' A' ' 141' ' ' TRP . 8.1 mp0 -42.96 -53.06 4.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.676 -1.147 . . . . 1.14 110.547 159.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.839 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -93.82 -22.06 18.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.739 -1.573 . . . . 0.45 111.237 -167.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.32 25.61 3.73 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.086 -1.054 . . . . 0.45 112.364 172.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.984 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -106.71 2.12 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.623 -0.799 . . . . 0.5 113.114 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.83 23.02 0.27 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.999 0.428 . . . . 1.3 110.944 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.748 HG23 HG22 ' A' ' 110' ' ' ILE . 17.5 m -136.44 112.21 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.912 -0.715 . . . . 0.32 112.834 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.737 HG21 ' HB3' ' A' ' 164' ' ' MET . 52.9 mt -76.89 117.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 1.23 110.808 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.802 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.3 m-85 -94.69 101.86 13.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.38 111.839 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.2 m -96.42 99.37 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.726 -0.67 . . . . 1.1 109.99 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.908 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 18.6 pttm -79.26 85.17 5.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.776 -0.824 . . . . 2.44 108.776 172.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.672 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -109.82 179.25 4.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.301 -0.863 . . . . 1.27 112.542 -169.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 118' ' ' ASP . 3.4 p -146.17 104.71 3.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.062 -0.972 . . . . 1.79 110.772 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 158' ' ' LEU . . . -66.86 -17.93 65.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.981 0.42 . . . . 0.87 111.44 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -78.62 -60.76 2.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.42 0.628 . . . . 3.03 110.299 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -85.45 -5.46 59.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.033 -0.985 . . . . 1.2 112.067 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HD23 ' A' ' 158' ' ' LEU . 5.1 tppp? 73.05 -7.08 1.56 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.618 0.574 . . . . 2.27 112.423 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -56.35 -55.39 33.99 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.984 0.897 . . . . 2.64 111.141 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.672 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -67.36 -19.57 70.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.995 -1.002 . . . . 0.62 113.695 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 152' ' ' ALA . 4.0 mm? -67.58 -41.43 84.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.486 0.643 . . . . 1.55 110.367 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.88 -44.47 97.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.728 -0.669 . . . . 2.5 109.926 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.483 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.4 t60 -65.55 -38.14 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.73 111.041 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.51 -58.34 8.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.91 112.051 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.604 ' O ' HD23 ' A' ' 166' ' ' LEU . 93.7 mt -56.05 -40.97 74.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.595 -0.275 . . . . 1.06 110.716 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.5 -30.98 71.43 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.954 -0.299 . . . . 2.49 111.144 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.737 ' HB3' HG21 ' A' ' 146' ' ' ILE . 24.5 mmt -70.4 -39.76 74.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.87 109.888 175.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 57' ' ' ILE . 78.9 mt -57.08 -56.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.093 -0.958 . . . . 0.64 110.559 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.577 0.584 . . . . 1.81 112.577 176.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.43 -37.15 77.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 1.42 110.462 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 146' ' ' ILE . 1.4 t -78.74 -35.14 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.146 -0.479 . . . . 1.17 110.612 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 172' ' ' GLU . 20.3 t -65.32 -24.95 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.543 0.687 . . . . 1.54 110.071 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.05 -25.49 34.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 2.79 109.88 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.5 ttp -93.64 -13.43 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 1.82 111.163 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 169' ' ' SER . 45.4 mt-10 -40.22 -45.42 2.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.198 0.599 . . . . 3.45 112.523 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -60.33 -30.82 69.77 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.485 0.55 . . . . 3.36 112.485 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -106.95 -40.91 5.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.731 0.301 . . . . 4.14 111.127 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.8 tptp 66.05 -57.2 0.35 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.442 1.097 . . . . 6.31 112.27 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -125.77 -177.63 3.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.768 -0.456 . . . . 4.57 109.768 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 42.5 m-80 61.25 62.0 2.77 Favored Pre-proline 0 N--CA 1.467 0.386 0 O-C-N 123.618 0.574 . . . . 6.38 110.842 -177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 177' ' ' ASN . 5.8 Cg_endo . . . . . 0 C--O 1.247 0.925 0 C-N-CA 122.918 2.412 . . . . 7.47 111.662 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.027 -0.429 . . . . 16.35 112.027 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -68.38 117.39 10.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.821 0.344 . . . . 14.69 110.837 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -122.99 65.75 0.97 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.377 0.608 . . . . 14.68 110.075 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.0 ptm -133.07 29.24 4.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.435 -0.802 . . . . 12.73 109.736 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.72 61.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 10.18 111.197 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -61.58 119.11 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.38 . . . . 9.14 110.831 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 60.67 78.85 0.3 Allowed Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.08 0.863 . . . . 8.35 112.154 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.23 128.52 15.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.977 1.785 . . . . 4.6 109.566 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.771 ' HD2' ' HG2' ' A' ' 56' ' ' LYS . 74.2 Cg_exo -48.71 101.33 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.008 2.472 . . . . 4.29 112.886 -178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 35.6 m -71.85 116.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.225 -0.657 . . . . 2.58 109.225 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.792 HG21 HG23 ' A' ' 57' ' ' ILE . 21.3 t -86.29 94.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.898 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 m -64.93 116.66 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.112 -0.949 . . . . 0.66 111.585 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.869 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.6 mt -104.73 128.19 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.45 . . . . 1.03 110.831 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.6 mtm -139.78 166.56 24.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.021 0.439 . . . . 1.04 111.096 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.59 -107.56 0.29 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.919 -0.872 . . . . 1.55 110.919 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -156.44 160.16 39.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.929 -0.397 . . . . 0.66 109.929 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.82 -56.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.68 0.252 . . . . 1.62 111.68 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.87 -15.14 63.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.435 0.532 . . . . 1.78 112.435 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' H ' ' A' ' 93' ' ' MET . 64.3 m170 -77.43 -2.52 35.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.653 0.739 . . . . 0.65 110.421 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.53 47.79 47.93 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.966 -1.015 . . . . 0.93 113.4 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.8 pttp -70.89 -10.84 60.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.798 0.808 . . . . 2.11 109.481 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -81.31 -5.22 57.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.957 -1.019 . . . . 1.8 110.563 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 p -84.67 -32.56 23.55 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 120.801 -0.36 . . . . 1.77 110.821 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 25' ' ' LEU . 4.5 pp -69.66 -34.96 74.73 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.593 -0.891 . . . . 1.78 108.593 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -56.98 -38.84 73.58 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.484 -0.932 . . . . 1.96 108.484 175.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.41 -52.89 7.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 1.38 112.216 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . . . -67.73 -33.59 75.18 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.348 -0.387 . . . . 0.91 111.274 -171.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' A' ' 48' ' ' TYR . 96.2 mt -71.65 -29.7 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 1.56 110.314 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 75.2 mtm180 -66.42 -40.96 89.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.218 -0.66 . . . . 3.56 109.218 172.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.34 -12.6 57.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 2.88 110.606 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -2.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.84 -0.618 . . . . 1.76 110.199 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' O ' HG12 ' A' ' 33' ' ' VAL . 43.1 mttp 65.01 -161.17 0.28 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 115.518 -0.764 . . . . 5.71 111.386 172.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.092 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 57.33 17.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.952 0.901 . . . . 2.99 112.438 174.279 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.583 HG22 HG12 ' A' ' 50' ' ' VAL . 3.5 p -84.68 135.3 34.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.243 0.544 . . . . 3.93 112.197 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.04 -41.68 61.42 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.435 -0.802 . . . . 4.2 110.345 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.752 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 78.3 mt-30 -108.17 78.3 1.17 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.392 -0.822 . . . . 5.38 109.183 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 49.72 1.39 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.303 -0.862 . . . . 5.79 112.464 -172.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HA ' HD12 ' A' ' 41' ' ' ILE . . . -151.27 37.24 0.61 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.285 0.564 . . . . 4.24 110.516 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.09 96.65 0.23 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.18 -0.918 . . . . 4.95 112.888 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.651 ' H ' ' HA2' ' A' ' 46' ' ' GLY . . . 87.01 15.34 62.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.265 -0.493 . . . . 6.66 113.003 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 38' ' ' ALA . 59.2 mt -90.89 -69.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 9.17 110.36 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.434 ' O ' HD12 ' A' ' 45' ' ' ILE . 48.2 m -94.49 143.52 26.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.817 -0.629 . . . . 7.36 109.482 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -80.39 65.54 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.417 0.627 . . . . 8.83 111.193 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -148.93 -43.54 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.998 -1.001 . . . . 6.76 108.351 175.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.643 HD12 ' H ' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -103.42 -168.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.659 -1.155 . . . . 5.19 109.464 173.096 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.651 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . 162.12 -42.94 0.37 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.121 -1.037 . . . . 2.97 112.025 -173.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.91 172.29 11.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.761 -0.829 . . . . 1.71 108.761 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.752 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -164.19 138.72 5.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.481 0.658 . . . . 2.54 111.893 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 58' ' ' THR . 44.3 mt-30 -101.82 123.4 45.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.175 -0.921 . . . . 1.96 108.921 175.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 34' ' ' THR . 12.3 m -97.6 144.64 10.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.151 0.5 . . . . 1.93 111.954 -175.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.092 ' HB ' HG22 ' A' ' 33' ' ' VAL . 59.8 m -88.1 82.6 7.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.614 0.721 . . . . 2.06 110.363 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG12 HD11 ' A' ' 166' ' ' LEU . 45.5 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.072 -1.085 . . . . 4.12 108.072 173.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 t30 70.39 -52.45 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.279 0.987 . . . . 4.43 111.177 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 51' ' ' THR . 19.8 t70 -126.72 -70.84 0.71 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.523 -0.762 . . . . 3.62 111.695 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.941 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 12.7 pttp 147.65 30.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.733 1.613 . . . . 7.44 108.121 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.771 ' HG2' ' HD2' ' A' ' 9' ' ' PRO . 12.1 ttmm -99.29 10.29 41.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.645 -1.161 . . . . 5.43 111.585 -167.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.792 HG23 HG21 ' A' ' 11' ' ' VAL . 58.4 mt -102.51 98.61 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 1.14 110.191 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 49' ' ' GLN . 14.2 m -86.69 111.1 20.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.913 -0.585 . . . . 1.28 110.103 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HE2' HG21 ' A' ' 50' ' ' VAL . 34.9 m-85 -93.39 130.13 39.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.715 0.293 . . . . 0.84 110.352 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.34 164.05 36.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 3.0 110.622 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -136.64 -94.61 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.845 -0.798 . . . . 6.48 108.845 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.5 m 51.85 80.33 0.3 Allowed Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.788 0.662 . . . . 5.57 112.788 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.82 64.33 3.98 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.056 2.504 . . . . 5.77 111.99 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.36 -114.07 2.98 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.121 -0.561 . . . . 5.54 112.384 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -80.11 100.44 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.608 -0.145 . . . . 8.09 110.608 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.76 98.49 0.05 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.944 0.778 . . . . 6.36 110.106 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 68' ' ' PHE . . . -77.2 58.98 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.611 . . . . 3.51 111.194 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 103' ' ' ALA . 22.1 t80 172.76 155.57 0.09 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.184 -1.043 . . . . 2.61 108.184 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -60.3 110.59 1.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.848 0.356 . . . . 4.74 110.395 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -58.96 130.86 49.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 5.89 111.43 -176.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.0 mtt -81.86 24.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 5.64 112.422 -172.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -163.02 59.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.611 0.719 . . . . 9.71 110.429 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.09 24.32 9.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.53 -0.759 . . . . 7.52 109.967 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 69.13 -58.76 0.49 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.59 0.756 . . . . 10.42 111.385 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.18 -113.52 2.12 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.147 -0.781 . . . . 6.75 111.147 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.08 38.62 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.816 0.446 . . . . 6.69 111.002 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 9' ' ' PRO . 21.6 mt-30 71.79 92.78 0.08 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.963 0.79 . . . . 7.72 111.474 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.85 -18.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.876 0.846 . . . . 4.38 109.076 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -109.2 96.85 6.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.834 -1.075 . . . . 4.18 109.212 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.56 -175.47 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.863 -0.608 . . . . 3.12 110.353 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 11' ' ' VAL . 8.5 mm -140.36 119.15 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.026 -0.534 . . . . 0.74 110.321 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 ' HB1' ' A' ' 103' ' ' ALA . 40.5 t -99.51 96.24 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.107 -0.637 . . . . 1.19 111.283 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.869 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 17.3 mm -74.29 117.41 18.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.198 -1.038 . . . . 1.32 108.198 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.6 tm? -110.65 96.03 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.784 -0.643 . . . . 1.33 110.245 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 49.4 t -84.9 130.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.213 0.53 . . . . 1.2 111.388 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.799 HG12 HG21 ' A' ' 96' ' ' THR . 28.0 m -128.4 -164.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.511 -0.922 . . . . 1.12 108.511 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.56 40.53 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.116 -0.634 . . . . 0.75 111.965 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 117' ' ' MET . . . -31.94 -64.68 0.16 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.93 1.394 . . . . 1.18 113.922 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.71 -20.13 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.864 -0.607 . . . . 2.01 112.356 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.36 -37.0 15.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.362 -0.535 . . . . 1.09 111.598 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.59 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 82.87 -144.35 22.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.528 -0.844 . . . . 0.52 111.783 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' HB ' ' A' ' 96' ' ' THR . 2.8 p -100.85 102.57 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 109.279 -0.637 . . . . 1.08 109.279 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.603 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -83.49 169.54 17.08 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.57 -0.53 . . . . 1.32 109.57 -175.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 29.0 Cg_exo -30.42 -56.17 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.092 3.195 . . . . 0.61 115.1 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -69.98 -34.68 73.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.533 0.206 . . . . 1.47 111.016 -175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.65 -31.48 72.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.649 0.738 . . . . 0.46 109.931 176.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.548 HG23 HG22 ' A' ' 92' ' ' VAL . 72.5 t -78.79 -45.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.354 -0.839 . . . . 1.05 111.055 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.6 mt-10 -63.94 -19.06 64.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.62 111.086 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.79 -41.04 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.646 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.581 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.21 -47.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.79 176.502 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -49.24 -34.78 15.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.926 0.491 . . . . 1.85 110.735 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -85.69 -31.93 22.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 0.85 111.02 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.83 -44.78 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.925 0.343 . . . . 0.48 111.925 -173.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -54.59 -30.75 55.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.654 . . . . 2.56 112.759 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.32 3.37 15.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.973 0.731 . . . . 0.76 112.973 -167.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.45 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -91.39 -2.3 57.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.721 -0.844 . . . . 0.9 108.721 173.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.1 t30 72.22 46.14 0.34 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.986 -1.461 . . . . 2.06 107.534 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -121.24 144.58 40.07 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 112.663 -2.062 . . . . 1.08 110.942 -170.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 108' ' ' VAL . 18.0 Cg_exo -67.45 154.47 73.67 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.681 2.254 . . . . 0.51 114.264 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.661 HG22 HG23 ' A' ' 145' ' ' THR . 1.2 mp -122.57 142.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.746 -1.57 . . . . 0.96 109.645 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.682 HD13 HD13 ' A' ' 83' ' ' ILE . 2.7 mp -121.23 99.96 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 CA-C-O 121.272 0.558 . . . . 0.71 111.292 -176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -68.56 137.12 25.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.361 -0.836 . . . . 0.23 110.613 179.108 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -122.52 89.48 3.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.966 -1.124 . . . . 0.25 107.966 173.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.812 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 6.6 mm -65.22 85.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.595 -1.184 . . . . 0.85 109.745 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -95.75 168.36 10.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.69 110.128 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 69.46 12.92 8.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.333 0.587 . . . . 2.61 110.206 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -95.54 41.09 1.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.424 0.63 . . . . 1.37 110.642 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.48 57.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.633 -1.167 . . . . 2.45 110.798 170.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.831 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 63.8 mttp -154.44 -172.91 0.34 Allowed Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 105.48 -2.045 . . . . 3.7 105.48 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.8 Cg_endo -55.59 -54.41 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.524 1.223 . . . . 2.67 110.705 168.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.546 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 6.2 pt-20 164.71 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.456 1.102 . . . . 4.03 108.346 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -53.4 -69.58 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 1.47 110.325 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -173.52 75.44 0.39 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 1.84 110.781 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.65 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.2 Cg_exo -38.98 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.051 3.168 . . . . 0.7 114.094 171.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -45.48 -49.02 13.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.859 0.688 . . . . 2.0 112.859 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -50.68 -57.06 9.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.496 0.665 . . . . 2.99 109.872 175.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.59 HG13 ' HA2' ' A' ' 91' ' ' GLY . 74.3 t -58.5 -45.51 90.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.389 -1.278 . . . . 0.4 110.514 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.676 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.0 mtp -62.74 -29.05 70.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.3 111.376 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -78.32 -24.31 46.67 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.513 -0.312 . . . . 1.28 110.773 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -72.61 -32.82 66.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.793 -0.817 . . . . 2.02 108.793 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -70.15 -44.67 68.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 120.048 -0.661 . . . . 1.06 109.569 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.875 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -76.95 -0.49 24.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.35 110.006 177.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.0 tp10 -77.5 -31.84 53.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.288 -1.375 . . . . 2.18 107.288 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -95.35 17.51 14.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.146 -0.933 . . . . 0.74 109.696 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.9 34.27 4.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.054 -1.43 . . . . 1.94 110.333 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -106.96 87.09 2.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.09 1.424 . . . . 1.68 109.0 173.225 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.842 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 93.3 t -83.91 119.74 73.93 Favored Pre-proline 0 C--N 1.285 -2.21 0 CA-C-N 111.559 -2.564 . . . . 0.61 111.334 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.84 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -47.74 157.97 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.791 2.994 . . . . 0.3 113.963 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 144' ' ' ASP . 6.8 mm-40 -74.33 -24.69 59.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.13 -1.395 . . . . 2.01 109.183 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.836 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -56.86 -40.65 76.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.286 -0.87 . . . . 1.14 109.045 169.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.875 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.6 m0 -96.04 -21.24 18.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.858 -1.065 . . . . 0.45 111.089 -169.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.36 30.16 4.51 Favored Glycine 0 CA--C 1.501 -0.786 0 C-N-CA 119.762 -1.209 . . . . 0.45 112.011 170.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.842 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.93 -109.48 2.64 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.377 -0.916 . . . . 0.5 111.48 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.485 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 9.0 p-10 -166.42 46.36 0.07 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.623 1.201 . . . . 1.3 109.591 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 110' ' ' ILE . 21.4 m -132.02 110.37 10.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.286 -1.325 . . . . 0.32 111.377 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.73 107.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.092 -0.958 . . . . 1.23 110.422 -175.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.84 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 22.6 m-85 -89.76 96.59 10.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.5 . . . . 0.38 111.33 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 150' ' ' LEU . 68.8 m -88.02 99.22 12.0 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.161 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.812 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.8 ptmt -76.35 83.97 3.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.872 -0.788 . . . . 2.44 108.872 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.488 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.5 -178.95 3.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.585 0.707 . . . . 1.27 112.23 -170.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -165.77 130.1 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.036 -0.983 . . . . 1.79 110.792 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 27' ' ' ALA . . . -84.47 -9.65 58.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.32 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 153' ' ' LYS . 5.3 tppp? -78.34 -58.69 3.12 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.295 -0.866 . . . . 3.03 109.342 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.711 ' HB ' ' HG2' ' A' ' 156' ' ' GLU . 22.1 p -73.99 -22.53 59.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.619 -1.173 . . . . 1.2 110.783 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 tptp 72.61 -2.64 2.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.092 -0.958 . . . . 2.27 110.981 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.711 ' HG2' ' HB ' ' A' ' 154' ' ' THR . 22.1 mm-40 -59.15 -73.33 0.08 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.459 0.647 . . . . 2.64 112.022 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -67.69 -9.1 55.06 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.62 113.454 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 28' ' ' ILE . 2.6 tm? -64.27 -51.22 64.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.513 -0.551 . . . . 1.55 109.513 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.71 -36.51 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 2.5 109.938 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.576 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 80.1 t60 -58.75 -37.71 76.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.258 -0.883 . . . . 0.73 110.478 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.79 -49.49 77.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.921 -0.581 . . . . 0.91 110.634 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.26 -38.53 77.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 1.06 110.769 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.5 -42.99 91.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 2.49 110.499 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -39.0 92.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.87 110.621 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.23 -48.8 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.985 -0.552 . . . . 0.64 110.213 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.794 HD11 HG12 ' A' ' 52' ' ' VAL . 94.4 mt -62.84 -46.98 85.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.854 -0.612 . . . . 1.81 111.034 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.0 tp -48.8 -49.29 39.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.393 -0.821 . . . . 1.42 110.86 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 45.9 t -68.85 -44.96 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.032 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 m -58.38 -35.04 71.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.45 . . . . 1.54 111.117 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.94 -31.62 25.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 2.79 110.463 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 50.0 ttp -71.57 -43.4 66.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 1.82 111.307 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 21.9 mm-40 -54.39 -24.89 21.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.113 0.782 . . . . 3.45 113.113 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.71 -30.39 70.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.301 0.572 . . . . 3.36 109.746 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.2 mt -106.57 -70.21 0.8 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.548 -0.751 . . . . 4.14 109.317 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttp 63.1 104.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.937 -1.029 . . . . 6.31 111.995 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -134.06 -58.17 0.85 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.614 -0.721 . . . . 4.57 109.989 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.89 137.5 5.69 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.467 -0.568 . . . . 6.38 109.467 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.208 2.606 . . . . 7.47 112.376 175.508 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.912 -0.475 . . . . 16.35 111.912 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -92.71 -4.91 52.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.004 0.431 . . . . 14.69 110.697 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -77.11 77.1 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.98 -0.555 . . . . 14.68 110.879 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.0 mtm -106.82 122.67 46.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.67 . . . . 12.73 110.015 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -86.03 32.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 10.18 111.428 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 13.8 mm-40 -69.83 -42.78 73.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.779 -0.646 . . . . 9.14 111.243 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 6' ' ' GLU . 15.0 mmm180 67.73 104.71 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 121.271 0.558 . . . . 8.35 111.286 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -87.13 116.77 1.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.837 2.358 . . . . 4.6 111.712 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 61' ' ' ASP . 76.3 Cg_exo -50.69 123.34 11.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.93 2.42 . . . . 4.29 111.993 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.788 HG11 ' HA ' ' A' ' 57' ' ' ILE . 43.0 t -93.57 -72.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.125 -0.488 . . . . 2.58 110.802 -177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG22 ' HB ' ' A' ' 81' ' ' ILE . 47.5 t -125.04 107.06 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 120.968 0.413 . . . . 1.0 111.028 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -98.12 132.53 43.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.157 0.503 . . . . 0.66 110.413 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.582 ' HB ' HD21 ' A' ' 60' ' ' LEU . 66.1 mt -94.87 127.51 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.708 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 54.8 mtt -127.48 173.12 10.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.726 -0.67 . . . . 1.04 110.922 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.11 -104.92 0.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.908 -0.877 . . . . 1.55 110.908 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' CD2' ' H ' ' A' ' 18' ' ' ASP . 81.6 t60 -166.55 143.34 4.88 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.261 -0.644 . . . . 0.66 109.261 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.42 -24.47 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.2 1.185 . . . . 1.62 114.2 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 21.1 m-20 -88.3 -11.83 45.3 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.561 0.578 . . . . 1.78 112.561 -173.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -77.6 -3.6 41.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.162 0.43 . . . . 0.65 112.162 -174.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.58 64.63 0.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.656 -0.783 . . . . 0.93 112.763 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -87.08 -34.69 19.06 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 2.11 110.871 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.628 -0.26 . . . . 1.8 110.472 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 p -78.54 -32.07 47.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.954 0.407 . . . . 1.77 110.635 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -54.45 13.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.851 -0.796 . . . . 1.78 108.851 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -59.1 -33.9 71.38 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.099 -0.955 . . . . 1.96 110.724 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.88 -55.83 6.81 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.035 -0.416 . . . . 1.38 111.398 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -59.71 -39.61 85.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.91 110.898 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 48' ' ' TYR . 10.8 tt -65.96 -28.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.504 -0.771 . . . . 1.56 111.252 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.781 ' HA ' HG21 ' A' ' 34' ' ' THR . 85.4 mtm180 -77.25 -26.59 52.71 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.595 0.712 . . . . 3.56 109.463 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -85.58 15.21 4.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.829 -1.078 . . . . 2.88 110.091 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 3.8 m -100.14 22.97 10.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.65 -0.704 . . . . 1.76 111.736 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 71.78 -48.13 0.67 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.181 1.178 . . . . 5.71 114.181 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 50' ' ' VAL . 29.2 m -71.95 6.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.473 0.916 . . . . 2.99 113.473 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.781 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -81.71 124.26 29.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.195 0.521 . . . . 3.93 111.623 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' OE1' ' HD3' ' A' ' 55' ' ' LYS . 37.3 mt-10 -72.38 -73.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 4.2 111.701 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -144.38 176.78 9.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.429 -0.805 . . . . 5.38 109.767 -173.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.831 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.6 mt-10 -124.95 100.67 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.427 0.454 . . . . 5.79 111.736 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.36 129.94 11.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.021 -0.536 . . . . 4.24 110.878 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . 105.51 -129.78 9.94 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.108 -0.567 . . . . 4.95 112.037 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . 72.5 165.2 8.15 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.516 0.566 . . . . 6.66 114.516 170.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 63' ' ' PRO . 40.1 pt -97.87 -25.8 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.007 0.432 . . . . 9.17 110.823 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.4 p -77.69 114.72 16.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 7.36 110.712 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -78.11 24.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 8.83 111.787 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -90.31 -20.39 22.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.481 -0.562 . . . . 6.76 109.481 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.934 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.2 tp -174.76 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.262 -1.014 . . . . 5.19 108.262 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.934 ' H ' HG13 ' A' ' 45' ' ' ILE . . . -90.94 -119.74 2.24 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.224 -0.989 . . . . 2.97 112.629 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.831 ' O ' ' HA ' ' A' ' 37' ' ' GLU . . . -135.4 -169.3 2.36 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.456 -0.942 . . . . 1.71 108.456 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.62 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.2 p90 -153.0 137.56 16.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.133 0.492 . . . . 2.54 111.156 -174.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.813 ' HG2' HG23 ' A' ' 58' ' ' THR . 18.0 mt-30 -109.44 134.09 52.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.581 -0.736 . . . . 1.96 109.284 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 90.3 t -88.62 150.26 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 CA-C-O 121.649 0.738 . . . . 1.93 110.609 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -92.63 83.8 4.94 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.606 -1.179 . . . . 2.06 110.588 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG13 ' HB2' ' A' ' 56' ' ' LYS . 3.3 p -125.31 120.3 57.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.38 -1.341 . . . . 4.12 107.38 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 22.0 t-20 73.73 -43.28 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.213 0.945 . . . . 4.43 108.889 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 52' ' ' VAL . 16.5 t70 178.18 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.681 -1.599 . . . . 3.62 108.712 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 3.1 pttm -176.98 57.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.049 -0.978 . . . . 7.44 110.501 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.746 ' HB2' HG13 ' A' ' 52' ' ' VAL . 12.9 mmmm -73.95 -43.69 57.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 5.43 111.483 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 ' HA ' HG11 ' A' ' 10' ' ' VAL . 59.5 mt -87.02 112.38 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.524 -0.47 . . . . 1.14 111.179 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.813 HG23 ' HG2' ' A' ' 49' ' ' GLN . 18.9 m -104.3 127.99 52.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 1.28 108.977 171.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.7 m-85 -97.28 127.01 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.976 -0.29 . . . . 0.84 110.92 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.582 HD21 ' HB ' ' A' ' 13' ' ' ILE . 95.0 mt 67.68 59.73 0.47 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.969 0.793 . . . . 3.0 111.285 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 9' ' ' PRO . 4.2 m-20 -66.58 -24.78 66.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 6.48 110.806 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -121.04 136.89 26.0 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.921 -0.581 . . . . 5.57 110.563 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.613 ' HA ' HG22 ' A' ' 41' ' ' ILE . 66.0 Cg_endo -75.94 55.41 4.43 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.735 2.29 . . . . 5.77 111.537 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.86 88.23 1.16 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.504 -0.771 . . . . 5.54 113.331 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -80.12 -33.32 38.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.106 -1.072 . . . . 8.09 108.106 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -94.89 46.3 1.13 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.614 -1.176 . . . . 6.36 108.907 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 73.87 -75.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.972 -1.013 . . . . 3.51 111.604 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.563 ' HB2' ' CE1' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -130.68 127.32 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.702 0.287 . . . . 2.61 110.915 -177.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.71 -31.8 61.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 4.74 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.681 HG22 ' H ' ' A' ' 71' ' ' MET . 1.5 m -114.16 -178.04 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.526 -0.761 . . . . 5.89 109.626 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.681 ' H ' HG22 ' A' ' 70' ' ' THR . 72.4 mtm 59.29 54.07 4.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.632 0.73 . . . . 5.64 111.251 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.45 -42.17 5.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.108 -0.951 . . . . 9.71 109.087 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.25 34.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.736 -1.12 . . . . 7.52 109.058 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 71' ' ' MET . 26.7 ttt180 -165.79 133.59 2.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.237 -0.892 . . . . 10.42 109.654 -172.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.76 140.95 7.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.937 -0.649 . . . . 6.75 111.505 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.4 -65.72 0.29 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 6.69 110.968 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -87.87 76.02 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.504 0.668 . . . . 7.72 110.116 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.04 101.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.431 -0.804 . . . . 4.38 109.959 176.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 p -87.06 71.83 10.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.797 -0.638 . . . . 4.18 111.042 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.51 134.58 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 3.12 109.774 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.697 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.6 mm -83.78 103.21 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.911 -0.586 . . . . 0.74 109.716 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.7 t -82.18 94.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 120.376 -0.53 . . . . 1.19 110.714 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.609 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 10.0 mm -80.66 97.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.369 -0.604 . . . . 1.32 109.369 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -87.71 96.26 10.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.005 -0.739 . . . . 1.33 109.005 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 55.2 t -81.71 137.98 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.428 0.632 . . . . 1.2 111.266 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.2 m -132.84 -168.19 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 1.12 108.547 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.26 20.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -58.64 -19.94 43.42 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.421 -0.809 . . . . 1.18 112.437 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.75 -12.48 33.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.515 0.191 . . . . 2.01 111.515 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 28.5 t70 -119.43 -49.65 2.36 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.375 0.607 . . . . 1.09 110.94 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 100.49 -124.67 8.32 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.18 -0.918 . . . . 0.52 111.239 -174.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.017 HG11 ' HE2' ' A' ' 134' ' ' TYR . 38.1 t -111.82 113.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.957 0.408 . . . . 1.08 111.029 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.563 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 77.2 mmm -80.33 168.12 28.06 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.557 -0.535 . . . . 1.32 109.557 172.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 6.3 Cg_endo -49.64 -42.83 41.87 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.393 2.062 . . . . 0.61 112.885 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.76 -26.86 62.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.659 0.266 . . . . 1.47 110.609 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.823 ' HB ' HG13 ' A' ' 92' ' ' VAL . 18.6 m -60.79 -35.77 77.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.128 -0.487 . . . . 0.46 110.483 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.584 HG12 ' CG1' ' A' ' 92' ' ' VAL . 2.0 m -84.15 -35.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.518 -0.31 . . . . 1.05 110.81 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.945 0.402 . . . . 1.62 111.474 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.695 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -66.82 -45.09 79.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.34 110.137 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.643 HG23 ' HD3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -64.27 -42.65 96.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.522 -0.763 . . . . 0.38 111.216 177.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -62.81 -30.73 71.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.509 0.723 . . . . 1.85 109.814 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.563 ' CE1' ' HB2' ' A' ' 68' ' ' PHE . 65.2 t-80 -83.96 -32.54 24.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.85 110.333 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -87.11 -48.78 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.334 0.494 . . . . 0.48 112.334 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.643 ' HD3' HG23 ' A' ' 100' ' ' ILE . 14.0 pttp -63.74 -16.4 61.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.526 0.565 . . . . 2.56 112.526 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.31 6.74 21.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.855 0.317 . . . . 0.76 111.855 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.542 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -98.21 2.14 48.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.803 -0.444 . . . . 0.9 109.803 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 77.92 31.87 0.4 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.742 1.258 . . . . 2.06 108.569 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -109.48 147.63 36.45 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 113.206 -1.815 . . . . 1.08 110.523 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_exo -73.38 151.42 48.17 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.569 2.179 . . . . 0.51 113.547 172.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.628 HG22 HG23 ' A' ' 145' ' ' THR . 1.1 mp -118.82 142.59 33.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.225 -1.352 . . . . 0.96 110.212 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -112.17 148.24 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 107.933 -1.136 . . . . 0.71 107.933 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -112.84 138.01 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 109.364 -0.606 . . . . 0.23 109.364 172.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -118.95 88.17 2.88 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.758 -1.201 . . . . 0.25 107.758 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.786 HD11 ' HD2' ' A' ' 147' ' ' PHE . 21.1 mt -73.79 83.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.754 -1.112 . . . . 0.85 109.507 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -89.09 164.63 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.934 -0.575 . . . . 0.69 110.105 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 66.97 34.1 5.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.04 -0.527 . . . . 2.61 112.131 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 4.3 ptp -88.22 13.19 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 1.37 109.792 169.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -24.37 67.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.676 -1.147 . . . . 2.45 108.904 165.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.883 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 14.7 mmmm -77.92 -178.76 1.09 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 114.902 -1.044 . . . . 3.7 109.343 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.8 Cg_endo -52.85 -21.35 15.1 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.315 2.01 . . . . 2.67 113.629 177.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 7.3 pt-20 64.11 123.34 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.765 1.626 . . . . 4.03 110.955 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 88' ' ' ALA . . . -79.28 11.78 2.72 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.123 -1.399 . . . . 1.47 110.958 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 122' ' ' ALA . 43.5 t30 77.6 108.87 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 114.74 -1.118 . . . . 1.84 112.092 171.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.4 Cg_exo -36.72 -60.78 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.572 3.515 . . . . 0.7 115.198 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -42.72 -41.85 3.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.6 0.76 . . . . 2.0 113.014 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.87 -54.07 51.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.701 0.762 . . . . 2.99 109.387 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.721 ' HA ' ' OE2' ' A' ' 130' ' ' GLU . 58.4 t -60.06 -39.38 80.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.083 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.679 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 86.3 mtp -65.64 -30.62 71.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.253 -0.885 . . . . 0.3 111.114 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.33 -15.45 57.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.543 -0.463 . . . . 1.28 110.898 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.721 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 12.9 mt-10 -72.3 -37.12 69.05 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.656 -0.868 . . . . 2.02 108.656 170.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.576 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -69.95 -45.17 68.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.45 0.643 . . . . 1.06 110.087 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.905 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -75.79 -5.52 46.24 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.309 -0.859 . . . . 0.35 109.645 177.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 14.4 tp10 -74.02 -32.37 63.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.785 -1.191 . . . . 2.18 107.785 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 1.017 ' HE2' HG11 ' A' ' 92' ' ' VAL . 30.2 m-85 -90.0 10.13 25.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.68 0.753 . . . . 0.74 109.1 173.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 71.95 38.73 0.89 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 113.898 -1.501 . . . . 1.94 110.565 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.2 mp -117.28 84.11 2.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.444 1.116 . . . . 1.68 108.679 172.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.977 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.2 t -69.67 127.31 92.7 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.022 -1.899 . . . . 0.61 112.139 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.839 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 81.3 Cg_exo -47.14 160.24 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.296 0 C-N-CA 124.109 3.206 . . . . 0.3 114.441 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -85.26 -5.87 59.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.336 -1.302 . . . . 2.01 110.11 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -74.13 -32.79 63.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.452 -1.314 . . . . 1.14 107.452 167.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.905 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -101.3 -26.27 13.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.191 -1.368 . . . . 0.45 111.286 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.5 30.8 3.19 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.845 -1.169 . . . . 0.45 112.315 172.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.977 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.87 -102.53 1.95 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 120.486 -0.864 . . . . 0.5 111.609 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -169.6 37.29 0.02 OUTLIER 'General case' 0 C--O 1.247 0.922 0 CA-C-O 122.168 0.985 . . . . 1.3 110.594 172.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.47 113.84 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.909 -1.041 . . . . 0.32 111.49 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.7 mp -82.72 108.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.587 -0.733 . . . . 1.23 110.555 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.839 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.7 m-85 -91.33 111.75 23.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.701 0.286 . . . . 0.38 111.752 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.403 ' O ' HD23 ' A' ' 150' ' ' LEU . 16.0 t -102.11 117.24 34.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.804 -0.813 . . . . 1.1 108.804 174.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.4 pttm -93.34 101.49 13.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.129 -0.693 . . . . 2.44 109.129 175.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.719 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -130.12 176.91 7.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.244 1.021 . . . . 1.27 113.567 -168.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.9 m -147.45 117.27 7.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.6 -1.636 . . . . 1.79 109.101 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.63 66.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.445 0.535 . . . . 0.87 112.445 -174.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.71 ' HG3' ' H ' ' A' ' 154' ' ' THR . 15.0 ptpt -73.95 -56.08 5.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.77 0.795 . . . . 3.03 110.12 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.71 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 10.3 p -72.77 -12.45 61.01 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.16 -1.382 . . . . 1.2 112.098 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HD2' HD12 ' A' ' 158' ' ' LEU . 3.0 tptm 71.72 2.75 4.41 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.061 0.544 . . . . 2.27 111.779 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.94 -72.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.714 0.768 . . . . 2.64 111.423 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.719 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.36 -9.3 60.85 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.155 -0.93 . . . . 0.62 113.623 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.684 HD12 ' HD2' ' A' ' 155' ' ' LYS . 31.2 mt -70.12 -42.69 72.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.365 0.582 . . . . 1.55 110.256 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.57 -44.86 92.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 2.5 109.569 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -67.39 -24.63 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.73 111.361 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.28 -50.02 65.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.551 -0.295 . . . . 0.91 110.289 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -55.7 -36.75 67.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.007 -0.542 . . . . 1.06 110.459 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.16 -51.6 69.31 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.032 0.444 . . . . 2.49 110.526 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.733 ' HB3' HG21 ' A' ' 146' ' ' ILE . 16.2 mmt -65.5 -40.84 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.87 110.799 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.92 -53.18 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.709 -0.678 . . . . 0.64 110.314 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.21 -43.94 95.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.792 -0.64 . . . . 1.81 111.44 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 171' ' ' MET . 62.4 tp -54.01 -47.8 71.1 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.043 -0.526 . . . . 1.42 110.196 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 171' ' ' MET . 48.0 t -73.0 -23.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.07 -0.513 . . . . 1.17 111.317 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.7 t -60.14 -32.11 70.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 1.54 110.13 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -99.25 -27.8 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.017 0.437 . . . . 2.79 110.593 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.503 ' HB3' ' HA ' ' A' ' 168' ' ' VAL . 13.5 ttp -82.45 5.67 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 1.82 111.432 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -40.97 -31.61 0.18 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.031 0.443 . . . . 3.45 111.235 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -57.84 -8.9 1.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.637 -0.71 . . . . 3.36 112.367 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.89 -49.97 19.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.177 0.513 . . . . 4.14 110.797 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -145.99 0.5 0.84 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.815 -0.629 . . . . 6.31 111.555 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.77 11.45 35.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.215 0.531 . . . . 4.57 110.217 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 27.2 t-20 -88.64 131.97 40.16 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.72 -0.673 . . . . 6.38 109.373 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 16.6 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.793 2.328 . . . . 7.47 112.108 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.023 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 10.5 t . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.613 0.721 . . . . 1.0 109.474 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -70.54 118.42 13.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.096 -0.957 . . . . 0.66 111.282 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.724 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.1 mt -87.18 116.06 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.371 0.605 . . . . 1.03 110.549 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 35.0 mtt -125.17 172.23 9.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.552 -0.749 . . . . 1.04 110.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 1.019 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 147.54 -96.64 0.18 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 109.851 -1.299 . . . . 1.55 109.851 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.622 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 71.3 t60 -175.0 164.28 3.35 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.659 -0.867 . . . . 0.66 108.659 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.09 -52.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.665 0.269 . . . . 1.62 111.439 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.443 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 31.8 t70 -61.13 -30.12 70.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.792 -0.64 . . . . 1.78 112.651 -172.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.622 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 39.9 m80 -64.76 -19.43 65.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.408 . . . . 0.65 110.949 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.89 44.15 2.92 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.679 -0.772 . . . . 0.93 112.978 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG11 ' A' ' 85' ' ' VAL . 22.0 ptmt -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.3 p -74.68 -35.68 62.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.738 -1.119 . . . . 1.8 109.62 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.8 m -63.3 -33.68 76.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.138 -0.937 . . . . 1.77 110.522 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.46 -56.19 20.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.408 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' HG22 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -62.64 -38.51 90.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.12 -0.491 . . . . 1.96 110.006 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 12.3 t70 -63.88 -49.49 72.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.98 0.363 . . . . 1.38 111.98 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -68.02 -37.31 81.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.227 0.537 . . . . 0.91 110.857 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.597 HG22 ' HA ' ' A' ' 25' ' ' LEU . 6.5 tt -74.11 -20.84 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.451 -0.795 . . . . 1.56 109.812 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 33.0 tpt180 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.115 -0.948 . . . . 3.56 109.831 174.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -88.84 7.44 34.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.584 -0.735 . . . . 2.88 110.145 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.316 0.579 . . . . 1.76 110.33 -177.545 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' A' ' 28' ' ' ILE . 3.0 p90 . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 120.814 0.34 . . . . 2.54 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HG2' HG23 ' A' ' 58' ' ' THR . 36.8 mt-30 -122.42 122.98 40.26 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.876 -0.787 . . . . 1.96 108.876 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' HE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.948 0 CA-C-O 121.364 0.602 . . . . 1.93 111.194 -173.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 11' ' ' VAL . 56.1 mt . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.057 0.456 . . . . 1.14 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -88.58 113.21 23.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.874 -0.603 . . . . 1.28 109.442 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HE2' HG21 ' A' ' 50' ' ' VAL . 27.6 m-85 . . . . . 0 C--N 1.328 -0.356 0 C-N-CA 120.932 -0.307 . . . . 0.84 111.417 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 24.5 mm . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 110.469 -0.197 . . . . 0.74 110.469 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.954 HG21 ' HB1' ' A' ' 103' ' ' ALA . 13.1 t -99.23 94.97 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 120.418 -0.513 . . . . 1.19 111.703 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 30.9 mm -80.36 115.27 22.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.206 -1.035 . . . . 1.32 108.206 170.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.9 tm? -105.72 101.13 10.66 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.487 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.019 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.1 p -79.96 142.49 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.478 0.656 . . . . 1.2 111.697 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 87' ' ' ALA . 25.3 t -136.1 173.04 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 107.583 -1.265 . . . . 1.12 107.583 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.59 112.8 5.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.231 0.469 . . . . 0.75 112.017 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 41.35 -97.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.599 1.16 . . . . 1.18 113.756 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.26 1.29 25.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 2.01 112.055 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.543 ' OD1' ' HG3' ' A' ' 93' ' ' MET . 14.1 t70 -71.24 -49.2 45.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.09 110.635 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.765 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 86.43 -107.6 3.21 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.159 -0.928 . . . . 0.52 111.606 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.874 HG13 ' HB ' ' A' ' 96' ' ' THR . 30.7 t -128.81 111.75 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 122.347 0.259 . . . . 1.08 110.709 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.633 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.9 mtp -82.8 172.09 10.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.695 -0.23 . . . . 1.32 110.445 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.633 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 99.4 Cg_exo -44.17 -52.03 6.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.028 2.486 . . . . 0.61 113.658 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -65.46 -28.83 69.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.591 -0.277 . . . . 1.47 111.241 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.874 ' HB ' HG13 ' A' ' 92' ' ' VAL . 8.1 m -62.97 -30.29 71.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.248 0.547 . . . . 0.46 110.624 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 70.9 t -84.46 -52.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.286 -0.416 . . . . 1.05 111.676 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.35 -18.83 60.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.849 -0.614 . . . . 1.62 111.473 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -88.09 -39.9 14.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.877 -0.601 . . . . 0.34 109.543 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.865 HD11 ' HG ' ' A' ' 84' ' ' LEU . 1.7 mt -71.59 -48.96 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.38 111.311 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.475 HD22 ' HA ' ' A' ' 101' ' ' ASN . 1.0 OUTLIER -50.45 -38.52 44.01 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.965 0.506 . . . . 1.85 110.982 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -76.64 -33.39 58.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.744 -0.662 . . . . 0.85 110.565 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.954 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.13 -50.38 9.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.033 -0.53 . . . . 0.48 112.342 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 11.8 ptmm? -59.87 -21.02 60.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.704 -0.68 . . . . 2.56 112.677 -167.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.48 10.99 30.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.707 0.632 . . . . 0.76 112.707 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -100.65 -0.12 38.09 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.035 -0.728 . . . . 0.9 109.035 174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.2 t30 75.98 41.54 0.23 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.685 1.231 . . . . 2.06 108.71 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -124.13 142.67 40.47 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 113.289 -1.778 . . . . 1.08 110.54 -174.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 19.4 Cg_exo -68.01 154.86 71.64 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.657 2.238 . . . . 0.51 113.981 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.709 HD13 HG12 ' A' ' 100' ' ' ILE . 84.7 mt -127.33 146.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.976 -1.465 . . . . 0.96 109.209 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 83' ' ' ILE . 3.4 mp -129.8 103.14 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.71 111.242 -167.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -67.42 133.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.137 -0.938 . . . . 0.23 110.237 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.34 87.69 2.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.826 -1.176 . . . . 0.25 107.826 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.746 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 18.5 mm -67.43 95.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.861 -1.063 . . . . 0.85 110.51 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.03 163.46 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.968 -0.753 . . . . 0.69 108.968 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 63.72 20.09 12.05 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.159 0.504 . . . . 2.61 111.162 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.761 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 13.1 tpp . . . . . 0 N--CA 1.444 -0.73 0 CA-C-O 121.833 0.825 . . . . 1.37 109.9 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.516 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 1.1 p30 . . . . . 0 N--CA 1.435 -1.178 0 CA-C-O 120.529 0.204 . . . . 1.84 111.33 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.9 Cg_exo -37.57 -67.1 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.095 3.197 . . . . 0.7 113.853 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -48.89 -49.78 38.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.882 0.473 . . . . 2.0 112.089 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 2.4 tmt_? -54.73 -56.93 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.098 0.475 . . . . 2.99 109.997 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.765 HG13 ' HA2' ' A' ' 91' ' ' GLY . 93.2 t -55.71 -41.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 0.4 111.016 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 89.4 mtp -66.02 -33.09 75.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 0.3 110.71 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 70.3 mt-30 -73.35 -24.55 60.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.425 . . . . 1.28 111.098 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.8 mm-40 -64.55 -37.66 88.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.715 -0.846 . . . . 2.02 108.715 172.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -70.28 -46.16 64.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.466 -0.788 . . . . 1.06 109.703 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.926 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -75.16 -1.1 21.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.001 177.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.1 tt0 -78.57 -28.97 46.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 2.18 107.539 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.665 ' CE2' HG11 ' A' ' 92' ' ' VAL . 61.5 m-85 -91.99 16.08 11.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.644 -0.707 . . . . 0.74 109.589 168.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.4 t30 71.01 22.16 4.65 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.048 -1.433 . . . . 1.94 110.188 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 100' ' ' ILE . 7.0 mp -91.65 72.55 5.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.315 -0.857 . . . . 1.68 109.693 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -64.87 119.95 62.37 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 114.482 -1.236 . . . . 0.61 110.822 178.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.869 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 80.9 Cg_exo -47.05 160.69 0.25 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.634 2.889 . . . . 0.3 113.57 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.29 -21.25 53.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.768 -1.105 . . . . 2.01 109.682 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.809 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -58.8 -41.11 85.99 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.302 -0.999 . . . . 1.14 108.302 168.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.926 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.6 m0 -95.85 -20.44 18.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.644 -1.162 . . . . 0.45 110.896 -170.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.98 31.6 4.7 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.315 -0.945 . . . . 0.45 112.697 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.15 -99.15 1.96 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.5 112.64 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.06 27.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.68 0.753 . . . . 1.3 110.845 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m -121.39 112.17 18.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 0.32 111.752 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.57 109.45 15.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.137 -0.938 . . . . 1.23 110.343 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.869 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -91.21 111.55 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.101 0.476 . . . . 0.38 111.192 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.3 m -105.9 100.0 9.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.036 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.761 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 19.2 pttp -81.37 91.96 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.726 -0.842 . . . . 2.44 108.726 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.859 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 1.1 pt? -119.31 -171.39 2.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.137 0.97 . . . . 1.27 112.851 -166.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.445 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 33.7 t -157.96 129.56 6.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.877 -1.511 . . . . 1.79 109.638 170.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -88.73 -25.64 22.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.815 -0.629 . . . . 0.87 110.809 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.3 ptmm? -76.68 -53.5 7.92 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.403 0.62 . . . . 3.03 110.061 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 153' ' ' LYS . 81.2 p -72.49 -14.97 61.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.868 -1.06 . . . . 1.2 110.504 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 69.59 17.0 7.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.182 -0.917 . . . . 2.27 111.107 175.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.29 -62.07 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.994 0.902 . . . . 2.64 109.993 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -75.01 -16.61 80.49 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.686 -1.143 . . . . 0.62 113.514 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 158' ' ' LEU . 1.8 tm? -56.4 -47.37 79.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.909 -0.774 . . . . 1.55 108.909 174.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.614 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -58.02 -53.4 58.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.362 -0.836 . . . . 2.5 110.304 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -60.99 -22.77 64.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.723 -0.672 . . . . 0.73 111.749 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 1.2 tm? -69.77 -53.2 19.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.382 -0.372 . . . . 0.91 110.032 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -65.84 -30.52 71.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.654 0.264 . . . . 1.06 110.321 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.5 mm-40 -58.28 -38.97 78.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.035 -0.529 . . . . 2.49 110.723 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -32.56 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.2 -0.454 . . . . 0.87 111.096 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 72.8 mt -59.77 -52.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.511 -0.313 . . . . 0.64 110.929 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -68.96 -30.83 69.35 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.89 0.376 . . . . 1.81 111.372 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 166' ' ' LEU . 65.3 tp -55.51 -31.09 61.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.44 -0.8 . . . . 1.42 110.148 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 41.0 t . . . . . 0 N--CA 1.443 -0.817 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.949 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 81' ' ' ILE . 54.7 t . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 120.832 0.349 . . . . 1.0 110.586 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -86.24 130.7 34.43 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.024 -0.535 . . . . 0.66 110.943 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -95.9 122.98 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.92 0.391 . . . . 1.03 110.376 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.404 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 50.0 mtt -138.24 175.69 9.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.565 0.697 . . . . 1.04 112.214 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.51 -100.27 0.35 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.838 -1.305 . . . . 1.55 109.838 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 16.0 t60 -160.1 132.68 6.47 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.053 -1.091 . . . . 0.66 108.053 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.793 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 14.0 p -62.17 -29.67 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.501 -0.772 . . . . 1.62 112.704 -167.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.92 -27.18 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.288 0.477 . . . . 1.78 112.288 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -56.54 -52.24 65.53 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.287 0.565 . . . . 0.65 111.098 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 177.14 33.45 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.4 -0.818 . . . . 0.93 111.096 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.793 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 12.6 tmtt? -88.43 -56.19 3.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.974 0.416 . . . . 2.11 110.277 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -68.19 -30.76 69.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.489 . . . . 1.8 110.062 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -77.06 -27.62 54.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.001 -0.545 . . . . 1.77 110.571 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 8.5 tt -65.98 -50.49 64.14 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.466 -0.568 . . . . 1.78 109.466 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 28' ' ' ILE . 4.9 tt -57.7 -40.51 79.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.762 -0.654 . . . . 1.96 110.195 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 24.7 t70 -70.73 -50.0 40.84 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.813 -0.355 . . . . 1.38 111.553 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.54 75.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.17 0.509 . . . . 0.91 111.142 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 25' ' ' LEU . 7.2 tt -70.25 -33.93 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.355 -0.838 . . . . 1.56 110.856 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 60.9 mtm180 -71.21 -33.97 70.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.474 0.654 . . . . 3.56 109.546 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -82.12 14.94 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.35 -0.841 . . . . 2.88 110.169 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 1.76 109.998 179.655 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.608 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 p90 . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.131 0.491 . . . . 2.54 111.358 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -116.14 154.75 29.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.108 -1.071 . . . . 1.96 108.108 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.93 111.785 179.428 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.4 mt . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.065 0.46 . . . . 1.14 110.948 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -98.89 112.1 24.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.573 -0.739 . . . . 1.28 109.492 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 41.9 m-85 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.84 111.477 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 11' ' ' VAL . 46.1 mm . . . . . 0 C--O 1.225 -0.208 0 N-CA-C 111.263 0.098 . . . . 0.74 111.263 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.9 t -97.41 106.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.652 0.263 . . . . 1.19 111.562 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.608 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 12.2 mm -89.72 106.72 17.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.651 -0.5 . . . . 1.32 109.651 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.627 HD22 HD11 ' A' ' 100' ' ' ILE . 8.4 tp -92.9 126.06 37.8 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.075 -0.511 . . . . 1.33 110.619 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.68 140.56 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.009 -0.432 . . . . 1.2 112.043 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.0 m -135.03 -177.34 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.94 -0.763 . . . . 1.12 108.94 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 126.66 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.875 0.694 . . . . 0.75 112.875 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 42.92 -104.41 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.302 1.223 . . . . 1.18 114.302 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -112.15 -8.65 13.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.813 -173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 2.8 t70 -62.83 -38.66 91.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.208 -0.664 . . . . 1.09 109.208 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . 78.98 -147.14 30.21 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.891 -1.05 . . . . 0.52 112.408 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.595 HG12 HG23 ' A' ' 97' ' ' VAL . 79.1 t -88.21 100.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 114.995 -0.602 . . . . 1.08 109.938 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 10.3 mtp -70.95 167.75 26.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 1.32 111.411 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 83.0 Cg_exo -47.37 -41.48 28.59 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.507 2.138 . . . . 0.61 112.435 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.668 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 4.6 mm-40 -65.74 -42.11 91.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.024 0.44 . . . . 1.47 110.187 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.624 HG22 HD21 ' A' ' 84' ' ' LEU . 3.5 m -61.06 -30.51 70.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.46 110.11 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 92' ' ' VAL . 44.3 t -78.07 -52.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.048 -0.978 . . . . 1.05 111.594 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.0 pt-20 -65.04 -32.25 73.88 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 1.62 111.681 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -66.29 -42.73 87.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.547 0.689 . . . . 0.34 109.404 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.977 HG12 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -68.19 -43.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.98 -1.009 . . . . 0.38 110.81 176.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.5 -27.25 62.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.909 -0.587 . . . . 1.85 110.743 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -85.57 -36.13 20.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.85 110.413 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -83.18 -49.54 9.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.554 0.576 . . . . 0.48 112.554 -172.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HD3' HG23 ' A' ' 100' ' ' ILE . 41.3 pttt -61.99 -16.88 54.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.669 0.618 . . . . 2.56 112.669 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.87 10.54 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.371 0.508 . . . . 0.76 112.371 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.666 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -99.57 4.09 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 0.9 109.768 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 86.13 6.11 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.461 1.124 . . . . 2.06 108.794 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -93.11 142.79 25.8 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.169 -1.832 . . . . 1.08 111.585 -174.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.17 160.15 50.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.945 2.43 . . . . 0.51 113.447 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.977 HD13 HG12 ' A' ' 100' ' ' ILE . 91.9 mt -127.54 150.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.163 -0.926 . . . . 0.96 110.394 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 mp -121.79 154.75 26.15 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.687 -0.857 . . . . 0.71 108.687 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -118.25 140.86 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 120.667 0.27 . . . . 0.23 110.494 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.42 89.04 3.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.207 -1.034 . . . . 0.25 108.207 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 86' ' ' VAL . 33.0 mt -73.54 94.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.587 -1.188 . . . . 0.85 111.075 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.76 156.55 24.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.537 0.208 . . . . 0.69 110.977 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt 59.2 33.86 22.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.863 0.84 . . . . 2.61 109.989 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.974 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 2.4 tpp . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.015 -0.993 . . . . 1.37 110.98 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.475 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 28.4 t-20 . . . . . 0 CA--C 1.511 -0.549 0 CA-C-O 122.289 1.043 . . . . 1.84 109.996 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.599 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -27.85 -75.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 1 C-N-CA 126.124 4.549 . . . . 0.7 115.46 169.407 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -43.7 -53.4 5.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.17 0.588 . . . . 2.0 112.293 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 11.8 tpt180 -53.07 -65.27 0.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.229 0.538 . . . . 2.99 110.185 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.475 HG22 ' HA2' ' A' ' 91' ' ' GLY . 47.1 t -55.27 -42.36 65.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.451 -1.249 . . . . 0.4 111.41 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.822 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 83.1 mtp -73.1 -30.83 63.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.141 -0.936 . . . . 0.3 111.405 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.08 -27.77 32.73 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.475 -0.49 . . . . 1.28 111.123 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 9.6 mt-10 -61.78 -40.09 93.96 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.016 -1.105 . . . . 2.02 108.016 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -71.45 -46.82 58.98 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.459 -0.791 . . . . 1.06 111.267 -172.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.939 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.2 ppp? -67.36 -8.64 34.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.49 -0.777 . . . . 0.35 109.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -78.1 -28.17 48.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.667 -0.864 . . . . 2.18 108.667 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -82.07 -1.95 50.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.816 0.817 . . . . 0.74 108.803 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 135' ' ' ASN . 1.5 t-20 76.78 42.95 0.14 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 113.101 -1.863 . . . . 1.94 111.203 163.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -123.05 86.75 2.63 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.942 -1.873 . . . . 1.68 105.942 167.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.43 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.44 131.91 94.24 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.789 -1.55 . . . . 0.61 111.313 -171.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.715 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 88.2 Cg_exo -46.87 152.64 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.178 2.585 . . . . 0.3 113.296 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.97 -30.57 62.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.078 -1.419 . . . . 2.01 108.469 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.837 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -51.34 -45.28 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.41 -1.268 . . . . 1.14 109.485 170.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.939 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.0 m0 -89.53 -21.98 22.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.366 -1.288 . . . . 0.45 110.598 -170.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.31 18.5 4.95 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.049 -1.072 . . . . 0.45 112.678 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.43 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.09 -115.54 3.08 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.701 -0.762 . . . . 0.5 112.499 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.07 30.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.886 0.374 . . . . 1.3 111.485 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 131' ' ' LEU . 24.9 m -129.22 108.99 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.857 -0.737 . . . . 0.32 112.175 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 164' ' ' MET . 2.2 mp -80.15 110.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.77 . . . . 1.23 110.698 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.822 ' CE2' ' HG2' ' A' ' 128' ' ' MET . 19.4 m-85 -88.09 115.54 25.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.19 0.519 . . . . 0.38 111.311 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 63.9 m -104.03 117.13 33.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.054 -0.721 . . . . 1.1 109.054 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.974 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 14.5 pttp -98.16 85.95 3.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.106 0.955 . . . . 2.44 109.72 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.691 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -110.64 -179.62 3.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.988 -1.005 . . . . 1.27 112.534 -170.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 10.1 t -143.46 131.7 21.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.418 -1.265 . . . . 1.79 109.196 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.484 0.659 . . . . 0.87 109.93 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -92.51 -58.92 2.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.371 -0.831 . . . . 3.03 110.038 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 151' ' ' SER . 3.9 m -68.71 -29.67 68.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.654 -1.157 . . . . 1.2 110.644 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 58.88 26.8 15.33 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.507 -1.224 . . . . 2.27 111.414 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -83.4 -45.84 13.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.86 0.838 . . . . 2.64 109.81 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -75.6 -11.65 84.28 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.01 -0.996 . . . . 0.62 112.668 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 158' ' ' LEU . 26.2 mt -64.18 -39.81 94.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 1.55 110.475 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -78.87 -37.5 40.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.38 -0.373 . . . . 2.5 110.089 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 164' ' ' MET . 65.1 t60 -59.45 -37.21 77.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.069 -0.514 . . . . 0.73 109.986 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 165' ' ' ILE . 63.5 tp -60.61 -58.32 8.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.91 110.528 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 165' ' ' ILE . 89.8 mt -54.24 -39.49 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.944 -0.571 . . . . 1.06 111.357 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.45 -41.33 96.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 2.49 111.251 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.75 ' HB3' HG21 ' A' ' 146' ' ' ILE . 29.8 mmt -69.89 -38.54 76.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.87 110.096 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 83' ' ' ILE . 80.7 mt -54.72 -54.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.64 110.242 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.45 -38.09 89.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 1.81 111.104 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.64 -42.22 87.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 1.42 110.312 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 116.354 -0.385 . . . . 1.17 110.978 -178.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.599 HG11 HD11 ' A' ' 83' ' ' ILE . 51.5 t . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 120.771 0.32 . . . . 1.0 111.569 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -104.36 136.3 44.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.66 110.741 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG22 ' HE2' ' A' ' 21' ' ' LYS . 56.3 mt -92.96 124.16 45.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 1.03 110.684 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.684 ' HG3' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -108.69 -175.04 2.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.365 -0.834 . . . . 1.04 110.326 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.949 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 109.15 133.9 6.91 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.27 -0.967 . . . . 1.55 111.834 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 65.8 t60 -44.58 135.88 4.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.564 -0.818 . . . . 0.66 110.887 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.08 -29.33 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.93 -1.032 . . . . 1.62 113.563 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 26.8 t70 -86.23 -21.78 27.25 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.045 0.387 . . . . 1.78 112.045 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.483 ' HB2' HG13 ' A' ' 85' ' ' VAL . 51.5 m170 -61.8 -35.92 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.65 111.14 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 152.55 71.49 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.175 -1.012 . . . . 0.93 113.041 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 28.9 mmtp -90.38 -71.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.029 0.443 . . . . 2.11 110.98 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 t -64.5 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 1.8 110.604 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -73.41 -26.17 60.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.292 -0.413 . . . . 1.77 110.787 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.3 tm? -79.35 -49.77 11.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.363 -0.977 . . . . 1.78 108.363 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.776 -1.102 . . . . 1.96 110.588 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.62 -56.53 9.05 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.174 -0.329 . . . . 1.38 111.794 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.56 92.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.316 -0.402 . . . . 0.91 110.849 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.651 HD13 ' OH ' ' A' ' 48' ' ' TYR . 6.7 tt -63.9 -32.91 58.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.029 -0.532 . . . . 1.56 110.128 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 70.4 mtp180 -70.4 -34.68 72.82 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.306 0.574 . . . . 3.56 110.657 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -77.59 14.48 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 2.88 111.028 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 108.538 -0.912 . . . . 1.76 108.538 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.651 ' OH ' HD13 ' A' ' 28' ' ' ILE . 9.6 p90 . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.953 0.406 . . . . 2.54 111.238 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.41 131.93 34.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.828 -0.805 . . . . 1.96 108.828 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 162' ' ' LEU . 61.0 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.541 0.686 . . . . 1.93 110.975 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.1 mt . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.61 0.243 . . . . 1.14 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -84.83 124.75 31.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.768 -0.456 . . . . 1.28 109.768 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.641 0.258 . . . . 0.84 110.581 -179.238 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.413 ' HB ' HG22 ' A' ' 11' ' ' VAL . 36.0 mm . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.161 -0.311 . . . . 0.74 110.161 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 73.1 t -113.24 112.71 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.022 -0.535 . . . . 1.19 111.46 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.77 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.9 mt -94.96 99.97 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 C-N-CA 120.264 -0.574 . . . . 1.32 110.049 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 100' ' ' ILE . 6.7 tp -87.1 113.14 22.59 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.693 -0.403 . . . . 1.33 110.796 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.949 HG12 ' HA3' ' A' ' 15' ' ' GLY . 8.7 p -81.39 142.41 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 1.2 110.667 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 87' ' ' ALA . 18.2 t -134.68 175.27 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 107.489 -1.3 . . . . 1.12 107.489 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.02 114.7 6.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.623 0.647 . . . . 0.75 112.497 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 40.63 -96.88 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.84 1.052 . . . . 1.18 113.84 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -108.11 -3.1 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.891 -170.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 3.8 t70 -71.05 -45.24 64.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.185 0.517 . . . . 1.09 110.423 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.74 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 81.41 -109.8 3.06 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.52 111.84 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 96' ' ' THR . 42.5 t -124.73 109.25 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.053 0.454 . . . . 1.08 111.349 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 65.4 mmm -80.48 168.84 22.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 1.32 110.246 173.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.7 Cg_exo -47.0 -50.07 11.55 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.633 2.222 . . . . 0.61 112.877 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.95 -37.02 73.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.47 111.041 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.59 HG23 HD11 ' A' ' 84' ' ' LEU . 33.7 m -63.39 -25.95 68.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.235 -0.438 . . . . 0.46 111.038 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG23 ' CG1' ' A' ' 92' ' ' VAL . 22.5 t -85.88 -55.54 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 112.177 0.436 . . . . 1.05 112.177 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.2 -21.56 61.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.9 0.381 . . . . 1.62 110.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.684 ' HB1' ' HG3' ' A' ' 14' ' ' MET . . . -82.18 -34.56 28.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 0.34 109.997 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.767 HD11 HD22 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -77.83 -44.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.38 110.41 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -55.1 -37.39 66.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.464 -0.789 . . . . 1.85 111.206 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -79.5 -25.72 41.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 0.85 110.521 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -86.0 -59.49 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.284 0.476 . . . . 0.48 112.284 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -17.25 63.95 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.286 0.476 . . . . 2.56 112.286 -167.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.22 5.3 17.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.849 0.357 . . . . 0.76 111.891 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.85 8.38 30.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.667 -0.864 . . . . 0.9 108.667 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.8 t30 75.44 30.38 0.83 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.361 -1.29 . . . . 2.06 110.242 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -107.97 146.48 33.56 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.245 -0.889 . . . . 1.08 110.734 178.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 5.7 Cg_exo -76.15 158.16 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.369 2.713 . . . . 0.51 113.311 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 145' ' ' THR . 4.4 mp -124.27 154.57 31.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.084 -0.962 . . . . 0.96 109.583 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.77 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 6.1 mt -118.94 155.83 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 108.353 -0.98 . . . . 0.71 108.353 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -119.77 134.13 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.002 0.429 . . . . 0.23 110.249 174.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.99 88.01 2.86 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.111 -1.07 . . . . 0.25 108.111 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.823 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 13.8 mm -66.85 95.1 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.042 -0.981 . . . . 0.85 110.148 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 55.0 t30 -92.85 169.02 10.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.164 -0.68 . . . . 0.69 109.164 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HD3' ' HB1' ' A' ' 87' ' ' ALA . 55.7 mtpt 58.51 26.37 14.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.688 0.756 . . . . 2.61 110.056 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.551 ' SD ' ' HE2' ' A' ' 149' ' ' LYS . 5.2 tpp . . . . . 0 N--CA 1.446 -0.673 0 CA-C-N 114.973 -1.012 . . . . 1.37 110.269 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.66 -0.496 . . . . 1.84 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.63 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.3 Cg_exo -38.95 -61.98 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.077 3.185 . . . . 0.7 113.694 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -47.21 -49.68 22.47 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 2.0 tmt_? -53.77 -56.44 17.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.325 0.583 . . . . 2.99 109.58 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.74 HG13 ' HA2' ' A' ' 91' ' ' GLY . 88.3 t -56.78 -41.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.787 -1.097 . . . . 0.4 110.847 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.673 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -67.07 -32.86 74.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.954 -0.567 . . . . 0.3 110.943 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 75.1 mt-30 -75.75 -24.32 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.665 -0.243 . . . . 1.28 110.883 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.6 mm-40 -63.48 -39.92 95.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.598 -0.89 . . . . 2.02 108.598 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.4 mm? -68.42 -46.6 69.45 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.06 110.016 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.827 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -73.44 -5.49 40.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.618 -0.719 . . . . 0.35 110.276 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 43.8 tt0 -76.56 -28.56 56.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.457 -0.942 . . . . 2.18 108.457 171.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.451 ' CE2' HG11 ' A' ' 92' ' ' VAL . 42.7 m-85 -90.49 13.01 16.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.507 0.67 . . . . 0.74 109.309 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.94 37.93 2.15 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.212 -1.358 . . . . 1.94 109.216 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.441 ' N ' ' HA ' ' A' ' 132' ' ' MET . 5.1 mp -105.7 70.97 0.89 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.575 -1.193 . . . . 1.68 109.471 170.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.991 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -67.45 121.02 77.14 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.016 -0.993 . . . . 0.61 109.677 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.844 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.5 Cg_exo -48.64 157.94 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.833 2.355 . . . . 0.3 112.969 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.8 -22.64 42.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.918 -1.037 . . . . 2.01 108.204 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 7.6 mp0 -46.46 -48.56 18.97 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.148 -1.387 . . . . 1.14 109.714 161.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.827 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.9 m0 -96.0 -30.07 13.79 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.533 -1.667 . . . . 0.45 110.896 -166.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.81 22.12 3.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.303 -0.951 . . . . 0.45 112.985 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.991 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.3 -113.91 2.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.445 -0.883 . . . . 0.5 112.725 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.44 32.9 0.51 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.193 0.521 . . . . 1.3 111.356 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 23.3 m -134.91 123.49 23.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.29 -0.564 . . . . 0.32 111.825 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.761 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.2 mp -92.68 109.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 1.23 110.55 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.844 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -86.35 134.77 33.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.173 0.511 . . . . 0.38 111.098 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.4 m -131.44 107.8 9.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.454 -0.794 . . . . 1.1 110.03 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.823 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.9 ptmm? -85.51 86.17 7.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.691 0.758 . . . . 2.44 109.89 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -103.92 -167.23 1.34 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.256 1.027 . . . . 1.27 112.129 -169.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p -161.36 116.08 2.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.802 -1.545 . . . . 1.79 109.318 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.29 -0.84 18.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.178 0.513 . . . . 0.87 111.029 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -83.46 -55.41 4.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.807 0.813 . . . . 3.03 109.681 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.5 p -98.85 -20.64 16.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.548 -1.206 . . . . 1.2 111.395 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 158' ' ' LEU . 9.7 mtpm? 72.75 18.1 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 2.27 112.132 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -54.49 -70.51 0.1 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.826 0.822 . . . . 2.64 110.729 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -75.64 -7.48 83.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.128 -0.942 . . . . 0.62 112.945 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -72.28 -51.18 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.634 -0.506 . . . . 1.55 109.634 -178.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.98 -30.61 70.78 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.447 -0.575 . . . . 2.5 109.447 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.594 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 84.9 t60 -66.49 -25.76 66.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.42 -0.809 . . . . 0.73 110.888 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 158' ' ' LEU . 56.0 tp -67.17 -47.57 70.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.461 . . . . 0.91 110.014 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.698 HD13 HG11 ' A' ' 50' ' ' VAL . 32.8 mt -58.64 -38.78 78.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.461 -0.79 . . . . 1.06 111.277 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 13.5 pt-20 -71.8 -32.35 67.51 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.127 -0.323 . . . . 2.49 110.127 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.761 ' HB3' HG21 ' A' ' 146' ' ' ILE . 25.9 mmt -69.85 -38.24 76.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.311 0.577 . . . . 0.87 109.897 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 162' ' ' LEU . 63.3 mt -56.3 -53.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.073 -0.967 . . . . 0.64 111.136 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.5 pp -71.85 -34.29 69.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 121.041 -0.264 . . . . 1.81 111.491 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 166' ' ' LEU . 14.0 tp -53.06 -31.62 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.97 -0.559 . . . . 1.42 110.73 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.444 -0.754 0 CA-C-N 116.033 -0.53 . . . . 1.17 110.281 -178.488 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.081 HG12 ' HB ' ' A' ' 81' ' ' ILE . 13.7 m . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 120.843 0.354 . . . . 1.0 110.755 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.404 ' O ' HG12 ' A' ' 83' ' ' ILE . 51.0 m -129.64 134.57 47.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.239 -0.437 . . . . 0.66 111.102 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.719 HD13 HG13 ' A' ' 83' ' ' ILE . 35.7 mm -81.07 129.7 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 1.03 111.062 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.46 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 14.4 mmt -138.29 157.12 46.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.684 0.394 . . . . 1.04 111.435 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.66 -110.55 0.46 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.116 -0.793 . . . . 1.55 111.116 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -156.85 137.61 13.31 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.75 -0.725 . . . . 0.66 109.594 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.64 -47.47 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.335 0.865 . . . . 1.62 113.335 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.55 -27.54 68.51 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.504 0.557 . . . . 1.78 112.504 -170.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -63.35 -21.27 66.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.281 0.562 . . . . 0.65 110.649 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.53 42.46 1.86 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.661 -0.699 . . . . 0.93 112.465 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -82.02 -22.12 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 2.11 110.215 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -39.88 23.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.174 -1.047 . . . . 1.8 108.174 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 m -62.57 -33.6 75.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.622 -1.172 . . . . 1.77 110.512 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.596 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 59.7 tp -57.39 -56.07 26.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 1.78 110.524 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.683 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.6 tt -63.78 -36.81 85.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.072 0.463 . . . . 1.96 109.994 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.18 -53.76 44.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.955 0.407 . . . . 1.38 111.596 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -32.17 72.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.91 111.196 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.654 HD13 ' OH ' ' A' ' 48' ' ' TYR . 3.9 tt -67.78 -33.47 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.84 -0.618 . . . . 1.56 110.43 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 15.5 mtm180 -73.62 -28.03 61.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.454 0.645 . . . . 3.56 110.031 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -84.9 5.18 30.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.626 -0.715 . . . . 2.88 110.148 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.319 -0.727 0 N-CA-C 106.703 -1.591 . . . . 1.76 106.703 168.633 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.654 ' OH ' HD13 ' A' ' 28' ' ' ILE . 23.2 p90 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.778 -0.453 . . . . 2.54 109.778 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 58' ' ' THR . 37.0 mt-30 -126.17 118.06 24.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.257 -0.646 . . . . 1.96 109.257 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.554 HG21 ' HE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 115.632 -0.713 . . . . 1.93 112.372 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.447 ' HB ' HG23 ' A' ' 50' ' ' VAL . 19.0 mt . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.023 0.44 . . . . 1.14 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.949 HG23 ' HG2' ' A' ' 49' ' ' GLN . 36.2 m -119.97 130.85 54.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.162 -0.681 . . . . 1.28 109.162 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HE1' HG21 ' A' ' 50' ' ' VAL . 16.1 m-85 . . . . . 0 C--O 1.222 -0.372 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.081 ' HB ' HG12 ' A' ' 11' ' ' VAL . 28.4 mm . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.74 109.782 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 76.4 t -81.45 108.14 14.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.063 -0.517 . . . . 1.19 111.182 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.747 HD11 ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -85.47 102.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.971 -0.751 . . . . 1.32 108.971 177.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.801 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.1 tm? -94.64 111.77 23.53 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.919 -0.582 . . . . 1.33 109.946 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.524 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 39.5 t -87.56 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.1 -0.5 . . . . 1.2 111.488 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 114' ' ' ILE . 17.9 m -135.29 -167.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.161 -0.927 . . . . 1.12 108.501 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -140.07 143.27 36.25 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.31 -0.556 . . . . 0.75 111.691 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -34.26 -55.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.678 1.236 . . . . 1.18 112.992 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -109.1 13.83 24.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.883 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -110.68 -43.02 3.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.511 -0.476 . . . . 1.09 111.284 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 78.0 -139.8 23.18 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.667 -0.778 . . . . 0.52 111.949 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.733 HG13 ' HB ' ' A' ' 96' ' ' THR . 44.0 t -96.97 114.8 34.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 122.783 0.433 . . . . 1.08 111.311 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.585 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 53.7 mtp -84.12 169.77 15.97 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.434 -0.348 . . . . 1.32 110.199 171.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 93.8 Cg_exo -45.25 -50.79 8.58 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.696 2.264 . . . . 0.61 113.341 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -72.72 -21.9 60.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.387 -0.369 . . . . 1.47 111.356 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.733 ' HB ' HG13 ' A' ' 92' ' ' VAL . 25.5 m -60.38 -28.74 68.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.397 0.617 . . . . 0.46 110.274 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.04 -45.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.958 -0.565 . . . . 1.05 111.726 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.79 -23.19 59.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 1.62 110.961 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -87.96 -30.96 19.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.34 110.018 -177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.863 HG12 HD13 ' A' ' 110' ' ' ILE . 1.7 mt -80.93 -51.21 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.261 -0.881 . . . . 0.38 111.293 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -49.13 -39.28 27.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 1.85 110.78 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -77.35 -30.2 53.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.85 110.968 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.27 -56.29 4.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.436 . . . . 0.48 111.967 -173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -73.2 -15.72 61.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.304 -0.407 . . . . 2.56 111.899 -168.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.12 -0.48 44.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.76 111.206 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -101.39 14.07 33.1 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.814 -0.81 . . . . 0.9 108.814 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 4.8 m-20 72.19 27.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.705 -1.134 . . . . 2.06 111.759 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.13 152.85 42.75 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-O 121.061 0.458 . . . . 1.08 111.254 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.63 ' O ' HG23 ' A' ' 108' ' ' VAL . 15.4 Cg_exo -72.54 162.82 40.31 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.678 2.919 . . . . 0.51 113.437 171.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.863 HD13 HG12 ' A' ' 100' ' ' ILE . 73.7 mt -132.61 148.17 31.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.672 -0.695 . . . . 0.96 110.586 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.801 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 37.3 mt -113.61 164.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 109.072 -0.714 . . . . 0.71 109.072 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.544 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -123.63 129.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 N-CA-C 109.044 -0.724 . . . . 0.23 109.044 169.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.28 87.25 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.592 -1.262 . . . . 0.25 107.592 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 54.1 mt -69.61 97.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.315 -1.311 . . . . 0.85 109.904 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -96.91 170.82 8.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.69 109.023 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 77.5 tttt 64.14 18.35 11.2 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.365 1.078 . . . . 2.61 109.227 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.622 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.1 tpp . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 123.063 1.411 . . . . 1.37 109.511 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.266 -0.272 . . . . 1.84 110.266 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.1 Cg_endo -44.53 -61.3 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.581 2.854 . . . . 0.7 113.325 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.73 -49.63 19.29 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.441 0.697 . . . . 2.0 112.352 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -49.21 -62.13 1.7 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.351 0.596 . . . . 2.99 109.69 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 91' ' ' GLY . 66.8 t -54.2 -47.84 67.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.341 -1.299 . . . . 0.4 110.848 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.654 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 90.4 mtp -59.42 -34.51 72.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.3 111.122 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -76.77 -20.14 56.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.618 -0.264 . . . . 1.28 111.23 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.662 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 4.2 mt-10 -75.98 -30.39 58.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.962 -0.755 . . . . 2.02 108.962 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -72.77 -44.27 61.79 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.831 -0.747 . . . . 1.06 109.311 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.834 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -73.01 -4.54 32.97 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.163 -0.615 . . . . 0.35 109.977 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.662 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 40.9 tt0 -74.41 -32.75 62.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 170.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.672 ' HE2' HG11 ' A' ' 92' ' ' VAL . 44.9 m-85 -89.9 9.39 27.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.911 0.862 . . . . 0.74 109.446 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 72.32 26.59 2.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 113.536 -1.665 . . . . 1.94 110.234 168.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.04 76.69 1.37 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.433 -1.321 . . . . 1.68 107.433 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.942 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -63.24 134.04 95.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 113.436 -1.711 . . . . 0.61 110.279 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -52.29 154.34 11.35 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 122.359 2.039 . . . . 0.3 112.135 173.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 mm-40 -80.28 -19.77 45.96 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.05 -0.977 . . . . 2.01 109.141 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.579 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.1 mp0 -47.2 -52.98 14.28 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.709 1.243 . . . . 1.14 108.958 160.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.834 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -89.73 -23.78 21.71 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.897 -1.956 . . . . 0.45 110.68 -167.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.87 23.02 4.79 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.553 -0.832 . . . . 0.45 112.446 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.942 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.93 -108.15 1.99 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.924 -0.655 . . . . 0.5 113.17 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.25 27.37 0.35 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 1.3 111.314 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 HD12 ' A' ' 136' ' ' LEU . 63.5 m -132.67 133.34 43.43 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.83 1.048 . . . . 0.32 113.83 -174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.797 HG13 HG11 ' A' ' 168' ' ' VAL . 4.1 mp -87.48 108.15 17.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.123 -0.944 . . . . 1.23 110.382 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 11.8 m-85 -94.54 115.77 27.99 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.839 -0.538 . . . . 0.38 111.224 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.9 t -118.63 128.7 54.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.439 -0.578 . . . . 1.1 109.439 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.718 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.6 pttm -103.65 87.06 2.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.609 0.718 . . . . 2.44 109.393 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -105.64 -177.03 3.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.43 -0.804 . . . . 1.27 112.486 -172.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.1 p -155.87 124.05 5.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.929 -1.032 . . . . 1.79 109.636 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -76.24 -13.19 60.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.141 0.496 . . . . 0.87 110.926 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -75.89 -57.64 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.47 -0.786 . . . . 3.03 109.855 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -97.29 -15.71 20.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.148 -0.933 . . . . 1.2 111.376 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HD12 ' A' ' 158' ' ' LEU . 59.4 mttp 64.58 24.82 13.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.23 -0.896 . . . . 2.27 111.888 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.21 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.843 0.83 . . . . 2.64 109.822 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.718 ' HA3' ' HA ' ' A' ' 150' ' ' LEU . . . -71.83 -10.46 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.811 -1.086 . . . . 0.62 113.543 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.816 HD12 ' HG2' ' A' ' 155' ' ' LYS . 25.5 mt -71.89 -43.1 65.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.699 0.75 . . . . 1.55 110.295 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 12.8 t70 -61.66 -42.82 99.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.753 -0.832 . . . . 2.5 108.753 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -66.7 -24.25 66.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.039 -0.982 . . . . 0.73 111.507 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.3 tp -63.31 -56.43 16.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.661 -0.245 . . . . 0.91 110.401 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.8 mt -54.62 -39.84 68.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 1.06 110.585 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.0 mm-40 -63.56 -47.28 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 2.49 110.339 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -67.07 -38.77 86.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.87 110.593 -176.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.14 -49.42 40.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.64 111.845 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 167' ' ' LEU . 1.6 pp -84.67 -35.15 22.8 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.406 0.521 . . . . 1.81 112.406 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.6 tp -63.41 -21.98 66.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.99 0.424 . . . . 1.42 110.937 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 146' ' ' ILE . 48.5 t . . . . . 0 N--CA 1.442 -0.845 0 CA-C-N 116.515 -0.311 . . . . 1.17 110.447 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 89.2 t . . . . . 0 N--CA 1.433 -1.309 0 CA-C-O 121.165 0.507 . . . . 1.0 110.051 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.996 -0.547 . . . . 0.66 110.728 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.681 ' HA ' HG13 ' A' ' 83' ' ' ILE . 26.4 mt -83.69 121.45 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.056 0.455 . . . . 1.03 111.148 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.448 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 20.8 mmt -115.7 178.99 4.1 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.077 -0.712 . . . . 1.04 109.077 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.931 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 114.67 131.05 5.04 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.852 -1.166 . . . . 1.55 111.411 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -44.88 132.37 6.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.332 0.586 . . . . 0.66 110.198 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -56.35 -30.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.55 0.944 . . . . 1.62 113.55 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.63 -15.8 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.78 111.296 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.439 ' HE1' ' H ' ' A' ' 93' ' ' MET . 32.8 m170 -67.25 -43.0 82.99 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.845 -0.428 . . . . 0.65 109.845 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 85' ' ' VAL . . . 147.12 69.79 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.034 -1.079 . . . . 0.93 113.766 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -87.55 -50.11 6.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.453 0.644 . . . . 2.11 109.513 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -64.12 -30.56 71.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.032 -0.986 . . . . 1.8 110.561 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.497 HG21 ' ND2' ' A' ' 115' ' ' ASN . 5.4 t -67.73 -26.64 66.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 1.77 110.64 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.02 -55.82 6.73 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.775 -0.824 . . . . 1.78 108.775 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.653 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 1.9 tt -55.49 -41.69 73.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.945 -0.571 . . . . 1.96 109.78 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.54 -62.5 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.507 0.558 . . . . 1.38 112.507 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -68.27 -38.48 81.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.91 111.843 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.78 -31.04 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.453 . . . . 1.56 110.536 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -64.04 -41.25 97.46 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.223 0.535 . . . . 3.56 110.372 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -76.5 9.3 2.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.38 -0.827 . . . . 2.88 109.818 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.876 -0.602 . . . . 1.76 110.342 174.468 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.653 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.943 0.402 . . . . 2.54 110.761 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.651 ' HG2' HG23 ' A' ' 58' ' ' THR . 47.8 mt-30 -98.98 152.0 20.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.169 -0.469 . . . . 1.96 109.879 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.796 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 95.1 t . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.891 0.853 . . . . 1.93 111.945 -172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.796 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 42.2 mt . . . . . 0 CA--C 1.523 -0.095 0 N-CA-C 110.019 -0.363 . . . . 1.14 110.019 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 49' ' ' GLN . 11.0 m -121.67 113.8 20.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.128 -0.323 . . . . 1.28 110.128 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HD2' HD11 ' A' ' 13' ' ' ILE . 3.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.84 110.876 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 45.8 mm . . . . . 0 C--O 1.231 0.128 0 N-CA-C 111.794 0.294 . . . . 0.74 111.794 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.907 HG21 ' HB1' ' A' ' 103' ' ' ALA . 89.7 t -100.92 98.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.79 -0.364 . . . . 1.19 111.274 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.681 HG13 ' HA ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -87.11 104.38 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.093 -0.643 . . . . 1.32 110.472 174.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.599 HD22 ' CD1' ' A' ' 100' ' ' ILE . 9.7 tp -91.46 114.08 26.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.884 -0.598 . . . . 1.33 110.33 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.931 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.6 p -85.7 142.72 12.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.882 -0.727 . . . . 1.2 110.844 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -137.3 -170.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.36 -0.978 . . . . 1.12 108.36 175.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.24 139.68 30.33 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.238 -0.585 . . . . 0.75 111.681 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -78.91 58.23 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.035 -0.984 . . . . 1.18 111.207 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -164.97 -33.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.452 -1.249 . . . . 2.01 109.301 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.51 -63.26 1.18 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.522 0.677 . . . . 1.09 110.954 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.77 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 117.07 -106.36 1.42 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.996 -1.002 . . . . 0.52 110.887 -172.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.98 HG13 ' HB ' ' A' ' 96' ' ' THR . 38.5 t -129.67 114.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 120.952 0.406 . . . . 1.08 110.572 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.711 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 60.3 mtp -91.96 172.81 5.92 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 1.32 109.741 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.711 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 58.0 Cg_exo -39.32 -59.76 0.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.269 2.646 . . . . 0.61 113.857 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -54.27 -35.01 62.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.47 111.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.98 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.3 m -64.26 -34.04 77.19 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.762 0.282 . . . . 0.46 111.762 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.621 HG12 ' CG1' ' A' ' 92' ' ' VAL . 1.4 m -85.7 -38.86 13.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 121.967 -0.458 . . . . 1.05 111.328 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.65 -30.06 70.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.165 0.507 . . . . 1.62 110.916 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.31 -17.6 59.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.647 -0.706 . . . . 0.34 110.491 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -93.41 -45.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.38 110.966 -176.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -53.41 -38.54 63.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.566 0.698 . . . . 1.85 110.086 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -75.2 -28.66 60.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.191 -0.913 . . . . 0.85 110.943 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.907 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.74 -53.88 3.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.889 0.7 . . . . 0.48 112.889 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -67.7 -16.21 64.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.225 0.454 . . . . 2.56 112.225 -166.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.65 10.7 4.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.309 0.485 . . . . 0.76 112.309 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -107.96 4.21 24.99 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.08 -0.711 . . . . 0.9 109.08 173.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 21.0 t-20 80.46 19.31 0.55 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 123.204 1.478 . . . . 2.06 108.858 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -96.06 142.47 24.61 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 113.741 -1.572 . . . . 1.08 110.462 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 8.3 Cg_exo -73.19 152.02 49.96 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.904 2.403 . . . . 0.51 114.264 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 100' ' ' ILE . 1.7 mp -114.48 143.11 24.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 113.239 -1.8 . . . . 0.96 109.637 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mp -113.46 147.52 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -110.37 138.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 109.32 -0.622 . . . . 0.23 109.32 174.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.1 87.8 2.82 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.232 -1.025 . . . . 0.25 108.232 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.687 ' HA ' HG23 ' A' ' 86' ' ' VAL . 37.5 mt -73.3 95.92 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.581 -1.191 . . . . 0.85 110.153 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.497 ' ND2' HG21 ' A' ' 23' ' ' THR . 53.3 t30 -90.8 156.53 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.671 -0.412 . . . . 0.69 111.174 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.2 mttp 71.51 37.32 1.15 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.732 0.813 . . . . 2.61 112.178 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.688 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 C-N-CA 119.873 -0.731 . . . . 1.37 111.661 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 34.1 t30 . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 119.841 -0.124 . . . . 1.84 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 58.1 Cg_exo -28.79 -69.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.548 3.499 . . . . 0.7 114.545 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.94 -45.72 15.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.725 0.81 . . . . 2.0 112.206 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -55.17 -56.13 23.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.493 0.663 . . . . 2.99 110.177 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.77 HG13 ' HA2' ' A' ' 91' ' ' GLY . 56.7 t -59.44 -39.73 79.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.565 -1.198 . . . . 0.4 110.346 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 87.3 mtp -66.29 -30.01 70.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.558 -0.746 . . . . 0.3 111.225 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.34 -21.06 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.627 0.251 . . . . 1.28 110.778 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.1 -38.58 85.93 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.646 -0.872 . . . . 2.02 108.646 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.929 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -69.47 -45.35 69.21 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.031 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.89 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -73.26 -5.04 36.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.363 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.62 -37.19 68.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.726 -1.213 . . . . 2.18 107.726 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.949 ' HE2' HG11 ' A' ' 92' ' ' VAL . 28.6 m-85 -84.38 7.6 19.0 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.944 0.878 . . . . 0.74 109.283 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.71 44.08 1.21 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.829 -1.532 . . . . 1.94 109.505 170.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.929 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -122.43 81.77 1.89 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 113.517 -1.674 . . . . 1.68 106.96 169.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -65.37 130.53 94.72 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.006 -1.452 . . . . 0.61 110.242 -173.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 58.2 Cg_exo -44.69 154.79 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.888 2.392 . . . . 0.3 112.54 170.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -74.43 -29.17 61.38 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.346 -1.297 . . . . 2.01 108.012 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.654 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -51.11 -42.17 60.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.584 -1.189 . . . . 1.14 109.572 168.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.89 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.2 m0 -96.16 -20.35 18.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.419 -0.81 . . . . 0.45 111.167 -172.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.99 29.85 4.44 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.139 -1.029 . . . . 0.45 112.707 170.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.824 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.78 -106.67 2.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.366 -0.921 . . . . 0.5 112.923 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.34 27.99 0.45 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.714 -0.243 . . . . 1.3 111.42 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 136' ' ' LEU . 26.6 m -134.55 129.04 34.45 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 119.171 -1.011 . . . . 0.32 113.548 -171.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 164' ' ' MET . 49.9 mm -94.35 110.33 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.332 -0.849 . . . . 1.23 110.566 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.757 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 14.2 m-85 -90.89 119.4 31.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.034 0.445 . . . . 0.38 111.429 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 75.8 m -110.37 111.99 23.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.625 -0.509 . . . . 1.1 109.625 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.688 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 25.9 pttt -93.29 100.06 12.48 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.811 -0.631 . . . . 2.44 109.392 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.69 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -123.07 179.13 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.615 1.198 . . . . 1.27 113.681 -169.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.58 116.83 5.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.285 -1.78 . . . . 1.79 108.15 171.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -63.02 -16.32 59.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.013 0.375 . . . . 0.87 112.013 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.71 -57.34 3.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.802 0.81 . . . . 3.03 109.503 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -72.69 -17.96 61.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.129 -1.396 . . . . 1.2 112.01 -175.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.713 ' HD3' HD12 ' A' ' 158' ' ' LEU . 30.2 mmtp 71.63 -0.11 3.28 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.791 -0.641 . . . . 2.27 112.007 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -45.99 -74.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.037 0.754 . . . . 2.64 113.037 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.69 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.51 -6.7 66.77 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.496 -0.774 . . . . 0.62 113.536 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.713 HD12 ' HD3' ' A' ' 155' ' ' LYS . 57.7 mt -73.55 -43.16 60.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.288 0.544 . . . . 1.55 110.561 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 26.9 m-20 -66.94 -40.43 87.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 174.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -65.29 -30.64 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.73 110.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 60.7 tp -63.39 -53.89 45.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.91 110.639 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.63 -39.29 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 1.06 110.731 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 8.1 mm-40 -61.41 -48.34 81.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.573 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.729 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.7 mmt -69.29 -40.12 77.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.87 110.854 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.41 -47.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.041 -0.527 . . . . 0.64 110.43 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.2 -46.72 87.68 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.29 -0.414 . . . . 1.81 111.137 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.43 -46.28 76.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 1.42 110.555 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 77.4 t . . . . . 0 N--CA 1.442 -0.871 0 CA-C-N 116.094 -0.503 . . . . 1.17 111.427 -178.371 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 4.0 t . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -95.34 121.66 37.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.244 -0.435 . . . . 0.66 111.466 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 83' ' ' ILE . 32.6 mt -95.67 120.06 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.316 0.579 . . . . 1.03 110.01 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' LEU . 50.0 mtt -128.59 152.28 48.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.798 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.913 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 168.82 -113.8 0.54 Allowed Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.281 -1.128 . . . . 1.55 110.281 173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 85.3 t60 -161.99 147.12 12.97 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.083 -0.71 . . . . 0.66 109.083 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -56.95 -51.38 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.592 0.59 . . . . 1.62 112.592 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -61.33 -28.23 69.06 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.796 0.665 . . . . 1.78 112.796 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HE1' ' H ' ' A' ' 93' ' ' MET . 27.7 m170 -66.63 -19.02 65.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.65 110.799 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.09 1.38 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.654 -0.784 . . . . 0.93 112.163 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -73.13 -48.8 32.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.235 0.541 . . . . 2.11 110.566 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 1.8 110.067 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 m -70.83 -29.08 65.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.779 -0.646 . . . . 1.77 110.428 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.33 -49.0 75.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.459 -0.571 . . . . 1.78 109.459 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 8.3 tt -60.09 -45.42 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.406 -0.816 . . . . 1.96 110.519 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.8 t70 -66.17 -48.33 71.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.144 -0.48 . . . . 1.38 111.908 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.06 99.66 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.115 0.483 . . . . 0.91 110.735 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 25' ' ' LEU . 9.6 tt -66.67 -34.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.753 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 29.5 ptt180 -78.33 -36.31 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.675 0.75 . . . . 3.56 109.092 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -76.16 14.39 0.73 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.799 -1.091 . . . . 2.88 111.578 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.369 -0.604 . . . . 1.76 109.369 177.313 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.721 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.609 0.242 . . . . 2.54 110.368 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 45.5 mt-30 -125.32 136.97 54.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.493 -0.321 . . . . 1.96 110.15 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 57' ' ' ILE . 5.0 m . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.135 0.493 . . . . 1.93 111.43 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 50' ' ' VAL . 39.3 mt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.768 0.318 . . . . 1.14 110.309 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.54 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 5.0 m -80.88 100.79 9.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.551 -0.537 . . . . 1.28 109.551 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HE2' ' CG1' ' A' ' 50' ' ' VAL . 59.5 m-85 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.001 0.429 . . . . 0.84 111.985 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 41.9 mm . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.32 -0.622 . . . . 0.74 109.32 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 103' ' ' ALA . 90.5 t -106.85 105.85 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.402 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -87.48 107.75 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.057 -0.72 . . . . 1.32 109.057 174.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 100' ' ' ILE . 3.1 tm? -96.76 114.65 26.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.236 -0.893 . . . . 1.33 109.928 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.913 HG12 ' HA3' ' A' ' 15' ' ' GLY . 9.9 p -88.04 141.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.295 0.569 . . . . 1.2 111.341 -176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.666 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.8 m -138.4 -171.09 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.243 -0.89 . . . . 1.12 108.631 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.87 136.91 25.88 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.752 -0.379 . . . . 0.75 110.535 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 59.37 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 1.18 111.235 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.72 -30.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.242 -1.344 . . . . 2.01 109.655 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -108.98 -52.53 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.102 0.477 . . . . 1.09 110.991 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 102.5 -113.42 4.59 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.581 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 96' ' ' THR . 41.4 t -125.85 112.26 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.973 0.415 . . . . 1.08 110.919 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.7 mtp -88.26 171.8 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.327 -0.397 . . . . 1.32 110.452 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 84.7 Cg_exo -46.98 -48.5 14.36 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.818 2.345 . . . . 0.61 114.112 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 6.1 mt-30 -62.03 -38.41 88.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.006 -0.278 . . . . 1.47 110.91 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 92' ' ' VAL . 6.4 m -58.57 -33.54 70.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.786 0.803 . . . . 0.46 110.102 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 21.4 t -76.99 -57.93 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.691 -1.14 . . . . 1.05 111.536 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -73.56 -8.55 56.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.857 -0.611 . . . . 1.62 112.543 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -84.32 -44.67 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.053 -1.091 . . . . 0.34 108.053 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.683 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.8 mt -62.9 -45.9 97.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.185 -1.371 . . . . 0.38 111.055 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 5.2 m-20 -54.61 -29.0 50.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 1.85 111.134 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -85.04 -28.89 25.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.85 110.284 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.02 -46.25 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.491 . . . . 0.48 111.691 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 101' ' ' ASN . 21.4 ptmt -54.89 -37.01 65.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 2.56 112.639 -171.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.98 11.41 34.07 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.627 0.973 . . . . 0.76 113.627 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -86.92 -51.59 5.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.023 -1.473 . . . . 0.9 107.023 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 2.5 p-10 149.59 14.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 125.858 1.974 . . . . 2.06 108.839 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.518 HG21 HG23 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -102.02 143.69 27.09 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.771 . . . . 1.08 112.204 -166.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 10.7 Cg_exo -72.72 156.96 52.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.215 2.61 . . . . 0.51 112.908 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.562 HD13 HG12 ' A' ' 100' ' ' ILE . 82.3 mt -126.33 149.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.151 -0.931 . . . . 0.96 110.056 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mt -120.28 161.1 20.22 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 N-CA-C 108.697 -0.853 . . . . 0.71 108.697 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -123.71 140.93 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 121.049 0.452 . . . . 0.23 110.67 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -122.39 88.63 2.97 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.039 -1.097 . . . . 0.25 108.039 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.695 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 44.1 mt -69.66 96.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.043 -0.981 . . . . 0.85 109.543 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -94.14 165.39 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.258 -0.428 . . . . 0.69 110.686 -172.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 64.62 14.18 8.82 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.652 -0.704 . . . . 2.61 112.641 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 119.622 -0.831 . . . . 1.37 111.433 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 109.226 -0.657 . . . . 1.84 109.226 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.673 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.6 Cg_exo -38.77 -55.74 1.29 Allowed 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 123.338 2.692 . . . . 0.7 113.73 171.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -47.39 -49.28 25.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.403 0.52 . . . . 2.0 112.403 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 20.5 tpt180 -49.08 -59.53 3.56 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.51 0.671 . . . . 2.99 109.798 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.475 HG13 ' HA2' ' A' ' 91' ' ' GLY . 51.4 t -55.99 -45.9 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.966 -1.47 . . . . 0.4 110.399 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.703 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 91.0 mtp -60.45 -34.37 73.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.3 111.449 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 132' ' ' MET . 92.9 mt-30 -73.9 -22.39 59.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 1.28 110.359 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 5.8 mt-10 -75.49 -32.64 60.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.875 -0.787 . . . . 2.02 108.875 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 136' ' ' LEU . 3.4 mm? -68.73 -45.56 71.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.609 0.719 . . . . 1.06 109.465 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.892 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -73.43 -5.82 42.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.563 -0.744 . . . . 0.35 110.181 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 19.8 tp10 -76.6 -29.57 56.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.865 -1.161 . . . . 2.18 107.865 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.538 ' CZ ' HG22 ' A' ' 97' ' ' VAL . 22.6 m-85 -92.29 6.67 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.424 0.63 . . . . 0.74 109.654 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.2 m120 78.43 24.47 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.277 -1.328 . . . . 1.94 111.585 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.93 HD11 HD12 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -105.63 78.94 1.39 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.626 -1.25 . . . . 1.68 107.626 172.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.416 HG23 ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -65.63 130.95 94.68 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 113.565 -1.652 . . . . 0.61 111.697 -176.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 71.1 Cg_exo -49.44 157.09 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.503 2.802 . . . . 0.3 113.376 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 146' ' ' ILE . 43.2 mm-40 -72.45 -26.32 61.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.302 -1.317 . . . . 2.01 109.488 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.868 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 3.3 mm-40 -58.55 -43.42 89.29 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.288 -0.869 . . . . 1.14 108.696 171.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.892 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -88.51 -24.78 22.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.064 -1.425 . . . . 0.45 110.283 -169.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.93 26.7 3.74 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.988 -1.101 . . . . 0.45 112.186 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA3' HG23 ' A' ' 137' ' ' VAL . . . -101.73 -115.47 3.96 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.405 -0.902 . . . . 0.5 111.896 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.91 33.39 0.48 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.596 0.236 . . . . 1.3 111.234 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HD12 ' A' ' 136' ' ' LEU . 36.2 m -128.0 120.24 27.14 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.779 -0.769 . . . . 0.32 112.588 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.479 HG13 ' HG3' ' A' ' 139' ' ' GLU . 3.5 mp -88.16 109.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.645 -0.707 . . . . 1.23 110.385 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.796 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 21.1 m-85 -88.55 108.03 19.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.896 0.379 . . . . 0.38 111.116 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 20.2 t -98.33 118.65 35.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.243 -0.651 . . . . 1.1 109.243 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 14.2 ptpt -92.3 102.97 15.46 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.162 -0.681 . . . . 2.44 109.162 173.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -130.17 -169.32 2.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.978 0.894 . . . . 1.27 112.789 -172.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 m -165.8 121.02 1.25 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 113.916 -1.493 . . . . 1.79 109.516 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.54 -12.51 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.623 -0.262 . . . . 0.87 111.668 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 154' ' ' THR . 18.9 pttp -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.879 0.847 . . . . 3.03 109.463 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.93 -22.57 45.59 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.246 -1.343 . . . . 1.2 109.84 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 158' ' ' LEU . 9.3 mtpm? 63.93 3.86 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.593 -1.185 . . . . 2.27 113.71 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.84 -56.11 25.88 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.058 0.932 . . . . 2.64 110.38 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -69.29 -11.98 65.28 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.519 -1.219 . . . . 0.62 113.535 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.7 HD12 ' HG2' ' A' ' 155' ' ' LYS . 31.5 mt -68.54 -43.0 77.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.314 0.557 . . . . 1.55 110.397 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.0 -45.65 91.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.764 -0.653 . . . . 2.5 109.611 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' A' ' 164' ' ' MET . 75.4 t60 -64.56 -29.82 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.73 110.783 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.1 tp -67.12 -59.38 3.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.383 -0.371 . . . . 0.91 111.149 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.33 -40.04 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.319 0.387 . . . . 1.06 110.704 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.76 -37.82 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 2.49 111.215 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 25.1 mmt -72.41 -39.84 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 0.87 110.077 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 161' ' ' LEU . 84.5 mt -58.49 -49.46 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.64 111.257 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -70.32 -35.19 73.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.81 111.268 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 166' ' ' LEU . 59.1 tp -56.93 -32.99 66.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.055 -0.521 . . . . 1.42 109.837 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 164' ' ' MET . 43.7 t . . . . . 0 N--CA 1.445 -0.688 0 CA-C-N 115.898 -0.592 . . . . 1.17 109.918 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 81' ' ' ILE . 74.4 t . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.698 0.761 . . . . 1.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -87.19 112.5 22.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 0.66 110.308 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 53.3 mt -74.34 117.08 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 121.613 0.72 . . . . 1.03 110.205 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 43.9 mtt -118.37 179.18 4.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.687 -1.142 . . . . 1.04 109.984 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.862 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.38 -96.8 0.2 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.158 -1.177 . . . . 1.55 110.158 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -172.33 143.56 1.45 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.969 -1.122 . . . . 0.66 107.969 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -24.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.387 0.884 . . . . 1.62 113.387 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.32 -33.74 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.855 0.317 . . . . 1.78 111.855 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -62.86 -23.95 67.56 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.503 0.557 . . . . 0.65 112.503 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 65.41 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.337 -0.935 . . . . 0.93 112.434 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -87.09 -15.58 38.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.332 0.587 . . . . 2.11 109.721 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -78.06 -30.05 49.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 1.8 110.451 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -27.49 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 1.77 111.089 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.02 -50.19 30.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.592 -0.521 . . . . 1.78 109.592 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -60.44 -22.18 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 1.96 110.789 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -92.64 -56.73 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.172 0.434 . . . . 1.38 112.172 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -28.16 69.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.91 111.397 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.12 -32.62 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.954 0.407 . . . . 1.56 110.109 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 29' ' ' ARG . 33.6 mtp-105 -68.52 -32.28 72.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.522 0.677 . . . . 3.56 109.347 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 10.1 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.066 -0.97 . . . . 2.88 110.601 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 m . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 1.76 109.456 175.87 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.281 0.563 . . . . 2.54 110.935 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 28.4 mt-30 -116.31 137.33 52.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.677 -0.692 . . . . 1.96 109.458 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 57' ' ' ILE . 3.9 m . . . . . 0 N--CA 1.441 -0.907 0 CA-C-O 121.606 0.717 . . . . 1.93 111.291 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.637 ' HB ' HG23 ' A' ' 50' ' ' VAL . 73.3 mt . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.656 0.265 . . . . 1.14 110.932 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 23.1 m -99.11 117.11 32.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.398 -0.365 . . . . 1.28 110.221 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.625 ' HE2' HG21 ' A' ' 50' ' ' VAL . 28.9 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.689 0.28 . . . . 0.84 110.775 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 11' ' ' VAL . 40.8 mm . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.622 0.249 . . . . 0.74 110.85 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.928 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.7 t -95.16 103.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 120.75 0.31 . . . . 1.19 111.01 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.673 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 9.2 mm -87.22 99.75 8.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.316 -0.624 . . . . 1.32 109.316 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 100' ' ' ILE . 11.4 tp -85.97 106.56 17.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.269 -0.423 . . . . 1.33 110.557 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.4 p -80.19 141.19 15.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.263 0.554 . . . . 1.2 110.978 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.3 m -141.2 -171.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 107.868 -1.16 . . . . 1.12 107.868 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.14 146.95 43.4 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.426 -0.51 . . . . 0.75 110.839 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -35.51 -53.89 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.778 1.299 . . . . 1.18 112.677 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.11 -9.93 20.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.593 0.59 . . . . 2.01 112.593 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.67 -40.46 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.126 -0.63 . . . . 1.09 111.559 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.49 -138.42 23.2 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.296 -0.954 . . . . 0.52 111.115 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.03 HG13 ' HB ' ' A' ' 96' ' ' THR . 23.9 t -101.04 113.44 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 122.766 0.426 . . . . 1.08 110.553 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.511 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -85.0 166.79 29.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.502 -0.925 . . . . 1.32 108.502 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 31.8 Cg_exo -34.56 -52.05 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.848 3.032 . . . . 0.61 115.09 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -78.06 -17.99 56.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 122.124 -0.36 . . . . 1.47 111.415 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.03 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.9 m -67.72 -19.06 65.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.35 0.595 . . . . 0.46 109.947 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.15 -44.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.266 -0.425 . . . . 1.05 110.78 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -27.25 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 1.62 110.967 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -75.9 -37.39 58.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.974 -0.557 . . . . 0.34 110.08 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.745 HD13 HD13 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -75.09 -43.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.38 111.209 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -51.43 -36.22 42.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.171 0.51 . . . . 1.85 110.669 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -83.85 -26.48 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.649 -0.705 . . . . 0.85 110.493 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.928 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -88.08 -50.22 6.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.49 0.552 . . . . 0.48 112.49 -173.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -69.57 -21.68 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.031 0.443 . . . . 2.56 111.174 -171.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.37 7.2 20.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.954 -0.567 . . . . 0.76 111.936 -172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.11 -2.68 27.02 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.001 -0.741 . . . . 0.9 109.001 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 t30 80.09 52.48 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.129 -1.396 . . . . 2.06 107.734 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.491 HG11 HG23 ' A' ' 82' ' ' VAL . 25.3 t -124.34 143.4 42.82 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.427 -1.715 . . . . 1.08 111.051 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 Cg_exo -75.27 152.72 39.87 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.799 2.333 . . . . 0.51 113.152 172.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.591 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -123.48 143.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.471 -1.24 . . . . 0.96 110.773 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 mp -114.54 147.81 17.75 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.044 -1.095 . . . . 0.71 108.044 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.27 130.86 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 109.308 -0.627 . . . . 0.23 109.308 172.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -115.22 87.59 2.69 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.25 107.991 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.842 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 23.3 mt -71.26 95.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.57 -1.195 . . . . 0.85 110.26 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.06 164.49 12.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.299 -0.259 . . . . 0.69 110.299 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 62.47 22.7 13.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.815 0.817 . . . . 2.61 109.964 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 4.8 tpp . . . . . 0 N--CA 1.45 -0.454 0 CA-C-N 114.348 -1.296 . . . . 1.37 109.687 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 . . . . . 0 C--O 1.233 0.186 0 N-CA-C 110.489 -0.189 . . . . 1.84 110.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.3 Cg_exo -43.07 -55.5 2.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 123.289 2.66 . . . . 0.7 113.611 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -46.64 -48.98 19.79 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.884 0.698 . . . . 2.0 112.884 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -53.81 -56.68 15.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 2.99 110.245 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.7 t -53.64 -46.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.094 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.648 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -63.23 -38.65 92.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.33 -0.85 . . . . 0.3 111.475 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.9 mt-30 -74.32 -25.06 59.32 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 110.073 -0.343 . . . . 1.28 110.073 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -74.22 -30.24 62.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.151 -0.477 . . . . 2.02 109.889 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.2 mm? -69.43 -45.14 69.87 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.635 0.731 . . . . 1.06 109.645 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.883 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -73.93 -6.07 45.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.957 -1.02 . . . . 0.35 109.793 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 35.5 tt0 -77.39 -28.62 52.85 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.251 -1.018 . . . . 2.18 108.251 173.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.596 ' HB2' HD12 ' A' ' 136' ' ' LEU . 30.5 m-85 -90.05 12.35 17.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.67 0.748 . . . . 0.74 108.987 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.54 42.75 1.48 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.102 -1.408 . . . . 1.94 109.93 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 100' ' ' ILE . 2.1 mp -117.7 78.24 1.22 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.617 -1.174 . . . . 1.68 108.803 171.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.54 125.76 91.64 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.608 -1.178 . . . . 0.61 110.913 -178.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.745 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -49.36 158.78 1.47 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.213 2.608 . . . . 0.3 112.822 172.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' HG12 ' A' ' 146' ' ' ILE . 30.4 mt-10 -81.14 -20.55 41.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.247 -0.888 . . . . 2.01 109.695 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.841 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -55.87 -39.89 72.15 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.252 -1.018 . . . . 1.14 108.252 168.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.883 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.1 m0 -94.08 -30.3 14.74 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.748 -1.569 . . . . 0.45 109.492 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.25 21.57 3.37 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.754 -1.212 . . . . 0.45 112.921 168.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.492 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.29 -114.97 2.14 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.243 -0.979 . . . . 0.5 112.545 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -151.23 28.88 0.65 Allowed 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.313 0.577 . . . . 1.3 111.237 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.62 122.35 32.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.459 0.647 . . . . 0.32 112.05 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 168' ' ' VAL . 15.8 mt -91.69 106.88 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 1.23 111.241 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.745 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -88.59 108.31 19.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.38 111.583 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 79.1 m -104.28 100.31 10.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.1 110.188 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.842 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 16.4 ptmt -82.03 94.68 7.23 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.306 -0.627 . . . . 2.44 109.306 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' MET . 0.7 OUTLIER -112.77 -176.84 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.955 0.884 . . . . 1.27 112.684 -168.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 24.6 t -165.97 121.64 1.27 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.263 -1.335 . . . . 1.79 109.737 177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -9.2 44.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.894 0.378 . . . . 0.87 111.197 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -83.89 -56.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.736 0.779 . . . . 3.03 109.675 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 46.5 p -81.04 -20.54 41.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.421 -1.263 . . . . 1.2 111.562 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 73.14 -2.65 2.67 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.659 -0.7 . . . . 2.27 111.201 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -48.35 -71.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.772 0.796 . . . . 2.64 112.061 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.63 -9.58 69.74 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.875 -1.057 . . . . 0.62 113.822 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 158' ' ' LEU . 4.3 mm? -69.09 -50.25 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.677 0.738 . . . . 1.55 110.367 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.91 -38.48 82.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.068 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' A' ' 164' ' ' MET . 80.2 t60 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.657 -0.701 . . . . 0.73 110.921 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 62.0 tp -63.25 -58.19 7.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.038 -0.356 . . . . 0.91 110.038 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.75 -37.05 65.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.381 0.61 . . . . 1.06 110.054 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' HE2' ' A' ' 164' ' ' MET . 16.1 tt0 -65.29 -48.26 73.77 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.027 -0.988 . . . . 2.49 110.829 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.632 ' HB3' HG21 ' A' ' 146' ' ' ILE . 17.3 mmt -63.12 -42.79 99.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.309 . . . . 0.87 110.466 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 161' ' ' LEU . 87.8 mt -53.72 -53.56 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.667 -0.697 . . . . 0.64 110.15 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.408 ' CD2' HD11 ' A' ' 57' ' ' ILE . 76.8 mt -59.58 -48.97 79.58 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.659 -0.7 . . . . 1.81 111.872 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.39 -47.18 73.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.746 -0.661 . . . . 1.42 111.098 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 146' ' ' ILE . 2.1 t . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.509 -0.314 . . . . 1.17 111.371 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 81' ' ' ILE . 59.9 t . . . . . 0 N--CA 1.435 -1.192 0 CA-C-O 121.157 0.503 . . . . 1.0 110.944 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.1 m -86.07 128.09 34.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.572 -0.74 . . . . 0.66 110.764 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 83' ' ' ILE . 29.0 mt -90.94 122.94 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 1.03 111.549 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.522 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.7 mtt -137.82 171.86 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.099 -0.501 . . . . 1.04 110.596 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.826 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 150.2 -104.52 0.27 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.051 -1.219 . . . . 1.55 110.051 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 66.1 t60 -167.07 158.68 12.45 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.46 -0.57 . . . . 0.66 109.46 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.45 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.728 0.27 . . . . 1.62 111.728 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.32 -22.07 65.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.114 -0.494 . . . . 1.78 112.233 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.412 ' HE1' ' H ' ' A' ' 93' ' ' MET . 62.0 m170 -71.07 -18.25 62.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.078 0.466 . . . . 0.65 110.565 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.29 40.47 3.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.926 -0.654 . . . . 0.93 113.566 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -76.92 -27.38 54.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.468 0.634 . . . . 2.11 110.974 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 -30.97 31.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 1.8 110.126 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -81.08 -17.06 51.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.283 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.37 -51.55 59.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.825 -0.806 . . . . 1.78 108.825 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.658 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 2.7 tt -62.18 -38.63 89.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 1.96 110.248 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.0 t70 -68.82 -46.84 67.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.489 -0.323 . . . . 1.38 111.373 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -64.69 -42.03 95.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.926 0.393 . . . . 0.91 110.784 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.1 tt -66.51 -28.98 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.54 -0.755 . . . . 1.56 109.62 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 14.3 tpt180 -69.37 -33.32 72.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 3.56 109.934 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -83.45 14.58 3.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.876 -0.602 . . . . 2.88 111.361 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 t . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.452 -0.34 . . . . 1.76 110.798 -178.324 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.8 p90 . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.056 0.455 . . . . 2.54 110.585 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -115.26 148.15 39.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.237 -0.653 . . . . 1.96 109.237 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.726 0.774 . . . . 1.93 110.813 -179.131 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mt . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.042 -0.355 . . . . 1.14 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 m -112.68 137.59 50.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.363 . . . . 1.28 110.101 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 110.191 -0.3 . . . . 0.84 110.191 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.638 HG21 HG22 ' A' ' 11' ' ' VAL . 31.7 mm . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.628 0.251 . . . . 0.74 111.457 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 103' ' ' ALA . 85.7 t -108.36 108.88 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.709 -0.223 . . . . 1.19 110.565 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.787 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -87.39 113.32 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 119.768 -0.773 . . . . 1.32 109.89 172.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG22 ' A' ' 96' ' ' THR . 12.4 tp -98.12 111.91 24.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.506 -0.77 . . . . 1.33 110.26 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.826 HG12 ' HA3' ' A' ' 15' ' ' GLY . 7.5 p -84.25 143.04 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.245 0.545 . . . . 1.2 111.036 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.849 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.0 m -135.31 -179.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.158 -1.053 . . . . 1.12 108.158 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.31 133.11 14.97 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.431 -0.908 . . . . 0.75 113.195 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 49.81 -115.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.404 -1.271 . . . . 1.18 113.1 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -115.47 8.95 15.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 2.01 110.289 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 16.4 t70 -64.04 -37.34 87.06 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.75 0.786 . . . . 1.09 109.422 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.61 -109.59 2.98 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.52 111.385 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.0 t -128.25 110.86 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.66 0.266 . . . . 1.08 110.698 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 72.6 mmm -74.52 170.96 12.7 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.307 -0.406 . . . . 1.32 110.181 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.2 Cg_exo -45.3 -52.11 6.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.611 2.208 . . . . 0.61 112.709 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.67 -34.31 75.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.431 -0.349 . . . . 1.47 111.19 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.989 ' HB ' HG13 ' A' ' 92' ' ' VAL . 2.6 m -64.58 -25.91 68.18 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.46 110.759 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 92' ' ' VAL . 69.1 t -86.31 -48.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.547 -0.297 . . . . 1.05 110.478 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 46.4 mt-10 -59.83 -23.94 63.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 1.62 111.335 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.522 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.23 -40.11 31.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.16 -0.681 . . . . 0.34 109.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 110' ' ' ILE . 1.4 mt -72.31 -56.28 10.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.38 110.212 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.444 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.7 t-20 -44.47 -34.34 2.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.438 0.695 . . . . 1.85 111.48 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 7.1 t60 -84.17 -35.25 23.69 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.983 -0.553 . . . . 0.85 111.354 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.32 -28.84 16.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.497 0.554 . . . . 0.48 112.497 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -76.95 -11.15 59.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.917 0.389 . . . . 2.56 110.978 -169.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.4 -1.55 56.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 0.76 111.895 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -95.91 8.64 43.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.915 -1.143 . . . . 0.9 107.915 170.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.15 33.11 14.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 113.866 -1.515 . . . . 2.06 110.457 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER -91.94 158.27 39.98 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.715 -0.675 . . . . 1.08 110.343 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.533 ' O ' HG23 ' A' ' 108' ' ' VAL . 6.9 Cg_exo -72.49 146.98 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.614 2.21 . . . . 0.51 113.047 170.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -120.24 142.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.089 -1.414 . . . . 0.96 109.331 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 mt -116.88 155.67 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 108.937 -0.764 . . . . 0.71 108.937 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -120.81 138.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 109.527 -0.546 . . . . 0.23 109.527 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.19 88.33 2.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.849 ' HA ' HG23 ' A' ' 86' ' ' VAL . 30.6 mt -68.57 90.2 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.837 -1.074 . . . . 0.85 110.264 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -80.31 154.8 27.57 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.112 0.258 . . . . 0.69 110.528 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 64.62 32.49 11.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.646 0.591 . . . . 2.61 110.946 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.2 tpp . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 1.37 110.469 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 51.5 t-20 . . . . . 0 CA--C 1.51 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.84 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -20.4 -81.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 1 C-N-CA 126.28 4.654 . . . . 0.7 115.904 175.793 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.84 -46.63 74.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.992 0.517 . . . . 2.0 112.255 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 30.3 tpt180 -50.78 -60.28 3.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.659 0.742 . . . . 2.99 109.658 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.4 t -59.69 -45.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 113.906 -1.497 . . . . 0.4 110.583 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.795 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 91.5 mtp -67.19 -26.13 66.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.906 -0.588 . . . . 0.3 111.25 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.31 -18.63 33.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.719 -0.392 . . . . 1.28 111.29 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.637 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.1 mm-40 -60.07 -42.52 94.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.557 -0.905 . . . . 2.02 108.557 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -73.63 -40.01 64.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.79 -1.095 . . . . 1.06 110.766 -173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.976 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -79.52 -3.68 47.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.811 -0.631 . . . . 0.35 109.76 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 11.2 tp10 -73.83 -33.47 64.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 2.18 107.463 171.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CE2' HG11 ' A' ' 92' ' ' VAL . 27.1 m-85 -87.83 7.94 28.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.613 -0.721 . . . . 0.74 109.862 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.56 34.22 1.28 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.755 -1.111 . . . . 1.94 110.638 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.6 mp -111.61 80.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.246 -1.02 . . . . 1.68 108.246 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.07 129.15 93.99 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.93 -1.486 . . . . 0.61 111.077 -176.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.811 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 76.0 Cg_exo -49.48 157.37 2.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.236 2.624 . . . . 0.3 113.649 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 146' ' ' ILE . 8.2 mm-40 -70.6 -31.29 68.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.304 -1.317 . . . . 2.01 109.006 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.639 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.3 mp0 -46.16 -54.02 9.41 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.576 -1.193 . . . . 1.14 110.698 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.976 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.2 m0 -89.45 -18.69 26.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.836 -1.529 . . . . 0.45 110.91 -166.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.59 28.08 4.14 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 120.014 -1.088 . . . . 0.45 112.287 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -99.65 -110.81 3.17 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.373 -0.918 . . . . 0.5 111.814 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.434 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 p30 -159.32 33.5 0.2 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.522 0.677 . . . . 1.3 110.81 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 27.7 m -125.56 112.45 16.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.412 0.625 . . . . 0.32 111.8 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -79.08 104.66 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.657 -0.701 . . . . 1.23 111.079 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -87.91 113.96 24.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.201 0.524 . . . . 0.38 111.811 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.41 ' O ' HD12 ' A' ' 150' ' ' LEU . 64.1 m -105.32 100.81 10.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.551 -0.75 . . . . 1.1 109.568 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 15.3 pttm -81.27 85.36 6.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.577 -0.897 . . . . 2.44 108.577 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.876 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -123.25 -175.64 3.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.176 -0.92 . . . . 1.27 112.671 -166.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 m -157.24 124.62 5.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.645 -1.161 . . . . 1.79 109.628 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -85.52 -12.93 50.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 0.87 110.297 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -73.49 -56.31 5.21 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.364 -0.834 . . . . 3.03 109.304 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.6 p -78.71 -21.57 47.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.884 -1.053 . . . . 1.2 108.997 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 1.023 ' HG3' HD12 ' A' ' 158' ' ' LEU . 2.1 ttmp? 70.79 7.03 6.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.715 -1.584 . . . . 2.27 112.038 172.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.26 -49.46 64.24 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.12 0.962 . . . . 2.64 110.652 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.876 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -62.14 -23.81 64.47 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 114.778 -1.101 . . . . 0.62 113.012 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.023 HD12 ' HG3' ' A' ' 155' ' ' LYS . 29.9 mt -64.65 -32.22 73.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.715 0.258 . . . . 1.55 110.558 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 13.7 m-20 -60.65 -53.26 59.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.036 -0.727 . . . . 2.5 109.036 172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.441 -0.8 . . . . 0.73 111.049 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.2 tp -61.05 -60.55 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.342 -0.39 . . . . 0.91 111.062 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.46 -40.36 68.32 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.221 0.325 . . . . 1.06 110.533 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 78.5 mm-40 -61.64 -49.7 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.539 . . . . 2.49 110.715 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.503 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -69.56 -34.66 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.87 110.444 -175.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.98 -52.32 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.928 -0.578 . . . . 0.64 110.714 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -76.8 -37.15 56.29 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.303 0.483 . . . . 1.81 112.303 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 166' ' ' LEU . 40.7 tp -61.53 -25.13 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.061 0.458 . . . . 1.42 110.166 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.615 HG21 HG12 ' A' ' 146' ' ' ILE . 2.7 t . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 1.17 110.12 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 58' ' ' THR . 51.4 t . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 121.146 0.498 . . . . 1.0 110.231 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -96.56 130.05 43.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.497 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 55.3 mt -97.76 126.75 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.712 0.292 . . . . 1.03 110.691 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.424 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 70.3 mtm -144.25 -177.73 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.075 -0.511 . . . . 1.04 110.888 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 84' ' ' LEU . . . 107.18 59.27 0.58 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.634 -0.793 . . . . 1.55 112.464 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 18.0 t60 62.07 163.62 0.09 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.068 0.937 . . . . 0.66 112.065 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.92 -32.28 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.861 -0.609 . . . . 1.62 111.633 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.444 ' HB3' ' NE2' ' A' ' 16' ' ' HIS . 28.0 t70 -72.83 -25.42 61.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.612 0.227 . . . . 1.78 111.612 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' MET . 32.5 m80 -61.71 -20.25 63.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 0.65 110.63 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.63 51.2 1.13 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.638 -0.71 . . . . 0.93 113.086 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.832 0.825 . . . . 2.11 109.021 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -36.79 80.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.451 -1.25 . . . . 1.8 110.76 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.5 p -73.24 -20.82 60.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 1.77 111.257 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.8 mm? -71.91 -48.13 47.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.947 -0.39 . . . . 1.78 109.947 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.22 -35.89 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.827 -0.624 . . . . 1.96 109.932 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.12 -58.31 8.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.794 0.331 . . . . 1.38 111.528 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -62.14 -29.15 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.91 111.133 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 HD21 ' A' ' 162' ' ' LEU . 5.2 tt -75.43 -25.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 1.56 111.029 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.0 mtp180 -78.97 -21.33 47.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.373 0.606 . . . . 3.56 110.049 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -88.6 -0.31 57.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 2.88 109.695 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.576 -0.738 . . . . 1.76 110.156 -179.511 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.162 0.506 . . . . 2.54 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.559 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 21.3 mt-30 -142.31 117.5 10.1 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.956 -1.127 . . . . 1.96 107.956 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--N 1.309 -1.168 0 N-CA-C 108.41 -0.959 . . . . 1.93 108.41 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 58' ' ' THR . 10.5 mt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.335 0.588 . . . . 1.14 110.966 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 4.0 t -151.61 144.16 24.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.6 -0.889 . . . . 1.28 108.6 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 13' ' ' ILE . 42.7 m-85 . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 120.715 -0.394 . . . . 0.84 110.481 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.673 HG23 HD11 ' A' ' 111' ' ' ILE . 28.3 mm . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.22 0.452 . . . . 0.74 112.22 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.731 ' HB ' HD13 ' A' ' 110' ' ' ILE . 75.8 t -107.09 120.62 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 116.44 -0.345 . . . . 1.19 110.899 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 111' ' ' ILE . 8.3 mm -86.31 123.08 39.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.531 -0.914 . . . . 1.32 108.531 171.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.0 tm? -107.66 113.94 27.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.704 . . . . 1.33 109.302 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.83 139.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.141 0.496 . . . . 1.2 111.855 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 114' ' ' ILE . 25.8 m -139.42 -171.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 108.822 -0.807 . . . . 1.12 108.822 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.9 109.92 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.968 0.729 . . . . 0.75 112.968 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . 44.68 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.809 1.041 . . . . 1.18 113.809 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -107.67 -3.96 18.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.347 0.499 . . . . 2.01 112.347 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 31.0 t70 -64.34 -43.79 93.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.419 0.628 . . . . 1.09 111.054 -175.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 88.93 -113.17 4.06 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.518 -0.848 . . . . 0.52 111.249 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.966 HG13 ' HB ' ' A' ' 96' ' ' THR . 35.5 t -129.36 119.2 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 120.656 0.265 . . . . 1.08 110.625 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 42.0 mtp -85.83 169.35 15.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.675 -0.491 . . . . 1.32 109.675 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.4 Cg_exo -42.64 -60.01 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.753 2.302 . . . . 0.61 112.801 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.684 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 42.0 mt-30 -59.27 -25.39 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.703 0.631 . . . . 1.47 112.703 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.966 ' HB ' HG13 ' A' ' 92' ' ' VAL . 29.9 m -60.21 -46.01 91.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.277 -0.169 . . . . 0.46 111.001 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.572 ' HA ' ' HB ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -88.52 -30.25 5.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 O-C-N 121.847 -0.533 . . . . 1.05 111.444 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 44.5 mt-10 -61.36 -26.94 68.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.411 . . . . 1.62 111.099 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -88.13 -22.31 24.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.34 109.959 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.805 HD13 HD22 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -80.79 -47.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.169 -0.923 . . . . 0.38 110.796 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -57.63 -32.78 67.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.398 0.618 . . . . 1.85 110.056 170.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.09 -29.46 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.35 -0.841 . . . . 0.85 109.936 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -96.18 -54.68 3.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.471 0.545 . . . . 0.48 112.471 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HG3' HD11 ' A' ' 136' ' ' LEU . 24.5 mmmt -55.18 -44.8 75.6 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.601 0.715 . . . . 2.56 111.021 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.59 10.24 2.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.318 -1.31 . . . . 0.76 112.133 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.53 8.43 21.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.374 -0.973 . . . . 0.9 108.374 167.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 70.1 48.6 0.52 Allowed 'General case' 0 C--N 1.339 0.149 0 CA-C-N 114.226 -1.352 . . . . 2.06 111.084 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -126.48 157.61 70.08 Favored Pre-proline 0 C--O 1.238 0.485 0 N-CA-C 112.954 0.724 . . . . 1.08 112.954 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.575 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.5 Cg_exo -76.2 159.56 36.89 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 124.611 3.541 . . . . 0.51 114.498 168.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.756 HD11 ' HB3' ' A' ' 103' ' ' ALA . 22.1 mm -129.66 148.26 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.78 -1.1 . . . . 0.96 111.166 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 83' ' ' ILE . 3.9 mt -122.06 150.95 25.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 N-CA-C 109.283 -0.636 . . . . 0.71 109.283 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.2 136.34 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.282 0.563 . . . . 0.23 110.442 174.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.9 88.41 2.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.022 -1.103 . . . . 0.25 108.022 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.779 ' HA ' HG23 ' A' ' 86' ' ' VAL . 45.2 mt -69.36 91.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.686 -1.143 . . . . 0.85 109.697 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.643 ' HA ' HD22 ' A' ' 150' ' ' LEU . 53.9 t30 -88.67 151.71 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.69 111.204 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt 54.89 36.47 26.74 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.951 0.782 . . . . 2.61 111.018 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.497 -0.774 . . . . 1.37 109.365 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 109.859 -0.422 . . . . 1.84 109.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.5 Cg_endo -42.89 -59.25 1.04 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.496 2.797 . . . . 0.7 113.063 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.9 -47.51 32.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.582 0.586 . . . . 2.0 112.582 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.634 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 24.0 tpt180 -58.43 -55.86 29.6 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.329 0.585 . . . . 2.99 109.709 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.583 HG13 ' HA2' ' A' ' 91' ' ' GLY . 82.3 t -52.46 -43.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.4 -1.273 . . . . 0.4 110.677 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.683 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 81.5 mtp -64.24 -34.05 77.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.032 -0.531 . . . . 0.3 110.527 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 58.1 mt-30 -73.63 -24.28 60.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 1.28 111.025 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 3.0 mm-40 -68.7 -36.78 78.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.685 -0.857 . . . . 2.02 108.685 172.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.6 mm? -71.73 -43.59 65.6 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.55 -0.75 . . . . 1.06 109.844 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.838 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -77.55 0.26 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.521 -0.763 . . . . 0.35 109.819 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.546 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 16.4 tp10 -81.18 -27.58 35.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.911 -1.144 . . . . 2.18 107.911 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.763 ' CE2' HG11 ' A' ' 92' ' ' VAL . 48.5 m-85 -91.99 10.35 29.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.533 0.683 . . . . 0.74 109.19 168.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.2 m120 72.46 32.57 1.58 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.23 -1.35 . . . . 1.94 110.889 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.805 HD22 HD13 ' A' ' 100' ' ' ILE . 7.5 mp -107.84 79.51 1.29 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.402 1.096 . . . . 1.68 109.475 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.027 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.3 t -66.94 126.18 92.04 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.245 -1.798 . . . . 0.61 112.014 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.85 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 74.5 Cg_exo -47.45 160.11 0.4 Allowed 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 123.848 3.032 . . . . 0.3 113.878 170.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.56 -19.07 42.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.677 -1.147 . . . . 2.01 109.835 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 1.9 mm-40 -59.23 -40.8 87.03 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.878 -1.156 . . . . 1.14 107.878 168.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.893 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.7 m0 -91.67 -31.64 15.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.952 -1.476 . . . . 0.45 110.979 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.37 28.61 2.98 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.018 -1.087 . . . . 0.45 112.045 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 1.027 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.96 -104.77 1.79 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.717 -0.754 . . . . 0.5 111.913 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -165.49 33.47 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.174 0.511 . . . . 1.3 111.248 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 16.0 m -130.8 113.43 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.244 -0.582 . . . . 0.32 112.016 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.823 HD11 HG21 ' A' ' 168' ' ' VAL . 37.6 mt -81.44 110.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 116.02 -0.537 . . . . 1.23 111.347 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.85 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 23.4 m-85 -89.55 115.0 26.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.933 0.397 . . . . 0.38 111.805 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 13.8 t -113.27 135.94 53.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.866 -0.606 . . . . 1.1 109.386 173.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.758 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.2 pttp -110.74 85.13 2.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.689 0.757 . . . . 2.44 109.949 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -103.55 168.97 8.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.223 1.011 . . . . 1.27 112.906 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.578 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 27.7 t -145.14 117.37 8.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.392 -1.276 . . . . 1.79 108.131 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.53 -26.44 61.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.27 0.841 . . . . 0.87 113.27 -170.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.639 ' HG3' ' H ' ' A' ' 154' ' ' THR . 46.4 pttt -84.27 -55.24 4.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.33 0.586 . . . . 3.03 110.945 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.639 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 40.8 p -64.21 -25.08 67.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.096 -0.956 . . . . 1.2 110.628 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.849 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 2.5 tppp? 66.8 16.27 10.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.88 -1.055 . . . . 2.27 111.805 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.85 -72.42 0.16 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.712 0.768 . . . . 2.64 111.021 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -61.97 -16.67 53.15 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.739 -1.119 . . . . 0.62 113.24 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 150' ' ' LEU . 4.5 mm? -61.4 -46.21 91.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.912 0.387 . . . . 1.55 110.692 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.58 -42.16 68.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.074 -0.512 . . . . 2.5 110.205 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.9 t60 -66.61 -21.23 66.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.802 -0.635 . . . . 0.73 110.827 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.55 -51.13 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.056 -0.35 . . . . 0.91 110.056 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.668 HD21 HD11 ' A' ' 28' ' ' ILE . 93.8 mt -56.17 -39.95 73.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.635 . . . . 1.06 111.107 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 13.6 pt-20 -69.54 -32.59 71.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 2.49 110.648 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.706 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 25.6 mmt -73.13 -41.34 64.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.073 0.463 . . . . 0.87 109.898 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.43 -51.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.323 -0.853 . . . . 0.64 111.123 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -75.99 -36.85 59.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.246 0.461 . . . . 1.81 112.246 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 166' ' ' LEU . 62.4 tp -52.23 -33.64 42.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.036 0.446 . . . . 1.42 110.575 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 146' ' ' ILE . 19.0 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.856 -0.611 . . . . 1.17 110.71 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 81' ' ' ILE . 58.9 t . . . . . 0 N--CA 1.437 -1.123 0 CA-C-O 121.041 0.448 . . . . 1.0 110.671 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 127.2 43.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.66 110.77 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.423 HD11 ' HD2' ' A' ' 59' ' ' PHE . 39.9 mt -83.99 115.77 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.319 0.58 . . . . 1.03 110.512 177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.419 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 mmt -107.49 -175.44 2.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.208 -0.905 . . . . 1.04 110.139 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.34 134.56 7.54 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.238 -0.982 . . . . 1.55 110.805 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 84.3 t60 -36.58 128.61 0.8 Allowed 'General case' 0 C--N 1.315 -0.894 0 O-C-N 124.634 0.843 . . . . 0.66 111.124 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 11.3 p -55.61 -21.28 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.352 -0.84 . . . . 1.62 113.107 -170.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 31.5 t70 -93.16 -8.22 43.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.8 0.333 . . . . 1.78 111.78 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.446 ' ND1' ' HA ' ' A' ' 86' ' ' VAL . 21.9 m170 -77.26 -7.24 55.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.484 0.55 . . . . 0.65 112.484 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.64 46.36 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.224 -0.989 . . . . 0.93 112.773 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 ptmm? -87.22 -24.26 24.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 2.11 110.174 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 t -72.8 -29.75 63.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.8 110.254 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 p -75.42 -25.74 57.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.128 -0.487 . . . . 1.77 110.871 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 152' ' ' ALA . 43.0 mt -67.9 -54.04 21.87 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.986 -0.746 . . . . 1.78 108.986 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.04 -41.21 62.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.851 -0.613 . . . . 1.96 110.258 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.9 t70 -77.96 -51.38 10.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.54 -33.38 64.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.897 0.332 . . . . 0.91 111.897 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.576 ' HB ' ' OH ' ' A' ' 48' ' ' TYR . 76.2 mt -70.0 -39.05 76.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 1.56 110.046 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.682 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 7.2 ptt180 -66.67 -33.47 75.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.325 0.584 . . . . 3.56 109.967 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -83.06 -3.85 57.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.485 -0.78 . . . . 2.88 111.604 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.713 0.292 . . . . 1.76 110.714 -177.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.576 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 5.7 p90 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.019 0.438 . . . . 2.54 111.468 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -140.14 133.56 30.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.359 -0.837 . . . . 1.96 110.191 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.688 0.756 . . . . 1.93 109.832 176.413 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 11' ' ' VAL . 4.0 mt . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.803 0.335 . . . . 1.14 111.663 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.9 m -99.23 112.29 24.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.167 -0.47 . . . . 1.28 109.793 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HD2' HD11 ' A' ' 13' ' ' ILE . 39.8 m-85 . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 110.217 -0.29 . . . . 0.84 110.217 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.988 ' HB ' HG22 ' A' ' 11' ' ' VAL . 47.8 mm . . . . . 0 C--O 1.235 0.303 0 N-CA-C 113.162 0.801 . . . . 0.74 113.162 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 103' ' ' ALA . 70.0 t -106.29 107.55 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 1.19 110.758 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.722 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -94.14 110.13 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 174.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 100' ' ' ILE . 10.5 tp -90.28 108.33 19.69 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.923 -0.581 . . . . 1.33 110.749 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.3 t -82.0 133.68 28.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.559 . . . . 1.2 111.483 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.3 m -134.08 -177.88 2.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.888 -1.153 . . . . 1.12 107.888 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.08 11.84 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.792 -0.763 . . . . 0.75 112.215 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.75 -109.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.625 -1.17 . . . . 1.18 112.903 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -116.51 19.05 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 2.01 110.472 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.14 -33.35 73.29 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.817 0.818 . . . . 1.09 109.0 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.822 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.68 -142.15 28.46 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.251 -1.341 . . . . 0.52 111.912 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 96' ' ' THR . 71.2 t -98.01 110.2 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 120.809 0.337 . . . . 1.08 111.391 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 80.5 mmm -80.49 171.61 11.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.15 -0.477 . . . . 1.32 109.804 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.67 -54.49 4.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.138 2.559 . . . . 0.61 113.257 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 35.6 mt-30 -60.74 -30.33 69.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 1.47 111.574 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 92' ' ' VAL . 9.8 m -64.58 -22.96 67.11 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.851 0.358 . . . . 0.46 111.102 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.65 -46.5 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.885 0.374 . . . . 1.05 111.111 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.0 -12.74 40.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 1.62 111.315 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -96.68 -18.82 19.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.34 110.085 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 84' ' ' LEU . 3.4 mt -93.3 -53.07 8.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.38 110.507 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -50.4 -37.79 39.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.708 -0.678 . . . . 1.85 110.53 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -75.9 -32.04 59.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.233 -0.894 . . . . 0.85 110.728 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.21 -55.79 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 0.48 112.084 -173.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HB3' HD11 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -71.41 -12.16 61.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 116.165 -0.47 . . . . 2.56 112.075 -168.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.37 -0.32 19.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.241 -0.436 . . . . 0.76 111.869 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.1 1.99 26.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 t30 82.14 38.04 0.06 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 114.566 -1.197 . . . . 2.06 108.113 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 23.5 t -101.93 142.01 23.72 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 113.151 -1.841 . . . . 1.08 111.122 -173.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 6.4 Cg_exo -73.86 149.98 43.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.754 2.303 . . . . 0.51 113.165 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.683 HD13 HG12 ' A' ' 100' ' ' ILE . 97.8 mt -124.78 149.79 29.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.325 -1.307 . . . . 0.96 109.989 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mt -125.11 157.35 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 109.065 -0.717 . . . . 0.71 109.065 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -115.25 134.6 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 109.651 -0.499 . . . . 0.23 109.651 171.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.69 87.71 2.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.748 -1.204 . . . . 0.25 107.748 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.0 mt -73.66 93.08 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.661 -1.154 . . . . 0.85 109.749 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.55 166.44 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.095 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 57.3 tptt 63.0 47.9 4.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.27 1.033 . . . . 2.61 110.585 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.427 ' SD ' HG22 ' A' ' 114' ' ' ILE . 69.3 mmm . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 115.13 -0.941 . . . . 1.37 108.501 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.5 t30 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.179 -0.674 . . . . 1.84 109.179 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.3 Cg_exo -19.29 -66.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 1 C-N-CA 126.389 4.726 . . . . 0.7 116.456 175.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -39.68 -52.03 2.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.096 0.776 . . . . 2.0 113.096 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.0 tmt_? -55.55 -56.7 17.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.985 0.422 . . . . 2.99 109.926 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.822 HG13 ' HA2' ' A' ' 91' ' ' GLY . 31.0 t -58.45 -45.17 89.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.4 110.008 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.695 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 88.8 mtp -63.41 -30.11 71.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.395 -0.82 . . . . 0.3 111.181 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 58.8 mt-30 -78.61 -25.21 45.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.118 -0.233 . . . . 1.28 110.669 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.75 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.6 mt-10 -63.45 -38.61 91.79 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.847 -0.798 . . . . 2.02 108.847 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.984 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -70.85 -42.36 70.23 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.094 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.824 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -72.92 -7.76 52.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.728 -0.669 . . . . 0.35 110.227 178.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.85 -24.36 35.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 19.1 m-85 -89.05 5.95 42.01 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 122.216 1.008 . . . . 0.74 108.306 167.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.2 m120 72.37 26.35 2.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 113.158 -1.837 . . . . 1.94 110.541 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.984 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -103.56 73.02 1.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.205 -1.406 . . . . 1.68 107.205 169.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.909 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -58.31 132.56 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 113.403 -1.726 . . . . 0.61 110.291 -173.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.856 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 94.4 Cg_exo -47.35 151.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.631 2.221 . . . . 0.3 112.971 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -76.0 -25.68 56.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.149 -1.387 . . . . 2.01 108.028 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.828 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -55.99 -38.9 71.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.288 -1.323 . . . . 1.14 109.149 169.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.828 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.6 m0 -96.03 -25.31 15.97 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.581 -1.191 . . . . 0.45 110.453 -172.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.48 24.15 3.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.908 -1.139 . . . . 0.45 112.192 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.909 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -115.85 2.93 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.396 -0.907 . . . . 0.5 112.978 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.28 25.03 1.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.965 0.358 . . . . 1.3 111.965 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.588 HG21 HD12 ' A' ' 136' ' ' LEU . 31.7 m -142.91 123.12 13.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 119.541 -0.864 . . . . 0.32 113.267 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.4 mp -85.19 118.42 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 1.23 110.36 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.3 m-85 -92.88 116.61 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.911 0.386 . . . . 0.38 111.352 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.6 m -114.46 110.24 19.54 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.72 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 14.9 ptmt -84.91 85.75 7.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.354 0.597 . . . . 2.44 109.707 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -114.3 -175.22 2.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.446 0.641 . . . . 1.27 111.816 -171.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.65 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 35.9 m -160.02 119.59 2.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.51 -0.768 . . . . 1.79 110.011 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' A' ' 24' ' ' LEU . . . -73.94 -53.25 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.897 -0.592 . . . . 0.87 112.553 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -75.34 -43.26 51.58 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.583 0.706 . . . . 3.03 109.785 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.3 OUTLIER -57.88 -22.14 46.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.15 -1.387 . . . . 1.2 110.196 171.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.743 ' HD3' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER 74.22 -39.28 0.42 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.601 -1.181 . . . . 2.27 113.903 170.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.99 -46.48 43.91 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.649 0.738 . . . . 2.64 112.024 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.65 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -63.99 -33.1 86.34 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.05 -0.977 . . . . 0.62 113.58 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.743 HD12 ' HD3' ' A' ' 155' ' ' LYS . 74.7 mt -59.68 -47.02 87.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.809 0.338 . . . . 1.55 111.182 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -59.96 -44.52 94.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.64 -0.709 . . . . 2.5 110.251 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -65.46 -38.75 90.74 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.309 -0.405 . . . . 0.73 110.898 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.9 -51.61 68.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 0.91 111.011 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 165' ' ' ILE . 81.7 mt -60.16 -33.88 72.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 1.06 110.911 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.83 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 2.49 110.642 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.56 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.87 110.638 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.43 HD12 HD23 ' A' ' 162' ' ' LEU . 81.7 mt -61.4 -48.77 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.64 110.596 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.6 -37.97 89.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.81 110.821 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.7 -45.45 73.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.733 -0.667 . . . . 1.42 109.656 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 116.078 -0.51 . . . . 1.17 111.035 -178.147 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 ' HB ' ' A' ' 81' ' ' ILE . 44.5 t . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -97.75 109.63 22.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 0.66 110.717 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 83' ' ' ILE . 14.7 tt -82.69 143.99 11.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.092 0.472 . . . . 1.03 110.772 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.68 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 59.4 mtt -139.94 -172.6 3.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.069 -0.514 . . . . 1.04 110.934 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.905 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 107.76 129.64 6.13 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.944 -0.862 . . . . 1.55 110.944 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 83.4 t60 -49.01 136.58 14.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.499 0.666 . . . . 0.66 110.971 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.624 HG12 ' HE2' ' A' ' 21' ' ' LYS . 29.2 m -64.74 -33.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.294 0.85 . . . . 1.62 113.294 -169.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.483 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 9.7 m-20 -67.15 -19.8 65.65 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.745 0.276 . . . . 1.78 111.745 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -68.93 -16.25 63.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.65 110.916 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 114.63 47.27 0.58 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.87 -0.681 . . . . 0.93 112.472 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.624 ' HE2' HG12 ' A' ' 17' ' ' VAL . 36.3 ttpt -87.09 -34.99 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.547 -0.538 . . . . 2.11 109.547 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -67.35 -47.73 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 1.8 109.954 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -69.49 -20.37 63.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.663 -0.699 . . . . 1.77 110.432 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 3.0 tm? -73.57 -51.01 18.4 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.519 -0.919 . . . . 1.78 108.519 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -58.09 -37.1 73.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.455 -0.793 . . . . 1.96 110.668 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.26 -55.55 11.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 1.38 110.81 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.2 98.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.91 111.203 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 25' ' ' LEU . 13.0 tt -65.03 -31.51 54.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.588 -0.733 . . . . 1.56 111.02 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -79.9 -28.07 39.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.475 0.655 . . . . 3.56 109.29 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.92 -9.29 59.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 2.88 111.489 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 CA--C 1.534 0.345 0 CA-C-N 116.442 -0.345 . . . . 1.76 111.709 -178.073 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.439 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.5 p90 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.19 0.519 . . . . 2.54 110.025 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.941 ' HG2' HG23 ' A' ' 58' ' ' THR . 77.9 mt-30 -100.07 114.78 28.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.925 -0.769 . . . . 1.96 108.925 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG21 ' HE1' ' A' ' 59' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.596 0.713 . . . . 1.93 111.909 -174.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 166' ' ' LEU . 63.5 mt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.45 0.643 . . . . 1.14 111.781 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.941 HG23 ' HG2' ' A' ' 49' ' ' GLN . 28.9 m -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 170.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HE1' HG21 ' A' ' 50' ' ' VAL . 83.0 m-85 . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 108.872 -0.788 . . . . 0.84 108.872 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 11' ' ' VAL . 37.5 mm . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.439 -0.578 . . . . 0.74 109.439 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 103' ' ' ALA . 87.5 t -91.84 95.7 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.257 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.806 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -81.94 97.66 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 120.291 -0.564 . . . . 1.32 109.632 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 96' ' ' THR . 20.4 tp -86.94 109.0 19.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.643 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HA3' ' A' ' 15' ' ' GLY . 5.0 p -85.23 142.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 1.2 111.298 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.1 m -138.9 -177.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.553 -0.906 . . . . 1.12 108.553 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.81 98.26 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.953 -0.699 . . . . 0.75 112.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.97 -95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.106 1.15 . . . . 1.18 114.106 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.17 -8.21 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 2.01 112.002 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.06 -32.58 39.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 1.09 110.458 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 72.31 -139.11 27.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.259 -0.882 . . . . 0.52 112.443 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.572 HG13 ' HB ' ' A' ' 96' ' ' THR . 78.4 t -97.1 106.54 18.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 123.012 0.525 . . . . 1.08 111.512 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.553 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 51.0 mtp -75.9 170.85 13.9 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 1.32 110.634 173.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 79.0 Cg_exo -43.85 -58.07 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.79 2.327 . . . . 0.61 112.898 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.2 mt-30 -56.13 -32.86 64.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.387 0.514 . . . . 1.47 112.387 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 84' ' ' LEU . 11.4 m -66.68 -23.16 66.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.134 0.492 . . . . 0.46 110.579 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 92' ' ' VAL . 91.1 t -91.79 -45.25 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.404 -0.362 . . . . 1.05 110.69 175.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 46.1 mt-10 -61.36 -18.13 57.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 1.62 111.147 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.68 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -86.32 -41.47 14.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.814 -0.63 . . . . 0.34 109.358 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 110' ' ' ILE . 1.3 mt -68.35 -55.46 16.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 CA-C-N 115.452 -0.795 . . . . 0.38 110.631 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 t-20 -45.33 -36.8 4.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.791 0.436 . . . . 1.85 111.432 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -79.01 -29.16 43.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.897 -0.592 . . . . 0.85 111.012 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -99.51 -42.62 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.96 0.726 . . . . 0.48 112.96 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -17.4 64.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.074 0.464 . . . . 2.56 111.092 -166.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' N ' ' HD3' ' A' ' 104' ' ' LYS . . . -87.47 5.22 40.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.52 . . . . 0.76 111.741 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -96.59 1.63 51.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.401 -0.592 . . . . 0.9 109.401 174.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 74.71 39.01 0.45 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.38 1.086 . . . . 2.06 108.966 176.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -118.52 143.59 33.62 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 113.5 -1.682 . . . . 1.08 110.248 -176.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.1 Cg_exo -69.14 154.35 70.33 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.628 2.219 . . . . 0.51 114.157 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -122.3 146.87 26.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 113.913 -1.494 . . . . 0.96 109.806 -177.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.806 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.54 148.36 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.89 -1.152 . . . . 0.71 107.89 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -115.41 130.03 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 109.851 -0.426 . . . . 0.23 109.851 174.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.66 87.28 2.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.911 -1.144 . . . . 0.25 107.911 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.748 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.5 mt -73.87 97.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.432 -1.258 . . . . 0.85 109.976 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 23.1 t-20 -88.19 147.5 24.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.448 -0.342 . . . . 0.69 111.066 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 115' ' ' ASN . 31.0 mtmm 76.98 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.024 0.828 . . . . 2.61 111.753 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 23.8 mmm . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 108.343 -0.984 . . . . 1.37 108.343 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.505 -0.554 . . . . 1.84 109.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.9 Cg_endo -42.15 -53.46 3.55 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 124.003 3.135 . . . . 0.7 113.627 175.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.53 -48.23 19.41 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.549 0.574 . . . . 2.0 112.549 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -52.2 -60.83 2.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.459 0.647 . . . . 2.99 110.115 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' HA2' ' A' ' 91' ' ' GLY . 48.4 t -54.1 -45.1 65.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.248 -1.342 . . . . 0.4 110.537 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.733 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.6 mtp -62.79 -33.11 74.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.029 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -72.15 -23.04 61.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.434 -0.348 . . . . 1.28 111.196 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 7.0 mt-10 -72.5 -32.52 66.24 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.976 -0.75 . . . . 2.02 108.976 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.487 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -72.35 -44.32 62.77 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.575 0.702 . . . . 1.06 109.295 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.964 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -76.0 -2.07 28.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.35 109.778 177.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.7 tp10 -78.63 -31.32 46.88 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.303 -1.369 . . . . 2.18 107.303 173.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 136' ' ' LEU . 40.1 m-85 -90.11 9.66 27.38 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.812 . . . . 0.74 109.107 171.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 74.99 16.96 2.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.814 -1.539 . . . . 1.94 110.37 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 100' ' ' ILE . 6.1 mp -91.13 72.19 6.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.212 1.006 . . . . 1.68 108.488 173.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.486 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.49 129.89 92.96 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.917 -1.492 . . . . 0.61 110.711 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.789 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -50.72 158.32 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.953 2.436 . . . . 0.3 112.831 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' OE1' HG13 ' A' ' 146' ' ' ILE . 9.6 mt-10 -73.7 -29.8 62.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.056 -0.974 . . . . 2.01 108.504 175.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.665 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.4 mp0 -42.14 -55.08 3.38 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.431 -1.259 . . . . 1.14 110.597 163.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.964 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 13.5 m0 -90.7 -23.21 20.79 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.861 -1.518 . . . . 0.45 111.286 -166.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.28 25.98 2.81 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.709 -1.234 . . . . 0.45 112.44 171.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -102.84 -113.81 3.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.45 -0.881 . . . . 0.5 112.689 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -154.45 30.15 0.43 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.087 0.47 . . . . 1.3 111.503 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 136' ' ' LEU . 30.6 m -125.22 124.0 40.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.157 -0.617 . . . . 0.32 112.254 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.3 mp -91.94 103.33 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.498 . . . . 1.23 111.419 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.789 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 30.7 m-85 -85.54 126.33 33.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.906 0.384 . . . . 0.38 111.842 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.4 m -126.91 124.63 39.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.501 -0.772 . . . . 1.1 109.959 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 18.6 ptpt -98.75 86.94 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.655 0.74 . . . . 2.44 109.369 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -106.75 174.01 6.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.89 0.852 . . . . 1.27 112.52 -173.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.64 127.68 5.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.599 -1.182 . . . . 1.79 110.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.27 -3.25 48.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.87 110.768 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -74.71 -46.62 36.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.281 -0.872 . . . . 3.03 109.897 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -106.61 -11.1 15.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.612 -1.176 . . . . 1.2 111.182 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HA ' HD23 ' A' ' 158' ' ' LEU . 54.6 mttp 62.78 15.82 8.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.339 -0.846 . . . . 2.27 112.706 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.16 -65.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.892 0.854 . . . . 2.64 110.912 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -67.04 -11.43 58.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.764 -1.107 . . . . 0.62 113.267 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 155' ' ' LYS . 4.2 mm? -64.44 -44.56 90.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.314 0.557 . . . . 1.55 109.844 178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.9 -48.36 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.053 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.93 -35.06 77.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.73 111.22 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' ILE . 65.5 tp -61.85 -57.84 10.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.558 -0.292 . . . . 0.91 111.398 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 165' ' ' ILE . 4.0 pp -63.08 -29.93 71.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.755 -0.202 . . . . 1.06 110.877 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 162' ' ' LEU . 52.1 mm-40 -63.58 -41.3 98.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 2.49 110.71 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.549 ' HB3' HG21 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -73.02 -38.68 66.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.669 0.271 . . . . 0.87 110.964 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 81' ' ' ILE . 85.6 mt -55.36 -52.73 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.931 -0.577 . . . . 0.64 110.991 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 57' ' ' ILE . 3.7 pp -71.19 -35.42 71.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.668 0.27 . . . . 1.81 111.526 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 166' ' ' LEU . 61.8 tp -52.12 -32.25 34.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.747 -0.661 . . . . 1.42 110.212 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.44 -0.963 0 CA-C-N 115.912 -0.585 . . . . 1.17 110.26 -179.43 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.029 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 4.2 t . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 83' ' ' ILE . 20.0 m -77.7 123.03 26.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.332 -0.849 . . . . 0.66 110.793 -173.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 24' ' ' LEU . 15.0 tt -86.61 135.57 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.486 0.66 . . . . 1.03 109.276 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.567 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 37.6 mtt -140.67 -175.58 4.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.455 -0.793 . . . . 1.04 110.954 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.835 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.86 -99.04 0.22 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.09 -1.204 . . . . 1.55 110.09 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.415 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 29.5 t60 -156.19 156.13 33.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.72 -56.35 18.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.653 0.263 . . . . 1.62 111.614 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.91 -18.37 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.314 0.487 . . . . 1.78 112.314 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 7.3 m170 -57.62 -37.03 72.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.012 0.435 . . . . 0.65 111.042 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 127.56 59.17 0.13 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.527 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -87.22 -37.18 17.49 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.512 -0.551 . . . . 2.11 109.512 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -68.99 -44.67 72.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.518 -0.765 . . . . 1.8 110.022 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -71.37 -16.91 62.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.178 -0.465 . . . . 1.77 110.398 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 13' ' ' ILE . 5.8 tt -81.17 -53.77 6.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.083 -0.71 . . . . 1.78 109.083 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.535 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -64.09 -36.07 82.83 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.211 -0.449 . . . . 1.96 110.022 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.25 -54.53 39.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 1.38 111.46 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.02 79.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.973 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.1 tt -72.59 -30.33 33.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.717 -0.674 . . . . 1.56 109.961 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 2.0 tpt180 -74.09 -33.34 63.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.603 -0.726 . . . . 3.56 110.084 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -73.01 -12.11 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 2.88 110.507 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 108.823 -0.806 . . . . 1.76 108.823 173.75 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 p90 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 108.207 -1.035 . . . . 2.54 108.207 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 50.2 mt-30 -118.76 137.92 53.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.939 0.4 . . . . 1.96 110.642 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.815 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 72.7 t . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.875 0.845 . . . . 1.93 110.991 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 11' ' ' VAL . 55.5 mt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 111.927 0.343 . . . . 1.14 111.927 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 13.4 m -94.44 107.91 19.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.493 -0.321 . . . . 1.28 110.262 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.84 111.282 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.029 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 40.2 mm . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 111.485 0.179 . . . . 0.74 111.485 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.679 HG21 ' HB1' ' A' ' 103' ' ' ALA . 92.3 t -113.78 106.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.541 -0.299 . . . . 1.19 111.077 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -94.39 99.65 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 175.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 15.1 tp -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.146 -0.479 . . . . 1.33 111.254 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.835 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.5 p -79.39 141.54 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.372 0.606 . . . . 1.2 110.809 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 114' ' ' ILE . 26.7 m -140.94 -160.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.569 -1.271 . . . . 1.12 107.569 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.14 147.99 34.45 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.139 -0.624 . . . . 0.75 111.684 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -35.25 -59.33 0.52 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.606 1.191 . . . . 1.18 112.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.79 -9.87 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.507 . . . . 2.01 112.1 -172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.49 -51.3 5.99 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.293 0.568 . . . . 1.09 111.402 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 85.65 -136.93 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.248 -0.887 . . . . 0.52 111.62 -172.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.971 HG13 ' HB ' ' A' ' 96' ' ' THR . 37.7 t -101.18 114.08 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 122.898 0.479 . . . . 1.08 111.248 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 39.5 mtp -81.19 169.79 17.85 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 1.32 110.025 172.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.1 Cg_endo -44.9 -48.01 11.25 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.121 2.547 . . . . 0.61 113.324 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 95' ' ' GLN . 2.9 mt-30 -71.35 -25.95 62.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.579 0.228 . . . . 1.47 110.83 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.971 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.5 m -64.54 -22.58 67.01 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.46 110.389 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.69 -38.84 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.516 -0.311 . . . . 1.05 110.821 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.0 -29.49 65.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.877 0.37 . . . . 1.62 111.49 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.567 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.31 -37.54 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.511 . . . . 0.34 109.661 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.598 HG12 HG12 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -72.63 -49.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.38 110.384 178.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -45.1 -35.62 3.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.385 0.674 . . . . 1.85 111.122 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -83.19 -34.68 25.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.85 111.2 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.95 -33.12 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.916 0.709 . . . . 0.48 112.916 -170.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.73 -16.92 60.72 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.114 0.483 . . . . 2.56 110.326 -167.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.8 7.66 44.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.76 112.307 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 108' ' ' VAL . . . -108.99 3.2 21.9 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.212 -0.662 . . . . 0.9 109.212 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t30 73.65 34.1 0.98 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.316 -1.364 . . . . 2.06 107.316 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' A' ' 103' ' ' ALA . 9.6 t -91.96 143.99 28.55 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 112.425 -2.171 . . . . 1.08 110.597 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 4.7 Cg_exo -74.17 142.88 31.3 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.344 2.029 . . . . 0.51 113.061 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 145' ' ' THR . 1.6 mp -121.6 143.4 34.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 113.19 -1.823 . . . . 0.96 109.442 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.766 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 11.3 mt -118.6 155.84 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 108.69 -0.855 . . . . 0.71 108.69 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -118.0 136.07 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 109.936 -0.394 . . . . 0.23 109.936 174.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.33 87.92 2.84 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.24 -1.022 . . . . 0.25 108.24 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.864 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 4.5 mm -66.09 88.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.546 -1.206 . . . . 0.85 109.658 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.12 161.29 18.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.525 -0.176 . . . . 0.69 110.525 -171.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.5 tttm 62.42 29.93 17.24 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.171 0.986 . . . . 2.61 109.402 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.668 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 3.0 tpp . . . . . 0 CA--C 1.542 0.665 0 CA-C-N 114.689 -1.141 . . . . 1.37 111.041 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 126' ' ' ARG . 50.5 t30 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.999 0.428 . . . . 1.84 110.618 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.573 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.4 Cg_endo -47.73 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.178 3.252 . . . . 0.7 113.744 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -46.28 -43.23 15.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.774 0.657 . . . . 2.0 112.774 -175.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.488 ' HB2' ' ND2' ' A' ' 123' ' ' ASN . 4.1 tmt_? -56.94 -53.99 51.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.428 0.632 . . . . 2.99 109.775 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.751 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 47.3 t -60.64 -45.18 97.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.614 -1.176 . . . . 0.4 109.559 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.672 ' HA ' ' CZ ' ' A' ' 147' ' ' PHE . 86.3 mtp -64.2 -32.14 73.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.425 -0.807 . . . . 0.3 111.609 -176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.6 mt-30 -83.41 -20.83 33.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.019 0.438 . . . . 1.28 110.283 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.751 ' OE1' ' HA ' ' A' ' 127' ' ' VAL . 3.0 pt-20 -79.05 -27.68 43.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.111 -0.7 . . . . 2.02 109.111 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.1 mm? -71.72 -42.69 67.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.542 0.687 . . . . 1.06 109.597 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.909 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.6 ppp? -77.11 -2.36 33.85 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.086 -0.961 . . . . 0.35 109.719 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.22 -27.09 35.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.674 -1.232 . . . . 2.18 107.674 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.456 ' HE2' HG11 ' A' ' 92' ' ' VAL . 25.6 m-85 -85.99 4.85 35.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.73 -0.841 . . . . 0.74 108.73 169.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.7 m120 75.11 19.35 2.32 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.203 -1.362 . . . . 1.94 111.126 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.3 mp -97.52 77.72 2.62 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.665 -1.235 . . . . 1.68 107.665 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.546 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.05 129.87 92.3 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 113.559 -1.655 . . . . 0.61 110.799 -176.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.873 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 99.7 Cg_exo -47.16 152.92 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.897 2.398 . . . . 0.3 112.78 172.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -73.65 -29.84 62.57 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.17 -1.377 . . . . 2.01 107.844 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.773 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -49.08 -47.56 44.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.549 -1.205 . . . . 1.14 109.462 168.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.909 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.1 m0 -92.66 -17.65 24.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.967 -1.015 . . . . 0.45 111.2 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.18 19.85 5.77 Favored Glycine 0 CA--C 1.507 -0.41 0 C-N-CA 119.612 -1.28 . . . . 0.45 112.892 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.12 -113.65 2.23 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.205 -0.998 . . . . 0.5 112.017 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -150.07 19.9 0.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.649 0.24 . . . . 1.3 111.649 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 110' ' ' ILE . 23.4 m -125.87 115.09 19.43 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.81 -0.756 . . . . 0.32 112.572 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.1 mp -84.56 110.73 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.526 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.873 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.4 m-85 -87.32 121.26 29.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.215 0.531 . . . . 0.38 111.673 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 61.5 m -115.87 103.52 10.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.764 -0.653 . . . . 1.1 110.012 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.864 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 12.1 ptmm? -81.64 84.61 6.74 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.687 -0.857 . . . . 2.44 108.687 172.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.886 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.08 -175.02 2.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.045 -0.98 . . . . 1.27 112.574 -168.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 150' ' ' LEU . 34.0 t -150.41 117.96 6.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.88 -1.055 . . . . 1.79 109.687 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 24' ' ' LEU . . . -74.4 -28.78 61.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.87 110.777 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 11.2 ptmm? -77.42 -50.4 12.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.807 0.813 . . . . 3.03 110.58 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.406 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 6.0 m -77.65 -11.69 59.89 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.425 -1.261 . . . . 1.2 111.655 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 71.25 -20.35 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.012 0.745 . . . . 2.27 113.012 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 154' ' ' THR . 10.8 tp10 -43.3 -63.18 0.87 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.617 0.722 . . . . 2.64 111.809 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.886 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.15 -17.69 74.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.329 -0.851 . . . . 0.62 113.663 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.5 mt -66.45 -46.08 77.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.469 0.635 . . . . 1.55 110.685 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.88 -37.65 88.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.826 -0.625 . . . . 2.5 110.212 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.609 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 78.4 t60 -73.38 -26.02 60.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.73 111.067 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.76 -47.26 75.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.421 -0.585 . . . . 0.91 109.421 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.5 mt -53.61 -44.0 69.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.802 -0.635 . . . . 1.06 110.642 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.609 ' OE1' ' HA ' ' A' ' 160' ' ' HIS . 45.3 mt-10 -54.99 -43.14 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.068 0.461 . . . . 2.49 110.866 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.713 ' HB3' HG21 ' A' ' 146' ' ' ILE . 8.4 mmt -71.2 -31.48 67.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.87 110.651 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 162' ' ' LEU . 79.7 mt -63.95 -53.02 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 0.64 110.524 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.58 -33.91 70.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.173 0.435 . . . . 1.81 112.173 174.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.67 -41.48 77.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.15 -0.685 . . . . 1.42 109.15 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.445 -0.695 0 CA-C-N 115.867 -0.606 . . . . 1.17 110.86 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.236 0.378 0 CA-C-O 120.993 0.425 . . . . 1.0 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -92.95 122.47 35.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.681 -0.69 . . . . 0.66 111.272 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.728 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 33.3 mt -104.47 122.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.866 -0.42 . . . . 1.03 109.866 172.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.56 165.57 19.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.187 -0.461 . . . . 1.04 110.075 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.828 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 166.27 -107.75 0.3 Allowed Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.486 -1.046 . . . . 1.55 110.486 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.451 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 60.1 t60 -159.21 137.58 10.65 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.431 -0.952 . . . . 0.66 108.431 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -59.93 -31.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.257 -0.883 . . . . 1.62 113.201 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.92 -20.57 52.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.271 . . . . 1.78 111.309 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.451 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 47.8 m170 -70.34 -2.61 14.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.152 0.501 . . . . 0.65 111.282 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.65 43.55 3.89 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.772 -0.728 . . . . 0.93 112.848 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -66.45 -39.42 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.276 0.56 . . . . 2.11 109.823 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -67.01 -36.04 81.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.414 -0.812 . . . . 1.8 109.82 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -67.78 -35.91 79.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.676 -0.693 . . . . 1.77 110.273 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 47.4 tp -65.36 -49.11 70.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.706 . . . . 1.78 110.209 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.649 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.96 -32.21 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 1.96 110.051 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 28.6 t70 -66.14 -56.8 9.63 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.171 -0.331 . . . . 1.38 111.481 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -61.35 -30.62 70.63 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.07 0.462 . . . . 0.91 110.89 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' A' ' 158' ' ' LEU . 3.1 tt -74.32 -27.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.644 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.9 mtm180 -80.23 -32.47 38.41 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 3.56 109.807 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -65.62 -8.51 20.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.136 -0.938 . . . . 2.88 109.918 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.626 -0.715 . . . . 1.76 109.47 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.769 ' HE2' ' HB ' ' A' ' 50' ' ' VAL . 4.2 p90 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.8 -0.445 . . . . 2.54 109.8 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.62 ' HG2' HG23 ' A' ' 58' ' ' THR . 71.8 mt-30 -139.07 113.36 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.136 -1.061 . . . . 1.96 108.136 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.769 ' HB ' ' HE2' ' A' ' 48' ' ' TYR . 4.6 p . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 121.976 0.893 . . . . 1.93 111.914 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 166' ' ' LEU . 4.8 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.882 0.372 . . . . 1.14 111.415 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.62 HG23 ' HG2' ' A' ' 49' ' ' GLN . 16.9 m -92.64 125.65 37.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.154 -0.684 . . . . 1.28 109.154 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 112.461 0.541 . . . . 0.84 112.461 -173.578 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.6 mm . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.649 -0.5 . . . . 0.74 109.649 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.981 HG21 ' HB1' ' A' ' 103' ' ' ALA . 99.0 t -118.86 101.58 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 O-C-N 122.173 -0.329 . . . . 1.19 111.101 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 7.0 mm -79.03 121.28 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.776 -1.194 . . . . 1.32 107.776 170.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -118.75 103.59 9.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.855 -176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.6 p -89.24 146.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.294 0.568 . . . . 1.2 112.09 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 114' ' ' ILE . 21.5 m -141.59 -175.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.926 -1.033 . . . . 1.12 108.223 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.47 134.37 13.0 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.341 -0.544 . . . . 0.75 112.078 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.47 -125.21 2.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.295 -0.866 . . . . 1.18 112.146 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -105.3 5.17 31.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.92 0.39 . . . . 2.01 110.022 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.78 -32.64 71.96 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.57 0.7 . . . . 1.09 109.75 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.773 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 68.42 -134.74 28.77 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 114.706 -1.133 . . . . 0.52 111.677 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 96' ' ' THR . 64.2 t -102.32 103.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.145 0.498 . . . . 1.08 111.033 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.573 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.4 mmm -72.77 170.74 12.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 1.32 110.631 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 72.4 Cg_exo -42.69 -51.21 5.4 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.789 2.326 . . . . 0.61 113.09 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.02 -37.87 89.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.47 110.717 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.726 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.1 m -62.18 -35.27 78.32 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.965 -0.562 . . . . 0.46 110.376 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.715 HG23 HG12 ' A' ' 92' ' ' VAL . 41.1 t -74.15 -50.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.152 -0.476 . . . . 1.05 110.688 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.52 -31.22 34.44 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.547 0.53 . . . . 1.62 111.528 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.03 -37.86 28.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.34 109.895 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.774 HG12 HD13 ' A' ' 110' ' ' ILE . 1.5 mt -75.45 -37.66 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.646 -0.706 . . . . 0.38 110.47 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -34.93 68.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.731 0.776 . . . . 1.85 109.737 174.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -85.15 -30.65 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.831 -1.077 . . . . 0.85 110.551 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.981 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.41 -49.2 10.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.48 111.9 -173.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -53.08 -27.24 19.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.39 0.885 . . . . 2.56 113.39 -166.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.1 10.87 36.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.079 0.77 . . . . 0.76 113.079 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.481 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -97.57 2.37 49.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.213 -0.662 . . . . 0.9 109.213 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t30 71.3 46.64 0.42 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 123.11 1.433 . . . . 2.06 107.831 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.657 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -129.5 143.06 47.43 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 112.809 -1.996 . . . . 1.08 111.194 -168.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 108' ' ' VAL . 21.9 Cg_exo -67.26 156.41 66.38 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.486 2.124 . . . . 0.51 112.982 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.774 HD13 HG12 ' A' ' 100' ' ' ILE . 85.1 mt -124.48 141.85 43.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.702 -1.135 . . . . 0.96 109.201 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.706 HD13 HD13 ' A' ' 83' ' ' ILE . 3.7 mt -125.93 96.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 C-N-CA 120.35 -0.54 . . . . 0.71 111.238 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -65.82 139.82 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.005 -0.998 . . . . 0.23 110.265 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -124.02 89.37 3.07 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.868 -1.16 . . . . 0.25 107.868 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.637 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 9.7 mm -65.92 86.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.565 -1.198 . . . . 0.85 110.197 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.05 148.45 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.69 110.721 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 60.63 33.31 20.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.404 -0.817 . . . . 2.61 110.758 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.418 ' HB3' HG22 ' A' ' 114' ' ' ILE . 1.4 ppp? . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.812 -0.631 . . . . 1.37 110.007 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 16.4 t-20 . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 121.228 0.537 . . . . 1.84 111.016 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -16.12 -82.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.119 1 C-N-CA 126.301 4.667 . . . . 0.7 116.579 172.73 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -43.81 -55.31 4.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.345 0.658 . . . . 2.0 112.344 -169.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 tpt85 -56.17 -62.16 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.401 0.62 . . . . 2.99 110.786 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.773 HG13 ' HA2' ' A' ' 91' ' ' GLY . 28.1 t -51.82 -49.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.441 -1.254 . . . . 0.4 110.489 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.625 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 86.5 mtp -66.45 -33.04 74.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 0.3 111.96 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.534 ' O ' ' HG3' ' A' ' 132' ' ' MET . 87.0 mt-30 -76.38 -26.2 55.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.813 -0.44 . . . . 1.28 109.813 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.458 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -71.12 -31.11 67.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.239 -0.652 . . . . 2.02 109.239 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 136' ' ' LEU . 2.8 mm? -68.54 -46.31 69.86 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.506 0.669 . . . . 1.06 109.716 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.863 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.3 ppp? -73.31 -4.57 34.12 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.392 -0.822 . . . . 0.35 110.0 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -81.77 -24.63 35.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.039 -0.726 . . . . 2.18 109.039 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.607 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 39.5 m-85 -84.75 0.61 50.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.896 . . . . 0.74 108.582 167.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 74.14 45.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 113.967 -1.47 . . . . 1.94 109.464 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -126.19 83.36 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.028 -1.442 . . . . 1.68 107.439 170.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.876 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.23 131.42 94.35 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.592 -1.64 . . . . 0.61 111.28 -173.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.741 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 87.5 Cg_exo -49.87 155.47 4.1 Favored 'Trans proline' 0 CA--C 1.516 -0.377 0 C-N-CA 123.315 2.677 . . . . 0.3 113.705 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 146' ' ' ILE . 6.8 mm-40 -80.17 -19.18 47.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.53 -1.214 . . . . 2.01 109.268 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.808 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -58.24 -40.17 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.501 -0.926 . . . . 1.14 108.501 167.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.863 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.3 m0 -96.71 -21.43 17.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.384 -1.28 . . . . 0.45 110.841 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.49 25.22 5.84 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.372 -0.918 . . . . 0.45 112.43 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.876 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.47 -101.11 1.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.721 -0.752 . . . . 0.5 112.612 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -165.11 27.01 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.244 0.545 . . . . 1.3 111.114 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.772 HG21 HD12 ' A' ' 136' ' ' LEU . 62.2 m -130.17 116.85 19.03 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.241 -0.584 . . . . 0.32 112.389 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -82.14 109.04 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.546 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.741 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.9 m-85 -89.54 96.24 10.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.984 0.421 . . . . 0.38 111.186 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.444 ' O ' HD12 ' A' ' 150' ' ' LEU . 75.1 m -84.32 99.55 10.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.313 -0.625 . . . . 1.1 109.313 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.637 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 2.4 pttm -82.83 84.16 7.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.552 -0.907 . . . . 2.44 108.552 176.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.568 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.44 -179.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.298 -0.865 . . . . 1.27 112.97 -168.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p -152.94 111.28 3.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 1.79 110.156 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.95 64.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.362 -0.381 . . . . 0.87 111.237 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -75.14 -46.91 31.27 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.896 0.855 . . . . 3.03 110.15 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m -72.62 -14.78 61.68 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.251 -1.34 . . . . 1.2 110.397 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 27' ' ' ALA . 21.2 tptp 58.61 27.33 15.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.499 -1.228 . . . . 2.27 111.576 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -92.35 -67.43 0.86 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.534 0.683 . . . . 2.64 110.266 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.02 -13.04 69.26 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.248 -0.887 . . . . 0.62 113.55 -176.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 28' ' ' ILE . 3.3 tm? -60.54 -54.44 45.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 1.55 109.38 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.29 -33.75 76.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.293 -0.867 . . . . 2.5 109.89 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.682 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.7 t60 -65.38 -25.98 67.8 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.666 -0.697 . . . . 0.73 111.075 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 59.7 tp -66.59 -55.4 15.54 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.002 -0.369 . . . . 0.91 110.002 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 165' ' ' ILE . 92.1 mt -55.9 -41.6 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 1.06 110.723 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 6.4 pt-20 -69.48 -27.73 65.46 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.598 -0.441 . . . . 2.49 110.61 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.467 ' HG2' HG21 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -81.3 -32.2 33.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 0.87 109.821 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 162' ' ' LEU . 32.6 mt -55.41 -54.63 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.361 -0.836 . . . . 0.64 111.896 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.607 HD12 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -81.2 -30.06 34.39 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.748 -0.595 . . . . 1.81 111.969 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.3 tt -59.53 -31.56 69.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.849 -0.426 . . . . 1.42 109.849 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.779 HG21 HG12 ' A' ' 146' ' ' ILE . 25.2 t . . . . . 0 N--CA 1.444 -0.737 0 CA-C-N 115.941 -0.572 . . . . 1.17 111.283 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.947 HG13 HG21 ' A' ' 81' ' ' ILE . 45.2 t . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.408 0.623 . . . . 1.0 109.715 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.477 ' O ' HG13 ' A' ' 83' ' ' ILE . 19.3 m -80.42 128.09 33.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 0.66 111.452 -171.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 HD12 ' A' ' 83' ' ' ILE . 52.1 mt -94.95 128.52 46.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.041 -0.527 . . . . 1.03 110.271 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.599 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 55.6 mtt -125.29 -177.94 4.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.459 177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.92 130.44 4.45 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.504 -0.855 . . . . 1.55 110.984 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -50.69 138.38 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.512 . . . . 0.66 110.4 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 21' ' ' LYS . 30.3 m -61.63 -27.5 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.871 1.063 . . . . 1.62 113.871 -167.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.31 -19.16 60.57 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.025 0.38 . . . . 1.78 112.025 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -72.01 -34.26 68.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.761 0.282 . . . . 0.65 111.761 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.58 67.63 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.392 -0.909 . . . . 0.93 112.75 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HE3' HG22 ' A' ' 13' ' ' ILE . 14.0 mmmm -89.03 -56.33 3.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.067 0.461 . . . . 2.11 111.128 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -65.91 -18.08 65.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 1.8 110.799 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 p -74.75 -19.94 60.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.011 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 68.0 mt -69.01 -52.19 31.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.715 -0.394 . . . . 1.78 110.307 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 8.7 mp -60.32 -34.09 73.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 1.96 110.973 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.74 -51.38 41.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.882 0.327 . . . . 1.38 111.882 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -69.6 -33.33 72.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.91 111.008 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.63 HD11 HD21 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -66.06 -24.21 33.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.996 -0.547 . . . . 1.56 110.54 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 51.5 mtp180 -79.09 -21.65 46.39 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.215 0.531 . . . . 3.56 110.636 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -71.78 -7.74 50.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.718 0.77 . . . . 2.88 109.647 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.966 -1.016 . . . . 1.76 110.172 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' CE2' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.407 0.622 . . . . 2.54 111.045 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.13 153.97 21.86 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.39 -0.823 . . . . 1.96 108.857 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG21 ' HE2' ' A' ' 59' ' ' PHE . 71.7 t . . . . . 0 C--N 1.309 -1.173 0 CA-C-N 115.468 -0.787 . . . . 1.93 109.259 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 11' ' ' VAL . 48.3 mt . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 110.18 -0.304 . . . . 1.14 110.18 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -105.75 131.71 52.77 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.172 -0.677 . . . . 1.28 109.172 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.461 ' HE2' HG21 ' A' ' 50' ' ' VAL . 43.7 m-85 . . . . . 0 CA--C 1.513 -0.469 0 C-N-CA 119.979 -0.688 . . . . 0.84 111.104 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.947 HG21 HG13 ' A' ' 11' ' ' VAL . 23.8 mm . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.673 0.273 . . . . 0.74 110.308 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 103' ' ' ALA . 53.5 t -117.28 106.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 116.331 -0.395 . . . . 1.19 110.818 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.83 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -90.5 105.15 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.222 -0.659 . . . . 1.32 109.222 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 100' ' ' ILE . 11.3 tp -90.34 109.65 20.75 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.289 -0.414 . . . . 1.33 111.361 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.2 t -80.89 130.91 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 1.2 110.953 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.648 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -131.36 -174.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.585 -0.894 . . . . 1.12 108.585 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -147.74 129.73 15.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.981 -0.687 . . . . 0.75 112.564 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 20.89 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.16 1.538 . . . . 1.18 114.97 169.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.95 -2.57 22.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.693 -0.685 . . . . 2.01 112.11 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -32.91 24.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.08 0.467 . . . . 1.09 110.725 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 69.77 -120.6 9.99 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.453 -0.794 . . . . 0.52 111.805 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 97' ' ' VAL . 58.7 t -124.21 109.77 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 120.847 0.356 . . . . 1.08 110.693 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.551 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 67.5 mtp -77.29 169.01 23.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 1.32 110.569 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.5 Cg_exo -44.79 -51.23 7.59 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.037 2.491 . . . . 0.61 113.417 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -66.78 -29.72 69.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.629 0.252 . . . . 1.47 111.366 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.596 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.4 m -69.47 -28.05 65.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.564 0.697 . . . . 0.46 109.467 174.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.682 HG23 HG12 ' A' ' 92' ' ' VAL . 12.4 t -76.69 -52.24 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.05 111.078 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -65.02 -19.24 65.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.04 0.385 . . . . 1.62 112.04 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -73.62 -37.36 65.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.203 -1.036 . . . . 0.34 108.203 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.815 HG12 HD13 ' A' ' 110' ' ' ILE . 2.8 mt -76.63 -41.16 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 113.969 -1.469 . . . . 0.38 110.727 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 98' ' ' GLU . 7.2 m-20 -54.04 -37.96 64.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.374 0.607 . . . . 1.85 110.367 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -74.85 -31.9 61.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.85 110.501 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.618 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -82.79 -48.62 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.447 . . . . 0.48 111.949 -175.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -56.86 -34.37 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.398 -0.819 . . . . 2.56 111.985 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.23 10.16 37.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.365 0.506 . . . . 0.76 112.365 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -104.39 5.87 34.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.151 -1.055 . . . . 0.9 108.151 169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.0 38.25 6.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.448 -1.251 . . . . 2.06 110.317 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 109' ' ' PRO . 2.0 m -105.68 148.48 36.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.57 -0.741 . . . . 1.08 110.95 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.93 155.27 62.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.098 2.532 . . . . 0.51 113.09 171.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 100' ' ' ILE . 68.8 mt -125.91 145.92 32.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.107 -0.951 . . . . 0.96 110.259 -174.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.83 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 mt -120.47 155.93 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 109.24 -0.652 . . . . 0.71 109.24 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.486 HG21 ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -120.32 137.3 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 120.997 0.427 . . . . 0.23 110.403 174.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.03 88.42 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.91 -1.145 . . . . 0.25 107.91 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 30.3 mt -72.51 97.02 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.956 -1.02 . . . . 0.85 110.487 178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.56 165.45 15.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.69 -0.485 . . . . 0.69 109.69 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.537 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 63.0 mttm 64.35 19.24 11.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.324 0.583 . . . . 2.61 110.896 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.884 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.3 tpp . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.646 -0.706 . . . . 1.37 110.949 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 109.838 -0.43 . . . . 1.84 109.838 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.8 Cg_exo -39.54 -60.01 0.59 Allowed 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.876 3.051 . . . . 0.7 112.77 172.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.8 -52.92 7.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.776 0.43 . . . . 2.0 111.53 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.568 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -54.97 -59.71 4.37 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.875 0.369 . . . . 2.99 110.061 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 91' ' ' GLY . 60.3 t -53.99 -44.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.266 -0.879 . . . . 0.4 110.831 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.675 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.6 mtp -68.17 -31.83 71.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.641 -0.709 . . . . 0.3 111.184 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.6 mt-30 -73.68 -26.87 60.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.458 -0.337 . . . . 1.28 110.621 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.1 mm-40 -62.52 -39.85 94.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.551 -0.907 . . . . 2.02 108.551 172.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.858 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -68.25 -42.95 78.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.55 0.69 . . . . 1.06 110.062 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.83 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -76.03 -5.87 48.43 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.346 -0.843 . . . . 0.35 110.107 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 45.5 tt0 -82.32 -26.28 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.886 -0.783 . . . . 2.18 108.886 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.651 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 13.5 m-85 -84.6 -0.41 53.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.282 -1.007 . . . . 0.74 108.282 168.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 72.18 42.67 0.56 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 113.931 -1.486 . . . . 1.94 110.44 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -121.8 82.73 1.99 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 106.479 -1.674 . . . . 1.68 106.479 168.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.6 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -63.33 131.59 94.84 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.002 -1.454 . . . . 0.61 110.773 -172.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.74 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 86.7 Cg_exo -46.52 151.74 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.879 2.386 . . . . 0.3 112.894 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -25.74 53.71 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.25 -1.341 . . . . 2.01 108.335 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.737 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.35 -43.0 64.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.258 -1.337 . . . . 1.14 109.435 167.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.83 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.1 m0 -94.56 -26.0 16.58 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.879 -1.055 . . . . 0.45 111.218 -170.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.46 25.3 2.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.943 -1.123 . . . . 0.45 112.583 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.88 -111.79 2.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.5 -0.857 . . . . 0.5 112.573 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -151.01 21.99 0.77 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.679 0.276 . . . . 1.3 111.606 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 36.4 m -125.78 118.79 26.3 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.932 -0.707 . . . . 0.32 112.743 -172.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.0 mp -85.44 108.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.23 110.554 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.74 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.3 m-85 -88.83 119.38 29.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.199 0.523 . . . . 0.38 111.486 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 56.8 m -114.93 121.75 44.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.68 -0.691 . . . . 1.1 109.557 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.884 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 58.2 pttt -97.15 104.37 16.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.302 -0.629 . . . . 2.44 109.302 174.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -125.47 -170.88 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.36 1.076 . . . . 1.27 113.07 -171.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 30.2 t -169.87 126.92 0.87 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.4 -1.727 . . . . 1.79 108.252 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.12 -12.37 59.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.072 0.463 . . . . 0.87 111.083 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -84.93 -57.13 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 3.03 110.174 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 28.4 p -81.53 -17.6 47.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.13 -0.941 . . . . 1.2 110.51 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 27' ' ' ALA . 6.5 tptm 74.22 -11.98 0.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.905 0.753 . . . . 2.27 112.311 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 156' ' ' GLU . 9.9 mm-40 -44.17 -70.11 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.499 0.72 . . . . 2.64 112.86 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -73.6 -5.62 68.87 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.62 113.872 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.513 HD12 ' HE2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -73.36 -45.46 54.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.0 -0.741 . . . . 1.55 109.0 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.69 -36.53 76.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 2.5 109.889 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 82.4 t60 -70.72 -20.21 62.68 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.862 -0.608 . . . . 0.73 110.812 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.04 -49.62 42.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.843 0.354 . . . . 0.91 110.123 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 28' ' ' ILE . 98.4 mt -58.2 -37.48 74.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.708 -0.678 . . . . 1.06 111.384 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -70.02 -36.37 75.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.798 -0.361 . . . . 2.49 110.67 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.751 ' HB3' HG21 ' A' ' 146' ' ' ILE . 22.0 mmt -69.06 -38.56 79.15 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.24 0.543 . . . . 0.87 109.72 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.51 -52.27 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.64 110.514 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.35 -42.5 98.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.986 -0.552 . . . . 1.81 111.491 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.2 -45.99 65.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.807 -0.633 . . . . 1.42 110.0 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 116.101 -0.5 . . . . 1.17 111.315 -177.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB ' ' A' ' 81' ' ' ILE . 56.2 t . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 109.281 -0.637 . . . . 1.0 109.281 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -82.59 120.6 25.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.66 111.557 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.552 HD12 ' HG ' ' A' ' 25' ' ' LEU . 42.7 mt -78.97 121.03 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 1.03 109.711 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 19.5 mmt -110.97 176.75 4.9 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.158 -0.928 . . . . 1.04 109.938 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 1.106 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 123.26 136.05 4.7 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.341 -0.933 . . . . 1.55 111.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.725 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 67.6 t60 -45.62 136.27 6.01 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.646 0.736 . . . . 0.66 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.79 -35.27 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.331 -1.304 . . . . 1.62 113.45 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 11.8 t70 -74.28 -18.48 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 1.78 111.095 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -71.33 -12.22 61.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.182 0.515 . . . . 0.65 110.766 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.47 45.77 6.75 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.506 -0.77 . . . . 0.93 113.34 172.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.672 ' HA ' HD23 ' A' ' 24' ' ' LEU . 58.7 pttt -67.46 -26.33 66.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 2.11 110.835 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -67.7 -28.56 67.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 1.8 110.324 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 90.5 m -68.16 -28.17 67.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.89 -0.596 . . . . 1.77 111.039 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 21' ' ' LYS . 3.9 mm? -62.51 -51.12 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 1.78 110.4 176.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HG ' HD12 ' A' ' 13' ' ' ILE . 6.6 mt -72.3 -25.65 61.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 1.96 111.474 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 20.9 t70 -68.39 -49.07 62.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.502 -0.317 . . . . 1.38 111.356 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.06 73.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.932 0.396 . . . . 0.91 110.683 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 162' ' ' LEU . 4.7 tt -76.71 -33.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.867 -0.606 . . . . 1.56 110.945 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 15.3 ptt180 -75.19 -32.23 61.17 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.742 0.782 . . . . 3.56 109.729 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -82.11 15.58 2.3 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.469 -1.242 . . . . 2.88 111.641 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 120.862 0.363 . . . . 1.76 111.278 -173.645 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.198 0.523 . . . . 2.54 111.898 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 13.9 mt-30 -107.55 109.71 21.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.869 -1.16 . . . . 1.96 107.869 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 121.362 0.601 . . . . 1.93 111.736 -171.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 11' ' ' VAL . 61.7 mt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.012 0.434 . . . . 1.14 112.044 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -101.2 97.83 8.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 1.28 109.896 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 110.394 -0.224 . . . . 0.84 110.394 -178.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 11' ' ' VAL . 44.9 mm . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.815 -0.439 . . . . 0.74 109.815 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.952 HG21 ' HB1' ' A' ' 103' ' ' ALA . 61.2 t -85.68 96.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 116.328 -0.396 . . . . 1.19 111.616 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 111' ' ' ILE . 6.5 mm -84.11 93.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.32 109.283 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.7 tm? -86.97 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.737 -0.665 . . . . 1.33 109.749 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.106 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.1 p -77.41 144.32 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.622 0.725 . . . . 1.2 110.728 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 127' ' ' VAL . 8.4 t -136.72 175.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.58 -1.267 . . . . 1.12 107.58 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -138.06 131.16 30.18 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 122.101 -0.375 . . . . 0.75 110.251 175.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -77.44 27.55 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.882 -0.599 . . . . 1.18 112.325 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -135.35 10.06 3.47 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.98 0.419 . . . . 2.01 110.056 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.81 -58.78 0.4 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.349 0.595 . . . . 1.09 110.605 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 86' ' ' VAL . . . 118.24 -115.09 3.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.232 -0.895 . . . . 0.52 111.457 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 97' ' ' VAL . 46.6 t -122.81 109.38 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.078 0.465 . . . . 1.08 110.233 -175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.899 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 62.5 mtp -88.49 174.45 5.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.121 -0.49 . . . . 1.32 109.775 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 7.0 Cg_endo -49.46 -53.13 7.53 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.769 2.313 . . . . 0.61 113.04 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 38.7 mt-30 -61.15 -32.39 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.624 0.231 . . . . 1.47 111.624 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.538 ' CG2' HD11 ' A' ' 84' ' ' LEU . 21.1 m -63.5 -31.24 72.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.806 0.812 . . . . 0.46 109.926 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.619 HG22 ' CE2' ' A' ' 134' ' ' TYR . 41.2 t -82.18 -52.54 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.713 -1.13 . . . . 1.05 111.305 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 48.4 mt-10 -55.71 -34.1 64.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.746 -0.661 . . . . 1.62 111.972 -176.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -70.6 -39.46 73.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.541 0.686 . . . . 0.34 109.504 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.535 HG12 HG12 ' A' ' 110' ' ' ILE . 1.7 mt -70.74 -42.18 77.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.395 -1.275 . . . . 0.38 110.188 174.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.467 ' ND2' HG12 ' A' ' 97' ' ' VAL . 94.8 m-20 -54.25 -37.79 65.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.522 . . . . 1.85 110.408 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -79.29 -27.02 42.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.294 -0.867 . . . . 0.85 110.874 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.952 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -97.72 -35.26 10.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.331 0.863 . . . . 0.48 113.331 -169.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -60.95 -27.11 68.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.863 0.69 . . . . 2.56 112.863 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.3 11.89 19.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.095 0.776 . . . . 0.76 113.095 -166.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.32 19.15 18.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.654 -1.239 . . . . 0.9 107.654 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 50.56 37.83 17.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.547 -1.661 . . . . 2.06 111.721 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.528 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -94.27 155.53 39.77 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.021 -0.99 . . . . 1.08 110.014 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.1 Cg_exo -73.97 150.12 43.05 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.686 2.257 . . . . 0.51 113.443 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.645 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -120.72 142.57 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.067 -1.424 . . . . 0.96 109.836 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 83' ' ' ILE . 4.3 mp -114.04 146.28 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 108.022 -1.103 . . . . 0.71 108.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -114.06 132.19 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.025 0 N-CA-C 109.634 -0.506 . . . . 0.23 109.634 174.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -118.82 87.09 2.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.636 -1.246 . . . . 0.25 107.636 175.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 28.2 mt -69.65 91.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.499 -1.228 . . . . 0.85 110.024 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 62.5 t30 -92.89 167.58 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.515 . . . . 0.69 109.748 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.2 mttt 66.76 8.45 5.97 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.5 0.5 . . . . 2.61 110.411 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.428 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 1.37 110.649 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.473 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 50.4 t-20 . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.042 -0.355 . . . . 1.84 110.042 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.678 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.0 OUTLIER -46.16 -65.62 0.18 Allowed 'Trans proline' 0 C--O 1.219 -0.436 0 C-N-CA 123.538 2.825 . . . . 0.7 112.834 173.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.34 -48.57 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.395 0.678 . . . . 2.0 112.601 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 126' ' ' ARG . 9.0 tpt180 -53.48 -55.85 21.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.621 0.724 . . . . 2.99 109.951 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 86' ' ' VAL . 81.9 t -57.97 -42.43 82.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.357 -1.292 . . . . 0.4 110.412 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.3 mtp -63.46 -31.43 72.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.61 -0.723 . . . . 0.3 111.265 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.473 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 73.8 mt-30 -77.8 -18.01 56.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.897 -0.321 . . . . 1.28 110.949 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.3 mm-40 -70.39 -35.28 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.934 -0.765 . . . . 2.02 108.934 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.515 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.0 mm? -71.21 -44.61 65.05 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.516 0.674 . . . . 1.06 109.741 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.934 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.5 ppp? -76.08 -2.57 31.48 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.099 -0.955 . . . . 0.35 109.61 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 36.4 tt0 -78.13 -28.91 48.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.411 -1.329 . . . . 2.18 107.411 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 97' ' ' VAL . 60.8 m-85 -91.07 10.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.646 -0.706 . . . . 0.74 109.819 170.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 72.36 22.5 3.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.362 -1.29 . . . . 1.94 111.057 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 100' ' ' ILE . 6.5 mp -96.94 76.41 2.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.951 -1.129 . . . . 1.68 107.951 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -66.8 127.99 93.68 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 113.506 -1.679 . . . . 0.61 110.899 -176.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.799 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 91.7 Cg_exo -47.76 155.16 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.221 2.614 . . . . 0.3 112.726 172.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -27.08 54.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.559 -1.2 . . . . 2.01 108.175 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.29 -42.73 64.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.548 -1.206 . . . . 1.14 109.336 169.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.934 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.0 m0 -95.19 -18.73 20.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.901 -1.045 . . . . 0.45 111.351 -171.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.67 26.52 4.16 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 119.989 -1.101 . . . . 0.45 112.447 170.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.95 -107.84 2.64 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.393 -0.908 . . . . 0.5 112.452 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -162.87 28.86 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.307 0.575 . . . . 1.3 111.127 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.645 HG23 HG22 ' A' ' 110' ' ' ILE . 23.3 m -121.85 123.73 42.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.064 -0.654 . . . . 0.32 111.983 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.59 HD12 HG13 ' A' ' 111' ' ' ILE . 26.5 mt -91.49 108.7 20.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.616 -0.72 . . . . 1.23 111.137 -175.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.799 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 24.3 m-85 -93.38 118.78 31.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.38 112.204 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 77.3 m -117.16 111.6 19.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.596 -0.729 . . . . 1.1 110.06 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.744 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.3 pttp -89.39 89.22 7.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.964 0.887 . . . . 2.44 108.83 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -116.66 179.93 3.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.696 -1.138 . . . . 1.27 112.745 -165.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 p -145.95 110.39 5.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.491 -1.231 . . . . 1.79 109.886 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -19.5 36.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.474 . . . . 0.87 111.298 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 154' ' ' THR . 19.2 ptpt -80.16 -52.76 7.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.382 0.61 . . . . 3.03 110.296 -176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.499 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 28.1 p -78.39 -2.12 36.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.107 -0.951 . . . . 1.2 111.145 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.0 tptp 61.66 45.72 7.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.872 -1.058 . . . . 2.27 111.989 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -107.23 -73.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.855 0.835 . . . . 2.64 110.167 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -65.95 -18.67 66.88 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.724 -1.126 . . . . 0.62 113.899 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.04 -47.07 71.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.213 0.53 . . . . 1.55 109.79 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.69 -35.37 67.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.625 -0.716 . . . . 2.5 110.678 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -66.25 -34.81 78.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.184 -0.462 . . . . 0.73 110.668 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 165' ' ' ILE . 61.8 tp -59.68 -53.07 62.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.819 -0.628 . . . . 0.91 110.806 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.796 HD21 HD11 ' A' ' 28' ' ' ILE . 94.9 mt -56.28 -37.6 70.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.886 -0.597 . . . . 1.06 111.351 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -61.92 -38.59 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 2.49 110.913 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.9 mmt -74.02 -44.29 54.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.87 110.368 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.447 HD12 HD23 ' A' ' 162' ' ' LEU . 94.7 mt -51.94 -56.08 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.525 -0.762 . . . . 0.64 110.544 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.52 -42.85 91.56 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.685 -0.689 . . . . 1.81 111.654 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.4 tp -51.42 -44.75 62.36 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.513 0.508 . . . . 1.42 110.62 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 146' ' ' ILE . 24.6 t . . . . . 0 N--CA 1.445 -0.717 0 CA-C-N 116.09 -0.505 . . . . 1.17 111.416 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.938 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 13.9 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.946 0.403 . . . . 1.0 111.159 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -98.08 141.42 31.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.66 110.812 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.8 mt -96.29 127.36 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.966 0.413 . . . . 1.03 110.517 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' HG13 ' A' ' 82' ' ' VAL . 51.2 mtt -133.84 177.81 7.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.31 0.576 . . . . 1.04 111.529 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.31 -92.32 0.21 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.508 -1.037 . . . . 1.55 110.508 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.469 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 t60 -164.24 149.29 10.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.765 -0.828 . . . . 0.66 108.765 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.37 -17.35 22.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.419 0.896 . . . . 1.62 113.419 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.76 -13.12 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.469 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 16.4 m170 -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.703 0.287 . . . . 0.65 111.544 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.29 61.08 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.84 -1.172 . . . . 0.93 113.904 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.39 -22.8 24.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.347 0.594 . . . . 2.11 109.49 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -71.03 -38.32 72.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.762 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -78.66 -23.93 45.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 1.77 109.823 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.5 tm? -63.54 -48.13 78.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.771 -0.826 . . . . 1.78 108.771 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.731 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 18.8 mt -66.41 -36.46 82.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.038 -0.528 . . . . 1.96 110.738 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -55.27 -58.05 9.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.873 0.323 . . . . 1.38 111.873 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.694 ' HB3' HD12 ' A' ' 158' ' ' LEU . . . -68.55 -24.82 64.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.91 111.313 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 25' ' ' LEU . 1.4 tt -78.79 -23.62 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.418 . . . . 1.56 110.097 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 53.4 mtt180 -76.27 -26.76 56.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.646 0.736 . . . . 3.56 109.264 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -75.32 6.22 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.059 -0.973 . . . . 2.88 109.411 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 115.529 -0.76 . . . . 1.76 109.453 176.888 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' HE1' ' HG2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.006 0.431 . . . . 2.54 110.71 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 95.0 mt-30 -135.13 98.31 3.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 1.96 108.433 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.591 -0.731 . . . . 1.93 110.8 -173.505 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.818 HD11 HD21 ' A' ' 166' ' ' LEU . 44.0 mt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.65 0.262 . . . . 1.14 110.767 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.8 m -83.92 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.704 -0.48 . . . . 1.28 109.704 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 14.9 m-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.98 0.419 . . . . 0.84 111.426 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 23.5 mm . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 111.745 0.276 . . . . 0.74 111.745 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.657 HG21 ' HB1' ' A' ' 103' ' ' ALA . 46.8 t -89.89 87.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 116.413 -0.358 . . . . 1.19 110.768 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.47 HD11 HG12 ' A' ' 165' ' ' ILE . 32.0 mm -75.76 104.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.866 -0.791 . . . . 1.32 108.866 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.926 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.6 tm? -91.26 92.9 8.84 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.254 -0.885 . . . . 1.33 110.235 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 61.7 t -80.86 129.44 37.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.19 0.519 . . . . 1.2 111.122 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.8 m -131.3 -165.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.208 -1.034 . . . . 1.12 108.208 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -139.61 143.86 37.45 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.24 -0.584 . . . . 0.75 111.861 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -37.08 -58.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.495 1.122 . . . . 1.18 112.709 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -103.92 19.19 20.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.571 . . . . 2.01 111.602 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 2.5 t70 -113.61 -51.59 2.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.237 0.541 . . . . 1.09 110.773 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.731 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.18 -138.6 17.43 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.294 -0.866 . . . . 0.52 111.198 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.2 t -97.02 115.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 122.818 0.447 . . . . 1.08 111.423 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.453 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 80.0 mmm -80.06 167.09 36.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.676 -0.49 . . . . 1.32 109.676 171.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 90.1 Cg_exo -46.35 -45.5 18.69 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.578 2.186 . . . . 0.61 113.054 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.84 -22.71 60.75 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.644 -0.253 . . . . 1.47 110.855 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.915 ' HB ' HG13 ' A' ' 92' ' ' VAL . 26.2 m -62.23 -30.71 71.29 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.177 0.513 . . . . 0.46 110.649 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.95 -46.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.272 -0.422 . . . . 1.05 111.345 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 1.07 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.717 -0.674 . . . . 1.62 111.196 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.49 -41.09 8.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.528 -0.916 . . . . 0.34 108.528 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.926 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.2 mt -73.13 -55.62 12.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.276 -0.874 . . . . 0.38 111.545 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' A' ' 101' ' ' ASN . 1.3 t-20 -51.7 -30.08 20.73 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.218 0.607 . . . . 1.85 111.101 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -82.91 -28.9 29.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.769 -0.651 . . . . 0.85 110.584 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.657 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.56 -57.83 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.668 0.618 . . . . 0.48 112.668 -172.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.706 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -64.18 -21.32 66.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.615 0.598 . . . . 2.56 112.615 -163.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.02 4.56 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.831 0.348 . . . . 0.76 111.629 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.64 2.56 44.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 0.9 109.37 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t30 81.16 49.27 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.618 -1.174 . . . . 2.06 108.998 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -134.98 143.33 45.64 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 114.037 -1.438 . . . . 1.08 110.873 -175.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 13.8 Cg_exo -71.94 159.28 50.76 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.371 2.714 . . . . 0.51 114.675 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 HG12 ' A' ' 100' ' ' ILE . 46.8 mt -125.24 146.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.235 -1.348 . . . . 0.96 109.89 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 84' ' ' LEU . 5.0 mp -131.52 107.59 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 120.872 0.368 . . . . 0.71 111.726 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -70.9 133.68 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.492 0.663 . . . . 0.23 110.717 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -124.08 89.41 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.328 -1.36 . . . . 0.25 107.328 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 56.1 mt -72.18 92.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.069 -0.969 . . . . 0.85 109.615 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.28 169.16 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.69 109.696 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 62.94 20.47 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.522 0.677 . . . . 2.61 109.826 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.635 ' O ' ' HG3' ' A' ' 117' ' ' MET . 17.4 tpp . . . . . 0 N--CA 1.426 -1.645 0 CA-C-O 123.274 1.511 . . . . 1.37 108.856 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 110.194 -0.299 . . . . 1.84 110.194 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.595 ' O ' ' HG3' ' A' ' 128' ' ' MET . 8.1 Cg_exo -33.53 -62.26 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.634 3.556 . . . . 0.7 113.998 171.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.18 -53.8 4.84 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.007 0.523 . . . . 2.0 112.247 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -50.75 -59.15 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 2.99 110.824 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.731 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.8 t -55.31 -48.17 77.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.364 -1.289 . . . . 0.4 110.738 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.66 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 89.2 mtp -62.78 -31.31 72.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.261 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -76.42 -17.5 59.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.364 -0.38 . . . . 1.28 111.064 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.5 mt-10 -73.81 -36.35 64.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.55 -0.907 . . . . 2.02 108.55 171.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 136' ' ' LEU . 3.8 mm? -69.12 -43.48 74.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.628 0.728 . . . . 1.06 109.369 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.864 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.698 -0.683 . . . . 0.35 109.884 177.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.606 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 39.4 tt0 -74.29 -32.06 62.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.728 -0.841 . . . . 2.18 108.728 171.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CE2' HG11 ' A' ' 92' ' ' VAL . 6.0 m-85 -89.63 2.73 54.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.762 0.791 . . . . 0.74 108.879 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.5 m120 75.15 29.99 0.91 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.544 -1.662 . . . . 1.94 110.913 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 1.024 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.53 74.25 1.15 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.984 -1.487 . . . . 1.68 106.984 168.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.763 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -60.84 131.39 91.44 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 113.796 -1.547 . . . . 0.61 110.459 -172.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 79.7 Cg_exo -47.52 154.82 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.705 2.27 . . . . 0.3 112.509 173.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.98 -23.99 48.18 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.614 -1.176 . . . . 2.01 107.833 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.788 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -55.05 -40.97 70.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.114 -1.403 . . . . 1.14 109.163 167.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.864 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.4 m0 -96.55 -20.53 18.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.789 -1.096 . . . . 0.45 110.66 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.66 28.74 4.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.147 -1.025 . . . . 0.45 112.179 170.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -98.32 -113.4 3.26 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.593 -0.813 . . . . 0.5 112.797 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -147.4 26.34 1.06 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.936 0.398 . . . . 1.3 111.717 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.605 HG21 HD12 ' A' ' 136' ' ' LEU . 57.3 m -137.01 126.62 25.29 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 119.09 -1.044 . . . . 0.32 113.685 -174.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.602 HG21 ' HB3' ' A' ' 164' ' ' MET . 38.8 mm -86.13 115.25 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.406 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.5 m-85 -95.95 123.51 39.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.726 0.298 . . . . 0.38 111.269 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 62.9 m -126.01 133.62 51.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.936 -0.575 . . . . 1.1 109.947 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.765 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pttp -101.47 123.53 45.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.494 -0.928 . . . . 2.44 108.494 170.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -145.96 175.5 10.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.493 1.14 . . . . 1.27 113.852 -173.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.31 6.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.382 -1.735 . . . . 1.79 109.154 170.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -66.57 -18.08 65.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.31 0.576 . . . . 0.87 110.881 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 18.1 ptmt -71.57 -52.11 19.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.774 0.797 . . . . 3.03 110.016 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.7 p -81.74 -5.32 58.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.486 -1.234 . . . . 1.2 111.855 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 76.97 -29.22 0.17 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.787 0.835 . . . . 2.27 112.178 175.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 156' ' ' GLU . 23.2 mt-10 -41.1 -69.33 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.08 0.952 . . . . 2.64 112.95 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.76 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.3 -22.29 70.93 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.988 -1.005 . . . . 0.62 114.28 -172.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -67.29 -39.47 85.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.326 0.563 . . . . 1.55 110.023 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.2 m-20 -65.19 -39.53 92.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.268 -0.424 . . . . 2.5 110.085 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -68.79 -29.81 68.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.352 -0.386 . . . . 0.73 110.701 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 165' ' ' ILE . 54.4 tp -63.31 -51.82 64.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.383 -0.372 . . . . 0.91 110.644 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.563 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.4 mt -53.36 -41.03 65.43 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.255 -0.43 . . . . 1.06 110.637 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 22.1 mm-40 -56.35 -45.02 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.552 . . . . 2.49 110.644 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.8 mmt -76.07 -31.32 58.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.87 110.674 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 83' ' ' ILE . 70.9 mt -59.04 -56.81 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.066 -0.516 . . . . 0.64 110.796 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 57' ' ' ILE . 3.8 mm? -58.52 -42.25 87.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.524 -0.307 . . . . 1.81 111.032 176.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.58 -41.91 67.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.775 -0.648 . . . . 1.42 110.559 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 1.17 111.446 -179.366 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.545 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 96.3 t . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 121.839 0.828 . . . . 1.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.652 HG22 ' HG3' ' A' ' 14' ' ' MET . 21.1 m -82.31 121.78 27.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.525 -1.216 . . . . 0.66 111.143 -171.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.6 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 34.3 mt -88.93 114.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.672 -0.492 . . . . 1.03 109.672 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.652 ' HG3' HG22 ' A' ' 12' ' ' THR . 73.7 mtm -139.59 168.0 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.592 -0.731 . . . . 1.04 111.94 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.33 -95.96 0.17 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.438 -1.065 . . . . 1.55 110.438 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.87 149.9 14.89 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.816 -0.809 . . . . 0.66 108.816 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.85 -27.1 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 113.499 0.926 . . . . 1.62 113.499 -168.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.48 -22.78 40.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 1.78 111.683 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -70.78 -60.16 2.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.029 0.442 . . . . 0.65 110.847 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 166.92 58.31 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.546 -0.835 . . . . 0.93 112.484 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -87.93 -73.56 0.48 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.641 0.734 . . . . 2.11 109.876 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.833 -1.076 . . . . 1.8 111.107 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.461 HG22 ' HA2' ' A' ' 20' ' ' GLY . 8.9 t -76.74 -18.24 58.59 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.981 -0.288 . . . . 1.77 110.234 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -70.59 -44.62 66.93 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.02 -1.104 . . . . 1.78 108.02 174.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.9 tt -63.28 -40.64 97.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.996 -1.002 . . . . 1.96 110.083 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 t70 -63.64 -52.29 61.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.521 -0.308 . . . . 1.38 111.725 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' HD11 ' A' ' 158' ' ' LEU . . . -62.15 -41.46 98.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.91 111.012 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 25' ' ' LEU . 3.2 tt -66.6 -30.04 48.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.577 -0.738 . . . . 1.56 109.54 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 29.4 tpt180 -69.99 -33.19 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.285 -0.87 . . . . 3.56 109.956 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -63.78 -28.33 69.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 2.88 109.521 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 114.923 -1.035 . . . . 1.76 110.774 178.233 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.63 ' CZ ' ' HG ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 121.273 0.558 . . . . 2.54 111.604 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -104.66 133.69 49.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.48 -0.782 . . . . 1.96 109.729 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 59' ' ' PHE . 15.1 m . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.268 0.556 . . . . 1.93 111.965 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 11' ' ' VAL . 70.2 mt . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.09 0.471 . . . . 1.14 111.38 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -87.66 105.65 17.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 1.28 109.993 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 50' ' ' VAL . 35.9 m-85 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.33 . . . . 0.84 110.422 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mm . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 112.008 0.373 . . . . 0.74 112.008 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.078 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.1 t -105.2 111.09 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 120.622 -0.431 . . . . 1.19 111.687 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 16.1 mm -87.42 107.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.82 -0.808 . . . . 1.32 108.82 173.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 100' ' ' ILE . 2.9 tm? -97.45 99.7 11.12 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.989 -1.005 . . . . 1.33 109.509 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.58 133.59 29.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.932 -0.576 . . . . 1.2 110.771 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG23 ' HA ' ' A' ' 114' ' ' ILE . 23.0 m -131.48 -174.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.4 -0.818 . . . . 1.12 108.809 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.49 143.86 44.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.59 -0.444 . . . . 0.75 110.671 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -36.83 -61.84 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.734 1.271 . . . . 1.18 113.312 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.84 8.47 39.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.729 0.64 . . . . 2.01 112.729 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.36 -44.76 2.96 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.179 -0.608 . . . . 1.09 111.077 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.0 -144.49 23.89 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.827 -0.701 . . . . 0.52 111.409 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.782 HG23 ' HB ' ' A' ' 96' ' ' THR . 3.5 p -94.06 106.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.305 0.574 . . . . 1.08 110.12 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.567 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.7 ppp? -83.95 169.29 17.53 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 1.32 109.263 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 40.9 Cg_exo -35.76 -51.98 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.614 2.876 . . . . 0.61 115.029 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.81 -24.11 55.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.827 0.346 . . . . 1.47 111.109 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.782 ' HB ' HG23 ' A' ' 92' ' ' VAL . 2.4 m -65.24 -23.78 67.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.416 0.627 . . . . 0.46 110.035 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 92' ' ' VAL . 64.0 t -87.73 -42.72 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.778 -0.646 . . . . 1.05 111.052 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -56.58 -33.92 66.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.013 0.435 . . . . 1.62 111.095 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.72 -33.27 46.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.34 110.187 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.667 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -75.25 -45.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.635 . . . . 0.38 110.761 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -51.4 -38.13 51.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.264 0.554 . . . . 1.85 110.504 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -78.55 -28.52 46.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.246 -0.888 . . . . 0.85 110.898 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.078 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.74 -44.78 8.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.588 . . . . 0.48 112.48 -172.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -65.69 -24.19 66.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.577 -0.738 . . . . 2.56 111.383 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.6 8.58 33.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.76 111.707 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.36 9.38 39.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.692 -0.855 . . . . 0.9 108.692 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t30 69.44 38.78 1.73 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 114.589 -1.187 . . . . 2.06 110.651 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 82' ' ' VAL . 1.5 m -119.23 150.05 48.46 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.372 -0.831 . . . . 1.08 110.779 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.1 Cg_exo -73.19 155.22 52.0 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.175 2.584 . . . . 0.51 113.639 171.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -115.86 142.44 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.261 -1.336 . . . . 0.96 109.922 -176.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 mp -112.7 140.55 31.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 108.521 -0.918 . . . . 0.71 108.521 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -107.58 136.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 C-N-CA 120.259 -0.576 . . . . 0.23 110.673 176.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.76 87.68 2.76 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.701 -1.222 . . . . 0.25 107.701 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.712 ' HA ' HG23 ' A' ' 86' ' ' VAL . 14.3 mt -75.58 92.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.941 -1.027 . . . . 0.85 109.469 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.988 ' HA ' ' HB2' ' A' ' 150' ' ' LEU . 55.4 t30 -84.6 163.6 19.2 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.094 -0.243 . . . . 0.69 110.43 -171.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 73.38 41.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.229 0.612 . . . . 2.61 112.223 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.632 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 5.3 mmm . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 108.371 -0.974 . . . . 1.37 108.371 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.692 0.282 . . . . 1.84 110.591 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.704 ' O ' ' HG3' ' A' ' 128' ' ' MET . 68.4 Cg_exo -39.9 -58.35 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.625 2.883 . . . . 0.7 113.386 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.23 -48.22 9.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.419 0.688 . . . . 2.0 112.375 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.4 tmt_? -52.91 -55.13 25.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.112 0.482 . . . . 2.99 109.794 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 86' ' ' VAL . 54.7 t -60.22 -43.57 93.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.839 -1.073 . . . . 0.4 110.144 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.704 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 81.0 mtp -62.14 -31.8 72.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.34 -0.845 . . . . 0.3 111.059 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.454 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 18.7 mt-30 -75.79 -25.15 56.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.392 -0.367 . . . . 1.28 110.439 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.3 mt-10 -74.24 -32.23 62.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.176 -0.676 . . . . 2.02 109.176 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.572 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.5 mm? -69.75 -43.41 72.31 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.0 -0.68 . . . . 1.06 109.712 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.846 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -74.85 -5.52 44.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.529 -0.759 . . . . 0.35 109.986 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 9.2 tp10 -71.03 -34.43 71.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.573 -1.269 . . . . 2.18 107.573 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HB2' HD12 ' A' ' 136' ' ' LEU . 41.3 m-85 -91.26 21.8 4.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.77 0.795 . . . . 0.74 109.535 172.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.36 29.55 17.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.189 -1.368 . . . . 1.94 109.636 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.637 ' CD1' HD13 ' A' ' 100' ' ' ILE . 13.8 mt -101.51 70.75 1.3 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.408 -1.269 . . . . 1.68 108.848 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.489 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -64.54 123.27 82.51 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.438 -1.255 . . . . 0.61 110.531 -178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.699 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.3 Cg_exo -47.25 158.24 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.306 2.67 . . . . 0.3 113.171 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -26.29 57.93 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.567 -1.197 . . . . 2.01 108.718 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.5 mp0 -44.73 -51.17 9.58 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.597 -1.183 . . . . 1.14 110.703 160.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.846 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 17.2 m0 -94.95 -24.17 17.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.996 -1.456 . . . . 0.45 111.123 -165.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.2 27.6 2.86 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 119.989 -1.1 . . . . 0.45 112.291 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.4 -115.9 4.13 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.265 -0.969 . . . . 0.5 112.514 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -151.89 34.61 0.54 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.645 0.736 . . . . 1.3 111.112 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 22.4 m -130.78 114.32 15.19 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.278 -0.569 . . . . 0.32 111.767 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.771 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.6 mp -84.87 110.76 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.826 -0.624 . . . . 1.23 110.379 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.699 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.6 m-85 -92.12 135.16 34.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.366 0.603 . . . . 0.38 111.427 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.1 m -133.53 126.41 30.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 1.1 109.505 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.632 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 25.2 pttt -91.72 110.83 22.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.582 0.706 . . . . 2.44 109.618 172.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.988 ' HB2' ' HA ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -83.07 173.89 11.34 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.217 1.932 . . . . 1.27 116.217 -166.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.839 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 24.8 p -175.27 99.3 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 110.562 -3.017 . . . . 1.79 109.245 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.18 -17.73 56.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.7 -0.682 . . . . 0.87 111.913 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 154' ' ' THR . 18.2 ptpt -80.47 -50.42 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.651 0.739 . . . . 3.03 110.086 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.401 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 3.3 p -82.2 -2.41 52.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.626 -1.17 . . . . 1.2 111.434 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 75.72 -6.9 1.9 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.351 -0.84 . . . . 2.27 113.156 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB2' ' OG ' ' A' ' 151' ' ' SER . 15.8 mm-40 -64.67 -37.16 86.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.151 0.5 . . . . 2.64 110.597 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.839 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -59.97 -44.35 97.27 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.446 -0.797 . . . . 0.62 112.5 176.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 27' ' ' ALA . 91.7 mt -67.31 -51.19 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.864 0.32 . . . . 1.55 111.864 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 30.2 t70 -57.97 -53.38 58.89 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.321 0.388 . . . . 2.5 111.077 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 164' ' ' MET . 76.1 t60 -61.14 -34.75 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.73 110.854 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 165' ' ' ILE . 52.5 tp -65.15 -56.18 14.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.91 111.078 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.82 -39.34 68.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 1.06 110.844 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 57.9 mm-40 -63.56 -40.68 97.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.853 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.771 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.8 mmt -71.82 -38.48 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.424 . . . . 0.87 110.282 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 162' ' ' LEU . 85.6 mt -56.23 -53.43 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.516 -0.766 . . . . 0.64 111.345 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 1.8 pp -72.25 -30.49 64.92 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.84 -0.344 . . . . 1.81 111.904 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 166' ' ' LEU . 55.3 tp -54.45 -33.95 60.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 1.42 110.511 175.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 164' ' ' MET . 76.6 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-N 115.837 -0.619 . . . . 1.17 110.523 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.776 HG12 ' HB ' ' A' ' 81' ' ' ILE . 5.7 m . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.147 0.499 . . . . 1.0 111.244 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -109.32 125.92 52.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.617 -0.72 . . . . 0.66 110.142 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' A' ' 21' ' ' LYS . 23.5 mt -89.12 116.85 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 1.03 110.705 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.526 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 21.6 mmt -119.78 -179.21 3.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.015 -0.993 . . . . 1.04 110.11 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.92 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 105.44 131.49 7.02 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.941 -1.264 . . . . 1.55 109.941 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -44.48 135.67 4.6 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.854 0.835 . . . . 0.66 111.102 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.7 t -56.22 -39.08 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.104 -1.407 . . . . 1.62 112.84 -167.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.53 -18.16 55.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.879 0.326 . . . . 1.78 111.879 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HE1' ' H ' ' A' ' 93' ' ' MET . 25.1 m170 -64.62 -31.24 72.38 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.037 0.446 . . . . 0.65 110.298 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.18 55.14 0.3 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.198 -1.001 . . . . 0.93 113.624 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 13' ' ' ILE . 35.8 pttt -87.83 -22.36 24.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.478 -0.934 . . . . 2.11 108.478 172.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -34.8 77.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.627 -1.169 . . . . 1.8 110.002 176.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 p -71.23 -24.67 62.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 1.77 111.068 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.65 -54.93 28.05 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.662 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 6.0 tt -51.61 -45.31 63.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.094 0.473 . . . . 1.96 110.487 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.51 -52.2 16.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 1.38 112.538 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.63 85.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.367 -0.208 . . . . 0.91 111.116 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' HE2' ' A' ' 48' ' ' TYR . 74.3 mt -67.22 -36.87 77.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.541 -0.54 . . . . 1.56 109.541 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' NH2' ' HB3' ' A' ' 48' ' ' TYR . 15.9 tpp180 -59.49 -38.77 81.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.425 0.631 . . . . 3.56 109.765 171.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -85.14 16.28 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 2.88 111.386 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.449 -0.341 . . . . 1.76 110.804 179.168 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.561 0.696 . . . . 2.54 111.628 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.804 ' HG2' HG23 ' A' ' 58' ' ' THR . 34.9 mt-30 -125.74 146.92 49.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.551 -1.204 . . . . 1.96 107.762 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 C--N 1.318 -0.794 0 N-CA-C 109.135 -0.691 . . . . 1.93 109.135 178.522 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 165' ' ' ILE . 14.8 mt . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.731 0.3 . . . . 1.14 110.509 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.804 HG23 ' HG2' ' A' ' 49' ' ' GLN . 6.9 m -95.04 119.99 34.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.12 -0.326 . . . . 1.28 110.12 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.454 ' HD2' HD11 ' A' ' 13' ' ' ILE . 54.2 m-85 . . . . . 0 CA--C 1.515 -0.396 0 C-N-CA 120.71 -0.396 . . . . 0.84 110.311 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.776 ' HB ' HG12 ' A' ' 11' ' ' VAL . 41.4 mm . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.74 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.709 HG21 ' HB1' ' A' ' 103' ' ' ALA . 42.0 t -92.65 101.6 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 120.764 0.316 . . . . 1.19 111.136 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 111' ' ' ILE . 11.1 mm -84.94 105.42 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.73 -0.841 . . . . 1.32 108.73 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -100.22 104.81 16.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.92 -0.582 . . . . 1.33 110.81 -174.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.92 HG12 ' HA3' ' A' ' 15' ' ' GLY . 2.8 p -83.59 143.82 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.337 0.589 . . . . 1.2 111.6 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 114' ' ' ILE . 31.2 m -140.79 -166.77 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.357 -0.979 . . . . 1.12 108.357 174.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.52 144.04 34.1 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.378 -0.529 . . . . 0.75 111.885 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.73 -54.71 1.2 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.504 1.127 . . . . 1.18 113.092 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.34 -37.65 9.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.644 0.609 . . . . 2.01 112.644 -172.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 13.7 t70 -68.66 -45.0 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.613 -0.435 . . . . 1.09 111.354 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.92 -119.76 5.1 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.476 -0.868 . . . . 0.52 111.503 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.919 HG13 ' HB ' ' A' ' 96' ' ' THR . 25.0 t -114.13 116.15 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 122.611 0.364 . . . . 1.08 111.505 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.576 ' H ' ' HE1' ' A' ' 19' ' ' HIS . 39.6 mtp -82.38 166.54 35.98 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.327 -0.62 . . . . 1.32 109.327 169.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 89.2 Cg_exo -44.32 -50.42 7.89 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.61 113.107 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 2.1 mt-30 -66.73 -23.79 66.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.411 0.523 . . . . 1.47 112.411 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.919 ' HB ' HG13 ' A' ' 92' ' ' VAL . 24.4 m -63.3 -38.24 90.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.647 0.26 . . . . 0.46 110.61 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -29.33 5.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 C-N-CA 120.615 -0.434 . . . . 1.05 111.053 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 20.9 mm-40 -51.42 -45.51 62.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.177 0.513 . . . . 1.62 110.524 174.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.457 -0.792 . . . . 0.34 110.973 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -78.55 -45.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.908 -0.587 . . . . 0.38 111.256 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.36 -35.89 68.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.516 0.674 . . . . 1.85 110.048 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -76.03 -29.8 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 0.85 110.324 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.709 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -90.04 -45.95 8.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.265 0.469 . . . . 0.48 112.265 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -55.84 -26.55 47.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.681 0.622 . . . . 2.56 112.681 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.53 7.08 15.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.555 0.576 . . . . 0.76 112.555 -171.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -95.58 -4.25 44.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.823 -0.806 . . . . 0.9 108.823 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 t30 78.15 47.56 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.381 -1.281 . . . . 2.06 108.091 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -130.35 142.5 45.68 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.393 -1.73 . . . . 1.08 111.164 -171.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.5 Cg_exo -69.66 160.22 50.56 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.308 2.672 . . . . 0.51 114.449 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.748 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -124.57 145.92 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.43 -1.259 . . . . 0.96 110.566 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 83' ' ' ILE . 5.2 mp -123.88 108.78 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 120.873 0.368 . . . . 0.71 110.97 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -74.26 136.04 26.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.424 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -121.59 88.38 2.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.908 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 38.2 mt -68.21 93.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.306 -1.315 . . . . 0.85 110.722 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -91.5 169.51 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.967 -0.383 . . . . 0.69 109.967 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 60.7 22.47 12.38 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.855 0.836 . . . . 2.61 110.081 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.2 tpp . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 122.564 1.173 . . . . 1.37 109.018 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 4.5 t-20 . . . . . 0 N--CA 1.462 0.129 0 N-CA-C 109.87 -0.419 . . . . 1.84 109.87 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.0 Cg_exo -39.15 -61.31 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.253 3.302 . . . . 0.7 113.727 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -49.45 -43.85 45.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.991 0.517 . . . . 2.0 112.19 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -53.5 -55.56 24.38 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.31 0.576 . . . . 2.99 109.696 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.569 HG13 ' HA2' ' A' ' 91' ' ' GLY . 55.2 t -61.37 -43.82 97.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.605 -1.179 . . . . 0.4 110.052 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.799 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.5 mtp -63.5 -28.14 69.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.249 -0.887 . . . . 0.3 111.303 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.9 mt-30 -79.06 -23.59 44.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.628 -0.26 . . . . 1.28 110.477 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -71.93 -34.42 69.04 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.249 -0.649 . . . . 2.02 109.249 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -72.26 -41.0 67.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.571 0.7 . . . . 1.06 109.827 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.839 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -75.63 -5.38 45.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.091 -0.959 . . . . 0.35 109.462 176.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.2 tt0 -84.01 -21.51 31.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.664 -0.865 . . . . 2.18 108.664 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.745 ' HE2' HG11 ' A' ' 92' ' ' VAL . 31.9 m-85 -94.27 10.57 33.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.281 -1.007 . . . . 0.74 108.281 166.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.4 m120 70.97 35.29 1.7 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 113.683 -1.599 . . . . 1.94 111.449 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.564 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.0 mp -112.0 78.16 1.1 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.402 -0.962 . . . . 1.68 108.402 170.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.984 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.63 130.13 93.35 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 113.936 -1.484 . . . . 0.61 110.682 -176.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.802 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 75.8 Cg_exo -51.13 153.33 9.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.849 2.366 . . . . 0.3 113.295 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.7 mm-40 -79.52 -23.52 42.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.488 -1.233 . . . . 2.01 109.083 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.69 ' HB3' ' CD1' ' A' ' 141' ' ' TRP . 8.1 mp0 -42.96 -53.06 4.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.676 -1.147 . . . . 1.14 110.547 159.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.839 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -93.82 -22.06 18.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.739 -1.573 . . . . 0.45 111.237 -167.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.32 25.61 3.73 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.086 -1.054 . . . . 0.45 112.364 172.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.984 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -106.71 2.12 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.623 -0.799 . . . . 0.5 113.114 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.83 23.02 0.27 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.999 0.428 . . . . 1.3 110.944 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.748 HG23 HG22 ' A' ' 110' ' ' ILE . 17.5 m -136.44 112.21 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.912 -0.715 . . . . 0.32 112.834 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.737 HG21 ' HB3' ' A' ' 164' ' ' MET . 52.9 mt -76.89 117.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 1.23 110.808 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.802 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.3 m-85 -94.69 101.86 13.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.38 111.839 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.2 m -96.42 99.37 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.726 -0.67 . . . . 1.1 109.99 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.908 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 18.6 pttm -79.26 85.17 5.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.776 -0.824 . . . . 2.44 108.776 172.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.672 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -109.82 179.25 4.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.301 -0.863 . . . . 1.27 112.542 -169.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 p -146.17 104.71 3.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.062 -0.972 . . . . 1.79 110.772 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 158' ' ' LEU . . . -66.86 -17.93 65.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.981 0.42 . . . . 0.87 111.44 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -78.62 -60.76 2.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.42 0.628 . . . . 3.03 110.299 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -85.45 -5.46 59.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.033 -0.985 . . . . 1.2 112.067 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HD23 ' A' ' 158' ' ' LEU . 5.1 tppp? 73.05 -7.08 1.56 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.618 0.574 . . . . 2.27 112.423 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -56.35 -55.39 33.99 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.984 0.897 . . . . 2.64 111.141 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.672 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -67.36 -19.57 70.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.995 -1.002 . . . . 0.62 113.695 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 152' ' ' ALA . 4.0 mm? -67.58 -41.43 84.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.486 0.643 . . . . 1.55 110.367 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.88 -44.47 97.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.728 -0.669 . . . . 2.5 109.926 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.483 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.4 t60 -65.55 -38.14 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.73 111.041 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.51 -58.34 8.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.91 112.051 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.604 ' O ' HD23 ' A' ' 166' ' ' LEU . 93.7 mt -56.05 -40.97 74.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.595 -0.275 . . . . 1.06 110.716 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.5 -30.98 71.43 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.954 -0.299 . . . . 2.49 111.144 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.737 ' HB3' HG21 ' A' ' 146' ' ' ILE . 24.5 mmt -70.4 -39.76 74.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.87 109.888 175.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 57' ' ' ILE . 78.9 mt -57.08 -56.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.093 -0.958 . . . . 0.64 110.559 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.577 0.584 . . . . 1.81 112.577 176.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.43 -37.15 77.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 1.42 110.462 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 146' ' ' ILE . 1.4 t . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.146 -0.479 . . . . 1.17 110.612 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.792 HG21 HG23 ' A' ' 57' ' ' ILE . 21.3 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.237 0.542 . . . . 1.0 109.898 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 m -64.93 116.66 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.112 -0.949 . . . . 0.66 111.585 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.869 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.6 mt -104.73 128.19 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.45 . . . . 1.03 110.831 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.6 mtm -139.78 166.56 24.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.021 0.439 . . . . 1.04 111.096 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.59 -107.56 0.29 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.919 -0.872 . . . . 1.55 110.919 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -156.44 160.16 39.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.929 -0.397 . . . . 0.66 109.929 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.82 -56.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.68 0.252 . . . . 1.62 111.68 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.87 -15.14 63.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.435 0.532 . . . . 1.78 112.435 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' H ' ' A' ' 93' ' ' MET . 64.3 m170 -77.43 -2.52 35.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.653 0.739 . . . . 0.65 110.421 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.53 47.79 47.93 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.966 -1.015 . . . . 0.93 113.4 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.8 pttp -70.89 -10.84 60.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.798 0.808 . . . . 2.11 109.481 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -81.31 -5.22 57.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.957 -1.019 . . . . 1.8 110.563 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 p -84.67 -32.56 23.55 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 120.801 -0.36 . . . . 1.77 110.821 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 25' ' ' LEU . 4.5 pp -69.66 -34.96 74.73 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.593 -0.891 . . . . 1.78 108.593 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -56.98 -38.84 73.58 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.484 -0.932 . . . . 1.96 108.484 175.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.41 -52.89 7.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 1.38 112.216 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . . . -67.73 -33.59 75.18 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.348 -0.387 . . . . 0.91 111.274 -171.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' A' ' 48' ' ' TYR . 96.2 mt -71.65 -29.7 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 1.56 110.314 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 75.2 mtm180 -66.42 -40.96 89.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.218 -0.66 . . . . 3.56 109.218 172.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.34 -12.6 57.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 2.88 110.606 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 115.84 -0.618 . . . . 1.76 110.199 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.521 ' HE1' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.481 0.658 . . . . 2.54 111.893 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 58' ' ' THR . 43.1 mt-30 -101.82 123.4 45.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.175 -0.921 . . . . 1.96 108.921 175.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG21 ' HE2' ' A' ' 59' ' ' PHE . 12.3 m . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 121.151 0.5 . . . . 1.93 111.954 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.792 HG23 HG21 ' A' ' 11' ' ' VAL . 58.4 mt . . . . . 0 C--O 1.236 0.36 0 CA-C-O 121.033 0.444 . . . . 1.14 110.191 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 49' ' ' GLN . 14.2 m -86.69 111.1 20.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.913 -0.585 . . . . 1.28 110.103 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HE2' HG21 ' A' ' 50' ' ' VAL . 34.9 m-85 . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.715 0.293 . . . . 0.84 110.352 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 11' ' ' VAL . 8.5 mm . . . . . 0 N--CA 1.458 -0.043 0 N-CA-C 110.321 -0.251 . . . . 0.74 110.321 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 ' HB1' ' A' ' 103' ' ' ALA . 40.5 t -99.51 96.24 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.107 -0.637 . . . . 1.19 111.283 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.869 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 17.3 mm -74.29 117.41 18.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.198 -1.038 . . . . 1.32 108.198 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.6 tm? -110.65 96.03 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.784 -0.643 . . . . 1.33 110.245 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 49.4 t -84.9 130.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.213 0.53 . . . . 1.2 111.388 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.799 HG12 HG21 ' A' ' 96' ' ' THR . 28.0 m -128.4 -164.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.511 -0.922 . . . . 1.12 108.511 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.56 40.53 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.116 -0.634 . . . . 0.75 111.965 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 117' ' ' MET . . . -31.94 -64.68 0.16 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.93 1.394 . . . . 1.18 113.922 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.71 -20.13 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.864 -0.607 . . . . 2.01 112.356 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.36 -37.0 15.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.362 -0.535 . . . . 1.09 111.598 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.59 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 82.87 -144.35 22.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.528 -0.844 . . . . 0.52 111.783 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' HB ' ' A' ' 96' ' ' THR . 2.8 p -100.85 102.57 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 109.279 -0.637 . . . . 1.08 109.279 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.603 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -83.49 169.54 17.08 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.57 -0.53 . . . . 1.32 109.57 -175.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 29.0 Cg_exo -30.42 -56.17 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.092 3.195 . . . . 0.61 115.1 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -69.98 -34.68 73.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.533 0.206 . . . . 1.47 111.016 -175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.65 -31.48 72.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.649 0.738 . . . . 0.46 109.931 176.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.548 HG23 HG22 ' A' ' 92' ' ' VAL . 72.5 t -78.79 -45.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.354 -0.839 . . . . 1.05 111.055 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.6 mt-10 -63.94 -19.06 64.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.62 111.086 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.79 -41.04 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.646 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.581 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.21 -47.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.79 176.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 101' ' ' ASN . 1.1 t-20 -49.24 -34.78 15.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.926 0.491 . . . . 1.85 110.735 173.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -85.69 -31.93 22.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 0.85 111.02 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.83 -44.78 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.925 0.343 . . . . 0.48 111.925 -173.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -54.59 -30.75 55.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.654 . . . . 2.56 112.759 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.32 3.37 15.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.973 0.731 . . . . 0.76 112.973 -167.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.45 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -91.39 -2.3 57.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.721 -0.844 . . . . 0.9 108.721 173.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.494 ' HA ' HD22 ' A' ' 107' ' ' ASN . 1.2 t-20 72.22 46.14 0.34 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.986 -1.461 . . . . 2.06 107.534 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -121.24 144.58 40.07 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 112.663 -2.062 . . . . 1.08 110.942 -170.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 108' ' ' VAL . 18.0 Cg_exo -67.45 154.47 73.67 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.681 2.254 . . . . 0.51 114.264 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.661 HG22 HG23 ' A' ' 145' ' ' THR . 1.2 mp -122.57 142.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.746 -1.57 . . . . 0.96 109.645 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.682 HD13 HD13 ' A' ' 83' ' ' ILE . 2.7 mp -121.23 99.96 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 CA-C-O 121.272 0.558 . . . . 0.71 111.292 -176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -68.56 137.12 25.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.361 -0.836 . . . . 0.23 110.613 179.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -122.52 89.48 3.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.966 -1.124 . . . . 0.25 107.966 173.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.812 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 6.6 mm -65.22 85.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.595 -1.184 . . . . 0.85 109.745 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -95.75 168.36 10.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.69 110.128 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 69.46 12.92 8.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.333 0.587 . . . . 2.61 110.206 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 121.424 0.63 . . . . 1.37 110.642 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.439 0.162 . . . . 1.84 110.781 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.65 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.2 Cg_exo -38.98 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.051 3.168 . . . . 0.7 114.094 171.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -45.48 -49.02 13.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.859 0.688 . . . . 2.0 112.859 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -50.68 -57.06 9.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.496 0.665 . . . . 2.99 109.872 175.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.59 HG13 ' HA2' ' A' ' 91' ' ' GLY . 74.3 t -58.5 -45.51 90.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.389 -1.278 . . . . 0.4 110.514 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.676 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.0 mtp -62.74 -29.05 70.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.3 111.376 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -78.32 -24.31 46.67 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.513 -0.312 . . . . 1.28 110.773 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -72.61 -32.82 66.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.793 -0.817 . . . . 2.02 108.793 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -70.15 -44.67 68.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 120.048 -0.661 . . . . 1.06 109.569 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.875 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -76.95 -0.49 24.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.35 110.006 177.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.0 tp10 -77.5 -31.84 53.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.288 -1.375 . . . . 2.18 107.288 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -95.35 17.51 14.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.146 -0.933 . . . . 0.74 109.696 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.9 34.27 4.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.054 -1.43 . . . . 1.94 110.333 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -106.96 87.09 2.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.09 1.424 . . . . 1.68 109.0 173.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.842 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 93.3 t -83.91 119.74 73.93 Favored Pre-proline 0 C--N 1.285 -2.21 0 CA-C-N 111.559 -2.564 . . . . 0.61 111.334 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.84 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -47.74 157.97 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.791 2.994 . . . . 0.3 113.963 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 144' ' ' ASP . 6.8 mm-40 -74.33 -24.69 59.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.13 -1.395 . . . . 2.01 109.183 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.836 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -56.86 -40.65 76.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.286 -0.87 . . . . 1.14 109.045 169.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.875 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.6 m0 -96.04 -21.24 18.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.858 -1.065 . . . . 0.45 111.089 -169.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.36 30.16 4.51 Favored Glycine 0 CA--C 1.501 -0.786 0 C-N-CA 119.762 -1.209 . . . . 0.45 112.011 170.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.842 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.93 -109.48 2.64 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.377 -0.916 . . . . 0.5 111.48 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.485 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 9.0 p-10 -166.42 46.36 0.07 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.623 1.201 . . . . 1.3 109.591 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 110' ' ' ILE . 21.4 m -132.02 110.37 10.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.286 -1.325 . . . . 0.32 111.377 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.73 107.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.092 -0.958 . . . . 1.23 110.422 -175.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.84 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 22.6 m-85 -89.76 96.59 10.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.5 . . . . 0.38 111.33 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 150' ' ' LEU . 68.8 m -88.02 99.22 12.0 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.161 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.812 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.8 ptmt -76.35 83.97 3.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.872 -0.788 . . . . 2.44 108.872 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.488 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.5 -178.95 3.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.585 0.707 . . . . 1.27 112.23 -170.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -165.77 130.1 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.036 -0.983 . . . . 1.79 110.792 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 27' ' ' ALA . . . -84.47 -9.65 58.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.32 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 153' ' ' LYS . 5.3 tppp? -78.34 -58.69 3.12 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.295 -0.866 . . . . 3.03 109.342 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.711 ' HB ' ' HG2' ' A' ' 156' ' ' GLU . 22.1 p -73.99 -22.53 59.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.619 -1.173 . . . . 1.2 110.783 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 tptp 72.61 -2.64 2.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.092 -0.958 . . . . 2.27 110.981 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.711 ' HG2' ' HB ' ' A' ' 154' ' ' THR . 22.1 mm-40 -59.15 -73.33 0.08 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.459 0.647 . . . . 2.64 112.022 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -67.69 -9.1 55.06 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.62 113.454 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 28' ' ' ILE . 2.6 tm? -64.27 -51.22 64.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.513 -0.551 . . . . 1.55 109.513 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.71 -36.51 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 2.5 109.938 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.576 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 80.1 t60 -58.75 -37.71 76.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.258 -0.883 . . . . 0.73 110.478 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.79 -49.49 77.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.921 -0.581 . . . . 0.91 110.634 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.26 -38.53 77.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 1.06 110.769 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.5 -42.99 91.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 2.49 110.499 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -39.0 92.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.87 110.621 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.23 -48.8 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.985 -0.552 . . . . 0.64 110.213 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.84 -46.98 85.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.854 -0.612 . . . . 1.81 111.034 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.0 tp -48.8 -49.29 39.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.393 -0.821 . . . . 1.42 110.86 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.445 -0.693 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.032 -179.131 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.697 HG22 ' HB ' ' A' ' 81' ' ' ILE . 47.5 t . . . . . 0 N--CA 1.439 -1.004 0 CA-C-O 120.968 0.413 . . . . 1.0 111.028 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -98.12 132.53 43.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.157 0.503 . . . . 0.66 110.413 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.439 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 66.1 mt -94.87 127.51 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.708 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 54.8 mtt -127.48 173.12 10.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.726 -0.67 . . . . 1.04 110.922 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.11 -104.92 0.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.908 -0.877 . . . . 1.55 110.908 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.488 ' CD2' ' H ' ' A' ' 18' ' ' ASP . 81.6 t60 -166.55 143.34 4.88 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.261 -0.644 . . . . 0.66 109.261 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.42 -24.47 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.2 1.185 . . . . 1.62 114.2 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 21.1 m-20 -88.3 -11.83 45.3 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.561 0.578 . . . . 1.78 112.561 -173.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -77.6 -3.6 41.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.162 0.43 . . . . 0.65 112.162 -174.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.58 64.63 0.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.656 -0.783 . . . . 0.93 112.763 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -87.08 -34.69 19.06 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 2.11 110.871 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.628 -0.26 . . . . 1.8 110.472 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 p -78.54 -32.07 47.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.954 0.407 . . . . 1.77 110.635 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -54.45 13.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.851 -0.796 . . . . 1.78 108.851 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -59.1 -33.9 71.38 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.099 -0.955 . . . . 1.96 110.724 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.88 -55.83 6.81 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.035 -0.416 . . . . 1.38 111.398 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -59.71 -39.61 85.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.91 110.898 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 48' ' ' TYR . 10.8 tt -65.96 -28.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.504 -0.771 . . . . 1.56 111.252 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 85.4 mtm180 -77.25 -26.59 52.71 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.595 0.712 . . . . 3.56 109.463 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -85.58 15.21 4.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.829 -1.078 . . . . 2.88 110.091 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 3.8 m . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.65 -0.704 . . . . 1.76 111.736 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.62 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.2 p90 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.133 0.492 . . . . 2.54 111.156 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.813 ' HG2' HG23 ' A' ' 58' ' ' THR . 18.0 mt-30 -109.44 134.09 52.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.581 -0.736 . . . . 1.96 109.284 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 CA--C 1.509 -0.608 0 CA-C-O 121.649 0.738 . . . . 1.93 110.609 -178.005 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.984 0.421 . . . . 1.14 111.179 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.813 HG23 ' HG2' ' A' ' 49' ' ' GLN . 18.9 m -104.3 127.99 52.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 1.28 108.977 171.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.7 m-85 . . . . . 0 C--N 1.325 -0.463 0 C-N-CA 120.976 -0.29 . . . . 0.84 110.92 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.697 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.6 mm . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 109.716 -0.476 . . . . 0.74 109.716 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.7 t -82.18 94.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 120.376 -0.53 . . . . 1.19 110.714 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.609 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 10.0 mm -80.66 97.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.369 -0.604 . . . . 1.32 109.369 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -87.71 96.26 10.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.005 -0.739 . . . . 1.33 109.005 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 55.2 t -81.71 137.98 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.428 0.632 . . . . 1.2 111.266 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.2 m -132.84 -168.19 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 1.12 108.547 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.26 20.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -58.64 -19.94 43.42 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.421 -0.809 . . . . 1.18 112.437 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.75 -12.48 33.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.515 0.191 . . . . 2.01 111.515 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.563 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 28.5 t70 -119.43 -49.65 2.36 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.375 0.607 . . . . 1.09 110.94 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 100.49 -124.67 8.32 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.18 -0.918 . . . . 0.52 111.239 -174.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.017 HG11 ' HE2' ' A' ' 134' ' ' TYR . 38.1 t -111.82 113.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.957 0.408 . . . . 1.08 111.029 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.563 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 77.2 mmm -80.33 168.12 28.06 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.557 -0.535 . . . . 1.32 109.557 172.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 6.3 Cg_endo -49.64 -42.83 41.87 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.393 2.062 . . . . 0.61 112.885 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.76 -26.86 62.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.659 0.266 . . . . 1.47 110.609 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.823 ' HB ' HG13 ' A' ' 92' ' ' VAL . 18.6 m -60.79 -35.77 77.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.128 -0.487 . . . . 0.46 110.483 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.584 HG12 ' CG1' ' A' ' 92' ' ' VAL . 2.0 m -84.15 -35.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.518 -0.31 . . . . 1.05 110.81 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.945 0.402 . . . . 1.62 111.474 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.695 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -66.82 -45.09 79.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.34 110.137 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.643 HG23 ' HD3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -64.27 -42.65 96.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.522 -0.763 . . . . 0.38 111.216 177.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -62.81 -30.73 71.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.509 0.723 . . . . 1.85 109.814 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -83.96 -32.54 24.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.85 110.333 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -87.11 -48.78 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.334 0.494 . . . . 0.48 112.334 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.643 ' HD3' HG23 ' A' ' 100' ' ' ILE . 14.0 pttp -63.74 -16.4 61.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.526 0.565 . . . . 2.56 112.526 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.31 6.74 21.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.855 0.317 . . . . 0.76 111.855 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.542 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -98.21 2.14 48.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.803 -0.444 . . . . 0.9 109.803 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 77.92 31.87 0.4 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.742 1.258 . . . . 2.06 108.569 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -109.48 147.63 36.45 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 113.206 -1.815 . . . . 1.08 110.523 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_exo -73.38 151.42 48.17 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.569 2.179 . . . . 0.51 113.547 172.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.628 HG22 HG23 ' A' ' 145' ' ' THR . 1.1 mp -118.82 142.59 33.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.225 -1.352 . . . . 0.96 110.212 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -112.17 148.24 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 107.933 -1.136 . . . . 0.71 107.933 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -112.84 138.01 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 109.364 -0.606 . . . . 0.23 109.364 172.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -118.95 88.17 2.88 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.758 -1.201 . . . . 0.25 107.758 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.786 HD11 ' HD2' ' A' ' 147' ' ' PHE . 21.1 mt -73.79 83.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.754 -1.112 . . . . 0.85 109.507 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -89.09 164.63 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.934 -0.575 . . . . 0.69 110.105 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 66.97 34.1 5.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.04 -0.527 . . . . 2.61 112.131 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 4.3 ptp . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 1.37 109.792 169.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.092 0.404 . . . . 1.84 112.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.4 Cg_exo -36.72 -60.78 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.572 3.515 . . . . 0.7 115.198 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -42.72 -41.85 3.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.6 0.76 . . . . 2.0 113.014 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.87 -54.07 51.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.701 0.762 . . . . 2.99 109.387 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.721 ' HA ' ' OE2' ' A' ' 130' ' ' GLU . 58.4 t -60.06 -39.38 80.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.083 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.679 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 86.3 mtp -65.64 -30.62 71.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.253 -0.885 . . . . 0.3 111.114 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.33 -15.45 57.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.543 -0.463 . . . . 1.28 110.898 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.721 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 12.9 mt-10 -72.3 -37.12 69.05 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.656 -0.868 . . . . 2.02 108.656 170.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.576 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -69.95 -45.17 68.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.45 0.643 . . . . 1.06 110.087 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.905 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -75.79 -5.52 46.24 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.309 -0.859 . . . . 0.35 109.645 177.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 14.4 tp10 -74.02 -32.37 63.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.785 -1.191 . . . . 2.18 107.785 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 1.017 ' HE2' HG11 ' A' ' 92' ' ' VAL . 30.2 m-85 -90.0 10.13 25.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.68 0.753 . . . . 0.74 109.1 173.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 71.95 38.73 0.89 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 113.898 -1.501 . . . . 1.94 110.565 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.2 mp -117.28 84.11 2.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.444 1.116 . . . . 1.68 108.679 172.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.977 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.2 t -69.67 127.31 92.7 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.022 -1.899 . . . . 0.61 112.139 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.839 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 81.3 Cg_exo -47.14 160.24 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.296 0 C-N-CA 124.109 3.206 . . . . 0.3 114.441 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -85.26 -5.87 59.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.336 -1.302 . . . . 2.01 110.11 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -74.13 -32.79 63.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.452 -1.314 . . . . 1.14 107.452 167.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.905 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -101.3 -26.27 13.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.191 -1.368 . . . . 0.45 111.286 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.5 30.8 3.19 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.845 -1.169 . . . . 0.45 112.315 172.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.977 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.87 -102.53 1.95 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 120.486 -0.864 . . . . 0.5 111.609 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -169.6 37.29 0.02 OUTLIER 'General case' 0 C--O 1.247 0.922 0 CA-C-O 122.168 0.985 . . . . 1.3 110.594 172.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.47 113.84 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.909 -1.041 . . . . 0.32 111.49 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.7 mp -82.72 108.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.587 -0.733 . . . . 1.23 110.555 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.839 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.7 m-85 -91.33 111.75 23.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.701 0.286 . . . . 0.38 111.752 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.403 ' O ' HD23 ' A' ' 150' ' ' LEU . 16.0 t -102.11 117.24 34.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.804 -0.813 . . . . 1.1 108.804 174.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.4 pttm -93.34 101.49 13.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.129 -0.693 . . . . 2.44 109.129 175.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.719 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -130.12 176.91 7.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.244 1.021 . . . . 1.27 113.567 -168.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.9 m -147.45 117.27 7.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.6 -1.636 . . . . 1.79 109.101 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.63 66.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.445 0.535 . . . . 0.87 112.445 -174.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.71 ' HG3' ' H ' ' A' ' 154' ' ' THR . 15.0 ptpt -73.95 -56.08 5.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.77 0.795 . . . . 3.03 110.12 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.71 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 10.3 p -72.77 -12.45 61.01 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.16 -1.382 . . . . 1.2 112.098 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HD2' HD12 ' A' ' 158' ' ' LEU . 3.0 tptm 71.72 2.75 4.41 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.061 0.544 . . . . 2.27 111.779 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.94 -72.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.714 0.768 . . . . 2.64 111.423 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.719 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.36 -9.3 60.85 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.155 -0.93 . . . . 0.62 113.623 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.684 HD12 ' HD2' ' A' ' 155' ' ' LYS . 31.2 mt -70.12 -42.69 72.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.365 0.582 . . . . 1.55 110.256 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.57 -44.86 92.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 2.5 109.569 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -67.39 -24.63 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.73 111.361 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.28 -50.02 65.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.551 -0.295 . . . . 0.91 110.289 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -55.7 -36.75 67.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.007 -0.542 . . . . 1.06 110.459 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.16 -51.6 69.31 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.032 0.444 . . . . 2.49 110.526 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.733 ' HB3' HG21 ' A' ' 146' ' ' ILE . 16.2 mmt -65.5 -40.84 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.87 110.799 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.92 -53.18 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.709 -0.678 . . . . 0.64 110.314 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.21 -43.94 95.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.792 -0.64 . . . . 1.81 111.44 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.4 tp -54.01 -47.8 71.1 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.043 -0.526 . . . . 1.42 110.196 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.446 -0.628 0 CA-C-N 116.07 -0.513 . . . . 1.17 111.317 -177.81 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 112.481 -0.248 . . . . 16.35 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -88.77 -9.21 52.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.699 0.285 . . . . 14.69 111.379 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -66.11 -38.39 88.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 14.68 110.017 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.418 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 24.5 mmt -101.91 32.6 3.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 12.73 109.732 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 4' ' ' MET . 98.4 t 72.68 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.491 -0.777 . . . . 10.18 111.039 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -72.73 88.87 1.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.591 . . . . 9.14 110.135 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -67.86 128.66 93.4 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 8.35 109.946 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.25 115.68 2.54 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.063 2.509 . . . . 4.6 112.278 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.38 85.92 0.85 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.709 2.273 . . . . 4.29 111.955 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -72.32 107.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.631 0.729 . . . . 2.58 109.936 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.023 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 10.5 t -85.36 84.72 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.613 0.721 . . . . 1.0 109.474 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -70.54 118.42 13.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.096 -0.957 . . . . 0.66 111.282 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.724 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 40.1 mt -87.18 116.06 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.371 0.605 . . . . 1.03 110.549 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 35.0 mtt -125.17 172.23 9.68 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.552 -0.749 . . . . 1.04 110.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 1.019 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 147.54 -96.64 0.18 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 109.851 -1.299 . . . . 1.55 109.851 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.622 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 71.3 t60 -175.0 164.28 3.35 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.659 -0.867 . . . . 0.66 108.659 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.4 t -62.09 -52.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.665 0.269 . . . . 1.62 111.439 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.443 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 31.8 t70 -61.13 -30.12 70.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.792 -0.64 . . . . 1.78 112.651 -172.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.622 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 39.9 m80 -64.76 -19.43 65.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.408 . . . . 0.65 110.949 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.89 44.15 2.92 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.679 -0.772 . . . . 0.93 112.978 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG11 ' A' ' 85' ' ' VAL . 22.0 ptmt -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.966 -0.753 . . . . 2.11 108.966 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.3 p -74.68 -35.68 62.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.738 -1.119 . . . . 1.8 109.62 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.8 m -63.3 -33.68 76.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.138 -0.937 . . . . 1.77 110.522 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.46 -56.19 20.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.217 -0.447 . . . . 1.78 110.408 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' HG22 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -62.64 -38.51 90.54 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.12 -0.491 . . . . 1.96 110.006 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 12.3 t70 -63.88 -49.49 72.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.98 0.363 . . . . 1.38 111.98 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -68.02 -37.31 81.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.227 0.537 . . . . 0.91 110.857 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.597 HG22 ' HA ' ' A' ' 25' ' ' LEU . 6.5 tt -74.11 -20.84 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.451 -0.795 . . . . 1.56 109.812 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 33.0 tpt180 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.115 -0.948 . . . . 3.56 109.831 174.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -88.84 7.44 34.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.584 -0.735 . . . . 2.88 110.145 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m -149.81 49.63 0.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.316 0.579 . . . . 1.76 110.33 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -93.18 160.61 14.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.71 . . . . 5.71 111.077 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 51' ' ' THR . 3.4 m -138.63 -2.4 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 113.072 0.768 . . . . 2.99 113.072 -174.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 93.9 m -161.81 -63.26 0.05 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.091 -0.381 . . . . 3.93 111.478 -172.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 34' ' ' THR . 8.4 pt-20 46.22 -169.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.973 1.309 . . . . 4.2 114.194 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -102.13 -80.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.712 -0.676 . . . . 5.38 110.435 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -139.39 -48.01 0.47 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.459 -0.791 . . . . 5.79 110.202 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.38 118.18 9.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.471 -0.786 . . . . 4.24 110.649 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.58 38.11 3.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 4.95 111.426 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -101.8 149.93 18.21 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.697 -0.561 . . . . 6.66 111.697 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.0 mp -75.71 88.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 9.17 110.867 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.7 m -145.03 139.2 27.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.933 -1.136 . . . . 7.36 107.933 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -70.8 24.78 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.278 1.214 . . . . 8.83 114.278 -167.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -111.82 -10.08 14.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 6.76 109.067 171.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.913 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.7 tp -168.59 -157.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.141 -1.059 . . . . 5.19 108.141 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.913 ' H ' HG13 ' A' ' 45' ' ' ILE . . . 146.3 -62.27 0.46 Allowed Glycine 0 C--N 1.311 -0.82 0 C-N-CA 120.437 -0.887 . . . . 2.97 112.556 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.77 179.25 7.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.757 0.313 . . . . 1.71 110.167 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' A' ' 28' ' ' ILE . 3.0 p90 -157.47 -172.83 4.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.814 0.34 . . . . 2.54 110.658 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HG2' HG23 ' A' ' 58' ' ' THR . 36.8 mt-30 -122.42 122.98 40.26 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 108.876 -0.787 . . . . 1.96 108.876 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' HE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -107.37 133.61 51.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.364 0.602 . . . . 1.93 111.194 -173.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 54' ' ' ASP . 87.0 m -110.08 82.46 1.6 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.962 -1.017 . . . . 2.06 110.088 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 54' ' ' ASP . 5.9 p -112.02 124.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.704 -1.221 . . . . 4.12 107.704 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.619 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 0.9 OUTLIER 73.87 -5.69 1.97 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.325 1.059 . . . . 4.43 108.705 -172.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.674 ' HA ' HG23 ' A' ' 51' ' ' THR . 1.7 m-20 77.21 23.85 0.88 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 112.263 -2.244 . . . . 3.62 110.933 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.619 ' HD3' ' HB3' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -88.69 129.15 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.572 -0.899 . . . . 7.44 108.572 172.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -72.06 92.08 1.29 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.388 0.43 . . . . 5.43 111.558 -174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 11' ' ' VAL . 56.1 mt -94.61 95.29 5.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 1.14 110.085 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -88.58 113.21 23.92 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.874 -0.603 . . . . 1.28 109.442 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HE2' HG21 ' A' ' 50' ' ' VAL . 27.6 m-85 -90.63 142.28 27.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.932 -0.307 . . . . 0.84 111.417 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.8 tp 73.79 137.47 0.05 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.306 1.004 . . . . 3.0 111.889 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.41 174.35 6.32 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.279 -0.873 . . . . 6.48 110.878 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.2 m -109.74 101.08 45.35 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.981 -0.554 . . . . 5.57 110.067 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.52 84.8 0.47 Allowed 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.975 2.45 . . . . 5.77 112.391 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.66 -48.52 5.22 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.343 -0.703 . . . . 5.54 111.343 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -123.45 -59.5 1.54 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.043 -0.725 . . . . 8.09 109.043 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.87 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 5.4 mp0 -116.96 140.76 49.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.883 -0.599 . . . . 6.36 110.169 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -75.31 128.17 34.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.687 -0.857 . . . . 3.51 108.687 170.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' HZ ' HG11 ' A' ' 108' ' ' VAL . 84.1 t80 68.87 87.19 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.693 0.621 . . . . 2.61 110.143 -170.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.1 m 54.96 107.77 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.143 0.794 . . . . 4.74 113.143 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.87 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 10.9 t -52.64 131.2 34.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.338 -0.615 . . . . 5.89 109.338 174.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -82.33 64.21 6.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.308 0.575 . . . . 5.64 111.826 -167.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -158.63 74.32 0.67 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.554 -0.748 . . . . 9.71 109.687 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -174.45 116.58 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 7.52 110.526 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -129.07 3.35 5.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.254 0.55 . . . . 10.42 110.374 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 19.52 23.3 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.941 -0.864 . . . . 6.75 110.941 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.14 79.14 0.83 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.114 -0.543 . . . . 6.69 110.088 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -79.04 101.95 8.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.149 0.5 . . . . 7.72 109.779 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -76.45 153.15 5.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.889 -0.596 . . . . 4.38 111.49 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.35 57.78 4.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.517 -0.765 . . . . 4.18 111.444 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.9 145.54 31.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.726 -0.67 . . . . 3.12 109.344 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 24.5 mm -120.31 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.685 -0.234 . . . . 0.74 110.469 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.954 HG21 ' HB1' ' A' ' 103' ' ' ALA . 13.1 t -99.23 94.97 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 120.418 -0.513 . . . . 1.19 111.703 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 30.9 mm -80.36 115.27 22.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.206 -1.035 . . . . 1.32 108.206 170.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.865 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.9 tm? -105.72 101.13 10.66 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.487 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.019 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.1 p -79.96 142.49 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.478 0.656 . . . . 1.2 111.697 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 87' ' ' ALA . 25.3 t -136.1 173.04 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 107.583 -1.265 . . . . 1.12 107.583 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.59 112.8 5.23 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.231 0.469 . . . . 0.75 112.017 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 41.35 -97.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.599 1.16 . . . . 1.18 113.756 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.26 1.29 25.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 2.01 112.055 -169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.543 ' OD1' ' HG3' ' A' ' 93' ' ' MET . 14.1 t70 -71.24 -49.2 45.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.386 0.612 . . . . 1.09 110.635 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.765 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 86.43 -107.6 3.21 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.159 -0.928 . . . . 0.52 111.606 -175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.874 HG13 ' HB ' ' A' ' 96' ' ' THR . 30.7 t -128.81 111.75 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 122.347 0.259 . . . . 1.08 110.709 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.633 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.9 mtp -82.8 172.09 10.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.695 -0.23 . . . . 1.32 110.445 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.633 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 99.4 Cg_exo -44.17 -52.03 6.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.028 2.486 . . . . 0.61 113.658 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -65.46 -28.83 69.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.591 -0.277 . . . . 1.47 111.241 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.874 ' HB ' HG13 ' A' ' 92' ' ' VAL . 8.1 m -62.97 -30.29 71.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.248 0.547 . . . . 0.46 110.624 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 70.9 t -84.46 -52.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.286 -0.416 . . . . 1.05 111.676 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.35 -18.83 60.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.849 -0.614 . . . . 1.62 111.473 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -88.09 -39.9 14.22 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.877 -0.601 . . . . 0.34 109.543 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.865 HD11 ' HG ' ' A' ' 84' ' ' LEU . 1.7 mt -71.59 -48.96 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.38 111.311 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.475 HD22 ' HA ' ' A' ' 101' ' ' ASN . 1.0 OUTLIER -50.45 -38.52 44.01 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.965 0.506 . . . . 1.85 110.982 172.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' ' HD2' ' A' ' 68' ' ' PHE . 53.2 t60 -76.64 -33.39 58.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.744 -0.662 . . . . 0.85 110.565 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.954 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.13 -50.38 9.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.033 -0.53 . . . . 0.48 112.342 -172.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 11.8 ptmm? -59.87 -21.02 60.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.704 -0.68 . . . . 2.56 112.677 -167.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.48 10.99 30.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.707 0.632 . . . . 0.76 112.707 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -100.65 -0.12 38.09 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.035 -0.728 . . . . 0.9 109.035 174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.2 t30 75.98 41.54 0.23 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.685 1.231 . . . . 2.06 108.71 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.736 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -124.13 142.67 40.47 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 113.289 -1.778 . . . . 1.08 110.54 -174.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 19.4 Cg_exo -68.01 154.86 71.64 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.657 2.238 . . . . 0.51 113.981 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.709 HD13 HG12 ' A' ' 100' ' ' ILE . 84.7 mt -127.33 146.58 32.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.976 -1.465 . . . . 0.96 109.209 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 83' ' ' ILE . 3.4 mp -129.8 103.14 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.71 111.242 -167.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -67.42 133.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.137 -0.938 . . . . 0.23 110.237 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.34 87.69 2.8 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.826 -1.176 . . . . 0.25 107.826 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.746 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 18.5 mm -67.43 95.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.861 -1.063 . . . . 0.85 110.51 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -82.03 163.46 22.08 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.968 -0.753 . . . . 0.69 108.968 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm 63.72 20.09 12.05 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.159 0.504 . . . . 2.61 111.162 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.761 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 13.1 tpp -88.57 -6.09 57.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.833 0.825 . . . . 1.37 109.9 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' HB3' ' CB ' ' A' ' 151' ' ' SER . 2.5 p-10 -61.79 -4.01 1.35 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.001 -0.999 . . . . 2.45 112.581 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.745 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 21.0 ptmt -83.3 -172.18 0.34 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.415 -1.328 . . . . 3.7 107.415 167.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 36.8 Cg_exo -52.17 -56.42 2.93 Favored 'Trans proline' 0 C--N 1.348 0.514 0 CA-C-N 120.793 1.319 . . . . 2.67 111.366 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 11.1 pt-20 159.99 128.93 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.532 1.133 . . . . 4.03 108.205 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.64 -88.27 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.006 -0.543 . . . . 1.47 109.813 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.516 ' OD1' ' HD2' ' A' ' 126' ' ' ARG . 1.1 p30 -156.49 75.46 4.61 Favored Pre-proline 0 N--CA 1.435 -1.178 0 CA-C-N 116.554 -0.294 . . . . 1.84 111.33 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.9 Cg_exo -37.57 -67.1 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.095 3.197 . . . . 0.7 113.853 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -48.89 -49.78 38.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.882 0.473 . . . . 2.0 112.089 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 123' ' ' ASN . 2.4 tmt_? -54.73 -56.93 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.098 0.475 . . . . 2.99 109.997 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.765 HG13 ' HA2' ' A' ' 91' ' ' GLY . 93.2 t -55.71 -41.73 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 0.4 111.016 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 89.4 mtp -66.02 -33.09 75.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.037 -0.529 . . . . 0.3 110.71 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 70.3 mt-30 -73.35 -24.55 60.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.425 . . . . 1.28 111.098 177.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.8 mm-40 -64.55 -37.66 88.33 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.715 -0.846 . . . . 2.02 108.715 172.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -70.28 -46.16 64.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.466 -0.788 . . . . 1.06 109.703 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.926 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -75.16 -1.1 21.64 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.82 -0.627 . . . . 0.35 110.001 177.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.1 tt0 -78.57 -28.97 46.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 2.18 107.539 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.665 ' CE2' HG11 ' A' ' 92' ' ' VAL . 61.5 m-85 -91.99 16.08 11.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.644 -0.707 . . . . 0.74 109.589 168.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 57.4 t30 71.01 22.16 4.65 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.048 -1.433 . . . . 1.94 110.188 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 100' ' ' ILE . 7.0 mp -91.65 72.55 5.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.315 -0.857 . . . . 1.68 109.693 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -64.87 119.95 62.37 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 114.482 -1.236 . . . . 0.61 110.822 178.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.869 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 80.9 Cg_exo -47.05 160.69 0.25 Allowed 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.634 2.889 . . . . 0.3 113.57 174.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -77.29 -21.25 53.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.768 -1.105 . . . . 2.01 109.682 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.809 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -58.8 -41.11 85.99 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.302 -0.999 . . . . 1.14 108.302 168.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.926 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.6 m0 -95.85 -20.44 18.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.644 -1.162 . . . . 0.45 110.896 -170.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.98 31.6 4.7 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.315 -0.945 . . . . 0.45 112.697 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.15 -99.15 1.96 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.568 -0.825 . . . . 0.5 112.64 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.06 27.68 0.03 OUTLIER 'General case' 0 C--O 1.244 0.79 0 CA-C-O 121.68 0.753 . . . . 1.3 110.845 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 13.9 m -121.39 112.17 18.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 0.32 111.752 -176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.57 109.45 15.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.137 -0.938 . . . . 1.23 110.343 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.869 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -91.21 111.55 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.101 0.476 . . . . 0.38 111.192 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.3 m -105.9 100.0 9.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.036 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.761 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 19.2 pttp -81.37 91.96 6.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.726 -0.842 . . . . 2.44 108.726 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.859 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 1.1 pt? -119.31 -171.39 2.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.137 0.97 . . . . 1.27 112.851 -166.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 33.7 t -157.96 129.56 6.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.877 -1.511 . . . . 1.79 109.638 170.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -88.73 -25.64 22.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.815 -0.629 . . . . 0.87 110.809 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 154' ' ' THR . 8.3 ptmm? -76.68 -53.5 7.92 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.403 0.62 . . . . 3.03 110.061 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 153' ' ' LYS . 81.2 p -72.49 -14.97 61.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.868 -1.06 . . . . 1.2 110.504 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 69.59 17.0 7.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.182 -0.917 . . . . 2.27 111.107 175.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.29 -62.07 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.994 0.902 . . . . 2.64 109.993 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.859 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -75.01 -16.61 80.49 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.686 -1.143 . . . . 0.62 113.514 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 158' ' ' LEU . 1.8 tm? -56.4 -47.37 79.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.909 -0.774 . . . . 1.55 108.909 174.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.614 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -58.02 -53.4 58.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.362 -0.836 . . . . 2.5 110.304 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -60.99 -22.77 64.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.723 -0.672 . . . . 0.73 111.749 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 1.2 tm? -69.77 -53.2 19.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.382 -0.372 . . . . 0.91 110.032 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 159' ' ' ASP . 4.2 pp -65.84 -30.52 71.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.654 0.264 . . . . 1.06 110.321 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.5 mm-40 -58.28 -38.97 78.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.035 -0.529 . . . . 2.49 110.723 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.25 -32.56 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.2 -0.454 . . . . 0.87 111.096 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 168' ' ' VAL . 72.8 mt -59.77 -52.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.511 -0.313 . . . . 0.64 110.929 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -68.96 -30.83 69.35 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.89 0.376 . . . . 1.81 111.372 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 166' ' ' LEU . 65.3 tp -55.51 -31.09 61.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.44 -0.8 . . . . 1.42 110.148 173.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 165' ' ' ILE . 41.0 t -73.03 -44.48 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 115.563 -0.744 . . . . 1.17 109.949 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.2 m -63.2 -15.39 56.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.366 0.603 . . . . 1.54 110.786 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -86.8 -62.91 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.806 -0.634 . . . . 2.79 109.827 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -71.41 -30.82 66.54 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.784 0.661 . . . . 1.82 112.784 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 29.5 mm-40 -65.1 -22.05 66.89 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.844 -0.342 . . . . 3.45 111.29 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -73.49 -18.98 61.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.4 -0.364 . . . . 3.36 110.607 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 174' ' ' LEU . 3.9 mm? -103.63 -78.01 0.56 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 4.14 111.204 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.9 5.2 0.19 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.207 0.447 . . . . 6.31 112.207 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 69.14 -112.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.605 0.566 . . . . 4.57 111.405 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.648 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 21.4 t-20 -88.87 -56.79 0.28 Allowed Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.961 0.356 . . . . 6.38 111.961 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 5.2 Cg_exo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.658 2.239 . . . . 7.47 112.559 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 111.752 -0.539 . . . . 16.35 111.752 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -106.98 136.62 46.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 14.69 110.494 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -101.35 14.6 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.37 0.605 . . . . 14.68 109.864 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.1 ttm -74.7 95.08 2.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.453 -0.573 . . . . 12.73 109.453 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.16 110.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 10.18 111.041 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -95.74 166.15 11.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 9.14 110.317 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 58.45 75.7 0.51 Allowed Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 123.752 0.658 . . . . 8.35 111.948 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 63.0 Cg_endo -74.32 149.28 39.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.376 2.051 . . . . 4.6 111.371 175.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 41.7 Cg_exo -57.89 91.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.086 2.524 . . . . 4.29 112.732 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 60' ' ' LEU . 13.1 m -86.02 119.3 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 2.58 110.695 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 81' ' ' ILE . 54.7 t -117.11 118.62 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.586 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.504 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 11.8 m -86.24 130.7 34.43 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.024 -0.535 . . . . 0.66 110.943 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -95.9 122.98 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.92 0.391 . . . . 1.03 110.376 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.404 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 50.0 mtt -138.24 175.69 9.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.565 0.697 . . . . 1.04 112.214 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.51 -100.27 0.35 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.838 -1.305 . . . . 1.55 109.838 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 16.0 t60 -160.1 132.68 6.47 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.053 -1.091 . . . . 0.66 108.053 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.793 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 14.0 p -62.17 -29.67 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.501 -0.772 . . . . 1.62 112.704 -167.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.92 -27.18 22.31 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.288 0.477 . . . . 1.78 112.288 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -56.54 -52.24 65.53 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.287 0.565 . . . . 0.65 111.098 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 177.14 33.45 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.4 -0.818 . . . . 0.93 111.096 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.793 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 12.6 tmtt? -88.43 -56.19 3.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.974 0.416 . . . . 2.11 110.277 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -68.19 -30.76 69.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.489 . . . . 1.8 110.062 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -77.06 -27.62 54.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 116.001 -0.545 . . . . 1.77 110.571 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 8.5 tt -65.98 -50.49 64.14 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.466 -0.568 . . . . 1.78 109.466 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 28' ' ' ILE . 4.9 tt -57.7 -40.51 79.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.762 -0.654 . . . . 1.96 110.195 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 24.7 t70 -70.73 -50.0 40.84 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.813 -0.355 . . . . 1.38 111.553 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.54 75.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.17 0.509 . . . . 0.91 111.142 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 25' ' ' LEU . 7.2 tt -70.25 -33.93 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.355 -0.838 . . . . 1.56 110.856 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.819 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 60.9 mtm180 -71.21 -33.97 70.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.474 0.654 . . . . 3.56 109.546 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -82.12 14.94 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.35 -0.841 . . . . 2.88 110.169 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 32' ' ' LYS . 34.5 t -123.76 -59.69 1.5 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.822 -0.627 . . . . 1.76 109.998 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -110.58 -177.13 3.15 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.546 0.689 . . . . 5.71 111.284 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.26 137.97 52.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.731 -1.122 . . . . 2.99 111.169 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m 153.57 -26.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 O-C-N 125.605 1.816 . . . . 3.93 110.073 169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.819 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -61.64 146.87 47.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 4.2 112.311 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -129.16 -74.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.576 -0.738 . . . . 5.38 110.319 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.703 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 2.9 pt-20 -56.65 -68.13 0.25 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.943 -0.572 . . . . 5.79 110.02 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . 42.54 81.12 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.988 0.805 . . . . 4.24 113.092 168.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.06 79.66 0.14 Allowed Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.297 -0.721 . . . . 4.95 111.297 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' H ' HD13 ' A' ' 25' ' ' LEU . . . -77.21 40.19 1.7 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.337 -0.459 . . . . 6.66 113.457 -174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.44 -30.53 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.478 -0.564 . . . . 9.17 109.478 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 m -77.44 118.67 20.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 7.36 110.661 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -79.9 57.36 2.57 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.888 0.852 . . . . 8.83 110.841 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -145.38 -49.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.933 -1.03 . . . . 6.76 108.269 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.836 HG13 ' H ' ' A' ' 46' ' ' GLY . 9.9 tp -177.05 -176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.543 -1.28 . . . . 5.19 107.543 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.836 ' H ' HG13 ' A' ' 45' ' ' ILE . . . 142.85 44.87 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.759 -0.734 . . . . 2.97 111.661 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.703 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -99.64 -169.56 1.77 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.282 -0.636 . . . . 1.71 109.282 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.78 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 10.6 p90 -170.24 166.24 8.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.131 0.491 . . . . 2.54 111.358 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -116.14 154.75 29.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.108 -1.071 . . . . 1.96 108.108 172.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.26 131.23 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.93 111.785 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 54' ' ' ASP . 8.3 m -81.61 94.92 7.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.674 0.75 . . . . 2.06 109.2 171.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 54' ' ' ASP . 5.8 p -127.92 113.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.461 -0.94 . . . . 4.12 108.461 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t30 70.97 -39.06 0.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.049 -0.978 . . . . 4.43 110.198 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 51' ' ' THR . 36.5 t70 -147.13 -86.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.53 -0.759 . . . . 3.62 112.874 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 36.4 ttpt 158.51 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 7.44 110.009 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 62.4 mttp -105.76 -24.13 12.57 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.042 0.756 . . . . 5.43 113.042 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 51.4 mt -74.33 109.23 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.266 -0.574 . . . . 1.14 110.948 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 m -98.89 112.1 24.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.573 -0.739 . . . . 1.28 109.492 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.572 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 41.9 m-85 -85.77 120.45 27.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.84 111.477 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 12' ' ' THR . 3.5 mm? -89.75 102.48 15.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.105 -0.702 . . . . 3.0 109.105 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 14.9 t70 -80.9 149.1 29.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.775 -0.648 . . . . 6.48 111.201 -175.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.867 HG22 ' HB3' ' A' ' 67' ' ' ALA . 2.0 p -103.48 93.33 4.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 5.57 110.603 175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 61' ' ' ASP . 83.3 Cg_endo -88.32 55.57 2.4 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.787 2.325 . . . . 5.77 112.774 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.56 -127.06 1.47 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.606 -0.807 . . . . 5.54 112.49 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -117.66 -47.51 2.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.685 0.279 . . . . 8.09 110.861 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -117.19 130.81 56.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.005 0.431 . . . . 6.36 110.451 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.867 ' HB3' HG22 ' A' ' 62' ' ' THR . . . -170.68 179.07 3.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 3.51 109.748 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' HE1' ' HA ' ' A' ' 103' ' ' ALA . 24.2 t80 -166.83 179.56 5.25 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.665 -0.865 . . . . 2.61 108.665 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 m -49.32 -46.48 46.78 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.855 0.462 . . . . 4.74 111.936 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 m -151.01 97.62 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.95 0.405 . . . . 5.89 111.106 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.8 mmt -86.15 88.42 7.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 5.64 109.946 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -155.34 -59.9 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.426 -0.352 . . . . 9.71 111.19 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.63 -168.52 1.82 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 7.52 111.547 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 74' ' ' ARG . 1.7 tpm_? -51.31 -49.28 61.63 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.937 0.773 . . . . 10.42 111.45 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.26 108.18 0.67 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.914 -0.585 . . . . 6.75 111.905 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.14 -14.94 19.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.25 0.548 . . . . 6.69 110.482 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -82.23 110.28 17.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.507 -0.77 . . . . 7.72 110.315 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.5 m -87.08 -32.01 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.99 -0.55 . . . . 4.38 110.721 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.472 ' HB ' ' OE2' ' A' ' 172' ' ' GLU . 23.5 p -146.38 123.81 11.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.991 -0.549 . . . . 4.18 110.242 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -140.46 -172.08 3.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.45 -0.574 . . . . 3.12 109.45 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 11' ' ' VAL . 46.1 mm -123.26 116.65 49.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 111.263 0.098 . . . . 0.74 111.263 -172.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.911 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.9 t -97.41 106.03 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.652 0.263 . . . . 1.19 111.562 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.608 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 12.2 mm -89.72 106.72 17.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.651 -0.5 . . . . 1.32 109.651 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.627 HD22 HD11 ' A' ' 100' ' ' ILE . 8.4 tp -92.9 126.06 37.8 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.075 -0.511 . . . . 1.33 110.619 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.68 140.56 19.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 122.009 -0.432 . . . . 1.2 112.043 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.0 m -135.03 -177.34 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 108.94 -0.763 . . . . 1.12 108.94 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 126.66 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.875 0.694 . . . . 0.75 112.875 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 121' ' ' GLU . . . 42.92 -104.41 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.302 1.223 . . . . 1.18 114.302 168.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -112.15 -8.65 13.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.813 -173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 2.8 t70 -62.83 -38.66 91.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.208 -0.664 . . . . 1.09 109.208 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 127' ' ' VAL . . . 78.98 -147.14 30.21 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.891 -1.05 . . . . 0.52 112.408 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.595 HG12 HG23 ' A' ' 97' ' ' VAL . 79.1 t -88.21 100.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 114.995 -0.602 . . . . 1.08 109.938 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 10.3 mtp -70.95 167.75 26.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 1.32 111.411 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 83.0 Cg_exo -47.37 -41.48 28.59 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.507 2.138 . . . . 0.61 112.435 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.668 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 4.6 mm-40 -65.74 -42.11 91.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.024 0.44 . . . . 1.47 110.187 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.624 HG22 HD21 ' A' ' 84' ' ' LEU . 3.5 m -61.06 -30.51 70.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.46 110.11 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 92' ' ' VAL . 44.3 t -78.07 -52.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.048 -0.978 . . . . 1.05 111.594 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' PRO . 9.0 pt-20 -65.04 -32.25 73.88 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 1.62 111.681 -176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -66.29 -42.73 87.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.547 0.689 . . . . 0.34 109.404 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.977 HG12 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -68.19 -43.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.98 -1.009 . . . . 0.38 110.81 176.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.5 -27.25 62.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.909 -0.587 . . . . 1.85 110.743 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -85.57 -36.13 20.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.85 110.413 175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.911 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -83.18 -49.54 9.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.554 0.576 . . . . 0.48 112.554 -172.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HD3' HG23 ' A' ' 100' ' ' ILE . 41.3 pttt -61.99 -16.88 54.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.669 0.618 . . . . 2.56 112.669 -167.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.87 10.54 36.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.371 0.508 . . . . 0.76 112.371 -174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.666 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -99.57 4.09 45.69 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 0.9 109.768 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 86.13 6.11 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.461 1.124 . . . . 2.06 108.794 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -93.11 142.79 25.8 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.169 -1.832 . . . . 1.08 111.585 -174.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.17 160.15 50.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.945 2.43 . . . . 0.51 113.447 173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.977 HD13 HG12 ' A' ' 100' ' ' ILE . 91.9 mt -127.54 150.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.163 -0.926 . . . . 0.96 110.394 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 mp -121.79 154.75 26.15 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.687 -0.857 . . . . 0.71 108.687 -175.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -118.25 140.86 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 120.667 0.27 . . . . 0.23 110.494 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.42 89.04 3.0 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.207 -1.034 . . . . 0.25 108.207 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 86' ' ' VAL . 33.0 mt -73.54 94.95 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.587 -1.188 . . . . 0.85 111.075 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.76 156.55 24.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.537 0.208 . . . . 0.69 110.977 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt 59.2 33.86 22.89 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.863 0.84 . . . . 2.61 109.989 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.974 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 2.4 tpp -88.49 -22.46 23.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.015 -0.993 . . . . 1.37 110.98 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -53.71 -30.87 45.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.561 0.696 . . . . 2.45 109.825 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -97.0 149.74 36.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 114.916 -1.038 . . . . 3.7 109.85 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.2 -3.04 0.44 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.463 3.442 . . . . 2.67 114.545 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . 64.3 mm-40 -61.18 -32.91 72.65 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.179 0.592 . . . . 4.03 110.471 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.417 ' HA ' ' C ' ' A' ' 88' ' ' ALA . . . -81.65 133.74 35.4 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.902 -0.59 . . . . 1.47 112.132 -174.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.475 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 28.4 t-20 -131.02 93.49 30.6 Favored Pre-proline 0 CA--C 1.511 -0.549 0 CA-C-O 122.289 1.043 . . . . 1.84 109.996 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.599 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -27.85 -75.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 1 C-N-CA 126.124 4.549 . . . . 0.7 115.46 169.407 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -43.7 -53.4 5.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.17 0.588 . . . . 2.0 112.293 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 11.8 tpt180 -53.07 -65.27 0.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.229 0.538 . . . . 2.99 110.185 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.475 HG22 ' HA2' ' A' ' 91' ' ' GLY . 47.1 t -55.27 -42.36 65.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.451 -1.249 . . . . 0.4 111.41 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.822 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 83.1 mtp -73.1 -30.83 63.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.141 -0.936 . . . . 0.3 111.405 -174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.08 -27.77 32.73 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.475 -0.49 . . . . 1.28 111.123 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 9.6 mt-10 -61.78 -40.09 93.96 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.016 -1.105 . . . . 2.02 108.016 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.887 HD21 HG21 ' A' ' 145' ' ' THR . 1.0 OUTLIER -71.45 -46.82 58.98 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 115.459 -0.791 . . . . 1.06 111.267 -172.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.939 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 2.2 ppp? -67.36 -8.64 34.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.49 -0.777 . . . . 0.35 109.915 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -78.1 -28.17 48.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.667 -0.864 . . . . 2.18 108.667 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -82.07 -1.95 50.23 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.816 0.817 . . . . 0.74 108.803 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 135' ' ' ASN . 1.5 t-20 76.78 42.95 0.14 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 113.101 -1.863 . . . . 1.94 111.203 163.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 0.9 OUTLIER -123.05 86.75 2.63 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.942 -1.873 . . . . 1.68 105.942 167.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.43 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.44 131.91 94.24 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.789 -1.55 . . . . 0.61 111.313 -171.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.715 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 88.2 Cg_exo -46.87 152.64 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.178 2.585 . . . . 0.3 113.296 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.97 -30.57 62.58 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.078 -1.419 . . . . 2.01 108.469 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.837 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -51.34 -45.28 62.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.41 -1.268 . . . . 1.14 109.485 170.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.939 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.0 m0 -89.53 -21.98 22.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.366 -1.288 . . . . 0.45 110.598 -170.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.31 18.5 4.95 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.049 -1.072 . . . . 0.45 112.678 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.43 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.09 -115.54 3.08 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.701 -0.762 . . . . 0.5 112.499 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.07 30.06 0.64 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.886 0.374 . . . . 1.3 111.485 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.887 HG21 HD21 ' A' ' 131' ' ' LEU . 24.9 m -129.22 108.99 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.857 -0.737 . . . . 0.32 112.175 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 164' ' ' MET . 2.2 mp -80.15 110.83 16.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.77 . . . . 1.23 110.698 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.822 ' CE2' ' HG2' ' A' ' 128' ' ' MET . 19.4 m-85 -88.09 115.54 25.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.19 0.519 . . . . 0.38 111.311 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 63.9 m -104.03 117.13 33.56 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.054 -0.721 . . . . 1.1 109.054 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.974 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 14.5 pttp -98.16 85.95 3.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.106 0.955 . . . . 2.44 109.72 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.691 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -110.64 -179.62 3.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.988 -1.005 . . . . 1.27 112.534 -170.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 10.1 t -143.46 131.7 21.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.418 -1.265 . . . . 1.79 109.196 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.484 0.659 . . . . 0.87 109.93 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -92.51 -58.92 2.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.371 -0.831 . . . . 3.03 110.038 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 151' ' ' SER . 3.9 m -68.71 -29.67 68.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.654 -1.157 . . . . 1.2 110.644 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 58.88 26.8 15.33 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.507 -1.224 . . . . 2.27 111.414 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -83.4 -45.84 13.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.86 0.838 . . . . 2.64 109.81 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -75.6 -11.65 84.28 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 115.01 -0.996 . . . . 0.62 112.668 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 158' ' ' LEU . 26.2 mt -64.18 -39.81 94.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 1.55 110.475 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -78.87 -37.5 40.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.38 -0.373 . . . . 2.5 110.089 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 164' ' ' MET . 65.1 t60 -59.45 -37.21 77.57 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.069 -0.514 . . . . 0.73 109.986 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 165' ' ' ILE . 63.5 tp -60.61 -58.32 8.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.91 110.528 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.567 ' HA ' HD12 ' A' ' 165' ' ' ILE . 89.8 mt -54.24 -39.49 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.944 -0.571 . . . . 1.06 111.357 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.45 -41.33 96.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 2.49 111.251 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.75 ' HB3' HG21 ' A' ' 146' ' ' ILE . 29.8 mmt -69.89 -38.54 76.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.879 0.371 . . . . 0.87 110.096 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 83' ' ' ILE . 80.7 mt -54.72 -54.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.64 110.242 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.45 -38.09 89.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.49 -0.777 . . . . 1.81 111.104 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.64 -42.22 87.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 1.42 110.312 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 45.3 t -76.39 -35.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 116.354 -0.385 . . . . 1.17 110.978 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.2 t -57.74 -22.41 46.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 1.54 110.063 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -97.23 -38.96 9.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.482 -0.781 . . . . 2.79 110.426 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 23.5 ttp -87.3 5.86 36.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 1.82 112.095 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.472 ' OE2' ' HB ' ' A' ' 79' ' ' THR . 8.4 mm-40 -34.73 -26.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.07 1.137 . . . . 3.45 114.07 173.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.62 -15.62 20.21 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 122.349 0.26 . . . . 3.36 111.281 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.7 tp -46.98 -50.68 18.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.117 0.567 . . . . 4.14 111.577 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -118.33 104.71 11.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.783 -0.644 . . . . 6.31 109.284 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.32 136.78 32.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.166 0.508 . . . . 4.57 111.834 -172.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.8 p30 -116.57 133.98 22.95 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 6.38 109.293 174.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.1 Cg_exo . . . . . 0 C--O 1.249 1.061 0 C-N-CA 123.138 2.558 . . . . 7.47 112.339 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 111.609 -0.597 . . . . 16.35 111.609 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -81.53 -14.51 56.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.771 0.32 . . . . 14.69 111.743 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.28 37.98 13.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.521 -0.763 . . . . 14.68 111.22 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.4 mtt -68.31 -25.12 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.172 0.51 . . . . 12.73 109.937 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.5 -10.67 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.476 -0.784 . . . . 10.18 110.729 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -98.94 85.25 3.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.013 -0.736 . . . . 9.14 109.013 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -138.56 58.84 15.1 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.369 -0.378 . . . . 8.35 110.515 -177.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.09 -59.44 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.596 2.197 . . . . 4.6 115.058 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 8' ' ' PRO . 86.1 Cg_endo -92.68 35.86 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.051 1.834 . . . . 4.29 113.758 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' CG2' ' HG3' ' A' ' 7' ' ' ARG . 89.6 t -108.77 104.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.305 0.574 . . . . 2.58 109.837 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.599 HG11 HD11 ' A' ' 83' ' ' ILE . 51.5 t -113.11 137.63 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.569 -172.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.451 ' OG1' HG21 ' A' ' 79' ' ' THR . 82.9 m -104.36 136.3 44.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.66 110.741 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG22 ' HE2' ' A' ' 21' ' ' LYS . 56.3 mt -92.96 124.16 45.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.078 0.466 . . . . 1.03 110.684 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.684 ' HG3' ' HB1' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -108.69 -175.04 2.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.365 -0.834 . . . . 1.04 110.326 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.949 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 109.15 133.9 6.91 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.27 -0.967 . . . . 1.55 111.834 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 65.8 t60 -44.58 135.88 4.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.564 -0.818 . . . . 0.66 110.887 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.08 -29.33 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.93 -1.032 . . . . 1.62 113.563 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 26.8 t70 -86.23 -21.78 27.25 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.045 0.387 . . . . 1.78 112.045 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.483 ' HB2' HG13 ' A' ' 85' ' ' VAL . 51.5 m170 -61.8 -35.92 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.65 111.14 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 152.55 71.49 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.175 -1.012 . . . . 0.93 113.041 176.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 28.9 mmtp -90.38 -71.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.029 0.443 . . . . 2.11 110.98 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 t -64.5 -30.69 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.687 -0.688 . . . . 1.8 110.604 -177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -73.41 -26.17 60.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.292 -0.413 . . . . 1.77 110.787 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 2.3 tm? -79.35 -49.77 11.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.363 -0.977 . . . . 1.78 108.363 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.776 -1.102 . . . . 1.96 110.588 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -67.62 -56.53 9.05 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.174 -0.329 . . . . 1.38 111.794 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.56 92.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.316 -0.402 . . . . 0.91 110.849 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.651 HD13 ' OH ' ' A' ' 48' ' ' TYR . 6.7 tt -63.9 -32.91 58.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.029 -0.532 . . . . 1.56 110.128 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.655 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 70.4 mtp180 -70.4 -34.68 72.82 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.306 0.574 . . . . 3.56 110.657 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -77.59 14.48 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.517 -0.765 . . . . 2.88 111.028 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.747 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -88.91 -13.05 39.97 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.538 -0.912 . . . . 1.76 108.538 175.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 31' ' ' SER . 16.9 ptmt 64.26 -14.84 0.09 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.862 1.801 . . . . 5.71 115.862 160.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -54.98 -27.95 19.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.203 0.446 . . . . 2.99 112.203 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.9 m -167.67 -41.32 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.891 0.376 . . . . 3.93 111.795 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.655 ' HG3' ' HA ' ' A' ' 29' ' ' ARG . 1.4 pm0 -59.71 145.85 43.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.566 0.95 . . . . 4.2 113.566 -166.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.14 -161.04 1.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.998 -1.456 . . . . 5.38 110.594 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.45 -29.45 28.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.8 0.333 . . . . 5.79 111.861 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.784 ' HB1' ' HA ' ' A' ' 45' ' ' ILE . . . -140.89 162.0 36.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.635 -0.257 . . . . 4.24 110.79 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.62 -34.42 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.436 -0.888 . . . . 4.95 112.995 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.519 ' HA3' ' H ' ' A' ' 48' ' ' TYR . . . -70.68 62.58 0.89 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.281 0.472 . . . . 6.66 114.281 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.501 HG12 ' HA3' ' A' ' 46' ' ' GLY . 24.2 mm -148.7 -54.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.941 -1.133 . . . . 9.17 107.941 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.816 HG23 ' H ' ' A' ' 43' ' ' GLN . 1.3 t -145.53 -82.57 0.14 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.723 -1.126 . . . . 7.36 109.681 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.816 ' H ' HG23 ' A' ' 42' ' ' THR . 12.8 pt20 -157.75 31.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 8.83 109.821 172.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -120.58 -94.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.371 -0.831 . . . . 6.76 110.917 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.784 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 2.6 pp -126.58 172.07 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 5.19 110.223 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA3' HG12 ' A' ' 41' ' ' ILE . . . 141.5 -85.95 0.2 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.311 -0.947 . . . . 2.97 112.672 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.92 -100.08 0.25 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.844 0.313 . . . . 1.71 111.844 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.651 ' OH ' HD13 ' A' ' 28' ' ' ILE . 9.6 p90 -169.37 178.97 4.06 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.953 0.406 . . . . 2.54 111.238 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -136.41 131.93 34.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.828 -0.805 . . . . 1.96 108.828 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 162' ' ' LEU . 61.0 t -97.56 153.33 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.541 0.686 . . . . 1.93 110.975 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 54' ' ' ASP . 71.2 m -131.32 82.8 2.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.473 -1.24 . . . . 2.06 110.653 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.9 p -116.55 122.01 68.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.473 -1.306 . . . . 4.12 107.473 170.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 74.13 -11.55 0.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.029 0.919 . . . . 4.43 109.694 -172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.75 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.6 t70 79.28 42.22 0.08 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.039 -1.891 . . . . 3.62 110.14 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -81.61 -22.12 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.093 -0.958 . . . . 7.44 109.949 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 55.86 73.37 0.44 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.884 -0.598 . . . . 5.43 111.196 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.1 mt -89.35 123.97 41.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.405 -0.816 . . . . 1.14 110.784 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -84.83 124.75 31.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.768 -0.456 . . . . 1.28 109.768 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -107.69 119.08 38.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.641 0.258 . . . . 0.84 110.581 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 69' ' ' THR . 87.0 mt -86.61 119.53 26.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.08 -0.509 . . . . 3.0 110.471 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.26 135.76 35.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.818 -0.628 . . . . 6.48 110.677 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -125.74 77.85 69.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 5.57 111.477 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.19 -22.94 21.71 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.455 2.103 . . . . 5.77 112.132 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.64 62.26 0.28 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.925 -0.655 . . . . 5.54 112.352 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -148.99 137.66 21.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.543 0.211 . . . . 8.09 110.438 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -114.05 -31.92 6.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.195 -0.457 . . . . 6.36 110.104 178.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.43 60.91 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.85 -0.614 . . . . 3.51 110.474 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.773 ' HD1' ' HD2' ' A' ' 102' ' ' HIS . 5.1 m-85 62.7 -99.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.28 -0.873 . . . . 2.61 110.651 -175.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.42 HG23 HG23 ' A' ' 12' ' ' THR . 3.9 p -133.99 -82.21 0.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.956 0.407 . . . . 4.74 111.065 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -112.24 21.73 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.673 0.749 . . . . 5.89 109.513 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.48 ' HG3' ' HA2' ' A' ' 75' ' ' GLY . 55.9 ttm -79.42 68.42 5.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.208 -0.905 . . . . 5.64 110.283 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -90.46 -48.31 7.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.962 -0.563 . . . . 9.71 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.24 -77.08 0.59 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.837 -0.345 . . . . 7.52 111.586 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -96.46 27.67 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.321 0.582 . . . . 10.42 110.86 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.48 ' HA2' ' HG3' ' A' ' 71' ' ' MET . . . 83.78 -55.82 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.895 -0.669 . . . . 6.75 112.801 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 70.01 -60.95 0.47 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.599 0.76 . . . . 6.69 111.973 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -111.41 100.64 9.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.977 -0.379 . . . . 7.72 109.977 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 50.2 t -66.54 128.18 29.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.935 -0.575 . . . . 4.38 110.6 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.451 HG21 ' OG1' ' A' ' 12' ' ' THR . 7.0 t -164.42 132.09 3.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.069 -0.514 . . . . 4.18 110.059 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -126.06 25.18 6.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 3.12 110.882 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.413 ' HB ' HG22 ' A' ' 11' ' ' VAL . 36.0 mm -128.22 118.08 47.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.22 -0.446 . . . . 0.74 110.161 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 73.1 t -113.24 112.71 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.022 -0.535 . . . . 1.19 111.46 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.77 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.9 mt -94.96 99.97 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 C-N-CA 120.264 -0.574 . . . . 1.32 110.049 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 100' ' ' ILE . 6.7 tp -87.1 113.14 22.59 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.693 -0.403 . . . . 1.33 110.796 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.949 HG12 ' HA3' ' A' ' 15' ' ' GLY . 8.7 p -81.39 142.41 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 1.2 110.667 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 87' ' ' ALA . 18.2 t -134.68 175.27 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 107.489 -1.3 . . . . 1.12 107.489 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 86' ' ' VAL . . . -148.02 114.7 6.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.623 0.647 . . . . 0.75 112.497 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 40.63 -96.88 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.84 1.052 . . . . 1.18 113.84 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 122' ' ' ALA . 10.9 p-10 -108.11 -3.1 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 2.01 111.891 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 3.8 t70 -71.05 -45.24 64.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.185 0.517 . . . . 1.09 110.423 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.74 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 81.41 -109.8 3.06 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.195 -0.911 . . . . 0.52 111.84 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.558 HG13 ' HB ' ' A' ' 96' ' ' THR . 42.5 t -124.73 109.25 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.053 0.454 . . . . 1.08 111.349 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 65.4 mmm -80.48 168.84 22.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.055 -0.521 . . . . 1.32 110.246 173.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 82.7 Cg_exo -47.0 -50.07 11.55 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.633 2.222 . . . . 0.61 112.877 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.95 -37.02 73.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.47 111.041 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.59 HG23 HD11 ' A' ' 84' ' ' LEU . 33.7 m -63.39 -25.95 68.52 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.235 -0.438 . . . . 0.46 111.038 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG23 ' CG1' ' A' ' 92' ' ' VAL . 22.5 t -85.88 -55.54 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 112.177 0.436 . . . . 1.05 112.177 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.2 -21.56 61.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.9 0.381 . . . . 1.62 110.953 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.684 ' HB1' ' HG3' ' A' ' 14' ' ' MET . . . -82.18 -34.56 28.99 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 0.34 109.997 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.767 HD11 HD22 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -77.83 -44.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.38 110.41 177.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -55.1 -37.39 66.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.464 -0.789 . . . . 1.85 111.206 172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.773 ' HD2' ' HD1' ' A' ' 68' ' ' PHE . 20.3 t60 -79.5 -25.72 41.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 0.85 110.521 176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -86.0 -59.49 2.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.284 0.476 . . . . 0.48 112.284 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -17.25 63.95 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.286 0.476 . . . . 2.56 112.286 -167.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.22 5.3 17.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.849 0.357 . . . . 0.76 111.891 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.85 8.38 30.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.667 -0.864 . . . . 0.9 108.667 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.8 t30 75.44 30.38 0.83 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.361 -1.29 . . . . 2.06 110.242 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.8 OUTLIER -107.97 146.48 33.56 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.245 -0.889 . . . . 1.08 110.734 178.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 5.7 Cg_exo -76.15 158.16 37.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.369 2.713 . . . . 0.51 113.311 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 145' ' ' THR . 4.4 mp -124.27 154.57 31.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.084 -0.962 . . . . 0.96 109.583 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.77 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 6.1 mt -118.94 155.83 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 108.353 -0.98 . . . . 0.71 108.353 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -119.77 134.13 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.002 0.429 . . . . 0.23 110.249 174.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.99 88.01 2.86 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.111 -1.07 . . . . 0.25 108.111 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.823 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 13.8 mm -66.85 95.1 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.042 -0.981 . . . . 0.85 110.148 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 55.0 t30 -92.85 169.02 10.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.164 -0.68 . . . . 0.69 109.164 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HD3' ' HB1' ' A' ' 87' ' ' ALA . 55.7 mtpt 58.51 26.37 14.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.688 0.756 . . . . 2.61 110.056 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.551 ' SD ' ' HE2' ' A' ' 149' ' ' LYS . 5.2 tpp -95.97 2.62 53.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.973 -1.012 . . . . 1.37 110.269 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.96 43.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.17 -0.923 . . . . 2.45 111.09 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 58.4 mttm -125.07 -175.33 0.39 Allowed Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.368 -1.715 . . . . 3.7 106.368 176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 31.3 Cg_exo -56.16 -51.87 8.5 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 CA-C-N 120.277 1.135 . . . . 2.67 110.353 169.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 6.4 pt-20 157.73 132.98 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 125.373 1.469 . . . . 4.03 107.364 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 89' ' ' ASP . . . -68.61 -72.96 0.16 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.67 -0.863 . . . . 1.47 108.67 168.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 11.2 t-20 177.11 81.4 0.12 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.459 -0.791 . . . . 1.84 109.66 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.63 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.3 Cg_exo -38.95 -61.98 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.077 3.185 . . . . 0.7 113.694 175.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -47.21 -49.68 22.47 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.68 0.622 . . . . 2.0 112.68 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 2.0 tmt_? -53.77 -56.44 17.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.325 0.583 . . . . 2.99 109.58 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.74 HG13 ' HA2' ' A' ' 91' ' ' GLY . 88.3 t -56.78 -41.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.787 -1.097 . . . . 0.4 110.847 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.673 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -67.07 -32.86 74.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.954 -0.567 . . . . 0.3 110.943 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 75.1 mt-30 -75.75 -24.32 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.665 -0.243 . . . . 1.28 110.883 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 9.6 mm-40 -63.48 -39.92 95.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.598 -0.89 . . . . 2.02 108.598 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.4 mm? -68.42 -46.6 69.45 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 115.52 -0.764 . . . . 1.06 110.016 -177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.827 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -73.44 -5.49 40.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.618 -0.719 . . . . 0.35 110.276 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 43.8 tt0 -76.56 -28.56 56.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.457 -0.942 . . . . 2.18 108.457 171.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.451 ' CE2' HG11 ' A' ' 92' ' ' VAL . 42.7 m-85 -90.49 13.01 16.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.507 0.67 . . . . 0.74 109.309 169.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 68.94 37.93 2.15 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.212 -1.358 . . . . 1.94 109.216 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.441 ' N ' ' HA ' ' A' ' 132' ' ' MET . 5.1 mp -105.7 70.97 0.89 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.575 -1.193 . . . . 1.68 109.471 170.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.991 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -67.45 121.02 77.14 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.016 -0.993 . . . . 0.61 109.677 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.844 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.5 Cg_exo -48.64 157.94 1.3 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.833 2.355 . . . . 0.3 112.969 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.8 -22.64 42.84 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.918 -1.037 . . . . 2.01 108.204 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 7.6 mp0 -46.46 -48.56 18.97 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.148 -1.387 . . . . 1.14 109.714 161.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.827 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.9 m0 -96.0 -30.07 13.79 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.533 -1.667 . . . . 0.45 110.896 -166.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.81 22.12 3.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.303 -0.951 . . . . 0.45 112.985 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.991 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.3 -113.91 2.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.445 -0.883 . . . . 0.5 112.725 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -152.44 32.9 0.51 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.193 0.521 . . . . 1.3 111.356 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 23.3 m -134.91 123.49 23.5 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.29 -0.564 . . . . 0.32 111.825 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.761 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.2 mp -92.68 109.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.366 -0.379 . . . . 1.23 110.55 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.844 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -86.35 134.77 33.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.173 0.511 . . . . 0.38 111.098 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.4 m -131.44 107.8 9.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.454 -0.794 . . . . 1.1 110.03 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.823 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 8.9 ptmm? -85.51 86.17 7.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.691 0.758 . . . . 2.44 109.89 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -103.92 -167.23 1.34 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.256 1.027 . . . . 1.27 112.129 -169.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p -161.36 116.08 2.04 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.802 -1.545 . . . . 1.79 109.318 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.29 -0.84 18.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.178 0.513 . . . . 0.87 111.029 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -83.46 -55.41 4.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.807 0.813 . . . . 3.03 109.681 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.5 p -98.85 -20.64 16.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.548 -1.206 . . . . 1.2 111.395 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 158' ' ' LEU . 9.7 mtpm? 72.75 18.1 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 2.27 112.132 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -54.49 -70.51 0.1 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.826 0.822 . . . . 2.64 110.729 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -75.64 -7.48 83.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.128 -0.942 . . . . 0.62 112.945 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -72.28 -51.18 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.634 -0.506 . . . . 1.55 109.634 -178.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.98 -30.61 70.78 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.447 -0.575 . . . . 2.5 109.447 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.594 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 84.9 t60 -66.49 -25.76 66.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.42 -0.809 . . . . 0.73 110.888 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 158' ' ' LEU . 56.0 tp -67.17 -47.57 70.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.461 . . . . 0.91 110.014 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.698 HD13 HG11 ' A' ' 50' ' ' VAL . 32.8 mt -58.64 -38.78 78.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.461 -0.79 . . . . 1.06 111.277 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 13.5 pt-20 -71.8 -32.35 67.51 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.127 -0.323 . . . . 2.49 110.127 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.761 ' HB3' HG21 ' A' ' 146' ' ' ILE . 25.9 mmt -69.85 -38.24 76.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.311 0.577 . . . . 0.87 109.897 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 162' ' ' LEU . 63.3 mt -56.3 -53.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.073 -0.967 . . . . 0.64 111.136 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.5 pp -71.85 -34.29 69.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 121.041 -0.264 . . . . 1.81 111.491 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 166' ' ' LEU . 14.0 tp -53.06 -31.62 42.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.97 -0.559 . . . . 1.42 110.73 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.52 -37.4 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.033 -0.53 . . . . 1.17 110.281 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.4 m -65.29 -32.38 74.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.843 -0.617 . . . . 1.54 110.288 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -86.02 -9.16 57.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.12 0.486 . . . . 2.79 110.605 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.806 ' HG3' ' HA ' ' A' ' 176' ' ' ALA . 35.0 ttm -88.79 -63.23 1.33 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 1.82 111.433 -177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -38.45 -62.96 0.54 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.242 1.201 . . . . 3.45 114.242 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.48 2.14 54.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.613 0.597 . . . . 3.36 112.613 -170.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 175' ' ' LYS . 4.3 mm? -103.39 -62.8 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.936 -0.394 . . . . 4.14 109.936 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 20.4 ttpp 166.15 -64.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.05 -1.093 . . . . 6.31 108.05 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.806 ' HA ' ' HG3' ' A' ' 171' ' ' MET . . . -160.53 -168.64 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.054 -1.43 . . . . 4.57 107.988 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.405 ' C ' HD22 ' A' ' 177' ' ' ASN . 0.2 OUTLIER -157.3 91.47 2.37 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 120.686 -0.406 . . . . 6.38 110.22 176.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.564 2.843 . . . . 7.47 111.725 177.526 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.92 -0.472 . . . . 16.35 111.92 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 t -89.9 -3.33 58.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.596 0.198 . . . . 14.69 111.519 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -93.91 16.43 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.347 -0.541 . . . . 14.68 111.888 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.6 ptp -87.05 109.73 19.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.451 -0.574 . . . . 12.73 109.451 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 63' ' ' PRO . 27.6 m -87.35 134.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.998 -0.547 . . . . 10.18 111.992 -174.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.44 147.09 28.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.003 -1.11 . . . . 9.14 108.003 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -100.01 131.07 24.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.725 0.298 . . . . 8.35 111.3 -172.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HG2' HG11 ' A' ' 78' ' ' VAL . 61.3 Cg_endo -76.46 111.05 3.18 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.779 2.319 . . . . 4.6 111.836 173.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -95.1 -56.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.371 2.714 . . . . 4.29 113.372 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.586 ' HB ' ' H ' ' A' ' 58' ' ' THR . 93.9 t -134.1 -59.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.724 -0.473 . . . . 2.58 109.724 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.081 HG12 ' HB ' ' A' ' 81' ' ' ILE . 13.7 m -125.29 150.96 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 120.843 0.354 . . . . 1.0 110.755 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.678 HG23 HD21 ' A' ' 60' ' ' LEU . 51.0 m -129.64 134.57 47.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.239 -0.437 . . . . 0.66 111.102 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.719 HD13 HG13 ' A' ' 83' ' ' ILE . 35.7 mm -81.07 129.7 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.584 0.353 . . . . 1.03 111.062 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.54 ' CE ' ' HB3' ' A' ' 68' ' ' PHE . 14.4 mmt -138.29 157.12 46.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.684 0.394 . . . . 1.04 111.435 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.66 -110.55 0.46 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.116 -0.793 . . . . 1.55 111.116 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -156.85 137.61 13.31 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.75 -0.725 . . . . 0.66 109.594 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.64 -47.47 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.335 0.865 . . . . 1.62 113.335 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.55 -27.54 68.51 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.504 0.557 . . . . 1.78 112.504 -170.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -63.35 -21.27 66.17 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.281 0.562 . . . . 0.65 110.649 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.53 42.46 1.86 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.661 -0.699 . . . . 0.93 112.465 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -82.02 -22.12 36.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 2.11 110.215 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -39.88 23.21 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.174 -1.047 . . . . 1.8 108.174 174.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 m -62.57 -33.6 75.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.622 -1.172 . . . . 1.77 110.512 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.596 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 59.7 tp -57.39 -56.07 26.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 1.78 110.524 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.683 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 1.6 tt -63.78 -36.81 85.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.072 0.463 . . . . 1.96 109.994 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.18 -53.76 44.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.955 0.407 . . . . 1.38 111.596 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.7 -32.17 72.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.91 111.196 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.654 HD13 ' OH ' ' A' ' 48' ' ' TYR . 3.9 tt -67.78 -33.47 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.84 -0.618 . . . . 1.56 110.43 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 15.5 mtm180 -73.62 -28.03 61.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.454 0.645 . . . . 3.56 110.031 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -84.9 5.18 30.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.626 -0.715 . . . . 2.88 110.148 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 m -115.81 38.49 3.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.703 -1.591 . . . . 1.76 106.703 168.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 20.0 pttm -54.85 150.23 10.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 113.349 -1.75 . . . . 5.71 113.567 -166.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.0 -27.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.285 -1.325 . . . . 2.99 110.296 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.8 m -159.93 -21.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.205 0.817 . . . . 3.93 113.205 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.5 pm0 -50.12 151.82 1.89 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.509 0.929 . . . . 4.2 113.509 -174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.717 ' HG3' ' HG3' ' A' ' 37' ' ' GLU . 10.9 pt20 -124.92 -28.87 3.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.648 -1.16 . . . . 5.38 111.003 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.717 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 47.9 mt-10 -117.93 -166.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 5.79 110.869 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.67 89.12 2.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.896 -0.593 . . . . 4.24 110.732 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -68.6 144.83 42.84 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.812 -0.708 . . . . 4.95 112.196 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.34 -115.12 0.62 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.758 -0.734 . . . . 6.66 112.438 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 pt -82.11 -26.81 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.789 0.328 . . . . 9.17 111.601 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 45' ' ' ILE . 1.9 p -89.53 91.64 8.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.338 -0.392 . . . . 7.36 110.968 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -77.4 63.03 2.5 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.907 0.86 . . . . 8.83 111.169 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -132.98 19.45 4.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.138 -0.937 . . . . 6.76 108.99 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 47' ' ' ALA . 1.8 pp -126.47 178.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.97 -1.014 . . . . 5.19 111.583 -171.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.58 31.08 7.09 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.07 -1.212 . . . . 2.97 110.07 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.694 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 50.63 -93.29 0.03 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.76 0.824 . . . . 1.71 111.369 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.87 ' HB2' ' HB3' ' A' ' 35' ' ' GLU . 23.2 p90 -170.32 156.24 5.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.778 -0.453 . . . . 2.54 109.778 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 58' ' ' THR . 37.0 mt-30 -126.17 118.06 24.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.257 -0.646 . . . . 1.96 109.257 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -92.37 126.45 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.632 -0.713 . . . . 1.93 112.372 -171.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 89.7 m -84.09 81.9 8.59 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.12 0.962 . . . . 2.06 109.008 171.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.4 t -96.74 108.71 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.557 -1.275 . . . . 4.12 107.557 170.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.55 -53.9 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.482 1.114 . . . . 4.43 111.851 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -131.12 -24.86 2.3 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.063 1.135 . . . . 3.62 114.063 -172.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 20.5 ttpp 79.01 52.11 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.715 0.769 . . . . 7.44 109.442 -167.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -101.92 4.24 39.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.405 -0.816 . . . . 5.43 110.347 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.519 ' HA ' HG11 ' A' ' 10' ' ' VAL . 19.0 mt -119.19 127.06 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 1.14 110.712 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.949 HG23 ' HG2' ' A' ' 49' ' ' GLN . 36.2 m -119.97 130.85 54.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.162 -0.681 . . . . 1.28 109.162 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.554 ' HE1' HG21 ' A' ' 50' ' ' VAL . 16.1 m-85 -103.9 89.84 3.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.048 -0.723 . . . . 0.84 109.048 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.678 HD21 HG23 ' A' ' 12' ' ' THR . 95.1 mt 62.57 145.11 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.78 0.675 . . . . 3.0 111.067 -171.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -171.38 113.85 0.38 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.889 0.7 . . . . 6.48 112.889 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.5 m 70.03 89.94 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.095 -0.957 . . . . 5.57 112.09 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 5' ' ' VAL . 51.1 Cg_exo -55.41 143.74 75.77 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.302 2.668 . . . . 5.77 112.781 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.95 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.787 -0.72 . . . . 5.54 112.23 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -67.28 120.52 13.95 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.743 -0.466 . . . . 8.09 109.743 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 69' ' ' THR . 10.4 pt-20 -84.16 175.25 9.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.151 0.5 . . . . 6.36 111.653 -174.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.6 -42.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.426 -0.806 . . . . 3.51 110.651 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.607 ' HD1' ' HD2' ' A' ' 102' ' ' HIS . 51.6 m-85 -109.82 23.0 14.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 2.61 111.805 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 66' ' ' GLU . 13.9 p -114.76 67.24 0.69 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.26 -0.427 . . . . 4.74 111.028 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 71' ' ' MET . 88.5 m 72.95 -20.24 0.29 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.239 0.459 . . . . 5.89 112.239 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 70' ' ' THR . 49.4 mtt 70.98 59.89 0.18 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.387 0.613 . . . . 5.64 110.792 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -76.19 -27.92 57.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 9.71 108.689 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.56 90.66 3.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.665 -1.152 . . . . 7.52 109.022 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.9 93.19 0.18 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.757 -0.656 . . . . 10.42 111.342 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.43 51.6 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.763 -0.653 . . . . 6.75 111.51 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.72 62.16 7.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.196 0.522 . . . . 6.69 111.245 -176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -81.34 64.98 6.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.996 -0.547 . . . . 7.72 110.532 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.433 HG11 ' HG2' ' A' ' 8' ' ' PRO . 29.9 m -132.02 -178.41 2.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.752 -0.658 . . . . 4.38 110.624 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.0 t -143.27 39.4 1.43 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.866 0.841 . . . . 4.18 108.739 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -63.64 148.68 48.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.505 -1.225 . . . . 3.12 112.97 -173.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.081 ' HB ' HG12 ' A' ' 11' ' ' VAL . 28.4 mm -90.18 108.72 19.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.778 -1.101 . . . . 0.74 109.782 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.95 HG21 ' HB1' ' A' ' 103' ' ' ALA . 76.4 t -81.45 108.14 14.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.063 -0.517 . . . . 1.19 111.182 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.747 HD11 ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -85.47 102.81 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.971 -0.751 . . . . 1.32 108.971 177.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.801 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.1 tm? -94.64 111.77 23.53 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.919 -0.582 . . . . 1.33 109.946 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.524 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 39.5 t -87.56 133.98 28.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.1 -0.5 . . . . 1.2 111.488 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 114' ' ' ILE . 17.9 m -135.29 -167.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.161 -0.927 . . . . 1.12 108.501 174.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -140.07 143.27 36.25 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.31 -0.556 . . . . 0.75 111.691 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -34.26 -55.67 0.51 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.678 1.236 . . . . 1.18 112.992 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -109.1 13.83 24.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.06 -0.518 . . . . 2.01 111.883 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -110.68 -43.02 3.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.511 -0.476 . . . . 1.09 111.284 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 78.0 -139.8 23.18 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.667 -0.778 . . . . 0.52 111.949 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.733 HG13 ' HB ' ' A' ' 96' ' ' THR . 44.0 t -96.97 114.8 34.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 122.783 0.433 . . . . 1.08 111.311 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.585 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 53.7 mtp -84.12 169.77 15.97 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.434 -0.348 . . . . 1.32 110.199 171.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 93.8 Cg_exo -45.25 -50.79 8.58 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.696 2.264 . . . . 0.61 113.341 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -72.72 -21.9 60.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.387 -0.369 . . . . 1.47 111.356 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.733 ' HB ' HG13 ' A' ' 92' ' ' VAL . 25.5 m -60.38 -28.74 68.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.397 0.617 . . . . 0.46 110.274 175.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.04 -45.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.958 -0.565 . . . . 1.05 111.726 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.79 -23.19 59.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 1.62 110.961 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -87.96 -30.96 19.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.34 110.018 -177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.863 HG12 HD13 ' A' ' 110' ' ' ILE . 1.7 mt -80.93 -51.21 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.261 -0.881 . . . . 0.38 111.293 -178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -49.13 -39.28 27.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 1.85 110.78 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.607 ' HD2' ' HD1' ' A' ' 68' ' ' PHE . 12.3 t60 -77.35 -30.2 53.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.85 110.968 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.95 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -81.27 -56.29 4.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.436 . . . . 0.48 111.967 -173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -73.2 -15.72 61.44 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.304 -0.407 . . . . 2.56 111.899 -168.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.12 -0.48 44.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.908 0.385 . . . . 0.76 111.206 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -101.39 14.07 33.1 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.814 -0.81 . . . . 0.9 108.814 174.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' ALA . 4.8 m-20 72.19 27.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.705 -1.134 . . . . 2.06 111.759 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -109.13 152.85 42.75 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-O 121.061 0.458 . . . . 1.08 111.254 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.63 ' O ' HG23 ' A' ' 108' ' ' VAL . 15.4 Cg_exo -72.54 162.82 40.31 Favored 'Trans proline' 0 CA--C 1.528 0.188 0 C-N-CA 123.678 2.919 . . . . 0.51 113.437 171.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.863 HD13 HG12 ' A' ' 100' ' ' ILE . 73.7 mt -132.61 148.17 31.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.672 -0.695 . . . . 0.96 110.586 -177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.801 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 37.3 mt -113.61 164.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 109.072 -0.714 . . . . 0.71 109.072 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.544 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -123.63 129.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 N-CA-C 109.044 -0.724 . . . . 0.23 109.044 169.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.28 87.25 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.592 -1.262 . . . . 0.25 107.592 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.718 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 54.1 mt -69.61 97.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.315 -1.311 . . . . 0.85 109.904 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -96.91 170.82 8.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.69 109.023 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 77.5 tttt 64.14 18.35 11.2 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.365 1.078 . . . . 2.61 109.227 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.622 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.1 tpp -95.09 13.97 23.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 123.063 1.411 . . . . 1.37 109.511 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 151' ' ' SER . 4.3 p-10 -64.14 48.71 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.585 -1.189 . . . . 2.45 112.234 171.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.836 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 94.2 mttt -144.84 -172.82 0.33 Allowed Pre-proline 0 C--N 1.318 -0.775 0 N-CA-C 105.669 -1.975 . . . . 3.7 105.669 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.836 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.2 Cg_endo -56.95 -56.06 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 120.536 1.227 . . . . 2.67 110.98 168.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 12.7 pt-20 164.04 121.98 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.28 1.032 . . . . 4.03 108.238 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -60.41 3.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.641 -0.708 . . . . 1.47 109.934 173.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -179.57 76.82 0.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.656 -0.702 . . . . 1.84 110.266 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.601 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.1 Cg_endo -44.53 -61.3 0.6 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.581 2.854 . . . . 0.7 113.325 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.73 -49.63 19.29 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.441 0.697 . . . . 2.0 112.352 -175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -49.21 -62.13 1.7 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.351 0.596 . . . . 2.99 109.69 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.614 HG13 ' HA2' ' A' ' 91' ' ' GLY . 66.8 t -54.2 -47.84 67.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.341 -1.299 . . . . 0.4 110.848 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.654 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 90.4 mtp -59.42 -34.51 72.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.3 111.122 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -76.77 -20.14 56.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.618 -0.264 . . . . 1.28 111.23 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.662 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 4.2 mt-10 -75.98 -30.39 58.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.962 -0.755 . . . . 2.02 108.962 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -72.77 -44.27 61.79 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.831 -0.747 . . . . 1.06 109.311 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.834 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -73.01 -4.54 32.97 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.163 -0.615 . . . . 0.35 109.977 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.662 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 40.9 tt0 -74.41 -32.75 62.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 170.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.672 ' HE2' HG11 ' A' ' 92' ' ' VAL . 44.9 m-85 -89.9 9.39 27.85 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.911 0.862 . . . . 0.74 109.446 172.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.7 t30 72.32 26.59 2.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 113.536 -1.665 . . . . 1.94 110.234 168.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.04 76.69 1.37 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.433 -1.321 . . . . 1.68 107.433 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.942 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -63.24 134.04 95.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 113.436 -1.711 . . . . 0.61 110.279 -176.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.765 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -52.29 154.34 11.35 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 122.359 2.039 . . . . 0.3 112.135 173.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.544 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 mm-40 -80.28 -19.77 45.96 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.05 -0.977 . . . . 2.01 109.141 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.579 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.1 mp0 -47.2 -52.98 14.28 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.709 1.243 . . . . 1.14 108.958 160.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.834 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -89.73 -23.78 21.71 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.897 -1.956 . . . . 0.45 110.68 -167.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.87 23.02 4.79 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.553 -0.832 . . . . 0.45 112.446 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.942 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.93 -108.15 1.99 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.924 -0.655 . . . . 0.5 113.17 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -156.25 27.37 0.35 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 1.3 111.314 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 HD12 ' A' ' 136' ' ' LEU . 63.5 m -132.67 133.34 43.43 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.83 1.048 . . . . 0.32 113.83 -174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.797 HG13 HG11 ' A' ' 168' ' ' VAL . 4.1 mp -87.48 108.15 17.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.123 -0.944 . . . . 1.23 110.382 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 11.8 m-85 -94.54 115.77 27.99 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.839 -0.538 . . . . 0.38 111.224 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.9 t -118.63 128.7 54.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.439 -0.578 . . . . 1.1 109.439 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.718 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.6 pttm -103.65 87.06 2.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.609 0.718 . . . . 2.44 109.393 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -105.64 -177.03 3.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.43 -0.804 . . . . 1.27 112.486 -172.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 118' ' ' ASP . 12.1 p -155.87 124.05 5.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.929 -1.032 . . . . 1.79 109.636 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -76.24 -13.19 60.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.141 0.496 . . . . 0.87 110.926 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.483 ' HG3' ' CG ' ' A' ' 118' ' ' ASP . 23.3 mmtp -75.89 -57.64 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.47 -0.786 . . . . 3.03 109.855 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -97.29 -15.71 20.65 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.148 -0.933 . . . . 1.2 111.376 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HD12 ' A' ' 158' ' ' LEU . 59.4 mttp 64.58 24.82 13.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.23 -0.896 . . . . 2.27 111.888 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.21 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.843 0.83 . . . . 2.64 109.822 175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.718 ' HA3' ' HA ' ' A' ' 150' ' ' LEU . . . -71.83 -10.46 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.811 -1.086 . . . . 0.62 113.543 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.816 HD12 ' HG2' ' A' ' 155' ' ' LYS . 25.5 mt -71.89 -43.1 65.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.699 0.75 . . . . 1.55 110.295 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 12.8 t70 -61.66 -42.82 99.44 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.753 -0.832 . . . . 2.5 108.753 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -66.7 -24.25 66.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.039 -0.982 . . . . 0.73 111.507 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.3 tp -63.31 -56.43 16.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.661 -0.245 . . . . 0.91 110.401 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.8 mt -54.62 -39.84 68.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 1.06 110.585 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 7.0 mm-40 -63.56 -47.28 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 2.49 110.339 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.567 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -67.07 -38.77 86.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.87 110.593 -176.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.14 -49.42 40.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.622 -0.717 . . . . 0.64 111.845 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 167' ' ' LEU . 1.6 pp -84.67 -35.15 22.8 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.406 0.521 . . . . 1.81 112.406 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 166' ' ' LEU . 35.6 tp -63.41 -21.98 66.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.99 0.424 . . . . 1.42 110.937 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.797 HG11 HG13 ' A' ' 146' ' ' ILE . 48.5 t -85.34 -28.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.515 -0.311 . . . . 1.17 110.447 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.2 m -61.56 -28.16 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.012 -0.736 . . . . 1.54 109.012 171.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -73.21 -48.82 31.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.15 -0.932 . . . . 2.79 109.39 169.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.463 ' HG3' ' HE3' ' A' ' 175' ' ' LYS . 11.1 tpp -50.33 -48.56 55.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.756 -0.657 . . . . 1.82 111.506 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 42.6 mt-10 -50.58 -62.98 1.27 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.549 0.69 . . . . 3.45 110.941 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.18 -31.76 71.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.741 -1.118 . . . . 3.36 111.642 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.34 -28.05 38.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.802 0.334 . . . . 4.14 111.291 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.463 ' HE3' ' HG3' ' A' ' 171' ' ' MET . 20.8 ttpp -94.51 -73.24 0.58 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.485 -0.325 . . . . 6.31 111.62 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 176.58 -174.25 0.11 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.113 -0.328 . . . . 4.57 110.113 -173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 64.41 67.03 0.93 Allowed Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 123.869 0.73 . . . . 6.38 111.421 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.996 2.464 . . . . 7.47 111.552 178.082 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.072 -0.411 . . . . 16.35 112.072 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 t -87.73 102.85 15.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.972 0.415 . . . . 14.69 110.349 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -133.1 13.24 4.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.176 0.512 . . . . 14.68 109.813 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.04 132.43 54.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.588 -0.733 . . . . 12.73 110.259 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 -48.27 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 10.18 110.467 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -72.98 111.71 8.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 9.14 110.579 -176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' HD2' ' HD2' ' A' ' 8' ' ' PRO . 6.2 tpt180 -110.25 118.52 49.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.11 -0.329 . . . . 8.35 110.11 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 10.4 Cg_endo -53.83 127.21 24.62 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.996 2.464 . . . . 4.6 112.101 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.726 ' HG2' ' HB3' ' A' ' 169' ' ' SER . 31.3 Cg_exo -60.55 118.57 5.45 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.086 2.524 . . . . 4.29 112.709 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HD13 ' A' ' 60' ' ' LEU . 6.2 p -79.0 125.52 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.486 0.66 . . . . 2.58 109.928 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 89.2 t -107.37 114.91 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.051 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -93.42 127.52 39.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.996 -0.547 . . . . 0.66 110.728 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.682 ' HB ' ' HA ' ' A' ' 61' ' ' ASP . 26.4 mt -83.69 121.45 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.056 0.455 . . . . 1.03 111.148 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.448 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 20.8 mmt -115.7 178.99 4.1 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.077 -0.712 . . . . 1.04 109.077 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.931 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 114.67 131.05 5.04 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 119.852 -1.166 . . . . 1.55 111.411 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -44.88 132.37 6.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.332 0.586 . . . . 0.66 110.198 172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.7 m -56.35 -30.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.55 0.944 . . . . 1.62 113.55 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.63 -15.8 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 1.78 111.296 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' HE1' ' H ' ' A' ' 93' ' ' MET . 32.8 m170 -67.25 -43.0 82.99 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.845 -0.428 . . . . 0.65 109.845 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 85' ' ' VAL . . . 147.12 69.79 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.034 -1.079 . . . . 0.93 113.766 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -87.55 -50.11 6.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.453 0.644 . . . . 2.11 109.513 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -64.12 -30.56 71.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.032 -0.986 . . . . 1.8 110.561 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.497 HG21 ' ND2' ' A' ' 115' ' ' ASN . 5.4 t -67.73 -26.64 66.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.412 -0.358 . . . . 1.77 110.64 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.02 -55.82 6.73 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.775 -0.824 . . . . 1.78 108.775 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.653 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 1.9 tt -55.49 -41.69 73.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.945 -0.571 . . . . 1.96 109.78 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.54 -62.5 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.507 0.558 . . . . 1.38 112.507 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -68.27 -38.48 81.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.91 111.843 -173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.5 mt -64.78 -31.04 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.453 . . . . 1.56 110.536 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 37' ' ' GLU . 15.2 mmm180 -64.04 -41.25 97.46 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.223 0.535 . . . . 3.56 110.372 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -76.5 9.3 2.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.38 -0.827 . . . . 2.88 109.818 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.8 m -105.76 12.07 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.876 -0.602 . . . . 1.76 110.342 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 73.73 -37.86 0.39 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.927 1.084 . . . . 5.71 113.927 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.894 HG22 ' H ' ' A' ' 51' ' ' THR . 9.9 p -71.47 27.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 123.696 0.798 . . . . 2.99 113.14 -172.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 48' ' ' TYR . 2.8 p -111.6 120.74 43.1 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 121.56 -0.712 . . . . 3.93 111.817 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.712 ' OE1' ' HG3' ' A' ' 55' ' ' LYS . 7.7 mt-10 -66.51 -58.82 4.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.981 -1.008 . . . . 4.2 112.348 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.575 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 77.1 mt-30 -87.1 136.81 32.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.343 0.592 . . . . 5.38 111.063 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . 35.9 mm-40 -85.44 -52.44 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.86 -1.064 . . . . 5.79 113.489 -167.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -100.53 58.76 0.95 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.775 0.321 . . . . 4.24 111.591 -167.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -68.73 101.85 0.83 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.575 -0.821 . . . . 4.95 111.903 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' H ' ' HA2' ' A' ' 46' ' ' GLY . . . -179.79 -144.31 5.88 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.41 -0.9 . . . . 6.66 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.414 ' H ' HG12 ' A' ' 41' ' ' ILE . 20.9 pt -91.25 21.33 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 112.426 0.528 . . . . 9.17 112.426 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.1 p -91.43 155.9 18.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 120.62 0.247 . . . . 7.36 111.038 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.75 20.21 5.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 8.83 110.386 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -103.13 -62.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.005 -0.739 . . . . 6.76 109.005 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.575 ' CG2' ' HB3' ' A' ' 36' ' ' GLN . 43.6 mm -127.14 166.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.526 -0.916 . . . . 5.19 108.526 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . -160.63 -52.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.492 -0.643 . . . . 2.97 111.492 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -96.81 -169.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.352 -0.61 . . . . 1.71 109.352 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.685 ' HD2' HG22 ' A' ' 34' ' ' THR . 1.1 p90 -163.71 137.91 5.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.943 0.402 . . . . 2.54 110.761 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.651 ' HG2' HG23 ' A' ' 58' ' ' THR . 47.8 mt-30 -98.98 152.0 20.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.169 -0.469 . . . . 1.96 109.879 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.796 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 95.1 t -107.08 150.31 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.891 0.853 . . . . 1.93 111.945 -172.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.894 ' H ' HG22 ' A' ' 33' ' ' VAL . 85.6 m -96.08 93.15 6.8 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.677 -1.601 . . . . 2.06 112.067 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.2 p -122.99 116.19 47.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.269 -1.012 . . . . 4.12 108.269 169.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 71.34 -44.62 0.6 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.032 0.92 . . . . 4.43 109.254 -167.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 52' ' ' VAL . 14.4 t70 -167.35 -57.85 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.931 -1.486 . . . . 3.62 109.029 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.712 ' HG3' ' OE1' ' A' ' 35' ' ' GLU . 5.3 tmmm? -177.75 110.47 0.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.664 -1.153 . . . . 7.44 109.085 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.455 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 35.1 mmtp -132.97 -3.08 3.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 5.43 110.519 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.796 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 42.2 mt -117.84 139.47 44.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.019 -0.363 . . . . 1.14 110.019 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 HG23 ' HG2' ' A' ' 49' ' ' GLN . 11.0 m -121.67 113.8 20.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.128 -0.323 . . . . 1.28 110.128 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HD2' HD11 ' A' ' 13' ' ' ILE . 3.7 m-85 -93.76 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.662 0.268 . . . . 0.84 110.876 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD13 HG23 ' A' ' 10' ' ' VAL . 9.7 mp -111.06 92.54 4.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 3.0 110.81 176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.682 ' HA ' ' HB ' ' A' ' 13' ' ' ILE . 36.7 t70 -75.08 -36.67 61.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.299 0.571 . . . . 6.48 109.464 174.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.1 p -121.12 100.38 45.61 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.205 -0.907 . . . . 5.57 109.817 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.52 -18.2 20.22 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.715 2.277 . . . . 5.77 112.581 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.12 -90.2 0.35 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.12 -0.792 . . . . 5.54 111.12 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -147.69 -28.4 0.35 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.028 0.442 . . . . 8.09 109.96 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.88 125.44 26.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.723 -0.671 . . . . 6.36 109.482 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.09 110.3 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.374 -0.376 . . . . 3.51 110.946 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' HZ ' HG11 ' A' ' 108' ' ' VAL . 15.0 t80 64.93 58.75 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.637 -0.71 . . . . 2.61 111.202 175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.4 p 55.24 -165.33 0.11 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.714 0.806 . . . . 4.74 112.518 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.3 m -120.32 38.03 4.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.442 -0.799 . . . . 5.89 109.164 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.8 mmt 60.52 46.78 9.21 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.636 -0.711 . . . . 5.64 110.485 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 72' ' ' ARG . 6.3 mmt180 65.69 -76.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.961 -1.018 . . . . 9.71 111.885 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.69 -9.74 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.572 0.225 . . . . 7.52 111.603 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -168.79 -58.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.017 0.436 . . . . 10.42 110.232 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.83 71.45 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.704 -0.68 . . . . 6.75 111.766 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.29 -84.68 0.51 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.69 110.561 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 1.012 ' HA ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -91.93 133.79 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.812 -0.44 . . . . 7.72 109.812 175.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.463 HG22 ' H ' ' A' ' 80' ' ' ASP . 12.5 p -113.07 146.23 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.638 -0.505 . . . . 4.38 109.638 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -152.31 31.43 0.53 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.079 -1.082 . . . . 4.18 108.079 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 78' ' ' VAL . 4.8 m-20 -102.7 96.04 6.6 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.095 -1.411 . . . . 3.12 109.513 -174.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 45.8 mm -68.01 126.57 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.798 -1.092 . . . . 0.74 111.794 -170.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.907 HG21 ' HB1' ' A' ' 103' ' ' ALA . 89.7 t -100.92 98.13 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 120.79 -0.364 . . . . 1.19 111.274 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.681 HG13 ' HA ' ' A' ' 13' ' ' ILE . 0.5 OUTLIER -87.11 104.38 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 C-N-CA 120.093 -0.643 . . . . 1.32 110.472 174.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.599 HD22 ' CD1' ' A' ' 100' ' ' ILE . 9.7 tp -91.46 114.08 26.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.884 -0.598 . . . . 1.33 110.33 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.931 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.6 p -85.7 142.72 12.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 119.882 -0.727 . . . . 1.2 110.844 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -137.3 -170.86 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.36 -0.978 . . . . 1.12 108.36 175.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.24 139.68 30.33 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.238 -0.585 . . . . 0.75 111.681 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -78.91 58.23 2.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.035 -0.984 . . . . 1.18 111.207 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -164.97 -33.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.452 -1.249 . . . . 2.01 109.301 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.51 -63.26 1.18 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.522 0.677 . . . . 1.09 110.954 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.77 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 117.07 -106.36 1.42 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.996 -1.002 . . . . 0.52 110.887 -172.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.98 HG13 ' HB ' ' A' ' 96' ' ' THR . 38.5 t -129.67 114.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 120.952 0.406 . . . . 1.08 110.572 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.711 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 60.3 mtp -91.96 172.81 5.92 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 1.32 109.741 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.711 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 58.0 Cg_exo -39.32 -59.76 0.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.269 2.646 . . . . 0.61 113.857 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -54.27 -35.01 62.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.47 111.888 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.98 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.3 m -64.26 -34.04 77.19 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.762 0.282 . . . . 0.46 111.762 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.621 HG12 ' CG1' ' A' ' 92' ' ' VAL . 1.4 m -85.7 -38.86 13.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 O-C-N 121.967 -0.458 . . . . 1.05 111.328 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.65 -30.06 70.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.165 0.507 . . . . 1.62 110.916 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -76.31 -17.6 59.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.647 -0.706 . . . . 0.34 110.491 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -93.41 -45.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 0.38 110.966 -176.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -53.41 -38.54 63.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.566 0.698 . . . . 1.85 110.086 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -75.2 -28.66 60.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.191 -0.913 . . . . 0.85 110.943 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.907 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.74 -53.88 3.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.889 0.7 . . . . 0.48 112.889 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -67.7 -16.21 64.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.225 0.454 . . . . 2.56 112.225 -166.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.65 10.7 4.5 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.309 0.485 . . . . 0.76 112.309 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -107.96 4.21 24.99 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.08 -0.711 . . . . 0.9 109.08 173.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 21.0 t-20 80.46 19.31 0.55 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 123.204 1.478 . . . . 2.06 108.858 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.6 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -96.06 142.47 24.61 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 113.741 -1.572 . . . . 1.08 110.462 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 8.3 Cg_exo -73.19 152.02 49.96 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.904 2.403 . . . . 0.51 114.264 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.677 HG12 HG12 ' A' ' 100' ' ' ILE . 1.7 mp -114.48 143.11 24.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 113.239 -1.8 . . . . 0.96 109.637 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.657 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mp -113.46 147.52 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -110.37 138.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 109.32 -0.622 . . . . 0.23 109.32 174.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.1 87.8 2.82 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.232 -1.025 . . . . 0.25 108.232 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.687 ' HA ' HG23 ' A' ' 86' ' ' VAL . 37.5 mt -73.3 95.92 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.581 -1.191 . . . . 0.85 110.153 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.497 ' ND2' HG21 ' A' ' 23' ' ' THR . 53.3 t30 -90.8 156.53 17.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.671 -0.412 . . . . 0.69 111.174 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.2 mttp 71.51 37.32 1.15 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.732 0.813 . . . . 2.61 112.178 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.688 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -110.86 18.41 19.57 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.873 -0.731 . . . . 1.37 111.661 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 151' ' ' SER . 5.8 t70 -64.98 -28.35 69.45 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.088 -0.506 . . . . 2.45 111.44 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.761 ' H ' ' HD2' ' A' ' 120' ' ' PRO . 0.0 OUTLIER -133.57 -56.17 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 113.503 0.927 . . . . 3.7 113.503 178.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.761 ' HD2' ' H ' ' A' ' 119' ' ' LYS . 29.1 Cg_endo -73.38 -53.38 0.13 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 123.251 2.634 . . . . 2.67 112.706 -176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' CB ' ' HB2' ' A' ' 117' ' ' MET . 10.1 pt-20 59.69 0.19 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.87 1.668 . . . . 4.03 113.793 171.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 42.99 -98.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.293 0.637 . . . . 1.47 111.381 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 34.1 t30 -163.65 93.87 1.08 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.114 -0.494 . . . . 1.84 110.826 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 58.1 Cg_exo -28.79 -69.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.548 3.499 . . . . 0.7 114.545 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.94 -45.72 15.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.725 0.81 . . . . 2.0 112.206 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -55.17 -56.13 23.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.493 0.663 . . . . 2.99 110.177 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.77 HG13 ' HA2' ' A' ' 91' ' ' GLY . 56.7 t -59.44 -39.73 79.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 114.565 -1.198 . . . . 0.4 110.346 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 87.3 mtp -66.29 -30.01 70.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.558 -0.746 . . . . 0.3 111.225 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.34 -21.06 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.627 0.251 . . . . 1.28 110.778 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.1 -38.58 85.93 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.646 -0.872 . . . . 2.02 108.646 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.929 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -69.47 -45.35 69.21 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.802 -0.636 . . . . 1.06 110.031 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.89 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -73.26 -5.04 36.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.363 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.62 -37.19 68.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.726 -1.213 . . . . 2.18 107.726 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.949 ' HE2' HG11 ' A' ' 92' ' ' VAL . 28.6 m-85 -84.38 7.6 19.0 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.944 0.878 . . . . 0.74 109.283 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.71 44.08 1.21 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 113.829 -1.532 . . . . 1.94 109.505 170.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.929 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -122.43 81.77 1.89 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 113.517 -1.674 . . . . 1.68 106.96 169.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -65.37 130.53 94.72 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 114.006 -1.452 . . . . 0.61 110.242 -173.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.757 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 58.2 Cg_exo -44.69 154.79 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.888 2.392 . . . . 0.3 112.54 170.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -74.43 -29.17 61.38 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.346 -1.297 . . . . 2.01 108.012 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.654 ' HG2' ' CB ' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -51.11 -42.17 60.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.584 -1.189 . . . . 1.14 109.572 168.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.89 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.2 m0 -96.16 -20.35 18.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.419 -0.81 . . . . 0.45 111.167 -172.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.99 29.85 4.44 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.139 -1.029 . . . . 0.45 112.707 170.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.824 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.78 -106.67 2.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.366 -0.921 . . . . 0.5 112.923 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.34 27.99 0.45 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.714 -0.243 . . . . 1.3 111.42 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 136' ' ' LEU . 26.6 m -134.55 129.04 34.45 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 119.171 -1.011 . . . . 0.32 113.548 -171.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.729 HG21 ' HB3' ' A' ' 164' ' ' MET . 49.9 mm -94.35 110.33 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.332 -0.849 . . . . 1.23 110.566 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.757 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 14.2 m-85 -90.89 119.4 31.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.034 0.445 . . . . 0.38 111.429 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 75.8 m -110.37 111.99 23.63 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.625 -0.509 . . . . 1.1 109.625 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.688 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 25.9 pttt -93.29 100.06 12.48 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.811 -0.631 . . . . 2.44 109.392 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.69 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -123.07 179.13 4.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.615 1.198 . . . . 1.27 113.681 -169.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.42 ' CB ' ' HB2' ' A' ' 118' ' ' ASP . 2.7 p -150.58 116.83 5.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.285 -1.78 . . . . 1.79 108.15 171.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 158' ' ' LEU . . . -63.02 -16.32 59.43 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.013 0.375 . . . . 0.87 112.013 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -80.71 -57.34 3.61 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.802 0.81 . . . . 3.03 109.503 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -72.69 -17.96 61.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.129 -1.396 . . . . 1.2 112.01 -175.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.713 ' HD3' HD12 ' A' ' 158' ' ' LEU . 30.2 mmtp 71.63 -0.11 3.28 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.791 -0.641 . . . . 2.27 112.007 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -45.99 -74.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.037 0.754 . . . . 2.64 113.037 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.69 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -72.51 -6.7 66.77 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.496 -0.774 . . . . 0.62 113.536 -176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.713 HD12 ' HD3' ' A' ' 155' ' ' LYS . 57.7 mt -73.55 -43.16 60.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.288 0.544 . . . . 1.55 110.561 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 26.9 m-20 -66.94 -40.43 87.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 174.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -65.29 -30.64 71.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.73 110.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 60.7 tp -63.39 -53.89 45.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.91 110.639 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.63 -39.29 67.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 1.06 110.731 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 8.1 mm-40 -61.41 -48.34 81.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.573 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.729 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.7 mmt -69.29 -40.12 77.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.87 110.854 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.41 -47.72 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 116.041 -0.527 . . . . 0.64 110.43 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.2 -46.72 87.68 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.29 -0.414 . . . . 1.81 111.137 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.43 -46.28 76.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.808 -0.633 . . . . 1.42 110.555 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.594 ' HA ' ' HG2' ' A' ' 171' ' ' MET . 77.4 t -74.05 -41.61 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 116.094 -0.503 . . . . 1.17 111.427 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.726 ' HB3' ' HG2' ' A' ' 9' ' ' PRO . 50.3 m -60.65 -26.88 67.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.088 0.471 . . . . 1.54 110.811 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -83.62 -45.75 13.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.836 -0.62 . . . . 2.79 111.061 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 19.6 ptt? -88.04 -11.96 45.71 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.391 0.515 . . . . 1.82 112.391 -172.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.1 -31.99 14.7 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.33 0.493 . . . . 3.45 112.33 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.2 -23.28 61.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.167 -0.47 . . . . 3.36 111.366 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.24 -65.54 0.98 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.888 -0.597 . . . . 4.14 109.413 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt 60.75 99.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.963 -1.017 . . . . 6.31 112.584 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -110.17 81.75 1.49 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.235 -0.893 . . . . 4.57 110.169 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -113.09 155.41 44.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.509 . . . . 6.38 110.303 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.849 2.366 . . . . 7.47 111.839 177.304 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.257 -0.337 . . . . 16.35 112.257 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -79.73 -11.23 59.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.758 0.313 . . . . 14.69 111.793 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -107.54 100.79 10.17 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 14.68 109.723 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -79.29 72.51 5.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 12.73 111.433 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -86.51 6.47 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.509 0.671 . . . . 10.18 109.946 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -85.43 38.58 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 9.14 111.177 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 ttt180 -144.89 66.34 12.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.485 . . . . 8.35 110.289 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 53.8 Cg_endo -95.33 138.44 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.918 2.412 . . . . 4.6 112.294 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 13.4 Cg_exo -71.0 65.38 2.53 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.944 2.429 . . . . 4.29 111.619 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.664 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 3.8 p -73.57 124.15 30.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 2.58 111.06 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.723 HG22 ' HB ' ' A' ' 81' ' ' ILE . 4.0 t -118.32 141.2 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.751 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -95.34 121.66 37.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.244 -0.435 . . . . 0.66 111.466 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 83' ' ' ILE . 32.6 mt -95.67 120.06 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.316 0.579 . . . . 1.03 110.01 174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 84' ' ' LEU . 50.0 mtt -128.59 152.28 48.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.798 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.913 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 168.82 -113.8 0.54 Allowed Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.281 -1.128 . . . . 1.55 110.281 173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 85.3 t60 -161.99 147.12 12.97 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.083 -0.71 . . . . 0.66 109.083 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -56.95 -51.38 69.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.592 0.59 . . . . 1.62 112.592 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -61.33 -28.23 69.06 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.796 0.665 . . . . 1.78 112.796 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HE1' ' H ' ' A' ' 93' ' ' MET . 27.7 m170 -66.63 -19.02 65.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.65 110.799 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.09 1.38 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.654 -0.784 . . . . 0.93 112.163 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -73.13 -48.8 32.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.235 0.541 . . . . 2.11 110.566 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 1.8 110.067 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 m -70.83 -29.08 65.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.779 -0.646 . . . . 1.77 110.428 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 tp -63.33 -49.0 75.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.459 -0.571 . . . . 1.78 109.459 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 8.3 tt -60.09 -45.42 93.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.406 -0.816 . . . . 1.96 110.519 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.8 t70 -66.17 -48.33 71.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.144 -0.48 . . . . 1.38 111.908 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.06 99.66 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.115 0.483 . . . . 0.91 110.735 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 25' ' ' LEU . 9.6 tt -66.67 -34.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.753 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 29.5 ptt180 -78.33 -36.31 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.675 0.75 . . . . 3.56 109.092 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -76.16 14.39 0.73 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.799 -1.091 . . . . 2.88 111.578 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.716 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 71.2 m -98.42 11.86 36.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.369 -0.604 . . . . 1.76 109.369 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 31' ' ' SER . 0.3 OUTLIER 57.53 1.36 0.12 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.525 1.53 . . . . 5.71 115.005 166.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.26 0.85 10.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.539 0.685 . . . . 2.99 109.227 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.525 ' HB ' ' HA ' ' A' ' 29' ' ' ARG . 2.4 m -119.99 150.95 39.7 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.163 -0.926 . . . . 3.93 112.039 -166.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 41.5 mt-10 -83.71 -162.76 0.67 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.279 -1.328 . . . . 4.2 108.659 170.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.746 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 2.1 pt20 -178.17 177.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.413 0.625 . . . . 5.38 111.422 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.527 ' HB3' ' CA ' ' A' ' 46' ' ' GLY . 11.6 tp10 -161.32 -179.09 7.13 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.653 -1.61 . . . . 5.79 106.653 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.452 ' H ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.87 90.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 118.145 0.429 . . . . 4.24 110.667 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.81 132.72 8.79 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 116.125 -0.488 . . . . 4.95 112.24 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.08 -102.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.918 -0.873 . . . . 6.66 110.918 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.97 -37.62 80.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.824 -0.806 . . . . 9.17 108.824 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.3 m -79.44 105.32 10.67 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.995 -1.002 . . . . 7.36 109.538 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 43' ' ' GLN . 1.4 pt20 -116.31 38.36 3.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.797 0.808 . . . . 8.83 110.649 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -103.2 -29.29 11.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.992 -1.114 . . . . 6.76 107.992 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 pt -142.58 -164.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.114 -1.403 . . . . 5.19 108.679 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' CA ' ' HB3' ' A' ' 37' ' ' GLU . . . 117.32 7.13 12.68 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.04 -1.076 . . . . 2.97 112.879 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.65 170.32 14.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.222 0.534 . . . . 1.71 111.242 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.746 ' HB3' ' HA ' ' A' ' 36' ' ' GLN . 3.4 p90 -162.48 159.11 24.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.559 -0.746 . . . . 2.54 110.368 -169.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 45.5 mt-30 -125.32 136.97 54.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.493 -0.321 . . . . 1.96 110.15 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 57' ' ' ILE . 5.0 m -93.22 145.0 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.135 0.493 . . . . 1.93 111.43 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -106.24 82.68 1.78 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.691 -0.686 . . . . 2.06 109.711 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.1 p -132.68 120.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.004 -0.998 . . . . 4.12 108.456 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 72.24 -10.47 0.9 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.14 0.972 . . . . 4.43 109.49 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.4 t70 75.24 28.06 1.04 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.697 -2.047 . . . . 3.62 109.774 -175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' HG13 ' A' ' 57' ' ' ILE . 18.3 tptm -93.82 101.54 13.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.055 -1.461 . . . . 7.44 107.055 170.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -74.3 76.94 1.85 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.291 0.567 . . . . 5.43 111.34 -168.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 50' ' ' VAL . 39.3 mt -66.9 106.71 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.247 -0.888 . . . . 1.14 110.309 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.664 ' HB ' ' HA ' ' A' ' 10' ' ' VAL . 5.0 m -80.88 100.79 9.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.551 -0.537 . . . . 1.28 109.551 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HE2' ' CG1' ' A' ' 50' ' ' VAL . 59.5 m-85 -80.0 118.7 21.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.001 0.429 . . . . 0.84 111.985 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -104.6 137.26 42.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.476 -0.784 . . . . 3.0 109.496 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -101.82 134.94 44.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.747 0.308 . . . . 6.48 110.565 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 67' ' ' ALA . 35.4 m -122.07 94.57 48.0 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 120.948 0.404 . . . . 5.57 111.308 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -94.53 13.13 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.079 2.519 . . . . 5.77 112.475 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.11 -163.64 12.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.869 -0.681 . . . . 5.54 112.446 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -99.36 -78.65 0.5 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 8.09 111.709 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -86.94 58.83 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.238 0.542 . . . . 6.36 111.652 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' HG23 ' A' ' 62' ' ' THR . . . -121.86 115.73 23.14 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.832 -0.622 . . . . 3.51 110.244 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB2' ' CD2' ' A' ' 102' ' ' HIS . 1.1 t80 -157.19 -53.29 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.791 -0.448 . . . . 2.61 109.791 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -71.37 90.4 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 4.74 111.245 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 p -113.63 0.46 14.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.907 -0.588 . . . . 5.89 110.662 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -80.48 143.09 33.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.643 -0.708 . . . . 5.64 110.422 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -88.67 45.42 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.587 0.708 . . . . 9.71 110.048 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -178.17 169.46 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.031 -0.986 . . . . 7.52 109.196 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -112.44 48.96 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.825 0.821 . . . . 10.42 109.068 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.07 -177.26 46.69 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.994 -1.242 . . . . 6.75 109.994 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.63 36.89 28.31 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.662 0.744 . . . . 6.69 109.942 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -88.01 119.38 28.31 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.94 -1.027 . . . . 7.72 111.216 -173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.57 7.61 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.259 -1.015 . . . . 4.38 108.259 173.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 1.1 m -84.74 5.46 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.495 -1.229 . . . . 4.18 111.507 -173.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 108' ' ' VAL . 19.6 m-20 -80.12 38.3 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 3.12 111.315 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.723 ' HB ' HG22 ' A' ' 11' ' ' VAL . 41.9 mm -125.02 104.98 14.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.32 -0.622 . . . . 0.74 109.32 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 103' ' ' ALA . 90.5 t -106.85 105.85 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.402 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -87.48 107.75 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 109.057 -0.72 . . . . 1.32 109.057 174.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 100' ' ' ILE . 3.1 tm? -96.76 114.65 26.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.236 -0.893 . . . . 1.33 109.928 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.913 HG12 ' HA3' ' A' ' 15' ' ' GLY . 9.9 p -88.04 141.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.295 0.569 . . . . 1.2 111.341 -176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.666 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.8 m -138.4 -171.09 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.243 -0.89 . . . . 1.12 108.631 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.87 136.91 25.88 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.752 -0.379 . . . . 0.75 110.535 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 59.37 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.695 0.76 . . . . 1.18 111.235 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -172.72 -30.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.242 -1.344 . . . . 2.01 109.655 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -108.98 -52.53 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.102 0.477 . . . . 1.09 110.991 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 102.5 -113.42 4.59 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.581 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 96' ' ' THR . 41.4 t -125.85 112.26 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 120.973 0.415 . . . . 1.08 110.919 -175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 66.7 mtp -88.26 171.8 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.327 -0.397 . . . . 1.32 110.452 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 84.7 Cg_exo -46.98 -48.5 14.36 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.818 2.345 . . . . 0.61 114.112 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 6.1 mt-30 -62.03 -38.41 88.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.006 -0.278 . . . . 1.47 110.91 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.706 ' HB ' HG13 ' A' ' 92' ' ' VAL . 6.4 m -58.57 -33.54 70.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.786 0.803 . . . . 0.46 110.102 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' CZ ' ' A' ' 134' ' ' TYR . 21.4 t -76.99 -57.93 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.691 -1.14 . . . . 1.05 111.536 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -73.56 -8.55 56.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.857 -0.611 . . . . 1.62 112.543 -169.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -84.32 -44.67 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.053 -1.091 . . . . 0.34 108.053 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.683 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.8 mt -62.9 -45.9 97.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.185 -1.371 . . . . 0.38 111.055 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 5.2 m-20 -54.61 -29.0 50.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 1.85 111.134 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.455 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 13.3 t60 -85.04 -28.89 25.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.339 -0.391 . . . . 0.85 110.284 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.02 -46.25 12.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.491 . . . . 0.48 111.691 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 101' ' ' ASN . 21.4 ptmt -54.89 -37.01 65.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 2.56 112.639 -171.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.98 11.41 34.07 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.627 0.973 . . . . 0.76 113.627 -167.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -86.92 -51.59 5.96 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 107.023 -1.473 . . . . 0.9 107.023 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 106' ' ' ALA . 2.5 p-10 149.59 14.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 125.858 1.974 . . . . 2.06 108.839 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 80' ' ' ASP . 0.4 OUTLIER -102.02 143.69 27.09 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.503 -0.771 . . . . 1.08 112.204 -166.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 10.7 Cg_exo -72.72 156.96 52.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.215 2.61 . . . . 0.51 112.908 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.562 HD13 HG12 ' A' ' 100' ' ' ILE . 82.3 mt -126.33 149.31 31.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.151 -0.931 . . . . 0.96 110.056 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 mt -120.28 161.1 20.22 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 N-CA-C 108.697 -0.853 . . . . 0.71 108.697 -177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -123.71 140.93 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 121.049 0.452 . . . . 0.23 110.67 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -122.39 88.63 2.97 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.039 -1.097 . . . . 0.25 108.039 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.695 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 44.1 mt -69.66 96.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.043 -0.981 . . . . 0.85 109.543 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -94.14 165.39 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.258 -0.428 . . . . 0.69 110.686 -172.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 48.8 mttp 64.62 14.18 8.82 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.652 -0.704 . . . . 2.61 112.641 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -85.29 9.13 16.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.622 -0.831 . . . . 1.37 111.433 -175.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.555 ' HB3' ' HE3' ' A' ' 153' ' ' LYS . 33.8 t70 -77.38 57.77 1.56 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.065 0.936 . . . . 2.45 109.038 171.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.995 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 16.6 pttm -164.84 -171.35 0.26 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.403 -1.332 . . . . 3.7 107.403 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.995 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.3 Cg_endo -46.03 -21.26 1.01 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.925 2.417 . . . . 2.67 114.08 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 119' ' ' LYS . 12.4 pt-20 53.47 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.545 1.138 . . . . 4.03 111.789 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -41.44 -67.14 0.27 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 113.933 -1.485 . . . . 1.47 111.483 -172.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 42.4 t-20 170.31 104.4 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 O-C-N 124.316 1.01 . . . . 1.84 109.226 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.673 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.6 Cg_exo -38.77 -55.74 1.29 Allowed 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 123.338 2.692 . . . . 0.7 113.73 171.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -47.39 -49.28 25.19 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.403 0.52 . . . . 2.0 112.403 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 20.5 tpt180 -49.08 -59.53 3.56 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.51 0.671 . . . . 2.99 109.798 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.475 HG13 ' HA2' ' A' ' 91' ' ' GLY . 51.4 t -55.99 -45.9 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.966 -1.47 . . . . 0.4 110.399 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.703 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 91.0 mtp -60.45 -34.37 73.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.3 111.449 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 132' ' ' MET . 92.9 mt-30 -73.9 -22.39 59.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 1.28 110.359 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 5.8 mt-10 -75.49 -32.64 60.62 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.875 -0.787 . . . . 2.02 108.875 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.93 HD12 HD11 ' A' ' 136' ' ' LEU . 3.4 mm? -68.73 -45.56 71.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.609 0.719 . . . . 1.06 109.465 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.892 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -73.43 -5.82 42.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.563 -0.744 . . . . 0.35 110.181 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 19.8 tp10 -76.6 -29.57 56.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.865 -1.161 . . . . 2.18 107.865 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.538 ' CZ ' HG22 ' A' ' 97' ' ' VAL . 22.6 m-85 -92.29 6.67 45.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.424 0.63 . . . . 0.74 109.654 171.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.2 m120 78.43 24.47 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.277 -1.328 . . . . 1.94 111.585 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.93 HD11 HD12 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -105.63 78.94 1.39 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.626 -1.25 . . . . 1.68 107.626 172.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.416 HG23 ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -65.63 130.95 94.68 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 113.565 -1.652 . . . . 0.61 111.697 -176.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 71.1 Cg_exo -49.44 157.09 2.34 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.503 2.802 . . . . 0.3 113.376 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 146' ' ' ILE . 43.2 mm-40 -72.45 -26.32 61.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.302 -1.317 . . . . 2.01 109.488 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.868 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 3.3 mm-40 -58.55 -43.42 89.29 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.288 -0.869 . . . . 1.14 108.696 171.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.892 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -88.51 -24.78 22.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.064 -1.425 . . . . 0.45 110.283 -169.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 113.93 26.7 3.74 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.988 -1.101 . . . . 0.45 112.186 170.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA3' HG23 ' A' ' 137' ' ' VAL . . . -101.73 -115.47 3.96 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.405 -0.902 . . . . 0.5 111.896 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.91 33.39 0.48 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.596 0.236 . . . . 1.3 111.234 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.679 HG21 HD12 ' A' ' 136' ' ' LEU . 36.2 m -128.0 120.24 27.14 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 119.779 -0.769 . . . . 0.32 112.588 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.479 HG13 ' HG3' ' A' ' 139' ' ' GLU . 3.5 mp -88.16 109.98 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.645 -0.707 . . . . 1.23 110.385 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.796 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 21.1 m-85 -88.55 108.03 19.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.896 0.379 . . . . 0.38 111.116 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 20.2 t -98.33 118.65 35.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.243 -0.651 . . . . 1.1 109.243 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 14.2 ptpt -92.3 102.97 15.46 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.162 -0.681 . . . . 2.44 109.162 173.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -130.17 -169.32 2.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.978 0.894 . . . . 1.27 112.789 -172.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 m -165.8 121.02 1.25 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 113.916 -1.493 . . . . 1.79 109.516 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.54 -12.51 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.623 -0.262 . . . . 0.87 111.668 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.555 ' HE3' ' HB3' ' A' ' 118' ' ' ASP . 18.9 pttp -80.69 -47.02 14.63 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.879 0.847 . . . . 3.03 109.463 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.463 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -78.93 -22.57 45.59 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.246 -1.343 . . . . 1.2 109.84 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.7 ' HG2' HD12 ' A' ' 158' ' ' LEU . 9.3 mtpm? 63.93 3.86 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.593 -1.185 . . . . 2.27 113.71 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.84 -56.11 25.88 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.058 0.932 . . . . 2.64 110.38 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -69.29 -11.98 65.28 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.519 -1.219 . . . . 0.62 113.535 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.7 HD12 ' HG2' ' A' ' 155' ' ' LYS . 31.5 mt -68.54 -43.0 77.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.314 0.557 . . . . 1.55 110.397 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.0 -45.65 91.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.764 -0.653 . . . . 2.5 109.611 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' A' ' 164' ' ' MET . 75.4 t60 -64.56 -29.82 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.73 110.783 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 165' ' ' ILE . 58.1 tp -67.12 -59.38 3.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.383 -0.371 . . . . 0.91 111.149 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.472 ' HB3' HG11 ' A' ' 52' ' ' VAL . 91.1 mt -54.33 -40.04 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.319 0.387 . . . . 1.06 110.704 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.76 -37.82 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 2.49 111.215 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 25.1 mmt -72.41 -39.84 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 0.87 110.077 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 161' ' ' LEU . 84.5 mt -58.49 -49.46 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.64 111.257 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -70.32 -35.19 73.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.77 0.319 . . . . 1.81 111.268 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 166' ' ' LEU . 59.1 tp -56.93 -32.99 66.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.055 -0.521 . . . . 1.42 109.837 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 164' ' ' MET . 43.7 t -78.03 -37.09 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.898 -0.592 . . . . 1.17 109.918 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 t -55.16 -35.46 64.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.642 -0.708 . . . . 1.54 110.483 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.45 -45.04 8.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 2.79 111.13 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.8 ttp -65.22 -19.75 66.11 Favored 'General case' 0 C--O 1.223 -0.289 0 N-CA-C 111.459 0.17 . . . . 1.82 111.459 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.95 -30.83 15.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.088 0.471 . . . . 3.45 111.188 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -95.94 -20.04 19.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 3.36 111.086 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.5 mp -107.36 -6.58 17.07 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.228 0.825 . . . . 4.14 113.228 -172.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -56.15 117.33 3.65 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.138 0.494 . . . . 6.31 111.393 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -112.29 17.42 19.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.637 -0.71 . . . . 4.57 110.891 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.3 t30 -108.3 126.76 28.89 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.836 -0.62 . . . . 6.38 110.055 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 12.2 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.008 2.472 . . . . 7.47 111.334 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 111.916 -0.474 . . . . 16.35 111.916 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t -89.6 45.35 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.379 0.609 . . . . 14.69 110.545 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.11 123.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 14.68 110.102 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.4 tpt -113.13 98.18 6.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.186 0.517 . . . . 12.73 110.14 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.6 m -107.7 139.49 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.776 -0.647 . . . . 10.18 109.574 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -81.92 58.99 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.161 0.505 . . . . 9.14 110.839 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -118.68 84.01 23.65 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.668 -0.696 . . . . 8.35 109.192 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -76.7 113.92 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.938 2.426 . . . . 4.6 112.298 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -91.47 92.85 0.22 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.068 2.512 . . . . 4.29 110.712 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.15 109.89 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.281 0.562 . . . . 2.58 110.194 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 81' ' ' ILE . 74.4 t -84.75 89.22 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 121.698 0.761 . . . . 1.0 110.131 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -87.19 112.5 22.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 0.66 110.308 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 53.3 mt -74.34 117.08 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 121.613 0.72 . . . . 1.03 110.205 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 43.9 mtt -118.37 179.18 4.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.687 -1.142 . . . . 1.04 109.984 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.862 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.38 -96.8 0.2 Allowed Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.158 -1.177 . . . . 1.55 110.158 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -172.33 143.56 1.45 Allowed 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.969 -1.122 . . . . 0.66 107.969 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.43 -24.92 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.387 0.884 . . . . 1.62 113.387 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.32 -33.74 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.855 0.317 . . . . 1.78 111.855 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -62.86 -23.95 67.56 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.503 0.557 . . . . 0.65 112.503 -172.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.05 65.41 0.7 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.337 -0.935 . . . . 0.93 112.434 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -87.09 -15.58 38.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.332 0.587 . . . . 2.11 109.721 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -78.06 -30.05 49.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.611 -0.722 . . . . 1.8 110.451 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.12 -27.49 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 1.77 111.089 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.02 -50.19 30.65 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.592 -0.521 . . . . 1.78 109.592 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -60.44 -22.18 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 1.96 110.789 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -92.64 -56.73 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.172 0.434 . . . . 1.38 112.172 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -28.16 69.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.646 0.26 . . . . 0.91 111.397 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -71.12 -32.62 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.954 0.407 . . . . 1.56 110.109 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HA ' HG21 ' A' ' 34' ' ' THR . 33.6 mtp-105 -68.52 -32.28 72.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.522 0.677 . . . . 3.56 109.347 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 10.1 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.066 -0.97 . . . . 2.88 110.601 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 m -119.38 27.89 8.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.68 -0.691 . . . . 1.76 109.456 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.751 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER 48.08 -161.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.569 1.168 . . . . 5.71 112.459 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.751 HG13 ' HG3' ' A' ' 32' ' ' LYS . 2.9 m 58.75 2.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.35 1.46 . . . . 2.99 113.768 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.3 t -86.35 156.65 20.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.181 0.515 . . . . 3.93 111.589 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 11.9 mm-40 -77.62 -92.72 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.279 -0.873 . . . . 4.2 111.522 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.646 HE21 ' HG3' ' A' ' 37' ' ' GLU . 13.5 pt20 -164.0 -179.65 6.38 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.372 0.878 . . . . 5.38 113.372 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.646 ' HG3' HE21 ' A' ' 36' ' ' GLN . 43.7 mt-10 62.79 -99.64 0.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.221 -1.354 . . . . 5.79 114.2 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.591 ' HB2' ' H ' ' A' ' 47' ' ' ALA . . . -47.07 121.23 3.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.118 0.785 . . . . 4.24 113.118 -171.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.64 35.73 0.24 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.358 -0.837 . . . . 4.95 112.305 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.54 -164.71 13.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.839 -0.696 . . . . 6.66 112.133 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.5 mm -92.22 -60.74 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.093 0.473 . . . . 9.17 110.388 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -78.69 -19.12 53.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.008 -0.542 . . . . 7.36 110.36 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -77.57 86.05 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.439 -0.578 . . . . 8.83 109.439 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -92.38 118.66 31.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 6.76 111.194 -175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.8 pt 51.0 -175.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.039 1.336 . . . . 5.19 113.207 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.09 -32.16 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.006 -0.997 . . . . 2.97 110.952 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.591 ' H ' ' HB2' ' A' ' 38' ' ' ALA . . . 62.99 -179.4 0.14 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.441 0.697 . . . . 1.71 110.826 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.4 p90 -159.37 154.17 24.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 2.54 110.935 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 28.4 mt-30 -116.31 137.33 52.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.677 -0.692 . . . . 1.96 109.458 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 57' ' ' ILE . 3.9 m -105.34 129.75 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 121.606 0.717 . . . . 1.93 111.291 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.2 m -99.23 82.26 2.68 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.122 -0.945 . . . . 2.06 110.392 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.605 ' C ' ' H ' ' A' ' 54' ' ' ASP . 4.5 p -124.48 123.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.83 -1.174 . . . . 4.12 107.83 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 72.52 -16.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.105 0.955 . . . . 4.43 109.973 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.605 ' H ' ' C ' ' A' ' 52' ' ' VAL . 46.7 t0 75.83 40.43 0.28 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.129 -1.85 . . . . 3.62 109.968 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 14.7 tptm -95.84 -2.79 46.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.213 -0.903 . . . . 7.44 109.683 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.6 mttp 60.21 51.33 5.64 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.358 -1.292 . . . . 5.43 112.3 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.637 ' HB ' HG23 ' A' ' 50' ' ' VAL . 73.3 mt -61.35 127.01 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 1.14 110.932 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 23.1 m -99.11 117.11 32.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.398 -0.365 . . . . 1.28 110.221 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.625 ' HE2' HG21 ' A' ' 50' ' ' VAL . 28.9 m-85 -96.31 109.67 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.689 0.28 . . . . 0.84 110.775 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.509 HD21 ' HB ' ' A' ' 13' ' ' ILE . 3.9 mm? 67.85 172.88 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.333 -0.849 . . . . 3.0 112.187 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.48 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 5.2 t70 -168.93 -160.18 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.704 -1.221 . . . . 6.48 107.704 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.536 ' HB ' ' HD3' ' A' ' 63' ' ' PRO . 21.7 m -67.89 -53.68 19.7 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 111.518 0.192 . . . . 5.57 111.518 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 62' ' ' THR . 71.9 Cg_endo -74.51 55.64 3.73 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.585 2.19 . . . . 5.77 113.221 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.05 -177.35 49.04 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.749 -0.739 . . . . 5.54 112.343 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 69.12 -72.94 0.1 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.219 0.607 . . . . 8.09 112.247 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -122.42 -24.26 5.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.439 0.533 . . . . 6.36 112.439 -170.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.53 4.74 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.45 0.537 . . . . 3.51 112.45 -171.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.784 ' HE1' ' HA ' ' A' ' 103' ' ' ALA . 26.6 t80 66.62 -95.32 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.211 -0.449 . . . . 2.61 111.118 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.3 p -147.21 -102.29 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.086 0.469 . . . . 4.74 111.288 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.3 m -79.73 105.78 11.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.418 -0.355 . . . . 5.89 110.819 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.6 mmt -116.26 14.62 15.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.38 0.61 . . . . 5.64 110.848 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -137.13 120.45 16.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.383 -0.826 . . . . 9.71 108.777 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.64 59.82 2.77 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.513 0.673 . . . . 7.52 109.233 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -96.03 126.71 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.396 -0.82 . . . . 10.42 111.332 -172.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.81 154.21 52.56 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.702 -0.761 . . . . 6.75 111.824 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.93 84.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.865 0.364 . . . . 6.69 111.137 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.38 83.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.06 0.457 . . . . 7.72 110.173 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.29 153.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.978 -0.555 . . . . 4.38 109.958 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 108' ' ' VAL . 5.9 t -153.71 58.62 0.74 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.839 0.828 . . . . 4.18 110.211 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.55 -173.53 2.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.116 -0.947 . . . . 3.12 110.884 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.687 ' HB ' HG22 ' A' ' 11' ' ' VAL . 40.8 mm -111.84 109.89 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.977 -0.556 . . . . 0.74 110.85 -174.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.928 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.7 t -95.16 103.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 120.75 0.31 . . . . 1.19 111.01 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.673 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 9.2 mm -87.22 99.75 8.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.316 -0.624 . . . . 1.32 109.316 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 100' ' ' ILE . 11.4 tp -85.97 106.56 17.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.269 -0.423 . . . . 1.33 110.557 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.862 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.4 p -80.19 141.19 15.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.263 0.554 . . . . 1.2 110.978 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.3 m -141.2 -171.2 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 107.868 -1.16 . . . . 1.12 107.868 175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.14 146.95 43.4 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.426 -0.51 . . . . 0.75 110.839 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . -35.51 -53.89 0.68 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.778 1.299 . . . . 1.18 112.677 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.11 -9.93 20.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.593 0.59 . . . . 2.01 112.593 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.67 -40.46 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.126 -0.63 . . . . 1.09 111.559 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.516 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.49 -138.42 23.2 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.296 -0.954 . . . . 0.52 111.115 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.03 HG13 ' HB ' ' A' ' 96' ' ' THR . 23.9 t -101.04 113.44 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 122.766 0.426 . . . . 1.08 110.553 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.511 ' HE1' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -85.0 166.79 29.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.502 -0.925 . . . . 1.32 108.502 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HD2' ' HE1' ' A' ' 93' ' ' MET . 31.8 Cg_exo -34.56 -52.05 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.848 3.032 . . . . 0.61 115.09 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -78.06 -17.99 56.33 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 122.124 -0.36 . . . . 1.47 111.415 -173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.03 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.9 m -67.72 -19.06 65.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.35 0.595 . . . . 0.46 109.947 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.15 -44.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.266 -0.425 . . . . 1.05 110.78 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -27.25 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 1.62 110.967 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -75.9 -37.39 58.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.974 -0.557 . . . . 0.34 110.08 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.745 HD13 HD13 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -75.09 -43.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.38 111.209 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -51.43 -36.22 42.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.171 0.51 . . . . 1.85 110.669 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -83.85 -26.48 29.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.649 -0.705 . . . . 0.85 110.493 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.928 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -88.08 -50.22 6.54 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.49 0.552 . . . . 0.48 112.49 -173.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -69.57 -21.68 63.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.031 0.443 . . . . 2.56 111.174 -171.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.37 7.2 20.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.954 -0.567 . . . . 0.76 111.936 -172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.11 -2.68 27.02 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.001 -0.741 . . . . 0.9 109.001 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 t30 80.09 52.48 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.129 -1.396 . . . . 2.06 107.734 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.711 HG21 ' HZ ' ' A' ' 68' ' ' PHE . 25.3 t -124.34 143.4 42.82 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.427 -1.715 . . . . 1.08 111.051 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 Cg_exo -75.27 152.72 39.87 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.799 2.333 . . . . 0.51 113.152 172.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.591 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -123.48 143.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.471 -1.24 . . . . 0.96 110.773 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 mp -114.54 147.81 17.75 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.044 -1.095 . . . . 0.71 108.044 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.27 130.86 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 109.308 -0.627 . . . . 0.23 109.308 172.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -115.22 87.59 2.69 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.25 107.991 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.842 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 23.3 mt -71.26 95.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.57 -1.195 . . . . 0.85 110.26 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.06 164.49 12.86 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.299 -0.259 . . . . 0.69 110.299 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 62.47 22.7 13.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.815 0.817 . . . . 2.61 109.964 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 4.8 tpp -82.51 1.34 38.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.348 -1.296 . . . . 1.37 109.687 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.593 ' HB3' ' OG ' ' A' ' 151' ' ' SER . 1.6 p30 -52.59 -6.68 0.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.666 -1.152 . . . . 2.45 113.111 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 38.1 mmtm -72.71 -172.83 0.24 Allowed Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.639 -1.245 . . . . 3.7 107.639 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 31.8 Cg_exo -56.38 -53.06 5.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.243 1.122 . . . . 2.67 109.852 166.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 20.1 pt-20 154.68 118.54 0.0 OUTLIER 'General case' 0 C--N 1.341 0.21 0 C-N-CA 125.969 1.707 . . . . 4.03 107.328 177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -60.43 -67.08 0.43 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 1.47 110.557 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 16.3 t-20 -179.39 80.85 0.2 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 123.513 0.508 . . . . 1.84 110.489 171.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.3 Cg_exo -43.07 -55.5 2.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 123.289 2.66 . . . . 0.7 113.611 173.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -46.64 -48.98 19.79 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.884 0.698 . . . . 2.0 112.884 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -53.81 -56.68 15.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 2.99 110.245 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.516 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.7 t -53.64 -46.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.094 177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.648 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.1 mtp -63.23 -38.65 92.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.33 -0.85 . . . . 0.3 111.475 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.9 mt-30 -74.32 -25.06 59.32 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 110.073 -0.343 . . . . 1.28 110.073 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -74.22 -30.24 62.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.151 -0.477 . . . . 2.02 109.889 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.2 mm? -69.43 -45.14 69.87 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.635 0.731 . . . . 1.06 109.645 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.883 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -73.93 -6.07 45.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.957 -1.02 . . . . 0.35 109.793 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 35.5 tt0 -77.39 -28.62 52.85 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.251 -1.018 . . . . 2.18 108.251 173.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.596 ' HB2' HD12 ' A' ' 136' ' ' LEU . 30.5 m-85 -90.05 12.35 17.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.67 0.748 . . . . 0.74 108.987 169.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.54 42.75 1.48 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.102 -1.408 . . . . 1.94 109.93 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 100' ' ' ILE . 2.1 mp -117.7 78.24 1.22 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.617 -1.174 . . . . 1.68 108.803 171.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.54 125.76 91.64 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.608 -1.178 . . . . 0.61 110.913 -178.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.745 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 85.0 Cg_exo -49.36 158.78 1.47 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 123.213 2.608 . . . . 0.3 112.822 172.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' HG12 ' A' ' 146' ' ' ILE . 30.4 mt-10 -81.14 -20.55 41.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.247 -0.888 . . . . 2.01 109.695 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.841 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -55.87 -39.89 72.15 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.252 -1.018 . . . . 1.14 108.252 168.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.883 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 6.1 m0 -94.08 -30.3 14.74 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.748 -1.569 . . . . 0.45 109.492 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 120.25 21.57 3.37 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.754 -1.212 . . . . 0.45 112.921 168.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.492 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -92.29 -114.97 2.14 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.243 -0.979 . . . . 0.5 112.545 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -151.23 28.88 0.65 Allowed 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.313 0.577 . . . . 1.3 111.237 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.591 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.62 122.35 32.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.459 0.647 . . . . 0.32 112.05 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 168' ' ' VAL . 15.8 mt -91.69 106.88 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 1.23 111.241 -176.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.745 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 26.6 m-85 -88.59 108.31 19.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.38 111.583 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 79.1 m -104.28 100.31 10.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.1 110.188 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.842 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 16.4 ptmt -82.03 94.68 7.23 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.306 -0.627 . . . . 2.44 109.306 174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' MET . 0.7 OUTLIER -112.77 -176.84 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.955 0.884 . . . . 1.27 112.684 -168.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.593 ' OG ' ' HB3' ' A' ' 118' ' ' ASP . 24.6 t -165.97 121.64 1.27 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.263 -1.335 . . . . 1.79 109.737 177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.04 -9.2 44.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.894 0.378 . . . . 0.87 111.197 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -83.89 -56.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.736 0.779 . . . . 3.03 109.675 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 46.5 p -81.04 -20.54 41.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.421 -1.263 . . . . 1.2 111.562 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 73.14 -2.65 2.67 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.659 -0.7 . . . . 2.27 111.201 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -48.35 -71.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.772 0.796 . . . . 2.64 112.061 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.457 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -71.63 -9.58 69.74 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.875 -1.057 . . . . 0.62 113.822 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 158' ' ' LEU . 4.3 mm? -69.09 -50.25 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.677 0.738 . . . . 1.55 110.367 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.91 -38.48 82.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.068 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' A' ' 164' ' ' MET . 80.2 t60 -69.39 -28.89 66.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.657 -0.701 . . . . 0.73 110.921 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 62.0 tp -63.25 -58.19 7.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.038 -0.356 . . . . 0.91 110.038 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.75 -37.05 65.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.381 0.61 . . . . 1.06 110.054 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.413 ' HG2' ' HE2' ' A' ' 164' ' ' MET . 16.1 tt0 -65.29 -48.26 73.77 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.027 -0.988 . . . . 2.49 110.829 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.632 ' HB3' HG21 ' A' ' 146' ' ' ILE . 17.3 mmt -63.12 -42.79 99.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.309 . . . . 0.87 110.466 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 161' ' ' LEU . 87.8 mt -53.72 -53.56 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.667 -0.697 . . . . 0.64 110.15 176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.461 HD11 HG13 ' A' ' 52' ' ' VAL . 76.8 mt -59.58 -48.97 79.58 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.659 -0.7 . . . . 1.81 111.872 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.39 -47.18 73.02 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.746 -0.661 . . . . 1.42 111.098 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 146' ' ' ILE . 2.1 t -67.58 -38.39 80.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.509 -0.314 . . . . 1.17 111.371 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.2 m -60.86 -25.18 66.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.18 0.514 . . . . 1.54 110.561 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -98.63 -22.84 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 2.79 110.856 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 56.4 ttp -77.9 -15.21 59.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.82 110.779 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -56.85 -19.68 18.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 3.45 111.793 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -63.37 -26.94 68.98 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.166 0.507 . . . . 3.36 109.691 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 mt -106.29 -71.97 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 4.14 109.481 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.584 ' HG2' ' H ' ' A' ' 176' ' ' ALA . 45.0 tttp 69.54 175.14 0.29 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.303 -0.862 . . . . 6.31 112.207 173.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.584 ' H ' ' HG2' ' A' ' 175' ' ' LYS . . . 74.12 -82.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.006 0.923 . . . . 4.57 112.315 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.72 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 53.2 t-20 -163.07 -58.33 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 119.696 -0.193 . . . . 6.38 111.155 -175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 1.4 Cg_endo . . . . . 0 C--O 1.251 1.127 0 C-N-CA 122.734 2.289 . . . . 7.47 112.685 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.359 -0.296 . . . . 16.35 112.359 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -64.04 131.28 47.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.577 0.227 . . . . 14.69 110.418 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -104.93 10.03 34.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.936 0.398 . . . . 14.68 111.165 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.6 tpt -81.97 96.15 7.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.1 -0.5 . . . . 12.73 110.216 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 m -83.94 92.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 10.18 110.876 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.79 79.08 5.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 9.14 110.031 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -106.64 137.25 19.41 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.715 -0.675 . . . . 8.35 110.18 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 34.2 Cg_endo -66.25 130.92 25.19 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.449 2.099 . . . . 4.6 111.366 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 63.9 Cg_exo -52.99 140.68 58.71 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.476 2.784 . . . . 4.29 112.853 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.851 HG21 ' HB3' ' A' ' 77' ' ' GLN . 20.5 t -112.13 111.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.257 0.551 . . . . 2.58 110.354 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 81' ' ' ILE . 59.9 t -82.72 104.06 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.944 -177.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.799 HG23 ' HA ' ' A' ' 61' ' ' ASP . 53.1 m -86.07 128.09 34.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.572 -0.74 . . . . 0.66 110.764 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 83' ' ' ILE . 29.0 mt -90.94 122.94 42.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 1.03 111.549 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.522 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 56.7 mtt -137.82 171.86 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.099 -0.501 . . . . 1.04 110.596 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.826 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 150.2 -104.52 0.27 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.051 -1.219 . . . . 1.55 110.051 175.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 93' ' ' MET . 66.1 t60 -167.07 158.68 12.45 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.46 -0.57 . . . . 0.66 109.46 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.45 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.728 0.27 . . . . 1.62 111.728 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.32 -22.07 65.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.114 -0.494 . . . . 1.78 112.233 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.412 ' HE1' ' H ' ' A' ' 93' ' ' MET . 62.0 m170 -71.07 -18.25 62.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.078 0.466 . . . . 0.65 110.565 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.29 40.47 3.96 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.926 -0.654 . . . . 0.93 113.566 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -76.92 -27.38 54.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.468 0.634 . . . . 2.11 110.974 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t -81.92 -30.97 31.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.042 0.449 . . . . 1.8 110.126 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -81.08 -17.06 51.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.283 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.37 -51.55 59.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.825 -0.806 . . . . 1.78 108.825 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.781 HD13 ' HA3' ' A' ' 39' ' ' GLY . 2.7 tt -62.18 -38.63 89.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 1.96 110.248 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 22.0 t70 -68.82 -46.84 67.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.489 -0.323 . . . . 1.38 111.373 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' A' ' 152' ' ' ALA . . . -64.69 -42.03 95.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.926 0.393 . . . . 0.91 110.784 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 25' ' ' LEU . 6.1 tt -66.51 -28.98 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.54 -0.755 . . . . 1.56 109.62 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HA ' HG21 ' A' ' 34' ' ' THR . 14.3 tpt180 -69.37 -33.32 72.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 3.56 109.934 175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -83.45 14.58 3.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.876 -0.602 . . . . 2.88 111.361 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 t -100.58 13.89 33.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.452 -0.34 . . . . 1.76 110.798 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 71.49 -41.23 0.5 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.388 0.884 . . . . 5.71 113.388 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' CG2' HG13 ' A' ' 50' ' ' VAL . 32.7 m -75.75 16.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.088 0.773 . . . . 2.99 113.088 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -96.96 121.46 38.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.386 0.613 . . . . 3.93 110.699 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -54.07 -63.22 1.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.643 -1.162 . . . . 4.2 112.466 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -162.59 167.1 23.81 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.177 -0.209 . . . . 5.38 111.409 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.38 174.71 0.24 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.248 0.967 . . . . 5.79 112.611 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.22 161.92 33.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.279 -0.873 . . . . 4.24 109.855 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.781 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . -138.63 53.33 0.71 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.174 -0.536 . . . . 4.95 112.204 -176.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.47 -96.1 0.58 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.746 -0.74 . . . . 6.66 112.469 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 41' ' ' ILE . 2.6 pp -96.59 -2.97 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.974 0.416 . . . . 9.17 111.687 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 p -88.03 128.84 35.4 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.102 -0.499 . . . . 7.36 111.192 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -84.39 74.04 10.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.782 0.801 . . . . 8.83 110.047 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -143.15 -67.57 0.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.803 -1.09 . . . . 6.76 108.576 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.4 mm 68.9 148.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 114.953 -1.021 . . . . 5.19 111.788 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.4 -100.32 0.17 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 114.367 -1.288 . . . . 2.97 110.9 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.863 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -171.6 174.35 4.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.816 0.341 . . . . 1.71 110.653 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.658 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.8 p90 -150.83 153.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.016 -0.538 . . . . 2.54 110.585 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -115.26 148.15 39.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.237 -0.653 . . . . 1.96 109.237 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 96.7 t -109.11 149.1 12.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.726 0.774 . . . . 1.93 110.813 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 54' ' ' ASP . 25.4 m -84.53 85.49 7.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.176 -1.374 . . . . 2.06 111.365 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -106.78 110.39 31.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.983 -1.117 . . . . 4.12 107.983 169.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.1 -50.83 0.54 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.414 1.071 . . . . 4.43 110.069 -167.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' OD2' ' HG2' ' A' ' 55' ' ' LYS . 32.9 t70 -151.23 -56.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.682 -1.145 . . . . 3.62 109.336 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 20.2 pttt 175.94 67.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.99 -1.005 . . . . 7.44 109.588 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -94.1 6.26 49.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.5 -0.773 . . . . 5.43 111.065 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mt -130.69 129.22 63.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 110.042 -0.355 . . . . 1.14 110.042 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.7 m -112.68 137.59 50.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.363 . . . . 1.28 110.101 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -112.7 117.79 33.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.191 -0.3 . . . . 0.84 110.191 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.863 HD13 ' HB2' ' A' ' 47' ' ' ALA . 42.7 tp -175.53 147.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.35 0.407 . . . . 3.0 111.081 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.799 ' HA ' HG23 ' A' ' 12' ' ' THR . 29.7 m-20 -74.54 85.56 2.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.743 -0.836 . . . . 6.48 108.743 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.571 ' HB ' HG11 ' A' ' 10' ' ' VAL . 14.9 t -90.29 139.39 26.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 5.57 112.051 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HB3' ' HG2' ' A' ' 71' ' ' MET . 72.3 Cg_endo -99.14 77.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 124.206 3.271 . . . . 5.77 112.017 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 78' ' ' VAL . . . -73.44 -8.0 74.61 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.674 -0.774 . . . . 5.54 113.207 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -178.03 -49.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.552 -0.536 . . . . 8.09 109.552 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.35 153.31 33.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 6.36 110.08 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.0 34.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.031 -0.359 . . . . 3.51 110.031 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 102' ' ' HIS . 56.8 m-85 -102.63 -17.3 15.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.597 0.591 . . . . 2.61 112.597 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 70' ' ' THR . 3.4 t -151.8 -70.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.807 -0.357 . . . . 4.74 111.084 174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.707 ' H ' HG23 ' A' ' 69' ' ' THR . 24.6 m -144.86 84.58 1.73 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 5.89 110.053 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.61 ' HG2' ' HB3' ' A' ' 63' ' ' PRO . 2.5 mpt? -119.83 138.12 53.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.916 -0.584 . . . . 5.64 110.106 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -114.08 -29.12 7.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.11 -0.495 . . . . 9.71 110.215 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.63 173.1 6.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.917 -0.583 . . . . 7.52 110.294 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -132.62 140.94 48.43 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.413 -0.358 . . . . 10.42 110.065 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.73 -179.23 16.1 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.75 -0.738 . . . . 6.75 112.423 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.59 -8.39 41.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.217 0.532 . . . . 6.69 110.331 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.851 ' HB3' HG21 ' A' ' 10' ' ' VAL . 15.9 mm100 -75.67 100.96 4.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.504 -0.771 . . . . 7.72 110.441 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 27.3 m -66.85 152.87 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.634 . . . . 4.38 111.711 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 m -91.51 74.7 5.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.58 -0.737 . . . . 4.18 109.694 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD2' ' HB3' ' A' ' 9' ' ' PRO . 12.5 p-10 -90.99 -25.86 19.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.072 -0.513 . . . . 3.12 111.639 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.638 HG21 HG22 ' A' ' 11' ' ' VAL . 31.7 mm -116.73 112.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.628 0.251 . . . . 0.74 111.457 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 103' ' ' ALA . 85.7 t -108.36 108.88 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.709 -0.223 . . . . 1.19 110.565 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.787 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -87.39 113.32 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 119.768 -0.773 . . . . 1.32 109.89 172.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 HG22 ' A' ' 96' ' ' THR . 12.4 tp -98.12 111.91 24.06 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.506 -0.77 . . . . 1.33 110.26 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.826 HG12 ' HA3' ' A' ' 15' ' ' GLY . 7.5 p -84.25 143.04 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.245 0.545 . . . . 1.2 111.036 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.849 HG23 ' HA ' ' A' ' 114' ' ' ILE . 30.0 m -135.31 -179.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.158 -1.053 . . . . 1.12 108.158 173.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.31 133.11 14.97 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.431 -0.908 . . . . 0.75 113.195 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.801 ' HB1' ' HB2' ' A' ' 121' ' ' GLU . . . 49.81 -115.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.404 -1.271 . . . . 1.18 113.1 169.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 13.8 p-10 -115.47 8.95 15.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 2.01 110.289 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 16.4 t70 -64.04 -37.34 87.06 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.75 0.786 . . . . 1.09 109.422 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.61 -109.59 2.98 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.52 111.385 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.989 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.0 t -128.25 110.86 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.66 0.266 . . . . 1.08 110.698 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.593 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 72.6 mmm -74.52 170.96 12.7 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.307 -0.406 . . . . 1.32 110.181 174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.2 Cg_exo -45.3 -52.11 6.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.611 2.208 . . . . 0.61 112.709 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -61.67 -34.31 75.5 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.431 -0.349 . . . . 1.47 111.19 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.989 ' HB ' HG13 ' A' ' 92' ' ' VAL . 2.6 m -64.58 -25.91 68.18 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.058 0.456 . . . . 0.46 110.759 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 92' ' ' VAL . 69.1 t -86.31 -48.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.547 -0.297 . . . . 1.05 110.478 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 102' ' ' HIS . 46.4 mt-10 -59.83 -23.94 63.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 1.62 111.335 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.522 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.23 -40.11 31.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.16 -0.681 . . . . 0.34 109.16 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 110' ' ' ILE . 1.4 mt -72.31 -56.28 10.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.38 110.212 176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.444 ' N ' HG22 ' A' ' 100' ' ' ILE . 3.7 t-20 -44.47 -34.34 2.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.438 0.695 . . . . 1.85 111.48 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.581 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 7.1 t60 -84.17 -35.25 23.69 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.983 -0.553 . . . . 0.85 111.354 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -92.32 -28.84 16.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.497 0.554 . . . . 0.48 112.497 -171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -76.95 -11.15 59.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.917 0.389 . . . . 2.56 110.978 -169.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.4 -1.55 56.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.877 0.37 . . . . 0.76 111.895 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -95.91 8.64 43.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.915 -1.143 . . . . 0.9 107.915 170.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.15 33.11 14.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 113.866 -1.515 . . . . 2.06 110.457 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER -91.94 158.27 39.98 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.715 -0.675 . . . . 1.08 110.343 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.533 ' O ' HG23 ' A' ' 108' ' ' VAL . 6.9 Cg_exo -72.49 146.98 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.614 2.21 . . . . 0.51 113.047 170.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.616 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -120.24 142.21 37.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.089 -1.414 . . . . 0.96 109.331 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 15.8 mt -116.88 155.67 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 108.937 -0.764 . . . . 0.71 108.937 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -120.81 138.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.916 0 N-CA-C 109.527 -0.546 . . . . 0.23 109.527 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.19 88.33 2.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.894 -1.15 . . . . 0.25 107.894 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.849 ' HA ' HG23 ' A' ' 86' ' ' VAL . 30.6 mt -68.57 90.2 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.837 -1.074 . . . . 0.85 110.264 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -80.31 154.8 27.57 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.112 0.258 . . . . 0.69 110.528 -172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 64.62 32.49 11.41 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.646 0.591 . . . . 2.61 110.946 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.2 tpp -85.54 -11.39 54.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 1.37 110.469 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.56 -10.44 59.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.337 0.589 . . . . 2.45 109.489 172.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.46 ' NZ ' ' HB3' ' A' ' 119' ' ' LYS . 7.2 mtpm? -113.76 155.23 45.37 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.537 -0.756 . . . . 3.7 110.053 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 13.1 Cg_endo -60.03 -8.97 8.94 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 124.144 3.229 . . . . 2.67 114.756 -176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.801 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -62.8 -38.27 90.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.746 0.308 . . . . 4.03 110.39 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 88' ' ' ALA . . . -69.56 133.14 47.28 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.775 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 51.5 t-20 -126.05 88.09 54.91 Favored Pre-proline 0 CA--C 1.51 -0.563 0 CA-C-O 121.457 0.646 . . . . 1.84 109.963 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -20.4 -81.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 1 C-N-CA 126.28 4.654 . . . . 0.7 115.904 175.793 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.84 -46.63 74.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.992 0.517 . . . . 2.0 112.255 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 30.3 tpt180 -50.78 -60.28 3.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.659 0.742 . . . . 2.99 109.658 178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.4 t -59.69 -45.08 94.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 113.906 -1.497 . . . . 0.4 110.583 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.795 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 91.5 mtp -67.19 -26.13 66.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.906 -0.588 . . . . 0.3 111.25 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -85.31 -18.63 33.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.719 -0.392 . . . . 1.28 111.29 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.637 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.1 mm-40 -60.07 -42.52 94.75 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 108.557 -0.905 . . . . 2.02 108.557 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -73.63 -40.01 64.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.79 -1.095 . . . . 1.06 110.766 -173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.976 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -79.52 -3.68 47.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.811 -0.631 . . . . 0.35 109.76 176.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 11.2 tp10 -73.83 -33.47 64.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 2.18 107.463 171.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CE2' HG11 ' A' ' 92' ' ' VAL . 27.1 m-85 -87.83 7.94 28.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.613 -0.721 . . . . 0.74 109.862 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.56 34.22 1.28 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.755 -1.111 . . . . 1.94 110.638 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.6 mp -111.61 80.48 1.32 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.246 -1.02 . . . . 1.68 108.246 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -67.07 129.15 93.99 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.93 -1.486 . . . . 0.61 111.077 -176.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.811 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 76.0 Cg_exo -49.48 157.37 2.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.236 2.624 . . . . 0.3 113.649 174.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.572 ' HG3' HG13 ' A' ' 146' ' ' ILE . 8.2 mm-40 -70.6 -31.29 68.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.304 -1.317 . . . . 2.01 109.006 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.639 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 3.3 mp0 -46.16 -54.02 9.41 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.576 -1.193 . . . . 1.14 110.698 165.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.976 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.2 m0 -89.45 -18.69 26.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.836 -1.529 . . . . 0.45 110.91 -166.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.59 28.08 4.14 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 120.014 -1.088 . . . . 0.45 112.287 169.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -99.65 -110.81 3.17 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.373 -0.918 . . . . 0.5 111.814 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.434 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 3.3 p30 -159.32 33.5 0.2 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.522 0.677 . . . . 1.3 110.81 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 27.7 m -125.56 112.45 16.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.412 0.625 . . . . 0.32 111.8 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.615 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -79.08 104.66 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.657 -0.701 . . . . 1.23 111.079 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.1 m-85 -87.91 113.96 24.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.201 0.524 . . . . 0.38 111.811 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.41 ' O ' HD12 ' A' ' 150' ' ' LEU . 64.1 m -105.32 100.81 10.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.551 -0.75 . . . . 1.1 109.568 174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.607 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 15.3 pttm -81.27 85.36 6.4 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.577 -0.897 . . . . 2.44 108.577 173.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.876 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -123.25 -175.64 3.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.176 -0.92 . . . . 1.27 112.671 -166.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.1 m -157.24 124.62 5.25 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.645 -1.161 . . . . 1.79 109.628 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 27' ' ' ALA . . . -85.52 -12.93 50.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.098 0.475 . . . . 0.87 110.297 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -73.49 -56.31 5.21 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.364 -0.834 . . . . 3.03 109.304 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.6 p -78.71 -21.57 47.93 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.884 -1.053 . . . . 1.2 108.997 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 1.023 ' HG3' HD12 ' A' ' 158' ' ' LEU . 2.1 ttmp? 70.79 7.03 6.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.715 -1.584 . . . . 2.27 112.038 172.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -67.26 -49.46 64.24 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 122.12 0.962 . . . . 2.64 110.652 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.876 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -62.14 -23.81 64.47 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 114.778 -1.101 . . . . 0.62 113.012 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.023 HD12 ' HG3' ' A' ' 155' ' ' LYS . 29.9 mt -64.65 -32.22 73.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.715 0.258 . . . . 1.55 110.558 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 13.7 m-20 -60.65 -53.26 59.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.036 -0.727 . . . . 2.5 109.036 172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -59.45 -34.03 72.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.441 -0.8 . . . . 0.73 111.049 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 65.2 tp -61.05 -60.55 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.342 -0.39 . . . . 0.91 111.062 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.46 -40.36 68.32 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.221 0.325 . . . . 1.06 110.533 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 78.5 mm-40 -61.64 -49.7 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.013 -0.539 . . . . 2.49 110.715 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.503 ' CE ' ' HA ' ' A' ' 164' ' ' MET . 0.0 OUTLIER -69.56 -34.66 74.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.483 . . . . 0.87 110.444 -175.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 42.7 mt -56.98 -52.32 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.928 -0.578 . . . . 0.64 110.714 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.9 pp -76.8 -37.15 56.29 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.303 0.483 . . . . 1.81 112.303 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 166' ' ' LEU . 40.7 tp -61.53 -25.13 67.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.061 0.458 . . . . 1.42 110.166 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.615 HG21 HG12 ' A' ' 146' ' ' ILE . 2.7 t -85.19 -37.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.071 -0.513 . . . . 1.17 110.12 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.2 t -57.44 -42.19 81.97 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.98 -0.554 . . . . 1.54 110.294 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.18 -28.15 42.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 2.79 110.629 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 56.0 ttp -66.25 -34.58 78.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.302 . . . . 1.82 110.354 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -53.13 -35.24 59.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.221 -0.445 . . . . 3.45 111.593 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -67.23 -24.22 65.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 3.36 110.836 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.97 -77.3 0.52 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.812 0.339 . . . . 4.14 110.127 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -172.35 143.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.954 -0.566 . . . . 6.31 109.63 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -135.79 98.45 3.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.643 -0.253 . . . . 4.57 110.968 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.536 ' N ' ' HD2' ' A' ' 178' ' ' PRO . 28.7 t-20 178.74 -52.73 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.76 -0.654 . . . . 6.38 111.076 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 177' ' ' ASN . 18.0 Cg_endo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.587 2.191 . . . . 7.47 112.441 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.493 -0.643 . . . . 16.35 111.493 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.467 ' OG ' ' HA2' ' A' ' 75' ' ' GLY . 8.6 t -80.6 64.65 5.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.607 0.718 . . . . 14.69 110.402 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -134.86 88.57 2.44 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.084 -0.71 . . . . 14.68 109.084 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 ttt -176.5 -41.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.246 -0.888 . . . . 12.73 109.944 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 7' ' ' ARG . 22.3 t -81.7 -35.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 10.18 110.315 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 53.92 70.35 0.61 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.673 0.608 . . . . 9.14 111.754 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HB2' ' H ' ' A' ' 77' ' ' GLN . 11.4 mmt85 -126.0 97.36 35.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 8.35 110.297 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HG3' ' HB3' ' A' ' 73' ' ' ALA . 4.4 Cg_exo -75.04 142.64 27.97 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.434 2.756 . . . . 4.6 112.595 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HB3' ' OE1' ' A' ' 77' ' ' GLN . 91.3 Cg_endo -80.18 53.09 4.59 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.86 2.373 . . . . 4.29 112.513 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.552 HG12 HG21 ' A' ' 58' ' ' THR . 27.9 m -115.42 127.87 72.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.299 -0.409 . . . . 2.58 110.867 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 58' ' ' THR . 51.4 t -73.48 111.84 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 121.146 0.498 . . . . 1.0 110.231 177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -96.56 130.05 43.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.078 -0.51 . . . . 0.66 110.497 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 55.3 mt -97.76 126.75 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.712 0.292 . . . . 1.03 110.691 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.424 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 70.3 mtm -144.25 -177.73 5.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.075 -0.511 . . . . 1.04 110.888 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 84' ' ' LEU . . . 107.18 59.27 0.58 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.634 -0.793 . . . . 1.55 112.464 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 18.0 t60 62.07 163.62 0.09 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.068 0.937 . . . . 0.66 112.065 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.1 p -100.92 -32.28 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.861 -0.609 . . . . 1.62 111.633 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.444 ' HB3' ' NE2' ' A' ' 16' ' ' HIS . 28.0 t70 -72.83 -25.42 61.12 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.612 0.227 . . . . 1.78 111.612 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 93' ' ' MET . 32.5 m80 -61.71 -20.25 63.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 0.65 110.63 176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.63 51.2 1.13 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.638 -0.71 . . . . 0.93 113.086 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.832 0.825 . . . . 2.11 109.021 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -36.79 80.99 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.451 -1.25 . . . . 1.8 110.76 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.5 p -73.24 -20.82 60.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 1.77 111.257 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 3.8 mm? -71.91 -48.13 47.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.947 -0.39 . . . . 1.78 109.947 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.656 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -69.22 -35.89 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.827 -0.624 . . . . 1.96 109.932 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.12 -58.31 8.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.794 0.331 . . . . 1.38 111.528 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.849 ' HB1' ' HE2' ' A' ' 155' ' ' LYS . . . -62.14 -29.15 70.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.91 111.133 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 HD21 ' A' ' 162' ' ' LEU . 5.2 tt -75.43 -25.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.785 -0.643 . . . . 1.56 111.029 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.618 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 74.0 mtp180 -78.97 -21.33 47.26 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.373 0.606 . . . . 3.56 110.049 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -88.6 -0.31 57.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 2.88 109.695 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -140.43 44.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.576 -0.738 . . . . 1.76 110.156 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.693 ' HD3' ' HG3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -112.37 160.91 17.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.761 . . . . 5.71 111.169 -176.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG12 ' OG1' ' A' ' 34' ' ' THR . 13.8 t -93.43 -57.1 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 108.84 -0.8 . . . . 2.99 108.84 167.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.457 ' OG1' HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -123.74 148.93 46.17 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.927 -1.033 . . . . 3.93 110.293 -176.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.693 ' HG3' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.5 150.12 37.06 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.284 -0.871 . . . . 4.2 110.705 170.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.486 ' CG ' ' HB2' ' A' ' 49' ' ' GLN . 83.3 mm-40 -118.89 175.76 5.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.371 -0.831 . . . . 5.38 109.045 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -82.85 32.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.461 -0.336 . . . . 5.79 110.695 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 176.13 157.44 0.25 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.228 -0.896 . . . . 4.24 109.157 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 48' ' ' TYR . . . -105.54 31.34 8.57 Favored Glycine 0 CA--C 1.512 -0.131 0 N-CA-C 111.046 -0.822 . . . . 4.95 111.046 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.57 -170.98 43.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.976 -0.85 . . . . 6.66 110.976 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.448 HD11 ' O ' ' A' ' 72' ' ' ARG . 19.5 pt -86.19 27.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 9.17 111.653 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -109.5 127.16 54.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.64 -0.709 . . . . 7.36 109.246 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.6 63.83 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.479 . . . . 8.83 112.01 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -147.08 126.93 13.51 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.255 -0.646 . . . . 6.76 109.255 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.632 HG12 ' H ' ' A' ' 46' ' ' GLY . 15.4 tt -84.45 170.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.386 0.612 . . . . 5.19 110.725 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 45' ' ' ILE . . . 129.41 -34.83 2.71 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 110.037 -1.225 . . . . 2.97 110.037 -172.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.585 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -107.93 -173.86 2.38 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.362 -0.977 . . . . 1.71 108.362 172.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.527 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 1.8 p90 -152.77 178.97 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.048 -0.661 . . . . 2.54 111.121 -175.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.559 ' HG2' ' OG1' ' A' ' 58' ' ' THR . 21.3 mt-30 -142.31 117.5 10.1 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.956 -1.127 . . . . 1.96 107.956 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 HG22 ' H ' ' A' ' 51' ' ' THR . 3.4 p -80.97 176.7 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.41 -0.959 . . . . 1.93 108.41 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.738 HG23 ' HB3' ' A' ' 54' ' ' ASP . 5.5 t -53.59 145.02 15.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.73 0.776 . . . . 2.06 111.08 -170.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 54' ' ' ASP . 62.2 t -111.6 138.06 41.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.336 -0.847 . . . . 4.12 109.59 -166.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -44.09 0.58 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.729 -0.841 . . . . 4.43 108.729 -172.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.738 ' HB3' HG23 ' A' ' 51' ' ' THR . 9.2 t70 -65.65 -46.13 80.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.958 -1.019 . . . . 3.62 109.806 170.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 51' ' ' THR . 2.8 mptp? -123.72 -37.88 2.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.15 -0.62 . . . . 7.44 111.431 169.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 76.83 -1.91 2.77 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.442 0.464 . . . . 5.43 111.691 170.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 58' ' ' THR . 10.5 mt -86.94 156.44 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.335 0.588 . . . . 1.14 110.966 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 49' ' ' GLN . 4.0 t -151.61 144.16 24.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.6 -0.889 . . . . 1.28 108.6 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 42.7 m-85 -118.92 121.09 39.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.715 -0.394 . . . . 0.84 110.481 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.6 tp -112.08 121.39 44.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 3.0 111.724 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -141.29 114.4 8.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.361 -0.836 . . . . 6.48 109.109 170.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.2 m -154.17 126.69 3.98 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 5.57 110.16 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 122.38 11.23 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.846 2.364 . . . . 5.77 111.939 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.01 38.66 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.447 -0.661 . . . . 5.54 111.447 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -98.6 9.13 43.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.829 0.314 . . . . 8.09 111.571 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.41 75.21 1.5 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.58 0.705 . . . . 6.36 110.61 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.72 79.74 7.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.548 -0.751 . . . . 3.51 110.697 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.606 ' HZ ' HG11 ' A' ' 108' ' ' VAL . 26.5 t80 -173.2 96.26 0.12 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.914 -0.773 . . . . 2.61 108.914 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p 53.54 -162.58 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.719 0.637 . . . . 4.74 111.001 -174.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.4 p -89.06 -23.5 22.53 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.601 -0.44 . . . . 5.89 110.369 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.3 tpp 67.09 -46.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.087 -0.961 . . . . 5.64 110.898 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' O ' HD11 ' A' ' 41' ' ' ILE . 74.7 mtp180 -64.77 98.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.065 -0.717 . . . . 9.71 109.065 170.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . . . -177.46 -163.81 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 7.52 110.805 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -138.64 169.96 16.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.531 -0.759 . . . . 10.42 109.064 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 84.2 160.96 31.99 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.747 -0.739 . . . . 6.75 113.714 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.74 87.8 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.667 -0.494 . . . . 6.69 109.667 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.643 ' H ' ' HB2' ' A' ' 7' ' ' ARG . 26.9 tp60 -65.85 -54.41 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.219 -0.446 . . . . 7.72 111.109 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t 73.96 -25.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.516 0.726 . . . . 4.38 111.197 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 77' ' ' GLN . 19.7 m -61.37 -40.8 95.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.505 -0.554 . . . . 4.18 109.505 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.669 ' HB2' ' HB ' ' A' ' 108' ' ' VAL . 24.5 m-20 28.51 69.9 0.07 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 125.012 1.445 . . . . 3.12 112.412 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.673 HG23 HD11 ' A' ' 111' ' ' ILE . 28.3 mm -69.2 112.15 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.317 -0.856 . . . . 0.74 112.22 -172.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.731 ' HB ' HD13 ' A' ' 110' ' ' ILE . 75.8 t -107.09 120.62 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 116.44 -0.345 . . . . 1.19 110.899 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 111' ' ' ILE . 8.3 mm -86.31 123.08 39.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.531 -0.914 . . . . 1.32 108.531 171.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 3.0 tm? -107.66 113.94 27.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.652 -0.704 . . . . 1.33 109.302 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -89.83 139.26 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.141 0.496 . . . . 1.2 111.855 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.779 HG23 ' HA ' ' A' ' 114' ' ' ILE . 25.8 m -139.42 -171.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 108.822 -0.807 . . . . 1.12 108.822 174.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.9 109.92 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.968 0.729 . . . . 0.75 112.968 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 117' ' ' MET . . . 44.68 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.809 1.041 . . . . 1.18 113.809 170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.843 ' HB3' ' HB1' ' A' ' 122' ' ' ALA . 10.2 p-10 -107.67 -3.96 18.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.347 0.499 . . . . 2.01 112.347 -170.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 31.0 t70 -64.34 -43.79 93.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.419 0.628 . . . . 1.09 111.054 -175.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 88.93 -113.17 4.06 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.518 -0.848 . . . . 0.52 111.249 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.966 HG13 ' HB ' ' A' ' 96' ' ' THR . 35.5 t -129.36 119.2 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 120.656 0.265 . . . . 1.08 110.625 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.581 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 42.0 mtp -85.83 169.35 15.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.675 -0.491 . . . . 1.32 109.675 169.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 88.4 Cg_exo -42.64 -60.01 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.753 2.302 . . . . 0.61 112.801 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.684 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 42.0 mt-30 -59.27 -25.39 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.703 0.631 . . . . 1.47 112.703 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.966 ' HB ' HG13 ' A' ' 92' ' ' VAL . 29.9 m -60.21 -46.01 91.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 121.277 -0.169 . . . . 0.46 111.001 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.572 ' HA ' ' HB ' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -88.52 -30.25 5.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 O-C-N 121.847 -0.533 . . . . 1.05 111.444 178.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 44.5 mt-10 -61.36 -26.94 68.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.411 . . . . 1.62 111.099 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -88.13 -22.31 24.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.34 109.959 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.805 HD13 HD22 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -80.79 -47.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.169 -0.923 . . . . 0.38 110.796 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -57.63 -32.78 67.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.398 0.618 . . . . 1.85 110.056 170.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -64.09 -29.46 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.35 -0.841 . . . . 0.85 109.936 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -96.18 -54.68 3.21 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.471 0.545 . . . . 0.48 112.471 -176.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HG3' HD11 ' A' ' 136' ' ' LEU . 24.5 mmmt -55.18 -44.8 75.6 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.601 0.715 . . . . 2.56 111.021 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.59 10.24 2.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.318 -1.31 . . . . 0.76 112.133 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.53 8.43 21.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.374 -0.973 . . . . 0.9 108.374 167.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 70.1 48.6 0.52 Allowed 'General case' 0 C--N 1.339 0.149 0 CA-C-N 114.226 -1.352 . . . . 2.06 111.084 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -126.48 157.61 70.08 Favored Pre-proline 0 C--O 1.238 0.485 0 N-CA-C 112.954 0.724 . . . . 1.08 112.954 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.575 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.5 Cg_exo -76.2 159.56 36.89 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 124.611 3.541 . . . . 0.51 114.498 168.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.756 HD11 ' HB3' ' A' ' 103' ' ' ALA . 22.1 mm -129.66 148.26 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.78 -1.1 . . . . 0.96 111.166 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 83' ' ' ILE . 3.9 mt -122.06 150.95 25.58 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 N-CA-C 109.283 -0.636 . . . . 0.71 109.283 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -111.2 136.34 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.282 0.563 . . . . 0.23 110.442 174.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -121.9 88.41 2.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.022 -1.103 . . . . 0.25 108.022 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.779 ' HA ' HG23 ' A' ' 86' ' ' VAL . 45.2 mt -69.36 91.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.686 -1.143 . . . . 0.85 109.697 176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.643 ' HA ' HD22 ' A' ' 150' ' ' LEU . 53.9 t30 -88.67 151.71 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.69 111.204 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt 54.89 36.47 26.74 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.951 0.782 . . . . 2.61 111.018 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -97.19 29.37 3.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.497 -0.774 . . . . 1.37 109.365 177.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.6 66.44 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.615 -1.175 . . . . 2.45 112.293 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.701 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 54.2 mtmt -150.56 -179.89 1.09 Allowed Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 105.721 -1.955 . . . . 3.7 105.721 171.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.701 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 4.2 Cg_endo -49.54 -46.22 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.285 1.323 . . . . 2.67 110.848 171.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.519 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 13.2 pt-20 166.68 122.66 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.901 -1.148 . . . . 4.03 107.901 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.843 ' HB1' ' HB3' ' A' ' 89' ' ' ASP . . . -58.64 -68.13 0.29 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.451 -0.795 . . . . 1.47 109.577 171.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -176.38 70.97 0.25 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.515 -0.766 . . . . 1.84 109.859 170.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.639 ' O ' ' HG3' ' A' ' 128' ' ' MET . 2.5 Cg_endo -42.89 -59.25 1.04 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.496 2.797 . . . . 0.7 113.063 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.9 -47.51 32.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.582 0.586 . . . . 2.0 112.582 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.634 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 24.0 tpt180 -58.43 -55.86 29.6 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.329 0.585 . . . . 2.99 109.709 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.583 HG13 ' HA2' ' A' ' 91' ' ' GLY . 82.3 t -52.46 -43.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.4 -1.273 . . . . 0.4 110.677 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.683 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 81.5 mtp -64.24 -34.05 77.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.032 -0.531 . . . . 0.3 110.527 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.403 ' HA ' ' CG ' ' A' ' 132' ' ' MET . 58.1 mt-30 -73.63 -24.28 60.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.121 -0.49 . . . . 1.28 111.025 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 3.0 mm-40 -68.7 -36.78 78.93 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.685 -0.857 . . . . 2.02 108.685 172.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.6 mm? -71.73 -43.59 65.6 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.55 -0.75 . . . . 1.06 109.844 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.838 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -77.55 0.26 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.521 -0.763 . . . . 0.35 109.819 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.546 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 16.4 tp10 -81.18 -27.58 35.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.911 -1.144 . . . . 2.18 107.911 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.763 ' CE2' HG11 ' A' ' 92' ' ' VAL . 48.5 m-85 -91.99 10.35 29.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.533 0.683 . . . . 0.74 109.19 168.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.2 m120 72.46 32.57 1.58 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.23 -1.35 . . . . 1.94 110.889 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.805 HD22 HD13 ' A' ' 100' ' ' ILE . 7.5 mp -107.84 79.51 1.29 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.402 1.096 . . . . 1.68 109.475 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.027 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 60.3 t -66.94 126.18 92.04 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.245 -1.798 . . . . 0.61 112.014 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.85 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 74.5 Cg_exo -47.45 160.11 0.4 Allowed 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 123.848 3.032 . . . . 0.3 113.878 170.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.56 -19.07 42.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.677 -1.147 . . . . 2.01 109.835 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 1.9 mm-40 -59.23 -40.8 87.03 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 107.878 -1.156 . . . . 1.14 107.878 168.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.893 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.7 m0 -91.67 -31.64 15.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.952 -1.476 . . . . 0.45 110.979 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.37 28.61 2.98 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.018 -1.087 . . . . 0.45 112.045 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 1.027 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.96 -104.77 1.79 Allowed Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 120.717 -0.754 . . . . 0.5 111.913 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -165.49 33.47 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.174 0.511 . . . . 1.3 111.248 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 16.0 m -130.8 113.43 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.244 -0.582 . . . . 0.32 112.016 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.823 HD11 HG21 ' A' ' 168' ' ' VAL . 37.6 mt -81.44 110.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 116.02 -0.537 . . . . 1.23 111.347 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.85 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 23.4 m-85 -89.55 115.0 26.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.933 0.397 . . . . 0.38 111.805 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 13.8 t -113.27 135.94 53.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.866 -0.606 . . . . 1.1 109.386 173.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.758 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.2 pttp -110.74 85.13 2.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.689 0.757 . . . . 2.44 109.949 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -103.55 168.97 8.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.223 1.011 . . . . 1.27 112.906 -173.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.578 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 27.7 t -145.14 117.37 8.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.392 -1.276 . . . . 1.79 108.131 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.53 -26.44 61.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.27 0.841 . . . . 0.87 113.27 -170.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.639 ' HG3' ' H ' ' A' ' 154' ' ' THR . 46.4 pttt -84.27 -55.24 4.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.33 0.586 . . . . 3.03 110.945 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.639 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 40.8 p -64.21 -25.08 67.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.096 -0.956 . . . . 1.2 110.628 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.849 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 2.5 tppp? 66.8 16.27 10.34 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.88 -1.055 . . . . 2.27 111.805 172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.85 -72.42 0.16 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.712 0.768 . . . . 2.64 111.021 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -61.97 -16.67 53.15 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.739 -1.119 . . . . 0.62 113.24 -175.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 150' ' ' LEU . 4.5 mm? -61.4 -46.21 91.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.912 0.387 . . . . 1.55 110.692 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -71.58 -42.16 68.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.074 -0.512 . . . . 2.5 110.205 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.9 t60 -66.61 -21.23 66.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.802 -0.635 . . . . 0.73 110.827 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.55 -51.13 21.17 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.056 -0.35 . . . . 0.91 110.056 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.668 HD21 HD11 ' A' ' 28' ' ' ILE . 93.8 mt -56.17 -39.95 73.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.804 -0.635 . . . . 1.06 111.107 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 13.6 pt-20 -69.54 -32.59 71.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.49 -0.323 . . . . 2.49 110.648 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.706 ' HE2' ' HA ' ' A' ' 164' ' ' MET . 25.6 mmt -73.13 -41.34 64.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.073 0.463 . . . . 0.87 109.898 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.43 -51.4 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.323 -0.853 . . . . 0.64 111.123 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.7 pp -75.99 -36.85 59.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.246 0.461 . . . . 1.81 112.246 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 166' ' ' LEU . 62.4 tp -52.23 -33.64 42.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.036 0.446 . . . . 1.42 110.575 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 146' ' ' ILE . 19.0 t -78.88 -38.37 20.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.856 -0.611 . . . . 1.17 110.71 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.9 t -61.27 -29.09 69.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.052 -0.522 . . . . 1.54 110.57 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.68 -29.86 13.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.923 -0.311 . . . . 2.79 111.753 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.623 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 10.7 ptt? -67.61 -30.29 69.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.973 -0.291 . . . . 1.82 110.718 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 36.4 mt-10 -61.03 -33.96 74.11 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.874 0.369 . . . . 3.45 110.529 174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -81.27 -36.08 30.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.964 -0.562 . . . . 3.36 110.005 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 171' ' ' MET . 96.8 mt -57.97 -60.36 3.84 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.365 -0.606 . . . . 4.14 109.365 173.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 176' ' ' ALA . 46.2 tptt -167.87 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.334 -0.848 . . . . 6.31 109.939 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.444 ' H ' ' HB3' ' A' ' 175' ' ' LYS . . . -165.8 -58.47 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.721 -0.672 . . . . 4.57 109.864 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 178' ' ' PRO . 62.3 t30 -111.24 -50.37 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.576 -0.738 . . . . 6.38 110.511 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 177' ' ' ASN . 10.6 Cg_endo . . . . . 0 C--O 1.253 1.254 0 C-N-CA 122.843 2.362 . . . . 7.47 112.004 174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.324 -0.31 . . . . 16.35 112.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -59.95 130.63 47.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 14.69 111.536 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -113.4 50.48 0.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 14.68 109.483 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.5 mtp -74.48 120.41 20.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.936 -0.575 . . . . 12.73 110.424 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.6 t -87.14 85.39 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.112 -0.699 . . . . 10.18 109.112 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.61 85.72 7.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.563 -0.744 . . . . 9.14 110.375 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 16.8 ttm180 -150.82 -52.0 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.448 -0.796 . . . . 8.35 111.157 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 53.0 Cg_exo -56.74 128.89 31.82 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.07 1.847 . . . . 4.6 112.025 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 8' ' ' PRO . 38.3 Cg_exo -60.44 118.3 5.16 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.841 2.361 . . . . 4.29 112.091 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.08 85.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.408 0.623 . . . . 2.58 109.334 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.988 HG22 ' HB ' ' A' ' 81' ' ' ILE . 58.9 t -72.4 123.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.671 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 127.2 43.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.66 110.77 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.505 ' H ' HD21 ' A' ' 60' ' ' LEU . 39.9 mt -83.99 115.77 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.319 0.58 . . . . 1.03 110.512 177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.419 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 mmt -107.49 -175.44 2.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.208 -0.905 . . . . 1.04 110.139 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.34 134.56 7.54 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.238 -0.982 . . . . 1.55 110.805 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 84.3 t60 -36.58 128.61 0.8 Allowed 'General case' 0 C--N 1.315 -0.894 0 O-C-N 124.634 0.843 . . . . 0.66 111.124 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 11.3 p -55.61 -21.28 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.352 -0.84 . . . . 1.62 113.107 -170.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 31.5 t70 -93.16 -8.22 43.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.8 0.333 . . . . 1.78 111.78 -175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.446 ' ND1' ' HA ' ' A' ' 86' ' ' VAL . 21.9 m170 -77.26 -7.24 55.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.484 0.55 . . . . 0.65 112.484 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.64 46.36 1.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.224 -0.989 . . . . 0.93 112.773 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 ptmm? -87.22 -24.26 24.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 2.11 110.174 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 41' ' ' ILE . 9.4 t -72.8 -29.75 63.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.8 110.254 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.1 p -75.42 -25.74 57.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.128 -0.487 . . . . 1.77 110.871 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 152' ' ' ALA . 43.0 mt -67.9 -54.04 21.87 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.986 -0.746 . . . . 1.78 108.986 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.04 -41.21 62.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.851 -0.613 . . . . 1.96 110.258 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.682 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.9 t70 -77.96 -51.38 10.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.584 0.587 . . . . 1.38 112.584 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.54 -33.38 64.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.897 0.332 . . . . 0.91 111.897 -173.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.576 ' HB ' ' OH ' ' A' ' 48' ' ' TYR . 76.2 mt -70.0 -39.05 76.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 1.56 110.046 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.682 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 7.2 ptt180 -66.67 -33.47 75.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.325 0.584 . . . . 3.56 109.967 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -83.06 -3.85 57.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.485 -0.78 . . . . 2.88 111.604 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t -97.83 -40.11 8.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.713 0.292 . . . . 1.76 110.714 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -100.43 -165.83 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.464 -0.334 . . . . 5.71 111.342 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.4 t -96.7 -67.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 112.979 0.733 . . . . 2.99 112.979 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 3.4 m -80.84 153.58 27.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.69 0.996 . . . . 3.93 113.69 -165.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.04 170.35 22.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.618 -1.174 . . . . 4.2 109.93 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -147.62 178.79 8.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.566 0.222 . . . . 5.38 110.94 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' HD12 ' A' ' 45' ' ' ILE . 42.5 mt-10 -76.67 79.2 3.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.052 0.453 . . . . 5.79 111.336 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -140.95 154.03 45.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.011 -0.54 . . . . 4.24 110.058 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.93 -62.83 2.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.436 -0.888 . . . . 4.95 112.936 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.49 -67.77 3.28 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.682 -0.771 . . . . 6.66 111.579 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 22' ' ' THR . 84.1 mt -141.29 -44.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.851 0.358 . . . . 9.17 110.302 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.89 148.73 47.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.826 -0.624 . . . . 7.36 111.607 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -83.64 23.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 8.83 111.641 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.435 ' HB2' ' H ' ' A' ' 45' ' ' ILE . 79.3 m-70 -133.78 -95.81 0.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.701 -0.852 . . . . 6.76 108.701 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 37' ' ' GLU . 45.6 mm -130.46 158.91 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.09 -1.078 . . . . 5.19 108.09 173.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 45' ' ' ILE . . . 177.26 -39.94 0.09 OUTLIER Glycine 0 C--N 1.311 -0.837 0 C-N-CA 120.685 -0.769 . . . . 2.97 112.225 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.729 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . . . -67.96 168.12 12.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.977 0.418 . . . . 1.71 110.864 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.576 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 5.7 p90 -162.71 -177.56 5.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.019 0.438 . . . . 2.54 111.468 -166.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.656 ' O ' ' HB ' ' A' ' 34' ' ' THR . 81.5 mt-30 -140.14 133.56 30.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.359 -0.837 . . . . 1.96 110.191 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.0 t -84.95 148.64 4.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.688 0.756 . . . . 1.93 109.832 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 21.7 m -137.54 98.47 3.7 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.043 -1.435 . . . . 2.06 110.658 -171.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 46.7 t -114.31 118.79 59.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 107.458 -1.312 . . . . 4.12 107.458 170.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 45.2 t30 71.93 -57.56 0.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.107 0.88 . . . . 4.43 110.88 -173.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.621 ' O ' HG23 ' A' ' 51' ' ' THR . 8.2 t70 -132.43 -63.98 0.78 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.158 -0.928 . . . . 3.62 111.395 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.893 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ptpp? 168.29 151.69 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.82 -1.082 . . . . 7.44 108.394 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -149.9 -80.49 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.989 0.423 . . . . 5.43 112.04 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 11' ' ' VAL . 4.0 mt -76.42 113.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 1.14 111.663 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 61' ' ' ASP . 60.9 m -99.23 112.29 24.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.167 -0.47 . . . . 1.28 109.793 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.423 ' HD2' HD11 ' A' ' 13' ' ' ILE . 39.8 m-85 -89.46 92.85 9.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.217 -0.29 . . . . 0.84 110.217 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.505 HD21 ' H ' ' A' ' 13' ' ' ILE . 3.3 mm? 55.2 85.68 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.984 0.802 . . . . 3.0 111.834 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 10.5 p-10 -82.02 26.83 0.5 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.549 0.69 . . . . 6.48 110.566 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 5.0 t -122.89 143.77 41.29 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.209 -0.905 . . . . 5.57 110.443 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 62' ' ' THR . 6.3 Cg_exo -80.17 -3.25 12.55 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.089 2.526 . . . . 5.77 111.768 175.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.81 153.6 19.86 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.942 -0.647 . . . . 5.54 112.556 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -86.01 64.59 8.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.089 0.471 . . . . 8.09 110.057 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.36 169.43 14.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.611 -0.722 . . . . 6.36 111.598 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.28 86.92 1.78 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 3.51 110.229 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CZ ' HG21 ' A' ' 108' ' ' VAL . 53.8 t80 56.48 73.49 0.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.658 -0.701 . . . . 2.61 110.886 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -85.23 -24.5 27.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.324 0.583 . . . . 4.74 109.827 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.7 m -76.97 81.58 3.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.496 -0.774 . . . . 5.89 111.402 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.545 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 53.7 ttm -106.26 60.04 0.65 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.67 0.748 . . . . 5.64 109.186 173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -82.79 93.7 7.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.189 -0.914 . . . . 9.71 109.848 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.6 57.18 3.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 7.52 111.921 -173.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.14 110.83 15.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.884 -0.598 . . . . 10.42 109.565 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.77 93.85 0.07 OUTLIER Glycine 0 C--N 1.33 0.212 0 O-C-N 123.52 0.512 . . . . 6.75 112.943 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.13 53.83 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 6.69 110.336 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 66.23 44.67 2.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.582 -0.735 . . . . 7.72 110.97 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.12 96.8 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.561 . . . . 4.38 109.907 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -121.61 54.08 1.15 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.05 0.928 . . . . 4.18 110.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.35 91.42 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.672 0.748 . . . . 3.12 109.402 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.988 ' HB ' HG22 ' A' ' 11' ' ' VAL . 47.8 mm -52.37 121.91 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.209 -1.36 . . . . 0.74 113.162 -172.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 103' ' ' ALA . 70.0 t -106.29 107.55 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 1.19 110.758 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.722 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.1 OUTLIER -94.14 110.13 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 174.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 100' ' ' ILE . 10.5 tp -90.28 108.33 19.69 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.923 -0.581 . . . . 1.33 110.749 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.3 t -82.0 133.68 28.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.273 0.559 . . . . 1.2 111.483 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.3 m -134.08 -177.88 2.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.888 -1.153 . . . . 1.12 107.888 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.08 11.84 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.792 -0.763 . . . . 0.75 112.215 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 44.75 -109.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.625 -1.17 . . . . 1.18 112.903 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.718 ' HB3' ' HB1' ' A' ' 122' ' ' ALA . 8.8 p-10 -116.51 19.05 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 2.01 110.472 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.14 -33.35 73.29 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.817 0.818 . . . . 1.09 109.0 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.822 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 75.68 -142.15 28.46 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.251 -1.341 . . . . 0.52 111.912 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 96' ' ' THR . 71.2 t -98.01 110.2 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-O 120.809 0.337 . . . . 1.08 111.391 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.635 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 80.5 mmm -80.49 171.61 11.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.15 -0.477 . . . . 1.32 109.804 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.635 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.5 Cg_endo -45.67 -54.49 4.45 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.138 2.559 . . . . 0.61 113.257 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 35.6 mt-30 -60.74 -30.33 69.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 1.47 111.574 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 92' ' ' VAL . 9.8 m -64.58 -22.96 67.11 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.851 0.358 . . . . 0.46 111.102 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.65 -46.5 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.885 0.374 . . . . 1.05 111.111 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.0 -12.74 40.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 1.62 111.315 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -96.68 -18.82 19.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.34 110.085 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 84' ' ' LEU . 3.4 mt -93.3 -53.07 8.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.38 110.507 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -50.4 -37.79 39.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.708 -0.678 . . . . 1.85 110.53 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 68' ' ' PHE . 29.4 t60 -75.9 -32.04 59.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.233 -0.894 . . . . 0.85 110.728 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -84.21 -55.79 4.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 0.48 112.084 -173.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.551 ' HB3' HD11 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -71.41 -12.16 61.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 116.165 -0.47 . . . . 2.56 112.075 -168.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.37 -0.32 19.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.241 -0.436 . . . . 0.76 111.869 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.545 ' HB2' ' HG3' ' A' ' 71' ' ' MET . . . -106.1 1.99 26.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.394 -0.595 . . . . 0.9 109.394 174.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 t30 82.14 38.04 0.06 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 114.566 -1.197 . . . . 2.06 108.113 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 23.5 t -101.93 142.01 23.72 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 113.151 -1.841 . . . . 1.08 111.122 -173.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 6.4 Cg_exo -73.86 149.98 43.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.754 2.303 . . . . 0.51 113.165 172.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.683 HD13 HG12 ' A' ' 100' ' ' ILE . 97.8 mt -124.78 149.79 29.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.325 -1.307 . . . . 0.96 109.989 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 7.9 mt -125.11 157.35 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 N-CA-C 109.065 -0.717 . . . . 0.71 109.065 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.532 HG21 ' CZ ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -115.25 134.6 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 109.651 -0.499 . . . . 0.23 109.651 171.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -121.69 87.71 2.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.748 -1.204 . . . . 0.25 107.748 174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.0 mt -73.66 93.08 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.661 -1.154 . . . . 0.85 109.749 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.55 166.44 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.095 -173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 57.3 tptt 63.0 47.9 4.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.27 1.033 . . . . 2.61 110.585 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.57 ' HE2' ' HB2' ' A' ' 121' ' ' GLU . 69.3 mmm -85.14 -45.9 11.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.13 -0.941 . . . . 1.37 108.501 173.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.12 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 O-C-N 125.203 1.565 . . . . 2.45 113.028 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 1.076 ' HG3' ' HD3' ' A' ' 120' ' ' PRO . 3.4 ptpt -145.32 -53.97 0.02 OUTLIER Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.137 -0.938 . . . . 3.7 113.528 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 1.076 ' HD3' ' HG3' ' A' ' 119' ' ' LYS . 35.8 Cg_endo -73.82 -27.15 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.169 2.579 . . . . 2.67 111.378 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.57 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 13.0 pt-20 50.34 32.95 6.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.201 -1.363 . . . . 4.03 113.106 170.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 89' ' ' ASP . . . 49.25 -129.17 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 1.47 111.748 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.5 t30 -160.67 84.93 1.92 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.695 -0.684 . . . . 1.84 109.179 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.544 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.3 Cg_exo -19.29 -66.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 1 C-N-CA 126.389 4.726 . . . . 0.7 116.456 175.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -39.68 -52.03 2.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.096 0.776 . . . . 2.0 113.096 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.0 tmt_? -55.55 -56.7 17.27 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.985 0.422 . . . . 2.99 109.926 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.822 HG13 ' HA2' ' A' ' 91' ' ' GLY . 31.0 t -58.45 -45.17 89.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.4 110.008 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.695 ' HA ' ' CE2' ' A' ' 147' ' ' PHE . 88.8 mtp -63.41 -30.11 71.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.395 -0.82 . . . . 0.3 111.181 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 58.8 mt-30 -78.61 -25.21 45.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.118 -0.233 . . . . 1.28 110.669 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.75 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 13.6 mt-10 -63.45 -38.61 91.79 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 108.847 -0.798 . . . . 2.02 108.847 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.984 HD12 HD11 ' A' ' 136' ' ' LEU . 3.9 mm? -70.85 -42.36 70.23 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.094 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.824 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -72.92 -7.76 52.5 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.728 -0.669 . . . . 0.35 110.227 178.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.85 -24.36 35.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.125 -0.695 . . . . 2.18 109.125 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 19.1 m-85 -89.05 5.95 42.01 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 122.216 1.008 . . . . 0.74 108.306 167.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.2 m120 72.37 26.35 2.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 113.158 -1.837 . . . . 1.94 110.541 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.984 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -103.56 73.02 1.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 107.205 -1.406 . . . . 1.68 107.205 169.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.909 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -58.31 132.56 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 113.403 -1.726 . . . . 0.61 110.291 -173.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.856 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 94.4 Cg_exo -47.35 151.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.631 2.221 . . . . 0.3 112.971 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -76.0 -25.68 56.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.149 -1.387 . . . . 2.01 108.028 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.828 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -55.99 -38.9 71.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.288 -1.323 . . . . 1.14 109.149 169.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.828 ' CD1' ' HB2' ' A' ' 140' ' ' GLU . 6.6 m0 -96.03 -25.31 15.97 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.581 -1.191 . . . . 0.45 110.453 -172.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.48 24.15 3.85 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 119.908 -1.139 . . . . 0.45 112.192 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.909 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -115.85 2.93 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.396 -0.907 . . . . 0.5 112.978 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.28 25.03 1.4 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.965 0.358 . . . . 1.3 111.965 -173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.588 HG21 HD12 ' A' ' 136' ' ' LEU . 31.7 m -142.91 123.12 13.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 119.541 -0.864 . . . . 0.32 113.267 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.4 mp -85.19 118.42 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 1.23 110.36 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.3 m-85 -92.88 116.61 29.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.911 0.386 . . . . 0.38 111.352 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.6 m -114.46 110.24 19.54 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.72 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.517 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 14.9 ptmt -84.91 85.75 7.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.354 0.597 . . . . 2.44 109.707 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -114.3 -175.22 2.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.446 0.641 . . . . 1.27 111.816 -171.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.65 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 35.9 m -160.02 119.59 2.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.51 -0.768 . . . . 1.79 110.011 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HD23 ' A' ' 24' ' ' LEU . . . -73.94 -53.25 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.897 -0.592 . . . . 0.87 112.553 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -75.34 -43.26 51.58 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.583 0.706 . . . . 3.03 109.785 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.649 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 0.3 OUTLIER -57.88 -22.14 46.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.15 -1.387 . . . . 1.2 110.196 171.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.743 ' HD3' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER 74.22 -39.28 0.42 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.601 -1.181 . . . . 2.27 113.903 170.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.99 -46.48 43.91 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.649 0.738 . . . . 2.64 112.024 -175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.65 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -63.99 -33.1 86.34 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.05 -0.977 . . . . 0.62 113.58 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.743 HD12 ' HD3' ' A' ' 155' ' ' LYS . 74.7 mt -59.68 -47.02 87.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.809 0.338 . . . . 1.55 111.182 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -59.96 -44.52 94.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.64 -0.709 . . . . 2.5 110.251 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -65.46 -38.75 90.74 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.309 -0.405 . . . . 0.73 110.898 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.9 -51.61 68.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 0.91 111.011 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 165' ' ' ILE . 81.7 mt -60.16 -33.88 72.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 1.06 110.911 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.83 -45.39 94.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 2.49 110.642 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -37.56 85.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.87 110.638 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.43 HD12 HD23 ' A' ' 162' ' ' LEU . 81.7 mt -61.4 -48.77 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.64 110.596 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.6 -37.97 89.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.81 110.821 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.7 -45.45 73.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.733 -0.667 . . . . 1.42 109.656 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.85 -43.55 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.078 -0.51 . . . . 1.17 111.035 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -56.17 -43.96 78.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 1.54 110.911 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -81.11 -28.26 35.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.702 -0.226 . . . . 2.79 111.336 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.7 ttp -67.28 -58.97 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.523 -0.308 . . . . 1.82 111.063 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.919 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 18.0 mt-10 -60.69 -35.39 76.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.537 0.569 . . . . 3.45 112.537 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.27 -13.7 60.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.928 0.394 . . . . 3.36 110.778 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 51.8 tp -106.83 -61.06 1.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.058 0.456 . . . . 4.14 110.739 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -149.97 106.84 3.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.539 . . . . 6.31 110.405 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.919 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -138.36 49.4 1.92 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.278 0.561 . . . . 4.57 110.055 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -144.47 119.73 6.02 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.784 -0.644 . . . . 6.38 109.624 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 C--O 1.25 1.12 0 C-N-CA 122.791 2.327 . . . . 7.47 112.428 179.156 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 112.167 -0.373 . . . . 16.35 112.167 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 p -116.98 26.52 9.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.871 0.367 . . . . 14.69 111.192 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.3 73.65 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 14.68 110.107 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.8 ptp -142.33 136.59 29.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 12.73 110.539 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.41 119.81 34.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.043 -0.526 . . . . 10.18 110.295 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -104.59 143.54 32.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.314 -0.403 . . . . 9.14 110.605 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -158.54 78.01 3.25 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.042 0.449 . . . . 8.35 110.793 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.04 136.35 10.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.337 2.024 . . . . 4.6 111.126 172.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 56' ' ' LYS . 98.5 Cg_exo -43.99 -52.44 5.53 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.421 2.747 . . . . 4.29 113.831 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t 63.59 91.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.547 0.689 . . . . 2.58 109.653 -172.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.793 HG22 ' HB ' ' A' ' 81' ' ' ILE . 44.5 t -87.81 132.12 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.222 -0.899 . . . . 1.0 112.082 -171.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -97.75 109.63 22.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 0.66 110.717 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 83' ' ' ILE . 14.7 tt -82.69 143.99 11.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.092 0.472 . . . . 1.03 110.772 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.68 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 59.4 mtt -139.94 -172.6 3.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.069 -0.514 . . . . 1.04 110.934 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.905 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 107.76 129.64 6.13 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.944 -0.862 . . . . 1.55 110.944 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 95' ' ' GLN . 83.4 t60 -49.01 136.58 14.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.499 0.666 . . . . 0.66 110.971 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.624 HG12 ' HE2' ' A' ' 21' ' ' LYS . 29.2 m -64.74 -33.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.294 0.85 . . . . 1.62 113.294 -169.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 9.7 m-20 -67.15 -19.8 65.65 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.745 0.276 . . . . 1.78 111.745 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -68.93 -16.25 63.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.983 0.421 . . . . 0.65 110.916 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 114.63 47.27 0.58 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.87 -0.681 . . . . 0.93 112.472 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.624 ' HE2' HG12 ' A' ' 17' ' ' VAL . 36.3 ttpt -87.09 -34.99 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.547 -0.538 . . . . 2.11 109.547 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -67.35 -47.73 69.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 1.8 109.954 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -69.49 -20.37 63.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.663 -0.699 . . . . 1.77 110.432 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 3.0 tm? -73.57 -51.01 18.4 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.519 -0.919 . . . . 1.78 108.519 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.561 HD12 ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -58.09 -37.1 73.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.455 -0.793 . . . . 1.96 110.668 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.26 -55.55 11.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 1.38 110.81 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.2 98.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.91 111.203 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 25' ' ' LEU . 13.0 tt -65.03 -31.51 54.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.588 -0.733 . . . . 1.56 111.02 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' HG21 ' A' ' 34' ' ' THR . 9.0 ptt180 -79.9 -28.07 39.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.475 0.655 . . . . 3.56 109.29 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -80.92 -9.29 59.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 2.88 111.489 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -77.35 16.32 0.63 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.442 -0.345 . . . . 1.76 111.709 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.558 ' O ' HG12 ' A' ' 33' ' ' VAL . 47.2 mmtm 68.19 177.59 0.25 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.323 0.649 . . . . 5.71 112.611 171.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.068 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 59.78 6.78 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.813 1.245 . . . . 2.99 111.779 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -82.49 120.17 25.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.984 -0.553 . . . . 3.93 111.16 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -70.5 -46.22 64.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.301 -0.863 . . . . 4.2 109.827 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -116.57 142.97 46.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.868 -1.16 . . . . 5.38 107.868 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.07 37.72 2.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.55 0.691 . . . . 5.79 110.283 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.574 ' HA ' HD11 ' A' ' 41' ' ' ILE . . . -85.32 56.4 3.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.373 -0.83 . . . . 4.24 110.387 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.561 ' HA3' HD12 ' A' ' 25' ' ' LEU . . . -124.92 99.13 0.57 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.879 -0.677 . . . . 4.95 111.853 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.568 ' H ' HG22 ' A' ' 45' ' ' ILE . . . 90.52 54.04 2.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 6.66 111.993 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 38' ' ' ALA . 56.1 mt -104.76 -73.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.1 0.476 . . . . 9.17 109.994 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.5 m -131.26 55.31 1.86 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.709 -0.678 . . . . 7.36 109.271 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.501 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.8 mm-40 69.92 -54.49 0.61 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.034 -0.985 . . . . 8.83 111.684 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -65.21 132.8 50.03 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.189 -0.671 . . . . 6.76 109.189 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 40' ' ' GLY . 28.6 pt -124.59 176.11 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.554 0.692 . . . . 5.19 111.545 -177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.69 20.65 1.3 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.964 -1.017 . . . . 2.97 111.304 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . 65.1 -168.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.046 0.497 . . . . 1.71 111.666 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.439 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.5 p90 -154.26 121.87 5.84 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.19 0.519 . . . . 2.54 110.025 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.941 ' HG2' HG23 ' A' ' 58' ' ' THR . 77.9 mt-30 -100.07 114.78 28.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.925 -0.769 . . . . 1.96 108.925 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG21 ' HE1' ' A' ' 59' ' ' PHE . 16.5 m -92.25 147.02 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.596 0.713 . . . . 1.93 111.909 -174.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.068 ' HB ' HG22 ' A' ' 33' ' ' VAL . 25.4 m -88.17 80.47 7.61 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.188 -0.915 . . . . 2.06 109.135 172.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG11 HD12 ' A' ' 57' ' ' ILE . 12.7 p -112.1 117.08 54.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.03 -1.1 . . . . 4.12 108.03 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 68.75 -51.52 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.847 0.717 . . . . 4.43 109.498 -164.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 52' ' ' VAL . 19.6 t70 147.97 99.05 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.602 1.561 . . . . 3.62 110.298 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 tptt 67.21 -2.1 1.31 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.568 0.951 . . . . 7.44 113.568 169.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 44.5 mttm -60.22 -64.54 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.62 0.6 . . . . 5.43 112.62 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 166' ' ' LEU . 63.5 mt -90.15 109.25 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.45 0.643 . . . . 1.14 111.781 -174.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.941 HG23 ' HG2' ' A' ' 49' ' ' GLN . 28.9 m -96.34 125.72 41.04 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 170.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HE1' HG21 ' A' ' 50' ' ' VAL . 83.0 m-85 -96.34 93.2 6.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.872 -0.788 . . . . 0.84 108.872 -177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.0 mt 65.8 160.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.154 0 O-C-N 124.018 0.824 . . . . 3.0 110.524 -170.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -139.17 -59.71 0.58 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.195 0.521 . . . . 6.48 109.699 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.2 m -105.41 102.32 36.6 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.665 -0.698 . . . . 5.57 109.574 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.31 177.48 8.58 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.792 2.328 . . . . 5.77 112.399 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.58 -125.43 5.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.501 -0.857 . . . . 5.54 112.617 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -119.99 37.82 4.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.128 0.489 . . . . 8.09 110.674 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.8 -38.26 86.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.716 -0.675 . . . . 6.36 110.496 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.85 63.87 1.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 O-C-N 123.674 0.609 . . . . 3.51 111.842 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' HB2' ' CE ' ' A' ' 14' ' ' MET . 44.5 t80 57.33 71.16 0.59 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.395 0.617 . . . . 2.61 109.816 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.508 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 5.5 t -97.66 14.71 25.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.585 -0.734 . . . . 4.74 110.338 -173.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.4 m -64.74 -12.43 46.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.488 -0.778 . . . . 5.89 111.138 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.3 mtt -71.65 7.11 1.58 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.978 -0.555 . . . . 5.64 111.817 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 69' ' ' THR . 60.1 mtt180 -84.95 -23.78 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 9.71 109.545 172.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.96 71.97 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.407 0.623 . . . . 7.52 110.455 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -89.68 154.56 19.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.539 -0.755 . . . . 10.42 110.369 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.6 -81.81 0.3 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.819 . . . . 6.75 112.815 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.58 59.41 5.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.82 0.304 . . . . 6.69 111.82 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 66.75 110.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.588 0.709 . . . . 7.72 112.251 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.67 71.21 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.664 -0.698 . . . . 4.38 109.278 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 t -93.11 111.32 22.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.546 0.689 . . . . 4.18 111.647 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -123.73 176.97 5.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.925 -1.139 . . . . 3.12 107.925 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 11' ' ' VAL . 37.5 mm -124.08 102.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.439 -0.578 . . . . 0.74 109.439 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 103' ' ' ALA . 87.5 t -91.84 95.7 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.409 -0.36 . . . . 1.19 111.257 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.806 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -81.94 97.66 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 C-N-CA 120.291 -0.564 . . . . 1.32 109.632 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.588 HD21 HG22 ' A' ' 96' ' ' THR . 20.4 tp -86.94 109.0 19.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.643 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG12 ' HA3' ' A' ' 15' ' ' GLY . 5.0 p -85.23 142.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 1.2 111.298 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 114' ' ' ILE . 18.1 m -138.9 -177.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.553 -0.906 . . . . 1.12 108.553 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.81 98.26 3.15 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.953 -0.699 . . . . 0.75 112.813 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 46.97 -95.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.106 1.15 . . . . 1.18 114.106 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.17 -8.21 27.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.806 -0.634 . . . . 2.01 112.002 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.06 -32.58 39.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.293 0.568 . . . . 1.09 110.458 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 72.31 -139.11 27.46 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.259 -0.882 . . . . 0.52 112.443 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.572 HG13 ' HB ' ' A' ' 96' ' ' THR . 78.4 t -97.1 106.54 18.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 123.012 0.525 . . . . 1.08 111.512 -176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.553 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 51.0 mtp -75.9 170.85 13.9 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 116.45 -0.341 . . . . 1.32 110.634 173.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 79.0 Cg_exo -43.85 -58.07 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.79 2.327 . . . . 0.61 112.898 175.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 16' ' ' HIS . 22.2 mt-30 -56.13 -32.86 64.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.387 0.514 . . . . 1.47 112.387 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.588 HG22 HD21 ' A' ' 84' ' ' LEU . 11.4 m -66.68 -23.16 66.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.134 0.492 . . . . 0.46 110.579 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.472 HG23 HG12 ' A' ' 92' ' ' VAL . 91.1 t -91.79 -45.25 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.404 -0.362 . . . . 1.05 110.69 175.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 46.1 mt-10 -61.36 -18.13 57.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 1.62 111.147 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.68 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -86.32 -41.47 14.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.814 -0.63 . . . . 0.34 109.358 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 110' ' ' ILE . 1.3 mt -68.35 -55.46 16.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 CA-C-N 115.452 -0.795 . . . . 0.38 110.631 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' ILE . 2.7 t-20 -45.33 -36.8 4.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.791 0.436 . . . . 1.85 111.432 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 18.2 t60 -79.01 -29.16 43.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.897 -0.592 . . . . 0.85 111.012 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -99.51 -42.62 6.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.96 0.726 . . . . 0.48 112.96 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -66.82 -17.4 64.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.074 0.464 . . . . 2.56 111.092 -166.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' N ' ' HD3' ' A' ' 104' ' ' LYS . . . -87.47 5.22 40.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.52 . . . . 0.76 111.741 -176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -96.59 1.63 51.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.401 -0.592 . . . . 0.9 109.401 174.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 74.71 39.01 0.45 Allowed 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.38 1.086 . . . . 2.06 108.966 176.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -118.52 143.59 33.62 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 113.5 -1.682 . . . . 1.08 110.248 -176.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.1 Cg_exo -69.14 154.35 70.33 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.628 2.219 . . . . 0.51 114.157 175.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -122.3 146.87 26.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 113.913 -1.494 . . . . 0.96 109.806 -177.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.806 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -114.54 148.36 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 107.89 -1.152 . . . . 0.71 107.89 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -115.41 130.03 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 109.851 -0.426 . . . . 0.23 109.851 174.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -116.66 87.28 2.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.911 -1.144 . . . . 0.25 107.911 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.748 ' HA ' HG23 ' A' ' 86' ' ' VAL . 7.5 mt -73.87 97.28 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.432 -1.258 . . . . 0.85 109.976 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' LYS . 23.1 t-20 -88.19 147.5 24.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.448 -0.342 . . . . 0.69 111.066 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.599 ' O ' ' HE2' ' A' ' 119' ' ' LYS . 31.0 mtmm 76.98 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.024 0.828 . . . . 2.61 111.753 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 23.8 mmm -117.99 4.22 12.11 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.343 -0.984 . . . . 1.37 108.343 175.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -67.99 -17.17 64.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.828 -1.533 . . . . 2.45 110.751 173.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 1.002 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 50.6 pttt -78.01 -160.31 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.189 -1.412 . . . . 3.7 107.189 165.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 1.002 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -47.9 -63.24 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 121.989 1.746 . . . . 2.67 109.575 167.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.973 ' HG3' ' H ' ' A' ' 122' ' ' ALA . 13.6 pt-20 152.8 -92.19 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.797 2.039 . . . . 4.03 108.574 167.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.973 ' H ' ' HG3' ' A' ' 121' ' ' GLU . . . 174.43 -89.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.728 0.811 . . . . 1.47 109.642 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.8 86.41 0.29 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.377 -0.828 . . . . 1.84 109.505 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.642 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.9 Cg_endo -42.15 -53.46 3.55 Favored 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 124.003 3.135 . . . . 0.7 113.627 175.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.53 -48.23 19.41 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.549 0.574 . . . . 2.0 112.549 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -52.2 -60.83 2.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.459 0.647 . . . . 2.99 110.115 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' HA2' ' A' ' 91' ' ' GLY . 48.4 t -54.1 -45.1 65.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.248 -1.342 . . . . 0.4 110.537 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.733 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.6 mtp -62.79 -33.11 74.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.029 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -72.15 -23.04 61.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.434 -0.348 . . . . 1.28 111.196 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 7.0 mt-10 -72.5 -32.52 66.24 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.976 -0.75 . . . . 2.02 108.976 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.487 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.1 mm? -72.35 -44.32 62.77 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.575 0.702 . . . . 1.06 109.295 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.964 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -76.0 -2.07 28.78 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.35 109.778 177.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.7 tp10 -78.63 -31.32 46.88 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.303 -1.369 . . . . 2.18 107.303 173.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 136' ' ' LEU . 40.1 m-85 -90.11 9.66 27.38 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.415 -0.812 . . . . 0.74 109.107 171.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 74.99 16.96 2.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.814 -1.539 . . . . 1.94 110.37 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.598 HD22 HD13 ' A' ' 100' ' ' ILE . 6.1 mp -91.13 72.19 6.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.212 1.006 . . . . 1.68 108.488 173.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.486 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.49 129.89 92.96 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.917 -1.492 . . . . 0.61 110.711 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.789 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 51.5 Cg_exo -50.72 158.32 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.953 2.436 . . . . 0.3 112.831 174.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' OE1' HG13 ' A' ' 146' ' ' ILE . 9.6 mt-10 -73.7 -29.8 62.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.056 -0.974 . . . . 2.01 108.504 175.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.665 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.4 mp0 -42.14 -55.08 3.38 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.431 -1.259 . . . . 1.14 110.597 163.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.964 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 13.5 m0 -90.7 -23.21 20.79 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.861 -1.518 . . . . 0.45 111.286 -166.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.28 25.98 2.81 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.709 -1.234 . . . . 0.45 112.44 171.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -102.84 -113.81 3.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.45 -0.881 . . . . 0.5 112.689 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -154.45 30.15 0.43 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.087 0.47 . . . . 1.3 111.503 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 136' ' ' LEU . 30.6 m -125.22 124.0 40.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.157 -0.617 . . . . 0.32 112.254 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.3 mp -91.94 103.33 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.103 -0.498 . . . . 1.23 111.419 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.789 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 30.7 m-85 -85.54 126.33 33.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.906 0.384 . . . . 0.38 111.842 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 59.4 m -126.91 124.63 39.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.501 -0.772 . . . . 1.1 109.959 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.524 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 18.6 ptpt -98.75 86.94 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.655 0.74 . . . . 2.44 109.369 174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -106.75 174.01 6.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.89 0.852 . . . . 1.27 112.52 -173.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.64 127.68 5.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.599 -1.182 . . . . 1.79 110.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.27 -3.25 48.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.87 110.768 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -74.71 -46.62 36.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.281 -0.872 . . . . 3.03 109.897 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.4 p -106.61 -11.1 15.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.612 -1.176 . . . . 1.2 111.182 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.572 ' HA ' HD23 ' A' ' 158' ' ' LEU . 54.6 mttp 62.78 15.82 8.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.339 -0.846 . . . . 2.27 112.706 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.16 -65.32 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.892 0.854 . . . . 2.64 110.912 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -67.04 -11.43 58.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.764 -1.107 . . . . 0.62 113.267 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 155' ' ' LYS . 4.2 mm? -64.44 -44.56 90.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.314 0.557 . . . . 1.55 109.844 178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.9 -48.36 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 2.5 110.053 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.93 -35.06 77.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.73 111.22 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' ILE . 65.5 tp -61.85 -57.84 10.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.558 -0.292 . . . . 0.91 111.398 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 165' ' ' ILE . 4.0 pp -63.08 -29.93 71.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.755 -0.202 . . . . 1.06 110.877 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 162' ' ' LEU . 52.1 mm-40 -63.58 -41.3 98.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 2.49 110.71 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.549 ' HB3' HG21 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -73.02 -38.68 66.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.669 0.271 . . . . 0.87 110.964 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 81' ' ' ILE . 85.6 mt -55.36 -52.73 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.931 -0.577 . . . . 0.64 110.991 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 57' ' ' ILE . 3.7 pp -71.19 -35.42 71.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.668 0.27 . . . . 1.81 111.526 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 166' ' ' LEU . 61.8 tp -52.12 -32.25 34.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.747 -0.661 . . . . 1.42 110.212 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 19.6 t -74.06 -51.47 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 115.912 -0.585 . . . . 1.17 110.26 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.5 m -59.76 -33.47 71.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 1.54 110.201 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.28 -48.78 21.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 2.79 111.207 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 168' ' ' VAL . 24.6 ptt? -71.66 -24.36 61.84 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.554 -0.458 . . . . 1.82 111.443 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 168' ' ' VAL . 42.6 mt-10 -47.38 -53.3 14.22 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.829 0.347 . . . . 3.45 111.383 172.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.93 -8.23 54.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 3.36 111.423 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 171' ' ' MET . 3.0 tm? -90.52 -49.06 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.002 0.43 . . . . 4.14 110.345 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -155.78 -76.27 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.1 -0.5 . . . . 6.31 110.314 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . 60.36 77.13 0.33 Allowed 'General case' 0 N--CA 1.463 0.189 0 O-C-N 123.837 0.71 . . . . 4.57 111.742 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.78 96.64 41.74 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 6.38 110.121 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.684 2.256 . . . . 7.47 111.644 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 N-CA-C 111.8 -0.52 . . . . 16.35 111.8 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -74.04 122.53 22.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.698 0.249 . . . . 14.69 110.8 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 54.12 57.61 5.77 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 14.68 111.325 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -85.38 76.39 10.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.497 -0.774 . . . . 12.73 110.161 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -64.75 136.52 26.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.625 -0.716 . . . . 10.18 110.895 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 31.4 mm-40 -80.55 64.43 5.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.784 -0.644 . . . . 9.14 110.558 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.0 93.72 11.4 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 8.35 109.755 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 71.5 Cg_endo -86.58 115.14 1.27 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.836 2.357 . . . . 4.6 112.161 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 56' ' ' LYS . 22.9 Cg_exo -64.78 104.29 0.54 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.935 2.424 . . . . 4.29 111.608 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.9 t -78.1 92.33 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.054 0.454 . . . . 2.58 110.29 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.029 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 4.2 t -76.2 82.9 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.42 ' O ' HG13 ' A' ' 83' ' ' ILE . 20.0 m -77.7 123.03 26.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.332 -0.849 . . . . 0.66 110.793 -173.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 24' ' ' LEU . 15.0 tt -86.61 135.57 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.486 0.66 . . . . 1.03 109.276 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.567 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 37.6 mtt -140.67 -175.58 4.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.455 -0.793 . . . . 1.04 110.954 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.835 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 142.86 -99.04 0.22 Allowed Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.09 -1.204 . . . . 1.55 110.09 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.415 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 29.5 t60 -156.19 156.13 33.64 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.72 -56.35 18.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.653 0.263 . . . . 1.62 111.614 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.91 -18.37 59.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.314 0.487 . . . . 1.78 112.314 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 7.3 m170 -57.62 -37.03 72.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.012 0.435 . . . . 0.65 111.042 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 127.56 59.17 0.13 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.527 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -87.22 -37.18 17.49 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.512 -0.551 . . . . 2.11 109.512 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -68.99 -44.67 72.37 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.518 -0.765 . . . . 1.8 110.022 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -71.37 -16.91 62.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.178 -0.465 . . . . 1.77 110.398 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 13' ' ' ILE . 5.8 tt -81.17 -53.77 6.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.083 -0.71 . . . . 1.78 109.083 177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -64.09 -36.07 82.83 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.211 -0.449 . . . . 1.96 110.022 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.25 -54.53 39.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 1.38 111.46 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.02 79.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.973 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 25' ' ' LEU . 4.1 tt -72.59 -30.33 33.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.717 -0.674 . . . . 1.56 109.961 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 2.0 tpt180 -74.09 -33.34 63.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.603 -0.726 . . . . 3.56 110.084 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -73.01 -12.11 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 2.88 110.507 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.1 t -93.05 -61.25 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.823 -0.806 . . . . 1.76 108.823 173.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER 51.47 151.99 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.4 1.48 . . . . 5.71 114.542 176.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.672 HG21 HG13 ' A' ' 50' ' ' VAL . 15.4 m -126.57 -33.37 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.267 -0.879 . . . . 2.99 111.652 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -153.86 -74.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 3.93 111.298 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 1.026 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 10.3 mm-40 -81.64 164.53 21.77 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.108 -0.33 . . . . 4.2 110.108 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -177.19 65.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.367 0.603 . . . . 5.38 110.639 -175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -72.6 -73.17 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.729 -0.669 . . . . 5.79 110.526 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.757 ' O ' ' HA ' ' A' ' 47' ' ' ALA . . . -159.97 130.08 5.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.288 -0.869 . . . . 4.24 109.554 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.51 67.58 2.83 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.084 -0.579 . . . . 4.95 114.192 -170.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.42 -36.25 2.22 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 114.368 0.507 . . . . 6.66 114.368 169.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.41 -32.57 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 112.529 0.566 . . . . 9.17 112.529 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.451 ' HB ' ' CG1' ' A' ' 45' ' ' ILE . 2.5 m -78.25 -5.02 50.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.828 0.346 . . . . 7.36 111.299 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.787 ' HG2' ' HG2' ' A' ' 63' ' ' PRO . 90.2 mt-30 69.32 -67.12 0.23 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.788 0.835 . . . . 8.83 112.578 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -82.1 30.87 0.38 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.926 0.393 . . . . 6.76 111.875 -173.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 47' ' ' ALA . 44.1 mm -122.2 155.19 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 5.19 109.644 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -95.48 21.03 46.76 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.69 -0.687 . . . . 2.97 111.831 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.757 ' HA ' ' O ' ' A' ' 38' ' ' ALA . . . 61.35 -77.49 0.03 OUTLIER 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.984 0.913 . . . . 1.71 112.052 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 35' ' ' GLU . 27.3 p90 -167.79 157.23 9.95 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.207 -1.035 . . . . 2.54 108.207 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.026 ' H ' ' HB2' ' A' ' 35' ' ' GLU . 50.2 mt-30 -118.76 137.92 53.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.939 0.4 . . . . 1.96 110.642 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.815 ' HB ' ' HB ' ' A' ' 57' ' ' ILE . 72.7 t -91.54 150.64 3.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.875 0.845 . . . . 1.93 110.991 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 54' ' ' ASP . 21.0 m -115.26 103.65 11.04 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.836 -1.529 . . . . 2.06 110.724 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 93.3 t -126.81 119.67 53.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.337 -1.357 . . . . 4.12 107.337 169.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 59.4 t30 73.87 -50.06 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 124.096 0.873 . . . . 4.43 110.324 -173.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 51' ' ' THR . 15.6 t70 -145.15 -68.78 0.29 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.265 -0.88 . . . . 3.62 111.839 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 26.0 ttpp 161.76 105.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 124.31 1.006 . . . . 7.44 108.604 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 27.3 mtpp -133.58 -26.71 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.267 0.469 . . . . 5.43 112.267 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 11' ' ' VAL . 55.5 mt -86.89 103.51 13.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.642 -0.423 . . . . 1.14 111.927 -171.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 13.4 m -94.44 107.91 19.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.493 -0.321 . . . . 1.28 110.262 174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -81.48 93.47 6.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.84 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.9 tp -98.79 132.86 43.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.647 -0.252 . . . . 3.0 110.874 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 31.9 t0 -114.77 144.04 44.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.798 -0.815 . . . . 6.48 108.798 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.716 HG21 ' HA ' ' A' ' 67' ' ' ALA . 16.0 m -115.53 94.66 40.82 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.916 0.389 . . . . 5.57 111.428 -176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HG2' ' HG2' ' A' ' 43' ' ' GLN . 61.1 Cg_endo -95.62 42.23 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.322 2.681 . . . . 5.77 112.169 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.55 -133.77 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 5.54 112.748 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -88.0 174.48 8.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.857 0.361 . . . . 8.09 111.724 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 62.27 37.0 14.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.165 -0.925 . . . . 6.36 111.25 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' A' ' 62' ' ' THR . . . -64.97 103.63 0.75 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.761 -0.654 . . . . 3.51 110.714 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HZ ' HG21 ' A' ' 108' ' ' VAL . 20.6 t80 61.05 64.35 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.499 -0.773 . . . . 2.61 110.944 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.745 HG21 HG11 ' A' ' 78' ' ' VAL . 44.7 p 62.99 144.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.522 1.129 . . . . 4.74 113.572 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.9 m -79.89 78.25 6.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.233 -0.894 . . . . 5.89 110.304 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 63.7 mtt -62.2 -17.42 58.11 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.632 -0.713 . . . . 5.64 112.165 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.19 -7.66 54.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.383 . . . . 9.71 110.589 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.33 -57.67 1.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.144 -0.48 . . . . 7.52 109.943 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -140.24 127.83 21.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.086 0.469 . . . . 10.42 110.481 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.07 65.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.508 -0.637 . . . . 6.75 111.508 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.61 -53.43 4.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 6.69 110.575 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -141.41 40.44 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.319 0.58 . . . . 7.72 110.365 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.745 HG11 HG21 ' A' ' 69' ' ' THR . 9.3 t -78.39 72.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.063 -0.717 . . . . 4.38 109.063 175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 108' ' ' VAL . 17.0 m -87.14 89.79 8.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.453 -0.794 . . . . 4.18 111.722 -174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' HB2' ' HE1' ' A' ' 68' ' ' PHE . 8.3 m-20 -97.3 -169.83 1.92 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.364 -0.606 . . . . 3.12 109.364 169.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.029 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 40.2 mm -98.89 133.07 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 121.136 -0.226 . . . . 0.74 111.485 -173.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.679 HG21 ' HB1' ' A' ' 103' ' ' ALA . 92.3 t -113.78 106.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 116.541 -0.299 . . . . 1.19 111.077 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -94.39 99.65 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 109.36 -0.607 . . . . 1.32 109.36 175.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 111' ' ' ILE . 15.1 tp -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.146 -0.479 . . . . 1.33 111.254 -174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.835 HG12 ' HA3' ' A' ' 15' ' ' GLY . 4.5 p -79.39 141.54 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.372 0.606 . . . . 1.2 110.809 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 114' ' ' ILE . 26.7 m -140.94 -160.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.569 -1.271 . . . . 1.12 107.569 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.14 147.99 34.45 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.139 -0.624 . . . . 0.75 111.684 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -35.25 -59.33 0.52 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.606 1.191 . . . . 1.18 112.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.79 -9.87 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.507 . . . . 2.01 112.1 -172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.49 -51.3 5.99 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.293 0.568 . . . . 1.09 111.402 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 85.65 -136.93 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.248 -0.887 . . . . 0.52 111.62 -172.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.971 HG13 ' HB ' ' A' ' 96' ' ' THR . 37.7 t -101.18 114.08 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 122.898 0.479 . . . . 1.08 111.248 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.589 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 39.5 mtp -81.19 169.79 17.85 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 1.32 110.025 172.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 1.1 Cg_endo -44.9 -48.01 11.25 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.121 2.547 . . . . 0.61 113.324 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 95' ' ' GLN . 2.9 mt-30 -71.35 -25.95 62.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 120.579 0.228 . . . . 1.47 110.83 -176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.971 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.5 m -64.54 -22.58 67.01 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.115 0.483 . . . . 0.46 110.389 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.69 -38.84 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 116.516 -0.311 . . . . 1.05 110.821 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.0 -29.49 65.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.877 0.37 . . . . 1.62 111.49 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.567 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -79.31 -37.54 37.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.511 . . . . 0.34 109.661 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.598 HG12 HG12 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -72.63 -49.59 39.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.635 -0.711 . . . . 0.38 110.384 178.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -45.1 -35.62 3.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.385 0.674 . . . . 1.85 111.122 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -83.19 -34.68 25.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 0.85 111.2 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.679 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.95 -33.12 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.916 0.709 . . . . 0.48 112.916 -170.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' C ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.73 -16.92 60.72 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.114 0.483 . . . . 2.56 110.326 -167.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.8 7.66 44.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.76 112.307 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.448 ' HB3' HG23 ' A' ' 108' ' ' VAL . . . -108.99 3.2 21.9 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.212 -0.662 . . . . 0.9 109.212 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 177' ' ' ASN . 2.7 t30 73.65 34.1 0.98 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 107.316 -1.364 . . . . 2.06 107.316 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 79' ' ' THR . 9.6 t -91.96 143.99 28.55 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 112.425 -2.171 . . . . 1.08 110.597 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 4.7 Cg_exo -74.17 142.88 31.3 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.344 2.029 . . . . 0.51 113.061 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.633 HG22 HG23 ' A' ' 145' ' ' THR . 1.6 mp -121.6 143.4 34.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 113.19 -1.823 . . . . 0.96 109.442 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.766 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 11.3 mt -118.6 155.84 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 108.69 -0.855 . . . . 0.71 108.69 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -118.0 136.07 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 109.936 -0.394 . . . . 0.23 109.936 174.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -120.33 87.92 2.84 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.24 -1.022 . . . . 0.25 108.24 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.864 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 4.5 mm -66.09 88.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.546 -1.206 . . . . 0.85 109.658 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.12 161.29 18.95 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.525 -0.176 . . . . 0.69 110.525 -171.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.5 tttm 62.42 29.93 17.24 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.171 0.986 . . . . 2.61 109.402 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.668 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 3.0 tpp -109.97 10.04 24.3 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.689 -1.141 . . . . 1.37 111.041 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' HB3' ' CB ' ' A' ' 151' ' ' SER . 4.9 p-10 -64.84 43.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.963 0.887 . . . . 2.45 112.873 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.957 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 99.1 mttt -120.77 -163.97 0.05 OUTLIER Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 105.669 -1.974 . . . . 3.7 105.669 166.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.957 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 11.6 Cg_endo -59.58 -53.79 3.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 CA-C-N 120.401 1.179 . . . . 2.67 111.306 164.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.653 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . 12.9 pt-20 168.4 127.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.532 0.733 . . . . 4.03 109.261 -173.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.1 -62.36 1.53 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.437 -0.802 . . . . 1.47 109.336 166.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 126' ' ' ARG . 50.5 t30 -177.79 80.53 0.24 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.623 -0.717 . . . . 1.84 110.618 169.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.653 ' CD ' ' HB2' ' A' ' 121' ' ' GLU . 6.4 Cg_endo -47.73 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.178 3.252 . . . . 0.7 113.744 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -46.28 -43.23 15.53 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.774 0.657 . . . . 2.0 112.774 -175.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.488 ' HB2' ' ND2' ' A' ' 123' ' ' ASN . 4.1 tmt_? -56.94 -53.99 51.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.428 0.632 . . . . 2.99 109.775 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.751 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 47.3 t -60.64 -45.18 97.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.614 -1.176 . . . . 0.4 109.559 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.672 ' HA ' ' CZ ' ' A' ' 147' ' ' PHE . 86.3 mtp -64.2 -32.14 73.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.425 -0.807 . . . . 0.3 111.609 -176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.6 mt-30 -83.41 -20.83 33.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.019 0.438 . . . . 1.28 110.283 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.751 ' OE1' ' HA ' ' A' ' 127' ' ' VAL . 3.0 pt-20 -79.05 -27.68 43.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.111 -0.7 . . . . 2.02 109.111 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.577 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.1 mm? -71.72 -42.69 67.03 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.542 0.687 . . . . 1.06 109.597 174.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.909 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.6 ppp? -77.11 -2.36 33.85 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.086 -0.961 . . . . 0.35 109.719 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -81.22 -27.09 35.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.674 -1.232 . . . . 2.18 107.674 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.456 ' HE2' HG11 ' A' ' 92' ' ' VAL . 25.6 m-85 -85.99 4.85 35.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.73 -0.841 . . . . 0.74 108.73 169.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.7 m120 75.11 19.35 2.32 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.203 -1.362 . . . . 1.94 111.126 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.549 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.3 mp -97.52 77.72 2.62 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.665 -1.235 . . . . 1.68 107.665 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.546 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.05 129.87 92.3 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 113.559 -1.655 . . . . 0.61 110.799 -176.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.873 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 99.7 Cg_exo -47.16 152.92 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.897 2.398 . . . . 0.3 112.78 172.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -73.65 -29.84 62.57 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.17 -1.377 . . . . 2.01 107.844 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.773 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -49.08 -47.56 44.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.549 -1.205 . . . . 1.14 109.462 168.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.909 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.1 m0 -92.66 -17.65 24.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.967 -1.015 . . . . 0.45 111.2 -170.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.18 19.85 5.77 Favored Glycine 0 CA--C 1.507 -0.41 0 C-N-CA 119.612 -1.28 . . . . 0.45 112.892 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -93.12 -113.65 2.23 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.205 -0.998 . . . . 0.5 112.017 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -150.07 19.9 0.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 111.649 0.24 . . . . 1.3 111.649 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.633 HG23 HG22 ' A' ' 110' ' ' ILE . 23.4 m -125.87 115.09 19.43 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.81 -0.756 . . . . 0.32 112.572 -173.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.713 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.1 mp -84.56 110.73 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.23 110.526 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.873 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.4 m-85 -87.32 121.26 29.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.215 0.531 . . . . 0.38 111.673 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 61.5 m -115.87 103.52 10.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.764 -0.653 . . . . 1.1 110.012 175.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.864 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 12.1 ptmm? -81.64 84.61 6.74 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.687 -0.857 . . . . 2.44 108.687 172.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.886 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -114.08 -175.02 2.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.045 -0.98 . . . . 1.27 112.574 -168.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.471 ' CB ' ' HB3' ' A' ' 118' ' ' ASP . 34.0 t -150.41 117.96 6.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.88 -1.055 . . . . 1.79 109.687 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 24' ' ' LEU . . . -74.4 -28.78 61.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.87 110.777 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 11.2 ptmm? -77.42 -50.4 12.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.807 0.813 . . . . 3.03 110.58 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.406 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 6.0 m -77.65 -11.69 59.89 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.425 -1.261 . . . . 1.2 111.655 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 71.25 -20.35 0.23 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.012 0.745 . . . . 2.27 113.012 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 154' ' ' THR . 10.8 tp10 -43.3 -63.18 0.87 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.617 0.722 . . . . 2.64 111.809 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.886 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.15 -17.69 74.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.329 -0.851 . . . . 0.62 113.663 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.5 mt -66.45 -46.08 77.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.469 0.635 . . . . 1.55 110.685 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.88 -37.65 88.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.826 -0.625 . . . . 2.5 110.212 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.609 ' HA ' ' OE1' ' A' ' 163' ' ' GLU . 78.4 t60 -73.38 -26.02 60.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.73 111.067 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.76 -47.26 75.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.421 -0.585 . . . . 0.91 109.421 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.5 mt -53.61 -44.0 69.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.802 -0.635 . . . . 1.06 110.642 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.609 ' OE1' ' HA ' ' A' ' 160' ' ' HIS . 45.3 mt-10 -54.99 -43.14 73.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.068 0.461 . . . . 2.49 110.866 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.713 ' HB3' HG21 ' A' ' 146' ' ' ILE . 8.4 mmt -71.2 -31.48 67.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.87 110.651 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 162' ' ' LEU . 79.7 mt -63.95 -53.02 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 0.64 110.524 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.58 -33.91 70.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.173 0.435 . . . . 1.81 112.173 174.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.67 -41.48 77.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.15 -0.685 . . . . 1.42 109.15 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 171' ' ' MET . 38.1 t -79.07 -29.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.867 -0.606 . . . . 1.17 110.86 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.0 m -57.83 -32.18 67.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.869 0.366 . . . . 1.54 110.626 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -95.61 -27.78 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 2.79 110.832 175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.503 ' HB3' ' HA ' ' A' ' 168' ' ' VAL . 39.2 ttp -70.28 -13.79 62.32 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 116.327 -0.397 . . . . 1.82 110.233 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 5.2 mm-40 -46.78 -38.16 9.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 3.45 112.045 171.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -76.12 -23.18 54.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.033 0.444 . . . . 3.36 110.908 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 52.5 tp -95.25 -0.9 52.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.354 0.597 . . . . 4.14 109.872 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.602 ' HD2' HG21 ' A' ' 79' ' ' THR . 7.9 ttpm? -61.2 105.69 0.52 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.679 -0.692 . . . . 6.31 109.912 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.2 122.09 36.37 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.69 -0.686 . . . . 4.57 111.341 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.713 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 51.4 m-80 -86.0 -51.7 0.47 Allowed Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.68 -0.691 . . . . 6.38 109.856 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.713 ' HD3' ' HB2' ' A' ' 177' ' ' ASN . 4.4 Cg_exo . . . . . 0 C--O 1.252 1.211 0 C-N-CA 122.67 2.247 . . . . 7.47 111.57 174.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.938 -0.465 . . . . 16.35 111.938 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 5.1 t -82.78 99.06 9.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.146 -0.687 . . . . 14.69 109.146 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 2' ' ' SER . 83.9 m-70 72.47 127.78 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.868 0.73 . . . . 14.68 110.26 -173.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -78.77 83.75 4.89 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.881 -0.599 . . . . 12.73 111.042 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 m -104.13 -27.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.907 -0.588 . . . . 10.18 110.472 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 35.0 tt0 -107.49 66.61 0.67 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.388 -0.597 . . . . 9.14 109.388 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.817 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 50.1 mtm180 -88.63 -63.36 0.21 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.826 -0.625 . . . . 8.35 111.888 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.817 ' HD3' ' HB2' ' A' ' 7' ' ' ARG . 19.9 Cg_exo -66.05 116.28 3.91 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.41 2.073 . . . . 4.6 111.941 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.779 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 71.8 Cg_endo -70.53 -174.22 1.01 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 123.685 2.923 . . . . 4.29 113.711 -168.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.714 ' O ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -57.42 179.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 122.908 0.483 . . . . 2.58 111.259 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 t -109.22 133.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 121.476 -0.765 . . . . 1.0 111.175 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 68' ' ' PHE . 6.7 m -92.95 122.47 35.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.681 -0.69 . . . . 0.66 111.272 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.728 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 33.3 mt -104.47 122.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.866 -0.42 . . . . 1.03 109.866 172.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.7 mtm -127.56 165.57 19.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.187 -0.461 . . . . 1.04 110.075 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.828 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 166.27 -107.75 0.3 Allowed Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.486 -1.046 . . . . 1.55 110.486 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.451 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 60.1 t60 -159.21 137.58 10.65 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.431 -0.952 . . . . 0.66 108.431 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -59.93 -31.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.257 -0.883 . . . . 1.62 113.201 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.92 -20.57 52.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.271 . . . . 1.78 111.309 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.451 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 47.8 m170 -70.34 -2.61 14.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.152 0.501 . . . . 0.65 111.282 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.65 43.55 3.89 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.772 -0.728 . . . . 0.93 112.848 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -66.45 -39.42 88.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.276 0.56 . . . . 2.11 109.823 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -67.01 -36.04 81.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.414 -0.812 . . . . 1.8 109.82 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -67.78 -35.91 79.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.676 -0.693 . . . . 1.77 110.273 176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 47.4 tp -65.36 -49.11 70.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.706 . . . . 1.78 110.209 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.649 ' O ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -66.96 -32.21 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 1.96 110.051 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 28.6 t70 -66.14 -56.8 9.63 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.171 -0.331 . . . . 1.38 111.481 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' O ' ' HE2' ' A' ' 155' ' ' LYS . . . -61.35 -30.62 70.63 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.07 0.462 . . . . 0.91 110.89 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' A' ' 158' ' ' LEU . 3.1 tt -74.32 -27.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.839 -0.619 . . . . 1.56 110.644 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HD3' ' O ' ' A' ' 46' ' ' GLY . 74.9 mtm180 -80.23 -32.47 38.41 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.226 0.536 . . . . 3.56 109.807 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -65.62 -8.51 20.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.136 -0.938 . . . . 2.88 109.918 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.44 -41.94 19.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.626 -0.715 . . . . 1.76 109.47 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 40.5 mmtm 61.55 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.595 0.758 . . . . 5.71 112.631 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.748 HG21 HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -146.98 -55.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.736 -0.665 . . . . 2.99 112.742 -174.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.897 HG22 ' HG3' ' A' ' 35' ' ' GLU . 71.6 m -152.25 -78.78 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.602 0.593 . . . . 3.93 112.602 -168.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.897 ' HG3' HG22 ' A' ' 34' ' ' THR . 41.9 mt-10 -118.67 -178.99 3.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.003 0.43 . . . . 4.2 111.921 -173.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 1.026 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 24.0 pt20 -151.02 162.69 40.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.362 -0.977 . . . . 5.38 108.362 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -156.87 173.77 16.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.847 0.356 . . . . 5.79 111.221 -169.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . . . -95.64 115.41 27.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.114 -0.494 . . . . 4.24 110.33 175.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' HB2' ' A' ' 47' ' ' ALA . . . 148.09 -146.3 15.76 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.666 -0.574 . . . . 4.95 111.666 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.49 -66.83 1.6 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.18 -0.533 . . . . 6.66 112.655 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.9 mt -103.13 -46.65 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.237 0.542 . . . . 9.17 110.257 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 43' ' ' GLN . 23.4 m -156.01 168.25 27.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.985 -1.117 . . . . 7.36 107.985 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 42' ' ' THR . 14.0 pt20 -75.76 26.08 0.11 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.758 0.651 . . . . 8.83 112.758 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.66 -172.73 2.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.918 -1.512 . . . . 6.76 106.918 164.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 13.8 tt -72.58 153.08 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 118.786 -1.165 . . . . 5.19 109.127 172.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.652 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . 152.18 -12.51 0.7 Allowed Glycine 0 C--N 1.307 -1.081 0 C-N-CA 120.319 -0.943 . . . . 2.97 112.894 -174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB2' ' C ' ' A' ' 39' ' ' GLY . . . -92.0 -172.33 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.507 -0.553 . . . . 1.71 109.507 175.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 1.026 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.2 p90 -168.61 177.47 5.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.8 -0.445 . . . . 2.54 109.8 -176.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.814 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 71.8 mt-30 -139.07 113.36 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.136 -1.061 . . . . 1.96 108.136 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.769 ' HB ' ' HE2' ' A' ' 48' ' ' TYR . 4.6 p -97.07 155.06 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.976 0.893 . . . . 1.93 111.914 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.6 m -130.0 83.94 2.17 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.18 -1.373 . . . . 2.06 110.243 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 54' ' ' ASP . 70.0 t -123.68 122.87 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.189 -1.412 . . . . 4.12 107.189 171.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' HG ' ' A' ' 166' ' ' LEU . 23.6 t-20 75.96 -26.74 0.19 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 122.473 1.13 . . . . 4.43 109.724 -172.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.8 t70 85.62 66.63 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.377 -2.192 . . . . 3.62 111.596 173.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.748 ' HD2' ' HB3' ' A' ' 166' ' ' LEU . 42.5 mttp -115.75 3.65 13.88 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.149 -0.932 . . . . 7.44 109.486 170.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 51.1 mttp 52.2 45.71 27.92 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.211 -1.359 . . . . 5.43 111.455 174.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 166' ' ' LEU . 4.8 mt -59.08 115.52 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.859 . . . . 1.14 111.415 -171.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' HG12 ' A' ' 10' ' ' VAL . 16.9 m -92.64 125.65 37.36 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.154 -0.684 . . . . 1.28 109.154 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -100.94 116.46 32.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.461 0.541 . . . . 0.84 112.461 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 13' ' ' ILE . 86.1 mt 58.73 56.28 4.25 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.722 -1.126 . . . . 3.0 113.309 170.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' C ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 t70 -71.37 93.96 1.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.553 -0.906 . . . . 6.48 108.553 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 66' ' ' GLU . 2.9 p -126.0 65.33 55.35 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 113.093 0.775 . . . . 5.57 113.093 -171.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' C ' ' A' ' 61' ' ' ASP . 55.5 Cg_endo -102.19 37.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.446 2.764 . . . . 5.77 111.138 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.81 35.4 0.48 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.705 -0.759 . . . . 5.54 112.02 -174.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 69' ' ' THR . 30.5 m170 -127.09 -77.26 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.729 -0.841 . . . . 8.09 108.729 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 62' ' ' THR . 1.3 mp0 62.24 178.36 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.975 -1.012 . . . . 6.36 112.449 172.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 54.05 -105.87 0.28 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.005 -0.998 . . . . 3.51 111.705 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' CE1' ' HG2' ' A' ' 71' ' ' MET . 24.1 t80 -138.46 84.48 2.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 2.61 110.037 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 65' ' ' HIS . 7.1 p -140.96 145.01 35.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.843 -0.617 . . . . 4.74 110.115 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.779 ' HB ' ' HB2' ' A' ' 9' ' ' PRO . 38.1 p 54.35 97.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.886 0.741 . . . . 5.89 112.335 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.714 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -147.39 107.57 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.248 0.833 . . . . 5.64 113.248 -175.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HA ' HG13 ' A' ' 81' ' ' ILE . 17.4 tpt180 -173.43 -55.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.457 -0.338 . . . . 9.71 111.818 169.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.47 -76.89 0.05 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 111.916 0.339 . . . . 7.52 111.916 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 47.2 ttt180 -162.8 113.34 1.46 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.925 0.49 . . . . 10.42 110.531 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.514 ' C ' ' HA ' ' A' ' 9' ' ' PRO . . . 156.45 -135.9 4.72 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.77 -0.729 . . . . 6.75 112.614 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 9' ' ' PRO . . . -162.89 106.8 1.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.484 0.313 . . . . 6.69 110.599 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 9' ' ' PRO . 25.8 tt0 -174.46 154.57 2.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.723 0.297 . . . . 7.72 110.315 -176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -79.63 103.75 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.638 -0.505 . . . . 4.38 109.638 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.9 OUTLIER -127.41 -147.19 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.046 -0.524 . . . . 4.18 109.77 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 108' ' ' VAL . 5.5 p-10 -153.21 103.51 2.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.613 0.598 . . . . 3.12 112.613 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.607 HG13 ' HA ' ' A' ' 72' ' ' ARG . 15.6 mm -151.76 113.93 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.933 -0.576 . . . . 0.74 109.649 170.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.981 HG21 ' HB1' ' A' ' 103' ' ' ALA . 99.0 t -118.86 101.58 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 O-C-N 122.173 -0.329 . . . . 1.19 111.101 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 7.0 mm -79.03 121.28 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.776 -1.194 . . . . 1.32 107.776 170.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -118.75 103.59 9.8 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.855 -176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.828 HG12 ' HA3' ' A' ' 15' ' ' GLY . 6.6 p -89.24 146.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.294 0.568 . . . . 1.2 112.09 -175.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 114' ' ' ILE . 21.5 m -141.59 -175.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.926 -1.033 . . . . 1.12 108.223 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.47 134.37 13.0 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.341 -0.544 . . . . 0.75 112.078 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . 51.47 -125.21 2.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.295 -0.866 . . . . 1.18 112.146 172.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -105.3 5.17 31.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.92 0.39 . . . . 2.01 110.022 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.78 -32.64 71.96 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.57 0.7 . . . . 1.09 109.75 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.773 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 68.42 -134.74 28.77 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 114.706 -1.133 . . . . 0.52 111.677 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 96' ' ' THR . 64.2 t -102.32 103.69 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.145 0.498 . . . . 1.08 111.033 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.573 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 83.4 mmm -72.77 170.74 12.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 1.32 110.631 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 72.4 Cg_exo -42.69 -51.21 5.4 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.789 2.326 . . . . 0.61 113.09 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.02 -37.87 89.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.47 110.717 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.726 ' HB ' HG13 ' A' ' 92' ' ' VAL . 3.1 m -62.18 -35.27 78.32 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.965 -0.562 . . . . 0.46 110.376 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.715 HG23 HG12 ' A' ' 92' ' ' VAL . 41.1 t -74.15 -50.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.152 -0.476 . . . . 1.05 110.688 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.52 -31.22 34.44 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.547 0.53 . . . . 1.62 111.528 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.03 -37.86 28.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.34 109.895 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.774 HG12 HD13 ' A' ' 110' ' ' ILE . 1.5 mt -75.45 -37.66 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.646 -0.706 . . . . 0.38 110.47 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -34.93 68.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.731 0.776 . . . . 1.85 109.737 174.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.597 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 28.3 t60 -85.15 -30.65 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.831 -1.077 . . . . 0.85 110.551 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.981 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.41 -49.2 10.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.168 -0.469 . . . . 0.48 111.9 -173.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -53.08 -27.24 19.23 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.39 0.885 . . . . 2.56 113.39 -166.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.1 10.87 36.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.079 0.77 . . . . 0.76 113.079 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.481 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -97.57 2.37 49.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.213 -0.662 . . . . 0.9 109.213 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t30 71.3 46.64 0.42 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 123.11 1.433 . . . . 2.06 107.831 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.657 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -129.5 143.06 47.43 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 112.809 -1.996 . . . . 1.08 111.194 -168.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 108' ' ' VAL . 21.9 Cg_exo -67.26 156.41 66.38 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.486 2.124 . . . . 0.51 112.982 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.774 HD13 HG12 ' A' ' 100' ' ' ILE . 85.1 mt -124.48 141.85 43.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.702 -1.135 . . . . 0.96 109.201 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.706 HD13 HD13 ' A' ' 83' ' ' ILE . 3.7 mt -125.93 96.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 C-N-CA 120.35 -0.54 . . . . 0.71 111.238 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -65.82 139.82 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.005 -0.998 . . . . 0.23 110.265 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -124.02 89.37 3.07 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.868 -1.16 . . . . 0.25 107.868 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.637 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 9.7 mm -65.92 86.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.565 -1.198 . . . . 0.85 110.197 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -84.05 148.45 26.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.69 110.721 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 60.63 33.31 20.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.404 -0.817 . . . . 2.61 110.758 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.418 ' HB3' HG22 ' A' ' 114' ' ' ILE . 1.4 ppp? -87.73 -0.74 57.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.812 -0.631 . . . . 1.37 110.007 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.17 -33.78 20.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.973 -1.012 . . . . 2.45 111.639 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.561 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 18.0 pttp -120.61 158.23 52.16 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.264 . . . . 3.7 110.718 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 5.2 Cg_endo -48.58 -4.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 1 C-N-CA 125.749 4.299 . . . . 2.67 117.044 -171.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -21.54 65.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 4.03 110.125 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 88' ' ' ALA . . . -98.53 127.87 44.63 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.598 -0.728 . . . . 1.47 110.4 173.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 16.4 t-20 -124.45 89.38 52.19 Favored Pre-proline 0 CA--C 1.51 -0.583 0 CA-C-O 121.228 0.537 . . . . 1.84 111.016 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.492 ' O ' ' HG3' ' A' ' 128' ' ' MET . 0.0 OUTLIER -16.12 -82.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.119 1 C-N-CA 126.301 4.667 . . . . 0.7 116.579 172.73 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -43.81 -55.31 4.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.345 0.658 . . . . 2.0 112.344 -169.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 tpt85 -56.17 -62.16 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.401 0.62 . . . . 2.99 110.786 -175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.773 HG13 ' HA2' ' A' ' 91' ' ' GLY . 28.1 t -51.82 -49.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.441 -1.254 . . . . 0.4 110.489 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.625 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 86.5 mtp -66.45 -33.04 74.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.84 -0.618 . . . . 0.3 111.96 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.534 ' O ' ' HG3' ' A' ' 132' ' ' MET . 87.0 mt-30 -76.38 -26.2 55.37 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.813 -0.44 . . . . 1.28 109.813 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.458 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -71.12 -31.11 67.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.239 -0.652 . . . . 2.02 109.239 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 136' ' ' LEU . 2.8 mm? -68.54 -46.31 69.86 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.506 0.669 . . . . 1.06 109.716 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.863 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.3 ppp? -73.31 -4.57 34.12 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.392 -0.822 . . . . 0.35 110.0 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -81.77 -24.63 35.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.039 -0.726 . . . . 2.18 109.039 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.607 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 39.5 m-85 -84.75 0.61 50.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.582 -0.896 . . . . 0.74 108.582 167.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 74.14 45.3 0.21 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 113.967 -1.47 . . . . 1.94 109.464 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -126.19 83.36 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.028 -1.442 . . . . 1.68 107.439 170.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.876 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -66.23 131.42 94.35 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.592 -1.64 . . . . 0.61 111.28 -173.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.741 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 87.5 Cg_exo -49.87 155.47 4.1 Favored 'Trans proline' 0 CA--C 1.516 -0.377 0 C-N-CA 123.315 2.677 . . . . 0.3 113.705 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HG3' HG13 ' A' ' 146' ' ' ILE . 6.8 mm-40 -80.17 -19.18 47.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.53 -1.214 . . . . 2.01 109.268 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.808 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -58.24 -40.17 81.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.501 -0.926 . . . . 1.14 108.501 167.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.863 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.3 m0 -96.71 -21.43 17.59 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.384 -1.28 . . . . 0.45 110.841 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.49 25.22 5.84 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.372 -0.918 . . . . 0.45 112.43 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.876 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -90.47 -101.11 1.17 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.721 -0.752 . . . . 0.5 112.612 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -165.11 27.01 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.244 0.545 . . . . 1.3 111.114 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.772 HG21 HD12 ' A' ' 136' ' ' LEU . 62.2 m -130.17 116.85 19.03 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.241 -0.584 . . . . 0.32 112.389 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 168' ' ' VAL . 4.0 mp -82.14 109.04 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.546 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.741 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 15.9 m-85 -89.54 96.24 10.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.984 0.421 . . . . 0.38 111.186 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.444 ' O ' HD12 ' A' ' 150' ' ' LEU . 75.1 m -84.32 99.55 10.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.313 -0.625 . . . . 1.1 109.313 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.637 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 2.4 pttm -82.83 84.16 7.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.552 -0.907 . . . . 2.44 108.552 176.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.568 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.44 -179.18 3.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.298 -0.865 . . . . 1.27 112.97 -168.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p -152.94 111.28 3.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.813 -1.085 . . . . 1.79 110.156 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.95 64.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.362 -0.381 . . . . 0.87 111.237 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -75.14 -46.91 31.27 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.896 0.855 . . . . 3.03 110.15 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.0 m -72.62 -14.78 61.68 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.251 -1.34 . . . . 1.2 110.397 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 27' ' ' ALA . 21.2 tptp 58.61 27.33 15.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.499 -1.228 . . . . 2.27 111.576 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -92.35 -67.43 0.86 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.534 0.683 . . . . 2.64 110.266 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -70.02 -13.04 69.26 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.248 -0.887 . . . . 0.62 113.55 -176.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 28' ' ' ILE . 3.3 tm? -60.54 -54.44 45.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 1.55 109.38 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.29 -33.75 76.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.293 -0.867 . . . . 2.5 109.89 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.682 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 86.7 t60 -65.38 -25.98 67.8 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.666 -0.697 . . . . 0.73 111.075 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 165' ' ' ILE . 59.7 tp -66.59 -55.4 15.54 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.002 -0.369 . . . . 0.91 110.002 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 165' ' ' ILE . 92.1 mt -55.9 -41.6 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.536 . . . . 1.06 110.723 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 160' ' ' HIS . 6.4 pt-20 -69.48 -27.73 65.46 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.598 -0.441 . . . . 2.49 110.61 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.467 ' HG2' HG21 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -81.3 -32.2 33.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.051 0.453 . . . . 0.87 109.821 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 162' ' ' LEU . 32.6 mt -55.41 -54.63 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.361 -0.836 . . . . 0.64 111.896 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.2 -30.06 34.39 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.748 -0.595 . . . . 1.81 111.969 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 171' ' ' MET . 10.3 tt -59.53 -31.56 69.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.849 -0.426 . . . . 1.42 109.849 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.779 HG21 HG12 ' A' ' 146' ' ' ILE . 25.2 t -87.37 -41.28 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.941 -0.572 . . . . 1.17 111.283 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 4.7 p -64.04 -24.17 67.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.317 . . . . 1.54 111.477 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.74 -21.69 18.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.644 0.259 . . . . 2.79 110.952 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 167' ' ' LEU . 55.9 ttp -68.82 -42.44 77.24 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.941 -0.392 . . . . 1.82 109.941 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 25.7 mm-40 -50.3 -31.36 14.16 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.946 0.779 . . . . 3.45 112.62 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.63 -34.86 65.29 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.142 0.496 . . . . 3.36 110.623 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -103.9 -49.56 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.956 -0.757 . . . . 4.14 108.956 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 61.54 -86.58 0.02 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.634 -1.166 . . . . 6.31 111.123 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.46 146.75 20.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.586 -0.734 . . . . 4.57 109.26 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -110.69 132.52 21.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 110.035 -0.357 . . . . 6.38 110.035 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 C--O 1.25 1.103 0 C-N-CA 122.982 2.455 . . . . 7.47 111.932 178.822 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.867 -0.493 . . . . 16.35 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -77.62 67.12 3.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.343 0.592 . . . . 14.69 111.808 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -121.79 71.33 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.552 -0.907 . . . . 14.68 108.552 171.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.0 mmm -85.7 69.86 10.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.048 -0.524 . . . . 12.73 110.628 -171.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.98 35.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.903 -0.589 . . . . 10.18 111.151 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.35 -45.22 80.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 9.14 110.607 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -67.99 118.67 60.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.678 -0.692 . . . . 8.35 111.534 -174.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 18.0 Cg_endo -96.62 145.45 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.651 2.901 . . . . 4.6 111.316 172.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.13 128.75 21.27 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.243 1.962 . . . . 4.29 111.969 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.46 ' CG2' HG22 ' A' ' 79' ' ' THR . 5.3 m -77.67 81.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.945 0.879 . . . . 2.58 110.626 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.947 HG13 HG21 ' A' ' 81' ' ' ILE . 45.2 t -72.53 98.21 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.816 -1.084 . . . . 1.0 109.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.477 ' O ' HG13 ' A' ' 83' ' ' ILE . 19.3 m -80.42 128.09 33.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 0.66 111.452 -171.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 HD12 ' A' ' 83' ' ' ILE . 52.1 mt -94.95 128.52 46.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.041 -0.527 . . . . 1.03 110.271 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.599 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 55.6 mtt -125.29 -177.94 4.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.459 177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.92 130.44 4.45 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.504 -0.855 . . . . 1.55 110.984 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -50.69 138.38 18.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.176 0.512 . . . . 0.66 110.4 174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 21' ' ' LYS . 30.3 m -61.63 -27.5 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.871 1.063 . . . . 1.62 113.871 -167.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.31 -19.16 60.57 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.025 0.38 . . . . 1.78 112.025 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -72.01 -34.26 68.72 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.761 0.282 . . . . 0.65 111.761 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.58 67.63 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.392 -0.909 . . . . 0.93 112.75 177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HE3' HG22 ' A' ' 13' ' ' ILE . 14.0 mmmm -89.03 -56.33 3.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.067 0.461 . . . . 2.11 111.128 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -65.91 -18.08 65.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 1.8 110.799 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.4 p -74.75 -19.94 60.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.011 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 68.0 mt -69.01 -52.19 31.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.715 -0.394 . . . . 1.78 110.307 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.607 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 8.7 mp -60.32 -34.09 73.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.9 -0.591 . . . . 1.96 110.973 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.74 -51.38 41.99 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.882 0.327 . . . . 1.38 111.882 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -69.6 -33.33 72.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.91 111.008 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.63 HD11 HD21 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -66.06 -24.21 33.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.996 -0.547 . . . . 1.56 110.54 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 51.5 mtp180 -79.09 -21.65 46.39 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.215 0.531 . . . . 3.56 110.636 177.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -71.78 -7.74 50.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.718 0.77 . . . . 2.88 109.647 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.74 18.37 21.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.966 -1.016 . . . . 1.76 110.172 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' HG12 ' A' ' 33' ' ' VAL . 59.8 mttp 53.31 -133.42 1.81 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.795 -0.817 . . . . 5.71 108.795 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.84 HG23 ' HB ' ' A' ' 51' ' ' THR . 2.9 p 53.3 19.04 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.135 0.897 . . . . 2.99 112.981 167.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -109.99 115.89 30.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.382 0.611 . . . . 3.93 111.453 -178.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.63 -42.28 12.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.045 -0.98 . . . . 4.2 110.049 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 48' ' ' TYR . 41.9 mt-30 71.14 10.9 6.88 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.972 -1.013 . . . . 5.38 112.961 170.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.14 103.24 15.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.029 -0.268 . . . . 5.79 110.747 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.17 77.67 0.21 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.904 0.752 . . . . 4.24 112.374 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 48' ' ' TYR . . . -82.98 56.08 5.06 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.612 -0.804 . . . . 4.95 112.475 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.95 47.12 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.513 -0.851 . . . . 6.66 112.421 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.6 -43.54 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.45 . . . . 9.17 110.431 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.574 HG22 ' HD2' ' A' ' 44' ' ' HIS . 6.2 m -80.42 114.39 19.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.403 -0.592 . . . . 7.36 109.403 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -63.31 93.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.416 0.627 . . . . 8.83 111.596 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.574 ' HD2' HG22 ' A' ' 42' ' ' THR . 29.1 m-70 -141.96 151.88 42.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.317 -0.856 . . . . 6.76 108.887 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.27 173.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 5.19 110.704 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.78 -46.67 1.2 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.864 -0.894 . . . . 2.97 110.864 -174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.78 169.25 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.708 -0.849 . . . . 1.71 108.708 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.731 ' HB2' ' HA ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -153.18 151.15 29.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.989 -0.684 . . . . 2.54 111.045 -169.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.13 153.97 21.86 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.39 -0.823 . . . . 1.96 108.857 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' A' ' 55' ' ' LYS . 71.7 t -92.9 172.05 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.468 -0.787 . . . . 1.93 109.259 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -51.94 161.05 0.62 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.365 1.078 . . . . 2.06 113.605 -167.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.1 p -101.32 127.73 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-N 115.231 -0.895 . . . . 4.12 110.85 -163.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.54 -31.12 0.2 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.204 0.94 . . . . 4.43 110.845 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.79 ' HB3' ' CG2' ' A' ' 51' ' ' THR . 31.4 t70 -85.85 -45.95 11.09 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.584 -0.28 . . . . 3.62 111.004 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HG3' HG21 ' A' ' 33' ' ' VAL . 49.9 mmtm -133.74 73.09 1.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.17 -0.612 . . . . 7.44 111.659 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.29 84.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 5.43 111.954 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.677 HG23 HG21 ' A' ' 11' ' ' VAL . 48.3 mt -139.59 127.86 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 1.14 110.18 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.4 m -105.75 131.71 52.77 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.172 -0.677 . . . . 1.28 109.172 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.461 ' HE2' HG21 ' A' ' 50' ' ' VAL . 43.7 m-85 -116.46 110.53 18.74 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 119.979 -0.688 . . . . 0.84 111.104 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.596 HD23 ' SD ' ' A' ' 71' ' ' MET . 44.3 tp -117.16 114.48 23.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.763 -0.653 . . . . 3.0 110.106 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.41 131.36 54.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.538 -0.912 . . . . 6.48 108.538 171.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.95 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 19.9 m -119.3 97.32 50.33 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.396 -0.365 . . . . 5.57 110.934 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.52 44.65 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.262 2.641 . . . . 5.77 111.393 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.7 69.77 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.507 -0.77 . . . . 5.54 111.241 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.2 m170 70.18 -71.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.55 0.74 . . . . 8.09 111.001 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.39 130.92 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 6.36 110.093 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.95 ' HA ' ' HB ' ' A' ' 62' ' ' THR . . . -69.72 -26.89 64.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 3.51 111.977 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HD1' ' HA ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -84.35 68.0 10.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.806 0.336 . . . . 2.61 110.629 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 88.8 m -126.53 123.29 37.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.351 -0.386 . . . . 4.74 110.828 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.4 p 50.29 37.09 14.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.497 0.719 . . . . 5.89 112.776 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.596 ' SD ' HD23 ' A' ' 60' ' ' LEU . 47.4 ttp -136.55 110.6 8.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.457 . . . . 5.64 111.503 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -139.56 19.65 2.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.72 . . . . 9.71 109.685 172.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 74' ' ' ARG . . . 58.98 -164.52 0.2 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.216 -0.902 . . . . 7.52 110.385 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 73' ' ' ALA . 36.9 mmt180 -126.85 29.05 5.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.442 -0.577 . . . . 10.42 109.442 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.85 -173.84 22.04 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.525 -0.761 . . . . 6.75 112.146 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 75.08 -59.8 0.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.763 0.825 . . . . 6.69 112.692 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 7' ' ' ARG . 26.1 mm-40 -111.38 152.88 26.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.853 0.359 . . . . 7.72 111.159 -174.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.4 m -75.69 147.61 7.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.78 -0.645 . . . . 4.38 111.278 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.46 HG22 ' CG2' ' A' ' 10' ' ' VAL . 39.8 p -111.2 0.28 16.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 4.18 110.679 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 108' ' ' VAL . 47.4 m-20 -86.89 61.85 7.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 3.12 111.188 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.947 HG21 HG13 ' A' ' 11' ' ' VAL . 23.8 mm -133.15 111.12 16.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.924 -0.58 . . . . 0.74 110.308 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 103' ' ' ALA . 53.5 t -117.28 106.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 116.331 -0.395 . . . . 1.19 110.818 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.83 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -90.5 105.15 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.222 -0.659 . . . . 1.32 109.222 175.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 100' ' ' ILE . 11.3 tp -90.34 109.65 20.75 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.289 -0.414 . . . . 1.33 111.361 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 46.2 t -80.89 130.91 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 1.2 110.953 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.648 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.4 m -131.36 -174.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.585 -0.894 . . . . 1.12 108.585 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' HD2' ' A' ' 116' ' ' LYS . . . -147.74 129.73 15.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.981 -0.687 . . . . 0.75 112.564 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 20.89 -89.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 125.16 1.538 . . . . 1.18 114.97 169.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.95 -2.57 22.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.693 -0.685 . . . . 2.01 112.11 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.07 -32.91 24.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.08 0.467 . . . . 1.09 110.725 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.729 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 69.77 -120.6 9.99 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.453 -0.794 . . . . 0.52 111.805 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 97' ' ' VAL . 58.7 t -124.21 109.77 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 120.847 0.356 . . . . 1.08 110.693 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.551 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 67.5 mtp -77.29 169.01 23.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 1.32 110.569 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 94.5 Cg_exo -44.79 -51.23 7.59 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.037 2.491 . . . . 0.61 113.417 177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -66.78 -29.72 69.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.629 0.252 . . . . 1.47 111.366 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.596 ' HB ' HG13 ' A' ' 92' ' ' VAL . 4.4 m -69.47 -28.05 65.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.564 0.697 . . . . 0.46 109.467 174.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.682 HG23 HG12 ' A' ' 92' ' ' VAL . 12.4 t -76.69 -52.24 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.05 111.078 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' ASN . 35.1 mt-10 -65.02 -19.24 65.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.04 0.385 . . . . 1.62 112.04 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -73.62 -37.36 65.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.203 -1.036 . . . . 0.34 108.203 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.815 HG12 HD13 ' A' ' 110' ' ' ILE . 2.8 mt -76.63 -41.16 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 113.969 -1.469 . . . . 0.38 110.727 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 98' ' ' GLU . 7.2 m-20 -54.04 -37.96 64.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.374 0.607 . . . . 1.85 110.367 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -74.85 -31.9 61.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.26 -0.882 . . . . 0.85 110.501 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.618 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -82.79 -48.62 10.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.447 . . . . 0.48 111.949 -175.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -56.86 -34.37 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.398 -0.819 . . . . 2.56 111.985 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.23 10.16 37.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.365 0.506 . . . . 0.76 112.365 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -104.39 5.87 34.66 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.151 -1.055 . . . . 0.9 108.151 169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.0 38.25 6.36 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 114.448 -1.251 . . . . 2.06 110.317 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 80' ' ' ASP . 2.0 m -105.68 148.48 36.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.57 -0.741 . . . . 1.08 110.95 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.6 Cg_exo -70.93 155.27 62.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.098 2.532 . . . . 0.51 113.09 171.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 HG12 ' A' ' 100' ' ' ILE . 68.8 mt -125.91 145.92 32.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.107 -0.951 . . . . 0.96 110.259 -174.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.83 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 mt -120.47 155.93 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 N-CA-C 109.24 -0.652 . . . . 0.71 109.24 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.486 HG21 ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -120.32 137.3 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-O 120.997 0.427 . . . . 0.23 110.403 174.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -124.03 88.42 2.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.91 -1.145 . . . . 0.25 107.91 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 30.3 mt -72.51 97.02 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.956 -1.02 . . . . 0.85 110.487 178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -87.56 165.45 15.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.69 -0.485 . . . . 0.69 109.69 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.537 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 63.0 mttm 64.35 19.24 11.71 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.324 0.583 . . . . 2.61 110.896 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.884 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 4.3 tpp -87.55 -4.45 58.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.646 -0.706 . . . . 1.37 110.949 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.78 0.74 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.87 -0.605 . . . . 2.45 112.469 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.65 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 22.1 mtpp -73.78 -176.4 0.49 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.313 -0.995 . . . . 3.7 108.313 167.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.65 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 37.1 Cg_exo -57.29 -49.77 12.97 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 CA-C-N 119.922 1.008 . . . . 2.67 110.163 169.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 6.4 pt-20 160.22 130.34 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.204 -1.406 . . . . 4.03 107.204 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -66.52 -61.15 2.14 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.012 -1.107 . . . . 1.47 108.012 166.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 3.3 t-20 168.75 91.4 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 114.641 -1.163 . . . . 1.84 109.838 166.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 128' ' ' MET . 4.8 Cg_exo -39.54 -60.01 0.59 Allowed 'Trans proline' 0 C--O 1.217 -0.562 0 C-N-CA 123.876 3.051 . . . . 0.7 112.77 172.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -44.8 -52.92 7.99 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.776 0.43 . . . . 2.0 111.53 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.568 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -54.97 -59.71 4.37 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.875 0.369 . . . . 2.99 110.061 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.729 HG13 ' HA2' ' A' ' 91' ' ' GLY . 60.3 t -53.99 -44.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.266 -0.879 . . . . 0.4 110.831 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.675 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.6 mtp -68.17 -31.83 71.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.641 -0.709 . . . . 0.3 111.184 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 44.6 mt-30 -73.68 -26.87 60.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.458 -0.337 . . . . 1.28 110.621 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 126' ' ' ARG . 2.1 mm-40 -62.52 -39.85 94.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.551 -0.907 . . . . 2.02 108.551 172.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.858 HD12 HD11 ' A' ' 136' ' ' LEU . 3.5 mm? -68.25 -42.95 78.91 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.55 0.69 . . . . 1.06 110.062 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.83 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -76.03 -5.87 48.43 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.346 -0.843 . . . . 0.35 110.107 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 45.5 tt0 -82.32 -26.28 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.886 -0.783 . . . . 2.18 108.886 171.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.651 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 13.5 m-85 -84.6 -0.41 53.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.282 -1.007 . . . . 0.74 108.282 168.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 72.18 42.67 0.56 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 113.931 -1.486 . . . . 1.94 110.44 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -121.8 82.73 1.99 Allowed 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 106.479 -1.674 . . . . 1.68 106.479 168.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.6 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -63.33 131.59 94.84 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.002 -1.454 . . . . 0.61 110.773 -172.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.74 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 86.7 Cg_exo -46.52 151.74 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.879 2.386 . . . . 0.3 112.894 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -25.74 53.71 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.25 -1.341 . . . . 2.01 108.335 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.737 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.35 -43.0 64.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.258 -1.337 . . . . 1.14 109.435 167.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.83 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 10.1 m0 -94.56 -26.0 16.58 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.879 -1.055 . . . . 0.45 111.218 -170.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.46 25.3 2.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.943 -1.123 . . . . 0.45 112.583 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -94.88 -111.79 2.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.5 -0.857 . . . . 0.5 112.573 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -151.01 21.99 0.77 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.679 0.276 . . . . 1.3 111.606 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 36.4 m -125.78 118.79 26.3 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.932 -0.707 . . . . 0.32 112.743 -172.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 164' ' ' MET . 4.0 mp -85.44 108.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.23 110.554 -177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.74 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.3 m-85 -88.83 119.38 29.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.199 0.523 . . . . 0.38 111.486 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 56.8 m -114.93 121.75 44.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.68 -0.691 . . . . 1.1 109.557 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.884 ' HB2' ' HG2' ' A' ' 117' ' ' MET . 58.2 pttt -97.15 104.37 16.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.302 -0.629 . . . . 2.44 109.302 174.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 157' ' ' GLY . 0.8 OUTLIER -125.47 -170.88 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.36 1.076 . . . . 1.27 113.07 -171.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 154' ' ' THR . 30.2 t -169.87 126.92 0.87 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 113.4 -1.727 . . . . 1.79 108.252 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.12 -12.37 59.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.072 0.463 . . . . 0.87 111.083 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -84.93 -57.13 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 3.03 110.174 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 151' ' ' SER . 28.4 p -81.53 -17.6 47.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.13 -0.941 . . . . 1.2 110.51 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 27' ' ' ALA . 6.5 tptm 74.22 -11.98 0.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.905 0.753 . . . . 2.27 112.311 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 156' ' ' GLU . 9.9 mm-40 -44.17 -70.11 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.499 0.72 . . . . 2.64 112.86 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 150' ' ' LEU . . . -73.6 -5.62 68.87 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.477 -0.783 . . . . 0.62 113.872 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.513 HD12 ' HE2' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -73.36 -45.46 54.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.0 -0.741 . . . . 1.55 109.0 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.69 -36.53 76.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.962 -0.563 . . . . 2.5 109.889 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 82.4 t60 -70.72 -20.21 62.68 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.862 -0.608 . . . . 0.73 110.812 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.04 -49.62 42.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.843 0.354 . . . . 0.91 110.123 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 28' ' ' ILE . 98.4 mt -58.2 -37.48 74.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.708 -0.678 . . . . 1.06 111.384 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 160' ' ' HIS . 12.0 pt-20 -70.02 -36.37 75.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.798 -0.361 . . . . 2.49 110.67 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.751 ' HB3' HG21 ' A' ' 146' ' ' ILE . 22.0 mmt -69.06 -38.56 79.15 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.24 0.543 . . . . 0.87 109.72 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 70.7 mt -59.51 -52.27 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.64 110.514 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.35 -42.5 98.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.986 -0.552 . . . . 1.81 111.491 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.2 -45.99 65.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.807 -0.633 . . . . 1.42 110.0 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.45 -26.44 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.101 -0.5 . . . . 1.17 111.315 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.9 m -61.24 -27.38 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.968 0.413 . . . . 1.54 110.443 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.23 -35.9 10.21 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.274 -0.421 . . . . 2.79 111.028 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.456 ' HE3' ' HB2' ' A' ' 174' ' ' LEU . 24.0 ttp -85.66 5.53 31.53 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.383 -0.371 . . . . 1.82 111.675 -175.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -32.83 -40.56 0.05 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.319 1.229 . . . . 3.45 114.319 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -76.01 4.77 7.69 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.38 0.511 . . . . 3.36 112.38 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 175' ' ' LYS . 2.0 tm? -36.26 -80.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.653 0.781 . . . . 4.14 112.303 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.49 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mptm? 53.17 -173.94 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.717 0.636 . . . . 6.31 112.717 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . 59.95 74.26 0.45 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.484 -0.78 . . . . 4.57 112.871 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.464 ' HA ' ' HD2' ' A' ' 178' ' ' PRO . 43.0 t30 -117.92 112.39 38.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.864 -0.421 . . . . 6.38 109.864 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 177' ' ' ASN . 11.8 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 123.339 2.693 . . . . 7.47 112.502 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.883 -0.487 . . . . 16.35 111.883 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 m -89.97 132.35 35.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.752 0.31 . . . . 14.69 110.453 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -76.61 78.77 3.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.834 0.35 . . . . 14.68 110.674 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 ttt -61.9 -37.89 86.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.657 -0.701 . . . . 12.73 110.205 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.0 m -99.62 137.51 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.524 -0.762 . . . . 10.18 109.95 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -86.13 59.15 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.534 0.683 . . . . 9.14 109.954 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -118.12 95.88 48.93 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.273 -0.876 . . . . 8.35 110.001 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.25 130.16 27.8 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.302 2.002 . . . . 4.6 110.967 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.33 118.22 5.06 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.038 2.492 . . . . 4.29 112.156 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 17.9 m -84.63 140.6 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.023 -0.535 . . . . 2.58 110.683 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB ' ' A' ' 81' ' ' ILE . 56.2 t -116.3 100.41 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.281 176.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -82.59 120.6 25.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.069 0.461 . . . . 0.66 111.557 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.552 HD12 ' HG ' ' A' ' 25' ' ' LEU . 42.7 mt -78.97 121.03 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 1.03 109.711 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.433 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 19.5 mmt -110.97 176.75 4.9 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.158 -0.928 . . . . 1.04 109.938 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 1.106 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 123.26 136.05 4.7 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.341 -0.933 . . . . 1.55 111.35 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.725 ' HA ' ' HB2' ' A' ' 95' ' ' GLN . 67.6 t60 -45.62 136.27 6.01 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.646 0.736 . . . . 0.66 110.775 173.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.79 -35.27 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.331 -1.304 . . . . 1.62 113.45 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 11.8 t70 -74.28 -18.48 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 1.78 111.095 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -71.33 -12.22 61.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.182 0.515 . . . . 0.65 110.766 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.47 45.77 6.75 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.506 -0.77 . . . . 0.93 113.34 172.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.672 ' HA ' HD23 ' A' ' 24' ' ' LEU . 58.7 pttt -67.46 -26.33 66.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.095 0.474 . . . . 2.11 110.835 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -67.7 -28.56 67.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 1.8 110.324 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 90.5 m -68.16 -28.17 67.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.89 -0.596 . . . . 1.77 111.039 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD23 ' HA ' ' A' ' 21' ' ' LYS . 3.9 mm? -62.51 -51.12 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 1.78 110.4 176.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HG ' HD12 ' A' ' 13' ' ' ILE . 6.6 mt -72.3 -25.65 61.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.419 -0.355 . . . . 1.96 111.474 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 20.9 t70 -68.39 -49.07 62.74 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.502 -0.317 . . . . 1.38 111.356 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.06 73.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.932 0.396 . . . . 0.91 110.683 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 162' ' ' LEU . 4.7 tt -76.71 -33.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.867 -0.606 . . . . 1.56 110.945 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 15.3 ptt180 -75.19 -32.23 61.17 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.742 0.782 . . . . 3.56 109.729 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -82.11 15.58 2.3 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.469 -1.242 . . . . 2.88 111.641 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 t -135.28 -65.1 0.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.862 0.363 . . . . 1.76 111.278 -173.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 51' ' ' THR . 28.3 mmmt -93.1 170.02 9.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.131 -0.486 . . . . 5.71 110.702 -172.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.895 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 91.7 t -75.43 102.94 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 120.957 0.408 . . . . 2.99 110.729 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.74 ' HB ' HG13 ' A' ' 50' ' ' VAL . 2.6 t -104.93 153.08 21.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.438 0.533 . . . . 3.93 112.438 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 49' ' ' GLN . 11.8 mm-40 -63.51 -59.53 4.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 4.2 109.687 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -126.18 158.79 34.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.957 -1.02 . . . . 5.38 109.893 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.19 153.78 46.53 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.125 -0.695 . . . . 5.79 109.125 169.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 69.17 -167.07 0.18 Allowed 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.9 0.75 . . . . 4.24 110.117 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -108.67 -36.55 2.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.621 -0.799 . . . . 4.95 112.337 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.75 -90.69 0.87 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.951 -0.642 . . . . 6.66 112.261 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.9 pt -79.1 -15.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.988 0.423 . . . . 9.17 111.214 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.616 HG21 ' HB2' ' A' ' 63' ' ' PRO . 12.2 t -128.24 126.45 40.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.313 0.577 . . . . 7.36 109.993 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -82.6 50.49 1.67 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.481 0.657 . . . . 8.83 110.476 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.405 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 92.3 m-70 -133.61 -10.01 2.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 6.76 110.812 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.3 pt 47.31 -164.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 124.287 0.992 . . . . 5.19 111.791 -173.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.24 66.35 1.98 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.839 -0.696 . . . . 2.97 113.442 173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . . . -163.53 87.12 0.52 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.758 0.314 . . . . 1.71 110.982 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -165.26 160.79 18.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.198 0.523 . . . . 2.54 111.898 -176.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 58' ' ' THR . 13.9 mt-30 -107.55 109.71 21.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.869 -1.16 . . . . 1.96 107.869 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 ' HB ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -94.96 131.83 40.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.362 0.601 . . . . 1.93 111.736 -171.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.895 ' HB ' ' HB ' ' A' ' 33' ' ' VAL . 22.6 m -69.83 94.44 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.964 -1.016 . . . . 2.06 111.201 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 54' ' ' ASP . 6.0 p -123.52 119.01 56.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.847 -0.797 . . . . 4.12 108.847 169.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 58.9 t30 71.51 -41.46 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.795 0.807 . . . . 4.43 109.866 -170.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 52' ' ' VAL . 18.2 t70 -158.37 -63.05 0.08 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.399 -1.273 . . . . 3.62 110.197 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 23.1 ttmm 167.59 -92.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.471 -1.307 . . . . 7.44 107.471 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 55' ' ' LYS . 22.1 mtpp 65.75 -63.17 0.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.839 0.856 . . . . 5.43 113.283 170.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.506 HG23 HG21 ' A' ' 11' ' ' VAL . 61.7 mt -65.21 120.59 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.012 0.434 . . . . 1.14 112.044 -172.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 19.3 m -101.2 97.83 8.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 1.28 109.896 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -81.27 100.01 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.394 -0.224 . . . . 0.84 110.394 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 60' ' ' LEU . 3.9 mm? 67.92 112.17 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.113 0.883 . . . . 3.0 111.771 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' HB2' HG11 ' A' ' 10' ' ' VAL . 15.4 t70 -79.31 -42.22 26.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.815 -0.629 . . . . 6.48 109.843 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.0 p -124.36 108.79 29.22 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.836 -0.62 . . . . 5.57 110.422 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.616 ' HB2' HG21 ' A' ' 42' ' ' THR . 66.6 Cg_endo -74.42 60.82 5.04 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.922 2.415 . . . . 5.77 112.412 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.76 -86.08 0.48 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.928 -0.578 . . . . 5.54 112.194 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -136.73 -5.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.531 0.205 . . . . 8.09 111.454 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.81 98.52 4.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.126 0.488 . . . . 6.36 110.874 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -115.75 109.87 18.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.678 -0.692 . . . . 3.51 109.767 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' A' ' 102' ' ' HIS . 82.3 t80 68.74 121.05 0.03 OUTLIER 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.884 0.74 . . . . 2.61 110.075 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 t -48.6 121.45 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 4.74 111.218 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.5 m -59.96 121.19 11.19 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.738 -0.664 . . . . 5.89 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.3 ptp -71.34 113.56 8.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 5.64 111.691 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -118.9 -35.77 3.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.457 -0.792 . . . . 9.71 109.064 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.45 145.1 44.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.239 -0.891 . . . . 7.52 110.039 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -80.31 -30.62 38.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.783 -0.644 . . . . 10.42 110.709 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.35 60.66 4.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.95 -0.643 . . . . 6.75 112.212 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.29 -33.05 17.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.451 0.167 . . . . 6.69 111.391 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 70.18 -54.04 0.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.442 0.697 . . . . 7.72 111.73 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.7 m -79.56 80.59 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.605 0.717 . . . . 4.38 110.523 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -70.15 143.55 52.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.503 -0.772 . . . . 4.18 111.024 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 17.9 t0 -82.51 130.33 35.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.715 -0.846 . . . . 3.12 108.715 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 11' ' ' VAL . 44.9 mm -88.53 107.66 17.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.815 -0.439 . . . . 0.74 109.815 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.952 HG21 ' HB1' ' A' ' 103' ' ' ALA . 61.2 t -85.68 96.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 116.328 -0.396 . . . . 1.19 111.616 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 111' ' ' ILE . 6.5 mm -84.11 93.75 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.283 -0.636 . . . . 1.32 109.283 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.7 tm? -86.97 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.737 -0.665 . . . . 1.33 109.749 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.106 HG12 ' HA3' ' A' ' 15' ' ' GLY . 3.1 p -77.41 144.32 11.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.622 0.725 . . . . 1.2 110.728 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 127' ' ' VAL . 8.4 t -136.72 175.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.58 -1.267 . . . . 1.12 107.58 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' VAL . . . -138.06 131.16 30.18 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 122.101 -0.375 . . . . 0.75 110.251 175.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.63 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -77.44 27.55 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.882 -0.599 . . . . 1.18 112.325 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.618 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 16.4 p-10 -135.35 10.06 3.47 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.98 0.419 . . . . 2.01 110.056 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.81 -58.78 0.4 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.349 0.595 . . . . 1.09 110.605 174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.568 ' O ' HG13 ' A' ' 86' ' ' VAL . . . 118.24 -115.09 3.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.232 -0.895 . . . . 0.52 111.457 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 97' ' ' VAL . 46.6 t -122.81 109.38 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.078 0.465 . . . . 1.08 110.233 -175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.899 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 62.5 mtp -88.49 174.45 5.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.121 -0.49 . . . . 1.32 109.775 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.899 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 7.0 Cg_endo -49.46 -53.13 7.53 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.769 2.313 . . . . 0.61 113.04 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.725 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 38.7 mt-30 -61.15 -32.39 72.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.624 0.231 . . . . 1.47 111.624 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.538 ' CG2' HD11 ' A' ' 84' ' ' LEU . 21.1 m -63.5 -31.24 72.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.806 0.812 . . . . 0.46 109.926 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.619 HG22 ' CE2' ' A' ' 134' ' ' TYR . 41.2 t -82.18 -52.54 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 114.713 -1.13 . . . . 1.05 111.305 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 48.4 mt-10 -55.71 -34.1 64.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.746 -0.661 . . . . 1.62 111.972 -176.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -70.6 -39.46 73.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.541 0.686 . . . . 0.34 109.504 -174.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.535 HG12 HG12 ' A' ' 110' ' ' ILE . 1.7 mt -70.74 -42.18 77.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.395 -1.275 . . . . 0.38 110.188 174.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.467 ' ND2' HG12 ' A' ' 97' ' ' VAL . 94.8 m-20 -54.25 -37.79 65.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.522 . . . . 1.85 110.408 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.481 ' HD2' ' HB3' ' A' ' 68' ' ' PHE . 58.3 t60 -79.29 -27.02 42.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.294 -0.867 . . . . 0.85 110.874 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.952 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -97.72 -35.26 10.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.331 0.863 . . . . 0.48 113.331 -169.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -60.95 -27.11 68.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.863 0.69 . . . . 2.56 112.863 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.3 11.89 19.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.095 0.776 . . . . 0.76 113.095 -166.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . . . -111.32 19.15 18.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.654 -1.239 . . . . 0.9 107.654 172.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 50.56 37.83 17.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 113.547 -1.661 . . . . 2.06 111.721 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.528 HG21 HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -94.27 155.53 39.77 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.021 -0.99 . . . . 1.08 110.014 178.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 108' ' ' VAL . 7.1 Cg_exo -73.97 150.12 43.05 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.686 2.257 . . . . 0.51 113.443 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.645 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -120.72 142.57 36.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.067 -1.424 . . . . 0.96 109.836 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.732 HD13 HD13 ' A' ' 83' ' ' ILE . 4.3 mp -114.04 146.28 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 108.022 -1.103 . . . . 0.71 108.022 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -114.06 132.19 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.025 0 N-CA-C 109.634 -0.506 . . . . 0.23 109.634 174.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -118.82 87.09 2.66 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.636 -1.246 . . . . 0.25 107.636 175.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 28.2 mt -69.65 91.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.499 -1.228 . . . . 0.85 110.024 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 62.5 t30 -92.89 167.58 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.068 -0.515 . . . . 0.69 109.748 -170.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 91.2 mttt 66.76 8.45 5.97 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.5 0.5 . . . . 2.61 110.411 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.428 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -76.96 -2.66 34.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 1.37 110.649 -176.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.424 ' OD2' ' HD2' ' A' ' 153' ' ' LYS . 5.1 p-10 -69.82 -13.85 62.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.187 -0.915 . . . . 2.45 110.222 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.879 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 18.6 ptmt -80.47 -175.66 0.64 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.182 -0.673 . . . . 3.7 109.182 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.879 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -45.07 -22.43 0.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.0 2.467 . . . . 2.67 114.496 176.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.725 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 6.6 pt-20 68.66 122.13 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.489 1.516 . . . . 4.03 110.46 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.41 -75.81 0.08 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.18 -1.373 . . . . 1.47 110.821 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.473 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 50.4 t-20 -179.1 105.92 0.2 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.919 -0.582 . . . . 1.84 110.042 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.678 ' O ' ' HG3' ' A' ' 128' ' ' MET . 1.0 OUTLIER -46.16 -65.62 0.18 Allowed 'Trans proline' 0 C--O 1.219 -0.436 0 C-N-CA 123.538 2.825 . . . . 0.7 112.834 173.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -44.34 -48.57 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.395 0.678 . . . . 2.0 112.601 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 126' ' ' ARG . 9.0 tpt180 -53.48 -55.85 21.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.621 0.724 . . . . 2.99 109.951 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.657 HG11 HG11 ' A' ' 86' ' ' VAL . 81.9 t -57.97 -42.43 82.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.357 -1.292 . . . . 0.4 110.412 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.697 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 88.3 mtp -63.46 -31.43 72.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.61 -0.723 . . . . 0.3 111.265 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.473 ' HA ' ' HG3' ' A' ' 132' ' ' MET . 73.8 mt-30 -77.8 -18.01 56.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.897 -0.321 . . . . 1.28 110.949 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.3 mm-40 -70.39 -35.28 73.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.934 -0.765 . . . . 2.02 108.934 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.515 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 4.0 mm? -71.21 -44.61 65.05 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.516 0.674 . . . . 1.06 109.741 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.934 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 1.5 ppp? -76.08 -2.57 31.48 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.099 -0.955 . . . . 0.35 109.61 176.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 36.4 tt0 -78.13 -28.91 48.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.411 -1.329 . . . . 2.18 107.411 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 97' ' ' VAL . 60.8 m-85 -91.07 10.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.646 -0.706 . . . . 0.74 109.819 170.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 72.36 22.5 3.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.362 -1.29 . . . . 1.94 111.057 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.473 HD22 HD13 ' A' ' 100' ' ' ILE . 6.5 mp -96.94 76.41 2.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.951 -1.129 . . . . 1.68 107.951 171.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -66.8 127.99 93.68 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 113.506 -1.679 . . . . 0.61 110.899 -176.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.799 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 91.7 Cg_exo -47.76 155.16 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.221 2.614 . . . . 0.3 112.726 172.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -27.08 54.69 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.559 -1.2 . . . . 2.01 108.175 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -52.29 -42.73 64.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.548 -1.206 . . . . 1.14 109.336 169.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.934 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.0 m0 -95.19 -18.73 20.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.901 -1.045 . . . . 0.45 111.351 -171.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.67 26.52 4.16 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 119.989 -1.101 . . . . 0.45 112.447 170.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -97.95 -107.84 2.64 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.393 -0.908 . . . . 0.5 112.452 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -162.87 28.86 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.307 0.575 . . . . 1.3 111.127 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.645 HG23 HG22 ' A' ' 110' ' ' ILE . 23.3 m -121.85 123.73 42.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.064 -0.654 . . . . 0.32 111.983 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.59 HD12 HG13 ' A' ' 111' ' ' ILE . 26.5 mt -91.49 108.7 20.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 115.616 -0.72 . . . . 1.23 111.137 -175.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.799 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 24.3 m-85 -93.38 118.78 31.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.129 0.49 . . . . 0.38 112.204 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 77.3 m -117.16 111.6 19.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.596 -0.729 . . . . 1.1 110.06 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.744 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.3 pttp -89.39 89.22 7.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.964 0.887 . . . . 2.44 108.83 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.924 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -116.66 179.93 3.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.696 -1.138 . . . . 1.27 112.745 -165.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.9 p -145.95 110.39 5.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.491 -1.231 . . . . 1.79 109.886 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.04 -19.5 36.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.474 . . . . 0.87 111.298 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' A' ' 154' ' ' THR . 19.2 ptpt -80.16 -52.76 7.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.382 0.61 . . . . 3.03 110.296 -176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.499 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 28.1 p -78.39 -2.12 36.74 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.107 -0.951 . . . . 1.2 111.145 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.0 tptp 61.66 45.72 7.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.872 -1.058 . . . . 2.27 111.989 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -107.23 -73.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.855 0.835 . . . . 2.64 110.167 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.924 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -65.95 -18.67 66.88 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.724 -1.126 . . . . 0.62 113.899 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.04 -47.07 71.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.213 0.53 . . . . 1.55 109.79 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.69 -35.37 67.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.625 -0.716 . . . . 2.5 110.678 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -66.25 -34.81 78.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.184 -0.462 . . . . 0.73 110.668 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 165' ' ' ILE . 61.8 tp -59.68 -53.07 62.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.819 -0.628 . . . . 0.91 110.806 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.796 HD21 HD11 ' A' ' 28' ' ' ILE . 94.9 mt -56.28 -37.6 70.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.886 -0.597 . . . . 1.06 111.351 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -61.92 -38.59 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 2.49 110.913 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.9 mmt -74.02 -44.29 54.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.87 110.368 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.447 HD12 HD23 ' A' ' 162' ' ' LEU . 94.7 mt -51.94 -56.08 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.525 -0.762 . . . . 0.64 110.544 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 52' ' ' VAL . 97.2 mt -65.52 -42.85 91.56 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.685 -0.689 . . . . 1.81 111.654 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.4 tp -51.42 -44.75 62.36 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.513 0.508 . . . . 1.42 110.62 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 146' ' ' ILE . 24.6 t -80.24 -40.67 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.09 -0.505 . . . . 1.17 111.416 -176.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 166' ' ' LEU . 72.3 p -59.58 -29.64 68.1 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.909 0.385 . . . . 1.54 110.813 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -91.1 -35.12 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 2.79 110.412 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 55.1 ttp -60.3 -42.82 96.32 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.375 -0.375 . . . . 1.82 111.494 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -57.6 -16.56 10.7 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.228 0.825 . . . . 3.45 113.228 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.17 -35.7 69.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.749 . . . . 3.36 109.174 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 mp -107.96 -34.97 6.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.011 . . . . 4.14 109.65 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.2 tttp 63.12 95.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.0 -1.0 . . . . 6.31 110.63 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -89.5 51.56 2.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.36 -0.837 . . . . 4.57 112.135 -170.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.47 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 11.8 m120 -77.0 -50.08 2.34 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.292 -0.413 . . . . 6.38 110.724 173.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 177' ' ' ASN . 66.0 Cg_endo . . . . . 0 C--O 1.247 0.928 0 C-N-CA 121.921 1.747 . . . . 7.47 111.181 171.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.587 -0.605 . . . . 16.35 111.587 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 m -61.7 110.65 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.123 0.487 . . . . 14.69 112.144 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -99.7 114.88 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.842 -0.799 . . . . 14.68 108.842 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 mmt -85.79 77.31 9.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.352 0.596 . . . . 12.73 111.695 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 m -90.38 60.42 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.609 -0.723 . . . . 10.18 109.615 173.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -67.31 123.53 20.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.48 -0.782 . . . . 9.14 112.02 -173.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 7' ' ' ARG . 17.8 mtp180 -83.22 -42.62 0.84 Allowed Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.143 -0.935 . . . . 8.35 112.575 177.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 81.9 Cg_exo -45.26 127.43 9.02 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.582 2.188 . . . . 4.6 113.774 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.882 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.3 Cg_exo -75.54 155.48 40.47 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.418 2.745 . . . . 4.29 112.101 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.503 ' HB ' ' H ' ' A' ' 58' ' ' THR . 47.0 t -133.53 -65.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.326 -0.397 . . . . 2.58 110.6 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.938 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 13.9 t -118.85 111.42 33.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.946 0.403 . . . . 1.0 111.159 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -98.08 141.42 31.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 0.66 110.812 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.8 mt -96.29 127.36 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.966 0.413 . . . . 1.03 110.517 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.562 ' SD ' HG13 ' A' ' 82' ' ' VAL . 51.2 mtt -133.84 177.81 7.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.31 0.576 . . . . 1.04 111.529 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.31 -92.32 0.21 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.508 -1.037 . . . . 1.55 110.508 173.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.469 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 t60 -164.24 149.29 10.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.765 -0.828 . . . . 0.66 108.765 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.37 -17.35 22.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.419 0.896 . . . . 1.62 113.419 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.76 -13.12 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.608 0.225 . . . . 1.78 111.608 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.469 ' ND1' ' HB3' ' A' ' 16' ' ' HIS . 16.4 m170 -65.18 -32.58 74.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.703 0.287 . . . . 0.65 111.544 -177.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.29 61.08 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 119.84 -1.172 . . . . 0.93 113.904 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.39 -22.8 24.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.347 0.594 . . . . 2.11 109.49 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 t -71.03 -38.32 72.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.762 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -78.66 -23.93 45.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 1.77 109.823 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.5 tm? -63.54 -48.13 78.77 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.771 -0.826 . . . . 1.78 108.771 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.731 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 18.8 mt -66.41 -36.46 82.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.038 -0.528 . . . . 1.96 110.738 175.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -55.27 -58.05 9.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.873 0.323 . . . . 1.38 111.873 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.694 ' HB3' HD12 ' A' ' 158' ' ' LEU . . . -68.55 -24.82 64.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.91 111.313 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 25' ' ' LEU . 1.4 tt -78.79 -23.62 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.418 . . . . 1.56 110.097 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 53.4 mtt180 -76.27 -26.76 56.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.646 0.736 . . . . 3.56 109.264 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -75.32 6.22 4.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.059 -0.973 . . . . 2.88 109.411 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.1 m -145.37 39.83 1.19 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.529 -0.76 . . . . 1.76 109.453 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' HE3' ' OE2' ' A' ' 35' ' ' GLU . 20.2 ptmt -68.04 159.17 31.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.216 -0.902 . . . . 5.71 111.699 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 m -163.27 -47.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.562 -0.745 . . . . 2.99 112.85 -171.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 34' ' ' THR . 39.9 m -134.55 -1.88 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.634 0.605 . . . . 3.93 112.634 -166.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.9 pm0 -47.89 153.41 0.63 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.893 0.854 . . . . 4.2 113.027 -177.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -134.61 -146.32 0.25 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.27 -1.332 . . . . 5.38 109.576 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' HA ' HD12 ' A' ' 41' ' ' ILE . 39.9 mt-10 -55.77 -31.33 62.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 5.79 108.912 171.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' TYR . . . -68.28 77.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.228 -0.896 . . . . 4.24 109.403 164.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -156.96 23.94 0.47 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.186 -0.915 . . . . 4.95 110.906 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.89 70.23 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.0 -0.6 . . . . 6.66 112.451 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 37' ' ' GLU . 62.5 mt -78.47 -64.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.151 0.5 . . . . 9.17 110.418 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.404 HG22 ' HD2' ' A' ' 44' ' ' HIS . 13.7 m -135.93 145.54 46.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.89 -0.596 . . . . 7.36 109.71 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.08 71.15 4.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.289 0.566 . . . . 8.83 111.507 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.404 ' HD2' HG22 ' A' ' 42' ' ' THR . 85.2 m-70 -141.69 28.93 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.505 -0.77 . . . . 6.76 109.129 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.956 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.8 tp -171.29 -165.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.928 -0.768 . . . . 5.19 108.928 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.956 ' H ' HG13 ' A' ' 45' ' ' ILE . . . -89.27 -116.61 1.53 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.774 -0.727 . . . . 2.97 112.43 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 25' ' ' LEU . . . -134.32 -34.21 0.97 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.134 0.42 . . . . 1.71 112.134 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -165.45 162.2 19.23 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.006 0.431 . . . . 2.54 110.71 -174.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 95.0 mt-30 -135.13 98.31 3.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 1.96 108.433 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 51' ' ' THR . 59.2 t -96.82 158.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.591 -0.731 . . . . 1.93 110.8 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.745 HG23 ' HA ' ' A' ' 54' ' ' ASP . 52.6 m -128.27 97.78 4.86 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.729 -1.123 . . . . 2.06 110.759 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 54' ' ' ASP . 72.4 t -118.97 127.81 75.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 4.12 108.154 173.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' HB3' ' HG2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 66.98 8.04 5.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.636 1.208 . . . . 4.43 109.087 -176.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.745 ' HA ' HG23 ' A' ' 51' ' ' THR . 5.5 p-10 48.96 45.31 22.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 111.751 -2.477 . . . . 3.62 111.275 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 53' ' ' ASN . 68.8 mmtt -87.46 -90.22 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.09 -0.959 . . . . 7.44 108.808 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' A' ' 55' ' ' LYS . 17.5 ptpt 175.97 131.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 5.43 109.879 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.818 HD11 HD21 ' A' ' 166' ' ' LEU . 44.0 mt -133.35 91.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.65 0.262 . . . . 1.14 110.767 175.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.503 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 16.8 m -83.92 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.704 -0.48 . . . . 1.28 109.704 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 14.9 m-85 -78.4 129.53 35.06 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.98 0.419 . . . . 0.84 111.426 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 9' ' ' PRO . 91.3 mt -114.74 104.58 12.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.757 -0.656 . . . . 3.0 110.219 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -73.04 -55.34 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.045 -0.724 . . . . 6.48 109.045 174.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.9 p -97.78 106.72 35.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.365 -0.834 . . . . 5.57 109.986 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.51 49.28 2.84 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.958 2.438 . . . . 5.77 112.939 -175.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.54 -81.19 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.298 -0.477 . . . . 5.54 112.803 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -160.63 150.02 17.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.228 0.211 . . . . 8.09 110.44 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 62.5 30.62 17.19 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.747 0.654 . . . . 6.36 112.158 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 54.67 45.49 26.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.64 -0.709 . . . . 3.51 112.764 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.638 ' HE2' ' HA ' ' A' ' 103' ' ' ALA . 4.2 t80 179.78 145.34 0.19 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.791 -0.448 . . . . 2.61 109.791 174.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 9' ' ' PRO . 3.1 m -73.07 76.59 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.077 -0.712 . . . . 4.74 109.077 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 p -58.45 99.66 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.193 0.52 . . . . 5.89 111.028 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.2 ptp -112.73 27.87 9.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.68 . . . . 5.64 110.216 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 65.69 -176.35 0.18 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.37 -0.832 . . . . 9.71 110.57 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 68.93 169.03 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.812 0.695 . . . . 7.52 111.663 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -136.98 74.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.926 -0.579 . . . . 10.42 109.926 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 125.98 3.43 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.659 -0.781 . . . . 6.75 112.723 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.56 -82.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 6.69 110.165 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -150.28 52.51 0.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.728 0.775 . . . . 7.72 109.53 176.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.7 t -74.99 90.69 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.325 -0.852 . . . . 4.38 110.803 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 58.7 m -82.62 66.26 8.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.928 0.871 . . . . 4.18 109.85 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -112.42 82.78 1.7 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.452 -1.314 . . . . 3.12 107.452 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 23.5 mm -50.05 117.1 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 115.152 -0.931 . . . . 0.74 111.745 -172.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.657 HG21 ' HB1' ' A' ' 103' ' ' ALA . 46.8 t -89.89 87.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 116.413 -0.358 . . . . 1.19 110.768 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.47 HD11 HG12 ' A' ' 165' ' ' ILE . 32.0 mm -75.76 104.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.866 -0.791 . . . . 1.32 108.866 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.926 ' HG ' HD11 ' A' ' 100' ' ' ILE . 2.6 tm? -91.26 92.9 8.84 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.254 -0.885 . . . . 1.33 110.235 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 61.7 t -80.86 129.44 37.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.19 0.519 . . . . 1.2 111.122 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 114' ' ' ILE . 16.8 m -131.3 -165.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.208 -1.034 . . . . 1.12 108.208 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . . . -139.61 143.86 37.45 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.24 -0.584 . . . . 0.75 111.861 177.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 117' ' ' MET . . . -37.08 -58.02 0.81 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.495 1.122 . . . . 1.18 112.709 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -103.92 19.19 20.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.943 -0.571 . . . . 2.01 111.602 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 2.5 t70 -113.61 -51.59 2.79 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.237 0.541 . . . . 1.09 110.773 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.731 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.18 -138.6 17.43 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.294 -0.866 . . . . 0.52 111.198 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 96' ' ' THR . 43.2 t -97.02 115.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 122.818 0.447 . . . . 1.08 111.423 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.453 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 80.0 mmm -80.06 167.09 36.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.676 -0.49 . . . . 1.32 109.676 171.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 90.1 Cg_exo -46.35 -45.5 18.69 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.578 2.186 . . . . 0.61 113.054 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.84 -22.71 60.75 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.644 -0.253 . . . . 1.47 110.855 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.915 ' HB ' HG13 ' A' ' 92' ' ' VAL . 26.2 m -62.23 -30.71 71.29 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.177 0.513 . . . . 0.46 110.649 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.0 t -82.95 -46.96 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.272 -0.422 . . . . 1.05 111.345 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.27 1.07 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.717 -0.674 . . . . 1.62 111.196 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -97.49 -41.09 8.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.528 -0.916 . . . . 0.34 108.528 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.926 HD11 ' HG ' ' A' ' 84' ' ' LEU . 7.2 mt -73.13 -55.62 12.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.276 -0.874 . . . . 0.38 111.545 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' A' ' 101' ' ' ASN . 1.3 t-20 -51.7 -30.08 20.73 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.218 0.607 . . . . 1.85 111.101 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 18.8 t60 -82.91 -28.9 29.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.769 -0.651 . . . . 0.85 110.584 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.657 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.56 -57.83 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.668 0.618 . . . . 0.48 112.668 -172.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.706 ' HE3' ' HB3' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -64.18 -21.32 66.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.615 0.598 . . . . 2.56 112.615 -163.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.02 4.56 9.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.831 0.348 . . . . 0.76 111.629 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.64 2.56 44.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 0.9 109.37 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t30 81.16 49.27 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 114.618 -1.174 . . . . 2.06 108.998 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -134.98 143.33 45.64 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 114.037 -1.438 . . . . 1.08 110.873 -175.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 13.8 Cg_exo -71.94 159.28 50.76 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.371 2.714 . . . . 0.51 114.675 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 HG12 ' A' ' 100' ' ' ILE . 46.8 mt -125.24 146.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.235 -1.348 . . . . 0.96 109.89 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 84' ' ' LEU . 5.0 mp -131.52 107.59 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 120.872 0.368 . . . . 0.71 111.726 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -70.9 133.68 31.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.492 0.663 . . . . 0.23 110.717 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -124.08 89.41 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.328 -1.36 . . . . 0.25 107.328 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 56.1 mt -72.18 92.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.069 -0.969 . . . . 0.85 109.615 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.28 169.16 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.69 109.696 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 62.94 20.47 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.522 0.677 . . . . 2.61 109.826 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.749 ' SD ' ' HA ' ' A' ' 121' ' ' GLU . 17.4 tpp -94.64 64.39 2.99 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 123.274 1.511 . . . . 1.37 108.856 174.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.91 -9.52 39.8 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.755 -1.566 . . . . 2.45 108.935 171.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 73.5 mmtt -85.32 171.53 10.59 Favored Pre-proline 0 N--CA 1.445 -0.72 0 N-CA-C 107.665 -1.235 . . . . 3.7 107.665 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 7.1 Cg_endo -51.98 -51.19 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.701 1.601 . . . . 2.67 111.547 175.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.749 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 13.5 pt-20 163.17 116.76 0.0 OUTLIER 'General case' 0 C--O 1.232 0.139 0 O-C-N 124.309 1.005 . . . . 4.03 109.376 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 123' ' ' ASN . . . -58.63 -58.81 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.516 -0.765 . . . . 1.47 109.989 174.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 15.6 t-20 174.05 78.65 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.302 -0.863 . . . . 1.84 110.194 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.595 ' O ' ' HG3' ' A' ' 128' ' ' MET . 8.1 Cg_exo -33.53 -62.26 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.634 3.556 . . . . 0.7 113.998 171.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.18 -53.8 4.84 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.007 0.523 . . . . 2.0 112.247 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -50.75 -59.15 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.475 0.655 . . . . 2.99 110.824 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.731 HG13 ' HA2' ' A' ' 91' ' ' GLY . 59.8 t -55.31 -48.17 77.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.364 -1.289 . . . . 0.4 110.738 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.66 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 89.2 mtp -62.78 -31.31 72.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.85 -0.614 . . . . 0.3 111.261 -176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -76.42 -17.5 59.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.364 -0.38 . . . . 1.28 111.064 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.606 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 5.5 mt-10 -73.81 -36.35 64.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.55 -0.907 . . . . 2.02 108.55 171.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 136' ' ' LEU . 3.8 mm? -69.12 -43.48 74.34 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.628 0.728 . . . . 1.06 109.369 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.864 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -74.25 -9.33 58.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.698 -0.683 . . . . 0.35 109.884 177.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.606 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 39.4 tt0 -74.29 -32.06 62.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.728 -0.841 . . . . 2.18 108.728 171.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.604 ' CE2' HG11 ' A' ' 92' ' ' VAL . 6.0 m-85 -89.63 2.73 54.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.762 0.791 . . . . 0.74 108.879 173.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.5 m120 75.15 29.99 0.91 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 113.544 -1.662 . . . . 1.94 110.913 168.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 1.024 HD11 HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -104.53 74.25 1.15 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.984 -1.487 . . . . 1.68 106.984 168.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.763 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -60.84 131.39 91.44 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 113.796 -1.547 . . . . 0.61 110.459 -172.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.766 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 79.7 Cg_exo -47.52 154.82 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.705 2.27 . . . . 0.3 112.509 173.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -77.98 -23.99 48.18 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.614 -1.176 . . . . 2.01 107.833 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.788 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -55.05 -40.97 70.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.114 -1.403 . . . . 1.14 109.163 167.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.864 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 7.4 m0 -96.55 -20.53 18.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.789 -1.096 . . . . 0.45 110.66 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.66 28.74 4.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.147 -1.025 . . . . 0.45 112.179 170.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.763 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -98.32 -113.4 3.26 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.593 -0.813 . . . . 0.5 112.797 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -147.4 26.34 1.06 Allowed 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.936 0.398 . . . . 1.3 111.717 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.605 HG21 HD12 ' A' ' 136' ' ' LEU . 57.3 m -137.01 126.62 25.29 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 119.09 -1.044 . . . . 0.32 113.685 -174.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.602 HG21 ' HB3' ' A' ' 164' ' ' MET . 38.8 mm -86.13 115.25 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.406 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 13.5 m-85 -95.95 123.51 39.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.726 0.298 . . . . 0.38 111.269 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.491 ' SG ' ' HG3' ' A' ' 164' ' ' MET . 62.9 m -126.01 133.62 51.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.936 -0.575 . . . . 1.1 109.947 174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.765 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pttp -101.47 123.53 45.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.494 -0.928 . . . . 2.44 108.494 170.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -145.96 175.5 10.39 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.493 1.14 . . . . 1.27 113.852 -173.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.31 6.52 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.382 -1.735 . . . . 1.79 109.154 170.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -66.57 -18.08 65.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.31 0.576 . . . . 0.87 110.881 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 18.1 ptmt -71.57 -52.11 19.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.774 0.797 . . . . 3.03 110.016 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.7 p -81.74 -5.32 58.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.486 -1.234 . . . . 1.2 111.855 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 76.97 -29.22 0.17 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.787 0.835 . . . . 2.27 112.178 175.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.42 ' H ' ' HG3' ' A' ' 156' ' ' GLU . 23.2 mt-10 -41.1 -69.33 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.08 0.952 . . . . 2.64 112.95 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.76 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -66.3 -22.29 70.93 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.988 -1.005 . . . . 0.62 114.28 -172.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -67.29 -39.47 85.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.326 0.563 . . . . 1.55 110.023 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 8.2 m-20 -65.19 -39.53 92.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.268 -0.424 . . . . 2.5 110.085 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -68.79 -29.81 68.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.352 -0.386 . . . . 0.73 110.701 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 165' ' ' ILE . 54.4 tp -63.31 -51.82 64.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.383 -0.372 . . . . 0.91 110.644 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.563 ' O ' HD23 ' A' ' 166' ' ' LEU . 91.4 mt -53.36 -41.03 65.43 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 116.255 -0.43 . . . . 1.06 110.637 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 22.1 mm-40 -56.35 -45.02 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.552 . . . . 2.49 110.644 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 146' ' ' ILE . 21.8 mmt -76.07 -31.32 58.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 0.87 110.674 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 83' ' ' ILE . 70.9 mt -59.04 -56.81 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.066 -0.516 . . . . 0.64 110.796 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.818 HD21 HD11 ' A' ' 57' ' ' ILE . 3.8 mm? -58.52 -42.25 87.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.524 -0.307 . . . . 1.81 111.032 176.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 171' ' ' MET . 60.0 tp -53.58 -41.91 67.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.775 -0.648 . . . . 1.42 110.559 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.491 ' O ' ' HG3' ' A' ' 172' ' ' GLU . 18.3 t -72.65 -42.67 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 116.232 -0.44 . . . . 1.17 111.446 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.58 ' HA ' ' OE2' ' A' ' 172' ' ' GLU . 14.1 t -60.62 -33.45 72.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.86 0.362 . . . . 1.54 110.596 -178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -88.23 -25.35 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.895 -0.322 . . . . 2.79 110.562 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 167' ' ' LEU . 15.8 tmm? -62.5 -42.38 99.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.178 -0.465 . . . . 1.82 110.038 176.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 169' ' ' SER . 41.5 mt-10 -44.45 -45.98 9.39 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.864 0.728 . . . . 3.45 111.344 175.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.77 -41.61 18.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 3.36 110.538 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.09 -70.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 4.14 111.761 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -155.83 96.89 1.78 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.332 -0.394 . . . . 6.31 110.629 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -106.36 133.52 50.93 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.898 -0.592 . . . . 4.57 109.462 176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 10.2 p30 -83.73 116.6 65.46 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.444 0.64 . . . . 6.38 111.819 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 6.0 Cg_exo . . . . . 0 C--O 1.251 1.134 0 C-N-CA 123.367 2.711 . . . . 7.47 112.085 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 112.261 -0.336 . . . . 16.35 112.261 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 m -74.09 131.93 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.81 0.338 . . . . 14.69 110.762 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -96.16 -0.18 50.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 14.68 111.098 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.1 tpt -82.66 85.22 7.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.88 -0.415 . . . . 12.73 109.88 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t 62.12 84.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.395 -0.821 . . . . 10.18 110.384 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -94.47 25.89 3.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.831 -0.622 . . . . 9.14 110.986 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 80' ' ' ASP . 16.7 tpt180 -129.28 99.17 21.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.498 -0.774 . . . . 8.35 109.344 172.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.67 119.68 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.289 1.993 . . . . 4.6 111.554 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.93 93.69 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.539 2.159 . . . . 4.29 110.672 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.1 m -62.46 107.25 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.429 0.633 . . . . 2.58 111.192 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.545 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 96.3 t -72.35 90.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.839 0.828 . . . . 1.0 108.816 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.652 HG22 ' HG3' ' A' ' 14' ' ' MET . 21.1 m -82.31 121.78 27.12 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.525 -1.216 . . . . 0.66 111.143 -171.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.6 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 34.3 mt -88.93 114.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.672 -0.492 . . . . 1.03 109.672 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.652 ' HG3' HG22 ' A' ' 12' ' ' THR . 73.7 mtm -139.59 168.0 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.592 -0.731 . . . . 1.04 111.94 -175.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.33 -95.96 0.17 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.438 -1.065 . . . . 1.55 110.438 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -161.87 149.9 14.89 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.816 -0.809 . . . . 0.66 108.816 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.85 -27.1 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 113.499 0.926 . . . . 1.62 113.499 -168.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.48 -22.78 40.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 1.78 111.683 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -70.78 -60.16 2.4 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.029 0.442 . . . . 0.65 110.847 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 166.92 58.31 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.546 -0.835 . . . . 0.93 112.484 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 17.2 ttpp -87.93 -73.56 0.48 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.641 0.734 . . . . 2.11 109.876 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.833 -1.076 . . . . 1.8 111.107 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.461 HG22 ' HA2' ' A' ' 20' ' ' GLY . 8.9 t -76.74 -18.24 58.59 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.981 -0.288 . . . . 1.77 110.234 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -70.59 -44.62 66.93 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 108.02 -1.104 . . . . 1.78 108.02 174.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 28' ' ' ILE . 2.9 tt -63.28 -40.64 97.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.996 -1.002 . . . . 1.96 110.083 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 t70 -63.64 -52.29 61.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.521 -0.308 . . . . 1.38 111.725 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' HD11 ' A' ' 158' ' ' LEU . . . -62.15 -41.46 98.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.121 0.486 . . . . 0.91 111.012 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 25' ' ' LEU . 3.2 tt -66.6 -30.04 48.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.577 -0.738 . . . . 1.56 109.54 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 26' ' ' ASP . 29.4 tpt180 -69.99 -33.19 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.285 -0.87 . . . . 3.56 109.956 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -63.78 -28.33 69.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 2.88 109.521 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m -87.88 11.66 15.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.923 -1.035 . . . . 1.76 110.774 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm 57.2 -131.88 1.46 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.441 -0.8 . . . . 5.71 111.282 175.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 m 49.67 20.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.985 1.314 . . . . 2.99 113.525 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.488 HG22 ' HD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -101.29 123.45 45.42 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.359 0.599 . . . . 3.93 112.052 -174.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -74.08 -48.37 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.27 -0.877 . . . . 4.2 109.785 174.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.653 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 73.5 mm-40 -96.91 126.45 42.06 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.625 -0.879 . . . . 5.38 108.625 176.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -51.32 -65.56 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 5.79 112.712 -170.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.17 173.53 14.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.213 -0.449 . . . . 4.24 110.86 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.49 126.74 6.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.705 -0.558 . . . . 4.95 111.705 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.54 -156.11 6.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.677 -0.773 . . . . 6.66 112.514 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -90.53 -26.82 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.134 0.492 . . . . 9.17 110.451 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -66.5 151.9 46.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 7.36 110.526 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -70.44 179.29 2.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.146 -0.479 . . . . 8.83 111.377 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 77.97 -37.54 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.873 0.869 . . . . 6.76 110.916 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.63 -176.85 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.431 -0.35 . . . . 5.19 110.818 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.54 -51.51 0.46 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.187 -0.765 . . . . 2.97 111.187 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 59' ' ' PHE . . . -117.3 171.18 8.13 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.415 -0.587 . . . . 1.71 109.415 173.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.653 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -148.64 143.51 26.57 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.273 0.558 . . . . 2.54 111.604 -173.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -104.66 133.69 49.08 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.48 -0.782 . . . . 1.96 109.729 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 59' ' ' PHE . 15.1 m -110.93 151.87 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.268 0.556 . . . . 1.93 111.965 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -108.62 80.57 1.35 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.694 0.759 . . . . 2.06 109.97 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 54' ' ' ASP . 3.3 p -120.69 123.33 70.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.057 -1.09 . . . . 4.12 108.057 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 69.6 -8.16 0.79 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.035 0.922 . . . . 4.43 110.067 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 52' ' ' VAL . 25.1 t0 67.62 35.29 4.15 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.08 -1.873 . . . . 3.62 109.65 -174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 170' ' ' GLU . 11.8 tptm -83.89 -9.37 58.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.065 -0.97 . . . . 7.44 109.526 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mttm 57.76 44.94 19.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 114.333 -1.303 . . . . 5.43 111.1 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 11' ' ' VAL . 70.2 mt -62.58 119.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.275 -0.875 . . . . 1.14 111.38 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -87.66 105.65 17.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.646 -0.706 . . . . 1.28 109.993 175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 50' ' ' VAL . 35.9 m-85 -88.8 109.07 19.87 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.33 . . . . 0.84 110.422 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 12' ' ' THR . 36.0 tp -90.0 82.11 6.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.97 -0.559 . . . . 3.0 109.576 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 21' ' ' LYS . 16.6 t0 -76.89 142.08 40.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.765 -0.652 . . . . 6.48 109.616 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 21' ' ' LYS . 21.5 m -64.29 108.99 2.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.464 0.477 . . . . 5.57 111.189 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -95.99 2.33 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.345 2.697 . . . . 5.77 113.224 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.09 -101.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.569 -0.824 . . . . 5.54 112.592 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -112.29 -35.87 5.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.882 0.373 . . . . 8.09 110.858 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -82.93 107.6 15.65 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.279 -0.638 . . . . 6.36 109.279 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -106.23 -63.19 1.29 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 3.51 110.787 -176.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.522 ' HB3' ' CD2' ' A' ' 102' ' ' HIS . 47.9 t80 -98.81 162.16 13.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.992 -0.549 . . . . 2.61 109.849 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 m -51.13 145.95 7.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.026 0.441 . . . . 4.74 111.027 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -90.33 24.24 2.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.388 0.613 . . . . 5.89 110.201 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 61.03 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.131 -0.941 . . . . 5.64 111.77 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -91.55 -33.89 14.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.488 -0.778 . . . . 9.71 110.041 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.42 119.91 23.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.089 -0.505 . . . . 7.52 110.75 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -47.28 -58.04 4.55 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.823 0.702 . . . . 10.42 112.6 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.08 29.55 12.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.76 . . . . 6.75 112.578 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 106' ' ' ALA . . . 56.59 66.37 1.2 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.28 0.562 . . . . 6.69 111.008 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.24 -6.7 23.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.702 . . . . 7.72 110.839 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -107.78 115.51 49.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.287 -0.415 . . . . 4.38 111.281 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.2 m -77.36 90.42 3.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 4.18 110.655 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.44 ' O ' HG21 ' A' ' 108' ' ' VAL . 67.4 m-20 -85.57 105.52 16.21 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.267 -0.642 . . . . 3.12 109.267 173.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 47.6 mm -51.04 120.02 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.567 -0.742 . . . . 0.74 112.008 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.078 HG21 ' HB1' ' A' ' 103' ' ' ALA . 98.1 t -105.2 111.09 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 120.622 -0.431 . . . . 1.19 111.687 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 16.1 mm -87.42 107.8 17.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.82 -0.808 . . . . 1.32 108.82 173.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 100' ' ' ILE . 2.9 tm? -97.45 99.7 11.12 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.989 -1.005 . . . . 1.33 109.509 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.58 133.59 29.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.932 -0.576 . . . . 1.2 110.771 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG23 ' HA ' ' A' ' 114' ' ' ILE . 23.0 m -131.48 -174.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.4 -0.818 . . . . 1.12 108.809 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.49 143.86 44.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.59 -0.444 . . . . 0.75 110.671 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' A' ' 117' ' ' MET . . . -36.83 -61.84 0.52 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.734 1.271 . . . . 1.18 113.312 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.84 8.47 39.42 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.729 0.64 . . . . 2.01 112.729 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.36 -44.76 2.96 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.179 -0.608 . . . . 1.09 111.077 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.0 -144.49 23.89 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.827 -0.701 . . . . 0.52 111.409 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.782 HG23 ' HB ' ' A' ' 96' ' ' THR . 3.5 p -94.06 106.49 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 121.305 0.574 . . . . 1.08 110.12 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.567 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.7 ppp? -83.95 169.29 17.53 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 1.32 109.263 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 40.9 Cg_exo -35.76 -51.98 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.614 2.876 . . . . 0.61 115.029 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.81 -24.11 55.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.827 0.346 . . . . 1.47 111.109 -174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.782 ' HB ' HG23 ' A' ' 92' ' ' VAL . 2.4 m -65.24 -23.78 67.15 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.416 0.627 . . . . 0.46 110.035 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.471 HG23 HG22 ' A' ' 92' ' ' VAL . 64.0 t -87.73 -42.72 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.778 -0.646 . . . . 1.05 111.052 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -56.58 -33.92 66.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.013 0.435 . . . . 1.62 111.095 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.72 -33.27 46.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.34 110.187 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.667 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -75.25 -45.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.635 . . . . 0.38 110.761 178.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -51.4 -38.13 51.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.264 0.554 . . . . 1.85 110.504 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 55.0 t60 -78.55 -28.52 46.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.246 -0.888 . . . . 0.85 110.898 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.078 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -91.74 -44.78 8.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.334 0.588 . . . . 0.48 112.48 -172.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -65.69 -24.19 66.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.577 -0.738 . . . . 2.56 111.383 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.6 8.58 33.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.76 111.707 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' A' ' 76' ' ' ALA . . . -102.36 9.38 39.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.692 -0.855 . . . . 0.9 108.692 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t30 69.44 38.78 1.73 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 114.589 -1.187 . . . . 2.06 110.651 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.727 HG21 HG23 ' A' ' 82' ' ' VAL . 1.5 m -119.23 150.05 48.46 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.372 -0.831 . . . . 1.08 110.779 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 108' ' ' VAL . 10.1 Cg_exo -73.19 155.22 52.0 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.175 2.584 . . . . 0.51 113.639 171.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 100' ' ' ILE . 1.5 mp -115.86 142.44 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.261 -1.336 . . . . 0.96 109.922 -176.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 mp -112.7 140.55 31.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.244 0 N-CA-C 108.521 -0.918 . . . . 0.71 108.521 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -107.58 136.9 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 C-N-CA 120.259 -0.576 . . . . 0.23 110.673 176.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.76 87.68 2.76 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.701 -1.222 . . . . 0.25 107.701 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.712 ' HA ' HG23 ' A' ' 86' ' ' VAL . 14.3 mt -75.58 92.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.941 -1.027 . . . . 0.85 109.469 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.988 ' HA ' ' HB2' ' A' ' 150' ' ' LEU . 55.4 t30 -84.6 163.6 19.2 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 121.094 -0.243 . . . . 0.69 110.43 -171.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 73.38 41.31 0.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.229 0.612 . . . . 2.61 112.223 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.632 ' HG3' ' HB2' ' A' ' 149' ' ' LYS . 5.3 mmm -95.93 6.61 48.47 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.371 -0.974 . . . . 1.37 108.371 171.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.08 -13.24 62.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.363 -1.289 . . . . 2.45 108.316 166.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 11.2 mmmm -70.47 -156.79 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 106.544 -1.65 . . . . 3.7 106.544 160.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 44.0 Cg_exo -56.77 -60.84 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 CA-C-N 121.827 1.688 . . . . 2.67 110.988 165.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 15.4 pt-20 155.74 -8.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.069 1.348 . . . . 4.03 108.098 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.21 -88.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.676 -1.602 . . . . 1.47 110.699 -172.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -177.36 89.71 0.24 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.544 -0.298 . . . . 1.84 110.591 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.704 ' O ' ' HG3' ' A' ' 128' ' ' MET . 68.4 Cg_exo -39.9 -58.35 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.625 2.883 . . . . 0.7 113.386 173.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.23 -48.22 9.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.419 0.688 . . . . 2.0 112.375 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 4.4 tmt_? -52.91 -55.13 25.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.112 0.482 . . . . 2.99 109.794 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 86' ' ' VAL . 54.7 t -60.22 -43.57 93.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.839 -1.073 . . . . 0.4 110.144 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.704 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 81.0 mtp -62.14 -31.8 72.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.34 -0.845 . . . . 0.3 111.059 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.454 ' HG3' ' HH2' ' A' ' 141' ' ' TRP . 18.7 mt-30 -75.79 -25.15 56.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.392 -0.367 . . . . 1.28 110.439 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.712 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.3 mt-10 -74.24 -32.23 62.89 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.176 -0.676 . . . . 2.02 109.176 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.572 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.5 mm? -69.75 -43.41 72.31 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.0 -0.68 . . . . 1.06 109.712 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.846 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -74.85 -5.52 44.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.529 -0.759 . . . . 0.35 109.986 176.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.712 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 9.2 tp10 -71.03 -34.43 71.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.573 -1.269 . . . . 2.18 107.573 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HB2' HD12 ' A' ' 136' ' ' LEU . 41.3 m-85 -91.26 21.8 4.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.77 0.795 . . . . 0.74 109.535 172.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.36 29.55 17.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.189 -1.368 . . . . 1.94 109.636 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.637 ' CD1' HD13 ' A' ' 100' ' ' ILE . 13.8 mt -101.51 70.75 1.3 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.408 -1.269 . . . . 1.68 108.848 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.489 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -64.54 123.27 82.51 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.438 -1.255 . . . . 0.61 110.531 -178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.699 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 72.3 Cg_exo -47.25 158.24 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.306 2.67 . . . . 0.3 113.171 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -26.29 57.93 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.567 -1.197 . . . . 2.01 108.718 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 141' ' ' TRP . 8.5 mp0 -44.73 -51.17 9.58 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.597 -1.183 . . . . 1.14 110.703 160.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.846 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 17.2 m0 -94.95 -24.17 17.08 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 113.996 -1.456 . . . . 0.45 111.123 -165.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.2 27.6 2.86 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 119.989 -1.1 . . . . 0.45 112.291 170.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -103.4 -115.9 4.13 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.265 -0.969 . . . . 0.5 112.514 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -151.89 34.61 0.54 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.645 0.736 . . . . 1.3 111.112 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 138' ' ' PRO . 22.4 m -130.78 114.32 15.19 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.278 -0.569 . . . . 0.32 111.767 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.771 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.6 mp -84.87 110.76 19.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.826 -0.624 . . . . 1.23 110.379 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.699 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.6 m-85 -92.12 135.16 34.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.366 0.603 . . . . 0.38 111.427 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 57.1 m -133.53 126.41 30.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 1.1 109.505 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.632 ' HB2' ' HG3' ' A' ' 117' ' ' MET . 25.2 pttt -91.72 110.83 22.17 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.582 0.706 . . . . 2.44 109.618 172.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.988 ' HB2' ' HA ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -83.07 173.89 11.34 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.217 1.932 . . . . 1.27 116.217 -166.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.839 ' H ' ' HA3' ' A' ' 157' ' ' GLY . 24.8 p -175.27 99.3 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 110.562 -3.017 . . . . 1.79 109.245 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.18 -17.73 56.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.7 -0.682 . . . . 0.87 111.913 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 154' ' ' THR . 18.2 ptpt -80.47 -50.42 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.651 0.739 . . . . 3.03 110.086 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.401 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 3.3 p -82.2 -2.41 52.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.626 -1.17 . . . . 1.2 111.434 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 75.72 -6.9 1.9 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.351 -0.84 . . . . 2.27 113.156 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB2' ' OG ' ' A' ' 151' ' ' SER . 15.8 mm-40 -64.67 -37.16 86.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.151 0.5 . . . . 2.64 110.597 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.839 ' HA3' ' H ' ' A' ' 151' ' ' SER . . . -59.97 -44.35 97.27 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.446 -0.797 . . . . 0.62 112.5 176.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 27' ' ' ALA . 91.7 mt -67.31 -51.19 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.864 0.32 . . . . 1.55 111.864 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 30.2 t70 -57.97 -53.38 58.89 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.321 0.388 . . . . 2.5 111.077 -176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 164' ' ' MET . 76.1 t60 -61.14 -34.75 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.73 110.854 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 165' ' ' ILE . 52.5 tp -65.15 -56.18 14.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.38 -0.373 . . . . 0.91 111.078 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 89.0 mt -54.82 -39.34 68.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 1.06 110.844 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 57.9 mm-40 -63.56 -40.68 97.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.091 -0.504 . . . . 2.49 110.853 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.771 ' HB3' HG21 ' A' ' 146' ' ' ILE . 23.8 mmt -71.82 -38.48 70.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.989 0.424 . . . . 0.87 110.282 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 162' ' ' LEU . 85.6 mt -56.23 -53.43 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.516 -0.766 . . . . 0.64 111.345 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 1.8 pp -72.25 -30.49 64.92 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.84 -0.344 . . . . 1.81 111.904 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 166' ' ' LEU . 55.3 tp -54.45 -33.95 60.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.174 0.511 . . . . 1.42 110.511 175.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 164' ' ' MET . 76.6 t -77.18 -30.5 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.837 -0.619 . . . . 1.17 110.523 -176.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.6 t -54.44 -32.06 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 1.54 110.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.561 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.3 mp0 -94.77 -36.54 11.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.473 -0.331 . . . . 2.79 110.833 175.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 60.4 ttp -52.66 -45.37 66.71 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.269 -0.423 . . . . 1.82 111.873 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -53.46 -45.02 69.36 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.499 0.5 . . . . 3.45 111.504 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -83.01 -7.74 59.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.99 -0.55 . . . . 3.36 111.689 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 170' ' ' GLU . 87.8 mt -91.97 -59.29 2.15 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.437 -0.579 . . . . 4.14 109.437 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -170.01 104.03 0.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.246 -0.888 . . . . 6.31 110.217 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.57 56.35 1.51 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.213 0.53 . . . . 4.57 110.183 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 7.6 t30 -170.64 131.85 0.91 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.734 -0.666 . . . . 6.38 110.183 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 25.9 Cg_exo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.938 2.426 . . . . 7.47 112.485 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 111.903 -0.479 . . . . 16.35 111.903 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 t -92.87 99.08 11.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.999 0.4 . . . . 14.69 110.718 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -171.99 57.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.716 0.77 . . . . 14.68 109.24 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 mmt -69.93 -69.65 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.942 -1.026 . . . . 12.73 111.696 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 61' ' ' ASP . 33.0 m -140.37 161.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.597 -0.274 . . . . 10.18 110.841 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 65' ' ' HIS . 9.0 pt-20 -131.03 122.68 27.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.283 -0.417 . . . . 9.14 110.831 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 60.03 72.34 0.77 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.333 -0.849 . . . . 8.35 112.03 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.44 113.04 2.56 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.107 2.538 . . . . 4.6 111.247 172.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HB3' HG12 ' A' ' 41' ' ' ILE . 48.8 Cg_endo -72.81 -37.72 3.58 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.709 2.273 . . . . 4.29 113.686 -177.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 11' ' ' VAL . 61.2 t -126.23 -85.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 121.106 -0.238 . . . . 2.58 110.844 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.776 HG12 ' HB ' ' A' ' 81' ' ' ILE . 5.7 m -98.03 147.36 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 119.717 -0.793 . . . . 1.0 111.244 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.543 HG23 HG21 ' A' ' 5' ' ' VAL . 21.8 m -109.32 125.92 52.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.617 -0.72 . . . . 0.66 110.142 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 61' ' ' ASP . 23.5 mt -89.12 116.85 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 1.03 110.705 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.526 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 21.6 mmt -119.78 -179.21 3.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.015 -0.993 . . . . 1.04 110.11 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.92 ' HA3' HG12 ' A' ' 85' ' ' VAL . . . 105.44 131.49 7.02 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 109.941 -1.264 . . . . 1.55 109.941 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -44.48 135.67 4.6 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.854 0.835 . . . . 0.66 111.102 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 17' ' ' VAL . 2.7 t -56.22 -39.08 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.104 -1.407 . . . . 1.62 112.84 -167.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -78.53 -18.16 55.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.879 0.326 . . . . 1.78 111.879 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.576 ' HE1' ' H ' ' A' ' 93' ' ' MET . 25.1 m170 -64.62 -31.24 72.38 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.037 0.446 . . . . 0.65 110.298 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.18 55.14 0.3 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.198 -1.001 . . . . 0.93 113.624 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 13' ' ' ILE . 35.8 pttt -87.83 -22.36 24.52 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.478 -0.934 . . . . 2.11 108.478 172.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -34.8 77.72 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.627 -1.169 . . . . 1.8 110.002 176.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.2 p -71.23 -24.67 62.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 1.77 111.068 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.65 -54.93 28.05 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.006 -0.739 . . . . 1.78 109.006 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 61' ' ' ASP . 6.0 tt -51.61 -45.31 63.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.094 0.473 . . . . 1.96 110.487 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.51 -52.2 16.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.604 -0.726 . . . . 1.38 112.538 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.63 85.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.367 -0.208 . . . . 0.91 111.116 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG22 ' HE2' ' A' ' 48' ' ' TYR . 74.3 mt -67.22 -36.87 77.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.541 -0.54 . . . . 1.56 109.541 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 1.009 ' HA ' HG21 ' A' ' 34' ' ' THR . 15.9 tpp180 -59.49 -38.77 81.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.425 0.631 . . . . 3.56 109.765 171.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -85.14 16.28 3.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.566 -0.743 . . . . 2.88 111.386 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -103.24 25.13 9.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.449 -0.341 . . . . 1.76 110.804 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.3 mttm 74.72 -53.33 0.68 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.481 0.919 . . . . 5.71 113.481 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG23 HG13 ' A' ' 50' ' ' VAL . 32.8 m -73.99 28.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.242 1.201 . . . . 2.99 114.242 -168.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.009 HG21 ' HA ' ' A' ' 29' ' ' ARG . 36.1 p -91.22 126.09 36.2 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.348 0.594 . . . . 3.93 111.712 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -74.48 -57.2 4.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.806 -1.088 . . . . 4.2 113.019 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -146.8 -178.98 6.48 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.281 -0.568 . . . . 5.38 111.783 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 12.7 tp10 -99.35 155.13 17.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.98 -1.118 . . . . 5.79 107.98 172.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 37' ' ' GLU . . . 73.84 131.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.786 0.678 . . . . 4.24 110.282 -172.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.481 ' N ' ' HB3' ' A' ' 47' ' ' ALA . . . -86.49 57.59 4.71 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.026 -0.607 . . . . 4.95 113.004 -170.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 -124.39 8.17 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.669 -0.776 . . . . 6.66 113.884 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' A' ' 9' ' ' PRO . 35.1 pt -86.76 26.59 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 112.526 0.565 . . . . 9.17 112.526 -171.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.548 HG21 HD21 ' A' ' 60' ' ' LEU . 10.5 t -131.6 134.61 46.21 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.757 -0.46 . . . . 7.36 109.757 174.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.66 71.01 7.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.415 0.626 . . . . 8.83 111.307 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -132.93 127.38 34.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.335 -0.848 . . . . 6.76 108.881 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 45' ' ' ILE . 2.8 pp -76.3 154.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.465 -0.494 . . . . 5.19 110.212 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.57 39.27 3.71 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.873 -0.891 . . . . 2.97 110.873 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' N ' ' A' ' 39' ' ' GLY . . . -163.23 176.03 10.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.997 -0.742 . . . . 1.71 108.997 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -170.09 168.75 8.29 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.561 0.696 . . . . 2.54 111.628 -163.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.804 ' HG2' HG23 ' A' ' 58' ' ' THR . 34.9 mt-30 -125.74 146.92 49.55 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.551 -1.204 . . . . 1.96 107.762 169.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 51' ' ' THR . 56.6 t -82.74 175.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.135 -0.691 . . . . 1.93 109.135 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.846 HG23 ' HB2' ' A' ' 54' ' ' ASP . 10.8 t -53.11 166.13 0.26 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.541 0.686 . . . . 2.06 111.518 -175.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 54' ' ' ASP . 12.9 p -121.6 144.25 31.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.27 -0.641 . . . . 4.12 109.27 -166.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t30 70.96 -40.45 0.48 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.944 0.778 . . . . 4.43 109.196 -167.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.846 ' HB2' HG23 ' A' ' 51' ' ' THR . 27.2 m-20 -75.22 -66.57 0.75 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 3.62 110.962 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' H ' HG23 ' A' ' 51' ' ' THR . 57.3 mttm -150.5 70.95 1.03 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.633 -0.427 . . . . 7.44 110.669 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -76.77 59.04 1.52 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.871 0.693 . . . . 5.43 112.871 -169.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 165' ' ' ILE . 14.8 mt -88.62 125.41 41.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.152 -0.476 . . . . 1.14 110.509 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.804 HG23 ' HG2' ' A' ' 49' ' ' GLN . 6.9 m -95.04 119.99 34.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.12 -0.326 . . . . 1.28 110.12 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.454 ' HD2' HD11 ' A' ' 13' ' ' ILE . 54.2 m-85 -104.9 111.16 23.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.71 -0.396 . . . . 0.84 110.311 -175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.61 HD12 ' HB ' ' A' ' 5' ' ' VAL . 1.8 tm? -108.38 111.16 22.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.941 -0.572 . . . . 3.0 110.002 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.74 ' HB3' HD12 ' A' ' 25' ' ' LEU . 25.3 t0 -140.02 70.54 1.36 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.842 0.829 . . . . 6.48 109.556 174.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.5 m -109.79 105.57 57.34 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.03 -0.986 . . . . 5.57 109.971 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.59 75.95 1.11 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.198 2.599 . . . . 5.77 112.626 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.37 -93.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.148 -0.781 . . . . 5.54 111.148 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 83.1 m-70 -81.76 178.97 8.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.707 0.289 . . . . 8.09 110.478 176.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.58 97.56 5.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.377 0.608 . . . . 6.36 110.314 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.61 112.24 6.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 3.51 111.168 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.687 ' CE2' ' HA ' ' A' ' 103' ' ' ALA . 8.5 t80 -86.12 -81.61 0.21 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.147 -0.479 . . . . 2.61 110.889 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 t -145.64 15.3 1.42 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.338 0.589 . . . . 4.74 111.104 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m 57.45 68.12 0.89 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.619 -0.719 . . . . 5.89 109.69 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 71' ' ' MET . 1.5 mpp? -72.09 95.47 1.63 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.49 -0.777 . . . . 5.64 111.022 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -118.62 -14.11 9.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.927 0.394 . . . . 9.71 110.075 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.03 169.23 18.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.768 -0.651 . . . . 7.52 110.164 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -96.59 123.38 40.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.762 -0.458 . . . . 10.42 109.762 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.31 110.37 3.2 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.699 -0.762 . . . . 6.75 113.004 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.96 -33.77 57.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.404 0.621 . . . . 6.69 109.385 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' A' ' 77' ' ' GLN . 6.3 tt0 -110.47 90.22 3.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.375 -0.83 . . . . 7.72 109.102 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 m -92.3 137.9 21.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.094 0.473 . . . . 4.38 111.8 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 m -114.39 0.46 14.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.022 -1.103 . . . . 4.18 108.022 171.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.94 130.19 35.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.914 -1.493 . . . . 3.12 109.933 -175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.776 ' HB ' HG12 ' A' ' 11' ' ' VAL . 41.4 mm -120.74 117.64 53.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 0.74 110.005 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.709 HG21 ' HB1' ' A' ' 103' ' ' ALA . 42.0 t -92.65 101.6 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-O 120.764 0.316 . . . . 1.19 111.136 -178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 111' ' ' ILE . 11.1 mm -84.94 105.42 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.73 -0.841 . . . . 1.32 108.73 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -100.22 104.81 16.33 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.92 -0.582 . . . . 1.33 110.81 -174.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.92 HG12 ' HA3' ' A' ' 15' ' ' GLY . 2.8 p -83.59 143.82 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.337 0.589 . . . . 1.2 111.6 -177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 114' ' ' ILE . 31.2 m -140.79 -166.77 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.357 -0.979 . . . . 1.12 108.357 174.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.52 144.04 34.1 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.378 -0.529 . . . . 0.75 111.885 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -37.73 -54.71 1.2 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 124.504 1.127 . . . . 1.18 113.092 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.34 -37.65 9.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.644 0.609 . . . . 2.01 112.644 -172.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 93' ' ' MET . 13.7 t70 -68.66 -45.0 72.92 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.613 -0.435 . . . . 1.09 111.354 -176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 84.92 -119.76 5.1 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.476 -0.868 . . . . 0.52 111.503 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.919 HG13 ' HB ' ' A' ' 96' ' ' THR . 25.0 t -114.13 116.15 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 122.611 0.364 . . . . 1.08 111.505 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.576 ' H ' ' HE1' ' A' ' 19' ' ' HIS . 39.6 mtp -82.38 166.54 35.98 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.327 -0.62 . . . . 1.32 109.327 169.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 89.2 Cg_exo -44.32 -50.42 7.89 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.519 2.146 . . . . 0.61 113.107 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 2.1 mt-30 -66.73 -23.79 66.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.411 0.523 . . . . 1.47 112.411 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.919 ' HB ' HG13 ' A' ' 92' ' ' VAL . 24.4 m -63.3 -38.24 90.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.647 0.26 . . . . 0.46 110.61 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -29.33 5.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 C-N-CA 120.615 -0.434 . . . . 1.05 111.053 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 20.9 mm-40 -51.42 -45.51 62.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.177 0.513 . . . . 1.62 110.524 174.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 14' ' ' MET . . . -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.457 -0.792 . . . . 0.34 110.973 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -78.55 -45.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.908 -0.587 . . . . 0.38 111.256 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.36 -35.89 68.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.516 0.674 . . . . 1.85 110.048 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -76.03 -29.8 58.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 0.85 110.324 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.709 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -90.04 -45.95 8.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.265 0.469 . . . . 0.48 112.265 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -55.84 -26.55 47.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.681 0.622 . . . . 2.56 112.681 -170.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.53 7.08 15.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.555 0.576 . . . . 0.76 112.555 -171.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -95.58 -4.25 44.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.823 -0.806 . . . . 0.9 108.823 174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.4 t30 78.15 47.56 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.381 -1.281 . . . . 2.06 108.091 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 106' ' ' ALA . 0.2 OUTLIER -130.35 142.5 45.68 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.393 -1.73 . . . . 1.08 111.164 -171.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' VAL . 17.5 Cg_exo -69.66 160.22 50.56 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.308 2.672 . . . . 0.51 114.449 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.748 HG22 HG23 ' A' ' 145' ' ' THR . 1.4 mp -124.57 145.92 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.43 -1.259 . . . . 0.96 110.566 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.485 HD13 HD13 ' A' ' 83' ' ' ILE . 5.2 mp -123.88 108.78 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-O 120.873 0.368 . . . . 0.71 110.97 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -74.26 136.04 26.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.424 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB3' HG23 ' A' ' 85' ' ' VAL . . . -121.59 88.38 2.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.908 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 38.2 mt -68.21 93.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.306 -1.315 . . . . 0.85 110.722 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -91.5 169.51 10.71 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.967 -0.383 . . . . 0.69 109.967 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 60.7 22.47 12.38 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.855 0.836 . . . . 2.61 110.081 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' A' ' 149' ' ' LYS . 7.2 tpp -93.04 2.03 56.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.564 1.173 . . . . 1.37 109.018 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 151' ' ' SER . 2.6 p30 -54.7 -18.52 4.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.498 -1.228 . . . . 2.45 112.332 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.917 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 19.2 pttm -83.84 -176.99 0.87 Allowed Pre-proline 0 C--O 1.221 -0.399 0 N-CA-C 108.475 -0.935 . . . . 3.7 108.475 173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.917 ' HD2' ' HB2' ' A' ' 119' ' ' LYS . 4.7 Cg_exo -42.41 -61.86 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.993 1.795 . . . . 2.67 113.19 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HB3' ' O ' ' A' ' 120' ' ' PRO . 12.8 pt-20 149.42 127.66 0.0 OUTLIER 'General case' 0 C--N 1.346 0.436 0 C-N-CA 124.922 1.289 . . . . 4.03 108.019 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.85 -71.56 0.23 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.022 -0.535 . . . . 1.47 109.731 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 4.5 t-20 -176.89 88.68 0.26 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 1.84 109.87 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 128' ' ' MET . 5.0 Cg_exo -39.15 -61.31 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.253 3.302 . . . . 0.7 113.727 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -49.45 -43.85 45.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.991 0.517 . . . . 2.0 112.19 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -53.5 -55.56 24.38 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.31 0.576 . . . . 2.99 109.696 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.569 HG13 ' HA2' ' A' ' 91' ' ' GLY . 55.2 t -61.37 -43.82 97.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.605 -1.179 . . . . 0.4 110.052 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.799 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 87.5 mtp -63.5 -28.14 69.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.249 -0.887 . . . . 0.3 111.303 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 132' ' ' MET . 41.9 mt-30 -79.06 -23.59 44.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.628 -0.26 . . . . 1.28 110.477 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -71.93 -34.42 69.04 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.249 -0.649 . . . . 2.02 109.249 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.776 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.9 mm? -72.26 -41.0 67.23 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.571 0.7 . . . . 1.06 109.827 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.839 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -75.63 -5.38 45.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.091 -0.959 . . . . 0.35 109.462 176.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 34.2 tt0 -84.01 -21.51 31.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.664 -0.865 . . . . 2.18 108.664 174.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.745 ' HE2' HG11 ' A' ' 92' ' ' VAL . 31.9 m-85 -94.27 10.57 33.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.281 -1.007 . . . . 0.74 108.281 166.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 18.4 m120 70.97 35.29 1.7 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 113.683 -1.599 . . . . 1.94 111.449 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.564 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.0 mp -112.0 78.16 1.1 Allowed 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.402 -0.962 . . . . 1.68 108.402 170.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.984 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -62.63 130.13 93.35 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 113.936 -1.484 . . . . 0.61 110.682 -176.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.802 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 75.8 Cg_exo -51.13 153.33 9.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.849 2.366 . . . . 0.3 113.295 174.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 4.7 mm-40 -79.52 -23.52 42.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.488 -1.233 . . . . 2.01 109.083 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.69 ' HB3' ' CD1' ' A' ' 141' ' ' TRP . 8.1 mp0 -42.96 -53.06 4.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.676 -1.147 . . . . 1.14 110.547 159.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.839 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 12.1 m0 -93.82 -22.06 18.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.739 -1.573 . . . . 0.45 111.237 -167.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.32 25.61 3.73 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.086 -1.054 . . . . 0.45 112.364 172.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.984 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.25 -106.71 2.12 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.623 -0.799 . . . . 0.5 113.114 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.83 23.02 0.27 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.999 0.428 . . . . 1.3 110.944 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.748 HG23 HG22 ' A' ' 110' ' ' ILE . 17.5 m -136.44 112.21 9.47 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.912 -0.715 . . . . 0.32 112.834 -173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.737 HG21 ' HB3' ' A' ' 164' ' ' MET . 52.9 mt -76.89 117.37 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 1.23 110.808 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.802 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 16.3 m-85 -94.69 101.86 13.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.38 111.839 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 80.2 m -96.42 99.37 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.726 -0.67 . . . . 1.1 109.99 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.908 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 18.6 pttm -79.26 85.17 5.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.776 -0.824 . . . . 2.44 108.776 172.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.672 ' HB2' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -109.82 179.25 4.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.301 -0.863 . . . . 1.27 112.542 -169.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 118' ' ' ASP . 3.4 p -146.17 104.71 3.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.062 -0.972 . . . . 1.79 110.772 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 158' ' ' LEU . . . -66.86 -17.93 65.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.981 0.42 . . . . 0.87 111.44 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -78.62 -60.76 2.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.42 0.628 . . . . 3.03 110.299 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.5 p -85.45 -5.46 59.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.033 -0.985 . . . . 1.2 112.067 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HD23 ' A' ' 158' ' ' LEU . 5.1 tppp? 73.05 -7.08 1.56 Allowed 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.618 0.574 . . . . 2.27 112.423 172.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -56.35 -55.39 33.99 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.984 0.897 . . . . 2.64 111.141 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.672 ' HA3' ' HB2' ' A' ' 150' ' ' LEU . . . -67.36 -19.57 70.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.995 -1.002 . . . . 0.62 113.695 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 152' ' ' ALA . 4.0 mm? -67.58 -41.43 84.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.486 0.643 . . . . 1.55 110.367 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.88 -44.47 97.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.728 -0.669 . . . . 2.5 109.926 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.483 ' O ' ' HG2' ' A' ' 164' ' ' MET . 82.4 t60 -65.55 -38.14 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.73 111.041 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.51 -58.34 8.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.91 112.051 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.604 ' O ' HD23 ' A' ' 166' ' ' LEU . 93.7 mt -56.05 -40.97 74.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.595 -0.275 . . . . 1.06 110.716 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.5 -30.98 71.43 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.954 -0.299 . . . . 2.49 111.144 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.737 ' HB3' HG21 ' A' ' 146' ' ' ILE . 24.5 mmt -70.4 -39.76 74.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.87 109.888 175.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 57' ' ' ILE . 78.9 mt -57.08 -56.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.093 -0.958 . . . . 0.64 110.559 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 162' ' ' LEU . 4.2 mm? -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.577 0.584 . . . . 1.81 112.577 176.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.43 -37.15 77.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 1.42 110.462 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 146' ' ' ILE . 1.4 t -78.74 -35.14 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.146 -0.479 . . . . 1.17 110.612 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 172' ' ' GLU . 20.3 t -65.32 -24.95 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.543 0.687 . . . . 1.54 110.071 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.05 -25.49 34.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 2.79 109.88 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.5 ttp -93.64 -13.43 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 1.82 111.163 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 169' ' ' SER . 45.4 mt-10 -40.22 -45.42 2.06 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.198 0.599 . . . . 3.45 112.523 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -60.33 -30.82 69.77 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.485 0.55 . . . . 3.36 112.485 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -106.95 -40.91 5.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.731 0.301 . . . . 4.14 111.127 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.8 tptp 66.05 -57.2 0.35 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.442 1.097 . . . . 6.31 112.27 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -125.77 -177.63 3.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.768 -0.456 . . . . 4.57 109.768 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.454 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 42.5 m-80 61.25 62.0 2.77 Favored Pre-proline 0 N--CA 1.467 0.386 0 O-C-N 123.618 0.574 . . . . 6.38 110.842 -177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 177' ' ' ASN . 5.8 Cg_endo . . . . . 0 C--O 1.247 0.925 0 C-N-CA 122.918 2.412 . . . . 7.47 111.662 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.027 -0.429 . . . . 16.35 112.027 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -68.38 117.39 10.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.821 0.344 . . . . 14.69 110.837 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -122.99 65.75 0.97 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.377 0.608 . . . . 14.68 110.075 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.0 ptm -133.07 29.24 4.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.435 -0.802 . . . . 12.73 109.736 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.72 61.07 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.798 -0.637 . . . . 10.18 111.197 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -61.58 119.11 8.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.38 . . . . 9.14 110.831 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 60.67 78.85 0.3 Allowed Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.08 0.863 . . . . 8.35 112.154 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.23 128.52 15.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.977 1.785 . . . . 4.6 109.566 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.771 ' HD2' ' HG2' ' A' ' 56' ' ' LYS . 74.2 Cg_exo -48.71 101.33 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.008 2.472 . . . . 4.29 112.886 -178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 35.6 m -71.85 116.03 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.225 -0.657 . . . . 2.58 109.225 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.792 HG21 HG23 ' A' ' 57' ' ' ILE . 21.3 t -86.29 94.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.898 -175.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.9 m -64.93 116.66 6.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.112 -0.949 . . . . 0.66 111.585 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.869 ' HA ' ' HB ' ' A' ' 83' ' ' ILE . 57.6 mt -104.73 128.19 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.209 -0.45 . . . . 1.03 110.831 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.6 mtm -139.78 166.56 24.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.021 0.439 . . . . 1.04 111.096 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.59 -107.56 0.29 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.919 -0.872 . . . . 1.55 110.919 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -156.44 160.16 39.34 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.929 -0.397 . . . . 0.66 109.929 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.82 -56.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.68 0.252 . . . . 1.62 111.68 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -66.87 -15.14 63.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.435 0.532 . . . . 1.78 112.435 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.458 ' HE1' ' H ' ' A' ' 93' ' ' MET . 64.3 m170 -77.43 -2.52 35.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.653 0.739 . . . . 0.65 110.421 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.53 47.79 47.93 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 114.966 -1.015 . . . . 0.93 113.4 172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 22.8 pttp -70.89 -10.84 60.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.798 0.808 . . . . 2.11 109.481 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -81.31 -5.22 57.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.957 -1.019 . . . . 1.8 110.563 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.1 p -84.67 -32.56 23.55 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 120.801 -0.36 . . . . 1.77 110.821 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 25' ' ' LEU . 4.5 pp -69.66 -34.96 74.73 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 108.593 -0.891 . . . . 1.78 108.593 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.705 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -56.98 -38.84 73.58 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.484 -0.932 . . . . 1.96 108.484 175.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.41 -52.89 7.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 1.38 112.216 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . . . -67.73 -33.59 75.18 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.348 -0.387 . . . . 0.91 111.274 -171.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' A' ' 48' ' ' TYR . 96.2 mt -71.65 -29.7 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 1.56 110.314 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' A' ' 25' ' ' LEU . 75.2 mtm180 -66.42 -40.96 89.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.218 -0.66 . . . . 3.56 109.218 172.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -66.34 -12.6 57.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 2.88 110.606 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -2.51 58.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.84 -0.618 . . . . 1.76 110.199 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' O ' HG12 ' A' ' 33' ' ' VAL . 43.1 mttp 65.01 -161.17 0.28 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 115.518 -0.764 . . . . 5.71 111.386 172.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.092 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 57.33 17.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.952 0.901 . . . . 2.99 112.438 174.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.583 HG22 HG12 ' A' ' 50' ' ' VAL . 3.5 p -84.68 135.3 34.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.243 0.544 . . . . 3.93 112.197 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.04 -41.68 61.42 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.435 -0.802 . . . . 4.2 110.345 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.752 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 26.9 mt-30 -108.17 78.3 1.17 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.392 -0.822 . . . . 5.38 109.183 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 49.72 1.39 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.303 -0.862 . . . . 5.79 112.464 -172.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HA ' HD12 ' A' ' 41' ' ' ILE . . . -151.27 37.24 0.61 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.285 0.564 . . . . 4.24 110.516 177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.09 96.65 0.23 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.18 -0.918 . . . . 4.95 112.888 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.651 ' H ' ' HA2' ' A' ' 46' ' ' GLY . . . 87.01 15.34 62.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.265 -0.493 . . . . 6.66 113.003 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 38' ' ' ALA . 59.2 mt -90.89 -69.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 9.17 110.36 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.434 ' O ' HD12 ' A' ' 45' ' ' ILE . 48.2 m -94.49 143.52 26.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.817 -0.629 . . . . 7.36 109.482 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -80.39 65.54 5.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.417 0.627 . . . . 8.83 111.193 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -148.93 -43.54 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.998 -1.001 . . . . 6.76 108.351 175.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.643 HD12 ' H ' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -103.42 -168.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.659 -1.155 . . . . 5.19 109.464 173.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.651 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . 162.12 -42.94 0.37 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.121 -1.037 . . . . 2.97 112.025 -173.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.91 172.29 11.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.761 -0.829 . . . . 1.71 108.761 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.752 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -164.19 138.72 5.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.481 0.658 . . . . 2.54 111.893 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.615 ' HG2' HG23 ' A' ' 58' ' ' THR . 43.1 mt-30 -101.82 123.4 45.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.175 -0.921 . . . . 1.96 108.921 175.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 34' ' ' THR . 12.3 m -97.6 144.64 10.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.151 0.5 . . . . 1.93 111.954 -175.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.092 ' HB ' HG22 ' A' ' 33' ' ' VAL . 59.8 m -88.1 82.6 7.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.614 0.721 . . . . 2.06 110.363 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG12 HD11 ' A' ' 166' ' ' LEU . 45.5 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.072 -1.085 . . . . 4.12 108.072 173.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 t30 70.39 -52.45 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.279 0.987 . . . . 4.43 111.177 -171.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 51' ' ' THR . 19.8 t70 -126.72 -70.84 0.71 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.523 -0.762 . . . . 3.62 111.695 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.941 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 12.7 pttp 147.65 30.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.733 1.613 . . . . 7.44 108.121 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.771 ' HG2' ' HD2' ' A' ' 9' ' ' PRO . 12.1 ttmm -99.29 10.29 41.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.645 -1.161 . . . . 5.43 111.585 -167.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.792 HG23 HG21 ' A' ' 11' ' ' VAL . 58.4 mt -102.51 98.61 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 1.14 110.191 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 49' ' ' GLN . 14.2 m -86.69 111.1 20.36 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.913 -0.585 . . . . 1.28 110.103 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HE2' HG21 ' A' ' 50' ' ' VAL . 34.9 m-85 -93.39 130.13 39.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.715 0.293 . . . . 0.84 110.352 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pp -150.34 164.05 36.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 3.0 110.622 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -136.64 -94.61 0.23 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.845 -0.798 . . . . 6.48 108.845 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.5 m 51.85 80.33 0.3 Allowed Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.788 0.662 . . . . 5.57 112.788 170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.82 64.33 3.98 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.056 2.504 . . . . 5.77 111.99 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.36 -114.07 2.98 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.121 -0.561 . . . . 5.54 112.384 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -80.11 100.44 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.608 -0.145 . . . . 8.09 110.608 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.76 98.49 0.05 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.944 0.778 . . . . 6.36 110.106 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 68' ' ' PHE . . . -77.2 58.98 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.611 . . . . 3.51 111.194 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 103' ' ' ALA . 22.1 t80 172.76 155.57 0.09 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.184 -1.043 . . . . 2.61 108.184 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -60.3 110.59 1.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.848 0.356 . . . . 4.74 110.395 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -58.96 130.86 49.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 5.89 111.43 -176.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.0 mtt -81.86 24.58 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 5.64 112.422 -172.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -163.02 59.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.611 0.719 . . . . 9.71 110.429 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.09 24.32 9.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.53 -0.759 . . . . 7.52 109.967 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 69.13 -58.76 0.49 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.59 0.756 . . . . 10.42 111.385 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.18 -113.52 2.12 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.147 -0.781 . . . . 6.75 111.147 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.08 38.62 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.816 0.446 . . . . 6.69 111.002 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 9' ' ' PRO . 21.6 mt-30 71.79 92.78 0.08 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.963 0.79 . . . . 7.72 111.474 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.85 -18.1 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.876 0.846 . . . . 4.38 109.076 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -109.2 96.85 6.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.834 -1.075 . . . . 4.18 109.212 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -117.56 -175.47 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.863 -0.608 . . . . 3.12 110.353 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 11' ' ' VAL . 8.5 mm -140.36 119.15 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.026 -0.534 . . . . 0.74 110.321 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 ' HB1' ' A' ' 103' ' ' ALA . 40.5 t -99.51 96.24 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.107 -0.637 . . . . 1.19 111.283 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.869 ' HB ' ' HA ' ' A' ' 13' ' ' ILE . 17.3 mm -74.29 117.41 18.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.198 -1.038 . . . . 1.32 108.198 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 2.6 tm? -110.65 96.03 5.93 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.784 -0.643 . . . . 1.33 110.245 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 49.4 t -84.9 130.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.213 0.53 . . . . 1.2 111.388 -177.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.799 HG12 HG21 ' A' ' 96' ' ' THR . 28.0 m -128.4 -164.5 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.511 -0.922 . . . . 1.12 108.511 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.8 149.56 40.53 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.116 -0.634 . . . . 0.75 111.965 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 117' ' ' MET . . . -31.94 -64.68 0.16 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 124.93 1.394 . . . . 1.18 113.922 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.71 -20.13 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.864 -0.607 . . . . 2.01 112.356 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.36 -37.0 15.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.362 -0.535 . . . . 1.09 111.598 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.59 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 82.87 -144.35 22.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.528 -0.844 . . . . 0.52 111.783 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.742 HG23 ' HB ' ' A' ' 96' ' ' THR . 2.8 p -100.85 102.57 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 109.279 -0.637 . . . . 1.08 109.279 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.603 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 2.5 ppp? -83.49 169.54 17.08 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.57 -0.53 . . . . 1.32 109.57 -175.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 93' ' ' MET . 29.0 Cg_exo -30.42 -56.17 0.2 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 124.092 3.195 . . . . 0.61 115.1 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -69.98 -34.68 73.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.533 0.206 . . . . 1.47 111.016 -175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.65 -31.48 72.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.649 0.738 . . . . 0.46 109.931 176.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.548 HG23 HG22 ' A' ' 92' ' ' VAL . 72.5 t -78.79 -45.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.354 -0.839 . . . . 1.05 111.055 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.6 mt-10 -63.94 -19.06 64.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.075 0.464 . . . . 1.62 111.086 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.79 -41.04 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.646 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.581 ' CD1' ' HG ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.21 -47.61 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.38 110.79 176.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 101' ' ' ASN . 1.1 t-20 -49.24 -34.78 15.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.926 0.491 . . . . 1.85 110.735 173.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -85.69 -31.93 22.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.66 -0.7 . . . . 0.85 111.02 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -82.83 -44.78 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.925 0.343 . . . . 0.48 111.925 -173.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -54.59 -30.75 55.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.654 . . . . 2.56 112.759 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.32 3.37 15.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.973 0.731 . . . . 0.76 112.973 -167.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.45 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -91.39 -2.3 57.35 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.721 -0.844 . . . . 0.9 108.721 173.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.494 ' HA ' HD22 ' A' ' 107' ' ' ASN . 1.2 t-20 72.22 46.14 0.34 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.986 -1.461 . . . . 2.06 107.534 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -121.24 144.58 40.07 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 112.663 -2.062 . . . . 1.08 110.942 -170.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 108' ' ' VAL . 18.0 Cg_exo -67.45 154.47 73.67 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.681 2.254 . . . . 0.51 114.264 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.661 HG22 HG23 ' A' ' 145' ' ' THR . 1.2 mp -122.57 142.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.746 -1.57 . . . . 0.96 109.645 -176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.682 HD13 HD13 ' A' ' 83' ' ' ILE . 2.7 mp -121.23 99.96 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 CA-C-O 121.272 0.558 . . . . 0.71 111.292 -176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -68.56 137.12 25.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.361 -0.836 . . . . 0.23 110.613 179.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . . . -122.52 89.48 3.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.966 -1.124 . . . . 0.25 107.966 173.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.812 ' HB ' ' HA ' ' A' ' 149' ' ' LYS . 6.6 mm -65.22 85.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.595 -1.184 . . . . 0.85 109.745 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -95.75 168.36 10.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.69 110.128 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 45.4 tttm 69.46 12.92 8.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.333 0.587 . . . . 2.61 110.206 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -95.54 41.09 1.1 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.424 0.63 . . . . 1.37 110.642 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.48 57.29 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.633 -1.167 . . . . 2.45 110.798 170.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.831 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 63.8 mttp -154.44 -172.91 0.34 Allowed Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 105.48 -2.045 . . . . 3.7 105.48 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.831 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.8 Cg_endo -55.59 -54.41 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 120.524 1.223 . . . . 2.67 110.705 168.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.546 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 6.2 pt-20 164.71 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.456 1.102 . . . . 4.03 108.346 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -53.4 -69.58 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 1.47 110.325 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -173.52 75.44 0.39 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 1.84 110.781 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.65 ' O ' ' HG3' ' A' ' 128' ' ' MET . 6.2 Cg_exo -38.98 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.051 3.168 . . . . 0.7 114.094 171.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -45.48 -49.02 13.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.859 0.688 . . . . 2.0 112.859 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -50.68 -57.06 9.17 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.496 0.665 . . . . 2.99 109.872 175.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.59 HG13 ' HA2' ' A' ' 91' ' ' GLY . 74.3 t -58.5 -45.51 90.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.389 -1.278 . . . . 0.4 110.514 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.676 ' HG2' ' CD2' ' A' ' 147' ' ' PHE . 84.0 mtp -62.74 -29.05 70.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.3 111.376 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -78.32 -24.31 46.67 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.513 -0.312 . . . . 1.28 110.773 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 6.2 mt-10 -72.61 -32.82 66.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.793 -0.817 . . . . 2.02 108.793 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -70.15 -44.67 68.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 120.048 -0.661 . . . . 1.06 109.569 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.875 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -76.95 -0.49 24.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.35 110.006 177.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 8.0 tp10 -77.5 -31.84 53.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.288 -1.375 . . . . 2.18 107.288 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -95.35 17.51 14.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.146 -0.933 . . . . 0.74 109.696 172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.9 34.27 4.32 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.054 -1.43 . . . . 1.94 110.333 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -106.96 87.09 2.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.09 1.424 . . . . 1.68 109.0 173.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.842 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 93.3 t -83.91 119.74 73.93 Favored Pre-proline 0 C--N 1.285 -2.21 0 CA-C-N 111.559 -2.564 . . . . 0.61 111.334 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.84 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 82.3 Cg_exo -47.74 157.97 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.791 2.994 . . . . 0.3 113.963 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 144' ' ' ASP . 6.8 mm-40 -74.33 -24.69 59.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.13 -1.395 . . . . 2.01 109.183 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.836 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -56.86 -40.65 76.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.286 -0.87 . . . . 1.14 109.045 169.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.875 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.6 m0 -96.04 -21.24 18.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.858 -1.065 . . . . 0.45 111.089 -169.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 106.36 30.16 4.51 Favored Glycine 0 CA--C 1.501 -0.786 0 C-N-CA 119.762 -1.209 . . . . 0.45 112.011 170.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.842 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -96.93 -109.48 2.64 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.377 -0.916 . . . . 0.5 111.48 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.485 ' HA ' ' OE1' ' A' ' 139' ' ' GLU . 9.0 p-10 -166.42 46.36 0.07 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.623 1.201 . . . . 1.3 109.591 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 110' ' ' ILE . 21.4 m -132.02 110.37 10.68 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.286 -1.325 . . . . 0.32 111.377 -178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 146' ' ' ILE . 3.9 mp -81.73 107.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.092 -0.958 . . . . 1.23 110.422 -175.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.84 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 22.6 m-85 -89.76 96.59 10.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.5 . . . . 0.38 111.33 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 150' ' ' LEU . 68.8 m -88.02 99.22 12.0 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.759 -0.655 . . . . 1.1 110.161 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.812 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 17.8 ptmt -76.35 83.97 3.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.872 -0.788 . . . . 2.44 108.872 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.488 ' HA ' ' HA3' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -113.5 -178.95 3.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.585 0.707 . . . . 1.27 112.23 -170.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.8 m -165.77 130.1 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.036 -0.983 . . . . 1.79 110.792 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 27' ' ' ALA . . . -84.47 -9.65 58.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.32 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 153' ' ' LYS . 5.3 tppp? -78.34 -58.69 3.12 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.295 -0.866 . . . . 3.03 109.342 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.711 ' HB ' ' HG2' ' A' ' 156' ' ' GLU . 22.1 p -73.99 -22.53 59.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.619 -1.173 . . . . 1.2 110.783 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.1 tptp 72.61 -2.64 2.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.092 -0.958 . . . . 2.27 110.981 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.711 ' HG2' ' HB ' ' A' ' 154' ' ' THR . 22.1 mm-40 -59.15 -73.33 0.08 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.459 0.647 . . . . 2.64 112.022 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 160' ' ' HIS . . . -67.69 -9.1 55.06 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.235 -0.893 . . . . 0.62 113.454 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 28' ' ' ILE . 2.6 tm? -64.27 -51.22 64.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.513 -0.551 . . . . 1.55 109.513 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.71 -36.51 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 2.5 109.938 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.576 ' HB3' ' HA2' ' A' ' 157' ' ' GLY . 80.1 t60 -58.75 -37.71 76.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.258 -0.883 . . . . 0.73 110.478 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.79 -49.49 77.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.921 -0.581 . . . . 0.91 110.634 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.26 -38.53 77.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 1.06 110.769 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.5 -42.99 91.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 2.49 110.499 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -39.0 92.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.87 110.621 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.23 -48.8 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.985 -0.552 . . . . 0.64 110.213 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.794 HD11 HG12 ' A' ' 52' ' ' VAL . 94.4 mt -62.84 -46.98 85.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.854 -0.612 . . . . 1.81 111.034 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.0 tp -48.8 -49.29 39.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.393 -0.821 . . . . 1.42 110.86 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 45.9 t -68.85 -44.96 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.032 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 m -58.38 -35.04 71.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.046 0.45 . . . . 1.54 111.117 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -83.94 -31.62 25.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 2.79 110.463 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 50.0 ttp -71.57 -43.4 66.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 1.82 111.307 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 168' ' ' VAL . 21.9 mm-40 -54.39 -24.89 21.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.113 0.782 . . . . 3.45 113.113 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.71 -30.39 70.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.301 0.572 . . . . 3.36 109.746 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.2 mt -106.57 -70.21 0.8 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.548 -0.751 . . . . 4.14 109.317 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 44.5 tttp 63.1 104.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.937 -1.029 . . . . 6.31 111.995 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -134.06 -58.17 0.85 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.614 -0.721 . . . . 4.57 109.989 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -161.89 137.5 5.69 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.467 -0.568 . . . . 6.38 109.467 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.208 2.606 . . . . 7.47 112.376 175.508 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.912 -0.475 . . . . 16.35 111.912 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -92.71 -4.91 52.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.004 0.431 . . . . 14.69 110.697 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -77.11 77.1 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.98 -0.555 . . . . 14.68 110.879 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.0 mtm -106.82 122.67 46.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.67 . . . . 12.73 110.015 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 m -86.03 32.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 10.18 111.428 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 13.8 mm-40 -69.83 -42.78 73.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.779 -0.646 . . . . 9.14 111.243 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 6' ' ' GLU . 15.0 mmm180 67.73 104.71 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 121.271 0.558 . . . . 8.35 111.286 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -87.13 116.77 1.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.837 2.358 . . . . 4.6 111.712 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 61' ' ' ASP . 76.3 Cg_exo -50.69 123.34 11.32 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.93 2.42 . . . . 4.29 111.993 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.788 HG11 ' HA ' ' A' ' 57' ' ' ILE . 43.0 t -93.57 -72.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.125 -0.488 . . . . 2.58 110.802 -177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.697 HG22 ' HB ' ' A' ' 81' ' ' ILE . 47.5 t -125.04 107.06 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 120.968 0.413 . . . . 1.0 111.028 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -98.12 132.53 43.57 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.157 0.503 . . . . 0.66 110.413 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.582 ' HB ' HD21 ' A' ' 60' ' ' LEU . 66.1 mt -94.87 127.51 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.708 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HB1' ' A' ' 99' ' ' ALA . 54.8 mtt -127.48 173.12 10.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.726 -0.67 . . . . 1.04 110.922 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.11 -104.92 0.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.908 -0.877 . . . . 1.55 110.908 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' CD2' ' H ' ' A' ' 18' ' ' ASP . 81.6 t60 -166.55 143.34 4.88 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.261 -0.644 . . . . 0.66 109.261 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.42 -24.47 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.2 1.185 . . . . 1.62 114.2 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 21.1 m-20 -88.3 -11.83 45.3 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.561 0.578 . . . . 1.78 112.561 -173.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -77.6 -3.6 41.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.162 0.43 . . . . 0.65 112.162 -174.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.58 64.63 0.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.656 -0.783 . . . . 0.93 112.763 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -87.08 -34.69 19.06 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 2.11 110.871 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.3 t -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.628 -0.26 . . . . 1.8 110.472 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.4 p -78.54 -32.07 47.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.954 0.407 . . . . 1.77 110.635 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -54.45 13.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.851 -0.796 . . . . 1.78 108.851 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -59.1 -33.9 71.38 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.099 -0.955 . . . . 1.96 110.724 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.88 -55.83 6.81 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.035 -0.416 . . . . 1.38 111.398 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . -59.71 -39.61 85.22 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.91 110.898 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 48' ' ' TYR . 10.8 tt -65.96 -28.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.504 -0.771 . . . . 1.56 111.252 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.781 ' HA ' HG21 ' A' ' 34' ' ' THR . 85.4 mtm180 -77.25 -26.59 52.71 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.595 0.712 . . . . 3.56 109.463 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -85.58 15.21 4.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.829 -1.078 . . . . 2.88 110.091 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 3.8 m -100.14 22.97 10.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.65 -0.704 . . . . 1.76 111.736 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 71.78 -48.13 0.67 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.181 1.178 . . . . 5.71 114.181 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' CG2' HG13 ' A' ' 50' ' ' VAL . 29.2 m -71.95 6.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.473 0.916 . . . . 2.99 113.473 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.781 HG21 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -81.71 124.26 29.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.195 0.521 . . . . 3.93 111.623 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.541 ' OE1' ' HD3' ' A' ' 55' ' ' LYS . 37.3 mt-10 -72.38 -73.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 4.2 111.701 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -144.38 176.78 9.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.429 -0.805 . . . . 5.38 109.767 -173.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.831 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.6 mt-10 -124.95 100.67 6.7 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.427 0.454 . . . . 5.79 111.736 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.36 129.94 11.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.021 -0.536 . . . . 4.24 110.878 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . 105.51 -129.78 9.94 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.108 -0.567 . . . . 4.95 112.037 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . 72.5 165.2 8.15 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.516 0.566 . . . . 6.66 114.516 170.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 63' ' ' PRO . 40.1 pt -97.87 -25.8 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.007 0.432 . . . . 9.17 110.823 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.4 p -77.69 114.72 16.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.595 . . . . 7.36 110.712 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -78.11 24.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.01 0.434 . . . . 8.83 111.787 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -90.31 -20.39 22.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.481 -0.562 . . . . 6.76 109.481 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.934 HG13 ' H ' ' A' ' 46' ' ' GLY . 10.2 tp -174.76 -162.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.262 -1.014 . . . . 5.19 108.262 -175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.934 ' H ' HG13 ' A' ' 45' ' ' ILE . . . -90.94 -119.74 2.24 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.224 -0.989 . . . . 2.97 112.629 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.831 ' O ' ' HA ' ' A' ' 37' ' ' GLU . . . -135.4 -169.3 2.36 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.456 -0.942 . . . . 1.71 108.456 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.62 ' OH ' HD13 ' A' ' 28' ' ' ILE . 7.2 p90 -153.0 137.56 16.82 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.133 0.492 . . . . 2.54 111.156 -174.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.813 ' HG2' HG23 ' A' ' 58' ' ' THR . 18.0 mt-30 -109.44 134.09 52.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.581 -0.736 . . . . 1.96 109.284 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 90.3 t -88.62 150.26 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 CA-C-O 121.649 0.738 . . . . 1.93 110.609 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 m -92.63 83.8 4.94 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.606 -1.179 . . . . 2.06 110.588 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG13 ' HB2' ' A' ' 56' ' ' LYS . 3.3 p -125.31 120.3 57.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.38 -1.341 . . . . 4.12 107.38 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 22.0 t-20 73.73 -43.28 0.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.213 0.945 . . . . 4.43 108.889 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 52' ' ' VAL . 16.5 t70 178.18 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.681 -1.599 . . . . 3.62 108.712 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 3.1 pttm -176.98 57.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.049 -0.978 . . . . 7.44 110.501 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.746 ' HB2' HG13 ' A' ' 52' ' ' VAL . 12.9 mmmm -73.95 -43.69 57.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 5.43 111.483 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 ' HA ' HG11 ' A' ' 10' ' ' VAL . 59.5 mt -87.02 112.38 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.524 -0.47 . . . . 1.14 111.179 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.813 HG23 ' HG2' ' A' ' 49' ' ' GLN . 18.9 m -104.3 127.99 52.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 1.28 108.977 171.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 42.7 m-85 -97.28 127.01 42.86 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.976 -0.29 . . . . 0.84 110.92 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.582 HD21 ' HB ' ' A' ' 13' ' ' ILE . 95.0 mt 67.68 59.73 0.47 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.969 0.793 . . . . 3.0 111.285 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 9' ' ' PRO . 4.2 m-20 -66.58 -24.78 66.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.814 -0.63 . . . . 6.48 110.806 176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.5 p -121.04 136.89 26.0 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.921 -0.581 . . . . 5.57 110.563 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.613 ' HA ' HG22 ' A' ' 41' ' ' ILE . 66.0 Cg_endo -75.94 55.41 4.43 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.735 2.29 . . . . 5.77 111.537 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.86 88.23 1.16 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.504 -0.771 . . . . 5.54 113.331 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -80.12 -33.32 38.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.106 -1.072 . . . . 8.09 108.106 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -94.89 46.3 1.13 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.614 -1.176 . . . . 6.36 108.907 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 73.87 -75.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.972 -1.013 . . . . 3.51 111.604 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.687 ' HB2' ' CD2' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -130.68 127.32 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.702 0.287 . . . . 2.61 110.915 -177.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.71 -31.8 61.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 4.74 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.681 HG22 ' H ' ' A' ' 71' ' ' MET . 1.5 m -114.16 -178.04 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.526 -0.761 . . . . 5.89 109.626 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.681 ' H ' HG22 ' A' ' 70' ' ' THR . 72.4 mtm 59.29 54.07 4.97 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.632 0.73 . . . . 5.64 111.251 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -103.45 -42.17 5.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.108 -0.951 . . . . 9.71 109.087 174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.25 34.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.736 -1.12 . . . . 7.52 109.058 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 71' ' ' MET . 26.7 ttt180 -165.79 133.59 2.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.237 -0.892 . . . . 10.42 109.654 -172.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.76 140.95 7.16 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.937 -0.649 . . . . 6.75 111.505 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.4 -65.72 0.29 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 6.69 110.968 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -87.87 76.02 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.504 0.668 . . . . 7.72 110.116 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.04 101.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.431 -0.804 . . . . 4.38 109.959 176.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 p -87.06 71.83 10.14 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.797 -0.638 . . . . 4.18 111.042 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.51 134.58 49.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 3.12 109.774 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.697 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.6 mm -83.78 103.21 10.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.911 -0.586 . . . . 0.74 109.716 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' HB1' ' A' ' 103' ' ' ALA . 86.7 t -82.18 94.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 120.376 -0.53 . . . . 1.19 110.714 -174.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.609 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 10.0 mm -80.66 97.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.369 -0.604 . . . . 1.32 109.369 177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 112' ' ' VAL . 3.1 tm? -87.71 96.26 10.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.005 -0.739 . . . . 1.33 109.005 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . 55.2 t -81.71 137.98 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.428 0.632 . . . . 1.2 111.266 -176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 114' ' ' ILE . 27.2 m -132.84 -168.19 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 1.12 108.547 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.26 20.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.371 -0.603 . . . . 0.75 109.371 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 114' ' ' ILE . . . -58.64 -19.94 43.42 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.421 -0.809 . . . . 1.18 112.437 -172.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.75 -12.48 33.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.515 0.191 . . . . 2.01 111.515 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' OD2' ' HG2' ' A' ' 93' ' ' MET . 28.5 t70 -119.43 -49.65 2.36 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.375 0.607 . . . . 1.09 110.94 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 127' ' ' VAL . . . 100.49 -124.67 8.32 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.18 -0.918 . . . . 0.52 111.239 -174.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.017 HG11 ' HE2' ' A' ' 134' ' ' TYR . 38.1 t -111.82 113.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.957 0.408 . . . . 1.08 111.029 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.563 ' HG2' ' OD2' ' A' ' 90' ' ' ASP . 77.2 mmm -80.33 168.12 28.06 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 109.557 -0.535 . . . . 1.32 109.557 172.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 93' ' ' MET . 6.3 Cg_endo -49.64 -42.83 41.87 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.393 2.062 . . . . 0.61 112.885 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.76 -26.86 62.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.659 0.266 . . . . 1.47 110.609 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.823 ' HB ' HG13 ' A' ' 92' ' ' VAL . 18.6 m -60.79 -35.77 77.31 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.128 -0.487 . . . . 0.46 110.483 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.584 HG12 ' CG1' ' A' ' 92' ' ' VAL . 2.0 m -84.15 -35.59 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.518 -0.31 . . . . 1.05 110.81 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.53 -39.95 89.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.945 0.402 . . . . 1.62 111.474 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.695 ' HB1' ' SD ' ' A' ' 14' ' ' MET . . . -66.82 -45.09 79.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.984 -0.553 . . . . 0.34 110.137 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.643 HG23 ' HD3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER -64.27 -42.65 96.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.522 -0.763 . . . . 0.38 111.216 177.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -62.81 -30.73 71.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 123.509 0.723 . . . . 1.85 109.814 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.687 ' CD2' ' HB2' ' A' ' 68' ' ' PHE . 8.8 t60 -83.96 -32.54 24.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.336 -0.847 . . . . 0.85 110.333 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -87.11 -48.78 7.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.334 0.494 . . . . 0.48 112.334 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.643 ' HD3' HG23 ' A' ' 100' ' ' ILE . 14.0 pttp -63.74 -16.4 61.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.526 0.565 . . . . 2.56 112.526 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.31 6.74 21.8 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.855 0.317 . . . . 0.76 111.855 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.542 ' HB3' HG12 ' A' ' 108' ' ' VAL . . . -98.21 2.14 48.06 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.803 -0.444 . . . . 0.9 109.803 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 77.92 31.87 0.4 Allowed 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 122.742 1.258 . . . . 2.06 108.569 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.589 HG21 HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -109.48 147.63 36.45 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 113.206 -1.815 . . . . 1.08 110.523 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.458 ' HD2' HG23 ' A' ' 108' ' ' VAL . 4.9 Cg_exo -73.38 151.42 48.17 Favored 'Trans proline' 0 C--O 1.245 0.844 0 C-N-CA 122.569 2.179 . . . . 0.51 113.547 172.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.628 HG22 HG23 ' A' ' 145' ' ' THR . 1.1 mp -118.82 142.59 33.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.225 -1.352 . . . . 0.96 110.212 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 mp -112.17 148.24 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.248 0 N-CA-C 107.933 -1.136 . . . . 0.71 107.933 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -112.84 138.01 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 109.364 -0.606 . . . . 0.23 109.364 172.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 150' ' ' LEU . . . -118.95 88.17 2.88 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.758 -1.201 . . . . 0.25 107.758 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.786 HD11 ' HD2' ' A' ' 147' ' ' PHE . 21.1 mt -73.79 83.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.754 -1.112 . . . . 0.85 109.507 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -89.09 164.63 14.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.934 -0.575 . . . . 0.69 110.105 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 66.97 34.1 5.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.04 -0.527 . . . . 2.61 112.131 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 149' ' ' LYS . 4.3 ptp -88.22 13.19 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 1.37 109.792 169.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -24.37 67.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.676 -1.147 . . . . 2.45 108.904 165.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.883 ' HB3' ' HD2' ' A' ' 120' ' ' PRO . 14.7 mmmm -77.92 -178.76 1.09 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 114.902 -1.044 . . . . 3.7 109.343 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 119' ' ' LYS . 9.8 Cg_endo -52.85 -21.35 15.1 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.315 2.01 . . . . 2.67 113.629 177.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 7.3 pt-20 64.11 123.34 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.765 1.626 . . . . 4.03 110.955 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 88' ' ' ALA . . . -79.28 11.78 2.72 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.123 -1.399 . . . . 1.47 110.958 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 122' ' ' ALA . 43.5 t30 77.6 108.87 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 114.74 -1.118 . . . . 1.84 112.092 171.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.628 ' O ' ' HG3' ' A' ' 128' ' ' MET . 38.4 Cg_exo -36.72 -60.78 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 124.572 3.515 . . . . 0.7 115.198 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -42.72 -41.85 3.31 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.6 0.76 . . . . 2.0 113.014 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -58.87 -54.07 51.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.701 0.762 . . . . 2.99 109.387 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.721 ' HA ' ' OE2' ' A' ' 130' ' ' GLU . 58.4 t -60.06 -39.38 80.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.338 -1.301 . . . . 0.4 110.083 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.679 ' HG2' ' CE2' ' A' ' 147' ' ' PHE . 86.3 mtp -65.64 -30.62 71.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.253 -0.885 . . . . 0.3 111.114 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -79.33 -15.45 57.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.543 -0.463 . . . . 1.28 110.898 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.721 ' OE2' ' HA ' ' A' ' 127' ' ' VAL . 12.9 mt-10 -72.3 -37.12 69.05 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.656 -0.868 . . . . 2.02 108.656 170.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.576 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . 3.8 mm? -69.95 -45.17 68.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.45 0.643 . . . . 1.06 110.087 -178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.905 ' HG2' ' HZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -75.79 -5.52 46.24 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.309 -0.859 . . . . 0.35 109.645 177.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 14.4 tp10 -74.02 -32.37 63.34 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.785 -1.191 . . . . 2.18 107.785 171.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 1.017 ' HE2' HG11 ' A' ' 92' ' ' VAL . 30.2 m-85 -90.0 10.13 25.28 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.68 0.753 . . . . 0.74 109.1 173.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 71.95 38.73 0.89 Allowed 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 113.898 -1.501 . . . . 1.94 110.565 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.457 ' HB3' ' OG1' ' A' ' 145' ' ' THR . 5.2 mp -117.28 84.11 2.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.444 1.116 . . . . 1.68 108.679 172.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.977 ' HB ' ' HA3' ' A' ' 143' ' ' GLY . 92.2 t -69.67 127.31 92.7 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 113.022 -1.899 . . . . 0.61 112.139 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.839 ' HG3' ' CE1' ' A' ' 147' ' ' PHE . 81.3 Cg_exo -47.14 160.24 0.31 Allowed 'Trans proline' 0 CA--C 1.518 -0.296 0 C-N-CA 124.109 3.206 . . . . 0.3 114.441 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -85.26 -5.87 59.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.336 -1.302 . . . . 2.01 110.11 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.858 ' HB2' ' CD1' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -74.13 -32.79 63.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.452 -1.314 . . . . 1.14 107.452 167.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.905 ' HZ3' ' HG2' ' A' ' 132' ' ' MET . 8.4 m0 -101.3 -26.27 13.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.191 -1.368 . . . . 0.45 111.286 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 110.5 30.8 3.19 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.845 -1.169 . . . . 0.45 112.315 172.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.977 ' HA3' ' HB ' ' A' ' 137' ' ' VAL . . . -95.87 -102.53 1.95 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 120.486 -0.864 . . . . 0.5 111.609 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -169.6 37.29 0.02 OUTLIER 'General case' 0 C--O 1.247 0.922 0 CA-C-O 122.168 0.985 . . . . 1.3 110.594 172.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.628 HG23 HG22 ' A' ' 110' ' ' ILE . 18.9 m -127.47 113.84 16.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.909 -1.041 . . . . 0.32 111.49 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 164' ' ' MET . 3.7 mp -82.72 108.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.587 -0.733 . . . . 1.23 110.555 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.839 ' CE1' ' HG3' ' A' ' 138' ' ' PRO . 17.7 m-85 -91.33 111.75 23.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.701 0.286 . . . . 0.38 111.752 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.403 ' O ' HD23 ' A' ' 150' ' ' LEU . 16.0 t -102.11 117.24 34.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.804 -0.813 . . . . 1.1 108.804 174.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.696 ' HA ' ' HB ' ' A' ' 114' ' ' ILE . 20.4 pttm -93.34 101.49 13.73 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.129 -0.693 . . . . 2.44 109.129 175.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.719 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . 0.6 OUTLIER -130.12 176.91 7.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.244 1.021 . . . . 1.27 113.567 -168.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.9 m -147.45 117.27 7.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.6 -1.636 . . . . 1.79 109.101 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.63 66.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.445 0.535 . . . . 0.87 112.445 -174.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.71 ' HG3' ' H ' ' A' ' 154' ' ' THR . 15.0 ptpt -73.95 -56.08 5.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.77 0.795 . . . . 3.03 110.12 -177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.71 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 10.3 p -72.77 -12.45 61.01 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.16 -1.382 . . . . 1.2 112.098 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HD2' HD12 ' A' ' 158' ' ' LEU . 3.0 tptm 71.72 2.75 4.41 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.061 0.544 . . . . 2.27 111.779 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.94 -72.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.714 0.768 . . . . 2.64 111.423 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.719 ' HA3' ' CB ' ' A' ' 150' ' ' LEU . . . -69.36 -9.3 60.85 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 115.155 -0.93 . . . . 0.62 113.623 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.684 HD12 ' HD2' ' A' ' 155' ' ' LYS . 31.2 mt -70.12 -42.69 72.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.365 0.582 . . . . 1.55 110.256 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.57 -44.86 92.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 2.5 109.569 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -67.39 -24.63 65.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.687 -0.688 . . . . 0.73 111.361 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.28 -50.02 65.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.551 -0.295 . . . . 0.91 110.289 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -55.7 -36.75 67.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.007 -0.542 . . . . 1.06 110.459 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.16 -51.6 69.31 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.032 0.444 . . . . 2.49 110.526 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.733 ' HB3' HG21 ' A' ' 146' ' ' ILE . 16.2 mmt -65.5 -40.84 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.612 -0.722 . . . . 0.87 110.799 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.92 -53.18 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.709 -0.678 . . . . 0.64 110.314 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.21 -43.94 95.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.792 -0.64 . . . . 1.81 111.44 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 171' ' ' MET . 62.4 tp -54.01 -47.8 71.1 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.043 -0.526 . . . . 1.42 110.196 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.503 ' HA ' ' HB3' ' A' ' 171' ' ' MET . 48.0 t -73.0 -23.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.07 -0.513 . . . . 1.17 111.317 -177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.7 t -60.14 -32.11 70.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.068 0.461 . . . . 1.54 110.13 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -99.25 -27.8 13.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.017 0.437 . . . . 2.79 110.593 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.503 ' HB3' ' HA ' ' A' ' 168' ' ' VAL . 13.5 ttp -82.45 5.67 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 1.82 111.432 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -40.97 -31.61 0.18 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.031 0.443 . . . . 3.45 111.235 172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -57.84 -8.9 1.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.637 -0.71 . . . . 3.36 112.367 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.7 tp -46.89 -49.97 19.49 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.177 0.513 . . . . 4.14 110.797 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -145.99 0.5 0.84 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.815 -0.629 . . . . 6.31 111.555 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.77 11.45 35.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.215 0.531 . . . . 4.57 110.217 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 27.2 t-20 -88.64 131.97 40.16 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.72 -0.673 . . . . 6.38 109.373 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 177' ' ' ASN . 16.6 Cg_exo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.793 2.328 . . . . 7.47 112.108 -179.731 . . . . . . . . 1 1 . 1 stop_ save_